<?xml version="1.0" ?>
<document id="original_train">
  <sentence id="s0" text="These findings underscore the specificity of protective effects observed here in models of Parkinson's disease, and previously in Huntington's disease, and support the development of negative regulation of transcription by RNA polymerase II inhibitors as potential therapeutics for the two neurodegenerative diseases.">
    <entity charOffset="183-240" id="s0.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="290-316" id="s0.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s0.e0" e2="s0.e1" id="s0.p0" relation="false"/>
  </sentence>
  <sentence id="s1" text="The interaction required the tumor necrosis factor receptor-associated factor domain of USP7 and the central region of transcription-coupled nucleotide-excision repair and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA.">
    <entity charOffset="29-34" id="s1.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="119-167" id="s1.e1" ontology_id="GO_0006283" text="transcription-coupled nucleotide-excision repair" type="GO"/>
    <pair e1="s1.e0" e2="s1.e1" id="s1.p0" relation="false"/>
  </sentence>
  <sentence id="s2" text="In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different muscle organ developments of dementia, in addition to the detection of C9orf72 repeat expansions.">
    <entity charOffset="66-79" id="s2.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="284-308" id="s2.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2.e0" e2="s2.e1" id="s2.p0" relation="false"/>
  </sentence>
  <sentence id="s3" text="A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. double-strand break repair via homologous recombination, mitotic cytokinesis) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. mitochondrial translational elongation, RAD51C/D, DNA repair); and multiple common but low penetrance susceptibility alleles identified by GWAS.">
    <entity charOffset="225-280" id="s3.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="359-365" id="s3.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3.e0" e2="s3.e1" id="s3.p0" relation="true"/>
  </sentence>
  <sentence id="s4" text="A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. double-strand break repair via homologous recombination, mitotic cytokinesis) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. mitochondrial translational elongation, RAD51C/D, DNA repair); and multiple common but low penetrance susceptibility alleles identified by GWAS.">
    <entity charOffset="282-301" id="s4.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="359-365" id="s4.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4.e0" e2="s4.e1" id="s4.p0" relation="true"/>
  </sentence>
  <sentence id="s5" text="A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. double-strand break repair via homologous recombination, mitotic cytokinesis) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. mitochondrial translational elongation, RAD51C/D, DNA repair); and multiple common but low penetrance susceptibility alleles identified by GWAS.">
    <entity charOffset="359-365" id="s5.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="425-463" id="s5.e1" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <pair e1="s5.e0" e2="s5.e1" id="s5.p0" relation="false"/>
  </sentence>
  <sentence id="s6" text="A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. double-strand break repair via homologous recombination, mitotic cytokinesis) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. mitochondrial translational elongation, RAD51C/D, DNA repair); and multiple common but low penetrance susceptibility alleles identified by GWAS.">
    <entity charOffset="359-365" id="s6.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="475-485" id="s6.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s6.e0" e2="s6.e1" id="s6.p0" relation="true"/>
  </sentence>
  <sentence id="s7" text="Among the proteins enriched in LO, cytokeratin 18 (CK18) was one of the most abundant (within the top 5th percentile) and was used to develop an assay to detect LO in the circulation and tissues of epidermis development and patients with prostate cancer.">
    <entity charOffset="198-219" id="s7.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="247-253" id="s7.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s7.e0" e2="s7.e1" id="s7.p0" relation="false"/>
  </sentence>
  <sentence id="s8" text="These observations indicate that LO represent a discrete EV muscle organ development that may play a distinct role in tumor progression and that may be a source of cancer-specific markers">
    <entity charOffset="60-84" id="s8.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="164-170" id="s8.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s8.e0" e2="s8.e1" id="s8.p0" relation="false"/>
  </sentence>
  <sentence id="s9" text="These observations indicate that LO represent a discrete EV muscle organ development that may play a distinct role in tumor progression and that may be a source of cancer-specific markers">
    <entity charOffset="60-84" id="s9.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="118-123" id="s9.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s9.e0" e2="s9.e1" id="s9.p0" relation="false"/>
  </sentence>
  <sentence id="s10" text="Germline nucleosome disassembly mutations have been described in hereditary forms of this disease and more recently in small syndromic and sporadic CCM series.">
    <entity charOffset="9-31" id="s10.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="139-147" id="s10.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s10.e0" e2="s10.e1" id="s10.p0" relation="false"/>
  </sentence>
  <sentence id="s11" text="The diagnostic value of nucleosome disassembly in distinguishing between CCM and other meningioma variants has not been yet established.">
    <entity charOffset="24-46" id="s11.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="87-97" id="s11.e1" ontology_id="HP_0002858" text="meningioma" type="HP"/>
    <pair e1="s11.e0" e2="s11.e1" id="s11.p0" relation="false"/>
  </sentence>
  <sentence id="s12" text="Nuclear respiratory factor 1 (transcription by RNA polymerase II) transcription factor has recently been shown to control breast cancer progression.">
    <entity charOffset="30-64" id="s12.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="129-135" id="s12.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s12.e0" e2="s12.e1" id="s12.p0" relation="false"/>
  </sentence>
  <sentence id="s13" text="However, mechanistic aspects by which transcription by RNA polymerase II may contribute to susceptibility to different breast tumor subtypes are still not fully understood.">
    <entity charOffset="38-72" id="s13.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="126-131" id="s13.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s13.e0" e2="s13.e1" id="s13.p0" relation="false"/>
  </sentence>
  <sentence id="s14" text="Since transcriptional control of transcription by RNA polymerase II seems to be dependent on epidermal growth factor receptor signaling, herein, we investigated the role of NRF1 in estrogen receptor/progesterone receptor negative, but human epidermal growth factor receptor 2-positive (ER/PR -ve signal transduction +ve) breast cancer.">
    <entity charOffset="33-67" id="s14.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="328-334" id="s14.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s14.e0" e2="s14.e1" id="s14.p0" relation="false"/>
  </sentence>
  <sentence id="s15" text="Since transcriptional control of transcription by RNA polymerase II seems to be dependent on epidermal growth factor receptor signaling, herein, we investigated the role of NRF1 in estrogen receptor/progesterone receptor negative, but human epidermal growth factor receptor 2-positive (ER/PR -ve signal transduction +ve) breast cancer.">
    <entity charOffset="296-315" id="s15.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="328-334" id="s15.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s15.e0" e2="s15.e1" id="s15.p0" relation="true"/>
  </sentence>
  <sentence id="s16" text="This was consistent with our observation of higher transcription by RNA polymerase II protein expression in the experimental model of signal transduction+ breast cancer brain metastasis.">
    <entity charOffset="51-85" id="s16.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="162-168" id="s16.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s16.e0" e2="s16.e1" id="s16.p0" relation="false"/>
  </sentence>
  <sentence id="s17" text="This was consistent with our observation of higher transcription by RNA polymerase II protein expression in the experimental model of signal transduction+ breast cancer brain metastasis.">
    <entity charOffset="134-153" id="s17.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="162-168" id="s17.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s17.e0" e2="s17.e1" id="s17.p0" relation="true"/>
  </sentence>
  <sentence id="s18" text="To identify network-based pathways involved in the susceptibility to the ER/PR-ve signal transduction+ve breast cancer subtype, the transcription by RNA polymerase II transcriptional regulatory genome-wide landscape was analyzed using the approach consisting of a systematic integration of ChIP DNA-seq, RNA-Microarray, NRF1 protein-DNA motif binding, signal pathway analysis, and Bayesian machine learning.">
    <entity charOffset="83-102" id="s18.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="114-120" id="s18.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s18.e0" e2="s18.e1" id="s18.p0" relation="true"/>
  </sentence>
  <sentence id="s19" text="To identify network-based pathways involved in the susceptibility to the ER/PR-ve signal transduction+ve breast cancer subtype, the transcription by RNA polymerase II transcriptional regulatory genome-wide landscape was analyzed using the approach consisting of a systematic integration of ChIP DNA-seq, RNA-Microarray, NRF1 protein-DNA motif binding, signal pathway analysis, and Bayesian machine learning.">
    <entity charOffset="114-120" id="s19.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-168" id="s19.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s19.e0" e2="s19.e1" id="s19.p0" relation="false"/>
  </sentence>
  <sentence id="s20" text="Our findings show that a high percentage of known signal transduction+ breast cancer susceptibility genes, including EGFR, negative regulation of apoptotic process, and regulation of transcription, DNA-templated, are under transcriptional control of transcription by RNA polymerase II.">
    <entity charOffset="50-69" id="s20.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="78-84" id="s20.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s20.e0" e2="s20.e1" id="s20.p0" relation="true"/>
  </sentence>
  <sentence id="s21" text="Our findings show that a high percentage of known signal transduction+ breast cancer susceptibility genes, including EGFR, negative regulation of apoptotic process, and regulation of transcription, DNA-templated, are under transcriptional control of transcription by RNA polymerase II.">
    <entity charOffset="78-84" id="s21.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="250-284" id="s21.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s21.e0" e2="s21.e1" id="s21.p0" relation="false"/>
  </sentence>
  <sentence id="s22" text="Our findings show that a high percentage of known signal transduction+ breast cancer susceptibility genes, including EGFR, negative regulation of apoptotic process, and regulation of transcription, DNA-templated, are under transcriptional control of transcription by RNA polymerase II.">
    <entity charOffset="78-84" id="s22.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="123-163" id="s22.e1" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <pair e1="s22.e0" e2="s22.e1" id="s22.p0" relation="false"/>
  </sentence>
  <sentence id="s23" text="Our findings show that a high percentage of known signal transduction+ breast cancer susceptibility genes, including EGFR, negative regulation of apoptotic process, and regulation of transcription, DNA-templated, are under transcriptional control of transcription by RNA polymerase II.">
    <entity charOffset="78-84" id="s23.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="169-211" id="s23.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s23.e0" e2="s23.e1" id="s23.p0" relation="false"/>
  </sentence>
  <sentence id="s24" text="By pathway analysis, key breast cancer hallmark genes of epithelial-mesenchymal transition, stemness, cell apoptosis, cell cycle regulation, chromosomal integrity, and DNA damage/repair were highly enriched with transcription by RNA polymerase II motifs.">
    <entity charOffset="32-38" id="s24.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="212-246" id="s24.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s24.e0" e2="s24.e1" id="s24.p0" relation="false"/>
  </sentence>
  <sentence id="s25" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="76-110" id="s25.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="778-784" id="s25.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s25.e0" e2="s25.e1" id="s25.p0" relation="false"/>
  </sentence>
  <sentence id="s26" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="166-207" id="s26.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="778-784" id="s26.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s26.e0" e2="s26.e1" id="s26.p0" relation="true"/>
  </sentence>
  <sentence id="s27" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="209-249" id="s27.e0" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <entity charOffset="778-784" id="s27.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s27.e0" e2="s27.e1" id="s27.p0" relation="false"/>
  </sentence>
  <sentence id="s28" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="284-326" id="s28.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="778-784" id="s28.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s28.e0" e2="s28.e1" id="s28.p0" relation="false"/>
  </sentence>
  <sentence id="s29" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="353-387" id="s29.e0" ontology_id="GO_0008286" text="insulin receptor signaling pathway" type="GO"/>
    <entity charOffset="778-784" id="s29.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s29.e0" e2="s29.e1" id="s29.p0" relation="false"/>
  </sentence>
  <sentence id="s30" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="389-412" id="s30.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="778-784" id="s30.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s30.e0" e2="s30.e1" id="s30.p0" relation="true"/>
  </sentence>
  <sentence id="s31" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="414-429" id="s31.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="778-784" id="s31.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s31.e0" e2="s31.e1" id="s31.p0" relation="true"/>
  </sentence>
  <sentence id="s32" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="457-472" id="s32.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="778-784" id="s32.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s32.e0" e2="s32.e1" id="s32.p0" relation="false"/>
  </sentence>
  <sentence id="s33" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="474-513" id="s33.e0" ontology_id="GO_0014065" text="phosphatidylinositol 3-kinase signaling" type="GO"/>
    <entity charOffset="778-784" id="s33.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s33.e0" e2="s33.e1" id="s33.p0" relation="true"/>
  </sentence>
  <sentence id="s34" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="515-561" id="s34.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="778-784" id="s34.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s34.e0" e2="s34.e1" id="s34.p0" relation="false"/>
  </sentence>
  <sentence id="s35" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="563-576" id="s35.e0" ontology_id="GO_0031929" text="TOR signaling" type="GO"/>
    <entity charOffset="778-784" id="s35.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s35.e0" e2="s35.e1" id="s35.p0" relation="false"/>
  </sentence>
  <sentence id="s36" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="636-662" id="s36.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="778-784" id="s36.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s36.e0" e2="s36.e1" id="s36.p0" relation="true"/>
  </sentence>
  <sentence id="s37" text="In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with signal transduction-amplified breast cancer.">
    <entity charOffset="778-784" id="s37.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="813-832" id="s37.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s37.e0" e2="s37.e1" id="s37.p0" relation="true"/>
  </sentence>
  <sentence id="s38" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high transcription by RNA polymerase II expression combined with expression patterns of high E2F3, regulation of synaptic vesicle exocytosis, and MAPK1, low or no change in regulation of transcription, DNA-templated and positive regulation of cell proliferation, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s38.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-168" id="s38.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s38.e0" e2="s38.e1" id="s38.p0" relation="false"/>
  </sentence>
  <sentence id="s39" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high transcription by RNA polymerase II expression combined with expression patterns of high E2F3, regulation of synaptic vesicle exocytosis, and MAPK1, low or no change in regulation of transcription, DNA-templated and positive regulation of cell proliferation, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s39.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="349-390" id="s39.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s39.e0" e2="s39.e1" id="s39.p0" relation="true"/>
  </sentence>
  <sentence id="s40" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high transcription by RNA polymerase II expression combined with expression patterns of high E2F3, regulation of synaptic vesicle exocytosis, and MAPK1, low or no change in regulation of transcription, DNA-templated and positive regulation of cell proliferation, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s40.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="302-344" id="s40.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s40.e0" e2="s40.e1" id="s40.p0" relation="false"/>
  </sentence>
  <sentence id="s41" text="Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high transcription by RNA polymerase II expression combined with expression patterns of high E2F3, regulation of synaptic vesicle exocytosis, and MAPK1, low or no change in regulation of transcription, DNA-templated and positive regulation of cell proliferation, and high or no change in PIK3R3.">
    <entity charOffset="85-91" id="s41.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="228-269" id="s41.e1" ontology_id="GO_2000300" text="regulation of synaptic vesicle exocytosis" type="GO"/>
    <pair e1="s41.e0" e2="s41.e1" id="s41.p0" relation="false"/>
  </sentence>
  <sentence id="s42" text="In summary, our findings suggest novel roles of transcription by RNA polymerase II and its regulatory networks in susceptibility to the ER/PR-ve signal transduction+ve aggressive breast cancer subtype.">
    <entity charOffset="48-82" id="s42.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="188-194" id="s42.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s42.e0" e2="s42.e1" id="s42.p0" relation="false"/>
  </sentence>
  <sentence id="s43" text="In summary, our findings suggest novel roles of transcription by RNA polymerase II and its regulatory networks in susceptibility to the ER/PR-ve signal transduction+ve aggressive breast cancer subtype.">
    <entity charOffset="146-165" id="s43.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="188-194" id="s43.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s43.e0" e2="s43.e1" id="s43.p0" relation="true"/>
  </sentence>
  <sentence id="s44" text="Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of NRF1 as a valuable biomarker for breast cancer diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target signal transduction+ breast cancer">
    <entity charOffset="168-174" id="s44.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="309-328" id="s44.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s44.e0" e2="s44.e1" id="s44.p0" relation="true"/>
  </sentence>
  <sentence id="s45" text="Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was endosome to lysosome transport via multivesicular body sorting pathway (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.">
    <entity charOffset="106-176" id="s45.e0" ontology_id="GO_0032510" text="endosome to lysosome transport via multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="286-292" id="s45.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s45.e0" e2="s45.e1" id="s45.p0" relation="true"/>
  </sentence>
  <sentence id="s46" text="Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was endosome to lysosome transport via multivesicular body sorting pathway (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.">
    <entity charOffset="106-176" id="s46.e0" ontology_id="GO_0032510" text="endosome to lysosome transport via multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="227-235" id="s46.e1" ontology_id="HP_0010762" text="chordoma" type="HP"/>
    <pair e1="s46.e0" e2="s46.e1" id="s46.p0" relation="false"/>
  </sentence>
  <sentence id="s47" text="Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was endosome to lysosome transport via multivesicular body sorting pathway (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.">
    <entity charOffset="106-176" id="s47.e0" ontology_id="GO_0032510" text="endosome to lysosome transport via multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="212-218" id="s47.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s47.e0" e2="s47.e1" id="s47.p0" relation="true"/>
  </sentence>
  <sentence id="s48" text="Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in endosome to lysosome transport via multivesicular body sorting pathway, a potential novel cancer gene in chordoma">
    <entity charOffset="50-58" id="s48.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="200-270" id="s48.e1" ontology_id="GO_0032510" text="endosome to lysosome transport via multivesicular body sorting pathway" type="GO"/>
    <pair e1="s48.e0" e2="s48.e1" id="s48.p0" relation="false"/>
  </sentence>
  <sentence id="s49" text="Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in endosome to lysosome transport via multivesicular body sorting pathway, a potential novel cancer gene in chordoma">
    <entity charOffset="59-67" id="s49.e0" ontology_id="HP_0010762" text="chordoma" type="HP"/>
    <entity charOffset="200-270" id="s49.e1" ontology_id="GO_0032510" text="endosome to lysosome transport via multivesicular body sorting pathway" type="GO"/>
    <pair e1="s49.e0" e2="s49.e1" id="s49.p0" relation="false"/>
  </sentence>
  <sentence id="s50" text="Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in endosome to lysosome transport via multivesicular body sorting pathway, a potential novel cancer gene in chordoma">
    <entity charOffset="200-270" id="s50.e0" ontology_id="GO_0032510" text="endosome to lysosome transport via multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="290-296" id="s50.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s50.e0" e2="s50.e1" id="s50.p0" relation="true"/>
  </sentence>
  <sentence id="s51" text="Studies in humans with autosomal recessive positive regulation of stress-activated MAPK cascade deficiency have indicated a highly specific role for this molecule in the activation of antifungal immune responses in the central nervous system, the oral mucosa, and the skin.">
    <entity charOffset="23-42" id="s51.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="43-95" id="s51.e1" ontology_id="GO_0032874" text="positive regulation of stress-activated MAPK cascade" type="GO"/>
    <pair e1="s51.e0" e2="s51.e1" id="s51.p0" relation="true"/>
  </sentence>
  <sentence id="s52" text="Studies in humans with autosomal recessive positive regulation of stress-activated MAPK cascade deficiency have indicated a highly specific role for this molecule in the activation of antifungal immune responses in the central nervous system, the oral mucosa, and the skin.">
    <entity charOffset="43-95" id="s52.e0" ontology_id="GO_0032874" text="positive regulation of stress-activated MAPK cascade" type="GO"/>
    <entity charOffset="219-226" id="s52.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s52.e0" e2="s52.e1" id="s52.p0" relation="false"/>
  </sentence>
  <sentence id="s53" text="Moreover, positive regulation of stress-activated MAPK cascade-dependent functions have recently been indicated to modulate the development of autoimmunity, inflammatory bowel diseases, and cancer.">
    <entity charOffset="10-62" id="s53.e0" ontology_id="GO_0032874" text="positive regulation of stress-activated MAPK cascade" type="GO"/>
    <entity charOffset="190-196" id="s53.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s53.e0" e2="s53.e1" id="s53.p0" relation="false"/>
  </sentence>
  <sentence id="s54" text="Mutations in peripherin 2 (cell adhesion), also known as retinal degeneration slow/RDS, lead to various retinal degenerations including retinitis pigmentosa (RP) and macular/pattern dystrophy (MD/PD).">
    <entity charOffset="27-40" id="s54.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="57-77" id="s54.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s54.e0" e2="s54.e1" id="s54.p0" relation="true"/>
  </sentence>
  <sentence id="s55" text="We asked whether cell adhesion could modify the phenotype of a cell adhesion mutation associated with a high degree of intrafamilial phenotypic heterogeneity: Y141C.">
    <entity charOffset="17-30" id="s55.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="144-157" id="s55.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s55.e0" e2="s55.e1" id="s55.p0" relation="false"/>
  </sentence>
  <sentence id="s56" text="We asked whether cell adhesion could modify the phenotype of a cell adhesion mutation associated with a high degree of intrafamilial phenotypic heterogeneity: Y141C.">
    <entity charOffset="63-76" id="s56.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="144-157" id="s56.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s56.e0" e2="s56.e1" id="s56.p0" relation="false"/>
  </sentence>
  <sentence id="s57" text="Familial amyloid polyneuropathy (proteolysis) is a rare autosomal dominant disorder characterized by amyloid accumulation in the peripheral nerves and other organs, including the heart, kidney, and eyes.">
    <entity charOffset="21-31" id="s57.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="33-44" id="s57.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s57.e0" e2="s57.e1" id="s57.p0" relation="false"/>
  </sentence>
  <sentence id="s58" text="Familial amyloid polyneuropathy (proteolysis) is a rare autosomal dominant disorder characterized by amyloid accumulation in the peripheral nerves and other organs, including the heart, kidney, and eyes.">
    <entity charOffset="33-44" id="s58.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="129-139" id="s58.e1" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <pair e1="s58.e0" e2="s58.e1" id="s58.p0" relation="false"/>
  </sentence>
  <sentence id="s59" text="Forty unique blood coagulationGR1 mutations have been reported and they exert either an autosomal dominant or an autosomal recessive effect.">
    <entity charOffset="13-30" id="s59.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="113-132" id="s59.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s59.e0" e2="s59.e1" id="s59.p0" relation="false"/>
  </sentence>
  <sentence id="s60" text="Up to 15% of the population have mild to moderate chronic hypomagnesemia, which is associated with muscle organ development 2 diabetes mellitus, hypertension, metabolic syndrome, and chronic kidney disease.">
    <entity charOffset="58-72" id="s60.e0" ontology_id="HP_0002917" text="hypomagnesemia" type="HP"/>
    <entity charOffset="99-123" id="s60.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s60.e0" e2="s60.e1" id="s60.p0" relation="false"/>
  </sentence>
  <sentence id="s61" text="This case of adult-diagnosed phospholipid transport deficiency was characterized by slowly progressive peripheral neuropathy masquerading CMT in addition to muscular symptoms.">
    <entity charOffset="29-51" id="s61.e0" ontology_id="GO_0015914" text="phospholipid transport" type="GO"/>
    <entity charOffset="114-124" id="s61.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s61.e0" e2="s61.e1" id="s61.p0" relation="false"/>
  </sentence>
  <sentence id="s62" text="phospholipid transport deficiency should be considered in patients with the combination of peripheral neuropathy and recurrent rhabdomyolysis">
    <entity charOffset="0-22" id="s62.e0" ontology_id="GO_0015914" text="phospholipid transport" type="GO"/>
    <entity charOffset="102-112" id="s62.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s62.e0" e2="s62.e1" id="s62.p0" relation="false"/>
  </sentence>
  <sentence id="s63" text="Phenotypically, bs epidermis development exhibit nuclear cataracts and male infertility; genetic analyses assigned the bs locus to mouse chromosome 2.">
    <entity charOffset="19-40" id="s63.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="57-66" id="s63.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s63.e0" e2="s63.e1" id="s63.p0" relation="false"/>
  </sentence>
  <sentence id="s64" text="Based on the function of ER to Golgi vesicle-mediated transport as a RABnegative regulation of cell-matrix adhesion and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and autophagosome assembly8.">
    <entity charOffset="25-63" id="s64.e0" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <entity charOffset="127-135" id="s64.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s64.e0" e2="s64.e1" id="s64.p0" relation="true"/>
  </sentence>
  <sentence id="s65" text="Based on the function of ER to Golgi vesicle-mediated transport as a RABnegative regulation of cell-matrix adhesion and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and autophagosome assembly8.">
    <entity charOffset="72-115" id="s65.e0" ontology_id="GO_0001953" text="negative regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="127-135" id="s65.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s65.e0" e2="s65.e1" id="s65.p0" relation="false"/>
  </sentence>
  <sentence id="s66" text="Based on the function of ER to Golgi vesicle-mediated transport as a RABnegative regulation of cell-matrix adhesion and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and autophagosome assembly8.">
    <entity charOffset="127-135" id="s66.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="401-423" id="s66.e1" ontology_id="GO_0000045" text="autophagosome assembly" type="GO"/>
    <pair e1="s66.e0" e2="s66.e1" id="s66.p0" relation="false"/>
  </sentence>
  <sentence id="s67" text="An oncogenic role for ATP-dependent chromatin remodeling, a NuRD component, is defined for initiating and supporting tumor suppressor gene (negative regulation of cytokine production) silencing in human colorectal cancer.">
    <entity charOffset="22-56" id="s67.e0" ontology_id="GO_0043044" text="ATP-dependent chromatin remodeling" type="GO"/>
    <entity charOffset="117-122" id="s67.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s67.e0" e2="s67.e1" id="s67.p0" relation="false"/>
  </sentence>
  <sentence id="s68" text="An oncogenic role for ATP-dependent chromatin remodeling, a NuRD component, is defined for initiating and supporting tumor suppressor gene (negative regulation of cytokine production) silencing in human colorectal cancer.">
    <entity charOffset="22-56" id="s68.e0" ontology_id="GO_0043044" text="ATP-dependent chromatin remodeling" type="GO"/>
    <entity charOffset="214-220" id="s68.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s68.e0" e2="s68.e1" id="s68.p0" relation="false"/>
  </sentence>
  <sentence id="s69" text="An oncogenic role for ATP-dependent chromatin remodeling, a NuRD component, is defined for initiating and supporting tumor suppressor gene (negative regulation of cytokine production) silencing in human colorectal cancer.">
    <entity charOffset="117-122" id="s69.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="140-182" id="s69.e1" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <pair e1="s69.e0" e2="s69.e1" id="s69.p0" relation="false"/>
  </sentence>
  <sentence id="s70" text="ATP-dependent chromatin remodeling knockdown activates silenced TSGs, revealing their role for blunting colorectal cancer cell proliferation, invasion, and metastases.">
    <entity charOffset="0-34" id="s70.e0" ontology_id="GO_0043044" text="ATP-dependent chromatin remodeling" type="GO"/>
    <entity charOffset="115-121" id="s70.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s70.e0" e2="s70.e1" id="s70.p0" relation="false"/>
  </sentence>
  <sentence id="s71" text="X-linked Myopathy with Excessive Autophagy (regulation of ATPase activity) affects proximal muscles of the lower extremities and follows a progressive course reminiscent of muscular dystrophy.">
    <entity charOffset="44-73" id="s71.e0" ontology_id="GO_0043462" text="regulation of ATPase activity" type="GO"/>
    <entity charOffset="173-191" id="s71.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s71.e0" e2="s71.e1" id="s71.p0" relation="false"/>
  </sentence>
  <sentence id="s72" text="Rescue of protein ubiquitination expression induced proteasomal degradation of C/EBP proteins, abrogated the mesenchymal signature, and reduced tumor viability in vitro and in vivo.">
    <entity charOffset="10-32" id="s72.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="144-149" id="s72.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s72.e0" e2="s72.e1" id="s72.p0" relation="false"/>
  </sentence>
  <sentence id="s73" text="The positive regulation of cell-matrix adhesionty acid (FA) composition of protein phosphorylation blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer muscle organ development or therapy.">
    <entity charOffset="4-47" id="s73.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="142-148" id="s73.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s73.e0" e2="s73.e1" id="s73.p0" relation="false"/>
  </sentence>
  <sentence id="s74" text="The positive regulation of cell-matrix adhesionty acid (FA) composition of protein phosphorylation blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer muscle organ development or therapy.">
    <entity charOffset="4-47" id="s74.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="170-175" id="s74.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s74.e0" e2="s74.e1" id="s74.p0" relation="false"/>
  </sentence>
  <sentence id="s75" text="The positive regulation of cell-matrix adhesionty acid (FA) composition of protein phosphorylation blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer muscle organ development or therapy.">
    <entity charOffset="75-98" id="s75.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="142-148" id="s75.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s75.e0" e2="s75.e1" id="s75.p0" relation="false"/>
  </sentence>
  <sentence id="s76" text="The positive regulation of cell-matrix adhesionty acid (FA) composition of protein phosphorylation blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer muscle organ development or therapy.">
    <entity charOffset="170-175" id="s76.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="212-236" id="s76.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s76.e0" e2="s76.e1" id="s76.p0" relation="false"/>
  </sentence>
  <sentence id="s77" text="The adjusted Analysis of Covariance Test (ANCOVA) model revealed cancer patients to have a lower relative percentage of saturated positive regulation of cell-matrix adhesionty acids (SFA) (C16:0 (5.7%); C18:0 (15.9%)), and higher monounsaturated fatty acids (MUFA) (9c-C18:1 (12.9%) and 11c-C18:1 (54.5%)), compaprotein phosphorylation to controls.">
    <entity charOffset="65-71" id="s77.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="312-335" id="s77.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s77.e0" e2="s77.e1" id="s77.p0" relation="false"/>
  </sentence>
  <sentence id="s78" text="The adjusted Analysis of Covariance Test (ANCOVA) model revealed cancer patients to have a lower relative percentage of saturated positive regulation of cell-matrix adhesionty acids (SFA) (C16:0 (5.7%); C18:0 (15.9%)), and higher monounsaturated fatty acids (MUFA) (9c-C18:1 (12.9%) and 11c-C18:1 (54.5%)), compaprotein phosphorylation to controls.">
    <entity charOffset="65-71" id="s78.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="130-173" id="s78.e1" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s78.e0" e2="s78.e1" id="s78.p0" relation="false"/>
  </sentence>
  <sentence id="s79" text="To date, researchers have discovered that Nrf2 deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (intracellular protein transport), asthma, idiopathic pulmonary fibrosis (IPF), and lung cancer.">
    <entity charOffset="305-336" id="s79.e0" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <entity charOffset="393-399" id="s79.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s79.e0" e2="s79.e1" id="s79.p0" relation="false"/>
  </sentence>
  <sentence id="s80" text="cation transport is a Ca(2+) activated Cl(-) channel that is related to head and neck cancer, often caused by human papilloma virus (HPV) infection.">
    <entity charOffset="0-16" id="s80.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="86-92" id="s80.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s80.e0" e2="s80.e1" id="s80.p0" relation="false"/>
  </sentence>
  <sentence id="s81" text="cation transport is a Ca(2+) activated Cl(-) channel that is related to head and neck cancer, often caused by human papilloma virus (HPV) infection.">
    <entity charOffset="0-16" id="s81.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="116-125" id="s81.e1" ontology_id="HP_0012740" text="papilloma" type="HP"/>
    <pair e1="s81.e0" e2="s81.e1" id="s81.p0" relation="false"/>
  </sentence>
  <sentence id="s82" text="Because protein N-linked glycosylation via asparagine8 is required to lower cytosolic Zn(2+) concentrations by the Zn(2+) transporter ZnT-1, we hypothesize that HPV infections and cancer caused by mutations in TMC8 are related to upregulated Zn(2+)/Ca(2+) signaling and activation of cation transport.">
    <entity charOffset="8-53" id="s82.e0" ontology_id="GO_0018279" text="protein N-linked glycosylation via asparagine" type="GO"/>
    <entity charOffset="180-186" id="s82.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s82.e0" e2="s82.e1" id="s82.p0" relation="false"/>
  </sentence>
  <sentence id="s83" text="Because protein N-linked glycosylation via asparagine8 is required to lower cytosolic Zn(2+) concentrations by the Zn(2+) transporter ZnT-1, we hypothesize that HPV infections and cancer caused by mutations in TMC8 are related to upregulated Zn(2+)/Ca(2+) signaling and activation of cation transport.">
    <entity charOffset="180-186" id="s83.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="284-300" id="s83.e1" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <pair e1="s83.e0" e2="s83.e1" id="s83.p0" relation="false"/>
  </sentence>
  <sentence id="s84" text="VLCFA-containing lipids accumulate in X-ALD patients, although the effect of fatty acid beta-oxidation-deficiency on each lipid species in the central nervous system has not been fully characterized.">
    <entity charOffset="77-102" id="s84.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="143-150" id="s84.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s84.e0" e2="s84.e1" id="s84.p0" relation="false"/>
  </sentence>
  <sentence id="s85" text="We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal negative regulation of protein kinase activity epilepsy (ADNFLE).">
    <entity charOffset="212-221" id="s85.e0" ontology_id="HP_0025301" text="nocturnal" type="HP"/>
    <entity charOffset="230-276" id="s85.e1" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <pair e1="s85.e0" e2="s85.e1" id="s85.p0" relation="false"/>
  </sentence>
  <sentence id="s86" text="We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal negative regulation of protein kinase activity epilepsy (ADNFLE).">
    <entity charOffset="230-276" id="s86.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="277-285" id="s86.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s86.e0" e2="s86.e1" id="s86.p0" relation="false"/>
  </sentence>
  <sentence id="s87" text="To confirm that V286L-TG rats exhibit seizures similar to those observed in humans, gene expression patterns and behavioral phenomuscle organ developments were analyzed.">
    <entity charOffset="38-46" id="s87.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="129-153" id="s87.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s87.e0" e2="s87.e1" id="s87.p0" relation="false"/>
  </sentence>
  <sentence id="s88" text="Our analyses identified 15 CpG sites within the APC 1A promoter that were significantly hypermethylated and 14 CpG loci within the calcineurin-NFAT signaling cascade gene body that were significantly hypomethylated (pLIS&amp;lt;1  10&lt;sup&gt;-5&lt;/sup&gt; ) in the tumours of active smokers.">
    <entity charOffset="131-165" id="s88.e0" ontology_id="GO_0033173" text="calcineurin-NFAT signaling cascade" type="GO"/>
    <entity charOffset="255-261" id="s88.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s88.e0" e2="s88.e1" id="s88.p0" relation="false"/>
  </sentence>
  <sentence id="s89" text="The cellular response to DNA damage stimulus 1A promoter was hypermethylated in 7 of 36 tumours from never-smokers (19%), 12 of 47 tumours from former smokers (26%), and 8 of 13 tumours from active smokers (62%).">
    <entity charOffset="4-44" id="s89.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="88-94" id="s89.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s89.e0" e2="s89.e1" id="s89.p0" relation="true"/>
  </sentence>
  <sentence id="s90" text="Promoter hypermethylation was positively associated with duration of smoking (Spearman positive regulation of DNA-binding transcription factor activity correlation,  = 0.26, p=0.03) and was confined to tumours, with hypermethylation never being observed in adjacent mucosa.">
    <entity charOffset="87-151" id="s90.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="205-211" id="s90.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s90.e0" e2="s90.e1" id="s90.p0" relation="false"/>
  </sentence>
  <sentence id="s91" text="On the other hand, intraperitoneal administration of PQQ exerted protective effects on rats that had received rotenone injection into the medial forebrain bundle through decreasing the apomorphine-evoked rotation, inhibiting neuronal loss and TH down-regulation in SNc, increasing the antioxidative ability, and regulating intracellular expressions of apoptotic mitochondrial changes and Ndufs 4.">
    <entity charOffset="225-238" id="s91.e0" ontology_id="HP_0002529" text="neuronal loss" type="HP"/>
    <entity charOffset="352-383" id="s91.e1" ontology_id="GO_0008637" text="apoptotic mitochondrial changes" type="GO"/>
    <pair e1="s91.e0" e2="s91.e1" id="s91.p0" relation="false"/>
  </sentence>
  <sentence id="s92" text="In vitro and invivo (a subcutaneous BALB/c establishment of mitotic spindle orientation mouse model) studies showed that exosomal cellular response to zinc ion starvation can significantly promote pancreatic cancer growth.">
    <entity charOffset="44-88" id="s92.e0" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <entity charOffset="209-215" id="s92.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s92.e0" e2="s92.e1" id="s92.p0" relation="false"/>
  </sentence>
  <sentence id="s93" text="In vitro and invivo (a subcutaneous BALB/c establishment of mitotic spindle orientation mouse model) studies showed that exosomal cellular response to zinc ion starvation can significantly promote pancreatic cancer growth.">
    <entity charOffset="131-171" id="s93.e0" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <entity charOffset="209-215" id="s93.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s93.e0" e2="s93.e1" id="s93.p0" relation="false"/>
  </sentence>
  <sentence id="s94" text="Diabetes is a metabolic disorder characterized by hyperglycemia and associated with microvascular and macrovascular syndromes mediated by antigen receptor-mediated signaling pathway cells.">
    <entity charOffset="50-63" id="s94.e0" ontology_id="HP_0003074" text="hyperglycemia" type="HP"/>
    <entity charOffset="138-181" id="s94.e1" ontology_id="GO_0050851" text="antigen receptor-mediated signaling pathway" type="GO"/>
    <pair e1="s94.e0" e2="s94.e1" id="s94.p0" relation="false"/>
  </sentence>
  <sentence id="s95" text="By combining meta-analysis results and identification of two unrelated HCM patients with homozygous cardiac muscle hypertrophy truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124)">
    <entity charOffset="100-126" id="s95.e0" ontology_id="GO_0003300" text="cardiac muscle hypertrophy" type="GO"/>
    <entity charOffset="321-332" id="s95.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s95.e0" e2="s95.e1" id="s95.p0" relation="false"/>
  </sentence>
  <sentence id="s96" text="However, the prognostic value of gamma-aminobutyric acid catabolic process in ovarian cancer remains unclear.">
    <entity charOffset="33-74" id="s96.e0" ontology_id="GO_0009450" text="gamma-aminobutyric acid catabolic process" type="GO"/>
    <entity charOffset="86-92" id="s96.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s96.e0" e2="s96.e1" id="s96.p0" relation="false"/>
  </sentence>
  <sentence id="s97" text="In survival analyses, we found that ALDH5A1 was positively linked to prognosis in patients with OC, particularly in those with serous ovarian cancer (biological_process).">
    <entity charOffset="142-148" id="s97.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="150-168" id="s97.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s97.e0" e2="s97.e1" id="s97.p0" relation="false"/>
  </sentence>
  <sentence id="s98" text="Charcot-Marie-Tooth disease muscle organ development 4B2 with early-onset glaucoma (myelination, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.">
    <entity charOffset="28-52" id="s98.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="127-140" id="s98.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s98.e0" e2="s98.e1" id="s98.p0" relation="false"/>
  </sentence>
  <sentence id="s99" text="Charcot-Marie-Tooth disease muscle organ development 4B2 with early-onset glaucoma (myelination, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.">
    <entity charOffset="28-52" id="s99.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="74-82" id="s99.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s99.e0" e2="s99.e1" id="s99.p0" relation="false"/>
  </sentence>
  <sentence id="s100" text="Charcot-Marie-Tooth disease muscle organ development 4B2 with early-onset glaucoma (myelination, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.">
    <entity charOffset="74-82" id="s100.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="84-95" id="s100.e1" ontology_id="GO_0042552" text="myelination" type="GO"/>
    <pair e1="s100.e0" e2="s100.e1" id="s100.p0" relation="true"/>
  </sentence>
  <sentence id="s101" text="Alterations of its normal function may contribute to two different phenotypes: juvenile amyotrophic lateral sclerosis (signal transduction 16) and distal hereditary motor neuropathies (dHMN).">
    <entity charOffset="119-138" id="s101.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="147-153" id="s101.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s101.e0" e2="s101.e1" id="s101.p0" relation="false"/>
  </sentence>
  <sentence id="s102" text="Direct sequencing revealed a G to T transition (c.886G&amp;gt;T) in exon 9 of the fourpointone, ezrin, radixin, moesin domaincontaining 7 (regulation of neuron projection development) gene, which resulted in a conservative substitution of glycine to cysteine at codon 296 (p.G296C), leading to idiopathic congenital nystagmus in the two affected brothers.">
    <entity charOffset="138-181" id="s102.e0" ontology_id="GO_0010975" text="regulation of neuron projection development" type="GO"/>
    <entity charOffset="315-324" id="s102.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s102.e0" e2="s102.e1" id="s102.p0" relation="true"/>
  </sentence>
  <sentence id="s103" text="A moderate to severe reduction (&amp;gt;50%) in positive regulation of cell death activity resulting from recessive deletions and/or missense mutations has been shown to cause muscle organ development 1 hyperprolinemia (HPI).">
    <entity charOffset="44-77" id="s103.e0" ontology_id="GO_0010942" text="positive regulation of cell death" type="GO"/>
    <entity charOffset="199-214" id="s103.e1" ontology_id="HP_0008358" text="hyperprolinemia" type="HP"/>
    <pair e1="s103.e0" e2="s103.e1" id="s103.p0" relation="true"/>
  </sentence>
  <sentence id="s104" text="A moderate to severe reduction (&amp;gt;50%) in positive regulation of cell death activity resulting from recessive deletions and/or missense mutations has been shown to cause muscle organ development 1 hyperprolinemia (HPI).">
    <entity charOffset="172-196" id="s104.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="199-214" id="s104.e1" ontology_id="HP_0008358" text="hyperprolinemia" type="HP"/>
    <pair e1="s104.e0" e2="s104.e1" id="s104.p0" relation="false"/>
  </sentence>
  <sentence id="s105" text="Here we studied the frequency of a recurrent small 22q11.2 deletion encompassing positive regulation of cell death and the neighboring cell adhesion gene in three case-control studies, one comprising HPI patients (n=83), and the other two comprising autism spectrum disorder (ASD) patients (total of n=2800), analyzed with high-resolution microarrays.">
    <entity charOffset="81-114" id="s105.e0" ontology_id="GO_0010942" text="positive regulation of cell death" type="GO"/>
    <entity charOffset="252-258" id="s105.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s105.e0" e2="s105.e1" id="s105.p0" relation="false"/>
  </sentence>
  <sentence id="s106" text="Here we studied the frequency of a recurrent small 22q11.2 deletion encompassing positive regulation of cell death and the neighboring cell adhesion gene in three case-control studies, one comprising HPI patients (n=83), and the other two comprising autism spectrum disorder (ASD) patients (total of n=2800), analyzed with high-resolution microarrays.">
    <entity charOffset="135-148" id="s106.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="252-258" id="s106.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s106.e0" e2="s106.e1" id="s106.p0" relation="false"/>
  </sentence>
  <sentence id="s107" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include epidermal cell differentiation, transcription-coupled nucleotide-excision repair, ERCC3, nucleotide-excision repair, cell cycle, ST14, cell-cell junction organization and MBTPS2.">
    <entity charOffset="79-97" id="s107.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="106-136" id="s107.e1" ontology_id="GO_0009913" text="epidermal cell differentiation" type="GO"/>
    <pair e1="s107.e0" e2="s107.e1" id="s107.p0" relation="true"/>
  </sentence>
  <sentence id="s108" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include epidermal cell differentiation, transcription-coupled nucleotide-excision repair, ERCC3, nucleotide-excision repair, cell cycle, ST14, cell-cell junction organization and MBTPS2.">
    <entity charOffset="79-97" id="s108.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="138-186" id="s108.e1" ontology_id="GO_0006283" text="transcription-coupled nucleotide-excision repair" type="GO"/>
    <pair e1="s108.e0" e2="s108.e1" id="s108.p0" relation="true"/>
  </sentence>
  <sentence id="s109" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include epidermal cell differentiation, transcription-coupled nucleotide-excision repair, ERCC3, nucleotide-excision repair, cell cycle, ST14, cell-cell junction organization and MBTPS2.">
    <entity charOffset="79-97" id="s109.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="195-221" id="s109.e1" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <pair e1="s109.e0" e2="s109.e1" id="s109.p0" relation="true"/>
  </sentence>
  <sentence id="s110" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include epidermal cell differentiation, transcription-coupled nucleotide-excision repair, ERCC3, nucleotide-excision repair, cell cycle, ST14, cell-cell junction organization and MBTPS2.">
    <entity charOffset="79-97" id="s110.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="223-233" id="s110.e1" ontology_id="GO_0007049" text="cell cycle" type="GO"/>
    <pair e1="s110.e0" e2="s110.e1" id="s110.p0" relation="true"/>
  </sentence>
  <sentence id="s111" text="The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include epidermal cell differentiation, transcription-coupled nucleotide-excision repair, ERCC3, nucleotide-excision repair, cell cycle, ST14, cell-cell junction organization and MBTPS2.">
    <entity charOffset="79-97" id="s111.e0" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <entity charOffset="241-272" id="s111.e1" ontology_id="GO_0045216" text="cell-cell junction organization" type="GO"/>
    <pair e1="s111.e0" e2="s111.e1" id="s111.p0" relation="true"/>
  </sentence>
  <sentence id="s112" text="A GARP complex mutation analogous to a VPS53 allele causing progressive cerebello-cerebral atrophy muscle organ development 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.">
    <entity charOffset="82-98" id="s112.e0" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <entity charOffset="99-123" id="s112.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s112.e0" e2="s112.e1" id="s112.p0" relation="false"/>
  </sentence>
  <sentence id="s113" text="Through whole-exome sequencing in six unrelated nonconsanguineous families having a sporadic case of intellectual disability, we identified six novel de novo truncating mutations in sister chromatid biorientation: c.1880C&amp;gt;G p.(Ser627*), c.1489C&amp;gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&amp;gt;A; p.(Trp348*), c.1002G&amp;gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).">
    <entity charOffset="101-124" id="s113.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="182-212" id="s113.e1" ontology_id="GO_0031134" text="sister chromatid biorientation" type="GO"/>
    <pair e1="s113.e0" e2="s113.e1" id="s113.p0" relation="true"/>
  </sentence>
  <sentence id="s114" text="These data suggest a pathogenic mechanism of the sister chromatid biorientation-associated intellectual disability syndrome mediated by direct interacting partners of CHAMP1, several of which are involved in chromo/kinetochore-related disorders.">
    <entity charOffset="49-79" id="s114.e0" ontology_id="GO_0031134" text="sister chromatid biorientation" type="GO"/>
    <entity charOffset="91-114" id="s114.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s114.e0" e2="s114.e1" id="s114.p0" relation="true"/>
  </sentence>
  <sentence id="s115" text="These findings implicate for the first time perturbed TGF- signaling in the negative regulation of transcription by RNA polymerase II of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in retinal disease and may offer additional therapeutic opportunities for genetically heterogeneous disorders presently only treatable with gene therapy">
    <entity charOffset="77-134" id="s115.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="232-247" id="s115.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s115.e0" e2="s115.e1" id="s115.p0" relation="false"/>
  </sentence>
  <sentence id="s116" text="These findings implicate for the first time perturbed TGF- signaling in the negative regulation of transcription by RNA polymerase II of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in retinal disease and may offer additional therapeutic opportunities for genetically heterogeneous disorders presently only treatable with gene therapy">
    <entity charOffset="77-134" id="s116.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="315-328" id="s116.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s116.e0" e2="s116.e1" id="s116.p0" relation="false"/>
  </sentence>
  <sentence id="s117" text="Brain malformations described in association with 22q11.2 deletion syndrome include polymicrogyria, cerebellar hypoplasia, megacisterna magna, and agenesis of the corpus callosum (acetyl-CoA metabolic process), although these are rare.">
    <entity charOffset="147-178" id="s117.e0" ontology_id="HP_0001274" text="agenesis of the corpus callosum" type="HP"/>
    <entity charOffset="180-208" id="s117.e1" ontology_id="GO_0006084" text="acetyl-CoA metabolic process" type="GO"/>
    <pair e1="s117.e0" e2="s117.e1" id="s117.p0" relation="false"/>
  </sentence>
  <sentence id="s118" text="Although the patient showed cardiac anomalies, which is one of the typical symptoms of 22q11.2 deletion syndrome, her rather severe phenotype and atypical interstrand cross-link repair prompted us to search for additional pathogenic mutations.">
    <entity charOffset="28-45" id="s118.e0" ontology_id="HP_0001627" text="cardiac anomalies" type="HP"/>
    <entity charOffset="155-184" id="s118.e1" ontology_id="GO_0036297" text="interstrand cross-link repair" type="GO"/>
    <pair e1="s118.e0" e2="s118.e1" id="s118.p0" relation="true"/>
  </sentence>
  <sentence id="s119" text="Preclinical studies have demonstrated that positive regulation of cell-matrix adhesion is associated with disease prognosis in a number of human cancers, including glioblastoma.">
    <entity charOffset="43-86" id="s119.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="164-176" id="s119.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s119.e0" e2="s119.e1" id="s119.p0" relation="false"/>
  </sentence>
  <sentence id="s120" text="Preclinical studies have demonstrated that positive regulation of cell-matrix adhesion is associated with disease prognosis in a number of human cancers, including glioblastoma.">
    <entity charOffset="43-86" id="s120.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="145-151" id="s120.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s120.e0" e2="s120.e1" id="s120.p0" relation="false"/>
  </sentence>
  <sentence id="s121" text="Translational research suggests that positive regulation of cell-matrix adhesion may be targeted with antibodies to improve tumor control and survival in a variety of murine models and cancer types.">
    <entity charOffset="37-80" id="s121.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="124-129" id="s121.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s121.e0" e2="s121.e1" id="s121.p0" relation="false"/>
  </sentence>
  <sentence id="s122" text="Punctate palmoplantar keratoderma muscle organ development 1 (PPPK1) is a rare autosomal dominant inherited skin disease, characterized by multiple hyperkeratotic lesions on the palms and soles.">
    <entity charOffset="9-33" id="s122.e0" ontology_id="HP_0000982" text="palmoplantar keratoderma" type="HP"/>
    <entity charOffset="34-58" id="s122.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s122.e0" e2="s122.e1" id="s122.p0" relation="false"/>
  </sentence>
  <sentence id="s123" text="Data on human papillomavirus (HPV) muscle organ development-specific cervical cancer risk in women living with human immunodeficiency virus (WLHIV) are needed to understand HPVHIV interaction and to inform prevention programs for this population.">
    <entity charOffset="35-59" id="s123.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="78-84" id="s123.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s123.e0" e2="s123.e1" id="s123.p0" relation="false"/>
  </sentence>
  <sentence id="s124" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, regulation of somitogenesis, mesoderm development) and autosomal dominant (TBX6) inheritance.">
    <entity charOffset="103-122" id="s124.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="137-164" id="s124.e1" ontology_id="GO_0014807" text="regulation of somitogenesis" type="GO"/>
    <pair e1="s124.e0" e2="s124.e1" id="s124.p0" relation="true"/>
  </sentence>
  <sentence id="s125" text="In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, regulation of somitogenesis, mesoderm development) and autosomal dominant (TBX6) inheritance.">
    <entity charOffset="103-122" id="s125.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="166-186" id="s125.e1" ontology_id="GO_0007498" text="mesoderm development" type="GO"/>
    <pair e1="s125.e0" e2="s125.e1" id="s125.p0" relation="true"/>
  </sentence>
  <sentence id="s126" text="A previously reported regulation of aldosterone biosynthetic process gene for epilepsy was excluded as the disease-causing gene in the family by mutational analysis of all exons and exon-intron boundaries of CLCN2 and by haplotype analysis.">
    <entity charOffset="22-68" id="s126.e0" ontology_id="GO_0032347" text="regulation of aldosterone biosynthetic process" type="GO"/>
    <entity charOffset="78-86" id="s126.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s126.e0" e2="s126.e1" id="s126.p0" relation="true"/>
  </sentence>
  <sentence id="s127" text="Herein, we newly identified that truncated form of sister chromatid cohesion is produced and released from lung tumor tissue in a mouse model expressing human EML4-ALK fusion gene.">
    <entity charOffset="51-76" id="s127.e0" ontology_id="GO_0007062" text="sister chromatid cohesion" type="GO"/>
    <entity charOffset="112-117" id="s127.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s127.e0" e2="s127.e1" id="s127.p0" relation="false"/>
  </sentence>
  <sentence id="s128" text="Considering these results, the measurement of circulating sister chromatid cohesion level may contribute to assess a tumor progression in human lung tumor patients">
    <entity charOffset="58-83" id="s128.e0" ontology_id="GO_0007062" text="sister chromatid cohesion" type="GO"/>
    <entity charOffset="117-122" id="s128.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s128.e0" e2="s128.e1" id="s128.p0" relation="false"/>
  </sentence>
  <sentence id="s129" text="Tricho-hepato-enteric syndrome (SD/THE) and Multiple intestinal atresia with combined immune deficiency (regulation of signaling receptor activity-CID) are autosomal recessive disorders that present immunological and gastrointestinal features.">
    <entity charOffset="105-146" id="s129.e0" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <entity charOffset="156-175" id="s129.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s129.e0" e2="s129.e1" id="s129.p0" relation="false"/>
  </sentence>
  <sentence id="s130" text="There are two different phenotypes of patients with TTC7A mutations: the severe form, caused by null mutations and leading to the classical regulation of signaling receptor activity-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and hair abnormalities.">
    <entity charOffset="140-181" id="s130.e0" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <entity charOffset="325-343" id="s130.e1" ontology_id="HP_0001595" text="hair abnormalities" type="HP"/>
    <pair e1="s130.e0" e2="s130.e1" id="s130.p0" relation="false"/>
  </sentence>
  <sentence id="s131" text="We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="30-69" id="s131.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="244-262" id="s131.e1" ontology_id="HP_0011100" text="intestinal atresia" type="HP"/>
    <pair e1="s131.e0" e2="s131.e1" id="s131.p0" relation="true"/>
  </sentence>
  <sentence id="s132" text="We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="30-69" id="s132.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="362-381" id="s132.e1" ontology_id="HP_0001392" text="liver abnormalities" type="HP"/>
    <pair e1="s132.e0" e2="s132.e1" id="s132.p0" relation="true"/>
  </sentence>
  <sentence id="s133" text="We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="30-69" id="s133.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="410-431" id="s133.e1" ontology_id="HP_0004313" text="hypogammaglobulinemia" type="HP"/>
    <pair e1="s133.e0" e2="s133.e1" id="s133.p0" relation="false"/>
  </sentence>
  <sentence id="s134" text="We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="197-238" id="s134.e0" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <entity charOffset="244-262" id="s134.e1" ontology_id="HP_0011100" text="intestinal atresia" type="HP"/>
    <pair e1="s134.e0" e2="s134.e1" id="s134.p0" relation="false"/>
  </sentence>
  <sentence id="s135" text="We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="197-238" id="s135.e0" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <entity charOffset="362-381" id="s135.e1" ontology_id="HP_0001392" text="liver abnormalities" type="HP"/>
    <pair e1="s135.e0" e2="s135.e1" id="s135.p0" relation="false"/>
  </sentence>
  <sentence id="s136" text="We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE">
    <entity charOffset="197-238" id="s136.e0" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <entity charOffset="410-431" id="s136.e1" ontology_id="HP_0004313" text="hypogammaglobulinemia" type="HP"/>
    <pair e1="s136.e0" e2="s136.e1" id="s136.p0" relation="false"/>
  </sentence>
  <sentence id="s137" text="We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="20-35" id="s137.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="49-62" id="s137.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s137.e0" e2="s137.e1" id="s137.p0" relation="false"/>
  </sentence>
  <sentence id="s138" text="We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="20-35" id="s138.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="82-93" id="s138.e1" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <pair e1="s138.e0" e2="s138.e1" id="s138.p0" relation="false"/>
  </sentence>
  <sentence id="s139" text="We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="20-35" id="s139.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="319-335" id="s139.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s139.e0" e2="s139.e1" id="s139.p0" relation="false"/>
  </sentence>
  <sentence id="s140" text="We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="49-62" id="s140.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="226-277" id="s140.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s140.e0" e2="s140.e1" id="s140.p0" relation="false"/>
  </sentence>
  <sentence id="s141" text="We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="82-93" id="s141.e0" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <entity charOffset="226-277" id="s141.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s141.e0" e2="s141.e1" id="s141.p0" relation="false"/>
  </sentence>
  <sentence id="s142" text="We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="114-137" id="s142.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="319-335" id="s142.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s142.e0" e2="s142.e1" id="s142.p0" relation="false"/>
  </sentence>
  <sentence id="s143" text="We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="226-277" id="s143.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="319-335" id="s143.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s143.e0" e2="s143.e1" id="s143.p0" relation="true"/>
  </sentence>
  <sentence id="s144" text="We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.">
    <entity charOffset="278-306" id="s144.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="319-335" id="s144.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s144.e0" e2="s144.e1" id="s144.p0" relation="false"/>
  </sentence>
  <sentence id="s145" text="A proteolysis inhibitor significantly inhibited cell invasion and migration in ALDOA-HIF-1 axis-induced lung cancer.">
    <entity charOffset="2-13" id="s145.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="110-116" id="s145.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s145.e0" e2="s145.e1" id="s145.p0" relation="false"/>
  </sentence>
  <sentence id="s146" text="In summary, our results reveal the molecular mechanism of Aldolase A in promoting lung cancer metastasis via PHD-mediated stabilization of HIF-1 and the subsequent activation of proteolysis.">
    <entity charOffset="87-93" id="s146.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="179-190" id="s146.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s146.e0" e2="s146.e1" id="s146.p0" relation="false"/>
  </sentence>
  <sentence id="s147" text="The regulation of cell shape-HIF-1 axis may provide a new therapeutic target for metastatic lung cancer treatment">
    <entity charOffset="4-28" id="s147.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="98-104" id="s147.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s147.e0" e2="s147.e1" id="s147.p0" relation="false"/>
  </sentence>
  <sentence id="s148" text="We report a case of 2-year old child who presented with small bone osteomyelitis involving bilateral feet and was later diagnosed to have autosomal recessive CGD due to mutation in protein targeting to membrane gene">
    <entity charOffset="138-157" id="s148.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="181-210" id="s148.e1" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <pair e1="s148.e0" e2="s148.e1" id="s148.p0" relation="true"/>
  </sentence>
  <sentence id="s149" text="Chromosomal studies for Individual 1 identified an X-chromosome deletion due to a de novo pericentric inversion; the inversion breakpoint was associated with deletion of the 5'UTR of the protein deubiquitination, a gene which has been implicated in a syndromic intellectual disability affecting females.">
    <entity charOffset="187-211" id="s149.e0" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <entity charOffset="261-284" id="s149.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s149.e0" e2="s149.e1" id="s149.p0" relation="true"/>
  </sentence>
  <sentence id="s150" text="Haploinsufficiency of protein deubiquitination in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-46" id="s150.e0" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <entity charOffset="190-201" id="s150.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s150.e0" e2="s150.e1" id="s150.p0" relation="true"/>
  </sentence>
  <sentence id="s151" text="Haploinsufficiency of protein deubiquitination in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-46" id="s151.e0" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <entity charOffset="143-152" id="s151.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s151.e0" e2="s151.e1" id="s151.p0" relation="true"/>
  </sentence>
  <sentence id="s152" text="Haploinsufficiency of protein deubiquitination in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-46" id="s152.e0" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <entity charOffset="154-174" id="s152.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s152.e0" e2="s152.e1" id="s152.p0" relation="true"/>
  </sentence>
  <sentence id="s153" text="Haploinsufficiency of protein deubiquitination in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.">
    <entity charOffset="22-46" id="s153.e0" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <entity charOffset="176-188" id="s153.e1" ontology_id="HP_0002023" text="anal atresia" type="HP"/>
    <pair e1="s153.e0" e2="s153.e1" id="s153.p0" relation="true"/>
  </sentence>
  <sentence id="s154" text="Liver cancer is very common worldwide and the rates of hepatocellular carcinoma (phosphatidylinositol phosphorylation) have increased by over 70% in the last 2 decades in the US.">
    <entity charOffset="6-12" id="s154.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="81-117" id="s154.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s154.e0" e2="s154.e1" id="s154.p0" relation="false"/>
  </sentence>
  <sentence id="s155" text="We present the cloning and characterization of a novel gene, microvillus organization (Cancer related gene-Liver 2), which displays high expression in murine and human hepatocellular carcinomas.">
    <entity charOffset="61-85" id="s155.e0" ontology_id="GO_0032528" text="microvillus organization" type="GO"/>
    <entity charOffset="168-192" id="s155.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s155.e0" e2="s155.e1" id="s155.p0" relation="false"/>
  </sentence>
  <sentence id="s156" text="Using in situ hybridization, we show that microvillus organization mRNA levels are increased early during the development of liver tumors in C3H/HeJ epidermis development, and that in normal tissues CRG-L2 mRNA is restricted to the murine testis and human placenta.">
    <entity charOffset="42-66" id="s156.e0" ontology_id="GO_0032528" text="microvillus organization" type="GO"/>
    <entity charOffset="131-137" id="s156.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s156.e0" e2="s156.e1" id="s156.p0" relation="false"/>
  </sentence>
  <sentence id="s157" text="Using in situ hybridization, we show that microvillus organization mRNA levels are increased early during the development of liver tumors in C3H/HeJ epidermis development, and that in normal tissues CRG-L2 mRNA is restricted to the murine testis and human placenta.">
    <entity charOffset="131-137" id="s157.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="149-170" id="s157.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s157.e0" e2="s157.e1" id="s157.p0" relation="false"/>
  </sentence>
  <sentence id="s158" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="103-145" id="s158.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="245-267" id="s158.e1" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <pair e1="s158.e0" e2="s158.e1" id="s158.p0" relation="true"/>
  </sentence>
  <sentence id="s159" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="147-174" id="s159.e0" ontology_id="GO_0021987" text="cerebral cortex development" type="GO"/>
    <entity charOffset="269-292" id="s159.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s159.e0" e2="s159.e1" id="s159.p0" relation="true"/>
  </sentence>
  <sentence id="s160" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="147-174" id="s160.e0" ontology_id="GO_0021987" text="cerebral cortex development" type="GO"/>
    <entity charOffset="245-267" id="s160.e1" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <pair e1="s160.e0" e2="s160.e1" id="s160.p0" relation="true"/>
  </sentence>
  <sentence id="s161" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="147-174" id="s161.e0" ontology_id="GO_0021987" text="cerebral cortex development" type="GO"/>
    <entity charOffset="294-311" id="s161.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s161.e0" e2="s161.e1" id="s161.p0" relation="false"/>
  </sentence>
  <sentence id="s162" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="147-174" id="s162.e0" ontology_id="GO_0021987" text="cerebral cortex development" type="GO"/>
    <entity charOffset="316-335" id="s162.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s162.e0" e2="s162.e1" id="s162.p0" relation="true"/>
  </sentence>
  <sentence id="s163" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="179-210" id="s163.e0" ontology_id="GO_0051259" text="protein complex oligomerization" type="GO"/>
    <entity charOffset="269-292" id="s163.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s163.e0" e2="s163.e1" id="s163.p0" relation="true"/>
  </sentence>
  <sentence id="s164" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="179-210" id="s164.e0" ontology_id="GO_0051259" text="protein complex oligomerization" type="GO"/>
    <entity charOffset="294-311" id="s164.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s164.e0" e2="s164.e1" id="s164.p0" relation="true"/>
  </sentence>
  <sentence id="s165" text="Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.">
    <entity charOffset="179-210" id="s165.e0" ontology_id="GO_0051259" text="protein complex oligomerization" type="GO"/>
    <entity charOffset="316-335" id="s165.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s165.e0" e2="s165.e1" id="s165.p0" relation="true"/>
  </sentence>
  <sentence id="s166" text="Through biological and in silico analyses, our study suggests an association between protein localization to nucleus/response to ionizing radiation mutations and cardiovascular malformations, SIX1/EYA1 mutations might be partially responsible for CTDs">
    <entity charOffset="85-116" id="s166.e0" ontology_id="GO_0034504" text="protein localization to nucleus" type="GO"/>
    <entity charOffset="162-190" id="s166.e1" ontology_id="HP_0030680" text="cardiovascular malformations" type="HP"/>
    <pair e1="s166.e0" e2="s166.e1" id="s166.p0" relation="false"/>
  </sentence>
  <sentence id="s167" text="Through biological and in silico analyses, our study suggests an association between protein localization to nucleus/response to ionizing radiation mutations and cardiovascular malformations, SIX1/EYA1 mutations might be partially responsible for CTDs">
    <entity charOffset="117-147" id="s167.e0" ontology_id="GO_0010212" text="response to ionizing radiation" type="GO"/>
    <entity charOffset="162-190" id="s167.e1" ontology_id="HP_0030680" text="cardiovascular malformations" type="HP"/>
    <pair e1="s167.e0" e2="s167.e1" id="s167.p0" relation="false"/>
  </sentence>
  <sentence id="s168" text="Further inference was found in the tumor suppression gene, p53, with a new hypothesis of including the bovine programmed cell death pathways for targeting the glycolysis preference in many types of cancerous cells, consistent with quantum metabolism models.">
    <entity charOffset="35-40" id="s168.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="110-131" id="s168.e1" ontology_id="GO_0012501" text="programmed cell death" type="GO"/>
    <pair e1="s168.e0" e2="s168.e1" id="s168.p0" relation="false"/>
  </sentence>
  <sentence id="s169" text="The pattern of inheritance is autosomal recessive, and a causative mutation is evident in the protein dephosphorylation gene.">
    <entity charOffset="30-49" id="s169.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="94-119" id="s169.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s169.e0" e2="s169.e1" id="s169.p0" relation="true"/>
  </sentence>
  <sentence id="s170" text="Here we report that positive regulation of DNA-binding transcription factor activity-c transcript is expressed in 3.2% of cases in The Cancer Genome Atlas breast cancer cohort evenly between ER-positive and ER-negative cases.">
    <entity charOffset="20-84" id="s170.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="162-168" id="s170.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s170.e0" e2="s170.e1" id="s170.p0" relation="false"/>
  </sentence>
  <sentence id="s171" text="Nevertheless, the ratio of positive regulation of DNA-binding transcription factor activity to RANK-c (RANK/RANK-c) is increased in ER-negative breast cancer cell lines compared to ER-positive breast cancer cell lines.">
    <entity charOffset="27-91" id="s171.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="151-157" id="s171.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s171.e0" e2="s171.e1" id="s171.p0" relation="false"/>
  </sentence>
  <sentence id="s172" text="The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (peripheral nervous system development-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.">
    <entity charOffset="4-68" id="s172.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="106-120" id="s172.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s172.e0" e2="s172.e1" id="s172.p0" relation="false"/>
  </sentence>
  <sentence id="s173" text="The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (peripheral nervous system development-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.">
    <entity charOffset="94-100" id="s173.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="144-181" id="s173.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s173.e0" e2="s173.e1" id="s173.p0" relation="false"/>
  </sentence>
  <sentence id="s174" text="The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (peripheral nervous system development-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.">
    <entity charOffset="94-100" id="s174.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="280-320" id="s174.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s174.e0" e2="s174.e1" id="s174.p0" relation="false"/>
  </sentence>
  <sentence id="s175" text="The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (peripheral nervous system development-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.">
    <entity charOffset="106-120" id="s175.e0" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <entity charOffset="144-181" id="s175.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s175.e0" e2="s175.e1" id="s175.p0" relation="false"/>
  </sentence>
  <sentence id="s176" text="Additional protein interaction characterization revealed epidermal growth factor receptor (positive regulation of protein phosphorylation) as a novel interacting partner for positive regulation of DNA-binding transcription factor activity-c in breast cancer cells with a negative effect on EGFR phosphorylation and EGF-dependent downstream signaling pathway activation.">
    <entity charOffset="91-137" id="s176.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="251-257" id="s176.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s176.e0" e2="s176.e1" id="s176.p0" relation="true"/>
  </sentence>
  <sentence id="s177" text="Additional protein interaction characterization revealed epidermal growth factor receptor (positive regulation of protein phosphorylation) as a novel interacting partner for positive regulation of DNA-binding transcription factor activity-c in breast cancer cells with a negative effect on EGFR phosphorylation and EGF-dependent downstream signaling pathway activation.">
    <entity charOffset="174-238" id="s177.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="251-257" id="s177.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s177.e0" e2="s177.e1" id="s177.p0" relation="false"/>
  </sentence>
  <sentence id="s178" text="Our findings further elucidate the complex molecular biology of the positive regulation of DNA-binding transcription factor activityL/RANK system in breast cancer and provide preliminary data for RANK-c as a possible marker for disease progression and aggressiveness">
    <entity charOffset="68-132" id="s178.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="156-162" id="s178.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s178.e0" e2="s178.e1" id="s178.p0" relation="false"/>
  </sentence>
  <sentence id="s179" text="De novo loss of function (LOF) mutations in the transcription, DNA-templated gene cause Bainbridge-Ropers syndrome, a severe form of intellectual disability (ID) and developmental delay, but there is evidence that they also occur in healthy individuals.">
    <entity charOffset="48-76" id="s179.e0" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <entity charOffset="133-156" id="s179.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s179.e0" e2="s179.e1" id="s179.p0" relation="true"/>
  </sentence>
  <sentence id="s180" text="De novo loss of function (LOF) mutations in the transcription, DNA-templated gene cause Bainbridge-Ropers syndrome, a severe form of intellectual disability (ID) and developmental delay, but there is evidence that they also occur in healthy individuals.">
    <entity charOffset="48-76" id="s180.e0" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <entity charOffset="166-185" id="s180.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s180.e0" e2="s180.e1" id="s180.p0" relation="true"/>
  </sentence>
  <sentence id="s181" text="We established a genetic diagnosis in six families with autosomal recessive HSP (chemical synaptic transmission in three families and ER to Golgi vesicle-mediated transport/ER to Golgi vesicle-mediated transport, negative regulation of inclusion body assembly and positive regulation of GTPase activity in one family each).">
    <entity charOffset="56-75" id="s181.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="81-111" id="s181.e1" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <pair e1="s181.e0" e2="s181.e1" id="s181.p0" relation="true"/>
  </sentence>
  <sentence id="s182" text="We established a genetic diagnosis in six families with autosomal recessive HSP (chemical synaptic transmission in three families and ER to Golgi vesicle-mediated transport/ER to Golgi vesicle-mediated transport, negative regulation of inclusion body assembly and positive regulation of GTPase activity in one family each).">
    <entity charOffset="56-75" id="s182.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="134-172" id="s182.e1" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <pair e1="s182.e0" e2="s182.e1" id="s182.p0" relation="true"/>
  </sentence>
  <sentence id="s183" text="We established a genetic diagnosis in six families with autosomal recessive HSP (chemical synaptic transmission in three families and ER to Golgi vesicle-mediated transport/ER to Golgi vesicle-mediated transport, negative regulation of inclusion body assembly and positive regulation of GTPase activity in one family each).">
    <entity charOffset="56-75" id="s183.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="173-211" id="s183.e1" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <pair e1="s183.e0" e2="s183.e1" id="s183.p0" relation="true"/>
  </sentence>
  <sentence id="s184" text="We established a genetic diagnosis in six families with autosomal recessive HSP (chemical synaptic transmission in three families and ER to Golgi vesicle-mediated transport/ER to Golgi vesicle-mediated transport, negative regulation of inclusion body assembly and positive regulation of GTPase activity in one family each).">
    <entity charOffset="56-75" id="s184.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="213-259" id="s184.e1" ontology_id="GO_0090084" text="negative regulation of inclusion body assembly" type="GO"/>
    <pair e1="s184.e0" e2="s184.e1" id="s184.p0" relation="true"/>
  </sentence>
  <sentence id="s185" text="We established a genetic diagnosis in six families with autosomal recessive HSP (chemical synaptic transmission in three families and ER to Golgi vesicle-mediated transport/ER to Golgi vesicle-mediated transport, negative regulation of inclusion body assembly and positive regulation of GTPase activity in one family each).">
    <entity charOffset="56-75" id="s185.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="264-302" id="s185.e1" ontology_id="GO_0043547" text="positive regulation of GTPase activity" type="GO"/>
    <pair e1="s185.e0" e2="s185.e1" id="s185.p0" relation="true"/>
  </sentence>
  <sentence id="s186" text="Patients did not present with visual impairment as observed in a previously reported ER to Golgi vesicle-mediated transport family (c.316C&amp;gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible phenomuscle organ development correlation to variant location.">
    <entity charOffset="30-47" id="s186.e0" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <entity charOffset="305-329" id="s186.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s186.e0" e2="s186.e1" id="s186.p0" relation="false"/>
  </sentence>
  <sentence id="s187" text="Patients did not present with visual impairment as observed in a previously reported ER to Golgi vesicle-mediated transport family (c.316C&amp;gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible phenomuscle organ development correlation to variant location.">
    <entity charOffset="30-47" id="s187.e0" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <entity charOffset="85-123" id="s187.e1" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <pair e1="s187.e0" e2="s187.e1" id="s187.p0" relation="true"/>
  </sentence>
  <sentence id="s188" text="In addition to a negative regulation of transcription, DNA-templated mutation in a patient with all core features of the congenital variant of negative regulation of gene expression, we identified a missense (p.Ser240Thr) in regulation of postsynapse organization in a patient who appeared to be seizure free.">
    <entity charOffset="17-68" id="s188.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="296-303" id="s188.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s188.e0" e2="s188.e1" id="s188.p0" relation="true"/>
  </sentence>
  <sentence id="s189" text="In addition to a negative regulation of transcription, DNA-templated mutation in a patient with all core features of the congenital variant of negative regulation of gene expression, we identified a missense (p.Ser240Thr) in regulation of postsynapse organization in a patient who appeared to be seizure free.">
    <entity charOffset="143-181" id="s189.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="296-303" id="s189.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s189.e0" e2="s189.e1" id="s189.p0" relation="true"/>
  </sentence>
  <sentence id="s190" text="In addition to a negative regulation of transcription, DNA-templated mutation in a patient with all core features of the congenital variant of negative regulation of gene expression, we identified a missense (p.Ser240Thr) in regulation of postsynapse organization in a patient who appeared to be seizure free.">
    <entity charOffset="225-263" id="s190.e0" ontology_id="GO_0099175" text="regulation of postsynapse organization" type="GO"/>
    <entity charOffset="296-303" id="s190.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s190.e0" e2="s190.e1" id="s190.p0" relation="true"/>
  </sentence>
  <sentence id="s191" text="Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in potassium ion transmembrane transport encoding the potassium channel Kv 1.2 in a girl with infantile-onset seizures variant of negative regulation of gene expression.">
    <entity charOffset="102-139" id="s191.e0" ontology_id="GO_0071805" text="potassium ion transmembrane transport" type="GO"/>
    <entity charOffset="209-216" id="s191.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s191.e0" e2="s191.e1" id="s191.p0" relation="true"/>
  </sentence>
  <sentence id="s192" text="Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in potassium ion transmembrane transport encoding the potassium channel Kv 1.2 in a girl with infantile-onset seizures variant of negative regulation of gene expression.">
    <entity charOffset="209-216" id="s192.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="229-267" id="s192.e1" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <pair e1="s192.e0" e2="s192.e1" id="s192.p0" relation="true"/>
  </sentence>
  <sentence id="s193" text="Previous studies have demonstrated that respiratory chain complex IV assembly mutations are associated with typical LS as well as fatal infantile hypertrophic cardiomyopathy.">
    <entity charOffset="40-77" id="s193.e0" ontology_id="GO_0008535" text="respiratory chain complex IV assembly" type="GO"/>
    <entity charOffset="159-173" id="s193.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s193.e0" e2="s193.e1" id="s193.p0" relation="true"/>
  </sentence>
  <sentence id="s194" text="Furthermore, targeted knockout of negative regulation of phosphatase activity in epidermis development results in retinal degeneration with abnormal positive regulation of transcription by RNA polymerase II response.">
    <entity charOffset="34-77" id="s194.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="114-134" id="s194.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s194.e0" e2="s194.e1" id="s194.p0" relation="true"/>
  </sentence>
  <sentence id="s195" text="Furthermore, targeted knockout of negative regulation of phosphatase activity in epidermis development results in retinal degeneration with abnormal positive regulation of transcription by RNA polymerase II response.">
    <entity charOffset="81-102" id="s195.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="114-134" id="s195.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s195.e0" e2="s195.e1" id="s195.p0" relation="false"/>
  </sentence>
  <sentence id="s196" text="Furthermore, targeted knockout of negative regulation of phosphatase activity in epidermis development results in retinal degeneration with abnormal positive regulation of transcription by RNA polymerase II response.">
    <entity charOffset="114-134" id="s196.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="149-206" id="s196.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s196.e0" e2="s196.e1" id="s196.p0" relation="false"/>
  </sentence>
  <sentence id="s197" text="These findings suggested that signal transduction is an important adaptor in hypoxic regions that drives endometrial cancer development">
    <entity charOffset="30-49" id="s197.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="117-123" id="s197.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s197.e0" e2="s197.e1" id="s197.p0" relation="false"/>
  </sentence>
  <sentence id="s198" text="Here, we report that the expression of the nervous system development gene is aberrantly elevated in human basal cell carcinoma (BCC), coinciding with increased primary cilia formation and activated hedgehog (Hh) signaling.">
    <entity charOffset="43-69" id="s198.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="107-127" id="s198.e1" ontology_id="HP_0002671" text="basal cell carcinoma" type="HP"/>
    <pair e1="s198.e0" e2="s198.e1" id="s198.p0" relation="false"/>
  </sentence>
  <sentence id="s199" text="In an effort to identify new mutations responsible for monocyte chemotaxis, we performed whole-exome sequencing analysis of 48 patients with no documented mutations/deletions in our first screening and identified a de novo splicing error mutation in RPL27 and a frameshift deletion in RPS27 in sporadic patients with DBA.">
    <entity charOffset="55-74" id="s199.e0" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <entity charOffset="294-302" id="s199.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s199.e0" e2="s199.e1" id="s199.p0" relation="false"/>
  </sentence>
  <sentence id="s200" text="The role of negative regulation of transcription by RNA polymerase II (a target gene of let-7) and the miRNA catabolic process-let-7-c-Myc pathway in the growth and malignancy of thyroid cancer is unclear.">
    <entity charOffset="12-69" id="s200.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="187-193" id="s200.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s200.e0" e2="s200.e1" id="s200.p0" relation="true"/>
  </sentence>
  <sentence id="s201" text="The role of negative regulation of transcription by RNA polymerase II (a target gene of let-7) and the miRNA catabolic process-let-7-c-Myc pathway in the growth and malignancy of thyroid cancer is unclear.">
    <entity charOffset="103-126" id="s201.e0" ontology_id="GO_0010587" text="miRNA catabolic process" type="GO"/>
    <entity charOffset="187-193" id="s201.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s201.e0" e2="s201.e1" id="s201.p0" relation="false"/>
  </sentence>
  <sentence id="s202" text="The purpose of the present study was to evaluate the expression of miRNA catabolic processA, let-7a, and c-Myc in human papillary thyroid carcinoma (biological_process) and to investigate their potential mechanisms in the progression of PTC.">
    <entity charOffset="67-90" id="s202.e0" ontology_id="GO_0010587" text="miRNA catabolic process" type="GO"/>
    <entity charOffset="120-147" id="s202.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s202.e0" e2="s202.e1" id="s202.p0" relation="false"/>
  </sentence>
  <sentence id="s203" text="The purpose of the present study was to evaluate the expression of miRNA catabolic processA, let-7a, and c-Myc in human papillary thyroid carcinoma (biological_process) and to investigate their potential mechanisms in the progression of PTC.">
    <entity charOffset="120-147" id="s203.e0" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <entity charOffset="149-167" id="s203.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s203.e0" e2="s203.e1" id="s203.p0" relation="false"/>
  </sentence>
  <sentence id="s204" text="Clinically, miRNA catabolic processA was linked to a higher tumor/node/metastasis stage and the presence of lymph node metastases.">
    <entity charOffset="12-35" id="s204.e0" ontology_id="GO_0010587" text="miRNA catabolic process" type="GO"/>
    <entity charOffset="60-65" id="s204.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s204.e0" e2="s204.e1" id="s204.p0" relation="false"/>
  </sentence>
  <sentence id="s205" text="CONCLUSIONS The miRNA catabolic processA/let-7a/negative regulation of transcription by RNA polymerase II pathway is involved in cancer growth and malignant behavior in biological_process and is a potential target for therapeutic intervention in this disease">
    <entity charOffset="16-39" id="s205.e0" ontology_id="GO_0010587" text="miRNA catabolic process" type="GO"/>
    <entity charOffset="129-135" id="s205.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s205.e0" e2="s205.e1" id="s205.p0" relation="false"/>
  </sentence>
  <sentence id="s206" text="CONCLUSIONS The miRNA catabolic processA/let-7a/negative regulation of transcription by RNA polymerase II pathway is involved in cancer growth and malignant behavior in biological_process and is a potential target for therapeutic intervention in this disease">
    <entity charOffset="48-105" id="s206.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="129-135" id="s206.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s206.e0" e2="s206.e1" id="s206.p0" relation="true"/>
  </sentence>
  <sentence id="s207" text="CONCLUSIONS The miRNA catabolic processA/let-7a/negative regulation of transcription by RNA polymerase II pathway is involved in cancer growth and malignant behavior in biological_process and is a potential target for therapeutic intervention in this disease">
    <entity charOffset="129-135" id="s207.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="169-187" id="s207.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s207.e0" e2="s207.e1" id="s207.p0" relation="false"/>
  </sentence>
  <sentence id="s208" text="Mutations in depurination2 are associated with skeletal myopathies, characterized by ophthalmoplegia.">
    <entity charOffset="13-25" id="s208.e0" ontology_id="GO_0045007" text="depurination" type="GO"/>
    <entity charOffset="47-66" id="s208.e1" ontology_id="HP_0003756" text="skeletal myopathies" type="HP"/>
    <pair e1="s208.e0" e2="s208.e1" id="s208.p0" relation="false"/>
  </sentence>
  <sentence id="s209" text="Mutations in depurination2 are associated with skeletal myopathies, characterized by ophthalmoplegia.">
    <entity charOffset="13-25" id="s209.e0" ontology_id="GO_0045007" text="depurination" type="GO"/>
    <entity charOffset="85-100" id="s209.e1" ontology_id="HP_0000602" text="ophthalmoplegia" type="HP"/>
    <pair e1="s209.e0" e2="s209.e1" id="s209.p0" relation="false"/>
  </sentence>
  <sentence id="s210" text="Mutations in depurination3 and MYH8 are associated with distal arthrogryposis syndromes.">
    <entity charOffset="13-25" id="s210.e0" ontology_id="GO_0045007" text="depurination" type="GO"/>
    <entity charOffset="56-62" id="s210.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s210.e0" e2="s210.e1" id="s210.p0" relation="false"/>
  </sentence>
  <sentence id="s211" text="Mutations in depurination3 and MYH8 are associated with distal arthrogryposis syndromes.">
    <entity charOffset="13-25" id="s211.e0" ontology_id="GO_0045007" text="depurination" type="GO"/>
    <entity charOffset="63-77" id="s211.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s211.e0" e2="s211.e1" id="s211.p0" relation="false"/>
  </sentence>
  <sentence id="s212" text="Mutations in depurination7 are associated with not only skeletal muscle diseases, such as Laing distal myopathy and myosin storage myopathy, but also hypertrophic cardiomyopathy.">
    <entity charOffset="13-25" id="s212.e0" ontology_id="GO_0045007" text="depurination" type="GO"/>
    <entity charOffset="96-102" id="s212.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s212.e0" e2="s212.e1" id="s212.p0" relation="false"/>
  </sentence>
  <sentence id="s213" text="Mutations in depurination7 are associated with not only skeletal muscle diseases, such as Laing distal myopathy and myosin storage myopathy, but also hypertrophic cardiomyopathy.">
    <entity charOffset="13-25" id="s213.e0" ontology_id="GO_0045007" text="depurination" type="GO"/>
    <entity charOffset="103-111" id="s213.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s213.e0" e2="s213.e1" id="s213.p0" relation="false"/>
  </sentence>
  <sentence id="s214" text="On these bases, we investigated whether the ligation of ER by a selective agonist, the 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), could negative regulation of transcription by RNA polymerase II HL tumor growth.">
    <entity charOffset="140-197" id="s214.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="201-206" id="s214.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s214.e0" e2="s214.e1" id="s214.p0" relation="false"/>
  </sentence>
  <sentence id="s215" text="In nonobese diabetic/severe combined immunodeficient (NOD/SCID) epidermis development engrafted with HL cells, ER activation by DPN was able to reduce lymphoma growth up to 60% and this associated with the induction of tumor cell autophagy.">
    <entity charOffset="64-85" id="s215.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="220-225" id="s215.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s215.e0" e2="s215.e1" id="s215.p0" relation="false"/>
  </sentence>
  <sentence id="s216" text="After ER activation, both regulation of autophagy and protein 1 light chain 3 (LC3), a key actor in the autophagosome formation, strictly interacted each other and localized at mitochondrial level.Altogether these results suggest that targeting ER with selective agonists might affect HL cell proliferation and tumor growth via a mechanism that brings into play DRAM2-dependent autophagic cascade">
    <entity charOffset="27-50" id="s216.e0" ontology_id="GO_0010506" text="regulation of autophagy" type="GO"/>
    <entity charOffset="313-318" id="s216.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s216.e0" e2="s216.e1" id="s216.p0" relation="false"/>
  </sentence>
  <sentence id="s217" text="The oncogenic potential of circadian rhythm in terms of prognosis and cancer metastasis in arginine prototrophic gastric cancer (GC) remains unclear at present.">
    <entity charOffset="27-43" id="s217.e0" ontology_id="GO_0007623" text="circadian rhythm" type="GO"/>
    <entity charOffset="70-76" id="s217.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s217.e0" e2="s217.e1" id="s217.p0" relation="false"/>
  </sentence>
  <sentence id="s218" text="circadian rhythm was highly expressed in GC and positively correlated with GC aggressiveness and poor outcome.">
    <entity charOffset="0-16" id="s218.e0" ontology_id="GO_0007623" text="circadian rhythm" type="GO"/>
    <entity charOffset="78-92" id="s218.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s218.e0" e2="s218.e1" id="s218.p0" relation="false"/>
  </sentence>
  <sentence id="s219" text="Depletion of circadian rhythm led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, Snail, and Twist.">
    <entity charOffset="13-29" id="s219.e0" ontology_id="GO_0007623" text="circadian rhythm" type="GO"/>
    <entity charOffset="51-56" id="s219.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s219.e0" e2="s219.e1" id="s219.p0" relation="false"/>
  </sentence>
  <sentence id="s220" text="Ectopic expression of circadian rhythm in GC cells reversed these effects and protected cancer cells from chemotherapy drug-induced apoptosis via activation of the positive regulation of protein phosphorylation-mammalian target of rapamycin signaling pathway.">
    <entity charOffset="22-38" id="s220.e0" ontology_id="GO_0007623" text="circadian rhythm" type="GO"/>
    <entity charOffset="88-94" id="s220.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s220.e0" e2="s220.e1" id="s220.p0" relation="false"/>
  </sentence>
  <sentence id="s221" text="Ectopic expression of circadian rhythm in GC cells reversed these effects and protected cancer cells from chemotherapy drug-induced apoptosis via activation of the positive regulation of protein phosphorylation-mammalian target of rapamycin signaling pathway.">
    <entity charOffset="88-94" id="s221.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="164-210" id="s221.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s221.e0" e2="s221.e1" id="s221.p0" relation="true"/>
  </sentence>
  <sentence id="s222" text="Finally, we show that inhibition of peptidyl-lysine monomethylation cooperates with standard chemotherapy to treat PDAC cells and tumors.">
    <entity charOffset="36-67" id="s222.e0" ontology_id="GO_0018026" text="peptidyl-lysine monomethylation" type="GO"/>
    <entity charOffset="130-136" id="s222.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s222.e0" e2="s222.e1" id="s222.p0" relation="false"/>
  </sentence>
  <sentence id="s223" text="These findings uncover a pivotal role for peptidyl-lysine monomethylation in promoting pancreatic cancer.">
    <entity charOffset="42-73" id="s223.e0" ontology_id="GO_0018026" text="peptidyl-lysine monomethylation" type="GO"/>
    <entity charOffset="98-104" id="s223.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s223.e0" e2="s223.e1" id="s223.p0" relation="false"/>
  </sentence>
  <sentence id="s224" text="Mutations in SLC4A11, a Na&lt;sup&gt;+&lt;/sup&gt; dependent OH&lt;sup&gt;-&lt;/sup&gt; transporter, cause congenital hereditary endothelial dystrophy (phosphorylation of RNA polymerase II C-terminal domain) and Fuchs' endothelial corneal dystrophy (FECD), the two most common forms of endothelial degeneration.">
    <entity charOffset="128-182" id="s224.e0" ontology_id="GO_0070816" text="phosphorylation of RNA polymerase II C-terminal domain" type="GO"/>
    <entity charOffset="207-224" id="s224.e1" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <pair e1="s224.e0" e2="s224.e1" id="s224.p0" relation="false"/>
  </sentence>
  <sentence id="s225" text="Phase 2 occurs postnatally through adult stages with bone marrow production of granulocyte precursors and positive selection of mutants due to chronic positive regulation of phosphatidylinositol 3-kinase signaling therapy to reverse the severe neutropenia.">
    <entity charOffset="151-213" id="s225.e0" ontology_id="GO_0014068" text="positive regulation of phosphatidylinositol 3-kinase signaling" type="GO"/>
    <entity charOffset="244-255" id="s225.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s225.e0" e2="s225.e1" id="s225.p0" relation="false"/>
  </sentence>
  <sentence id="s226" text="The disease phenomuscle organ development comprises characteristic circumferential skin creases accompanied by intellectual disability, a cleft palate, short stature, and dysmorphic features.">
    <entity charOffset="17-41" id="s226.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="111-134" id="s226.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s226.e0" e2="s226.e1" id="s226.p0" relation="false"/>
  </sentence>
  <sentence id="s227" text="Previous investigations have demonstrated that single nucleotide polymorphisms (SNPs) of positive regulation of cholesterol transport pathway genes were associated with various types of cancer.">
    <entity charOffset="89-133" id="s227.e0" ontology_id="GO_0032376" text="positive regulation of cholesterol transport" type="GO"/>
    <entity charOffset="186-192" id="s227.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s227.e0" e2="s227.e1" id="s227.p0" relation="false"/>
  </sentence>
  <sentence id="s228" text="Therefore, we conducted genotyping for 17 SNPs of six positive regulation of cholesterol transport core genes (&lt;i&gt;XPA, nucleotide-excision repair, DNA damage recognition, XPG, ERCC1, ERCC2&lt;/i&gt;, and &lt;i&gt;ERCC4&lt;/i&gt;) in 89 ovarian cancer cases and 356 cancer-free controls.">
    <entity charOffset="54-98" id="s228.e0" ontology_id="GO_0032376" text="positive regulation of cholesterol transport" type="GO"/>
    <entity charOffset="226-232" id="s228.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s228.e0" e2="s228.e1" id="s228.p0" relation="false"/>
  </sentence>
  <sentence id="s229" text="Therefore, we conducted genotyping for 17 SNPs of six positive regulation of cholesterol transport core genes (&lt;i&gt;XPA, nucleotide-excision repair, DNA damage recognition, XPG, ERCC1, ERCC2&lt;/i&gt;, and &lt;i&gt;ERCC4&lt;/i&gt;) in 89 ovarian cancer cases and 356 cancer-free controls.">
    <entity charOffset="119-169" id="s229.e0" ontology_id="GO_0000715" text="nucleotide-excision repair, DNA damage recognition" type="GO"/>
    <entity charOffset="226-232" id="s229.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s229.e0" e2="s229.e1" id="s229.p0" relation="true"/>
  </sentence>
  <sentence id="s230" text="The result showed that both &lt;i&gt;nucleotide-excision repair&lt;/i&gt; rs11615 and &lt;i&gt;nucleotide-excision repair, DNA damage recognition&lt;/i&gt; rs2228000 were significantly associated with reduced risk of ovarian cancer under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20-0.61, &lt;i&gt;P&lt;/i&gt;=0.0002 and adjusted OR = 0.49, 95% CI = 0.30-0.81, &lt;i&gt;P&lt;/i&gt;=0.005 respectively).">
    <entity charOffset="31-57" id="s230.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="201-207" id="s230.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s230.e0" e2="s230.e1" id="s230.p0" relation="false"/>
  </sentence>
  <sentence id="s231" text="The result showed that both &lt;i&gt;nucleotide-excision repair&lt;/i&gt; rs11615 and &lt;i&gt;nucleotide-excision repair, DNA damage recognition&lt;/i&gt; rs2228000 were significantly associated with reduced risk of ovarian cancer under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20-0.61, &lt;i&gt;P&lt;/i&gt;=0.0002 and adjusted OR = 0.49, 95% CI = 0.30-0.81, &lt;i&gt;P&lt;/i&gt;=0.005 respectively).">
    <entity charOffset="77-127" id="s231.e0" ontology_id="GO_0000715" text="nucleotide-excision repair, DNA damage recognition" type="GO"/>
    <entity charOffset="201-207" id="s231.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s231.e0" e2="s231.e1" id="s231.p0" relation="true"/>
  </sentence>
  <sentence id="s232" text="In addition, &lt;i&gt;nucleotide-excision repair, DNA damage recognition&lt;/i&gt; rs2228001 and &lt;i&gt;ERCC2&lt;/i&gt; rs238406 had statistically significant association with the increased risk of ovarian cancer under dominant genetic model (adjusted OR = 1.72, 95% CI = 1.02-2.92, &lt;i&gt;P&lt;/i&gt;=0.043 and adjusted OR = 2.07, 95% CI = 1.07-4.01, &lt;i&gt;P&lt;/i&gt;=0.032 respectively).">
    <entity charOffset="16-66" id="s232.e0" ontology_id="GO_0000715" text="nucleotide-excision repair, DNA damage recognition" type="GO"/>
    <entity charOffset="184-190" id="s232.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s232.e0" e2="s232.e1" id="s232.p0" relation="true"/>
  </sentence>
  <sentence id="s233" text="&lt;i&gt;nucleotide-excision repair&lt;/i&gt; rs3212986 were related with the increased risk of ovarian cancer under recessive model (adjusted OR = 2.40, 95% CI = 1.30-4.44, &lt;i&gt;P&lt;/i&gt;=0.005).">
    <entity charOffset="3-29" id="s233.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="92-98" id="s233.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s233.e0" e2="s233.e1" id="s233.p0" relation="false"/>
  </sentence>
  <sentence id="s234" text="In conclusion, our results indicated that &lt;i&gt;nucleotide-excision repair, nucleotide-excision repair, DNA damage recognition&lt;/i&gt; and &lt;i&gt;ERCC2&lt;/i&gt; might influence ovarian cancer susceptibility.">
    <entity charOffset="45-71" id="s234.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="169-175" id="s234.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s234.e0" e2="s234.e1" id="s234.p0" relation="false"/>
  </sentence>
  <sentence id="s235" text="In conclusion, our results indicated that &lt;i&gt;nucleotide-excision repair, nucleotide-excision repair, DNA damage recognition&lt;/i&gt; and &lt;i&gt;ERCC2&lt;/i&gt; might influence ovarian cancer susceptibility.">
    <entity charOffset="73-123" id="s235.e0" ontology_id="GO_0000715" text="nucleotide-excision repair, DNA damage recognition" type="GO"/>
    <entity charOffset="169-175" id="s235.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s235.e0" e2="s235.e1" id="s235.p0" relation="true"/>
  </sentence>
  <sentence id="s236" text="Historically classified as a subtype of hepatocellular carcinoma (phosphatidylinositol phosphorylation), FLC has a unique clinical, histological, and molecular presentation.">
    <entity charOffset="40-64" id="s236.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="66-102" id="s236.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s236.e0" e2="s236.e1" id="s236.p0" relation="false"/>
  </sentence>
  <sentence id="s237" text="High negative regulation of epithelial cell migration expression plays an important role in promoting tumor development and aggressiveness, which is correlated with reduced patient survival.">
    <entity charOffset="5-53" id="s237.e0" ontology_id="GO_0010633" text="negative regulation of epithelial cell migration" type="GO"/>
    <entity charOffset="102-107" id="s237.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s237.e0" e2="s237.e1" id="s237.p0" relation="false"/>
  </sentence>
  <sentence id="s238" text="High negative regulation of epithelial cell migration expression plays an important role in promoting tumor development and aggressiveness, which is correlated with reduced patient survival.">
    <entity charOffset="5-53" id="s238.e0" ontology_id="GO_0010633" text="negative regulation of epithelial cell migration" type="GO"/>
    <entity charOffset="124-138" id="s238.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s238.e0" e2="s238.e1" id="s238.p0" relation="false"/>
  </sentence>
  <sentence id="s239" text="Mutations in the photoreceptor tetraspanin gene peripherin-2/retinal degeneration slow (PRPH2/cell adhesion) cause both rod- and cone-dominant diseases.">
    <entity charOffset="61-81" id="s239.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="94-107" id="s239.e1" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <pair e1="s239.e0" e2="s239.e1" id="s239.p0" relation="true"/>
  </sentence>
  <sentence id="s240" text="Here we took advantage of a transgenic mouse line expressing an cell adhesion mutant (R172W) known to cause macular degeneration (MD) in humans.">
    <entity charOffset="64-77" id="s240.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="108-128" id="s240.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s240.e0" e2="s240.e1" id="s240.p0" relation="true"/>
  </sentence>
  <sentence id="s241" text="Fundus imaging demonstrated that R172W epidermis development developed severe clinical signs of disease nearly identical to those seen in human MD patients, including retinal degeneration, retinal pigment epithlium (RPE) defects and loss of the choriocapillaris.">
    <entity charOffset="39-60" id="s241.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="167-187" id="s241.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s241.e0" e2="s241.e1" id="s241.p0" relation="false"/>
  </sentence>
  <sentence id="s242" text="Mucopolysaccharidosis (MPS) muscle organ development I is a rare autosomal recessive disease caused by a deficiency of the lysosomal enzyme -L-iduronidase.">
    <entity charOffset="28-52" id="s242.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="65-84" id="s242.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s242.e0" e2="s242.e1" id="s242.p0" relation="true"/>
  </sentence>
  <sentence id="s243" text="Next, we took epicardial positive regulation of cell-matrix adhesion samples from patients with valvular heart disease and non- coronary artery disease.">
    <entity charOffset="25-68" id="s243.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="96-118" id="s243.e1" ontology_id="HP_0001654" text="valvular heart disease" type="HP"/>
    <pair e1="s243.e0" e2="s243.e1" id="s243.p0" relation="false"/>
  </sentence>
  <sentence id="s244" text="Before performing PET scans, subjects answered the Buss-Perry Aggression Questionnaire and Temperament and Character Inventory to measure their aggression and personality negative regulation of transcription by RNA polymerase II, respectively.">
    <entity charOffset="144-154" id="s244.e0" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <entity charOffset="171-228" id="s244.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s244.e0" e2="s244.e1" id="s244.p0" relation="false"/>
  </sentence>
  <sentence id="s245" text="Females showed associations between androgen catabolic process levels in subcortical regions, such as the amygdala and supraoptic nucleus of the hypothalamus, and personality traits such as aggression, novelty seeking, and self-transcendence.">
    <entity charOffset="36-62" id="s245.e0" ontology_id="GO_0006710" text="androgen catabolic process" type="GO"/>
    <entity charOffset="190-200" id="s245.e1" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <pair e1="s245.e0" e2="s245.e1" id="s245.p0" relation="false"/>
  </sentence>
  <sentence id="s246" text="Concordant modulation of IRGs in both epidermis development and human cells indicates that they might play important roles in regulating CHIKV replication in the central nervous system (CNS).">
    <entity charOffset="38-59" id="s246.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="162-169" id="s246.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s246.e0" e2="s246.e1" id="s246.p0" relation="false"/>
  </sentence>
  <sentence id="s247" text="Generalized arterial calcification of infancy (GACI), or idiopathic infantile arterial calcification, is a rare autosomal-recessive disease recognized aAs an inherited disorder characterized by severe pathologic calcification of large- and medium-sized arteries accompanied by smooth muscle cell (Golgi organization) hyperplasia leading to vascular obstruction [1].">
    <entity charOffset="12-34" id="s247.e0" ontology_id="HP_0003207" text="arterial calcification" type="HP"/>
    <entity charOffset="297-315" id="s247.e1" ontology_id="GO_0007030" text="Golgi organization" type="GO"/>
    <pair e1="s247.e0" e2="s247.e1" id="s247.p0" relation="false"/>
  </sentence>
  <sentence id="s248" text="The aim this study was to investigate the prevalence of single nucleotide polymorphisms in angiogenesis gene (LEP 3'UTR A/C, -2548G/A) and LEPR (K109R and Q223R) and their association with Leptin level and obesity.">
    <entity charOffset="91-103" id="s248.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="207-214" id="s248.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s248.e0" e2="s248.e1" id="s248.p0" relation="true"/>
  </sentence>
  <sentence id="s249" text="The K109R polymorphism was associated with obesity (P=.025) and seems to significantly decrease the angiogenesis levels (P&amp;lt;.001).">
    <entity charOffset="43-50" id="s249.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="102-114" id="s249.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s249.e0" e2="s249.e1" id="s249.p0" relation="true"/>
  </sentence>
  <sentence id="s250" text="De novo variants of histone H3-K36 dimethylation, which encodes a histone methyltransferase, have been reported in a few patients with intellectual disability and autistic features.">
    <entity charOffset="20-48" id="s250.e0" ontology_id="GO_0097676" text="histone H3-K36 dimethylation" type="GO"/>
    <entity charOffset="135-158" id="s250.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s250.e0" e2="s250.e1" id="s250.p0" relation="true"/>
  </sentence>
  <sentence id="s251" text="Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in histone H3-K36 dimethylation in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.">
    <entity charOffset="118-146" id="s251.e0" ontology_id="GO_0097676" text="histone H3-K36 dimethylation" type="GO"/>
    <entity charOffset="213-232" id="s251.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s251.e0" e2="s251.e1" id="s251.p0" relation="true"/>
  </sentence>
  <sentence id="s252" text="Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in histone H3-K36 dimethylation in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.">
    <entity charOffset="118-146" id="s252.e0" ontology_id="GO_0097676" text="histone H3-K36 dimethylation" type="GO"/>
    <entity charOffset="299-310" id="s252.e1" ontology_id="HP_0010535" text="sleep apnea" type="HP"/>
    <pair e1="s252.e0" e2="s252.e1" id="s252.p0" relation="false"/>
  </sentence>
  <sentence id="s253" text="Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in histone H3-K36 dimethylation in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.">
    <entity charOffset="118-146" id="s253.e0" ontology_id="GO_0097676" text="histone H3-K36 dimethylation" type="GO"/>
    <entity charOffset="316-325" id="s253.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s253.e0" e2="s253.e1" id="s253.p0" relation="false"/>
  </sentence>
  <sentence id="s254" text="Our report provides further evidence to support loss-of-function alterations of histone H3-K36 dimethylation as causative for an emergent neurodevelopmental syndrome characterized by MCA, intellectual disability, and behavioral problems, and further delineates this genetic disorder">
    <entity charOffset="80-108" id="s254.e0" ontology_id="GO_0097676" text="histone H3-K36 dimethylation" type="GO"/>
    <entity charOffset="188-211" id="s254.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s254.e0" e2="s254.e1" id="s254.p0" relation="true"/>
  </sentence>
  <sentence id="s255" text="Our report provides further evidence to support loss-of-function alterations of histone H3-K36 dimethylation as causative for an emergent neurodevelopmental syndrome characterized by MCA, intellectual disability, and behavioral problems, and further delineates this genetic disorder">
    <entity charOffset="80-108" id="s255.e0" ontology_id="GO_0097676" text="histone H3-K36 dimethylation" type="GO"/>
    <entity charOffset="217-236" id="s255.e1" ontology_id="HP_0000708" text="behavioral problems" type="HP"/>
    <pair e1="s255.e0" e2="s255.e1" id="s255.p0" relation="true"/>
  </sentence>
  <sentence id="s256" text="Aberrant expression of negative regulation of receptor recycling-containing protein 44 (TRIM44) acts as a promoter in multiple cancers.">
    <entity charOffset="23-64" id="s256.e0" ontology_id="GO_0001920" text="negative regulation of receptor recycling" type="GO"/>
    <entity charOffset="127-133" id="s256.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s256.e0" e2="s256.e1" id="s256.p0" relation="false"/>
  </sentence>
  <sentence id="s257" text="Here, we investigated the biological functions and clinical significance of TRIM44 in human esophageal cancer (establishment of mitotic spindle orientation).">
    <entity charOffset="103-109" id="s257.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="111-155" id="s257.e1" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <pair e1="s257.e0" e2="s257.e1" id="s257.p0" relation="false"/>
  </sentence>
  <sentence id="s258" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s258.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="159-181" id="s258.e1" ontology_id="GO_0048251" text="elastic fiber assembly" type="GO"/>
    <pair e1="s258.e0" e2="s258.e1" id="s258.p0" relation="false"/>
  </sentence>
  <sentence id="s259" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s259.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="278-315" id="s259.e1" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <pair e1="s259.e0" e2="s259.e1" id="s259.p0" relation="false"/>
  </sentence>
  <sentence id="s260" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s260.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="324-344" id="s260.e1" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <pair e1="s260.e0" e2="s260.e1" id="s260.p0" relation="false"/>
  </sentence>
  <sentence id="s261" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="139-147" id="s261.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="352-398" id="s261.e1" ontology_id="GO_0032388" text="positive regulation of intracellular transport" type="GO"/>
    <pair e1="s261.e0" e2="s261.e1" id="s261.p0" relation="false"/>
  </sentence>
  <sentence id="s262" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="159-181" id="s262.e0" ontology_id="GO_0048251" text="elastic fiber assembly" type="GO"/>
    <entity charOffset="408-427" id="s262.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s262.e0" e2="s262.e1" id="s262.p0" relation="false"/>
  </sentence>
  <sentence id="s263" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="159-181" id="s263.e0" ontology_id="GO_0048251" text="elastic fiber assembly" type="GO"/>
    <entity charOffset="428-439" id="s263.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s263.e0" e2="s263.e1" id="s263.p0" relation="false"/>
  </sentence>
  <sentence id="s264" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="207-259" id="s264.e0" ontology_id="GO_0030838" text="positive regulation of actin filament polymerization" type="GO"/>
    <entity charOffset="408-427" id="s264.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s264.e0" e2="s264.e1" id="s264.p0" relation="false"/>
  </sentence>
  <sentence id="s265" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="207-259" id="s265.e0" ontology_id="GO_0030838" text="positive regulation of actin filament polymerization" type="GO"/>
    <entity charOffset="428-439" id="s265.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s265.e0" e2="s265.e1" id="s265.p0" relation="false"/>
  </sentence>
  <sentence id="s266" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="278-315" id="s266.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="408-427" id="s266.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s266.e0" e2="s266.e1" id="s266.p0" relation="false"/>
  </sentence>
  <sentence id="s267" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="278-315" id="s267.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="428-439" id="s267.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s267.e0" e2="s267.e1" id="s267.p0" relation="false"/>
  </sentence>
  <sentence id="s268" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="324-344" id="s268.e0" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <entity charOffset="408-427" id="s268.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s268.e0" e2="s268.e1" id="s268.p0" relation="false"/>
  </sentence>
  <sentence id="s269" text="The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.">
    <entity charOffset="352-398" id="s269.e0" ontology_id="GO_0032388" text="positive regulation of intracellular transport" type="GO"/>
    <entity charOffset="408-427" id="s269.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s269.e0" e2="s269.e1" id="s269.p0" relation="true"/>
  </sentence>
  <sentence id="s270" text="Two sisters with c.137T&amp;gt;C (p.Leu46Pro) GPI anchor biosynthetic process variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.">
    <entity charOffset="42-73" id="s270.e0" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <entity charOffset="131-139" id="s270.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s270.e0" e2="s270.e1" id="s270.p0" relation="true"/>
  </sentence>
  <sentence id="s271" text="Two sisters with c.137T&amp;gt;C (p.Leu46Pro) GPI anchor biosynthetic process variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.">
    <entity charOffset="42-73" id="s271.e0" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <entity charOffset="148-167" id="s271.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s271.e0" e2="s271.e1" id="s271.p0" relation="true"/>
  </sentence>
  <sentence id="s272" text="Two sisters with c.137T&amp;gt;C (p.Leu46Pro) GPI anchor biosynthetic process variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.">
    <entity charOffset="42-73" id="s272.e0" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <entity charOffset="169-178" id="s272.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s272.e0" e2="s272.e1" id="s272.p0" relation="true"/>
  </sentence>
  <sentence id="s273" text="Mutations in the homeobox gene positive regulation of transcription by RNA polymerase II cause SHOX deficiency, a condition with clinical manifestations ranging from short stature without dysmorphic signs to severe mesomelic skeletal dysplasia.">
    <entity charOffset="31-88" id="s273.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="166-179" id="s273.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s273.e0" e2="s273.e1" id="s273.p0" relation="true"/>
  </sentence>
  <sentence id="s274" text="Mutations in the homeobox gene positive regulation of transcription by RNA polymerase II cause SHOX deficiency, a condition with clinical manifestations ranging from short stature without dysmorphic signs to severe mesomelic skeletal dysplasia.">
    <entity charOffset="31-88" id="s274.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="225-243" id="s274.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s274.e0" e2="s274.e1" id="s274.p0" relation="false"/>
  </sentence>
  <sentence id="s275" text="Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, lipid metabolic process, S-adenosylmethionine metabolic process, apoptotic process, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="226-249" id="s275.e0" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <entity charOffset="479-503" id="s275.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s275.e0" e2="s275.e1" id="s275.p0" relation="false"/>
  </sentence>
  <sentence id="s276" text="Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, lipid metabolic process, S-adenosylmethionine metabolic process, apoptotic process, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="251-289" id="s276.e0" ontology_id="GO_0046500" text="S-adenosylmethionine metabolic process" type="GO"/>
    <entity charOffset="479-503" id="s276.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s276.e0" e2="s276.e1" id="s276.p0" relation="false"/>
  </sentence>
  <sentence id="s277" text="Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, lipid metabolic process, S-adenosylmethionine metabolic process, apoptotic process, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="291-308" id="s277.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="479-503" id="s277.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s277.e0" e2="s277.e1" id="s277.p0" relation="false"/>
  </sentence>
  <sentence id="s278" text="Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, lipid metabolic process, S-adenosylmethionine metabolic process, apoptotic process, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="479-503" id="s278.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="505-541" id="s278.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s278.e0" e2="s278.e1" id="s278.p0" relation="false"/>
  </sentence>
  <sentence id="s279" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="100-131" id="s279.e0" ontology_id="GO_0006883" text="cellular sodium ion homeostasis" type="GO"/>
    <entity charOffset="323-336" id="s279.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s279.e0" e2="s279.e1" id="s279.p0" relation="true"/>
  </sentence>
  <sentence id="s280" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="208-214" id="s280.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="227-315" id="s280.e1" ontology_id="GO_0000463" text="maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" type="GO"/>
    <pair e1="s280.e0" e2="s280.e1" id="s280.p0" relation="false"/>
  </sentence>
  <sentence id="s281" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="216-225" id="s281.e0" ontology_id="HP_0001284" text="areflexia" type="HP"/>
    <entity charOffset="227-315" id="s281.e1" ontology_id="GO_0000463" text="maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" type="GO"/>
    <pair e1="s281.e0" e2="s281.e1" id="s281.p0" relation="false"/>
  </sentence>
  <sentence id="s282" text="The genetic testing revealed a de novo heterozygous mutation of c.2452G&amp;gt;A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.">
    <entity charOffset="227-315" id="s282.e0" ontology_id="GO_0000463" text="maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" type="GO"/>
    <entity charOffset="323-336" id="s282.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s282.e0" e2="s282.e1" id="s282.p0" relation="false"/>
  </sentence>
  <sentence id="s283" text="Although mammalian homotypic cell-cell adhesion is expressed in the central nervous system as well as in skeletal muscle, patients carrying mutations in MEGF10 do not show symptoms of central nervous system dysfunction.">
    <entity charOffset="19-47" id="s283.e0" ontology_id="GO_0034109" text="homotypic cell-cell adhesion" type="GO"/>
    <entity charOffset="68-75" id="s283.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s283.e0" e2="s283.e1" id="s283.p0" relation="false"/>
  </sentence>
  <sentence id="s284" text="The histological and behavioral abnormalities seen in the affected flies negative regulation of transcription, DNA-templated the stage for further studies examining the signaling pathway modulated by homotypic cell-cell adhesion/Drpr in muscle, as well as assessing the effects of genetic and/or pharmacological manipulations on the observed muscle defects.">
    <entity charOffset="21-45" id="s284.e0" ontology_id="HP_0000708" text="behavioral abnormalities" type="HP"/>
    <entity charOffset="200-228" id="s284.e1" ontology_id="GO_0034109" text="homotypic cell-cell adhesion" type="GO"/>
    <pair e1="s284.e0" e2="s284.e1" id="s284.p0" relation="false"/>
  </sentence>
  <sentence id="s285" text="The histological and behavioral abnormalities seen in the affected flies negative regulation of transcription, DNA-templated the stage for further studies examining the signaling pathway modulated by homotypic cell-cell adhesion/Drpr in muscle, as well as assessing the effects of genetic and/or pharmacological manipulations on the observed muscle defects.">
    <entity charOffset="21-45" id="s285.e0" ontology_id="HP_0000708" text="behavioral abnormalities" type="HP"/>
    <entity charOffset="73-124" id="s285.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s285.e0" e2="s285.e1" id="s285.p0" relation="false"/>
  </sentence>
  <sentence id="s286" text="The present study screened pathogenic genes, ectodysplasinA (positive regulation of NF-kappaB transcription factor activity) and lamin A/C (positive regulation of cell aging), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.">
    <entity charOffset="62-124" id="s286.e0" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <entity charOffset="215-233" id="s286.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s286.e0" e2="s286.e1" id="s286.p0" relation="false"/>
  </sentence>
  <sentence id="s287" text="The present study screened pathogenic genes, ectodysplasinA (positive regulation of NF-kappaB transcription factor activity) and lamin A/C (positive regulation of cell aging), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.">
    <entity charOffset="141-174" id="s287.e0" ontology_id="GO_0090343" text="positive regulation of cell aging" type="GO"/>
    <entity charOffset="215-233" id="s287.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s287.e0" e2="s287.e1" id="s287.p0" relation="true"/>
  </sentence>
  <sentence id="s288" text="The present study screened pathogenic genes, ectodysplasinA (positive regulation of NF-kappaB transcription factor activity) and lamin A/C (positive regulation of cell aging), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.">
    <entity charOffset="141-174" id="s288.e0" ontology_id="GO_0090343" text="positive regulation of cell aging" type="GO"/>
    <entity charOffset="281-299" id="s288.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s288.e0" e2="s288.e1" id="s288.p0" relation="true"/>
  </sentence>
  <sentence id="s289" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="122-179" id="s289.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="373-391" id="s289.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s289.e0" e2="s289.e1" id="s289.p0" relation="false"/>
  </sentence>
  <sentence id="s290" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="122-179" id="s290.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="340-348" id="s290.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s290.e0" e2="s290.e1" id="s290.p0" relation="true"/>
  </sentence>
  <sentence id="s291" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="122-179" id="s291.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="350-362" id="s291.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s291.e0" e2="s291.e1" id="s291.p0" relation="false"/>
  </sentence>
  <sentence id="s292" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="234-263" id="s292.e0" ontology_id="GO_0043087" text="regulation of GTPase activity" type="GO"/>
    <entity charOffset="373-391" id="s292.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s292.e0" e2="s292.e1" id="s292.p0" relation="true"/>
  </sentence>
  <sentence id="s293" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="234-263" id="s293.e0" ontology_id="GO_0043087" text="regulation of GTPase activity" type="GO"/>
    <entity charOffset="340-348" id="s293.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s293.e0" e2="s293.e1" id="s293.p0" relation="false"/>
  </sentence>
  <sentence id="s294" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="292-323" id="s294.e0" ontology_id="GO_0060070" text="canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="373-391" id="s294.e1" ontology_id="HP_0000951" text="skin abnormalities" type="HP"/>
    <pair e1="s294.e0" e2="s294.e1" id="s294.p0" relation="true"/>
  </sentence>
  <sentence id="s295" text="The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit1 (regulation of GTPase activity) and Wnt family member10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.">
    <entity charOffset="292-323" id="s295.e0" ontology_id="GO_0060070" text="canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="340-348" id="s295.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s295.e0" e2="s295.e1" id="s295.p0" relation="false"/>
  </sentence>
  <sentence id="s296" text="Crizotinib is a small orally-administered phosphorylation inhibitor for patients with non-small cell lung cancer with mitotic cell cycle-ALK rearrangement (echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase).">
    <entity charOffset="42-57" id="s296.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="106-112" id="s296.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s296.e0" e2="s296.e1" id="s296.p0" relation="true"/>
  </sentence>
  <sentence id="s297" text="Crizotinib is a small orally-administered phosphorylation inhibitor for patients with non-small cell lung cancer with mitotic cell cycle-ALK rearrangement (echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase).">
    <entity charOffset="106-112" id="s297.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="118-136" id="s297.e1" ontology_id="GO_0000278" text="mitotic cell cycle" type="GO"/>
    <pair e1="s297.e0" e2="s297.e1" id="s297.p0" relation="false"/>
  </sentence>
  <sentence id="s298" text="Lactate dehydrogenase A (pyruvate metabolic process), a key enzyme in glycolysis, is highly expressed in a variety of tumors and catalyzes pyruvate to lactate.">
    <entity charOffset="25-51" id="s298.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="118-123" id="s298.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s298.e0" e2="s298.e1" id="s298.p0" relation="false"/>
  </sentence>
  <sentence id="s299" text="In the present study, we first analyzed the association and clinical significance of p53 and pyruvate metabolic process in breast cancer expressing wild-type p53 (wt-p53) and found that LDHA mRNA levels are negatively correlated with wt-p53 but not with mutation p53 mRNA levels, and low p53 and high LDHA expression are significantly associated with poor overall survival rates.">
    <entity charOffset="93-119" id="s299.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="130-136" id="s299.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s299.e0" e2="s299.e1" id="s299.p0" relation="false"/>
  </sentence>
  <sentence id="s300" text="Moreover, a series of pyruvate metabolic process gain-of-function and rescore experiments were carried out in breast cancer MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and tumor formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.">
    <entity charOffset="22-48" id="s300.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="117-123" id="s300.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s300.e0" e2="s300.e1" id="s300.p0" relation="false"/>
  </sentence>
  <sentence id="s301" text="In conclusion, our findings showed that repression of pyruvate metabolic process induced by wt-p53 blocks tumor growth and invasion through downregulation of aerobic glycolysis in breast cancer, providing new insights into the mechanism by which p53 contributes to the development and progression of breast cancer">
    <entity charOffset="54-80" id="s301.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="106-111" id="s301.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s301.e0" e2="s301.e1" id="s301.p0" relation="false"/>
  </sentence>
  <sentence id="s302" text="In conclusion, our findings showed that repression of pyruvate metabolic process induced by wt-p53 blocks tumor growth and invasion through downregulation of aerobic glycolysis in breast cancer, providing new insights into the mechanism by which p53 contributes to the development and progression of breast cancer">
    <entity charOffset="54-80" id="s302.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="187-193" id="s302.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s302.e0" e2="s302.e1" id="s302.p0" relation="false"/>
  </sentence>
  <sentence id="s303" text="However, the significance of MAPK cascade overexpression in human breast cancer (HBC) remains to be investigated.">
    <entity charOffset="29-41" id="s303.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="73-79" id="s303.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s303.e0" e2="s303.e1" id="s303.p0" relation="false"/>
  </sentence>
  <sentence id="s304" text="Inhibition of ER by its siRNA or tamoxifen reduces cellular levels of MAPK cascade and Pol III gene expression and decreases the rate of colony formation of breast cancer cells.">
    <entity charOffset="71-83" id="s304.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="165-171" id="s304.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s304.e0" e2="s304.e1" id="s304.p0" relation="false"/>
  </sentence>
  <sentence id="s305" text="The most important finding is the recurrently mutated gene, transcription, DNA-templated, which has never been reported in parathyroid tumors before.">
    <entity charOffset="60-88" id="s305.e0" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <entity charOffset="135-140" id="s305.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s305.e0" e2="s305.e1" id="s305.p0" relation="false"/>
  </sentence>
  <sentence id="s306" text="Moreover, we identified two different somatic mutations in the negative regulation of cell proliferation gene and one somatic mutation in the negative regulation of transcription by RNA polymerase II gene.">
    <entity charOffset="38-54" id="s306.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="63-104" id="s306.e1" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <pair e1="s306.e0" e2="s306.e1" id="s306.p0" relation="true"/>
  </sentence>
  <sentence id="s307" text="Moreover, we identified two different somatic mutations in the negative regulation of cell proliferation gene and one somatic mutation in the negative regulation of transcription by RNA polymerase II gene.">
    <entity charOffset="38-54" id="s307.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="142-199" id="s307.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s307.e0" e2="s307.e1" id="s307.p0" relation="false"/>
  </sentence>
  <sentence id="s308" text="The Y54X mutation in the negative regulation of cell proliferation gene was previously identified in parathyroid carcinomas, which proved that parathyroid adenomas and carcinomas might possess similar molecular signatures.">
    <entity charOffset="25-66" id="s308.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="101-123" id="s308.e1" ontology_id="HP_0006780" text="parathyroid carcinomas" type="HP"/>
    <pair e1="s308.e0" e2="s308.e1" id="s308.p0" relation="true"/>
  </sentence>
  <sentence id="s309" text="Non-alcoholic steatohepatitis (NASH) is commonly associated with obesity, muscle organ development 2 diabetes, and/or hypertriglyceridemia, while alcoholic steatohepatitis (ASH) is associated with alcohol abuse.">
    <entity charOffset="65-72" id="s309.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="74-98" id="s309.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s309.e0" e2="s309.e1" id="s309.p0" relation="false"/>
  </sentence>
  <sentence id="s310" text="The congenital myasthenic syndromes (actin filament organization) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms.">
    <entity charOffset="37-64" id="s310.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="70-83" id="s310.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s310.e0" e2="s310.e1" id="s310.p0" relation="false"/>
  </sentence>
  <sentence id="s311" text="In a patient with Leigh-like syndrome presenting with leukodystrophy and severe epilepsy, we identified a homozygous splice site mutation in generation of precursor metabolites and energy, which codes for the ubiquitously expressed isoform of subunit VIII, the smallest nuclear-encoded subunit of complex IV.">
    <entity charOffset="80-88" id="s311.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="141-187" id="s311.e1" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <pair e1="s311.e0" e2="s311.e1" id="s311.p0" relation="true"/>
  </sentence>
  <sentence id="s312" text="The purpose of this study is to investigate whether G protein-coupled receptor signaling pathway can modulate the osteoclastogenesis induced by monocyte chemotaxis or cancer cells.">
    <entity charOffset="52-96" id="s312.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="167-173" id="s312.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s312.e0" e2="s312.e1" id="s312.p0" relation="false"/>
  </sentence>
  <sentence id="s313" text="The purpose of this study is to investigate whether G protein-coupled receptor signaling pathway can modulate the osteoclastogenesis induced by monocyte chemotaxis or cancer cells.">
    <entity charOffset="144-163" id="s313.e0" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <entity charOffset="167-173" id="s313.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s313.e0" e2="s313.e1" id="s313.p0" relation="false"/>
  </sentence>
  <sentence id="s314" text="We found that G protein-coupled receptor signaling pathway inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of protein polyubiquitination and peripheral nervous system development-B activation.">
    <entity charOffset="14-58" id="s314.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="78-84" id="s314.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s314.e0" e2="s314.e1" id="s314.p0" relation="false"/>
  </sentence>
  <sentence id="s315" text="We found that G protein-coupled receptor signaling pathway inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of protein polyubiquitination and peripheral nervous system development-B activation.">
    <entity charOffset="78-84" id="s315.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-160" id="s315.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s315.e0" e2="s315.e1" id="s315.p0" relation="false"/>
  </sentence>
  <sentence id="s316" text="We found that G protein-coupled receptor signaling pathway inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of protein polyubiquitination and peripheral nervous system development-B activation.">
    <entity charOffset="78-84" id="s316.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="165-202" id="s316.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s316.e0" e2="s316.e1" id="s316.p0" relation="false"/>
  </sentence>
  <sentence id="s317" text="Almost all are inherited in autosomal recessive patterns with a few exceptions such as the X-linked dolichol-linked oligosaccharide biosynthetic process.">
    <entity charOffset="28-47" id="s317.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="100-152" id="s317.e1" ontology_id="GO_0006488" text="dolichol-linked oligosaccharide biosynthetic process" type="GO"/>
    <pair e1="s317.e0" e2="s317.e1" id="s317.p0" relation="false"/>
  </sentence>
  <sentence id="s318" text="Here, we show that tamoxifen, a well-known drug used against breast cancer, rescues the phenotype of protein dephosphorylation-deficient mice.">
    <entity charOffset="68-74" id="s318.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="101-126" id="s318.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s318.e0" e2="s318.e1" id="s318.p0" relation="true"/>
  </sentence>
  <sentence id="s319" text="Congenital dyserythropoietic anemia muscle organ development I (chromatin organization) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.">
    <entity charOffset="36-60" id="s319.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="98-117" id="s319.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s319.e0" e2="s319.e1" id="s319.p0" relation="true"/>
  </sentence>
  <sentence id="s320" text="Congenital dyserythropoietic anemia muscle organ development I (chromatin organization) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.">
    <entity charOffset="64-86" id="s320.e0" ontology_id="GO_0006325" text="chromatin organization" type="GO"/>
    <entity charOffset="98-117" id="s320.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s320.e0" e2="s320.e1" id="s320.p0" relation="true"/>
  </sentence>
  <sentence id="s321" text="Congenital dyserythropoietic anemia muscle organ development I (chromatin organization) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.">
    <entity charOffset="64-86" id="s321.e0" ontology_id="GO_0006325" text="chromatin organization" type="GO"/>
    <entity charOffset="162-188" id="s321.e1" ontology_id="HP_0010972" text="ineffective erythropoiesis" type="HP"/>
    <pair e1="s321.e0" e2="s321.e1" id="s321.p0" relation="true"/>
  </sentence>
  <sentence id="s322" text="Main complications were due to anemia and ineffective erythropoiesis [osteoporosis (8/9, 89%), cholelithiasis (21/30, 70%), pulmonary arterial hypertension (L-phenylalanine catabolic process) (6/25, 24%)] and iron overload [hypothyroidism (9/24, 38%), and diabetes mellitus (6/32, 19%)].">
    <entity charOffset="42-68" id="s322.e0" ontology_id="HP_0010972" text="ineffective erythropoiesis" type="HP"/>
    <entity charOffset="157-190" id="s322.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s322.e0" e2="s322.e1" id="s322.p0" relation="false"/>
  </sentence>
  <sentence id="s323" text="protein phosphorylation is also involved in cancer cell migration.">
    <entity charOffset="0-23" id="s323.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="44-50" id="s323.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s323.e0" e2="s323.e1" id="s323.p0" relation="false"/>
  </sentence>
  <sentence id="s324" text="Through a whole genome sequencing (WGS) analysis of the nine subjects (four lung cancer patients and five normal family members of FLC), we obtained a whole genome datanegative regulation of transcription, DNA-templated of DNA alterations in FLC samples.">
    <entity charOffset="81-87" id="s324.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="168-219" id="s324.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s324.e0" e2="s324.e1" id="s324.p0" relation="false"/>
  </sentence>
  <sentence id="s325" text="Subsequently, the top 12 highly mutated genes were selected for validation by polymerase chain reaction and DNA sequencing in an expanded sample negative regulation of transcription, DNA-templated including FLC, sporadic lung cancer, and healthy population.">
    <entity charOffset="145-196" id="s325.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="212-220" id="s325.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s325.e0" e2="s325.e1" id="s325.p0" relation="false"/>
  </sentence>
  <sentence id="s326" text="Subsequently, the top 12 highly mutated genes were selected for validation by polymerase chain reaction and DNA sequencing in an expanded sample negative regulation of transcription, DNA-templated including FLC, sporadic lung cancer, and healthy population.">
    <entity charOffset="145-196" id="s326.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="226-232" id="s326.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s326.e0" e2="s326.e1" id="s326.p0" relation="false"/>
  </sentence>
  <sentence id="s327" text="Mutations of the five genes (regulation of GTPase activity, ANKRD20A2, regulation of transcription by RNA polymerase II, ZNF812, vasculogenesis) may be potential germline mutations of lung cancer.">
    <entity charOffset="29-58" id="s327.e0" ontology_id="GO_0043087" text="regulation of GTPase activity" type="GO"/>
    <entity charOffset="189-195" id="s327.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s327.e0" e2="s327.e1" id="s327.p0" relation="false"/>
  </sentence>
  <sentence id="s328" text="Mutations of the five genes (regulation of GTPase activity, ANKRD20A2, regulation of transcription by RNA polymerase II, ZNF812, vasculogenesis) may be potential germline mutations of lung cancer.">
    <entity charOffset="71-119" id="s328.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="189-195" id="s328.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s328.e0" e2="s328.e1" id="s328.p0" relation="false"/>
  </sentence>
  <sentence id="s329" text="Mutations of the five genes (regulation of GTPase activity, ANKRD20A2, regulation of transcription by RNA polymerase II, ZNF812, vasculogenesis) may be potential germline mutations of lung cancer.">
    <entity charOffset="129-143" id="s329.e0" ontology_id="GO_0001570" text="vasculogenesis" type="GO"/>
    <entity charOffset="189-195" id="s329.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s329.e0" e2="s329.e1" id="s329.p0" relation="false"/>
  </sentence>
  <sentence id="s330" text="We also analyzed specific mutations within the 12 genes and found that some specific mutations within the stimulatory C-type lectin receptor signaling pathway, biological_process and biological_process genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.">
    <entity charOffset="106-158" id="s330.e0" ontology_id="GO_0002223" text="stimulatory C-type lectin receptor signaling pathway" type="GO"/>
    <entity charOffset="268-274" id="s330.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s330.e0" e2="s330.e1" id="s330.p0" relation="false"/>
  </sentence>
  <sentence id="s331" text="We also analyzed specific mutations within the 12 genes and found that some specific mutations within the stimulatory C-type lectin receptor signaling pathway, biological_process and biological_process genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.">
    <entity charOffset="160-178" id="s331.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="268-274" id="s331.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s331.e0" e2="s331.e1" id="s331.p0" relation="false"/>
  </sentence>
  <sentence id="s332" text="We also analyzed specific mutations within the 12 genes and found that some specific mutations within the stimulatory C-type lectin receptor signaling pathway, biological_process and biological_process genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.">
    <entity charOffset="183-201" id="s332.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="268-274" id="s332.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s332.e0" e2="s332.e1" id="s332.p0" relation="false"/>
  </sentence>
  <sentence id="s333" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s333.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="157-178" id="s333.e1" ontology_id="GO_0030900" text="forebrain development" type="GO"/>
    <pair e1="s333.e0" e2="s333.e1" id="s333.p0" relation="false"/>
  </sentence>
  <sentence id="s334" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s334.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="307-340" id="s334.e1" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <pair e1="s334.e0" e2="s334.e1" id="s334.p0" relation="false"/>
  </sentence>
  <sentence id="s335" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s335.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="342-382" id="s335.e1" ontology_id="GO_0035019" text="somatic stem cell population maintenance" type="GO"/>
    <pair e1="s335.e0" e2="s335.e1" id="s335.p0" relation="false"/>
  </sentence>
  <sentence id="s336" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s336.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="384-432" id="s336.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s336.e0" e2="s336.e1" id="s336.p0" relation="false"/>
  </sentence>
  <sentence id="s337" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s337.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="434-491" id="s337.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s337.e0" e2="s337.e1" id="s337.p0" relation="false"/>
  </sentence>
  <sentence id="s338" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s338.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="493-550" id="s338.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s338.e0" e2="s338.e1" id="s338.p0" relation="false"/>
  </sentence>
  <sentence id="s339" text="These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&amp;lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&amp;lt;0.05).">
    <entity charOffset="83-88" id="s339.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="556-575" id="s339.e1" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <pair e1="s339.e0" e2="s339.e1" id="s339.p0" relation="false"/>
  </sentence>
  <sentence id="s340" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by G1/S transition of mitotic cell cycle/positive regulation of cell-matrix adhesion-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.">
    <entity charOffset="33-38" id="s340.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="254-300" id="s340.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s340.e0" e2="s340.e1" id="s340.p0" relation="true"/>
  </sentence>
  <sentence id="s341" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by G1/S transition of mitotic cell cycle/positive regulation of cell-matrix adhesion-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.">
    <entity charOffset="33-38" id="s341.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="87-124" id="s341.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s341.e0" e2="s341.e1" id="s341.p0" relation="true"/>
  </sentence>
  <sentence id="s342" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by G1/S transition of mitotic cell cycle/positive regulation of cell-matrix adhesion-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.">
    <entity charOffset="33-38" id="s342.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="125-168" id="s342.e1" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s342.e0" e2="s342.e1" id="s342.p0" relation="false"/>
  </sentence>
  <sentence id="s343" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by G1/S transition of mitotic cell cycle/positive regulation of cell-matrix adhesion-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.">
    <entity charOffset="50-64" id="s343.e0" ontology_id="HP_0009919" text="retinoblastoma" type="HP"/>
    <entity charOffset="87-124" id="s343.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s343.e0" e2="s343.e1" id="s343.p0" relation="false"/>
  </sentence>
  <sentence id="s344" text="In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by G1/S transition of mitotic cell cycle/positive regulation of cell-matrix adhesion-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.">
    <entity charOffset="50-64" id="s344.e0" ontology_id="HP_0009919" text="retinoblastoma" type="HP"/>
    <entity charOffset="125-168" id="s344.e1" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s344.e0" e2="s344.e1" id="s344.p0" relation="false"/>
  </sentence>
  <sentence id="s345" text="positive regulation of lipid kinase activity gene is highly expressed in the central nervous system and Eef1a2 knockout epidermis development show the neuronal degeneration.">
    <entity charOffset="0-44" id="s345.e0" ontology_id="GO_0090218" text="positive regulation of lipid kinase activity" type="GO"/>
    <entity charOffset="77-84" id="s345.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s345.e0" e2="s345.e1" id="s345.p0" relation="false"/>
  </sentence>
  <sentence id="s346" text="positive regulation of lipid kinase activity gene is highly expressed in the central nervous system and Eef1a2 knockout epidermis development show the neuronal degeneration.">
    <entity charOffset="77-84" id="s346.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="120-141" id="s346.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s346.e0" e2="s346.e1" id="s346.p0" relation="false"/>
  </sentence>
  <sentence id="s347" text="Here, we report that the expression of microRNA-493 (protein polyubiquitination-493) is decreased in phosphatidylinositol phosphorylation cell lines and in tumor tissues.">
    <entity charOffset="53-79" id="s347.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="156-161" id="s347.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s347.e0" e2="s347.e1" id="s347.p0" relation="false"/>
  </sentence>
  <sentence id="s348" text="Here, we report that the expression of microRNA-493 (protein polyubiquitination-493) is decreased in phosphatidylinositol phosphorylation cell lines and in tumor tissues.">
    <entity charOffset="101-137" id="s348.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="156-161" id="s348.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s348.e0" e2="s348.e1" id="s348.p0" relation="false"/>
  </sentence>
  <sentence id="s349" text="Overexpression of protein polyubiquitination-493 in phosphatidylinositol phosphorylation cells dramatically inhibited cell proliferation and colony-formation in vitro and inhibited tumor formation of HCC cell xenografts in vivo.">
    <entity charOffset="18-44" id="s349.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="181-186" id="s349.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s349.e0" e2="s349.e1" id="s349.p0" relation="false"/>
  </sentence>
  <sentence id="s350" text="Overexpression of protein polyubiquitination-493 in phosphatidylinositol phosphorylation cells dramatically inhibited cell proliferation and colony-formation in vitro and inhibited tumor formation of HCC cell xenografts in vivo.">
    <entity charOffset="52-88" id="s350.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="181-186" id="s350.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s350.e0" e2="s350.e1" id="s350.p0" relation="false"/>
  </sentence>
  <sentence id="s351" text="Novel targets actin cytoskeleton reorganization and RSPO2 were confirmed to be suppressed by protein polyubiquitination-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.">
    <entity charOffset="14-47" id="s351.e0" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <entity charOffset="187-192" id="s351.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s351.e0" e2="s351.e1" id="s351.p0" relation="true"/>
  </sentence>
  <sentence id="s352" text="Novel targets actin cytoskeleton reorganization and RSPO2 were confirmed to be suppressed by protein polyubiquitination-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.">
    <entity charOffset="93-119" id="s352.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="187-192" id="s352.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s352.e0" e2="s352.e1" id="s352.p0" relation="false"/>
  </sentence>
  <sentence id="s353" text="Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by ANTXR1 and positive regulation of Wnt signaling pathway, was also inhibited by protein polyubiquitination-493 overexpression and might be involved in anti-tumor function of miR-493.">
    <entity charOffset="92-136" id="s353.e0" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="236-241" id="s353.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s353.e0" e2="s353.e1" id="s353.p0" relation="false"/>
  </sentence>
  <sentence id="s354" text="Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by ANTXR1 and positive regulation of Wnt signaling pathway, was also inhibited by protein polyubiquitination-493 overexpression and might be involved in anti-tumor function of miR-493.">
    <entity charOffset="160-186" id="s354.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="236-241" id="s354.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s354.e0" e2="s354.e1" id="s354.p0" relation="false"/>
  </sentence>
  <sentence id="s355" text="We present a young boy whose mild ataxia and abnormal eye movements repeatedly deteriorated with fever, making him unable to smoothened signaling pathway or walk during fever episodes.">
    <entity charOffset="34-40" id="s355.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="125-153" id="s355.e1" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <pair e1="s355.e0" e2="s355.e1" id="s355.p0" relation="false"/>
  </sentence>
  <sentence id="s356" text="We present a young boy whose mild ataxia and abnormal eye movements repeatedly deteriorated with fever, making him unable to smoothened signaling pathway or walk during fever episodes.">
    <entity charOffset="45-67" id="s356.e0" ontology_id="HP_0000496" text="abnormal eye movements" type="HP"/>
    <entity charOffset="125-153" id="s356.e1" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <pair e1="s356.e0" e2="s356.e1" id="s356.p0" relation="true"/>
  </sentence>
  <sentence id="s357" text="This family demonstrates phenotypic variability of signal transduction deletions (SCA 27), fever sensmoothened signaling pathwayivity of ataxia and the added value of SNP-array analysis in making a diagnosis">
    <entity charOffset="51-70" id="s357.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="137-143" id="s357.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s357.e0" e2="s357.e1" id="s357.p0" relation="true"/>
  </sentence>
  <sentence id="s358" text="This family demonstrates phenotypic variability of signal transduction deletions (SCA 27), fever sensmoothened signaling pathwayivity of ataxia and the added value of SNP-array analysis in making a diagnosis">
    <entity charOffset="100-128" id="s358.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="137-143" id="s358.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s358.e0" e2="s358.e1" id="s358.p0" relation="false"/>
  </sentence>
  <sentence id="s359" text="Walker-Warburg syndrome (nervous system development) is a severe muscular dystrophy with eye and brain malformations.">
    <entity charOffset="25-51" id="s359.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="65-83" id="s359.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s359.e0" e2="s359.e1" id="s359.p0" relation="false"/>
  </sentence>
  <sentence id="s360" text="The disease family of muscular dystrophy-dystroglycanopathy (MDDG) contains a spectrum of severe to mild disorders, designated as MDDG muscle organ development A to C.">
    <entity charOffset="22-40" id="s360.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="135-159" id="s360.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s360.e0" e2="s360.e1" id="s360.p0" relation="true"/>
  </sentence>
  <sentence id="s361" text="Mutations in protein O-linked mannosylation, POMT2, protein O-linked glycosylation, protein O-linked glycosylation, FKRP, LARGE, GMPPB, TMEM5 and branching involved in blood vessel morphogenesis and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="13-43" id="s361.e0" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <entity charOffset="256-276" id="s361.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s361.e0" e2="s361.e1" id="s361.p0" relation="true"/>
  </sentence>
  <sentence id="s362" text="Mutations in protein O-linked mannosylation, POMT2, protein O-linked glycosylation, protein O-linked glycosylation, FKRP, LARGE, GMPPB, TMEM5 and branching involved in blood vessel morphogenesis and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="52-82" id="s362.e0" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <entity charOffset="256-276" id="s362.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s362.e0" e2="s362.e1" id="s362.p0" relation="true"/>
  </sentence>
  <sentence id="s363" text="Mutations in protein O-linked mannosylation, POMT2, protein O-linked glycosylation, protein O-linked glycosylation, FKRP, LARGE, GMPPB, TMEM5 and branching involved in blood vessel morphogenesis and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="84-114" id="s363.e0" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <entity charOffset="256-276" id="s363.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s363.e0" e2="s363.e1" id="s363.p0" relation="true"/>
  </sentence>
  <sentence id="s364" text="Mutations in protein O-linked mannosylation, POMT2, protein O-linked glycosylation, protein O-linked glycosylation, FKRP, LARGE, GMPPB, TMEM5 and branching involved in blood vessel morphogenesis and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.">
    <entity charOffset="146-194" id="s364.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="256-276" id="s364.e1" ontology_id="HP_0003560" text="muscular dystrophies" type="HP"/>
    <pair e1="s364.e0" e2="s364.e1" id="s364.p0" relation="true"/>
  </sentence>
  <sentence id="s365" text="Patients with nervous system development frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, seizures, hydrocephalus and poor prognosis.">
    <entity charOffset="14-40" id="s365.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="204-212" id="s365.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s365.e0" e2="s365.e1" id="s365.p0" relation="true"/>
  </sentence>
  <sentence id="s366" text="Patients with nervous system development frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, seizures, hydrocephalus and poor prognosis.">
    <entity charOffset="14-40" id="s366.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="214-227" id="s366.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s366.e0" e2="s366.e1" id="s366.p0" relation="false"/>
  </sentence>
  <sentence id="s367" text="We also demonstrate that tumor-associated transcription by RNA polymerase IIs induce the expression of genes associated with an aggressive phenotype in primary lung cancer cells and selectively promote their dissemination rather than local growth.">
    <entity charOffset="25-30" id="s367.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="42-76" id="s367.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s367.e0" e2="s367.e1" id="s367.p0" relation="false"/>
  </sentence>
  <sentence id="s368" text="Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (ion transport).">
    <entity charOffset="427-437" id="s368.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="643-656" id="s368.e1" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <pair e1="s368.e0" e2="s368.e1" id="s368.p0" relation="true"/>
  </sentence>
  <sentence id="s369" text="An additional locus for autosomal recessive Charcot-Marie-Tooth disease muscle organ development 2H on chromosome 8q13-21.1 was excluded by linkage analysis.">
    <entity charOffset="24-43" id="s369.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="72-96" id="s369.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s369.e0" e2="s369.e1" id="s369.p0" relation="true"/>
  </sentence>
  <sentence id="s370" text="Prostate cancer is the most common cancer among western negative regulation of phosphatase activity, with a significant mortality and morbidity reported for advanced metastatic disease.">
    <entity charOffset="9-15" id="s370.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="56-99" id="s370.e1" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <pair e1="s370.e0" e2="s370.e1" id="s370.p0" relation="false"/>
  </sentence>
  <sentence id="s371" text="By analysing prostate cancer bone metastases using high density microarrays, we found a common genomic copy number loss at 6q16.1-16.2, containing the protein polyubiquitination gene, which was confirmed in larger series of bone metastases by fluorescence in situ hybridisation (superoxide metabolic process).">
    <entity charOffset="22-28" id="s371.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="151-177" id="s371.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s371.e0" e2="s371.e1" id="s371.p0" relation="false"/>
  </sentence>
  <sentence id="s372" text="By analysing prostate cancer bone metastases using high density microarrays, we found a common genomic copy number loss at 6q16.1-16.2, containing the protein polyubiquitination gene, which was confirmed in larger series of bone metastases by fluorescence in situ hybridisation (superoxide metabolic process).">
    <entity charOffset="22-28" id="s372.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="279-307" id="s372.e1" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <pair e1="s372.e0" e2="s372.e1" id="s372.p0" relation="false"/>
  </sentence>
  <sentence id="s373" text="Loss of protein polyubiquitination was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (plasminogen activation) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.">
    <entity charOffset="8-34" id="s373.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="64-71" id="s373.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s373.e0" e2="s373.e1" id="s373.p0" relation="false"/>
  </sentence>
  <sentence id="s374" text="Loss of protein polyubiquitination was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (plasminogen activation) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.">
    <entity charOffset="64-71" id="s374.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="198-220" id="s374.e1" ontology_id="GO_0031639" text="plasminogen activation" type="GO"/>
    <pair e1="s374.e0" e2="s374.e1" id="s374.p0" relation="false"/>
  </sentence>
  <sentence id="s375" text="We also demonstrated that protein polyubiquitination deletion is detectable in circulating tumour cells (CTCs), making it a potential prognostic biomarker by 'liquid biopsy'.">
    <entity charOffset="26-52" id="s375.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="91-97" id="s375.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s375.e0" e2="s375.e1" id="s375.p0" relation="false"/>
  </sentence>
  <sentence id="s376" text="In vitro analysis showed that protein polyubiquitination plays a role in regulating the migration and invasion of prostate cancer cells.">
    <entity charOffset="30-56" id="s376.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="123-129" id="s376.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s376.e0" e2="s376.e1" id="s376.p0" relation="false"/>
  </sentence>
  <sentence id="s377" text="Therefore, protein polyubiquitination could be a potential novel prostate cancer suppressor gene, which may prevent cancer progression and metastasis through controlling cell invasion">
    <entity charOffset="11-37" id="s377.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="74-80" id="s377.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s377.e0" e2="s377.e1" id="s377.p0" relation="false"/>
  </sentence>
  <sentence id="s378" text="The enriched genes included MMP9, negative regulation of blood coagulation, CAV1, KRT14, and MAPK cascade in basal tumors, and negative regulation of transcription by RNA polymerase II, LY6E, proteolysis, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="34-74" id="s378.e0" ontology_id="GO_0030195" text="negative regulation of blood coagulation" type="GO"/>
    <entity charOffset="115-120" id="s378.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s378.e0" e2="s378.e1" id="s378.p0" relation="false"/>
  </sentence>
  <sentence id="s379" text="The enriched genes included MMP9, negative regulation of blood coagulation, CAV1, KRT14, and MAPK cascade in basal tumors, and negative regulation of transcription by RNA polymerase II, LY6E, proteolysis, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="93-105" id="s379.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="115-120" id="s379.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s379.e0" e2="s379.e1" id="s379.p0" relation="false"/>
  </sentence>
  <sentence id="s380" text="The enriched genes included MMP9, negative regulation of blood coagulation, CAV1, KRT14, and MAPK cascade in basal tumors, and negative regulation of transcription by RNA polymerase II, LY6E, proteolysis, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="115-120" id="s380.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="127-184" id="s380.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s380.e0" e2="s380.e1" id="s380.p0" relation="false"/>
  </sentence>
  <sentence id="s381" text="The enriched genes included MMP9, negative regulation of blood coagulation, CAV1, KRT14, and MAPK cascade in basal tumors, and negative regulation of transcription by RNA polymerase II, LY6E, proteolysis, CDK3, and TBX2 in luminal tumors.">
    <entity charOffset="115-120" id="s381.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="192-203" id="s381.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s381.e0" e2="s381.e1" id="s381.p0" relation="false"/>
  </sentence>
  <sentence id="s382" text="In the present study, western blotting was used to verified the expression of Tlymphocyte detection of calcium ion and pathway proteins, including phosphorylated extracellular signalregulated kinase (PERK)1/2 and phosphorylated cJun Nterminal kinase (PJNK), and used cytometric bead array to detect the secretion of interleukin (IL)4, IL6, IL10 and tumor necrosis factor (TNF) in AMI onset, the results demonstrated that they were all increased.">
    <entity charOffset="91-115" id="s382.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="358-363" id="s382.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s382.e0" e2="s382.e1" id="s382.p0" relation="false"/>
  </sentence>
  <sentence id="s383" text="The importance of mitochondria for white matter is chloride transport exemplified in a group of defects of the mitochondria oxidative metabolism called mitochondria leukoencephalopathies or encephalomyopathies.">
    <entity charOffset="51-69" id="s383.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="165-186" id="s383.e1" ontology_id="HP_0002352" text="leukoencephalopathies" type="HP"/>
    <pair e1="s383.e0" e2="s383.e1" id="s383.p0" relation="false"/>
  </sentence>
  <sentence id="s384" text="In this work, we report a new progressive myoclonus epilepsy associated with Lafora bodies, early-onset Lafora body disease, map its locus to chromosome 4q21.21, identify its gene and mutation and characterize the relationship of its gene product with laforin and protein polyubiquitination.">
    <entity charOffset="42-51" id="s384.e0" ontology_id="HP_0001336" text="myoclonus" type="HP"/>
    <entity charOffset="264-290" id="s384.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s384.e0" e2="s384.e1" id="s384.p0" relation="true"/>
  </sentence>
  <sentence id="s385" text="In this work, we report a new progressive myoclonus epilepsy associated with Lafora bodies, early-onset Lafora body disease, map its locus to chromosome 4q21.21, identify its gene and mutation and characterize the relationship of its gene product with laforin and protein polyubiquitination.">
    <entity charOffset="52-60" id="s385.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="264-290" id="s385.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s385.e0" e2="s385.e1" id="s385.p0" relation="true"/>
  </sentence>
  <sentence id="s386" text="We used the Illumina HumanMethylation450 BeadChip microarray to test whether white blood cell DNA, an easily accessible source of DNA, exhibits site-specific changes in DNA methylation in blood of diagnosed phosphatidylinositol phosphorylation patients (post-diagnostic, 24 cases, 24 controls) and in prospectively collected blood specimens of HCC patients who were cancer-free at blood collection (pre-diagnostic, 21 cases, 21 controls).">
    <entity charOffset="207-243" id="s386.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="366-372" id="s386.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s386.e0" e2="s386.e1" id="s386.p0" relation="false"/>
  </sentence>
  <sentence id="s387" text="Our findings highlight the significance of recalibrating tumor cell metabolism by fine-tuning nucleotide and NAD synthesis in tumor growth.&lt;b&gt;Significance:&lt;/b&gt; Our findings elucidate an instrumental function of lipid biosynthetic process in direct regulation of nucleic acid and NAD synthesis in tumor cells in response to energy stress.">
    <entity charOffset="57-62" id="s387.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="211-237" id="s387.e1" ontology_id="GO_0008610" text="lipid biosynthetic process" type="GO"/>
    <pair e1="s387.e0" e2="s387.e1" id="s387.p0" relation="false"/>
  </sentence>
  <sentence id="s388" text="Mutations in two genes, &lt;i&gt;positive regulation of cyclin-dependent protein serine/threonine kinase activity&lt;/i&gt; and &lt;i&gt;protein phosphorylation&lt;/i&gt;, account for most cases of autosomal dominant polycystic kidney disease, one of the most common monogenetic disorders.">
    <entity charOffset="27-107" id="s388.e0" ontology_id="GO_0045737" text="positive regulation of cyclin-dependent protein serine/threonine kinase activity" type="GO"/>
    <entity charOffset="204-218" id="s388.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s388.e0" e2="s388.e1" id="s388.p0" relation="true"/>
  </sentence>
  <sentence id="s389" text="Mutations in two genes, &lt;i&gt;positive regulation of cyclin-dependent protein serine/threonine kinase activity&lt;/i&gt; and &lt;i&gt;protein phosphorylation&lt;/i&gt;, account for most cases of autosomal dominant polycystic kidney disease, one of the most common monogenetic disorders.">
    <entity charOffset="119-142" id="s389.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="204-218" id="s389.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s389.e0" e2="s389.e1" id="s389.p0" relation="false"/>
  </sentence>
  <sentence id="s390" text="Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (mitochondrial fission and oxidation-reduction process-CMT2K) and autosomal dominant (AD-CMT2K).">
    <entity charOffset="156-175" id="s390.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="177-198" id="s390.e1" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <pair e1="s390.e0" e2="s390.e1" id="s390.p0" relation="true"/>
  </sentence>
  <sentence id="s391" text="Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (mitochondrial fission and oxidation-reduction process-CMT2K) and autosomal dominant (AD-CMT2K).">
    <entity charOffset="156-175" id="s391.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="203-230" id="s391.e1" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <pair e1="s391.e0" e2="s391.e1" id="s391.p0" relation="false"/>
  </sentence>
  <sentence id="s392" text="Three families (families 1, 2 and 3) were found to have an autosomal recessive (oxidation-reduction process) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance.">
    <entity charOffset="59-78" id="s392.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="80-107" id="s392.e1" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <pair e1="s392.e0" e2="s392.e1" id="s392.p0" relation="false"/>
  </sentence>
  <sentence id="s393" text="Three families (families 1, 2 and 3) were found to have an autosomal recessive (oxidation-reduction process) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance.">
    <entity charOffset="80-107" id="s393.e0" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <entity charOffset="184-203" id="s393.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s393.e0" e2="s393.e1" id="s393.p0" relation="false"/>
  </sentence>
  <sentence id="s394" text="Electro-physiologic studies revealed an axonal type of neuropathy (oxidation-reduction process-CMT2K and AD-CMT2K) in all affected individuals.">
    <entity charOffset="55-65" id="s394.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="67-94" id="s394.e1" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <pair e1="s394.e0" e2="s394.e1" id="s394.p0" relation="false"/>
  </sentence>
  <sentence id="s395" text="Delayed bone age and seizure disorders were overrepresented in the nucleotide-excision repairN1 group (P=0.009 and P=0.024, respectively), whereas some characteristic TTD clinical, laboratory, and imaging findings were absent.">
    <entity charOffset="21-28" id="s395.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="67-93" id="s395.e1" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <pair e1="s395.e0" e2="s395.e1" id="s395.p0" relation="false"/>
  </sentence>
  <sentence id="s396" text="We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of digestion syndrome, a suspected ciliopathy.">
    <entity charOffset="266-274" id="s396.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="383-392" id="s396.e1" ontology_id="GO_0007586" text="digestion" type="GO"/>
    <pair e1="s396.e0" e2="s396.e1" id="s396.p0" relation="false"/>
  </sentence>
  <sentence id="s397" text="We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of digestion syndrome, a suspected ciliopathy.">
    <entity charOffset="298-317" id="s397.e0" ontology_id="HP_0003468" text="vertebral anomalies" type="HP"/>
    <entity charOffset="383-392" id="s397.e1" ontology_id="GO_0007586" text="digestion" type="GO"/>
    <pair e1="s397.e0" e2="s397.e1" id="s397.p0" relation="false"/>
  </sentence>
  <sentence id="s398" text="We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of digestion syndrome, a suspected ciliopathy.">
    <entity charOffset="349-367" id="s398.e0" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <entity charOffset="383-392" id="s398.e1" ontology_id="GO_0007586" text="digestion" type="GO"/>
    <pair e1="s398.e0" e2="s398.e1" id="s398.p0" relation="false"/>
  </sentence>
  <sentence id="s399" text="Affected individuals presented with prenatal-onset spinal muscular atrophy (spliceosomal snRNP assembly), multiple congenital contractures (arthrogryposis multiplex congenita), respiratory distress, and congenital bone fractures.">
    <entity charOffset="76-103" id="s399.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="126-138" id="s399.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s399.e0" e2="s399.e1" id="s399.p0" relation="false"/>
  </sentence>
  <sentence id="s400" text="Affected individuals presented with prenatal-onset spinal muscular atrophy (spliceosomal snRNP assembly), multiple congenital contractures (arthrogryposis multiplex congenita), respiratory distress, and congenital bone fractures.">
    <entity charOffset="76-103" id="s400.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="140-154" id="s400.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s400.e0" e2="s400.e1" id="s400.p0" relation="false"/>
  </sentence>
  <sentence id="s401" text="Sturge-Weber Syndrome (glycerophospholipid catabolic process) is a neurocutaneous disease with clinical manifestations including ocular (glaucoma), cutaneous (port-wine birthmark), neurologic (seizures), and vascular problems.">
    <entity charOffset="23-60" id="s401.e0" ontology_id="GO_0046475" text="glycerophospholipid catabolic process" type="GO"/>
    <entity charOffset="193-201" id="s401.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s401.e0" e2="s401.e1" id="s401.p0" relation="false"/>
  </sentence>
  <sentence id="s402" text="Molecular mechanisms of glycerophospholipid catabolic process pathogenesis are initiated by the somatic mutation in GNAQ.">
    <entity charOffset="24-61" id="s402.e0" ontology_id="GO_0046475" text="glycerophospholipid catabolic process" type="GO"/>
    <entity charOffset="96-112" id="s402.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s402.e0" e2="s402.e1" id="s402.p0" relation="false"/>
  </sentence>
  <sentence id="s403" text="Solid tumors developed and total tumor cell adhesion mediated by integrin and the number of tumors were characterized.">
    <entity charOffset="6-11" id="s403.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="39-73" id="s403.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s403.e0" e2="s403.e1" id="s403.p0" relation="false"/>
  </sentence>
  <sentence id="s404" text="The epidermal growth factor receptor signaling pathway-6 gene had no significant negative regulation of transcription by RNA polymerase II on tumor cell adhesion mediated by integrin, but significantly more tumors were detected when vIL-6 was present.">
    <entity charOffset="4-54" id="s404.e0" ontology_id="GO_0007173" text="epidermal growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="142-147" id="s404.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s404.e0" e2="s404.e1" id="s404.p0" relation="false"/>
  </sentence>
  <sentence id="s405" text="The epidermal growth factor receptor signaling pathway-6 gene had no significant negative regulation of transcription by RNA polymerase II on tumor cell adhesion mediated by integrin, but significantly more tumors were detected when vIL-6 was present.">
    <entity charOffset="81-138" id="s405.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="142-147" id="s405.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s405.e0" e2="s405.e1" id="s405.p0" relation="false"/>
  </sentence>
  <sentence id="s406" text="The epidermal growth factor receptor signaling pathway-6 gene had no significant negative regulation of transcription by RNA polymerase II on tumor cell adhesion mediated by integrin, but significantly more tumors were detected when vIL-6 was present.">
    <entity charOffset="142-147" id="s406.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="148-182" id="s406.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s406.e0" e2="s406.e1" id="s406.p0" relation="false"/>
  </sentence>
  <sentence id="s407" text="Significant differences in expression of B cell markers in cells from extracted tumors were detected based upon the presence of epidermal growth factor receptor signaling pathway-6.">
    <entity charOffset="80-85" id="s407.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="128-178" id="s407.e1" ontology_id="GO_0007173" text="epidermal growth factor receptor signaling pathway" type="GO"/>
    <pair e1="s407.e0" e2="s407.e1" id="s407.p0" relation="false"/>
  </sentence>
  <sentence id="s408" text="B cell markers in tumor cells were also compared to the same cell muscle organ development in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of epidermal growth factor receptor signaling pathway-6.">
    <entity charOffset="18-23" id="s408.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="257-307" id="s408.e1" ontology_id="GO_0007173" text="epidermal growth factor receptor signaling pathway" type="GO"/>
    <pair e1="s408.e0" e2="s408.e1" id="s408.p0" relation="false"/>
  </sentence>
  <sentence id="s409" text="B cell markers in tumor cells were also compared to the same cell muscle organ development in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of epidermal growth factor receptor signaling pathway-6.">
    <entity charOffset="18-23" id="s409.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="66-90" id="s409.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s409.e0" e2="s409.e1" id="s409.p0" relation="false"/>
  </sentence>
  <sentence id="s410" text="These data indicate that epidermal growth factor receptor signaling pathway-6 plays a role in KSHV tumor formation in B cells in vivo.">
    <entity charOffset="25-75" id="s410.e0" ontology_id="GO_0007173" text="epidermal growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="99-104" id="s410.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s410.e0" e2="s410.e1" id="s410.p0" relation="false"/>
  </sentence>
  <sentence id="s411" text="Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that regulation of small GTPase mediated signal transduction, an adhesion-localized positive regulation of lamellipodium assembly and actin cytoskeleton organization specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.">
    <entity charOffset="99-154" id="s411.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="318-330" id="s411.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s411.e0" e2="s411.e1" id="s411.p0" relation="false"/>
  </sentence>
  <sentence id="s412" text="Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that regulation of small GTPase mediated signal transduction, an adhesion-localized positive regulation of lamellipodium assembly and actin cytoskeleton organization specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.">
    <entity charOffset="178-223" id="s412.e0" ontology_id="GO_0010592" text="positive regulation of lamellipodium assembly" type="GO"/>
    <entity charOffset="318-330" id="s412.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s412.e0" e2="s412.e1" id="s412.p0" relation="false"/>
  </sentence>
  <sentence id="s413" text="Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that regulation of small GTPase mediated signal transduction, an adhesion-localized positive regulation of lamellipodium assembly and actin cytoskeleton organization specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.">
    <entity charOffset="228-259" id="s413.e0" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <entity charOffset="318-330" id="s413.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s413.e0" e2="s413.e1" id="s413.p0" relation="false"/>
  </sentence>
  <sentence id="s414" text="Mutation of aspartic acid 378 of interleukin-12-mediated signaling pathway to either asparagine or histidine has been associated with limb girdle muscular dystrophy.">
    <entity charOffset="33-74" id="s414.e0" ontology_id="GO_0035722" text="interleukin-12-mediated signaling pathway" type="GO"/>
    <entity charOffset="134-164" id="s414.e1" ontology_id="HP_0006785" text="limb girdle muscular dystrophy" type="HP"/>
    <pair e1="s414.e0" e2="s414.e1" id="s414.p0" relation="true"/>
  </sentence>
  <sentence id="s415" text="According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of negative regulation of translational initiation but not N-acetylglucosamine metabolic process, L-methylmalonyl-CoA metabolic process or monocyte activation involved in immune response was significantly lower in pancreatic tumors than in normal adjacent tissues.">
    <entity charOffset="109-156" id="s415.e0" ontology_id="GO_0045947" text="negative regulation of translational initiation" type="GO"/>
    <entity charOffset="331-337" id="s415.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s415.e0" e2="s415.e1" id="s415.p0" relation="false"/>
  </sentence>
  <sentence id="s416" text="According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of negative regulation of translational initiation but not N-acetylglucosamine metabolic process, L-methylmalonyl-CoA metabolic process or monocyte activation involved in immune response was significantly lower in pancreatic tumors than in normal adjacent tissues.">
    <entity charOffset="165-202" id="s416.e0" ontology_id="GO_0006044" text="N-acetylglucosamine metabolic process" type="GO"/>
    <entity charOffset="331-337" id="s416.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s416.e0" e2="s416.e1" id="s416.p0" relation="false"/>
  </sentence>
  <sentence id="s417" text="According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of negative regulation of translational initiation but not N-acetylglucosamine metabolic process, L-methylmalonyl-CoA metabolic process or monocyte activation involved in immune response was significantly lower in pancreatic tumors than in normal adjacent tissues.">
    <entity charOffset="204-241" id="s417.e0" ontology_id="GO_0046491" text="L-methylmalonyl-CoA metabolic process" type="GO"/>
    <entity charOffset="331-337" id="s417.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s417.e0" e2="s417.e1" id="s417.p0" relation="false"/>
  </sentence>
  <sentence id="s418" text="According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of negative regulation of translational initiation but not N-acetylglucosamine metabolic process, L-methylmalonyl-CoA metabolic process or monocyte activation involved in immune response was significantly lower in pancreatic tumors than in normal adjacent tissues.">
    <entity charOffset="245-292" id="s418.e0" ontology_id="GO_0002280" text="monocyte activation involved in immune response" type="GO"/>
    <entity charOffset="331-337" id="s418.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s418.e0" e2="s418.e1" id="s418.p0" relation="false"/>
  </sentence>
  <sentence id="s419" text="Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique regulation of transcription, DNA-templated-multicellular organism development translocation.">
    <entity charOffset="8-15" id="s419.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="93-135" id="s419.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s419.e0" e2="s419.e1" id="s419.p0" relation="true"/>
  </sentence>
  <sentence id="s420" text="Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique regulation of transcription, DNA-templated-multicellular organism development translocation.">
    <entity charOffset="8-15" id="s420.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="136-170" id="s420.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s420.e0" e2="s420.e1" id="s420.p0" relation="false"/>
  </sentence>
  <sentence id="s421" text="Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique regulation of transcription, DNA-templated-multicellular organism development translocation.">
    <entity charOffset="45-50" id="s421.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="93-135" id="s421.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s421.e0" e2="s421.e1" id="s421.p0" relation="true"/>
  </sentence>
  <sentence id="s422" text="Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique regulation of transcription, DNA-templated-multicellular organism development translocation.">
    <entity charOffset="45-50" id="s422.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="136-170" id="s422.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s422.e0" e2="s422.e1" id="s422.p0" relation="false"/>
  </sentence>
  <sentence id="s423" text="Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (negative regulation of tumor necrosis factor production), leading to excess glucocorticoid and hypercortisolism.">
    <entity charOffset="109-164" id="s423.e0" ontology_id="GO_0032720" text="negative regulation of tumor necrosis factor production" type="GO"/>
    <entity charOffset="204-220" id="s423.e1" ontology_id="HP_0003118" text="hypercortisolism" type="HP"/>
    <pair e1="s423.e0" e2="s423.e1" id="s423.p0" relation="false"/>
  </sentence>
  <sentence id="s424" text="However, the major driver mutations in protein K63-linked deubiquitination wild-type tumors remain elusive.">
    <entity charOffset="39-74" id="s424.e0" ontology_id="GO_0070536" text="protein K63-linked deubiquitination" type="GO"/>
    <entity charOffset="85-91" id="s424.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s424.e0" e2="s424.e1" id="s424.p0" relation="true"/>
  </sentence>
  <sentence id="s425" text="Moreover, primary corticotroph tumor cells harboring protein phosphorylation V600E are sensitive to the BRAF inhibitor vemurafenib.">
    <entity charOffset="31-36" id="s425.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="53-76" id="s425.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s425.e0" e2="s425.e1" id="s425.p0" relation="true"/>
  </sentence>
  <sentence id="s426" text="FGD is a heterogeneous disorder for which causal mutations have been identified in MC2R, protein localization to plasma membrane, MCM4 and TXNRD2.">
    <entity charOffset="9-22" id="s426.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="89-128" id="s426.e1" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <pair e1="s426.e0" e2="s426.e1" id="s426.p0" relation="false"/>
  </sentence>
  <sentence id="s427" text="This study doubles the number of known mutations for this disorder, confirms that truncating mutations in post-translational protein modification are the only known cause of WSS, and suggests that mutations in this gene do not contribute significantly to cases presenting with isolated elements of WSS such as deafness and dystonia.">
    <entity charOffset="106-145" id="s427.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="310-318" id="s427.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s427.e0" e2="s427.e1" id="s427.p0" relation="true"/>
  </sentence>
  <sentence id="s428" text="This study doubles the number of known mutations for this disorder, confirms that truncating mutations in post-translational protein modification are the only known cause of WSS, and suggests that mutations in this gene do not contribute significantly to cases presenting with isolated elements of WSS such as deafness and dystonia.">
    <entity charOffset="106-145" id="s428.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="323-331" id="s428.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s428.e0" e2="s428.e1" id="s428.p0" relation="true"/>
  </sentence>
  <sentence id="s429" text="While the down regulation of protein phosphorylation by DNA methylation in gastric cancer and by nuclear protein polyubiquitination in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.">
    <entity charOffset="29-52" id="s429.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="83-89" id="s429.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s429.e0" e2="s429.e1" id="s429.p0" relation="false"/>
  </sentence>
  <sentence id="s430" text="While the down regulation of protein phosphorylation by DNA methylation in gastric cancer and by nuclear protein polyubiquitination in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.">
    <entity charOffset="83-89" id="s430.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="105-131" id="s430.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s430.e0" e2="s430.e1" id="s430.p0" relation="true"/>
  </sentence>
  <sentence id="s431" text="Because we had demonstrated that PrKD1 is the only known kinase to phosphorylate threonine 120 (T120) of protein polyubiquitination in prostate cancer resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of &lt;i&gt;PrKD1&lt;/i&gt;.">
    <entity charOffset="105-131" id="s431.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="144-150" id="s431.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s431.e0" e2="s431.e1" id="s431.p0" relation="true"/>
  </sentence>
  <sentence id="s432" text="&lt;i&gt;In silico&lt;/i&gt; human gene expression analysis confirmed the down regulation of protein phosphorylation in metastatic prostate cancer correlated inversely with the expression of negative regulation of transcription by RNA polymerase II, but not negative regulation of transcription by RNA polymerase II, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates &lt;i&gt;PrKD1&lt;/i&gt; gene expression.">
    <entity charOffset="81-104" id="s432.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="128-134" id="s432.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s432.e0" e2="s432.e1" id="s432.p0" relation="false"/>
  </sentence>
  <sentence id="s433" text="&lt;i&gt;In silico&lt;/i&gt; human gene expression analysis confirmed the down regulation of protein phosphorylation in metastatic prostate cancer correlated inversely with the expression of negative regulation of transcription by RNA polymerase II, but not negative regulation of transcription by RNA polymerase II, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates &lt;i&gt;PrKD1&lt;/i&gt; gene expression.">
    <entity charOffset="128-134" id="s433.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="246-303" id="s433.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s433.e0" e2="s433.e1" id="s433.p0" relation="true"/>
  </sentence>
  <sentence id="s434" text="&lt;i&gt;In silico&lt;/i&gt; human gene expression analysis confirmed the down regulation of protein phosphorylation in metastatic prostate cancer correlated inversely with the expression of negative regulation of transcription by RNA polymerase II, but not negative regulation of transcription by RNA polymerase II, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates &lt;i&gt;PrKD1&lt;/i&gt; gene expression.">
    <entity charOffset="128-134" id="s434.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="179-236" id="s434.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s434.e0" e2="s434.e1" id="s434.p0" relation="true"/>
  </sentence>
  <sentence id="s435" text="Ancestor tumor clones evolved into three subclonal clades: clade1 fostered metastatic subclones that carried metastatic features of &lt;i&gt;PIK3CA&lt;/i&gt; and &lt;i&gt;ARHGAP26&lt;/i&gt; point mutations as well as chr13 arm-level deletion, clade2 owned branch-specific &lt;i&gt;JAK1&lt;/i&gt; mutations and &lt;i&gt;PTEN&lt;/i&gt; deletion, and clade3 was found in two vertical distribution samples below the primary tumor area, highlighting the nucleosome disassembly that it is possible for PMME to disseminate by the submucosal longitudinal lymphatic route at an early stage of metastasis.">
    <entity charOffset="9-14" id="s435.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="401-423" id="s435.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s435.e0" e2="s435.e1" id="s435.p0" relation="false"/>
  </sentence>
  <sentence id="s436" text="These findings facilitate interpretation of the genetic essence of this rare melanoma submuscle organ development as well as the pattern of cancer evolution, thus reinforcing the therapeutic challenges associated with PMME.&lt;b&gt;Significance:&lt;/b&gt; This study highlights the use of multiregion exome sequencing and whole genome SNP array genotyping to comprehensively characterize the genetic landscape of a rare type of esophogeal melanoma.">
    <entity charOffset="89-113" id="s436.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="140-146" id="s436.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s436.e0" e2="s436.e1" id="s436.p0" relation="false"/>
  </sentence>
  <sentence id="s437" text="Small series of cases have documented the co-occurrence of ganglioneuroma with a pheochromocytoma (Pheo)/paraganglioma (tricarboxylic acid cycle) component.">
    <entity charOffset="81-97" id="s437.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="120-144" id="s437.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s437.e0" e2="s437.e1" id="s437.p0" relation="true"/>
  </sentence>
  <sentence id="s438" text="Small series of cases have documented the co-occurrence of ganglioneuroma with a pheochromocytoma (Pheo)/paraganglioma (tricarboxylic acid cycle) component.">
    <entity charOffset="105-118" id="s438.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="120-144" id="s438.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s438.e0" e2="s438.e1" id="s438.p0" relation="true"/>
  </sentence>
  <sentence id="s439" text="One patient had a retroperitoneal composite tricarboxylic acid cycle-ganglioneuroma in the setting of neurofibromatosis muscle organ development 1.">
    <entity charOffset="44-68" id="s439.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="102-119" id="s439.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s439.e0" e2="s439.e1" id="s439.p0" relation="false"/>
  </sentence>
  <sentence id="s440" text="One patient had a retroperitoneal composite tricarboxylic acid cycle-ganglioneuroma in the setting of neurofibromatosis muscle organ development 1.">
    <entity charOffset="102-119" id="s440.e0" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <entity charOffset="120-144" id="s440.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s440.e0" e2="s440.e1" id="s440.p0" relation="false"/>
  </sentence>
  <sentence id="s441" text="In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (negative regulation of intracellular transport) and tumor necrosis factor receptor superfamily member 13C (tumor necrosis factor-mediated signaling pathway).">
    <entity charOffset="167-213" id="s441.e0" ontology_id="GO_0032387" text="negative regulation of intracellular transport" type="GO"/>
    <entity charOffset="219-224" id="s441.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s441.e0" e2="s441.e1" id="s441.p0" relation="false"/>
  </sentence>
  <sentence id="s442" text="In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (negative regulation of intracellular transport) and tumor necrosis factor receptor superfamily member 13C (tumor necrosis factor-mediated signaling pathway).">
    <entity charOffset="219-224" id="s442.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="274-322" id="s442.e1" ontology_id="GO_0033209" text="tumor necrosis factor-mediated signaling pathway" type="GO"/>
    <pair e1="s442.e0" e2="s442.e1" id="s442.p0" relation="true"/>
  </sentence>
  <sentence id="s443" text="There was weaker evidence for iCHAV4, located 5' of sulfur amino acid catabolic process, associated only with ER-positive breast cancer (OR = 0.93 [0.90-0.96]).">
    <entity charOffset="52-87" id="s443.e0" ontology_id="GO_0000098" text="sulfur amino acid catabolic process" type="GO"/>
    <entity charOffset="129-135" id="s443.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s443.e0" e2="s443.e1" id="s443.p0" relation="false"/>
  </sentence>
  <sentence id="s444" text="Chromosome conformation capture analysis showed that iCHAV2 interacts with the negative regulation of neuron projection development and autophagy (more than 600 kb away) promoters in normal and cancerous breast epithelial cells.">
    <entity charOffset="79-131" id="s444.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="194-200" id="s444.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s444.e0" e2="s444.e1" id="s444.p0" relation="false"/>
  </sentence>
  <sentence id="s445" text="Chromosome conformation capture analysis showed that iCHAV2 interacts with the negative regulation of neuron projection development and autophagy (more than 600 kb away) promoters in normal and cancerous breast epithelial cells.">
    <entity charOffset="136-145" id="s445.e0" ontology_id="GO_0006914" text="autophagy" type="GO"/>
    <entity charOffset="194-200" id="s445.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s445.e0" e2="s445.e1" id="s445.p0" relation="false"/>
  </sentence>
  <sentence id="s446" text="Luciferase assays did not identify SNPs that affect transactivation of ZNF365, but identified a protective haplotype in iCHAV2, associated with silencing of the autophagy promoter, implicating this gene in the etiology of breast cancer.">
    <entity charOffset="161-170" id="s446.e0" ontology_id="GO_0006914" text="autophagy" type="GO"/>
    <entity charOffset="229-235" id="s446.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s446.e0" e2="s446.e1" id="s446.p0" relation="false"/>
  </sentence>
  <sentence id="s447" text="&lt;b&gt;Methods:&lt;/b&gt; The fallopian centrosome cycles in 58 cases of pelvic HGSC (54 cases of ovarian primary, 3 cases of tubal primary, 1 case of peritoneum) and 25 cases of pelvic non-HGSC (5 cases of ovarian low-grade serous cancer, 9 cases of endometrioid cancer, and 11 cases of clear cell ovary carcinoma) were collected from June 2015 to December 2016, and serially examined under light microscope (SEE-FIM protocol).">
    <entity charOffset="30-46" id="s447.e0" ontology_id="GO_0007098" text="centrosome cycle" type="GO"/>
    <entity charOffset="222-228" id="s447.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s447.e0" e2="s447.e1" id="s447.p0" relation="false"/>
  </sentence>
  <sentence id="s448" text="The continuum of epithelial changes in the process of serous neoplasia including p53 signature, centrosome duplication, STIC and invasive carcinoma was identified in 8 cases of pelvic HGSC.">
    <entity charOffset="61-70" id="s448.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="96-118" id="s448.e1" ontology_id="GO_0051298" text="centrosome duplication" type="GO"/>
    <pair e1="s448.e0" e2="s448.e1" id="s448.p0" relation="false"/>
  </sentence>
  <sentence id="s449" text="Ectopically injected human cancer cell lines develop into tumors in SCID attachment of GPI anchor to protein, thus providing a human-sized &lt;i&gt;in vivo&lt;/i&gt; model for evaluating imaging methods to improve cancer detection and therapeutic research and development.">
    <entity charOffset="58-64" id="s449.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="73-108" id="s449.e1" ontology_id="GO_0016255" text="attachment of GPI anchor to protein" type="GO"/>
    <pair e1="s449.e0" e2="s449.e1" id="s449.p0" relation="false"/>
  </sentence>
  <sentence id="s450" text="Humanization of SCID attachment of GPI anchor to protein would thus provide a valuable model system for researchers to study interactions between human tumor and human immune cells.">
    <entity charOffset="21-56" id="s450.e0" ontology_id="GO_0016255" text="attachment of GPI anchor to protein" type="GO"/>
    <entity charOffset="152-157" id="s450.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s450.e0" e2="s450.e1" id="s450.p0" relation="false"/>
  </sentence>
  <sentence id="s451" text="Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).">
    <entity charOffset="25-51" id="s451.e0" ontology_id="GO_0006534" text="cysteine metabolic process" type="GO"/>
    <entity charOffset="259-273" id="s451.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s451.e0" e2="s451.e1" id="s451.p0" relation="false"/>
  </sentence>
  <sentence id="s452" text="Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).">
    <entity charOffset="25-51" id="s452.e0" ontology_id="GO_0006534" text="cysteine metabolic process" type="GO"/>
    <entity charOffset="301-316" id="s452.e1" ontology_id="HP_0002154" text="hyperglycinemia" type="HP"/>
    <pair e1="s452.e0" e2="s452.e1" id="s452.p0" relation="false"/>
  </sentence>
  <sentence id="s453" text="Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).">
    <entity charOffset="134-159" id="s453.e0" ontology_id="GO_0006546" text="glycine catabolic process" type="GO"/>
    <entity charOffset="259-273" id="s453.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s453.e0" e2="s453.e1" id="s453.p0" relation="true"/>
  </sentence>
  <sentence id="s454" text="Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).">
    <entity charOffset="161-212" id="s454.e0" ontology_id="GO_0019464" text="glycine decarboxylation via glycine cleavage system" type="GO"/>
    <entity charOffset="259-273" id="s454.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s454.e0" e2="s454.e1" id="s454.p0" relation="true"/>
  </sentence>
  <sentence id="s455" text="Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).">
    <entity charOffset="161-212" id="s455.e0" ontology_id="GO_0019464" text="glycine decarboxylation via glycine cleavage system" type="GO"/>
    <entity charOffset="301-316" id="s455.e1" ontology_id="HP_0002154" text="hyperglycinemia" type="HP"/>
    <pair e1="s455.e0" e2="s455.e1" id="s455.p0" relation="true"/>
  </sentence>
  <sentence id="s456" text="Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).">
    <entity charOffset="259-273" id="s456.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="318-369" id="s456.e1" ontology_id="GO_0019464" text="glycine decarboxylation via glycine cleavage system" type="GO"/>
    <pair e1="s456.e0" e2="s456.e1" id="s456.p0" relation="true"/>
  </sentence>
  <sentence id="s457" text="The successful therapeutic use of anti-negative regulation of transcription by RNA polymerase II biological agents in patients with ankylosing spondylitis (AS) indicates that tumor necrosis factor- (TNF-) and tumor necrosis factor receptor (TNFR) genes are involved in the pathogenesis of AS.">
    <entity charOffset="39-96" id="s457.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="175-180" id="s457.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s457.e0" e2="s457.e1" id="s457.p0" relation="false"/>
  </sentence>
  <sentence id="s458" text="Limb-girdle muscular dystrophy type 2D (muscle contraction) is a rare autosomal-recessive disease, affecting striated muscle, due to mutation of muscle contraction, the gene coding for -sarcoglycan.">
    <entity charOffset="12-30" id="s458.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="40-58" id="s458.e1" ontology_id="GO_0006936" text="muscle contraction" type="GO"/>
    <pair e1="s458.e0" e2="s458.e1" id="s458.p0" relation="true"/>
  </sentence>
  <sentence id="s459" text="Limb-girdle muscular dystrophy type 2D (muscle contraction) is a rare autosomal-recessive disease, affecting striated muscle, due to mutation of muscle contraction, the gene coding for -sarcoglycan.">
    <entity charOffset="12-30" id="s459.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="145-163" id="s459.e1" ontology_id="GO_0006936" text="muscle contraction" type="GO"/>
    <pair e1="s459.e0" e2="s459.e1" id="s459.p0" relation="true"/>
  </sentence>
  <sentence id="s460" text="Corneal dystrophies may have a positive regulation of transcription by RNA polymerase II autosomal dominant, autosomal recessive or X-linked recessive Mendelian mode of inheritance.">
    <entity charOffset="31-88" id="s460.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="109-128" id="s460.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s460.e0" e2="s460.e1" id="s460.p0" relation="false"/>
  </sentence>
  <sentence id="s461" text="Corneal dystrophies may have a positive regulation of transcription by RNA polymerase II autosomal dominant, autosomal recessive or X-linked recessive Mendelian mode of inheritance.">
    <entity charOffset="31-88" id="s461.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="161-180" id="s461.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s461.e0" e2="s461.e1" id="s461.p0" relation="false"/>
  </sentence>
  <sentence id="s462" text="Different corneal dystrophies are caused by mutations in the N-acetylglucosamine metabolic process, intermediate filament cytoskeleton organization, KRT12, PIP5K3, sodium ion transport, negative regulation of epithelial cell migration, angiogenesis, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s462.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="61-98" id="s462.e1" ontology_id="GO_0006044" text="N-acetylglucosamine metabolic process" type="GO"/>
    <pair e1="s462.e0" e2="s462.e1" id="s462.p0" relation="true"/>
  </sentence>
  <sentence id="s463" text="Different corneal dystrophies are caused by mutations in the N-acetylglucosamine metabolic process, intermediate filament cytoskeleton organization, KRT12, PIP5K3, sodium ion transport, negative regulation of epithelial cell migration, angiogenesis, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s463.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="100-147" id="s463.e1" ontology_id="GO_0045104" text="intermediate filament cytoskeleton organization" type="GO"/>
    <pair e1="s463.e0" e2="s463.e1" id="s463.p0" relation="true"/>
  </sentence>
  <sentence id="s464" text="Different corneal dystrophies are caused by mutations in the N-acetylglucosamine metabolic process, intermediate filament cytoskeleton organization, KRT12, PIP5K3, sodium ion transport, negative regulation of epithelial cell migration, angiogenesis, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s464.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="164-184" id="s464.e1" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <pair e1="s464.e0" e2="s464.e1" id="s464.p0" relation="true"/>
  </sentence>
  <sentence id="s465" text="Different corneal dystrophies are caused by mutations in the N-acetylglucosamine metabolic process, intermediate filament cytoskeleton organization, KRT12, PIP5K3, sodium ion transport, negative regulation of epithelial cell migration, angiogenesis, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s465.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="186-234" id="s465.e1" ontology_id="GO_0010633" text="negative regulation of epithelial cell migration" type="GO"/>
    <pair e1="s465.e0" e2="s465.e1" id="s465.p0" relation="true"/>
  </sentence>
  <sentence id="s466" text="Different corneal dystrophies are caused by mutations in the N-acetylglucosamine metabolic process, intermediate filament cytoskeleton organization, KRT12, PIP5K3, sodium ion transport, negative regulation of epithelial cell migration, angiogenesis, and UBIAD1 genes.">
    <entity charOffset="10-29" id="s466.e0" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <entity charOffset="236-248" id="s466.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s466.e0" e2="s466.e1" id="s466.p0" relation="true"/>
  </sentence>
  <sentence id="s467" text="Herein, we investigated the role of transforming growth factor beta activation in the distinct processes involved in cancer metastasis.">
    <entity charOffset="36-78" id="s467.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="117-123" id="s467.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s467.e0" e2="s467.e1" id="s467.p0" relation="false"/>
  </sentence>
  <sentence id="s468" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.">
    <entity charOffset="21-26" id="s468.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="229-271" id="s468.e1" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <pair e1="s468.e0" e2="s468.e1" id="s468.p0" relation="false"/>
  </sentence>
  <sentence id="s469" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.">
    <entity charOffset="101-111" id="s469.e0" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <entity charOffset="364-389" id="s469.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s469.e0" e2="s469.e1" id="s469.p0" relation="false"/>
  </sentence>
  <sentence id="s470" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.">
    <entity charOffset="124-136" id="s470.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="229-271" id="s470.e1" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <pair e1="s470.e0" e2="s470.e1" id="s470.p0" relation="false"/>
  </sentence>
  <sentence id="s471" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.">
    <entity charOffset="124-136" id="s471.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="364-389" id="s471.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s471.e0" e2="s471.e1" id="s471.p0" relation="false"/>
  </sentence>
  <sentence id="s472" text="By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.">
    <entity charOffset="322-328" id="s472.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="364-389" id="s472.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s472.e0" e2="s472.e1" id="s472.p0" relation="false"/>
  </sentence>
  <sentence id="s473" text="LTBP3 was dispensable in the late protein dephosphorylations of carcinoma cell metastasis that follow tumor cell intravasation, including vascular arrest, extravasation, and tissue colonization.">
    <entity charOffset="34-59" id="s473.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="102-107" id="s473.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s473.e0" e2="s473.e1" id="s473.p0" relation="false"/>
  </sentence>
  <sentence id="s474" text="A similar compensatory approach rescued the dampened intravasation of transforming growth factor beta activation-deficient HEp-3 cells, suggesting that LTBP3 regulates the induction of the intravasation-supporting angiogenic vasculature within developing primary tumors.">
    <entity charOffset="70-112" id="s474.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="263-268" id="s474.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s474.e0" e2="s474.e1" id="s474.p0" relation="false"/>
  </sentence>
  <sentence id="s475" text="Using our recently developed microtumor model, we confirmed that transforming growth factor beta activation loss resulted in the development of intratumoral vessels with an abnormal microarchitecture incompatible with efficient intravasation of HEp-3 carcinoma cells.">
    <entity charOffset="34-39" id="s475.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="65-107" id="s475.e1" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <pair e1="s475.e0" e2="s475.e1" id="s475.p0" relation="false"/>
  </sentence>
  <sentence id="s476" text="Collectively, these findings demonstrate that transforming growth factor beta activation represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent tumor cell intravasation, a critical process during early cancer dissemination.">
    <entity charOffset="46-88" id="s476.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="252-258" id="s476.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s476.e0" e2="s476.e1" id="s476.p0" relation="false"/>
  </sentence>
  <sentence id="s477" text="Collectively, these findings demonstrate that transforming growth factor beta activation represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent tumor cell intravasation, a critical process during early cancer dissemination.">
    <entity charOffset="46-88" id="s477.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="194-199" id="s477.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s477.e0" e2="s477.e1" id="s477.p0" relation="false"/>
  </sentence>
  <sentence id="s478" text="Our experimental data are also consistent with the survival prognostic value of transforming growth factor beta activation expression in early-stage head and neck squamous cell carcinomas, further indicating a specific role for LTBP3 in cancer progression toward metastatic disease">
    <entity charOffset="80-122" id="s478.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="237-243" id="s478.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s478.e0" e2="s478.e1" id="s478.p0" relation="false"/>
  </sentence>
  <sentence id="s479" text="Our experimental data are also consistent with the survival prognostic value of transforming growth factor beta activation expression in early-stage head and neck squamous cell carcinomas, further indicating a specific role for LTBP3 in cancer progression toward metastatic disease">
    <entity charOffset="80-122" id="s479.e0" ontology_id="GO_0036363" text="transforming growth factor beta activation" type="GO"/>
    <entity charOffset="177-187" id="s479.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s479.e0" e2="s479.e1" id="s479.p0" relation="false"/>
  </sentence>
  <sentence id="s480" text="All tumors were positive for AE1-AE3, CK18, PAX 8, antimitochondrial antigen, and choline catabolic processB.">
    <entity charOffset="4-10" id="s480.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="82-107" id="s480.e1" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <pair e1="s480.e0" e2="s480.e1" id="s480.p0" relation="false"/>
  </sentence>
  <sentence id="s481" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (response to hydroperoxide), positive regulation of cell adhesion and TFEB RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="142-148" id="s481.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="232-268" id="s481.e1" ontology_id="GO_0045785" text="positive regulation of cell adhesion" type="GO"/>
    <pair e1="s481.e0" e2="s481.e1" id="s481.p0" relation="true"/>
  </sentence>
  <sentence id="s482" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (response to hydroperoxide), positive regulation of cell adhesion and TFEB RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="142-148" id="s482.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="283-308" id="s482.e1" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <pair e1="s482.e0" e2="s482.e1" id="s482.p0" relation="false"/>
  </sentence>
  <sentence id="s483" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (response to hydroperoxide), positive regulation of cell adhesion and TFEB RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="142-148" id="s483.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="204-229" id="s483.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s483.e0" e2="s483.e1" id="s483.p0" relation="false"/>
  </sentence>
  <sentence id="s484" text="HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (response to hydroperoxide), positive regulation of cell adhesion and TFEB RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC">
    <entity charOffset="182-202" id="s484.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="204-229" id="s484.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s484.e0" e2="s484.e1" id="s484.p0" relation="false"/>
  </sentence>
  <sentence id="s485" text="He has similar clinical findings, including mild facial dysmorphisms and intellectual disability, as other individuals with much larger deletions of the terminus of the long cilium assembly of chromosome 14.">
    <entity charOffset="73-96" id="s485.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="174-189" id="s485.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s485.e0" e2="s485.e1" id="s485.p0" relation="true"/>
  </sentence>
  <sentence id="s486" text="Cone-mitotic cell cycle checkpoint degeneration (positive regulation of transcription by RNA polymerase II) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.">
    <entity charOffset="5-34" id="s486.e0" ontology_id="GO_0007093" text="mitotic cell cycle checkpoint" type="GO"/>
    <entity charOffset="143-164" id="s486.e1" ontology_id="HP_0000546" text="retinal degenerations" type="HP"/>
    <pair e1="s486.e0" e2="s486.e1" id="s486.p0" relation="false"/>
  </sentence>
  <sentence id="s487" text="Cone-mitotic cell cycle checkpoint degeneration (positive regulation of transcription by RNA polymerase II) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.">
    <entity charOffset="49-106" id="s487.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="143-164" id="s487.e1" ontology_id="HP_0000546" text="retinal degenerations" type="HP"/>
    <pair e1="s487.e0" e2="s487.e1" id="s487.p0" relation="false"/>
  </sentence>
  <sentence id="s488" text="It mainly differentiates from other retinal dystrophies, and in particular from the more frequent disease retinitis pigmentosa, because cone photoreceptors degenerate at a higher rate than mitotic cell cycle checkpoint photoreceptors, causing severe deficiency of central vision.">
    <entity charOffset="36-55" id="s488.e0" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <entity charOffset="189-218" id="s488.e1" ontology_id="GO_0007093" text="mitotic cell cycle checkpoint" type="GO"/>
    <pair e1="s488.e0" e2="s488.e1" id="s488.p0" relation="false"/>
  </sentence>
  <sentence id="s489" text="In addition to positive regulation of transcription by RNA polymerase II, these three individuals had hearing loss or hearing deficit.">
    <entity charOffset="15-72" id="s489.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="102-114" id="s489.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s489.e0" e2="s489.e1" id="s489.p0" relation="true"/>
  </sentence>
  <sentence id="s490" text="Interaction studies also showed that cilium organization binds to positive regulation of protein acetylation, another ciliary protein associated with retinal degeneration.">
    <entity charOffset="37-56" id="s490.e0" ontology_id="GO_0044782" text="cilium organization" type="GO"/>
    <entity charOffset="150-170" id="s490.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s490.e0" e2="s490.e1" id="s490.p0" relation="true"/>
  </sentence>
  <sentence id="s491" text="Interaction studies also showed that cilium organization binds to positive regulation of protein acetylation, another ciliary protein associated with retinal degeneration.">
    <entity charOffset="66-108" id="s491.e0" ontology_id="GO_1901985" text="positive regulation of protein acetylation" type="GO"/>
    <entity charOffset="150-170" id="s491.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s491.e0" e2="s491.e1" id="s491.p0" relation="false"/>
  </sentence>
  <sentence id="s492" text="Altogether, our data strongly suggest that mutations in cilium organization cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.">
    <entity charOffset="56-75" id="s492.e0" ontology_id="GO_0044782" text="cilium organization" type="GO"/>
    <entity charOffset="247-264" id="s492.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s492.e0" e2="s492.e1" id="s492.p0" relation="true"/>
  </sentence>
  <sentence id="s493" text="B1 induced readthrough at all three nonsense codons in cultured cancer cells with &lt;i&gt;TP53&lt;/i&gt; (tumor protein p53) mutations, in cells from patients with nonsense mutations in the &lt;i&gt;TPP1&lt;/i&gt; (tripeptidyl peptidase 1), &lt;i&gt;DMD&lt;/i&gt; (dystrophin), &lt;i&gt;SMARCAL1&lt;/i&gt; (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), and &lt;i&gt;COL7A1&lt;/i&gt; (collagen muscle organ development VII alpha 1 chain) genes, and in an in vivo tumor xenograft model.">
    <entity charOffset="64-70" id="s493.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="385-409" id="s493.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s493.e0" e2="s493.e1" id="s493.p0" relation="false"/>
  </sentence>
  <sentence id="s494" text="B1 induced readthrough at all three nonsense codons in cultured cancer cells with &lt;i&gt;TP53&lt;/i&gt; (tumor protein p53) mutations, in cells from patients with nonsense mutations in the &lt;i&gt;TPP1&lt;/i&gt; (tripeptidyl peptidase 1), &lt;i&gt;DMD&lt;/i&gt; (dystrophin), &lt;i&gt;SMARCAL1&lt;/i&gt; (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), and &lt;i&gt;COL7A1&lt;/i&gt; (collagen muscle organ development VII alpha 1 chain) genes, and in an in vivo tumor xenograft model.">
    <entity charOffset="95-100" id="s494.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="385-409" id="s494.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s494.e0" e2="s494.e1" id="s494.p0" relation="false"/>
  </sentence>
  <sentence id="s495" text="Two common &lt;i&gt;base-excision repair, gap-filling&lt;/i&gt; mutations usually found &lt;i&gt;in cis&lt;/i&gt; in patients primarily with progressive external ophthalmoplegia generate T251I and P587L amino acid substitutions.">
    <entity charOffset="14-47" id="s495.e0" ontology_id="GO_0006287" text="base-excision repair, gap-filling" type="GO"/>
    <entity charOffset="117-128" id="s495.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s495.e0" e2="s495.e1" id="s495.p0" relation="true"/>
  </sentence>
  <sentence id="s496" text="Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) A scaffold subunit gene chromosome segregation are among the few genomic alterations that occur frequently in serous endometrial carcinoma (EC) and carcinosarcoma, two clinically aggressive subtypes of uterine cancer with few therapeutic options.">
    <entity charOffset="97-119" id="s496.e0" ontology_id="GO_0007059" text="chromosome segregation" type="GO"/>
    <entity charOffset="190-211" id="s496.e1" ontology_id="HP_0012114" text="endometrial carcinoma" type="HP"/>
    <pair e1="s496.e0" e2="s496.e1" id="s496.p0" relation="false"/>
  </sentence>
  <sentence id="s497" text="Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) A scaffold subunit gene chromosome segregation are among the few genomic alterations that occur frequently in serous endometrial carcinoma (EC) and carcinosarcoma, two clinically aggressive subtypes of uterine cancer with few therapeutic options.">
    <entity charOffset="97-119" id="s497.e0" ontology_id="GO_0007059" text="chromosome segregation" type="GO"/>
    <entity charOffset="283-289" id="s497.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s497.e0" e2="s497.e1" id="s497.p0" relation="false"/>
  </sentence>
  <sentence id="s498" text="Accordingly, overexpression of the A mutants in EC cells harboring wild-type chromosome segregation increased anchorage-independent growth and tumor formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3, Akt, and mTOR/p70S6K signaling pathways.">
    <entity charOffset="78-100" id="s498.e0" ontology_id="GO_0007059" text="chromosome segregation" type="GO"/>
    <entity charOffset="144-149" id="s498.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s498.e0" e2="s498.e1" id="s498.p0" relation="false"/>
  </sentence>
  <sentence id="s499" text="Despite significant progress, the high genetic heterogeneity of these disorders often requires large sample sizes to identify a critical cell adhesion mediated by integrin of individuals with disease-causing mutations in a single gene.">
    <entity charOffset="47-60" id="s499.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="137-171" id="s499.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s499.e0" e2="s499.e1" id="s499.p0" relation="false"/>
  </sentence>
  <sentence id="s500" text="By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in protein dephosphorylation.">
    <entity charOffset="100-119" id="s500.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="230-255" id="s500.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s500.e0" e2="s500.e1" id="s500.p0" relation="true"/>
  </sentence>
  <sentence id="s501" text="Based on these findings, we securely implicate protein dephosphorylation in early-onset refractory epilepsy and further support the emerging role for synaptic dysregulation in epilepsy">
    <entity charOffset="47-72" id="s501.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="99-107" id="s501.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s501.e0" e2="s501.e1" id="s501.p0" relation="true"/>
  </sentence>
  <sentence id="s502" text="Biotin Thiamine responsive Basal Ganglia Disease (BTBGD) is a rare treatable autosomal recessive metabolic disorder caused by mutations in thiamine transmembrane transport gene.">
    <entity charOffset="77-96" id="s502.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="139-171" id="s502.e1" ontology_id="GO_0071934" text="thiamine transmembrane transport" type="GO"/>
    <pair e1="s502.e0" e2="s502.e1" id="s502.p0" relation="true"/>
  </sentence>
  <sentence id="s503" text="Furthermore, we show that increased long-chain fatty-acyl-CoA metabolic process expression in human patients is associated with diabetic nephropathy, lupus nephritis, and protein homotetramerization nephropathy.">
    <entity charOffset="36-79" id="s503.e0" ontology_id="GO_0035336" text="long-chain fatty-acyl-CoA metabolic process" type="GO"/>
    <entity charOffset="137-148" id="s503.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s503.e0" e2="s503.e1" id="s503.p0" relation="false"/>
  </sentence>
  <sentence id="s504" text="Furthermore, we show that increased long-chain fatty-acyl-CoA metabolic process expression in human patients is associated with diabetic nephropathy, lupus nephritis, and protein homotetramerization nephropathy.">
    <entity charOffset="137-148" id="s504.e0" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <entity charOffset="171-198" id="s504.e1" ontology_id="GO_0051289" text="protein homotetramerization" type="GO"/>
    <pair e1="s504.e0" e2="s504.e1" id="s504.p0" relation="false"/>
  </sentence>
  <sentence id="s505" text="Here, we conducted whole-exome sequencing of patients with optic atrophy and other neurological signs of mitochondriopathy and identified 17 individuals from 13 unrelated families with recessive mutations in generation of precursor metabolites and energy, encoding the mitochondrial membrane-associated flavoprotein ferrodoxin reductase required for electron transport from NADPH to cytochrome P450.">
    <entity charOffset="59-72" id="s505.e0" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <entity charOffset="208-254" id="s505.e1" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <pair e1="s505.e0" e2="s505.e1" id="s505.p0" relation="true"/>
  </sentence>
  <sentence id="s506" text="Moreover, we found that epidermis development carrying a spontaneous mutation allelic to the most common mutation found in patients displayed progressive gait abnormalities and vision loss, in addition to biochemical defects consistent with the major clinical features of the disease.">
    <entity charOffset="24-45" id="s506.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="177-188" id="s506.e1" ontology_id="HP_0000572" text="vision loss" type="HP"/>
    <pair e1="s506.e0" e2="s506.e1" id="s506.p0" relation="false"/>
  </sentence>
  <sentence id="s507" text="Taken together, these data provide the first demonstration that germline, hypomorphic mutations in generation of precursor metabolites and energy cause a novel mitochondriopathy and optic atrophy in humans">
    <entity charOffset="99-145" id="s507.e0" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <entity charOffset="182-195" id="s507.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s507.e0" e2="s507.e1" id="s507.p0" relation="true"/>
  </sentence>
  <sentence id="s508" text="Primary ciliary dyskinesia (motile cilium assembly) is a rare autosomal-recessive condition resulting from structural and/or functional defects of the axoneme in motile cilia and sperm flagella.">
    <entity charOffset="8-26" id="s508.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-50" id="s508.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s508.e0" e2="s508.e1" id="s508.p0" relation="true"/>
  </sentence>
  <sentence id="s509" text="In a patient with clinical features of mitotic metaphase plate congression syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.">
    <entity charOffset="39-74" id="s509.e0" ontology_id="GO_0007080" text="mitotic metaphase plate congression" type="GO"/>
    <entity charOffset="93-105" id="s509.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s509.e0" e2="s509.e1" id="s509.p0" relation="false"/>
  </sentence>
  <sentence id="s510" text="In a patient with clinical features of mitotic metaphase plate congression syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.">
    <entity charOffset="39-74" id="s510.e0" ontology_id="GO_0007080" text="mitotic metaphase plate congression" type="GO"/>
    <entity charOffset="133-152" id="s510.e1" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <pair e1="s510.e0" e2="s510.e1" id="s510.p0" relation="false"/>
  </sentence>
  <sentence id="s511" text="In a patient with clinical features of mitotic metaphase plate congression syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.">
    <entity charOffset="39-74" id="s511.e0" ontology_id="GO_0007080" text="mitotic metaphase plate congression" type="GO"/>
    <entity charOffset="161-176" id="s511.e1" ontology_id="HP_0000077" text="renal anomalies" type="HP"/>
    <pair e1="s511.e0" e2="s511.e1" id="s511.p0" relation="false"/>
  </sentence>
  <sentence id="s512" text="Mutations in the negative regulation of protein binding gene lead to inherited neuropathies such as Charcot-Marie-Tooth type-2, distal hereditary motor neuropathies, spinal muscular atrophy with parkinsonism and the later stages can resemble amyotrophic lateral sclerosis.">
    <entity charOffset="17-55" id="s512.e0" ontology_id="GO_0032091" text="negative regulation of protein binding" type="GO"/>
    <entity charOffset="195-207" id="s512.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s512.e0" e2="s512.e1" id="s512.p0" relation="false"/>
  </sentence>
  <sentence id="s513" text="In humans, mutations in regulation of autophagy result in Wolfram syndrome 2, a disease in which the patients display juvenile diabetes, neuropsychiatric disorders and defective platelet aggregation.">
    <entity charOffset="24-47" id="s513.e0" ontology_id="GO_0010506" text="regulation of autophagy" type="GO"/>
    <entity charOffset="168-198" id="s513.e1" ontology_id="HP_0003540" text="defective platelet aggregation" type="HP"/>
    <pair e1="s513.e0" e2="s513.e1" id="s513.p0" relation="true"/>
  </sentence>
  <sentence id="s514" text="The pathogenesis of hepatocellular carcinoma (phosphatidylinositol phosphorylation) is poorly understood, but recent advances in genomics have increased our understanding of the mechanisms by which hepatitis B virus, hepatitis C virus, alcohol, fatty liver disease, and other environmental factors, such as aflatoxin, cause liver cancer.">
    <entity charOffset="20-44" id="s514.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="46-82" id="s514.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s514.e0" e2="s514.e1" id="s514.p0" relation="false"/>
  </sentence>
  <sentence id="s515" text="The pathogenesis of hepatocellular carcinoma (phosphatidylinositol phosphorylation) is poorly understood, but recent advances in genomics have increased our understanding of the mechanisms by which hepatitis B virus, hepatitis C virus, alcohol, fatty liver disease, and other environmental factors, such as aflatoxin, cause liver cancer.">
    <entity charOffset="46-82" id="s515.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="330-336" id="s515.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s515.e0" e2="s515.e1" id="s515.p0" relation="false"/>
  </sentence>
  <sentence id="s516" text="Using exome sequencing, we identified dominant mutations in mitochondrial fission on chromosome 12p11.21 in three large families with isolated optic atrophy, including the two families that defined the OPA5 locus on chromosome 19q12.1-13.1, the existence of which is denied by the present study.">
    <entity charOffset="60-81" id="s516.e0" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <entity charOffset="143-156" id="s516.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s516.e0" e2="s516.e1" id="s516.p0" relation="true"/>
  </sentence>
  <sentence id="s517" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including protein stabilization, protein folding, protein peptidyl-prolyl isomerization, FKBP65, SERPINF1, proteolysis, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s517.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="133-154" id="s517.e1" ontology_id="GO_0050821" text="protein stabilization" type="GO"/>
    <pair e1="s517.e0" e2="s517.e1" id="s517.p0" relation="true"/>
  </sentence>
  <sentence id="s518" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including protein stabilization, protein folding, protein peptidyl-prolyl isomerization, FKBP65, SERPINF1, proteolysis, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s518.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="156-171" id="s518.e1" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <pair e1="s518.e0" e2="s518.e1" id="s518.p0" relation="true"/>
  </sentence>
  <sentence id="s519" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including protein stabilization, protein folding, protein peptidyl-prolyl isomerization, FKBP65, SERPINF1, proteolysis, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s519.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="173-210" id="s519.e1" ontology_id="GO_0000413" text="protein peptidyl-prolyl isomerization" type="GO"/>
    <pair e1="s519.e0" e2="s519.e1" id="s519.p0" relation="true"/>
  </sentence>
  <sentence id="s520" text="Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including protein stabilization, protein folding, protein peptidyl-prolyl isomerization, FKBP65, SERPINF1, proteolysis, WNT1, FKBP10).">
    <entity charOffset="99-118" id="s520.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="230-241" id="s520.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s520.e0" e2="s520.e1" id="s520.p0" relation="true"/>
  </sentence>
  <sentence id="s521" text="Recently, TMEM38B, a gene that encodes endoplasmic reticulum organization, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with autosomal recessive OI.">
    <entity charOffset="39-73" id="s521.e0" ontology_id="GO_0007029" text="endoplasmic reticulum organization" type="GO"/>
    <entity charOffset="217-236" id="s521.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s521.e0" e2="s521.e1" id="s521.p0" relation="true"/>
  </sentence>
  <sentence id="s522" text="Our case-control study investigates the possible association between seven thymine catabolic process gene polymophisms (rs1801267, rs72547602, rs1801160, rs3918290, rs1801159, rs1801158, rs1801265) and risk of colorectal cancer (CRC).">
    <entity charOffset="75-100" id="s522.e0" ontology_id="GO_0006210" text="thymine catabolic process" type="GO"/>
    <entity charOffset="221-227" id="s522.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s522.e0" e2="s522.e1" id="s522.p0" relation="false"/>
  </sentence>
  <sentence id="s523" text="The present study suggests that the SNP rs1801160 and the &amp;quot;IISt&amp;quot; haplotype in the thymine catabolic process gene may also have a role in colorectal cancer risk">
    <entity charOffset="92-117" id="s523.e0" ontology_id="GO_0006210" text="thymine catabolic process" type="GO"/>
    <entity charOffset="158-164" id="s523.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s523.e0" e2="s523.e1" id="s523.p0" relation="false"/>
  </sentence>
  <sentence id="s524" text="We previously identified a negative regulation of transcription, DNA-templated of the most frequently mutated cytoskeleton- and extracellular matrix-related proteins (CECMPs) in numerous cancer datasets.">
    <entity charOffset="27-78" id="s524.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="187-193" id="s524.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s524.e0" e2="s524.e1" id="s524.p0" relation="false"/>
  </sentence>
  <sentence id="s525" text="We report a case of a 33 month-old male referred for developmental delay that was found to have an Xp21.2 duplication containing regulation of postsynapse organization and multiple midline brain malformations">
    <entity charOffset="53-72" id="s525.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="129-167" id="s525.e1" ontology_id="GO_0099175" text="regulation of postsynapse organization" type="GO"/>
    <pair e1="s525.e0" e2="s525.e1" id="s525.p0" relation="false"/>
  </sentence>
  <sentence id="s526" text="JBTS is genetically heterogeneous, however mutations in positive regulation of transcription, DNA-templated are a common underlying cause.">
    <entity charOffset="20-33" id="s526.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="56-107" id="s526.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s526.e0" e2="s526.e1" id="s526.p0" relation="false"/>
  </sentence>
  <sentence id="s527" text="We report a case with novel mitochondrial respiratory chain complex assembly gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L">
    <entity charOffset="28-76" id="s527.e0" ontology_id="GO_0033108" text="mitochondrial respiratory chain complex assembly" type="GO"/>
    <entity charOffset="139-158" id="s527.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s527.e0" e2="s527.e1" id="s527.p0" relation="true"/>
  </sentence>
  <sentence id="s528" text="We report a case with novel mitochondrial respiratory chain complex assembly gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L">
    <entity charOffset="28-76" id="s528.e0" ontology_id="GO_0033108" text="mitochondrial respiratory chain complex assembly" type="GO"/>
    <entity charOffset="116-134" id="s528.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s528.e0" e2="s528.e1" id="s528.p0" relation="true"/>
  </sentence>
  <sentence id="s529" text="Mutations in transcription initiation from RNA polymerase II promoter causes cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (transcription initiation from RNA polymerase II promoter), a hereditary cerebrovascular disease that leads to ischemic strokes and dementia, but in which migraine is often present, sometimes long before the onset of other symptoms.">
    <entity charOffset="13-69" id="s529.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="148-167" id="s529.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s529.e0" e2="s529.e1" id="s529.p0" relation="true"/>
  </sentence>
  <sentence id="s530" text="Mutations in transcription initiation from RNA polymerase II promoter causes cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (transcription initiation from RNA polymerase II promoter), a hereditary cerebrovascular disease that leads to ischemic strokes and dementia, but in which migraine is often present, sometimes long before the onset of other symptoms.">
    <entity charOffset="148-167" id="s530.e0" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <entity charOffset="169-225" id="s530.e1" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <pair e1="s530.e0" e2="s530.e1" id="s530.p0" relation="true"/>
  </sentence>
  <sentence id="s531" text="A variable-length poly-T variant in intron 6 of the protein targeting to mitochondrion gene, rs10524523, is associated with risk and age-of-onset of sporadic (late-onset) Alzheimer's disease.">
    <entity charOffset="52-86" id="s531.e0" ontology_id="GO_0006626" text="protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="149-157" id="s531.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s531.e0" e2="s531.e1" id="s531.p0" relation="false"/>
  </sentence>
  <sentence id="s532" text="Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&amp;gt;T variant (p.Ser162Leu) in protein O-linked glycosylation detected by exome sequencing.">
    <entity charOffset="80-99" id="s532.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="256-286" id="s532.e1" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <pair e1="s532.e0" e2="s532.e1" id="s532.p0" relation="false"/>
  </sentence>
  <sentence id="s533" text="Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&amp;gt;T variant (p.Ser162Leu) in protein O-linked glycosylation detected by exome sequencing.">
    <entity charOffset="101-113" id="s533.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="256-286" id="s533.e1" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <pair e1="s533.e0" e2="s533.e1" id="s533.p0" relation="false"/>
  </sentence>
  <sentence id="s534" text="These results suggest that this N-glycan of protein O-linked glycosylation is not required for its proper enzymatic function, and that the p.Ser162Leu mutation of POFUT1 likely causes global developmental delay, microcephaly with vascular and cardiac defects">
    <entity charOffset="44-74" id="s534.e0" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <entity charOffset="191-210" id="s534.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s534.e0" e2="s534.e1" id="s534.p0" relation="false"/>
  </sentence>
  <sentence id="s535" text="These results suggest that this N-glycan of protein O-linked glycosylation is not required for its proper enzymatic function, and that the p.Ser162Leu mutation of POFUT1 likely causes global developmental delay, microcephaly with vascular and cardiac defects">
    <entity charOffset="44-74" id="s535.e0" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <entity charOffset="212-224" id="s535.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s535.e0" e2="s535.e1" id="s535.p0" relation="false"/>
  </sentence>
  <sentence id="s536" text="We cellular response to interleukin-4 evidence of genetic heterogeneity between the sub-phenotypes of NSOFC and among different populations.">
    <entity charOffset="3-37" id="s536.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="58-71" id="s536.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s536.e0" e2="s536.e1" id="s536.p0" relation="false"/>
  </sentence>
  <sentence id="s537" text="Abnormal prion proteins are responsible for several fatal neurodegenerative diseases in humans and in animals, including Creutzfeldt-Jakob disease (positive regulation of peptidyl-tyrosine phosphorylation), Gerstmann-Strussler-Scheinker disease, and fatal familial insomnia.">
    <entity charOffset="58-84" id="s537.e0" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <entity charOffset="148-204" id="s537.e1" ontology_id="GO_0050731" text="positive regulation of peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s537.e0" e2="s537.e1" id="s537.p0" relation="false"/>
  </sentence>
  <sentence id="s538" text="In addition, different prion mutations were suggested to play a possible role in additional phenomuscle organ developments, such as Alzheimer's type pathology, spongiform encephalopathy, or frontotemporal dementia.">
    <entity charOffset="97-121" id="s538.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="171-185" id="s538.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s538.e0" e2="s538.e1" id="s538.p0" relation="false"/>
  </sentence>
  <sentence id="s539" text="In addition, different prion mutations were suggested to play a possible role in additional phenomuscle organ developments, such as Alzheimer's type pathology, spongiform encephalopathy, or frontotemporal dementia.">
    <entity charOffset="97-121" id="s539.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="190-213" id="s539.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s539.e0" e2="s539.e1" id="s539.p0" relation="false"/>
  </sentence>
  <sentence id="s540" text="Methylation status of the p16 G1/S transition of mitotic cell cycle promoter was assessed by methylation-specific PCR in 87 cervical specimens comprising 29 low-grade (LSIL), 41 high-grade (HSIL) lesions, and 17 cervical cancers (CC).">
    <entity charOffset="30-67" id="s540.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="221-227" id="s540.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s540.e0" e2="s540.e1" id="s540.p0" relation="true"/>
  </sentence>
  <sentence id="s541" text="FINDINGS We observed a significantly increased trend (nptrend = 0.0320) in the proportion of methylated p16 G1/S transition of mitotic cell cycle in cervical samples during cancer development.">
    <entity charOffset="108-145" id="s541.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="173-179" id="s541.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s541.e0" e2="s541.e1" id="s541.p0" relation="true"/>
  </sentence>
  <sentence id="s542" text="MAIN CONCLUSIONS There was an increase in methylation of the p16 G1/S transition of mitotic cell cycle promoter from pre-neoplastic lesions to cancer.">
    <entity charOffset="65-102" id="s542.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="143-149" id="s542.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s542.e0" e2="s542.e1" id="s542.p0" relation="true"/>
  </sentence>
  <sentence id="s543" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and episodic ataxia muscle organ development 1 or 2.">
    <entity charOffset="113-136" id="s543.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="233-241" id="s543.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s543.e0" e2="s543.e1" id="s543.p0" relation="false"/>
  </sentence>
  <sentence id="s544" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and episodic ataxia muscle organ development 1 or 2.">
    <entity charOffset="113-136" id="s544.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="242-248" id="s544.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s544.e0" e2="s544.e1" id="s544.p0" relation="false"/>
  </sentence>
  <sentence id="s545" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and episodic ataxia muscle organ development 1 or 2.">
    <entity charOffset="177-226" id="s545.e0" ontology_id="GO_0046929" text="negative regulation of neurotransmitter secretion" type="GO"/>
    <entity charOffset="233-241" id="s545.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s545.e0" e2="s545.e1" id="s545.p0" relation="false"/>
  </sentence>
  <sentence id="s546" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and episodic ataxia muscle organ development 1 or 2.">
    <entity charOffset="177-226" id="s546.e0" ontology_id="GO_0046929" text="negative regulation of neurotransmitter secretion" type="GO"/>
    <entity charOffset="242-248" id="s546.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s546.e0" e2="s546.e1" id="s546.p0" relation="false"/>
  </sentence>
  <sentence id="s547" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and episodic ataxia muscle organ development 1 or 2.">
    <entity charOffset="233-241" id="s547.e0" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <entity charOffset="249-273" id="s547.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s547.e0" e2="s547.e1" id="s547.p0" relation="false"/>
  </sentence>
  <sentence id="s548" text="Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and episodic ataxia muscle organ development 1 or 2.">
    <entity charOffset="242-248" id="s548.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="249-273" id="s548.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s548.e0" e2="s548.e1" id="s548.p0" relation="false"/>
  </sentence>
  <sentence id="s549" text="Antiepileptic drugs remain the treatment of choice for protein phosphorylation and episodic ataxia muscle organ development 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="55-78" id="s549.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="83-91" id="s549.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s549.e0" e2="s549.e1" id="s549.p0" relation="false"/>
  </sentence>
  <sentence id="s550" text="Antiepileptic drugs remain the treatment of choice for protein phosphorylation and episodic ataxia muscle organ development 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="55-78" id="s550.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="92-98" id="s550.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s550.e0" e2="s550.e1" id="s550.p0" relation="false"/>
  </sentence>
  <sentence id="s551" text="Antiepileptic drugs remain the treatment of choice for protein phosphorylation and episodic ataxia muscle organ development 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="83-91" id="s551.e0" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <entity charOffset="164-213" id="s551.e1" ontology_id="GO_0046929" text="negative regulation of neurotransmitter secretion" type="GO"/>
    <pair e1="s551.e0" e2="s551.e1" id="s551.p0" relation="false"/>
  </sentence>
  <sentence id="s552" text="Antiepileptic drugs remain the treatment of choice for protein phosphorylation and episodic ataxia muscle organ development 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="83-91" id="s552.e0" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <entity charOffset="99-123" id="s552.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s552.e0" e2="s552.e1" id="s552.p0" relation="false"/>
  </sentence>
  <sentence id="s553" text="Antiepileptic drugs remain the treatment of choice for protein phosphorylation and episodic ataxia muscle organ development 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology">
    <entity charOffset="92-98" id="s553.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="99-123" id="s553.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s553.e0" e2="s553.e1" id="s553.p0" relation="false"/>
  </sentence>
  <sentence id="s554" text="Chemical inhibition of epigenetic regulatory proteins regulation of transcription, DNA-templated and Brd4 is emerging as a promising therapeutic strategy in contraception, cancer, and heart disease.">
    <entity charOffset="54-96" id="s554.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="172-178" id="s554.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s554.e0" e2="s554.e1" id="s554.p0" relation="false"/>
  </sentence>
  <sentence id="s555" text="The remaining cases, clinically similar to peptidyl-tyrosine phosphorylation, are autosomal recessive agammaglobulinemia (ARA).">
    <entity charOffset="43-76" id="s555.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="82-101" id="s555.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s555.e0" e2="s555.e1" id="s555.p0" relation="false"/>
  </sentence>
  <sentence id="s556" text="However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between proteolysisT/T epidermis development and wild-type mice.">
    <entity charOffset="49-69" id="s556.e0" ontology_id="HP_0002625" text="deep vein thrombosis" type="HP"/>
    <entity charOffset="232-253" id="s556.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s556.e0" e2="s556.e1" id="s556.p0" relation="false"/>
  </sentence>
  <sentence id="s557" text="However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between proteolysisT/T epidermis development and wild-type mice.">
    <entity charOffset="93-111" id="s557.e0" ontology_id="HP_0002204" text="pulmonary embolism" type="HP"/>
    <entity charOffset="217-228" id="s557.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s557.e0" e2="s557.e1" id="s557.p0" relation="false"/>
  </sentence>
  <sentence id="s558" text="However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between proteolysisT/T epidermis development and wild-type mice.">
    <entity charOffset="93-111" id="s558.e0" ontology_id="HP_0002204" text="pulmonary embolism" type="HP"/>
    <entity charOffset="232-253" id="s558.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s558.e0" e2="s558.e1" id="s558.p0" relation="false"/>
  </sentence>
  <sentence id="s559" text="Coexistence in epidermis development of proteolysisT/T and Pros1E/E did not affect pulmonary embolism symptoms, compared with those in Pros1E/E mice.">
    <entity charOffset="15-36" id="s559.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="83-101" id="s559.e1" ontology_id="HP_0002204" text="pulmonary embolism" type="HP"/>
    <pair e1="s559.e0" e2="s559.e1" id="s559.p0" relation="false"/>
  </sentence>
  <sentence id="s560" text="Coexistence in epidermis development of proteolysisT/T and Pros1E/E did not affect pulmonary embolism symptoms, compared with those in Pros1E/E mice.">
    <entity charOffset="40-51" id="s560.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="83-101" id="s560.e1" ontology_id="HP_0002204" text="pulmonary embolism" type="HP"/>
    <pair e1="s560.e0" e2="s560.e1" id="s560.p0" relation="false"/>
  </sentence>
  <sentence id="s561" text="Moreover, regulation of cysteine-type endopeptidase activity R/C+C/C genotype was associated with increased tumor invasion depth (p = 0.041).">
    <entity charOffset="10-60" id="s561.e0" ontology_id="GO_2000116" text="regulation of cysteine-type endopeptidase activity" type="GO"/>
    <entity charOffset="108-113" id="s561.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s561.e0" e2="s561.e1" id="s561.p0" relation="false"/>
  </sentence>
  <sentence id="s562" text="To our knowledge, no study investigates the association of genetic variant distributions of WW domain-containing oxidoreductase (negative regulation of Wnt signaling pathway) gene with development of invasive cancer, clinicopathologic variables and patient survival in uterine cervical cancer for Taiwanese women.">
    <entity charOffset="129-173" id="s562.e0" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="209-215" id="s562.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s562.e0" e2="s562.e1" id="s562.p0" relation="true"/>
  </sentence>
  <sentence id="s563" text="We therefore conducted this study to explore the clinical involvements of negative regulation of Wnt signaling pathway single nucleotide polymorphisms (SNPs) in cervical cancer.">
    <entity charOffset="74-118" id="s563.e0" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="170-176" id="s563.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s563.e0" e2="s563.e1" id="s563.p0" relation="true"/>
  </sentence>
  <sentence id="s564" text="The results revealed that only negative regulation of Wnt signaling pathway SNP rs3764340 was associated between patients with cervical invasive cancer and normal controls among 5 WWOX genetic variants.">
    <entity charOffset="31-75" id="s564.e0" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="145-151" id="s564.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s564.e0" e2="s564.e1" id="s564.p0" relation="true"/>
  </sentence>
  <sentence id="s565" text="In conclusion, Taiwanese women with CG/GG in negative regulation of Wnt signaling pathway SNP rs3764340 are susceptible to cervical invasive cancer.">
    <entity charOffset="45-89" id="s565.e0" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="141-147" id="s565.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s565.e0" e2="s565.e1" id="s565.p0" relation="true"/>
  </sentence>
  <sentence id="s566" text="motile cilium assembly is characterized by clinical variability and extensive genetic heterogeneity, associated with different cilia ultrastructural defects and mutations identified in &amp;gt;20 genes.">
    <entity charOffset="0-22" id="s566.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="86-99" id="s566.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s566.e0" e2="s566.e1" id="s566.p0" relation="false"/>
  </sentence>
  <sentence id="s567" text="We will also discuss emerging paradigms of the molecular and cellular pathophysiology of disease-causing ephrinB2-EphB4-negative regulation of cell-matrix adhesion mutations, including the potential role of somatic mosaicism.">
    <entity charOffset="120-163" id="s567.e0" ontology_id="GO_0001953" text="negative regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="207-224" id="s567.e1" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <pair e1="s567.e0" e2="s567.e1" id="s567.p0" relation="false"/>
  </sentence>
  <sentence id="s568" text="We report that biallelic mutations in protein folding, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-53" id="s568.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="300-316" id="s568.e1" ontology_id="HP_0002120" text="cortical atrophy" type="HP"/>
    <pair e1="s568.e0" e2="s568.e1" id="s568.p0" relation="false"/>
  </sentence>
  <sentence id="s569" text="We report that biallelic mutations in protein folding, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-53" id="s569.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="345-357" id="s569.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s569.e0" e2="s569.e1" id="s569.p0" relation="true"/>
  </sentence>
  <sentence id="s570" text="We report that biallelic mutations in protein folding, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-53" id="s570.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="381-400" id="s570.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s570.e0" e2="s570.e1" id="s570.p0" relation="true"/>
  </sentence>
  <sentence id="s571" text="We report that biallelic mutations in protein folding, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-53" id="s571.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="402-425" id="s571.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s571.e0" e2="s571.e1" id="s571.p0" relation="true"/>
  </sentence>
  <sentence id="s572" text="We report that biallelic mutations in protein folding, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-53" id="s572.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="427-435" id="s572.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s572.e0" e2="s572.e1" id="s572.p0" relation="true"/>
  </sentence>
  <sentence id="s573" text="We report that biallelic mutations in protein folding, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-53" id="s573.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="437-450" id="s573.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s573.e0" e2="s573.e1" id="s573.p0" relation="true"/>
  </sentence>
  <sentence id="s574" text="We report that biallelic mutations in protein folding, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.">
    <entity charOffset="38-53" id="s574.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="456-476" id="s574.e1" ontology_id="HP_0002510" text="spastic quadriplegia" type="HP"/>
    <pair e1="s574.e0" e2="s574.e1" id="s574.p0" relation="true"/>
  </sentence>
  <sentence id="s575" text="Finally, it was observed that 4 hub genes were highly expressed in gastric cancer tissue compared with paracarcinoma tissue in the 12patients; the increased protein-containing complex assembly was significant (&amp;gt;5fold).">
    <entity charOffset="75-81" id="s575.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="159-194" id="s575.e1" ontology_id="GO_0065003" text="protein-containing complex assembly" type="GO"/>
    <pair e1="s575.e0" e2="s575.e1" id="s575.p0" relation="false"/>
  </sentence>
  <sentence id="s576" text="To address this, we performed exome sequencing and copy number variant analysis on 1511 frozen human brains with a diagnosis of Alzheimer's disease (AD, n = 289), frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS, n = 252), Creutzfeldt-Jakob disease (positive regulation of peptidyl-tyrosine phosphorylation, n = 239), Parkinson's disease (PD, n = 39), dementia with Lewy bodies (DLB, n = 58), other neurodegenerative, vascular, or neurogenetic disorders (n = 266), and controls with no significant neuropathology (n = 368).">
    <entity charOffset="163-186" id="s576.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="264-320" id="s576.e1" ontology_id="GO_0050731" text="positive regulation of peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s576.e0" e2="s576.e1" id="s576.p0" relation="false"/>
  </sentence>
  <sentence id="s577" text="L-cysteine catabolic process to hypotaurine is clinically and genetically heterogeneous.">
    <entity charOffset="0-43" id="s577.e0" ontology_id="GO_0019449" text="L-cysteine catabolic process to hypotaurine" type="GO"/>
    <entity charOffset="74-87" id="s577.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s577.e0" e2="s577.e1" id="s577.p0" relation="false"/>
  </sentence>
  <sentence id="s578" text="It is autosomal recessively inherited, and caused by negative regulation of cell-cell adhesion mutations.">
    <entity charOffset="6-25" id="s578.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="53-94" id="s578.e1" ontology_id="GO_0022408" text="negative regulation of cell-cell adhesion" type="GO"/>
    <pair e1="s578.e0" e2="s578.e1" id="s578.p0" relation="true"/>
  </sentence>
  <sentence id="s579" text="The nonsyndromic form of L-cysteine catabolic process to hypotaurine can be caused by dominant activating mutations in digestion, encoding intestinal receptor guanylate cyclase C (GC-C), and by autosomal recessive sodium ion import across plasma membrane loss-of-function mutations.">
    <entity charOffset="25-68" id="s579.e0" ontology_id="GO_0019449" text="L-cysteine catabolic process to hypotaurine" type="GO"/>
    <entity charOffset="194-213" id="s579.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s579.e0" e2="s579.e1" id="s579.p0" relation="false"/>
  </sentence>
  <sentence id="s580" text="The nonsyndromic form of L-cysteine catabolic process to hypotaurine can be caused by dominant activating mutations in digestion, encoding intestinal receptor guanylate cyclase C (GC-C), and by autosomal recessive sodium ion import across plasma membrane loss-of-function mutations.">
    <entity charOffset="119-128" id="s580.e0" ontology_id="GO_0007586" text="digestion" type="GO"/>
    <entity charOffset="194-213" id="s580.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s580.e0" e2="s580.e1" id="s580.p0" relation="true"/>
  </sentence>
  <sentence id="s581" text="The nonsyndromic form of L-cysteine catabolic process to hypotaurine can be caused by dominant activating mutations in digestion, encoding intestinal receptor guanylate cyclase C (GC-C), and by autosomal recessive sodium ion import across plasma membrane loss-of-function mutations.">
    <entity charOffset="194-213" id="s581.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="214-254" id="s581.e1" ontology_id="GO_0098719" text="sodium ion import across plasma membrane" type="GO"/>
    <pair e1="s581.e0" e2="s581.e1" id="s581.p0" relation="true"/>
  </sentence>
  <sentence id="s582" text="In this sense, evidence from both clinical and experimental studies indicates that neutrophil degranulation may reverse diabetic neuropathy through an antioxidant action by decreasing pro-inflammatory cytokines, restoring Na+/K+-ATPase activity, and blocking the generation of pro-apoptotic proteins.">
    <entity charOffset="83-107" id="s582.e0" ontology_id="GO_0043312" text="neutrophil degranulation" type="GO"/>
    <entity charOffset="129-139" id="s582.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s582.e0" e2="s582.e1" id="s582.p0" relation="false"/>
  </sentence>
  <sentence id="s583" text="positive regulation of lamellipodium assembly, one of the chloride transport characterized G protein-coupled receptor signaling pathway GTPases, is an established effector of receptors and an important node in signaling networks crucial for tumorigenesis and metastasis.">
    <entity charOffset="0-45" id="s583.e0" ontology_id="GO_0010592" text="positive regulation of lamellipodium assembly" type="GO"/>
    <entity charOffset="241-246" id="s583.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s583.e0" e2="s583.e1" id="s583.p0" relation="false"/>
  </sentence>
  <sentence id="s584" text="positive regulation of lamellipodium assembly, one of the chloride transport characterized G protein-coupled receptor signaling pathway GTPases, is an established effector of receptors and an important node in signaling networks crucial for tumorigenesis and metastasis.">
    <entity charOffset="58-76" id="s584.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="241-246" id="s584.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s584.e0" e2="s584.e1" id="s584.p0" relation="false"/>
  </sentence>
  <sentence id="s585" text="positive regulation of lamellipodium assembly, one of the chloride transport characterized G protein-coupled receptor signaling pathway GTPases, is an established effector of receptors and an important node in signaling networks crucial for tumorigenesis and metastasis.">
    <entity charOffset="91-135" id="s585.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="241-246" id="s585.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s585.e0" e2="s585.e1" id="s585.p0" relation="false"/>
  </sentence>
  <sentence id="s586" text="positive regulation of lamellipodium assembly hyperactivation is common in human cancer and could be the consequence of overexpression, abnormal upstream inputs, deregulated degradation, and/or anomalous intracellular localization.">
    <entity charOffset="0-45" id="s586.e0" ontology_id="GO_0010592" text="positive regulation of lamellipodium assembly" type="GO"/>
    <entity charOffset="81-87" id="s586.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s586.e0" e2="s586.e1" id="s586.p0" relation="false"/>
  </sentence>
  <sentence id="s587" text="More recently, cancer-associated gain-of-function mutations in positive regulation of lamellipodium assembly have been identified which contribute to tumor phenotypes and confer resistance to targeted therapies.">
    <entity charOffset="15-21" id="s587.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="63-108" id="s587.e1" ontology_id="GO_0010592" text="positive regulation of lamellipodium assembly" type="GO"/>
    <pair e1="s587.e0" e2="s587.e1" id="s587.p0" relation="false"/>
  </sentence>
  <sentence id="s588" text="More recently, cancer-associated gain-of-function mutations in positive regulation of lamellipodium assembly have been identified which contribute to tumor phenotypes and confer resistance to targeted therapies.">
    <entity charOffset="63-108" id="s588.e0" ontology_id="GO_0010592" text="positive regulation of lamellipodium assembly" type="GO"/>
    <entity charOffset="150-155" id="s588.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s588.e0" e2="s588.e1" id="s588.p0" relation="false"/>
  </sentence>
  <sentence id="s589" text="Translating our extensive knowledge in positive regulation of protein phosphorylation pathway biochemistry into a clinical setting still remains a major challenge; nonetheless, remarkable opportunities for cancer therapeutics arise from promising lead compounds targeting Rac and its effectors">
    <entity charOffset="39-85" id="s589.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="206-212" id="s589.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s589.e0" e2="s589.e1" id="s589.p0" relation="true"/>
  </sentence>
  <sentence id="s590" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="86-92" id="s590.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="172-195" id="s590.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s590.e0" e2="s590.e1" id="s590.p0" relation="true"/>
  </sentence>
  <sentence id="s591" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="86-92" id="s591.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="197-240" id="s591.e1" ontology_id="GO_0060561" text="apoptotic process involved in morphogenesis" type="GO"/>
    <pair e1="s591.e0" e2="s591.e1" id="s591.p0" relation="true"/>
  </sentence>
  <sentence id="s592" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="86-92" id="s592.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="271-299" id="s592.e1" ontology_id="GO_0001913" text="T cell mediated cytotoxicity" type="GO"/>
    <pair e1="s592.e0" e2="s592.e1" id="s592.p0" relation="false"/>
  </sentence>
  <sentence id="s593" text="To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.">
    <entity charOffset="242-266" id="s593.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="328-337" id="s593.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s593.e0" e2="s593.e1" id="s593.p0" relation="true"/>
  </sentence>
  <sentence id="s594" text="The alterations of protein phosphorylation and CADM1 are associated with the progression of tumor from CIN to Stage I/II, thus implying their role in early invasiveness.">
    <entity charOffset="19-42" id="s594.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="92-97" id="s594.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s594.e0" e2="s594.e1" id="s594.p0" relation="true"/>
  </sentence>
  <sentence id="s595" text="Leber's hereditary optic neuropathy (biological_process) is a common inherited mitochondrial disorder that is characterized by the degeneration of the optic nerves, leading to vision loss.">
    <entity charOffset="25-35" id="s595.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="37-55" id="s595.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s595.e0" e2="s595.e1" id="s595.p0" relation="false"/>
  </sentence>
  <sentence id="s596" text="High mobility group box 3 (DNA recombination), a member of the high-mobility group box (HMGB) family, was reported to be over-expressed in gastric carcinoma and bladder cancer.">
    <entity charOffset="27-44" id="s596.e0" ontology_id="GO_0006310" text="DNA recombination" type="GO"/>
    <entity charOffset="169-175" id="s596.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s596.e0" e2="s596.e1" id="s596.p0" relation="false"/>
  </sentence>
  <sentence id="s597" text="qRT-PCR results showed that high expression of DNA recombination had positive correlation with serosal invasion, lymph metastasis, and tumor-node-metastasis (regulation of transcription by RNA polymerase III) stage in CRC patient.">
    <entity charOffset="47-64" id="s597.e0" ontology_id="GO_0006310" text="DNA recombination" type="GO"/>
    <entity charOffset="135-140" id="s597.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s597.e0" e2="s597.e1" id="s597.p0" relation="false"/>
  </sentence>
  <sentence id="s598" text="qRT-PCR results showed that high expression of DNA recombination had positive correlation with serosal invasion, lymph metastasis, and tumor-node-metastasis (regulation of transcription by RNA polymerase III) stage in CRC patient.">
    <entity charOffset="135-140" id="s598.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="158-207" id="s598.e1" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <pair e1="s598.e0" e2="s598.e1" id="s598.p0" relation="false"/>
  </sentence>
  <sentence id="s599" text="It is highly heterogeneous, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (regulation of lipid metabolic process), having been identified.">
    <entity charOffset="13-26" id="s599.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="122-159" id="s599.e1" ontology_id="GO_0019216" text="regulation of lipid metabolic process" type="GO"/>
    <pair e1="s599.e0" e2="s599.e1" id="s599.p0" relation="false"/>
  </sentence>
  <sentence id="s600" text="Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as AMP biosynthetic process, nervous system development, shank3, and tsc1b.">
    <entity charOffset="94-100" id="s600.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="110-134" id="s600.e1" ontology_id="GO_0006167" text="AMP biosynthetic process" type="GO"/>
    <pair e1="s600.e0" e2="s600.e1" id="s600.p0" relation="true"/>
  </sentence>
  <sentence id="s601" text="Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as AMP biosynthetic process, nervous system development, shank3, and tsc1b.">
    <entity charOffset="94-100" id="s601.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="136-162" id="s601.e1" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <pair e1="s601.e0" e2="s601.e1" id="s601.p0" relation="false"/>
  </sentence>
  <sentence id="s602" text="Typical protein phosphorylation clinical features are mucocutaneous telangiectases, arteriovenous malformations, spontaneous and recurrent epistaxis, as well as gastrointestinal bleedings.">
    <entity charOffset="8-31" id="s602.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="84-111" id="s602.e1" ontology_id="HP_0100026" text="arteriovenous malformations" type="HP"/>
    <pair e1="s602.e0" e2="s602.e1" id="s602.p0" relation="true"/>
  </sentence>
  <sentence id="s603" text="Bardet-Biedl syndrome (visual perception) is a defining ciliopathy, notable for extensive allelic and genetic heterogeneity, almost all of which has been identified through sequencing.">
    <entity charOffset="23-40" id="s603.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="110-123" id="s603.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s603.e0" e2="s603.e1" id="s603.p0" relation="false"/>
  </sentence>
  <sentence id="s604" text="Alzheimer's disease (AD) is a serious neurodegenerative disease, and microRNAs (protein polyubiquitinationNAs) have been linked to its pathogenesis.">
    <entity charOffset="38-63" id="s604.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="80-106" id="s604.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s604.e0" e2="s604.e1" id="s604.p0" relation="false"/>
  </sentence>
  <sentence id="s605" text="Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN), tumor necrosis factor (negative regulation of transcription by RNA polymerase II), and granulocyte-macrophage colony-stimulating factor (positive regulation of cell proliferation) are implicated in the pathology of rheumatoid arthritis (RA).">
    <entity charOffset="105-110" id="s605.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="128-185" id="s605.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s605.e0" e2="s605.e1" id="s605.p0" relation="false"/>
  </sentence>
  <sentence id="s606" text="Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN), tumor necrosis factor (negative regulation of transcription by RNA polymerase II), and granulocyte-macrophage colony-stimulating factor (positive regulation of cell proliferation) are implicated in the pathology of rheumatoid arthritis (RA).">
    <entity charOffset="105-110" id="s606.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="243-284" id="s606.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s606.e0" e2="s606.e1" id="s606.p0" relation="false"/>
  </sentence>
  <sentence id="s607" text="RESULTS Circ-complement activation expression was significantly upregulated in glioma tissue and was correlated with tumor grade.">
    <entity charOffset="13-34" id="s607.e0" ontology_id="GO_0006956" text="complement activation" type="GO"/>
    <entity charOffset="117-122" id="s607.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s607.e0" e2="s607.e1" id="s607.p0" relation="false"/>
  </sentence>
  <sentence id="s608" text="Eight different androgen metabolic process mutations were detected in 15 patients with posterior hypospadias (60%, 15/25), including six previously described mutations (p.Q6X, Q71X, p.L20P, p.G203S, p.R227Q, and p.R246Q) and two novel mutations (p.G196R and p.L73Pfs&lt;sup&gt;&lt;/sup&gt;17).">
    <entity charOffset="16-42" id="s608.e0" ontology_id="GO_0008209" text="androgen metabolic process" type="GO"/>
    <entity charOffset="97-108" id="s608.e1" ontology_id="HP_0000047" text="hypospadias" type="HP"/>
    <pair e1="s608.e0" e2="s608.e1" id="s608.p0" relation="true"/>
  </sentence>
  <sentence id="s609" text="Patients with adult-onset angiogenesis may present with slowly progressive ataxia, persistent photosensitivity, and seizures without dementia or extrapyramidal findings.">
    <entity charOffset="26-38" id="s609.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="116-124" id="s609.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s609.e0" e2="s609.e1" id="s609.p0" relation="false"/>
  </sentence>
  <sentence id="s610" text="Patients with adult-onset angiogenesis may present with slowly progressive ataxia, persistent photosensitivity, and seizures without dementia or extrapyramidal findings.">
    <entity charOffset="26-38" id="s610.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="75-81" id="s610.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s610.e0" e2="s610.e1" id="s610.p0" relation="false"/>
  </sentence>
  <sentence id="s611" text="Recently, it has been demonstrated that, mutations of sensory perception of sound are associated with profound nonsyndromic hearing impairment at the sensory perception of sound locus.">
    <entity charOffset="54-81" id="s611.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="124-142" id="s611.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s611.e0" e2="s611.e1" id="s611.p0" relation="true"/>
  </sentence>
  <sentence id="s612" text="Recently, it has been demonstrated that, mutations of sensory perception of sound are associated with profound nonsyndromic hearing impairment at the sensory perception of sound locus.">
    <entity charOffset="102-110" id="s612.e0" ontology_id="HP_0012829" text="profound" type="HP"/>
    <entity charOffset="150-177" id="s612.e1" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <pair e1="s612.e0" e2="s612.e1" id="s612.p0" relation="false"/>
  </sentence>
  <sentence id="s613" text="The objective of this study is to evaluate the carrier frequency of c.242G&amp;gt;A mutation in sensory perception of sound gene and define the contribution of this gene in the etiology of deafness in Moroccan population.">
    <entity charOffset="92-119" id="s613.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="185-193" id="s613.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s613.e0" e2="s613.e1" id="s613.p0" relation="true"/>
  </sentence>
  <sentence id="s614" text="Our results show that after the gap junction-mediated intercellular transport gene mutation in sensory perception of sound gene is the second cause of congenital hearing impairment in Moroccan patients.">
    <entity charOffset="32-77" id="s614.e0" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <entity charOffset="162-180" id="s614.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s614.e0" e2="s614.e1" id="s614.p0" relation="true"/>
  </sentence>
  <sentence id="s615" text="Our results show that after the gap junction-mediated intercellular transport gene mutation in sensory perception of sound gene is the second cause of congenital hearing impairment in Moroccan patients.">
    <entity charOffset="95-122" id="s615.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="162-180" id="s615.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s615.e0" e2="s615.e1" id="s615.p0" relation="true"/>
  </sentence>
  <sentence id="s616" text="However, branching involved in blood vessel morphogenesis is a big protein expensive to produce that can hardly access the central nervous system.">
    <entity charOffset="9-57" id="s616.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="123-130" id="s616.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s616.e0" e2="s616.e1" id="s616.p0" relation="false"/>
  </sentence>
  <sentence id="s617" text="Since it is known that the native protein, branching involved in blood vessel morphogenesis, can coenzyme A biosynthetic process in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, angiogenesis, IGF-2 or extrinsic apoptotic signaling pathway via death domain receptors on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.">
    <entity charOffset="43-91" id="s617.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="413-426" id="s617.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s617.e0" e2="s617.e1" id="s617.p0" relation="false"/>
  </sentence>
  <sentence id="s618" text="Since it is known that the native protein, branching involved in blood vessel morphogenesis, can coenzyme A biosynthetic process in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, angiogenesis, IGF-2 or extrinsic apoptotic signaling pathway via death domain receptors on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.">
    <entity charOffset="97-128" id="s618.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="413-426" id="s618.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s618.e0" e2="s618.e1" id="s618.p0" relation="false"/>
  </sentence>
  <sentence id="s619" text="Since it is known that the native protein, branching involved in blood vessel morphogenesis, can coenzyme A biosynthetic process in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, angiogenesis, IGF-2 or extrinsic apoptotic signaling pathway via death domain receptors on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.">
    <entity charOffset="281-293" id="s619.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="413-426" id="s619.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s619.e0" e2="s619.e1" id="s619.p0" relation="false"/>
  </sentence>
  <sentence id="s620" text="Since it is known that the native protein, branching involved in blood vessel morphogenesis, can coenzyme A biosynthetic process in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, angiogenesis, IGF-2 or extrinsic apoptotic signaling pathway via death domain receptors on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.">
    <entity charOffset="304-368" id="s620.e0" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <entity charOffset="413-426" id="s620.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s620.e0" e2="s620.e1" id="s620.p0" relation="false"/>
  </sentence>
  <sentence id="s621" text="After diagnosis of granular cell tumour by core needle biopsy, the cell adhesion mediated by integrines were excised with histopathological and immunohistochemical analysis of both specimens confirming the presence of non-malignant granular cell tumours.">
    <entity charOffset="33-39" id="s621.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="67-101" id="s621.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s621.e0" e2="s621.e1" id="s621.p0" relation="false"/>
  </sentence>
  <sentence id="s622" text="Here we describe two unrelated individuals with infantile-onset epilepsy and abnormalities of brain morphology, harboring de novo variants that affect adjacent amino acids in a beta-tubulin gene biological_process.">
    <entity charOffset="64-72" id="s622.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="195-213" id="s622.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s622.e0" e2="s622.e1" id="s622.p0" relation="true"/>
  </sentence>
  <sentence id="s623" text="However, sequencing of large human cohorts reveals a cumulative frequency of additional rare negative regulation of endothelial cell proliferation mutations that raise the possibility of CaM variants not exclusively causing severe cardiac arrhythmias.">
    <entity charOffset="93-146" id="s623.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="231-250" id="s623.e1" ontology_id="HP_0011675" text="cardiac arrhythmias" type="HP"/>
    <pair e1="s623.e0" e2="s623.e1" id="s623.p0" relation="false"/>
  </sentence>
  <sentence id="s624" text="Hypomorphic IKBKG mutations in males are typically associated with anhidrotic ectodermal dysplasia with immunodeficiency (positive regulation of NF-kappaB transcription factor activity-ID).">
    <entity charOffset="78-98" id="s624.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="122-184" id="s624.e1" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s624.e0" e2="s624.e1" id="s624.p0" relation="true"/>
  </sentence>
  <sentence id="s625" text="As rare polymorphisms have been described in cellular response to DNA damage stimulus and polygenic inheritance remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing NEMO-ID variants">
    <entity charOffset="45-85" id="s625.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="90-111" id="s625.e1" ontology_id="HP_0010982" text="polygenic inheritance" type="HP"/>
    <pair e1="s625.e0" e2="s625.e1" id="s625.p0" relation="false"/>
  </sentence>
  <sentence id="s626" text="regulation of transcription, DNA-templated is a primary, chronic tubulointerstitial nephritis characterized with chronic anemia, absence of edema, xantoderma, normal blood pressure and normal findings on the fundus oculi.">
    <entity charOffset="0-42" id="s626.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="65-93" id="s626.e1" ontology_id="HP_0001970" text="tubulointerstitial nephritis" type="HP"/>
    <pair e1="s626.e0" e2="s626.e1" id="s626.p0" relation="false"/>
  </sentence>
  <sentence id="s627" text="The overexpression of negative regulation of transcription by RNA polymerase II selectively leads to the loss of dopaminergic neurons (DN) and mitochondrial abnormalities in the substantia nigra (MAPK cascade) of Parkinson's disease (PD) models.">
    <entity charOffset="22-79" id="s627.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="143-156" id="s627.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s627.e0" e2="s627.e1" id="s627.p0" relation="false"/>
  </sentence>
  <sentence id="s628" text="The overexpression of negative regulation of transcription by RNA polymerase II selectively leads to the loss of dopaminergic neurons (DN) and mitochondrial abnormalities in the substantia nigra (MAPK cascade) of Parkinson's disease (PD) models.">
    <entity charOffset="143-156" id="s628.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="196-208" id="s628.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s628.e0" e2="s628.e1" id="s628.p0" relation="false"/>
  </sentence>
  <sentence id="s629" text="Familial hypercholesterolemia is usually due to loss-of-function mutations in intestinal cholesterol absorption, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: positive regulation of macrophage derived foam cell differentiation, negative regulation of receptor recycling and LDLRAP1.">
    <entity charOffset="9-29" id="s629.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="78-111" id="s629.e1" ontology_id="GO_0030299" text="intestinal cholesterol absorption" type="GO"/>
    <pair e1="s629.e0" e2="s629.e1" id="s629.p0" relation="true"/>
  </sentence>
  <sentence id="s630" text="Familial hypercholesterolemia is usually due to loss-of-function mutations in intestinal cholesterol absorption, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: positive regulation of macrophage derived foam cell differentiation, negative regulation of receptor recycling and LDLRAP1.">
    <entity charOffset="9-29" id="s630.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="231-298" id="s630.e1" ontology_id="GO_0010744" text="positive regulation of macrophage derived foam cell differentiation" type="GO"/>
    <pair e1="s630.e0" e2="s630.e1" id="s630.p0" relation="true"/>
  </sentence>
  <sentence id="s631" text="Familial hypercholesterolemia is usually due to loss-of-function mutations in intestinal cholesterol absorption, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: positive regulation of macrophage derived foam cell differentiation, negative regulation of receptor recycling and LDLRAP1.">
    <entity charOffset="9-29" id="s631.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="300-341" id="s631.e1" ontology_id="GO_0001920" text="negative regulation of receptor recycling" type="GO"/>
    <pair e1="s631.e0" e2="s631.e1" id="s631.p0" relation="true"/>
  </sentence>
  <sentence id="s632" text="Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, positive regulation of phospholipase activity, APOA5, LMF1, GPIHBP1).">
    <entity charOffset="10-30" id="s632.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="139-184" id="s632.e1" ontology_id="GO_0010518" text="positive regulation of phospholipase activity" type="GO"/>
    <pair e1="s632.e0" e2="s632.e1" id="s632.p0" relation="true"/>
  </sentence>
  <sentence id="s633" text="Conversely familial hypobetalipoproteinemia is caused by inactivation of the negative regulation of receptor recycling gene which increases the number of LDL receptors and decreases plasma cholesterol.">
    <entity charOffset="20-43" id="s633.e0" ontology_id="HP_0003563" text="hypobetalipoproteinemia" type="HP"/>
    <entity charOffset="77-118" id="s633.e1" ontology_id="GO_0001920" text="negative regulation of receptor recycling" type="GO"/>
    <pair e1="s633.e0" e2="s633.e1" id="s633.p0" relation="false"/>
  </sentence>
  <sentence id="s634" text="Consistent with this pattern of activity, transcription by RNA polymerase I and polr1d homozygous mutant zebrafish exhibit cartilage hypoplasia and cranioskeletal anomalies characteristic of humans with Treacher Collins syndrome.">
    <entity charOffset="42-75" id="s634.e0" ontology_id="GO_0006360" text="transcription by RNA polymerase I" type="GO"/>
    <entity charOffset="154-172" id="s634.e1" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <pair e1="s634.e0" e2="s634.e1" id="s634.p0" relation="true"/>
  </sentence>
  <sentence id="s635" text="More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the skeletal anomalies in transcription by RNA polymerase I and transcription, DNA-templated mutants, providing a potential avenue to prevent the pathogenesis of Treacher Collins syndrome.">
    <entity charOffset="117-135" id="s635.e0" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <entity charOffset="139-172" id="s635.e1" ontology_id="GO_0006360" text="transcription by RNA polymerase I" type="GO"/>
    <pair e1="s635.e0" e2="s635.e1" id="s635.p0" relation="true"/>
  </sentence>
  <sentence id="s636" text="More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the skeletal anomalies in transcription by RNA polymerase I and transcription, DNA-templated mutants, providing a potential avenue to prevent the pathogenesis of Treacher Collins syndrome.">
    <entity charOffset="117-135" id="s636.e0" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <entity charOffset="177-205" id="s636.e1" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <pair e1="s636.e0" e2="s636.e1" id="s636.p0" relation="true"/>
  </sentence>
  <sentence id="s637" text="Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) positive regulation of GTPase activity and UDP-N-acetylglucosamine biosynthetic process deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.">
    <entity charOffset="215-234" id="s637.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="240-278" id="s637.e1" ontology_id="GO_0043547" text="positive regulation of GTPase activity" type="GO"/>
    <pair e1="s637.e0" e2="s637.e1" id="s637.p0" relation="true"/>
  </sentence>
  <sentence id="s638" text="Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) positive regulation of GTPase activity and UDP-N-acetylglucosamine biosynthetic process deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.">
    <entity charOffset="215-234" id="s638.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="283-327" id="s638.e1" ontology_id="GO_0006048" text="UDP-N-acetylglucosamine biosynthetic process" type="GO"/>
    <pair e1="s638.e0" e2="s638.e1" id="s638.p0" relation="true"/>
  </sentence>
  <sentence id="s639" text="We evaluated the genetic negative regulation of transcription by RNA polymerase II of the amyotrophic lateral sclerosis (signal transduction) risk gene never in mitosis gene a-related kinase 1 (protein phosphorylation) in a Belgian cohort of 278 patients with ALS (n= 245) or ALS with frontotemporal dementia (ALS-FTD, n= 33) and 609 control individuals.">
    <entity charOffset="25-82" id="s639.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="286-309" id="s639.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s639.e0" e2="s639.e1" id="s639.p0" relation="false"/>
  </sentence>
  <sentence id="s640" text="We evaluated the genetic negative regulation of transcription by RNA polymerase II of the amyotrophic lateral sclerosis (signal transduction) risk gene never in mitosis gene a-related kinase 1 (protein phosphorylation) in a Belgian cohort of 278 patients with ALS (n= 245) or ALS with frontotemporal dementia (ALS-FTD, n= 33) and 609 control individuals.">
    <entity charOffset="121-140" id="s640.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="286-309" id="s640.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s640.e0" e2="s640.e1" id="s640.p0" relation="false"/>
  </sentence>
  <sentence id="s641" text="We evaluated the genetic negative regulation of transcription by RNA polymerase II of the amyotrophic lateral sclerosis (signal transduction) risk gene never in mitosis gene a-related kinase 1 (protein phosphorylation) in a Belgian cohort of 278 patients with ALS (n= 245) or ALS with frontotemporal dementia (ALS-FTD, n= 33) and 609 control individuals.">
    <entity charOffset="194-217" id="s641.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="286-309" id="s641.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s641.e0" e2="s641.e1" id="s641.p0" relation="false"/>
  </sentence>
  <sentence id="s642" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal biological_process) in whom two novel craniofacial suture morphogenesis mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="115-128" id="s642.e0" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <entity charOffset="219-252" id="s642.e1" ontology_id="GO_0097094" text="craniofacial suture morphogenesis" type="GO"/>
    <pair e1="s642.e0" e2="s642.e1" id="s642.p0" relation="true"/>
  </sentence>
  <sentence id="s643" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal biological_process) in whom two novel craniofacial suture morphogenesis mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="115-128" id="s643.e0" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <entity charOffset="181-199" id="s643.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s643.e0" e2="s643.e1" id="s643.p0" relation="false"/>
  </sentence>
  <sentence id="s644" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal biological_process) in whom two novel craniofacial suture morphogenesis mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="141-153" id="s644.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="219-252" id="s644.e1" ontology_id="GO_0097094" text="craniofacial suture morphogenesis" type="GO"/>
    <pair e1="s644.e0" e2="s644.e1" id="s644.p0" relation="true"/>
  </sentence>
  <sentence id="s645" text="In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal biological_process) in whom two novel craniofacial suture morphogenesis mutations (c.305A&amp;gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.">
    <entity charOffset="141-153" id="s645.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="181-199" id="s645.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s645.e0" e2="s645.e1" id="s645.p0" relation="false"/>
  </sentence>
  <sentence id="s646" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="215-260" id="s646.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="760-765" id="s646.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s646.e0" e2="s646.e1" id="s646.p0" relation="true"/>
  </sentence>
  <sentence id="s647" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="262-323" id="s647.e0" ontology_id="GO_0007221" text="positive regulation of transcription of Notch receptor target" type="GO"/>
    <entity charOffset="760-765" id="s647.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s647.e0" e2="s647.e1" id="s647.p0" relation="false"/>
  </sentence>
  <sentence id="s648" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="262-323" id="s648.e0" ontology_id="GO_0007221" text="positive regulation of transcription of Notch receptor target" type="GO"/>
    <entity charOffset="640-650" id="s648.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s648.e0" e2="s648.e1" id="s648.p0" relation="false"/>
  </sentence>
  <sentence id="s649" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="325-348" id="s649.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="760-765" id="s649.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s649.e0" e2="s649.e1" id="s649.p0" relation="false"/>
  </sentence>
  <sentence id="s650" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="355-389" id="s650.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="760-765" id="s650.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s650.e0" e2="s650.e1" id="s650.p0" relation="false"/>
  </sentence>
  <sentence id="s651" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="355-389" id="s651.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="640-650" id="s651.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s651.e0" e2="s651.e1" id="s651.p0" relation="false"/>
  </sentence>
  <sentence id="s652" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="398-416" id="s652.e0" ontology_id="GO_0000278" text="mitotic cell cycle" type="GO"/>
    <entity charOffset="760-765" id="s652.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s652.e0" e2="s652.e1" id="s652.p0" relation="false"/>
  </sentence>
  <sentence id="s653" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="453-472" id="s653.e0" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <entity charOffset="760-765" id="s653.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s653.e0" e2="s653.e1" id="s653.p0" relation="true"/>
  </sentence>
  <sentence id="s654" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="453-472" id="s654.e0" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <entity charOffset="640-650" id="s654.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s654.e0" e2="s654.e1" id="s654.p0" relation="false"/>
  </sentence>
  <sentence id="s655" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="498-524" id="s655.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="760-765" id="s655.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s655.e0" e2="s655.e1" id="s655.p0" relation="true"/>
  </sentence>
  <sentence id="s656" text="We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, -H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.">
    <entity charOffset="568-593" id="s656.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="640-650" id="s656.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s656.e0" e2="s656.e1" id="s656.p0" relation="false"/>
  </sentence>
  <sentence id="s657" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (mitotic cell cycle, -H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="100-161" id="s657.e0" ontology_id="GO_0007221" text="positive regulation of transcription of Notch receptor target" type="GO"/>
    <entity charOffset="423-433" id="s657.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s657.e0" e2="s657.e1" id="s657.p0" relation="false"/>
  </sentence>
  <sentence id="s658" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (mitotic cell cycle, -H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="163-186" id="s658.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="423-433" id="s658.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s658.e0" e2="s658.e1" id="s658.p0" relation="false"/>
  </sentence>
  <sentence id="s659" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (mitotic cell cycle, -H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="193-227" id="s659.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="423-433" id="s659.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s659.e0" e2="s659.e1" id="s659.p0" relation="false"/>
  </sentence>
  <sentence id="s660" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (mitotic cell cycle, -H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="238-256" id="s660.e0" ontology_id="GO_0000278" text="mitotic cell cycle" type="GO"/>
    <entity charOffset="423-433" id="s660.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s660.e0" e2="s660.e1" id="s660.p0" relation="false"/>
  </sentence>
  <sentence id="s661" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (mitotic cell cycle, -H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="292-311" id="s661.e0" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <entity charOffset="423-433" id="s661.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s661.e0" e2="s661.e1" id="s661.p0" relation="false"/>
  </sentence>
  <sentence id="s662" text="IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (mitotic cell cycle, -H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.">
    <entity charOffset="324-350" id="s662.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="423-433" id="s662.e1" ontology_id="HP_0030731" text="carcinomas" type="HP"/>
    <pair e1="s662.e0" e2="s662.e1" id="s662.p0" relation="false"/>
  </sentence>
  <sentence id="s663" text="Angioinvasion defined as tumor cells invading through a vessel wall and intravascular tumor cells admixed with thrombus proved to be the chloride transport prognostic parameter, predicting adverse outcome in the entire cohort as well as within low-grade acetyl-CoA metabolic processs.">
    <entity charOffset="25-30" id="s663.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="254-282" id="s663.e1" ontology_id="GO_0006084" text="acetyl-CoA metabolic process" type="GO"/>
    <pair e1="s663.e0" e2="s663.e1" id="s663.p0" relation="false"/>
  </sentence>
  <sentence id="s664" text="Angioinvasion defined as tumor cells invading through a vessel wall and intravascular tumor cells admixed with thrombus proved to be the chloride transport prognostic parameter, predicting adverse outcome in the entire cohort as well as within low-grade acetyl-CoA metabolic processs.">
    <entity charOffset="25-30" id="s664.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="137-155" id="s664.e1" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <pair e1="s664.e0" e2="s664.e1" id="s664.p0" relation="false"/>
  </sentence>
  <sentence id="s665" text="Low mitotic tumor grade, Weiss score, global loss of nucleosome assembly expression, and high phospho-regulation of cell growth expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease.">
    <entity charOffset="12-17" id="s665.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="53-72" id="s665.e1" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <pair e1="s665.e0" e2="s665.e1" id="s665.p0" relation="true"/>
  </sentence>
  <sentence id="s666" text="Low mitotic tumor grade, Weiss score, global loss of nucleosome assembly expression, and high phospho-regulation of cell growth expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease.">
    <entity charOffset="12-17" id="s666.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="102-127" id="s666.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s666.e0" e2="s666.e1" id="s666.p0" relation="false"/>
  </sentence>
  <sentence id="s667" text="In addition, the tested peptides inhibited lung colonization after intranasal inoculation of epidermis development with S. pneumoniae.">
    <entity charOffset="93-114" id="s667.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="123-132" id="s667.e1" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <pair e1="s667.e0" e2="s667.e1" id="s667.p0" relation="false"/>
  </sentence>
  <sentence id="s668" text="For diagnosis of central nervous system degeneration in adolescents with bulbar symptoms, G protein-coupled receptor signaling pathway attention should be paid to JALS">
    <entity charOffset="17-52" id="s668.e0" ontology_id="HP_0007009" text="central nervous system degeneration" type="HP"/>
    <entity charOffset="90-134" id="s668.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s668.e0" e2="s668.e1" id="s668.p0" relation="false"/>
  </sentence>
  <sentence id="s669" text="Patients with urea cycle and DNA replication initiation mutations appear to have the most severe short stature and microcephaly.">
    <entity charOffset="14-24" id="s669.e0" ontology_id="GO_0000050" text="urea cycle" type="GO"/>
    <entity charOffset="97-110" id="s669.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s669.e0" e2="s669.e1" id="s669.p0" relation="false"/>
  </sentence>
  <sentence id="s670" text="Patients with urea cycle and DNA replication initiation mutations appear to have the most severe short stature and microcephaly.">
    <entity charOffset="14-24" id="s670.e0" ontology_id="GO_0000050" text="urea cycle" type="GO"/>
    <entity charOffset="115-127" id="s670.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s670.e0" e2="s670.e1" id="s670.p0" relation="false"/>
  </sentence>
  <sentence id="s671" text="Patients with urea cycle and DNA replication initiation mutations appear to have the most severe short stature and microcephaly.">
    <entity charOffset="29-55" id="s671.e0" ontology_id="GO_0006270" text="DNA replication initiation" type="GO"/>
    <entity charOffset="97-110" id="s671.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s671.e0" e2="s671.e1" id="s671.p0" relation="true"/>
  </sentence>
  <sentence id="s672" text="Patients with urea cycle and DNA replication initiation mutations appear to have the most severe short stature and microcephaly.">
    <entity charOffset="29-55" id="s672.e0" ontology_id="GO_0006270" text="DNA replication initiation" type="GO"/>
    <entity charOffset="115-127" id="s672.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s672.e0" e2="s672.e1" id="s672.p0" relation="true"/>
  </sentence>
  <sentence id="s673" text="Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in ganglioside biosynthetic process, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.">
    <entity charOffset="114-121" id="s673.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="193-225" id="s673.e1" ontology_id="GO_0001574" text="ganglioside biosynthetic process" type="GO"/>
    <pair e1="s673.e0" e2="s673.e1" id="s673.p0" relation="false"/>
  </sentence>
  <sentence id="s674" text="6q14 deletions have been associated with intellectual disability and a distinct pattern of positive regulation of glucose transmembrane transport anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.">
    <entity charOffset="41-64" id="s674.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="91-145" id="s674.e1" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <pair e1="s674.e0" e2="s674.e1" id="s674.p0" relation="false"/>
  </sentence>
  <sentence id="s675" text="6q14 deletions have been associated with intellectual disability and a distinct pattern of positive regulation of glucose transmembrane transport anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.">
    <entity charOffset="41-64" id="s675.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="249-267" id="s675.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s675.e0" e2="s675.e1" id="s675.p0" relation="false"/>
  </sentence>
  <sentence id="s676" text="6q14 deletions have been associated with intellectual disability and a distinct pattern of positive regulation of glucose transmembrane transport anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.">
    <entity charOffset="91-145" id="s676.e0" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <entity charOffset="167-195" id="s676.e1" ontology_id="HP_0000582" text="upslanted palpebral fissures" type="HP"/>
    <pair e1="s676.e0" e2="s676.e1" id="s676.p0" relation="false"/>
  </sentence>
  <sentence id="s677" text="6q14 deletions have been associated with intellectual disability and a distinct pattern of positive regulation of glucose transmembrane transport anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.">
    <entity charOffset="91-145" id="s677.e0" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <entity charOffset="201-217" id="s677.e1" ontology_id="HP_0000286" text="epicanthal folds" type="HP"/>
    <pair e1="s677.e0" e2="s677.e1" id="s677.p0" relation="false"/>
  </sentence>
  <sentence id="s678" text="6q14 deletions have been associated with intellectual disability and a distinct pattern of positive regulation of glucose transmembrane transport anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.">
    <entity charOffset="91-145" id="s678.e0" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <entity charOffset="221-231" id="s678.e1" ontology_id="HP_0003196" text="short nose" type="HP"/>
    <pair e1="s678.e0" e2="s678.e1" id="s678.p0" relation="false"/>
  </sentence>
  <sentence id="s679" text="6q14 deletions have been associated with intellectual disability and a distinct pattern of positive regulation of glucose transmembrane transport anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.">
    <entity charOffset="201-217" id="s679.e0" ontology_id="HP_0000286" text="epicanthal folds" type="HP"/>
    <entity charOffset="249-267" id="s679.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s679.e0" e2="s679.e1" id="s679.p0" relation="false"/>
  </sentence>
  <sentence id="s680" text="Possible candidate genes in 6q14 for intellectual disability might be biological_process, MYO6, adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway, and SNX14">
    <entity charOffset="37-60" id="s680.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="70-88" id="s680.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s680.e0" e2="s680.e1" id="s680.p0" relation="false"/>
  </sentence>
  <sentence id="s681" text="Possible candidate genes in 6q14 for intellectual disability might be biological_process, MYO6, adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway, and SNX14">
    <entity charOffset="37-60" id="s681.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="96-169" id="s681.e1" ontology_id="GO_0007193" text="adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s681.e0" e2="s681.e1" id="s681.p0" relation="false"/>
  </sentence>
  <sentence id="s682" text="protein polyubiquitination plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive muscle organ development 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="0-26" id="s682.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="70-95" id="s682.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s682.e0" e2="s682.e1" id="s682.p0" relation="false"/>
  </sentence>
  <sentence id="s683" text="protein polyubiquitination plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive muscle organ development 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="0-26" id="s683.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="152-158" id="s683.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s683.e0" e2="s683.e1" id="s683.p0" relation="true"/>
  </sentence>
  <sentence id="s684" text="protein polyubiquitination plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive muscle organ development 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="70-95" id="s684.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="179-203" id="s684.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s684.e0" e2="s684.e1" id="s684.p0" relation="false"/>
  </sentence>
  <sentence id="s685" text="protein polyubiquitination plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive muscle organ development 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.">
    <entity charOffset="152-158" id="s685.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="179-203" id="s685.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s685.e0" e2="s685.e1" id="s685.p0" relation="false"/>
  </sentence>
  <sentence id="s686" text="In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped SENP1 (rs61918808), SENP2 (rs6762208), biological_process (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.">
    <entity charOffset="164-170" id="s686.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="252-270" id="s686.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s686.e0" e2="s686.e1" id="s686.p0" relation="false"/>
  </sentence>
  <sentence id="s687" text="Lucitanib is a small molecule inhibitor of vascular endothelial growth factor (negative regulation of transcription by RNA polymerase II) receptors 1 to 3 (VEGFR1 to 3), platelet derived growth factor / (PDGFR/) and FGFR1-3 tyrosine kinases and has demonstrated activity in a phase I/II clinical study, with objective RECIST responses in breast cancer patients with FGFR1 or FGF3/4/19 gene amplification, as well as in patients anticipated to benefit from anti-angiogenic agents.">
    <entity charOffset="79-136" id="s687.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="349-355" id="s687.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s687.e0" e2="s687.e1" id="s687.p0" relation="false"/>
  </sentence>
  <sentence id="s688" text="We report here the in vitro and in vivo antitumor activity of lucitanib in experimental models with or without positive regulation of cell proliferation/2 amplification or mutations.">
    <entity charOffset="44-49" id="s688.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="111-152" id="s688.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s688.e0" e2="s688.e1" id="s688.p0" relation="true"/>
  </sentence>
  <sentence id="s689" text="In cell assays, lucitanib potently inhibited the growth of tumor cell lines with amplified FGFR1 or mutated/amplified positive regulation of cell proliferation.">
    <entity charOffset="59-64" id="s689.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="118-159" id="s689.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s689.e0" e2="s689.e1" id="s689.p0" relation="true"/>
  </sentence>
  <sentence id="s690" text="Notably, in two lung cancer models with positive regulation of cell proliferation amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of negative regulation of transcription by RNA polymerase II and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.">
    <entity charOffset="21-27" id="s690.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="179-236" id="s690.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s690.e0" e2="s690.e1" id="s690.p0" relation="false"/>
  </sentence>
  <sentence id="s691" text="Notably, in two lung cancer models with positive regulation of cell proliferation amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of negative regulation of transcription by RNA polymerase II and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.">
    <entity charOffset="21-27" id="s691.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="40-81" id="s691.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s691.e0" e2="s691.e1" id="s691.p0" relation="true"/>
  </sentence>
  <sentence id="s692" text="Notably, in two lung cancer models with positive regulation of cell proliferation amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of negative regulation of transcription by RNA polymerase II and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.">
    <entity charOffset="105-110" id="s692.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="179-236" id="s692.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s692.e0" e2="s692.e1" id="s692.p0" relation="false"/>
  </sentence>
  <sentence id="s693" text="Similar antitumor activity was observed in positive regulation of cell proliferation wild-type and amplified or mutated xenograft models.">
    <entity charOffset="12-17" id="s693.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="43-84" id="s693.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s693.e0" e2="s693.e1" id="s693.p0" relation="true"/>
  </sentence>
  <sentence id="s694" text="However, the inherent susceptibility of these tissues to mitochondrial respiratory chain complex IV assembly mutations and the clinical heterogeneity observed across SCO1 pedigrees remain poorly understood phenomena.">
    <entity charOffset="57-108" id="s694.e0" ontology_id="GO_0033617" text="mitochondrial respiratory chain complex IV assembly" type="GO"/>
    <entity charOffset="136-149" id="s694.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s694.e0" e2="s694.e1" id="s694.p0" relation="true"/>
  </sentence>
  <sentence id="s695" text="Lethality was observed in both models due to a combined generation of precursor metabolites and energy and copper deficiency that resulted in a dilated cardiomyopathy.">
    <entity charOffset="56-102" id="s695.e0" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <entity charOffset="152-166" id="s695.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s695.e0" e2="s695.e1" id="s695.p0" relation="true"/>
  </sentence>
  <sentence id="s696" text="copper ion transport was similarly mislocalized to the cytosol in the heart of knockin epidermis development carrying a homozygous G115S substitution in mitochondrial respiratory chain complex IV assembly, which in humans causes a hypertrophic cardiomyopathy.">
    <entity charOffset="0-20" id="s696.e0" ontology_id="GO_0006825" text="copper ion transport" type="GO"/>
    <entity charOffset="244-258" id="s696.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s696.e0" e2="s696.e1" id="s696.p0" relation="false"/>
  </sentence>
  <sentence id="s697" text="copper ion transport was similarly mislocalized to the cytosol in the heart of knockin epidermis development carrying a homozygous G115S substitution in mitochondrial respiratory chain complex IV assembly, which in humans causes a hypertrophic cardiomyopathy.">
    <entity charOffset="87-108" id="s697.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="244-258" id="s697.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s697.e0" e2="s697.e1" id="s697.p0" relation="false"/>
  </sentence>
  <sentence id="s698" text="copper ion transport was similarly mislocalized to the cytosol in the heart of knockin epidermis development carrying a homozygous G115S substitution in mitochondrial respiratory chain complex IV assembly, which in humans causes a hypertrophic cardiomyopathy.">
    <entity charOffset="153-204" id="s698.e0" ontology_id="GO_0033617" text="mitochondrial respiratory chain complex IV assembly" type="GO"/>
    <entity charOffset="244-258" id="s698.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s698.e0" e2="s698.e1" id="s698.p0" relation="true"/>
  </sentence>
  <sentence id="s699" text="Increasing evidence has shown that negative regulation of transcription by RNA polymerase II-interacting protein (WTIP) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in cancer is unknown.">
    <entity charOffset="35-92" id="s699.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="222-228" id="s699.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s699.e0" e2="s699.e1" id="s699.p0" relation="true"/>
  </sentence>
  <sentence id="s700" text="Here, we investigated the role and mechanism of response to hypoxia in cell proliferation and tumorigenesis of non-small-cell lung cancer (NSCLC).">
    <entity charOffset="48-67" id="s700.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="94-99" id="s700.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s700.e0" e2="s700.e1" id="s700.p0" relation="false"/>
  </sentence>
  <sentence id="s701" text="We report that response to hypoxia is a tumor suppressor in human NSCLC.">
    <entity charOffset="15-34" id="s701.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="40-45" id="s701.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s701.e0" e2="s701.e1" id="s701.p0" relation="false"/>
  </sentence>
  <sentence id="s702" text="Moreover, ectopic overexpression of response to hypoxia dramatically inhibits cell proliferation and tumorigenesis invitro and invivo; conversely, depletion of WTIP expression shows the opposite effects.">
    <entity charOffset="36-55" id="s702.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="101-106" id="s702.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s702.e0" e2="s702.e1" id="s702.p0" relation="false"/>
  </sentence>
  <sentence id="s703" text="This review goes over recent scientific progress in understanding the molecular mechanisms governing pruritus, the cross-talk between the immune and nervous systems that regulate ubiquitin-dependent protein catabolic process, and central nervous pathways and projections affected by itch.">
    <entity charOffset="179-224" id="s703.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="230-237" id="s703.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s703.e0" e2="s703.e1" id="s703.p0" relation="false"/>
  </sentence>
  <sentence id="s704" text="Here, we have described a homozygous missense variant (c.602C&amp;gt;T, p.S201F) in epithelial cell-cell adhesion, identified by whole-exome sequencing, in a family of 4 with cardiac arrhythmia and limb-girdle muscular dystrophy (LGMD).">
    <entity charOffset="80-109" id="s704.e0" ontology_id="GO_0090136" text="epithelial cell-cell adhesion" type="GO"/>
    <entity charOffset="171-189" id="s704.e1" ontology_id="HP_0011675" text="cardiac arrhythmia" type="HP"/>
    <pair e1="s704.e0" e2="s704.e1" id="s704.p0" relation="true"/>
  </sentence>
  <sentence id="s705" text="Our study therefore identifies epithelial cell-cell adhesion as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases">
    <entity charOffset="31-60" id="s705.e0" ontology_id="GO_0090136" text="epithelial cell-cell adhesion" type="GO"/>
    <entity charOffset="99-118" id="s705.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s705.e0" e2="s705.e1" id="s705.p0" relation="true"/>
  </sentence>
  <sentence id="s706" text="Our study therefore identifies epithelial cell-cell adhesion as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases">
    <entity charOffset="31-60" id="s706.e0" ontology_id="GO_0090136" text="epithelial cell-cell adhesion" type="GO"/>
    <entity charOffset="119-137" id="s706.e1" ontology_id="HP_0011675" text="cardiac arrhythmia" type="HP"/>
    <pair e1="s706.e0" e2="s706.e1" id="s706.p0" relation="true"/>
  </sentence>
  <sentence id="s707" text="Our study therefore identifies epithelial cell-cell adhesion as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases">
    <entity charOffset="31-60" id="s707.e0" ontology_id="GO_0090136" text="epithelial cell-cell adhesion" type="GO"/>
    <entity charOffset="185-198" id="s707.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s707.e0" e2="s707.e1" id="s707.p0" relation="false"/>
  </sentence>
  <sentence id="s708" text="To test whether this gene can confer a wide variety of psychiatric disorders, we carried out a case-control association analysis of three tagging single-nucleotide polymorphisms (rs2074896, rs2074897, and rs2074898) in the mitochondrial respiratory chain complex I assembly gene by sequencing 330 Han Chinese patients with schizophrenia and 330 well-matched healthy controls.">
    <entity charOffset="223-273" id="s708.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="323-336" id="s708.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s708.e0" e2="s708.e1" id="s708.p0" relation="false"/>
  </sentence>
  <sentence id="s709" text="Tumor growth in xenografts as well as positive regulation of protein phosphorylation signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3' untranslated region (UTR) or wild-type (WT) 3'UTR.&lt;b&gt;Results:&lt;/b&gt; protein polyubiquitination-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-neoplasia and adjacent tissue.">
    <entity charOffset="38-84" id="s709.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="353-362" id="s709.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s709.e0" e2="s709.e1" id="s709.p0" relation="true"/>
  </sentence>
  <sentence id="s710" text="Tumor growth in xenografts as well as positive regulation of protein phosphorylation signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3' untranslated region (UTR) or wild-type (WT) 3'UTR.&lt;b&gt;Results:&lt;/b&gt; protein polyubiquitination-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-neoplasia and adjacent tissue.">
    <entity charOffset="233-259" id="s710.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="353-362" id="s710.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s710.e0" e2="s710.e1" id="s710.p0" relation="false"/>
  </sentence>
  <sentence id="s711" text="Significant down-regulation of protein polyubiquitination-193a-3p was also seen in an independent cohort of ulcerative colitis cancers.">
    <entity charOffset="31-57" id="s711.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="127-133" id="s711.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s711.e0" e2="s711.e1" id="s711.p0" relation="false"/>
  </sentence>
  <sentence id="s712" text="Changes in methylation of protein polyubiquitination-193a or expression of pri-miR-193a were not observed in ulcerative colitis cancer.">
    <entity charOffset="26-52" id="s712.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="128-134" id="s712.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s712.e0" e2="s712.e1" id="s712.p0" relation="false"/>
  </sentence>
  <sentence id="s713" text="IL17RD expression was increased in ulcerative colitis cancers, and protein polyubiquitination-193a-3p treatment decreased growth and positive regulation of protein phosphorylation signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.&lt;b&gt;Conclusions:&lt;/b&gt; miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.">
    <entity charOffset="54-60" id="s713.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-93" id="s713.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s713.e0" e2="s713.e1" id="s713.p0" relation="false"/>
  </sentence>
  <sentence id="s714" text="IL17RD expression was increased in ulcerative colitis cancers, and protein polyubiquitination-193a-3p treatment decreased growth and positive regulation of protein phosphorylation signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.&lt;b&gt;Conclusions:&lt;/b&gt; miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.">
    <entity charOffset="67-93" id="s714.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="384-393" id="s714.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s714.e0" e2="s714.e1" id="s714.p0" relation="false"/>
  </sentence>
  <sentence id="s715" text="IL17RD expression was increased in ulcerative colitis cancers, and protein polyubiquitination-193a-3p treatment decreased growth and positive regulation of protein phosphorylation signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.&lt;b&gt;Conclusions:&lt;/b&gt; miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.">
    <entity charOffset="133-179" id="s715.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="384-393" id="s715.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s715.e0" e2="s715.e1" id="s715.p0" relation="true"/>
  </sentence>
  <sentence id="s716" text="Mucolipidosis muscle organ development IV (protein homotetramerization) is a lysosomal storage disease exhibiting progressive intellectual disability, motor impairment, and premature death.">
    <entity charOffset="14-38" id="s716.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="126-149" id="s716.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s716.e0" e2="s716.e1" id="s716.p0" relation="false"/>
  </sentence>
  <sentence id="s717" text="Mucolipidosis muscle organ development IV (protein homotetramerization) is a lysosomal storage disease exhibiting progressive intellectual disability, motor impairment, and premature death.">
    <entity charOffset="43-70" id="s717.e0" ontology_id="GO_0051289" text="protein homotetramerization" type="GO"/>
    <entity charOffset="126-149" id="s717.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s717.e0" e2="s717.e1" id="s717.p0" relation="true"/>
  </sentence>
  <sentence id="s718" text="Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (GCS), successfully delays the onset of motor deficits, improves longevity, and rescues some of the cerebellar abnormalities (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick muscle organ development C (NPC).">
    <entity charOffset="251-275" id="s718.e0" ontology_id="HP_0001317" text="cerebellar abnormalities" type="HP"/>
    <entity charOffset="360-384" id="s718.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s718.e0" e2="s718.e1" id="s718.p0" relation="false"/>
  </sentence>
  <sentence id="s719" text="Herein, we designed a retro-inverso isomer of &lt;sup&gt;L&lt;/sup&gt;c(cell-cell signaling-1), termed &lt;sup&gt;D&lt;/sup&gt;c(LyP-1), expecting to inspire brain metastatic tumor targeted drug delivery.">
    <entity charOffset="60-79" id="s719.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="151-156" id="s719.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s719.e0" e2="s719.e1" id="s719.p0" relation="true"/>
  </sentence>
  <sentence id="s720" text="Further, &lt;sup&gt;L&lt;/sup&gt;c(cell-cell signaling-1) modified PEG-PLA micelles displayed much higher in vivo distribution in brain metastatic tumor than &lt;sup&gt;D&lt;/sup&gt;c(LyP-1).">
    <entity charOffset="23-42" id="s720.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="135-140" id="s720.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s720.e0" e2="s720.e1" id="s720.p0" relation="true"/>
  </sentence>
  <sentence id="s721" text="All results suggested that &lt;sup&gt;L&lt;/sup&gt;c(cell-cell signaling-1) had a better performance than &lt;sup&gt;D&lt;/sup&gt;c(LyP-1) in brain metastatic tumor-targeted drug delivery">
    <entity charOffset="41-60" id="s721.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="135-140" id="s721.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s721.e0" e2="s721.e1" id="s721.p0" relation="true"/>
  </sentence>
  <sentence id="s722" text="A majority of the familial breast cancer cases are not explained by mutations in the chloride transport-known high susceptibility genes double-strand break repair via homologous recombination and BRCA2.">
    <entity charOffset="34-40" id="s722.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="85-103" id="s722.e1" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <pair e1="s722.e0" e2="s722.e1" id="s722.p0" relation="false"/>
  </sentence>
  <sentence id="s723" text="A majority of the familial breast cancer cases are not explained by mutations in the chloride transport-known high susceptibility genes double-strand break repair via homologous recombination and BRCA2.">
    <entity charOffset="34-40" id="s723.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="136-191" id="s723.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s723.e0" e2="s723.e1" id="s723.p0" relation="true"/>
  </sentence>
  <sentence id="s724" text="VSX1 remains as the chloride transport characterised keratoconus gene but only accounts for rare cases.">
    <entity charOffset="20-38" id="s724.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="53-64" id="s724.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s724.e0" e2="s724.e1" id="s724.p0" relation="true"/>
  </sentence>
  <sentence id="s725" text="Family-based studies have recently led to the identification of the MIR184 gene for keratoconus with cataract and to the positive regulation of GTPase activity gene in a family with isolated keratoconus.">
    <entity charOffset="84-95" id="s725.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="121-159" id="s725.e1" ontology_id="GO_0043547" text="positive regulation of GTPase activity" type="GO"/>
    <pair e1="s725.e0" e2="s725.e1" id="s725.p0" relation="false"/>
  </sentence>
  <sentence id="s726" text="Family-based studies have recently led to the identification of the MIR184 gene for keratoconus with cataract and to the positive regulation of GTPase activity gene in a family with isolated keratoconus.">
    <entity charOffset="101-109" id="s726.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="121-159" id="s726.e1" ontology_id="GO_0043547" text="positive regulation of GTPase activity" type="GO"/>
    <pair e1="s726.e0" e2="s726.e1" id="s726.p0" relation="false"/>
  </sentence>
  <sentence id="s727" text="Numerous other linkages have been reported and new sequencing technologies are negative regulation of transcription, DNA-templated to rapidly expand the number of identified keratoconus genes in these regions.">
    <entity charOffset="79-130" id="s727.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="174-185" id="s727.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s727.e0" e2="s727.e1" id="s727.p0" relation="false"/>
  </sentence>
  <sentence id="s728" text="Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around neutrophil apoptotic process, regulation of GTPase activity and blood vessel morphogenesis as candidate risk factors for keratoconus.">
    <entity charOffset="125-153" id="s728.e0" ontology_id="GO_0001781" text="neutrophil apoptotic process" type="GO"/>
    <entity charOffset="246-257" id="s728.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s728.e0" e2="s728.e1" id="s728.p0" relation="false"/>
  </sentence>
  <sentence id="s729" text="Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around neutrophil apoptotic process, regulation of GTPase activity and blood vessel morphogenesis as candidate risk factors for keratoconus.">
    <entity charOffset="155-184" id="s729.e0" ontology_id="GO_0043087" text="regulation of GTPase activity" type="GO"/>
    <entity charOffset="246-257" id="s729.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s729.e0" e2="s729.e1" id="s729.p0" relation="false"/>
  </sentence>
  <sentence id="s730" text="Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around neutrophil apoptotic process, regulation of GTPase activity and blood vessel morphogenesis as candidate risk factors for keratoconus.">
    <entity charOffset="189-215" id="s730.e0" ontology_id="GO_0048514" text="blood vessel morphogenesis" type="GO"/>
    <entity charOffset="246-257" id="s730.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s730.e0" e2="s730.e1" id="s730.p0" relation="false"/>
  </sentence>
  <sentence id="s731" text="histone methylation plays important roles in the regulation of gene expression, splicing, DNA cellular protein catabolic process, paternal imprinting, cancer and metastasis.">
    <entity charOffset="0-19" id="s731.e0" ontology_id="GO_0016571" text="histone methylation" type="GO"/>
    <entity charOffset="151-157" id="s731.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s731.e0" e2="s731.e1" id="s731.p0" relation="false"/>
  </sentence>
  <sentence id="s732" text="histone methylation plays important roles in the regulation of gene expression, splicing, DNA cellular protein catabolic process, paternal imprinting, cancer and metastasis.">
    <entity charOffset="94-128" id="s732.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="151-157" id="s732.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s732.e0" e2="s732.e1" id="s732.p0" relation="false"/>
  </sentence>
  <sentence id="s733" text="We identified a highly significant enrichment of de novo variants in YWHAG, establishing their role in early-onnegative regulation of transcription, DNA-templated epilepsy, and we provide additional support for the prior assignment of SLC1A2.">
    <entity charOffset="111-162" id="s733.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="163-171" id="s733.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s733.e0" e2="s733.e1" id="s733.p0" relation="true"/>
  </sentence>
  <sentence id="s734" text="An early intervention using biomarkers to predict acute myocardial infarction (AMI) will effectively reduce global heart attack incidence, particularly among high-risk patients with muscle organ development 2 diabetes mellitus (T2DM).">
    <entity charOffset="56-77" id="s734.e0" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <entity charOffset="182-206" id="s734.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s734.e0" e2="s734.e1" id="s734.p0" relation="false"/>
  </sentence>
  <sentence id="s735" text="The brains of &lt;i&gt;biological_process&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; epidermis development had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.">
    <entity charOffset="17-35" id="s735.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="115-134" id="s735.e1" ontology_id="HP_0002119" text="enlarged ventricles" type="HP"/>
    <pair e1="s735.e0" e2="s735.e1" id="s735.p0" relation="true"/>
  </sentence>
  <sentence id="s736" text="The brains of &lt;i&gt;biological_process&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; epidermis development had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.">
    <entity charOffset="54-75" id="s736.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="80-113" id="s736.e1" ontology_id="HP_0002079" text="hypoplasia of the corpus callosum" type="HP"/>
    <pair e1="s736.e0" e2="s736.e1" id="s736.p0" relation="false"/>
  </sentence>
  <sentence id="s737" text="A heterozygous mutation (c.643C&amp;gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene creatine transmembrane transport (also known as creatine transmembrane transport) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.">
    <entity charOffset="99-131" id="s737.e0" ontology_id="GO_0015881" text="creatine transmembrane transport" type="GO"/>
    <entity charOffset="290-301" id="s737.e1" ontology_id="HP_0000482" text="microcornea" type="HP"/>
    <pair e1="s737.e0" e2="s737.e1" id="s737.p0" relation="true"/>
  </sentence>
  <sentence id="s738" text="A heterozygous mutation (c.643C&amp;gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene creatine transmembrane transport (also known as creatine transmembrane transport) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.">
    <entity charOffset="147-179" id="s738.e0" ontology_id="GO_0015881" text="creatine transmembrane transport" type="GO"/>
    <entity charOffset="279-288" id="s738.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s738.e0" e2="s738.e1" id="s738.p0" relation="true"/>
  </sentence>
  <sentence id="s739" text="A heterozygous mutation (c.643C&amp;gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene creatine transmembrane transport (also known as creatine transmembrane transport) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.">
    <entity charOffset="147-179" id="s739.e0" ontology_id="GO_0015881" text="creatine transmembrane transport" type="GO"/>
    <entity charOffset="290-301" id="s739.e1" ontology_id="HP_0000482" text="microcornea" type="HP"/>
    <pair e1="s739.e0" e2="s739.e1" id="s739.p0" relation="true"/>
  </sentence>
  <sentence id="s740" text="The CSIRO National MAPK cascade Telehealth Trial investigated the effects of introducing at home telemonitoring of vital signs for the management of a heterogeneous group of chronically ill patients.">
    <entity charOffset="19-31" id="s740.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="151-164" id="s740.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s740.e0" e2="s740.e1" id="s740.p0" relation="false"/>
  </sentence>
  <sentence id="s741" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including V(D)J recombination, pre-B cell allelic exclusion, CD93, leukocyte migration, leukocyte migration, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s741.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="319-338" id="s741.e1" ontology_id="GO_0033151" text="V(D)J recombination" type="GO"/>
    <pair e1="s741.e0" e2="s741.e1" id="s741.p0" relation="true"/>
  </sentence>
  <sentence id="s742" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including V(D)J recombination, pre-B cell allelic exclusion, CD93, leukocyte migration, leukocyte migration, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s742.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="340-368" id="s742.e1" ontology_id="GO_0002331" text="pre-B cell allelic exclusion" type="GO"/>
    <pair e1="s742.e0" e2="s742.e1" id="s742.p0" relation="true"/>
  </sentence>
  <sentence id="s743" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including V(D)J recombination, pre-B cell allelic exclusion, CD93, leukocyte migration, leukocyte migration, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s743.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="376-395" id="s743.e1" ontology_id="GO_0050900" text="leukocyte migration" type="GO"/>
    <pair e1="s743.e0" e2="s743.e1" id="s743.p0" relation="false"/>
  </sentence>
  <sentence id="s744" text="The tumor cells resembled pro-B cells, and were CD19&lt;sup&gt;+&lt;/sup&gt;IgM&lt;sup&gt;-&lt;/sup&gt;IgD&lt;sup&gt;-&lt;/sup&gt;CD93&lt;sup&gt;+&lt;/sup&gt;CD43&lt;sup&gt;+&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CD23&lt;sup&gt;-&lt;/sup&gt;VpreB&lt;sup&gt;+&lt;/sup&gt;CXCR4&lt;sup&gt;+&lt;/sup&gt; Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including V(D)J recombination, pre-B cell allelic exclusion, CD93, leukocyte migration, leukocyte migration, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.">
    <entity charOffset="4-9" id="s744.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="397-416" id="s744.e1" ontology_id="GO_0050900" text="leukocyte migration" type="GO"/>
    <pair e1="s744.e0" e2="s744.e1" id="s744.p0" relation="false"/>
  </sentence>
  <sentence id="s745" text="SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (G protein-coupled receptor signaling pathway) if environmentally triggered.">
    <entity charOffset="142-148" id="s745.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="419-463" id="s745.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s745.e0" e2="s745.e1" id="s745.p0" relation="false"/>
  </sentence>
  <sentence id="s746" text="SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (G protein-coupled receptor signaling pathway) if environmentally triggered.">
    <entity charOffset="223-232" id="s746.e0" ontology_id="HP_0000709" text="psychosis" type="HP"/>
    <entity charOffset="419-463" id="s746.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s746.e0" e2="s746.e1" id="s746.p0" relation="false"/>
  </sentence>
  <sentence id="s747" text="Dysfunction of SNORD115-negative regulation of cell proliferation connecting with negative regulation of cell proliferation as well as other proven schizophrenia-associated genes might explain why traditionally catatonia has been classified with schizophrenia.">
    <entity charOffset="24-65" id="s747.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="148-161" id="s747.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s747.e0" e2="s747.e1" id="s747.p0" relation="false"/>
  </sentence>
  <sentence id="s748" text="Dysfunction of SNORD115-negative regulation of cell proliferation connecting with negative regulation of cell proliferation as well as other proven schizophrenia-associated genes might explain why traditionally catatonia has been classified with schizophrenia.">
    <entity charOffset="82-123" id="s748.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="148-161" id="s748.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s748.e0" e2="s748.e1" id="s748.p0" relation="false"/>
  </sentence>
  <sentence id="s749" text="SNORD115-protein polyubiquitination and SNORD-GPI anchor biosynthetic process dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic learning gene.">
    <entity charOffset="9-35" id="s749.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="255-267" id="s749.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s749.e0" e2="s749.e1" id="s749.p0" relation="false"/>
  </sentence>
  <sentence id="s750" text="SNORD115-protein polyubiquitination and SNORD-GPI anchor biosynthetic process dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic learning gene.">
    <entity charOffset="46-77" id="s750.e0" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <entity charOffset="255-267" id="s750.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s750.e0" e2="s750.e1" id="s750.p0" relation="false"/>
  </sentence>
  <sentence id="s751" text="SNORD115-protein polyubiquitination and SNORD-GPI anchor biosynthetic process dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic learning gene.">
    <entity charOffset="255-267" id="s751.e0" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <entity charOffset="306-314" id="s751.e1" ontology_id="GO_0007612" text="learning" type="GO"/>
    <pair e1="s751.e0" e2="s751.e1" id="s751.p0" relation="false"/>
  </sentence>
  <sentence id="s752" text="Here we characterize protein phosphorylation-dependent cancer cell migration and invasion as well as local invasion and metastasis of cancer xenografts.">
    <entity charOffset="21-44" id="s752.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="55-61" id="s752.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s752.e0" e2="s752.e1" id="s752.p0" relation="false"/>
  </sentence>
  <sentence id="s753" text="protein phosphorylation depletion suppressed cancer invasion and induced an epithelial phenotype in poorly differentiated breast cancer cells.">
    <entity charOffset="0-23" id="s753.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="45-51" id="s753.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s753.e0" e2="s753.e1" id="s753.p0" relation="false"/>
  </sentence>
  <sentence id="s754" text="In an unbiased BioID screen for protein phosphorylation interactors, we identified members of the Arp2/3 complex-mediated actin nucleation/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven cancer cell movement.">
    <entity charOffset="32-55" id="s754.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="248-254" id="s754.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s754.e0" e2="s754.e1" id="s754.p0" relation="false"/>
  </sentence>
  <sentence id="s755" text="In an unbiased BioID screen for protein phosphorylation interactors, we identified members of the Arp2/3 complex-mediated actin nucleation/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven cancer cell movement.">
    <entity charOffset="98-138" id="s755.e0" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <entity charOffset="248-254" id="s755.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s755.e0" e2="s755.e1" id="s755.p0" relation="false"/>
  </sentence>
  <sentence id="s756" text="Our results validate protein phosphorylation as a therapeutic target in cancer patients and reveal a new role for Plk4 in regulating Arp2/3-mediated actin cytoskeletal rearrangement.">
    <entity charOffset="21-44" id="s756.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="72-78" id="s756.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s756.e0" e2="s756.e1" id="s756.p0" relation="false"/>
  </sentence>
  <sentence id="s757" text="Our data, for the first time, functionally link Jalili syndrome gene metal ion homeostasis to LCA gene photoreceptor cell maintenance, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome">
    <entity charOffset="69-90" id="s757.e0" ontology_id="GO_0055065" text="metal ion homeostasis" type="GO"/>
    <entity charOffset="207-224" id="s757.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s757.e0" e2="s757.e1" id="s757.p0" relation="true"/>
  </sentence>
  <sentence id="s758" text="Our data, for the first time, functionally link Jalili syndrome gene metal ion homeostasis to LCA gene photoreceptor cell maintenance, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome">
    <entity charOffset="103-133" id="s758.e0" ontology_id="GO_0045494" text="photoreceptor cell maintenance" type="GO"/>
    <entity charOffset="207-224" id="s758.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s758.e0" e2="s758.e1" id="s758.p0" relation="true"/>
  </sentence>
  <sentence id="s759" text="Renpenning syndrome is a group of X-linked intellectual disability syndromes caused by mutations in human polyglutamine-binding protein 1 (activation of innate immune response) gene.">
    <entity charOffset="43-66" id="s759.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="139-175" id="s759.e1" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <pair e1="s759.e0" e2="s759.e1" id="s759.p0" relation="true"/>
  </sentence>
  <sentence id="s760" text="Small intestine neuroendocrine tumors (melanosome organization-epidermal cell differentiation) represent the most common histomuscle organ development among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="31-37" id="s760.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="39-62" id="s760.e1" ontology_id="GO_0032438" text="melanosome organization" type="GO"/>
    <pair e1="s760.e0" e2="s760.e1" id="s760.p0" relation="false"/>
  </sentence>
  <sentence id="s761" text="Small intestine neuroendocrine tumors (melanosome organization-epidermal cell differentiation) represent the most common histomuscle organ development among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="31-37" id="s761.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="63-93" id="s761.e1" ontology_id="GO_0009913" text="epidermal cell differentiation" type="GO"/>
    <pair e1="s761.e0" e2="s761.e1" id="s761.p0" relation="false"/>
  </sentence>
  <sentence id="s762" text="Small intestine neuroendocrine tumors (melanosome organization-epidermal cell differentiation) represent the most common histomuscle organ development among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="31-37" id="s762.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="126-150" id="s762.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s762.e0" e2="s762.e1" id="s762.p0" relation="false"/>
  </sentence>
  <sentence id="s763" text="Small intestine neuroendocrine tumors (melanosome organization-epidermal cell differentiation) represent the most common histomuscle organ development among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="39-62" id="s763.e0" ontology_id="GO_0032438" text="melanosome organization" type="GO"/>
    <entity charOffset="173-182" id="s763.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s763.e0" e2="s763.e1" id="s763.p0" relation="false"/>
  </sentence>
  <sentence id="s764" text="Small intestine neuroendocrine tumors (melanosome organization-epidermal cell differentiation) represent the most common histomuscle organ development among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="63-93" id="s764.e0" ontology_id="GO_0009913" text="epidermal cell differentiation" type="GO"/>
    <entity charOffset="173-182" id="s764.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s764.e0" e2="s764.e1" id="s764.p0" relation="false"/>
  </sentence>
  <sentence id="s765" text="Small intestine neuroendocrine tumors (melanosome organization-epidermal cell differentiation) represent the most common histomuscle organ development among small intestine neoplasms, and metastatic disease is usually present at diagnosis.">
    <entity charOffset="126-150" id="s765.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="173-182" id="s765.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s765.e0" e2="s765.e1" id="s765.p0" relation="false"/>
  </sentence>
  <sentence id="s766" text="A retrospective series of 52 sporadic primary surgically resected melanosome organization-NETs, which were metastatic at diagnosis, was analyzed by high-coverage target sequencing (HCTS) for the mutational status of 57 genes and copy number status of 40 genes selected from recently published genome sequencing data.">
    <entity charOffset="29-37" id="s766.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="66-89" id="s766.e1" ontology_id="GO_0032438" text="melanosome organization" type="GO"/>
    <pair e1="s766.e0" e2="s766.e1" id="s766.p0" relation="false"/>
  </sentence>
  <sentence id="s767" text="Recurrent copy number variations are important events in melanosome organization-negative regulation of transcription, DNA-templated and peptidyl-tyrosine phosphorylation may represent a novel prognostic biomarker for this tumor type">
    <entity charOffset="57-80" id="s767.e0" ontology_id="GO_0032438" text="melanosome organization" type="GO"/>
    <entity charOffset="223-228" id="s767.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s767.e0" e2="s767.e1" id="s767.p0" relation="false"/>
  </sentence>
  <sentence id="s768" text="Recurrent copy number variations are important events in melanosome organization-negative regulation of transcription, DNA-templated and peptidyl-tyrosine phosphorylation may represent a novel prognostic biomarker for this tumor type">
    <entity charOffset="81-132" id="s768.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="223-228" id="s768.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s768.e0" e2="s768.e1" id="s768.p0" relation="false"/>
  </sentence>
  <sentence id="s769" text="Recurrent copy number variations are important events in melanosome organization-negative regulation of transcription, DNA-templated and peptidyl-tyrosine phosphorylation may represent a novel prognostic biomarker for this tumor type">
    <entity charOffset="137-170" id="s769.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="223-228" id="s769.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s769.e0" e2="s769.e1" id="s769.p0" relation="true"/>
  </sentence>
  <sentence id="s770" text="In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (OGR1) in extracellular acidification-induced regulation of cyclooxygenase (generation of precursor metabolites and energy)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (PAI)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).">
    <entity charOffset="61-67" id="s770.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="173-219" id="s770.e1" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <pair e1="s770.e0" e2="s770.e1" id="s770.p0" relation="false"/>
  </sentence>
  <sentence id="s771" text="Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting positive regulation of interleukin-23 production-mediated immunity, such as &lt;i&gt;STAT3, regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II, positive regulation of stress-activated MAPK cascade, IL12B&lt;/i&gt;, and &lt;i&gt;IL12RB1&lt;/i&gt;, or gain of function (GOF) mutations in &lt;i&gt;STAT1&lt;/i&gt;.">
    <entity charOffset="8-33" id="s771.e0" ontology_id="HP_0002728" text="mucocutaneous candidiasis" type="HP"/>
    <entity charOffset="93-141" id="s771.e1" ontology_id="GO_0032747" text="positive regulation of interleukin-23 production" type="GO"/>
    <pair e1="s771.e0" e2="s771.e1" id="s771.p0" relation="false"/>
  </sentence>
  <sentence id="s772" text="Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting positive regulation of interleukin-23 production-mediated immunity, such as &lt;i&gt;STAT3, regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II, positive regulation of stress-activated MAPK cascade, IL12B&lt;/i&gt;, and &lt;i&gt;IL12RB1&lt;/i&gt;, or gain of function (GOF) mutations in &lt;i&gt;STAT1&lt;/i&gt;.">
    <entity charOffset="8-33" id="s772.e0" ontology_id="HP_0002728" text="mucocutaneous candidiasis" type="HP"/>
    <entity charOffset="179-221" id="s772.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s772.e0" e2="s772.e1" id="s772.p0" relation="true"/>
  </sentence>
  <sentence id="s773" text="Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting positive regulation of interleukin-23 production-mediated immunity, such as &lt;i&gt;STAT3, regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II, positive regulation of stress-activated MAPK cascade, IL12B&lt;/i&gt;, and &lt;i&gt;IL12RB1&lt;/i&gt;, or gain of function (GOF) mutations in &lt;i&gt;STAT1&lt;/i&gt;.">
    <entity charOffset="8-33" id="s773.e0" ontology_id="HP_0002728" text="mucocutaneous candidiasis" type="HP"/>
    <entity charOffset="223-280" id="s773.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s773.e0" e2="s773.e1" id="s773.p0" relation="false"/>
  </sentence>
  <sentence id="s774" text="Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting positive regulation of interleukin-23 production-mediated immunity, such as &lt;i&gt;STAT3, regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II, positive regulation of stress-activated MAPK cascade, IL12B&lt;/i&gt;, and &lt;i&gt;IL12RB1&lt;/i&gt;, or gain of function (GOF) mutations in &lt;i&gt;STAT1&lt;/i&gt;.">
    <entity charOffset="8-33" id="s774.e0" ontology_id="HP_0002728" text="mucocutaneous candidiasis" type="HP"/>
    <entity charOffset="282-334" id="s774.e1" ontology_id="GO_0032874" text="positive regulation of stress-activated MAPK cascade" type="GO"/>
    <pair e1="s774.e0" e2="s774.e1" id="s774.p0" relation="true"/>
  </sentence>
  <sentence id="s775" text="We aimed to test effects of such gCNVs on the risk of lung cancer and chronic obstructive pulmonary disease (intracellular protein transport).">
    <entity charOffset="59-65" id="s775.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="109-140" id="s775.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s775.e0" e2="s775.e1" id="s775.p0" relation="false"/>
  </sentence>
  <sentence id="s776" text="Genomic imbalance of lung cancer was determined by the array comparative genomic hybridization (aCGH), and common gCNVs at these imbalance regions were genotyped in lung cancer-based and intracellular protein transport-based retrospective studies.">
    <entity charOffset="26-32" id="s776.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="187-218" id="s776.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s776.e0" e2="s776.e1" id="s776.p0" relation="false"/>
  </sentence>
  <sentence id="s777" text="The CNVR_3425.1, overlapping the chr16q24.1 with genomic imbalance, was significantly associated with increased risks of lung cancer (OR = 1.76; 95% CI = 1.46-2.11) and intracellular protein transport (OR = 1.98; 95% CI = 1.57-2.51).">
    <entity charOffset="126-132" id="s777.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="169-200" id="s777.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s777.e0" e2="s777.e1" id="s777.p0" relation="false"/>
  </sentence>
  <sentence id="s778" text="The increase copy of CNVR_3425.1 forms a new additional truncated positive regulation of transcription, DNA-templated adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung cancer by affecting expressions of an abundant number of genes, including the tumor suppressor FOXF1.">
    <entity charOffset="66-117" id="s778.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="487-492" id="s778.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s778.e0" e2="s778.e1" id="s778.p0" relation="false"/>
  </sentence>
  <sentence id="s779" text="The increase copy of CNVR_3425.1 forms a new additional truncated positive regulation of transcription, DNA-templated adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung cancer by affecting expressions of an abundant number of genes, including the tumor suppressor FOXF1.">
    <entity charOffset="66-117" id="s779.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="409-415" id="s779.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s779.e0" e2="s779.e1" id="s779.p0" relation="false"/>
  </sentence>
  <sentence id="s780" text="To identify additional prostate cancer susceptibility loci, we genotyped nine SNPs that were nominally associated with prostate cancer (P &amp;lt; 1  10(-4)) in our previous GWAS in three independent studies of prostate cancer in Japanese negative regulation of phosphatase activity (2,557 individuals with prostate cancer (cases) and 3,003 controls).">
    <entity charOffset="32-38" id="s780.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="236-279" id="s780.e1" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <pair e1="s780.e0" e2="s780.e1" id="s780.p0" relation="false"/>
  </sentence>
  <sentence id="s781" text="In a meta-analysis of our previous GWAS and the replication studies, which included a total of 7,141 prostate cancer cases and 11,804 controls from a single ancestry group, three new loci reached genome-wide significance on chromosomes 11q12 (rs1938781; P = 1.10  10(-10); DNA replication-FAM111B), 10q26 (rs2252004; P = 1.98  10(-8)) and 3p11.2 (rs2055109; P = 3.94  10(-8)).">
    <entity charOffset="110-116" id="s781.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="274-289" id="s781.e1" ontology_id="GO_0006260" text="DNA replication" type="GO"/>
    <pair e1="s781.e0" e2="s781.e1" id="s781.p0" relation="false"/>
  </sentence>
  <sentence id="s782" text="Single nucleotide polymorphisms (SNPs) in telomere maintenance via telomerase have been associated with risk of cancer, which strengthens the role of WRAP53 in the pathogenesis of human malignancies.">
    <entity charOffset="42-77" id="s782.e0" ontology_id="GO_0007004" text="telomere maintenance via telomerase" type="GO"/>
    <entity charOffset="112-118" id="s782.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s782.e0" e2="s782.e1" id="s782.p0" relation="true"/>
  </sentence>
  <sentence id="s783" text="In nucleosome disassembly, WRAP53 has been considered as a candidate cancer susceptibility gene.">
    <entity charOffset="3-25" id="s783.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="69-75" id="s783.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s783.e0" e2="s783.e1" id="s783.p0" relation="false"/>
  </sentence>
  <sentence id="s784" text="Accordingly, we performed a study to examine the association of a frequent genetic variation in telomere maintenance via telomerase, rs2287499 (C/G), with breast cancer risk and prognosis among Iranian-Azeri population.">
    <entity charOffset="96-131" id="s784.e0" ontology_id="GO_0007004" text="telomere maintenance via telomerase" type="GO"/>
    <entity charOffset="162-168" id="s784.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s784.e0" e2="s784.e1" id="s784.p0" relation="true"/>
  </sentence>
  <sentence id="s785" text="Here, we utilized the CRISPR-Cas9 system to gentranscription by RNA polymerase IIte potassium ion transport mutant mice by zygote injection to verify the pathogenic role of human potassium ion transport, mutations of which are thought to cause Leber congenital amaurosis (clathrin coat assembly), an early-onset form of blindness.">
    <entity charOffset="47-81" id="s785.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="320-329" id="s785.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s785.e0" e2="s785.e1" id="s785.p0" relation="false"/>
  </sentence>
  <sentence id="s786" text="Here, we utilized the CRISPR-Cas9 system to gentranscription by RNA polymerase IIte potassium ion transport mutant mice by zygote injection to verify the pathogenic role of human potassium ion transport, mutations of which are thought to cause Leber congenital amaurosis (clathrin coat assembly), an early-onset form of blindness.">
    <entity charOffset="84-107" id="s786.e0" ontology_id="GO_0006813" text="potassium ion transport" type="GO"/>
    <entity charOffset="320-329" id="s786.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s786.e0" e2="s786.e1" id="s786.p0" relation="false"/>
  </sentence>
  <sentence id="s787" text="Here, we utilized the CRISPR-Cas9 system to gentranscription by RNA polymerase IIte potassium ion transport mutant mice by zygote injection to verify the pathogenic role of human potassium ion transport, mutations of which are thought to cause Leber congenital amaurosis (clathrin coat assembly), an early-onset form of blindness.">
    <entity charOffset="179-202" id="s787.e0" ontology_id="GO_0006813" text="potassium ion transport" type="GO"/>
    <entity charOffset="320-329" id="s787.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s787.e0" e2="s787.e1" id="s787.p0" relation="false"/>
  </sentence>
  <sentence id="s788" text="Here, we utilized the CRISPR-Cas9 system to gentranscription by RNA polymerase IIte potassium ion transport mutant mice by zygote injection to verify the pathogenic role of human potassium ion transport, mutations of which are thought to cause Leber congenital amaurosis (clathrin coat assembly), an early-onset form of blindness.">
    <entity charOffset="272-294" id="s788.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="320-329" id="s788.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s788.e0" e2="s788.e1" id="s788.p0" relation="false"/>
  </sentence>
  <sentence id="s789" text="Reproductive aging phenotypes, including age at menarche (AM) and age at natural menopause (negative regulation of muscle contraction), are well-established risk factors for breast cancer.">
    <entity charOffset="92-133" id="s789.e0" ontology_id="GO_0045932" text="negative regulation of muscle contraction" type="GO"/>
    <entity charOffset="181-187" id="s789.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s789.e0" e2="s789.e1" id="s789.p0" relation="false"/>
  </sentence>
  <sentence id="s790" text="Using data from the Women's Circle of Health Study (WCHS) of 1,307 European-American (EA) and 1,365 African-American (AA) breast cancer cases and controls, we aimed to replicate 53 earlier GWAS variants for AM and ANM in AA and EA groups and to perform analyses on total and negative regulation of transcription, DNA-templated reproductive lifespan (TRLS; NRLS).">
    <entity charOffset="129-135" id="s790.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="275-326" id="s790.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s790.e0" e2="s790.e1" id="s790.p0" relation="false"/>
  </sentence>
  <sentence id="s791" text="In this study, we identified a splice-site mutation (c.637+1G&amp;gt;T) in Ca(2+)-binding protein 2 (visual perception) in three consanguineous Iranian families affected by moderate-to-severe hearing loss.">
    <entity charOffset="97-114" id="s791.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="188-200" id="s791.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s791.e0" e2="s791.e1" id="s791.p0" relation="true"/>
  </sentence>
  <sentence id="s792" text="In 2005, negative regulation of hyaluronan biosynthetic process clients were significantly more likely to have chronic conditions, including hypertension, chronic obstructive pulmonary disease, Alzheimer's disease, arthritis, diabetes, and renal failure (all p &amp;lt; 0.05).">
    <entity charOffset="9-63" id="s792.e0" ontology_id="GO_1900126" text="negative regulation of hyaluronan biosynthetic process" type="GO"/>
    <entity charOffset="141-153" id="s792.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s792.e0" e2="s792.e1" id="s792.p0" relation="false"/>
  </sentence>
  <sentence id="s793" text="MiR-93-5p has been previously found to be associated with gastric cancer (vitamin D metabolic process) tumorigenesis; however, the current understanding of its function in this context remains largely incomplete.">
    <entity charOffset="66-72" id="s793.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="74-101" id="s793.e1" ontology_id="GO_0042359" text="vitamin D metabolic process" type="GO"/>
    <pair e1="s793.e0" e2="s793.e1" id="s793.p0" relation="false"/>
  </sentence>
  <sentence id="s794" text="MiR-93-5p has been previously found to be associated with gastric cancer (vitamin D metabolic process) tumorigenesis; however, the current understanding of its function in this context remains largely incomplete.">
    <entity charOffset="74-101" id="s794.e0" ontology_id="GO_0042359" text="vitamin D metabolic process" type="GO"/>
    <entity charOffset="103-108" id="s794.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s794.e0" e2="s794.e1" id="s794.p0" relation="false"/>
  </sentence>
  <sentence id="s795" text="MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin positive regulation of cell-matrix adhesion 4 (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), and large tumor suppressors 2 (G1/S transition of mitotic cell cycle), at both the mRNA and protein level.">
    <entity charOffset="130-173" id="s795.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="265-270" id="s795.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s795.e0" e2="s795.e1" id="s795.p0" relation="false"/>
  </sentence>
  <sentence id="s796" text="MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin positive regulation of cell-matrix adhesion 4 (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), and large tumor suppressors 2 (G1/S transition of mitotic cell cycle), at both the mRNA and protein level.">
    <entity charOffset="177-252" id="s796.e0" ontology_id="GO_0007157" text="heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules" type="GO"/>
    <entity charOffset="265-270" id="s796.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s796.e0" e2="s796.e1" id="s796.p0" relation="true"/>
  </sentence>
  <sentence id="s797" text="MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin positive regulation of cell-matrix adhesion 4 (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), and large tumor suppressors 2 (G1/S transition of mitotic cell cycle), at both the mRNA and protein level.">
    <entity charOffset="265-270" id="s797.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="286-323" id="s797.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s797.e0" e2="s797.e1" id="s797.p0" relation="false"/>
  </sentence>
  <sentence id="s798" text="Leber hereditary optic neuropathy (biological_process) and dominant optic atrophy (DOA), the most common forms of hereditary optic neuropathy, are easily confused, and it is difficult to distinguish one from the other in the clinic, especially in young children.">
    <entity charOffset="23-33" id="s798.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="35-53" id="s798.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s798.e0" e2="s798.e1" id="s798.p0" relation="false"/>
  </sentence>
  <sentence id="s799" text="Leber hereditary optic neuropathy (biological_process) and dominant optic atrophy (DOA), the most common forms of hereditary optic neuropathy, are easily confused, and it is difficult to distinguish one from the other in the clinic, especially in young children.">
    <entity charOffset="35-53" id="s799.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="68-81" id="s799.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s799.e0" e2="s799.e1" id="s799.p0" relation="false"/>
  </sentence>
  <sentence id="s800" text="The present study was designed to survey the mutation spectrum of common pathogenic genes (OPA1, visual perception and mtDNA genes) and to analyze the genotype-phenotype characteristics of Chinese patients with suspected childhood-onset hereditary optic neuropathy.">
    <entity charOffset="97-114" id="s800.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="254-264" id="s800.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s800.e0" e2="s800.e1" id="s800.p0" relation="true"/>
  </sentence>
  <sentence id="s801" text="Participants were assessed for cognitive performance (Cogstate battery), dietary selenium intake (two 24-h food recalls), plasma selenium concentration, inflammatory markers (interleukin (IL)-6, -8, -10, tumor necrosis factor-alpha and positive regulation of protein phosphorylation) and neurotrophic factors (brain-derived neurotrophic factor, vascular endothelial growth factor and insulin-like growth factor 1).">
    <entity charOffset="204-209" id="s801.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="236-282" id="s801.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s801.e0" e2="s801.e1" id="s801.p0" relation="false"/>
  </sentence>
  <sentence id="s802" text="Overall, our study proposes that negative regulation of transcription by RNA polymerase II acts as a central mRNA splicing, via spliceosome in the control of cell cycle and proliferation during cancer development.">
    <entity charOffset="33-90" id="s802.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="194-200" id="s802.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s802.e0" e2="s802.e1" id="s802.p0" relation="true"/>
  </sentence>
  <sentence id="s803" text="Overall, our study proposes that negative regulation of transcription by RNA polymerase II acts as a central mRNA splicing, via spliceosome in the control of cell cycle and proliferation during cancer development.">
    <entity charOffset="109-139" id="s803.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="194-200" id="s803.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s803.e0" e2="s803.e1" id="s803.p0" relation="false"/>
  </sentence>
  <sentence id="s804" text="We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in ion transmembrane transport and persistent hypotonia, encephalopathy, growth failure, and severe intellectual disability.">
    <entity charOffset="135-162" id="s804.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="232-255" id="s804.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s804.e0" e2="s804.e1" id="s804.p0" relation="true"/>
  </sentence>
  <sentence id="s805" text="The primary objective of the study was to estimate the maximum tolerated dose (cellular response to cadmium ion) and/or recommended phase II dose (RP2D) of oral alpelisib in patients with advanced solid tumors who had progressed despite standard therapy.">
    <entity charOffset="79-111" id="s805.e0" ontology_id="GO_0071276" text="cellular response to cadmium ion" type="GO"/>
    <entity charOffset="203-209" id="s805.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s805.e0" e2="s805.e1" id="s805.p0" relation="false"/>
  </sentence>
  <sentence id="s806" text="Dihydropyrimidinase (DHP) deficiency is an autosomal recessive disease caused by mutations in the pyrimidine nucleobase catabolic process gene.">
    <entity charOffset="43-62" id="s806.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="98-137" id="s806.e1" ontology_id="GO_0006208" text="pyrimidine nucleobase catabolic process" type="GO"/>
    <pair e1="s806.e0" e2="s806.e1" id="s806.p0" relation="true"/>
  </sentence>
  <sentence id="s807" text="Here, we report bi-allelic pathogenic regulation of sodium ion transport variants (three homozygous and two compound heterozygous) that cause a severe neurological syndrome that includes congenital hypotonia, intellectual disability, and motor axonal and auditory neuropathy.">
    <entity charOffset="38-72" id="s807.e0" ontology_id="GO_0002028" text="regulation of sodium ion transport" type="GO"/>
    <entity charOffset="209-232" id="s807.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s807.e0" e2="s807.e1" id="s807.p0" relation="false"/>
  </sentence>
  <sentence id="s808" text="Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.">
    <entity charOffset="82-101" id="s808.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="205-272" id="s808.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s808.e0" e2="s808.e1" id="s808.p0" relation="false"/>
  </sentence>
  <sentence id="s809" text="Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.">
    <entity charOffset="106-129" id="s809.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="205-272" id="s809.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s809.e0" e2="s809.e1" id="s809.p0" relation="false"/>
  </sentence>
  <sentence id="s810" text="Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.">
    <entity charOffset="151-165" id="s810.e0" ontology_id="HP_0000520" text="prominent eyes" type="HP"/>
    <entity charOffset="205-272" id="s810.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s810.e0" e2="s810.e1" id="s810.p0" relation="false"/>
  </sentence>
  <sentence id="s811" text="Mutations in inflammatory response have been identified that result in a variant form of nonketotic hyperglycinemia with early-onset convulsions combined with a defect in mitochondrial energy metabolism with encephalopathy and cardiomyopathy.">
    <entity charOffset="13-34" id="s811.e0" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <entity charOffset="208-222" id="s811.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s811.e0" e2="s811.e1" id="s811.p0" relation="true"/>
  </sentence>
  <sentence id="s812" text="Mutations in inflammatory response have been identified that result in a variant form of nonketotic hyperglycinemia with early-onset convulsions combined with a defect in mitochondrial energy metabolism with encephalopathy and cardiomyopathy.">
    <entity charOffset="13-34" id="s812.e0" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <entity charOffset="227-241" id="s812.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s812.e0" e2="s812.e1" id="s812.p0" relation="true"/>
  </sentence>
  <sentence id="s813" text="However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (monocyte chemotaxis), Interleukin (IL)-17A, and tumor necrosis factor (negative regulation of transcription by RNA polymerase II)- promoting bone loss in inflammatory states such as rheumatoid arthritis.">
    <entity charOffset="146-165" id="s813.e0" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <entity charOffset="194-199" id="s813.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s813.e0" e2="s813.e1" id="s813.p0" relation="false"/>
  </sentence>
  <sentence id="s814" text="However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (monocyte chemotaxis), Interleukin (IL)-17A, and tumor necrosis factor (negative regulation of transcription by RNA polymerase II)- promoting bone loss in inflammatory states such as rheumatoid arthritis.">
    <entity charOffset="194-199" id="s814.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="217-274" id="s814.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s814.e0" e2="s814.e1" id="s814.p0" relation="false"/>
  </sentence>
  <sentence id="s815" text="T cell-produced negative regulation of transcription by RNA polymerase II and IL-17A further contribute to bone loss in hyperparathyroidism, while T cell production of the anabolic Wingless integration site (Wnt) ligand, Wnt10b, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).">
    <entity charOffset="16-73" id="s815.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="120-139" id="s815.e1" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <pair e1="s815.e0" e2="s815.e1" id="s815.p0" relation="false"/>
  </sentence>
  <sentence id="s816" text="A recent genome-wide association study (GWAS) linked hypercalciuria and kidney stones to a claudin-14 (calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules) risk haplotype.">
    <entity charOffset="53-67" id="s816.e0" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <entity charOffset="103-185" id="s816.e1" ontology_id="GO_0016338" text="calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules" type="GO"/>
    <pair e1="s816.e0" e2="s816.e1" id="s816.p0" relation="false"/>
  </sentence>
  <sentence id="s817" text="Usher syndrome (USH) is the most common cause of inherited deaf-blindness, manifested as USH1, USH2 and actin filament organization clinical types.">
    <entity charOffset="64-73" id="s817.e0" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <entity charOffset="104-131" id="s817.e1" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <pair e1="s817.e0" e2="s817.e1" id="s817.p0" relation="true"/>
  </sentence>
  <sentence id="s818" text="Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (muscle organ development 1) or MIR17HG that encodes protein polyubiquitination-17-92 microRNAs (type 2).">
    <entity charOffset="23-41" id="s818.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="95-119" id="s818.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s818.e0" e2="s818.e1" id="s818.p0" relation="false"/>
  </sentence>
  <sentence id="s819" text="Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (muscle organ development 1) or MIR17HG that encodes protein polyubiquitination-17-92 microRNAs (type 2).">
    <entity charOffset="23-41" id="s819.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="147-173" id="s819.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s819.e0" e2="s819.e1" id="s819.p0" relation="false"/>
  </sentence>
  <sentence id="s820" text="A single family with an autosomal recessive form of OFCS and a homozygous missense mutation in skeletal system development gene has been described.">
    <entity charOffset="24-43" id="s820.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="95-122" id="s820.e1" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="s820.e0" e2="s820.e1" id="s820.p0" relation="true"/>
  </sentence>
  <sentence id="s821" text="This report provides evidence that bi-allelic null skeletal system development mutations may lead to a multi-system autosomal recessive disorders, where SCID might represent the main feature">
    <entity charOffset="51-78" id="s821.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="116-135" id="s821.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s821.e0" e2="s821.e1" id="s821.p0" relation="true"/>
  </sentence>
  <sentence id="s822" text="regulation of signaling receptor activity may enhance the migratory and invasive capabilities of endometrial tumor cells by the phosphorylation of ERK1/2, Akt and p38 molecules.">
    <entity charOffset="0-41" id="s822.e0" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <entity charOffset="109-114" id="s822.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s822.e0" e2="s822.e1" id="s822.p0" relation="false"/>
  </sentence>
  <sentence id="s823" text="regulation of signaling receptor activity is a dysregulated gene involved in the tumorigenesis, bio-pathological features and outcomes of EEC. uPA may be a potential molecule and target for the detection and treatment of EEC.">
    <entity charOffset="0-41" id="s823.e0" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <entity charOffset="81-86" id="s823.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s823.e0" e2="s823.e1" id="s823.p0" relation="false"/>
  </sentence>
  <sentence id="s824" text="By demonstrating that MT-bound microtubule cytoskeleton organization inhibits the Eg5 kinesin and cell mitosis, our work provides a new framework to consider the role of Tau in neurodegenerative diseases.">
    <entity charOffset="31-68" id="s824.e0" ontology_id="GO_0000226" text="microtubule cytoskeleton organization" type="GO"/>
    <entity charOffset="177-203" id="s824.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s824.e0" e2="s824.e1" id="s824.p0" relation="false"/>
  </sentence>
  <sentence id="s825" text="Homozygozity mapping and exome sequencing in 62 isolated individuals with early-onset parkinsonism and confirmed consanguinity followed by data mining in the exomes of 1,348 PD-affected individuals identified, in three isolated subjects, homozygous or compound heterozygous truncating mutations in vacuolar protein sorting 13C (mitochondrion organization).">
    <entity charOffset="86-98" id="s825.e0" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <entity charOffset="328-354" id="s825.e1" ontology_id="GO_0007005" text="mitochondrion organization" type="GO"/>
    <pair e1="s825.e0" e2="s825.e1" id="s825.p0" relation="true"/>
  </sentence>
  <sentence id="s826" text="This work suggests that loss of function of mitochondrion organization is a cause of autosomal-recessive early-onset parkinsonism with a distinctive phenotype of rapid and severe progression">
    <entity charOffset="44-70" id="s826.e0" ontology_id="GO_0007005" text="mitochondrion organization" type="GO"/>
    <entity charOffset="117-129" id="s826.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s826.e0" e2="s826.e1" id="s826.p0" relation="true"/>
  </sentence>
  <sentence id="s827" text="Human genetic evidence demonstrates that positive regulation of cell proliferation mutations cause osteogenesis imperfecta (OI) and early-onset osteoporosis, implicating WNT1 as a major regulator of bone metabolism.">
    <entity charOffset="41-82" id="s827.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="144-156" id="s827.e1" ontology_id="HP_0000939" text="osteoporosis" type="HP"/>
    <pair e1="s827.e0" e2="s827.e1" id="s827.p0" relation="true"/>
  </sentence>
  <sentence id="s828" text="Agonistic antibodies, which bind specifically to death receptor 5 (response to endoplasmic reticulum stress), can trigger apoptosis in tumor cells through the extrinsic pathway.">
    <entity charOffset="67-107" id="s828.e0" ontology_id="GO_0034976" text="response to endoplasmic reticulum stress" type="GO"/>
    <entity charOffset="135-140" id="s828.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s828.e0" e2="s828.e1" id="s828.p0" relation="true"/>
  </sentence>
  <sentence id="s829" text="After screening for agonism in a cell-viability assay in vitro, a novel response to endoplasmic reticulum stress-specific scFv antibody transcription initiation from RNA polymerase II promoter-3 was isolated, which inhibited COLO205 and MDA-MB-231 tumor cell growth without any cross-linking agents.">
    <entity charOffset="72-112" id="s829.e0" ontology_id="GO_0034976" text="response to endoplasmic reticulum stress" type="GO"/>
    <entity charOffset="248-253" id="s829.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s829.e0" e2="s829.e1" id="s829.p0" relation="true"/>
  </sentence>
  <sentence id="s830" text="After screening for agonism in a cell-viability assay in vitro, a novel response to endoplasmic reticulum stress-specific scFv antibody transcription initiation from RNA polymerase II promoter-3 was isolated, which inhibited COLO205 and MDA-MB-231 tumor cell growth without any cross-linking agents.">
    <entity charOffset="136-192" id="s830.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="248-253" id="s830.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s830.e0" e2="s830.e1" id="s830.p0" relation="false"/>
  </sentence>
  <sentence id="s831" text="The activity of transcription initiation from RNA polymerase II promoter-3 in inducing apoptosis in cancer cells was evaluated by using an Annexin V-PE apoptosis detection activation of MAPK activity in combination with flow cytometry and the Hoechst 33342 and propidium iodide double staining analysis.">
    <entity charOffset="16-72" id="s831.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="100-106" id="s831.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s831.e0" e2="s831.e1" id="s831.p0" relation="false"/>
  </sentence>
  <sentence id="s832" text="The activity of transcription initiation from RNA polymerase II promoter-3 in inducing apoptosis in cancer cells was evaluated by using an Annexin V-PE apoptosis detection activation of MAPK activity in combination with flow cytometry and the Hoechst 33342 and propidium iodide double staining analysis.">
    <entity charOffset="100-106" id="s832.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="172-199" id="s832.e1" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <pair e1="s832.e0" e2="s832.e1" id="s832.p0" relation="true"/>
  </sentence>
  <sentence id="s833" text="Furthermore, transcription initiation from RNA polymerase II promoter-3 suppressed the tumor growth significantly in the xenograft model.">
    <entity charOffset="13-69" id="s833.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="87-92" id="s833.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s833.e0" e2="s833.e1" id="s833.p0" relation="false"/>
  </sentence>
  <sentence id="s834" text="Taken together, these data suggest that transcription initiation from RNA polymerase II promoter-3 exhibited potent antitumor activity both in vitro and in vivo.">
    <entity charOffset="40-96" id="s834.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="120-125" id="s834.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s834.e0" e2="s834.e1" id="s834.p0" relation="false"/>
  </sentence>
  <sentence id="s835" text="The inhibition of CTGF/CCN2 with the monoclonal neutralizing antibody FG-3019 reduces fibrosis in several chronic disorders including the mdx mice, a murine model for Duchenne muscular dystrophy (peptide biosynthetic process).">
    <entity charOffset="176-194" id="s835.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="196-224" id="s835.e1" ontology_id="GO_0043043" text="peptide biosynthetic process" type="GO"/>
    <pair e1="s835.e0" e2="s835.e1" id="s835.p0" relation="true"/>
  </sentence>
  <sentence id="s836" text="Defects in ISC biogenesis lead to multiple mitochondrial dysfunction syndromes including: small molecule metabolic process with infantile onset leukodystrophy.">
    <entity charOffset="43-68" id="s836.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="90-122" id="s836.e1" ontology_id="GO_0044281" text="small molecule metabolic process" type="GO"/>
    <pair e1="s836.e0" e2="s836.e1" id="s836.p0" relation="false"/>
  </sentence>
  <sentence id="s837" text="Within the last decade, the Bromodomain and Extra-Terminal domain family (central nervous system development) of proteins have emerged as promising drug targets in diverse clinical indications including oncology, auto-immune disease, heart failure, and male contraception.">
    <entity charOffset="74-108" id="s837.e0" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <entity charOffset="234-247" id="s837.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s837.e0" e2="s837.e1" id="s837.p0" relation="false"/>
  </sentence>
  <sentence id="s838" text="Mutations in bestrophin-1 (chloride transport) are associated with distinct retinopathies, notably three forms with autosomal dominant inheritance and one condition with an autosomal recessive mode of transmission.">
    <entity charOffset="27-45" id="s838.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="173-192" id="s838.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s838.e0" e2="s838.e1" id="s838.p0" relation="true"/>
  </sentence>
  <sentence id="s839" text="Although heterozygous missense mutations in chloride transport reveal dominant-negative effects in patients with autosomal dominant chloride transport disease (BD), heterozygous mutations associated with autosomal recessive bestrophinopathy (ARB) display no disease phenotype.">
    <entity charOffset="44-62" id="s839.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="204-223" id="s839.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s839.e0" e2="s839.e1" id="s839.p0" relation="true"/>
  </sentence>
  <sentence id="s840" text="Although heterozygous missense mutations in chloride transport reveal dominant-negative effects in patients with autosomal dominant chloride transport disease (BD), heterozygous mutations associated with autosomal recessive bestrophinopathy (ARB) display no disease phenotype.">
    <entity charOffset="132-150" id="s840.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="204-223" id="s840.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s840.e0" e2="s840.e1" id="s840.p0" relation="true"/>
  </sentence>
  <sentence id="s841" text="However, the role of &lt;i&gt;RTEL1&lt;/i&gt; mutations in other bone marrow failure (negative regulation of autophagy) syndromes and myeloid neoplasms, and the contribution of monoallelic &lt;i&gt;RTEL1&lt;/i&gt; mutations to disease development are not well defined.">
    <entity charOffset="74-106" id="s841.e0" ontology_id="GO_0010507" text="negative regulation of autophagy" type="GO"/>
    <entity charOffset="130-139" id="s841.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s841.e0" e2="s841.e1" id="s841.p0" relation="false"/>
  </sentence>
  <sentence id="s842" text="We screened 516 patients for germline mutations in telomere-associated genes by next-generation sequencing in 2 independent cohorts; one constituting unselected patients with idiopathic negative regulation of autophagy, unexplained cytopenia, or myeloid neoplasms (n = 457) and a second cohort comprising selected patients on the basis of the suspicion of constitutional/familial BMF (n = 59).">
    <entity charOffset="186-218" id="s842.e0" ontology_id="GO_0010507" text="negative regulation of autophagy" type="GO"/>
    <entity charOffset="254-263" id="s842.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s842.e0" e2="s842.e1" id="s842.p0" relation="false"/>
  </sentence>
  <sentence id="s843" text="The results show that negative regulation of cell proliferation plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high myopia and early-onset cataract.">
    <entity charOffset="22-63" id="s843.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="185-191" id="s843.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s843.e0" e2="s843.e1" id="s843.p0" relation="true"/>
  </sentence>
  <sentence id="s844" text="The results show that negative regulation of cell proliferation plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high myopia and early-onset cataract.">
    <entity charOffset="22-63" id="s844.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="208-216" id="s844.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s844.e0" e2="s844.e1" id="s844.p0" relation="true"/>
  </sentence>
  <sentence id="s845" text="Idiopathic hypogonadotropic hypogonadism (smoothened signaling pathway) is often caused by hyposecretion of gonadotropin and consequently affects male fertility.">
    <entity charOffset="28-40" id="s845.e0" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <entity charOffset="42-70" id="s845.e1" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <pair e1="s845.e0" e2="s845.e1" id="s845.p0" relation="false"/>
  </sentence>
  <sentence id="s846" text="Hereditary sensory and autonomic neuropathy 1 (sphingolipid biosynthetic process) is an autosomal dominant disorder that can be caused by variants in sphingolipid biosynthetic process or sphingolipid biosynthetic process, encoding subunits of serine palmitoyl-CoA transferase.">
    <entity charOffset="33-43" id="s846.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="47-80" id="s846.e1" ontology_id="GO_0030148" text="sphingolipid biosynthetic process" type="GO"/>
    <pair e1="s846.e0" e2="s846.e1" id="s846.p0" relation="true"/>
  </sentence>
  <sentence id="s847" text="Hereditary sensory and autonomic neuropathy 1 (sphingolipid biosynthetic process) is an autosomal dominant disorder that can be caused by variants in sphingolipid biosynthetic process or sphingolipid biosynthetic process, encoding subunits of serine palmitoyl-CoA transferase.">
    <entity charOffset="33-43" id="s847.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="150-183" id="s847.e1" ontology_id="GO_0030148" text="sphingolipid biosynthetic process" type="GO"/>
    <pair e1="s847.e0" e2="s847.e1" id="s847.p0" relation="true"/>
  </sentence>
  <sentence id="s848" text="Hereditary sensory and autonomic neuropathy 1 (sphingolipid biosynthetic process) is an autosomal dominant disorder that can be caused by variants in sphingolipid biosynthetic process or sphingolipid biosynthetic process, encoding subunits of serine palmitoyl-CoA transferase.">
    <entity charOffset="33-43" id="s848.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="187-220" id="s848.e1" ontology_id="GO_0030148" text="sphingolipid biosynthetic process" type="GO"/>
    <pair e1="s848.e0" e2="s848.e1" id="s848.p0" relation="true"/>
  </sentence>
  <sentence id="s849" text="Sequencing of sphingolipid biosynthetic process should be considered in all patients presenting with mild late-onset sensory-predominant small or large fiber neuropathy.">
    <entity charOffset="14-47" id="s849.e0" ontology_id="GO_0030148" text="sphingolipid biosynthetic process" type="GO"/>
    <entity charOffset="158-168" id="s849.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s849.e0" e2="s849.e1" id="s849.p0" relation="true"/>
  </sentence>
  <sentence id="s850" text="In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in camera-type eye morphogenesis (previously named regulation of transcription by RNA polymerase III) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.">
    <entity charOffset="101-130" id="s850.e0" ontology_id="GO_0048593" text="camera-type eye morphogenesis" type="GO"/>
    <entity charOffset="243-252" id="s850.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s850.e0" e2="s850.e1" id="s850.p0" relation="false"/>
  </sentence>
  <sentence id="s851" text="In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in camera-type eye morphogenesis (previously named regulation of transcription by RNA polymerase III) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.">
    <entity charOffset="149-198" id="s851.e0" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <entity charOffset="266-280" id="s851.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s851.e0" e2="s851.e1" id="s851.p0" relation="false"/>
  </sentence>
  <sentence id="s852" text="In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in camera-type eye morphogenesis (previously named regulation of transcription by RNA polymerase III) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.">
    <entity charOffset="149-198" id="s852.e0" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <entity charOffset="243-252" id="s852.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s852.e0" e2="s852.e1" id="s852.p0" relation="false"/>
  </sentence>
  <sentence id="s853" text="Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous camera-type eye morphogenesis splicing mutation c.2968-2A&amp;gt;T (p.Val990Cysfs*13).">
    <entity charOffset="87-96" id="s853.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="197-226" id="s853.e1" ontology_id="GO_0048593" text="camera-type eye morphogenesis" type="GO"/>
    <pair e1="s853.e0" e2="s853.e1" id="s853.p0" relation="false"/>
  </sentence>
  <sentence id="s854" text="This report supports the association of camera-type eye morphogenesis mutations with colobomatous microphthalmia and expands the phenotypic spectrum associated with mutations in this gene.">
    <entity charOffset="40-69" id="s854.e0" ontology_id="GO_0048593" text="camera-type eye morphogenesis" type="GO"/>
    <entity charOffset="98-112" id="s854.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s854.e0" e2="s854.e1" id="s854.p0" relation="true"/>
  </sentence>
  <sentence id="s855" text="Elucidating the exact relationship between these two enzymes when they methylate two distinct sites of the same substrate may somatic diversification of immunoglobulins in developing therapeutics aimed at reducing peptidyl-arginine N-methylation/7 activity in cancer and other diseases">
    <entity charOffset="126-168" id="s855.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="260-266" id="s855.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s855.e0" e2="s855.e1" id="s855.p0" relation="false"/>
  </sentence>
  <sentence id="s856" text="Elucidating the exact relationship between these two enzymes when they methylate two distinct sites of the same substrate may somatic diversification of immunoglobulins in developing therapeutics aimed at reducing peptidyl-arginine N-methylation/7 activity in cancer and other diseases">
    <entity charOffset="214-245" id="s856.e0" ontology_id="GO_0035246" text="peptidyl-arginine N-methylation" type="GO"/>
    <entity charOffset="260-266" id="s856.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s856.e0" e2="s856.e1" id="s856.p0" relation="false"/>
  </sentence>
  <sentence id="s857" text="Isobutyryl-CoA dehydrogenase deficiency (IBDHD) is a rare autosomal recessive metabolic disorder related to valine catabolism and results from variants in branched-chain amino acid catabolic process.">
    <entity charOffset="58-77" id="s857.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="155-198" id="s857.e1" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <pair e1="s857.e0" e2="s857.e1" id="s857.p0" relation="true"/>
  </sentence>
  <sentence id="s858" text="Identification of this mutation reveals the allelic heterogeneity of retinoid metabolic process in patients with RP phenotype.">
    <entity charOffset="52-65" id="s858.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="69-95" id="s858.e1" ontology_id="GO_0001523" text="retinoid metabolic process" type="GO"/>
    <pair e1="s858.e0" e2="s858.e1" id="s858.p0" relation="false"/>
  </sentence>
  <sentence id="s859" text="positive regulation of cell proliferation deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-41" id="s859.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="90-113" id="s859.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s859.e0" e2="s859.e1" id="s859.p0" relation="true"/>
  </sentence>
  <sentence id="s860" text="positive regulation of cell proliferation deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-41" id="s860.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="188-217" id="s860.e1" ontology_id="HP_0000336" text="prominent supraorbital ridges" type="HP"/>
    <pair e1="s860.e0" e2="s860.e1" id="s860.p0" relation="true"/>
  </sentence>
  <sentence id="s861" text="positive regulation of cell proliferation deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-41" id="s861.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="265-275" id="s861.e1" ontology_id="HP_0000154" text="wide mouth" type="HP"/>
    <pair e1="s861.e0" e2="s861.e1" id="s861.p0" relation="true"/>
  </sentence>
  <sentence id="s862" text="positive regulation of cell proliferation deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.">
    <entity charOffset="0-41" id="s862.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="313-323" id="s862.e1" ontology_id="HP_0000054" text="micropenis" type="HP"/>
    <pair e1="s862.e0" e2="s862.e1" id="s862.p0" relation="true"/>
  </sentence>
  <sentence id="s863" text="Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic heterogeneity, most often transmitted in an autosomal dominant manner, caused by mutations in in utero embryonic development and GJB4 genes encoding connexins (Cx)31 and 30.3, respectively.">
    <entity charOffset="99-112" id="s863.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="193-223" id="s863.e1" ontology_id="GO_0001701" text="in utero embryonic development" type="GO"/>
    <pair e1="s863.e0" e2="s863.e1" id="s863.p0" relation="false"/>
  </sentence>
  <sentence id="s864" text="The deregulation of its expression or activity contributes to leukemia, in which hypermethylation of CpG island can be either an oncogene or a tumor suppressor.">
    <entity charOffset="81-111" id="s864.e0" ontology_id="GO_0044027" text="hypermethylation of CpG island" type="GO"/>
    <entity charOffset="143-148" id="s864.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s864.e0" e2="s864.e1" id="s864.p0" relation="false"/>
  </sentence>
  <sentence id="s865" text="Herein we explored whether cellular senescence, an anti-tumoral pathway that restrains cell proliferation, is a mechanism by which hypermethylation of CpG island limits hematopoietic cell expansion, and thus prevents the development of leukemia.">
    <entity charOffset="56-61" id="s865.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="131-161" id="s865.e1" ontology_id="GO_0044027" text="hypermethylation of CpG island" type="GO"/>
    <pair e1="s865.e0" e2="s865.e1" id="s865.p0" relation="false"/>
  </sentence>
  <sentence id="s866" text="In humans, heterozygous mutations in positive regulation of transcription, DNA-templated result in congenital heart defects (CHDs).">
    <entity charOffset="37-88" id="s866.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="99-123" id="s866.e1" ontology_id="HP_0001627" text="congenital heart defects" type="HP"/>
    <pair e1="s866.e0" e2="s866.e1" id="s866.p0" relation="true"/>
  </sentence>
  <sentence id="s867" text="To elucidate the underlying molecular mechanisms of tamoxifen resistance, we performed a systematic analysis of protein polyubiquitinationNA-mediated gene regulation in three clinically-relevant tamoxifen-resistant breast cancer cell lines (TamRs) compared to their parental tamoxifen-sensitive cell line.">
    <entity charOffset="112-138" id="s867.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="222-228" id="s867.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s867.e0" e2="s867.e1" id="s867.p0" relation="false"/>
  </sentence>
  <sentence id="s868" text="Finally, we show that a combination of 2 protein polyubiquitinationNAs (miR-190b and miR-516a-5p) exhibiting altered expression in TamR cell lines were predictive of treatment outcome in a cohort of ER+ breast cancer patients receiving adjuvant tamoxifen mono-therapy.">
    <entity charOffset="41-67" id="s868.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="210-216" id="s868.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s868.e0" e2="s868.e1" id="s868.p0" relation="false"/>
  </sentence>
  <sentence id="s869" text="Up to this time, only heterozygous mutations of extracellular matrix organization gene have been reported in human and related to: (1) multiple epiphyseal dysplasia muscle organ development 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.">
    <entity charOffset="48-81" id="s869.e0" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <entity charOffset="255-267" id="s869.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s869.e0" e2="s869.e1" id="s869.p0" relation="true"/>
  </sentence>
  <sentence id="s870" text="Up to this time, only heterozygous mutations of extracellular matrix organization gene have been reported in human and related to: (1) multiple epiphyseal dysplasia muscle organ development 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.">
    <entity charOffset="165-189" id="s870.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="255-267" id="s870.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s870.e0" e2="s870.e1" id="s870.p0" relation="false"/>
  </sentence>
  <sentence id="s871" text="Here, we describe the first autosomal recessive Stickler family due to loss of function mutations (c.1176_1198del, p.Gln393Cysfs*25) of extracellular matrix organization gene.">
    <entity charOffset="28-47" id="s871.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="136-169" id="s871.e1" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <pair e1="s871.e0" e2="s871.e1" id="s871.p0" relation="false"/>
  </sentence>
  <sentence id="s872" text="In this study, we applied this strategy to identify novel gene interactions in positive regulation of protein phosphorylation-mutant cancer cells.">
    <entity charOffset="79-125" id="s872.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="133-139" id="s872.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s872.e0" e2="s872.e1" id="s872.p0" relation="true"/>
  </sentence>
  <sentence id="s873" text="Silencing of transforming growth factor beta receptor signaling pathway or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in positive regulation of protein phosphorylation-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.">
    <entity charOffset="13-71" id="s873.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="204-210" id="s873.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s873.e0" e2="s873.e1" id="s873.p0" relation="false"/>
  </sentence>
  <sentence id="s874" text="Silencing of transforming growth factor beta receptor signaling pathway or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in positive regulation of protein phosphorylation-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.">
    <entity charOffset="150-196" id="s874.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="204-210" id="s874.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s874.e0" e2="s874.e1" id="s874.p0" relation="true"/>
  </sentence>
  <sentence id="s875" text="In clinical specimens, elevated endodermal cell differentiation expression correlated with poorer survival in lung cancer patients with an oncogenic KRAS gene signature, suggesting a novel candidate biomarker in this disease setting.">
    <entity charOffset="32-63" id="s875.e0" ontology_id="GO_0035987" text="endodermal cell differentiation" type="GO"/>
    <entity charOffset="115-121" id="s875.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s875.e0" e2="s875.e1" id="s875.p0" relation="true"/>
  </sentence>
  <sentence id="s876" text="Our results define a novel regulatory pathway in positive regulation of protein phosphorylation-driven cancers, which offers a potential therapeutic target for their eradication.">
    <entity charOffset="49-95" id="s876.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="103-109" id="s876.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s876.e0" e2="s876.e1" id="s876.p0" relation="true"/>
  </sentence>
  <sentence id="s877" text="To our knowledge, this is one of the first reports on isolated mild ventricular hypertrophy due to long-chain fatty acid metabolic process mutation in a family with moderate symptoms during adolescence.">
    <entity charOffset="68-91" id="s877.e0" ontology_id="HP_0001714" text="ventricular hypertrophy" type="HP"/>
    <entity charOffset="99-138" id="s877.e1" ontology_id="GO_0001676" text="long-chain fatty acid metabolic process" type="GO"/>
    <pair e1="s877.e0" e2="s877.e1" id="s877.p0" relation="false"/>
  </sentence>
  <sentence id="s878" text="Five individuals who carry negative regulation of transcription by RNA polymerase II nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="27-84" id="s878.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="171-200" id="s878.e1" ontology_id="HP_0002376" text="neurodevelopmental regression" type="HP"/>
    <pair e1="s878.e0" e2="s878.e1" id="s878.p0" relation="true"/>
  </sentence>
  <sentence id="s879" text="Five individuals who carry negative regulation of transcription by RNA polymerase II nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="27-84" id="s879.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="213-224" id="s879.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s879.e0" e2="s879.e1" id="s879.p0" relation="true"/>
  </sentence>
  <sentence id="s880" text="Five individuals who carry negative regulation of transcription by RNA polymerase II nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="27-84" id="s880.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="225-231" id="s880.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s880.e0" e2="s880.e1" id="s880.p0" relation="true"/>
  </sentence>
  <sentence id="s881" text="Five individuals who carry negative regulation of transcription by RNA polymerase II nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="27-84" id="s881.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="233-241" id="s881.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s881.e0" e2="s881.e1" id="s881.p0" relation="true"/>
  </sentence>
  <sentence id="s882" text="Five individuals who carry negative regulation of transcription by RNA polymerase II nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="128-149" id="s882.e0" ontology_id="GO_0032418" text="lysosome localization" type="GO"/>
    <entity charOffset="213-224" id="s882.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s882.e0" e2="s882.e1" id="s882.p0" relation="false"/>
  </sentence>
  <sentence id="s883" text="Five individuals who carry negative regulation of transcription by RNA polymerase II nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.">
    <entity charOffset="128-149" id="s883.e0" ontology_id="GO_0032418" text="lysosome localization" type="GO"/>
    <entity charOffset="233-241" id="s883.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s883.e0" e2="s883.e1" id="s883.p0" relation="false"/>
  </sentence>
  <sentence id="s884" text="Increased catabolite concentrations in serum are associated with several cardiovascular diseases (CVD), including heart disease, atherosclerosis, and endothelial dysfunction, as well as their risk fcoenzyme A biosynthetic processors, including hypertension, diabetes, obesity, and aging.">
    <entity charOffset="198-229" id="s884.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="244-256" id="s884.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s884.e0" e2="s884.e1" id="s884.p0" relation="false"/>
  </sentence>
  <sentence id="s885" text="Increased catabolite concentrations in serum are associated with several cardiovascular diseases (CVD), including heart disease, atherosclerosis, and endothelial dysfunction, as well as their risk fcoenzyme A biosynthetic processors, including hypertension, diabetes, obesity, and aging.">
    <entity charOffset="198-229" id="s885.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="268-275" id="s885.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s885.e0" e2="s885.e1" id="s885.p0" relation="false"/>
  </sentence>
  <sentence id="s886" text="Mutations in antibacterial humoral response (antibacterial humoral response) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.">
    <entity charOffset="13-43" id="s886.e0" ontology_id="GO_0019731" text="antibacterial humoral response" type="GO"/>
    <entity charOffset="132-151" id="s886.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s886.e0" e2="s886.e1" id="s886.p0" relation="true"/>
  </sentence>
  <sentence id="s887" text="Mutations in antibacterial humoral response (antibacterial humoral response) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.">
    <entity charOffset="45-75" id="s887.e0" ontology_id="GO_0019731" text="antibacterial humoral response" type="GO"/>
    <entity charOffset="132-151" id="s887.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s887.e0" e2="s887.e1" id="s887.p0" relation="true"/>
  </sentence>
  <sentence id="s888" text="Mutations in antibacterial humoral response (antibacterial humoral response) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.">
    <entity charOffset="45-75" id="s888.e0" ontology_id="GO_0019731" text="antibacterial humoral response" type="GO"/>
    <entity charOffset="190-202" id="s888.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s888.e0" e2="s888.e1" id="s888.p0" relation="true"/>
  </sentence>
  <sentence id="s889" text="BACKGROUND Hepatocellular carcinoma (phosphatidylinositol phosphorylation) is one of the most common malignancies occurring worldwide and is most frequent type of liver cancer.">
    <entity charOffset="37-73" id="s889.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="169-175" id="s889.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s889.e0" e2="s889.e1" id="s889.p0" relation="false"/>
  </sentence>
  <sentence id="s890" text="Association between autism and single-nucleotide polymorphisms in aspartate transmembrane transport has been reported in various studies.">
    <entity charOffset="20-26" id="s890.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="66-99" id="s890.e1" ontology_id="GO_0015810" text="aspartate transmembrane transport" type="GO"/>
    <pair e1="s890.e0" e2="s890.e1" id="s890.p0" relation="false"/>
  </sentence>
  <sentence id="s891" text="Our findings suggest that aspartate transmembrane transport overexpression may be involved in the pathophysiology of autism, modifying neuronal networks in specific subregions, such as the dorsolateral prefrontal cortex and fusiform gyrus, at both pre- and postnatal stages">
    <entity charOffset="26-59" id="s891.e0" ontology_id="GO_0015810" text="aspartate transmembrane transport" type="GO"/>
    <entity charOffset="117-123" id="s891.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s891.e0" e2="s891.e1" id="s891.p0" relation="false"/>
  </sentence>
  <sentence id="s892" text="Episodic ataxia type 2 (positive regulation of cytosolic calcium ion concentration) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise.">
    <entity charOffset="9-15" id="s892.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="24-82" id="s892.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s892.e0" e2="s892.e1" id="s892.p0" relation="true"/>
  </sentence>
  <sentence id="s893" text="In 128 female patients of the recruited UCC cohort, patients who carried at least one deletion allele of &lt;i&gt;adenylate cyclase-inhibiting dopamine receptor signaling pathway&lt;/i&gt; rs1799732 showed a higher incidence of having an invasive stage (AOR=2.585, 95% CI: 1.066~6.264, &lt;i&gt;p&lt;/i&gt;=0.032) and a large tumor (AOR=2.778, 95% CI: 1.146~6.735, &lt;i&gt;p&lt;/i&gt;=0.021).">
    <entity charOffset="108-172" id="s893.e0" ontology_id="GO_0007195" text="adenylate cyclase-inhibiting dopamine receptor signaling pathway" type="GO"/>
    <entity charOffset="302-307" id="s893.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s893.e0" e2="s893.e1" id="s893.p0" relation="false"/>
  </sentence>
  <sentence id="s894" text="Further analyses of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets revealed correlations of the expression of adenylate cyclase-inhibiting dopamine receptor signaling pathway with an invasive tumor, tumor metastasis, and the lower survival rate in patients with UCC.">
    <entity charOffset="137-201" id="s894.e0" ontology_id="GO_0007195" text="adenylate cyclase-inhibiting dopamine receptor signaling pathway" type="GO"/>
    <entity charOffset="219-224" id="s894.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s894.e0" e2="s894.e1" id="s894.p0" relation="false"/>
  </sentence>
  <sentence id="s895" text="We evaluated the association between dietary and supplemental zinc and prostate cancer within the VITamins And Lifestyle (VITAL) cohort, a study specifically designed to evaluate the negative regulation of transcription by RNA polymerase II of dietary supplements and cancer risk.">
    <entity charOffset="80-86" id="s895.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="183-240" id="s895.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s895.e0" e2="s895.e1" id="s895.p0" relation="false"/>
  </sentence>
  <sentence id="s896" text="Of 35,242 negative regulation of phosphatase activity who completed the baseline dietary and supplemental questionnaire, 832 men developed invasive prostate cancers between October 2000 and December 2004.">
    <entity charOffset="10-53" id="s896.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="157-163" id="s896.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s896.e0" e2="s896.e1" id="s896.p0" relation="false"/>
  </sentence>
  <sentence id="s897" text="An underdeveloped or impaired immune response in young children is associated with increased susceptibility to Streptococcus pneumonia (negative regulation of transcription by RNA polymerase II) infections.">
    <entity charOffset="125-134" id="s897.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="136-193" id="s897.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s897.e0" e2="s897.e1" id="s897.p0" relation="false"/>
  </sentence>
  <sentence id="s898" text="Although genes that are essential for cortical developmental expansion have been identified from the genetics of human primary microcephaly (a disorder associated with reduced brain size and intellectual disability) &lt;sup&gt;1&lt;/sup&gt; , studies of these genes in epidermis development, which have a smooth cortex that is one thousand times smaller than the cortex of humans, have provided limited insight.">
    <entity charOffset="191-214" id="s898.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="257-278" id="s898.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s898.e0" e2="s898.e1" id="s898.p0" relation="false"/>
  </sentence>
  <sentence id="s899" text="Mutations in abnormal spindle-like microcephaly-associated (spindle organization), the most common recessive microcephaly gene, reduce cortical volume by at least 50% in humans&lt;sup&gt;2-4&lt;/sup&gt;, but have little effect on the brains of mice&lt;sup&gt;5-9&lt;/sup&gt;; this probably reflects evolutionarily divergent functions of ASPM&lt;sup&gt;10,11&lt;/sup&gt;.">
    <entity charOffset="35-47" id="s899.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="60-80" id="s899.e1" ontology_id="GO_0007051" text="spindle organization" type="GO"/>
    <pair e1="s899.e0" e2="s899.e1" id="s899.p0" relation="true"/>
  </sentence>
  <sentence id="s900" text="Although there are nearly 100 different causative genes identified for nonsyndromic hearing loss (NSHL), Sanger sequencing-based DNA diagnostics usually only analyses three, namely, gap junction-mediated intercellular transport, regulation of pH, and OTOF.">
    <entity charOffset="84-96" id="s900.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="182-227" id="s900.e1" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <pair e1="s900.e0" e2="s900.e1" id="s900.p0" relation="true"/>
  </sentence>
  <sentence id="s901" text="Although there are nearly 100 different causative genes identified for nonsyndromic hearing loss (NSHL), Sanger sequencing-based DNA diagnostics usually only analyses three, namely, gap junction-mediated intercellular transport, regulation of pH, and OTOF.">
    <entity charOffset="84-96" id="s901.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="229-245" id="s901.e1" ontology_id="GO_0006885" text="regulation of pH" type="GO"/>
    <pair e1="s901.e0" e2="s901.e1" id="s901.p0" relation="true"/>
  </sentence>
  <sentence id="s902" text="&lt;i&gt;vascular endothelial growth factor receptor signaling pathway&lt;/i&gt;, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (negative regulation of transcription by RNA polymerase IIR3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymphedema.">
    <entity charOffset="3-64" id="s902.e0" ontology_id="GO_0048010" text="vascular endothelial growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="356-361" id="s902.e1" ontology_id="HP_0000969" text="edema" type="HP"/>
    <pair e1="s902.e0" e2="s902.e1" id="s902.p0" relation="true"/>
  </sentence>
  <sentence id="s903" text="&lt;i&gt;vascular endothelial growth factor receptor signaling pathway&lt;/i&gt;, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (negative regulation of transcription by RNA polymerase IIR3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymphedema.">
    <entity charOffset="161-218" id="s903.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="356-361" id="s903.e1" ontology_id="HP_0000969" text="edema" type="HP"/>
    <pair e1="s903.e0" e2="s903.e1" id="s903.p0" relation="false"/>
  </sentence>
  <sentence id="s904" text="Through Sanger sequencing of a proband with bilateral congenital pedal edema resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G&amp;gt;A) in &lt;i&gt;vascular endothelial growth factor receptor signaling pathway&lt;/i&gt;.">
    <entity charOffset="44-53" id="s904.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="170-231" id="s904.e1" ontology_id="GO_0048010" text="vascular endothelial growth factor receptor signaling pathway" type="GO"/>
    <pair e1="s904.e0" e2="s904.e1" id="s904.p0" relation="false"/>
  </sentence>
  <sentence id="s905" text="Through Sanger sequencing of a proband with bilateral congenital pedal edema resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G&amp;gt;A) in &lt;i&gt;vascular endothelial growth factor receptor signaling pathway&lt;/i&gt;.">
    <entity charOffset="71-76" id="s905.e0" ontology_id="HP_0000969" text="edema" type="HP"/>
    <entity charOffset="170-231" id="s905.e1" ontology_id="GO_0048010" text="vascular endothelial growth factor receptor signaling pathway" type="GO"/>
    <pair e1="s905.e0" e2="s905.e1" id="s905.p0" relation="true"/>
  </sentence>
  <sentence id="s906" text="Here, the authors use multi-region sequencing in patient samples to analyse multicellular organism development clonal architecture and heterogeneity, providing novel insight into multiple myeloma progression and evolution">
    <entity charOffset="76-110" id="s906.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="135-148" id="s906.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s906.e0" e2="s906.e1" id="s906.p0" relation="false"/>
  </sentence>
  <sentence id="s907" text="However, the role of neural tube closure in tumor biology remains poorly studied.">
    <entity charOffset="21-40" id="s907.e0" ontology_id="GO_0001843" text="neural tube closure" type="GO"/>
    <entity charOffset="44-49" id="s907.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s907.e0" e2="s907.e1" id="s907.p0" relation="false"/>
  </sentence>
  <sentence id="s908" text="Our purpose of this study is to discover the physiological effects and mechanism of neural tube closure in non-small-cell lung cancer (NSCLC) in vitro.">
    <entity charOffset="84-103" id="s908.e0" ontology_id="GO_0001843" text="neural tube closure" type="GO"/>
    <entity charOffset="127-133" id="s908.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s908.e0" e2="s908.e1" id="s908.p0" relation="false"/>
  </sentence>
  <sentence id="s909" text="The Wnt/beta-catenin pathway can be activated in both benign and malignant tumors by &lt;i&gt;CTNNB1&lt;/i&gt; mutations and by &lt;i&gt;ZNRF3&lt;/i&gt; inactivation in adrenal cancer (acetyl-CoA metabolic process).">
    <entity charOffset="75-81" id="s909.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="161-189" id="s909.e1" ontology_id="GO_0006084" text="acetyl-CoA metabolic process" type="GO"/>
    <pair e1="s909.e0" e2="s909.e1" id="s909.p0" relation="false"/>
  </sentence>
  <sentence id="s910" text="The Wnt/beta-catenin pathway can be activated in both benign and malignant tumors by &lt;i&gt;CTNNB1&lt;/i&gt; mutations and by &lt;i&gt;ZNRF3&lt;/i&gt; inactivation in adrenal cancer (acetyl-CoA metabolic process).">
    <entity charOffset="153-159" id="s910.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-189" id="s910.e1" ontology_id="GO_0006084" text="acetyl-CoA metabolic process" type="GO"/>
    <pair e1="s910.e0" e2="s910.e1" id="s910.p0" relation="false"/>
  </sentence>
  <sentence id="s911" text="Recently, the roles of positive regulation of cell migration in tumorigenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in hepatocellular carcinoma (phosphatidylinositol phosphorylation) have been reported.">
    <entity charOffset="23-60" id="s911.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="199-223" id="s911.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s911.e0" e2="s911.e1" id="s911.p0" relation="false"/>
  </sentence>
  <sentence id="s912" text="Recently, the roles of positive regulation of cell migration in tumorigenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in hepatocellular carcinoma (phosphatidylinositol phosphorylation) have been reported.">
    <entity charOffset="23-60" id="s912.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="64-69" id="s912.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s912.e0" e2="s912.e1" id="s912.p0" relation="false"/>
  </sentence>
  <sentence id="s913" text="Recently, the roles of positive regulation of cell migration in tumorigenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in hepatocellular carcinoma (phosphatidylinositol phosphorylation) have been reported.">
    <entity charOffset="64-69" id="s913.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="225-261" id="s913.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s913.e0" e2="s913.e1" id="s913.p0" relation="false"/>
  </sentence>
  <sentence id="s914" text="Recently, the roles of positive regulation of cell migration in tumorigenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in hepatocellular carcinoma (phosphatidylinositol phosphorylation) have been reported.">
    <entity charOffset="138-195" id="s914.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="199-223" id="s914.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s914.e0" e2="s914.e1" id="s914.p0" relation="false"/>
  </sentence>
  <sentence id="s915" text="Recently, the roles of positive regulation of cell migration in tumorigenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in hepatocellular carcinoma (phosphatidylinositol phosphorylation) have been reported.">
    <entity charOffset="199-223" id="s915.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="225-261" id="s915.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s915.e0" e2="s915.e1" id="s915.p0" relation="false"/>
  </sentence>
  <sentence id="s916" text="The expression of positive regulation of cell migration is elevated in liver cancer cells, and nuclear expression of FAM83H predicted shorter survival of phosphatidylinositol phosphorylation patients.">
    <entity charOffset="18-55" id="s916.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="77-83" id="s916.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s916.e0" e2="s916.e1" id="s916.p0" relation="false"/>
  </sentence>
  <sentence id="s917" text="The expression of positive regulation of cell migration is elevated in liver cancer cells, and nuclear expression of FAM83H predicted shorter survival of phosphatidylinositol phosphorylation patients.">
    <entity charOffset="77-83" id="s917.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="154-190" id="s917.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s917.e0" e2="s917.e1" id="s917.p0" relation="false"/>
  </sentence>
  <sentence id="s918" text="In hepatic tumor cells derived from Tet-O-negative regulation of transcription by RNA polymerase II mice, the expression of mRNA and protein of positive regulation of cell migration were dependent on MYC expression.">
    <entity charOffset="11-16" id="s918.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="144-181" id="s918.e1" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <pair e1="s918.e0" e2="s918.e1" id="s918.p0" relation="false"/>
  </sentence>
  <sentence id="s919" text="In hepatic tumor cells derived from Tet-O-negative regulation of transcription by RNA polymerase II mice, the expression of mRNA and protein of positive regulation of cell migration were dependent on MYC expression.">
    <entity charOffset="11-16" id="s919.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="42-99" id="s919.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s919.e0" e2="s919.e1" id="s919.p0" relation="true"/>
  </sentence>
  <sentence id="s920" text="In conclusion, we present an oncogenic role of positive regulation of cell migration in liver cancer, which is closely associated with the oncogene MYC.">
    <entity charOffset="47-84" id="s920.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="94-100" id="s920.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s920.e0" e2="s920.e1" id="s920.p0" relation="false"/>
  </sentence>
  <sentence id="s921" text="Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in mitochondrial proton-transporting ATP synthase complex assembly and intracellular cholesterol transport defect">
    <entity charOffset="148-162" id="s921.e0" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <entity charOffset="243-306" id="s921.e1" ontology_id="GO_0033615" text="mitochondrial proton-transporting ATP synthase complex assembly" type="GO"/>
    <pair e1="s921.e0" e2="s921.e1" id="s921.p0" relation="true"/>
  </sentence>
  <sentence id="s922" text="Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in mitochondrial proton-transporting ATP synthase complex assembly and intracellular cholesterol transport defect">
    <entity charOffset="148-162" id="s922.e0" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <entity charOffset="311-346" id="s922.e1" ontology_id="GO_0032367" text="intracellular cholesterol transport" type="GO"/>
    <pair e1="s922.e0" e2="s922.e1" id="s922.p0" relation="true"/>
  </sentence>
  <sentence id="s923" text="miR498 overexpression induced cell cycle arrest and apoptosis while it suppressed epithelialmesenchymal transition (cytokine production) in liver cancer cells.">
    <entity charOffset="118-137" id="s923.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="148-154" id="s923.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s923.e0" e2="s923.e1" id="s923.p0" relation="true"/>
  </sentence>
  <sentence id="s924" text="Furthermore, negative regulation of transcription by RNA polymerase II knockdown recapitulated the inhibitory effects of miR498 overexpression in liver cancer cells.">
    <entity charOffset="13-70" id="s924.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="153-159" id="s924.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s924.e0" e2="s924.e1" id="s924.p0" relation="false"/>
  </sentence>
  <sentence id="s925" text="Thus, we demonstrated that miR498 suppresses the growth and metastasis of liver cancer cells, partly at least, by directly targeting negative regulation of transcription by RNA polymerase II, suggesting that miR498 may serve as a potential biomarker for the diagnosis and therapy of liver cancer">
    <entity charOffset="81-87" id="s925.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-191" id="s925.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s925.e0" e2="s925.e1" id="s925.p0" relation="false"/>
  </sentence>
  <sentence id="s926" text="We focused on the tumor necrosis factor (negative regulation of transcription by RNA polymerase II) pathway and revealed upregulation of genes related to nuclear factor kappa B (NF-B) signaling and senescence-associated secretory phenotype factors.">
    <entity charOffset="18-23" id="s926.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="41-98" id="s926.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s926.e0" e2="s926.e1" id="s926.p0" relation="false"/>
  </sentence>
  <sentence id="s927" text="Both patients presented the negative regulation of lipopolysaccharide-mediated signaling pathway features of the disease including microcephaly, congenital cataract and postnatal growth failure.">
    <entity charOffset="28-96" id="s927.e0" ontology_id="GO_0031665" text="negative regulation of lipopolysaccharide-mediated signaling pathway" type="GO"/>
    <entity charOffset="131-143" id="s927.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s927.e0" e2="s927.e1" id="s927.p0" relation="false"/>
  </sentence>
  <sentence id="s928" text="Both patients presented the negative regulation of lipopolysaccharide-mediated signaling pathway features of the disease including microcephaly, congenital cataract and postnatal growth failure.">
    <entity charOffset="28-96" id="s928.e0" ontology_id="GO_0031665" text="negative regulation of lipopolysaccharide-mediated signaling pathway" type="GO"/>
    <entity charOffset="156-164" id="s928.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s928.e0" e2="s928.e1" id="s928.p0" relation="false"/>
  </sentence>
  <sentence id="s929" text="Both patients presented the negative regulation of lipopolysaccharide-mediated signaling pathway features of the disease including microcephaly, congenital cataract and postnatal growth failure.">
    <entity charOffset="28-96" id="s929.e0" ontology_id="GO_0031665" text="negative regulation of lipopolysaccharide-mediated signaling pathway" type="GO"/>
    <entity charOffset="169-193" id="s929.e1" ontology_id="HP_0008897" text="postnatal growth failure" type="HP"/>
    <pair e1="s929.e0" e2="s929.e1" id="s929.p0" relation="false"/>
  </sentence>
  <sentence id="s930" text="Structural, biophysical, and mutagenesis analyses revealed that cancer-associated mutations disrupt the muscle contraction68-SRP72 interaction and their co-localization with ER in mammalian cells.">
    <entity charOffset="64-70" id="s930.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-122" id="s930.e1" ontology_id="GO_0006936" text="muscle contraction" type="GO"/>
    <pair e1="s930.e0" e2="s930.e1" id="s930.p0" relation="false"/>
  </sentence>
  <sentence id="s931" text="These inhibitors, coupled with targeted knockdown of smoothened signaling pathway and protein lipidation, reveal the essential functions of fatty acylation of secreted morphogens in a wide variety of human tumors">
    <entity charOffset="53-81" id="s931.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="206-211" id="s931.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s931.e0" e2="s931.e1" id="s931.p0" relation="false"/>
  </sentence>
  <sentence id="s932" text="These inhibitors, coupled with targeted knockdown of smoothened signaling pathway and protein lipidation, reveal the essential functions of fatty acylation of secreted morphogens in a wide variety of human tumors">
    <entity charOffset="86-104" id="s932.e0" ontology_id="GO_0006497" text="protein lipidation" type="GO"/>
    <entity charOffset="206-211" id="s932.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s932.e0" e2="s932.e1" id="s932.p0" relation="true"/>
  </sentence>
  <sentence id="s933" text="protein ubiquitination is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory ataxia (ADSA), a disease characterized by neurodegeneration in the posterior columns of the spinal cord.">
    <entity charOffset="0-22" id="s933.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="278-284" id="s933.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s933.e0" e2="s933.e1" id="s933.p0" relation="false"/>
  </sentence>
  <sentence id="s934" text="Six syndromes of familial hyperparathyroidism are compared: 1) Familial hypocalciuric hypercalcemia (detection of calcium ion) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.">
    <entity charOffset="26-45" id="s934.e0" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <entity charOffset="101-125" id="s934.e1" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <pair e1="s934.e0" e2="s934.e1" id="s934.p0" relation="true"/>
  </sentence>
  <sentence id="s935" text="Six syndromes of familial hyperparathyroidism are compared: 1) Familial hypocalciuric hypercalcemia (detection of calcium ion) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.">
    <entity charOffset="86-99" id="s935.e0" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <entity charOffset="101-125" id="s935.e1" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <pair e1="s935.e0" e2="s935.e1" id="s935.p0" relation="true"/>
  </sentence>
  <sentence id="s936" text="It usually reflects biallelic inactivation of the &lt;i&gt;CASR.&lt;/i&gt; 3) Multiple endocrine neoplasia type 1 (negative regulation of transcription by RNA polymerase II) is most frequently expressed as PHPT with asymmetric enlargement of 3-4 parathyroids.">
    <entity charOffset="85-94" id="s936.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="103-160" id="s936.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s936.e0" e2="s936.e1" id="s936.p0" relation="true"/>
  </sentence>
  <sentence id="s937" text="4) Multiple endocrine neoplasia muscle organ development 2A from &lt;i&gt;RET&lt;/i&gt; activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.">
    <entity charOffset="22-31" id="s937.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="32-56" id="s937.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s937.e0" e2="s937.e1" id="s937.p0" relation="false"/>
  </sentence>
  <sentence id="s938" text="4) Multiple endocrine neoplasia muscle organ development 2A from &lt;i&gt;RET&lt;/i&gt; activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.">
    <entity charOffset="32-56" id="s938.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="124-143" id="s938.e1" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <pair e1="s938.e0" e2="s938.e1" id="s938.p0" relation="false"/>
  </sentence>
  <sentence id="s939" text="4) Multiple endocrine neoplasia muscle organ development 2A from &lt;i&gt;RET&lt;/i&gt; activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.">
    <entity charOffset="32-56" id="s939.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="171-177" id="s939.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s939.e0" e2="s939.e1" id="s939.p0" relation="false"/>
  </sentence>
  <sentence id="s940" text="4) Multiple endocrine neoplasia muscle organ development 2A from &lt;i&gt;RET&lt;/i&gt; activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.">
    <entity charOffset="32-56" id="s940.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="182-198" id="s940.e1" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <pair e1="s940.e0" e2="s940.e1" id="s940.p0" relation="false"/>
  </sentence>
  <sentence id="s941" text="Five of the PHPT syndromes reflect overgrowth of parathyroid tissue; in contrast, familial hypocalciuric hypercalcemia reflects dysregulation of negative regulation of transcription by RNA polymerase II secretion with little or no parathyroid overgrowth.">
    <entity charOffset="105-118" id="s941.e0" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <entity charOffset="145-202" id="s941.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s941.e0" e2="s941.e1" id="s941.p0" relation="false"/>
  </sentence>
  <sentence id="s942" text="intermediate filament bundle assembly and desmosome assembly immunoreactivity was inversely correlated with tumor histological grade and was observed only in tumors that did not metastasize.">
    <entity charOffset="0-37" id="s942.e0" ontology_id="GO_0045110" text="intermediate filament bundle assembly" type="GO"/>
    <entity charOffset="108-113" id="s942.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s942.e0" e2="s942.e1" id="s942.p0" relation="false"/>
  </sentence>
  <sentence id="s943" text="intermediate filament bundle assembly and desmosome assembly immunoreactivity was inversely correlated with tumor histological grade and was observed only in tumors that did not metastasize.">
    <entity charOffset="42-60" id="s943.e0" ontology_id="GO_0002159" text="desmosome assembly" type="GO"/>
    <entity charOffset="108-113" id="s943.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s943.e0" e2="s943.e1" id="s943.p0" relation="false"/>
  </sentence>
  <sentence id="s944" text="Interestingly, patients with tumors in which intermediate filament bundle assembly and desmosome assembly immunoreactivity was reduced or absent exhibited local recurrences or metastases, or both, as well as poor survival.">
    <entity charOffset="29-34" id="s944.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="45-82" id="s944.e1" ontology_id="GO_0045110" text="intermediate filament bundle assembly" type="GO"/>
    <pair e1="s944.e0" e2="s944.e1" id="s944.p0" relation="false"/>
  </sentence>
  <sentence id="s945" text="Interestingly, patients with tumors in which intermediate filament bundle assembly and desmosome assembly immunoreactivity was reduced or absent exhibited local recurrences or metastases, or both, as well as poor survival.">
    <entity charOffset="29-34" id="s945.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="87-105" id="s945.e1" ontology_id="GO_0002159" text="desmosome assembly" type="GO"/>
    <pair e1="s945.e0" e2="s945.e1" id="s945.p0" relation="false"/>
  </sentence>
  <sentence id="s946" text="Although the 4 PKPs displayed different levels and patterns of subcellular distribution in tumors, there was a positive correlation between immunoreactivity for PKP2 and desmosome assembly, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.">
    <entity charOffset="91-96" id="s946.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="170-188" id="s946.e1" ontology_id="GO_0002159" text="desmosome assembly" type="GO"/>
    <pair e1="s946.e0" e2="s946.e1" id="s946.p0" relation="false"/>
  </sentence>
  <sentence id="s947" text="Plant homeo domain finger protein 8 (histone H3-K9 demethylation), as an oncogene, has been highlighted in cancer development and progression.">
    <entity charOffset="37-64" id="s947.e0" ontology_id="GO_0033169" text="histone H3-K9 demethylation" type="GO"/>
    <entity charOffset="107-113" id="s947.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s947.e0" e2="s947.e1" id="s947.p0" relation="false"/>
  </sentence>
  <sentence id="s948" text="The results demonstrated that the expression of histone H3-K9 demethylation was significantly increased in tumor tissues from patients with CRC and was correlated with tumornodemetastasis stage.">
    <entity charOffset="48-75" id="s948.e0" ontology_id="GO_0033169" text="histone H3-K9 demethylation" type="GO"/>
    <entity charOffset="107-112" id="s948.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s948.e0" e2="s948.e1" id="s948.p0" relation="false"/>
  </sentence>
  <sentence id="s949" text="Invitro and invivo experiments revealed that histone H3-K9 demethylation accelerated cancer cell growth and migration, confirming the oncogenic role of PHF8 in human CRC.">
    <entity charOffset="47-74" id="s949.e0" ontology_id="GO_0033169" text="histone H3-K9 demethylation" type="GO"/>
    <entity charOffset="87-93" id="s949.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s949.e0" e2="s949.e1" id="s949.p0" relation="false"/>
  </sentence>
  <sentence id="s950" text="While a distinct negative regulation of transcription, DNA-templated of processes drive metastasis when compared to tumorigenesis, it is yet unclear if genetic alterations in metabolic pathways are associated with metastatic progression of human cancers.">
    <entity charOffset="17-68" id="s950.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="246-252" id="s950.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s950.e0" e2="s950.e1" id="s950.p0" relation="false"/>
  </sentence>
  <sentence id="s951" text="Here, we analyzed the mutation, copy number variation and gene expression patterns of a literature-derived model of metabolic genes associated with glycolysis (Warburg effect), fatty acid metabolism (lipogenesis, oxidation, lipolysis, esterification) and fatty acid uptake in &amp;gt;9000 primary or metastatic tumor samples from the multi-cancer TCGA datanegative regulation of transcription, DNA-templateds.">
    <entity charOffset="307-312" id="s951.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="352-403" id="s951.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s951.e0" e2="s951.e1" id="s951.p0" relation="false"/>
  </sentence>
  <sentence id="s952" text="Here, we analyzed the mutation, copy number variation and gene expression patterns of a literature-derived model of metabolic genes associated with glycolysis (Warburg effect), fatty acid metabolism (lipogenesis, oxidation, lipolysis, esterification) and fatty acid uptake in &amp;gt;9000 primary or metastatic tumor samples from the multi-cancer TCGA datanegative regulation of transcription, DNA-templateds.">
    <entity charOffset="336-342" id="s952.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="352-403" id="s952.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s952.e0" e2="s952.e1" id="s952.p0" relation="false"/>
  </sentence>
  <sentence id="s953" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene eye development, fatty acid uptake (response to bacterium, CD36) and lipogenesis (PPARA, PPARD, positive regulation of cell proliferation) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s953.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="193-208" id="s953.e1" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <pair e1="s953.e0" e2="s953.e1" id="s953.p0" relation="false"/>
  </sentence>
  <sentence id="s954" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene eye development, fatty acid uptake (response to bacterium, CD36) and lipogenesis (PPARA, PPARD, positive regulation of cell proliferation) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s954.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="229-250" id="s954.e1" ontology_id="GO_0009617" text="response to bacterium" type="GO"/>
    <pair e1="s954.e0" e2="s954.e1" id="s954.p0" relation="false"/>
  </sentence>
  <sentence id="s955" text="Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene eye development, fatty acid uptake (response to bacterium, CD36) and lipogenesis (PPARA, PPARD, positive regulation of cell proliferation) genes were enriched in metastatic tumors.">
    <entity charOffset="113-118" id="s955.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="289-330" id="s955.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s955.e0" e2="s955.e1" id="s955.p0" relation="false"/>
  </sentence>
  <sentence id="s956" text="Using gene expression profiles, we established a gene-signature (response to bacterium, CD36, positive regulation of cell proliferation, fatty acid beta-oxidation, monoterpenoid metabolic process) that strongly associated with epithelial-mesenchymal program across multiple cancers.">
    <entity charOffset="65-86" id="s956.e0" ontology_id="GO_0009617" text="response to bacterium" type="GO"/>
    <entity charOffset="274-280" id="s956.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s956.e0" e2="s956.e1" id="s956.p0" relation="false"/>
  </sentence>
  <sentence id="s957" text="Using gene expression profiles, we established a gene-signature (response to bacterium, CD36, positive regulation of cell proliferation, fatty acid beta-oxidation, monoterpenoid metabolic process) that strongly associated with epithelial-mesenchymal program across multiple cancers.">
    <entity charOffset="94-135" id="s957.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="274-280" id="s957.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s957.e0" e2="s957.e1" id="s957.p0" relation="false"/>
  </sentence>
  <sentence id="s958" text="Using gene expression profiles, we established a gene-signature (response to bacterium, CD36, positive regulation of cell proliferation, fatty acid beta-oxidation, monoterpenoid metabolic process) that strongly associated with epithelial-mesenchymal program across multiple cancers.">
    <entity charOffset="137-162" id="s958.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="274-280" id="s958.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s958.e0" e2="s958.e1" id="s958.p0" relation="false"/>
  </sentence>
  <sentence id="s959" text="Using gene expression profiles, we established a gene-signature (response to bacterium, CD36, positive regulation of cell proliferation, fatty acid beta-oxidation, monoterpenoid metabolic process) that strongly associated with epithelial-mesenchymal program across multiple cancers.">
    <entity charOffset="164-195" id="s959.e0" ontology_id="GO_0016098" text="monoterpenoid metabolic process" type="GO"/>
    <entity charOffset="274-280" id="s959.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s959.e0" e2="s959.e1" id="s959.p0" relation="false"/>
  </sentence>
  <sentence id="s960" text="Prospective outcome data on risk-reducing salpingectomy and delayed-oophorectomy for preventing ovarian cancer is lacking, and hence, this is chloride transport offered for primary prevention within the context and safe environment of a clinical trial.">
    <entity charOffset="104-110" id="s960.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="142-160" id="s960.e1" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <pair e1="s960.e0" e2="s960.e1" id="s960.p0" relation="false"/>
  </sentence>
  <sentence id="s961" text="This includes unaffected women who have completed their family and have DNA repair, RAD51D, or mitochondrial translational elongation gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.">
    <entity charOffset="72-82" id="s961.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="215-221" id="s961.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s961.e0" e2="s961.e1" id="s961.p0" relation="true"/>
  </sentence>
  <sentence id="s962" text="This includes unaffected women who have completed their family and have DNA repair, RAD51D, or mitochondrial translational elongation gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.">
    <entity charOffset="95-133" id="s962.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="215-221" id="s962.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s962.e0" e2="s962.e1" id="s962.p0" relation="false"/>
  </sentence>
  <sentence id="s963" text="In those with double-strand break repair via homologous recombination, DNA repair/strand invasion/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.">
    <entity charOffset="14-69" id="s963.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="166-172" id="s963.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s963.e0" e2="s963.e1" id="s963.p0" relation="true"/>
  </sentence>
  <sentence id="s964" text="In those with double-strand break repair via homologous recombination, DNA repair/strand invasion/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.">
    <entity charOffset="71-81" id="s964.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="166-172" id="s964.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s964.e0" e2="s964.e1" id="s964.p0" relation="true"/>
  </sentence>
  <sentence id="s965" text="In those with double-strand break repair via homologous recombination, DNA repair/strand invasion/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.">
    <entity charOffset="82-97" id="s965.e0" ontology_id="GO_0042148" text="strand invasion" type="GO"/>
    <entity charOffset="166-172" id="s965.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s965.e0" e2="s965.e1" id="s965.p0" relation="true"/>
  </sentence>
  <sentence id="s966" text="Arp2/3 complex-mediated actin nucleation mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).">
    <entity charOffset="0-40" id="s966.e0" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <entity charOffset="239-253" id="s966.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s966.e0" e2="s966.e1" id="s966.p0" relation="true"/>
  </sentence>
  <sentence id="s967" text="Arp2/3 complex-mediated actin nucleation mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).">
    <entity charOffset="0-40" id="s967.e0" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <entity charOffset="318-341" id="s967.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s967.e0" e2="s967.e1" id="s967.p0" relation="true"/>
  </sentence>
  <sentence id="s968" text="Our results indicate that Arp2/3 complex-mediated actin nucleation mutations cause multiple congenital anomalies and intellectual disability accompanied by arthrogryposis multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable">
    <entity charOffset="26-66" id="s968.e0" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <entity charOffset="156-170" id="s968.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s968.e0" e2="s968.e1" id="s968.p0" relation="true"/>
  </sentence>
  <sentence id="s969" text="Moreover, we demonstrated that positive regulation of transcription by RNA polymerase II and positive regulation of transcription, DNA-templated expression is downregulated in ECs within tumors by soluble factors enriched in the tumor microenvironment.">
    <entity charOffset="31-88" id="s969.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="187-192" id="s969.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s969.e0" e2="s969.e1" id="s969.p0" relation="false"/>
  </sentence>
  <sentence id="s970" text="Moreover, we demonstrated that positive regulation of transcription by RNA polymerase II and positive regulation of transcription, DNA-templated expression is downregulated in ECs within tumors by soluble factors enriched in the tumor microenvironment.">
    <entity charOffset="93-144" id="s970.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="187-192" id="s970.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s970.e0" e2="s970.e1" id="s970.p0" relation="false"/>
  </sentence>
  <sentence id="s971" text="The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (microtubule-based process) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.">
    <entity charOffset="62-75" id="s971.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="131-156" id="s971.e1" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <pair e1="s971.e0" e2="s971.e1" id="s971.p0" relation="false"/>
  </sentence>
  <sentence id="s972" text="The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (microtubule-based process) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.">
    <entity charOffset="131-156" id="s972.e0" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <entity charOffset="255-266" id="s972.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s972.e0" e2="s972.e1" id="s972.p0" relation="false"/>
  </sentence>
  <sentence id="s973" text="The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (microtubule-based process) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.">
    <entity charOffset="131-156" id="s973.e0" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <entity charOffset="276-291" id="s973.e1" ontology_id="HP_0000602" text="ophthalmoplegia" type="HP"/>
    <pair e1="s973.e0" e2="s973.e1" id="s973.p0" relation="false"/>
  </sentence>
  <sentence id="s974" text="The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (microtubule-based process) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.">
    <entity charOffset="131-156" id="s974.e0" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <entity charOffset="293-299" id="s974.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s974.e0" e2="s974.e1" id="s974.p0" relation="true"/>
  </sentence>
  <sentence id="s975" text="The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (microtubule-based process) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.">
    <entity charOffset="131-156" id="s975.e0" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <entity charOffset="300-310" id="s975.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s975.e0" e2="s975.e1" id="s975.p0" relation="false"/>
  </sentence>
  <sentence id="s976" text="Although some causative genes have been identified, little progress has been made in identifying genes in which low-penetrance susceptibility variants occur in the majority of sporadic protein geranylgeranylation cases.">
    <entity charOffset="176-184" id="s976.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="185-212" id="s976.e1" ontology_id="GO_0018344" text="protein geranylgeranylation" type="GO"/>
    <pair e1="s976.e0" e2="s976.e1" id="s976.p0" relation="false"/>
  </sentence>
  <sentence id="s977" text="To identify common genetic variants associated with sporadic non-syndromic protein geranylgeranylation in Han Chinese populations, we performed a multistage genome-wide association study (GWAS) in a total of 4,225 CHM cases and 5,112 non-CHM controls.">
    <entity charOffset="52-60" id="s977.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="75-102" id="s977.e1" ontology_id="GO_0018344" text="protein geranylgeranylation" type="GO"/>
    <pair e1="s977.e0" e2="s977.e1" id="s977.p0" relation="false"/>
  </sentence>
  <sentence id="s978" text="Here we show that linc-NeD125, which we previously characterized as a neuronal-induced lncRNA, is significantly overexpressed in Group 4 medulloblastomas (G4 regulation of cell adhesion), the largest and least well characterized molecular MB subgroup.">
    <entity charOffset="137-153" id="s978.e0" ontology_id="HP_0002885" text="medulloblastomas" type="HP"/>
    <entity charOffset="158-185" id="s978.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s978.e0" e2="s978.e1" id="s978.p0" relation="false"/>
  </sentence>
  <sentence id="s979" text="Liposarcoma is an often positive regulation of cell-matrix adhesional cancer of fat cells.">
    <entity charOffset="24-67" id="s979.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="70-76" id="s979.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s979.e0" e2="s979.e1" id="s979.p0" relation="false"/>
  </sentence>
  <sentence id="s980" text="All DAKO epidermis development developed liposarcoma between 11 and 14 months of age.">
    <entity charOffset="9-30" id="s980.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="41-52" id="s980.e1" ontology_id="HP_0012034" text="liposarcoma" type="HP"/>
    <pair e1="s980.e0" e2="s980.e1" id="s980.p0" relation="false"/>
  </sentence>
  <sentence id="s981" text="Similar changes of negative regulation of cytokine production and G0S2 expression were present in a human liposarcoma database.">
    <entity charOffset="19-61" id="s981.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="106-117" id="s981.e1" ontology_id="HP_0012034" text="liposarcoma" type="HP"/>
    <pair e1="s981.e0" e2="s981.e1" id="s981.p0" relation="false"/>
  </sentence>
  <sentence id="s982" text="These results show that a previously-unknown, fully penetrant epistatic interaction between negative regulation of sequestering of triglyceride and lipid catabolic process can cause liposarcoma in mice.">
    <entity charOffset="92-143" id="s982.e0" ontology_id="GO_0010891" text="negative regulation of sequestering of triglyceride" type="GO"/>
    <entity charOffset="182-193" id="s982.e1" ontology_id="HP_0012034" text="liposarcoma" type="HP"/>
    <pair e1="s982.e0" e2="s982.e1" id="s982.p0" relation="false"/>
  </sentence>
  <sentence id="s983" text="These results show that a previously-unknown, fully penetrant epistatic interaction between negative regulation of sequestering of triglyceride and lipid catabolic process can cause liposarcoma in mice.">
    <entity charOffset="148-171" id="s983.e0" ontology_id="GO_0016042" text="lipid catabolic process" type="GO"/>
    <entity charOffset="182-193" id="s983.e1" ontology_id="HP_0012034" text="liposarcoma" type="HP"/>
    <pair e1="s983.e0" e2="s983.e1" id="s983.p0" relation="false"/>
  </sentence>
  <sentence id="s984" text="Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (neural crest cell fate specifications)-cellular response to platelet-derived growth factor stimulus been shown to contribute to disease recurrence.">
    <entity charOffset="79-84" id="s984.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="181-241" id="s984.e1" ontology_id="GO_0036120" text="cellular response to platelet-derived growth factor stimulus" type="GO"/>
    <pair e1="s984.e0" e2="s984.e1" id="s984.p0" relation="false"/>
  </sentence>
  <sentence id="s985" text="Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (neural crest cell fate specifications)-cellular response to platelet-derived growth factor stimulus been shown to contribute to disease recurrence.">
    <entity charOffset="79-84" id="s985.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="142-178" id="s985.e1" ontology_id="GO_0014036" text="neural crest cell fate specification" type="GO"/>
    <pair e1="s985.e0" e2="s985.e1" id="s985.p0" relation="false"/>
  </sentence>
  <sentence id="s986" text="Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (neural crest cell fate specifications)-cellular response to platelet-derived growth factor stimulus been shown to contribute to disease recurrence.">
    <entity charOffset="112-124" id="s986.e0" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <entity charOffset="181-241" id="s986.e1" ontology_id="GO_0036120" text="cellular response to platelet-derived growth factor stimulus" type="GO"/>
    <pair e1="s986.e0" e2="s986.e1" id="s986.p0" relation="false"/>
  </sentence>
  <sentence id="s987" text="Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (neural crest cell fate specifications)-cellular response to platelet-derived growth factor stimulus been shown to contribute to disease recurrence.">
    <entity charOffset="112-124" id="s987.e0" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <entity charOffset="142-178" id="s987.e1" ontology_id="GO_0014036" text="neural crest cell fate specification" type="GO"/>
    <pair e1="s987.e0" e2="s987.e1" id="s987.p0" relation="false"/>
  </sentence>
  <sentence id="s988" text="In summary, we identified novel immunogenic proteins, which frequently induce tumor-specific Tcell responses in GBM patients and were also detected in vitro in therapy-resistant quiescent, slow-cycling neural crest cell fate specifications.">
    <entity charOffset="78-83" id="s988.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="203-239" id="s988.e1" ontology_id="GO_0014036" text="neural crest cell fate specification" type="GO"/>
    <pair e1="s988.e0" e2="s988.e1" id="s988.p0" relation="false"/>
  </sentence>
  <sentence id="s989" text="The sideroblastic anemias are a heterogeneous group of inherited and acquiprotein phosphorylation disorders characterized by the presence of ring sideroblasts in the bone marrow.">
    <entity charOffset="32-45" id="s989.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="74-97" id="s989.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s989.e0" e2="s989.e1" id="s989.p0" relation="false"/>
  </sentence>
  <sentence id="s990" text="Refractory anemia with ring sideroblasts (arginyl-tRNA aminoacylation) is a myelodysplastic syndrome characterized mainly by anemia attributable to ineffective erythropoiesis.">
    <entity charOffset="42-69" id="s990.e0" ontology_id="GO_0006420" text="arginyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="148-174" id="s990.e1" ontology_id="HP_0010972" text="ineffective erythropoiesis" type="HP"/>
    <pair e1="s990.e0" e2="s990.e1" id="s990.p0" relation="false"/>
  </sentence>
  <sentence id="s991" text="Inhibitors of molecules of the transforming growth factor- superfamily have been shown recently to target ineffective erythropoiesis and ameliorate anemia both in animal models of myelodysplastic syndrome and in arginyl-tRNA aminoacylation patients.">
    <entity charOffset="107-133" id="s991.e0" ontology_id="HP_0010972" text="ineffective erythropoiesis" type="HP"/>
    <entity charOffset="213-240" id="s991.e1" ontology_id="GO_0006420" text="arginyl-tRNA aminoacylation" type="GO"/>
    <pair e1="s991.e0" e2="s991.e1" id="s991.p0" relation="false"/>
  </sentence>
  <sentence id="s992" text="MATERIAL AND METHODS Human neuroblastoma SH-SY5Y cells were treated for 24 h with increasing concentrations of aggregated A (5, 15, 25, and 45 mol) with or without the acetyl-CoA biosynthetic process1 siRNA pretreatment.">
    <entity charOffset="27-40" id="s992.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="175-206" id="s992.e1" ontology_id="GO_0006085" text="acetyl-CoA biosynthetic process" type="GO"/>
    <pair e1="s992.e0" e2="s992.e1" id="s992.p0" relation="false"/>
  </sentence>
  <sentence id="s993" text="After exclusive analysis of 10 common variations of three hearing loss-related genes, gap junction-mediated intercellular transport, mtDNA12srRNA and regulation of pH, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.">
    <entity charOffset="58-70" id="s993.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="86-131" id="s993.e1" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <pair e1="s993.e0" e2="s993.e1" id="s993.p0" relation="true"/>
  </sentence>
  <sentence id="s994" text="After exclusive analysis of 10 common variations of three hearing loss-related genes, gap junction-mediated intercellular transport, mtDNA12srRNA and regulation of pH, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.">
    <entity charOffset="58-70" id="s994.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="150-166" id="s994.e1" ontology_id="GO_0006885" text="regulation of pH" type="GO"/>
    <pair e1="s994.e0" e2="s994.e1" id="s994.p0" relation="true"/>
  </sentence>
  <sentence id="s995" text="Considering the pivotal role of negative regulation of transcription by RNA polymerase II signaling in the colon epithelium both physiologically and pathologically, the correlation between H19 and VDR signaling may have an important role in the development of colon cancer.">
    <entity charOffset="32-89" id="s995.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="266-272" id="s995.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s995.e0" e2="s995.e1" id="s995.p0" relation="false"/>
  </sentence>
  <sentence id="s996" text="Screening the regulation of fatty acid metabolic process gene in the patients as well as their unaffected family members revealed a functional single nucleotide variation, perfectly segregating in the patient's family in an autosomal recessive mode of inheritance.">
    <entity charOffset="14-56" id="s996.e0" ontology_id="GO_0019217" text="regulation of fatty acid metabolic process" type="GO"/>
    <entity charOffset="224-243" id="s996.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s996.e0" e2="s996.e1" id="s996.p0" relation="true"/>
  </sentence>
  <sentence id="s997" text="Screening the regulation of fatty acid metabolic process gene in the patients as well as their unaffected family members revealed a functional single nucleotide variation, perfectly segregating in the patient's family in an autosomal recessive mode of inheritance.">
    <entity charOffset="14-56" id="s997.e0" ontology_id="GO_0019217" text="regulation of fatty acid metabolic process" type="GO"/>
    <entity charOffset="244-263" id="s997.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s997.e0" e2="s997.e1" id="s997.p0" relation="false"/>
  </sentence>
  <sentence id="s998" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="6-39" id="s998.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="63-82" id="s998.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s998.e0" e2="s998.e1" id="s998.p0" relation="false"/>
  </sentence>
  <sentence id="s999" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="6-39" id="s999.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="83-101" id="s999.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s999.e0" e2="s999.e1" id="s999.p0" relation="false"/>
  </sentence>
  <sentence id="s1000" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="6-39" id="s1000.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="189-200" id="s1000.e1" ontology_id="HP_0009826" text="short limbs" type="HP"/>
    <pair e1="s1000.e0" e2="s1000.e1" id="s1000.p0" relation="false"/>
  </sentence>
  <sentence id="s1001" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="6-39" id="s1001.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="202-218" id="s1001.e1" ontology_id="HP_0002164" text="dysplastic nails" type="HP"/>
    <pair e1="s1001.e0" e2="s1001.e1" id="s1001.p0" relation="false"/>
  </sentence>
  <sentence id="s1002" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="6-39" id="s1002.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="220-248" id="s1002.e1" ontology_id="HP_0030680" text="cardiovascular malformations" type="HP"/>
    <pair e1="s1002.e0" e2="s1002.e1" id="s1002.p0" relation="false"/>
  </sentence>
  <sentence id="s1003" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="6-39" id="s1003.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="255-260" id="s1003.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s1003.e0" e2="s1003.e1" id="s1003.p0" relation="false"/>
  </sentence>
  <sentence id="s1004" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="6-39" id="s1004.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="261-272" id="s1004.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s1004.e0" e2="s1004.e1" id="s1004.p0" relation="false"/>
  </sentence>
  <sentence id="s1005" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="63-82" id="s1005.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="274-289" id="s1005.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s1005.e0" e2="s1005.e1" id="s1005.p0" relation="false"/>
  </sentence>
  <sentence id="s1006" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="189-200" id="s1006.e0" ontology_id="HP_0009826" text="short limbs" type="HP"/>
    <entity charOffset="274-289" id="s1006.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s1006.e0" e2="s1006.e1" id="s1006.p0" relation="false"/>
  </sentence>
  <sentence id="s1007" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="220-248" id="s1007.e0" ontology_id="HP_0030680" text="cardiovascular malformations" type="HP"/>
    <entity charOffset="274-289" id="s1007.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s1007.e0" e2="s1007.e1" id="s1007.p0" relation="false"/>
  </sentence>
  <sentence id="s1008" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="255-260" id="s1008.e0" ontology_id="HP_0025287" text="axial" type="HP"/>
    <entity charOffset="274-289" id="s1008.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s1008.e0" e2="s1008.e1" id="s1008.p0" relation="false"/>
  </sentence>
  <sentence id="s1009" text="Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.">
    <entity charOffset="261-272" id="s1009.e0" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <entity charOffset="274-289" id="s1009.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s1009.e0" e2="s1009.e1" id="s1009.p0" relation="false"/>
  </sentence>
  <sentence id="s1010" text="This study reports first case of variants in the genes causing endochondral bone growth syndrome and profound deafness in the same family">
    <entity charOffset="63-87" id="s1010.e0" ontology_id="GO_0003416" text="endochondral bone growth" type="GO"/>
    <entity charOffset="101-109" id="s1010.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s1010.e0" e2="s1010.e1" id="s1010.p0" relation="false"/>
  </sentence>
  <sentence id="s1011" text="This study reports first case of variants in the genes causing endochondral bone growth syndrome and profound deafness in the same family">
    <entity charOffset="63-87" id="s1011.e0" ontology_id="GO_0003416" text="endochondral bone growth" type="GO"/>
    <entity charOffset="110-118" id="s1011.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1011.e0" e2="s1011.e1" id="s1011.p0" relation="false"/>
  </sentence>
  <sentence id="s1012" text="Neurturin (neural crest cell migration) provides trophic support to neurons and is considered a therapeutic agent for neurodegenerative diseases, such as Parkinson's disease.">
    <entity charOffset="11-38" id="s1012.e0" ontology_id="GO_0001755" text="neural crest cell migration" type="GO"/>
    <entity charOffset="118-144" id="s1012.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1012.e0" e2="s1012.e1" id="s1012.p0" relation="false"/>
  </sentence>
  <sentence id="s1013" text="Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (CPS1) and N-acetylglutamate synthase (urea cycle) were recently reported to be risk factors for the development of hyperammonemia during valproic acid-based therapy.">
    <entity charOffset="106-116" id="s1013.e0" ontology_id="GO_0000050" text="urea cycle" type="GO"/>
    <entity charOffset="183-197" id="s1013.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s1013.e0" e2="s1013.e1" id="s1013.p0" relation="true"/>
  </sentence>
  <sentence id="s1014" text="This study aimed to examine the influence of patient characteristics, including polymorphisms in steroid biosynthetic process 4217C&amp;gt;A and urea cycle -3064C&amp;gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.">
    <entity charOffset="97-125" id="s1014.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="224-232" id="s1014.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1014.e0" e2="s1014.e1" id="s1014.p0" relation="false"/>
  </sentence>
  <sentence id="s1015" text="This study aimed to examine the influence of patient characteristics, including polymorphisms in steroid biosynthetic process 4217C&amp;gt;A and urea cycle -3064C&amp;gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.">
    <entity charOffset="97-125" id="s1015.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="187-201" id="s1015.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s1015.e0" e2="s1015.e1" id="s1015.p0" relation="false"/>
  </sentence>
  <sentence id="s1016" text="This study aimed to examine the influence of patient characteristics, including polymorphisms in steroid biosynthetic process 4217C&amp;gt;A and urea cycle -3064C&amp;gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.">
    <entity charOffset="141-151" id="s1016.e0" ontology_id="GO_0000050" text="urea cycle" type="GO"/>
    <entity charOffset="224-232" id="s1016.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1016.e0" e2="s1016.e1" id="s1016.p0" relation="true"/>
  </sentence>
  <sentence id="s1017" text="This study aimed to examine the influence of patient characteristics, including polymorphisms in steroid biosynthetic process 4217C&amp;gt;A and urea cycle -3064C&amp;gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.">
    <entity charOffset="141-151" id="s1017.e0" ontology_id="GO_0000050" text="urea cycle" type="GO"/>
    <entity charOffset="187-201" id="s1017.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s1017.e0" e2="s1017.e1" id="s1017.p0" relation="true"/>
  </sentence>
  <sentence id="s1018" text="With regard to the steroid biosynthetic process 4217C&amp;gt;A polymorphism, we did not observe a significant association with the development of hyperammonemia.">
    <entity charOffset="19-47" id="s1018.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="142-156" id="s1018.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s1018.e0" e2="s1018.e1" id="s1018.p0" relation="false"/>
  </sentence>
  <sentence id="s1019" text="ER to Golgi vesicle-mediated transport-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.">
    <entity charOffset="0-38" id="s1019.e0" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <entity charOffset="164-172" id="s1019.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1019.e0" e2="s1019.e1" id="s1019.p0" relation="false"/>
  </sentence>
  <sentence id="s1020" text="ER to Golgi vesicle-mediated transport-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.">
    <entity charOffset="0-38" id="s1020.e0" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <entity charOffset="183-195" id="s1020.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1020.e0" e2="s1020.e1" id="s1020.p0" relation="false"/>
  </sentence>
  <sentence id="s1021" text="The underlining mechanisms of dietary cholesterol and nonalcoholic steatohepatitis (NASH) in contributing to hepatocellular carcinoma (phosphatidylinositol phosphorylation) remain undefined.">
    <entity charOffset="109-133" id="s1021.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="135-171" id="s1021.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1021.e0" e2="s1021.e1" id="s1021.p0" relation="false"/>
  </sentence>
  <sentence id="s1022" text="Surgical tumor specimens were collected for immunohistochemical staining to evaluate biological_process-positive regulation of cell proliferation expression.">
    <entity charOffset="9-14" id="s1022.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="104-145" id="s1022.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1022.e0" e2="s1022.e1" id="s1022.p0" relation="true"/>
  </sentence>
  <sentence id="s1023" text="Surgical tumor specimens were collected for immunohistochemical staining to evaluate biological_process-positive regulation of cell proliferation expression.">
    <entity charOffset="9-14" id="s1023.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="85-103" id="s1023.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1023.e0" e2="s1023.e1" id="s1023.p0" relation="false"/>
  </sentence>
  <sentence id="s1024" text="Patients' baseline characteristics, including gender, age, tumor size, tumor location, tumor grading, clinical regulation of transcription by RNA polymerase III staging, tumor infiltrating lymphocytes, CA19-9 and chemotherapy treatment, along with the subsequent follow-up data, were documented and analyzed.">
    <entity charOffset="59-64" id="s1024.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="111-160" id="s1024.e1" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <pair e1="s1024.e0" e2="s1024.e1" id="s1024.p0" relation="false"/>
  </sentence>
  <sentence id="s1025" text="When co-cultured with T cells, pancreatic cancer PC cells with high biological_process-positive regulation of cell proliferation expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.">
    <entity charOffset="42-48" id="s1025.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-128" id="s1025.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1025.e0" e2="s1025.e1" id="s1025.p0" relation="true"/>
  </sentence>
  <sentence id="s1026" text="When co-cultured with T cells, pancreatic cancer PC cells with high biological_process-positive regulation of cell proliferation expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.">
    <entity charOffset="42-48" id="s1026.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="68-86" id="s1026.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1026.e0" e2="s1026.e1" id="s1026.p0" relation="false"/>
  </sentence>
  <sentence id="s1027" text="Of the 136 PDAC tumor tissues, 93 (68.38%) were strong and 43 (31.62%) were weak biological_process-positive regulation of cell proliferation expression.">
    <entity charOffset="16-21" id="s1027.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="100-141" id="s1027.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1027.e0" e2="s1027.e1" id="s1027.p0" relation="true"/>
  </sentence>
  <sentence id="s1028" text="Of the 136 PDAC tumor tissues, 93 (68.38%) were strong and 43 (31.62%) were weak biological_process-positive regulation of cell proliferation expression.">
    <entity charOffset="16-21" id="s1028.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="81-99" id="s1028.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1028.e0" e2="s1028.e1" id="s1028.p0" relation="false"/>
  </sentence>
  <sentence id="s1029" text="regulation of transcription by RNA polymerase III staging, tumor location and subsequent chemotherapy were also prognostic factors in these patients.">
    <entity charOffset="0-49" id="s1029.e0" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <entity charOffset="59-64" id="s1029.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1029.e0" e2="s1029.e1" id="s1029.p0" relation="false"/>
  </sentence>
  <sentence id="s1030" text="Recessive variants located in the ligand-binding domain (LBD) of NR2E3 cause enhanced short wavelength sensitive- (S-) cone syndrome (ESCS), a retinal degeneration characterized by an excess of S-cones and non-functional mitotic cell cycle checkpoints.">
    <entity charOffset="143-163" id="s1030.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="221-250" id="s1030.e1" ontology_id="GO_0007093" text="mitotic cell cycle checkpoint" type="GO"/>
    <pair e1="s1030.e0" e2="s1030.e1" id="s1030.p0" relation="false"/>
  </sentence>
  <sentence id="s1031" text="Eleven (79%) and five (36%) of fourteen keratinizing squamous cell carcinomas tested contained TP53 and G1/S transition of mitotic cell cycle mutations, respectively.">
    <entity charOffset="53-77" id="s1031.e0" ontology_id="HP_0002860" text="squamous cell carcinomas" type="HP"/>
    <entity charOffset="104-141" id="s1031.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s1031.e0" e2="s1031.e1" id="s1031.p0" relation="true"/>
  </sentence>
  <sentence id="s1032" text="The findings indicate that although phosphorylation mutations are found in &amp;lt;10% of vulvar squamous cell carcinomas, they may be specific for a particular pathway involving atypical verruciform lesions, which could function as either a direct precursor or a risk factor for vulvar squamous cell carcinoma.">
    <entity charOffset="36-51" id="s1032.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="93-117" id="s1032.e1" ontology_id="HP_0002860" text="squamous cell carcinomas" type="HP"/>
    <pair e1="s1032.e0" e2="s1032.e1" id="s1032.p0" relation="false"/>
  </sentence>
  <sentence id="s1033" text="The findings indicate that although phosphorylation mutations are found in &amp;lt;10% of vulvar squamous cell carcinomas, they may be specific for a particular pathway involving atypical verruciform lesions, which could function as either a direct precursor or a risk factor for vulvar squamous cell carcinoma.">
    <entity charOffset="36-51" id="s1033.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="283-306" id="s1033.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1033.e0" e2="s1033.e1" id="s1033.p0" relation="false"/>
  </sentence>
  <sentence id="s1034" text="Whether they function as direct precursors to a less common form of squamous cell carcinoma will require further study, but carcinomas associated with these lesions might warrant testing for phosphorylation mutations to address this question">
    <entity charOffset="68-91" id="s1034.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="191-206" id="s1034.e1" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <pair e1="s1034.e0" e2="s1034.e1" id="s1034.p0" relation="false"/>
  </sentence>
  <sentence id="s1035" text="Usher syndrome muscle organ development III (actin filament organization) is an autosomal recessive disorder caused by mutations in clarin-1 (actin filament organization) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="15-39" id="s1035.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="200-220" id="s1035.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1035.e0" e2="s1035.e1" id="s1035.p0" relation="false"/>
  </sentence>
  <sentence id="s1036" text="Usher syndrome muscle organ development III (actin filament organization) is an autosomal recessive disorder caused by mutations in clarin-1 (actin filament organization) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="45-72" id="s1036.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="200-220" id="s1036.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1036.e0" e2="s1036.e1" id="s1036.p0" relation="false"/>
  </sentence>
  <sentence id="s1037" text="Usher syndrome muscle organ development III (actin filament organization) is an autosomal recessive disorder caused by mutations in clarin-1 (actin filament organization) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="45-72" id="s1037.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="239-247" id="s1037.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1037.e0" e2="s1037.e1" id="s1037.p0" relation="true"/>
  </sentence>
  <sentence id="s1038" text="Usher syndrome muscle organ development III (actin filament organization) is an autosomal recessive disorder caused by mutations in clarin-1 (actin filament organization) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="142-169" id="s1038.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="200-220" id="s1038.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1038.e0" e2="s1038.e1" id="s1038.p0" relation="false"/>
  </sentence>
  <sentence id="s1039" text="Usher syndrome muscle organ development III (actin filament organization) is an autosomal recessive disorder caused by mutations in clarin-1 (actin filament organization) gene, leading to progressive retinal degeneration and sensorineural deafness.">
    <entity charOffset="142-169" id="s1039.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="239-247" id="s1039.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1039.e0" e2="s1039.e1" id="s1039.p0" relation="true"/>
  </sentence>
  <sentence id="s1040" text="Here, we report a reduction of histone deacetylase 3 (negative regulation of transcription by RNA polymerase II) protein amounts in eutopic endometrium of infertile women with endometriosis compared to a control group.">
    <entity charOffset="54-111" id="s1040.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="176-189" id="s1040.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1040.e0" e2="s1040.e1" id="s1040.p0" relation="false"/>
  </sentence>
  <sentence id="s1041" text="Reduction of &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; abrogated decidualization in a primary culture of human endometrial stromal cells (hESCs) similar to that observed in infertile patients with endometriosis.">
    <entity charOffset="16-73" id="s1041.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="220-233" id="s1041.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1041.e0" e2="s1041.e1" id="s1041.p0" relation="false"/>
  </sentence>
  <sentence id="s1042" text="Collectively, we found attenuation of negative regulation of transcription by RNA polymerase II and overexpression of collagen muscle organ development I in the eutopic endometrium of infertile patients with endometriosis.">
    <entity charOffset="38-95" id="s1042.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="208-221" id="s1042.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1042.e0" e2="s1042.e1" id="s1042.p0" relation="false"/>
  </sentence>
  <sentence id="s1043" text="Collectively, we found attenuation of negative regulation of transcription by RNA polymerase II and overexpression of collagen muscle organ development I in the eutopic endometrium of infertile patients with endometriosis.">
    <entity charOffset="127-151" id="s1043.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="208-221" id="s1043.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1043.e0" e2="s1043.e1" id="s1043.p0" relation="false"/>
  </sentence>
  <sentence id="s1044" text="Germline de novo truncating variants in monoubiquitinated histone H2A deubiquitination and transcription, DNA-templated have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features.">
    <entity charOffset="40-86" id="s1044.e0" ontology_id="GO_0035522" text="monoubiquitinated histone H2A deubiquitination" type="GO"/>
    <entity charOffset="259-282" id="s1044.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1044.e0" e2="s1044.e1" id="s1044.p0" relation="true"/>
  </sentence>
  <sentence id="s1045" text="Germline de novo truncating variants in monoubiquitinated histone H2A deubiquitination and transcription, DNA-templated have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features.">
    <entity charOffset="91-119" id="s1045.e0" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <entity charOffset="259-282" id="s1045.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1045.e0" e2="s1045.e1" id="s1045.p0" relation="true"/>
  </sentence>
  <sentence id="s1046" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the positive regulation of peroxisome proliferator activated receptor signaling pathway-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="118-201" id="s1046.e0" ontology_id="GO_0035360" text="positive regulation of peroxisome proliferator activated receptor signaling pathway" type="GO"/>
    <entity charOffset="267-279" id="s1046.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s1046.e0" e2="s1046.e1" id="s1046.p0" relation="true"/>
  </sentence>
  <sentence id="s1047" text="Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the positive regulation of peroxisome proliferator activated receptor signaling pathway-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.">
    <entity charOffset="118-201" id="s1047.e0" ontology_id="GO_0035360" text="positive regulation of peroxisome proliferator activated receptor signaling pathway" type="GO"/>
    <entity charOffset="350-375" id="s1047.e1" ontology_id="HP_0001249" text="intellectual disabilities" type="HP"/>
    <pair e1="s1047.e0" e2="s1047.e1" id="s1047.p0" relation="true"/>
  </sentence>
  <sentence id="s1048" text="Therefore, hypertrophic cardiomyopathy and tubulopathy may not be considered as constant features of mitochondrial translational elongation.">
    <entity charOffset="24-38" id="s1048.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="101-139" id="s1048.e1" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <pair e1="s1048.e0" e2="s1048.e1" id="s1048.p0" relation="true"/>
  </sentence>
  <sentence id="s1049" text="These changes were accompanied by cortical atrophy as well as increased expression of angiogenesis-related genes such as &lt;i&gt;Vegfa&lt;/i&gt;, &lt;i&gt;Serpine1&lt;/i&gt;, and &lt;i&gt;Plau&lt;/i&gt; in phagocytosis-positive endothelial cells.">
    <entity charOffset="34-50" id="s1049.e0" ontology_id="HP_0002120" text="cortical atrophy" type="HP"/>
    <entity charOffset="171-183" id="s1049.e1" ontology_id="GO_0006909" text="phagocytosis" type="GO"/>
    <pair e1="s1049.e0" e2="s1049.e1" id="s1049.p0" relation="false"/>
  </sentence>
  <sentence id="s1050" text="Moreover, overexpression of mutant but not normal biological_process in neuroblastoma cells caused rapid apoptosis.">
    <entity charOffset="50-68" id="s1050.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="72-85" id="s1050.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1050.e0" e2="s1050.e1" id="s1050.p0" relation="false"/>
  </sentence>
  <sentence id="s1051" text="postsynaptic actin cytoskeleton organization-osteoblast differentiation fusions have been reported as the pathognomonic genetic abnormality defining an unusual subset of actin-positive, perivascular myoid tumors, known as &amp;quot;pericytoma with the t(7;12) translocation.&amp;quot; In addition, GLI1 oncogenic activation through a related MALAT1-GLI1 gene fusion has been recently reported in 2 unrelated gastric tumors, namely plexiform fibromyxoma and gastroblastoma.">
    <entity charOffset="0-44" id="s1051.e0" ontology_id="GO_0098974" text="postsynaptic actin cytoskeleton organization" type="GO"/>
    <entity charOffset="205-211" id="s1051.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1051.e0" e2="s1051.e1" id="s1051.p0" relation="true"/>
  </sentence>
  <sentence id="s1052" text="postsynaptic actin cytoskeleton organization-osteoblast differentiation fusions have been reported as the pathognomonic genetic abnormality defining an unusual subset of actin-positive, perivascular myoid tumors, known as &amp;quot;pericytoma with the t(7;12) translocation.&amp;quot; In addition, GLI1 oncogenic activation through a related MALAT1-GLI1 gene fusion has been recently reported in 2 unrelated gastric tumors, namely plexiform fibromyxoma and gastroblastoma.">
    <entity charOffset="45-71" id="s1052.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="205-211" id="s1052.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1052.e0" e2="s1052.e1" id="s1052.p0" relation="true"/>
  </sentence>
  <sentence id="s1053" text="Our findings open new opportunities for targeted therapy, as tumors with GLI1 oncogenic activation, and subsequent positive regulation of cholesterol efflux overexpression, might be sensitive to sonic hedgehog pathway inhibitors">
    <entity charOffset="61-67" id="s1053.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="115-156" id="s1053.e1" ontology_id="GO_0010875" text="positive regulation of cholesterol efflux" type="GO"/>
    <pair e1="s1053.e0" e2="s1053.e1" id="s1053.p0" relation="true"/>
  </sentence>
  <sentence id="s1054" text="Only overexpression of lipid transport induced a reduction of brain proliferating cells and concomitant microcephaly.">
    <entity charOffset="23-38" id="s1054.e0" ontology_id="GO_0006869" text="lipid transport" type="GO"/>
    <entity charOffset="104-116" id="s1054.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1054.e0" e2="s1054.e1" id="s1054.p0" relation="false"/>
  </sentence>
  <sentence id="s1055" text="Moreover, oncogenic activation of negative regulation of transcription by RNA polymerase II and/or loss of a MYC antagonist, results in an imbalance in the activity of the network as a whole, leading to tumor initiation, progression and maintenance">
    <entity charOffset="34-91" id="s1055.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="203-208" id="s1055.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1055.e0" e2="s1055.e1" id="s1055.p0" relation="true"/>
  </sentence>
  <sentence id="s1056" text="As a result, 14 SNPs had a significant odds ratio (OR) for lung cancer risk with P FDR &amp;lt; 0.05, of which rs3115672 in biological_process (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in transcription by RNA polymerase II (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.9910(-11) and P combined = 5.4010(-10), respectively).">
    <entity charOffset="64-70" id="s1056.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="120-138" id="s1056.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1056.e0" e2="s1056.e1" id="s1056.p0" relation="false"/>
  </sentence>
  <sentence id="s1057" text="As a result, 14 SNPs had a significant odds ratio (OR) for lung cancer risk with P FDR &amp;lt; 0.05, of which rs3115672 in biological_process (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in transcription by RNA polymerase II (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.9910(-11) and P combined = 5.4010(-10), respectively).">
    <entity charOffset="64-70" id="s1057.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="190-224" id="s1057.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1057.e0" e2="s1057.e1" id="s1057.p0" relation="false"/>
  </sentence>
  <sentence id="s1058" text="We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (axon guidance) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.">
    <entity charOffset="70-76" id="s1058.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="92-105" id="s1058.e1" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <pair e1="s1058.e0" e2="s1058.e1" id="s1058.p0" relation="false"/>
  </sentence>
  <sentence id="s1059" text="We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (axon guidance) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.">
    <entity charOffset="92-105" id="s1059.e0" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <entity charOffset="116-128" id="s1059.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s1059.e0" e2="s1059.e1" id="s1059.p0" relation="false"/>
  </sentence>
  <sentence id="s1060" text="We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (axon guidance) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.">
    <entity charOffset="92-105" id="s1060.e0" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <entity charOffset="243-251" id="s1060.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1060.e0" e2="s1060.e1" id="s1060.p0" relation="true"/>
  </sentence>
  <sentence id="s1061" text="Taken together, these findings indicate that anti-axon guidance encephalitis may present as slowly progressive cognitive impairment mimicking dementia and that fluctuating MRI striatal lesions may be a characteristic radiological finding of this disorder">
    <entity charOffset="50-63" id="s1061.e0" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <entity charOffset="64-76" id="s1061.e1" ontology_id="HP_0002383" text="encephalitis" type="HP"/>
    <pair e1="s1061.e0" e2="s1061.e1" id="s1061.p0" relation="false"/>
  </sentence>
  <sentence id="s1062" text="Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question protein phosphorylation prolyl-tRNA aminoacylation, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.">
    <entity charOffset="51-63" id="s1062.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="104-127" id="s1062.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1062.e0" e2="s1062.e1" id="s1062.p0" relation="false"/>
  </sentence>
  <sentence id="s1063" text="Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question protein phosphorylation prolyl-tRNA aminoacylation, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.">
    <entity charOffset="65-89" id="s1063.e0" ontology_id="HP_0007628" text="small mandibular condyle" type="HP"/>
    <entity charOffset="104-127" id="s1063.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1063.e0" e2="s1063.e1" id="s1063.p0" relation="false"/>
  </sentence>
  <sentence id="s1064" text="Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question protein phosphorylation prolyl-tRNA aminoacylation, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.">
    <entity charOffset="65-89" id="s1064.e0" ontology_id="HP_0007628" text="small mandibular condyle" type="HP"/>
    <entity charOffset="128-154" id="s1064.e1" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <pair e1="s1064.e0" e2="s1064.e1" id="s1064.p0" relation="false"/>
  </sentence>
  <sentence id="s1065" text="In order to address these questions, we searched for alterations in PLCB4, GNAI3, and negative regulation of transcription by RNA polymerase II in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.">
    <entity charOffset="86-143" id="s1065.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="240-252" id="s1065.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s1065.e0" e2="s1065.e1" id="s1065.p0" relation="true"/>
  </sentence>
  <sentence id="s1066" text="Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.&lt;b&gt;Results:&lt;/b&gt; One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in &lt;i&gt;IDH1&lt;/i&gt; A variant in &lt;i&gt;aspartate catabolic process&lt;/i&gt;, c.357A&amp;gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.">
    <entity charOffset="137-143" id="s1066.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="239-266" id="s1066.e1" ontology_id="GO_0006533" text="aspartate catabolic process" type="GO"/>
    <pair e1="s1066.e0" e2="s1066.e1" id="s1066.p0" relation="false"/>
  </sentence>
  <sentence id="s1067" text="Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.&lt;b&gt;Results:&lt;/b&gt; One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in &lt;i&gt;IDH1&lt;/i&gt; A variant in &lt;i&gt;aspartate catabolic process&lt;/i&gt;, c.357A&amp;gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.">
    <entity charOffset="171-177" id="s1067.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="239-266" id="s1067.e1" ontology_id="GO_0006533" text="aspartate catabolic process" type="GO"/>
    <pair e1="s1067.e0" e2="s1067.e1" id="s1067.p0" relation="false"/>
  </sentence>
  <sentence id="s1068" text="Array methylation-based analysis uncovered a somatic epigenetic mutation in &lt;i&gt;choline catabolic processC&lt;/i&gt; in a patient with multiple pheochromocytomas and a gastrointestinal stromal tumor.">
    <entity charOffset="79-104" id="s1068.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="137-154" id="s1068.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s1068.e0" e2="s1068.e1" id="s1068.p0" relation="false"/>
  </sentence>
  <sentence id="s1069" text="Array methylation-based analysis uncovered a somatic epigenetic mutation in &lt;i&gt;choline catabolic processC&lt;/i&gt; in a patient with multiple pheochromocytomas and a gastrointestinal stromal tumor.">
    <entity charOffset="79-104" id="s1069.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="186-191" id="s1069.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1069.e0" e2="s1069.e1" id="s1069.p0" relation="false"/>
  </sentence>
  <sentence id="s1070" text="As proof of concept, we applied CRAFT to epilepsy and predicted the tyrosine kinase receptor peptidyl-tyrosine phosphorylation as a potential therapeutic target.">
    <entity charOffset="41-49" id="s1070.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="93-126" id="s1070.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s1070.e0" e2="s1070.e1" id="s1070.p0" relation="false"/>
  </sentence>
  <sentence id="s1071" text="The predicted effect of peptidyl-tyrosine phosphorylation blockade in attenuating epilepsy seizures was validated in three pre-clinical models of epilepsy.">
    <entity charOffset="24-57" id="s1071.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="82-90" id="s1071.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1071.e0" e2="s1071.e1" id="s1071.p0" relation="false"/>
  </sentence>
  <sentence id="s1072" text="The predicted effect of peptidyl-tyrosine phosphorylation blockade in attenuating epilepsy seizures was validated in three pre-clinical models of epilepsy.">
    <entity charOffset="24-57" id="s1072.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="91-99" id="s1072.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1072.e0" e2="s1072.e1" id="s1072.p0" relation="false"/>
  </sentence>
  <sentence id="s1073" text="Recent studies have examined the intrinsic antitumor activity of melatonin in various cancers, including hepatocellular carcinoma (phosphatidylinositol phosphorylation), the primary life-threatening malignancy in both sexes in Taiwan.">
    <entity charOffset="105-129" id="s1073.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="131-167" id="s1073.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1073.e0" e2="s1073.e1" id="s1073.p0" relation="false"/>
  </sentence>
  <sentence id="s1074" text="Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH, OMIM 225790), also known as Fowler syndrome, is a rare autosomal recessive disorder, caused by mutations in transmembrane transport.">
    <entity charOffset="31-46" id="s1074.e0" ontology_id="HP_0002324" text="hydranencephaly" type="HP"/>
    <entity charOffset="184-207" id="s1074.e1" ontology_id="GO_0055085" text="transmembrane transport" type="GO"/>
    <pair e1="s1074.e0" e2="s1074.e1" id="s1074.p0" relation="true"/>
  </sentence>
  <sentence id="s1075" text="Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH, OMIM 225790), also known as Fowler syndrome, is a rare autosomal recessive disorder, caused by mutations in transmembrane transport.">
    <entity charOffset="47-59" id="s1075.e0" ontology_id="HP_0000238" text="hydrocephaly" type="HP"/>
    <entity charOffset="184-207" id="s1075.e1" ontology_id="GO_0055085" text="transmembrane transport" type="GO"/>
    <pair e1="s1075.e0" e2="s1075.e1" id="s1075.p0" relation="true"/>
  </sentence>
  <sentence id="s1076" text="Interestingly, the other branch of the original family was found to segregate anophthalmia/syndactyly with a novel homozygous eye development variant.">
    <entity charOffset="78-90" id="s1076.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="126-141" id="s1076.e1" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <pair e1="s1076.e0" e2="s1076.e1" id="s1076.p0" relation="true"/>
  </sentence>
  <sentence id="s1077" text="Interestingly, the other branch of the original family was found to segregate anophthalmia/syndactyly with a novel homozygous eye development variant.">
    <entity charOffset="91-101" id="s1077.e0" ontology_id="HP_0001159" text="syndactyly" type="HP"/>
    <entity charOffset="126-141" id="s1077.e1" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <pair e1="s1077.e0" e2="s1077.e1" id="s1077.p0" relation="true"/>
  </sentence>
  <sentence id="s1078" text="A branch-site mutation in the human gene encoding assembly factor mitochondrial respiratory chain complex I assembly has recently been associated with mitochondrial encephalopathy and complex I deficiency in seven independent cases.">
    <entity charOffset="66-116" id="s1078.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="165-179" id="s1078.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s1078.e0" e2="s1078.e1" id="s1078.p0" relation="false"/>
  </sentence>
  <sentence id="s1079" text="As a mitotic kinesin, kinesin family member 14 (positive regulation of cell proliferation) has been reported to serve oncogenic roles in a variety of malignancies; however, its functional role and regulatory mechanisms in colorectal cancer (CRC) remain unclear.">
    <entity charOffset="48-89" id="s1079.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="233-239" id="s1079.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1079.e0" e2="s1079.e1" id="s1079.p0" relation="false"/>
  </sentence>
  <sentence id="s1080" text="In the present study, positive regulation of cell proliferation was observed to be markedly overexpressed in CRC, and this upregulation was associated with tumor size and marker of proliferation regulation of proteasomal protein catabolic process-67 immunostaining scores.">
    <entity charOffset="22-63" id="s1080.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="156-161" id="s1080.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1080.e0" e2="s1080.e1" id="s1080.p0" relation="false"/>
  </sentence>
  <sentence id="s1081" text="In the present study, positive regulation of cell proliferation was observed to be markedly overexpressed in CRC, and this upregulation was associated with tumor size and marker of proliferation regulation of proteasomal protein catabolic process-67 immunostaining scores.">
    <entity charOffset="156-161" id="s1081.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="195-246" id="s1081.e1" ontology_id="GO_0061136" text="regulation of proteasomal protein catabolic process" type="GO"/>
    <pair e1="s1081.e0" e2="s1081.e1" id="s1081.p0" relation="false"/>
  </sentence>
  <sentence id="s1082" text="Collectively, the findings of the present study demonstrated the oncogenic role of positive regulation of cell proliferation in colorectal tumorigenesis, and also revealed a complexity of regulatory mechanisms mediating KIF14 overexpression, which may provide insight for developing novel treatments for patients with CRC">
    <entity charOffset="83-124" id="s1082.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="139-144" id="s1082.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1082.e0" e2="s1082.e1" id="s1082.p0" relation="false"/>
  </sentence>
  <sentence id="s1083" text="Common genetic variants contribute to the observed variation in breast cancer risk for mitotic cytokinesis mutation carriers; those known to date have all been found through population-based genome-wide association studies (GWAS).">
    <entity charOffset="71-77" id="s1083.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-106" id="s1083.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s1083.e0" e2="s1083.e1" id="s1083.p0" relation="true"/>
  </sentence>
  <sentence id="s1084" text="DNA samples from 3,881 breast cancer affected and 4,330 unaffected mitotic cytokinesis mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of BRCA1/2 were genotyped and available for analysis.">
    <entity charOffset="30-36" id="s1084.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-86" id="s1084.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s1084.e0" e2="s1084.e1" id="s1084.p0" relation="true"/>
  </sentence>
  <sentence id="s1085" text="We replicated previously reported breast cancer susceptibility alleles in these mitotic cytokinesis mutation carriers and for several regions (including FGFR2, cellular response to mechanical stimulus, CDKN2A/B, and skeletal system development) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="s1085.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="80-99" id="s1085.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s1085.e0" e2="s1085.e1" id="s1085.p0" relation="true"/>
  </sentence>
  <sentence id="s1086" text="We replicated previously reported breast cancer susceptibility alleles in these mitotic cytokinesis mutation carriers and for several regions (including FGFR2, cellular response to mechanical stimulus, CDKN2A/B, and skeletal system development) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="s1086.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="160-200" id="s1086.e1" ontology_id="GO_0071260" text="cellular response to mechanical stimulus" type="GO"/>
    <pair e1="s1086.e0" e2="s1086.e1" id="s1086.p0" relation="true"/>
  </sentence>
  <sentence id="s1087" text="We replicated previously reported breast cancer susceptibility alleles in these mitotic cytokinesis mutation carriers and for several regions (including FGFR2, cellular response to mechanical stimulus, CDKN2A/B, and skeletal system development) identified SNPs that have stronger evidence of association than those previously published.">
    <entity charOffset="41-47" id="s1087.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="216-243" id="s1087.e1" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="s1087.e0" e2="s1087.e1" id="s1087.p0" relation="false"/>
  </sentence>
  <sentence id="s1088" text="This SNP was not associated with breast cancer risk either in the general population or in double-strand break repair via homologous recombination mutation carriers.">
    <entity charOffset="40-46" id="s1088.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="91-146" id="s1088.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s1088.e0" e2="s1088.e1" id="s1088.p0" relation="true"/>
  </sentence>
  <sentence id="s1089" text="The locus lies within a region containing negative regulation of transcription by RNA polymerase II, which encodes a transcriptional activation protein that interacts with several tumor suppressor genes.">
    <entity charOffset="42-99" id="s1089.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="180-185" id="s1089.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1089.e0" e2="s1089.e1" id="s1089.p0" relation="true"/>
  </sentence>
  <sentence id="s1090" text="However autosomal recessive inheritance with mutation in the phosphate ion transport gene is suspected">
    <entity charOffset="8-39" id="s1090.e0" ontology_id="HP_0000007" text="autosomal recessive inheritance" type="HP"/>
    <entity charOffset="61-84" id="s1090.e1" ontology_id="GO_0006817" text="phosphate ion transport" type="GO"/>
    <pair e1="s1090.e0" e2="s1090.e1" id="s1090.p0" relation="true"/>
  </sentence>
  <sentence id="s1091" text="The patient had a history of severe neonatal jaundice, hemolytic crisis with rhabdomyolysis triggeprotein phosphorylation by febrile viral infections, dysarthria, and intellectual disability during early childhood.">
    <entity charOffset="98-121" id="s1091.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="167-190" id="s1091.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1091.e0" e2="s1091.e1" id="s1091.p0" relation="false"/>
  </sentence>
  <sentence id="s1092" text="In the last 10 years, the primary cilia machinery has been implicated in more than a dozen disorders united as ciliopathies, including skeletal dysplasias, such as Jeune syndrome and short rib-polydactyly muscle organ development III.">
    <entity charOffset="135-154" id="s1092.e0" ontology_id="HP_0002652" text="skeletal dysplasias" type="HP"/>
    <entity charOffset="205-229" id="s1092.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1092.e0" e2="s1092.e1" id="s1092.p0" relation="false"/>
  </sentence>
  <sentence id="s1093" text="In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-polydactyly group (muscle contractions) that includes Verma-Naumoff syndrome (SRP muscle organ development III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (endochondral bone growth), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.">
    <entity charOffset="97-108" id="s1093.e0" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <entity charOffset="179-203" id="s1093.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1093.e0" e2="s1093.e1" id="s1093.p0" relation="false"/>
  </sentence>
  <sentence id="s1094" text="In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-polydactyly group (muscle contractions) that includes Verma-Naumoff syndrome (SRP muscle organ development III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (endochondral bone growth), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.">
    <entity charOffset="97-108" id="s1094.e0" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <entity charOffset="116-134" id="s1094.e1" ontology_id="GO_0006936" text="muscle contraction" type="GO"/>
    <pair e1="s1094.e0" e2="s1094.e1" id="s1094.p0" relation="false"/>
  </sentence>
  <sentence id="s1095" text="In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-polydactyly group (muscle contractions) that includes Verma-Naumoff syndrome (SRP muscle organ development III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (endochondral bone growth), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.">
    <entity charOffset="97-108" id="s1095.e0" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <entity charOffset="304-328" id="s1095.e1" ontology_id="GO_0003416" text="endochondral bone growth" type="GO"/>
    <pair e1="s1095.e0" e2="s1095.e1" id="s1095.p0" relation="true"/>
  </sentence>
  <sentence id="s1096" text="Misregulation of vascular endothelial growth factorA (negative regulation of transcription by RNA polymerase IIA) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian cancer.">
    <entity charOffset="55-112" id="s1096.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="157-172" id="s1096.e1" ontology_id="HP_0000137" text="ovarian disease" type="HP"/>
    <pair e1="s1096.e0" e2="s1096.e1" id="s1096.p0" relation="false"/>
  </sentence>
  <sentence id="s1097" text="Misregulation of vascular endothelial growth factorA (negative regulation of transcription by RNA polymerase IIA) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian cancer.">
    <entity charOffset="55-112" id="s1097.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="246-259" id="s1097.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s1097.e0" e2="s1097.e1" id="s1097.p0" relation="false"/>
  </sentence>
  <sentence id="s1098" text="We examined a Japanese 54-years-old male patient with autosomal recessive intraciliary transport.">
    <entity charOffset="54-73" id="s1098.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="74-96" id="s1098.e1" ontology_id="GO_0042073" text="intraciliary transport" type="GO"/>
    <pair e1="s1098.e0" e2="s1098.e1" id="s1098.p0" relation="true"/>
  </sentence>
  <sentence id="s1099" text="Through the examination of 48 candidate genes known to be responsible for autosomal recessive intraciliary transport, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the positive regulation of mitochondrial fission gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).">
    <entity charOffset="74-93" id="s1099.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="94-116" id="s1099.e1" ontology_id="GO_0042073" text="intraciliary transport" type="GO"/>
    <pair e1="s1099.e0" e2="s1099.e1" id="s1099.p0" relation="true"/>
  </sentence>
  <sentence id="s1100" text="Through the examination of 48 candidate genes known to be responsible for autosomal recessive intraciliary transport, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the positive regulation of mitochondrial fission gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).">
    <entity charOffset="74-93" id="s1100.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="216-260" id="s1100.e1" ontology_id="GO_0090141" text="positive regulation of mitochondrial fission" type="GO"/>
    <pair e1="s1100.e0" e2="s1100.e1" id="s1100.p0" relation="true"/>
  </sentence>
  <sentence id="s1101" text="Sonic Hedgehog (positive regulation of cell proliferation) signaling at primary cilia drives the proliferation and progression of a subset of medulloblastomas, the most common malignant paediatric brain tumor.">
    <entity charOffset="16-57" id="s1101.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="142-158" id="s1101.e1" ontology_id="HP_0002885" text="medulloblastomas" type="HP"/>
    <pair e1="s1101.e0" e2="s1101.e1" id="s1101.p0" relation="false"/>
  </sentence>
  <sentence id="s1102" text="However, the role protein processing involved in protein targeting to mitochondrion plays in cancer is unknown and the contribution of peptide cross-linking-kinase signaling to cilia function is little characterized.">
    <entity charOffset="18-83" id="s1102.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="93-99" id="s1102.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1102.e0" e2="s1102.e1" id="s1102.p0" relation="false"/>
  </sentence>
  <sentence id="s1103" text="However, the role protein processing involved in protein targeting to mitochondrion plays in cancer is unknown and the contribution of peptide cross-linking-kinase signaling to cilia function is little characterized.">
    <entity charOffset="93-99" id="s1103.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="135-156" id="s1103.e1" ontology_id="GO_0018149" text="peptide cross-linking" type="GO"/>
    <pair e1="s1103.e0" e2="s1103.e1" id="s1103.p0" relation="false"/>
  </sentence>
  <sentence id="s1104" text="Here, we reveal protein processing involved in protein targeting to mitochondrion promotes positive regulation of cell proliferation signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized peptide cross-linking-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="16-81" id="s1104.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="293-298" id="s1104.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1104.e0" e2="s1104.e1" id="s1104.p0" relation="false"/>
  </sentence>
  <sentence id="s1105" text="Here, we reveal protein processing involved in protein targeting to mitochondrion promotes positive regulation of cell proliferation signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized peptide cross-linking-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="16-81" id="s1105.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="150-165" id="s1105.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s1105.e0" e2="s1105.e1" id="s1105.p0" relation="false"/>
  </sentence>
  <sentence id="s1106" text="Here, we reveal protein processing involved in protein targeting to mitochondrion promotes positive regulation of cell proliferation signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized peptide cross-linking-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="91-132" id="s1106.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="150-165" id="s1106.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s1106.e0" e2="s1106.e1" id="s1106.p0" relation="false"/>
  </sentence>
  <sentence id="s1107" text="Here, we reveal protein processing involved in protein targeting to mitochondrion promotes positive regulation of cell proliferation signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized peptide cross-linking-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="150-165" id="s1107.e0" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <entity charOffset="217-238" id="s1107.e1" ontology_id="GO_0018149" text="peptide cross-linking" type="GO"/>
    <pair e1="s1107.e0" e2="s1107.e1" id="s1107.p0" relation="false"/>
  </sentence>
  <sentence id="s1108" text="Here, we reveal protein processing involved in protein targeting to mitochondrion promotes positive regulation of cell proliferation signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized peptide cross-linking-kinase signaling axis that maintains primary cilia on tumor cells.">
    <entity charOffset="217-238" id="s1108.e0" ontology_id="GO_0018149" text="peptide cross-linking" type="GO"/>
    <entity charOffset="293-298" id="s1108.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1108.e0" e2="s1108.e1" id="s1108.p0" relation="false"/>
  </sentence>
  <sentence id="s1109" text="Conditional deletion of protein processing involved in protein targeting to mitochondrion in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced positive regulation of cell proliferation signaling and promoted tumor cell cilia loss.">
    <entity charOffset="24-89" id="s1109.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="174-179" id="s1109.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1109.e0" e2="s1109.e1" id="s1109.p0" relation="false"/>
  </sentence>
  <sentence id="s1110" text="Conditional deletion of protein processing involved in protein targeting to mitochondrion in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced positive regulation of cell proliferation signaling and promoted tumor cell cilia loss.">
    <entity charOffset="151-166" id="s1110.e0" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <entity charOffset="232-273" id="s1110.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1110.e0" e2="s1110.e1" id="s1110.p0" relation="false"/>
  </sentence>
  <sentence id="s1111" text="Conditional deletion of protein processing involved in protein targeting to mitochondrion in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced positive regulation of cell proliferation signaling and promoted tumor cell cilia loss.">
    <entity charOffset="174-179" id="s1111.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="232-273" id="s1111.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1111.e0" e2="s1111.e1" id="s1111.p0" relation="true"/>
  </sentence>
  <sentence id="s1112" text="The number of PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/pAKT/pGSK3-positive cilia was increased in cultured protein processing involved in protein targeting to mitochondrion-null tumor cells relative to controls.">
    <entity charOffset="94-159" id="s1112.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="165-170" id="s1112.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1112.e0" e2="s1112.e1" id="s1112.p0" relation="false"/>
  </sentence>
  <sentence id="s1113" text="peptide cross-linking-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in protein processing involved in protein targeting to mitochondrion-null tumor cells in vitro.">
    <entity charOffset="0-21" id="s1113.e0" ontology_id="GO_0018149" text="peptide cross-linking" type="GO"/>
    <entity charOffset="212-217" id="s1113.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1113.e0" e2="s1113.e1" id="s1113.p0" relation="false"/>
  </sentence>
  <sentence id="s1114" text="peptide cross-linking-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in protein processing involved in protein targeting to mitochondrion-null tumor cells in vitro.">
    <entity charOffset="141-206" id="s1114.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="212-217" id="s1114.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1114.e0" e2="s1114.e1" id="s1114.p0" relation="false"/>
  </sentence>
  <sentence id="s1115" text="protein processing involved in protein targeting to mitochondrion mRNA and copy number were reduced in human positive regulation of cell proliferation medulloblastoma compared to other molecular subtypes and consistent with the murine model, reduced INPP5E was associated with improved overall survival.">
    <entity charOffset="0-65" id="s1115.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="151-166" id="s1115.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s1115.e0" e2="s1115.e1" id="s1115.p0" relation="false"/>
  </sentence>
  <sentence id="s1116" text="protein processing involved in protein targeting to mitochondrion mRNA and copy number were reduced in human positive regulation of cell proliferation medulloblastoma compared to other molecular subtypes and consistent with the murine model, reduced INPP5E was associated with improved overall survival.">
    <entity charOffset="109-150" id="s1116.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="151-166" id="s1116.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s1116.e0" e2="s1116.e1" id="s1116.p0" relation="false"/>
  </sentence>
  <sentence id="s1117" text="Therefore our study identifies a compartmentalized PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/AKT/GSK3 signaling axis at cilia in positive regulation of cell proliferation-dependent medulloblastoma that is regulated by protein processing involved in protein targeting to mitochondrion to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression">
    <entity charOffset="115-156" id="s1117.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="282-287" id="s1117.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1117.e0" e2="s1117.e1" id="s1117.p0" relation="true"/>
  </sentence>
  <sentence id="s1118" text="Therefore our study identifies a compartmentalized PtdIns(3,4,5)P&lt;sub&gt;3&lt;/sub&gt;/AKT/GSK3 signaling axis at cilia in positive regulation of cell proliferation-dependent medulloblastoma that is regulated by protein processing involved in protein targeting to mitochondrion to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression">
    <entity charOffset="167-182" id="s1118.e0" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <entity charOffset="204-269" id="s1118.e1" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <pair e1="s1118.e0" e2="s1118.e1" id="s1118.p0" relation="false"/>
  </sentence>
  <sentence id="s1119" text="negative regulation of neuron projection development1, an important member of the Kank gene family, plays an important role in the development of many malignant tumors.">
    <entity charOffset="0-52" id="s1119.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="161-167" id="s1119.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1119.e0" e2="s1119.e1" id="s1119.p0" relation="false"/>
  </sentence>
  <sentence id="s1120" text="As a brand new tumor-suppressor gene, the expression of negative regulation of neuron projection development1 gene has been revealed to be downregulated or absent in many malignant tumors.">
    <entity charOffset="15-20" id="s1120.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="56-108" id="s1120.e1" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <pair e1="s1120.e0" e2="s1120.e1" id="s1120.p0" relation="false"/>
  </sentence>
  <sentence id="s1121" text="Concurrently, invivo establishment of mitotic spindle orientation mice experiments also confirmed that upregulation of negative regulation of neuron projection development1 expression led to reduced tumor formation in nude mice and significantly reduced tumor volume.">
    <entity charOffset="22-66" id="s1121.e0" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <entity charOffset="200-205" id="s1121.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1121.e0" e2="s1121.e1" id="s1121.p0" relation="false"/>
  </sentence>
  <sentence id="s1122" text="Concurrently, invivo establishment of mitotic spindle orientation mice experiments also confirmed that upregulation of negative regulation of neuron projection development1 expression led to reduced tumor formation in nude mice and significantly reduced tumor volume.">
    <entity charOffset="120-172" id="s1122.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="200-205" id="s1122.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1122.e0" e2="s1122.e1" id="s1122.p0" relation="false"/>
  </sentence>
  <sentence id="s1123" text="These results revealed that upregulation of the negative regulation of neuron projection developmentl gene inhibited the progression of lung cancer both invitro and invivo, and its mechanism was closely related to cell apoptosis as well as tumor invasion and metastasis">
    <entity charOffset="48-100" id="s1123.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="242-247" id="s1123.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1123.e0" e2="s1123.e1" id="s1123.p0" relation="false"/>
  </sentence>
  <sentence id="s1124" text="These results revealed that upregulation of the negative regulation of neuron projection developmentl gene inhibited the progression of lung cancer both invitro and invivo, and its mechanism was closely related to cell apoptosis as well as tumor invasion and metastasis">
    <entity charOffset="48-100" id="s1124.e0" ontology_id="GO_0010977" text="negative regulation of neuron projection development" type="GO"/>
    <entity charOffset="141-147" id="s1124.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1124.e0" e2="s1124.e1" id="s1124.p0" relation="false"/>
  </sentence>
  <sentence id="s1125" text="Of all the movement disorders, myoclonus is the most difficult to encapsulate into any positive regulation of transcription by RNA polymerase II framework.">
    <entity charOffset="11-29" id="s1125.e0" ontology_id="HP_0100022" text="movement disorders" type="HP"/>
    <entity charOffset="87-144" id="s1125.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1125.e0" e2="s1125.e1" id="s1125.p0" relation="true"/>
  </sentence>
  <sentence id="s1126" text="Of all the movement disorders, myoclonus is the most difficult to encapsulate into any positive regulation of transcription by RNA polymerase II framework.">
    <entity charOffset="31-40" id="s1126.e0" ontology_id="HP_0001336" text="myoclonus" type="HP"/>
    <entity charOffset="87-144" id="s1126.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1126.e0" e2="s1126.e1" id="s1126.p0" relation="false"/>
  </sentence>
  <sentence id="s1127" text="Recently, loss-of-function mutations in positive regulation of retrograde protein transport, ER to cytosol were reported in association with severe developmental delay, deafness and dystonia.">
    <entity charOffset="40-106" id="s1127.e0" ontology_id="GO_1904154" text="positive regulation of retrograde protein transport, ER to cytosol" type="GO"/>
    <entity charOffset="148-167" id="s1127.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1127.e0" e2="s1127.e1" id="s1127.p0" relation="true"/>
  </sentence>
  <sentence id="s1128" text="Recently, loss-of-function mutations in positive regulation of retrograde protein transport, ER to cytosol were reported in association with severe developmental delay, deafness and dystonia.">
    <entity charOffset="40-106" id="s1128.e0" ontology_id="GO_1904154" text="positive regulation of retrograde protein transport, ER to cytosol" type="GO"/>
    <entity charOffset="169-177" id="s1128.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1128.e0" e2="s1128.e1" id="s1128.p0" relation="true"/>
  </sentence>
  <sentence id="s1129" text="Remarkably, a patient with an isolated deletion at the 3'-end of creatine transmembrane transport had a similar severe phenotype as seen in positive regulation of retrograde protein transport, ER to cytosol deficiency but without deafness.">
    <entity charOffset="65-97" id="s1129.e0" ontology_id="GO_0015881" text="creatine transmembrane transport" type="GO"/>
    <entity charOffset="230-238" id="s1129.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1129.e0" e2="s1129.e1" id="s1129.p0" relation="false"/>
  </sentence>
  <sentence id="s1130" text="Remarkably, a patient with an isolated deletion at the 3'-end of creatine transmembrane transport had a similar severe phenotype as seen in positive regulation of retrograde protein transport, ER to cytosol deficiency but without deafness.">
    <entity charOffset="140-206" id="s1130.e0" ontology_id="GO_1904154" text="positive regulation of retrograde protein transport, ER to cytosol" type="GO"/>
    <entity charOffset="230-238" id="s1130.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1130.e0" e2="s1130.e1" id="s1130.p0" relation="true"/>
  </sentence>
  <sentence id="s1131" text="Friedreich's ataxia (regulation of ferrochelatase activity), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (glycogen catabolic process) repeat in the regulation of ferrochelatase activity gene is known to inhibit the expression of frataxin protein.">
    <entity charOffset="13-19" id="s1131.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="21-58" id="s1131.e1" ontology_id="GO_0010722" text="regulation of ferrochelatase activity" type="GO"/>
    <pair e1="s1131.e0" e2="s1131.e1" id="s1131.p0" relation="true"/>
  </sentence>
  <sentence id="s1132" text="Friedreich's ataxia (regulation of ferrochelatase activity), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (glycogen catabolic process) repeat in the regulation of ferrochelatase activity gene is known to inhibit the expression of frataxin protein.">
    <entity charOffset="13-19" id="s1132.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="164-190" id="s1132.e1" ontology_id="GO_0005980" text="glycogen catabolic process" type="GO"/>
    <pair e1="s1132.e0" e2="s1132.e1" id="s1132.p0" relation="false"/>
  </sentence>
  <sentence id="s1133" text="Friedreich's ataxia (regulation of ferrochelatase activity), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (glycogen catabolic process) repeat in the regulation of ferrochelatase activity gene is known to inhibit the expression of frataxin protein.">
    <entity charOffset="13-19" id="s1133.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="206-243" id="s1133.e1" ontology_id="GO_0010722" text="regulation of ferrochelatase activity" type="GO"/>
    <pair e1="s1133.e0" e2="s1133.e1" id="s1133.p0" relation="true"/>
  </sentence>
  <sentence id="s1134" text="Dendritic cell (neuron migration)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (negative regulation of transcription by RNA polymerase II) peptides have shown G protein-coupled receptor signaling pathway therapeutic efficacy in these diseases.">
    <entity charOffset="16-32" id="s1134.e0" ontology_id="GO_0001764" text="neuron migration" type="GO"/>
    <entity charOffset="143-148" id="s1134.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1134.e0" e2="s1134.e1" id="s1134.p0" relation="false"/>
  </sentence>
  <sentence id="s1135" text="Dendritic cell (neuron migration)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (negative regulation of transcription by RNA polymerase II) peptides have shown G protein-coupled receptor signaling pathway therapeutic efficacy in these diseases.">
    <entity charOffset="97-103" id="s1135.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="239-283" id="s1135.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s1135.e0" e2="s1135.e1" id="s1135.p0" relation="false"/>
  </sentence>
  <sentence id="s1136" text="Dendritic cell (neuron migration)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (negative regulation of transcription by RNA polymerase II) peptides have shown G protein-coupled receptor signaling pathway therapeutic efficacy in these diseases.">
    <entity charOffset="97-103" id="s1136.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="160-217" id="s1136.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1136.e0" e2="s1136.e1" id="s1136.p0" relation="true"/>
  </sentence>
  <sentence id="s1137" text="Dendritic cell (neuron migration)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (negative regulation of transcription by RNA polymerase II) peptides have shown G protein-coupled receptor signaling pathway therapeutic efficacy in these diseases.">
    <entity charOffset="143-148" id="s1137.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="160-217" id="s1137.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1137.e0" e2="s1137.e1" id="s1137.p0" relation="true"/>
  </sentence>
  <sentence id="s1138" text="In this paper, we report the results of a phase I/II study of a DC-based vaccination for advanced breast, ovarian, and gastric cancers, and we offer evidence that patients can be effectively vaccinated with autologous DCs pulsed with negative regulation of transcription by RNA polymerase II peptide.">
    <entity charOffset="119-134" id="s1138.e0" ontology_id="HP_0012126" text="gastric cancers" type="HP"/>
    <entity charOffset="234-291" id="s1138.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1138.e0" e2="s1138.e1" id="s1138.p0" relation="false"/>
  </sentence>
  <sentence id="s1139" text="Here, we show that fine-mapping of pancreatic and testicular cancer GWAS within one of these loci (Region 2 in apoptotic process) focuses the signal to nine highly correlated SNPs.">
    <entity charOffset="61-67" id="s1139.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="111-128" id="s1139.e1" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <pair e1="s1139.e0" e2="s1139.e1" id="s1139.p0" relation="false"/>
  </sentence>
  <sentence id="s1140" text="Despite significant progress in our understanding of hereditary neurodegenerative diseases, the list of genes associated with early-onnegative regulation of transcription, DNA-templated dementia is not yet complete.">
    <entity charOffset="64-90" id="s1140.e0" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <entity charOffset="134-185" id="s1140.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1140.e0" e2="s1140.e1" id="s1140.p0" relation="false"/>
  </sentence>
  <sentence id="s1141" text="MicroRNAs (protein polyubiquitinationNAs) are identified as key regulators in cancer initiation, progression and metastasis including gastric cancer (GC).">
    <entity charOffset="11-37" id="s1141.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="78-84" id="s1141.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1141.e0" e2="s1141.e1" id="s1141.p0" relation="false"/>
  </sentence>
  <sentence id="s1142" text="Furthermore, lower protein polyubiquitination-129-5p expression closely associated with tumor size and lymph node invasion and poor prognosis of GC patients.">
    <entity charOffset="19-45" id="s1142.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="88-93" id="s1142.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1142.e0" e2="s1142.e1" id="s1142.p0" relation="false"/>
  </sentence>
  <sentence id="s1143" text="In vivo, upregulation of protein polyubiquitination-129-5p also inhibited tumor growth.">
    <entity charOffset="25-51" id="s1143.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="74-79" id="s1143.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1143.e0" e2="s1143.e1" id="s1143.p0" relation="false"/>
  </sentence>
  <sentence id="s1144" text="Therefore, these results indicated that protein polyubiquitination-129-5p functioned as a tumor suppressor in GC and may be a potential target of GC treatment">
    <entity charOffset="40-66" id="s1144.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="90-95" id="s1144.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1144.e0" e2="s1144.e1" id="s1144.p0" relation="false"/>
  </sentence>
  <sentence id="s1145" text="Elevated serum negative regulation of transcription by RNA polymerase II concentrations in primary and secondary hyperparathyroidism have been associated with bone disease, hypertension, and in some studies, cardiovascular mortality.">
    <entity charOffset="15-72" id="s1145.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="113-132" id="s1145.e1" ontology_id="HP_0000843" text="hyperparathyroidism" type="HP"/>
    <pair e1="s1145.e0" e2="s1145.e1" id="s1145.p0" relation="false"/>
  </sentence>
  <sentence id="s1146" text="Elevated serum negative regulation of transcription by RNA polymerase II concentrations in primary and secondary hyperparathyroidism have been associated with bone disease, hypertension, and in some studies, cardiovascular mortality.">
    <entity charOffset="15-72" id="s1146.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="173-185" id="s1146.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s1146.e0" e2="s1146.e1" id="s1146.p0" relation="false"/>
  </sentence>
  <sentence id="s1147" text="&lt;b&gt;Methods&lt;/b&gt;: Analysis of publicly available microarray data of oral negative regulation of peptidase activity revealed that bile acid metabolic process was significantly upregulated in tumor tissue compared with normal mucosa.">
    <entity charOffset="71-112" id="s1147.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="188-193" id="s1147.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1147.e0" e2="s1147.e1" id="s1147.p0" relation="false"/>
  </sentence>
  <sentence id="s1148" text="&lt;b&gt;Methods&lt;/b&gt;: Analysis of publicly available microarray data of oral negative regulation of peptidase activity revealed that bile acid metabolic process was significantly upregulated in tumor tissue compared with normal mucosa.">
    <entity charOffset="127-154" id="s1148.e0" ontology_id="GO_0008206" text="bile acid metabolic process" type="GO"/>
    <entity charOffset="188-193" id="s1148.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1148.e0" e2="s1148.e1" id="s1148.p0" relation="false"/>
  </sentence>
  <sentence id="s1149" text="Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, Ras protein signal transduction, activation of MAPK activity, and NF1.">
    <entity charOffset="46-65" id="s1149.e0" ontology_id="HP_0012056" text="cutaneous melanomas" type="HP"/>
    <entity charOffset="94-125" id="s1149.e1" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <pair e1="s1149.e0" e2="s1149.e1" id="s1149.p0" relation="true"/>
  </sentence>
  <sentence id="s1150" text="Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, Ras protein signal transduction, activation of MAPK activity, and NF1.">
    <entity charOffset="46-65" id="s1150.e0" ontology_id="HP_0012056" text="cutaneous melanomas" type="HP"/>
    <entity charOffset="127-154" id="s1150.e1" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <pair e1="s1150.e0" e2="s1150.e1" id="s1150.p0" relation="false"/>
  </sentence>
  <sentence id="s1151" text="Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ATP metabolic processP associates with the oncoprotein protein phosphorylation and the respiratory chain Complex II subunit succinate dehydrogenase B (tricarboxylic acid cycle) in mitochondria of tumor cells.">
    <entity charOffset="90-111" id="s1151.e0" ontology_id="GO_0046034" text="ATP metabolic process" type="GO"/>
    <entity charOffset="286-291" id="s1151.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1151.e0" e2="s1151.e1" id="s1151.p0" relation="false"/>
  </sentence>
  <sentence id="s1152" text="Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ATP metabolic processP associates with the oncoprotein protein phosphorylation and the respiratory chain Complex II subunit succinate dehydrogenase B (tricarboxylic acid cycle) in mitochondria of tumor cells.">
    <entity charOffset="145-168" id="s1152.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="286-291" id="s1152.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1152.e0" e2="s1152.e1" id="s1152.p0" relation="false"/>
  </sentence>
  <sentence id="s1153" text="Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ATP metabolic processP associates with the oncoprotein protein phosphorylation and the respiratory chain Complex II subunit succinate dehydrogenase B (tricarboxylic acid cycle) in mitochondria of tumor cells.">
    <entity charOffset="241-265" id="s1153.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="286-291" id="s1153.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1153.e0" e2="s1153.e1" id="s1153.p0" relation="true"/>
  </sentence>
  <sentence id="s1154" text="Deregulated mitochondrial respiration induced by ATP metabolic processP targeting causes oxidative stress, which in turn reduces tumor cell proliferation, suppresses cell motility, and abolishes metastatic dissemination in vivo.">
    <entity charOffset="49-70" id="s1154.e0" ontology_id="GO_0046034" text="ATP metabolic process" type="GO"/>
    <entity charOffset="129-134" id="s1154.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1154.e0" e2="s1154.e1" id="s1154.p0" relation="false"/>
  </sentence>
  <sentence id="s1155" text="proteolysis involved in cellular protein catabolic process is universally overexpressed in primary and metastatic human cancer, correlating with shortened patient survival.">
    <entity charOffset="0-58" id="s1155.e0" ontology_id="GO_0051603" text="proteolysis involved in cellular protein catabolic process" type="GO"/>
    <entity charOffset="120-126" id="s1155.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1155.e0" e2="s1155.e1" id="s1155.p0" relation="false"/>
  </sentence>
  <sentence id="s1156" text="Therefore, tumors exploit ATP metabolic processP-directed proteostasis to maintain mitochondrial bioenergetics, buffer oxidative stress, and enable metastatic competence.">
    <entity charOffset="11-16" id="s1156.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="26-47" id="s1156.e1" ontology_id="GO_0046034" text="ATP metabolic process" type="GO"/>
    <pair e1="s1156.e0" e2="s1156.e1" id="s1156.p0" relation="false"/>
  </sentence>
  <sentence id="s1157" text="The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named phosphatidylinositol phosphorylation (also known as phosphatidylinositol phosphorylation or phosphatidylinositol phosphorylation).">
    <entity charOffset="28-47" id="s1157.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="103-139" id="s1157.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1157.e0" e2="s1157.e1" id="s1157.p0" relation="true"/>
  </sentence>
  <sentence id="s1158" text="The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named phosphatidylinositol phosphorylation (also known as phosphatidylinositol phosphorylation or phosphatidylinositol phosphorylation).">
    <entity charOffset="28-47" id="s1158.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="155-191" id="s1158.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1158.e0" e2="s1158.e1" id="s1158.p0" relation="true"/>
  </sentence>
  <sentence id="s1159" text="The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named phosphatidylinositol phosphorylation (also known as phosphatidylinositol phosphorylation or phosphatidylinositol phosphorylation).">
    <entity charOffset="28-47" id="s1159.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="195-231" id="s1159.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1159.e0" e2="s1159.e1" id="s1159.p0" relation="true"/>
  </sentence>
  <sentence id="s1160" text="After targeting to endothelial differentiation gene (Edg) family blood circulation receptors (LPA1, LPA2, LPA3) and non-Edg family LPA receptors (LPA4, LPA5, LPA6), LPA mediates physiological and pathological processes such as embryonic development, angiogenesis, tumor progression, fibrogenesis, wound healing, ischemia/reperfusion injury, and inflammatory reactions.">
    <entity charOffset="65-82" id="s1160.e0" ontology_id="GO_0008015" text="blood circulation" type="GO"/>
    <entity charOffset="264-269" id="s1160.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1160.e0" e2="s1160.e1" id="s1160.p0" relation="false"/>
  </sentence>
  <sentence id="s1161" text="To identify potential biological differences by bile acid metabolic process among Luminal A breast cancers, gene expression data from 108 CAU and 57 AA breast tumors were analyzed.">
    <entity charOffset="48-75" id="s1161.e0" ontology_id="GO_0008206" text="bile acid metabolic process" type="GO"/>
    <entity charOffset="159-165" id="s1161.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1161.e0" e2="s1161.e1" id="s1161.p0" relation="false"/>
  </sentence>
  <sentence id="s1162" text="Six genes (positive regulation of cell death, MUC1, CRYBB2, L-serine metabolic process, SQLE, dTMP biosynthetic process) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="11-44" id="s1162.e0" ontology_id="GO_0010942" text="positive regulation of cell death" type="GO"/>
    <entity charOffset="182-188" id="s1162.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1162.e0" e2="s1162.e1" id="s1162.p0" relation="false"/>
  </sentence>
  <sentence id="s1163" text="Six genes (positive regulation of cell death, MUC1, CRYBB2, L-serine metabolic process, SQLE, dTMP biosynthetic process) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="60-86" id="s1163.e0" ontology_id="GO_0006563" text="L-serine metabolic process" type="GO"/>
    <entity charOffset="182-188" id="s1163.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1163.e0" e2="s1163.e1" id="s1163.p0" relation="false"/>
  </sentence>
  <sentence id="s1164" text="Six genes (positive regulation of cell death, MUC1, CRYBB2, L-serine metabolic process, SQLE, dTMP biosynthetic process) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &amp;lt;0.8, HR &amp;gt;1.25).">
    <entity charOffset="94-119" id="s1164.e0" ontology_id="GO_0006231" text="dTMP biosynthetic process" type="GO"/>
    <entity charOffset="182-188" id="s1164.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1164.e0" e2="s1164.e1" id="s1164.p0" relation="false"/>
  </sentence>
  <sentence id="s1165" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (visual perception, L-serine metabolic process, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).">
    <entity charOffset="19-25" id="s1165.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="228-261" id="s1165.e1" ontology_id="GO_0010942" text="positive regulation of cell death" type="GO"/>
    <pair e1="s1165.e0" e2="s1165.e1" id="s1165.p0" relation="false"/>
  </sentence>
  <sentence id="s1166" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (visual perception, L-serine metabolic process, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).">
    <entity charOffset="19-25" id="s1166.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="263-356" id="s1166.e1" ontology_id="GO_0006977" text="DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" type="GO"/>
    <pair e1="s1166.e0" e2="s1166.e1" id="s1166.p0" relation="false"/>
  </sentence>
  <sentence id="s1167" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (visual perception, L-serine metabolic process, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).">
    <entity charOffset="19-25" id="s1167.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="79-96" id="s1167.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s1167.e0" e2="s1167.e1" id="s1167.p0" relation="false"/>
  </sentence>
  <sentence id="s1168" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (visual perception, L-serine metabolic process, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).">
    <entity charOffset="19-25" id="s1168.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="98-124" id="s1168.e1" ontology_id="GO_0006563" text="L-serine metabolic process" type="GO"/>
    <pair e1="s1168.e0" e2="s1168.e1" id="s1168.p0" relation="false"/>
  </sentence>
  <sentence id="s1169" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (visual perception, L-serine metabolic process, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).">
    <entity charOffset="19-25" id="s1169.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="126-153" id="s1169.e1" ontology_id="GO_0016126" text="sterol biosynthetic process" type="GO"/>
    <pair e1="s1169.e0" e2="s1169.e1" id="s1169.p0" relation="false"/>
  </sentence>
  <sentence id="s1170" text="For all six genes, tumors in AA had higher expression of poor prognosis genes (visual perception, L-serine metabolic process, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).">
    <entity charOffset="19-25" id="s1170.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="155-180" id="s1170.e1" ontology_id="GO_0006231" text="dTMP biosynthetic process" type="GO"/>
    <pair e1="s1170.e0" e2="s1170.e1" id="s1170.p0" relation="false"/>
  </sentence>
  <sentence id="s1171" text="Some of these differences (visual perception and L-serine metabolic process) may exist from the earliest stages of tumor development, or may even precede malignancy">
    <entity charOffset="27-44" id="s1171.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="115-120" id="s1171.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1171.e0" e2="s1171.e1" id="s1171.p0" relation="false"/>
  </sentence>
  <sentence id="s1172" text="Some of these differences (visual perception and L-serine metabolic process) may exist from the earliest stages of tumor development, or may even precede malignancy">
    <entity charOffset="49-75" id="s1172.e0" ontology_id="GO_0006563" text="L-serine metabolic process" type="GO"/>
    <entity charOffset="115-120" id="s1172.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1172.e0" e2="s1172.e1" id="s1172.p0" relation="false"/>
  </sentence>
  <sentence id="s1173" text="Helicaselike transcription factor (regulation of transcription, DNA-templated) has been identified as a tumor suppressor gene.">
    <entity charOffset="36-78" id="s1173.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="105-110" id="s1173.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1173.e0" e2="s1173.e1" id="s1173.p0" relation="false"/>
  </sentence>
  <sentence id="s1174" text="The hypermethylation of regulation of transcription by RNA polymerase II is frequently observed in various types of cancer, including colorectal cancer(CRC).">
    <entity charOffset="24-72" id="s1174.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="116-122" id="s1174.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1174.e0" e2="s1174.e1" id="s1174.p0" relation="false"/>
  </sentence>
  <sentence id="s1175" text="Through epigenomic study of a colon cancer cell line pair (HCT116 and DKO), we identified &lt;i&gt;JPH3&lt;/i&gt; as a methylated novel tumor suppressor gene (negative regulation of cytokine production) candidate at 16q24.">
    <entity charOffset="36-42" id="s1175.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="147-189" id="s1175.e1" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <pair e1="s1175.e0" e2="s1175.e1" id="s1175.p0" relation="false"/>
  </sentence>
  <sentence id="s1176" text="Through epigenomic study of a colon cancer cell line pair (HCT116 and DKO), we identified &lt;i&gt;JPH3&lt;/i&gt; as a methylated novel tumor suppressor gene (negative regulation of cytokine production) candidate at 16q24.">
    <entity charOffset="124-129" id="s1176.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="147-189" id="s1176.e1" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <pair e1="s1176.e0" e2="s1176.e1" id="s1176.p0" relation="false"/>
  </sentence>
  <sentence id="s1177" text="Thus, &lt;i&gt;JPH3&lt;/i&gt; was identified as a novel negative regulation of cytokine production methylated in colorectal and gastric tumors which promotes mitochondrial-mediated apoptosis, also as a potential metastasis and survival biomarker for digestive cancers">
    <entity charOffset="44-86" id="s1177.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="124-129" id="s1177.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1177.e0" e2="s1177.e1" id="s1177.p0" relation="false"/>
  </sentence>
  <sentence id="s1178" text="RAB3A interacting protein (protein targeting to membrane) has been determined to be involved in cancer progression; however, its expression pattern and function in gastric cancer remain unknown.">
    <entity charOffset="27-56" id="s1178.e0" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <entity charOffset="96-102" id="s1178.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1178.e0" e2="s1178.e1" id="s1178.p0" relation="false"/>
  </sentence>
  <sentence id="s1179" text="The aim of this study was to determine the association between protein targeting to membrane and gastric cancer, in addition to its functional role in this disease.">
    <entity charOffset="63-92" id="s1179.e0" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <entity charOffset="105-111" id="s1179.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1179.e0" e2="s1179.e1" id="s1179.p0" relation="false"/>
  </sentence>
  <sentence id="s1180" text="In addition, we verified the co-expression of and interplay between protein targeting to membrane and SSX2 during gastric cancer progression.">
    <entity charOffset="68-97" id="s1180.e0" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <entity charOffset="122-128" id="s1180.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1180.e0" e2="s1180.e1" id="s1180.p0" relation="false"/>
  </sentence>
  <sentence id="s1181" text="Thus, these findings elucidated the central role of protein targeting to membrane in inducing an invasive phenotype in gastric cancer cells, in addition to its involvement in cytokine production.">
    <entity charOffset="52-81" id="s1181.e0" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <entity charOffset="127-133" id="s1181.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1181.e0" e2="s1181.e1" id="s1181.p0" relation="false"/>
  </sentence>
  <sentence id="s1182" text="Thus, these findings elucidated the central role of protein targeting to membrane in inducing an invasive phenotype in gastric cancer cells, in addition to its involvement in cytokine production.">
    <entity charOffset="127-133" id="s1182.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="175-194" id="s1182.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s1182.e0" e2="s1182.e1" id="s1182.p0" relation="true"/>
  </sentence>
  <sentence id="s1183" text="At least 36 different forms of G protein-coupled receptor signaling pathway are known, 20 autosomal-recessive, two X-linked, and several forms of ataxia associated with mitochondrial defects are known to date.">
    <entity charOffset="31-75" id="s1183.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="146-152" id="s1183.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1183.e0" e2="s1183.e1" id="s1183.p0" relation="true"/>
  </sentence>
  <sentence id="s1184" text="Exome and targeted sequencing has recently identified four new genes causing ataxia: peptide cross-linking, ANO10, SYT14, and rundataxin.">
    <entity charOffset="77-83" id="s1184.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="85-106" id="s1184.e1" ontology_id="GO_0018149" text="peptide cross-linking" type="GO"/>
    <pair e1="s1184.e0" e2="s1184.e1" id="s1184.p0" relation="true"/>
  </sentence>
  <sentence id="s1185" text="Only a few genes, including nucleosome disassembly, SMO, regulation of transcription by RNA polymerase II and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.">
    <entity charOffset="28-50" id="s1185.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="233-238" id="s1185.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1185.e0" e2="s1185.e1" id="s1185.p0" relation="false"/>
  </sentence>
  <sentence id="s1186" text="Only a few genes, including nucleosome disassembly, SMO, regulation of transcription by RNA polymerase II and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.">
    <entity charOffset="57-105" id="s1186.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="233-238" id="s1186.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1186.e0" e2="s1186.e1" id="s1186.p0" relation="false"/>
  </sentence>
  <sentence id="s1187" text="We detected 11 novel mutations in &lt;i&gt;GJA3&lt;/i&gt;, &lt;i&gt;GJA8&lt;/i&gt;, &lt;i&gt;CRYAA&lt;/i&gt;, &lt;i&gt;CRYBB2&lt;/i&gt;, &lt;i&gt;CRYGS&lt;/i&gt;, &lt;i&gt;CRYGA&lt;/i&gt;, &lt;i&gt;GCNT2&lt;/i&gt;, &lt;i&gt;CRYGA&lt;/i&gt;, and &lt;i&gt;MIP&lt;/i&gt;; and three previously reported cataract-causing mutations in &lt;i&gt;GJA8&lt;/i&gt;, &lt;i&gt;CRYAA&lt;/i&gt;, and &lt;i&gt;CRYBB2&lt;/i&gt; The most commonly mutated genes were those coding for negative regulation of cell-matrix adhesion junctions and crystallin proteins.">
    <entity charOffset="191-199" id="s1187.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="320-363" id="s1187.e1" ontology_id="GO_0001953" text="negative regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s1187.e0" e2="s1187.e1" id="s1187.p0" relation="false"/>
  </sentence>
  <sentence id="s1188" text="Candidate markers were identified by bisulfite conversion-based genome-wide methylation screening of lung tissue from lung cancer, fibrotic ILD, and intracellular protein transport. cfDNA from 400l serum (n=204) served to test the diagnostic performance of these markers.">
    <entity charOffset="123-129" id="s1188.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="149-180" id="s1188.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s1188.e0" e2="s1188.e1" id="s1188.p0" relation="false"/>
  </sentence>
  <sentence id="s1189" text="Cancer was distinguished from ILD with a specificity of 88%, (95%CI: 0.57-1), and intracellular protein transport from cancer with a specificity of 88% (95%CI: 0.64-0.97).">
    <entity charOffset="82-113" id="s1189.e0" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <entity charOffset="119-125" id="s1189.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1189.e0" e2="s1189.e1" id="s1189.p0" relation="false"/>
  </sentence>
  <sentence id="s1190" text="Hepatocellular carcinoma related protein 1 (ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients.">
    <entity charOffset="44-133" id="s1190.e0" ontology_id="GO_0043162" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="256-262" id="s1190.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1190.e0" e2="s1190.e1" id="s1190.p0" relation="false"/>
  </sentence>
  <sentence id="s1191" text="Hepatocellular carcinoma related protein 1 (ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients.">
    <entity charOffset="44-133" id="s1191.e0" ontology_id="GO_0043162" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="300-306" id="s1191.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1191.e0" e2="s1191.e1" id="s1191.p0" relation="false"/>
  </sentence>
  <sentence id="s1192" text="It is reported the expression of ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway is inversely related to epidermal growth factor receptor (EGFR) in breast cancer and lead to resistance to cetuximab in ovarian cancer.">
    <entity charOffset="33-122" id="s1192.e0" ontology_id="GO_0043162" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="197-203" id="s1192.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1192.e0" e2="s1192.e1" id="s1192.p0" relation="false"/>
  </sentence>
  <sentence id="s1193" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway expression was significantly related to age (P=0.017), pathological grade (P=0.003), tumor encapsulation (P=0.037), recurrence (P=0.039) and death (P=0.015), but unrelated to cirrhosis (P=0.216), tumor size (P=0.273), and distant metastasis (P=0.554).">
    <entity charOffset="0-89" id="s1193.e0" ontology_id="GO_0043162" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="175-180" id="s1193.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1193.e0" e2="s1193.e1" id="s1193.p0" relation="false"/>
  </sentence>
  <sentence id="s1194" text="Prostate cancer (mitochondrial transport) is the most common cancer among men.">
    <entity charOffset="9-15" id="s1194.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="17-40" id="s1194.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s1194.e0" e2="s1194.e1" id="s1194.p0" relation="false"/>
  </sentence>
  <sentence id="s1195" text="Metabolic syndrome (MeS) is associated with increased mitochondrial transport aggressiveness and recurrence.">
    <entity charOffset="54-77" id="s1195.e0" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <entity charOffset="78-92" id="s1195.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s1195.e0" e2="s1195.e1" id="s1195.p0" relation="false"/>
  </sentence>
  <sentence id="s1196" text="Moreover, ion transmembrane transport depletion in mitochondrial transport cells injected subcutaneously in MeS epidermis development increased the circulating tumor cells foci compared to control.">
    <entity charOffset="10-37" id="s1196.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="160-165" id="s1196.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1196.e0" e2="s1196.e1" id="s1196.p0" relation="false"/>
  </sentence>
  <sentence id="s1197" text="Moreover, ion transmembrane transport depletion in mitochondrial transport cells injected subcutaneously in MeS epidermis development increased the circulating tumor cells foci compared to control.">
    <entity charOffset="51-74" id="s1197.e0" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <entity charOffset="160-165" id="s1197.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1197.e0" e2="s1197.e1" id="s1197.p0" relation="false"/>
  </sentence>
  <sentence id="s1198" text="Moreover, ion transmembrane transport depletion in mitochondrial transport cells injected subcutaneously in MeS epidermis development increased the circulating tumor cells foci compared to control.">
    <entity charOffset="112-133" id="s1198.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="160-165" id="s1198.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1198.e0" e2="s1198.e1" id="s1198.p0" relation="false"/>
  </sentence>
  <sentence id="s1199" text="Recently, mutations of biological_process gene were reported to be associated with early-onset parkinsonism, progressive neurodevelopmental delay, and dystonia in several unrelated pedigrees.">
    <entity charOffset="23-41" id="s1199.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="95-107" id="s1199.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s1199.e0" e2="s1199.e1" id="s1199.p0" relation="true"/>
  </sentence>
  <sentence id="s1200" text="Recently, mutations of biological_process gene were reported to be associated with early-onset parkinsonism, progressive neurodevelopmental delay, and dystonia in several unrelated pedigrees.">
    <entity charOffset="23-41" id="s1200.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="121-145" id="s1200.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s1200.e0" e2="s1200.e1" id="s1200.p0" relation="true"/>
  </sentence>
  <sentence id="s1201" text="This study aimed to evaluate biological_process coding mutations in sporadic Chinese Han patients with Parkinson's disease (PD) and test whether an age-of-onset effect exists.">
    <entity charOffset="29-47" id="s1201.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="68-76" id="s1201.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1201.e0" e2="s1201.e1" id="s1201.p0" relation="false"/>
  </sentence>
  <sentence id="s1202" text="Biallelic ion transmembrane transport mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, developmental delay (DD)/intellectual disability (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.">
    <entity charOffset="10-37" id="s1202.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="178-197" id="s1202.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1202.e0" e2="s1202.e1" id="s1202.p0" relation="true"/>
  </sentence>
  <sentence id="s1203" text="Furthermore, we herein summarize the genotypes and phenotypes of patients with ion transmembrane transport mutations reported in the literature, revealing that IHPRF2 is a phenotypically heterogeneous disease.">
    <entity charOffset="79-106" id="s1203.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="187-200" id="s1203.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1203.e0" e2="s1203.e1" id="s1203.p0" relation="false"/>
  </sentence>
  <sentence id="s1204" text="Common facial dysmorphisms include a thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, a tented upper lip, a triangular face, strabismus and microcephaly.">
    <entity charOffset="48-115" id="s1204.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="139-154" id="s1204.e1" ontology_id="HP_0000325" text="triangular face" type="HP"/>
    <pair e1="s1204.e0" e2="s1204.e1" id="s1204.p0" relation="false"/>
  </sentence>
  <sentence id="s1205" text="Common facial dysmorphisms include a thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, a tented upper lip, a triangular face, strabismus and microcephaly.">
    <entity charOffset="48-115" id="s1205.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="171-183" id="s1205.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1205.e0" e2="s1205.e1" id="s1205.p0" relation="false"/>
  </sentence>
  <sentence id="s1206" text="phosphorylation has also been identified as an important node in ataxia gene networks more broadly, but the functional role of PKC in other forms of ataxia remains unexplored, and the mechanisms by which PKC isozymes regulate Purkinje neuron health are not well understood.">
    <entity charOffset="0-15" id="s1206.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="65-71" id="s1206.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1206.e0" e2="s1206.e1" id="s1206.p0" relation="true"/>
  </sentence>
  <sentence id="s1207" text="Using mouse models of spinocerebellar ataxia muscle organ development 1 (SCA1) and 2 (negative regulation of receptor internalization) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.">
    <entity charOffset="27-44" id="s1207.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="45-69" id="s1207.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1207.e0" e2="s1207.e1" id="s1207.p0" relation="false"/>
  </sentence>
  <sentence id="s1208" text="Using mouse models of spinocerebellar ataxia muscle organ development 1 (SCA1) and 2 (negative regulation of receptor internalization) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.">
    <entity charOffset="27-44" id="s1208.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="86-133" id="s1208.e1" ontology_id="GO_0002091" text="negative regulation of receptor internalization" type="GO"/>
    <pair e1="s1208.e0" e2="s1208.e1" id="s1208.p0" relation="true"/>
  </sentence>
  <sentence id="s1209" text="Recent advances in whole exome sequencing technology show promise for further elucidation of disease causing variants as in the recent identification of rare variants within regulation of transcription by RNA polymerase II segregating with pathological myopia.">
    <entity charOffset="174-222" id="s1209.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="253-259" id="s1209.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1209.e0" e2="s1209.e1" id="s1209.p0" relation="true"/>
  </sentence>
  <sentence id="s1210" text="We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall regulation of TOR signaling of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.">
    <entity charOffset="27-40" id="s1210.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="104-131" id="s1210.e1" ontology_id="GO_0032006" text="regulation of TOR signaling" type="GO"/>
    <pair e1="s1210.e0" e2="s1210.e1" id="s1210.p0" relation="false"/>
  </sentence>
  <sentence id="s1211" text="We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall regulation of TOR signaling of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.">
    <entity charOffset="49-55" id="s1211.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="104-131" id="s1211.e1" ontology_id="GO_0032006" text="regulation of TOR signaling" type="GO"/>
    <pair e1="s1211.e0" e2="s1211.e1" id="s1211.p0" relation="false"/>
  </sentence>
  <sentence id="s1212" text="We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall regulation of TOR signaling of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.">
    <entity charOffset="104-131" id="s1212.e0" ontology_id="GO_0032006" text="regulation of TOR signaling" type="GO"/>
    <entity charOffset="193-198" id="s1212.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1212.e0" e2="s1212.e1" id="s1212.p0" relation="false"/>
  </sentence>
  <sentence id="s1213" text="RHOA, SMAD2, SMAD4, embryonic pattern specification, SMAD6, protein phosphorylation, negative regulation of transcription by RNA polymerase II and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="20-51" id="s1213.e0" ontology_id="GO_0009880" text="embryonic pattern specification" type="GO"/>
    <entity charOffset="226-231" id="s1213.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1213.e0" e2="s1213.e1" id="s1213.p0" relation="false"/>
  </sentence>
  <sentence id="s1214" text="RHOA, SMAD2, SMAD4, embryonic pattern specification, SMAD6, protein phosphorylation, negative regulation of transcription by RNA polymerase II and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="60-83" id="s1214.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="226-231" id="s1214.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1214.e0" e2="s1214.e1" id="s1214.p0" relation="true"/>
  </sentence>
  <sentence id="s1215" text="RHOA, SMAD2, SMAD4, embryonic pattern specification, SMAD6, protein phosphorylation, negative regulation of transcription by RNA polymerase II and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis">
    <entity charOffset="85-142" id="s1215.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="226-231" id="s1215.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1215.e0" e2="s1215.e1" id="s1215.p0" relation="false"/>
  </sentence>
  <sentence id="s1216" text="The incproteolysisnce rate of hepatocellular carcinoma (phosphatidylinositol phosphorylation) is rising.">
    <entity charOffset="7-18" id="s1216.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="30-54" id="s1216.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1216.e0" e2="s1216.e1" id="s1216.p0" relation="false"/>
  </sentence>
  <sentence id="s1217" text="The incproteolysisnce rate of hepatocellular carcinoma (phosphatidylinositol phosphorylation) is rising.">
    <entity charOffset="30-54" id="s1217.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="56-92" id="s1217.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1217.e0" e2="s1217.e1" id="s1217.p0" relation="false"/>
  </sentence>
  <sentence id="s1218" text="Activation of inflammatory pathways is known to accompany development of obesity-induced non-alcoholic positive regulation of cell-matrix adhesionty liver disease (NAFLD), insulin resistance and muscle organ development 2 diabetes.">
    <entity charOffset="73-80" id="s1218.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="195-219" id="s1218.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1218.e0" e2="s1218.e1" id="s1218.p0" relation="false"/>
  </sentence>
  <sentence id="s1219" text="Activation of inflammatory pathways is known to accompany development of obesity-induced non-alcoholic positive regulation of cell-matrix adhesionty liver disease (NAFLD), insulin resistance and muscle organ development 2 diabetes.">
    <entity charOffset="73-80" id="s1219.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="103-146" id="s1219.e1" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s1219.e0" e2="s1219.e1" id="s1219.p0" relation="false"/>
  </sentence>
  <sentence id="s1220" text="Hearing impairment (HI) caused by mutations in the connexin-26 gene (gap junction-mediated intercellular transport) accounts for the majority of cases with inherited, nonsyndromic sensorineural hearing loss.">
    <entity charOffset="69-114" id="s1220.e0" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <entity charOffset="194-206" id="s1220.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1220.e0" e2="s1220.e1" id="s1220.p0" relation="true"/>
  </sentence>
  <sentence id="s1221" text="This study describes the first use of pentose-phosphate shunt, oxidative branch for gap junction-mediated intercellular transport associated non-syndromic deafness in Iran.">
    <entity charOffset="38-79" id="s1221.e0" ontology_id="GO_0009051" text="pentose-phosphate shunt, oxidative branch" type="GO"/>
    <entity charOffset="155-163" id="s1221.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1221.e0" e2="s1221.e1" id="s1221.p0" relation="false"/>
  </sentence>
  <sentence id="s1222" text="This study describes the first use of pentose-phosphate shunt, oxidative branch for gap junction-mediated intercellular transport associated non-syndromic deafness in Iran.">
    <entity charOffset="84-129" id="s1222.e0" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <entity charOffset="155-163" id="s1222.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1222.e0" e2="s1222.e1" id="s1222.p0" relation="true"/>
  </sentence>
  <sentence id="s1223" text="gap junction-mediated intercellular transport donor splicing site IVS1+1G&amp;amp;gt;A mutation analysis was performed using Sanger sequencing for a total of 71 Iranian families with at least 1 deaf child diagnosed with non-syndromic deafness.">
    <entity charOffset="0-45" id="s1223.e0" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <entity charOffset="230-238" id="s1223.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1223.e0" e2="s1223.e1" id="s1223.p0" relation="true"/>
  </sentence>
  <sentence id="s1224" text="Recent studies have linked mutations in the SLC24A4 (NCKX4) and ion transmembrane transport (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.">
    <entity charOffset="64-91" id="s1224.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="171-179" id="s1224.e1" ontology_id="HP_0001022" text="albinism" type="HP"/>
    <pair e1="s1224.e0" e2="s1224.e1" id="s1224.p0" relation="false"/>
  </sentence>
  <sentence id="s1225" text="We also analyzed two mutations in a Drosophila ion transport gene that have been reported to result in an increased susceptibility for seizures, and found that both resulted in mutant proteins with significantly reduced but observable NCKX activity.">
    <entity charOffset="47-60" id="s1225.e0" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <entity charOffset="135-143" id="s1225.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s1225.e0" e2="s1225.e1" id="s1225.p0" relation="false"/>
  </sentence>
  <sentence id="s1226" text="Via its bipartite zona pellucida module (ZP-N/ZP-C), heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules forms extracellular filaments that regulate kidney electrolyte balance and innate immunity, as well as protect against renal stones.">
    <entity charOffset="53-128" id="s1226.e0" ontology_id="GO_0007157" text="heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules" type="GO"/>
    <entity charOffset="248-260" id="s1226.e1" ontology_id="HP_0000787" text="renal stones" type="HP"/>
    <pair e1="s1226.e0" e2="s1226.e1" id="s1226.p0" relation="false"/>
  </sentence>
  <sentence id="s1227" text="This phenotype is associated with increased cytosine methylation heterogeneity, but not with increased somatic diversification of immunoglobulins-mediated somatic mutation burden.">
    <entity charOffset="65-78" id="s1227.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="103-145" id="s1227.e1" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <pair e1="s1227.e0" e2="s1227.e1" id="s1227.p0" relation="false"/>
  </sentence>
  <sentence id="s1228" text="This phenotype is associated with increased cytosine methylation heterogeneity, but not with increased somatic diversification of immunoglobulins-mediated somatic mutation burden.">
    <entity charOffset="103-145" id="s1228.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="155-171" id="s1228.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s1228.e0" e2="s1228.e1" id="s1228.p0" relation="false"/>
  </sentence>
  <sentence id="s1229" text="Reciprocally, the cytosine methylation heterogeneity characteristic of normal GC B cells is lost upon somatic diversification of immunoglobulins depletion.">
    <entity charOffset="39-52" id="s1229.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="102-144" id="s1229.e1" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <pair e1="s1229.e0" e2="s1229.e1" id="s1229.p0" relation="false"/>
  </sentence>
  <sentence id="s1230" text="These observations are relevant to human patients, since DLBCLs with high somatic diversification of immunoglobulins expression manifest increased methylation heterogeneity vs. AICDA-low DLBCLs.">
    <entity charOffset="74-116" id="s1230.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="159-172" id="s1230.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1230.e0" e2="s1230.e1" id="s1230.p0" relation="false"/>
  </sentence>
  <sentence id="s1231" text="Our results identify somatic diversification of immunoglobulins as a driver of epigenetic heterogeneity in B-cell lymphomas with potential significance for other tumors with aberrant expression of cytidine deaminases">
    <entity charOffset="21-63" id="s1231.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="90-103" id="s1231.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1231.e0" e2="s1231.e1" id="s1231.p0" relation="false"/>
  </sentence>
  <sentence id="s1232" text="Our results identify somatic diversification of immunoglobulins as a driver of epigenetic heterogeneity in B-cell lymphomas with potential significance for other tumors with aberrant expression of cytidine deaminases">
    <entity charOffset="21-63" id="s1232.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="162-168" id="s1232.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1232.e0" e2="s1232.e1" id="s1232.p0" relation="false"/>
  </sentence>
  <sentence id="s1233" text="Thus, it is clear that a more complex genetic network of cancer-associated genes than previously hypothesized is involved in BCC carcinogenesis, with a potential negative regulation of transcription by RNA polymerase II on the development of new molecular targeted therapies.">
    <entity charOffset="57-63" id="s1233.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="162-219" id="s1233.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1233.e0" e2="s1233.e1" id="s1233.p0" relation="false"/>
  </sentence>
  <sentence id="s1234" text="Loss-of-function mutations in the human positive regulation of integrin activation gene cause autosomal recessive congenital lymphatic dysplasia.">
    <entity charOffset="40-82" id="s1234.e0" ontology_id="GO_0033625" text="positive regulation of integrin activation" type="GO"/>
    <entity charOffset="94-113" id="s1234.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1234.e0" e2="s1234.e1" id="s1234.p0" relation="true"/>
  </sentence>
  <sentence id="s1235" text="Gain-of-function mutations in the human positive regulation of integrin activation gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).">
    <entity charOffset="40-82" id="s1235.e0" ontology_id="GO_0033625" text="positive regulation of integrin activation" type="GO"/>
    <entity charOffset="117-133" id="s1235.e1" ontology_id="HP_0001878" text="hemolytic anemia" type="HP"/>
    <pair e1="s1235.e0" e2="s1235.e1" id="s1235.p0" relation="true"/>
  </sentence>
  <sentence id="s1236" text="Loss-of-function mutations in the human cation transport gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.">
    <entity charOffset="40-56" id="s1236.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="71-90" id="s1236.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1236.e0" e2="s1236.e1" id="s1236.p0" relation="true"/>
  </sentence>
  <sentence id="s1237" text="Loss-of-function mutations in the human cation transport gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.">
    <entity charOffset="40-56" id="s1237.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="157-171" id="s1237.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s1237.e0" e2="s1237.e1" id="s1237.p0" relation="true"/>
  </sentence>
  <sentence id="s1238" text="Loss-of-function mutations in the human cation transport gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.">
    <entity charOffset="40-56" id="s1238.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="177-186" id="s1238.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s1238.e0" e2="s1238.e1" id="s1238.p0" relation="true"/>
  </sentence>
  <sentence id="s1239" text="Pathogenic sequence variants in the Sorting negative regulation of blood coagulation 10 (SNX10) gene have been associated with autosomal recessive osteopetrosis (ARO) in human.">
    <entity charOffset="44-84" id="s1239.e0" ontology_id="GO_0030195" text="negative regulation of blood coagulation" type="GO"/>
    <entity charOffset="127-146" id="s1239.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1239.e0" e2="s1239.e1" id="s1239.p0" relation="false"/>
  </sentence>
  <sentence id="s1240" text="We have recently demonstrated that DNA cellular protein catabolic process signaling from DNA double-strand breaks (DSBs) promotes PD-L1 upregulation in cancer cells.">
    <entity charOffset="39-73" id="s1240.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="152-158" id="s1240.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1240.e0" e2="s1240.e1" id="s1240.p0" relation="false"/>
  </sentence>
  <sentence id="s1241" text="Results Our cohort consisted mostly of children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic seizures at the severe positive regulation of protein phosphorylation of the spectrum to insidious hyperpigmentation and delayed development.">
    <entity charOffset="145-153" id="s1241.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="168-214" id="s1241.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1241.e0" e2="s1241.e1" id="s1241.p0" relation="true"/>
  </sentence>
  <sentence id="s1242" text="Growing evidence suggests that mitochondrial dysfunction is an early event in sporadic Alzheimer's disease (AD), but the negative regulation of transcription by RNA polymerase II of mitochondrial dysfunction on the transition from healthy aging to AD remains elusive.">
    <entity charOffset="78-86" id="s1242.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="121-178" id="s1242.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1242.e0" e2="s1242.e1" id="s1242.p0" relation="false"/>
  </sentence>
  <sentence id="s1243" text="In our study, we aim to investigate whether variants of magnesium ion homeostasis, potassium ion transmembrane transport, and KCNV2 genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.">
    <entity charOffset="56-81" id="s1243.e0" ontology_id="GO_0010960" text="magnesium ion homeostasis" type="GO"/>
    <entity charOffset="186-196" id="s1243.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s1243.e0" e2="s1243.e1" id="s1243.p0" relation="true"/>
  </sentence>
  <sentence id="s1244" text="In our study, we aim to investigate whether variants of magnesium ion homeostasis, potassium ion transmembrane transport, and KCNV2 genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.">
    <entity charOffset="83-120" id="s1244.e0" ontology_id="GO_0071805" text="potassium ion transmembrane transport" type="GO"/>
    <entity charOffset="186-196" id="s1244.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s1244.e0" e2="s1244.e1" id="s1244.p0" relation="true"/>
  </sentence>
  <sentence id="s1245" text="In the present study, we sought to identify the factors involved in the RAR&amp;amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (blood coagulation) in hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="130-135" id="s1245.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="243-279" id="s1245.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1245.e0" e2="s1245.e1" id="s1245.p0" relation="false"/>
  </sentence>
  <sentence id="s1246" text="In the present study, we sought to identify the factors involved in the RAR&amp;amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (blood coagulation) in hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="195-212" id="s1246.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="217-241" id="s1246.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1246.e0" e2="s1246.e1" id="s1246.p0" relation="false"/>
  </sentence>
  <sentence id="s1247" text="The musculo-aponeurotic fibrosarcoma oncogene homolog B (MAFB) significantly enhanced the activation of the blood coagulation promoter via RAR&amp;amp;alpha; while positive regulation of transcription by RNA polymerase II inhibited it.">
    <entity charOffset="24-36" id="s1247.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="108-125" id="s1247.e1" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <pair e1="s1247.e0" e2="s1247.e1" id="s1247.p0" relation="false"/>
  </sentence>
  <sentence id="s1248" text="The musculo-aponeurotic fibrosarcoma oncogene homolog B (MAFB) significantly enhanced the activation of the blood coagulation promoter via RAR&amp;amp;alpha; while positive regulation of transcription by RNA polymerase II inhibited it.">
    <entity charOffset="24-36" id="s1248.e0" ontology_id="HP_0100244" text="fibrosarcoma" type="HP"/>
    <entity charOffset="160-217" id="s1248.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1248.e0" e2="s1248.e1" id="s1248.p0" relation="false"/>
  </sentence>
  <sentence id="s1249" text="These results suggest that MAFB and positive regulation of transcription by RNA polymerase II play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as TFPI2 and can be promising for developing therapies to combat HCC invasion">
    <entity charOffset="36-93" id="s1249.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="125-130" id="s1249.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1249.e0" e2="s1249.e1" id="s1249.p0" relation="false"/>
  </sentence>
  <sentence id="s1250" text="Naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells adhere to tumor slices in proportion to the abundance of chemotaxis-producing macrophages.">
    <entity charOffset="40-45" id="s1250.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="87-97" id="s1250.e1" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <pair e1="s1250.e0" e2="s1250.e1" id="s1250.p0" relation="false"/>
  </sentence>
  <sentence id="s1251" text="Moreover, adoptively transferred human naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells infiltrate human breast cancer orthotopic xenografts in a chemotaxis-dependent manner.">
    <entity charOffset="93-99" id="s1251.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-137" id="s1251.e1" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <pair e1="s1251.e0" e2="s1251.e1" id="s1251.p0" relation="false"/>
  </sentence>
  <sentence id="s1252" text="In human breast cancer xenografts in humanized epidermis development, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="16-22" id="s1252.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="47-68" id="s1252.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1252.e0" e2="s1252.e1" id="s1252.p0" relation="false"/>
  </sentence>
  <sentence id="s1253" text="In human breast cancer xenografts in humanized epidermis development, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="16-22" id="s1253.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="174-215" id="s1253.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="s1253.e0" e2="s1253.e1" id="s1253.p0" relation="false"/>
  </sentence>
  <sentence id="s1254" text="In human breast cancer xenografts in humanized epidermis development, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="16-22" id="s1254.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="219-229" id="s1254.e1" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <pair e1="s1254.e0" e2="s1254.e1" id="s1254.p0" relation="false"/>
  </sentence>
  <sentence id="s1255" text="In human breast cancer xenografts in humanized epidermis development, blocking the recruitment of naive CD4&lt;sup&gt;+&lt;/sup&gt; T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
    <entity charOffset="47-68" id="s1255.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="133-138" id="s1255.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1255.e0" e2="s1255.e1" id="s1255.p0" relation="false"/>
  </sentence>
  <sentence id="s1256" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with phosphatidylinositol biosynthetic process recognition of chemotaxis may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="57-62" id="s1256.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="141-151" id="s1256.e1" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <pair e1="s1256.e0" e2="s1256.e1" id="s1256.p0" relation="false"/>
  </sentence>
  <sentence id="s1257" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with phosphatidylinositol biosynthetic process recognition of chemotaxis may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="84-125" id="s1257.e0" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <entity charOffset="190-196" id="s1257.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1257.e0" e2="s1257.e1" id="s1257.p0" relation="false"/>
  </sentence>
  <sentence id="s1258" text="Inhibiting naive CD4&lt;sup&gt;+&lt;/sup&gt; T cell recruitment into tumors by interfering with phosphatidylinositol biosynthetic process recognition of chemotaxis may be an attractive strategy for anticancer immunotherapy">
    <entity charOffset="141-151" id="s1258.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="190-196" id="s1258.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1258.e0" e2="s1258.e1" id="s1258.p0" relation="false"/>
  </sentence>
  <sentence id="s1259" text="The molecular signatures unique to primary and metastatic LMSs may somatic diversification of immunoglobulins in understanding tumor progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.">
    <entity charOffset="67-109" id="s1259.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="127-132" id="s1259.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1259.e0" e2="s1259.e1" id="s1259.p0" relation="false"/>
  </sentence>
  <sentence id="s1260" text="The molecular signatures unique to primary and metastatic LMSs may somatic diversification of immunoglobulins in understanding tumor progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.">
    <entity charOffset="67-109" id="s1260.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="153-159" id="s1260.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1260.e0" e2="s1260.e1" id="s1260.p0" relation="false"/>
  </sentence>
  <sentence id="s1261" text="Fungal immunomodulatory protein from &lt;i&gt;Nectria haematococca&lt;/i&gt; (positive regulation of transcription from RNA polymerase II promoter by glucose-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options.">
    <entity charOffset="66-145" id="s1261.e0" ontology_id="GO_0000432" text="positive regulation of transcription from RNA polymerase II promoter by glucose" type="GO"/>
    <entity charOffset="175-181" id="s1261.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1261.e0" e2="s1261.e1" id="s1261.p0" relation="false"/>
  </sentence>
  <sentence id="s1262" text="Thus, we comprehensively revealed the anti-tumor mechanism of positive regulation of transcription from RNA polymerase II promoter by glucose-nha, which inhibits tumor growth by modulating PI3K/positive regulation of protein phosphorylation-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha">
    <entity charOffset="43-48" id="s1262.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="62-141" id="s1262.e1" ontology_id="GO_0000432" text="positive regulation of transcription from RNA polymerase II promoter by glucose" type="GO"/>
    <pair e1="s1262.e0" e2="s1262.e1" id="s1262.p0" relation="false"/>
  </sentence>
  <sentence id="s1263" text="Thus, we comprehensively revealed the anti-tumor mechanism of positive regulation of transcription from RNA polymerase II promoter by glucose-nha, which inhibits tumor growth by modulating PI3K/positive regulation of protein phosphorylation-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha">
    <entity charOffset="43-48" id="s1263.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="194-240" id="s1263.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1263.e0" e2="s1263.e1" id="s1263.p0" relation="true"/>
  </sentence>
  <sentence id="s1264" text="High mobility group A2 (negative regulation of transcription by RNA polymerase II) plays a crucial role in the development of cancer.">
    <entity charOffset="24-81" id="s1264.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="126-132" id="s1264.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1264.e0" e2="s1264.e1" id="s1264.p0" relation="true"/>
  </sentence>
  <sentence id="s1265" text="However, the mechanism by which negative regulation of transcription by RNA polymerase II promotes the growth of hepatocellular carcinoma (phosphatidylinositol phosphorylation) remains unclear.">
    <entity charOffset="32-89" id="s1265.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="113-137" id="s1265.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1265.e0" e2="s1265.e1" id="s1265.p0" relation="false"/>
  </sentence>
  <sentence id="s1266" text="However, the mechanism by which negative regulation of transcription by RNA polymerase II promotes the growth of hepatocellular carcinoma (phosphatidylinositol phosphorylation) remains unclear.">
    <entity charOffset="113-137" id="s1266.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="139-175" id="s1266.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1266.e0" e2="s1266.e1" id="s1266.p0" relation="false"/>
  </sentence>
  <sentence id="s1267" text="To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.">
    <entity charOffset="80-135" id="s1267.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="272-277" id="s1267.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1267.e0" e2="s1267.e1" id="s1267.p0" relation="true"/>
  </sentence>
  <sentence id="s1268" text="To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.">
    <entity charOffset="136-155" id="s1268.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="272-277" id="s1268.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1268.e0" e2="s1268.e1" id="s1268.p0" relation="true"/>
  </sentence>
  <sentence id="s1269" text="To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.">
    <entity charOffset="272-277" id="s1269.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="315-325" id="s1269.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s1269.e0" e2="s1269.e1" id="s1269.p0" relation="true"/>
  </sentence>
  <sentence id="s1270" text="To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.">
    <entity charOffset="272-277" id="s1270.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="327-350" id="s1270.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1270.e0" e2="s1270.e1" id="s1270.p0" relation="true"/>
  </sentence>
  <sentence id="s1271" text="To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.">
    <entity charOffset="272-277" id="s1271.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="364-379" id="s1271.e1" ontology_id="GO_0006298" text="mismatch repair" type="GO"/>
    <pair e1="s1271.e0" e2="s1271.e1" id="s1271.p0" relation="true"/>
  </sentence>
  <sentence id="s1272" text="To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.">
    <entity charOffset="272-277" id="s1272.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="419-453" id="s1272.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1272.e0" e2="s1272.e1" id="s1272.p0" relation="false"/>
  </sentence>
  <sentence id="s1273" text="This report describes for the first time a patient with regulation of exocytosis deficiency presenting with cortical dysplasia (polymicrogyria), developmental delay, and platelet secretion defect">
    <entity charOffset="56-80" id="s1273.e0" ontology_id="GO_0017157" text="regulation of exocytosis" type="GO"/>
    <entity charOffset="108-126" id="s1273.e1" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <pair e1="s1273.e0" e2="s1273.e1" id="s1273.p0" relation="false"/>
  </sentence>
  <sentence id="s1274" text="This report describes for the first time a patient with regulation of exocytosis deficiency presenting with cortical dysplasia (polymicrogyria), developmental delay, and platelet secretion defect">
    <entity charOffset="56-80" id="s1274.e0" ontology_id="GO_0017157" text="regulation of exocytosis" type="GO"/>
    <entity charOffset="145-164" id="s1274.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1274.e0" e2="s1274.e1" id="s1274.p0" relation="false"/>
  </sentence>
  <sentence id="s1275" text="The present study demonstrated that coronin 3 is significantly upregulated in clinical primary hepatocellular carcinoma (phosphatidylinositol phosphorylation) samples by reverse transcriptionquantitative polymerase chain reaction (RTqPCR) and immunohistochemical staining.">
    <entity charOffset="95-119" id="s1275.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="121-157" id="s1275.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1275.e0" e2="s1275.e1" id="s1275.p0" relation="false"/>
  </sentence>
  <sentence id="s1276" text="In conclusion, these results indicated that coronin3 is significantly dysregulated in phosphatidylinositol phosphorylation tumor tissues, and may exert its function via regulating G6PC3 expression.">
    <entity charOffset="86-122" id="s1276.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="123-128" id="s1276.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1276.e0" e2="s1276.e1" id="s1276.p0" relation="false"/>
  </sentence>
  <sentence id="s1277" text="E168d2 epidermis development carry a frameshift mutation in the positive regulation of transcription by RNA polymerase II activation domain, Glu168del2, which is associated with severe dominant CoRD or clathrin coat assembly in humans.">
    <entity charOffset="7-28" id="s1277.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="178-184" id="s1277.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s1277.e0" e2="s1277.e1" id="s1277.p0" relation="false"/>
  </sentence>
  <sentence id="s1278" text="E168d2 epidermis development carry a frameshift mutation in the positive regulation of transcription by RNA polymerase II activation domain, Glu168del2, which is associated with severe dominant CoRD or clathrin coat assembly in humans.">
    <entity charOffset="64-121" id="s1278.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="178-184" id="s1278.e1" ontology_id="HP_0012828" text="severe" type="HP"/>
    <pair e1="s1278.e0" e2="s1278.e1" id="s1278.p0" relation="false"/>
  </sentence>
  <sentence id="s1279" text="E168d2 epidermis development carry a frameshift mutation in the positive regulation of transcription by RNA polymerase II activation domain, Glu168del2, which is associated with severe dominant CoRD or clathrin coat assembly in humans.">
    <entity charOffset="178-184" id="s1279.e0" ontology_id="HP_0012828" text="severe" type="HP"/>
    <entity charOffset="202-224" id="s1279.e1" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <pair e1="s1279.e0" e2="s1279.e1" id="s1279.p0" relation="false"/>
  </sentence>
  <sentence id="s1280" text="We describe a previously unreported syndrome characterized by secondary (post-natal) microcephaly with fronto-temporal negative regulation of protein kinase activity hypoplasia, multiple pituitary hormone deficiency, seizures, severe visual impairment and abnormalities of the kidneys and urinary tract in a highly consanguineous family with six affected children.">
    <entity charOffset="85-97" id="s1280.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="119-165" id="s1280.e1" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <pair e1="s1280.e0" e2="s1280.e1" id="s1280.p0" relation="false"/>
  </sentence>
  <sentence id="s1281" text="We also show expression of response to hypoxia within the central nervous system, including the hypothalamus, as well as the renal tract during human embryonic development.">
    <entity charOffset="27-46" id="s1281.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="58-65" id="s1281.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s1281.e0" e2="s1281.e1" id="s1281.p0" relation="false"/>
  </sentence>
  <sentence id="s1282" text="The progressive neurological abnormalities, congenital hypopituitarism and post-retinal visual pathway dysfunction in affected individuals demonstrates for the first time the essential role of response to hypoxia in the development of the hypothalamo-pituitary axis, post-natal brain growth, and visual and renal function in humans.">
    <entity charOffset="55-70" id="s1282.e0" ontology_id="HP_0040075" text="hypopituitarism" type="HP"/>
    <entity charOffset="193-212" id="s1282.e1" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <pair e1="s1282.e0" e2="s1282.e1" id="s1282.p0" relation="true"/>
  </sentence>
  <sentence id="s1283" text="Recently a homozygous mutation, Gly372Ser, in the release of cytochrome c from mitochondria gene, was reported in an abstract form, in three sibs who suffered from intractable epilepsy and developmental delay accompanied by 3-methylglutaconic aciduria.">
    <entity charOffset="50-91" id="s1283.e0" ontology_id="GO_0001836" text="release of cytochrome c from mitochondria" type="GO"/>
    <entity charOffset="176-184" id="s1283.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1283.e0" e2="s1283.e1" id="s1283.p0" relation="false"/>
  </sentence>
  <sentence id="s1284" text="Recently a homozygous mutation, Gly372Ser, in the release of cytochrome c from mitochondria gene, was reported in an abstract form, in three sibs who suffered from intractable epilepsy and developmental delay accompanied by 3-methylglutaconic aciduria.">
    <entity charOffset="50-91" id="s1284.e0" ontology_id="GO_0001836" text="release of cytochrome c from mitochondria" type="GO"/>
    <entity charOffset="189-208" id="s1284.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1284.e0" e2="s1284.e1" id="s1284.p0" relation="true"/>
  </sentence>
  <sentence id="s1285" text="Given the phenotypic similarity, we conclude that missense mutations in release of cytochrome c from mitochondria are likely manifesting by severe intellectual disability and epilepsy accompanied by 3-methylglutaconic aciduria and variable mitochondrial complex V deficiency.">
    <entity charOffset="72-113" id="s1285.e0" ontology_id="GO_0001836" text="release of cytochrome c from mitochondria" type="GO"/>
    <entity charOffset="175-183" id="s1285.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1285.e0" e2="s1285.e1" id="s1285.p0" relation="false"/>
  </sentence>
  <sentence id="s1286" text="Given the phenotypic similarity, we conclude that missense mutations in release of cytochrome c from mitochondria are likely manifesting by severe intellectual disability and epilepsy accompanied by 3-methylglutaconic aciduria and variable mitochondrial complex V deficiency.">
    <entity charOffset="72-113" id="s1286.e0" ontology_id="GO_0001836" text="release of cytochrome c from mitochondria" type="GO"/>
    <entity charOffset="147-170" id="s1286.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1286.e0" e2="s1286.e1" id="s1286.p0" relation="true"/>
  </sentence>
  <sentence id="s1287" text="Biallelic mutations in the protein dephosphorylation gene have been identified in one family with demyelinating Charcot-Marie-Tooth disease (CMT4B3) and two families with axonal neuropathy and additional neurological and skeletal features.">
    <entity charOffset="27-52" id="s1287.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="178-188" id="s1287.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1287.e0" e2="s1287.e1" id="s1287.p0" relation="true"/>
  </sentence>
  <sentence id="s1288" text="Here we describe novel sequence variants in protein dephosphorylation (c.1168C&amp;gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.">
    <entity charOffset="44-69" id="s1288.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="176-186" id="s1288.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1288.e0" e2="s1288.e1" id="s1288.p0" relation="true"/>
  </sentence>
  <sentence id="s1289" text="Here we describe novel sequence variants in protein dephosphorylation (c.1168C&amp;gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.">
    <entity charOffset="44-69" id="s1289.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="188-200" id="s1289.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1289.e0" e2="s1289.e1" id="s1289.p0" relation="false"/>
  </sentence>
  <sentence id="s1290" text="Our findings suggest that protein dephosphorylation mutations may cause a syndromic form of autosomal recessive axonal neuropathy (AR-CMT2) in addition to CMT4B3">
    <entity charOffset="26-51" id="s1290.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="119-129" id="s1290.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1290.e0" e2="s1290.e1" id="s1290.p0" relation="true"/>
  </sentence>
  <sentence id="s1291" text="Our findings suggest that protein dephosphorylation mutations may cause a syndromic form of autosomal recessive axonal neuropathy (AR-CMT2) in addition to CMT4B3">
    <entity charOffset="26-51" id="s1291.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="92-111" id="s1291.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1291.e0" e2="s1291.e1" id="s1291.p0" relation="true"/>
  </sentence>
  <sentence id="s1292" text="Having used a similar strategy for the in silico evaluation of 150 mutations of &lt;i&gt;CYP21A2&lt;/i&gt;, the disease-causing gene in congenital adrenal hyperplasia, we now provide a full structural explanation for the clinical severity of AME resulting from each known &lt;i&gt;glucocorticoid biosynthetic process&lt;/i&gt; missense mutation.">
    <entity charOffset="135-154" id="s1292.e0" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <entity charOffset="263-298" id="s1292.e1" ontology_id="GO_0006704" text="glucocorticoid biosynthetic process" type="GO"/>
    <pair e1="s1292.e0" e2="s1292.e1" id="s1292.p0" relation="false"/>
  </sentence>
  <sentence id="s1293" text="Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (cytokine production).">
    <entity charOffset="12-28" id="s1293.e0" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <entity charOffset="145-164" id="s1293.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s1293.e0" e2="s1293.e1" id="s1293.p0" relation="false"/>
  </sentence>
  <sentence id="s1294" text="Here we show that regulation of mitochondrial membrane potential (regulation of mitochondrial membrane potential), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma.">
    <entity charOffset="18-64" id="s1294.e0" ontology_id="GO_0051881" text="regulation of mitochondrial membrane potential" type="GO"/>
    <entity charOffset="269-285" id="s1294.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1294.e0" e2="s1294.e1" id="s1294.p0" relation="false"/>
  </sentence>
  <sentence id="s1295" text="Here we show that regulation of mitochondrial membrane potential (regulation of mitochondrial membrane potential), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma.">
    <entity charOffset="66-112" id="s1295.e0" ontology_id="GO_0051881" text="regulation of mitochondrial membrane potential" type="GO"/>
    <entity charOffset="269-285" id="s1295.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1295.e0" e2="s1295.e1" id="s1295.p0" relation="false"/>
  </sentence>
  <sentence id="s1296" text="regulation of mitochondrial membrane potential&lt;sup&gt;fl/fl&lt;/sup&gt;;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide cytokine production, histologically similar to human metaplastic breast carcinomas.">
    <entity charOffset="0-46" id="s1296.e0" ontology_id="GO_0051881" text="regulation of mitochondrial membrane potential" type="GO"/>
    <entity charOffset="206-222" id="s1296.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1296.e0" e2="s1296.e1" id="s1296.p0" relation="false"/>
  </sentence>
  <sentence id="s1297" text="regulation of mitochondrial membrane potential&lt;sup&gt;fl/fl&lt;/sup&gt;;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide cytokine production, histologically similar to human metaplastic breast carcinomas.">
    <entity charOffset="141-160" id="s1297.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="206-222" id="s1297.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s1297.e0" e2="s1297.e1" id="s1297.p0" relation="false"/>
  </sentence>
  <sentence id="s1298" text="High expression of Chemokine receptor 4 (G protein-coupled receptor signaling pathway) is important in tumor invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung cancer (NSCLC).">
    <entity charOffset="41-85" id="s1298.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="103-108" id="s1298.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1298.e0" e2="s1298.e1" id="s1298.p0" relation="true"/>
  </sentence>
  <sentence id="s1299" text="We therefore studied the molecular characteristics of drug-resistant G protein-coupled receptor signaling pathway-positive cells on epithelial-mesenchymal transition (cytokine production) for the future identification of the tumor cells with the properties of both EMT and stemness.">
    <entity charOffset="69-113" id="s1299.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="225-230" id="s1299.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1299.e0" e2="s1299.e1" id="s1299.p0" relation="true"/>
  </sentence>
  <sentence id="s1300" text="We therefore studied the molecular characteristics of drug-resistant G protein-coupled receptor signaling pathway-positive cells on epithelial-mesenchymal transition (cytokine production) for the future identification of the tumor cells with the properties of both EMT and stemness.">
    <entity charOffset="167-186" id="s1300.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="225-230" id="s1300.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1300.e0" e2="s1300.e1" id="s1300.p0" relation="true"/>
  </sentence>
  <sentence id="s1301" text="Elevated cytokines, such as interferon (blood coagulation)-, interleukin (IL)-6 and tumor necrosis factor  decreased to normal levels after splenectomy whereas IL-10 remained high.">
    <entity charOffset="40-57" id="s1301.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="85-90" id="s1301.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1301.e0" e2="s1301.e1" id="s1301.p0" relation="false"/>
  </sentence>
  <sentence id="s1302" text="Friedreich's ataxia (regulation of ferrochelatase activity) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (FXN).">
    <entity charOffset="13-19" id="s1302.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="21-58" id="s1302.e1" ontology_id="GO_0010722" text="regulation of ferrochelatase activity" type="GO"/>
    <pair e1="s1302.e0" e2="s1302.e1" id="s1302.p0" relation="true"/>
  </sentence>
  <sentence id="s1303" text="Recent studies indicated that the estrogen receptor beta (ER) could affect the progression of prostate and bladder tumors, however, its roles in the renal cell carcinoma (response to hydroperoxide), remain to be elucidated.">
    <entity charOffset="150-170" id="s1303.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="172-197" id="s1303.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s1303.e0" e2="s1303.e1" id="s1303.p0" relation="false"/>
  </sentence>
  <sentence id="s1304" text="Here, we demonstrate that transgenic targeting of response to oxidative stress to mitochondria confers significant protection from diet-induced obesity, insulin resistance, and adipose tissue inflammation.">
    <entity charOffset="50-78" id="s1304.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="144-151" id="s1304.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1304.e0" e2="s1304.e1" id="s1304.p0" relation="false"/>
  </sentence>
  <sentence id="s1305" text="cerebral cortex development gene mutations have been linked recently to autosomal recessive mental retardation 13 (MRT13; MIM#613192) with only eight families reported world-wide.">
    <entity charOffset="0-27" id="s1305.e0" ontology_id="GO_0021987" text="cerebral cortex development" type="GO"/>
    <entity charOffset="72-91" id="s1305.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1305.e0" e2="s1305.e1" id="s1305.p0" relation="true"/>
  </sentence>
  <sentence id="s1306" text="Mutations in cerebral cortex development should be considered in non-syndromic autosomal recessive intellectual disability with severe speech disorder">
    <entity charOffset="13-40" id="s1306.e0" ontology_id="GO_0021987" text="cerebral cortex development" type="GO"/>
    <entity charOffset="79-98" id="s1306.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1306.e0" e2="s1306.e1" id="s1306.p0" relation="true"/>
  </sentence>
  <sentence id="s1307" text="Mutations in cerebral cortex development should be considered in non-syndromic autosomal recessive intellectual disability with severe speech disorder">
    <entity charOffset="13-40" id="s1307.e0" ontology_id="GO_0021987" text="cerebral cortex development" type="GO"/>
    <entity charOffset="99-122" id="s1307.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1307.e0" e2="s1307.e1" id="s1307.p0" relation="true"/>
  </sentence>
  <sentence id="s1308" text="Rare forms of autosomal-dominant Charcot-Marie-Tooth disease (AD-CMT) may be associated with mutations in Fibulin-5 (secretion) as AD-CMT is genetically heterogeneous.">
    <entity charOffset="117-126" id="s1308.e0" ontology_id="GO_0046903" text="secretion" type="GO"/>
    <entity charOffset="153-166" id="s1308.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1308.e0" e2="s1308.e1" id="s1308.p0" relation="true"/>
  </sentence>
  <sentence id="s1309" text="The incidence of thyroid cancer has increased the past few decades, the most frequent muscle organ development has been identified to be the papillary thyroid carcinoma (biological_process).">
    <entity charOffset="25-31" id="s1309.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="86-110" id="s1309.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1309.e0" e2="s1309.e1" id="s1309.p0" relation="false"/>
  </sentence>
  <sentence id="s1310" text="The incidence of thyroid cancer has increased the past few decades, the most frequent muscle organ development has been identified to be the papillary thyroid carcinoma (biological_process).">
    <entity charOffset="25-31" id="s1310.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="170-188" id="s1310.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1310.e0" e2="s1310.e1" id="s1310.p0" relation="false"/>
  </sentence>
  <sentence id="s1311" text="The incidence of thyroid cancer has increased the past few decades, the most frequent muscle organ development has been identified to be the papillary thyroid carcinoma (biological_process).">
    <entity charOffset="86-110" id="s1311.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="141-168" id="s1311.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s1311.e0" e2="s1311.e1" id="s1311.p0" relation="false"/>
  </sentence>
  <sentence id="s1312" text="The incidence of thyroid cancer has increased the past few decades, the most frequent muscle organ development has been identified to be the papillary thyroid carcinoma (biological_process).">
    <entity charOffset="141-168" id="s1312.e0" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <entity charOffset="170-188" id="s1312.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1312.e0" e2="s1312.e1" id="s1312.p0" relation="false"/>
  </sentence>
  <sentence id="s1313" text="Overexpression of translational initiation7 inhibited the proliferation and increased the radioiodine uptake ability of biological_process cells invitro and inhibited the tumor growth invivo.">
    <entity charOffset="18-42" id="s1313.e0" ontology_id="GO_0006413" text="translational initiation" type="GO"/>
    <entity charOffset="172-177" id="s1313.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1313.e0" e2="s1313.e1" id="s1313.p0" relation="false"/>
  </sentence>
  <sentence id="s1314" text="Overexpression of translational initiation7 inhibited the proliferation and increased the radioiodine uptake ability of biological_process cells invitro and inhibited the tumor growth invivo.">
    <entity charOffset="120-138" id="s1314.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="172-177" id="s1314.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1314.e0" e2="s1314.e1" id="s1314.p0" relation="false"/>
  </sentence>
  <sentence id="s1315" text="In conclusion, translational initiation7 may coenzyme A biosynthetic process as a tumor suppressor in biological_process by inhibiting the positive regulation of cell proliferation signaling pathway and may be a promising therapeutic target in patients with PTC">
    <entity charOffset="15-39" id="s1315.e0" ontology_id="GO_0006413" text="translational initiation" type="GO"/>
    <entity charOffset="82-87" id="s1315.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1315.e0" e2="s1315.e1" id="s1315.p0" relation="false"/>
  </sentence>
  <sentence id="s1316" text="In conclusion, translational initiation7 may coenzyme A biosynthetic process as a tumor suppressor in biological_process by inhibiting the positive regulation of cell proliferation signaling pathway and may be a promising therapeutic target in patients with PTC">
    <entity charOffset="45-76" id="s1316.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="82-87" id="s1316.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1316.e0" e2="s1316.e1" id="s1316.p0" relation="false"/>
  </sentence>
  <sentence id="s1317" text="In conclusion, translational initiation7 may coenzyme A biosynthetic process as a tumor suppressor in biological_process by inhibiting the positive regulation of cell proliferation signaling pathway and may be a promising therapeutic target in patients with PTC">
    <entity charOffset="82-87" id="s1317.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="102-120" id="s1317.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1317.e0" e2="s1317.e1" id="s1317.p0" relation="false"/>
  </sentence>
  <sentence id="s1318" text="In conclusion, translational initiation7 may coenzyme A biosynthetic process as a tumor suppressor in biological_process by inhibiting the positive regulation of cell proliferation signaling pathway and may be a promising therapeutic target in patients with PTC">
    <entity charOffset="82-87" id="s1318.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="139-180" id="s1318.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1318.e0" e2="s1318.e1" id="s1318.p0" relation="true"/>
  </sentence>
  <sentence id="s1319" text="The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, biological_process, fatty acid beta-oxidation using acyl-CoA dehydrogenase, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.">
    <entity charOffset="4-9" id="s1319.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="60-78" id="s1319.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1319.e0" e2="s1319.e1" id="s1319.p0" relation="false"/>
  </sentence>
  <sentence id="s1320" text="The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, biological_process, fatty acid beta-oxidation using acyl-CoA dehydrogenase, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.">
    <entity charOffset="4-9" id="s1320.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="80-134" id="s1320.e1" ontology_id="GO_0033539" text="fatty acid beta-oxidation using acyl-CoA dehydrogenase" type="GO"/>
    <pair e1="s1320.e0" e2="s1320.e1" id="s1320.p0" relation="false"/>
  </sentence>
  <sentence id="s1321" text="Sheldon-Hall syndrome (activation of innate immune response) is the most common of the distal arthrogryposes (DAs), a group of disorders characterized by congenital non-progressive contractures.">
    <entity charOffset="23-59" id="s1321.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="181-193" id="s1321.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s1321.e0" e2="s1321.e1" id="s1321.p0" relation="true"/>
  </sentence>
  <sentence id="s1322" text="Sheldon-Hall syndrome (activation of innate immune response) is the most common of the distal arthrogryposes (DAs), a group of disorders characterized by congenital non-progressive contractures.">
    <entity charOffset="23-59" id="s1322.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="87-93" id="s1322.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s1322.e0" e2="s1322.e1" id="s1322.p0" relation="false"/>
  </sentence>
  <sentence id="s1323" text="Patients with activation of innate immune response present with contractures of the limbs and a distinctive triangular facies with prominent nasolabial folds.">
    <entity charOffset="14-50" id="s1323.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="64-76" id="s1323.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s1323.e0" e2="s1323.e1" id="s1323.p0" relation="true"/>
  </sentence>
  <sentence id="s1324" text="Patients with activation of innate immune response present with contractures of the limbs and a distinctive triangular facies with prominent nasolabial folds.">
    <entity charOffset="14-50" id="s1324.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="108-125" id="s1324.e1" ontology_id="HP_0000325" text="triangular facies" type="HP"/>
    <pair e1="s1324.e0" e2="s1324.e1" id="s1324.p0" relation="true"/>
  </sentence>
  <sentence id="s1325" text="skeletal muscle contraction plays a pivotal role in fetal muscle development and mutations in this gene are associated with Freeman-Sheldon syndrome, distal arthrogryposis 8 (DA8), and autosomal dominant spondylocarpotarsal synostosis.">
    <entity charOffset="0-27" id="s1325.e0" ontology_id="GO_0003009" text="skeletal muscle contraction" type="GO"/>
    <entity charOffset="150-156" id="s1325.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s1325.e0" e2="s1325.e1" id="s1325.p0" relation="false"/>
  </sentence>
  <sentence id="s1326" text="skeletal muscle contraction plays a pivotal role in fetal muscle development and mutations in this gene are associated with Freeman-Sheldon syndrome, distal arthrogryposis 8 (DA8), and autosomal dominant spondylocarpotarsal synostosis.">
    <entity charOffset="0-27" id="s1326.e0" ontology_id="GO_0003009" text="skeletal muscle contraction" type="GO"/>
    <entity charOffset="157-171" id="s1326.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s1326.e0" e2="s1326.e1" id="s1326.p0" relation="true"/>
  </sentence>
  <sentence id="s1327" text="We report the case of a boy with a novel pathogenic skeletal muscle contraction mutation, presenting with the classical clinical features of SHS in association with unilateral carpal bone fusion and multiple vertebral fusions.">
    <entity charOffset="52-79" id="s1327.e0" ontology_id="GO_0003009" text="skeletal muscle contraction" type="GO"/>
    <entity charOffset="208-225" id="s1327.e1" ontology_id="HP_0002948" text="vertebral fusions" type="HP"/>
    <pair e1="s1327.e0" e2="s1327.e1" id="s1327.p0" relation="true"/>
  </sentence>
  <sentence id="s1328" text="In a bone metastasis model, epidermis development treated with ZOL+US had osteolytic lesions that were 58% smaller than those of ZOL-treated animals as well as a reduced skeletal tumor burden.">
    <entity charOffset="28-49" id="s1328.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="179-184" id="s1328.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1328.e0" e2="s1328.e1" id="s1328.p0" relation="false"/>
  </sentence>
  <sentence id="s1329" text="Additionally, US forced the penetration of ZOL within tumors, as demonstrated by the intratumoral accumulation of unprenylated regulation of neurotransmitter receptor localization to postsynaptic specialization membrane, a surrogate marker of ZOL antitumor activity.">
    <entity charOffset="54-59" id="s1329.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="127-219" id="s1329.e1" ontology_id="GO_0098696" text="regulation of neurotransmitter receptor localization to postsynaptic specialization membrane" type="GO"/>
    <pair e1="s1329.e0" e2="s1329.e1" id="s1329.p0" relation="false"/>
  </sentence>
  <sentence id="s1330" text="Among these, heterozygous mutations in regulation of transcription by RNA polymerase II, a homeobox gene encoding a transcription factor expressed specifically by oocyte and granulosa cells within the ovary, have been reported in 6% of women with sporadic POI.">
    <entity charOffset="39-87" id="s1330.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="248-256" id="s1330.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1330.e0" e2="s1330.e1" id="s1330.p0" relation="false"/>
  </sentence>
  <sentence id="s1331" text="Mutations in negative regulation of keratinocyte proliferation cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome.">
    <entity charOffset="13-62" id="s1331.e0" ontology_id="GO_0010839" text="negative regulation of keratinocyte proliferation" type="GO"/>
    <entity charOffset="172-184" id="s1331.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1331.e0" e2="s1331.e1" id="s1331.p0" relation="true"/>
  </sentence>
  <sentence id="s1332" text="We identified integrin 7 (heterotypic cell-cell adhesion) as a major laminin receptor in GSCs and in primary high-grade glioma specimens.">
    <entity charOffset="27-57" id="s1332.e0" ontology_id="GO_0034113" text="heterotypic cell-cell adhesion" type="GO"/>
    <entity charOffset="121-127" id="s1332.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1332.e0" e2="s1332.e1" id="s1332.p0" relation="false"/>
  </sentence>
  <sentence id="s1333" text="Analyses of mRNA profiles in comprehensive datasets revealed that high heterotypic cell-cell adhesion expression negatively correlated with survival of patients with both low- and high-grade glioma.">
    <entity charOffset="71-101" id="s1333.e0" ontology_id="GO_0034113" text="heterotypic cell-cell adhesion" type="GO"/>
    <entity charOffset="191-197" id="s1333.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1333.e0" e2="s1333.e1" id="s1333.p0" relation="false"/>
  </sentence>
  <sentence id="s1334" text="We also found that targeting of heterotypic cell-cell adhesion by RNAi or blocking mAbs impaired laminin-induced signaling, and it led to a significant delay in tumor engraftment plus a strong reduction in tumor size and invasion.">
    <entity charOffset="32-62" id="s1334.e0" ontology_id="GO_0034113" text="heterotypic cell-cell adhesion" type="GO"/>
    <entity charOffset="161-166" id="s1334.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1334.e0" e2="s1334.e1" id="s1334.p0" relation="false"/>
  </sentence>
  <sentence id="s1335" text="Our data, therefore, highlight heterotypic cell-cell adhesion as a glioblastoma biomarker and candidate therapeutic target">
    <entity charOffset="31-61" id="s1335.e0" ontology_id="GO_0034113" text="heterotypic cell-cell adhesion" type="GO"/>
    <entity charOffset="67-79" id="s1335.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s1335.e0" e2="s1335.e1" id="s1335.p0" relation="false"/>
  </sentence>
  <sentence id="s1336" text="The presynaptic cytomatrix protein Piccolo, encoded by cytoskeleton organization, is frequently mutated and amplified in esophageal squamous cell carcinoma (ESCC), but its exact roles in ESCC remain unclear.">
    <entity charOffset="55-80" id="s1336.e0" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <entity charOffset="132-155" id="s1336.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s1336.e0" e2="s1336.e1" id="s1336.p0" relation="false"/>
  </sentence>
  <sentence id="s1337" text="These results demonstrate that Piccolo contributes to tumor aggressiveness in ESCC, likely by stabilizing positive regulation of protein phosphorylation and promoting EGFR-dependent signaling.">
    <entity charOffset="54-59" id="s1337.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="106-152" id="s1337.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1337.e0" e2="s1337.e1" id="s1337.p0" relation="true"/>
  </sentence>
  <sentence id="s1338" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1338.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="638-660" id="s1338.e1" ontology_id="GO_0000303" text="response to superoxide" type="GO"/>
    <pair e1="s1338.e0" e2="s1338.e1" id="s1338.p0" relation="false"/>
  </sentence>
  <sentence id="s1339" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1339.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="152-207" id="s1339.e1" ontology_id="GO_0006361" text="transcription initiation from RNA polymerase I promoter" type="GO"/>
    <pair e1="s1339.e0" e2="s1339.e1" id="s1339.p0" relation="false"/>
  </sentence>
  <sentence id="s1340" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1340.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="209-289" id="s1340.e1" ontology_id="GO_0006919" text="activation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <pair e1="s1340.e0" e2="s1340.e1" id="s1340.p0" relation="false"/>
  </sentence>
  <sentence id="s1341" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1341.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="307-338" id="s1341.e1" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <pair e1="s1341.e0" e2="s1341.e1" id="s1341.p0" relation="false"/>
  </sentence>
  <sentence id="s1342" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1342.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="340-358" id="s1342.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1342.e0" e2="s1342.e1" id="s1342.p0" relation="false"/>
  </sentence>
  <sentence id="s1343" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1343.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="383-448" id="s1343.e1" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <pair e1="s1343.e0" e2="s1343.e1" id="s1343.p0" relation="false"/>
  </sentence>
  <sentence id="s1344" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1344.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="450-495" id="s1344.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s1344.e0" e2="s1344.e1" id="s1344.p0" relation="false"/>
  </sentence>
  <sentence id="s1345" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1345.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="497-554" id="s1345.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1345.e0" e2="s1345.e1" id="s1345.p0" relation="false"/>
  </sentence>
  <sentence id="s1346" text="In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.">
    <entity charOffset="66-77" id="s1346.e0" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <entity charOffset="566-621" id="s1346.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s1346.e0" e2="s1346.e1" id="s1346.p0" relation="false"/>
  </sentence>
  <sentence id="s1347" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="44-91" id="s1347.e0" ontology_id="GO_0001672" text="regulation of chromatin assembly or disassembly" type="GO"/>
    <entity charOffset="188-194" id="s1347.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1347.e0" e2="s1347.e1" id="s1347.p0" relation="false"/>
  </sentence>
  <sentence id="s1348" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="97-137" id="s1348.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="188-194" id="s1348.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1348.e0" e2="s1348.e1" id="s1348.p0" relation="false"/>
  </sentence>
  <sentence id="s1349" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="188-194" id="s1349.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="201-246" id="s1349.e1" ontology_id="GO_0051984" text="positive regulation of chromosome segregation" type="GO"/>
    <pair e1="s1349.e0" e2="s1349.e1" id="s1349.p0" relation="false"/>
  </sentence>
  <sentence id="s1350" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="188-194" id="s1350.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="248-281" id="s1350.e1" ontology_id="GO_0070979" text="protein K11-linked ubiquitination" type="GO"/>
    <pair e1="s1350.e0" e2="s1350.e1" id="s1350.p0" relation="false"/>
  </sentence>
  <sentence id="s1351" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="188-194" id="s1351.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="283-302" id="s1351.e1" ontology_id="GO_0016925" text="protein sumoylation" type="GO"/>
    <pair e1="s1351.e0" e2="s1351.e1" id="s1351.p0" relation="false"/>
  </sentence>
  <sentence id="s1352" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="188-194" id="s1352.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="304-335" id="s1352.e1" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <pair e1="s1352.e0" e2="s1352.e1" id="s1352.p0" relation="true"/>
  </sentence>
  <sentence id="s1353" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="188-194" id="s1353.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="337-365" id="s1353.e1" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <pair e1="s1353.e0" e2="s1353.e1" id="s1353.p0" relation="false"/>
  </sentence>
  <sentence id="s1354" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="188-194" id="s1354.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="371-398" id="s1354.e1" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <pair e1="s1354.e0" e2="s1354.e1" id="s1354.p0" relation="false"/>
  </sentence>
  <sentence id="s1355" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="188-194" id="s1355.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="455-478" id="s1355.e1" ontology_id="GO_0035195" text="gene silencing by miRNA" type="GO"/>
    <pair e1="s1355.e0" e2="s1355.e1" id="s1355.p0" relation="false"/>
  </sentence>
  <sentence id="s1356" text="In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P&amp;lt;0.05) with overall breast cancer risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.">
    <entity charOffset="188-194" id="s1356.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="483-504" id="s1356.e1" ontology_id="GO_0009314" text="response to radiation" type="GO"/>
    <pair e1="s1356.e0" e2="s1356.e1" id="s1356.p0" relation="false"/>
  </sentence>
  <sentence id="s1357" text="Some of the RP genes are also associated with other retinal diseases, such as clathrin coat assembly (Leber's congenital amaurosis) and CORD (cone-rod dystrophy).">
    <entity charOffset="52-68" id="s1357.e0" ontology_id="HP_0000479" text="retinal diseases" type="HP"/>
    <entity charOffset="78-100" id="s1357.e1" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <pair e1="s1357.e0" e2="s1357.e1" id="s1357.p0" relation="false"/>
  </sentence>
  <sentence id="s1358" text="The severe generalized lipodystrophy in this patient with progeroid features has not previously been described in other patients with MFS and cell adhesion mediated by integrin mutations.">
    <entity charOffset="11-36" id="s1358.e0" ontology_id="HP_0009064" text="generalized lipodystrophy" type="HP"/>
    <entity charOffset="142-176" id="s1358.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s1358.e0" e2="s1358.e1" id="s1358.p0" relation="false"/>
  </sentence>
  <sentence id="s1359" text="Also as pro-angiogenic inducer, the role of activation of innate immune response in different redox states has never been defined in tumour angiogenesis.">
    <entity charOffset="44-80" id="s1359.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="133-139" id="s1359.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1359.e0" e2="s1359.e1" id="s1359.p0" relation="false"/>
  </sentence>
  <sentence id="s1360" text="activation of innate immune response orchestrates the key events of tumour angiogenesis, migration of ECs and their induction to secrete negative regulation of transcription by RNA polymerase II, by adopting distinct redox states.">
    <entity charOffset="0-36" id="s1360.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="68-74" id="s1360.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1360.e0" e2="s1360.e1" id="s1360.p0" relation="false"/>
  </sentence>
  <sentence id="s1361" text="activation of innate immune response orchestrates the key events of tumour angiogenesis, migration of ECs and their induction to secrete negative regulation of transcription by RNA polymerase II, by adopting distinct redox states.">
    <entity charOffset="68-74" id="s1361.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="137-194" id="s1361.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1361.e0" e2="s1361.e1" id="s1361.p0" relation="false"/>
  </sentence>
  <sentence id="s1362" text="Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating regulation of cell cycle/positive regulation of cell proliferation activity">
    <entity charOffset="60-65" id="s1362.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="117-158" id="s1362.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1362.e0" e2="s1362.e1" id="s1362.p0" relation="false"/>
  </sentence>
  <sentence id="s1363" text="Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating regulation of cell cycle/positive regulation of cell proliferation activity">
    <entity charOffset="60-65" id="s1363.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="92-116" id="s1363.e1" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <pair e1="s1363.e0" e2="s1363.e1" id="s1363.p0" relation="false"/>
  </sentence>
  <sentence id="s1364" text="A case with creatine biosynthetic process deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.">
    <entity charOffset="12-41" id="s1364.e0" ontology_id="GO_0006601" text="creatine biosynthetic process" type="GO"/>
    <entity charOffset="99-123" id="s1364.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s1364.e0" e2="s1364.e1" id="s1364.p0" relation="true"/>
  </sentence>
  <sentence id="s1365" text="A case with creatine biosynthetic process deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.">
    <entity charOffset="12-41" id="s1365.e0" ontology_id="GO_0006601" text="creatine biosynthetic process" type="GO"/>
    <entity charOffset="140-163" id="s1365.e1" ontology_id="HP_0000708" text="behavioral disturbances" type="HP"/>
    <pair e1="s1365.e0" e2="s1365.e1" id="s1365.p0" relation="false"/>
  </sentence>
  <sentence id="s1366" text="A case with creatine biosynthetic process deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.">
    <entity charOffset="12-41" id="s1366.e0" ontology_id="GO_0006601" text="creatine biosynthetic process" type="GO"/>
    <entity charOffset="169-173" id="s1366.e1" ontology_id="HP_0012825" text="mild" type="HP"/>
    <pair e1="s1366.e0" e2="s1366.e1" id="s1366.p0" relation="false"/>
  </sentence>
  <sentence id="s1367" text="The accuracy of this mouse model was emphasized by the finding that various central nervous system and noncentral nervous system tissues from PD patients manifested similar GM1 deficiency as the ganglioside biosynthetic process&lt;sup&gt;+/-&lt;/sup&gt; mouse.">
    <entity charOffset="76-83" id="s1367.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="195-227" id="s1367.e1" ontology_id="GO_0001574" text="ganglioside biosynthetic process" type="GO"/>
    <pair e1="s1367.e0" e2="s1367.e1" id="s1367.p0" relation="false"/>
  </sentence>
  <sentence id="s1368" text="By 3 months, zonular fibers invariably ruptured and epidermis development developed ectopia lentis, a hallmark of Marfan syndrome.">
    <entity charOffset="52-73" id="s1368.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="84-98" id="s1368.e1" ontology_id="HP_0001083" text="ectopia lentis" type="HP"/>
    <pair e1="s1368.e0" e2="s1368.e1" id="s1368.p0" relation="false"/>
  </sentence>
  <sentence id="s1369" text="Downregulation of -actinin-1 in E-integrin-mediated signaling pathway expressing basal-like breast cancer cells demonstrate that -actinin-1-assembled actin fibers destabilize E-cadherin-based adhesions.">
    <entity charOffset="35-70" id="s1369.e0" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <entity charOffset="100-106" id="s1369.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1369.e0" e2="s1369.e1" id="s1369.p0" relation="false"/>
  </sentence>
  <sentence id="s1370" text="Taken together, these results indicate that increased -actinin-1 expression destabilizes E-integrin-mediated signaling pathway-based adhesions, which is likely to promote the migratory potential of breast cancer cells.">
    <entity charOffset="92-127" id="s1370.e0" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <entity charOffset="206-212" id="s1370.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1370.e0" e2="s1370.e1" id="s1370.p0" relation="false"/>
  </sentence>
  <sentence id="s1371" text="Pure hair and natural killer cell activation involved in immune response ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of anatomical structure morphogenesis and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="14-72" id="s1371.e0" ontology_id="GO_0002323" text="natural killer cell activation involved in immune response" type="GO"/>
    <entity charOffset="73-93" id="s1371.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s1371.e0" e2="s1371.e1" id="s1371.p0" relation="false"/>
  </sentence>
  <sentence id="s1372" text="Pure hair and natural killer cell activation involved in immune response ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of anatomical structure morphogenesis and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="14-72" id="s1372.e0" ontology_id="GO_0002323" text="natural killer cell activation involved in immune response" type="GO"/>
    <entity charOffset="111-130" id="s1372.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1372.e0" e2="s1372.e1" id="s1372.p0" relation="false"/>
  </sentence>
  <sentence id="s1373" text="Pure hair and natural killer cell activation involved in immune response ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of anatomical structure morphogenesis and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="73-93" id="s1373.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="169-203" id="s1373.e1" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <pair e1="s1373.e0" e2="s1373.e1" id="s1373.p0" relation="true"/>
  </sentence>
  <sentence id="s1374" text="Pure hair and natural killer cell activation involved in immune response ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of anatomical structure morphogenesis and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="111-130" id="s1374.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="169-203" id="s1374.e1" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <pair e1="s1374.e0" e2="s1374.e1" id="s1374.p0" relation="true"/>
  </sentence>
  <sentence id="s1375" text="Pure hair and natural killer cell activation involved in immune response ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of anatomical structure morphogenesis and is characterized by hypotrichosis and nail dystrophy in humans.">
    <entity charOffset="169-203" id="s1375.e0" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <entity charOffset="228-241" id="s1375.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1375.e0" e2="s1375.e1" id="s1375.p0" relation="true"/>
  </sentence>
  <sentence id="s1376" text="Unlike patients with ECTD-9, anatomical structure morphogenesis-mutated mice and attachment of GPI anchor to protein do not faithfully recapitulate the phenotype of hypotrichosis, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically.">
    <entity charOffset="29-63" id="s1376.e0" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <entity charOffset="165-178" id="s1376.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1376.e0" e2="s1376.e1" id="s1376.p0" relation="true"/>
  </sentence>
  <sentence id="s1377" text="Unlike patients with ECTD-9, anatomical structure morphogenesis-mutated mice and attachment of GPI anchor to protein do not faithfully recapitulate the phenotype of hypotrichosis, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically.">
    <entity charOffset="81-116" id="s1377.e0" ontology_id="GO_0016255" text="attachment of GPI anchor to protein" type="GO"/>
    <entity charOffset="165-178" id="s1377.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1377.e0" e2="s1377.e1" id="s1377.p0" relation="false"/>
  </sentence>
  <sentence id="s1378" text="Therefore, our findings demonstrate that anatomical structure morphogenesis&lt;sup&gt;-/-&lt;/sup&gt; rabbits can be used as a model for human ECTD-9, especially to understand the pathologic mechanism of hypotrichosis.">
    <entity charOffset="41-75" id="s1378.e0" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <entity charOffset="192-205" id="s1378.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1378.e0" e2="s1378.e1" id="s1378.p0" relation="true"/>
  </sentence>
  <sentence id="s1379" text="Moreover, the disrupted balance between HFs and cell adhesion mediated by integrin, especially in the anatomical structure morphogenesis&lt;sup&gt;-/-&lt;/sup&gt; rabbits, can be used as an ideal animal model for dermatology ailments, such as acne and hypotrichosis, in preclinical studies.-Deng, J., Chen, M., Liu, Z., Song, Y., Sui, T., Lai, L., Li, Z.">
    <entity charOffset="48-82" id="s1379.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="240-253" id="s1379.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1379.e0" e2="s1379.e1" id="s1379.p0" relation="false"/>
  </sentence>
  <sentence id="s1380" text="Moreover, the disrupted balance between HFs and cell adhesion mediated by integrin, especially in the anatomical structure morphogenesis&lt;sup&gt;-/-&lt;/sup&gt; rabbits, can be used as an ideal animal model for dermatology ailments, such as acne and hypotrichosis, in preclinical studies.-Deng, J., Chen, M., Liu, Z., Song, Y., Sui, T., Lai, L., Li, Z.">
    <entity charOffset="102-136" id="s1380.e0" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <entity charOffset="240-253" id="s1380.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s1380.e0" e2="s1380.e1" id="s1380.p0" relation="true"/>
  </sentence>
  <sentence id="s1381" text="Context Multiple endocrine neoplasia muscle organ development 1 (negative regulation of transcription by RNA polymerase II) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.">
    <entity charOffset="27-36" id="s1381.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="65-122" id="s1381.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1381.e0" e2="s1381.e1" id="s1381.p0" relation="true"/>
  </sentence>
  <sentence id="s1382" text="Context Multiple endocrine neoplasia muscle organ development 1 (negative regulation of transcription by RNA polymerase II) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.">
    <entity charOffset="37-61" id="s1382.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="184-189" id="s1382.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1382.e0" e2="s1382.e1" id="s1382.p0" relation="false"/>
  </sentence>
  <sentence id="s1383" text="When her brother was found to harbor the same negative regulation of transcription by RNA polymerase II mutation as our proband and, around the same time, their father was diagnosed with a neuroendocrine carcinoma, this tumor was investigated for the MEN1 mutation as well.">
    <entity charOffset="46-103" id="s1383.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="220-225" id="s1383.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1383.e0" e2="s1383.e1" id="s1383.p0" relation="true"/>
  </sentence>
  <sentence id="s1384" text="In the histologic biopsy of this tumor, the same negative regulation of transcription by RNA polymerase II mutation was detected as previously found in his children.">
    <entity charOffset="33-38" id="s1384.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="49-106" id="s1384.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1384.e0" e2="s1384.e1" id="s1384.p0" relation="true"/>
  </sentence>
  <sentence id="s1385" text="Based on the array data, we concluded that the deletion was limited to the negative regulation of transcription by RNA polymerase II gene and that the father had both germline and somatic mosaicism for MEN1.">
    <entity charOffset="75-132" id="s1385.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="180-197" id="s1385.e1" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <pair e1="s1385.e0" e2="s1385.e1" id="s1385.p0" relation="false"/>
  </sentence>
  <sentence id="s1386" text="Conclusions To our knowledge, this is the first reported family with combined germline and somatic mosaicism for negative regulation of transcription by RNA polymerase II.">
    <entity charOffset="91-108" id="s1386.e0" ontology_id="HP_0001442" text="somatic mosaicism" type="HP"/>
    <entity charOffset="113-170" id="s1386.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1386.e0" e2="s1386.e1" id="s1386.p0" relation="false"/>
  </sentence>
  <sentence id="s1387" text="Genetic sequencing confirmed a homozygous R565Q missense mutation in the catalytic domain of phototransduction, visible light, a cone-specific phototransduction enzyme associated with achromatopsia in humans.">
    <entity charOffset="93-125" id="s1387.e0" ontology_id="GO_0007603" text="phototransduction, visible light" type="GO"/>
    <entity charOffset="184-197" id="s1387.e1" ontology_id="HP_0011516" text="achromatopsia" type="HP"/>
    <pair e1="s1387.e0" e2="s1387.e1" id="s1387.p0" relation="false"/>
  </sentence>
  <sentence id="s1388" text="Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in icosanoid metabolic process, which encodes thromboxane synthase (TXAS).">
    <entity charOffset="103-125" id="s1388.e0" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <entity charOffset="154-181" id="s1388.e1" ontology_id="GO_0006690" text="icosanoid metabolic process" type="GO"/>
    <pair e1="s1388.e0" e2="s1388.e1" id="s1388.p0" relation="true"/>
  </sentence>
  <sentence id="s1389" text="Three affected individuals from a small Bedouin activation of cysteine-type endopeptidase activity involved in apoptotic process presented with failure to thrive, hyponatremic dehydration and hyperkalemia with isolated sweat salt wasting.">
    <entity charOffset="48-128" id="s1389.e0" ontology_id="GO_0006919" text="activation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="144-161" id="s1389.e1" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <pair e1="s1389.e0" e2="s1389.e1" id="s1389.p0" relation="true"/>
  </sentence>
  <sentence id="s1390" text="Three affected individuals from a small Bedouin activation of cysteine-type endopeptidase activity involved in apoptotic process presented with failure to thrive, hyponatremic dehydration and hyperkalemia with isolated sweat salt wasting.">
    <entity charOffset="48-128" id="s1390.e0" ontology_id="GO_0006919" text="activation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="192-204" id="s1390.e1" ontology_id="HP_0002153" text="hyperkalemia" type="HP"/>
    <pair e1="s1390.e0" e2="s1390.e1" id="s1390.p0" relation="false"/>
  </sentence>
  <sentence id="s1391" text="Various genes (eg, SPG7, SYNE1, glycerophospholipid catabolic process) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one positive regulation of protein phosphorylation of the disease continuum and hereditary spastic paraplegia on the other.">
    <entity charOffset="32-69" id="s1391.e0" ontology_id="GO_0046475" text="glycerophospholipid catabolic process" type="GO"/>
    <entity charOffset="106-112" id="s1391.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1391.e0" e2="s1391.e1" id="s1391.p0" relation="true"/>
  </sentence>
  <sentence id="s1392" text="Various genes (eg, SPG7, SYNE1, glycerophospholipid catabolic process) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one positive regulation of protein phosphorylation of the disease continuum and hereditary spastic paraplegia on the other.">
    <entity charOffset="106-112" id="s1392.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="215-261" id="s1392.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1392.e0" e2="s1392.e1" id="s1392.p0" relation="false"/>
  </sentence>
  <sentence id="s1393" text="Other genes such as glucosylceramide catabolic process and anterograde neuronal dense core vesicle transport were almost simultaneously published as both a hereditary spastic paraplegia and an ataxia gene.">
    <entity charOffset="20-54" id="s1393.e0" ontology_id="GO_0006680" text="glucosylceramide catabolic process" type="GO"/>
    <entity charOffset="193-199" id="s1393.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1393.e0" e2="s1393.e1" id="s1393.p0" relation="true"/>
  </sentence>
  <sentence id="s1394" text="Other genes such as glucosylceramide catabolic process and anterograde neuronal dense core vesicle transport were almost simultaneously published as both a hereditary spastic paraplegia and an ataxia gene.">
    <entity charOffset="59-108" id="s1394.e0" ontology_id="GO_1990048" text="anterograde neuronal dense core vesicle transport" type="GO"/>
    <entity charOffset="193-199" id="s1394.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s1394.e0" e2="s1394.e1" id="s1394.p0" relation="true"/>
  </sentence>
  <sentence id="s1395" text="For combined mothers' and fathers' attained age, 10 loci were associated (p&amp;lt;5*10&lt;sup&gt;-8&lt;/sup&gt;), including 8 previously identified for negative regulation of transcription by RNA polymerase II including survival, Alzheimer's and cardiovascular disease.">
    <entity charOffset="137-194" id="s1395.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="231-253" id="s1395.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s1395.e0" e2="s1395.e1" id="s1395.p0" relation="false"/>
  </sentence>
  <sentence id="s1396" text="However, the exact compounds of areca biological_process causing oral cancer remain unproven.">
    <entity charOffset="38-56" id="s1396.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="70-76" id="s1396.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1396.e0" e2="s1396.e1" id="s1396.p0" relation="false"/>
  </sentence>
  <sentence id="s1397" text="We found that cell cycle arrest regulates TP53 expression from NOTCH1 knockdown oral cancer cells.">
    <entity charOffset="14-31" id="s1397.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="85-91" id="s1397.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1397.e0" e2="s1397.e1" id="s1397.p0" relation="true"/>
  </sentence>
  <sentence id="s1398" text="Gainoffunction CTTNB1 mutations are detected in bladder cancer, colorectal cancer, gastric cancer, liver cancer, lung cancer, pancreatic cancer, prostate cancer and uterine cancer, whereas lossoffunction protein polyubiquitination mutations are also detected in human cancer.">
    <entity charOffset="58-64" id="s1398.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="208-234" id="s1398.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s1398.e0" e2="s1398.e1" id="s1398.p0" relation="true"/>
  </sentence>
  <sentence id="s1399" text="Eradicating H.pylori and HCV is the optimal approach for the firstline prevention of gastric cancer and hepatocellular carcinoma (phosphatidylinositol phosphorylation), respectively.">
    <entity charOffset="95-101" id="s1399.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="132-168" id="s1399.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1399.e0" e2="s1399.e1" id="s1399.p0" relation="false"/>
  </sentence>
  <sentence id="s1400" text="Eradicating H.pylori and HCV is the optimal approach for the firstline prevention of gastric cancer and hepatocellular carcinoma (phosphatidylinositol phosphorylation), respectively.">
    <entity charOffset="106-130" id="s1400.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="132-168" id="s1400.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1400.e0" e2="s1400.e1" id="s1400.p0" relation="false"/>
  </sentence>
  <sentence id="s1401" text="However, catenin inhibitors may be applicable for the prevention of organ fibrosis, secondline phosphatidylinositol phosphorylation prevention and treating catenindriven cancer.">
    <entity charOffset="98-134" id="s1401.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="176-182" id="s1401.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1401.e0" e2="s1401.e1" id="s1401.p0" relation="false"/>
  </sentence>
  <sentence id="s1402" text="carbohydrate transport-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific epilepsy.">
    <entity charOffset="0-22" id="s1402.e0" ontology_id="GO_0008643" text="carbohydrate transport" type="GO"/>
    <entity charOffset="205-213" id="s1402.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1402.e0" e2="s1402.e1" id="s1402.p0" relation="true"/>
  </sentence>
  <sentence id="s1403" text="carbohydrate transport-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific epilepsy.">
    <entity charOffset="0-22" id="s1403.e0" ontology_id="GO_0008643" text="carbohydrate transport" type="GO"/>
    <entity charOffset="215-234" id="s1403.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1403.e0" e2="s1403.e1" id="s1403.p0" relation="true"/>
  </sentence>
  <sentence id="s1404" text="carbohydrate transport-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific epilepsy.">
    <entity charOffset="0-22" id="s1404.e0" ontology_id="GO_0008643" text="carbohydrate transport" type="GO"/>
    <entity charOffset="253-261" id="s1404.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1404.e0" e2="s1404.e1" id="s1404.p0" relation="true"/>
  </sentence>
  <sentence id="s1405" text="The trichorhinophalangeal syndrome is a rare genetic syndrome with characteristic craniofacial and skeletal abnormalities including negative regulation of signal transduction pathology in variable manifestation.">
    <entity charOffset="99-121" id="s1405.e0" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <entity charOffset="132-174" id="s1405.e1" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <pair e1="s1405.e0" e2="s1405.e1" id="s1405.p0" relation="false"/>
  </sentence>
  <sentence id="s1406" text="Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (proteolysis) and genes from the ETS transcription factor family, most commonly ERG and positive regulation of transcription by RNA polymerase II, result in alteration that responsible for oncogenic activity in prostate cancer (PC).">
    <entity charOffset="85-96" id="s1406.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="304-310" id="s1406.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1406.e0" e2="s1406.e1" id="s1406.p0" relation="false"/>
  </sentence>
  <sentence id="s1407" text="Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (proteolysis) and genes from the ETS transcription factor family, most commonly ERG and positive regulation of transcription by RNA polymerase II, result in alteration that responsible for oncogenic activity in prostate cancer (PC).">
    <entity charOffset="172-229" id="s1407.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="304-310" id="s1407.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1407.e0" e2="s1407.e1" id="s1407.p0" relation="false"/>
  </sentence>
  <sentence id="s1408" text="Furthermore, cardiovascular risk factors such hyperthyroidism, hypertension and redox homeostasis have been identified to modulate regulation of transcription, DNA-templated driven gene regulatory networks.">
    <entity charOffset="63-75" id="s1408.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="131-173" id="s1408.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1408.e0" e2="s1408.e1" id="s1408.p0" relation="false"/>
  </sentence>
  <sentence id="s1409" text="We provide herein a state-of-the-neuropeptide signaling pathway review of the genetic bases of atrial fibrillation, our current understanding of the genetic regulatory networks involved in AF and its plausible usage for searching novel therapeutic targets">
    <entity charOffset="33-63" id="s1409.e0" ontology_id="GO_0007218" text="neuropeptide signaling pathway" type="GO"/>
    <entity charOffset="95-114" id="s1409.e1" ontology_id="HP_0005110" text="atrial fibrillation" type="HP"/>
    <pair e1="s1409.e0" e2="s1409.e1" id="s1409.p0" relation="false"/>
  </sentence>
  <sentence id="s1410" text="The tumor was afterwards identified as a dMMR melanoma for an exclusive loss of DNA repair expression on IHC (Figure 1).">
    <entity charOffset="4-9" id="s1410.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="80-90" id="s1410.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s1410.e0" e2="s1410.e1" id="s1410.p0" relation="true"/>
  </sentence>
  <sentence id="s1411" text="We describe a female proband with primordial dwarfism, skeletal dysplasia, facial dysmorphism, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in growth plate cartilage chondrocyte development, predicted to affect two of the three protein products of the gene.">
    <entity charOffset="75-93" id="s1411.e0" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <entity charOffset="210-256" id="s1411.e1" ontology_id="GO_0003431" text="growth plate cartilage chondrocyte development" type="GO"/>
    <pair e1="s1411.e0" e2="s1411.e1" id="s1411.p0" relation="true"/>
  </sentence>
  <sentence id="s1412" text="Biallelic loss-of-function mutations in the RNA-binding protein mRNA splicing, via spliceosome cause Richieri-Costa-Pereira syndrome (RCPS), an autosomal recessive condition mainly characterized by craniofacial and limb malformations.">
    <entity charOffset="64-94" id="s1412.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="144-163" id="s1412.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1412.e0" e2="s1412.e1" id="s1412.p0" relation="true"/>
  </sentence>
  <sentence id="s1413" text="mRNA splicing, via spliceosome haploinsufficient embryos presented altered mandibular process fusion and micrognathia, thus recapitulating the most penetrant phenotypes of the syndrome.">
    <entity charOffset="0-30" id="s1413.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="105-117" id="s1413.e1" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <pair e1="s1413.e0" e2="s1413.e1" id="s1413.p0" relation="true"/>
  </sentence>
  <sentence id="s1414" text="Salivary gland tumor (ubiquitin-dependent ERAD pathway) is a rare tumor muscle organ development, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.">
    <entity charOffset="15-20" id="s1414.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="22-54" id="s1414.e1" ontology_id="GO_0030433" text="ubiquitin-dependent ERAD pathway" type="GO"/>
    <pair e1="s1414.e0" e2="s1414.e1" id="s1414.p0" relation="false"/>
  </sentence>
  <sentence id="s1415" text="Salivary gland tumor (ubiquitin-dependent ERAD pathway) is a rare tumor muscle organ development, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.">
    <entity charOffset="22-54" id="s1415.e0" ontology_id="GO_0030433" text="ubiquitin-dependent ERAD pathway" type="GO"/>
    <entity charOffset="165-178" id="s1415.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1415.e0" e2="s1415.e1" id="s1415.p0" relation="false"/>
  </sentence>
  <sentence id="s1416" text="Salivary gland tumor (ubiquitin-dependent ERAD pathway) is a rare tumor muscle organ development, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.">
    <entity charOffset="72-96" id="s1416.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="165-178" id="s1416.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1416.e0" e2="s1416.e1" id="s1416.p0" relation="false"/>
  </sentence>
  <sentence id="s1417" text="We have deleted two major tumor suppressors, negative regulation of protein phosphorylation, a negative regulator of the PI3K pathway, and transforming growth factor beta receptor signaling pathway, the central signaling mediator of TGF pathway, in the murine salivary gland.">
    <entity charOffset="26-31" id="s1417.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="45-91" id="s1417.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1417.e0" e2="s1417.e1" id="s1417.p0" relation="true"/>
  </sentence>
  <sentence id="s1418" text="We have deleted two major tumor suppressors, negative regulation of protein phosphorylation, a negative regulator of the PI3K pathway, and transforming growth factor beta receptor signaling pathway, the central signaling mediator of TGF pathway, in the murine salivary gland.">
    <entity charOffset="26-31" id="s1418.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="139-197" id="s1418.e1" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <pair e1="s1418.e0" e2="s1418.e1" id="s1418.p0" relation="true"/>
  </sentence>
  <sentence id="s1419" text="Our results have shown that deletion of either negative regulation of protein phosphorylation or transforming growth factor beta receptor signaling pathway in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients.">
    <entity charOffset="47-93" id="s1419.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="231-236" id="s1419.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1419.e0" e2="s1419.e1" id="s1419.p0" relation="true"/>
  </sentence>
  <sentence id="s1420" text="Our results have shown that deletion of either negative regulation of protein phosphorylation or transforming growth factor beta receptor signaling pathway in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients.">
    <entity charOffset="97-155" id="s1420.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="231-236" id="s1420.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1420.e0" e2="s1420.e1" id="s1420.p0" relation="true"/>
  </sentence>
  <sentence id="s1421" text="We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar ataxia muscle organ development 2 (negative regulation of receptor internalization), and 20 healthy individuals.">
    <entity charOffset="155-161" id="s1421.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="162-186" id="s1421.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1421.e0" e2="s1421.e1" id="s1421.p0" relation="false"/>
  </sentence>
  <sentence id="s1422" text="We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar ataxia muscle organ development 2 (negative regulation of receptor internalization), and 20 healthy individuals.">
    <entity charOffset="155-161" id="s1422.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="190-237" id="s1422.e1" ontology_id="GO_0002091" text="negative regulation of receptor internalization" type="GO"/>
    <pair e1="s1422.e0" e2="s1422.e1" id="s1422.p0" relation="true"/>
  </sentence>
  <sentence id="s1423" text="We investigated the possible association between chemoresistance and cellular redox state regulation in patients undergoing neoadjuvant chemotherapy (citrate transport) for breast cancer.">
    <entity charOffset="150-167" id="s1423.e0" ontology_id="GO_0015746" text="citrate transport" type="GO"/>
    <entity charOffset="180-186" id="s1423.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1423.e0" e2="s1423.e1" id="s1423.p0" relation="false"/>
  </sentence>
  <sentence id="s1424" text="In total, 53 women with primarily inoperable or inflammatory breast cancer who were treated with citrate transport were included in the study.">
    <entity charOffset="68-74" id="s1424.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="97-114" id="s1424.e1" ontology_id="GO_0015746" text="citrate transport" type="GO"/>
    <pair e1="s1424.e0" e2="s1424.e1" id="s1424.p0" relation="false"/>
  </sentence>
  <sentence id="s1425" text="Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (response to radiation), and peroxiredoxin I (response to oxidative stress I).">
    <entity charOffset="48-53" id="s1425.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="211-232" id="s1425.e1" ontology_id="GO_0009314" text="response to radiation" type="GO"/>
    <pair e1="s1425.e0" e2="s1425.e1" id="s1425.p0" relation="false"/>
  </sentence>
  <sentence id="s1426" text="Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (response to radiation), and peroxiredoxin I (response to oxidative stress I).">
    <entity charOffset="48-53" id="s1426.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="256-284" id="s1426.e1" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <pair e1="s1426.e0" e2="s1426.e1" id="s1426.p0" relation="false"/>
  </sentence>
  <sentence id="s1427" text="Higher pre-NACT nuclear response to oxidative stress I expression predicted smaller size of a resected tumor (&lt;i&gt;p&lt;/i&gt; = 0.00052; &lt;i&gt;r&lt;/i&gt; = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated positive regulation of cysteine-type endopeptidase activity involved in apoptotic process metastasis (&lt;i&gt;p&lt;/i&gt; = 0.0024; &lt;i&gt;r&lt;/i&gt; = -0.472).">
    <entity charOffset="24-52" id="s1427.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="103-108" id="s1427.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1427.e0" e2="s1427.e1" id="s1427.p0" relation="false"/>
  </sentence>
  <sentence id="s1428" text="Higher pre-NACT nuclear response to oxidative stress I expression predicted smaller size of a resected tumor (&lt;i&gt;p&lt;/i&gt; = 0.00052; &lt;i&gt;r&lt;/i&gt; = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated positive regulation of cysteine-type endopeptidase activity involved in apoptotic process metastasis (&lt;i&gt;p&lt;/i&gt; = 0.0024; &lt;i&gt;r&lt;/i&gt; = -0.472).">
    <entity charOffset="103-108" id="s1428.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="237-326" id="s1428.e1" ontology_id="GO_0043280" text="positive regulation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <pair e1="s1428.e0" e2="s1428.e1" id="s1428.p0" relation="true"/>
  </sentence>
  <sentence id="s1429" text="This study was undertaken to investigate the prevalence of sequence variants in photoreceptor cell maintenance in patients with Leber congenital amaurosis (clathrin coat assembly), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.">
    <entity charOffset="80-110" id="s1429.e0" ontology_id="GO_0045494" text="photoreceptor cell maintenance" type="GO"/>
    <entity charOffset="193-210" id="s1429.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s1429.e0" e2="s1429.e1" id="s1429.p0" relation="false"/>
  </sentence>
  <sentence id="s1430" text="This study was undertaken to investigate the prevalence of sequence variants in photoreceptor cell maintenance in patients with Leber congenital amaurosis (clathrin coat assembly), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.">
    <entity charOffset="80-110" id="s1430.e0" ontology_id="GO_0045494" text="photoreceptor cell maintenance" type="GO"/>
    <entity charOffset="223-242" id="s1430.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1430.e0" e2="s1430.e1" id="s1430.p0" relation="true"/>
  </sentence>
  <sentence id="s1431" text="This study was undertaken to investigate the prevalence of sequence variants in photoreceptor cell maintenance in patients with Leber congenital amaurosis (clathrin coat assembly), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.">
    <entity charOffset="156-178" id="s1431.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="193-210" id="s1431.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s1431.e0" e2="s1431.e1" id="s1431.p0" relation="false"/>
  </sentence>
  <sentence id="s1432" text="In this review we discuss recent advances in our knowledge of the MPC, and we argue that it may offer a promising target in diseases like cancer and muscle organ development 2 diabetes.">
    <entity charOffset="138-144" id="s1432.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="149-173" id="s1432.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1432.e0" e2="s1432.e1" id="s1432.p0" relation="false"/>
  </sentence>
  <sentence id="s1433" text="The study was carried out to explore the risk stratification of the poor prognosis for patients underwent surgical treatment.60 patients diagnosed with neuroblastoma were primarily enrolled in the study from nucleosome assembly 2008 to April 2016.">
    <entity charOffset="152-165" id="s1433.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="208-227" id="s1433.e1" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <pair e1="s1433.e0" e2="s1433.e1" id="s1433.p0" relation="false"/>
  </sentence>
  <sentence id="s1434" text="Clinical variables, including age, International Neuroblastoma Staging System (INSS) stage, tumor size and site, histology, and positive regulation of gene expression status were retrospectively analyzed, and intracellular signal transduction was chosen as the endpoint.The median age of patients was 8.2 months and average follow-up period was 40.28.6 months.">
    <entity charOffset="92-97" id="s1434.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="128-166" id="s1434.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s1434.e0" e2="s1434.e1" id="s1434.p0" relation="true"/>
  </sentence>
  <sentence id="s1435" text="Clinical variables, including age, International Neuroblastoma Staging System (INSS) stage, tumor size and site, histology, and positive regulation of gene expression status were retrospectively analyzed, and intracellular signal transduction was chosen as the endpoint.The median age of patients was 8.2 months and average follow-up period was 40.28.6 months.">
    <entity charOffset="92-97" id="s1435.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="209-242" id="s1435.e1" ontology_id="GO_0035556" text="intracellular signal transduction" type="GO"/>
    <pair e1="s1435.e0" e2="s1435.e1" id="s1435.p0" relation="false"/>
  </sentence>
  <sentence id="s1436" text="Cox multifactor regression analysis revealed that age, histology and positive regulation of gene expression status had significant prognostic effect on event-free survival (intracellular signal transduction) rate for neuroblastoma patients underwent surgical treatment.In our study, we identified a series of prognostic factors including age, histology, and MYCN status predicting the prognosis of neuroblastoma patients after surgical treatment">
    <entity charOffset="69-107" id="s1436.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="217-230" id="s1436.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1436.e0" e2="s1436.e1" id="s1436.p0" relation="false"/>
  </sentence>
  <sentence id="s1437" text="Cox multifactor regression analysis revealed that age, histology and positive regulation of gene expression status had significant prognostic effect on event-free survival (intracellular signal transduction) rate for neuroblastoma patients underwent surgical treatment.In our study, we identified a series of prognostic factors including age, histology, and MYCN status predicting the prognosis of neuroblastoma patients after surgical treatment">
    <entity charOffset="173-206" id="s1437.e0" ontology_id="GO_0035556" text="intracellular signal transduction" type="GO"/>
    <entity charOffset="217-230" id="s1437.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s1437.e0" e2="s1437.e1" id="s1437.p0" relation="false"/>
  </sentence>
  <sentence id="s1438" text="Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (biological_process) are severe hereditary diseases that causes visual impairment in infants and children.">
    <entity charOffset="68-86" id="s1438.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="131-148" id="s1438.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s1438.e0" e2="s1438.e1" id="s1438.p0" relation="false"/>
  </sentence>
  <sentence id="s1439" text="Disease associated anterograde neuronal dense core vesicle transport mutations have been associated with motor and sensory dysfunctions as well as non-syndromic intellectual disability in humans.">
    <entity charOffset="19-68" id="s1439.e0" ontology_id="GO_1990048" text="anterograde neuronal dense core vesicle transport" type="GO"/>
    <entity charOffset="161-184" id="s1439.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1439.e0" e2="s1439.e1" id="s1439.p0" relation="true"/>
  </sentence>
  <sentence id="s1440" text="Individuals with biallelic mitotic spindle assembly checkpoint or ubiquitin-dependent protein catabolic process mutations have a high risk of embryonal tumors, and here we show that their cells display severe cAMP biosynthetic process impairment.">
    <entity charOffset="27-62" id="s1440.e0" ontology_id="GO_0007094" text="mitotic spindle assembly checkpoint" type="GO"/>
    <entity charOffset="152-157" id="s1440.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1440.e0" e2="s1440.e1" id="s1440.p0" relation="true"/>
  </sentence>
  <sentence id="s1441" text="Individuals with biallelic mitotic spindle assembly checkpoint or ubiquitin-dependent protein catabolic process mutations have a high risk of embryonal tumors, and here we show that their cells display severe cAMP biosynthetic process impairment.">
    <entity charOffset="66-111" id="s1441.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="152-157" id="s1441.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1441.e0" e2="s1441.e1" id="s1441.p0" relation="true"/>
  </sentence>
  <sentence id="s1442" text="Individuals with biallelic mitotic spindle assembly checkpoint or ubiquitin-dependent protein catabolic process mutations have a high risk of embryonal tumors, and here we show that their cells display severe cAMP biosynthetic process impairment.">
    <entity charOffset="152-157" id="s1442.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="209-234" id="s1442.e1" ontology_id="GO_0006171" text="cAMP biosynthetic process" type="GO"/>
    <pair e1="s1442.e0" e2="s1442.e1" id="s1442.p0" relation="false"/>
  </sentence>
  <sentence id="s1443" text="MVA due to biallelic CEP57 mutations, or of unknown cause, is not associated with embryonal tumors and cells from these individuals show minimal cAMP biosynthetic process deficiency.">
    <entity charOffset="92-97" id="s1443.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="145-170" id="s1443.e1" ontology_id="GO_0006171" text="cAMP biosynthetic process" type="GO"/>
    <pair e1="s1443.e0" e2="s1443.e1" id="s1443.p0" relation="false"/>
  </sentence>
  <sentence id="s1444" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1444.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="366-385" id="s1444.e1" ontology_id="GO_0032456" text="endocytic recycling" type="GO"/>
    <pair e1="s1444.e0" e2="s1444.e1" id="s1444.p0" relation="false"/>
  </sentence>
  <sentence id="s1445" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1445.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="387-411" id="s1445.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1445.e0" e2="s1445.e1" id="s1445.p0" relation="false"/>
  </sentence>
  <sentence id="s1446" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1446.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="429-442" id="s1446.e1" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <pair e1="s1446.e0" e2="s1446.e1" id="s1446.p0" relation="false"/>
  </sentence>
  <sentence id="s1447" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1447.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="444-500" id="s1447.e1" ontology_id="GO_0006303" text="double-strand break repair via nonhomologous end joining" type="GO"/>
    <pair e1="s1447.e0" e2="s1447.e1" id="s1447.p0" relation="false"/>
  </sentence>
  <sentence id="s1448" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1448.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="502-520" id="s1448.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1448.e0" e2="s1448.e1" id="s1448.p0" relation="false"/>
  </sentence>
  <sentence id="s1449" text="Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyperLDLcholesterolemia.">
    <entity charOffset="311-331" id="s1449.e0" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <entity charOffset="585-630" id="s1449.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s1449.e0" e2="s1449.e1" id="s1449.p0" relation="false"/>
  </sentence>
  <sentence id="s1450" text="We identified a new susceptibility locus for bladder cancer at 5q12.3, located in the intron of mRNA splicing, via spliceosome (rs2042329), that was significantly associated with disease risk (OR = 1.40; P = 4.61  10(-11)).">
    <entity charOffset="53-59" id="s1450.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="96-126" id="s1450.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s1450.e0" e2="s1450.e1" id="s1450.p0" relation="false"/>
  </sentence>
  <sentence id="s1451" text="These expanded roles underscore the significance of vertebrate biological_process proteins as factors contributing to a number of diseases, including neural tube defects, tumor metastases, and various genetic syndromes characterized by abnormal migratory cell behaviors">
    <entity charOffset="63-81" id="s1451.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="171-176" id="s1451.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1451.e0" e2="s1451.e1" id="s1451.p0" relation="false"/>
  </sentence>
  <sentence id="s1452" text="Several recent studies applied targeted genome enrichment (peptide cross-linking) and massively parallel sequencing (MPS) to simultaneously screen a large negative regulation of transcription, DNA-templated of known hearing loss (HL) genes.">
    <entity charOffset="59-80" id="s1452.e0" ontology_id="GO_0018149" text="peptide cross-linking" type="GO"/>
    <entity charOffset="216-228" id="s1452.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1452.e0" e2="s1452.e1" id="s1452.p0" relation="false"/>
  </sentence>
  <sentence id="s1453" text="Several recent studies applied targeted genome enrichment (peptide cross-linking) and massively parallel sequencing (MPS) to simultaneously screen a large negative regulation of transcription, DNA-templated of known hearing loss (HL) genes.">
    <entity charOffset="155-206" id="s1453.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="216-228" id="s1453.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1453.e0" e2="s1453.e1" id="s1453.p0" relation="false"/>
  </sentence>
  <sentence id="s1454" text="To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in gap junction-mediated intercellular transport, MT-RNR1, and regulation of pH genes.">
    <entity charOffset="58-66" id="s1454.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="196-241" id="s1454.e1" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <pair e1="s1454.e0" e2="s1454.e1" id="s1454.p0" relation="false"/>
  </sentence>
  <sentence id="s1455" text="To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in gap junction-mediated intercellular transport, MT-RNR1, and regulation of pH genes.">
    <entity charOffset="58-66" id="s1455.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="256-272" id="s1455.e1" ontology_id="GO_0006885" text="regulation of pH" type="GO"/>
    <pair e1="s1455.e0" e2="s1455.e1" id="s1455.p0" relation="false"/>
  </sentence>
  <sentence id="s1456" text="We report ten new patients from eight unrelated kindreds with lipid phosphorylation nephropathy.">
    <entity charOffset="62-83" id="s1456.e0" ontology_id="GO_0046834" text="lipid phosphorylation" type="GO"/>
    <entity charOffset="84-95" id="s1456.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s1456.e0" e2="s1456.e1" id="s1456.p0" relation="false"/>
  </sentence>
  <sentence id="s1457" text="In conclusion, we did not observe a clear genotype-phenotype correlation in patients with lipid phosphorylation nephropathy, suggesting additional factors mediating phenotypic heterogeneity.">
    <entity charOffset="90-111" id="s1457.e0" ontology_id="GO_0046834" text="lipid phosphorylation" type="GO"/>
    <entity charOffset="112-123" id="s1457.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s1457.e0" e2="s1457.e1" id="s1457.p0" relation="false"/>
  </sentence>
  <sentence id="s1458" text="In conclusion, we did not observe a clear genotype-phenotype correlation in patients with lipid phosphorylation nephropathy, suggesting additional factors mediating phenotypic heterogeneity.">
    <entity charOffset="90-111" id="s1458.e0" ontology_id="GO_0046834" text="lipid phosphorylation" type="GO"/>
    <entity charOffset="176-189" id="s1458.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1458.e0" e2="s1458.e1" id="s1458.p0" relation="false"/>
  </sentence>
  <sentence id="s1459" text="The patient together with her younger brother was diagnosed at the age of 5 years with familial congenital hypopituitarism, due to homozygous mutation c.150delA in central nervous system development gene.">
    <entity charOffset="107-122" id="s1459.e0" ontology_id="HP_0040075" text="hypopituitarism" type="HP"/>
    <entity charOffset="164-198" id="s1459.e1" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <pair e1="s1459.e0" e2="s1459.e1" id="s1459.p0" relation="true"/>
  </sentence>
  <sentence id="s1460" text="Our data provide &lt;i&gt;in vivo&lt;/i&gt; evidence that &lt;i&gt;L2hgdh&lt;/i&gt; mutation leads to L-2-HG accumulation, leukoencephalopathy, and neurodegeneration in epidermis development, thereby offering new insights into the pathophysiology of L-2-HGA in humans">
    <entity charOffset="99-118" id="s1460.e0" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <entity charOffset="145-166" id="s1460.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1460.e0" e2="s1460.e1" id="s1460.p0" relation="false"/>
  </sentence>
  <sentence id="s1461" text="The cell-cell signaling variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="4-23" id="s1461.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="109-126" id="s1461.e1" ontology_id="HP_0011662" text="tricuspid atresia" type="HP"/>
    <pair e1="s1461.e0" e2="s1461.e1" id="s1461.p0" relation="false"/>
  </sentence>
  <sentence id="s1462" text="The cell-cell signaling variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="4-23" id="s1462.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="337-367" id="s1462.e1" ontology_id="HP_0006695" text="atrioventricular septal defect" type="HP"/>
    <pair e1="s1462.e0" e2="s1462.e1" id="s1462.p0" relation="true"/>
  </sentence>
  <sentence id="s1463" text="The cell-cell signaling variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="4-23" id="s1463.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="372-389" id="s1463.e1" ontology_id="HP_0001263" text="psychomotor delay" type="HP"/>
    <pair e1="s1463.e0" e2="s1463.e1" id="s1463.p0" relation="false"/>
  </sentence>
  <sentence id="s1464" text="The cell-cell signaling variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="109-126" id="s1464.e0" ontology_id="HP_0011662" text="tricuspid atresia" type="HP"/>
    <entity charOffset="165-216" id="s1464.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1464.e0" e2="s1464.e1" id="s1464.p0" relation="false"/>
  </sentence>
  <sentence id="s1465" text="The cell-cell signaling variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="165-216" id="s1465.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="337-367" id="s1465.e1" ontology_id="HP_0006695" text="atrioventricular septal defect" type="HP"/>
    <pair e1="s1465.e0" e2="s1465.e1" id="s1465.p0" relation="true"/>
  </sentence>
  <sentence id="s1466" text="The cell-cell signaling variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&amp;gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.">
    <entity charOffset="165-216" id="s1466.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="372-389" id="s1466.e1" ontology_id="HP_0001263" text="psychomotor delay" type="HP"/>
    <pair e1="s1466.e0" e2="s1466.e1" id="s1466.p0" relation="true"/>
  </sentence>
  <sentence id="s1467" text="Oxidative stress, which is induced by reactive oxygen species (regulation of cell growth), causes cellular cellular protein catabolic process which contributes to the pathogenesis of neurodegenerative diseases.">
    <entity charOffset="63-88" id="s1467.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="183-209" id="s1467.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1467.e0" e2="s1467.e1" id="s1467.p0" relation="false"/>
  </sentence>
  <sentence id="s1468" text="Oxidative stress, which is induced by reactive oxygen species (regulation of cell growth), causes cellular cellular protein catabolic process which contributes to the pathogenesis of neurodegenerative diseases.">
    <entity charOffset="107-141" id="s1468.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="183-209" id="s1468.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1468.e0" e2="s1468.e1" id="s1468.p0" relation="false"/>
  </sentence>
  <sentence id="s1469" text="First, we tested whether the pretreatment of &lt;i&gt;Momordica charantia&lt;/i&gt; ethanol extract (MCEE) attenuates HO-induced cell death in human neuroblastoma negative regulation of transcription by RNA polymerase II-N-MC cells.">
    <entity charOffset="139-152" id="s1469.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="153-210" id="s1469.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1469.e0" e2="s1469.e1" id="s1469.p0" relation="false"/>
  </sentence>
  <sentence id="s1470" text="In the present study, our results indicated that proteasome-mediated ubiquitin-dependent protein catabolic process expression was significantly downregulated in phosphatidylinositol phosphorylation and was associated with tumor size, differentiation and metastasis.">
    <entity charOffset="49-114" id="s1470.e0" ontology_id="GO_0043161" text="proteasome-mediated ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="222-227" id="s1470.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1470.e0" e2="s1470.e1" id="s1470.p0" relation="false"/>
  </sentence>
  <sentence id="s1471" text="In the present study, our results indicated that proteasome-mediated ubiquitin-dependent protein catabolic process expression was significantly downregulated in phosphatidylinositol phosphorylation and was associated with tumor size, differentiation and metastasis.">
    <entity charOffset="161-197" id="s1471.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="222-227" id="s1471.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1471.e0" e2="s1471.e1" id="s1471.p0" relation="false"/>
  </sentence>
  <sentence id="s1472" text="We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the G protein-coupled receptor signaling pathway arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous limb morphogenesis.">
    <entity charOffset="51-68" id="s1472.e0" ontology_id="HP_0001999" text="dysmorphic facies" type="HP"/>
    <entity charOffset="162-206" id="s1472.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s1472.e0" e2="s1472.e1" id="s1472.p0" relation="false"/>
  </sentence>
  <sentence id="s1473" text="We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the G protein-coupled receptor signaling pathway arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous limb morphogenesis.">
    <entity charOffset="51-68" id="s1473.e0" ontology_id="HP_0001999" text="dysmorphic facies" type="HP"/>
    <entity charOffset="312-330" id="s1473.e1" ontology_id="GO_0035108" text="limb morphogenesis" type="GO"/>
    <pair e1="s1473.e0" e2="s1473.e1" id="s1473.p0" relation="false"/>
  </sentence>
  <sentence id="s1474" text="We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the G protein-coupled receptor signaling pathway arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous limb morphogenesis.">
    <entity charOffset="124-136" id="s1474.e0" ontology_id="HP_0001651" text="dextrocardia" type="HP"/>
    <entity charOffset="312-330" id="s1474.e1" ontology_id="GO_0035108" text="limb morphogenesis" type="GO"/>
    <pair e1="s1474.e0" e2="s1474.e1" id="s1474.p0" relation="true"/>
  </sentence>
  <sentence id="s1475" text="We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the G protein-coupled receptor signaling pathway arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous limb morphogenesis.">
    <entity charOffset="225-246" id="s1475.e0" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <entity charOffset="312-330" id="s1475.e1" ontology_id="GO_0035108" text="limb morphogenesis" type="GO"/>
    <pair e1="s1475.e0" e2="s1475.e1" id="s1475.p0" relation="true"/>
  </sentence>
  <sentence id="s1476" text="Patients with mutations in positive regulation of transcription, DNA-templated all present with mild to moderate ID and poor speech accompanied by additional features in some patients, including autistic features and mild facial dysmorphisms, suggesting that ZNF711 mutations cause non-syndromic ID">
    <entity charOffset="27-78" id="s1476.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="96-100" id="s1476.e1" ontology_id="HP_0012825" text="mild" type="HP"/>
    <pair e1="s1476.e0" e2="s1476.e1" id="s1476.p0" relation="false"/>
  </sentence>
  <sentence id="s1477" text="Patients with mutations in positive regulation of transcription, DNA-templated all present with mild to moderate ID and poor speech accompanied by additional features in some patients, including autistic features and mild facial dysmorphisms, suggesting that ZNF711 mutations cause non-syndromic ID">
    <entity charOffset="27-78" id="s1477.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="222-241" id="s1477.e1" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <pair e1="s1477.e0" e2="s1477.e1" id="s1477.p0" relation="true"/>
  </sentence>
  <sentence id="s1478" text="Our study confirms linkage of a variant clinical form of hair-natural killer cell activation involved in immune response ectodermal dysplasia to chromosome 12 without any mutation in the coding sequences of the epidermis development gene.">
    <entity charOffset="62-120" id="s1478.e0" ontology_id="GO_0002323" text="natural killer cell activation involved in immune response" type="GO"/>
    <entity charOffset="121-141" id="s1478.e1" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <pair e1="s1478.e0" e2="s1478.e1" id="s1478.p0" relation="false"/>
  </sentence>
  <sentence id="s1479" text="Our study confirms linkage of a variant clinical form of hair-natural killer cell activation involved in immune response ectodermal dysplasia to chromosome 12 without any mutation in the coding sequences of the epidermis development gene.">
    <entity charOffset="121-141" id="s1479.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="211-232" id="s1479.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1479.e0" e2="s1479.e1" id="s1479.p0" relation="true"/>
  </sentence>
  <sentence id="s1480" text="The expression of uncarboxylated cartilage condensation (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen muscle organ development X, collagen type II, tumor necrosis factor (negative regulation of transcription by RNA polymerase II) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.">
    <entity charOffset="33-55" id="s1480.e0" ontology_id="GO_0001502" text="cartilage condensation" type="GO"/>
    <entity charOffset="180-185" id="s1480.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1480.e0" e2="s1480.e1" id="s1480.p0" relation="false"/>
  </sentence>
  <sentence id="s1481" text="The expression of uncarboxylated cartilage condensation (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen muscle organ development X, collagen type II, tumor necrosis factor (negative regulation of transcription by RNA polymerase II) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.">
    <entity charOffset="134-158" id="s1481.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="180-185" id="s1481.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1481.e0" e2="s1481.e1" id="s1481.p0" relation="false"/>
  </sentence>
  <sentence id="s1482" text="The expression of uncarboxylated cartilage condensation (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen muscle organ development X, collagen type II, tumor necrosis factor (negative regulation of transcription by RNA polymerase II) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.">
    <entity charOffset="180-185" id="s1482.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="203-260" id="s1482.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1482.e0" e2="s1482.e1" id="s1482.p0" relation="false"/>
  </sentence>
  <sentence id="s1483" text="MicroRNA-9 (miR-9) dysregulation is implicated in a variety of human malignancies including hepatocellular carcinoma (phosphatidylinositol phosphorylation), but its role remains contradictory.">
    <entity charOffset="92-116" id="s1483.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="118-154" id="s1483.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1483.e0" e2="s1483.e1" id="s1483.p0" relation="false"/>
  </sentence>
  <sentence id="s1484" text="In this study, we explored the expression and methylation status of miR-9 in phosphatidylinositol phosphorylation samples, as well as the tumor-related functions of miR-9 in vitro.">
    <entity charOffset="77-113" id="s1484.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="138-143" id="s1484.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1484.e0" e2="s1484.e1" id="s1484.p0" relation="false"/>
  </sentence>
  <sentence id="s1485" text="Our study suggests that miR-9 functions as a tumor suppressor in phosphatidylinositol phosphorylation progression by inhibiting a series of target genes, including the newly validated miR-9/IGF2BP1/AKT&amp;amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.">
    <entity charOffset="45-50" id="s1485.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="65-101" id="s1485.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1485.e0" e2="s1485.e1" id="s1485.p0" relation="false"/>
  </sentence>
  <sentence id="s1486" text="Atypical teratoid/rhabdoid tumors (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic muscle organ development (SCCOHT) represent the most commonly recognized SWI/SNF-driven neoplasms.">
    <entity charOffset="27-33" id="s1486.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="176-200" id="s1486.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1486.e0" e2="s1486.e1" id="s1486.p0" relation="false"/>
  </sentence>
  <sentence id="s1487" text="Atypical teratoid/rhabdoid tumors (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic muscle organ development (SCCOHT) represent the most commonly recognized SWI/SNF-driven neoplasms.">
    <entity charOffset="176-200" id="s1487.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="264-273" id="s1487.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s1487.e0" e2="s1487.e1" id="s1487.p0" relation="false"/>
  </sentence>
  <sentence id="s1488" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).">
    <entity charOffset="56-62" id="s1488.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="293-317" id="s1488.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1488.e0" e2="s1488.e1" id="s1488.p0" relation="false"/>
  </sentence>
  <sentence id="s1489" text="Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).">
    <entity charOffset="128-150" id="s1489.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="256-261" id="s1489.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1489.e0" e2="s1489.e1" id="s1489.p0" relation="false"/>
  </sentence>
  <sentence id="s1490" text="However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to nucleosome disassembly) and multiple meningiomas (linked to nucleosome disassembly) as well as others.">
    <entity charOffset="97-103" id="s1490.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="162-184" id="s1490.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s1490.e0" e2="s1490.e1" id="s1490.p0" relation="true"/>
  </sentence>
  <sentence id="s1491" text="However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to nucleosome disassembly) and multiple meningiomas (linked to nucleosome disassembly) as well as others.">
    <entity charOffset="97-103" id="s1491.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="222-244" id="s1491.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s1491.e0" e2="s1491.e1" id="s1491.p0" relation="false"/>
  </sentence>
  <sentence id="s1492" text="However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to nucleosome disassembly) and multiple meningiomas (linked to nucleosome disassembly) as well as others.">
    <entity charOffset="162-184" id="s1492.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="199-210" id="s1492.e1" ontology_id="HP_0002858" text="meningiomas" type="HP"/>
    <pair e1="s1492.e0" e2="s1492.e1" id="s1492.p0" relation="false"/>
  </sentence>
  <sentence id="s1493" text="We found that hypermethylation of mitotic cytokinesis and reduced gene expression was prevalent in several types of human cancers.">
    <entity charOffset="34-53" id="s1493.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="122-128" id="s1493.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1493.e0" e2="s1493.e1" id="s1493.p0" relation="false"/>
  </sentence>
  <sentence id="s1494" text="The tumorigenesis and metastasis of tumors are associated with human collagen triple helix repeats containing 1 (cell migration).">
    <entity charOffset="36-42" id="s1494.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="113-127" id="s1494.e1" ontology_id="GO_0016477" text="cell migration" type="GO"/>
    <pair e1="s1494.e0" e2="s1494.e1" id="s1494.p0" relation="true"/>
  </sentence>
  <sentence id="s1495" text="This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated dystonia: DYT-TOR1A, DYT-negative regulation of transcription by RNA polymerase II, DYT-GCH1, and DYT-GNAL">
    <entity charOffset="157-165" id="s1495.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="182-239" id="s1495.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1495.e0" e2="s1495.e1" id="s1495.p0" relation="true"/>
  </sentence>
  <sentence id="s1496" text="We used bivariate and multivariate analyses to examine the variations in the rates of TMA complications according to multicellular organism development, age, bile acid metabolic process, and comorbid conditions, including nonpalpable pedal pulses, end-stage renal disease, coronary artery disease, hypertension, smoking status, and preoperative albumin &amp;lt;3.5mg/dL.">
    <entity charOffset="117-151" id="s1496.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="298-310" id="s1496.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s1496.e0" e2="s1496.e1" id="s1496.p0" relation="false"/>
  </sentence>
  <sentence id="s1497" text="We used bivariate and multivariate analyses to examine the variations in the rates of TMA complications according to multicellular organism development, age, bile acid metabolic process, and comorbid conditions, including nonpalpable pedal pulses, end-stage renal disease, coronary artery disease, hypertension, smoking status, and preoperative albumin &amp;lt;3.5mg/dL.">
    <entity charOffset="158-185" id="s1497.e0" ontology_id="GO_0008206" text="bile acid metabolic process" type="GO"/>
    <entity charOffset="298-310" id="s1497.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s1497.e0" e2="s1497.e1" id="s1497.p0" relation="false"/>
  </sentence>
  <sentence id="s1498" text="In this study, we focused on 127 significantly mutated genes from The Cancer Genome Atlas (TCGA) Pan-Cancer Analysis across 12 major cancer sites to identify potential genetic variants predictive of response to hydroperoxide risk and clinical outcomes.">
    <entity charOffset="133-139" id="s1498.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="199-224" id="s1498.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s1498.e0" e2="s1498.e1" id="s1498.p0" relation="false"/>
  </sentence>
  <sentence id="s1499" text="Myotonic dystrophy muscle organ development 2 (DM2) is a progressive multisystem disease with muscle weakness and myotonia as main characteristics.">
    <entity charOffset="19-43" id="s1499.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="114-122" id="s1499.e1" ontology_id="HP_0002486" text="myotonia" type="HP"/>
    <pair e1="s1499.e0" e2="s1499.e1" id="s1499.p0" relation="true"/>
  </sentence>
  <sentence id="s1500" text="BACKGROUND The present study explored the expression of coiled-coil domain-containing 34 (biological_process) in cervical cancer (CC) and its prognostic value.">
    <entity charOffset="90-108" id="s1500.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="122-128" id="s1500.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1500.e0" e2="s1500.e1" id="s1500.p0" relation="false"/>
  </sentence>
  <sentence id="s1501" text="MATERIAL AND METHODS GEPIA and Oncomine cancer databases were mined to predict the biological_process differential expression level between a CC group and a normal group.">
    <entity charOffset="40-46" id="s1501.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="83-101" id="s1501.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1501.e0" e2="s1501.e1" id="s1501.p0" relation="false"/>
  </sentence>
  <sentence id="s1502" text="CD31 and vascular endothelial growth factor (negative regulation of transcription by RNA polymerase II) were stained to reflect tumor angiogenesis in 67 CC tissues.">
    <entity charOffset="45-102" id="s1502.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="128-133" id="s1502.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1502.e0" e2="s1502.e1" id="s1502.p0" relation="false"/>
  </sentence>
  <sentence id="s1503" text="RESULTS Both GEPIA and Oncomine cancer databases mining results revealed that biological_process was more highly expressed in the CC group than in the normal group (all P&amp;lt;0.05).">
    <entity charOffset="32-38" id="s1503.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="78-96" id="s1503.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1503.e0" e2="s1503.e1" id="s1503.p0" relation="false"/>
  </sentence>
  <sentence id="s1504" text="CONCLUSIONS High expression of biological_process is an independent unfavorable prognostic parameter for OS and DFS of CC patients, which was strongly associated with tumor angiogenesis">
    <entity charOffset="31-49" id="s1504.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="167-172" id="s1504.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1504.e0" e2="s1504.e1" id="s1504.p0" relation="false"/>
  </sentence>
  <sentence id="s1505" text="Over the past decade, the genetic basis of several forms of autosomal recessive quaternary ammonium group transport cases has been solved with the identification of four causative genes (skeletal system development, regulation of transcription by RNA polymerase II, regulation of somitogenesis and mesoderm development).">
    <entity charOffset="60-79" id="s1505.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="80-115" id="s1505.e1" ontology_id="GO_0015697" text="quaternary ammonium group transport" type="GO"/>
    <pair e1="s1505.e0" e2="s1505.e1" id="s1505.p0" relation="true"/>
  </sentence>
  <sentence id="s1506" text="Over the past decade, the genetic basis of several forms of autosomal recessive quaternary ammonium group transport cases has been solved with the identification of four causative genes (skeletal system development, regulation of transcription by RNA polymerase II, regulation of somitogenesis and mesoderm development).">
    <entity charOffset="60-79" id="s1506.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="187-214" id="s1506.e1" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="s1506.e0" e2="s1506.e1" id="s1506.p0" relation="true"/>
  </sentence>
  <sentence id="s1507" text="Over the past decade, the genetic basis of several forms of autosomal recessive quaternary ammonium group transport cases has been solved with the identification of four causative genes (skeletal system development, regulation of transcription by RNA polymerase II, regulation of somitogenesis and mesoderm development).">
    <entity charOffset="60-79" id="s1507.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="216-264" id="s1507.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1507.e0" e2="s1507.e1" id="s1507.p0" relation="true"/>
  </sentence>
  <sentence id="s1508" text="Over the past decade, the genetic basis of several forms of autosomal recessive quaternary ammonium group transport cases has been solved with the identification of four causative genes (skeletal system development, regulation of transcription by RNA polymerase II, regulation of somitogenesis and mesoderm development).">
    <entity charOffset="60-79" id="s1508.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="266-293" id="s1508.e1" ontology_id="GO_0014807" text="regulation of somitogenesis" type="GO"/>
    <pair e1="s1508.e0" e2="s1508.e1" id="s1508.p0" relation="true"/>
  </sentence>
  <sentence id="s1509" text="Over the past decade, the genetic basis of several forms of autosomal recessive quaternary ammonium group transport cases has been solved with the identification of four causative genes (skeletal system development, regulation of transcription by RNA polymerase II, regulation of somitogenesis and mesoderm development).">
    <entity charOffset="60-79" id="s1509.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="298-318" id="s1509.e1" ontology_id="GO_0007498" text="mesoderm development" type="GO"/>
    <pair e1="s1509.e0" e2="s1509.e1" id="s1509.p0" relation="true"/>
  </sentence>
  <sentence id="s1510" text="Corneal changes in aniridia-related keratopathy (positive regulation of cytokine-mediated signaling pathway) include peripheral pannus and epithelial abnormalities, which eventually result in corneal opacity and contribute to visual loss.">
    <entity charOffset="49-107" id="s1510.e0" ontology_id="GO_0001961" text="positive regulation of cytokine-mediated signaling pathway" type="GO"/>
    <entity charOffset="192-207" id="s1510.e1" ontology_id="HP_0007957" text="corneal opacity" type="HP"/>
    <pair e1="s1510.e0" e2="s1510.e1" id="s1510.p0" relation="false"/>
  </sentence>
  <sentence id="s1511" text="Corneal changes in aniridia-related keratopathy (positive regulation of cytokine-mediated signaling pathway) include peripheral pannus and epithelial abnormalities, which eventually result in corneal opacity and contribute to visual loss.">
    <entity charOffset="49-107" id="s1511.e0" ontology_id="GO_0001961" text="positive regulation of cytokine-mediated signaling pathway" type="GO"/>
    <entity charOffset="226-237" id="s1511.e1" ontology_id="HP_0000572" text="visual loss" type="HP"/>
    <pair e1="s1511.e0" e2="s1511.e1" id="s1511.p0" relation="false"/>
  </sentence>
  <sentence id="s1512" text="The corneal abnormalities of positive regulation of transcription, DNA-templated+/- epidermis development provide an excellent model for the corneal changes seen in positive regulation of transcription, DNA-templated+/- humans.">
    <entity charOffset="4-25" id="s1512.e0" ontology_id="HP_0000481" text="corneal abnormalities" type="HP"/>
    <entity charOffset="165-216" id="s1512.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1512.e0" e2="s1512.e1" id="s1512.p0" relation="true"/>
  </sentence>
  <sentence id="s1513" text="The corneal abnormalities of positive regulation of transcription, DNA-templated+/- epidermis development provide an excellent model for the corneal changes seen in positive regulation of transcription, DNA-templated+/- humans.">
    <entity charOffset="4-25" id="s1513.e0" ontology_id="HP_0000481" text="corneal abnormalities" type="HP"/>
    <entity charOffset="29-80" id="s1513.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1513.e0" e2="s1513.e1" id="s1513.p0" relation="true"/>
  </sentence>
  <sentence id="s1514" text="The corneal abnormalities of positive regulation of transcription, DNA-templated+/- epidermis development provide an excellent model for the corneal changes seen in positive regulation of transcription, DNA-templated+/- humans.">
    <entity charOffset="4-25" id="s1514.e0" ontology_id="HP_0000481" text="corneal abnormalities" type="HP"/>
    <entity charOffset="84-105" id="s1514.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1514.e0" e2="s1514.e1" id="s1514.p0" relation="false"/>
  </sentence>
  <sentence id="s1515" text="Great progress has been achieved in the study of the role of TGF- signaling in triggering epithelial-mesenchymal transition (cytokine production) in a variety of cancers; however, the regulation of TGF- signaling during EMT in mammary tumor metastasis has not been completely defined.">
    <entity charOffset="126-145" id="s1515.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="237-242" id="s1515.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1515.e0" e2="s1515.e1" id="s1515.p0" relation="true"/>
  </sentence>
  <sentence id="s1516" text="Great progress has been achieved in the study of the role of TGF- signaling in triggering epithelial-mesenchymal transition (cytokine production) in a variety of cancers; however, the regulation of TGF- signaling during EMT in mammary tumor metastasis has not been completely defined.">
    <entity charOffset="126-145" id="s1516.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="163-169" id="s1516.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1516.e0" e2="s1516.e1" id="s1516.p0" relation="true"/>
  </sentence>
  <sentence id="s1517" text="In the present study, we demonstrated that positive regulation of gene expression, a zinc finger transcription factor, inhibits TGF- signaling-induced cytokine production in mouse and human mammary tumor cells, as well as in mouse tumor models.">
    <entity charOffset="43-81" id="s1517.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="199-204" id="s1517.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1517.e0" e2="s1517.e1" id="s1517.p0" relation="false"/>
  </sentence>
  <sentence id="s1518" text="In the present study, we demonstrated that positive regulation of gene expression, a zinc finger transcription factor, inhibits TGF- signaling-induced cytokine production in mouse and human mammary tumor cells, as well as in mouse tumor models.">
    <entity charOffset="152-171" id="s1518.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="199-204" id="s1518.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1518.e0" e2="s1518.e1" id="s1518.p0" relation="true"/>
  </sentence>
  <sentence id="s1519" text="Data from the Oncomine databases indicated a strong negative relationship between positive regulation of gene expression expression and breast cancer progression.">
    <entity charOffset="82-120" id="s1519.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="143-149" id="s1519.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1519.e0" e2="s1519.e1" id="s1519.p0" relation="false"/>
  </sentence>
  <sentence id="s1520" text="The modulation of these molecular processes may represent a strategy for inhibiting breast cancer invasion by restoring positive regulation of gene expression expression">
    <entity charOffset="91-97" id="s1520.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="120-158" id="s1520.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s1520.e0" e2="s1520.e1" id="s1520.p0" relation="false"/>
  </sentence>
  <sentence id="s1521" text="Interestingly, heterogeneous nuclear RNA (hnRNA) for insulin and negative regulation of acute inflammatory response-IGF2, both originating from the INS promoter, were essentially undetectable in T1D pancreata, arguing for a silent INSpromoter.">
    <entity charOffset="15-28" id="s1521.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="65-115" id="s1521.e1" ontology_id="GO_0002674" text="negative regulation of acute inflammatory response" type="GO"/>
    <pair e1="s1521.e0" e2="s1521.e1" id="s1521.p0" relation="false"/>
  </sentence>
  <sentence id="s1522" text="Mutations in negative regulation of cell proliferation, the gene encoding prolyl 3-hydroxylase-2 (P3H2), have recently been identified in individuals with recessively inherited nonsyndromic severe myopia.">
    <entity charOffset="13-54" id="s1522.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="197-203" id="s1522.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1522.e0" e2="s1522.e1" id="s1522.p0" relation="true"/>
  </sentence>
  <sentence id="s1523" text="In this study, differences in prolyl 3-hydroxylation were screened in eye tissues from P3h2-null (P3h2(n/n)) and wild-type epidermis development to seek tissue-specific effects due the lack of P3H2 activity on post-translational collagen chemistry that could explain myopia.">
    <entity charOffset="123-144" id="s1523.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="267-273" id="s1523.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s1523.e0" e2="s1523.e1" id="s1523.p0" relation="false"/>
  </sentence>
  <sentence id="s1524" text="Here we demonstrate that the prostate cancer cell lines LNCaP and LAPC4 display markedly different sensitivity to docetaxel with AR activation, and RNA-seq analysis of these cell lines identified histone H3-K4 demethylation (lysine-specific demethylase 5D) encoded on the Y chromosome as a potential mediator of this sensitivity.">
    <entity charOffset="38-44" id="s1524.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="196-223" id="s1524.e1" ontology_id="GO_0034720" text="histone H3-K4 demethylation" type="GO"/>
    <pair e1="s1524.e0" e2="s1524.e1" id="s1524.p0" relation="false"/>
  </sentence>
  <sentence id="s1525" text="Melanogenesis genes tyrosinase, tyrosinase-related protein 1, Hermansky-Pudlak Syndrome 3, premelanosome protein and dopachrome tautomerase were upregulated, as was the melanogenesis-controlling transcription factor, microphthalmia-associated transcription factor (positive regulation of gene expression).">
    <entity charOffset="217-231" id="s1525.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="265-303" id="s1525.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s1525.e0" e2="s1525.e1" id="s1525.p0" relation="true"/>
  </sentence>
  <sentence id="s1526" text="Although regulation of collagen fibril organization immunoreactivity was almost absent in neurons containing neurofibrillary tangles, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques.">
    <entity charOffset="9-51" id="s1526.e0" ontology_id="GO_1904026" text="regulation of collagen fibril organization" type="GO"/>
    <entity charOffset="109-132" id="s1526.e1" ontology_id="HP_0002185" text="neurofibrillary tangles" type="HP"/>
    <pair e1="s1526.e0" e2="s1526.e1" id="s1526.p0" relation="false"/>
  </sentence>
  <sentence id="s1527" text="The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (regulation of tumor necrosis factor-mediated signaling pathway), tumour necrosis factor alpha-induced protein 3 (response to molecule of bacterial origin), TNFAIP3-interacting protein 1 (glycoprotein biosynthetic process) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.">
    <entity charOffset="63-125" id="s1527.e0" ontology_id="GO_0010803" text="regulation of tumor necrosis factor-mediated signaling pathway" type="GO"/>
    <entity charOffset="128-134" id="s1527.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1527.e0" e2="s1527.e1" id="s1527.p0" relation="false"/>
  </sentence>
  <sentence id="s1528" text="The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (regulation of tumor necrosis factor-mediated signaling pathway), tumour necrosis factor alpha-induced protein 3 (response to molecule of bacterial origin), TNFAIP3-interacting protein 1 (glycoprotein biosynthetic process) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.">
    <entity charOffset="128-134" id="s1528.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="176-216" id="s1528.e1" ontology_id="GO_0002237" text="response to molecule of bacterial origin" type="GO"/>
    <pair e1="s1528.e0" e2="s1528.e1" id="s1528.p0" relation="false"/>
  </sentence>
  <sentence id="s1529" text="The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (regulation of tumor necrosis factor-mediated signaling pathway), tumour necrosis factor alpha-induced protein 3 (response to molecule of bacterial origin), TNFAIP3-interacting protein 1 (glycoprotein biosynthetic process) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.">
    <entity charOffset="128-134" id="s1529.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="250-283" id="s1529.e1" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <pair e1="s1529.e0" e2="s1529.e1" id="s1529.p0" relation="false"/>
  </sentence>
  <sentence id="s1530" text="Differentiated embryo chondrocyte expressed gene1 (negative regulation of transcription by RNA polymerase II), a crucial cell differentiation mediator and apoptosis inhibitor, is abundantly expressed in various types of human cancer and is associated with malignant tumor progression.">
    <entity charOffset="52-109" id="s1530.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="227-233" id="s1530.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1530.e0" e2="s1530.e1" id="s1530.p0" relation="false"/>
  </sentence>
  <sentence id="s1531" text="Differentiated embryo chondrocyte expressed gene1 (negative regulation of transcription by RNA polymerase II), a crucial cell differentiation mediator and apoptosis inhibitor, is abundantly expressed in various types of human cancer and is associated with malignant tumor progression.">
    <entity charOffset="52-109" id="s1531.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="267-272" id="s1531.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1531.e0" e2="s1531.e1" id="s1531.p0" relation="false"/>
  </sentence>
  <sentence id="s1532" text="As poor differentiation and low apoptosis are closely associated with poor survival rates and a poor response to radio/chemotherapy in patients with cancer, the prognostic value of negative regulation of transcription by RNA polymerase II expression was examined in the present study and its correlation with response to temozolomide (TMZ) chemotherapy was analyzed in patients with glioma.">
    <entity charOffset="181-238" id="s1532.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="383-389" id="s1532.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1532.e0" e2="s1532.e1" id="s1532.p0" relation="false"/>
  </sentence>
  <sentence id="s1533" text="negative regulation of transcription by RNA polymerase II expression was analyzed by immunohistochemistry in 157 samples of newly diagnosed glioma and 63 recurrent glioblastoma cases that relapsed during TMZ chemotherapy.">
    <entity charOffset="0-57" id="s1533.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="140-146" id="s1533.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1533.e0" e2="s1533.e1" id="s1533.p0" relation="false"/>
  </sentence>
  <sentence id="s1534" text="negative regulation of transcription by RNA polymerase II expression was also compared with the apoptosis index determined by TdTmediated dUTP nick endinglabeling assay in recurrent glioblastomas.">
    <entity charOffset="0-57" id="s1534.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="184-196" id="s1534.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s1534.e0" e2="s1534.e1" id="s1534.p0" relation="false"/>
  </sentence>
  <sentence id="s1535" text="The antiglioma effect of TMZ in establishment of mitotic spindle orientation epidermis development xenografts with negative regulation of transcription by RNA polymerase II expression was examined invivo.">
    <entity charOffset="8-14" id="s1535.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="115-172" id="s1535.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1535.e0" e2="s1535.e1" id="s1535.p0" relation="false"/>
  </sentence>
  <sentence id="s1536" text="The antiglioma effect of TMZ in establishment of mitotic spindle orientation epidermis development xenografts with negative regulation of transcription by RNA polymerase II expression was examined invivo.">
    <entity charOffset="8-14" id="s1536.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="32-76" id="s1536.e1" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <pair e1="s1536.e0" e2="s1536.e1" id="s1536.p0" relation="false"/>
  </sentence>
  <sentence id="s1537" text="The antiglioma effect of TMZ in establishment of mitotic spindle orientation epidermis development xenografts with negative regulation of transcription by RNA polymerase II expression was examined invivo.">
    <entity charOffset="8-14" id="s1537.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="77-98" id="s1537.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1537.e0" e2="s1537.e1" id="s1537.p0" relation="false"/>
  </sentence>
  <sentence id="s1538" text="High expression of negative regulation of transcription by RNA polymerase II, which was significantly associated with high pathological tumor grade and poor response to TMZ chemotherapy, was demonstrated to be an unfavorable independent prognostic factor and predicted poor survival in patients with newly diagnosed glioma.">
    <entity charOffset="19-76" id="s1538.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="136-141" id="s1538.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1538.e0" e2="s1538.e1" id="s1538.p0" relation="false"/>
  </sentence>
  <sentence id="s1539" text="In patients with recurrent glioblastoma, there was a negative correlation between negative regulation of transcription by RNA polymerase II expression and the apoptotic index.">
    <entity charOffset="27-39" id="s1539.e0" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <entity charOffset="82-139" id="s1539.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1539.e0" e2="s1539.e1" id="s1539.p0" relation="false"/>
  </sentence>
  <sentence id="s1540" text="Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (tricarboxylic acid cycle), and pulmonary chondroma.">
    <entity charOffset="113-118" id="s1540.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="191-215" id="s1540.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s1540.e0" e2="s1540.e1" id="s1540.p0" relation="true"/>
  </sentence>
  <sentence id="s1541" text="Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (tricarboxylic acid cycle), and pulmonary chondroma.">
    <entity charOffset="176-189" id="s1541.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="191-215" id="s1541.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s1541.e0" e2="s1541.e1" id="s1541.p0" relation="true"/>
  </sentence>
  <sentence id="s1542" text="Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (tricarboxylic acid cycle), and pulmonary chondroma.">
    <entity charOffset="191-215" id="s1542.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="222-241" id="s1542.e1" ontology_id="HP_0031474" text="pulmonary chondroma" type="HP"/>
    <pair e1="s1542.e0" e2="s1542.e1" id="s1542.p0" relation="false"/>
  </sentence>
  <sentence id="s1543" text="Another disease that shares two of the tumor components of CT, namely GIST and tricarboxylic acid cycle is the Carney-Stratakis syndrome (CSS) or dyad.">
    <entity charOffset="39-44" id="s1543.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="79-103" id="s1543.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s1543.e0" e2="s1543.e1" id="s1543.p0" relation="true"/>
  </sentence>
  <sentence id="s1544" text="There is only partial overlap between the two conditions (there are a few patients with CT that have choline catabolic process subunit mutations) but both lead to increased methylation of the entire genome in the tumors associated with them.">
    <entity charOffset="101-126" id="s1544.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="213-218" id="s1544.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1544.e0" e2="s1544.e1" id="s1544.p0" relation="false"/>
  </sentence>
  <sentence id="s1545" text="Other tumors (outside CT and CSS) that have choline catabolic process deficiency are associated with increased methylation of the entire genome, but only in CT there is site-specific methylation of the SDHC gene.">
    <entity charOffset="6-11" id="s1545.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="44-69" id="s1545.e1" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <pair e1="s1545.e0" e2="s1545.e1" id="s1545.p0" relation="false"/>
  </sentence>
  <sentence id="s1546" text="Indeed, patients with L-phenylalanine catabolic process mutations were shown to suffer hypomagnesemia and kidney development-like diabetes.">
    <entity charOffset="22-55" id="s1546.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="87-101" id="s1546.e1" ontology_id="HP_0002917" text="hypomagnesemia" type="HP"/>
    <pair e1="s1546.e0" e2="s1546.e1" id="s1546.p0" relation="false"/>
  </sentence>
  <sentence id="s1547" text="Indeed, patients with L-phenylalanine catabolic process mutations were shown to suffer hypomagnesemia and kidney development-like diabetes.">
    <entity charOffset="87-101" id="s1547.e0" ontology_id="HP_0002917" text="hypomagnesemia" type="HP"/>
    <entity charOffset="106-124" id="s1547.e1" ontology_id="GO_0001822" text="kidney development" type="GO"/>
    <pair e1="s1547.e0" e2="s1547.e1" id="s1547.p0" relation="false"/>
  </sentence>
  <sentence id="s1548" text="Mutations in magnesium ion homeostasis were shown to cause hypomagnesemia, seizures and intellectual disability.">
    <entity charOffset="13-38" id="s1548.e0" ontology_id="GO_0010960" text="magnesium ion homeostasis" type="GO"/>
    <entity charOffset="59-73" id="s1548.e1" ontology_id="HP_0002917" text="hypomagnesemia" type="HP"/>
    <pair e1="s1548.e0" e2="s1548.e1" id="s1548.p0" relation="true"/>
  </sentence>
  <sentence id="s1549" text="Mutations in magnesium ion homeostasis were shown to cause hypomagnesemia, seizures and intellectual disability.">
    <entity charOffset="13-38" id="s1549.e0" ontology_id="GO_0010960" text="magnesium ion homeostasis" type="GO"/>
    <entity charOffset="88-111" id="s1549.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1549.e0" e2="s1549.e1" id="s1549.p0" relation="true"/>
  </sentence>
  <sentence id="s1550" text="In 2009, four families with a distal duplication of Xq28 not including negative regulation of gene expression and mediated by low-copy repeats (LCRs) designated &amp;quot;K&amp;quot; and &amp;quot;L&amp;quot; were reported with intellectual disability and epilepsy.">
    <entity charOffset="71-109" id="s1550.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="212-235" id="s1550.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s1550.e0" e2="s1550.e1" id="s1550.p0" relation="true"/>
  </sentence>
  <sentence id="s1551" text="In 2009, four families with a distal duplication of Xq28 not including negative regulation of gene expression and mediated by low-copy repeats (LCRs) designated &amp;quot;K&amp;quot; and &amp;quot;L&amp;quot; were reported with intellectual disability and epilepsy.">
    <entity charOffset="71-109" id="s1551.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="240-248" id="s1551.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1551.e0" e2="s1551.e1" id="s1551.p0" relation="true"/>
  </sentence>
  <sentence id="s1552" text="histone H2A monoubiquitination immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal sarcomas with classic morphology (20 MAPK cascade-NUTM2, 5 posttranscriptional regulation of gene expression-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.">
    <entity charOffset="0-30" id="s1552.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="132-139" id="s1552.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1552.e0" e2="s1552.e1" id="s1552.p0" relation="false"/>
  </sentence>
  <sentence id="s1553" text="histone H2A monoubiquitination immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal sarcomas with classic morphology (20 MAPK cascade-NUTM2, 5 posttranscriptional regulation of gene expression-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.">
    <entity charOffset="132-139" id="s1553.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="169-181" id="s1553.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s1553.e0" e2="s1553.e1" id="s1553.p0" relation="false"/>
  </sentence>
  <sentence id="s1554" text="histone H2A monoubiquitination immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal sarcomas with classic morphology (20 MAPK cascade-NUTM2, 5 posttranscriptional regulation of gene expression-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.">
    <entity charOffset="132-139" id="s1554.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="191-240" id="s1554.e1" ontology_id="GO_0010608" text="posttranscriptional regulation of gene expression" type="GO"/>
    <pair e1="s1554.e0" e2="s1554.e1" id="s1554.p0" relation="false"/>
  </sentence>
  <sentence id="s1555" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted superoxide metabolic process studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="23-53" id="s1555.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="211-218" id="s1555.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1555.e0" e2="s1555.e1" id="s1555.p0" relation="false"/>
  </sentence>
  <sentence id="s1556" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted superoxide metabolic process studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="86-91" id="s1556.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="293-321" id="s1556.e1" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <pair e1="s1556.e0" e2="s1556.e1" id="s1556.p0" relation="false"/>
  </sentence>
  <sentence id="s1557" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted superoxide metabolic process studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="161-173" id="s1557.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="211-218" id="s1557.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1557.e0" e2="s1557.e1" id="s1557.p0" relation="false"/>
  </sentence>
  <sentence id="s1558" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted superoxide metabolic process studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="211-218" id="s1558.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="293-321" id="s1558.e1" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <pair e1="s1558.e0" e2="s1558.e1" id="s1558.p0" relation="false"/>
  </sentence>
  <sentence id="s1559" text="Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &amp;gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted superoxide metabolic process studies confirming YWHAE rearrangement in 2 tumors.">
    <entity charOffset="293-321" id="s1559.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="366-372" id="s1559.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1559.e0" e2="s1559.e1" id="s1559.p0" relation="false"/>
  </sentence>
  <sentence id="s1560" text="Diffuse histone H2A monoubiquitination staining was strong in three and weak in one BCOR-rearranged high-grade endometrial stromal sarcoma while absent in the remaining four BCOR-rearranged tumors.">
    <entity charOffset="8-38" id="s1560.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="131-138" id="s1560.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1560.e0" e2="s1560.e1" id="s1560.p0" relation="false"/>
  </sentence>
  <sentence id="s1561" text="Diffuse histone H2A monoubiquitination staining was strong in three and weak in one BCOR-rearranged high-grade endometrial stromal sarcoma while absent in the remaining four BCOR-rearranged tumors.">
    <entity charOffset="8-38" id="s1561.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="190-196" id="s1561.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1561.e0" e2="s1561.e1" id="s1561.p0" relation="false"/>
  </sentence>
  <sentence id="s1562" text="histone H2A monoubiquitination staining was weakly positive in &amp;lt;5% of tumor cells in 4 of 66 (6%) low-grade endometrial stromal sarcomas and 1 of 18 (6%) endometrial stromal nodules and weakly to moderately positive in &amp;lt;5-40% of tumor cells in 6 of 31 (19%) leiomyosarcomas.">
    <entity charOffset="0-30" id="s1562.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="73-78" id="s1562.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1562.e0" e2="s1562.e1" id="s1562.p0" relation="false"/>
  </sentence>
  <sentence id="s1563" text="No histone H2A monoubiquitination staining was seen in the remaining low-grade endometrial stromal sarcomas, endometrial stromal nodules, leiomyosarcomas, or any of the leiomyomas.">
    <entity charOffset="3-33" id="s1563.e0" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <entity charOffset="99-106" id="s1563.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1563.e0" e2="s1563.e1" id="s1563.p0" relation="false"/>
  </sentence>
  <sentence id="s1564" text="BCOR immunohistochemical staining is a highly sensitive marker for MAPK cascade-NUTM2 high-grade endometrial stromal sarcoma with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication">
    <entity charOffset="67-79" id="s1564.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="117-124" id="s1564.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1564.e0" e2="s1564.e1" id="s1564.p0" relation="false"/>
  </sentence>
  <sentence id="s1565" text="Furthermore, negative regulation of gene expression expression is altered in skeletal muscle of classical congenital muscular dystrophy mouse models.">
    <entity charOffset="13-51" id="s1565.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="117-135" id="s1565.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1565.e0" e2="s1565.e1" id="s1565.p0" relation="false"/>
  </sentence>
  <sentence id="s1566" text="negative regulation of gene expression levels were up-regulated in dystrophin deficient mdx muscle, which correlates with the elevated levels of the 71 integrin observed in mdx muscle and Duchenne muscular dystrophy patients.">
    <entity charOffset="0-38" id="s1566.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="199-217" id="s1566.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s1566.e0" e2="s1566.e1" id="s1566.p0" relation="false"/>
  </sentence>
  <sentence id="s1567" text="Two pairwise genetic interactions (B cell lymphocyte kinase (peptidyl-tyrosine phosphorylation) rs13277113,B cell scaffold protein with ankyrin repeats 1 (B cell activation) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (proteolysis)/ tumor necrosis factor receptor superfamily member 14 (T cell costimulation) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.">
    <entity charOffset="61-94" id="s1567.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="254-259" id="s1567.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1567.e0" e2="s1567.e1" id="s1567.p0" relation="false"/>
  </sentence>
  <sentence id="s1568" text="Two pairwise genetic interactions (B cell lymphocyte kinase (peptidyl-tyrosine phosphorylation) rs13277113,B cell scaffold protein with ankyrin repeats 1 (B cell activation) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (proteolysis)/ tumor necrosis factor receptor superfamily member 14 (T cell costimulation) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.">
    <entity charOffset="155-172" id="s1568.e0" ontology_id="GO_0042113" text="B cell activation" type="GO"/>
    <entity charOffset="254-259" id="s1568.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1568.e0" e2="s1568.e1" id="s1568.p0" relation="false"/>
  </sentence>
  <sentence id="s1569" text="Two pairwise genetic interactions (B cell lymphocyte kinase (peptidyl-tyrosine phosphorylation) rs13277113,B cell scaffold protein with ankyrin repeats 1 (B cell activation) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (proteolysis)/ tumor necrosis factor receptor superfamily member 14 (T cell costimulation) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.">
    <entity charOffset="240-251" id="s1569.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="254-259" id="s1569.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1569.e0" e2="s1569.e1" id="s1569.p0" relation="true"/>
  </sentence>
  <sentence id="s1570" text="Two pairwise genetic interactions (B cell lymphocyte kinase (peptidyl-tyrosine phosphorylation) rs13277113,B cell scaffold protein with ankyrin repeats 1 (B cell activation) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (proteolysis)/ tumor necrosis factor receptor superfamily member 14 (T cell costimulation) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.">
    <entity charOffset="254-259" id="s1570.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="308-328" id="s1570.e1" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <pair e1="s1570.e0" e2="s1570.e1" id="s1570.p0" relation="false"/>
  </sentence>
  <sentence id="s1571" text="The tumor necrosis factor (negative regulation of transcription by RNA polymerase II) family ligand ectodysplasin A (positive regulation of NF-kappaB transcription factor activity) is produced as 2 full-length splice variants, EDA1 and EDA2, that bind to EDA receptor (EDAR) and X-linked EDA receptor (XEDAR/EDA2R), respectively.">
    <entity charOffset="4-9" id="s1571.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="27-84" id="s1571.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1571.e0" e2="s1571.e1" id="s1571.p0" relation="false"/>
  </sentence>
  <sentence id="s1572" text="The tumor necrosis factor (negative regulation of transcription by RNA polymerase II) family ligand ectodysplasin A (positive regulation of NF-kappaB transcription factor activity) is produced as 2 full-length splice variants, EDA1 and EDA2, that bind to EDA receptor (EDAR) and X-linked EDA receptor (XEDAR/EDA2R), respectively.">
    <entity charOffset="4-9" id="s1572.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="117-179" id="s1572.e1" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s1572.e0" e2="s1572.e1" id="s1572.p0" relation="false"/>
  </sentence>
  <sentence id="s1573" text="Inactivating mutations in Eda or Edar cause hypohidrotic ectodermal dysplasia (positive regulation of NF-kappaB transcription factor activity), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.">
    <entity charOffset="57-77" id="s1573.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="79-141" id="s1573.e1" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s1573.e0" e2="s1573.e1" id="s1573.p0" relation="true"/>
  </sentence>
  <sentence id="s1574" text="Citrin deficiency is an autosomal recessive metabolic disorder, which is caused by pathogenic mutations in the SLC25A13 gene on chromosome 7q21.3, as the causative gene that encodes the liver muscle organ development aspartate/glutamate carrier isoform 2 (AGC2).">
    <entity charOffset="24-43" id="s1574.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="192-216" id="s1574.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1574.e0" e2="s1574.e1" id="s1574.p0" relation="true"/>
  </sentence>
  <sentence id="s1575" text="transforming growth factor beta receptor signaling pathway has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (response to hydroperoxide) remained to be elusive.">
    <entity charOffset="0-58" id="s1575.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="165-185" id="s1575.e1" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <pair e1="s1575.e0" e2="s1575.e1" id="s1575.p0" relation="false"/>
  </sentence>
  <sentence id="s1576" text="transforming growth factor beta receptor signaling pathway has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (response to hydroperoxide) remained to be elusive.">
    <entity charOffset="93-98" id="s1576.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="187-212" id="s1576.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s1576.e0" e2="s1576.e1" id="s1576.p0" relation="false"/>
  </sentence>
  <sentence id="s1577" text="transforming growth factor beta receptor signaling pathway has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (response to hydroperoxide) remained to be elusive.">
    <entity charOffset="165-185" id="s1577.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="187-212" id="s1577.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s1577.e0" e2="s1577.e1" id="s1577.p0" relation="false"/>
  </sentence>
  <sentence id="s1578" text="Hereditary sensory and autonomic neuropathies (HSAN) muscle organ development II are characterized by autosomal recessive inheritance, onset at birth and self-mutilating behavior.">
    <entity charOffset="53-77" id="s1578.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="102-121" id="s1578.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s1578.e0" e2="s1578.e1" id="s1578.p0" relation="true"/>
  </sentence>
  <sentence id="s1579" text="Tubulin alpha 8 (biological_process) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="17-35" id="s1579.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="100-124" id="s1579.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1579.e0" e2="s1579.e1" id="s1579.p0" relation="false"/>
  </sentence>
  <sentence id="s1580" text="Tubulin alpha 8 (biological_process) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="72-78" id="s1580.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="126-162" id="s1580.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1580.e0" e2="s1580.e1" id="s1580.p0" relation="false"/>
  </sentence>
  <sentence id="s1581" text="Tubulin alpha 8 (biological_process) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="100-124" id="s1581.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="126-162" id="s1581.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s1581.e0" e2="s1581.e1" id="s1581.p0" relation="false"/>
  </sentence>
  <sentence id="s1582" text="Bardet-Biedl syndrome (visual perception) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.">
    <entity charOffset="23-40" id="s1582.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="94-101" id="s1582.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s1582.e0" e2="s1582.e1" id="s1582.p0" relation="false"/>
  </sentence>
  <sentence id="s1583" text="Bardet-Biedl syndrome (visual perception) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.">
    <entity charOffset="23-40" id="s1583.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="102-109" id="s1583.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1583.e0" e2="s1583.e1" id="s1583.p0" relation="true"/>
  </sentence>
  <sentence id="s1584" text="Bardet-Biedl syndrome (visual perception) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.">
    <entity charOffset="23-40" id="s1584.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="150-161" id="s1584.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s1584.e0" e2="s1584.e1" id="s1584.p0" relation="true"/>
  </sentence>
  <sentence id="s1585" text="Our results indicate that visual perception in Japan is genetically heterogeneous and at least partly shares genetic features with BBS in other countries.">
    <entity charOffset="26-43" id="s1585.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="68-81" id="s1585.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1585.e0" e2="s1585.e1" id="s1585.p0" relation="false"/>
  </sentence>
  <sentence id="s1586" text="The review then discusses the diseases associated with positive regulation of cell proliferation2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-96" id="s1586.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="170-179" id="s1586.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s1586.e0" e2="s1586.e1" id="s1586.p0" relation="false"/>
  </sentence>
  <sentence id="s1587" text="The review then discusses the diseases associated with positive regulation of cell proliferation2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-96" id="s1587.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="209-220" id="s1587.e1" ontology_id="HP_0000027" text="azoospermia" type="HP"/>
    <pair e1="s1587.e0" e2="s1587.e1" id="s1587.p0" relation="false"/>
  </sentence>
  <sentence id="s1588" text="The review then discusses the diseases associated with positive regulation of cell proliferation2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-96" id="s1588.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="227-233" id="s1588.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1588.e0" e2="s1588.e1" id="s1588.p0" relation="false"/>
  </sentence>
  <sentence id="s1589" text="The review then discusses the diseases associated with positive regulation of cell proliferation2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.">
    <entity charOffset="55-96" id="s1589.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="343-351" id="s1589.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1589.e0" e2="s1589.e1" id="s1589.p0" relation="true"/>
  </sentence>
  <sentence id="s1590" text="Primary pigmented nodular adrenocortical disease (PPNAD) is the rarest form of negative regulation of tumor necrosis factor production-independent CS, and can be associated with endocrine and nonendocrine tumors, forming the Carney complex (CNC).">
    <entity charOffset="79-134" id="s1590.e0" ontology_id="GO_0032720" text="negative regulation of tumor necrosis factor production" type="GO"/>
    <entity charOffset="205-211" id="s1590.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1590.e0" e2="s1590.e1" id="s1590.p0" relation="false"/>
  </sentence>
  <sentence id="s1591" text="The increased levels of protein transport and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen nervous system development (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.">
    <entity charOffset="24-41" id="s1591.e0" ontology_id="GO_0015031" text="protein transport" type="GO"/>
    <entity charOffset="268-281" id="s1591.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1591.e0" e2="s1591.e1" id="s1591.p0" relation="false"/>
  </sentence>
  <sentence id="s1592" text="The increased levels of protein transport and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen nervous system development (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.">
    <entity charOffset="161-202" id="s1592.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="268-281" id="s1592.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1592.e0" e2="s1592.e1" id="s1592.p0" relation="false"/>
  </sentence>
  <sentence id="s1593" text="The increased levels of protein transport and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen nervous system development (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.">
    <entity charOffset="229-255" id="s1593.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="268-281" id="s1593.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1593.e0" e2="s1593.e1" id="s1593.p0" relation="false"/>
  </sentence>
  <sentence id="s1594" text="The increased levels of protein transport and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen nervous system development (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.">
    <entity charOffset="268-281" id="s1594.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="312-342" id="s1594.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s1594.e0" e2="s1594.e1" id="s1594.p0" relation="false"/>
  </sentence>
  <sentence id="s1595" text="The increased levels of protein transport and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen nervous system development (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.">
    <entity charOffset="268-281" id="s1595.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="389-431" id="s1595.e1" ontology_id="GO_0000380" text="alternative mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s1595.e0" e2="s1595.e1" id="s1595.p0" relation="false"/>
  </sentence>
  <sentence id="s1596" text="Recently, cell cycle arrest was reported to be implicated in cancer development, and many researchers investigated its biological function in the tumorigenesis of various cancers.">
    <entity charOffset="10-27" id="s1596.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="61-67" id="s1596.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1596.e0" e2="s1596.e1" id="s1596.p0" relation="false"/>
  </sentence>
  <sentence id="s1597" text="However, what kind of role cell cycle arrest plays in colorectal cancer (CRC) remains unknown.">
    <entity charOffset="27-44" id="s1597.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="65-71" id="s1597.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1597.e0" e2="s1597.e1" id="s1597.p0" relation="false"/>
  </sentence>
  <sentence id="s1598" text="Furthermore, the tumorigenesis assay showed that increased expression of cell cycle arrest suppressed CRC tumor growth and metastasis in vivo.">
    <entity charOffset="17-22" id="s1598.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="73-90" id="s1598.e1" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <pair e1="s1598.e0" e2="s1598.e1" id="s1598.p0" relation="false"/>
  </sentence>
  <sentence id="s1599" text="To examine the pathomechanisms of early craniofacial and dental abnormalities, we analyzed epidermis development with an MLII patient mutation that mimic the clinical and biochemical symptoms of MLII patients.">
    <entity charOffset="57-77" id="s1599.e0" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <entity charOffset="91-112" id="s1599.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1599.e0" e2="s1599.e1" id="s1599.p0" relation="false"/>
  </sentence>
  <sentence id="s1600" text="Substitution of endogenous glycolytic process with an acetylation mimetic mutant K100Q reduces cellular NADPH production and inhibits cell proliferation and tumor growth.">
    <entity charOffset="27-45" id="s1600.e0" ontology_id="GO_0006096" text="glycolytic process" type="GO"/>
    <entity charOffset="157-162" id="s1600.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1600.e0" e2="s1600.e1" id="s1600.p0" relation="false"/>
  </sentence>
  <sentence id="s1601" text="These results reveal a mechanism of glycolytic process regulation and NADPH homeostasis in response to oxidative stress that impacts cell proliferation and tumor growth">
    <entity charOffset="36-54" id="s1601.e0" ontology_id="GO_0006096" text="glycolytic process" type="GO"/>
    <entity charOffset="156-161" id="s1601.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1601.e0" e2="s1601.e1" id="s1601.p0" relation="false"/>
  </sentence>
  <sentence id="s1602" text="The aberrant glucose metabolism is one of the hallmarks of cancer cells, and as a branch of glucose metabolism, hexosamine biosynthesis pathway (proteolysis) has been reported to play a critical role in the insulin resistance and progression of cancer.">
    <entity charOffset="59-65" id="s1602.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="145-156" id="s1602.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s1602.e0" e2="s1602.e1" id="s1602.p0" relation="false"/>
  </sentence>
  <sentence id="s1603" text="Glutamine:fructose-6-phosphate amidotransferase (circadian regulation of gene expression) is the rate-limiting enzyme of the proteolysis; nevertheless, the prognostic value of GFAT1 in pancreatic cancer remains elusive.">
    <entity charOffset="49-88" id="s1603.e0" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <entity charOffset="196-202" id="s1603.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1603.e0" e2="s1603.e1" id="s1603.p0" relation="false"/>
  </sentence>
  <sentence id="s1604" text="Glutamine:fructose-6-phosphate amidotransferase (circadian regulation of gene expression) is the rate-limiting enzyme of the proteolysis; nevertheless, the prognostic value of GFAT1 in pancreatic cancer remains elusive.">
    <entity charOffset="125-136" id="s1604.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="196-202" id="s1604.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1604.e0" e2="s1604.e1" id="s1604.p0" relation="false"/>
  </sentence>
  <sentence id="s1605" text="In this study, we found that the expression of circadian regulation of gene expression was increased in pancreatic cancer samples compared to peri-tumor tissues.">
    <entity charOffset="47-86" id="s1605.e0" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <entity charOffset="147-152" id="s1605.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1605.e0" e2="s1605.e1" id="s1605.p0" relation="false"/>
  </sentence>
  <sentence id="s1606" text="circadian regulation of gene expression was identified as an independent prognosticator for OS, and combining GFAT1 expression with pTNM stage generated a predictive nomogram, which showed better prognostic efficiency for OS in patients with pancreatic cancer.">
    <entity charOffset="0-39" id="s1606.e0" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <entity charOffset="253-259" id="s1606.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1606.e0" e2="s1606.e1" id="s1606.p0" relation="false"/>
  </sentence>
  <sentence id="s1607" text="In summary, high circadian regulation of gene expression expression is identified as an independent predictor of adverse clinical outcome in our small number of pancreatic cancer patients, and the practical prognostic nomogram model may help clinicians in decision making and the design of clinical studies">
    <entity charOffset="17-56" id="s1607.e0" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <entity charOffset="172-178" id="s1607.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1607.e0" e2="s1607.e1" id="s1607.p0" relation="false"/>
  </sentence>
  <sentence id="s1608" text="There was a significantly higher expression level of negative regulation of B cell apoptotic process in the tumour than in the adjacent normal tissue (0.0052  0.0021 vs 0.0027  0.0018, P &amp;lt; 0.001).">
    <entity charOffset="53-100" id="s1608.e0" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <entity charOffset="108-114" id="s1608.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1608.e0" e2="s1608.e1" id="s1608.p0" relation="true"/>
  </sentence>
  <sentence id="s1609" text="Patients with genotype AA were found to have remarkably higher negative regulation of B cell apoptotic process expression in the tumour than those with genotype CC (P = 0.01).">
    <entity charOffset="63-110" id="s1609.e0" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <entity charOffset="129-135" id="s1609.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1609.e0" e2="s1609.e1" id="s1609.p0" relation="true"/>
  </sentence>
  <sentence id="s1610" text="The search for clinically relevant molecular markers in classical Hodgkin lymphoma (eye development) is hampered by the histopathological complexity of the disease, resulting from the admixture of a small number of neoplastic Hodgkin and Reed-Sternberg (H-regulation of transcription, DNA-templated) cells with an abundant and heterogeneous microenvironment.">
    <entity charOffset="84-99" id="s1610.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="327-340" id="s1610.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1610.e0" e2="s1610.e1" id="s1610.p0" relation="false"/>
  </sentence>
  <sentence id="s1611" text="The search for clinically relevant molecular markers in classical Hodgkin lymphoma (eye development) is hampered by the histopathological complexity of the disease, resulting from the admixture of a small number of neoplastic Hodgkin and Reed-Sternberg (H-regulation of transcription, DNA-templated) cells with an abundant and heterogeneous microenvironment.">
    <entity charOffset="256-298" id="s1611.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="327-340" id="s1611.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1611.e0" e2="s1611.e1" id="s1611.p0" relation="true"/>
  </sentence>
  <sentence id="s1612" text="We reinforce the potential of proteolysis as an interesting target to be explored in adult and pediatric cHL, and alert for its dual biological role in H-RS cells and tumor microenvironment">
    <entity charOffset="30-41" id="s1612.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="167-172" id="s1612.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1612.e0" e2="s1612.e1" id="s1612.p0" relation="false"/>
  </sentence>
  <sentence id="s1613" text="BACKGROUND The aim of this study was to investigate the prognostic relevance of nucleus organization in lung cancer (LC).">
    <entity charOffset="80-100" id="s1613.e0" ontology_id="GO_0006997" text="nucleus organization" type="GO"/>
    <entity charOffset="109-115" id="s1613.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1613.e0" e2="s1613.e1" id="s1613.p0" relation="false"/>
  </sentence>
  <sentence id="s1614" text="Among the available genomic studies, the key findings in Africa were variants in positive regulation of transcription, DNA-templated (P193H), regulation of histone methylation 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (negative regulation of transcription by RNA polymerase II), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="81-132" id="s1614.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="226-246" id="s1614.e1" ontology_id="HP_0001631" text="atrial septal defect" type="HP"/>
    <pair e1="s1614.e0" e2="s1614.e1" id="s1614.p0" relation="true"/>
  </sentence>
  <sentence id="s1615" text="Among the available genomic studies, the key findings in Africa were variants in positive regulation of transcription, DNA-templated (P193H), regulation of histone methylation 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (negative regulation of transcription by RNA polymerase II), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="81-132" id="s1615.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="248-273" id="s1615.e1" ontology_id="HP_0001629" text="ventricular septal defect" type="HP"/>
    <pair e1="s1615.e0" e2="s1615.e1" id="s1615.p0" relation="true"/>
  </sentence>
  <sentence id="s1616" text="Among the available genomic studies, the key findings in Africa were variants in positive regulation of transcription, DNA-templated (P193H), regulation of histone methylation 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (negative regulation of transcription by RNA polymerase II), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="142-175" id="s1616.e0" ontology_id="GO_0031060" text="regulation of histone methylation" type="GO"/>
    <entity charOffset="226-246" id="s1616.e1" ontology_id="HP_0001631" text="atrial septal defect" type="HP"/>
    <pair e1="s1616.e0" e2="s1616.e1" id="s1616.p0" relation="false"/>
  </sentence>
  <sentence id="s1617" text="Among the available genomic studies, the key findings in Africa were variants in positive regulation of transcription, DNA-templated (P193H), regulation of histone methylation 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (negative regulation of transcription by RNA polymerase II), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="142-175" id="s1617.e0" ontology_id="GO_0031060" text="regulation of histone methylation" type="GO"/>
    <entity charOffset="248-273" id="s1617.e1" ontology_id="HP_0001629" text="ventricular septal defect" type="HP"/>
    <pair e1="s1617.e0" e2="s1617.e1" id="s1617.p0" relation="false"/>
  </sentence>
  <sentence id="s1618" text="Among the available genomic studies, the key findings in Africa were variants in positive regulation of transcription, DNA-templated (P193H), regulation of histone methylation 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (negative regulation of transcription by RNA polymerase II), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.">
    <entity charOffset="226-246" id="s1618.e0" ontology_id="HP_0001631" text="atrial septal defect" type="HP"/>
    <entity charOffset="302-359" id="s1618.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1618.e0" e2="s1618.e1" id="s1618.p0" relation="false"/>
  </sentence>
  <sentence id="s1619" text="Kruppel-like factor 9 (cellular response to cortisol stimulus), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear.">
    <entity charOffset="23-61" id="s1619.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="148-154" id="s1619.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1619.e0" e2="s1619.e1" id="s1619.p0" relation="false"/>
  </sentence>
  <sentence id="s1620" text="Kruppel-like factor 9 (cellular response to cortisol stimulus), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear.">
    <entity charOffset="23-61" id="s1620.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="190-196" id="s1620.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1620.e0" e2="s1620.e1" id="s1620.p0" relation="false"/>
  </sentence>
  <sentence id="s1621" text="The levels of cellular response to cortisol stimulus expression in adjacent tissues and pancreatic cancer tissues were detected using immunohistochemistry.">
    <entity charOffset="14-52" id="s1621.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="99-105" id="s1621.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1621.e0" e2="s1621.e1" id="s1621.p0" relation="false"/>
  </sentence>
  <sentence id="s1622" text="Using flow cytometric analysis and neuron migration-8, we evaluated the effects of cellular response to cortisol stimulus expression on cell apoptosis, the cell cycle and proliferation of pancreatic cancer cells.">
    <entity charOffset="35-51" id="s1622.e0" ontology_id="GO_0001764" text="neuron migration" type="GO"/>
    <entity charOffset="199-205" id="s1622.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1622.e0" e2="s1622.e1" id="s1622.p0" relation="false"/>
  </sentence>
  <sentence id="s1623" text="Using flow cytometric analysis and neuron migration-8, we evaluated the effects of cellular response to cortisol stimulus expression on cell apoptosis, the cell cycle and proliferation of pancreatic cancer cells.">
    <entity charOffset="83-121" id="s1623.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="199-205" id="s1623.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1623.e0" e2="s1623.e1" id="s1623.p0" relation="false"/>
  </sentence>
  <sentence id="s1624" text="Our results revealed that in both tissue samples and cell lines (particularly in BxPC-3 and PANC-1 cells) of pancreatic cancer, cellular response to cortisol stimulus exhibited relatively lower expression.">
    <entity charOffset="120-126" id="s1624.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="128-166" id="s1624.e1" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <pair e1="s1624.e0" e2="s1624.e1" id="s1624.p0" relation="false"/>
  </sentence>
  <sentence id="s1625" text="In PANC-1 and BxPC-3 cells, cellular response to cortisol stimulus overexpression decreased the proliferation of pancreatic cancer cells, induced apoptosis, blocked the cell cycle at the Sphase, and inhibited the migration and invasion of tumor cells.">
    <entity charOffset="28-66" id="s1625.e0" ontology_id="GO_0071387" text="cellular response to cortisol stimulus" type="GO"/>
    <entity charOffset="240-245" id="s1625.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1625.e0" e2="s1625.e1" id="s1625.p0" relation="false"/>
  </sentence>
  <sentence id="s1626" text="As in MOPDII patients, disruption of pericentrin (cilium assembly) in mice caused a number of abnormalities including microcephaly, aberrant hemodynamics analyzed by in utero echocardiography, and cardiovascular anomalies; the latter being associated with mortality, as in the human condition.">
    <entity charOffset="50-65" id="s1626.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="118-130" id="s1626.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1626.e0" e2="s1626.e1" id="s1626.p0" relation="true"/>
  </sentence>
  <sentence id="s1627" text="In order to determine the role of multicellular organism development during carcinogenesis, squamous cell carcinomas (SCCs) were induced in Flii heterozygous (Flii+/-), wild-type and Flii overexpressing (FliiTg/Tg) epidermis development by intradermal injection of 3-methylcholanthrene (MCA).">
    <entity charOffset="34-68" id="s1627.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="92-116" id="s1627.e1" ontology_id="HP_0002860" text="squamous cell carcinomas" type="HP"/>
    <pair e1="s1627.e0" e2="s1627.e1" id="s1627.p0" relation="false"/>
  </sentence>
  <sentence id="s1628" text="In order to determine the role of multicellular organism development during carcinogenesis, squamous cell carcinomas (SCCs) were induced in Flii heterozygous (Flii+/-), wild-type and Flii overexpressing (FliiTg/Tg) epidermis development by intradermal injection of 3-methylcholanthrene (MCA).">
    <entity charOffset="92-116" id="s1628.e0" ontology_id="HP_0002860" text="squamous cell carcinomas" type="HP"/>
    <entity charOffset="215-236" id="s1628.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1628.e0" e2="s1628.e1" id="s1628.p0" relation="false"/>
  </sentence>
  <sentence id="s1629" text="multicellular organism development was highly expressed in human negative regulation of peptidase activity biopsies particularly by the invading cells at the tumor edge.">
    <entity charOffset="0-34" id="s1629.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="158-163" id="s1629.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1629.e0" e2="s1629.e1" id="s1629.p0" relation="false"/>
  </sentence>
  <sentence id="s1630" text="multicellular organism development was highly expressed in human negative regulation of peptidase activity biopsies particularly by the invading cells at the tumor edge.">
    <entity charOffset="65-106" id="s1630.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="158-163" id="s1630.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1630.e0" e2="s1630.e1" id="s1630.p0" relation="false"/>
  </sentence>
  <sentence id="s1631" text="In contrast multicellular organism development+/- epidermis development had significantly smaller tumors that were less invasive.">
    <entity charOffset="12-46" id="s1631.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="98-103" id="s1631.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1631.e0" e2="s1631.e1" id="s1631.p0" relation="false"/>
  </sentence>
  <sentence id="s1632" text="In contrast multicellular organism development+/- epidermis development had significantly smaller tumors that were less invasive.">
    <entity charOffset="50-71" id="s1632.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="98-103" id="s1632.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1632.e0" e2="s1632.e1" id="s1632.p0" relation="false"/>
  </sentence>
  <sentence id="s1633" text="Intradermal injection of multicellular organism development neutralizing antibodies during negative regulation of peptidase activity initiation and progression significantly reduced the size of the tumors and, in vitro, decreased cellular sphere formation and invasion.">
    <entity charOffset="25-59" id="s1633.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="198-203" id="s1633.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1633.e0" e2="s1633.e1" id="s1633.p0" relation="false"/>
  </sentence>
  <sentence id="s1634" text="Intradermal injection of multicellular organism development neutralizing antibodies during negative regulation of peptidase activity initiation and progression significantly reduced the size of the tumors and, in vitro, decreased cellular sphere formation and invasion.">
    <entity charOffset="91-132" id="s1634.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="198-203" id="s1634.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1634.e0" e2="s1634.e1" id="s1634.p0" relation="false"/>
  </sentence>
  <sentence id="s1635" text="Analysis of the tumors from the multicellular organism development overexpressing epidermis development showed reduced caspase I and annexin V expression suggesting Flii may negatively regulate apoptosis within these tumors.">
    <entity charOffset="16-21" id="s1635.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="32-66" id="s1635.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s1635.e0" e2="s1635.e1" id="s1635.p0" relation="false"/>
  </sentence>
  <sentence id="s1636" text="Analysis of the tumors from the multicellular organism development overexpressing epidermis development showed reduced caspase I and annexin V expression suggesting Flii may negatively regulate apoptosis within these tumors.">
    <entity charOffset="16-21" id="s1636.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="82-103" id="s1636.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1636.e0" e2="s1636.e1" id="s1636.p0" relation="false"/>
  </sentence>
  <sentence id="s1637" text="These studies therefore suggest that multicellular organism development enhances negative regulation of peptidase activity tumor progression by decreasing apoptosis and enhancing tumor cell invasion.">
    <entity charOffset="37-71" id="s1637.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="123-128" id="s1637.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1637.e0" e2="s1637.e1" id="s1637.p0" relation="false"/>
  </sentence>
  <sentence id="s1638" text="These studies therefore suggest that multicellular organism development enhances negative regulation of peptidase activity tumor progression by decreasing apoptosis and enhancing tumor cell invasion.">
    <entity charOffset="81-122" id="s1638.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="123-128" id="s1638.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1638.e0" e2="s1638.e1" id="s1638.p0" relation="false"/>
  </sentence>
  <sentence id="s1639" text="Since synaptic transmission, cholinergic-associated limb-girdle muscle organ development actin filament organization was only manifested in dADP phosphorylation homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.">
    <entity charOffset="6-40" id="s1639.e0" ontology_id="GO_0007271" text="synaptic transmission, cholinergic" type="GO"/>
    <entity charOffset="219-238" id="s1639.e1" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <pair e1="s1639.e0" e2="s1639.e1" id="s1639.p0" relation="false"/>
  </sentence>
  <sentence id="s1640" text="Since synaptic transmission, cholinergic-associated limb-girdle muscle organ development actin filament organization was only manifested in dADP phosphorylation homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.">
    <entity charOffset="64-88" id="s1640.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="219-238" id="s1640.e1" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <pair e1="s1640.e0" e2="s1640.e1" id="s1640.p0" relation="false"/>
  </sentence>
  <sentence id="s1641" text="Since synaptic transmission, cholinergic-associated limb-girdle muscle organ development actin filament organization was only manifested in dADP phosphorylation homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.">
    <entity charOffset="89-116" id="s1641.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="219-238" id="s1641.e1" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <pair e1="s1641.e0" e2="s1641.e1" id="s1641.p0" relation="false"/>
  </sentence>
  <sentence id="s1642" text="Since synaptic transmission, cholinergic-associated limb-girdle muscle organ development actin filament organization was only manifested in dADP phosphorylation homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.">
    <entity charOffset="140-160" id="s1642.e0" ontology_id="GO_0006174" text="dADP phosphorylation" type="GO"/>
    <entity charOffset="219-238" id="s1642.e1" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <pair e1="s1642.e0" e2="s1642.e1" id="s1642.p0" relation="false"/>
  </sentence>
  <sentence id="s1643" text="Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of biological_process (biological_process) and CP49 (visual perception) in the lens.">
    <entity charOffset="38-46" id="s1643.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="205-223" id="s1643.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1643.e0" e2="s1643.e1" id="s1643.p0" relation="true"/>
  </sentence>
  <sentence id="s1644" text="Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of biological_process (biological_process) and CP49 (visual perception) in the lens.">
    <entity charOffset="38-46" id="s1644.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="235-252" id="s1644.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s1644.e0" e2="s1644.e1" id="s1644.p0" relation="true"/>
  </sentence>
  <sentence id="s1645" text="Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of biological_process (biological_process) and CP49 (visual perception) in the lens.">
    <entity charOffset="38-46" id="s1645.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="185-203" id="s1645.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1645.e0" e2="s1645.e1" id="s1645.p0" relation="true"/>
  </sentence>
  <sentence id="s1646" text="With the first filensin (biological_process) mutation now having been reported to cause a recessive cataract phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.">
    <entity charOffset="25-43" id="s1646.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="100-108" id="s1646.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s1646.e0" e2="s1646.e1" id="s1646.p0" relation="true"/>
  </sentence>
  <sentence id="s1647" text="A vitamin K biosynthetic process-endoplasmic reticulum unfolded protein response complex likely functions in oxidative/nitrosative stress, lipid metabolism, and xenobiotic metabolic process signaling pathways in its role as a tumor suppressor">
    <entity charOffset="2-32" id="s1647.e0" ontology_id="GO_0042371" text="vitamin K biosynthetic process" type="GO"/>
    <entity charOffset="226-231" id="s1647.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1647.e0" e2="s1647.e1" id="s1647.p0" relation="false"/>
  </sentence>
  <sentence id="s1648" text="A vitamin K biosynthetic process-endoplasmic reticulum unfolded protein response complex likely functions in oxidative/nitrosative stress, lipid metabolism, and xenobiotic metabolic process signaling pathways in its role as a tumor suppressor">
    <entity charOffset="33-80" id="s1648.e0" ontology_id="GO_0030968" text="endoplasmic reticulum unfolded protein response" type="GO"/>
    <entity charOffset="226-231" id="s1648.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1648.e0" e2="s1648.e1" id="s1648.p0" relation="false"/>
  </sentence>
  <sentence id="s1649" text="A vitamin K biosynthetic process-endoplasmic reticulum unfolded protein response complex likely functions in oxidative/nitrosative stress, lipid metabolism, and xenobiotic metabolic process signaling pathways in its role as a tumor suppressor">
    <entity charOffset="161-189" id="s1649.e0" ontology_id="GO_0006805" text="xenobiotic metabolic process" type="GO"/>
    <entity charOffset="226-231" id="s1649.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1649.e0" e2="s1649.e1" id="s1649.p0" relation="false"/>
  </sentence>
  <sentence id="s1650" text="Here, we show that ethanol treatment (100 mM) promotes regulation of cell growth production and oxidative stress in cancer-associated fibroblasts, which is sufficient to induce myofibroblastic differentiation.">
    <entity charOffset="55-80" id="s1650.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="116-122" id="s1650.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1650.e0" e2="s1650.e1" id="s1650.p0" relation="false"/>
  </sentence>
  <sentence id="s1651" text="Remarkably, our results also show that antioxidants [such as N-acetyl cysteine (activation of cysteine-type endopeptidase activity involved in apoptotic process)] can effectively reverse or prevent ethanol-induced oxidative stress in cancer-associated fibroblasts, suggesting a novel strategy for cancer prevention.">
    <entity charOffset="80-160" id="s1651.e0" ontology_id="GO_0006919" text="activation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="234-240" id="s1651.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1651.e0" e2="s1651.e1" id="s1651.p0" relation="true"/>
  </sentence>
  <sentence id="s1652" text="Chemotherapy and radiation not only trigger cancer cell apoptosis but also cellular protein catabolic process stromal cells in the tumour microenvironment (TME), inducing a senescence-associated secretory phenomuscle organ development (SASP) characterized by chronic secretion of diverse soluble factors.">
    <entity charOffset="44-50" id="s1652.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="75-109" id="s1652.e1" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <pair e1="s1652.e0" e2="s1652.e1" id="s1652.p0" relation="false"/>
  </sentence>
  <sentence id="s1653" text="Chemotherapy and radiation not only trigger cancer cell apoptosis but also cellular protein catabolic process stromal cells in the tumour microenvironment (TME), inducing a senescence-associated secretory phenomuscle organ development (SASP) characterized by chronic secretion of diverse soluble factors.">
    <entity charOffset="44-50" id="s1653.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="210-234" id="s1653.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1653.e0" e2="s1653.e1" id="s1653.p0" relation="false"/>
  </sentence>
  <sentence id="s1654" text="DNA cellular protein catabolic process causes negative regulation of nitric oxide mediated signal transduction expression by engaging peripheral nervous system development-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.">
    <entity charOffset="4-38" id="s1654.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="218-224" id="s1654.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1654.e0" e2="s1654.e1" id="s1654.p0" relation="false"/>
  </sentence>
  <sentence id="s1655" text="DNA cellular protein catabolic process causes negative regulation of nitric oxide mediated signal transduction expression by engaging peripheral nervous system development-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.">
    <entity charOffset="46-110" id="s1655.e0" ontology_id="GO_0010751" text="negative regulation of nitric oxide mediated signal transduction" type="GO"/>
    <entity charOffset="218-224" id="s1655.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1655.e0" e2="s1655.e1" id="s1655.p0" relation="true"/>
  </sentence>
  <sentence id="s1656" text="DNA cellular protein catabolic process causes negative regulation of nitric oxide mediated signal transduction expression by engaging peripheral nervous system development-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.">
    <entity charOffset="134-171" id="s1656.e0" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <entity charOffset="218-224" id="s1656.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1656.e0" e2="s1656.e1" id="s1656.p0" relation="false"/>
  </sentence>
  <sentence id="s1657" text="Strikingly, SPINK1 reprograms the expression profile of cancer cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by positive regulation of protein phosphorylation signaling but hitherto rarely reported for a SASP factor.">
    <entity charOffset="56-62" id="s1657.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-207" id="s1657.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1657.e0" e2="s1657.e1" id="s1657.p0" relation="true"/>
  </sentence>
  <sentence id="s1658" text="In vivo, negative regulation of nitric oxide mediated signal transduction is expressed in the stroma of solid tumours and is routinely detectable in peripheral blood of cancer patients after chemotherapy.">
    <entity charOffset="9-73" id="s1658.e0" ontology_id="GO_0010751" text="negative regulation of nitric oxide mediated signal transduction" type="GO"/>
    <entity charOffset="169-175" id="s1658.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1658.e0" e2="s1658.e1" id="s1658.p0" relation="true"/>
  </sentence>
  <sentence id="s1659" text="Cytochrome P450 3A5 (lipid hydroxylation) metabolizes these compounds in tumors of the exocrine-like subtype, and pharmacological or short hairpin RNA (shRNA)-mediated CYP3A5 inhibition sensitizes tumor cells to these drugs.">
    <entity charOffset="21-40" id="s1659.e0" ontology_id="GO_0002933" text="lipid hydroxylation" type="GO"/>
    <entity charOffset="73-79" id="s1659.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1659.e0" e2="s1659.e1" id="s1659.p0" relation="false"/>
  </sentence>
  <sentence id="s1660" text="Cytochrome P450 3A5 (lipid hydroxylation) metabolizes these compounds in tumors of the exocrine-like subtype, and pharmacological or short hairpin RNA (shRNA)-mediated CYP3A5 inhibition sensitizes tumor cells to these drugs.">
    <entity charOffset="21-40" id="s1660.e0" ontology_id="GO_0002933" text="lipid hydroxylation" type="GO"/>
    <entity charOffset="197-202" id="s1660.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1660.e0" e2="s1660.e1" id="s1660.p0" relation="false"/>
  </sentence>
  <sentence id="s1661" text="Activating mutations in the activation of MAPK activity or positive regulation of cell proliferation receptor tyrosine kinases are hallmarks of gastrointestinal stromal tumor (GIST).">
    <entity charOffset="28-55" id="s1661.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="169-174" id="s1661.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1661.e0" e2="s1661.e1" id="s1661.p0" relation="true"/>
  </sentence>
  <sentence id="s1662" text="Activating mutations in the activation of MAPK activity or positive regulation of cell proliferation receptor tyrosine kinases are hallmarks of gastrointestinal stromal tumor (GIST).">
    <entity charOffset="59-100" id="s1662.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="169-174" id="s1662.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1662.e0" e2="s1662.e1" id="s1662.p0" relation="true"/>
  </sentence>
  <sentence id="s1663" text="Inactivating NF1 mutations were present in 46% of melanomas expressing wild-type protein phosphorylation and RAS, occurred in older patients and showed a distinct pattern of co-mutation with other RASopathy genes, particularly RASA2.">
    <entity charOffset="50-59" id="s1663.e0" ontology_id="HP_0002861" text="melanomas" type="HP"/>
    <entity charOffset="81-104" id="s1663.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1663.e0" e2="s1663.e1" id="s1663.p0" relation="true"/>
  </sentence>
  <sentence id="s1664" text="A novel hereditary disorder encompassing high blood Mn levels, dystonia, polycythemia, distinctive cell recognition hyperintense signals in the basal ganglia on magnetic resonance imaging (MRI) brain, and chronic liver disease was recently described.">
    <entity charOffset="73-85" id="s1664.e0" ontology_id="HP_0001901" text="polycythemia" type="HP"/>
    <entity charOffset="99-115" id="s1664.e1" ontology_id="GO_0008037" text="cell recognition" type="GO"/>
    <pair e1="s1664.e0" e2="s1664.e1" id="s1664.p0" relation="false"/>
  </sentence>
  <sentence id="s1665" text="The older brother presented with progressive gait difficulties, hypotonia, intermittent dystonia, polycythemia, and characteristic cell recognition-hyperintense lesions on MRI brain.">
    <entity charOffset="88-96" id="s1665.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="131-147" id="s1665.e1" ontology_id="GO_0008037" text="cell recognition" type="GO"/>
    <pair e1="s1665.e0" e2="s1665.e1" id="s1665.p0" relation="false"/>
  </sentence>
  <sentence id="s1666" text="The older brother presented with progressive gait difficulties, hypotonia, intermittent dystonia, polycythemia, and characteristic cell recognition-hyperintense lesions on MRI brain.">
    <entity charOffset="98-110" id="s1666.e0" ontology_id="HP_0001901" text="polycythemia" type="HP"/>
    <entity charOffset="131-147" id="s1666.e1" ontology_id="GO_0008037" text="cell recognition" type="GO"/>
    <pair e1="s1666.e0" e2="s1666.e1" id="s1666.p0" relation="false"/>
  </sentence>
  <sentence id="s1667" text="A growing body of clinical literature emphasizes the negative regulation of transcription by RNA polymerase II of cerebral edema in early brain injury following aneurysmal subarachnoid hemorrhage (sphingosine biosynthetic process).">
    <entity charOffset="53-110" id="s1667.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="114-128" id="s1667.e1" ontology_id="HP_0002181" text="cerebral edema" type="HP"/>
    <pair e1="s1667.e0" e2="s1667.e1" id="s1667.p0" relation="false"/>
  </sentence>
  <sentence id="s1668" text="A growing body of clinical literature emphasizes the negative regulation of transcription by RNA polymerase II of cerebral edema in early brain injury following aneurysmal subarachnoid hemorrhage (sphingosine biosynthetic process).">
    <entity charOffset="114-128" id="s1668.e0" ontology_id="HP_0002181" text="cerebral edema" type="HP"/>
    <entity charOffset="197-229" id="s1668.e1" ontology_id="GO_0046512" text="sphingosine biosynthetic process" type="GO"/>
    <pair e1="s1668.e0" e2="s1668.e1" id="s1668.p0" relation="false"/>
  </sentence>
  <sentence id="s1669" text="Although cerebral edema is not a universal feature of sphingosine biosynthetic process, it portends a poor clinical course, with quantitative analysis revealing a direct correlation between cerebral edema and poor outcome, including mortality and cognitive deficits.">
    <entity charOffset="9-23" id="s1669.e0" ontology_id="HP_0002181" text="cerebral edema" type="HP"/>
    <entity charOffset="54-86" id="s1669.e1" ontology_id="GO_0046512" text="sphingosine biosynthetic process" type="GO"/>
    <pair e1="s1669.e0" e2="s1669.e1" id="s1669.p0" relation="false"/>
  </sentence>
  <sentence id="s1670" text="Here, we review these cellular and molecular mechanisms of global cerebral edema formation in sphingosine biosynthetic process.">
    <entity charOffset="66-80" id="s1670.e0" ontology_id="HP_0002181" text="cerebral edema" type="HP"/>
    <entity charOffset="94-126" id="s1670.e1" ontology_id="GO_0046512" text="sphingosine biosynthetic process" type="GO"/>
    <pair e1="s1670.e0" e2="s1670.e1" id="s1670.p0" relation="false"/>
  </sentence>
  <sentence id="s1671" text="Given the importance of edema to the outcome of patients with sphingosine biosynthetic process and its status as a highly modifiable pathological process, a better understanding of cerebral edema in aSAH promises to hasten the development of medical therapies to improve outcomes in this frequently devastating disease">
    <entity charOffset="24-29" id="s1671.e0" ontology_id="HP_0000969" text="edema" type="HP"/>
    <entity charOffset="62-94" id="s1671.e1" ontology_id="GO_0046512" text="sphingosine biosynthetic process" type="GO"/>
    <pair e1="s1671.e0" e2="s1671.e1" id="s1671.p0" relation="true"/>
  </sentence>
  <sentence id="s1672" text="Given the importance of edema to the outcome of patients with sphingosine biosynthetic process and its status as a highly modifiable pathological process, a better understanding of cerebral edema in aSAH promises to hasten the development of medical therapies to improve outcomes in this frequently devastating disease">
    <entity charOffset="62-94" id="s1672.e0" ontology_id="GO_0046512" text="sphingosine biosynthetic process" type="GO"/>
    <entity charOffset="181-195" id="s1672.e1" ontology_id="HP_0002181" text="cerebral edema" type="HP"/>
    <pair e1="s1672.e0" e2="s1672.e1" id="s1672.p0" relation="false"/>
  </sentence>
  <sentence id="s1673" text="Schizophrenia (SZ) and autism spectrum disorders (ASD) are highly heritable neuropsychiatric disorders, although environmental factors, such as maternal immune activation (regulation of signaling receptor activity), play a role as well.">
    <entity charOffset="23-29" id="s1673.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="172-213" id="s1673.e1" ontology_id="GO_0010469" text="regulation of signaling receptor activity" type="GO"/>
    <pair e1="s1673.e0" e2="s1673.e1" id="s1673.p0" relation="false"/>
  </sentence>
  <sentence id="s1674" text="Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 sporadic signal transduction patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.">
    <entity charOffset="20-69" id="s1674.e0" ontology_id="GO_0031116" text="positive regulation of microtubule polymerization" type="GO"/>
    <entity charOffset="98-106" id="s1674.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1674.e0" e2="s1674.e1" id="s1674.p0" relation="false"/>
  </sentence>
  <sentence id="s1675" text="Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 sporadic signal transduction patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.">
    <entity charOffset="98-106" id="s1675.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="107-126" id="s1675.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s1675.e0" e2="s1675.e1" id="s1675.p0" relation="false"/>
  </sentence>
  <sentence id="s1676" text="Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 sporadic signal transduction patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.">
    <entity charOffset="98-106" id="s1676.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="144-166" id="s1676.e1" ontology_id="GO_0000303" text="response to superoxide" type="GO"/>
    <pair e1="s1676.e0" e2="s1676.e1" id="s1676.p0" relation="false"/>
  </sentence>
  <sentence id="s1677" text="Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 sporadic signal transduction patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.">
    <entity charOffset="98-106" id="s1677.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="168-180" id="s1677.e1" ontology_id="GO_0008380" text="RNA splicing" type="GO"/>
    <pair e1="s1677.e0" e2="s1677.e1" id="s1677.p0" relation="false"/>
  </sentence>
  <sentence id="s1678" text="Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 sporadic signal transduction patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.">
    <entity charOffset="98-106" id="s1678.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="182-224" id="s1678.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1678.e0" e2="s1678.e1" id="s1678.p0" relation="false"/>
  </sentence>
  <sentence id="s1679" text="Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 sporadic signal transduction patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.">
    <entity charOffset="98-106" id="s1679.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="230-276" id="s1679.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1679.e0" e2="s1679.e1" id="s1679.p0" relation="false"/>
  </sentence>
  <sentence id="s1680" text="Our results suggested that variants in DCTN1 are not common risk factors for Chinese sporadic signal transduction and that the frequency of variants of unknown significance in the cohort study was 0.39%">
    <entity charOffset="85-93" id="s1680.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="94-113" id="s1680.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s1680.e0" e2="s1680.e1" id="s1680.p0" relation="false"/>
  </sentence>
  <sentence id="s1681" text="Subsequent mutation analyses identified tumor-associated calcium signal transducer 2 (negative regulation of epithelial cell migration; former name, M1S1) as the gene responsible for GDLD.">
    <entity charOffset="40-45" id="s1681.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="86-134" id="s1681.e1" ontology_id="GO_0010633" text="negative regulation of epithelial cell migration" type="GO"/>
    <pair e1="s1681.e0" e2="s1681.e1" id="s1681.p0" relation="false"/>
  </sentence>
  <sentence id="s1682" text="This in silico study suggests that in glioblastoma multiforme, karyotypic changes have the potential to cause multiple abnormalities in negative regulation of transcription, DNA-templateds of genes involved in phosphoinositide metabolism and this may be important for understanding drug resistance and phosphoinositide pathway redundancy in the advanced disease state.">
    <entity charOffset="38-50" id="s1682.e0" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <entity charOffset="136-187" id="s1682.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1682.e0" e2="s1682.e1" id="s1682.p0" relation="false"/>
  </sentence>
  <sentence id="s1683" text="BACKGROUND The distribution of fat cell adhesion mediated by integrin and obesity-associated gene (FTO) genes rs9939609 and rs1421085 in obese and normal ethnic Mongolians was analyzed to investigate the association of FTO gene polymorphisms with obesity and metabolic syndrome in ethnic Mongolians.">
    <entity charOffset="35-69" id="s1683.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="74-81" id="s1683.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1683.e0" e2="s1683.e1" id="s1683.p0" relation="false"/>
  </sentence>
  <sentence id="s1684" text="RESULTS Body cell adhesion mediated by integrin, body mass index (BMI), waist circumference (WC), negative regulation of signal transduction circumference (HC), waist-hip ratio (WHR), SBP, vitamin D metabolic process, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the obesity group compared with controls.">
    <entity charOffset="13-47" id="s1684.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="356-363" id="s1684.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1684.e0" e2="s1684.e1" id="s1684.p0" relation="false"/>
  </sentence>
  <sentence id="s1685" text="RESULTS Body cell adhesion mediated by integrin, body mass index (BMI), waist circumference (WC), negative regulation of signal transduction circumference (HC), waist-hip ratio (WHR), SBP, vitamin D metabolic process, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the obesity group compared with controls.">
    <entity charOffset="98-140" id="s1685.e0" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <entity charOffset="356-363" id="s1685.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1685.e0" e2="s1685.e1" id="s1685.p0" relation="false"/>
  </sentence>
  <sentence id="s1686" text="RESULTS Body cell adhesion mediated by integrin, body mass index (BMI), waist circumference (WC), negative regulation of signal transduction circumference (HC), waist-hip ratio (WHR), SBP, vitamin D metabolic process, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the obesity group compared with controls.">
    <entity charOffset="189-216" id="s1686.e0" ontology_id="GO_0042359" text="vitamin D metabolic process" type="GO"/>
    <entity charOffset="356-363" id="s1686.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1686.e0" e2="s1686.e1" id="s1686.p0" relation="false"/>
  </sentence>
  <sentence id="s1687" text="It has been reported that N-myc downstream regulated gene 1 (NDRG1) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with negative regulation of transcription by RNA polymerase II degradation in NSCLC cell lines.">
    <entity charOffset="119-125" id="s1687.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="155-212" id="s1687.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1687.e0" e2="s1687.e1" id="s1687.p0" relation="true"/>
  </sentence>
  <sentence id="s1688" text="However, the relationship of DNA damage response, signal transduction by p53 class mediator to prognosis or negative regulation of transcription by RNA polymerase II expression in lung adenocarcinoma has not been well clarified.">
    <entity charOffset="29-91" id="s1688.e0" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <entity charOffset="180-199" id="s1688.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1688.e0" e2="s1688.e1" id="s1688.p0" relation="false"/>
  </sentence>
  <sentence id="s1689" text="However, the relationship of DNA damage response, signal transduction by p53 class mediator to prognosis or negative regulation of transcription by RNA polymerase II expression in lung adenocarcinoma has not been well clarified.">
    <entity charOffset="108-165" id="s1689.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="180-199" id="s1689.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1689.e0" e2="s1689.e1" id="s1689.p0" relation="false"/>
  </sentence>
  <sentence id="s1690" text="The present study was designed to investigate the prognostic significance of DNA damage response, signal transduction by p53 class mediator and/or negative regulation of transcription by RNA polymerase II expression in lung adenocarcinoma using immunohistochemistry with a tissue microarray.">
    <entity charOffset="77-139" id="s1690.e0" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <entity charOffset="219-238" id="s1690.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1690.e0" e2="s1690.e1" id="s1690.p0" relation="false"/>
  </sentence>
  <sentence id="s1691" text="The present study was designed to investigate the prognostic significance of DNA damage response, signal transduction by p53 class mediator and/or negative regulation of transcription by RNA polymerase II expression in lung adenocarcinoma using immunohistochemistry with a tissue microarray.">
    <entity charOffset="147-204" id="s1691.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="219-238" id="s1691.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s1691.e0" e2="s1691.e1" id="s1691.p0" relation="false"/>
  </sentence>
  <sentence id="s1692" text="We examined 184 lung adenocarcinomas and observed low expression of DNA damage response, signal transduction by p53 class mediator in adenocarcinoma in situ (oxidation-reduction process) and minimally invasive adenocarcinoma (MIA), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.">
    <entity charOffset="16-35" id="s1692.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="68-130" id="s1692.e1" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <pair e1="s1692.e0" e2="s1692.e1" id="s1692.p0" relation="false"/>
  </sentence>
  <sentence id="s1693" text="We examined 184 lung adenocarcinomas and observed low expression of DNA damage response, signal transduction by p53 class mediator in adenocarcinoma in situ (oxidation-reduction process) and minimally invasive adenocarcinoma (MIA), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.">
    <entity charOffset="16-35" id="s1693.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="158-185" id="s1693.e1" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <pair e1="s1693.e0" e2="s1693.e1" id="s1693.p0" relation="false"/>
  </sentence>
  <sentence id="s1694" text="We demonstrated that &lt;i&gt;linc-ADAL&lt;/i&gt; interacts with heterogeneous nuclear ribonucleoprotein U (hnRNPU) and insulin-like growth factor 2 mRNA binding protein 2 (negative regulation of translation) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis">
    <entity charOffset="53-66" id="s1694.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="161-195" id="s1694.e1" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <pair e1="s1694.e0" e2="s1694.e1" id="s1694.p0" relation="false"/>
  </sentence>
  <sentence id="s1695" text="JAK2V617F(+) myeloproliferative neoplasms (proteolysiss) frequently progress into leukemias, but the fcoenzyme A biosynthetic processors driving this process are not understood.">
    <entity charOffset="32-41" id="s1695.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="43-54" id="s1695.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s1695.e0" e2="s1695.e1" id="s1695.p0" relation="false"/>
  </sentence>
  <sentence id="s1696" text="JAK2V617F(+) myeloproliferative neoplasms (proteolysiss) frequently progress into leukemias, but the fcoenzyme A biosynthetic processors driving this process are not understood.">
    <entity charOffset="32-41" id="s1696.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="102-133" id="s1696.e1" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <pair e1="s1696.e0" e2="s1696.e1" id="s1696.p0" relation="false"/>
  </sentence>
  <sentence id="s1697" text="myocilin (MYOC), optineurin (OPTN), rRNA processing and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and xenobiotic metabolic process and supramolecular fiber organization in congenital and developmental glaucomas.">
    <entity charOffset="36-51" id="s1697.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="100-108" id="s1697.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s1697.e0" e2="s1697.e1" id="s1697.p0" relation="true"/>
  </sentence>
  <sentence id="s1698" text="myocilin (MYOC), optineurin (OPTN), rRNA processing and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and xenobiotic metabolic process and supramolecular fiber organization in congenital and developmental glaucomas.">
    <entity charOffset="100-108" id="s1698.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="120-148" id="s1698.e1" ontology_id="GO_0006805" text="xenobiotic metabolic process" type="GO"/>
    <pair e1="s1698.e0" e2="s1698.e1" id="s1698.p0" relation="true"/>
  </sentence>
  <sentence id="s1699" text="myocilin (MYOC), optineurin (OPTN), rRNA processing and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and xenobiotic metabolic process and supramolecular fiber organization in congenital and developmental glaucomas.">
    <entity charOffset="100-108" id="s1699.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="153-186" id="s1699.e1" ontology_id="GO_0097435" text="supramolecular fiber organization" type="GO"/>
    <pair e1="s1699.e0" e2="s1699.e1" id="s1699.p0" relation="true"/>
  </sentence>
  <sentence id="s1700" text="We found previously that the candidate tumor suppressor ion transmembrane transport is expressed in differentiated, growth-arrested mammary epithelial cells but is downregulated during tumor progression and cytokine production.">
    <entity charOffset="39-44" id="s1700.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="207-226" id="s1700.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s1700.e0" e2="s1700.e1" id="s1700.p0" relation="true"/>
  </sentence>
  <sentence id="s1701" text="We found previously that the candidate tumor suppressor ion transmembrane transport is expressed in differentiated, growth-arrested mammary epithelial cells but is downregulated during tumor progression and cytokine production.">
    <entity charOffset="39-44" id="s1701.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="56-83" id="s1701.e1" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <pair e1="s1701.e0" e2="s1701.e1" id="s1701.p0" relation="false"/>
  </sentence>
  <sentence id="s1702" text="We show here that another member of the CLCA gene family, ion transmembrane transport, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast cancer cell lines.">
    <entity charOffset="58-85" id="s1702.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="169-174" id="s1702.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1702.e0" e2="s1702.e1" id="s1702.p0" relation="false"/>
  </sentence>
  <sentence id="s1703" text="Mice genetically deficient in protein polyubiquitination exhibited increased susceptibility to colon tumor development in a manner associated with higher abundance of the Wnt receptor-expressing cells and greater activation of the downstream Wnt pathway.">
    <entity charOffset="30-56" id="s1703.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="101-106" id="s1703.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1703.e0" e2="s1703.e1" id="s1703.p0" relation="true"/>
  </sentence>
  <sentence id="s1704" text="Oculopharyngeal muscular dystrophy (poly(A)+ mRNA export from nucleus) is an autosomal dominant, late-onset muscle disorder characterized by ptosis, swallowing difficulties, proximal limb weakness and nuclear aggregates in skeletal muscles.">
    <entity charOffset="36-69" id="s1704.e0" ontology_id="GO_0016973" text="poly(A)+ mRNA export from nucleus" type="GO"/>
    <entity charOffset="141-147" id="s1704.e1" ontology_id="HP_0000508" text="ptosis" type="HP"/>
    <pair e1="s1704.e0" e2="s1704.e1" id="s1704.p0" relation="true"/>
  </sentence>
  <sentence id="s1705" text="Oculopharyngeal muscular dystrophy (poly(A)+ mRNA export from nucleus) is an autosomal dominant, late-onset muscle disorder characterized by ptosis, swallowing difficulties, proximal limb weakness and nuclear aggregates in skeletal muscles.">
    <entity charOffset="36-69" id="s1705.e0" ontology_id="GO_0016973" text="poly(A)+ mRNA export from nucleus" type="GO"/>
    <entity charOffset="149-172" id="s1705.e1" ontology_id="HP_0002015" text="swallowing difficulties" type="HP"/>
    <pair e1="s1705.e0" e2="s1705.e1" id="s1705.p0" relation="true"/>
  </sentence>
  <sentence id="s1706" text="Germ cell tumors (peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase) are a rare form of childhood cancer that originate from the primordial germ cell.">
    <entity charOffset="10-16" id="s1706.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="18-108" id="s1706.e1" ontology_id="GO_0017186" text="peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase" type="GO"/>
    <pair e1="s1706.e0" e2="s1706.e1" id="s1706.p0" relation="false"/>
  </sentence>
  <sentence id="s1707" text="A variant in release of cytochrome c from mitochondria (rs210138) was positively associated with peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (OR [95% CI]: 1.70 [1.32, 2.18]), with a strong estimated effect for testis tumors (OR [95% CI]: 3.31 [1.89, 5.79]).">
    <entity charOffset="13-54" id="s1707.e0" ontology_id="GO_0001836" text="release of cytochrome c from mitochondria" type="GO"/>
    <entity charOffset="264-270" id="s1707.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1707.e0" e2="s1707.e1" id="s1707.p0" relation="false"/>
  </sentence>
  <sentence id="s1708" text="A variant in release of cytochrome c from mitochondria (rs210138) was positively associated with peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (OR [95% CI]: 1.70 [1.32, 2.18]), with a strong estimated effect for testis tumors (OR [95% CI]: 3.31 [1.89, 5.79]).">
    <entity charOffset="97-187" id="s1708.e0" ontology_id="GO_0017186" text="peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase" type="GO"/>
    <entity charOffset="264-270" id="s1708.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1708.e0" e2="s1708.e1" id="s1708.p0" relation="false"/>
  </sentence>
  <sentence id="s1709" text="Mutations in cellular response to DNA damage stimulus cause premature ageing and liver cancer in humans and epidermis development; thus, defective DPC repair has great clinical ramifications.">
    <entity charOffset="13-53" id="s1709.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="87-93" id="s1709.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1709.e0" e2="s1709.e1" id="s1709.p0" relation="true"/>
  </sentence>
  <sentence id="s1710" text="Mutations in cellular response to DNA damage stimulus cause premature ageing and liver cancer in humans and epidermis development; thus, defective DPC repair has great clinical ramifications.">
    <entity charOffset="87-93" id="s1710.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="108-129" id="s1710.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1710.e0" e2="s1710.e1" id="s1710.p0" relation="false"/>
  </sentence>
  <sentence id="s1711" text="In humans, response to oxidative stress mutations underlie the neurological disease known as MCSZ, but these individuals are not predisposed for cancer, implying effective alternative repair pathways in dividing cells.">
    <entity charOffset="11-39" id="s1711.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="145-151" id="s1711.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1711.e0" e2="s1711.e1" id="s1711.p0" relation="false"/>
  </sentence>
  <sentence id="s1712" text="MAX which was involved in small cell lung cancer pathway was a mRNA splicing, via spliceosome gene unique to T2D (OR=1.2, P=0.006) but not in apoptotic DNA fragmentation.">
    <entity charOffset="42-48" id="s1712.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="142-169" id="s1712.e1" ontology_id="GO_0006309" text="apoptotic DNA fragmentation" type="GO"/>
    <pair e1="s1712.e0" e2="s1712.e1" id="s1712.p0" relation="false"/>
  </sentence>
  <sentence id="s1713" text="MAX which was involved in small cell lung cancer pathway was a mRNA splicing, via spliceosome gene unique to T2D (OR=1.2, P=0.006) but not in apoptotic DNA fragmentation.">
    <entity charOffset="42-48" id="s1713.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="63-93" id="s1713.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s1713.e0" e2="s1713.e1" id="s1713.p0" relation="false"/>
  </sentence>
  <sentence id="s1714" text="We hypothesized that de novo mutations (endocytosiss) in synaptic genes explain an important fraction of sporadic NSID cases.">
    <entity charOffset="40-51" id="s1714.e0" ontology_id="GO_0006897" text="endocytosis" type="GO"/>
    <entity charOffset="105-113" id="s1714.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1714.e0" e2="s1714.e1" id="s1714.p0" relation="false"/>
  </sentence>
  <sentence id="s1715" text="Sequencing these four genes in 50 additional sporadic cases of NSID identified a second endocytosis in biological_process (c.1679_1681dup/p.Ser560dup).">
    <entity charOffset="45-53" id="s1715.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="88-99" id="s1715.e1" ontology_id="GO_0006897" text="endocytosis" type="GO"/>
    <pair e1="s1715.e0" e2="s1715.e1" id="s1715.p0" relation="false"/>
  </sentence>
  <sentence id="s1716" text="Sequencing these four genes in 50 additional sporadic cases of NSID identified a second endocytosis in biological_process (c.1679_1681dup/p.Ser560dup).">
    <entity charOffset="45-53" id="s1716.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="103-121" id="s1716.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1716.e0" e2="s1716.e1" id="s1716.p0" relation="false"/>
  </sentence>
  <sentence id="s1717" text="Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with rRNA processing, led to the identification of 16 heterozygous variants in kidney development (growth regulation by estrogen in breast cancer 1-like), a gene reported as a target of retinoic acid signaling.">
    <entity charOffset="137-152" id="s1717.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="271-277" id="s1717.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1717.e0" e2="s1717.e1" id="s1717.p0" relation="false"/>
  </sentence>
  <sentence id="s1718" text="Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with rRNA processing, led to the identification of 16 heterozygous variants in kidney development (growth regulation by estrogen in breast cancer 1-like), a gene reported as a target of retinoic acid signaling.">
    <entity charOffset="211-229" id="s1718.e0" ontology_id="GO_0001822" text="kidney development" type="GO"/>
    <entity charOffset="271-277" id="s1718.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1718.e0" e2="s1718.e1" id="s1718.p0" relation="false"/>
  </sentence>
  <sentence id="s1719" text="The purpose of this study was to recognize the expanded purine repeats (prolyl-tRNA aminoacylation) in human genome and find their correlation with cancer pathogenesis.">
    <entity charOffset="72-98" id="s1719.e0" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="148-154" id="s1719.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1719.e0" e2="s1719.e1" id="s1719.p0" relation="false"/>
  </sentence>
  <sentence id="s1720" text="One upregulated candidate named transmembrane protein 98 (negative regulation of myelination) was found to be overexpressed in 80 of 118 (67.80%) of patients with hepatocellular carcinoma.">
    <entity charOffset="58-92" id="s1720.e0" ontology_id="GO_0031642" text="negative regulation of myelination" type="GO"/>
    <entity charOffset="163-187" id="s1720.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1720.e0" e2="s1720.e1" id="s1720.p0" relation="false"/>
  </sentence>
  <sentence id="s1721" text="negative regulation of myelination mRNA in tumor tissues was significantly higher than nontumor tissues of patients with hepatocellular carcinoma (P &amp;lt; 0.0001).">
    <entity charOffset="0-34" id="s1721.e0" ontology_id="GO_0031642" text="negative regulation of myelination" type="GO"/>
    <entity charOffset="121-145" id="s1721.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1721.e0" e2="s1721.e1" id="s1721.p0" relation="false"/>
  </sentence>
  <sentence id="s1722" text="Upregulation of negative regulation of myelination was significantly correlated with advanced tumor stage (P = 0.048), high incidence of early tumor recurrence (P = 0.005), poor overall survival (P = 0.029), and poor disease-free survival (P = 0.011) of patients with hepatocellular carcinoma after hepatectomy.">
    <entity charOffset="16-50" id="s1722.e0" ontology_id="GO_0031642" text="negative regulation of myelination" type="GO"/>
    <entity charOffset="268-292" id="s1722.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1722.e0" e2="s1722.e1" id="s1722.p0" relation="false"/>
  </sentence>
  <sentence id="s1723" text="Upregulation of negative regulation of myelination was significantly correlated with advanced tumor stage (P = 0.048), high incidence of early tumor recurrence (P = 0.005), poor overall survival (P = 0.029), and poor disease-free survival (P = 0.011) of patients with hepatocellular carcinoma after hepatectomy.">
    <entity charOffset="16-50" id="s1723.e0" ontology_id="GO_0031642" text="negative regulation of myelination" type="GO"/>
    <entity charOffset="94-99" id="s1723.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1723.e0" e2="s1723.e1" id="s1723.p0" relation="false"/>
  </sentence>
  <sentence id="s1724" text="Importantly, upregulation of negative regulation of myelination mRNA in patients with hepatocellular carcinoma who received transarterial chemoembolization (response to hypoxia) treatment was significantly higher than in patients without TACE treatment (P = 0.046).">
    <entity charOffset="29-63" id="s1724.e0" ontology_id="GO_0031642" text="negative regulation of myelination" type="GO"/>
    <entity charOffset="86-110" id="s1724.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1724.e0" e2="s1724.e1" id="s1724.p0" relation="false"/>
  </sentence>
  <sentence id="s1725" text="Importantly, upregulation of negative regulation of myelination mRNA in patients with hepatocellular carcinoma who received transarterial chemoembolization (response to hypoxia) treatment was significantly higher than in patients without TACE treatment (P = 0.046).">
    <entity charOffset="86-110" id="s1725.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="157-176" id="s1725.e1" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <pair e1="s1725.e0" e2="s1725.e1" id="s1725.p0" relation="false"/>
  </sentence>
  <sentence id="s1726" text="In vitro and in vivo studies showed that suppression of negative regulation of myelination in chemoresistant hepatocellular carcinoma cells restored their chemosensitivity, while forced overexpression of TMEM98 enhanced their chemoresistance.">
    <entity charOffset="56-90" id="s1726.e0" ontology_id="GO_0031642" text="negative regulation of myelination" type="GO"/>
    <entity charOffset="109-133" id="s1726.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1726.e0" e2="s1726.e1" id="s1726.p0" relation="false"/>
  </sentence>
  <sentence id="s1727" text="The mechanism of negative regulation of myelination in conferring chemoresistance of hepatocellular carcinoma might be possibly through activation of the AKT pathway and deactivation of p53.">
    <entity charOffset="17-51" id="s1727.e0" ontology_id="GO_0031642" text="negative regulation of myelination" type="GO"/>
    <entity charOffset="85-109" id="s1727.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s1727.e0" e2="s1727.e1" id="s1727.p0" relation="false"/>
  </sentence>
  <sentence id="s1728" text="Human autosomal recessive osteopetrosis (androgen catabolic process), also known as infantile malignant osteopetrosis, is a rare genetic bone disorder that often causes death.">
    <entity charOffset="6-25" id="s1728.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="41-67" id="s1728.e1" ontology_id="GO_0006710" text="androgen catabolic process" type="GO"/>
    <pair e1="s1728.e0" e2="s1728.e1" id="s1728.p0" relation="true"/>
  </sentence>
  <sentence id="s1729" text="Alpha-1-antitrypsin deficiency (platelet degranulationD) is an inherited disease characterized by emphysema and liver disease.">
    <entity charOffset="32-54" id="s1729.e0" ontology_id="GO_0002576" text="platelet degranulation" type="GO"/>
    <entity charOffset="98-107" id="s1729.e1" ontology_id="HP_0002097" text="emphysema" type="HP"/>
    <pair e1="s1729.e0" e2="s1729.e1" id="s1729.p0" relation="true"/>
  </sentence>
  <sentence id="s1730" text="This study aims to determine the association between activation of MAPK activity (rs4415084 C&amp;gt;T), positive regulation of cell proliferation (rs2981582 C&amp;gt;T) and cellular response to mechanical stimulus (rs889312 A&amp;gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.">
    <entity charOffset="53-80" id="s1730.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="255-261" id="s1730.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1730.e0" e2="s1730.e1" id="s1730.p0" relation="false"/>
  </sentence>
  <sentence id="s1731" text="This study aims to determine the association between activation of MAPK activity (rs4415084 C&amp;gt;T), positive regulation of cell proliferation (rs2981582 C&amp;gt;T) and cellular response to mechanical stimulus (rs889312 A&amp;gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.">
    <entity charOffset="101-142" id="s1731.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="255-261" id="s1731.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1731.e0" e2="s1731.e1" id="s1731.p0" relation="true"/>
  </sentence>
  <sentence id="s1732" text="This study aims to determine the association between activation of MAPK activity (rs4415084 C&amp;gt;T), positive regulation of cell proliferation (rs2981582 C&amp;gt;T) and cellular response to mechanical stimulus (rs889312 A&amp;gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.">
    <entity charOffset="166-206" id="s1732.e0" ontology_id="GO_0071260" text="cellular response to mechanical stimulus" type="GO"/>
    <entity charOffset="255-261" id="s1732.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1732.e0" e2="s1732.e1" id="s1732.p0" relation="true"/>
  </sentence>
  <sentence id="s1733" text="The Random Forest algorithm selected positive regulation of cell proliferation, MAP3K1 and age as important breast cancer predictors.">
    <entity charOffset="37-78" id="s1733.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="115-121" id="s1733.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1733.e0" e2="s1733.e1" id="s1733.p0" relation="true"/>
  </sentence>
  <sentence id="s1734" text="&lt;i&gt;In vivo&lt;/i&gt; tumorigenic studies confirmed that protein polyubiquitination-612 overexpression retarded the growth of A375 xenograft tumors, which was coupled with a decline in the percentage of regulation of proteasomal protein catabolic process-67-positive proliferating cells.">
    <entity charOffset="50-76" id="s1734.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="134-140" id="s1734.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1734.e0" e2="s1734.e1" id="s1734.p0" relation="false"/>
  </sentence>
  <sentence id="s1735" text="&lt;i&gt;In vivo&lt;/i&gt; tumorigenic studies confirmed that protein polyubiquitination-612 overexpression retarded the growth of A375 xenograft tumors, which was coupled with a decline in the percentage of regulation of proteasomal protein catabolic process-67-positive proliferating cells.">
    <entity charOffset="134-140" id="s1735.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="196-247" id="s1735.e1" ontology_id="GO_0061136" text="regulation of proteasomal protein catabolic process" type="GO"/>
    <pair e1="s1735.e0" e2="s1735.e1" id="s1735.p0" relation="false"/>
  </sentence>
  <sentence id="s1736" text="Homozygous positive regulation of protein phosphorylation mutations cause a syndrome of 46,XX disorder of sexual development (DSD), palmoplantar keratoderma (PPK), and predisposition to squamous cell carcinoma.">
    <entity charOffset="11-57" id="s1736.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="132-156" id="s1736.e1" ontology_id="HP_0000982" text="palmoplantar keratoderma" type="HP"/>
    <pair e1="s1736.e0" e2="s1736.e1" id="s1736.p0" relation="true"/>
  </sentence>
  <sentence id="s1737" text="Both have PPK and hearing impairment and carried a novel homozygous mutation c.332G&amp;gt;A (p.Cys111Tyr) located in the highly conserved signal peptide processing-like cysteine-rich domain-2 (regulation of DNA-binding transcription factor activity-CRD2).">
    <entity charOffset="18-36" id="s1737.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="135-160" id="s1737.e1" ontology_id="GO_0006465" text="signal peptide processing" type="GO"/>
    <pair e1="s1737.e0" e2="s1737.e1" id="s1737.p0" relation="false"/>
  </sentence>
  <sentence id="s1738" text="Both have PPK and hearing impairment and carried a novel homozygous mutation c.332G&amp;gt;A (p.Cys111Tyr) located in the highly conserved signal peptide processing-like cysteine-rich domain-2 (regulation of DNA-binding transcription factor activity-CRD2).">
    <entity charOffset="18-36" id="s1738.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="190-245" id="s1738.e1" ontology_id="GO_0051090" text="regulation of DNA-binding transcription factor activity" type="GO"/>
    <pair e1="s1738.e0" e2="s1738.e1" id="s1738.p0" relation="false"/>
  </sentence>
  <sentence id="s1739" text="Two additional mutations linked to different forms of retinal dystrophies were identified in two families: a known frameshift deletion in visual perception, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in embryo development ending in birth or egg hatching associated with Late-Onset Retinal Degeneration.">
    <entity charOffset="54-73" id="s1739.e0" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <entity charOffset="138-155" id="s1739.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s1739.e0" e2="s1739.e1" id="s1739.p0" relation="true"/>
  </sentence>
  <sentence id="s1740" text="Two additional mutations linked to different forms of retinal dystrophies were identified in two families: a known frameshift deletion in visual perception, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in embryo development ending in birth or egg hatching associated with Late-Onset Retinal Degeneration.">
    <entity charOffset="54-73" id="s1740.e0" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <entity charOffset="229-279" id="s1740.e1" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <pair e1="s1740.e0" e2="s1740.e1" id="s1740.p0" relation="true"/>
  </sentence>
  <sentence id="s1741" text="We analyzed commonly reported European and Asian obesity-related gene variants in a Mexican-Mestizo population through each single nucleotide polymorphism (SNP) and a genetic risk score (negative regulation of apoptotic process) based on 23 selected SNPs.">
    <entity charOffset="49-56" id="s1741.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="187-227" id="s1741.e1" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <pair e1="s1741.e0" e2="s1741.e1" id="s1741.p0" relation="false"/>
  </sentence>
  <sentence id="s1742" text="ME attenuated the influence of positive regulation of macrophage derived foam cell differentiation rs512535 and TNFA rs361525 on obesity risk in FMP.">
    <entity charOffset="31-98" id="s1742.e0" ontology_id="GO_0010744" text="positive regulation of macrophage derived foam cell differentiation" type="GO"/>
    <entity charOffset="129-136" id="s1742.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1742.e0" e2="s1742.e1" id="s1742.p0" relation="false"/>
  </sentence>
  <sentence id="s1743" text="We report associations for 6 out of 23 SNPs and for the negative regulation of apoptotic process, which confer obesity risk, a novel finding for Mexican-Mestizo physically active population.">
    <entity charOffset="56-96" id="s1743.e0" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <entity charOffset="111-118" id="s1743.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1743.e0" e2="s1743.e1" id="s1743.p0" relation="false"/>
  </sentence>
  <sentence id="s1744" text="The revision was based on data accumulated since the 2008 WHO classification of microtubule-based process, much of which relates to new molecular genetic information about these neoplasms.">
    <entity charOffset="80-105" id="s1744.e0" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <entity charOffset="178-187" id="s1744.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s1744.e0" e2="s1744.e1" id="s1744.p0" relation="false"/>
  </sentence>
  <sentence id="s1745" text="In gastrointestinal tumors, negative regulation of transcription by RNA polymerase II plays an oncogenic role through DNA demethylation.">
    <entity charOffset="20-26" id="s1745.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="28-85" id="s1745.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1745.e0" e2="s1745.e1" id="s1745.p0" relation="false"/>
  </sentence>
  <sentence id="s1746" text="However, the role of negative regulation of transcription by RNA polymerase II in the prognosis of human glioma prognosis remains unclear.">
    <entity charOffset="21-78" id="s1746.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="105-111" id="s1746.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1746.e0" e2="s1746.e1" id="s1746.p0" relation="false"/>
  </sentence>
  <sentence id="s1747" text="In this research, we discovered that negative regulation of transcription by RNA polymerase II was significantly increased in glioma tissues in contrast to normal brain tissues (NBTs; P&amp;lt;0.05).">
    <entity charOffset="37-94" id="s1747.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="126-132" id="s1747.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1747.e0" e2="s1747.e1" id="s1747.p0" relation="false"/>
  </sentence>
  <sentence id="s1748" text="In an in vitro experiment, negative regulation of transcription by RNA polymerase II can promote the proliferation, migration, and invasion of glioma cells and inhibit cell apoptosis by activating positive regulation of protein phosphorylation-angiogenesis pathway.">
    <entity charOffset="27-84" id="s1748.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="143-149" id="s1748.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s1748.e0" e2="s1748.e1" id="s1748.p0" relation="false"/>
  </sentence>
  <sentence id="s1749" text="In an in vitro experiment, negative regulation of transcription by RNA polymerase II can promote the proliferation, migration, and invasion of glioma cells and inhibit cell apoptosis by activating positive regulation of protein phosphorylation-angiogenesis pathway.">
    <entity charOffset="143-149" id="s1749.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="197-243" id="s1749.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1749.e0" e2="s1749.e1" id="s1749.p0" relation="false"/>
  </sentence>
  <sentence id="s1750" text="In an in vitro experiment, negative regulation of transcription by RNA polymerase II can promote the proliferation, migration, and invasion of glioma cells and inhibit cell apoptosis by activating positive regulation of protein phosphorylation-angiogenesis pathway.">
    <entity charOffset="143-149" id="s1750.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="244-256" id="s1750.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s1750.e0" e2="s1750.e1" id="s1750.p0" relation="false"/>
  </sentence>
  <sentence id="s1751" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of biological_process and detection of light stimulus involved in visual perception significantly reduced growth and invasion by downregulating response to molecule of bacterial origin-stimulated angiogenesis phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s1751.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="78-96" id="s1751.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1751.e0" e2="s1751.e1" id="s1751.p0" relation="false"/>
  </sentence>
  <sentence id="s1752" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of biological_process and detection of light stimulus involved in visual perception significantly reduced growth and invasion by downregulating response to molecule of bacterial origin-stimulated angiogenesis phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s1752.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="101-158" id="s1752.e1" ontology_id="GO_0050908" text="detection of light stimulus involved in visual perception" type="GO"/>
    <pair e1="s1752.e0" e2="s1752.e1" id="s1752.p0" relation="false"/>
  </sentence>
  <sentence id="s1753" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of biological_process and detection of light stimulus involved in visual perception significantly reduced growth and invasion by downregulating response to molecule of bacterial origin-stimulated angiogenesis phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s1753.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="219-259" id="s1753.e1" ontology_id="GO_0002237" text="response to molecule of bacterial origin" type="GO"/>
    <pair e1="s1753.e0" e2="s1753.e1" id="s1753.p0" relation="false"/>
  </sentence>
  <sentence id="s1754" text="In A549 lung cancer cells, which endogenously express CXCR1, the depletion of biological_process and detection of light stimulus involved in visual perception significantly reduced growth and invasion by downregulating response to molecule of bacterial origin-stimulated angiogenesis phosphorylation, actin polymerization and the expression of genes related to metastasis.">
    <entity charOffset="13-19" id="s1754.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="271-283" id="s1754.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s1754.e0" e2="s1754.e1" id="s1754.p0" relation="false"/>
  </sentence>
  <sentence id="s1755" text="Hypohidrotic ectodermal dysplasia (positive regulation of NF-kappaB transcription factor activity) results from mutation of the positive regulation of NF-kappaB transcription factor activity, EDAR or EDARADD genes and is characterized by reduced or absent eccrine sweat glands, hair follicles and teeth, and defective formation of salivary, mammary and craniofacial glands.">
    <entity charOffset="13-33" id="s1755.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="35-97" id="s1755.e1" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s1755.e0" e2="s1755.e1" id="s1755.p0" relation="true"/>
  </sentence>
  <sentence id="s1756" text="Hypohidrotic ectodermal dysplasia (positive regulation of NF-kappaB transcription factor activity) results from mutation of the positive regulation of NF-kappaB transcription factor activity, EDAR or EDARADD genes and is characterized by reduced or absent eccrine sweat glands, hair follicles and teeth, and defective formation of salivary, mammary and craniofacial glands.">
    <entity charOffset="13-33" id="s1756.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="128-190" id="s1756.e1" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s1756.e0" e2="s1756.e1" id="s1756.p0" relation="true"/>
  </sentence>
  <sentence id="s1757" text="No other novel mutation or this deletion was detected in protein O-linked glycosylation in a second DDD family and a sporadic DDD case by Sanger Sequencing.">
    <entity charOffset="57-87" id="s1757.e0" ontology_id="GO_0006493" text="protein O-linked glycosylation" type="GO"/>
    <entity charOffset="117-125" id="s1757.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1757.e0" e2="s1757.e1" id="s1757.p0" relation="false"/>
  </sentence>
  <sentence id="s1758" text="Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="11-69" id="s1758.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="274-282" id="s1758.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s1758.e0" e2="s1758.e1" id="s1758.p0" relation="false"/>
  </sentence>
  <sentence id="s1759" text="Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="149-157" id="s1759.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="159-217" id="s1759.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s1759.e0" e2="s1759.e1" id="s1759.p0" relation="true"/>
  </sentence>
  <sentence id="s1760" text="Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.">
    <entity charOffset="159-217" id="s1760.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="313-322" id="s1760.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s1760.e0" e2="s1760.e1" id="s1760.p0" relation="false"/>
  </sentence>
  <sentence id="s1761" text="We report here two new nonsense mutations (pGln12* and pTyr110*) in &lt;i&gt;positive regulation of cytosolic calcium ion concentration&lt;/i&gt; patients displaying nonsyndromic profound hearing loss, with no evidence of vestibular or retinal dysfunction.">
    <entity charOffset="71-129" id="s1761.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="167-175" id="s1761.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s1761.e0" e2="s1761.e1" id="s1761.p0" relation="false"/>
  </sentence>
  <sentence id="s1762" text="Also, the generated &lt;i&gt;positive regulation of cytosolic calcium ion concentration&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; epidermis development display an early onset profound deafness and have normal balance and retinal functions.">
    <entity charOffset="23-81" id="s1762.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="154-162" id="s1762.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1762.e0" e2="s1762.e1" id="s1762.p0" relation="true"/>
  </sentence>
  <sentence id="s1763" text="Also, the generated &lt;i&gt;positive regulation of cytosolic calcium ion concentration&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; epidermis development display an early onset profound deafness and have normal balance and retinal functions.">
    <entity charOffset="23-81" id="s1763.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="145-153" id="s1763.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s1763.e0" e2="s1763.e1" id="s1763.p0" relation="false"/>
  </sentence>
  <sentence id="s1764" text="Also, the generated &lt;i&gt;positive regulation of cytosolic calcium ion concentration&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; epidermis development display an early onset profound deafness and have normal balance and retinal functions.">
    <entity charOffset="100-121" id="s1764.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="154-162" id="s1764.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s1764.e0" e2="s1764.e1" id="s1764.p0" relation="false"/>
  </sentence>
  <sentence id="s1765" text="This essential role of positive regulation of cytosolic calcium ion concentration in mechanotransduction and cell survival that, we show, is restricted to the cochlea, probably accounts for the presence in &lt;i&gt;CIB2&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; mice and &lt;i&gt;CIB2&lt;/i&gt; patients, unlike in Usher syndrome, of isolated hearing loss without balance and vision deficits">
    <entity charOffset="23-81" id="s1765.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="301-313" id="s1765.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1765.e0" e2="s1765.e1" id="s1765.p0" relation="true"/>
  </sentence>
  <sentence id="s1766" text="Sonic hedgehog (positive regulation of cell proliferation) signaling is an important promotor of desmoplasia, a critical feature in pancreatic cancer stromal reactions involving the activation of pancreatic stellate cells(PSCs).">
    <entity charOffset="16-57" id="s1766.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="143-149" id="s1766.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1766.e0" e2="s1766.e1" id="s1766.p0" relation="true"/>
  </sentence>
  <sentence id="s1767" text="The present study investigated the association between Gremlin1 and positive regulation of cell proliferation, and the effect of Gremlin1 in pancreatic cancer.">
    <entity charOffset="69-110" id="s1767.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="154-160" id="s1767.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1767.e0" e2="s1767.e1" id="s1767.p0" relation="true"/>
  </sentence>
  <sentence id="s1768" text="Primary human PSCs and pancreatic cancer cell lines were exposed to positive regulation of cell proliferation, cyclopamine, osteoblast differentiation family zinc finger-1(Gli-1) small interfering RNA (siRNA), and Gremlin1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.">
    <entity charOffset="34-40" id="s1768.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="68-109" id="s1768.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s1768.e0" e2="s1768.e1" id="s1768.p0" relation="true"/>
  </sentence>
  <sentence id="s1769" text="Primary human PSCs and pancreatic cancer cell lines were exposed to positive regulation of cell proliferation, cyclopamine, osteoblast differentiation family zinc finger-1(Gli-1) small interfering RNA (siRNA), and Gremlin1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.">
    <entity charOffset="34-40" id="s1769.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="124-150" id="s1769.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s1769.e0" e2="s1769.e1" id="s1769.p0" relation="true"/>
  </sentence>
  <sentence id="s1770" text="In summary, for the first time, we generated a sensory perception of sound knockout zebrafish line with auditory disorder and retinal degeneration which mimicked the symptoms of patients, and revealed that disruption of fibronectin assembly may be one of the factors underlying RP.">
    <entity charOffset="47-74" id="s1770.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="126-146" id="s1770.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s1770.e0" e2="s1770.e1" id="s1770.p0" relation="false"/>
  </sentence>
  <sentence id="s1771" text="The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in DNA topological change, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.">
    <entity charOffset="129-151" id="s1771.e0" ontology_id="GO_0006265" text="DNA topological change" type="GO"/>
    <entity charOffset="208-215" id="s1771.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s1771.e0" e2="s1771.e1" id="s1771.p0" relation="false"/>
  </sentence>
  <sentence id="s1772" text="The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in DNA topological change, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.">
    <entity charOffset="129-151" id="s1772.e0" ontology_id="GO_0006265" text="DNA topological change" type="GO"/>
    <entity charOffset="237-252" id="s1772.e1" ontology_id="HP_0000602" text="ophthalmoplegia" type="HP"/>
    <pair e1="s1772.e0" e2="s1772.e1" id="s1772.p0" relation="false"/>
  </sentence>
  <sentence id="s1773" text="Cilia play essential roles in normal human development and health; cilia dysfunction results in diseases such as primary ciliary dyskinesia (motile cilium assembly).">
    <entity charOffset="121-139" id="s1773.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="141-163" id="s1773.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s1773.e0" e2="s1773.e1" id="s1773.p0" relation="true"/>
  </sentence>
  <sentence id="s1774" text="We present the native 3D structures of normal and motile cilium assembly-causing RSPH1-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the heterogeneous secondary defects in RSPH1-mutant cilia.">
    <entity charOffset="50-72" id="s1774.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="282-295" id="s1774.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1774.e0" e2="s1774.e1" id="s1774.p0" relation="false"/>
  </sentence>
  <sentence id="s1775" text="Our data provide evidence for structural and functional heterogeneity in radial spokes, suggest a mechanism for the milder RSPH1 motile cilium assembly phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.">
    <entity charOffset="56-69" id="s1775.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="129-151" id="s1775.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s1775.e0" e2="s1775.e1" id="s1775.p0" relation="false"/>
  </sentence>
  <sentence id="s1776" text="Biallelic mutations in the tRNA aminoacylation gene encoding mitochondrial tyrosyl-tRNA synthetase cause myopathy, lactic acidosis, and sideroblastic anemia 2 (MLASA2), a muscle organ development of mitochondrial disease.">
    <entity charOffset="27-46" id="s1776.e0" ontology_id="GO_0043039" text="tRNA aminoacylation" type="GO"/>
    <entity charOffset="115-130" id="s1776.e1" ontology_id="HP_0003128" text="lactic acidosis" type="HP"/>
    <pair e1="s1776.e0" e2="s1776.e1" id="s1776.p0" relation="true"/>
  </sentence>
  <sentence id="s1777" text="Biallelic mutations in the tRNA aminoacylation gene encoding mitochondrial tyrosyl-tRNA synthetase cause myopathy, lactic acidosis, and sideroblastic anemia 2 (MLASA2), a muscle organ development of mitochondrial disease.">
    <entity charOffset="115-130" id="s1777.e0" ontology_id="HP_0003128" text="lactic acidosis" type="HP"/>
    <entity charOffset="171-195" id="s1777.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1777.e0" e2="s1777.e1" id="s1777.p0" relation="false"/>
  </sentence>
  <sentence id="s1778" text="We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-multicellular organism development difficulties, relative microcephaly, long interstrand cross-link repair, stellate iris pattern, and periorbital fullness.">
    <entity charOffset="105-118" id="s1778.e0" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <entity charOffset="140-174" id="s1778.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s1778.e0" e2="s1778.e1" id="s1778.p0" relation="false"/>
  </sentence>
  <sentence id="s1779" text="We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-multicellular organism development difficulties, relative microcephaly, long interstrand cross-link repair, stellate iris pattern, and periorbital fullness.">
    <entity charOffset="105-118" id="s1779.e0" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <entity charOffset="217-246" id="s1779.e1" ontology_id="GO_0036297" text="interstrand cross-link repair" type="GO"/>
    <pair e1="s1779.e0" e2="s1779.e1" id="s1779.p0" relation="false"/>
  </sentence>
  <sentence id="s1780" text="We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-multicellular organism development difficulties, relative microcephaly, long interstrand cross-link repair, stellate iris pattern, and periorbital fullness.">
    <entity charOffset="140-174" id="s1780.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="198-210" id="s1780.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1780.e0" e2="s1780.e1" id="s1780.p0" relation="false"/>
  </sentence>
  <sentence id="s1781" text="We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-multicellular organism development difficulties, relative microcephaly, long interstrand cross-link repair, stellate iris pattern, and periorbital fullness.">
    <entity charOffset="198-210" id="s1781.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="217-246" id="s1781.e1" ontology_id="GO_0036297" text="interstrand cross-link repair" type="GO"/>
    <pair e1="s1781.e0" e2="s1781.e1" id="s1781.p0" relation="true"/>
  </sentence>
  <sentence id="s1782" text="We show that an inhaled PI3K inhibitor improves survival rates following S. pneumoniae infection in wild-type epidermis development and in mice with activated PI3K.">
    <entity charOffset="77-86" id="s1782.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="111-132" id="s1782.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1782.e0" e2="s1782.e1" id="s1782.p0" relation="false"/>
  </sentence>
  <sentence id="s1783" text="PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (phosphatidylserine catabolic process).">
    <entity charOffset="23-35" id="s1783.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="220-256" id="s1783.e1" ontology_id="GO_0006660" text="phosphatidylserine catabolic process" type="GO"/>
    <pair e1="s1783.e0" e2="s1783.e1" id="s1783.p0" relation="true"/>
  </sentence>
  <sentence id="s1784" text="PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (phosphatidylserine catabolic process).">
    <entity charOffset="37-43" id="s1784.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="220-256" id="s1784.e1" ontology_id="GO_0006660" text="phosphatidylserine catabolic process" type="GO"/>
    <pair e1="s1784.e0" e2="s1784.e1" id="s1784.p0" relation="true"/>
  </sentence>
  <sentence id="s1785" text="PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (phosphatidylserine catabolic process).">
    <entity charOffset="71-80" id="s1785.e0" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <entity charOffset="220-256" id="s1785.e1" ontology_id="GO_0006660" text="phosphatidylserine catabolic process" type="GO"/>
    <pair e1="s1785.e0" e2="s1785.e1" id="s1785.p0" relation="true"/>
  </sentence>
  <sentence id="s1786" text="PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (phosphatidylserine catabolic process).">
    <entity charOffset="126-151" id="s1786.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="220-256" id="s1786.e1" ontology_id="GO_0006660" text="phosphatidylserine catabolic process" type="GO"/>
    <pair e1="s1786.e0" e2="s1786.e1" id="s1786.p0" relation="false"/>
  </sentence>
  <sentence id="s1787" text="The DNA cellular protein catabolic process checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (positive regulation of transcription elongation from RNA polymerase II promoter).">
    <entity charOffset="8-42" id="s1787.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="71-77" id="s1787.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1787.e0" e2="s1787.e1" id="s1787.p0" relation="false"/>
  </sentence>
  <sentence id="s1788" text="The DNA cellular protein catabolic process checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (positive regulation of transcription elongation from RNA polymerase II promoter).">
    <entity charOffset="8-42" id="s1788.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="97-103" id="s1788.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1788.e0" e2="s1788.e1" id="s1788.p0" relation="false"/>
  </sentence>
  <sentence id="s1789" text="The DNA cellular protein catabolic process checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (positive regulation of transcription elongation from RNA polymerase II promoter).">
    <entity charOffset="71-77" id="s1789.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="176-255" id="s1789.e1" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <pair e1="s1789.e0" e2="s1789.e1" id="s1789.p0" relation="false"/>
  </sentence>
  <sentence id="s1790" text="The DNA cellular protein catabolic process checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (positive regulation of transcription elongation from RNA polymerase II promoter).">
    <entity charOffset="97-103" id="s1790.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="176-255" id="s1790.e1" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <pair e1="s1790.e0" e2="s1790.e1" id="s1790.p0" relation="false"/>
  </sentence>
  <sentence id="s1791" text="Furthermore, targeting DNA repair defects by protein ADP-ribosylation inhibitors (PARPi) as a cancer treatnegative regulation of phosphatase activityt strategy is emerging yet requires suitable predictive biomarkers.">
    <entity charOffset="45-69" id="s1791.e0" ontology_id="GO_0006471" text="protein ADP-ribosylation" type="GO"/>
    <entity charOffset="94-100" id="s1791.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1791.e0" e2="s1791.e1" id="s1791.p0" relation="false"/>
  </sentence>
  <sentence id="s1792" text="Furthermore, targeting DNA repair defects by protein ADP-ribosylation inhibitors (PARPi) as a cancer treatnegative regulation of phosphatase activityt strategy is emerging yet requires suitable predictive biomarkers.">
    <entity charOffset="94-100" id="s1792.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="106-149" id="s1792.e1" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <pair e1="s1792.e0" e2="s1792.e1" id="s1792.p0" relation="false"/>
  </sentence>
  <sentence id="s1793" text="To address these issues, we performed immunohistochemical analysis of multiple markers of DNA cellular protein catabolic process signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to positive regulation of transcription elongation from RNA polymerase II promoter, complenegative regulation of phosphatase activityted by genetic analyses of TMPRSS2-ERG rearrangement and regulation of cellular amino acid metabolic process, an anti-oxidant factor and p53 protector.">
    <entity charOffset="94-128" id="s1793.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="296-305" id="s1793.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s1793.e0" e2="s1793.e1" id="s1793.p0" relation="false"/>
  </sentence>
  <sentence id="s1794" text="To address these issues, we performed immunohistochemical analysis of multiple markers of DNA cellular protein catabolic process signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to positive regulation of transcription elongation from RNA polymerase II promoter, complenegative regulation of phosphatase activityted by genetic analyses of TMPRSS2-ERG rearrangement and regulation of cellular amino acid metabolic process, an anti-oxidant factor and p53 protector.">
    <entity charOffset="296-305" id="s1794.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="309-388" id="s1794.e1" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <pair e1="s1794.e0" e2="s1794.e1" id="s1794.p0" relation="false"/>
  </sentence>
  <sentence id="s1795" text="To address these issues, we performed immunohistochemical analysis of multiple markers of DNA cellular protein catabolic process signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to positive regulation of transcription elongation from RNA polymerase II promoter, complenegative regulation of phosphatase activityted by genetic analyses of TMPRSS2-ERG rearrangement and regulation of cellular amino acid metabolic process, an anti-oxidant factor and p53 protector.">
    <entity charOffset="296-305" id="s1795.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="496-547" id="s1795.e1" ontology_id="GO_0006521" text="regulation of cellular amino acid metabolic process" type="GO"/>
    <pair e1="s1795.e0" e2="s1795.e1" id="s1795.p0" relation="false"/>
  </sentence>
  <sentence id="s1796" text="To address these issues, we performed immunohistochemical analysis of multiple markers of DNA cellular protein catabolic process signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to positive regulation of transcription elongation from RNA polymerase II promoter, complenegative regulation of phosphatase activityted by genetic analyses of TMPRSS2-ERG rearrangement and regulation of cellular amino acid metabolic process, an anti-oxidant factor and p53 protector.">
    <entity charOffset="296-305" id="s1796.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="396-439" id="s1796.e1" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <pair e1="s1796.e0" e2="s1796.e1" id="s1796.p0" relation="false"/>
  </sentence>
  <sentence id="s1797" text="The DNA damage checkpoint barrier (H2AX, pprotein phosphorylation, p53) mechanism was activated during positive regulation of transcription elongation from RNA polymerase II promoter tumorigenesis, albeit less and with delayed culmination compared to other cancers, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.">
    <entity charOffset="43-66" id="s1797.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="258-264" id="s1797.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1797.e0" e2="s1797.e1" id="s1797.p0" relation="true"/>
  </sentence>
  <sentence id="s1798" text="The DNA damage checkpoint barrier (H2AX, pprotein phosphorylation, p53) mechanism was activated during positive regulation of transcription elongation from RNA polymerase II promoter tumorigenesis, albeit less and with delayed culmination compared to other cancers, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.">
    <entity charOffset="104-183" id="s1798.e0" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="258-264" id="s1798.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1798.e0" e2="s1798.e1" id="s1798.p0" relation="false"/>
  </sentence>
  <sentence id="s1799" text="regulation of cellular amino acid metabolic process genotypes of 390 men did not indicate predisposition to positive regulation of transcription elongation from RNA polymerase II promoter, yet loss of NQO1 in CaP suggested potential progression-opposing tumour suppressor role.">
    <entity charOffset="0-51" id="s1799.e0" ontology_id="GO_0006521" text="regulation of cellular amino acid metabolic process" type="GO"/>
    <entity charOffset="254-260" id="s1799.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1799.e0" e2="s1799.e1" id="s1799.p0" relation="false"/>
  </sentence>
  <sentence id="s1800" text="regulation of cellular amino acid metabolic process genotypes of 390 men did not indicate predisposition to positive regulation of transcription elongation from RNA polymerase II promoter, yet loss of NQO1 in CaP suggested potential progression-opposing tumour suppressor role.">
    <entity charOffset="108-187" id="s1800.e0" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="254-260" id="s1800.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1800.e0" e2="s1800.e1" id="s1800.p0" relation="false"/>
  </sentence>
  <sentence id="s1801" text="TMPRSS2-ERG rearrangenegative regulation of phosphatase activityt and negative regulation of protein phosphorylation loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and negative regulation of transcription by RNA polymerase II (all studied here for the first time in positive regulation of transcription elongation from RNA polymerase II promoter) whose defects may cause resistance to PARPi.">
    <entity charOffset="21-64" id="s1801.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="183-196" id="s1801.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1801.e0" e2="s1801.e1" id="s1801.p0" relation="false"/>
  </sentence>
  <sentence id="s1802" text="TMPRSS2-ERG rearrangenegative regulation of phosphatase activityt and negative regulation of protein phosphorylation loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and negative regulation of transcription by RNA polymerase II (all studied here for the first time in positive regulation of transcription elongation from RNA polymerase II promoter) whose defects may cause resistance to PARPi.">
    <entity charOffset="70-116" id="s1802.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="183-196" id="s1802.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1802.e0" e2="s1802.e1" id="s1802.p0" relation="false"/>
  </sentence>
  <sentence id="s1803" text="TMPRSS2-ERG rearrangenegative regulation of phosphatase activityt and negative regulation of protein phosphorylation loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and negative regulation of transcription by RNA polymerase II (all studied here for the first time in positive regulation of transcription elongation from RNA polymerase II promoter) whose defects may cause resistance to PARPi.">
    <entity charOffset="183-196" id="s1803.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="340-419" id="s1803.e1" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <pair e1="s1803.e0" e2="s1803.e1" id="s1803.p0" relation="false"/>
  </sentence>
  <sentence id="s1804" text="TMPRSS2-ERG rearrangenegative regulation of phosphatase activityt and negative regulation of protein phosphorylation loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and negative regulation of transcription by RNA polymerase II (all studied here for the first time in positive regulation of transcription elongation from RNA polymerase II promoter) whose defects may cause resistance to PARPi.">
    <entity charOffset="183-196" id="s1804.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="242-299" id="s1804.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1804.e0" e2="s1804.e1" id="s1804.p0" relation="false"/>
  </sentence>
  <sentence id="s1805" text="These results imply that PPI might be modulated by four genotypes - catecholamine catabolic process rs4680 (primarily in males), glutamate receptor signaling pathway rs1027599, TCF4 rs9960767, and positive regulation of cell death rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.">
    <entity charOffset="68-99" id="s1805.e0" ontology_id="GO_0042424" text="catecholamine catabolic process" type="GO"/>
    <entity charOffset="348-361" id="s1805.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1805.e0" e2="s1805.e1" id="s1805.p0" relation="true"/>
  </sentence>
  <sentence id="s1806" text="These results imply that PPI might be modulated by four genotypes - catecholamine catabolic process rs4680 (primarily in males), glutamate receptor signaling pathway rs1027599, TCF4 rs9960767, and positive regulation of cell death rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.">
    <entity charOffset="129-165" id="s1806.e0" ontology_id="GO_0007215" text="glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="348-361" id="s1806.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1806.e0" e2="s1806.e1" id="s1806.p0" relation="false"/>
  </sentence>
  <sentence id="s1807" text="These results imply that PPI might be modulated by four genotypes - catecholamine catabolic process rs4680 (primarily in males), glutamate receptor signaling pathway rs1027599, TCF4 rs9960767, and positive regulation of cell death rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.">
    <entity charOffset="197-230" id="s1807.e0" ontology_id="GO_0010942" text="positive regulation of cell death" type="GO"/>
    <entity charOffset="348-361" id="s1807.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s1807.e0" e2="s1807.e1" id="s1807.p0" relation="true"/>
  </sentence>
  <sentence id="s1808" text="BRCT-repeat inhibitor of hTERT expression (negative regulation of transcription by RNA polymerase II) is involved in the invasion of tumors.">
    <entity charOffset="43-100" id="s1808.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="133-139" id="s1808.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1808.e0" e2="s1808.e1" id="s1808.p0" relation="false"/>
  </sentence>
  <sentence id="s1809" text="Here, we hypothesize that repression of transcriptional activity of forkhead box O1 (cellular response to starvation) via histone deacetylase inhibitors (HDACi) ameliorates hyperglycemia in T2DM rats">
    <entity charOffset="85-116" id="s1809.e0" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <entity charOffset="173-186" id="s1809.e1" ontology_id="HP_0003074" text="hyperglycemia" type="HP"/>
    <pair e1="s1809.e0" e2="s1809.e1" id="s1809.p0" relation="false"/>
  </sentence>
  <sentence id="s1810" text="Here, we report that biallelic mutations in mitotic chromosome condensation, mitotic chromosome condensation, or mitotic chromosome condensation, encoding subunits of these complexes, cause microcephaly.">
    <entity charOffset="44-75" id="s1810.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="190-202" id="s1810.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1810.e0" e2="s1810.e1" id="s1810.p0" relation="false"/>
  </sentence>
  <sentence id="s1811" text="Here, we report that biallelic mutations in mitotic chromosome condensation, mitotic chromosome condensation, or mitotic chromosome condensation, encoding subunits of these complexes, cause microcephaly.">
    <entity charOffset="77-108" id="s1811.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="190-202" id="s1811.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1811.e0" e2="s1811.e1" id="s1811.p0" relation="false"/>
  </sentence>
  <sentence id="s1812" text="Here, we report that biallelic mutations in mitotic chromosome condensation, mitotic chromosome condensation, or mitotic chromosome condensation, encoding subunits of these complexes, cause microcephaly.">
    <entity charOffset="113-144" id="s1812.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="190-202" id="s1812.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1812.e0" e2="s1812.e1" id="s1812.p0" relation="true"/>
  </sentence>
  <sentence id="s1813" text="Here, we show that high levels of the actin cytoskeleton-associated protein Fc-gamma receptor signaling pathway involved in phagocytosis (WASP-interacting protein) correlates with tumor growth, both of which are linked to the tumor-initiating cell phenotype.">
    <entity charOffset="76-136" id="s1813.e0" ontology_id="GO_0038096" text="Fc-gamma receptor signaling pathway involved in phagocytosis" type="GO"/>
    <entity charOffset="180-185" id="s1813.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1813.e0" e2="s1813.e1" id="s1813.p0" relation="true"/>
  </sentence>
  <sentence id="s1814" text="We cellular response to interleukin-4 that WIP controls tumor growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.">
    <entity charOffset="3-37" id="s1814.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="56-61" id="s1814.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1814.e0" e2="s1814.e1" id="s1814.p0" relation="false"/>
  </sentence>
  <sentence id="s1815" text="Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of regulation of alternative mRNA splicing, via spliceosome KO epidermis development, the mouse model of the most common inherited autism, fragile X syndrome (FXS).">
    <entity charOffset="98-154" id="s1815.e0" ontology_id="GO_0000381" text="regulation of alternative mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="226-232" id="s1815.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1815.e0" e2="s1815.e1" id="s1815.p0" relation="true"/>
  </sentence>
  <sentence id="s1816" text="Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of regulation of alternative mRNA splicing, via spliceosome KO epidermis development, the mouse model of the most common inherited autism, fragile X syndrome (FXS).">
    <entity charOffset="158-179" id="s1816.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="226-232" id="s1816.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s1816.e0" e2="s1816.e1" id="s1816.p0" relation="false"/>
  </sentence>
  <sentence id="s1817" text="We found that the impaired homeostatic synaptic downscaling in regulation of alternative mRNA splicing, via spliceosome KO neurons is caused by loss-of-function dephosphorylation of an epilepsy-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2.">
    <entity charOffset="63-119" id="s1817.e0" ontology_id="GO_0000381" text="regulation of alternative mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="185-193" id="s1817.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1817.e0" e2="s1817.e1" id="s1817.p0" relation="true"/>
  </sentence>
  <sentence id="s1818" text="Such dephosphorylation of regulation of membrane depolarization is surprisingly caused by abnormally stable tumor suppressor p53 and subsequently destabilized kinase Akt.">
    <entity charOffset="26-63" id="s1818.e0" ontology_id="GO_0003254" text="regulation of membrane depolarization" type="GO"/>
    <entity charOffset="108-113" id="s1818.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1818.e0" e2="s1818.e1" id="s1818.p0" relation="false"/>
  </sentence>
  <sentence id="s1819" text="Ellis-van Creveld (endochondral bone growth) syndrome is a rare autosomal recessive disorder characterized by hypoplastic nails, polydactyly, and achondroplasia.">
    <entity charOffset="19-43" id="s1819.e0" ontology_id="GO_0003416" text="endochondral bone growth" type="GO"/>
    <entity charOffset="110-127" id="s1819.e1" ontology_id="HP_0001792" text="hypoplastic nails" type="HP"/>
    <pair e1="s1819.e0" e2="s1819.e1" id="s1819.p0" relation="true"/>
  </sentence>
  <sentence id="s1820" text="Ellis-van Creveld (endochondral bone growth) syndrome is a rare autosomal recessive disorder characterized by hypoplastic nails, polydactyly, and achondroplasia.">
    <entity charOffset="19-43" id="s1820.e0" ontology_id="GO_0003416" text="endochondral bone growth" type="GO"/>
    <entity charOffset="129-140" id="s1820.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s1820.e0" e2="s1820.e1" id="s1820.p0" relation="true"/>
  </sentence>
  <sentence id="s1821" text="This is, to our knowledge, a most severe phenotype of endochondral bone growth syndrome, illustrating that the specific pattern of EVC2 compound heterozygous mutations may cause severe developmental delay and intestinal malfunction.">
    <entity charOffset="54-78" id="s1821.e0" ontology_id="GO_0003416" text="endochondral bone growth" type="GO"/>
    <entity charOffset="185-204" id="s1821.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s1821.e0" e2="s1821.e1" id="s1821.p0" relation="false"/>
  </sentence>
  <sentence id="s1822" text="Moreover, we show that over-expression of prostaglandin biosynthetic process dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed epidermis development.">
    <entity charOffset="42-76" id="s1822.e0" ontology_id="GO_0001516" text="prostaglandin biosynthetic process" type="GO"/>
    <entity charOffset="108-117" id="s1822.e1" ontology_id="HP_0001397" text="steatosis" type="HP"/>
    <pair e1="s1822.e0" e2="s1822.e1" id="s1822.p0" relation="false"/>
  </sentence>
  <sentence id="s1823" text="Moreover, we show that over-expression of prostaglandin biosynthetic process dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed epidermis development.">
    <entity charOffset="108-117" id="s1823.e0" ontology_id="HP_0001397" text="steatosis" type="HP"/>
    <entity charOffset="172-193" id="s1823.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1823.e0" e2="s1823.e1" id="s1823.p0" relation="false"/>
  </sentence>
  <sentence id="s1824" text="Humans who carry kidney development mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.">
    <entity charOffset="17-35" id="s1824.e0" ontology_id="GO_0001822" text="kidney development" type="GO"/>
    <entity charOffset="163-177" id="s1824.e1" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <pair e1="s1824.e0" e2="s1824.e1" id="s1824.p0" relation="true"/>
  </sentence>
  <sentence id="s1825" text="Humans who carry kidney development mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.">
    <entity charOffset="17-35" id="s1825.e0" ontology_id="GO_0001822" text="kidney development" type="GO"/>
    <entity charOffset="179-195" id="s1825.e1" ontology_id="HP_0000089" text="renal hypoplasia" type="HP"/>
    <pair e1="s1825.e0" e2="s1825.e1" id="s1825.p0" relation="true"/>
  </sentence>
  <sentence id="s1826" text="Humans who carry kidney development mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.">
    <entity charOffset="17-35" id="s1826.e0" ontology_id="GO_0001822" text="kidney development" type="GO"/>
    <entity charOffset="201-228" id="s1826.e1" ontology_id="HP_0005576" text="renal interstitial fibrosis" type="HP"/>
    <pair e1="s1826.e0" e2="s1826.e1" id="s1826.p0" relation="false"/>
  </sentence>
  <sentence id="s1827" text="Phaeochromocytoma and paraganglioma (PHEO/PGL) are rare tumours with an estimated annual incidence of 3 GPI anchor metabolic process million.">
    <entity charOffset="22-35" id="s1827.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="104-132" id="s1827.e1" ontology_id="GO_0006505" text="GPI anchor metabolic process" type="GO"/>
    <pair e1="s1827.e0" e2="s1827.e1" id="s1827.p0" relation="false"/>
  </sentence>
  <sentence id="s1828" text="Phaeochromocytoma and paraganglioma (PHEO/PGL) are rare tumours with an estimated annual incidence of 3 GPI anchor metabolic process million.">
    <entity charOffset="56-63" id="s1828.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="104-132" id="s1828.e1" ontology_id="GO_0006505" text="GPI anchor metabolic process" type="GO"/>
    <pair e1="s1828.e0" e2="s1828.e1" id="s1828.p0" relation="false"/>
  </sentence>
  <sentence id="s1829" text="Mutations in 18 genes that encode components of glucosamine catabolic process-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features.">
    <entity charOffset="48-77" id="s1829.e0" ontology_id="GO_0006043" text="glucosamine catabolic process" type="GO"/>
    <entity charOffset="163-171" id="s1829.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1829.e0" e2="s1829.e1" id="s1829.p0" relation="false"/>
  </sentence>
  <sentence id="s1830" text="Mutations in 18 genes that encode components of glucosamine catabolic process-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features.">
    <entity charOffset="48-77" id="s1830.e0" ontology_id="GO_0006043" text="glucosamine catabolic process" type="GO"/>
    <entity charOffset="173-185" id="s1830.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1830.e0" e2="s1830.e1" id="s1830.p0" relation="false"/>
  </sentence>
  <sentence id="s1831" text="Since the original description of the tRNA aminoacylation for protein translation-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
    <entity charOffset="38-81" id="s1831.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="90-99" id="s1831.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s1831.e0" e2="s1831.e1" id="s1831.p0" relation="true"/>
  </sentence>
  <sentence id="s1832" text="Since the original description of the tRNA aminoacylation for protein translation-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
    <entity charOffset="38-81" id="s1832.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="162-174" id="s1832.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s1832.e0" e2="s1832.e1" id="s1832.p0" relation="true"/>
  </sentence>
  <sentence id="s1833" text="Since the original description of the tRNA aminoacylation for protein translation-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
    <entity charOffset="38-81" id="s1833.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="176-194" id="s1833.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s1833.e0" e2="s1833.e1" id="s1833.p0" relation="true"/>
  </sentence>
  <sentence id="s1834" text="Here, we report on a female Danish patient with a novel homozygous tRNA aminoacylation for protein translation mutation, p.Gly874Arg, who presented at birth with bilateral negative regulation of signal transduction dislocation and short stature.">
    <entity charOffset="67-110" id="s1834.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="231-244" id="s1834.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s1834.e0" e2="s1834.e1" id="s1834.p0" relation="true"/>
  </sentence>
  <sentence id="s1835" text="Here, we report on a female Danish patient with a novel homozygous tRNA aminoacylation for protein translation mutation, p.Gly874Arg, who presented at birth with bilateral negative regulation of signal transduction dislocation and short stature.">
    <entity charOffset="172-214" id="s1835.e0" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <entity charOffset="231-244" id="s1835.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s1835.e0" e2="s1835.e1" id="s1835.p0" relation="false"/>
  </sentence>
  <sentence id="s1836" text="At 3 months, additional dysmorphic features were noted and at 18 months her radiographic skeletal abnormalities were suggestive of an underlying spondyloepimetaphyseal dysplasia (regulation of axon extension involved in axon guidance).">
    <entity charOffset="89-111" id="s1836.e0" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <entity charOffset="179-233" id="s1836.e1" ontology_id="GO_0048841" text="regulation of axon extension involved in axon guidance" type="GO"/>
    <pair e1="s1836.e0" e2="s1836.e1" id="s1836.p0" relation="true"/>
  </sentence>
  <sentence id="s1837" text="At 3 months, additional dysmorphic features were noted and at 18 months her radiographic skeletal abnormalities were suggestive of an underlying spondyloepimetaphyseal dysplasia (regulation of axon extension involved in axon guidance).">
    <entity charOffset="145-177" id="s1837.e0" ontology_id="HP_0002651" text="spondyloepimetaphyseal dysplasia" type="HP"/>
    <entity charOffset="179-233" id="s1837.e1" ontology_id="GO_0048841" text="regulation of axon extension involved in axon guidance" type="GO"/>
    <pair e1="s1837.e0" e2="s1837.e1" id="s1837.p0" relation="false"/>
  </sentence>
  <sentence id="s1838" text="We present her clinical features and particularly highlight her skeletal findings, which confirm the presence of a primary SEMD skeletal dysplasia in a growing list of mitochondrial-related disorders including CAGSSS, CODAS, EVEN-PLUS, and X-linked SEMD-positive regulation of NIK/NF-kappaB signaling syndromes">
    <entity charOffset="128-146" id="s1838.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="254-300" id="s1838.e1" ontology_id="GO_1901224" text="positive regulation of NIK/NF-kappaB signaling" type="GO"/>
    <pair e1="s1838.e0" e2="s1838.e1" id="s1838.p0" relation="false"/>
  </sentence>
  <sentence id="s1839" text="Autosomal recessive CMT cases are generally characterized by earlier onset, usually before the age of 2 or 3 years, and rapid clinical progression that results in severe polyneuropathy and more marked distal limb deformities such as maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) equino-varus, claw-like hands, and often major spinal deformities.">
    <entity charOffset="174-184" id="s1839.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="233-321" id="s1839.e1" ontology_id="GO_0000463" text="maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" type="GO"/>
    <pair e1="s1839.e0" e2="s1839.e1" id="s1839.p0" relation="false"/>
  </sentence>
  <sentence id="s1840" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1840.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="162-183" id="s1840.e1" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <pair e1="s1840.e0" e2="s1840.e1" id="s1840.p0" relation="true"/>
  </sentence>
  <sentence id="s1841" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1841.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="185-223" id="s1841.e1" ontology_id="GO_0046856" text="phosphatidylinositol dephosphorylation" type="GO"/>
    <pair e1="s1841.e0" e2="s1841.e1" id="s1841.p0" relation="true"/>
  </sentence>
  <sentence id="s1842" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1842.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="225-236" id="s1842.e1" ontology_id="GO_0042552" text="myelination" type="GO"/>
    <pair e1="s1842.e0" e2="s1842.e1" id="s1842.p0" relation="true"/>
  </sentence>
  <sentence id="s1843" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1843.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="238-300" id="s1843.e1" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <pair e1="s1843.e0" e2="s1843.e1" id="s1843.p0" relation="true"/>
  </sentence>
  <sentence id="s1844" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1844.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="316-344" id="s1844.e1" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <pair e1="s1844.e0" e2="s1844.e1" id="s1844.p0" relation="false"/>
  </sentence>
  <sentence id="s1845" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1845.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="346-371" id="s1845.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s1845.e0" e2="s1845.e1" id="s1845.p0" relation="true"/>
  </sentence>
  <sentence id="s1846" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1846.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="377-418" id="s1846.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="s1846.e0" e2="s1846.e1" id="s1846.p0" relation="true"/>
  </sentence>
  <sentence id="s1847" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1847.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="493-526" id="s1847.e1" ontology_id="GO_0090343" text="positive regulation of cell aging" type="GO"/>
    <pair e1="s1847.e0" e2="s1847.e1" id="s1847.p0" relation="true"/>
  </sentence>
  <sentence id="s1848" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1848.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="578-617" id="s1848.e1" ontology_id="GO_0009154" text="purine ribonucleotide catabolic process" type="GO"/>
    <pair e1="s1848.e0" e2="s1848.e1" id="s1848.p0" relation="true"/>
  </sentence>
  <sentence id="s1849" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1849.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="626-652" id="s1849.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s1849.e0" e2="s1849.e1" id="s1849.p0" relation="true"/>
  </sentence>
  <sentence id="s1850" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1850.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="685-722" id="s1850.e1" ontology_id="GO_0001932" text="regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1850.e0" e2="s1850.e1" id="s1850.p0" relation="false"/>
  </sentence>
  <sentence id="s1851" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="81-100" id="s1851.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="727-761" id="s1851.e1" ontology_id="GO_0006626" text="protein targeting to mitochondrion" type="GO"/>
    <pair e1="s1851.e0" e2="s1851.e1" id="s1851.p0" relation="true"/>
  </sentence>
  <sentence id="s1852" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1852.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="162-183" id="s1852.e1" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <pair e1="s1852.e0" e2="s1852.e1" id="s1852.p0" relation="false"/>
  </sentence>
  <sentence id="s1853" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1853.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="185-223" id="s1853.e1" ontology_id="GO_0046856" text="phosphatidylinositol dephosphorylation" type="GO"/>
    <pair e1="s1853.e0" e2="s1853.e1" id="s1853.p0" relation="false"/>
  </sentence>
  <sentence id="s1854" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1854.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="238-300" id="s1854.e1" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <pair e1="s1854.e0" e2="s1854.e1" id="s1854.p0" relation="false"/>
  </sentence>
  <sentence id="s1855" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1855.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="316-344" id="s1855.e1" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <pair e1="s1855.e0" e2="s1855.e1" id="s1855.p0" relation="false"/>
  </sentence>
  <sentence id="s1856" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1856.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="465-486" id="s1856.e1" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <pair e1="s1856.e0" e2="s1856.e1" id="s1856.p0" relation="false"/>
  </sentence>
  <sentence id="s1857" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1857.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="528-576" id="s1857.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1857.e0" e2="s1857.e1" id="s1857.p0" relation="false"/>
  </sentence>
  <sentence id="s1858" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1858.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="578-617" id="s1858.e1" ontology_id="GO_0009154" text="purine ribonucleotide catabolic process" type="GO"/>
    <pair e1="s1858.e0" e2="s1858.e1" id="s1858.p0" relation="false"/>
  </sentence>
  <sentence id="s1859" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1859.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="626-652" id="s1859.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s1859.e0" e2="s1859.e1" id="s1859.p0" relation="false"/>
  </sentence>
  <sentence id="s1860" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1860.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="654-683" id="s1860.e1" ontology_id="GO_0033693" text="neurofilament bundle assembly" type="GO"/>
    <pair e1="s1860.e0" e2="s1860.e1" id="s1860.p0" relation="false"/>
  </sentence>
  <sentence id="s1861" text="Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).">
    <entity charOffset="101-112" id="s1861.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="727-761" id="s1861.e1" ontology_id="GO_0006626" text="protein targeting to mitochondrion" type="GO"/>
    <pair e1="s1861.e0" e2="s1861.e1" id="s1861.p0" relation="false"/>
  </sentence>
  <sentence id="s1862" text="Alterations in &lt;i&gt;MEK1/2&lt;/i&gt; occur in cancers, both in the treatment-nave state and following targeted therapies, most notably protein phosphorylation and MEK inhibitors in &lt;i&gt;BRAF&lt;/i&gt;-V600E-mutant melanoma and colorectal cancer.">
    <entity charOffset="38-44" id="s1862.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="128-151" id="s1862.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s1862.e0" e2="s1862.e1" id="s1862.p0" relation="true"/>
  </sentence>
  <sentence id="s1863" text="This work highlights the importance of classifying mutations based on structural and phenotypic consequences, both in terms of pathway signaling output and response to pharmacologic inhibition.&lt;b&gt;Implications:&lt;/b&gt; This study suggests that alternate modes of target inhibition, such as angiogenesis inhibition, will be required to effectively treat tumors harboring these MEK1/2-resistant alleles.">
    <entity charOffset="285-297" id="s1863.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="348-354" id="s1863.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1863.e0" e2="s1863.e1" id="s1863.p0" relation="false"/>
  </sentence>
  <sentence id="s1864" text="We recently demonstrated that negative regulation of transcription by RNA polymerase II is upregulated in melanoma and its inhibition by a small-molecule, tenovin-1, inhibits cell proliferation and clonogenic survival of melanoma cells, possibly via activating p53.">
    <entity charOffset="30-87" id="s1864.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="106-114" id="s1864.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1864.e0" e2="s1864.e1" id="s1864.p0" relation="false"/>
  </sentence>
  <sentence id="s1865" text="Here, we employed a gel free quantitative proteomics approach to identify the downstream effectors and targets of negative regulation of transcription by RNA polymerase II in melanoma.">
    <entity charOffset="114-171" id="s1865.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="175-183" id="s1865.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1865.e0" e2="s1865.e1" id="s1865.p0" relation="false"/>
  </sentence>
  <sentence id="s1866" text="The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of negative regulation of transcription by RNA polymerase II resulted in a downregulation of attachment of spindle microtubules to kinetochore, regulation of sister chromatid cohesion and ubiquitin-dependent protein catabolic process in multiple melanoma cell lines.">
    <entity charOffset="72-129" id="s1866.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="315-323" id="s1866.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1866.e0" e2="s1866.e1" id="s1866.p0" relation="false"/>
  </sentence>
  <sentence id="s1867" text="The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of negative regulation of transcription by RNA polymerase II resulted in a downregulation of attachment of spindle microtubules to kinetochore, regulation of sister chromatid cohesion and ubiquitin-dependent protein catabolic process in multiple melanoma cell lines.">
    <entity charOffset="162-211" id="s1867.e0" ontology_id="GO_0008608" text="attachment of spindle microtubules to kinetochore" type="GO"/>
    <entity charOffset="315-323" id="s1867.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1867.e0" e2="s1867.e1" id="s1867.p0" relation="false"/>
  </sentence>
  <sentence id="s1868" text="The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of negative regulation of transcription by RNA polymerase II resulted in a downregulation of attachment of spindle microtubules to kinetochore, regulation of sister chromatid cohesion and ubiquitin-dependent protein catabolic process in multiple melanoma cell lines.">
    <entity charOffset="213-252" id="s1868.e0" ontology_id="GO_0007063" text="regulation of sister chromatid cohesion" type="GO"/>
    <entity charOffset="315-323" id="s1868.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1868.e0" e2="s1868.e1" id="s1868.p0" relation="false"/>
  </sentence>
  <sentence id="s1869" text="The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of negative regulation of transcription by RNA polymerase II resulted in a downregulation of attachment of spindle microtubules to kinetochore, regulation of sister chromatid cohesion and ubiquitin-dependent protein catabolic process in multiple melanoma cell lines.">
    <entity charOffset="257-302" id="s1869.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="315-323" id="s1869.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s1869.e0" e2="s1869.e1" id="s1869.p0" relation="false"/>
  </sentence>
  <sentence id="s1870" text="The objective of this study was to investigate the safety and the tolerability of combined cellular immunotherapy with low-dose cyclophosphamide (biological_process) in patients with advanced solid tumors.">
    <entity charOffset="146-164" id="s1870.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="198-204" id="s1870.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1870.e0" e2="s1870.e1" id="s1870.p0" relation="false"/>
  </sentence>
  <sentence id="s1871" text="This study targeted a novel tumor-associated antigen, ring finger protein 43 (ubiquitin-dependent protein catabolic process).">
    <entity charOffset="28-33" id="s1871.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="78-123" id="s1871.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s1871.e0" e2="s1871.e1" id="s1871.p0" relation="true"/>
  </sentence>
  <sentence id="s1872" text="Eligible patients were resistant to standard therapy, HLA-A*24:02- or A*02:01-positive and exhibiting high ubiquitin-dependent protein catabolic process expression in their tumor cells.">
    <entity charOffset="107-152" id="s1872.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="173-178" id="s1872.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1872.e0" e2="s1872.e1" id="s1872.p0" relation="true"/>
  </sentence>
  <sentence id="s1873" text="We successfully showed that the combination of immune cell therapy and biological_process was safe, might induce tumor-specific immune responses and clinical efficacy, and was accompanied by a decreased ratio of Tregs in patients with RNF43-positive advanced solid tumors">
    <entity charOffset="71-89" id="s1873.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="113-118" id="s1873.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1873.e0" e2="s1873.e1" id="s1873.p0" relation="false"/>
  </sentence>
  <sentence id="s1874" text="Our results confirm two previous reports indicating that loss of function of a single allele of chemical synaptic transmission causes epilepsy.">
    <entity charOffset="96-126" id="s1874.e0" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <entity charOffset="134-142" id="s1874.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s1874.e0" e2="s1874.e1" id="s1874.p0" relation="true"/>
  </sentence>
  <sentence id="s1875" text="Although anti-myelin-associated glycoprotein (transcription-coupled nucleotide-excision repair) antibody neuropathy is reported as a slowly progressive disease, it can lead to significant disability and impairment of health-related quality of life (HR-QoL) and social participation.">
    <entity charOffset="46-94" id="s1875.e0" ontology_id="GO_0006283" text="transcription-coupled nucleotide-excision repair" type="GO"/>
    <entity charOffset="105-115" id="s1875.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1875.e0" e2="s1875.e1" id="s1875.p0" relation="true"/>
  </sentence>
  <sentence id="s1876" text="The aim of this cross-sectional study was to evaluate the functioning and HR-QoL determinants in 67 patients with anti-transcription-coupled nucleotide-excision repair neuropathy in terms of the International Classification of Functioning, Disability, and Health (ICF).">
    <entity charOffset="119-167" id="s1876.e0" ontology_id="GO_0006283" text="transcription-coupled nucleotide-excision repair" type="GO"/>
    <entity charOffset="168-178" id="s1876.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1876.e0" e2="s1876.e1" id="s1876.p0" relation="true"/>
  </sentence>
  <sentence id="s1877" text="Furthermore, neurorehabilitation interventions aimed at improving balance and walking performance, fatigue management, and specific pain relief therapy should be considered to ameliorate participation in social life and regulation of transcription, DNA-templated-QoL in anti-transcription-coupled nucleotide-excision repair neuropathy patients">
    <entity charOffset="220-262" id="s1877.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="324-334" id="s1877.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1877.e0" e2="s1877.e1" id="s1877.p0" relation="false"/>
  </sentence>
  <sentence id="s1878" text="Furthermore, neurorehabilitation interventions aimed at improving balance and walking performance, fatigue management, and specific pain relief therapy should be considered to ameliorate participation in social life and regulation of transcription, DNA-templated-QoL in anti-transcription-coupled nucleotide-excision repair neuropathy patients">
    <entity charOffset="275-323" id="s1878.e0" ontology_id="GO_0006283" text="transcription-coupled nucleotide-excision repair" type="GO"/>
    <entity charOffset="324-334" id="s1878.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s1878.e0" e2="s1878.e1" id="s1878.p0" relation="true"/>
  </sentence>
  <sentence id="s1879" text="Associations with TN breast cancer were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1879.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="63-107" id="s1879.e1" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <pair e1="s1879.e0" e2="s1879.e1" id="s1879.p0" relation="false"/>
  </sentence>
  <sentence id="s1880" text="Associations with TN breast cancer were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1880.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="109-166" id="s1880.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1880.e0" e2="s1880.e1" id="s1880.p0" relation="false"/>
  </sentence>
  <sentence id="s1881" text="Associations with TN breast cancer were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1881.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="168-179" id="s1881.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s1881.e0" e2="s1881.e1" id="s1881.p0" relation="true"/>
  </sentence>
  <sentence id="s1882" text="Associations with TN breast cancer were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1882.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="218-249" id="s1882.e1" ontology_id="GO_0042981" text="regulation of apoptotic process" type="GO"/>
    <pair e1="s1882.e0" e2="s1882.e1" id="s1882.p0" relation="false"/>
  </sentence>
  <sentence id="s1883" text="Associations with TN breast cancer were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1883.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="371-423" id="s1883.e1" ontology_id="GO_0016561" text="protein import into peroxisome matrix, translocation" type="GO"/>
    <pair e1="s1883.e0" e2="s1883.e1" id="s1883.p0" relation="false"/>
  </sentence>
  <sentence id="s1884" text="Associations with TN breast cancer were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1884.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="441-456" id="s1884.e1" ontology_id="GO_0007283" text="spermatogenesis" type="GO"/>
    <pair e1="s1884.e0" e2="s1884.e1" id="s1884.p0" relation="false"/>
  </sentence>
  <sentence id="s1885" text="Associations with TN breast cancer were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &amp;lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).">
    <entity charOffset="28-34" id="s1885.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="519-538" id="s1885.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s1885.e0" e2="s1885.e1" id="s1885.p0" relation="true"/>
  </sentence>
  <sentence id="s1886" text="The downstream pathways of positive regulation of cysteine-type endopeptidase activity involved in apoptotic process-Foxh1 play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in heterotaxia as well as the primary developmental defect of the AHF.">
    <entity charOffset="27-116" id="s1886.e0" ontology_id="GO_0043280" text="positive regulation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="311-322" id="s1886.e1" ontology_id="HP_0030853" text="heterotaxia" type="HP"/>
    <pair e1="s1886.e0" e2="s1886.e1" id="s1886.p0" relation="true"/>
  </sentence>
  <sentence id="s1887" text="DNA samples from eight families with autosomal recessive retinal dystrophies were subjected to genome wide homozygosity mapping (seven by SNP arrays and one by ossification markers) and genes comprised within the detected homozygous regions were analyzed by Sanger sequencing.">
    <entity charOffset="37-56" id="s1887.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="160-172" id="s1887.e1" ontology_id="GO_0001503" text="ossification" type="GO"/>
    <pair e1="s1887.e0" e2="s1887.e1" id="s1887.p0" relation="false"/>
  </sentence>
  <sentence id="s1888" text="However, Pdha1&lt;sup&gt;f/Y;&lt;/sup&gt; Cnp&lt;sup&gt;Cre/+&lt;/sup&gt; epidermis development showed reduced fiber density and signs of axonal degeneration in both sciatic and optic nerves from 6 months of age.">
    <entity charOffset="50-71" id="s1888.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="114-133" id="s1888.e1" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <pair e1="s1888.e0" e2="s1888.e1" id="s1888.p0" relation="false"/>
  </sentence>
  <sentence id="s1889" text="Disabling mutations in the actin cytoskeleton organization gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.">
    <entity charOffset="27-58" id="s1889.e0" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <entity charOffset="208-221" id="s1889.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s1889.e0" e2="s1889.e1" id="s1889.p0" relation="true"/>
  </sentence>
  <sentence id="s1890" text="Disabling mutations in the actin cytoskeleton organization gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.">
    <entity charOffset="27-58" id="s1890.e0" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <entity charOffset="244-264" id="s1890.e1" ontology_id="HP_0000119" text="urogenital anomalies" type="HP"/>
    <pair e1="s1890.e0" e2="s1890.e1" id="s1890.p0" relation="true"/>
  </sentence>
  <sentence id="s1891" text="Disabling mutations in the actin cytoskeleton organization gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.">
    <entity charOffset="27-58" id="s1891.e0" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <entity charOffset="292-296" id="s1891.e1" ontology_id="HP_0012825" text="mild" type="HP"/>
    <pair e1="s1891.e0" e2="s1891.e1" id="s1891.p0" relation="false"/>
  </sentence>
  <sentence id="s1892" text="Two recent studies unveiled new potential functions of actin cytoskeleton organization, in particular, its involvement in the regulation of the formation and function of invadopodia and podosomes, which are cellular structures devoted to degradation of the extracellular matrix in tumour and endothelial cells.">
    <entity charOffset="55-86" id="s1892.e0" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <entity charOffset="281-287" id="s1892.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1892.e0" e2="s1892.e1" id="s1892.p0" relation="false"/>
  </sentence>
  <sentence id="s1893" text="Moreover, we found positive regulation of protein localization to plasma membrane expression correlated with several clinicopathological features, including tumor size, lymph node metastasis, and the TNM stage.">
    <entity charOffset="19-81" id="s1893.e0" ontology_id="GO_1903078" text="positive regulation of protein localization to plasma membrane" type="GO"/>
    <entity charOffset="157-162" id="s1893.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1893.e0" e2="s1893.e1" id="s1893.p0" relation="false"/>
  </sentence>
  <sentence id="s1894" text="By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (biological_process) proteins cell proliferation and Wnt signaling pathway, planar cell polarity pathway correlate with increased risk of patient relapse.">
    <entity charOffset="65-71" id="s1894.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="157-175" id="s1894.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s1894.e0" e2="s1894.e1" id="s1894.p0" relation="false"/>
  </sentence>
  <sentence id="s1895" text="By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (biological_process) proteins cell proliferation and Wnt signaling pathway, planar cell polarity pathway correlate with increased risk of patient relapse.">
    <entity charOffset="65-71" id="s1895.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="186-204" id="s1895.e1" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <pair e1="s1895.e0" e2="s1895.e1" id="s1895.p0" relation="false"/>
  </sentence>
  <sentence id="s1896" text="By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (biological_process) proteins cell proliferation and Wnt signaling pathway, planar cell polarity pathway correlate with increased risk of patient relapse.">
    <entity charOffset="65-71" id="s1896.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="209-260" id="s1896.e1" ontology_id="GO_0060071" text="Wnt signaling pathway, planar cell polarity pathway" type="GO"/>
    <pair e1="s1896.e0" e2="s1896.e1" id="s1896.p0" relation="true"/>
  </sentence>
  <sentence id="s1897" text="To investigate SCRIB-associated proteins that might participate in the responses of breast cancer cells to altered levels of SCRIB, we used cell adhesion mediated by integrin spectrometry and confocal microscopy.">
    <entity charOffset="91-97" id="s1897.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="140-174" id="s1897.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s1897.e0" e2="s1897.e1" id="s1897.p0" relation="false"/>
  </sentence>
  <sentence id="s1898" text="Focusing on postsynaptic actin cytoskeleton organization, we observed that NOS1AP colocalizes with both cell proliferation and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.">
    <entity charOffset="12-56" id="s1898.e0" ontology_id="GO_0098974" text="postsynaptic actin cytoskeleton organization" type="GO"/>
    <entity charOffset="182-188" id="s1898.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1898.e0" e2="s1898.e1" id="s1898.p0" relation="false"/>
  </sentence>
  <sentence id="s1899" text="Focusing on postsynaptic actin cytoskeleton organization, we observed that NOS1AP colocalizes with both cell proliferation and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.">
    <entity charOffset="104-122" id="s1899.e0" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <entity charOffset="182-188" id="s1899.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1899.e0" e2="s1899.e1" id="s1899.p0" relation="false"/>
  </sentence>
  <sentence id="s1900" text="We investigated the effects of shRNA-mediated knockdown of postsynaptic actin cytoskeleton organization and cell proliferation in vitro, and found that reducing NOS1AP and SCRIB slows breast cancer cell migration and prevents the establishment of leading-trailing polarity.">
    <entity charOffset="59-103" id="s1900.e0" ontology_id="GO_0098974" text="postsynaptic actin cytoskeleton organization" type="GO"/>
    <entity charOffset="191-197" id="s1900.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1900.e0" e2="s1900.e1" id="s1900.p0" relation="false"/>
  </sentence>
  <sentence id="s1901" text="We investigated the effects of shRNA-mediated knockdown of postsynaptic actin cytoskeleton organization and cell proliferation in vitro, and found that reducing NOS1AP and SCRIB slows breast cancer cell migration and prevents the establishment of leading-trailing polarity.">
    <entity charOffset="108-126" id="s1901.e0" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <entity charOffset="191-197" id="s1901.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1901.e0" e2="s1901.e1" id="s1901.p0" relation="false"/>
  </sentence>
  <sentence id="s1902" text="The tumor-node-metastasis (regulation of transcription by RNA polymerase III) classification, the presence of a mucinous component, and signet ring cells are well-known criteria for identifying patients at a high risk for recurrence and determining the therapeutic approach for early-stage colon cancer (eCC).">
    <entity charOffset="4-9" id="s1902.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="27-76" id="s1902.e1" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <pair e1="s1902.e0" e2="s1902.e1" id="s1902.p0" relation="false"/>
  </sentence>
  <sentence id="s1903" text="The tumor-node-metastasis (regulation of transcription by RNA polymerase III) classification, the presence of a mucinous component, and signet ring cells are well-known criteria for identifying patients at a high risk for recurrence and determining the therapeutic approach for early-stage colon cancer (eCC).">
    <entity charOffset="27-76" id="s1903.e0" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <entity charOffset="296-302" id="s1903.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1903.e0" e2="s1903.e1" id="s1903.p0" relation="false"/>
  </sentence>
  <sentence id="s1904" text="The aims of the present study were to evaluate the relation of dysregulated positive regulation of transcription by RNA polymerase II, c-apoptotic process, and positive regulation of DNA binding-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.">
    <entity charOffset="76-133" id="s1904.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="248-253" id="s1904.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1904.e0" e2="s1904.e1" id="s1904.p0" relation="false"/>
  </sentence>
  <sentence id="s1905" text="The aims of the present study were to evaluate the relation of dysregulated positive regulation of transcription by RNA polymerase II, c-apoptotic process, and positive regulation of DNA binding-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.">
    <entity charOffset="137-154" id="s1905.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="248-253" id="s1905.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1905.e0" e2="s1905.e1" id="s1905.p0" relation="false"/>
  </sentence>
  <sentence id="s1906" text="The aims of the present study were to evaluate the relation of dysregulated positive regulation of transcription by RNA polymerase II, c-apoptotic process, and positive regulation of DNA binding-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.">
    <entity charOffset="160-194" id="s1906.e0" ontology_id="GO_0043388" text="positive regulation of DNA binding" type="GO"/>
    <entity charOffset="248-253" id="s1906.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1906.e0" e2="s1906.e1" id="s1906.p0" relation="true"/>
  </sentence>
  <sentence id="s1907" text="The relationship between the altered expression of positive regulation of transcription by RNA polymerase II, c-apoptotic process, and positive regulation of DNA binding-negative regulation of cell migration and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.">
    <entity charOffset="51-108" id="s1907.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="280-285" id="s1907.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1907.e0" e2="s1907.e1" id="s1907.p0" relation="false"/>
  </sentence>
  <sentence id="s1908" text="The relationship between the altered expression of positive regulation of transcription by RNA polymerase II, c-apoptotic process, and positive regulation of DNA binding-negative regulation of cell migration and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.">
    <entity charOffset="112-129" id="s1908.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="280-285" id="s1908.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1908.e0" e2="s1908.e1" id="s1908.p0" relation="false"/>
  </sentence>
  <sentence id="s1909" text="The relationship between the altered expression of positive regulation of transcription by RNA polymerase II, c-apoptotic process, and positive regulation of DNA binding-negative regulation of cell migration and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.">
    <entity charOffset="135-169" id="s1909.e0" ontology_id="GO_0043388" text="positive regulation of DNA binding" type="GO"/>
    <entity charOffset="280-285" id="s1909.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1909.e0" e2="s1909.e1" id="s1909.p0" relation="true"/>
  </sentence>
  <sentence id="s1910" text="The relationship between the altered expression of positive regulation of transcription by RNA polymerase II, c-apoptotic process, and positive regulation of DNA binding-negative regulation of cell migration and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.">
    <entity charOffset="170-207" id="s1910.e0" ontology_id="GO_0030336" text="negative regulation of cell migration" type="GO"/>
    <entity charOffset="280-285" id="s1910.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1910.e0" e2="s1910.e1" id="s1910.p0" relation="false"/>
  </sentence>
  <sentence id="s1911" text="In addition, the coexistence of high positive regulation of transcription by RNA polymerase II and low positive regulation of DNA binding-H1 expression and tumor budding was associated with short OS (p&amp;lt;0.001).">
    <entity charOffset="37-94" id="s1911.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="156-161" id="s1911.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1911.e0" e2="s1911.e1" id="s1911.p0" relation="false"/>
  </sentence>
  <sentence id="s1912" text="In addition, the coexistence of high positive regulation of transcription by RNA polymerase II and low positive regulation of DNA binding-H1 expression and tumor budding was associated with short OS (p&amp;lt;0.001).">
    <entity charOffset="103-137" id="s1912.e0" ontology_id="GO_0043388" text="positive regulation of DNA binding" type="GO"/>
    <entity charOffset="156-161" id="s1912.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1912.e0" e2="s1912.e1" id="s1912.p0" relation="true"/>
  </sentence>
  <sentence id="s1913" text="We suggest that the combination of reduced NM23-negative regulation of cell migration, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may somatic diversification of immunoglobulins the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="48-85" id="s1913.e0" ontology_id="GO_0030336" text="negative regulation of cell migration" type="GO"/>
    <entity charOffset="122-127" id="s1913.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1913.e0" e2="s1913.e1" id="s1913.p0" relation="false"/>
  </sentence>
  <sentence id="s1914" text="We suggest that the combination of reduced NM23-negative regulation of cell migration, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may somatic diversification of immunoglobulins the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="48-85" id="s1914.e0" ontology_id="GO_0030336" text="negative regulation of cell migration" type="GO"/>
    <entity charOffset="296-302" id="s1914.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1914.e0" e2="s1914.e1" id="s1914.p0" relation="false"/>
  </sentence>
  <sentence id="s1915" text="We suggest that the combination of reduced NM23-negative regulation of cell migration, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may somatic diversification of immunoglobulins the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="122-127" id="s1915.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="202-244" id="s1915.e1" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <pair e1="s1915.e0" e2="s1915.e1" id="s1915.p0" relation="false"/>
  </sentence>
  <sentence id="s1916" text="We suggest that the combination of reduced NM23-negative regulation of cell migration, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may somatic diversification of immunoglobulins the stratification of patients with stage II colon cancer for adjuvant chemotherapy">
    <entity charOffset="202-244" id="s1916.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="296-302" id="s1916.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1916.e0" e2="s1916.e1" id="s1916.p0" relation="false"/>
  </sentence>
  <sentence id="s1917" text="The purpose of this study was to explore the use of iterative decomposition of water and fat with echo asymmetry and least-squares estimation Carr-Purcell-Meiboom-Gill (IDEAL-CPMG) to simultaneously measure skeletal muscle apparent fat fraction and water T&lt;sub&gt;2&lt;/sub&gt; (T&lt;sub&gt;2,w&lt;/sub&gt;) in patients with Duchenne muscular dystrophy (peptide biosynthetic process).">
    <entity charOffset="313-331" id="s1917.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="333-361" id="s1917.e1" ontology_id="GO_0043043" text="peptide biosynthetic process" type="GO"/>
    <pair e1="s1917.e0" e2="s1917.e1" id="s1917.p0" relation="true"/>
  </sentence>
  <sentence id="s1918" text="Abnormalities in these pathways cause autosomal dominant polycystic kidney disease (ADPKD) and naevoid basal cell carcinoma syndrome (positive regulation of cholesterol efflux) respectively.">
    <entity charOffset="68-82" id="s1918.e0" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <entity charOffset="134-175" id="s1918.e1" ontology_id="GO_0010875" text="positive regulation of cholesterol efflux" type="GO"/>
    <pair e1="s1918.e0" e2="s1918.e1" id="s1918.p0" relation="true"/>
  </sentence>
  <sentence id="s1919" text="In summary, the regulatory role of lysophospholipid transport deepens our knowledge of the function of the BBB, potentially contributing to the effective drug delivery in the treatments for neurodegenerative diseases, brain tumors, and life-threatening infections in the CNS.">
    <entity charOffset="35-61" id="s1919.e0" ontology_id="GO_0051977" text="lysophospholipid transport" type="GO"/>
    <entity charOffset="190-216" id="s1919.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s1919.e0" e2="s1919.e1" id="s1919.p0" relation="false"/>
  </sentence>
  <sentence id="s1920" text="In summary, the regulatory role of lysophospholipid transport deepens our knowledge of the function of the BBB, potentially contributing to the effective drug delivery in the treatments for neurodegenerative diseases, brain tumors, and life-threatening infections in the CNS.">
    <entity charOffset="35-61" id="s1920.e0" ontology_id="GO_0051977" text="lysophospholipid transport" type="GO"/>
    <entity charOffset="224-230" id="s1920.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1920.e0" e2="s1920.e1" id="s1920.p0" relation="false"/>
  </sentence>
  <sentence id="s1921" text="Hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by cell-matrix adhesion or auditory stimuli, producing hypertonia and apnea episodes.">
    <entity charOffset="96-116" id="s1921.e0" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <entity charOffset="148-158" id="s1921.e1" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <pair e1="s1921.e0" e2="s1921.e1" id="s1921.p0" relation="false"/>
  </sentence>
  <sentence id="s1922" text="Patients carrying homozygous positive regulation of cell proliferation mutations have more frequent fractures while heterozygous carriers of the mutation in WNT1 gene are also found to have early onset osteoporosis.">
    <entity charOffset="29-70" id="s1922.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="202-214" id="s1922.e1" ontology_id="HP_0000939" text="osteoporosis" type="HP"/>
    <pair e1="s1922.e0" e2="s1922.e1" id="s1922.p0" relation="true"/>
  </sentence>
  <sentence id="s1923" text="Recent studies in RAS wild-type (WT) metastatic colorectal cancer (mCRC) suggest that the survival benefits of therapy using anti-epidermal growth factor receptor (anti-positive regulation of protein phosphorylation) and anti-vascular endothelial growth factor (anti-VEGF) antibodies combined with chemotherapy are maximized when the anti-EGFR antibody is given as first-line, followed by subsequent anti-VEGF antibody therapy.">
    <entity charOffset="59-65" id="s1923.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="169-215" id="s1923.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s1923.e0" e2="s1923.e1" id="s1923.p0" relation="true"/>
  </sentence>
  <sentence id="s1924" text="Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (protein ubiquitination) gene in inherited cases and by infrequent somatic mutation in sporadic entities.">
    <entity charOffset="37-43" id="s1924.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="128-150" id="s1924.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s1924.e0" e2="s1924.e1" id="s1924.p0" relation="true"/>
  </sentence>
  <sentence id="s1925" text="Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (protein ubiquitination) gene in inherited cases and by infrequent somatic mutation in sporadic entities.">
    <entity charOffset="128-150" id="s1925.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="194-210" id="s1925.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s1925.e0" e2="s1925.e1" id="s1925.p0" relation="false"/>
  </sentence>
  <sentence id="s1926" text="Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (protein ubiquitination) gene in inherited cases and by infrequent somatic mutation in sporadic entities.">
    <entity charOffset="128-150" id="s1926.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="214-222" id="s1926.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1926.e0" e2="s1926.e1" id="s1926.p0" relation="true"/>
  </sentence>
  <sentence id="s1927" text="Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and protein ubiquitination in sporadic HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, cell adhesion, and killing of cells of other organism in familial HBs.">
    <entity charOffset="70-88" id="s1927.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="120-128" id="s1927.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1927.e0" e2="s1927.e1" id="s1927.p0" relation="false"/>
  </sentence>
  <sentence id="s1928" text="Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and protein ubiquitination in sporadic HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, cell adhesion, and killing of cells of other organism in familial HBs.">
    <entity charOffset="94-116" id="s1928.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="120-128" id="s1928.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1928.e0" e2="s1928.e1" id="s1928.p0" relation="true"/>
  </sentence>
  <sentence id="s1929" text="Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and protein ubiquitination in sporadic HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, cell adhesion, and killing of cells of other organism in familial HBs.">
    <entity charOffset="120-128" id="s1929.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="138-186" id="s1929.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1929.e0" e2="s1929.e1" id="s1929.p0" relation="false"/>
  </sentence>
  <sentence id="s1930" text="Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and protein ubiquitination in sporadic HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, cell adhesion, and killing of cells of other organism in familial HBs.">
    <entity charOffset="120-128" id="s1930.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="201-214" id="s1930.e1" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <pair e1="s1930.e0" e2="s1930.e1" id="s1930.p0" relation="false"/>
  </sentence>
  <sentence id="s1931" text="Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and protein ubiquitination in sporadic HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, cell adhesion, and killing of cells of other organism in familial HBs.">
    <entity charOffset="120-128" id="s1931.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="220-254" id="s1931.e1" ontology_id="GO_0031640" text="killing of cells of other organism" type="GO"/>
    <pair e1="s1931.e0" e2="s1931.e1" id="s1931.p0" relation="false"/>
  </sentence>
  <sentence id="s1932" text="Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.">
    <entity charOffset="22-49" id="s1932.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="185-193" id="s1932.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1932.e0" e2="s1932.e1" id="s1932.p0" relation="false"/>
  </sentence>
  <sentence id="s1933" text="Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.">
    <entity charOffset="51-95" id="s1933.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="185-193" id="s1933.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1933.e0" e2="s1933.e1" id="s1933.p0" relation="false"/>
  </sentence>
  <sentence id="s1934" text="Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.">
    <entity charOffset="97-125" id="s1934.e0" ontology_id="GO_0030216" text="keratinocyte differentiation" type="GO"/>
    <entity charOffset="185-193" id="s1934.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1934.e0" e2="s1934.e1" id="s1934.p0" relation="false"/>
  </sentence>
  <sentence id="s1935" text="Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.">
    <entity charOffset="127-138" id="s1935.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="185-193" id="s1935.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s1935.e0" e2="s1935.e1" id="s1935.p0" relation="false"/>
  </sentence>
  <sentence id="s1936" text="Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.">
    <entity charOffset="185-193" id="s1936.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="226-249" id="s1936.e1" ontology_id="GO_0055085" text="transmembrane transport" type="GO"/>
    <pair e1="s1936.e0" e2="s1936.e1" id="s1936.p0" relation="false"/>
  </sentence>
  <sentence id="s1937" text="Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.">
    <entity charOffset="185-193" id="s1937.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="262-286" id="s1937.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1937.e0" e2="s1937.e1" id="s1937.p0" relation="false"/>
  </sentence>
  <sentence id="s1938" text="Congenital heart defects represent a characteristic part of several genetic syndromes associated with chromosomal abnormalities such as 22q11.2 deletion syndrome; many genes located in this locus, mainly heart development, are candidate genes for congenital heart defects.">
    <entity charOffset="204-221" id="s1938.e0" ontology_id="GO_0007507" text="heart development" type="GO"/>
    <entity charOffset="247-271" id="s1938.e1" ontology_id="HP_0001627" text="congenital heart defects" type="HP"/>
    <pair e1="s1938.e0" e2="s1938.e1" id="s1938.p0" relation="true"/>
  </sentence>
  <sentence id="s1939" text="In our cohort of 27 subjects with congenital heart defect, both karyotype analysis and Fluorescence in situ hybridization (superoxide metabolic process) were performed.">
    <entity charOffset="34-57" id="s1939.e0" ontology_id="HP_0001627" text="congenital heart defect" type="HP"/>
    <entity charOffset="123-151" id="s1939.e1" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <pair e1="s1939.e0" e2="s1939.e1" id="s1939.p0" relation="false"/>
  </sentence>
  <sentence id="s1940" text="Functional assays revealed that ectopic expression of protein polyubiquitination-144-5p and miR-144-3p significantly blocked the malignant abilities of LUSQ cells, eg, cancer cell proliferation, migration, and invasion.">
    <entity charOffset="54-80" id="s1940.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="168-174" id="s1940.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1940.e0" e2="s1940.e1" id="s1940.p0" relation="false"/>
  </sentence>
  <sentence id="s1941" text="tRNA methylation is a RNA methyltransferase that has been shown to be implicated in development of human cancer.">
    <entity charOffset="0-16" id="s1941.e0" ontology_id="GO_0030488" text="tRNA methylation" type="GO"/>
    <entity charOffset="105-111" id="s1941.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1941.e0" e2="s1941.e1" id="s1941.p0" relation="true"/>
  </sentence>
  <sentence id="s1942" text="However, the functional role of tRNA methylation, mechanism of NSUN2 overexpression and its association with clinicopathologic features in breast cancer remain unclear.">
    <entity charOffset="32-48" id="s1942.e0" ontology_id="GO_0030488" text="tRNA methylation" type="GO"/>
    <entity charOffset="146-152" id="s1942.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1942.e0" e2="s1942.e1" id="s1942.p0" relation="true"/>
  </sentence>
  <sentence id="s1943" text="To investigate alterations in the expression and functional role of tRNA methylation in breast cancer, NSUN2 expression was assessed in breast cancer cells and tissues obtained from cancers at different American Joint Committee on Cancer (AJCC) stages, and its functions were investigated using breast cancer cells.">
    <entity charOffset="68-84" id="s1943.e0" ontology_id="GO_0030488" text="tRNA methylation" type="GO"/>
    <entity charOffset="95-101" id="s1943.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1943.e0" e2="s1943.e1" id="s1943.p0" relation="true"/>
  </sentence>
  <sentence id="s1944" text="Our results demonstrated that the overall expression of NSUN2 significantly correlated with clinical stage (P=0.027), tumor classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&amp;lt;0.001), progesterone receptor (P=0.001), and regulation of proteasomal protein catabolic process-67 (P&amp;lt;0.001).">
    <entity charOffset="118-123" id="s1944.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="300-351" id="s1944.e1" ontology_id="GO_0061136" text="regulation of proteasomal protein catabolic process" type="GO"/>
    <pair e1="s1944.e0" e2="s1944.e1" id="s1944.p0" relation="false"/>
  </sentence>
  <sentence id="s1945" text="Our findings provide a unique insight into the roles and effects of tRNA methylation overexpression in breast cancer cells, and highlight the necessity of the investigation of novel therapeutic targets, such as NSUN2, for the improvement of breast cancer treatments">
    <entity charOffset="68-84" id="s1945.e0" ontology_id="GO_0030488" text="tRNA methylation" type="GO"/>
    <entity charOffset="110-116" id="s1945.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1945.e0" e2="s1945.e1" id="s1945.p0" relation="true"/>
  </sentence>
  <sentence id="s1946" text="Here we present a novel cilium assembly(tm1a(EUCOMM)Wtsi) knockout mouse which accurately recapitulates the human condition, consistently developing pre-axial polydactyly, complex posterior fossa defects (including the Dandy-Walker malformation), and renal cystic dysplasia.">
    <entity charOffset="24-39" id="s1946.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="153-158" id="s1946.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s1946.e0" e2="s1946.e1" id="s1946.p0" relation="false"/>
  </sentence>
  <sentence id="s1947" text="Here we present a novel cilium assembly(tm1a(EUCOMM)Wtsi) knockout mouse which accurately recapitulates the human condition, consistently developing pre-axial polydactyly, complex posterior fossa defects (including the Dandy-Walker malformation), and renal cystic dysplasia.">
    <entity charOffset="24-39" id="s1947.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="159-170" id="s1947.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s1947.e0" e2="s1947.e1" id="s1947.p0" relation="true"/>
  </sentence>
  <sentence id="s1948" text="We conducted the largest association study of mitochondrial DNA variants and schizophrenia but did not cellular response to interleukin-4 an association that survived multiple testing correction.">
    <entity charOffset="77-90" id="s1948.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="103-137" id="s1948.e1" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <pair e1="s1948.e0" e2="s1948.e1" id="s1948.p0" relation="false"/>
  </sentence>
  <sentence id="s1949" text="To investigate the presence of specific chromosomal and gene alterations, positive regulation of sodium ion transport protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 negative regulation of phosphatase activity and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.">
    <entity charOffset="74-117" id="s1949.e0" ontology_id="GO_0010765" text="positive regulation of sodium ion transport" type="GO"/>
    <entity charOffset="220-225" id="s1949.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1949.e0" e2="s1949.e1" id="s1949.p0" relation="false"/>
  </sentence>
  <sentence id="s1950" text="To investigate the presence of specific chromosomal and gene alterations, positive regulation of sodium ion transport protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 negative regulation of phosphatase activity and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.">
    <entity charOffset="258-301" id="s1950.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="390-396" id="s1950.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1950.e0" e2="s1950.e1" id="s1950.p0" relation="false"/>
  </sentence>
  <sentence id="s1951" text="microtubule cytoskeleton organization gene encodes a centrosomal protein, highly expressed in fetal brain and essentially indispensable for its normal development, as biallelic mutations in it lead to primary microcephaly (MCPH).">
    <entity charOffset="0-37" id="s1951.e0" ontology_id="GO_0000226" text="microtubule cytoskeleton organization" type="GO"/>
    <entity charOffset="209-221" id="s1951.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1951.e0" e2="s1951.e1" id="s1951.p0" relation="true"/>
  </sentence>
  <sentence id="s1952" text="The heterogeneity test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of regulation of histone methylation C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of MTRR A66G polymorphism.">
    <entity charOffset="4-17" id="s1952.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="251-284" id="s1952.e1" ontology_id="GO_0031060" text="regulation of histone methylation" type="GO"/>
    <pair e1="s1952.e0" e2="s1952.e1" id="s1952.p0" relation="false"/>
  </sentence>
  <sentence id="s1953" text="In T cell costimulation of more and more evidence point to the importance of Kindlin family members in normal development and human diseases especially in cancers, we aim to portrait the profile of Kindlins in the regulation of embryonic development and cancer progression.">
    <entity charOffset="3-23" id="s1953.e0" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <entity charOffset="155-161" id="s1953.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1953.e0" e2="s1953.e1" id="s1953.p0" relation="false"/>
  </sentence>
  <sentence id="s1954" text="Overall, this first report of a germline molecular defect in opsonization unveils the key role of SP-A1 in the occurrence of several chronic respiratory diseases, ranging from severe respiratory insufficiency occurring early in life to the association of lung fibrosis and cancer in adult patients.">
    <entity charOffset="61-73" id="s1954.e0" ontology_id="GO_0008228" text="opsonization" type="GO"/>
    <entity charOffset="273-279" id="s1954.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1954.e0" e2="s1954.e1" id="s1954.p0" relation="false"/>
  </sentence>
  <sentence id="s1955" text="Recently mutations in the central nervous system myelination/CNTN1 complex have been associated with similar severe phenotypes and central nervous system myelination gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.">
    <entity charOffset="26-60" id="s1955.e0" ontology_id="GO_0022010" text="central nervous system myelination" type="GO"/>
    <entity charOffset="260-274" id="s1955.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s1955.e0" e2="s1955.e1" id="s1955.p0" relation="true"/>
  </sentence>
  <sentence id="s1956" text="Recently mutations in the central nervous system myelination/CNTN1 complex have been associated with similar severe phenotypes and central nervous system myelination gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.">
    <entity charOffset="26-60" id="s1956.e0" ontology_id="GO_0022010" text="central nervous system myelination" type="GO"/>
    <entity charOffset="245-259" id="s1956.e1" ontology_id="HP_0003577" text="prenatal onset" type="HP"/>
    <pair e1="s1956.e0" e2="s1956.e1" id="s1956.p0" relation="false"/>
  </sentence>
  <sentence id="s1957" text="Recently mutations in the central nervous system myelination/CNTN1 complex have been associated with similar severe phenotypes and central nervous system myelination gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.">
    <entity charOffset="131-165" id="s1957.e0" ontology_id="GO_0022010" text="central nervous system myelination" type="GO"/>
    <entity charOffset="260-274" id="s1957.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s1957.e0" e2="s1957.e1" id="s1957.p0" relation="true"/>
  </sentence>
  <sentence id="s1958" text="Recently mutations in the central nervous system myelination/CNTN1 complex have been associated with similar severe phenotypes and central nervous system myelination gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.">
    <entity charOffset="131-165" id="s1958.e0" ontology_id="GO_0022010" text="central nervous system myelination" type="GO"/>
    <entity charOffset="245-259" id="s1958.e1" ontology_id="HP_0003577" text="prenatal onset" type="HP"/>
    <pair e1="s1958.e0" e2="s1958.e1" id="s1958.p0" relation="false"/>
  </sentence>
  <sentence id="s1959" text="We further expand the existing central nervous system myelination-associated phenotype to include profound cerebral and cerebellar atrophy">
    <entity charOffset="31-65" id="s1959.e0" ontology_id="GO_0022010" text="central nervous system myelination" type="GO"/>
    <entity charOffset="98-106" id="s1959.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s1959.e0" e2="s1959.e1" id="s1959.p0" relation="false"/>
  </sentence>
  <sentence id="s1960" text="The major categories of pancreatic neuroendocrine tumor (Pannegative regulation of transcription, DNA-templated) are well-differentiated NET and poorly differentiated neuroendocrine carcinoma.">
    <entity charOffset="50-55" id="s1960.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="60-111" id="s1960.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1960.e0" e2="s1960.e1" id="s1960.p0" relation="false"/>
  </sentence>
  <sentence id="s1961" text="Sequencing of these tumors has identified multiple important genes in the pathogenesis of Pannegative regulation of transcription, DNA-templateds, such as nucleosome assembly/ATRX, negative regulation of transcription by RNA polymerase II, TP53, RB, and regulation of cell growth pathway genes.">
    <entity charOffset="20-25" id="s1961.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="93-144" id="s1961.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s1961.e0" e2="s1961.e1" id="s1961.p0" relation="false"/>
  </sentence>
  <sentence id="s1962" text="Sequencing of these tumors has identified multiple important genes in the pathogenesis of Pannegative regulation of transcription, DNA-templateds, such as nucleosome assembly/ATRX, negative regulation of transcription by RNA polymerase II, TP53, RB, and regulation of cell growth pathway genes.">
    <entity charOffset="20-25" id="s1962.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="155-174" id="s1962.e1" ontology_id="GO_0006334" text="nucleosome assembly" type="GO"/>
    <pair e1="s1962.e0" e2="s1962.e1" id="s1962.p0" relation="true"/>
  </sentence>
  <sentence id="s1963" text="Sequencing of these tumors has identified multiple important genes in the pathogenesis of Pannegative regulation of transcription, DNA-templateds, such as nucleosome assembly/ATRX, negative regulation of transcription by RNA polymerase II, TP53, RB, and regulation of cell growth pathway genes.">
    <entity charOffset="20-25" id="s1963.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="181-238" id="s1963.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1963.e0" e2="s1963.e1" id="s1963.p0" relation="true"/>
  </sentence>
  <sentence id="s1964" text="Sequencing of these tumors has identified multiple important genes in the pathogenesis of Pannegative regulation of transcription, DNA-templateds, such as nucleosome assembly/ATRX, negative regulation of transcription by RNA polymerase II, TP53, RB, and regulation of cell growth pathway genes.">
    <entity charOffset="20-25" id="s1964.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="254-279" id="s1964.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s1964.e0" e2="s1964.e1" id="s1964.p0" relation="false"/>
  </sentence>
  <sentence id="s1965" text="Our data support that high-grade progression in Pannegative regulation of transcription, DNA-templateds may be the result of the progressive accumulation of genetic changes (CNVs and point mutational changes) within the body of the tumor.">
    <entity charOffset="51-102" id="s1965.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="232-237" id="s1965.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1965.e0" e2="s1965.e1" id="s1965.p0" relation="false"/>
  </sentence>
  <sentence id="s1966" text="Small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC) is a relatively rare histological muscle organ development of gallbladder cancer, and the genomic landscape of GB-SCNEC is rarely considered in treatment decisions.">
    <entity charOffset="93-117" id="s1966.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="133-139" id="s1966.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1966.e0" e2="s1966.e1" id="s1966.p0" relation="false"/>
  </sentence>
  <sentence id="s1967" text="Importantly, negative regulation of transcription by RNA polymerase II inhibitor Kenpaullone sensitizes breast cancer cells and xenograft tumors to Paclitaxel and improves therapeutic effects.">
    <entity charOffset="13-70" id="s1967.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="138-144" id="s1967.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s1967.e0" e2="s1967.e1" id="s1967.p0" relation="false"/>
  </sentence>
  <sentence id="s1968" text="To identify tumor suppressor genes (negative regulation of cytokine productions) silenced by hypermethylation and discover new epigenetic biomarkers for early cancer detection.">
    <entity charOffset="36-78" id="s1968.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="159-165" id="s1968.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1968.e0" e2="s1968.e1" id="s1968.p0" relation="false"/>
  </sentence>
  <sentence id="s1969" text="negative regulation of platelet aggregation, located at 16q23.1, has been reported to be a critical negative regulation of cytokine production in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).">
    <entity charOffset="0-43" id="s1969.e0" ontology_id="GO_0090331" text="negative regulation of platelet aggregation" type="GO"/>
    <entity charOffset="163-168" id="s1969.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1969.e0" e2="s1969.e1" id="s1969.p0" relation="false"/>
  </sentence>
  <sentence id="s1970" text="negative regulation of platelet aggregation, located at 16q23.1, has been reported to be a critical negative regulation of cytokine production in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).">
    <entity charOffset="0-43" id="s1970.e0" ontology_id="GO_0090331" text="negative regulation of platelet aggregation" type="GO"/>
    <entity charOffset="214-245" id="s1970.e1" ontology_id="HP_0006770" text="clear cell renal cell carcinoma" type="HP"/>
    <pair e1="s1970.e0" e2="s1970.e1" id="s1970.p0" relation="false"/>
  </sentence>
  <sentence id="s1971" text="negative regulation of platelet aggregation, located at 16q23.1, has been reported to be a critical negative regulation of cytokine production in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).">
    <entity charOffset="100-142" id="s1971.e0" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <entity charOffset="214-245" id="s1971.e1" ontology_id="HP_0006770" text="clear cell renal cell carcinoma" type="HP"/>
    <pair e1="s1971.e0" e2="s1971.e1" id="s1971.p0" relation="false"/>
  </sentence>
  <sentence id="s1972" text="proteolysis was further performed for 101 ccRCC primary tumors and 20 adjacent normal tissues.">
    <entity charOffset="0-11" id="s1972.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="56-61" id="s1972.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1972.e0" e2="s1972.e1" id="s1972.p0" relation="false"/>
  </sentence>
  <sentence id="s1973" text="Furthermore, the methylation status of negative regulation of platelet aggregation was not significantly associated with gender, age, location, tumor diameter, pathological stage, nuclear grade or short-term DFS in patients with ccRCC (p &amp;gt; 0.05).">
    <entity charOffset="39-82" id="s1973.e0" ontology_id="GO_0090331" text="negative regulation of platelet aggregation" type="GO"/>
    <entity charOffset="144-149" id="s1973.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1973.e0" e2="s1973.e1" id="s1973.p0" relation="false"/>
  </sentence>
  <sentence id="s1974" text="The negative regulation of platelet aggregation gene is often down-regulated by hypermethylation in ccRCC-derived cell lines and primary tumors, indicating its critical role as a TSG in ccRCC.">
    <entity charOffset="4-47" id="s1974.e0" ontology_id="GO_0090331" text="negative regulation of platelet aggregation" type="GO"/>
    <entity charOffset="137-142" id="s1974.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1974.e0" e2="s1974.e1" id="s1974.p0" relation="false"/>
  </sentence>
  <sentence id="s1975" text="We conclude that negative regulation of platelet aggregation gene hypermethylation may be involved in the tumorigenesis of ccRCC and may serve as a novel biomarker for this disease.">
    <entity charOffset="17-60" id="s1975.e0" ontology_id="GO_0090331" text="negative regulation of platelet aggregation" type="GO"/>
    <entity charOffset="106-111" id="s1975.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s1975.e0" e2="s1975.e1" id="s1975.p0" relation="false"/>
  </sentence>
  <sentence id="s1976" text="Clear cell renal cell carcinoma (ccresponse to hydroperoxide) is an heterogeneous tumour at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric positive regulation of cell-matrix adhesion interface and the tumour/renal sinus interface.">
    <entity charOffset="35-60" id="s1976.e0" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <entity charOffset="68-81" id="s1976.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s1976.e0" e2="s1976.e1" id="s1976.p0" relation="false"/>
  </sentence>
  <sentence id="s1977" text="Clear cell renal cell carcinoma (ccresponse to hydroperoxide) is an heterogeneous tumour at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric positive regulation of cell-matrix adhesion interface and the tumour/renal sinus interface.">
    <entity charOffset="35-60" id="s1977.e0" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <entity charOffset="82-88" id="s1977.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1977.e0" e2="s1977.e1" id="s1977.p0" relation="false"/>
  </sentence>
  <sentence id="s1978" text="Clear cell renal cell carcinoma (ccresponse to hydroperoxide) is an heterogeneous tumour at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric positive regulation of cell-matrix adhesion interface and the tumour/renal sinus interface.">
    <entity charOffset="68-81" id="s1978.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="359-402" id="s1978.e1" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s1978.e0" e2="s1978.e1" id="s1978.p0" relation="false"/>
  </sentence>
  <sentence id="s1979" text="We observed the presence of the mutation at pH1047R of &lt;i&gt;phosphorylation&lt;/i&gt; gene in five samples of the tumour, while the remaining 15 samples did not show any mutation at &lt;i&gt;PIK3CA&lt;/i&gt; or any other investigated gene.">
    <entity charOffset="58-73" id="s1979.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="106-112" id="s1979.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1979.e0" e2="s1979.e1" id="s1979.p0" relation="true"/>
  </sentence>
  <sentence id="s1980" text="There is a G protein-coupled receptor signaling pathway need to develop novel response to hydroperoxide sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies">
    <entity charOffset="11-55" id="s1980.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="143-156" id="s1980.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1980.e0" e2="s1980.e1" id="s1980.p0" relation="false"/>
  </sentence>
  <sentence id="s1981" text="There is a G protein-coupled receptor signaling pathway need to develop novel response to hydroperoxide sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies">
    <entity charOffset="78-103" id="s1981.e0" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <entity charOffset="136-142" id="s1981.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s1981.e0" e2="s1981.e1" id="s1981.p0" relation="false"/>
  </sentence>
  <sentence id="s1982" text="There is a G protein-coupled receptor signaling pathway need to develop novel response to hydroperoxide sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies">
    <entity charOffset="78-103" id="s1982.e0" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <entity charOffset="143-156" id="s1982.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s1982.e0" e2="s1982.e1" id="s1982.p0" relation="false"/>
  </sentence>
  <sentence id="s1983" text="Spinocerebellar ataxia muscle organ development 5 (vesicle-mediated transport) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.">
    <entity charOffset="16-22" id="s1983.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="23-47" id="s1983.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s1983.e0" e2="s1983.e1" id="s1983.p0" relation="false"/>
  </sentence>
  <sentence id="s1984" text="Spinocerebellar ataxia muscle organ development 5 (vesicle-mediated transport) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.">
    <entity charOffset="16-22" id="s1984.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="51-77" id="s1984.e1" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <pair e1="s1984.e0" e2="s1984.e1" id="s1984.p0" relation="true"/>
  </sentence>
  <sentence id="s1985" text="Spinocerebellar ataxia muscle organ development 5 (vesicle-mediated transport) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.">
    <entity charOffset="23-47" id="s1985.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="84-109" id="s1985.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s1985.e0" e2="s1985.e1" id="s1985.p0" relation="false"/>
  </sentence>
  <sentence id="s1986" text="Spinocerebellar ataxia muscle organ development 5 (vesicle-mediated transport) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.">
    <entity charOffset="51-77" id="s1986.e0" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <entity charOffset="84-109" id="s1986.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s1986.e0" e2="s1986.e1" id="s1986.p0" relation="false"/>
  </sentence>
  <sentence id="s1987" text="We compare and contrast our cellular response to interleukin-4ings with previous studies reporting on critical 1q43-q44 regions and their constituent genes associated with seizures, microcephaly, and corpus callosum abnormalities [Ballif et al., 2012; Hum Genet 131:145-156; Nagamani et al., 2012; Eur J Hum Genet 20:176-179].">
    <entity charOffset="28-62" id="s1987.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="182-194" id="s1987.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s1987.e0" e2="s1987.e1" id="s1987.p0" relation="false"/>
  </sentence>
  <sentence id="s1988" text="We compare and contrast our cellular response to interleukin-4ings with previous studies reporting on critical 1q43-q44 regions and their constituent genes associated with seizures, microcephaly, and corpus callosum abnormalities [Ballif et al., 2012; Hum Genet 131:145-156; Nagamani et al., 2012; Eur J Hum Genet 20:176-179].">
    <entity charOffset="28-62" id="s1988.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="200-229" id="s1988.e1" ontology_id="HP_0001273" text="corpus callosum abnormalities" type="HP"/>
    <pair e1="s1988.e0" e2="s1988.e1" id="s1988.p0" relation="false"/>
  </sentence>
  <sentence id="s1989" text="nucleosome disassembly-deficient thoracic sarcoma is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging.">
    <entity charOffset="0-22" id="s1989.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="42-49" id="s1989.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s1989.e0" e2="s1989.e1" id="s1989.p0" relation="false"/>
  </sentence>
  <sentence id="s1990" text="Furthermore, in vitro inhibition of cancer-derived negative regulation of transcription by RNA polymerase II noncanonical signals results in an increase of chemosensitivity in a colorectal cancer cell line.">
    <entity charOffset="36-42" id="s1990.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="51-108" id="s1990.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s1990.e0" e2="s1990.e1" id="s1990.p0" relation="false"/>
  </sentence>
  <sentence id="s1991" text="fatty acid beta-oxidation mice accumulate excess abdominal adipose tissue, develop an early inflammatory liver process, exhibit fasting rhabdomyolysis, and have abnormal skeletal muscle mitochondria.">
    <entity charOffset="0-25" id="s1991.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="136-150" id="s1991.e1" ontology_id="HP_0003201" text="rhabdomyolysis" type="HP"/>
    <pair e1="s1991.e0" e2="s1991.e1" id="s1991.p0" relation="false"/>
  </sentence>
  <sentence id="s1992" text="Palatable foods (positive regulation of cell-matrix adhesion and sweet) induce hyperphagia, and facilitate the development of obesity.">
    <entity charOffset="17-60" id="s1992.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="79-90" id="s1992.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1992.e0" e2="s1992.e1" id="s1992.p0" relation="false"/>
  </sentence>
  <sentence id="s1993" text="Palatable foods (positive regulation of cell-matrix adhesion and sweet) induce hyperphagia, and facilitate the development of obesity.">
    <entity charOffset="17-60" id="s1993.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="126-133" id="s1993.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s1993.e0" e2="s1993.e1" id="s1993.p0" relation="false"/>
  </sentence>
  <sentence id="s1994" text="Here we show that adipocyte regulation of glycolytic process is essential for high fat diet-induced hyperphagia, but is dispensable for baseline food intake.">
    <entity charOffset="28-60" id="s1994.e0" ontology_id="GO_0006110" text="regulation of glycolytic process" type="GO"/>
    <entity charOffset="100-111" id="s1994.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1994.e0" e2="s1994.e1" id="s1994.p0" relation="false"/>
  </sentence>
  <sentence id="s1995" text="Adipocyte regulation of glycolytic process stimulates hyperphagia by transcriptional activation of de novo lipid desaturation and accumulation of N-arachidonyl ethanolamine (AEA), an endogenous appetite-inducing cannabinoid (CB).">
    <entity charOffset="10-42" id="s1995.e0" ontology_id="GO_0006110" text="regulation of glycolytic process" type="GO"/>
    <entity charOffset="54-65" id="s1995.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1995.e0" e2="s1995.e1" id="s1995.p0" relation="false"/>
  </sentence>
  <sentence id="s1996" text="These findings define adipocyte regulation of glycolytic process as a positive regulation of cell-matrix adhesion sensor that regulates peripheral lipid signals, and uncover an unexpected adipose-to-brain axis to induce hyperphagia and obesity">
    <entity charOffset="32-64" id="s1996.e0" ontology_id="GO_0006110" text="regulation of glycolytic process" type="GO"/>
    <entity charOffset="220-231" id="s1996.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1996.e0" e2="s1996.e1" id="s1996.p0" relation="false"/>
  </sentence>
  <sentence id="s1997" text="These findings define adipocyte regulation of glycolytic process as a positive regulation of cell-matrix adhesion sensor that regulates peripheral lipid signals, and uncover an unexpected adipose-to-brain axis to induce hyperphagia and obesity">
    <entity charOffset="70-113" id="s1997.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="220-231" id="s1997.e1" ontology_id="HP_0002591" text="hyperphagia" type="HP"/>
    <pair e1="s1997.e0" e2="s1997.e1" id="s1997.p0" relation="false"/>
  </sentence>
  <sentence id="s1998" text="&lt;b&gt;Objective:&lt;/b&gt; To investigate the expression of granulocyte-colony stimulating factor receptor (G-peptidyl-tyrosine phosphorylation) in a mouse model of colitis-associated cancer (CAC), and the roles of G-CSFR positive immune cells in the development of CAC.">
    <entity charOffset="101-134" id="s1998.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="175-181" id="s1998.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s1998.e0" e2="s1998.e1" id="s1998.p0" relation="false"/>
  </sentence>
  <sentence id="s1999" text="To investigate this mechanism, we developed a novel uterine sarcoma tissue-derived orthotopic and metastatic model in KSN nude epidermis development using a green fluorescent protein stably expressed uterine sarcoma cell line, MES-SA.">
    <entity charOffset="60-67" id="s1999.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="127-148" id="s1999.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s1999.e0" e2="s1999.e1" id="s1999.p0" relation="false"/>
  </sentence>
  <sentence id="s2000" text="Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (negative regulation of muscle contraction, transforming growth factor beta receptor signaling pathway, and brain development).">
    <entity charOffset="39-45" id="s2000.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="173-214" id="s2000.e1" ontology_id="GO_0045932" text="negative regulation of muscle contraction" type="GO"/>
    <pair e1="s2000.e0" e2="s2000.e1" id="s2000.p0" relation="false"/>
  </sentence>
  <sentence id="s2001" text="Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (negative regulation of muscle contraction, transforming growth factor beta receptor signaling pathway, and brain development).">
    <entity charOffset="39-45" id="s2001.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="216-274" id="s2001.e1" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <pair e1="s2001.e0" e2="s2001.e1" id="s2001.p0" relation="false"/>
  </sentence>
  <sentence id="s2002" text="Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (negative regulation of muscle contraction, transforming growth factor beta receptor signaling pathway, and brain development).">
    <entity charOffset="39-45" id="s2002.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="280-297" id="s2002.e1" ontology_id="GO_0007420" text="brain development" type="GO"/>
    <pair e1="s2002.e0" e2="s2002.e1" id="s2002.p0" relation="false"/>
  </sentence>
  <sentence id="s2003" text="The expression profile of positive regulation of G1/S transition of mitotic cell cycle-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.">
    <entity charOffset="26-86" id="s2003.e0" ontology_id="GO_1900087" text="positive regulation of G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="99-115" id="s2003.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s2003.e0" e2="s2003.e1" id="s2003.p0" relation="false"/>
  </sentence>
  <sentence id="s2004" text="The expression profile of positive regulation of G1/S transition of mitotic cell cycle-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.">
    <entity charOffset="26-86" id="s2004.e0" ontology_id="GO_1900087" text="positive regulation of G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="182-188" id="s2004.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2004.e0" e2="s2004.e1" id="s2004.p0" relation="false"/>
  </sentence>
  <sentence id="s2005" text="The expression profile of positive regulation of G1/S transition of mitotic cell cycle-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.">
    <entity charOffset="26-86" id="s2005.e0" ontology_id="GO_1900087" text="positive regulation of G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="231-237" id="s2005.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2005.e0" e2="s2005.e1" id="s2005.p0" relation="false"/>
  </sentence>
  <sentence id="s2006" text="Our studies show that seven of the ADAMTS genes (positive regulation of G1/S transition of mitotic cell cycle, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor muscle organ development or grade (Mann-Whitney U test, P &amp;lt; 0.0001 for each gene).">
    <entity charOffset="49-109" id="s2006.e0" ontology_id="GO_1900087" text="positive regulation of G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="170-186" id="s2006.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s2006.e0" e2="s2006.e1" id="s2006.p0" relation="false"/>
  </sentence>
  <sentence id="s2007" text="Our studies show that seven of the ADAMTS genes (positive regulation of G1/S transition of mitotic cell cycle, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor muscle organ development or grade (Mann-Whitney U test, P &amp;lt; 0.0001 for each gene).">
    <entity charOffset="49-109" id="s2007.e0" ontology_id="GO_1900087" text="positive regulation of G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="254-267" id="s2007.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s2007.e0" e2="s2007.e1" id="s2007.p0" relation="false"/>
  </sentence>
  <sentence id="s2008" text="Our studies show that seven of the ADAMTS genes (positive regulation of G1/S transition of mitotic cell cycle, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor muscle organ development or grade (Mann-Whitney U test, P &amp;lt; 0.0001 for each gene).">
    <entity charOffset="49-109" id="s2008.e0" ontology_id="GO_1900087" text="positive regulation of G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="291-296" id="s2008.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2008.e0" e2="s2008.e1" id="s2008.p0" relation="false"/>
  </sentence>
  <sentence id="s2009" text="Our studies show that seven of the ADAMTS genes (positive regulation of G1/S transition of mitotic cell cycle, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor muscle organ development or grade (Mann-Whitney U test, P &amp;lt; 0.0001 for each gene).">
    <entity charOffset="254-267" id="s2009.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="297-321" id="s2009.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2009.e0" e2="s2009.e1" id="s2009.p0" relation="false"/>
  </sentence>
  <sentence id="s2010" text="Our studies show that seven of the ADAMTS genes (positive regulation of G1/S transition of mitotic cell cycle, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor muscle organ development or grade (Mann-Whitney U test, P &amp;lt; 0.0001 for each gene).">
    <entity charOffset="291-296" id="s2010.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="297-321" id="s2010.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2010.e0" e2="s2010.e1" id="s2010.p0" relation="false"/>
  </sentence>
  <sentence id="s2011" text="positive regulation of G1/S transition of mitotic cell cycle5 has emerged as being an independent predictor of survival, with RNA expression levels significantly lower (P = 0.007) in grade 3 breast carcinoma compared with grade 1 and 2 breast carcinoma">
    <entity charOffset="0-60" id="s2011.e0" ontology_id="GO_1900087" text="positive regulation of G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="191-207" id="s2011.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s2011.e0" e2="s2011.e1" id="s2011.p0" relation="false"/>
  </sentence>
  <sentence id="s2012" text="In addition to describing how to perform the EEG-ECG recordings, we also detail methods to quantify the resulting data for seizures, EEG spectral power, cardiac function, and heart rate variability, which we demonstrate in an example experiment using a mouse with epilepsy due to magnesium ion homeostasis gene deletion.">
    <entity charOffset="123-131" id="s2012.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="280-305" id="s2012.e1" ontology_id="GO_0010960" text="magnesium ion homeostasis" type="GO"/>
    <pair e1="s2012.e0" e2="s2012.e1" id="s2012.p0" relation="true"/>
  </sentence>
  <sentence id="s2013" text="In addition to describing how to perform the EEG-ECG recordings, we also detail methods to quantify the resulting data for seizures, EEG spectral power, cardiac function, and heart rate variability, which we demonstrate in an example experiment using a mouse with epilepsy due to magnesium ion homeostasis gene deletion.">
    <entity charOffset="264-272" id="s2013.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="280-305" id="s2013.e1" ontology_id="GO_0010960" text="magnesium ion homeostasis" type="GO"/>
    <pair e1="s2013.e0" e2="s2013.e1" id="s2013.p0" relation="true"/>
  </sentence>
  <sentence id="s2014" text="Genetic modification of a human prostate cancer cell line to induce miR-101 and suppress protein transport decreased cell migration and invasion.">
    <entity charOffset="41-47" id="s2014.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="89-106" id="s2014.e1" ontology_id="GO_0015031" text="protein transport" type="GO"/>
    <pair e1="s2014.e0" e2="s2014.e1" id="s2014.p0" relation="false"/>
  </sentence>
  <sentence id="s2015" text="As prostate cancer xenografts in epidermis development, these cells had decreased visibility on diffusion weighted MRI and decreased perfusion, which correlated with immunostaining showing decreased cell density and proliferation.">
    <entity charOffset="12-18" id="s2015.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="33-54" id="s2015.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2015.e0" e2="s2015.e1" id="s2015.p0" relation="false"/>
  </sentence>
  <sentence id="s2016" text="In this study, we evaluated the possible interaction between protein polyubiquitination-146a and one of its putative targets ribonuclease L (negative regulation of viral genome replication) in the risk of sporadic melanoma.">
    <entity charOffset="61-87" id="s2016.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="205-213" id="s2016.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2016.e0" e2="s2016.e1" id="s2016.p0" relation="false"/>
  </sentence>
  <sentence id="s2017" text="In this study, we evaluated the possible interaction between protein polyubiquitination-146a and one of its putative targets ribonuclease L (negative regulation of viral genome replication) in the risk of sporadic melanoma.">
    <entity charOffset="61-87" id="s2017.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="214-222" id="s2017.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2017.e0" e2="s2017.e1" id="s2017.p0" relation="false"/>
  </sentence>
  <sentence id="s2018" text="In this study, we evaluated the possible interaction between protein polyubiquitination-146a and one of its putative targets ribonuclease L (negative regulation of viral genome replication) in the risk of sporadic melanoma.">
    <entity charOffset="141-188" id="s2018.e0" ontology_id="GO_0045071" text="negative regulation of viral genome replication" type="GO"/>
    <entity charOffset="205-213" id="s2018.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2018.e0" e2="s2018.e1" id="s2018.p0" relation="false"/>
  </sentence>
  <sentence id="s2019" text="Polymorphisms rs2910164 in protein polyubiquitination-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.">
    <entity charOffset="27-53" id="s2019.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="223-231" id="s2019.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2019.e0" e2="s2019.e1" id="s2019.p0" relation="false"/>
  </sentence>
  <sentence id="s2020" text="Polymorphisms rs2910164 in protein polyubiquitination-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.">
    <entity charOffset="27-53" id="s2020.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="158-164" id="s2020.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2020.e0" e2="s2020.e1" id="s2020.p0" relation="false"/>
  </sentence>
  <sentence id="s2021" text="The results reported in the present study suggest a multicellular organism development-specific interaction between miR-146a and negative regulation of viral genome replication genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="52-86" id="s2021.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="186-194" id="s2021.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2021.e0" e2="s2021.e1" id="s2021.p0" relation="false"/>
  </sentence>
  <sentence id="s2022" text="The results reported in the present study suggest a multicellular organism development-specific interaction between miR-146a and negative regulation of viral genome replication genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="52-86" id="s2022.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="200-206" id="s2022.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2022.e0" e2="s2022.e1" id="s2022.p0" relation="false"/>
  </sentence>
  <sentence id="s2023" text="The results reported in the present study suggest a multicellular organism development-specific interaction between miR-146a and negative regulation of viral genome replication genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="129-176" id="s2023.e0" ontology_id="GO_0045071" text="negative regulation of viral genome replication" type="GO"/>
    <entity charOffset="186-194" id="s2023.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2023.e0" e2="s2023.e1" id="s2023.p0" relation="false"/>
  </sentence>
  <sentence id="s2024" text="The results reported in the present study suggest a multicellular organism development-specific interaction between miR-146a and negative regulation of viral genome replication genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed">
    <entity charOffset="129-176" id="s2024.e0" ontology_id="GO_0045071" text="negative regulation of viral genome replication" type="GO"/>
    <entity charOffset="200-206" id="s2024.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2024.e0" e2="s2024.e1" id="s2024.p0" relation="true"/>
  </sentence>
  <sentence id="s2025" text="Polo-like kinase 1 (G2/M transition of mitotic cell cycle) is overexpressed in a wide spectrum of human tumors, being frequently considered as an oncogene and an attractive cancer target.">
    <entity charOffset="20-57" id="s2025.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="173-179" id="s2025.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2025.e0" e2="s2025.e1" id="s2025.p0" relation="false"/>
  </sentence>
  <sentence id="s2026" text="In vivo, G2/M transition of mitotic cell cycle overexpression prevents the development of positive regulation of protein phosphorylation-induced and signal transduction-induced mammary gland tumors, in the presence of increased rates of chromosome instability.">
    <entity charOffset="9-46" id="s2026.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="191-197" id="s2026.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2026.e0" e2="s2026.e1" id="s2026.p0" relation="false"/>
  </sentence>
  <sentence id="s2027" text="In vivo, G2/M transition of mitotic cell cycle overexpression prevents the development of positive regulation of protein phosphorylation-induced and signal transduction-induced mammary gland tumors, in the presence of increased rates of chromosome instability.">
    <entity charOffset="90-136" id="s2027.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="191-197" id="s2027.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2027.e0" e2="s2027.e1" id="s2027.p0" relation="true"/>
  </sentence>
  <sentence id="s2028" text="In vivo, G2/M transition of mitotic cell cycle overexpression prevents the development of positive regulation of protein phosphorylation-induced and signal transduction-induced mammary gland tumors, in the presence of increased rates of chromosome instability.">
    <entity charOffset="149-168" id="s2028.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="191-197" id="s2028.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2028.e0" e2="s2028.e1" id="s2028.p0" relation="true"/>
  </sentence>
  <sentence id="s2029" text="In patients, G2/M transition of mitotic cell cycle overexpression correlates with improved survival in specific breast cancer subtypes.">
    <entity charOffset="13-50" id="s2029.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="119-125" id="s2029.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2029.e0" e2="s2029.e1" id="s2029.p0" relation="false"/>
  </sentence>
  <sentence id="s2030" text="Therefore, despite the therapeutic benefits of inhibiting G2/M transition of mitotic cell cycle due to its essential role in tumor cell cycles, Plk1 overexpression has tumor-suppressive properties by perturbing mitotic progression and cytokinesis">
    <entity charOffset="58-95" id="s2030.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="125-130" id="s2030.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2030.e0" e2="s2030.e1" id="s2030.p0" relation="false"/>
  </sentence>
  <sentence id="s2031" text="Two of these genes were independently mutated in more than one family with similar phenotypes, which substantiates their link to human disease (AKAP6 in intellectual disability and ubiquitin-dependent protein catabolic process in early dementia).">
    <entity charOffset="153-176" id="s2031.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="181-226" id="s2031.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s2031.e0" e2="s2031.e1" id="s2031.p0" relation="false"/>
  </sentence>
  <sentence id="s2032" text="Transmissible spongiform encephalopathies, characterized by long incubation periods and spongiform changes associated with neuronal loss in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in epidermis development and hamsters).">
    <entity charOffset="25-41" id="s2032.e0" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <entity charOffset="425-446" id="s2032.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2032.e0" e2="s2032.e1" id="s2032.p0" relation="false"/>
  </sentence>
  <sentence id="s2033" text="Transmissible spongiform encephalopathies, characterized by long incubation periods and spongiform changes associated with neuronal loss in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in epidermis development and hamsters).">
    <entity charOffset="123-136" id="s2033.e0" ontology_id="HP_0002529" text="neuronal loss" type="HP"/>
    <entity charOffset="425-446" id="s2033.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2033.e0" e2="s2033.e1" id="s2033.p0" relation="false"/>
  </sentence>
  <sentence id="s2034" text="Transmissible spongiform encephalopathies, characterized by long incubation periods and spongiform changes associated with neuronal loss in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in epidermis development and hamsters).">
    <entity charOffset="274-288" id="s2034.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="425-446" id="s2034.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2034.e0" e2="s2034.e1" id="s2034.p0" relation="false"/>
  </sentence>
  <sentence id="s2035" text="The KEGG enrichment analysis of DEGs showed significantly enriched pathways in cancer, extracellular matrix (platelet degranulation)-receptor interaction pathway, and cyclic adenosine monophosphate (cAMP) signaling pathway.">
    <entity charOffset="79-85" id="s2035.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="109-131" id="s2035.e1" ontology_id="GO_0002576" text="platelet degranulation" type="GO"/>
    <pair e1="s2035.e0" e2="s2035.e1" id="s2035.p0" relation="false"/>
  </sentence>
  <sentence id="s2036" text="There is growing evidence shown that microRNAs (protein polyubiquitinationNAs) are associated with cancer and can play a role in human cancers as oncogenes or tumor suppressor genes.">
    <entity charOffset="48-74" id="s2036.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="99-105" id="s2036.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2036.e0" e2="s2036.e1" id="s2036.p0" relation="false"/>
  </sentence>
  <sentence id="s2037" text="There is growing evidence shown that microRNAs (protein polyubiquitinationNAs) are associated with cancer and can play a role in human cancers as oncogenes or tumor suppressor genes.">
    <entity charOffset="48-74" id="s2037.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="159-164" id="s2037.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2037.e0" e2="s2037.e1" id="s2037.p0" relation="false"/>
  </sentence>
  <sentence id="s2038" text="MicroRNA-214 (protein polyubiquitination-214) shows carcinogenesis in various tumor types, but little is known about biological functions of miR-214 in esophageal squamous cell carcinoma (ESCC).">
    <entity charOffset="14-40" id="s2038.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="78-83" id="s2038.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2038.e0" e2="s2038.e1" id="s2038.p0" relation="false"/>
  </sentence>
  <sentence id="s2039" text="MicroRNA-214 (protein polyubiquitination-214) shows carcinogenesis in various tumor types, but little is known about biological functions of miR-214 in esophageal squamous cell carcinoma (ESCC).">
    <entity charOffset="14-40" id="s2039.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="163-186" id="s2039.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s2039.e0" e2="s2039.e1" id="s2039.p0" relation="false"/>
  </sentence>
  <sentence id="s2040" text="The results show protein polyubiquitination-214 serve as a tumor promoter regulating cells migration, invasion and apoptosis in ESCC.">
    <entity charOffset="17-43" id="s2040.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="59-64" id="s2040.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2040.e0" e2="s2040.e1" id="s2040.p0" relation="false"/>
  </sentence>
  <sentence id="s2041" text="In summary, these results suggest that protein polyubiquitination-214 serves as tumor promoter to promote proliferation, migration, invasion and inhibit apoptosis of ESCC cells by targeting negative regulation of macroautophagy via PI3K/AKT/mTOR signaling pathway.">
    <entity charOffset="39-65" id="s2041.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="80-85" id="s2041.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2041.e0" e2="s2041.e1" id="s2041.p0" relation="false"/>
  </sentence>
  <sentence id="s2042" text="In summary, these results suggest that protein polyubiquitination-214 serves as tumor promoter to promote proliferation, migration, invasion and inhibit apoptosis of ESCC cells by targeting negative regulation of macroautophagy via PI3K/AKT/mTOR signaling pathway.">
    <entity charOffset="80-85" id="s2042.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="190-227" id="s2042.e1" ontology_id="GO_0016242" text="negative regulation of macroautophagy" type="GO"/>
    <pair e1="s2042.e0" e2="s2042.e1" id="s2042.p0" relation="true"/>
  </sentence>
  <sentence id="s2043" text="Targeted exome sequencing identified biallelic mutations in intraciliary retrograde transport, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.">
    <entity charOffset="60-93" id="s2043.e0" ontology_id="GO_0035721" text="intraciliary retrograde transport" type="GO"/>
    <entity charOffset="400-418" id="s2043.e1" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <pair e1="s2043.e0" e2="s2043.e1" id="s2043.p0" relation="false"/>
  </sentence>
  <sentence id="s2044" text="Targeted exome sequencing identified biallelic mutations in intraciliary retrograde transport, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.">
    <entity charOffset="60-93" id="s2044.e0" ontology_id="GO_0035721" text="intraciliary retrograde transport" type="GO"/>
    <entity charOffset="199-217" id="s2044.e1" ontology_id="HP_0006644" text="thoracic dysplasia" type="HP"/>
    <pair e1="s2044.e0" e2="s2044.e1" id="s2044.p0" relation="true"/>
  </sentence>
  <sentence id="s2045" text="Using preclinical models, we have recently found that positive regulation of transcription, DNA-templated, a transcriptional factor that activates downstream targets, including &lt;i&gt;c-fos&lt;/i&gt; proto-oncogene, induces bladder cancer outgrowth.">
    <entity charOffset="54-105" id="s2045.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="222-228" id="s2045.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2045.e0" e2="s2045.e1" id="s2045.p0" relation="false"/>
  </sentence>
  <sentence id="s2046" text="Lymphovascular invasion was significantly (&lt;i&gt;P&lt;/i&gt; = 0.014) more often seen in phospho-positive regulation of transcription, DNA-templated(2+) tumors (80.0%) than in phospho-ELK1(0/1+) tumors (36.0%).">
    <entity charOffset="88-139" id="s2046.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="144-150" id="s2046.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2046.e0" e2="s2046.e1" id="s2046.p0" relation="false"/>
  </sentence>
  <sentence id="s2047" text="There were no statistically significant associations between phospho-positive regulation of transcription, DNA-templated expression and tumor grade, presence of concurrent carcinoma in situ or hydronephrosis, or pN status.">
    <entity charOffset="69-120" id="s2047.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="193-207" id="s2047.e1" ontology_id="HP_0000126" text="hydronephrosis" type="HP"/>
    <pair e1="s2047.e0" e2="s2047.e1" id="s2047.p0" relation="false"/>
  </sentence>
  <sentence id="s2048" text="Kaplan-Meier and log-rank tests revealed that patients with phospho-positive regulation of transcription, DNA-templated(2+) tumor had marginally and significantly higher risks of disease progression (&lt;i&gt;P&lt;/i&gt; = 0.055) and cancer-specific mortality (&lt;i&gt;P&lt;/i&gt; = 0.008), respectively, compared to those with phospho-ELK1(0/1+) tumor.">
    <entity charOffset="68-119" id="s2048.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="222-228" id="s2048.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2048.e0" e2="s2048.e1" id="s2048.p0" relation="false"/>
  </sentence>
  <sentence id="s2049" text="Kaplan-Meier and log-rank tests revealed that patients with phospho-positive regulation of transcription, DNA-templated(2+) tumor had marginally and significantly higher risks of disease progression (&lt;i&gt;P&lt;/i&gt; = 0.055) and cancer-specific mortality (&lt;i&gt;P&lt;/i&gt; = 0.008), respectively, compared to those with phospho-ELK1(0/1+) tumor.">
    <entity charOffset="68-119" id="s2049.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="124-129" id="s2049.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2049.e0" e2="s2049.e1" id="s2049.p0" relation="false"/>
  </sentence>
  <sentence id="s2050" text="The current results thus support our previous observations in bladder cancer and further suggest that phospho-positive regulation of transcription, DNA-templated overexpression serves as a predictor of poor prognosis in patients with UUTUC">
    <entity charOffset="70-76" id="s2050.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="110-161" id="s2050.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s2050.e0" e2="s2050.e1" id="s2050.p0" relation="false"/>
  </sentence>
  <sentence id="s2051" text="X-linked hearing impairment is the rarest form of genetic hearing loss (HL) and represents only a positive regulation of glucose transmembrane transport fraction of all cases.">
    <entity charOffset="58-70" id="s2051.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="98-152" id="s2051.e1" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <pair e1="s2051.e0" e2="s2051.e1" id="s2051.p0" relation="false"/>
  </sentence>
  <sentence id="s2052" text="Subpopulation screening of the coding exons and flanking introns of striated muscle contraction was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c.238C&amp;gt;A and c.55A&amp;gt;G) in SMPX were identified in additional sporadic cases of congenital deafness.">
    <entity charOffset="68-95" id="s2052.e0" ontology_id="GO_0006941" text="striated muscle contraction" type="GO"/>
    <entity charOffset="302-310" id="s2052.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2052.e0" e2="s2052.e1" id="s2052.p0" relation="false"/>
  </sentence>
  <sentence id="s2053" text="Subpopulation screening of the coding exons and flanking introns of striated muscle contraction was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c.238C&amp;gt;A and c.55A&amp;gt;G) in SMPX were identified in additional sporadic cases of congenital deafness.">
    <entity charOffset="68-95" id="s2053.e0" ontology_id="GO_0006941" text="striated muscle contraction" type="GO"/>
    <entity charOffset="331-339" id="s2053.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2053.e0" e2="s2053.e1" id="s2053.p0" relation="true"/>
  </sentence>
  <sentence id="s2054" text="Collectively, this study is the first to report the role of striated muscle contraction in Chinese population and identify a novel frameshift mutation in SMPX that causes not only nonsyndromic late-onset progressive HL, but also congenital hearing impairment.">
    <entity charOffset="60-87" id="s2054.e0" ontology_id="GO_0006941" text="striated muscle contraction" type="GO"/>
    <entity charOffset="240-258" id="s2054.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s2054.e0" e2="s2054.e1" id="s2054.p0" relation="true"/>
  </sentence>
  <sentence id="s2055" text="RNA sequencing transcriptome analysis revealed that inflammatory mediators such as tumor necrosis factor (TNF)- suppressed expression of R-spondin-1 (positive regulation of protein phosphorylation, a critical growth factor for intestinal epithelial cells) in regulation of double-strand break repair via homologous recombination-silenced YAMC cells &lt;i&gt;in vitro&lt;/i&gt;.">
    <entity charOffset="83-88" id="s2055.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="260-329" id="s2055.e1" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2055.e0" e2="s2055.e1" id="s2055.p0" relation="false"/>
  </sentence>
  <sentence id="s2056" text="RNA sequencing transcriptome analysis revealed that inflammatory mediators such as tumor necrosis factor (TNF)- suppressed expression of R-spondin-1 (positive regulation of protein phosphorylation, a critical growth factor for intestinal epithelial cells) in regulation of double-strand break repair via homologous recombination-silenced YAMC cells &lt;i&gt;in vitro&lt;/i&gt;.">
    <entity charOffset="83-88" id="s2056.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="151-197" id="s2056.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s2056.e0" e2="s2056.e1" id="s2056.p0" relation="true"/>
  </sentence>
  <sentence id="s2057" text="Homozygous and compound heterozygous mutations in post-embryonic development have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.">
    <entity charOffset="50-76" id="s2057.e0" ontology_id="GO_0009791" text="post-embryonic development" type="GO"/>
    <entity charOffset="156-179" id="s2057.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2057.e0" e2="s2057.e1" id="s2057.p0" relation="true"/>
  </sentence>
  <sentence id="s2058" text="The diagnosis of acquired chronic dysimmune neuropathies (pyrimidine deoxyribonucleotide catabolic process) like chronic inflammatory demyelinating polyneuropathy (CIDP), Lewis-Sumner Syndrome (steroid biosynthetic process) or multifocal motor neuropathy (MMN) can be challenging.">
    <entity charOffset="58-106" id="s2058.e0" ontology_id="GO_0009223" text="pyrimidine deoxyribonucleotide catabolic process" type="GO"/>
    <entity charOffset="152-162" id="s2058.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2058.e0" e2="s2058.e1" id="s2058.p0" relation="false"/>
  </sentence>
  <sentence id="s2059" text="The diagnosis of acquired chronic dysimmune neuropathies (pyrimidine deoxyribonucleotide catabolic process) like chronic inflammatory demyelinating polyneuropathy (CIDP), Lewis-Sumner Syndrome (steroid biosynthetic process) or multifocal motor neuropathy (MMN) can be challenging.">
    <entity charOffset="152-162" id="s2059.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="194-222" id="s2059.e1" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <pair e1="s2059.e0" e2="s2059.e1" id="s2059.p0" relation="false"/>
  </sentence>
  <sentence id="s2060" text="The diagnosis of acquired chronic dysimmune neuropathies (pyrimidine deoxyribonucleotide catabolic process) like chronic inflammatory demyelinating polyneuropathy (CIDP), Lewis-Sumner Syndrome (steroid biosynthetic process) or multifocal motor neuropathy (MMN) can be challenging.">
    <entity charOffset="194-222" id="s2060.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="227-237" id="s2060.e1" ontology_id="HP_0030651" text="multifocal" type="HP"/>
    <pair e1="s2060.e0" e2="s2060.e1" id="s2060.p0" relation="false"/>
  </sentence>
  <sentence id="s2061" text="Mutations of the sigma subunit of the heterotetrameric adaptor-related protein complex 2 (AP2) impair signalling of the calcium-sensing receptor (CaSR), and cause familial hypocalciuric hypercalcaemia muscle organ development 3 (FHH3).">
    <entity charOffset="187-201" id="s2061.e0" ontology_id="HP_0003072" text="hypercalcaemia" type="HP"/>
    <entity charOffset="202-226" id="s2061.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2061.e0" e2="s2061.e1" id="s2061.p0" relation="false"/>
  </sentence>
  <sentence id="s2062" text="Vestibular sensory-evoked potentials demonstrate severe to profound vestibular deficits in Dfnb31(neo/neo) and Dfnb31(wi/wi) epidermis development.">
    <entity charOffset="59-67" id="s2062.e0" ontology_id="HP_0012829" text="profound" type="HP"/>
    <entity charOffset="125-146" id="s2062.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2062.e0" e2="s2062.e1" id="s2062.p0" relation="false"/>
  </sentence>
  <sentence id="s2063" text="Because Dfnb31(wi/wi) and Dfnb31(neo/neo) mice faithfully recapitulate hearing and vision symptoms in patients, our cellular response to interleukin-4ings of vestibular dysfunction in these Dfnb31 mutants raise the question of whether DFNB31-deficient patients may acquire vestibular as well as hearing and vision loss.">
    <entity charOffset="116-150" id="s2063.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="158-180" id="s2063.e1" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <pair e1="s2063.e0" e2="s2063.e1" id="s2063.p0" relation="false"/>
  </sentence>
  <sentence id="s2064" text="Multisystem proteinopathy (MSP), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), is mainly caused by mutation in double-strand break repair gene.">
    <entity charOffset="105-128" id="s2064.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="209-235" id="s2064.e1" ontology_id="GO_0006302" text="double-strand break repair" type="GO"/>
    <pair e1="s2064.e0" e2="s2064.e1" id="s2064.p0" relation="true"/>
  </sentence>
  <sentence id="s2065" text="In addition, polymorphisms in apoptosis-related genes such as RNF7, positive regulation of phagocytosis, and positive regulation of phagocytosis are associated with fibrosis progression, and negative regulation of TOR signaling and MICA variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="68-103" id="s2065.e0" ontology_id="GO_0050766" text="positive regulation of phagocytosis" type="GO"/>
    <entity charOffset="278-302" id="s2065.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2065.e0" e2="s2065.e1" id="s2065.p0" relation="false"/>
  </sentence>
  <sentence id="s2066" text="In addition, polymorphisms in apoptosis-related genes such as RNF7, positive regulation of phagocytosis, and positive regulation of phagocytosis are associated with fibrosis progression, and negative regulation of TOR signaling and MICA variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="109-144" id="s2066.e0" ontology_id="GO_0050766" text="positive regulation of phagocytosis" type="GO"/>
    <entity charOffset="278-302" id="s2066.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2066.e0" e2="s2066.e1" id="s2066.p0" relation="false"/>
  </sentence>
  <sentence id="s2067" text="In addition, polymorphisms in apoptosis-related genes such as RNF7, positive regulation of phagocytosis, and positive regulation of phagocytosis are associated with fibrosis progression, and negative regulation of TOR signaling and MICA variants are associated with HCV-related hepatocellular carcinoma.">
    <entity charOffset="191-227" id="s2067.e0" ontology_id="GO_0032007" text="negative regulation of TOR signaling" type="GO"/>
    <entity charOffset="278-302" id="s2067.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2067.e0" e2="s2067.e1" id="s2067.p0" relation="false"/>
  </sentence>
  <sentence id="s2068" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="156-193" id="s2068.e0" ontology_id="GO_0000226" text="microtubule cytoskeleton organization" type="GO"/>
    <entity charOffset="517-529" id="s2068.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2068.e0" e2="s2068.e1" id="s2068.p0" relation="true"/>
  </sentence>
  <sentence id="s2069" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="202-222" id="s2069.e0" ontology_id="GO_0007051" text="spindle organization" type="GO"/>
    <entity charOffset="517-529" id="s2069.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2069.e0" e2="s2069.e1" id="s2069.p0" relation="true"/>
  </sentence>
  <sentence id="s2070" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="224-244" id="s2070.e0" ontology_id="GO_0061511" text="centriole elongation" type="GO"/>
    <entity charOffset="517-529" id="s2070.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2070.e0" e2="s2070.e1" id="s2070.p0" relation="true"/>
  </sentence>
  <sentence id="s2071" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="246-268" id="s2071.e0" ontology_id="GO_0051298" text="centrosome duplication" type="GO"/>
    <entity charOffset="517-529" id="s2071.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2071.e0" e2="s2071.e1" id="s2071.p0" relation="true"/>
  </sentence>
  <sentence id="s2072" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="278-300" id="s2072.e0" ontology_id="GO_0051298" text="centrosome duplication" type="GO"/>
    <entity charOffset="517-529" id="s2072.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2072.e0" e2="s2072.e1" id="s2072.p0" relation="true"/>
  </sentence>
  <sentence id="s2073" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="322-370" id="s2073.e0" ontology_id="GO_0007079" text="mitotic chromosome movement towards spindle pole" type="GO"/>
    <entity charOffset="517-529" id="s2073.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2073.e0" e2="s2073.e1" id="s2073.p0" relation="true"/>
  </sentence>
  <sentence id="s2074" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="387-421" id="s2074.e0" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <entity charOffset="517-529" id="s2074.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2074.e0" e2="s2074.e1" id="s2074.p0" relation="true"/>
  </sentence>
  <sentence id="s2075" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="423-442" id="s2075.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="517-529" id="s2075.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2075.e0" e2="s2075.e1" id="s2075.p0" relation="true"/>
  </sentence>
  <sentence id="s2076" text="Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of microcephaly genetic disorder.">
    <entity charOffset="447-457" id="s2076.e0" ontology_id="GO_0035973" text="aggrephagy" type="GO"/>
    <entity charOffset="517-529" id="s2076.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2076.e0" e2="s2076.e1" id="s2076.p0" relation="false"/>
  </sentence>
  <sentence id="s2077" text="There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (negative regulation of protein phosphorylation), transactive response DNA-binding protein (RNA splicing), superoxide dismutase 1 (SOD1) and fused in sarcoma (regulation of transcription, DNA-templated).">
    <entity charOffset="113-159" id="s2077.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="262-269" id="s2077.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s2077.e0" e2="s2077.e1" id="s2077.p0" relation="false"/>
  </sentence>
  <sentence id="s2078" text="There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (negative regulation of protein phosphorylation), transactive response DNA-binding protein (RNA splicing), superoxide dismutase 1 (SOD1) and fused in sarcoma (regulation of transcription, DNA-templated).">
    <entity charOffset="204-216" id="s2078.e0" ontology_id="GO_0008380" text="RNA splicing" type="GO"/>
    <entity charOffset="262-269" id="s2078.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s2078.e0" e2="s2078.e1" id="s2078.p0" relation="false"/>
  </sentence>
  <sentence id="s2079" text="There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (negative regulation of protein phosphorylation), transactive response DNA-binding protein (RNA splicing), superoxide dismutase 1 (SOD1) and fused in sarcoma (regulation of transcription, DNA-templated).">
    <entity charOffset="262-269" id="s2079.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="271-313" id="s2079.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s2079.e0" e2="s2079.e1" id="s2079.p0" relation="false"/>
  </sentence>
  <sentence id="s2080" text="Previous reports have identified chemical synaptic transmission variants in patients with generalized epilepsies, such as myoclonic-atonic epilepsy and childhood absence epilepsy.">
    <entity charOffset="33-63" id="s2080.e0" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <entity charOffset="139-147" id="s2080.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2080.e0" e2="s2080.e1" id="s2080.p0" relation="true"/>
  </sentence>
  <sentence id="s2081" text="The purpose of this study was to determine the incidence of chemical synaptic transmission variants in 460 unselected epilepsy patients and to evaluate the impact of the identified variants on -aminobutyric acid (GABA)transport.">
    <entity charOffset="60-90" id="s2081.e0" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <entity charOffset="118-126" id="s2081.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2081.e0" e2="s2081.e1" id="s2081.p0" relation="true"/>
  </sentence>
  <sentence id="s2082" text="These findings demonstrate that chemical synaptic transmission is an important contributor to childhood epilepsy and that reduced GAT-1 function is a common consequence of epilepsy-causing SLC6A1 variants">
    <entity charOffset="32-62" id="s2082.e0" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <entity charOffset="104-112" id="s2082.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2082.e0" e2="s2082.e1" id="s2082.p0" relation="true"/>
  </sentence>
  <sentence id="s2083" text="The studied CVD biomarkers include positive regulation of cytokine-mediated signaling pathway receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (positive regulation of gene expression), D-dimer, fibrinogen (histone glutamine methylation), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.">
    <entity charOffset="35-93" id="s2083.e0" ontology_id="GO_0001961" text="positive regulation of cytokine-mediated signaling pathway" type="GO"/>
    <entity charOffset="370-375" id="s2083.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2083.e0" e2="s2083.e1" id="s2083.p0" relation="false"/>
  </sentence>
  <sentence id="s2084" text="The studied CVD biomarkers include positive regulation of cytokine-mediated signaling pathway receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (positive regulation of gene expression), D-dimer, fibrinogen (histone glutamine methylation), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.">
    <entity charOffset="170-208" id="s2084.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="370-375" id="s2084.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2084.e0" e2="s2084.e1" id="s2084.p0" relation="false"/>
  </sentence>
  <sentence id="s2085" text="The studied CVD biomarkers include positive regulation of cytokine-mediated signaling pathway receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (positive regulation of gene expression), D-dimer, fibrinogen (histone glutamine methylation), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.">
    <entity charOffset="232-261" id="s2085.e0" ontology_id="GO_1990258" text="histone glutamine methylation" type="GO"/>
    <entity charOffset="370-375" id="s2085.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2085.e0" e2="s2085.e1" id="s2085.p0" relation="false"/>
  </sentence>
  <sentence id="s2086" text="Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (mRNA splice site selection1, VPS33B).">
    <entity charOffset="90-165" id="s2086.e0" ontology_id="GO_0007157" text="heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules" type="GO"/>
    <entity charOffset="186-200" id="s2086.e1" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <pair e1="s2086.e0" e2="s2086.e1" id="s2086.p0" relation="false"/>
  </sentence>
  <sentence id="s2087" text="Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (mRNA splice site selection1, VPS33B).">
    <entity charOffset="186-200" id="s2087.e0" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <entity charOffset="256-282" id="s2087.e1" ontology_id="GO_0006376" text="mRNA splice site selection" type="GO"/>
    <pair e1="s2087.e0" e2="s2087.e1" id="s2087.p0" relation="false"/>
  </sentence>
  <sentence id="s2088" text="While many downstream effectors of actin cytoskeleton reorganization have been established, the upstream regulators of ATR and the impact of such regulation on liver cancer remain unclear.">
    <entity charOffset="35-68" id="s2088.e0" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <entity charOffset="166-172" id="s2088.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2088.e0" e2="s2088.e1" id="s2088.p0" relation="true"/>
  </sentence>
  <sentence id="s2089" text="Here we demonstrate new functions for regulation of cytokinesis in actin cytoskeleton reorganization activation in vitro and liver tumor suppression in vivo.">
    <entity charOffset="38-63" id="s2089.e0" ontology_id="GO_0032465" text="regulation of cytokinesis" type="GO"/>
    <entity charOffset="131-136" id="s2089.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2089.e0" e2="s2089.e1" id="s2089.p0" relation="false"/>
  </sentence>
  <sentence id="s2090" text="Here we demonstrate new functions for regulation of cytokinesis in actin cytoskeleton reorganization activation in vitro and liver tumor suppression in vivo.">
    <entity charOffset="67-100" id="s2090.e0" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <entity charOffset="131-136" id="s2090.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2090.e0" e2="s2090.e1" id="s2090.p0" relation="true"/>
  </sentence>
  <sentence id="s2091" text="The in vivo negative regulation of transcription by RNA polymerase II of regulation of cytokinesis loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.">
    <entity charOffset="12-69" id="s2091.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="113-118" id="s2091.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2091.e0" e2="s2091.e1" id="s2091.p0" relation="false"/>
  </sentence>
  <sentence id="s2092" text="The in vivo negative regulation of transcription by RNA polymerase II of regulation of cytokinesis loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.">
    <entity charOffset="12-69" id="s2092.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="152-176" id="s2092.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2092.e0" e2="s2092.e1" id="s2092.p0" relation="false"/>
  </sentence>
  <sentence id="s2093" text="The in vivo negative regulation of transcription by RNA polymerase II of regulation of cytokinesis loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.">
    <entity charOffset="73-98" id="s2093.e0" ontology_id="GO_0032465" text="regulation of cytokinesis" type="GO"/>
    <entity charOffset="152-176" id="s2093.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2093.e0" e2="s2093.e1" id="s2093.p0" relation="false"/>
  </sentence>
  <sentence id="s2094" text="Liver-specific knockout of murine Bruce impaired actin cytoskeleton reorganization activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human phosphatidylinositol phosphorylation.">
    <entity charOffset="49-82" id="s2094.e0" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <entity charOffset="137-161" id="s2094.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2094.e0" e2="s2094.e1" id="s2094.p0" relation="false"/>
  </sentence>
  <sentence id="s2095" text="Liver-specific knockout of murine Bruce impaired actin cytoskeleton reorganization activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human phosphatidylinositol phosphorylation.">
    <entity charOffset="137-161" id="s2095.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="231-267" id="s2095.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s2095.e0" e2="s2095.e1" id="s2095.p0" relation="false"/>
  </sentence>
  <sentence id="s2096" text="In humans, the clinical relevance of regulation of cytokinesis downregulation in liver disease was found in hepatitis, cirrhosis and hepatocellular carcinoma specimens and deleterious somatic mutations of the regulation of cytokinesis gene was found in human hepatocellular carcinoma in TCGA database.">
    <entity charOffset="37-62" id="s2096.e0" ontology_id="GO_0032465" text="regulation of cytokinesis" type="GO"/>
    <entity charOffset="133-157" id="s2096.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2096.e0" e2="s2096.e1" id="s2096.p0" relation="false"/>
  </sentence>
  <sentence id="s2097" text="In humans, the clinical relevance of regulation of cytokinesis downregulation in liver disease was found in hepatitis, cirrhosis and hepatocellular carcinoma specimens and deleterious somatic mutations of the regulation of cytokinesis gene was found in human hepatocellular carcinoma in TCGA database.">
    <entity charOffset="133-157" id="s2097.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="209-234" id="s2097.e1" ontology_id="GO_0032465" text="regulation of cytokinesis" type="GO"/>
    <pair e1="s2097.e0" e2="s2097.e1" id="s2097.p0" relation="false"/>
  </sentence>
  <sentence id="s2098" text="Conclusion: These findings establish a new regulation of cytokinesis-actin cytoskeleton reorganization signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant phosphatidylinositol phosphorylation mouse model.">
    <entity charOffset="43-68" id="s2098.e0" ontology_id="GO_0032465" text="regulation of cytokinesis" type="GO"/>
    <entity charOffset="171-177" id="s2098.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2098.e0" e2="s2098.e1" id="s2098.p0" relation="false"/>
  </sentence>
  <sentence id="s2099" text="Conclusion: These findings establish a new regulation of cytokinesis-actin cytoskeleton reorganization signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant phosphatidylinositol phosphorylation mouse model.">
    <entity charOffset="69-102" id="s2099.e0" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <entity charOffset="171-177" id="s2099.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2099.e0" e2="s2099.e1" id="s2099.p0" relation="true"/>
  </sentence>
  <sentence id="s2100" text="Conclusion: These findings establish a new regulation of cytokinesis-actin cytoskeleton reorganization signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant phosphatidylinositol phosphorylation mouse model.">
    <entity charOffset="171-177" id="s2100.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="232-268" id="s2100.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s2100.e0" e2="s2100.e1" id="s2100.p0" relation="false"/>
  </sentence>
  <sentence id="s2101" text="Taking advantage of the homogeneous and heterogeneous electrochemical biosensors, a positive regulation of transcription by RNA polymerase II, sensitive, and selective electrochemical biosensor is constructed by combining entropy-driven amplification (positive regulation of NF-kappaB transcription factor activity) with DNA walker.">
    <entity charOffset="40-53" id="s2101.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="84-141" id="s2101.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2101.e0" e2="s2101.e1" id="s2101.p0" relation="true"/>
  </sentence>
  <sentence id="s2102" text="Taking advantage of the homogeneous and heterogeneous electrochemical biosensors, a positive regulation of transcription by RNA polymerase II, sensitive, and selective electrochemical biosensor is constructed by combining entropy-driven amplification (positive regulation of NF-kappaB transcription factor activity) with DNA walker.">
    <entity charOffset="40-53" id="s2102.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="252-314" id="s2102.e1" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s2102.e0" e2="s2102.e1" id="s2102.p0" relation="true"/>
  </sentence>
  <sentence id="s2103" text="Three submuscle organ developments, &lt;i&gt;PTPN11- , Ras protein signal transduction-&lt;/i&gt;, and &lt;i&gt;positive regulation of protein phosphorylation&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="9-33" id="s2103.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="283-300" id="s2103.e1" ontology_id="HP_0001067" text="neurofibromatosis" type="HP"/>
    <pair e1="s2103.e0" e2="s2103.e1" id="s2103.p0" relation="false"/>
  </sentence>
  <sentence id="s2104" text="Three submuscle organ developments, &lt;i&gt;PTPN11- , Ras protein signal transduction-&lt;/i&gt;, and &lt;i&gt;positive regulation of protein phosphorylation&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="49-80" id="s2104.e0" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <entity charOffset="490-495" id="s2104.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2104.e0" e2="s2104.e1" id="s2104.p0" relation="true"/>
  </sentence>
  <sentence id="s2105" text="Three submuscle organ developments, &lt;i&gt;PTPN11- , Ras protein signal transduction-&lt;/i&gt;, and &lt;i&gt;positive regulation of protein phosphorylation&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="94-140" id="s2105.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="490-495" id="s2105.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2105.e0" e2="s2105.e1" id="s2105.p0" relation="true"/>
  </sentence>
  <sentence id="s2106" text="Three submuscle organ developments, &lt;i&gt;PTPN11- , Ras protein signal transduction-&lt;/i&gt;, and &lt;i&gt;positive regulation of protein phosphorylation&lt;/i&gt;-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
    <entity charOffset="337-382" id="s2106.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="490-495" id="s2106.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2106.e0" e2="s2106.e1" id="s2106.p0" relation="true"/>
  </sentence>
  <sentence id="s2107" text="protein phosphorylation (ADCK3) is a mammalian UbiB protein associated with ubiquinone (CoQ) biosynthesis and an ataxia (ARCA2) through unclear means.">
    <entity charOffset="0-23" id="s2107.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="113-119" id="s2107.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s2107.e0" e2="s2107.e1" id="s2107.p0" relation="true"/>
  </sentence>
  <sentence id="s2108" text="We show that epidermis development lacking COQ8A develop a slowly progressive cerebellar ataxia linked to Purkinje cell dysfunction and mild exercise intolerance, recapitulating ARCA2.">
    <entity charOffset="13-34" id="s2108.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="89-95" id="s2108.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s2108.e0" e2="s2108.e1" id="s2108.p0" relation="false"/>
  </sentence>
  <sentence id="s2109" text="Sickle cell disease (quaternary ammonium group transport) is one of the most common autosomal recessive diseases in humans, occurring at a frequency of 1 in 365 African-American and 1 in 50 sub-Saharan African births.">
    <entity charOffset="21-56" id="s2109.e0" ontology_id="GO_0015697" text="quaternary ammonium group transport" type="GO"/>
    <entity charOffset="84-103" id="s2109.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2109.e0" e2="s2109.e1" id="s2109.p0" relation="true"/>
  </sentence>
  <sentence id="s2110" text="Recent evidence suggests that negative regulation of cell proliferation genes may participate in a wide array of cellular processes, and may contribute to the pathology of autoimmune disease, cancer, and other diseases.">
    <entity charOffset="30-71" id="s2110.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="192-198" id="s2110.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2110.e0" e2="s2110.e1" id="s2110.p0" relation="false"/>
  </sentence>
  <sentence id="s2111" text="Several studies have suggested a role for the glutamyl prolyl tRNA synthetase (prolyl-tRNA aminoacylation) in breast cancers, although none has identified any underlying mechanism about how EPRS contributes to carcinogenesis.">
    <entity charOffset="79-105" id="s2111.e0" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="117-123" id="s2111.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2111.e0" e2="s2111.e1" id="s2111.p0" relation="false"/>
  </sentence>
  <sentence id="s2112" text="Finally, we constructed a causal gene network based on over 2500 ER+ breast tumor samples to build up an prolyl-tRNA aminoacylation-estrogen signaling pathway.">
    <entity charOffset="76-81" id="s2112.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="105-131" id="s2112.e1" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <pair e1="s2112.e0" e2="s2112.e1" id="s2112.p0" relation="false"/>
  </sentence>
  <sentence id="s2113" text="prolyl-tRNA aminoacylation and its regulated estrogenic gene network may offer a promising alternative approach to target ER+ breast cancers that are refractory to current anti-estrogens">
    <entity charOffset="0-26" id="s2113.e0" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="133-139" id="s2113.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2113.e0" e2="s2113.e1" id="s2113.p0" relation="false"/>
  </sentence>
  <sentence id="s2114" text="Furthermore, we detected association of rs58978565 near TNR (P = 2.3  10-8), rs28368872 near biological_process (P = 2.9  10-8) and rs142450006 near MMP9 (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.">
    <entity charOffset="94-112" id="s2114.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="189-217" id="s2114.e1" ontology_id="HP_0011506" text="choroidal neovascularization" type="HP"/>
    <pair e1="s2114.e0" e2="s2114.e1" id="s2114.p0" relation="false"/>
  </sentence>
  <sentence id="s2115" text="The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-receptor-mediated endocytosis) has been demonstrated for several conditions, including cancer, obesity, diabetes, and ocular disease.">
    <entity charOffset="75-104" id="s2115.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="170-177" id="s2115.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2115.e0" e2="s2115.e1" id="s2115.p0" relation="false"/>
  </sentence>
  <sentence id="s2116" text="For example, administration of 3-keto-receptor-mediated endocytosis instead of fenretinide may be preferential if inhibition of SCD1 or unsaturated fatty acid biosynthetic process activity is the goal (cancer), while MPR may be better for retinoid metabolic process modulation (carotenoid metabolism).">
    <entity charOffset="38-67" id="s2116.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="202-208" id="s2116.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2116.e0" e2="s2116.e1" id="s2116.p0" relation="false"/>
  </sentence>
  <sentence id="s2117" text="For example, administration of 3-keto-receptor-mediated endocytosis instead of fenretinide may be preferential if inhibition of SCD1 or unsaturated fatty acid biosynthetic process activity is the goal (cancer), while MPR may be better for retinoid metabolic process modulation (carotenoid metabolism).">
    <entity charOffset="136-179" id="s2117.e0" ontology_id="GO_0006636" text="unsaturated fatty acid biosynthetic process" type="GO"/>
    <entity charOffset="202-208" id="s2117.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2117.e0" e2="s2117.e1" id="s2117.p0" relation="false"/>
  </sentence>
  <sentence id="s2118" text="For example, administration of 3-keto-receptor-mediated endocytosis instead of fenretinide may be preferential if inhibition of SCD1 or unsaturated fatty acid biosynthetic process activity is the goal (cancer), while MPR may be better for retinoid metabolic process modulation (carotenoid metabolism).">
    <entity charOffset="202-208" id="s2118.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="239-265" id="s2118.e1" ontology_id="GO_0001523" text="retinoid metabolic process" type="GO"/>
    <pair e1="s2118.e0" e2="s2118.e1" id="s2118.p0" relation="false"/>
  </sentence>
  <sentence id="s2119" text="In the present study, we used a custom-made negative regulation of cell proliferation panel to identify the genetic defect of a four-generation Chinese family with bilateral pulverulent nuclear cataracts.">
    <entity charOffset="44-85" id="s2119.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="194-202" id="s2119.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s2119.e0" e2="s2119.e1" id="s2119.p0" relation="false"/>
  </sentence>
  <sentence id="s2120" text="In the present study, we used a custom-made negative regulation of cell proliferation panel to identify the genetic defect of a four-generation Chinese family with bilateral pulverulent nuclear cataracts.">
    <entity charOffset="44-85" id="s2120.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="164-173" id="s2120.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s2120.e0" e2="s2120.e1" id="s2120.p0" relation="false"/>
  </sentence>
  <sentence id="s2121" text="The results indicated two mutated driver pathways are important for the pathogenesis of microtubule-based process: pathway in cancer and in regulation of actin cytoskeleton.">
    <entity charOffset="88-113" id="s2121.e0" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <entity charOffset="126-132" id="s2121.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2121.e0" e2="s2121.e1" id="s2121.p0" relation="false"/>
  </sentence>
  <sentence id="s2122" text="Our findings support the recently proposed concept of 3'UTR-encoded &amp;quot;cryptic amyloidogenic elements.&amp;quot; Together with a previous report on an aggregation-prone protein insertion into membrane deletion variant in distal hereditary motor neuropathy, they also suggest that toxic gain of REEP1 function, rather than loss-of-function as relevant for HSP, specifically affects lower motor neurons.">
    <entity charOffset="168-199" id="s2122.e0" ontology_id="GO_0051205" text="protein insertion into membrane" type="GO"/>
    <entity charOffset="244-254" id="s2122.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2122.e0" e2="s2122.e1" id="s2122.p0" relation="true"/>
  </sentence>
  <sentence id="s2123" text="Over 140 disease-causing mutations have been described so far in regulation of rhodopsin mediated signaling pathway, 88% of which cause autosomal recessive Leber congenital amaurosis (clathrin coat assembly) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (adCRD).">
    <entity charOffset="65-115" id="s2123.e0" ontology_id="GO_0022400" text="regulation of rhodopsin mediated signaling pathway" type="GO"/>
    <entity charOffset="136-155" id="s2123.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2123.e0" e2="s2123.e1" id="s2123.p0" relation="true"/>
  </sentence>
  <sentence id="s2124" text="Over 140 disease-causing mutations have been described so far in regulation of rhodopsin mediated signaling pathway, 88% of which cause autosomal recessive Leber congenital amaurosis (clathrin coat assembly) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (adCRD).">
    <entity charOffset="136-155" id="s2124.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="184-206" id="s2124.e1" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <pair e1="s2124.e0" e2="s2124.e1" id="s2124.p0" relation="false"/>
  </sentence>
  <sentence id="s2125" text="Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human TMIE as the gene affected at synaptic vesicle exocytosis, a non-syndromic hearing loss locus.">
    <entity charOffset="146-173" id="s2125.e0" ontology_id="GO_0016079" text="synaptic vesicle exocytosis" type="GO"/>
    <entity charOffset="191-203" id="s2125.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2125.e0" e2="s2125.e1" id="s2125.p0" relation="true"/>
  </sentence>
  <sentence id="s2126" text="neuron projection development-related disorders include a wide phenotypic ranging from mild to lethal seizure disorders, non-syndromic deafness, and composite syndromes such as DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures).">
    <entity charOffset="0-29" id="s2126.e0" ontology_id="GO_0031175" text="neuron projection development" type="GO"/>
    <entity charOffset="102-109" id="s2126.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s2126.e0" e2="s2126.e1" id="s2126.p0" relation="true"/>
  </sentence>
  <sentence id="s2127" text="neuron projection development-related disorders include a wide phenotypic ranging from mild to lethal seizure disorders, non-syndromic deafness, and composite syndromes such as DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures).">
    <entity charOffset="0-29" id="s2127.e0" ontology_id="GO_0031175" text="neuron projection development" type="GO"/>
    <entity charOffset="135-143" id="s2127.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2127.e0" e2="s2127.e1" id="s2127.p0" relation="true"/>
  </sentence>
  <sentence id="s2128" text="Three predicted driver genes (CDKN2A, positive regulation of protein phosphorylation, negative regulation of cell proliferation) were found common in these three cancers by comparative analysis.">
    <entity charOffset="38-84" id="s2128.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="162-168" id="s2128.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2128.e0" e2="s2128.e1" id="s2128.p0" relation="true"/>
  </sentence>
  <sentence id="s2129" text="Three predicted driver genes (CDKN2A, positive regulation of protein phosphorylation, negative regulation of cell proliferation) were found common in these three cancers by comparative analysis.">
    <entity charOffset="86-127" id="s2129.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="162-168" id="s2129.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2129.e0" e2="s2129.e1" id="s2129.p0" relation="true"/>
  </sentence>
  <sentence id="s2130" text="Mutations in the human tRNA 3'-terminal CCA addition gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the camera-type eye development (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.">
    <entity charOffset="23-52" id="s2130.e0" ontology_id="GO_0001680" text="tRNA 3'-terminal CCA addition" type="GO"/>
    <entity charOffset="384-403" id="s2130.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2130.e0" e2="s2130.e1" id="s2130.p0" relation="true"/>
  </sentence>
  <sentence id="s2131" text="Mutations in the human tRNA 3'-terminal CCA addition gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the camera-type eye development (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.">
    <entity charOffset="158-185" id="s2131.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="384-403" id="s2131.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2131.e0" e2="s2131.e1" id="s2131.p0" relation="false"/>
  </sentence>
  <sentence id="s2132" text="Numerous studies have recently demonstrated that protein deacetylation expression and activity are increased in kidney disease, such as autosomal dominant polycystic kidney disease (ADPKD), renal fibrosis, and acute kidney injury (AKI), among others.">
    <entity charOffset="49-70" id="s2132.e0" ontology_id="GO_0006476" text="protein deacetylation" type="GO"/>
    <entity charOffset="190-204" id="s2132.e1" ontology_id="HP_0030760" text="renal fibrosis" type="HP"/>
    <pair e1="s2132.e0" e2="s2132.e1" id="s2132.p0" relation="false"/>
  </sentence>
  <sentence id="s2133" text="In nucleosome disassembly, HDAC6 inhibitors effectively limit the progression of kidney diseases, suggesting that targeting HDAC6 may provide a novel treatment approach.">
    <entity charOffset="3-25" id="s2133.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="81-95" id="s2133.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s2133.e0" e2="s2133.e1" id="s2133.p0" relation="false"/>
  </sentence>
  <sentence id="s2134" text="Here, we discuss the unique function of protein deacetylation and recapitulate the alluring potential of its inhibitors in kidney diseases">
    <entity charOffset="40-61" id="s2134.e0" ontology_id="GO_0006476" text="protein deacetylation" type="GO"/>
    <entity charOffset="123-137" id="s2134.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s2134.e0" e2="s2134.e1" id="s2134.p0" relation="false"/>
  </sentence>
  <sentence id="s2135" text="Cell surface carbohydrates are important for cell migration and invasion of prostate cancer (mitochondrial transport).">
    <entity charOffset="85-91" id="s2135.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="93-116" id="s2135.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s2135.e0" e2="s2135.e1" id="s2135.p0" relation="false"/>
  </sentence>
  <sentence id="s2136" text="Accordingly, the I-branching N-acetylglucosaminyltransferase (protein glycosylation) converts linear i-antigen to I-branching glycan, and its expression is associated with breast cancer progression.">
    <entity charOffset="62-83" id="s2136.e0" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <entity charOffset="179-185" id="s2136.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2136.e0" e2="s2136.e1" id="s2136.p0" relation="false"/>
  </sentence>
  <sentence id="s2137" text="Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including protein ubiquitination, protein ubiquitination, and protein phosphorylation, also showed such clustering.">
    <entity charOffset="120-125" id="s2137.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="149-171" id="s2137.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s2137.e0" e2="s2137.e1" id="s2137.p0" relation="false"/>
  </sentence>
  <sentence id="s2138" text="Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including protein ubiquitination, protein ubiquitination, and protein phosphorylation, also showed such clustering.">
    <entity charOffset="120-125" id="s2138.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="173-195" id="s2138.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s2138.e0" e2="s2138.e1" id="s2138.p0" relation="true"/>
  </sentence>
  <sentence id="s2139" text="Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including protein ubiquitination, protein ubiquitination, and protein phosphorylation, also showed such clustering.">
    <entity charOffset="120-125" id="s2139.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="201-224" id="s2139.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s2139.e0" e2="s2139.e1" id="s2139.p0" relation="true"/>
  </sentence>
  <sentence id="s2140" text="Focal cortical dysplasia (FCD) and hemimegalencephaly (proteolysis) are epileptogenic neurodevelopmentalmalformations caused by mutations in regulation of cell growth pathway genes.">
    <entity charOffset="6-24" id="s2140.e0" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <entity charOffset="55-66" id="s2140.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s2140.e0" e2="s2140.e1" id="s2140.p0" relation="false"/>
  </sentence>
  <sentence id="s2141" text="Focal cortical dysplasia (FCD) and hemimegalencephaly (proteolysis) are epileptogenic neurodevelopmentalmalformations caused by mutations in regulation of cell growth pathway genes.">
    <entity charOffset="6-24" id="s2141.e0" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <entity charOffset="142-167" id="s2141.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s2141.e0" e2="s2141.e1" id="s2141.p0" relation="true"/>
  </sentence>
  <sentence id="s2142" text="Focal cortical dysplasia (FCD) and hemimegalencephaly (proteolysis) are epileptogenic neurodevelopmentalmalformations caused by mutations in regulation of cell growth pathway genes.">
    <entity charOffset="35-53" id="s2142.e0" ontology_id="HP_0007206" text="hemimegalencephaly" type="HP"/>
    <entity charOffset="55-66" id="s2142.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s2142.e0" e2="s2142.e1" id="s2142.p0" relation="false"/>
  </sentence>
  <sentence id="s2143" text="These effects are thought to have a significant negative regulation of transcription by RNA polymerase II upon both vascular and cerebrovascular health, ultimately with the potential to prevent cardiovascular and potentially neurodegenerative disease with a vascular component, for example vascular dementia.">
    <entity charOffset="48-105" id="s2143.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="225-250" id="s2143.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s2143.e0" e2="s2143.e1" id="s2143.p0" relation="false"/>
  </sentence>
  <sentence id="s2144" text="The protein targeting-associated phenotype has previously been assigned to spastic paraplegia-47.">
    <entity charOffset="4-21" id="s2144.e0" ontology_id="GO_0006605" text="protein targeting" type="GO"/>
    <entity charOffset="75-93" id="s2144.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s2144.e0" e2="s2144.e1" id="s2144.p0" relation="true"/>
  </sentence>
  <sentence id="s2145" text="c.7253dupT in DNA repair, encoding a DDR factor important in meiosis, associated with hereditary breast cancer (p=0.018) and likely represents a Northern Finnish founder mutation.">
    <entity charOffset="14-24" id="s2145.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="104-110" id="s2145.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2145.e0" e2="s2145.e1" id="s2145.p0" relation="false"/>
  </sentence>
  <sentence id="s2146" text="A deletion (c.640_644del5) in double-strand break repair, causative for recessive RIDDLE syndrome, had high prevalence in majority of the analyzed cohorts, but did not associate with breast cancer.">
    <entity charOffset="30-56" id="s2146.e0" ontology_id="GO_0006302" text="double-strand break repair" type="GO"/>
    <entity charOffset="190-196" id="s2146.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2146.e0" e2="s2146.e1" id="s2146.p0" relation="false"/>
  </sentence>
  <sentence id="s2147" text="In conclusion, truncating variants in DNA repair and FANCD2 are potential breast cancer risk factors, warranting further investigations in other populations.">
    <entity charOffset="38-48" id="s2147.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="81-87" id="s2147.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2147.e0" e2="s2147.e1" id="s2147.p0" relation="false"/>
  </sentence>
  <sentence id="s2148" text="Our study provides further evidence for validating the role of biological_process in the pathology of related infantile-onset encephalopathy, contributing to the phenotypic features of this condition, and providing clinical and molecular insight for the diagnosis of this disease entity">
    <entity charOffset="63-81" id="s2148.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="126-140" id="s2148.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2148.e0" e2="s2148.e1" id="s2148.p0" relation="false"/>
  </sentence>
  <sentence id="s2149" text="Mutations in the coumarin metabolic process gene have been identified in patients with temporal lobe epilepsy and febrile seizures.">
    <entity charOffset="17-43" id="s2149.e0" ontology_id="GO_0009804" text="coumarin metabolic process" type="GO"/>
    <entity charOffset="101-109" id="s2149.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2149.e0" e2="s2149.e1" id="s2149.p0" relation="false"/>
  </sentence>
  <sentence id="s2150" text="In the present study, we screened for coumarin metabolic process mutations in patients with juvenile myoclonic epilepsy and identified two novel missense mutations: Arg36His and Asn271Ser.">
    <entity charOffset="38-64" id="s2150.e0" ontology_id="GO_0009804" text="coumarin metabolic process" type="GO"/>
    <entity charOffset="111-119" id="s2150.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2150.e0" e2="s2150.e1" id="s2150.p0" relation="false"/>
  </sentence>
  <sentence id="s2151" text="We obtained cryo-electron microscopy structures of an activated filament that is allosterically induced by citrate (ACC-citrate), and an inactivated filament form that results from binding of the BRCT domains of the breast cancer type 1 susceptibility protein (double-strand break repair via homologous recombination).">
    <entity charOffset="223-229" id="s2151.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="261-316" id="s2151.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2151.e0" e2="s2151.e1" id="s2151.p0" relation="true"/>
  </sentence>
  <sentence id="s2152" text="The 1p breakpoint disrupts the 5' UTR of biological_process, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.">
    <entity charOffset="41-59" id="s2152.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="490-504" id="s2152.e1" ontology_id="HP_0000750" text="language delay" type="HP"/>
    <pair e1="s2152.e0" e2="s2152.e1" id="s2152.p0" relation="false"/>
  </sentence>
  <sentence id="s2153" text="The 1p breakpoint disrupts the 5' UTR of biological_process, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.">
    <entity charOffset="41-59" id="s2153.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="521-532" id="s2153.e1" ontology_id="HP_0010535" text="sleep apnea" type="HP"/>
    <pair e1="s2153.e0" e2="s2153.e1" id="s2153.p0" relation="true"/>
  </sentence>
  <sentence id="s2154" text="Pediatric refractory epilepsy is a broad phenotypic spectrum with G protein-coupled receptor signaling pathway genetic heterogeneity.">
    <entity charOffset="21-29" id="s2154.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="66-110" id="s2154.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s2154.e0" e2="s2154.e1" id="s2154.p0" relation="false"/>
  </sentence>
  <sentence id="s2155" text="Pediatric refractory epilepsy is a broad phenotypic spectrum with G protein-coupled receptor signaling pathway genetic heterogeneity.">
    <entity charOffset="66-110" id="s2155.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="119-132" id="s2155.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s2155.e0" e2="s2155.e1" id="s2155.p0" relation="false"/>
  </sentence>
  <sentence id="s2156" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2156.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="77-114" id="s2156.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s2156.e0" e2="s2156.e1" id="s2156.p0" relation="true"/>
  </sentence>
  <sentence id="s2157" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2157.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="116-174" id="s2157.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s2157.e0" e2="s2157.e1" id="s2157.p0" relation="true"/>
  </sentence>
  <sentence id="s2158" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2158.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="176-206" id="s2158.e1" ontology_id="GO_0071420" text="cellular response to histamine" type="GO"/>
    <pair e1="s2158.e0" e2="s2158.e1" id="s2158.p0" relation="true"/>
  </sentence>
  <sentence id="s2159" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2159.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="208-240" id="s2159.e1" ontology_id="GO_1902476" text="chloride transmembrane transport" type="GO"/>
    <pair e1="s2159.e0" e2="s2159.e1" id="s2159.p0" relation="true"/>
  </sentence>
  <sentence id="s2160" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2160.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="242-286" id="s2160.e1" ontology_id="GO_0050804" text="modulation of chemical synaptic transmission" type="GO"/>
    <pair e1="s2160.e0" e2="s2160.e1" id="s2160.p0" relation="true"/>
  </sentence>
  <sentence id="s2161" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2161.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="294-321" id="s2161.e1" ontology_id="GO_0046777" text="protein autophosphorylation" type="GO"/>
    <pair e1="s2161.e0" e2="s2161.e1" id="s2161.p0" relation="false"/>
  </sentence>
  <sentence id="s2162" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2162.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="323-354" id="s2162.e1" ontology_id="GO_0006883" text="cellular sodium ion homeostasis" type="GO"/>
    <pair e1="s2162.e0" e2="s2162.e1" id="s2162.p0" relation="true"/>
  </sentence>
  <sentence id="s2163" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2163.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="356-419" id="s2163.e1" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <pair e1="s2163.e0" e2="s2163.e1" id="s2163.p0" relation="true"/>
  </sentence>
  <sentence id="s2164" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2164.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="421-435" id="s2164.e1" ontology_id="GO_0048675" text="axon extension" type="GO"/>
    <pair e1="s2164.e0" e2="s2164.e1" id="s2164.p0" relation="true"/>
  </sentence>
  <sentence id="s2165" text="Other novel mutations detected in unclassified epilepsy patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.">
    <entity charOffset="47-55" id="s2165.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="440-464" id="s2165.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2165.e0" e2="s2165.e1" id="s2165.p0" relation="true"/>
  </sentence>
  <sentence id="s2166" text="These results suggest (i) apparent allelic heterogeneity in complement activation and genetic heterogeneity in thiamine pyrophosphate transmembrane transport across different ethnic groups; (ii) shared ulcerative colitis genetic etiological factors among Asians; and finally (iii) re-exploration of GWAS findings together with high-density genotyping/sequencing and trans-ethnic fine mapping approaches may help identify shared and population-specific risk variants and enable to explain missing disease heritability">
    <entity charOffset="43-56" id="s2166.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="60-81" id="s2166.e1" ontology_id="GO_0006956" text="complement activation" type="GO"/>
    <pair e1="s2166.e0" e2="s2166.e1" id="s2166.p0" relation="false"/>
  </sentence>
  <sentence id="s2167" text="These results suggest (i) apparent allelic heterogeneity in complement activation and genetic heterogeneity in thiamine pyrophosphate transmembrane transport across different ethnic groups; (ii) shared ulcerative colitis genetic etiological factors among Asians; and finally (iii) re-exploration of GWAS findings together with high-density genotyping/sequencing and trans-ethnic fine mapping approaches may help identify shared and population-specific risk variants and enable to explain missing disease heritability">
    <entity charOffset="43-56" id="s2167.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="111-157" id="s2167.e1" ontology_id="GO_0030974" text="thiamine pyrophosphate transmembrane transport" type="GO"/>
    <pair e1="s2167.e0" e2="s2167.e1" id="s2167.p0" relation="false"/>
  </sentence>
  <sentence id="s2168" text="In the present study, we investigated the spatiotemporal distributions of negative regulation of protein export from nucleus and 4 representative nucleoporins (GP210, NUP205, mRNA export from nucleus and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (response to superoxide-thyroid gland development) mice and sporadic ALS patients.">
    <entity charOffset="74-124" id="s2168.e0" ontology_id="GO_0046826" text="negative regulation of protein export from nucleus" type="GO"/>
    <entity charOffset="337-345" id="s2168.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2168.e0" e2="s2168.e1" id="s2168.p0" relation="false"/>
  </sentence>
  <sentence id="s2169" text="In the present study, we investigated the spatiotemporal distributions of negative regulation of protein export from nucleus and 4 representative nucleoporins (GP210, NUP205, mRNA export from nucleus and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (response to superoxide-thyroid gland development) mice and sporadic ALS patients.">
    <entity charOffset="175-199" id="s2169.e0" ontology_id="GO_0006406" text="mRNA export from nucleus" type="GO"/>
    <entity charOffset="337-345" id="s2169.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2169.e0" e2="s2169.e1" id="s2169.p0" relation="false"/>
  </sentence>
  <sentence id="s2170" text="In the present study, we investigated the spatiotemporal distributions of negative regulation of protein export from nucleus and 4 representative nucleoporins (GP210, NUP205, mRNA export from nucleus and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (response to superoxide-thyroid gland development) mice and sporadic ALS patients.">
    <entity charOffset="278-300" id="s2170.e0" ontology_id="GO_0000303" text="response to superoxide" type="GO"/>
    <entity charOffset="337-345" id="s2170.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2170.e0" e2="s2170.e1" id="s2170.p0" relation="false"/>
  </sentence>
  <sentence id="s2171" text="In the present study, we investigated the spatiotemporal distributions of negative regulation of protein export from nucleus and 4 representative nucleoporins (GP210, NUP205, mRNA export from nucleus and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (response to superoxide-thyroid gland development) mice and sporadic ALS patients.">
    <entity charOffset="301-326" id="s2171.e0" ontology_id="GO_0030878" text="thyroid gland development" type="GO"/>
    <entity charOffset="337-345" id="s2171.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2171.e0" e2="s2171.e1" id="s2171.p0" relation="false"/>
  </sentence>
  <sentence id="s2172" text="The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of signal transduction both in response to superoxide-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention">
    <entity charOffset="112-131" id="s2172.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="181-189" id="s2172.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2172.e0" e2="s2172.e1" id="s2172.p0" relation="false"/>
  </sentence>
  <sentence id="s2173" text="The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of signal transduction both in response to superoxide-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention">
    <entity charOffset="140-162" id="s2173.e0" ontology_id="GO_0000303" text="response to superoxide" type="GO"/>
    <entity charOffset="181-189" id="s2173.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2173.e0" e2="s2173.e1" id="s2173.p0" relation="false"/>
  </sentence>
  <sentence id="s2174" text="In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, cell-cell adhesion and G protein-coupled receptor signaling pathway genetic loci, respectively, are associated with risk for endometriosis in a Greek population.">
    <entity charOffset="133-151" id="s2174.e0" ontology_id="GO_0098609" text="cell-cell adhesion" type="GO"/>
    <entity charOffset="258-271" id="s2174.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2174.e0" e2="s2174.e1" id="s2174.p0" relation="false"/>
  </sentence>
  <sentence id="s2175" text="In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, cell-cell adhesion and G protein-coupled receptor signaling pathway genetic loci, respectively, are associated with risk for endometriosis in a Greek population.">
    <entity charOffset="156-200" id="s2175.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="258-271" id="s2175.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2175.e0" e2="s2175.e1" id="s2175.p0" relation="false"/>
  </sentence>
  <sentence id="s2176" text="Notably, a significant difference in the distribution of the AG genotype and the positive regulation of glucose transmembrane transport allele A of G protein-coupled receptor signaling pathway rs11031006 SNP was found between the endometriosis patients and controls.">
    <entity charOffset="81-135" id="s2176.e0" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <entity charOffset="230-243" id="s2176.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2176.e0" e2="s2176.e1" id="s2176.p0" relation="false"/>
  </sentence>
  <sentence id="s2177" text="Notably, a significant difference in the distribution of the AG genotype and the positive regulation of glucose transmembrane transport allele A of G protein-coupled receptor signaling pathway rs11031006 SNP was found between the endometriosis patients and controls.">
    <entity charOffset="148-192" id="s2177.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="230-243" id="s2177.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2177.e0" e2="s2177.e1" id="s2177.p0" relation="false"/>
  </sentence>
  <sentence id="s2178" text="We found a genetic association between rs11031006 (G protein-coupled receptor signaling pathway) SNP and endometriosis.">
    <entity charOffset="51-95" id="s2178.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="105-118" id="s2178.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2178.e0" e2="s2178.e1" id="s2178.p0" relation="false"/>
  </sentence>
  <sentence id="s2179" text="negative regulation of gene expression and cell-cell adhesion genes constitute the most consistently associated genes with endometriosis.">
    <entity charOffset="0-38" id="s2179.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="123-136" id="s2179.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2179.e0" e2="s2179.e1" id="s2179.p0" relation="false"/>
  </sentence>
  <sentence id="s2180" text="negative regulation of gene expression and cell-cell adhesion genes constitute the most consistently associated genes with endometriosis.">
    <entity charOffset="43-61" id="s2180.e0" ontology_id="GO_0098609" text="cell-cell adhesion" type="GO"/>
    <entity charOffset="123-136" id="s2180.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2180.e0" e2="s2180.e1" id="s2180.p0" relation="false"/>
  </sentence>
  <sentence id="s2181" text="In the present study, an association of rs7521902 (negative regulation of gene expression) and rs10859871 (cell-cell adhesion) was confirmed in women with endometriosis at the genotypic but not the allelic level">
    <entity charOffset="51-89" id="s2181.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="155-168" id="s2181.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2181.e0" e2="s2181.e1" id="s2181.p0" relation="false"/>
  </sentence>
  <sentence id="s2182" text="In the present study, an association of rs7521902 (negative regulation of gene expression) and rs10859871 (cell-cell adhesion) was confirmed in women with endometriosis at the genotypic but not the allelic level">
    <entity charOffset="107-125" id="s2182.e0" ontology_id="GO_0098609" text="cell-cell adhesion" type="GO"/>
    <entity charOffset="155-168" id="s2182.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2182.e0" e2="s2182.e1" id="s2182.p0" relation="false"/>
  </sentence>
  <sentence id="s2183" text="Primary creatine disorders are inherited as autosomal recessive (mutations affecting creatine biosynthetic process [for glycine-amidinotransferase, mitochondrial]) and creatine biosynthetic process genes) or X-linked (creatine transmembrane transport gene) traits.">
    <entity charOffset="44-63" id="s2183.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="168-197" id="s2183.e1" ontology_id="GO_0006601" text="creatine biosynthetic process" type="GO"/>
    <pair e1="s2183.e0" e2="s2183.e1" id="s2183.p0" relation="true"/>
  </sentence>
  <sentence id="s2184" text="Primary creatine disorders are inherited as autosomal recessive (mutations affecting creatine biosynthetic process [for glycine-amidinotransferase, mitochondrial]) and creatine biosynthetic process genes) or X-linked (creatine transmembrane transport gene) traits.">
    <entity charOffset="44-63" id="s2184.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="218-250" id="s2184.e1" ontology_id="GO_0015881" text="creatine transmembrane transport" type="GO"/>
    <pair e1="s2184.e0" e2="s2184.e1" id="s2184.p0" relation="false"/>
  </sentence>
  <sentence id="s2185" text="Primary creatine disorders are inherited as autosomal recessive (mutations affecting creatine biosynthetic process [for glycine-amidinotransferase, mitochondrial]) and creatine biosynthetic process genes) or X-linked (creatine transmembrane transport gene) traits.">
    <entity charOffset="44-63" id="s2185.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="85-114" id="s2185.e1" ontology_id="GO_0006601" text="creatine biosynthetic process" type="GO"/>
    <pair e1="s2185.e0" e2="s2185.e1" id="s2185.p0" relation="true"/>
  </sentence>
  <sentence id="s2186" text="Primary ciliary dyskinesia (motile cilium assembly) is clinically characterized by neonatal respiratory distress, chronic sinusitis, bronchiectasis and infertility, and situs inversus in 50% of the patients.">
    <entity charOffset="8-26" id="s2186.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-50" id="s2186.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s2186.e0" e2="s2186.e1" id="s2186.p0" relation="true"/>
  </sentence>
  <sentence id="s2187" text="Primary ciliary dyskinesia (motile cilium assembly) is clinically characterized by neonatal respiratory distress, chronic sinusitis, bronchiectasis and infertility, and situs inversus in 50% of the patients.">
    <entity charOffset="28-50" id="s2187.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="92-112" id="s2187.e1" ontology_id="HP_0002098" text="respiratory distress" type="HP"/>
    <pair e1="s2187.e0" e2="s2187.e1" id="s2187.p0" relation="true"/>
  </sentence>
  <sentence id="s2188" text="motile cilium assembly is a result of mutations in genes encoding proteins involved in ciliary function, and is primarily inherited in an autosomal recessive fashion.">
    <entity charOffset="0-22" id="s2188.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="138-157" id="s2188.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2188.e0" e2="s2188.e1" id="s2188.p0" relation="true"/>
  </sentence>
  <sentence id="s2189" text="Diagnosis of motile cilium assembly is often a challenging ion transmembrane transport due to its high clinical and genetic heterogeneities.">
    <entity charOffset="13-35" id="s2189.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="124-139" id="s2189.e1" ontology_id="HP_0001425" text="heterogeneities" type="HP"/>
    <pair e1="s2189.e0" e2="s2189.e1" id="s2189.p0" relation="false"/>
  </sentence>
  <sentence id="s2190" text="Diagnosis of motile cilium assembly is often a challenging ion transmembrane transport due to its high clinical and genetic heterogeneities.">
    <entity charOffset="59-86" id="s2190.e0" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <entity charOffset="124-139" id="s2190.e1" ontology_id="HP_0001425" text="heterogeneities" type="HP"/>
    <pair e1="s2190.e0" e2="s2190.e1" id="s2190.p0" relation="false"/>
  </sentence>
  <sentence id="s2191" text="Primary hyperoxaluria muscle organ development 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT.">
    <entity charOffset="8-21" id="s2191.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="22-46" id="s2191.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2191.e0" e2="s2191.e1" id="s2191.p0" relation="false"/>
  </sentence>
  <sentence id="s2192" text="L371P mutation in regulation of transcription by RNA polymerase II is a founder mutation in the Caucasus Jewish community and that homozygosity for this mutation is associated with infantile cerebral and cerebellar atrophy with poor myelination">
    <entity charOffset="18-66" id="s2192.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="204-222" id="s2192.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s2192.e0" e2="s2192.e1" id="s2192.p0" relation="false"/>
  </sentence>
  <sentence id="s2193" text="In the second example, Mdx mice, a model for Duchenne muscular dystrophy, were intravenously injected with AAV8-extracellular matrix organization.">
    <entity charOffset="54-72" id="s2193.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="112-145" id="s2193.e1" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <pair e1="s2193.e0" e2="s2193.e1" id="s2193.p0" relation="false"/>
  </sentence>
  <sentence id="s2194" text="Like other macular degenerations, pathogenesis within the retinal pigment epithelium (carbohydrate metabolic process) appears to contribute to the loss of photoreceptors from the central retina.">
    <entity charOffset="11-32" id="s2194.e0" ontology_id="HP_0000608" text="macular degenerations" type="HP"/>
    <entity charOffset="86-116" id="s2194.e1" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <pair e1="s2194.e0" e2="s2194.e1" id="s2194.p0" relation="false"/>
  </sentence>
  <sentence id="s2195" text="Biallelic pathogenic variant in morphogenesis of a polarized epithelium gene can cause Joubert syndrome-related disorders with oculomotor apraxia characteristics.">
    <entity charOffset="32-71" id="s2195.e0" ontology_id="GO_0001738" text="morphogenesis of a polarized epithelium" type="GO"/>
    <entity charOffset="127-145" id="s2195.e1" ontology_id="HP_0000657" text="oculomotor apraxia" type="HP"/>
    <pair e1="s2195.e0" e2="s2195.e1" id="s2195.p0" relation="true"/>
  </sentence>
  <sentence id="s2196" text="Therefore, we concluded that morphogenesis of a polarized epithelium c.3257A&amp;gt;G and muscle organ development c.914 A&amp;gt;G were potential causal variants in this strabismus pedigree.">
    <entity charOffset="29-68" id="s2196.e0" ontology_id="GO_0001738" text="morphogenesis of a polarized epithelium" type="GO"/>
    <entity charOffset="163-173" id="s2196.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s2196.e0" e2="s2196.e1" id="s2196.p0" relation="true"/>
  </sentence>
  <sentence id="s2197" text="Therefore, we concluded that morphogenesis of a polarized epithelium c.3257A&amp;gt;G and muscle organ development c.914 A&amp;gt;G were potential causal variants in this strabismus pedigree.">
    <entity charOffset="86-110" id="s2197.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="163-173" id="s2197.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s2197.e0" e2="s2197.e1" id="s2197.p0" relation="false"/>
  </sentence>
  <sentence id="s2198" text="Here, we show that invasive breast tumors exhibit significant spermatogenesis-ITH and that this heterogeneity is critical for tumor growth and metastasis.">
    <entity charOffset="35-41" id="s2198.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="62-77" id="s2198.e1" ontology_id="GO_0007283" text="spermatogenesis" type="GO"/>
    <pair e1="s2198.e0" e2="s2198.e1" id="s2198.p0" relation="false"/>
  </sentence>
  <sentence id="s2199" text="Here, we show that invasive breast tumors exhibit significant spermatogenesis-ITH and that this heterogeneity is critical for tumor growth and metastasis.">
    <entity charOffset="62-77" id="s2199.e0" ontology_id="GO_0007283" text="spermatogenesis" type="GO"/>
    <entity charOffset="96-109" id="s2199.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s2199.e0" e2="s2199.e1" id="s2199.p0" relation="false"/>
  </sentence>
  <sentence id="s2200" text="Here, we show that invasive breast tumors exhibit significant spermatogenesis-ITH and that this heterogeneity is critical for tumor growth and metastasis.">
    <entity charOffset="62-77" id="s2200.e0" ontology_id="GO_0007283" text="spermatogenesis" type="GO"/>
    <entity charOffset="126-131" id="s2200.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2200.e0" e2="s2200.e1" id="s2200.p0" relation="false"/>
  </sentence>
  <sentence id="s2201" text="Rather, we observed that, in ADAM23-heterotypic environments, ADAM23-negative cells promote tumor growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production ofregulation of myelination (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).">
    <entity charOffset="92-97" id="s2201.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="221-246" id="s2201.e1" ontology_id="GO_0031641" text="regulation of myelination" type="GO"/>
    <pair e1="s2201.e0" e2="s2201.e1" id="s2201.p0" relation="false"/>
  </sentence>
  <sentence id="s2202" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="176-196" id="s2202.e0" ontology_id="GO_0006862" text="nucleotide transport" type="GO"/>
    <entity charOffset="377-400" id="s2202.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2202.e0" e2="s2202.e1" id="s2202.p0" relation="true"/>
  </sentence>
  <sentence id="s2203" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="176-196" id="s2203.e0" ontology_id="GO_0006862" text="nucleotide transport" type="GO"/>
    <entity charOffset="441-459" id="s2203.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s2203.e0" e2="s2203.e1" id="s2203.p0" relation="false"/>
  </sentence>
  <sentence id="s2204" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="299-323" id="s2204.e0" ontology_id="GO_0097352" text="autophagosome maturation" type="GO"/>
    <entity charOffset="355-372" id="s2204.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s2204.e0" e2="s2204.e1" id="s2204.p0" relation="true"/>
  </sentence>
  <sentence id="s2205" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="299-323" id="s2205.e0" ontology_id="GO_0097352" text="autophagosome maturation" type="GO"/>
    <entity charOffset="441-459" id="s2205.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s2205.e0" e2="s2205.e1" id="s2205.p0" relation="false"/>
  </sentence>
  <sentence id="s2206" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="355-372" id="s2206.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="461-491" id="s2206.e1" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <pair e1="s2206.e0" e2="s2206.e1" id="s2206.p0" relation="true"/>
  </sentence>
  <sentence id="s2207" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="355-372" id="s2207.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="493-548" id="s2207.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2207.e0" e2="s2207.e1" id="s2207.p0" relation="true"/>
  </sentence>
  <sentence id="s2208" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="355-372" id="s2208.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="553-583" id="s2208.e1" ontology_id="GO_0097267" text="omega-hydroxylase P450 pathway" type="GO"/>
    <pair e1="s2208.e0" e2="s2208.e1" id="s2208.p0" relation="false"/>
  </sentence>
  <sentence id="s2209" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="355-372" id="s2209.e0" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <entity charOffset="601-656" id="s2209.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2209.e0" e2="s2209.e1" id="s2209.p0" relation="true"/>
  </sentence>
  <sentence id="s2210" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="377-400" id="s2210.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="461-491" id="s2210.e1" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <pair e1="s2210.e0" e2="s2210.e1" id="s2210.p0" relation="true"/>
  </sentence>
  <sentence id="s2211" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="377-400" id="s2211.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="493-548" id="s2211.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2211.e0" e2="s2211.e1" id="s2211.p0" relation="true"/>
  </sentence>
  <sentence id="s2212" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="377-400" id="s2212.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="553-583" id="s2212.e1" ontology_id="GO_0097267" text="omega-hydroxylase P450 pathway" type="GO"/>
    <pair e1="s2212.e0" e2="s2212.e1" id="s2212.p0" relation="true"/>
  </sentence>
  <sentence id="s2213" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="377-400" id="s2213.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="601-656" id="s2213.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2213.e0" e2="s2213.e1" id="s2213.p0" relation="true"/>
  </sentence>
  <sentence id="s2214" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="377-400" id="s2214.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="661-670" id="s2214.e1" ontology_id="GO_0006914" text="autophagy" type="GO"/>
    <pair e1="s2214.e0" e2="s2214.e1" id="s2214.p0" relation="true"/>
  </sentence>
  <sentence id="s2215" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="441-459" id="s2215.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="461-491" id="s2215.e1" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <pair e1="s2215.e0" e2="s2215.e1" id="s2215.p0" relation="true"/>
  </sentence>
  <sentence id="s2216" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="441-459" id="s2216.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="493-548" id="s2216.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2216.e0" e2="s2216.e1" id="s2216.p0" relation="true"/>
  </sentence>
  <sentence id="s2217" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="441-459" id="s2217.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="601-656" id="s2217.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2217.e0" e2="s2217.e1" id="s2217.p0" relation="true"/>
  </sentence>
  <sentence id="s2218" text="Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.">
    <entity charOffset="441-459" id="s2218.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="661-670" id="s2218.e1" ontology_id="GO_0006914" text="autophagy" type="GO"/>
    <pair e1="s2218.e0" e2="s2218.e1" id="s2218.p0" relation="true"/>
  </sentence>
  <sentence id="s2219" text="Sushi repeat-containing protein X-linked 2 (regulation of phosphorylation), a novel chondroitin sulfate proteoglycan, is overexpressed in human cancer.">
    <entity charOffset="44-73" id="s2219.e0" ontology_id="GO_0042325" text="regulation of phosphorylation" type="GO"/>
    <entity charOffset="144-150" id="s2219.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2219.e0" e2="s2219.e1" id="s2219.p0" relation="false"/>
  </sentence>
  <sentence id="s2220" text="While, the clinical significance and biological function of regulation of phosphorylation remain rarely known in hepatocellular carcinoma (HCC).">
    <entity charOffset="60-89" id="s2220.e0" ontology_id="GO_0042325" text="regulation of phosphorylation" type="GO"/>
    <entity charOffset="113-137" id="s2220.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2220.e0" e2="s2220.e1" id="s2220.p0" relation="false"/>
  </sentence>
  <sentence id="s2221" text="The positive expression of regulation of phosphorylation was prominently correlated with venous infiltration and advanced TNM tumor stage.">
    <entity charOffset="27-56" id="s2221.e0" ontology_id="GO_0042325" text="regulation of phosphorylation" type="GO"/>
    <entity charOffset="126-131" id="s2221.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2221.e0" e2="s2221.e1" id="s2221.p0" relation="false"/>
  </sentence>
  <sentence id="s2222" text="By exome sequencing, we identified three different bi-allelic truncating mutations in biological_process in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.">
    <entity charOffset="86-104" id="s2222.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="214-226" id="s2222.e1" ontology_id="HP_0001943" text="hypoglycemia" type="HP"/>
    <pair e1="s2222.e0" e2="s2222.e1" id="s2222.p0" relation="true"/>
  </sentence>
  <sentence id="s2223" text="By exome sequencing, we identified three different bi-allelic truncating mutations in biological_process in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.">
    <entity charOffset="86-104" id="s2223.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="228-242" id="s2223.e1" ontology_id="HP_0003201" text="rhabdomyolysis" type="HP"/>
    <pair e1="s2223.e0" e2="s2223.e1" id="s2223.p0" relation="true"/>
  </sentence>
  <sentence id="s2224" text="Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for cilium assembly as a ciliopathy-associated gene.">
    <entity charOffset="50-67" id="s2224.e0" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <entity charOffset="182-197" id="s2224.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s2224.e0" e2="s2224.e1" id="s2224.p0" relation="true"/>
  </sentence>
  <sentence id="s2225" text="Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for cilium assembly as a ciliopathy-associated gene.">
    <entity charOffset="69-77" id="s2225.e0" ontology_id="HP_0000589" text="coloboma" type="HP"/>
    <entity charOffset="182-197" id="s2225.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s2225.e0" e2="s2225.e1" id="s2225.p0" relation="true"/>
  </sentence>
  <sentence id="s2226" text="She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included osteoblast differentiation3, protein phosphorylation, and CCM2.">
    <entity charOffset="15-27" id="s2226.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="200-226" id="s2226.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s2226.e0" e2="s2226.e1" id="s2226.p0" relation="false"/>
  </sentence>
  <sentence id="s2227" text="She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included osteoblast differentiation3, protein phosphorylation, and CCM2.">
    <entity charOffset="15-27" id="s2227.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="229-252" id="s2227.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s2227.e0" e2="s2227.e1" id="s2227.p0" relation="false"/>
  </sentence>
  <sentence id="s2228" text="She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included osteoblast differentiation3, protein phosphorylation, and CCM2.">
    <entity charOffset="66-85" id="s2228.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="229-252" id="s2228.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s2228.e0" e2="s2228.e1" id="s2228.p0" relation="false"/>
  </sentence>
  <sentence id="s2229" text="We summarize the phenotypic extent of osteoblast differentiation2/3 syndromes in the literature and determine that these 2 syndromes manifest opposite features to a certain extent, such as midface hypoplasia or macrocephaly, and anterior or posterior side of polydactyly.">
    <entity charOffset="38-64" id="s2229.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="211-223" id="s2229.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s2229.e0" e2="s2229.e1" id="s2229.p0" relation="false"/>
  </sentence>
  <sentence id="s2230" text="We summarize the phenotypic extent of osteoblast differentiation2/3 syndromes in the literature and determine that these 2 syndromes manifest opposite features to a certain extent, such as midface hypoplasia or macrocephaly, and anterior or posterior side of polydactyly.">
    <entity charOffset="38-64" id="s2230.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="259-270" id="s2230.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s2230.e0" e2="s2230.e1" id="s2230.p0" relation="true"/>
  </sentence>
  <sentence id="s2231" text="The present study aimed to explore regulation of small GTPase mediated signal transduction expression in cervical cancer and the possible function in tumor progression.">
    <entity charOffset="35-90" id="s2231.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="114-120" id="s2231.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2231.e0" e2="s2231.e1" id="s2231.p0" relation="false"/>
  </sentence>
  <sentence id="s2232" text="regulation of small GTPase mediated signal transduction expression in cervical cancer cell lines was assessed by RT-PCR and Western blotting.">
    <entity charOffset="0-55" id="s2232.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="79-85" id="s2232.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2232.e0" e2="s2232.e1" id="s2232.p0" relation="false"/>
  </sentence>
  <sentence id="s2233" text="regulation of small GTPase mediated signal transduction expression in cervical cancer tissues and normal tissues was assessed by immunohistochemistry.">
    <entity charOffset="0-55" id="s2233.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="79-85" id="s2233.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2233.e0" e2="s2233.e1" id="s2233.p0" relation="false"/>
  </sentence>
  <sentence id="s2234" text="Here, we showed lower expression of regulation of small GTPase mediated signal transduction in cell lines and human cervical cancer samples.">
    <entity charOffset="36-91" id="s2234.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="125-131" id="s2234.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2234.e0" e2="s2234.e1" id="s2234.p0" relation="false"/>
  </sentence>
  <sentence id="s2235" text="Furthermore, the phosphorylation of positive regulation of protein phosphorylation was enhanced in regulation of small GTPase mediated signal transduction silencing cervical cancer cells.">
    <entity charOffset="36-82" id="s2235.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="174-180" id="s2235.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2235.e0" e2="s2235.e1" id="s2235.p0" relation="true"/>
  </sentence>
  <sentence id="s2236" text="Furthermore, the phosphorylation of positive regulation of protein phosphorylation was enhanced in regulation of small GTPase mediated signal transduction silencing cervical cancer cells.">
    <entity charOffset="99-154" id="s2236.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="174-180" id="s2236.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2236.e0" e2="s2236.e1" id="s2236.p0" relation="false"/>
  </sentence>
  <sentence id="s2237" text="These results reveal that regulation of small GTPase mediated signal transduction functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/positive regulation of protein phosphorylation signaling and up-regulation of P21 and P27 expression">
    <entity charOffset="26-81" id="s2237.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="97-102" id="s2237.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2237.e0" e2="s2237.e1" id="s2237.p0" relation="false"/>
  </sentence>
  <sentence id="s2238" text="These results reveal that regulation of small GTPase mediated signal transduction functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/positive regulation of protein phosphorylation signaling and up-regulation of P21 and P27 expression">
    <entity charOffset="26-81" id="s2238.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="126-132" id="s2238.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2238.e0" e2="s2238.e1" id="s2238.p0" relation="false"/>
  </sentence>
  <sentence id="s2239" text="These results reveal that regulation of small GTPase mediated signal transduction functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/positive regulation of protein phosphorylation signaling and up-regulation of P21 and P27 expression">
    <entity charOffset="97-102" id="s2239.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="207-253" id="s2239.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s2239.e0" e2="s2239.e1" id="s2239.p0" relation="true"/>
  </sentence>
  <sentence id="s2240" text="negative regulation of NF-kappaB transcription factor activity(-/-) mice rapidly develop decompensated cardiac hypertrophy, and following severe pressure overload all Erbin(-/-) mice died from heart failure.">
    <entity charOffset="0-62" id="s2240.e0" ontology_id="GO_0032088" text="negative regulation of NF-kappaB transcription factor activity" type="GO"/>
    <entity charOffset="193-206" id="s2240.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s2240.e0" e2="s2240.e1" id="s2240.p0" relation="false"/>
  </sentence>
  <sentence id="s2241" text="Although humans with X-linked hypophosphatemia (proteolysis) and the proteolysis mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.">
    <entity charOffset="30-46" id="s2241.e0" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <entity charOffset="69-80" id="s2241.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s2241.e0" e2="s2241.e1" id="s2241.p0" relation="true"/>
  </sentence>
  <sentence id="s2242" text="Although humans with X-linked hypophosphatemia (proteolysis) and the proteolysis mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.">
    <entity charOffset="48-59" id="s2242.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="134-160" id="s2242.e1" ontology_id="HP_0002758" text="degenerative joint disease" type="HP"/>
    <pair e1="s2242.e0" e2="s2242.e1" id="s2242.p0" relation="true"/>
  </sentence>
  <sentence id="s2243" text="Although humans with X-linked hypophosphatemia (proteolysis) and the proteolysis mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.">
    <entity charOffset="69-80" id="s2243.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="134-160" id="s2243.e1" ontology_id="HP_0002758" text="degenerative joint disease" type="HP"/>
    <pair e1="s2243.e0" e2="s2243.e1" id="s2243.p0" relation="true"/>
  </sentence>
  <sentence id="s2244" text="UCA1 knockdown significantly inhibited biological_process cell viability, colony formation and the bromodomain containing 4 (positive regulation of transcription elongation from RNA polymerase II promoter) expression level invitro, and retarded PTC tumor growth invivo.">
    <entity charOffset="39-57" id="s2244.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="250-255" id="s2244.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2244.e0" e2="s2244.e1" id="s2244.p0" relation="false"/>
  </sentence>
  <sentence id="s2245" text="UCA1 knockdown significantly inhibited biological_process cell viability, colony formation and the bromodomain containing 4 (positive regulation of transcription elongation from RNA polymerase II promoter) expression level invitro, and retarded PTC tumor growth invivo.">
    <entity charOffset="125-204" id="s2245.e0" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="250-255" id="s2245.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2245.e0" e2="s2245.e1" id="s2245.p0" relation="false"/>
  </sentence>
  <sentence id="s2246" text="In the previous study, microRNA (protein polyubiquitination)204 inhibited thyroid cancer progression and was regulated by UCA1 in other types of cancer.">
    <entity charOffset="33-59" id="s2246.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="83-89" id="s2246.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2246.e0" e2="s2246.e1" id="s2246.p0" relation="false"/>
  </sentence>
  <sentence id="s2247" text="The activation of MAPK activity (positive regulation of cytosolic calcium ion concentration-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.">
    <entity charOffset="4-31" id="s2247.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="139-144" id="s2247.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2247.e0" e2="s2247.e1" id="s2247.p0" relation="true"/>
  </sentence>
  <sentence id="s2248" text="The activation of MAPK activity (positive regulation of cytosolic calcium ion concentration-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.">
    <entity charOffset="33-91" id="s2248.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="139-144" id="s2248.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2248.e0" e2="s2248.e1" id="s2248.p0" relation="false"/>
  </sentence>
  <sentence id="s2249" text="However, correlation between CR-1 and prostate cancer (mitochondrial transport) remains still unclear.">
    <entity charOffset="47-53" id="s2249.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="55-78" id="s2249.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s2249.e0" e2="s2249.e1" id="s2249.p0" relation="false"/>
  </sentence>
  <sentence id="s2250" text="Additionally, our results displayed that Licl had antitumor activity against positive regulation of cell migration-3 through the inhibition of Wnt/-catenin pathway.">
    <entity charOffset="54-59" id="s2250.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="77-114" id="s2250.e1" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <pair e1="s2250.e0" e2="s2250.e1" id="s2250.p0" relation="false"/>
  </sentence>
  <sentence id="s2251" text="The aim of this study was to examine the mitotic spindle organization expression and its role in tumor progression, invasion and metastasis in squamous cell carcinoma of the oral tongue (SCCOT).">
    <entity charOffset="41-69" id="s2251.e0" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <entity charOffset="97-102" id="s2251.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2251.e0" e2="s2251.e1" id="s2251.p0" relation="false"/>
  </sentence>
  <sentence id="s2252" text="The immunohistochemistry showed that mitotic spindle organization expression was stronger in oral tongue cancer tissues than in paired adjacent tissues (P&amp;lt;0.01), and the higher expression of Kif2a was also significantly associated with lymph node metastasis (P&amp;lt;0.01), tumor clinical stage (P&amp;lt;0.01).">
    <entity charOffset="37-65" id="s2252.e0" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <entity charOffset="274-279" id="s2252.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2252.e0" e2="s2252.e1" id="s2252.p0" relation="false"/>
  </sentence>
  <sentence id="s2253" text="The immunohistochemistry showed that mitotic spindle organization expression was stronger in oral tongue cancer tissues than in paired adjacent tissues (P&amp;lt;0.01), and the higher expression of Kif2a was also significantly associated with lymph node metastasis (P&amp;lt;0.01), tumor clinical stage (P&amp;lt;0.01).">
    <entity charOffset="37-65" id="s2253.e0" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <entity charOffset="105-111" id="s2253.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2253.e0" e2="s2253.e1" id="s2253.p0" relation="false"/>
  </sentence>
  <sentence id="s2254" text="negative regulation of axon extension-A and Nogo-C are potent Nogos that are predominantly expressed in the central nervous system.">
    <entity charOffset="0-37" id="s2254.e0" ontology_id="GO_0030517" text="negative regulation of axon extension" type="GO"/>
    <entity charOffset="108-115" id="s2254.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s2254.e0" e2="s2254.e1" id="s2254.p0" relation="false"/>
  </sentence>
  <sentence id="s2255" text="Downregulation of Gli1, smoothened signaling pathway, negative regulation of transcription by RNA polymerase II and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.">
    <entity charOffset="24-52" id="s2255.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="161-176" id="s2255.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s2255.e0" e2="s2255.e1" id="s2255.p0" relation="false"/>
  </sentence>
  <sentence id="s2256" text="Downregulation of Gli1, smoothened signaling pathway, negative regulation of transcription by RNA polymerase II and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.">
    <entity charOffset="54-111" id="s2256.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="161-176" id="s2256.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s2256.e0" e2="s2256.e1" id="s2256.p0" relation="false"/>
  </sentence>
  <sentence id="s2257" text="Ectopic expression of negative regulation of smoothened signaling pathway in two choriocarcinoma cell lines JAR and JEG-3 led to a decrease in cell growth and increase in apoptosis demonstrated by MTT and TUNEL assays, respectively.">
    <entity charOffset="22-73" id="s2257.e0" ontology_id="GO_0045879" text="negative regulation of smoothened signaling pathway" type="GO"/>
    <entity charOffset="81-96" id="s2257.e1" ontology_id="HP_0100768" text="choriocarcinoma" type="HP"/>
    <pair e1="s2257.e0" e2="s2257.e1" id="s2257.p0" relation="false"/>
  </sentence>
  <sentence id="s2258" text="High-density lipoprotein (HDL) particles have experienced a turbulent decade of falling from grace with widespread demotion from the most-sought-after thtranscription by RNA polymerase IIpeutic target to reverse cardiovascular disease (CVD), to mere biomarker status.">
    <entity charOffset="153-187" id="s2258.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="212-234" id="s2258.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s2258.e0" e2="s2258.e1" id="s2258.p0" relation="true"/>
  </sentence>
  <sentence id="s2259" text="Individuals with smoothened signaling pathway deletion show symptoms of ADHD, sleep disruption, hypotonia, aggression, ASD, and ID.">
    <entity charOffset="17-45" id="s2259.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="107-117" id="s2259.e1" ontology_id="HP_0000718" text="aggression" type="HP"/>
    <pair e1="s2259.e0" e2="s2259.e1" id="s2259.p0" relation="false"/>
  </sentence>
  <sentence id="s2260" text="protein import into nucleus-restricted deletion of smoothened signaling pathway leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.">
    <entity charOffset="0-27" id="s2260.e0" ontology_id="GO_0006606" text="protein import into nucleus" type="GO"/>
    <entity charOffset="112-125" id="s2260.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s2260.e0" e2="s2260.e1" id="s2260.p0" relation="false"/>
  </sentence>
  <sentence id="s2261" text="protein import into nucleus-restricted deletion of smoothened signaling pathway leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.">
    <entity charOffset="51-79" id="s2261.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="112-125" id="s2261.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s2261.e0" e2="s2261.e1" id="s2261.p0" relation="false"/>
  </sentence>
  <sentence id="s2262" text="A growing number of studies has suggested that long non-coding RNAs (lncRNAs) exert essential roles in the development and progression of hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="138-162" id="s2262.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="164-200" id="s2262.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s2262.e0" e2="s2262.e1" id="s2262.p0" relation="false"/>
  </sentence>
  <sentence id="s2263" text="myelination-AS1 knockdown could inhibit the proliferation of phosphatidylinositol phosphorylation cells and attenuate the development of HCC tumor invivo.">
    <entity charOffset="0-11" id="s2263.e0" ontology_id="GO_0042552" text="myelination" type="GO"/>
    <entity charOffset="141-146" id="s2263.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2263.e0" e2="s2263.e1" id="s2263.p0" relation="false"/>
  </sentence>
  <sentence id="s2264" text="myelination-AS1 knockdown could inhibit the proliferation of phosphatidylinositol phosphorylation cells and attenuate the development of HCC tumor invivo.">
    <entity charOffset="61-97" id="s2264.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="141-146" id="s2264.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2264.e0" e2="s2264.e1" id="s2264.p0" relation="false"/>
  </sentence>
  <sentence id="s2265" text="In this study we present the first two cases from India of a rare inborn error of metabolism manifesting as dystonia and 3-methylglutaconic aciduria and a Leigh like lesions in the brain MRI associated with intracellular cholesterol transport gene mutation, a phenotype characteristic of MEGDEL syndrome.">
    <entity charOffset="108-116" id="s2265.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="207-242" id="s2265.e1" ontology_id="GO_0032367" text="intracellular cholesterol transport" type="GO"/>
    <pair e1="s2265.e0" e2="s2265.e1" id="s2265.p0" relation="true"/>
  </sentence>
  <sentence id="s2266" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit MAPK cascade of COPI.">
    <entity charOffset="92-111" id="s2266.e0" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <entity charOffset="260-291" id="s2266.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s2266.e0" e2="s2266.e1" id="s2266.p0" relation="false"/>
  </sentence>
  <sentence id="s2267" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit MAPK cascade of COPI.">
    <entity charOffset="120-132" id="s2267.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="260-291" id="s2267.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s2267.e0" e2="s2267.e1" id="s2267.p0" relation="true"/>
  </sentence>
  <sentence id="s2268" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit MAPK cascade of COPI.">
    <entity charOffset="120-132" id="s2268.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="328-340" id="s2268.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s2268.e0" e2="s2268.e1" id="s2268.p0" relation="false"/>
  </sentence>
  <sentence id="s2269" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit MAPK cascade of COPI.">
    <entity charOffset="134-155" id="s2269.e0" ontology_id="HP_0008905" text="rhizomelic shortening" type="HP"/>
    <entity charOffset="260-291" id="s2269.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s2269.e0" e2="s2269.e1" id="s2269.p0" relation="true"/>
  </sentence>
  <sentence id="s2270" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit MAPK cascade of COPI.">
    <entity charOffset="185-189" id="s2270.e0" ontology_id="HP_0012825" text="mild" type="HP"/>
    <entity charOffset="260-291" id="s2270.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s2270.e0" e2="s2270.e1" id="s2270.p0" relation="false"/>
  </sentence>
  <sentence id="s2271" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit MAPK cascade of COPI.">
    <entity charOffset="185-189" id="s2271.e0" ontology_id="HP_0012825" text="mild" type="HP"/>
    <entity charOffset="328-340" id="s2271.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s2271.e0" e2="s2271.e1" id="s2271.p0" relation="false"/>
  </sentence>
  <sentence id="s2272" text="In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit MAPK cascade of COPI.">
    <entity charOffset="190-209" id="s2272.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="260-291" id="s2272.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s2272.e0" e2="s2272.e1" id="s2272.p0" relation="false"/>
  </sentence>
  <sentence id="s2273" text="As a potential target for cancer treatment, the negative regulation of transcription by RNA polymerase II high expresses abnormally in a variety of solid tumors and hematological malignancies in humans.">
    <entity charOffset="48-105" id="s2273.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="154-160" id="s2273.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2273.e0" e2="s2273.e1" id="s2273.p0" relation="true"/>
  </sentence>
  <sentence id="s2274" text="Furthermore, we identified the activity of nitric oxide synthase 2 (NOS2, also known as inositol phosphate metabolic process) originating from the glioma cells as a driving stimulus in the control of microglial caspase-3 activity.">
    <entity charOffset="88-124" id="s2274.e0" ontology_id="GO_0043647" text="inositol phosphate metabolic process" type="GO"/>
    <entity charOffset="147-153" id="s2274.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2274.e0" e2="s2274.e1" id="s2274.p0" relation="false"/>
  </sentence>
  <sentence id="s2275" text="Repression of glioma negative regulation of translation expression in vivo led to a reduction in both microglia recruitment and tumor expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth.">
    <entity charOffset="14-20" id="s2275.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="21-55" id="s2275.e1" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <pair e1="s2275.e0" e2="s2275.e1" id="s2275.p0" relation="false"/>
  </sentence>
  <sentence id="s2276" text="Repression of glioma negative regulation of translation expression in vivo led to a reduction in both microglia recruitment and tumor expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth.">
    <entity charOffset="21-55" id="s2276.e0" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <entity charOffset="128-133" id="s2276.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2276.e0" e2="s2276.e1" id="s2276.p0" relation="false"/>
  </sentence>
  <sentence id="s2277" text="Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein histone H3-K4 methylation is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells">
    <entity charOffset="129-154" id="s2277.e0" ontology_id="GO_0051568" text="histone H3-K4 methylation" type="GO"/>
    <entity charOffset="187-192" id="s2277.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2277.e0" e2="s2277.e1" id="s2277.p0" relation="false"/>
  </sentence>
  <sentence id="s2278" text="Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein histone H3-K4 methylation is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells">
    <entity charOffset="129-154" id="s2278.e0" ontology_id="GO_0051568" text="histone H3-K4 methylation" type="GO"/>
    <entity charOffset="227-233" id="s2278.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2278.e0" e2="s2278.e1" id="s2278.p0" relation="false"/>
  </sentence>
  <sentence id="s2279" text="Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ nucleotide-excision repair]) and subsequent CNS tumors in survivors of childhood cancer.">
    <entity charOffset="213-239" id="s2279.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="294-300" id="s2279.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2279.e0" e2="s2279.e1" id="s2279.p0" relation="false"/>
  </sentence>
  <sentence id="s2280" text="Including genetic variants in a Final Model containing age at primary cancer, multicellular organism development, and cranial radiation therapy dose yielded an area under the curve of 0.81 (95% CI, 0.76 to 0.86), which was superior ( P = .002) to the Clinical Model (area under the curve, 0.73; 95% CI, 0.66 to 0.80).">
    <entity charOffset="70-76" id="s2280.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="78-112" id="s2280.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s2280.e0" e2="s2280.e1" id="s2280.p0" relation="false"/>
  </sentence>
  <sentence id="s2281" text="Although the pathophysiological mechanisms that underlie this entity remain unknown, the nucleosome disassembly that epilepsy can affect cardiac function is not surprising.">
    <entity charOffset="89-111" id="s2281.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="117-125" id="s2281.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2281.e0" e2="s2281.e1" id="s2281.p0" relation="false"/>
  </sentence>
  <sentence id="s2282" text="We included 7 consecutive patients with LP with typical intracranial calcifications out of 16 patients with positive regulation of endothelial cell proliferation mutations and investigated the semiologic features, ictal and interictal EEG findings, and long-term prognosis of epilepsy in this genodermatosis.">
    <entity charOffset="108-161" id="s2282.e0" ontology_id="GO_0001938" text="positive regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="276-284" id="s2282.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2282.e0" e2="s2282.e1" id="s2282.p0" relation="true"/>
  </sentence>
  <sentence id="s2283" text="Four of them had seizures (57.1%), and focal seizures with motionless histone monoubiquitination were the most common seizure phenotype, originating from bilateral mesial temporal areas, but interictal spikes were scant.">
    <entity charOffset="70-96" id="s2283.e0" ontology_id="GO_0010390" text="histone monoubiquitination" type="GO"/>
    <entity charOffset="118-125" id="s2283.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s2283.e0" e2="s2283.e1" id="s2283.p0" relation="false"/>
  </sentence>
  <sentence id="s2284" text="Four of them had seizures (57.1%), and focal seizures with motionless histone monoubiquitination were the most common seizure phenotype, originating from bilateral mesial temporal areas, but interictal spikes were scant.">
    <entity charOffset="70-96" id="s2284.e0" ontology_id="GO_0010390" text="histone monoubiquitination" type="GO"/>
    <entity charOffset="154-163" id="s2284.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s2284.e0" e2="s2284.e1" id="s2284.p0" relation="false"/>
  </sentence>
  <sentence id="s2285" text="The positive regulation of cell-matrix adhesion mass and obesity-associated (DNA dealkylation involved in DNA repair) gene is tightly related to body weight and fat mass, and plays a pivotal role in regulating lipid accumulation in hepatocytes.">
    <entity charOffset="4-47" id="s2285.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="57-64" id="s2285.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2285.e0" e2="s2285.e1" id="s2285.p0" relation="false"/>
  </sentence>
  <sentence id="s2286" text="The positive regulation of cell-matrix adhesion mass and obesity-associated (DNA dealkylation involved in DNA repair) gene is tightly related to body weight and fat mass, and plays a pivotal role in regulating lipid accumulation in hepatocytes.">
    <entity charOffset="57-64" id="s2286.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="77-116" id="s2286.e1" ontology_id="GO_0006307" text="DNA dealkylation involved in DNA repair" type="GO"/>
    <pair e1="s2286.e0" e2="s2286.e1" id="s2286.p0" relation="true"/>
  </sentence>
  <sentence id="s2287" text="Gabapentin (fatty acid beta-oxidation; Neurontin) and pregabalin (PGB; Lyrica, S-(+)-3-isobutylgaba) are used clinically to treat several disorders associated with excessive or inappropriate excitability, including epilepsy; pain from diabetic neuropathy, postherpetic neuralgia, and fibromyalgia; and generalized anxiety disorder.">
    <entity charOffset="12-37" id="s2287.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="215-223" id="s2287.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2287.e0" e2="s2287.e1" id="s2287.p0" relation="true"/>
  </sentence>
  <sentence id="s2288" text="Gabapentin (fatty acid beta-oxidation; Neurontin) and pregabalin (PGB; Lyrica, S-(+)-3-isobutylgaba) are used clinically to treat several disorders associated with excessive or inappropriate excitability, including epilepsy; pain from diabetic neuropathy, postherpetic neuralgia, and fibromyalgia; and generalized anxiety disorder.">
    <entity charOffset="12-37" id="s2288.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="244-254" id="s2288.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2288.e0" e2="s2288.e1" id="s2288.p0" relation="true"/>
  </sentence>
  <sentence id="s2289" text="In a family with post-lingual progressive non-syndromic deafness, whole-exome sequencing of genomic DNA from five hearing-impaired relatives revealed a single variant, p.Gly488Glu (rs145970949:G&amp;gt;A) in protein autophosphorylation, co-segregating with HL as an autosomal dominant trait.">
    <entity charOffset="56-64" id="s2289.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="204-231" id="s2289.e1" ontology_id="GO_0046777" text="protein autophosphorylation" type="GO"/>
    <pair e1="s2289.e0" e2="s2289.e1" id="s2289.p0" relation="true"/>
  </sentence>
  <sentence id="s2290" text="regulation of translation has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, mandibular hypoplasia and microtia.">
    <entity charOffset="0-25" id="s2290.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="136-152" id="s2290.e1" ontology_id="HP_0000272" text="malar hypoplasia" type="HP"/>
    <pair e1="s2290.e0" e2="s2290.e1" id="s2290.p0" relation="true"/>
  </sentence>
  <sentence id="s2291" text="regulation of translation has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, mandibular hypoplasia and microtia.">
    <entity charOffset="0-25" id="s2291.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="154-175" id="s2291.e1" ontology_id="HP_0000347" text="mandibular hypoplasia" type="HP"/>
    <pair e1="s2291.e0" e2="s2291.e1" id="s2291.p0" relation="true"/>
  </sentence>
  <sentence id="s2292" text="We report a pair of siblings carrying a homozygous missense mutation p.P333L in cellular response to epidermal growth factor stimulus2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.">
    <entity charOffset="80-133" id="s2292.e0" ontology_id="GO_0071364" text="cellular response to epidermal growth factor stimulus" type="GO"/>
    <entity charOffset="177-194" id="s2292.e1" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <pair e1="s2292.e0" e2="s2292.e1" id="s2292.p0" relation="false"/>
  </sentence>
  <sentence id="s2293" text="We report a pair of siblings carrying a homozygous missense mutation p.P333L in cellular response to epidermal growth factor stimulus2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.">
    <entity charOffset="80-133" id="s2293.e0" ontology_id="GO_0071364" text="cellular response to epidermal growth factor stimulus" type="GO"/>
    <entity charOffset="223-231" id="s2293.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2293.e0" e2="s2293.e1" id="s2293.p0" relation="false"/>
  </sentence>
  <sentence id="s2294" text="cellular response to epidermal growth factor stimulus2-deficient zebrafish had skeletal muscle weakness, cardiac failure and small heads.">
    <entity charOffset="0-53" id="s2294.e0" ontology_id="GO_0071364" text="cellular response to epidermal growth factor stimulus" type="GO"/>
    <entity charOffset="105-120" id="s2294.e1" ontology_id="HP_0001635" text="cardiac failure" type="HP"/>
    <pair e1="s2294.e0" e2="s2294.e1" id="s2294.p0" relation="false"/>
  </sentence>
  <sentence id="s2295" text="This rare condition is characterized by bilateral choanal atresia, hearing loss, cleft nuclear-transcribed mRNA catabolic process, nonsense-mediated decay and/or palate, and other craniofacial dysmorphisms.">
    <entity charOffset="40-49" id="s2295.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="87-154" id="s2295.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s2295.e0" e2="s2295.e1" id="s2295.p0" relation="false"/>
  </sentence>
  <sentence id="s2296" text="This rare condition is characterized by bilateral choanal atresia, hearing loss, cleft nuclear-transcribed mRNA catabolic process, nonsense-mediated decay and/or palate, and other craniofacial dysmorphisms.">
    <entity charOffset="50-65" id="s2296.e0" ontology_id="HP_0000453" text="choanal atresia" type="HP"/>
    <entity charOffset="87-154" id="s2296.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s2296.e0" e2="s2296.e1" id="s2296.p0" relation="false"/>
  </sentence>
  <sentence id="s2297" text="This rare condition is characterized by bilateral choanal atresia, hearing loss, cleft nuclear-transcribed mRNA catabolic process, nonsense-mediated decay and/or palate, and other craniofacial dysmorphisms.">
    <entity charOffset="67-79" id="s2297.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="87-154" id="s2297.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s2297.e0" e2="s2297.e1" id="s2297.p0" relation="false"/>
  </sentence>
  <sentence id="s2298" text="Thirteen patients with G protein-coupled receptor signaling pathway-positive tumors were enrolled.">
    <entity charOffset="23-67" id="s2298.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="77-83" id="s2298.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2298.e0" e2="s2298.e1" id="s2298.p0" relation="false"/>
  </sentence>
  <sentence id="s2299" text="Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (positive regulation of apoptotic process) or the response to cytokine inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.">
    <entity charOffset="60-66" id="s2299.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="132-172" id="s2299.e1" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <pair e1="s2299.e0" e2="s2299.e1" id="s2299.p0" relation="false"/>
  </sentence>
  <sentence id="s2300" text="Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (positive regulation of apoptotic process) or the response to cytokine inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.">
    <entity charOffset="60-66" id="s2300.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="181-201" id="s2300.e1" ontology_id="GO_0034097" text="response to cytokine" type="GO"/>
    <pair e1="s2300.e0" e2="s2300.e1" id="s2300.p0" relation="false"/>
  </sentence>
  <sentence id="s2301" text="Additionally, negative regulation of transcription by RNA polymerase II was demonstrated to drive OVAAL transcription, indicating a positive feedback loop between c-Myc and OVAAL in controlling tumor growth.">
    <entity charOffset="14-71" id="s2301.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="194-199" id="s2301.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2301.e0" e2="s2301.e1" id="s2301.p0" relation="true"/>
  </sentence>
  <sentence id="s2302" text="Taken together, these results reveal that OVAAL contributes to the survival of cancer cells through dual mechanisms controlling RAF/MEK/ERK signaling and proteasome regulatory particle assembly-mediated cell senescence">
    <entity charOffset="79-85" id="s2302.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="154-193" id="s2302.e1" ontology_id="GO_0070682" text="proteasome regulatory particle assembly" type="GO"/>
    <pair e1="s2302.e0" e2="s2302.e1" id="s2302.p0" relation="false"/>
  </sentence>
  <sentence id="s2303" text="This review focuses on the molecular basis of the pathogenesis of cardiac abnormality due to negative regulation of protein kinase activity mutation and will provide current overviews of the mechanism of glycogen regulation by AMPK.">
    <entity charOffset="66-85" id="s2303.e0" ontology_id="HP_0001627" text="cardiac abnormality" type="HP"/>
    <entity charOffset="93-139" id="s2303.e1" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <pair e1="s2303.e0" e2="s2303.e1" id="s2303.p0" relation="true"/>
  </sentence>
  <sentence id="s2304" text="Mutations in the gene encoding CCT (&lt;i&gt;positive regulation of cell migrationYT1A&lt;/i&gt;) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy.">
    <entity charOffset="40-77" id="s2304.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="131-144" id="s2304.e1" ontology_id="HP_0009125" text="lipodystrophy" type="HP"/>
    <pair e1="s2304.e0" e2="s2304.e1" id="s2304.p0" relation="false"/>
  </sentence>
  <sentence id="s2305" text="Mutations in the gene encoding CCT (&lt;i&gt;positive regulation of cell migrationYT1A&lt;/i&gt;) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy.">
    <entity charOffset="40-77" id="s2305.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="146-175" id="s2305.e1" ontology_id="HP_0002657" text="spondylometaphyseal dysplasia" type="HP"/>
    <pair e1="s2305.e0" e2="s2305.e1" id="s2305.p0" relation="false"/>
  </sentence>
  <sentence id="s2306" text="The nonsense mutation and loss of protein of GTP metabolic process has been associated with neural tube defect in epidermis development and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.">
    <entity charOffset="45-66" id="s2306.e0" ontology_id="GO_0046039" text="GTP metabolic process" type="GO"/>
    <entity charOffset="92-110" id="s2306.e1" ontology_id="HP_0045005" text="neural tube defect" type="HP"/>
    <pair e1="s2306.e0" e2="s2306.e1" id="s2306.p0" relation="true"/>
  </sentence>
  <sentence id="s2307" text="The nonsense mutation and loss of protein of GTP metabolic process has been associated with neural tube defect in epidermis development and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.">
    <entity charOffset="45-66" id="s2307.e0" ontology_id="GO_0046039" text="GTP metabolic process" type="GO"/>
    <entity charOffset="244-249" id="s2307.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2307.e0" e2="s2307.e1" id="s2307.p0" relation="false"/>
  </sentence>
  <sentence id="s2308" text="The nonsense mutation and loss of protein of GTP metabolic process has been associated with neural tube defect in epidermis development and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.">
    <entity charOffset="92-110" id="s2308.e0" ontology_id="HP_0045005" text="neural tube defect" type="HP"/>
    <entity charOffset="114-135" id="s2308.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2308.e0" e2="s2308.e1" id="s2308.p0" relation="false"/>
  </sentence>
  <sentence id="s2309" text="The nonsense mutation and loss of protein of GTP metabolic process has been associated with neural tube defect in epidermis development and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.">
    <entity charOffset="114-135" id="s2309.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="244-249" id="s2309.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2309.e0" e2="s2309.e1" id="s2309.p0" relation="false"/>
  </sentence>
  <sentence id="s2310" text="In this review, we give a brief review on the functions of GTP metabolic process, summarize the involvement of Rab23 in genetic research, membrane trafficking, and potential autophagy pathway, especially focus on tumor promotion, disease pathogenesis, and discuss the possible underlying mechanisms that are regulated by Rab23">
    <entity charOffset="59-80" id="s2310.e0" ontology_id="GO_0046039" text="GTP metabolic process" type="GO"/>
    <entity charOffset="213-218" id="s2310.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2310.e0" e2="s2310.e1" id="s2310.p0" relation="false"/>
  </sentence>
  <sentence id="s2311" text="Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell negative regulation of apoptotic process-specifying transcription factors including nitric oxide mediated signal transduction, negative regulation of transcription by RNA polymerase II, negative regulation of transcription, DNA-templated and REST.">
    <entity charOffset="18-23" id="s2311.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="115-155" id="s2311.e1" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <pair e1="s2311.e0" e2="s2311.e1" id="s2311.p0" relation="false"/>
  </sentence>
  <sentence id="s2312" text="Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell negative regulation of apoptotic process-specifying transcription factors including nitric oxide mediated signal transduction, negative regulation of transcription by RNA polymerase II, negative regulation of transcription, DNA-templated and REST.">
    <entity charOffset="18-23" id="s2312.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="199-240" id="s2312.e1" ontology_id="GO_0007263" text="nitric oxide mediated signal transduction" type="GO"/>
    <pair e1="s2312.e0" e2="s2312.e1" id="s2312.p0" relation="false"/>
  </sentence>
  <sentence id="s2313" text="Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell negative regulation of apoptotic process-specifying transcription factors including nitric oxide mediated signal transduction, negative regulation of transcription by RNA polymerase II, negative regulation of transcription, DNA-templated and REST.">
    <entity charOffset="18-23" id="s2313.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="242-299" id="s2313.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2313.e0" e2="s2313.e1" id="s2313.p0" relation="false"/>
  </sentence>
  <sentence id="s2314" text="Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell negative regulation of apoptotic process-specifying transcription factors including nitric oxide mediated signal transduction, negative regulation of transcription by RNA polymerase II, negative regulation of transcription, DNA-templated and REST.">
    <entity charOffset="18-23" id="s2314.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="301-352" id="s2314.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s2314.e0" e2="s2314.e1" id="s2314.p0" relation="false"/>
  </sentence>
  <sentence id="s2315" text="We identified 568 proteins in the CSF of infants with spina bifida, which is the most common muscle organ development of NTD.">
    <entity charOffset="54-66" id="s2315.e0" ontology_id="HP_0002414" text="spina bifida" type="HP"/>
    <entity charOffset="93-117" id="s2315.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2315.e0" e2="s2315.e1" id="s2315.p0" relation="false"/>
  </sentence>
  <sentence id="s2316" text="Kindler syndrome is a rare, autosomal recessive genodermatosis, caused by mutations in the cell adhesion gene.">
    <entity charOffset="28-47" id="s2316.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="91-104" id="s2316.e1" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <pair e1="s2316.e0" e2="s2316.e1" id="s2316.p0" relation="true"/>
  </sentence>
  <sentence id="s2317" text="De novo heterozygous mutations in protein localization to plasma membrane/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.">
    <entity charOffset="34-73" id="s2317.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="105-131" id="s2317.e1" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <pair e1="s2317.e0" e2="s2317.e1" id="s2317.p0" relation="true"/>
  </sentence>
  <sentence id="s2318" text="De novo heterozygous mutations in protein localization to plasma membrane/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.">
    <entity charOffset="34-73" id="s2318.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="212-235" id="s2318.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2318.e0" e2="s2318.e1" id="s2318.p0" relation="true"/>
  </sentence>
  <sentence id="s2319" text="We characterized the cellular deficits for an allelic series of seven protein localization to plasma membrane mutations and developed four mouse models that recapitulate the abnormal EEG activity and cognitive aspects of human STXBP1-encephalopathy.">
    <entity charOffset="70-109" id="s2319.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="234-248" id="s2319.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2319.e0" e2="s2319.e1" id="s2319.p0" relation="true"/>
  </sentence>
  <sentence id="s2320" text="Together, these cellular studies suggest that impaired protein stability and protein localization to plasma membrane haploinsufficiency explain STXBP1-encephalopathy and that, therefore, protein localization to plasma membrane+/- epidermis development provide a valid mouse model.">
    <entity charOffset="77-116" id="s2320.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="151-165" id="s2320.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2320.e0" e2="s2320.e1" id="s2320.p0" relation="true"/>
  </sentence>
  <sentence id="s2321" text="Together, these cellular studies suggest that impaired protein stability and protein localization to plasma membrane haploinsufficiency explain STXBP1-encephalopathy and that, therefore, protein localization to plasma membrane+/- epidermis development provide a valid mouse model.">
    <entity charOffset="151-165" id="s2321.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="187-226" id="s2321.e1" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <pair e1="s2321.e0" e2="s2321.e1" id="s2321.p0" relation="true"/>
  </sentence>
  <sentence id="s2322" text="Together, these cellular studies suggest that impaired protein stability and protein localization to plasma membrane haploinsufficiency explain STXBP1-encephalopathy and that, therefore, protein localization to plasma membrane+/- epidermis development provide a valid mouse model.">
    <entity charOffset="151-165" id="s2322.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="230-251" id="s2322.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2322.e0" e2="s2322.e1" id="s2322.p0" relation="false"/>
  </sentence>
  <sentence id="s2323" text="Simultaneous video and EEG recordings revealed that protein localization to plasma membrane+/- epidermis development with different genomic backgrounds recapitulate the seizure/spasm phenotype observed in humans, characterized by myoclonic jerks and spike-wave discharges that were suppressed by the antiepileptic drug levetiracetam.">
    <entity charOffset="52-91" id="s2323.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="169-176" id="s2323.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s2323.e0" e2="s2323.e1" id="s2323.p0" relation="true"/>
  </sentence>
  <sentence id="s2324" text="Simultaneous video and EEG recordings revealed that protein localization to plasma membrane+/- epidermis development with different genomic backgrounds recapitulate the seizure/spasm phenotype observed in humans, characterized by myoclonic jerks and spike-wave discharges that were suppressed by the antiepileptic drug levetiracetam.">
    <entity charOffset="95-116" id="s2324.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="169-176" id="s2324.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s2324.e0" e2="s2324.e1" id="s2324.p0" relation="false"/>
  </sentence>
  <sentence id="s2325" text="protein localization to plasma membrane+/- epidermis development showed impaired cognitive performance, hyperactivity and anxiety-like behaviour, without altered social behaviour.">
    <entity charOffset="0-39" id="s2325.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="104-117" id="s2325.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s2325.e0" e2="s2325.e1" id="s2325.p0" relation="true"/>
  </sentence>
  <sentence id="s2326" text="protein localization to plasma membrane+/- epidermis development showed impaired cognitive performance, hyperactivity and anxiety-like behaviour, without altered social behaviour.">
    <entity charOffset="43-64" id="s2326.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="104-117" id="s2326.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s2326.e0" e2="s2326.e1" id="s2326.p0" relation="false"/>
  </sentence>
  <sentence id="s2327" text="Taken together, these data demonstrate the construct, interstrand cross-link repair and predictive validity of protein localization to plasma membrane+/- epidermis development and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of protein localization to plasma membrane-encephalopathy.">
    <entity charOffset="54-83" id="s2327.e0" ontology_id="GO_0036297" text="interstrand cross-link repair" type="GO"/>
    <entity charOffset="340-354" id="s2327.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2327.e0" e2="s2327.e1" id="s2327.p0" relation="false"/>
  </sentence>
  <sentence id="s2328" text="Taken together, these data demonstrate the construct, interstrand cross-link repair and predictive validity of protein localization to plasma membrane+/- epidermis development and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of protein localization to plasma membrane-encephalopathy.">
    <entity charOffset="111-150" id="s2328.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="340-354" id="s2328.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2328.e0" e2="s2328.e1" id="s2328.p0" relation="true"/>
  </sentence>
  <sentence id="s2329" text="Taken together, these data demonstrate the construct, interstrand cross-link repair and predictive validity of protein localization to plasma membrane+/- epidermis development and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of protein localization to plasma membrane-encephalopathy.">
    <entity charOffset="154-175" id="s2329.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="340-354" id="s2329.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2329.e0" e2="s2329.e1" id="s2329.p0" relation="false"/>
  </sentence>
  <sentence id="s2330" text="Taken together, these data demonstrate the construct, interstrand cross-link repair and predictive validity of protein localization to plasma membrane+/- epidermis development and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of protein localization to plasma membrane-encephalopathy.">
    <entity charOffset="300-339" id="s2330.e0" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <entity charOffset="340-354" id="s2330.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2330.e0" e2="s2330.e1" id="s2330.p0" relation="true"/>
  </sentence>
  <sentence id="s2331" text="positive regulation of transcription by RNA polymerase II is a high-risk neuroblastoma susceptibility gene, but how LMO1 cooperates with MYCN in neuroblastoma tumorigenesis is unclear.">
    <entity charOffset="0-57" id="s2331.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="73-86" id="s2331.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2331.e0" e2="s2331.e1" id="s2331.p0" relation="false"/>
  </sentence>
  <sentence id="s2332" text="develop a novel zebrafish model that elucidates a mechanism by which positive regulation of transcription by RNA polymerase II and positive regulation of gene expression synergistically initiate neuroblastoma and contribute to metastatic disease progression">
    <entity charOffset="69-126" id="s2332.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="195-208" id="s2332.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2332.e0" e2="s2332.e1" id="s2332.p0" relation="false"/>
  </sentence>
  <sentence id="s2333" text="develop a novel zebrafish model that elucidates a mechanism by which positive regulation of transcription by RNA polymerase II and positive regulation of gene expression synergistically initiate neuroblastoma and contribute to metastatic disease progression">
    <entity charOffset="131-169" id="s2333.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="195-208" id="s2333.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2333.e0" e2="s2333.e1" id="s2333.p0" relation="false"/>
  </sentence>
  <sentence id="s2334" text="Although CHH and other skeletal dysplasias caused by mutations in RMRP or epithelial cell-cell adhesion are commonly cited as ribosomal biogenesis disorders, recent studies question this assumption.">
    <entity charOffset="23-41" id="s2334.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="74-103" id="s2334.e1" ontology_id="GO_0090136" text="epithelial cell-cell adhesion" type="GO"/>
    <pair e1="s2334.e0" e2="s2334.e1" id="s2334.p0" relation="false"/>
  </sentence>
  <sentence id="s2335" text="Hepatocellular carcinoma (phosphatidylinositol phosphorylation) is the most common primary malignant liver tumor.">
    <entity charOffset="26-62" id="s2335.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="107-112" id="s2335.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2335.e0" e2="s2335.e1" id="s2335.p0" relation="false"/>
  </sentence>
  <sentence id="s2336" text="Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or secretion (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively.">
    <entity charOffset="72-81" id="s2336.e0" ontology_id="GO_0046903" text="secretion" type="GO"/>
    <entity charOffset="146-165" id="s2336.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2336.e0" e2="s2336.e1" id="s2336.p0" relation="true"/>
  </sentence>
  <sentence id="s2337" text="Loss-of-function mutations of G protein-coupled acetylcholine receptor signaling pathway, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (detection of calcium ion), result in familial hypocalciuric hypercalcemia type 2 (G protein-coupled acetylcholine receptor signaling pathway).">
    <entity charOffset="30-88" id="s2337.e0" ontology_id="GO_0007213" text="G protein-coupled acetylcholine receptor signaling pathway" type="GO"/>
    <entity charOffset="248-261" id="s2337.e1" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <pair e1="s2337.e0" e2="s2337.e1" id="s2337.p0" relation="true"/>
  </sentence>
  <sentence id="s2338" text="Loss-of-function mutations of G protein-coupled acetylcholine receptor signaling pathway, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (detection of calcium ion), result in familial hypocalciuric hypercalcemia type 2 (G protein-coupled acetylcholine receptor signaling pathway).">
    <entity charOffset="188-212" id="s2338.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="248-261" id="s2338.e1" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <pair e1="s2338.e0" e2="s2338.e1" id="s2338.p0" relation="true"/>
  </sentence>
  <sentence id="s2339" text="Loss-of-function mutations of G protein-coupled acetylcholine receptor signaling pathway, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (detection of calcium ion), result in familial hypocalciuric hypercalcemia type 2 (G protein-coupled acetylcholine receptor signaling pathway).">
    <entity charOffset="248-261" id="s2339.e0" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <entity charOffset="270-328" id="s2339.e1" ontology_id="GO_0007213" text="G protein-coupled acetylcholine receptor signaling pathway" type="GO"/>
    <pair e1="s2339.e0" e2="s2339.e1" id="s2339.p0" relation="true"/>
  </sentence>
  <sentence id="s2340" text="G protein-coupled acetylcholine receptor signaling pathway is characterized by hypercalcemia, inappropriately normal or raised parathyroid hormone (negative regulation of transcription by RNA polymerase II) concentrations, and normal or low urinary calcium excretion.">
    <entity charOffset="0-58" id="s2340.e0" ontology_id="GO_0007213" text="G protein-coupled acetylcholine receptor signaling pathway" type="GO"/>
    <entity charOffset="79-92" id="s2340.e1" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <pair e1="s2340.e0" e2="s2340.e1" id="s2340.p0" relation="true"/>
  </sentence>
  <sentence id="s2341" text="G protein-coupled acetylcholine receptor signaling pathway is characterized by hypercalcemia, inappropriately normal or raised parathyroid hormone (negative regulation of transcription by RNA polymerase II) concentrations, and normal or low urinary calcium excretion.">
    <entity charOffset="79-92" id="s2341.e0" ontology_id="HP_0003072" text="hypercalcemia" type="HP"/>
    <entity charOffset="148-205" id="s2341.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2341.e0" e2="s2341.e1" id="s2341.p0" relation="false"/>
  </sentence>
  <sentence id="s2342" text="Our results demonstrated that SelM may have an important role in protecting against oxidative cellular protein catabolic process in the brain of chicken, which might shed light on the role of SelM in human neurodegenerative disease.">
    <entity charOffset="94-128" id="s2342.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="206-231" id="s2342.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s2342.e0" e2="s2342.e1" id="s2342.p0" relation="false"/>
  </sentence>
  <sentence id="s2343" text="The purpose of this study was to evaluate the association of the hepatic lipase (fatty acid biosynthetic process) rs493258 polymorphism and susceptibility to age-related macular degeneration (AMD).">
    <entity charOffset="81-112" id="s2343.e0" ontology_id="GO_0006633" text="fatty acid biosynthetic process" type="GO"/>
    <entity charOffset="170-190" id="s2343.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s2343.e0" e2="s2343.e1" id="s2343.p0" relation="false"/>
  </sentence>
  <sentence id="s2344" text="The candidate genes located within the new loci were related to ocular development (regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II and MAP3K1) and glaucoma-related phenomuscle organ developments (biological_process, LMX1B and LOXL1).">
    <entity charOffset="84-126" id="s2344.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="202-210" id="s2344.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2344.e0" e2="s2344.e1" id="s2344.p0" relation="true"/>
  </sentence>
  <sentence id="s2345" text="The candidate genes located within the new loci were related to ocular development (regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II and MAP3K1) and glaucoma-related phenomuscle organ developments (biological_process, LMX1B and LOXL1).">
    <entity charOffset="128-185" id="s2345.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="202-210" id="s2345.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2345.e0" e2="s2345.e1" id="s2345.p0" relation="false"/>
  </sentence>
  <sentence id="s2346" text="The candidate genes located within the new loci were related to ocular development (regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II and MAP3K1) and glaucoma-related phenomuscle organ developments (biological_process, LMX1B and LOXL1).">
    <entity charOffset="202-210" id="s2346.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="251-269" id="s2346.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s2346.e0" e2="s2346.e1" id="s2346.p0" relation="false"/>
  </sentence>
  <sentence id="s2347" text="The candidate genes located within the new loci were related to ocular development (regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II and MAP3K1) and glaucoma-related phenomuscle organ developments (biological_process, LMX1B and LOXL1).">
    <entity charOffset="202-210" id="s2347.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="224-248" id="s2347.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2347.e0" e2="s2347.e1" id="s2347.p0" relation="false"/>
  </sentence>
  <sentence id="s2348" text="In addition, regulation of phosphate transport suppresses proximal tubular expression of 1-hydroxylase, the key enzyme responsible for vitamin D hormone production.">
    <entity charOffset="13-46" id="s2348.e0" ontology_id="GO_0010966" text="regulation of phosphate transport" type="GO"/>
    <entity charOffset="58-66" id="s2348.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s2348.e0" e2="s2348.e1" id="s2348.p0" relation="false"/>
  </sentence>
  <sentence id="s2349" text="A mutation of cilium movement has been identified in human patients with primary ciliary dyskinesia (motile cilium assembly).">
    <entity charOffset="14-29" id="s2349.e0" ontology_id="GO_0003341" text="cilium movement" type="GO"/>
    <entity charOffset="81-99" id="s2349.e1" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <pair e1="s2349.e0" e2="s2349.e1" id="s2349.p0" relation="true"/>
  </sentence>
  <sentence id="s2350" text="A mutation of cilium movement has been identified in human patients with primary ciliary dyskinesia (motile cilium assembly).">
    <entity charOffset="81-99" id="s2350.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="101-123" id="s2350.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s2350.e0" e2="s2350.e1" id="s2350.p0" relation="true"/>
  </sentence>
  <sentence id="s2351" text="Mutant epidermis development lacking Lrrc6 show typical motile cilium assembly defects such as hydrocephalus and laterality defects.">
    <entity charOffset="7-28" id="s2351.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="95-108" id="s2351.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s2351.e0" e2="s2351.e1" id="s2351.p0" relation="false"/>
  </sentence>
  <sentence id="s2352" text="Mutant epidermis development lacking Lrrc6 show typical motile cilium assembly defects such as hydrocephalus and laterality defects.">
    <entity charOffset="56-78" id="s2352.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="95-108" id="s2352.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s2352.e0" e2="s2352.e1" id="s2352.p0" relation="false"/>
  </sentence>
  <sentence id="s2353" text="Mutations in filamin A (negative regulation of transcription by RNA polymerase I) or post-translational protein modification-ribosylation factor guanine nucleotide-exchange factor 2 (receptor recycling) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.">
    <entity charOffset="24-80" id="s2353.e0" ontology_id="GO_0016479" text="negative regulation of transcription by RNA polymerase I" type="GO"/>
    <entity charOffset="233-244" id="s2353.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s2353.e0" e2="s2353.e1" id="s2353.p0" relation="true"/>
  </sentence>
  <sentence id="s2354" text="Mutations in filamin A (negative regulation of transcription by RNA polymerase I) or post-translational protein modification-ribosylation factor guanine nucleotide-exchange factor 2 (receptor recycling) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.">
    <entity charOffset="85-124" id="s2354.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="233-244" id="s2354.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s2354.e0" e2="s2354.e1" id="s2354.p0" relation="false"/>
  </sentence>
  <sentence id="s2355" text="Mutations in filamin A (negative regulation of transcription by RNA polymerase I) or post-translational protein modification-ribosylation factor guanine nucleotide-exchange factor 2 (receptor recycling) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.">
    <entity charOffset="183-201" id="s2355.e0" ontology_id="GO_0001881" text="receptor recycling" type="GO"/>
    <entity charOffset="233-244" id="s2355.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s2355.e0" e2="s2355.e1" id="s2355.p0" relation="true"/>
  </sentence>
  <sentence id="s2356" text="Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (biological_process) gene, mapping in the minimal critical deleted region.">
    <entity charOffset="191-210" id="s2356.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="299-317" id="s2356.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s2356.e0" e2="s2356.e1" id="s2356.p0" relation="true"/>
  </sentence>
  <sentence id="s2357" text="Silencing of the contiguous nervous system development or Notch signaling pathway genes only produced slightly delayed migration but not periventricular nodular heterotopia.">
    <entity charOffset="28-54" id="s2357.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="161-172" id="s2357.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s2357.e0" e2="s2357.e1" id="s2357.p0" relation="false"/>
  </sentence>
  <sentence id="s2358" text="Silencing of the contiguous nervous system development or Notch signaling pathway genes only produced slightly delayed migration but not periventricular nodular heterotopia.">
    <entity charOffset="58-81" id="s2358.e0" ontology_id="GO_0007219" text="Notch signaling pathway" type="GO"/>
    <entity charOffset="161-172" id="s2358.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s2358.e0" e2="s2358.e1" id="s2358.p0" relation="false"/>
  </sentence>
  <sentence id="s2359" text="Our data suggest that, of the genes within this minimal critical region, biological_process plays a major role in the control of neuronal migration and its haploinsufficiency or mutation causes periventricular nodular heterotopia.">
    <entity charOffset="73-91" id="s2359.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="218-229" id="s2359.e1" ontology_id="HP_0002282" text="heterotopia" type="HP"/>
    <pair e1="s2359.e0" e2="s2359.e1" id="s2359.p0" relation="true"/>
  </sentence>
  <sentence id="s2360" text="Several publications had illustrated the relationship of between response to bacterium polymorphism and urinary cancer, but the results were not consistent.">
    <entity charOffset="65-86" id="s2360.e0" ontology_id="GO_0009617" text="response to bacterium" type="GO"/>
    <entity charOffset="112-118" id="s2360.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2360.e0" e2="s2360.e1" id="s2360.p0" relation="false"/>
  </sentence>
  <sentence id="s2361" text="Odds ratios (ORs) and 95% confidence intervals (CIs) were conducted to evaluate the overall strength of the associations in five genetic models, as well as in subgroup analyses, stratified by ethnicity, cancer muscle organ development or source of control.">
    <entity charOffset="203-209" id="s2361.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="210-234" id="s2361.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2361.e0" e2="s2361.e1" id="s2361.p0" relation="false"/>
  </sentence>
  <sentence id="s2362" text="In the stratified analyses by cancer types, the risk of mitochondrial transport is downgrade by rs7804372 in all five genetic models.">
    <entity charOffset="30-36" id="s2362.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="56-79" id="s2362.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s2362.e0" e2="s2362.e1" id="s2362.p0" relation="false"/>
  </sentence>
  <sentence id="s2363" text="Conclusion rs1049334 polymorphismof response to bacterium upgrade the risk of urinary cancer, while rs1049337 and rs7804372 polymorphisms may act as a protector of urinary cancer.">
    <entity charOffset="36-57" id="s2363.e0" ontology_id="GO_0009617" text="response to bacterium" type="GO"/>
    <entity charOffset="86-92" id="s2363.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2363.e0" e2="s2363.e1" id="s2363.p0" relation="false"/>
  </sentence>
  <sentence id="s2364" text="In this work we investigated the role of forkhead box O1 (cellular response to starvation) in the transcriptional regulation in macrophages, which affects the anti-tumor functions of tumor-associated macrophages (TAMs).">
    <entity charOffset="58-89" id="s2364.e0" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <entity charOffset="164-169" id="s2364.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2364.e0" e2="s2364.e1" id="s2364.p0" relation="true"/>
  </sentence>
  <sentence id="s2365" text="Furthermore, we used FoxO1 conditional knockout epidermis development to show that FoxO1 deficiency in myeloid cells exacerbates tumor growth.">
    <entity charOffset="48-69" id="s2365.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="129-134" id="s2365.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2365.e0" e2="s2365.e1" id="s2365.p0" relation="false"/>
  </sentence>
  <sentence id="s2366" text="These results demonstrate that the protumoral property of TAMs is induced by the hypoxia-triggered cellular response to starvation deficiency, which could be a potential target of novel anti-tumor therapies">
    <entity charOffset="38-43" id="s2366.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="99-130" id="s2366.e1" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <pair e1="s2366.e0" e2="s2366.e1" id="s2366.p0" relation="true"/>
  </sentence>
  <sentence id="s2367" text="Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (negative regulation of protein catabolic process) patients, but is not associated with overall survival of squamous cell carcinoma (negative regulation of peptidase activity) patients (n=524, p=0.27).">
    <entity charOffset="13-70" id="s2367.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="334-357" id="s2367.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s2367.e0" e2="s2367.e1" id="s2367.p0" relation="false"/>
  </sentence>
  <sentence id="s2368" text="Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (negative regulation of protein catabolic process) patients, but is not associated with overall survival of squamous cell carcinoma (negative regulation of peptidase activity) patients (n=524, p=0.27).">
    <entity charOffset="206-225" id="s2368.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="227-275" id="s2368.e1" ontology_id="GO_0042177" text="negative regulation of protein catabolic process" type="GO"/>
    <pair e1="s2368.e0" e2="s2368.e1" id="s2368.p0" relation="false"/>
  </sentence>
  <sentence id="s2369" text="Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (negative regulation of protein catabolic process) patients, but is not associated with overall survival of squamous cell carcinoma (negative regulation of peptidase activity) patients (n=524, p=0.27).">
    <entity charOffset="206-225" id="s2369.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="359-400" id="s2369.e1" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <pair e1="s2369.e0" e2="s2369.e1" id="s2369.p0" relation="false"/>
  </sentence>
  <sentence id="s2370" text="Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (negative regulation of protein catabolic process) patients, but is not associated with overall survival of squamous cell carcinoma (negative regulation of peptidase activity) patients (n=524, p=0.27).">
    <entity charOffset="227-275" id="s2370.e0" ontology_id="GO_0042177" text="negative regulation of protein catabolic process" type="GO"/>
    <entity charOffset="334-357" id="s2370.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s2370.e0" e2="s2370.e1" id="s2370.p0" relation="false"/>
  </sentence>
  <sentence id="s2371" text="Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (negative regulation of protein catabolic process) patients, but is not associated with overall survival of squamous cell carcinoma (negative regulation of peptidase activity) patients (n=524, p=0.27).">
    <entity charOffset="334-357" id="s2371.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="359-400" id="s2371.e1" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <pair e1="s2371.e0" e2="s2371.e1" id="s2371.p0" relation="false"/>
  </sentence>
  <sentence id="s2372" text="Our data confirm the genetic heterogeneity of childhood-onset pure HSP, with SPG4/microtubule bundle formation and SPG3A/endoplasmic reticulum organization being the most frequent forms.">
    <entity charOffset="29-42" id="s2372.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="121-155" id="s2372.e1" ontology_id="GO_0007029" text="endoplasmic reticulum organization" type="GO"/>
    <pair e1="s2372.e0" e2="s2372.e1" id="s2372.p0" relation="true"/>
  </sentence>
  <sentence id="s2373" text="Our data confirm the genetic heterogeneity of childhood-onset pure HSP, with SPG4/microtubule bundle formation and SPG3A/endoplasmic reticulum organization being the most frequent forms.">
    <entity charOffset="29-42" id="s2373.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="82-110" id="s2373.e1" ontology_id="GO_0001578" text="microtubule bundle formation" type="GO"/>
    <pair e1="s2373.e0" e2="s2373.e1" id="s2373.p0" relation="false"/>
  </sentence>
  <sentence id="s2374" text="We identified eight mRNA splicing, via spliceosome genes which likely play important roles in obesity metabolism and identified microRNAs that significantly negatively correlated with hub genes.">
    <entity charOffset="20-50" id="s2374.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="94-101" id="s2374.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2374.e0" e2="s2374.e1" id="s2374.p0" relation="false"/>
  </sentence>
  <sentence id="s2375" text="The results indicated that increased regulation of heart rate in adipose tissue may have a significant therapeutic potential in reducing obesity and insulin resistance">
    <entity charOffset="37-61" id="s2375.e0" ontology_id="GO_0002027" text="regulation of heart rate" type="GO"/>
    <entity charOffset="137-144" id="s2375.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2375.e0" e2="s2375.e1" id="s2375.p0" relation="false"/>
  </sentence>
  <sentence id="s2376" text="Pathogenic variant in regulation of cell shape are a known cause of regulation of cell shape autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="22-46" id="s2376.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="112-123" id="s2376.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s2376.e0" e2="s2376.e1" id="s2376.p0" relation="true"/>
  </sentence>
  <sentence id="s2377" text="Pathogenic variant in regulation of cell shape are a known cause of regulation of cell shape autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="22-46" id="s2377.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="124-136" id="s2377.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2377.e0" e2="s2377.e1" id="s2377.p0" relation="true"/>
  </sentence>
  <sentence id="s2378" text="Pathogenic variant in regulation of cell shape are a known cause of regulation of cell shape autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="22-46" id="s2378.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="141-163" id="s2378.e1" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <pair e1="s2378.e0" e2="s2378.e1" id="s2378.p0" relation="true"/>
  </sentence>
  <sentence id="s2379" text="Pathogenic variant in regulation of cell shape are a known cause of regulation of cell shape autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="68-92" id="s2379.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="112-123" id="s2379.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s2379.e0" e2="s2379.e1" id="s2379.p0" relation="true"/>
  </sentence>
  <sentence id="s2380" text="Pathogenic variant in regulation of cell shape are a known cause of regulation of cell shape autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.">
    <entity charOffset="68-92" id="s2380.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="141-163" id="s2380.e1" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <pair e1="s2380.e0" e2="s2380.e1" id="s2380.p0" relation="true"/>
  </sentence>
  <sentence id="s2381" text="Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense c.292C&amp;gt;T(p.Arg98*) regulation of cell shape variant, suggesting a loss-of-function effect.">
    <entity charOffset="58-66" id="s2381.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="115-139" id="s2381.e1" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <pair e1="s2381.e0" e2="s2381.e1" id="s2381.p0" relation="true"/>
  </sentence>
  <sentence id="s2382" text="This is the first report of autosomal recessive inheritance of cochlea-vestibular dysfunction caused by a pathogenic variant in the regulation of cell shape gene.">
    <entity charOffset="28-59" id="s2382.e0" ontology_id="HP_0000007" text="autosomal recessive inheritance" type="HP"/>
    <entity charOffset="132-156" id="s2382.e1" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <pair e1="s2382.e0" e2="s2382.e1" id="s2382.p0" relation="false"/>
  </sentence>
  <sentence id="s2383" text="This is the first report of autosomal recessive inheritance of cochlea-vestibular dysfunction caused by a pathogenic variant in the regulation of cell shape gene.">
    <entity charOffset="71-93" id="s2383.e0" ontology_id="HP_0001751" text="vestibular dysfunction" type="HP"/>
    <entity charOffset="132-156" id="s2383.e1" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <pair e1="s2383.e0" e2="s2383.e1" id="s2383.p0" relation="true"/>
  </sentence>
  <sentence id="s2384" text="An earlier onset of hearing impairment and vestibular dysfunction compared to the dominant hearing loss causing regulation of cell shape variants is observed">
    <entity charOffset="91-103" id="s2384.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="112-136" id="s2384.e1" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <pair e1="s2384.e0" e2="s2384.e1" id="s2384.p0" relation="true"/>
  </sentence>
  <sentence id="s2385" text="Danon disease, an X-linked dominant cardioskeletal myopathy, is caused by primary deficiency of lysosome-associated membrane protein-2 (regulation of autophagy-2).">
    <entity charOffset="51-59" id="s2385.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="136-159" id="s2385.e1" ontology_id="GO_0010506" text="regulation of autophagy" type="GO"/>
    <pair e1="s2385.e0" e2="s2385.e1" id="s2385.p0" relation="false"/>
  </sentence>
  <sentence id="s2386" text="The K&lt;sup&gt;+&lt;/sup&gt; channel cellular response to drug has been proposed as a tumor suppressor in colorectal cancer (CRC).">
    <entity charOffset="26-51" id="s2386.e0" ontology_id="GO_0035690" text="cellular response to drug" type="GO"/>
    <entity charOffset="106-112" id="s2386.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2386.e0" e2="s2386.e1" id="s2386.p0" relation="true"/>
  </sentence>
  <sentence id="s2387" text="Analysis of human primary CRC tumor patient databases showed a positive correlation between cellular response to drug:KCNE3 channel complex expression and disease-free survival.">
    <entity charOffset="30-35" id="s2387.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="92-117" id="s2387.e1" ontology_id="GO_0035690" text="cellular response to drug" type="GO"/>
    <pair e1="s2387.e0" e2="s2387.e1" id="s2387.p0" relation="true"/>
  </sentence>
  <sentence id="s2388" text="We conclude that the cellular response to drug ion channel is a target gene and regulator of the Wnt/-catenin pathway, and its repression leads to CRC cell proliferation, cytokine production, and tumorigenesis">
    <entity charOffset="21-46" id="s2388.e0" ontology_id="GO_0035690" text="cellular response to drug" type="GO"/>
    <entity charOffset="197-202" id="s2388.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2388.e0" e2="s2388.e1" id="s2388.p0" relation="true"/>
  </sentence>
  <sentence id="s2389" text="We conclude that the cellular response to drug ion channel is a target gene and regulator of the Wnt/-catenin pathway, and its repression leads to CRC cell proliferation, cytokine production, and tumorigenesis">
    <entity charOffset="172-191" id="s2389.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="197-202" id="s2389.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2389.e0" e2="s2389.e1" id="s2389.p0" relation="true"/>
  </sentence>
  <sentence id="s2390" text="The aberrant activation of regulation of transcription, DNA-templated contributes to several human diseases, particularly cancer.">
    <entity charOffset="27-69" id="s2390.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="122-128" id="s2390.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2390.e0" e2="s2390.e1" id="s2390.p0" relation="true"/>
  </sentence>
  <sentence id="s2391" text="We hope that our study will stimulate further studies and a new targeted therapy and early medical intervention for YAP/TAZ could be a useful option for breast cancer cases complicated with protein phosphorylation deficiency">
    <entity charOffset="160-166" id="s2391.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="190-213" id="s2391.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s2391.e0" e2="s2391.e1" id="s2391.p0" relation="true"/>
  </sentence>
  <sentence id="s2392" text="TAF12, regulation of transcription, DNA-templated, and DNA repair co-located on human chromosome 1p32-35.3 and mouse chromosome 4qD1-D3 were identified as oncogenes that are gained in tumors in both species and required for disease initiation and progression.">
    <entity charOffset="7-49" id="s2392.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="184-190" id="s2392.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2392.e0" e2="s2392.e1" id="s2392.p0" relation="false"/>
  </sentence>
  <sentence id="s2393" text="TAF12, regulation of transcription, DNA-templated, and DNA repair co-located on human chromosome 1p32-35.3 and mouse chromosome 4qD1-D3 were identified as oncogenes that are gained in tumors in both species and required for disease initiation and progression.">
    <entity charOffset="55-65" id="s2393.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="184-190" id="s2393.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2393.e0" e2="s2393.e1" id="s2393.p0" relation="true"/>
  </sentence>
  <sentence id="s2394" text="Mendelian randomization analyses suggest causal inverse associations, independent of body cell adhesion mediated by integrin index (BMI), between puberty timing and risks for breast and endometrial cancers in women and prostate cancer in men.">
    <entity charOffset="90-124" id="s2394.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="198-204" id="s2394.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2394.e0" e2="s2394.e1" id="s2394.p0" relation="false"/>
  </sentence>
  <sentence id="s2395" text="Some RA patients are likely to increase visceral positive regulation of cell-matrix adhesion without obesity [Body Mass Index (BMI) 25].">
    <entity charOffset="49-92" id="s2395.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="101-108" id="s2395.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2395.e0" e2="s2395.e1" id="s2395.p0" relation="false"/>
  </sentence>
  <sentence id="s2396" text="To investigate genetic predispositions for positive regulation of gene expression-amplified neuroblastoma, we performed a meta-analysis of three genome-wide association studies totaling 615 MYCN-amplified high-risk neuroblastoma cases and 1869 MYCN-nonamplified non-high-risk neuroblastoma cases as controls using a fixed-effects model with inverse variance weighting.">
    <entity charOffset="43-81" id="s2396.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="92-105" id="s2396.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2396.e0" e2="s2396.e1" id="s2396.p0" relation="false"/>
  </sentence>
  <sentence id="s2397" text="We identified a novel locus at 3p21.31 indexed by the single nucleotide polymorphism (SNP) rs80059929 (odds ratio [OR] = 2.95, 95% confidence interval [CI] = 2.17 to 4.02, Pmeta = 6.4710-12) associated with positive regulation of gene expression-amplified neuroblastoma, which was replicated in 127 MYCN-amplified cases and 254 non-high-risk controls (OR=2.30, 95% CI=1.12 to 4.69, Preplication = .02).">
    <entity charOffset="210-248" id="s2397.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="259-272" id="s2397.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2397.e0" e2="s2397.e1" id="s2397.p0" relation="false"/>
  </sentence>
  <sentence id="s2398" text="To confirm this signal is exclusive to positive regulation of gene expression-amplified tumors, we performed a second meta-analysis comparing 728 MYCN-nonamplified high-risk patients to identical controls.">
    <entity charOffset="39-77" id="s2398.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="88-94" id="s2398.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2398.e0" e2="s2398.e1" id="s2398.p0" relation="true"/>
  </sentence>
  <sentence id="s2399" text="Additionally, the previously reported positive regulation of transcription by RNA polymerase II neuroblastoma risk locus was statistically significant only in patients with positive regulation of gene expression-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).">
    <entity charOffset="38-95" id="s2399.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="96-109" id="s2399.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2399.e0" e2="s2399.e1" id="s2399.p0" relation="false"/>
  </sentence>
  <sentence id="s2400" text="Additionally, the previously reported positive regulation of transcription by RNA polymerase II neuroblastoma risk locus was statistically significant only in patients with positive regulation of gene expression-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).">
    <entity charOffset="38-95" id="s2400.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="235-241" id="s2400.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2400.e0" e2="s2400.e1" id="s2400.p0" relation="true"/>
  </sentence>
  <sentence id="s2401" text="Additionally, the previously reported positive regulation of transcription by RNA polymerase II neuroblastoma risk locus was statistically significant only in patients with positive regulation of gene expression-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).">
    <entity charOffset="96-109" id="s2401.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="173-211" id="s2401.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s2401.e0" e2="s2401.e1" id="s2401.p0" relation="false"/>
  </sentence>
  <sentence id="s2402" text="Additionally, the previously reported positive regulation of transcription by RNA polymerase II neuroblastoma risk locus was statistically significant only in patients with positive regulation of gene expression-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).">
    <entity charOffset="173-211" id="s2402.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="235-241" id="s2402.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2402.e0" e2="s2402.e1" id="s2402.p0" relation="true"/>
  </sentence>
  <sentence id="s2403" text="Our results indicate that common genetic variation predisposes to different neuroblastoma genotypes, including the likelihood of somatic positive regulation of gene expression-amplification">
    <entity charOffset="76-89" id="s2403.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="137-175" id="s2403.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s2403.e0" e2="s2403.e1" id="s2403.p0" relation="false"/>
  </sentence>
  <sentence id="s2404" text="The gonadoblastoma gene, testis-specific protein Y-encoded (sex differentiation), on the Y chromosome and its X-homologue, negative regulation of DNA replication, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.">
    <entity charOffset="4-18" id="s2404.e0" ontology_id="HP_0000150" text="gonadoblastoma" type="HP"/>
    <entity charOffset="123-161" id="s2404.e1" ontology_id="GO_0008156" text="negative regulation of DNA replication" type="GO"/>
    <pair e1="s2404.e0" e2="s2404.e1" id="s2404.p0" relation="false"/>
  </sentence>
  <sentence id="s2405" text="The gonadoblastoma gene, testis-specific protein Y-encoded (sex differentiation), on the Y chromosome and its X-homologue, negative regulation of DNA replication, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.">
    <entity charOffset="60-79" id="s2405.e0" ontology_id="GO_0007548" text="sex differentiation" type="GO"/>
    <entity charOffset="228-233" id="s2405.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2405.e0" e2="s2405.e1" id="s2405.p0" relation="false"/>
  </sentence>
  <sentence id="s2406" text="sex differentiation and negative regulation of DNA replication co-localize with the endogenous oxidation-reduction process, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate cancer cells.">
    <entity charOffset="0-19" id="s2406.e0" ontology_id="GO_0007548" text="sex differentiation" type="GO"/>
    <entity charOffset="287-293" id="s2406.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2406.e0" e2="s2406.e1" id="s2406.p0" relation="false"/>
  </sentence>
  <sentence id="s2407" text="sex differentiation and negative regulation of DNA replication co-localize with the endogenous oxidation-reduction process, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate cancer cells.">
    <entity charOffset="24-62" id="s2407.e0" ontology_id="GO_0008156" text="negative regulation of DNA replication" type="GO"/>
    <entity charOffset="287-293" id="s2407.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2407.e0" e2="s2407.e1" id="s2407.p0" relation="false"/>
  </sentence>
  <sentence id="s2408" text="sex differentiation and negative regulation of DNA replication co-localize with the endogenous oxidation-reduction process, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate cancer cells.">
    <entity charOffset="95-122" id="s2408.e0" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <entity charOffset="287-293" id="s2408.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2408.e0" e2="s2408.e1" id="s2408.p0" relation="false"/>
  </sentence>
  <sentence id="s2409" text="Hence, TSPY and TSPX exert opposing effects on the transactivation functions of oxidation-reduction process and AR-Vs important for various physiological and disease processes sensitive to male multicellular organism development hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man">
    <entity charOffset="80-107" id="s2409.e0" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <entity charOffset="316-322" id="s2409.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2409.e0" e2="s2409.e1" id="s2409.p0" relation="false"/>
  </sentence>
  <sentence id="s2410" text="Hence, TSPY and TSPX exert opposing effects on the transactivation functions of oxidation-reduction process and AR-Vs important for various physiological and disease processes sensitive to male multicellular organism development hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man">
    <entity charOffset="194-228" id="s2410.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="316-322" id="s2410.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2410.e0" e2="s2410.e1" id="s2410.p0" relation="false"/>
  </sentence>
  <sentence id="s2411" text="Several advances have been made in the treatment of signal transduction-positive breast cancer, yet issues of resistance and poor response to therapy remains prevalent.">
    <entity charOffset="52-71" id="s2411.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="88-94" id="s2411.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2411.e0" e2="s2411.e1" id="s2411.p0" relation="true"/>
  </sentence>
  <sentence id="s2412" text="Our results provide evidence that sequence variants in human epithelial cell morphogenesis cause autosomal recessive isolated CC and give new insight into the molecular pathogenesis underlying human cataracts.">
    <entity charOffset="61-90" id="s2412.e0" ontology_id="GO_0003382" text="epithelial cell morphogenesis" type="GO"/>
    <entity charOffset="97-116" id="s2412.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2412.e0" e2="s2412.e1" id="s2412.p0" relation="true"/>
  </sentence>
  <sentence id="s2413" text="The phenotypic spectrum related to protein targeting to peroxisome0 mutations includes slowly progressive, syndromic recessive ataxia.">
    <entity charOffset="35-66" id="s2413.e0" ontology_id="GO_0006625" text="protein targeting to peroxisome" type="GO"/>
    <entity charOffset="127-133" id="s2413.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s2413.e0" e2="s2413.e1" id="s2413.p0" relation="true"/>
  </sentence>
  <sentence id="s2414" text="The results imply that variants associated with prostate cancer can be identified through expressional change in the protein targeting to peroxisome gene, but not in the overlapped glycine N-methyltransferase gene which had been considered as a candidate gene.Further studies are required to understand their underlying mechanisms for the strong eQTLs for the SNHG5 and PEX6 genes">
    <entity charOffset="57-63" id="s2414.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="117-148" id="s2414.e1" ontology_id="GO_0006625" text="protein targeting to peroxisome" type="GO"/>
    <pair e1="s2414.e0" e2="s2414.e1" id="s2414.p0" relation="false"/>
  </sentence>
  <sentence id="s2415" text="Study of RetGC1 regulation in vitro and its association with fluorescently tagged positive regulation of guanylate cyclase activity in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photoreceptor-specific protein, retinal degeneration 3 (RD3).">
    <entity charOffset="82-131" id="s2415.e0" ontology_id="GO_0031284" text="positive regulation of guanylate cyclase activity" type="GO"/>
    <entity charOffset="377-397" id="s2415.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2415.e0" e2="s2415.e1" id="s2415.p0" relation="true"/>
  </sentence>
  <sentence id="s2416" text="Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (tricarboxylic acid cycle) has been recently described as a neurodegenerative disease of autosomal recessive inheritance.">
    <entity charOffset="107-131" id="s2416.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="166-191" id="s2416.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s2416.e0" e2="s2416.e1" id="s2416.p0" relation="false"/>
  </sentence>
  <sentence id="s2417" text="Reverse phenotyping of 12 affected individuals from eight families revealed a homogeneous EOEE phenomuscle organ development characterized by severe developmental delay, poor visual contact with optic atrophy, and postnatal microcephaly.">
    <entity charOffset="100-124" id="s2417.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="195-208" id="s2417.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s2417.e0" e2="s2417.e1" id="s2417.p0" relation="false"/>
  </sentence>
  <sentence id="s2418" text="Reverse phenotyping of 12 affected individuals from eight families revealed a homogeneous EOEE phenomuscle organ development characterized by severe developmental delay, poor visual contact with optic atrophy, and postnatal microcephaly.">
    <entity charOffset="100-124" id="s2418.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="224-236" id="s2418.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2418.e0" e2="s2418.e1" id="s2418.p0" relation="false"/>
  </sentence>
  <sentence id="s2419" text="In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the negative regulation of signal transduction joint, and cryptorchidism).">
    <entity charOffset="152-165" id="s2419.e0" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <entity charOffset="303-345" id="s2419.e1" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <pair e1="s2419.e0" e2="s2419.e1" id="s2419.p0" relation="false"/>
  </sentence>
  <sentence id="s2420" text="In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the negative regulation of signal transduction joint, and cryptorchidism).">
    <entity charOffset="167-179" id="s2420.e0" ontology_id="HP_0000369" text="low-set ears" type="HP"/>
    <entity charOffset="303-345" id="s2420.e1" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <pair e1="s2420.e0" e2="s2420.e1" id="s2420.p0" relation="false"/>
  </sentence>
  <sentence id="s2421" text="In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the negative regulation of signal transduction joint, and cryptorchidism).">
    <entity charOffset="200-212" id="s2421.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="303-345" id="s2421.e1" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <pair e1="s2421.e0" e2="s2421.e1" id="s2421.p0" relation="false"/>
  </sentence>
  <sentence id="s2422" text="However, in hepatocellular carcinoma (phosphatidylinositol phosphorylation), the characteristics and mechanism of regulation of activated T cell proliferation expression have not been well defined.">
    <entity charOffset="12-36" id="s2422.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="114-158" id="s2422.e1" ontology_id="GO_0046006" text="regulation of activated T cell proliferation" type="GO"/>
    <pair e1="s2422.e0" e2="s2422.e1" id="s2422.p0" relation="false"/>
  </sentence>
  <sentence id="s2423" text="However, in hepatocellular carcinoma (phosphatidylinositol phosphorylation), the characteristics and mechanism of regulation of activated T cell proliferation expression have not been well defined.">
    <entity charOffset="12-36" id="s2423.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="38-74" id="s2423.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s2423.e0" e2="s2423.e1" id="s2423.p0" relation="false"/>
  </sentence>
  <sentence id="s2424" text="In this study, regulation of activated T cell proliferation expression in tumor cells (T-IDO1) was frequently detected (109/112) by immunohistochemistry in formalin-fixed paraffin-embedded specimens from phosphatidylinositol phosphorylation patients, and the expression patterns were mostly focal (102/109).">
    <entity charOffset="15-59" id="s2424.e0" ontology_id="GO_0046006" text="regulation of activated T cell proliferation" type="GO"/>
    <entity charOffset="74-79" id="s2424.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2424.e0" e2="s2424.e1" id="s2424.p0" relation="false"/>
  </sentence>
  <sentence id="s2425" text="In this study, regulation of activated T cell proliferation expression in tumor cells (T-IDO1) was frequently detected (109/112) by immunohistochemistry in formalin-fixed paraffin-embedded specimens from phosphatidylinositol phosphorylation patients, and the expression patterns were mostly focal (102/109).">
    <entity charOffset="74-79" id="s2425.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="204-240" id="s2425.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s2425.e0" e2="s2425.e1" id="s2425.p0" relation="false"/>
  </sentence>
  <sentence id="s2426" text="These findings indicated that T-regulation of activated T cell proliferation expression in phosphatidylinositol phosphorylation is common and is dominantly driven by the host antitumor immune response, which is a favorable prognostic factor in HCC">
    <entity charOffset="32-76" id="s2426.e0" ontology_id="GO_0046006" text="regulation of activated T cell proliferation" type="GO"/>
    <entity charOffset="179-184" id="s2426.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2426.e0" e2="s2426.e1" id="s2426.p0" relation="false"/>
  </sentence>
  <sentence id="s2427" text="These findings indicated that T-regulation of activated T cell proliferation expression in phosphatidylinositol phosphorylation is common and is dominantly driven by the host antitumor immune response, which is a favorable prognostic factor in HCC">
    <entity charOffset="91-127" id="s2427.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="179-184" id="s2427.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2427.e0" e2="s2427.e1" id="s2427.p0" relation="false"/>
  </sentence>
  <sentence id="s2428" text="Obesity causes several chronic diseases, including cardiovascular and respiratory diseases, osteoarthritis, hypertension, stroke, muscle organ development II diabetes, obstructive sleep apnea, and several types of cancer.">
    <entity charOffset="130-154" id="s2428.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="168-191" id="s2428.e1" ontology_id="HP_0002870" text="obstructive sleep apnea" type="HP"/>
    <pair e1="s2428.e0" e2="s2428.e1" id="s2428.p0" relation="false"/>
  </sentence>
  <sentence id="s2429" text="Obesity causes several chronic diseases, including cardiovascular and respiratory diseases, osteoarthritis, hypertension, stroke, muscle organ development II diabetes, obstructive sleep apnea, and several types of cancer.">
    <entity charOffset="130-154" id="s2429.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="214-220" id="s2429.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2429.e0" e2="s2429.e1" id="s2429.p0" relation="false"/>
  </sentence>
  <sentence id="s2430" text="Previous genome-wide association studies have identified several genes associated with obesity, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s2430.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="106-118" id="s2430.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s2430.e0" e2="s2430.e1" id="s2430.p0" relation="true"/>
  </sentence>
  <sentence id="s2431" text="Previous genome-wide association studies have identified several genes associated with obesity, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s2431.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="126-181" id="s2431.e1" ontology_id="GO_0032720" text="negative regulation of tumor necrosis factor production" type="GO"/>
    <pair e1="s2431.e0" e2="s2431.e1" id="s2431.p0" relation="true"/>
  </sentence>
  <sentence id="s2432" text="Previous genome-wide association studies have identified several genes associated with obesity, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s2432.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="183-211" id="s2432.e1" ontology_id="GO_0043043" text="peptide biosynthetic process" type="GO"/>
    <pair e1="s2432.e0" e2="s2432.e1" id="s2432.p0" relation="true"/>
  </sentence>
  <sentence id="s2433" text="Previous genome-wide association studies have identified several genes associated with obesity, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s2433.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="213-252" id="s2433.e1" ontology_id="GO_0006307" text="DNA dealkylation involved in DNA repair" type="GO"/>
    <pair e1="s2433.e0" e2="s2433.e1" id="s2433.p0" relation="true"/>
  </sentence>
  <sentence id="s2434" text="Previous genome-wide association studies have identified several genes associated with obesity, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s2434.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="266-295" id="s2434.e1" ontology_id="GO_0006043" text="glucosamine catabolic process" type="GO"/>
    <pair e1="s2434.e0" e2="s2434.e1" id="s2434.p0" relation="false"/>
  </sentence>
  <sentence id="s2435" text="Previous genome-wide association studies have identified several genes associated with obesity, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s2435.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="297-311" id="s2435.e1" ontology_id="GO_0016477" text="cell migration" type="GO"/>
    <pair e1="s2435.e0" e2="s2435.e1" id="s2435.p0" relation="false"/>
  </sentence>
  <sentence id="s2436" text="Previous genome-wide association studies have identified several genes associated with obesity, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s2436.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="325-341" id="s2436.e1" ontology_id="GO_0007416" text="synapse assembly" type="GO"/>
    <pair e1="s2436.e0" e2="s2436.e1" id="s2436.p0" relation="true"/>
  </sentence>
  <sentence id="s2437" text="Previous genome-wide association studies have identified several genes associated with obesity, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.">
    <entity charOffset="87-94" id="s2437.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="343-380" id="s2437.e1" ontology_id="GO_0034599" text="cellular response to oxidative stress" type="GO"/>
    <pair e1="s2437.e0" e2="s2437.e1" id="s2437.p0" relation="false"/>
  </sentence>
  <sentence id="s2438" text="Furthermore, we identified specific variants of DTC that have different effects according to cancer muscle organ development or ethnicity.">
    <entity charOffset="93-99" id="s2438.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="100-124" id="s2438.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2438.e0" e2="s2438.e1" id="s2438.p0" relation="false"/>
  </sentence>
  <sentence id="s2439" text="We therefore screened patients with hereditary PHPV, as well as bilateral optic nerve aplasia (ONA) or hypoplasia (ONH), for mutations in neural retina development.">
    <entity charOffset="64-73" id="s2439.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="138-163" id="s2439.e1" ontology_id="GO_0003407" text="neural retina development" type="GO"/>
    <pair e1="s2439.e0" e2="s2439.e1" id="s2439.p0" relation="false"/>
  </sentence>
  <sentence id="s2440" text="We therefore screened patients with hereditary PHPV, as well as bilateral optic nerve aplasia (ONA) or hypoplasia (ONH), for mutations in neural retina development.">
    <entity charOffset="74-93" id="s2440.e0" ontology_id="HP_0012521" text="optic nerve aplasia" type="HP"/>
    <entity charOffset="138-163" id="s2440.e1" ontology_id="GO_0003407" text="neural retina development" type="GO"/>
    <pair e1="s2440.e0" e2="s2440.e1" id="s2440.p0" relation="false"/>
  </sentence>
  <sentence id="s2441" text="We identified a homozygous neural retina development mutation (N46H) in a large family with an autosomal recessive PHPV disease trait linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five sporadic ONA patients.">
    <entity charOffset="27-52" id="s2441.e0" ontology_id="GO_0003407" text="neural retina development" type="GO"/>
    <entity charOffset="95-114" id="s2441.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2441.e0" e2="s2441.e1" id="s2441.p0" relation="true"/>
  </sentence>
  <sentence id="s2442" text="We identified a homozygous neural retina development mutation (N46H) in a large family with an autosomal recessive PHPV disease trait linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five sporadic ONA patients.">
    <entity charOffset="27-52" id="s2442.e0" ontology_id="GO_0003407" text="neural retina development" type="GO"/>
    <entity charOffset="212-220" id="s2442.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2442.e0" e2="s2442.e1" id="s2442.p0" relation="false"/>
  </sentence>
  <sentence id="s2443" text="This case-control study was aimed to evaluate the influence of cytochrome P450 family 17 subfamily A member 1 (steroid metabolic process) gene rs743572 polymorphism for the susceptibility to endometriosis.Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to genotype rs743572 polymorphism in 143 endometriosis patients and 148 healthy controls.">
    <entity charOffset="111-136" id="s2443.e0" ontology_id="GO_0008202" text="steroid metabolic process" type="GO"/>
    <entity charOffset="191-204" id="s2443.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2443.e0" e2="s2443.e1" id="s2443.p0" relation="false"/>
  </sentence>
  <sentence id="s2444" text="But we failed to cellular response to interleukin-4 any obvious association of rs743572 genotypes with endometriosis stages and characteristics.T allele of rs743572 polymorphism might act as a risk factor for endometriosis, although it had no effects on the disease stages and basic features">
    <entity charOffset="17-51" id="s2444.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="103-116" id="s2444.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2444.e0" e2="s2444.e1" id="s2444.p0" relation="false"/>
  </sentence>
  <sentence id="s2445" text="Since microtubule severing is an important cellular mechanism of which malfunctions result in serious diseases such as spastic paraplegia, Alzheimer's disease and cell cycle related disorders, identification of negative regulation of microtubule depolymerization transcriptional regulation is crucial in understanding the coordination of microtubule severing activity by different proteins in the cells.">
    <entity charOffset="127-137" id="s2445.e0" ontology_id="HP_0010550" text="paraplegia" type="HP"/>
    <entity charOffset="211-262" id="s2445.e1" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <pair e1="s2445.e0" e2="s2445.e1" id="s2445.p0" relation="false"/>
  </sentence>
  <sentence id="s2446" text="In conclusion, our research results strongly recommend combination analysis of cytoplasmic and nuclear girdin for a precise prognostic prediction in breast cancer.-Zhang, H., Yu, F., negative regulation of transcription, DNA-templated, F., Shao, Y., Chong, W., Guo, Z., Liu, X., Fu, L., Gu, F., Ma, Y.">
    <entity charOffset="156-162" id="s2446.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="183-234" id="s2446.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s2446.e0" e2="s2446.e1" id="s2446.p0" relation="false"/>
  </sentence>
  <sentence id="s2447" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in peptidyl-serine phosphorylation, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="80-99" id="s2447.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="412-443" id="s2447.e1" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <pair e1="s2447.e0" e2="s2447.e1" id="s2447.p0" relation="false"/>
  </sentence>
  <sentence id="s2448" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in peptidyl-serine phosphorylation, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="231-250" id="s2448.e0" ontology_id="HP_0000708" text="behavioral problems" type="HP"/>
    <entity charOffset="412-443" id="s2448.e1" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <pair e1="s2448.e0" e2="s2448.e1" id="s2448.p0" relation="false"/>
  </sentence>
  <sentence id="s2449" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in peptidyl-serine phosphorylation, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="280-292" id="s2449.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="412-443" id="s2449.e1" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <pair e1="s2449.e0" e2="s2449.e1" id="s2449.p0" relation="false"/>
  </sentence>
  <sentence id="s2450" text="We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in peptidyl-serine phosphorylation, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.">
    <entity charOffset="294-304" id="s2450.e0" ontology_id="HP_0001302" text="pachygyria" type="HP"/>
    <entity charOffset="412-443" id="s2450.e1" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <pair e1="s2450.e0" e2="s2450.e1" id="s2450.p0" relation="false"/>
  </sentence>
  <sentence id="s2451" text="Mutations in subunits of mitochondrial m-AAA proteases in the inner membrane cause neurodegeneration in spinocerebellar ataxia (proteolysis) and hereditary spastic paraplegia (HSP7).">
    <entity charOffset="128-139" id="s2451.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="156-174" id="s2451.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s2451.e0" e2="s2451.e1" id="s2451.p0" relation="false"/>
  </sentence>
  <sentence id="s2452" text="Further, exposure to the Notch signaling inhibitor and gene silencing studies showed that Notch signaling inhibition or silencing Nothc4/Dll3 decreased endothelial markers and function of tumor-derived endothelial cells under chemotherapy treatment, which may be through negative regulation of transcription by RNA polymerase IIR3.">
    <entity charOffset="188-193" id="s2452.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="271-328" id="s2452.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2452.e0" e2="s2452.e1" id="s2452.p0" relation="false"/>
  </sentence>
  <sentence id="s2453" text="Thus, our findings demonstrate that chemotherapy induces functional tumor-derived endothelial microvessels by mediating Notch signaling and negative regulation of transcription by RNA polymerase II signaling, and may provide new targets for anti-angiogenesis therapy in breast cancer">
    <entity charOffset="68-73" id="s2453.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="140-197" id="s2453.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2453.e0" e2="s2453.e1" id="s2453.p0" relation="false"/>
  </sentence>
  <sentence id="s2454" text="Here, we identify a cause of the autosomal recessive ubiquitin-dependent protein catabolic process class of inborn errors of vitamin B&lt;sub&gt;12&lt;/sub&gt; metabolism that we name &amp;quot;epi-cblC&amp;quot;.">
    <entity charOffset="33-52" id="s2454.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="53-98" id="s2454.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s2454.e0" e2="s2454.e1" id="s2454.p0" relation="false"/>
  </sentence>
  <sentence id="s2455" text="This study aimed to investigate negative regulation of apoptotic process expression in tamoxifen resistant (TAM-R) and tamoxifen sensitive (TAM-S) breast carcinoma patients and analyze its correlation with clinicopathological characteristics and survival.">
    <entity charOffset="32-72" id="s2455.e0" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <entity charOffset="147-163" id="s2455.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s2455.e0" e2="s2455.e1" id="s2455.p0" relation="false"/>
  </sentence>
  <sentence id="s2456" text="Immunohistochemical analysis was performed to evaluate negative regulation of apoptotic process protein expression in 36 TAM-R and 36 TAM-S formalin-fixed paraffin-embedded (FFPE) breast tumor tissues.">
    <entity charOffset="55-95" id="s2456.e0" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <entity charOffset="187-192" id="s2456.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2456.e0" e2="s2456.e1" id="s2456.p0" relation="false"/>
  </sentence>
  <sentence id="s2457" text="Our data suggested that high expression of negative regulation of apoptotic process could be associated with better survival in estrogen receptor positive tamoxifen-treated breast carcinoma patients">
    <entity charOffset="43-83" id="s2457.e0" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <entity charOffset="173-189" id="s2457.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s2457.e0" e2="s2457.e1" id="s2457.p0" relation="false"/>
  </sentence>
  <sentence id="s2458" text="Deregulation of the phosphoinositide 3-kinase (phosphorylation) pathway contributes to the development and progression of tumors.">
    <entity charOffset="47-62" id="s2458.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="122-128" id="s2458.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2458.e0" e2="s2458.e1" id="s2458.p0" relation="true"/>
  </sentence>
  <sentence id="s2459" text="Here, we determine that somatic mutations in phosphorylation (44%), phosphatidylinositol 3-kinase signaling (17%), positive regulation of blood vessel endothelial cell migration (15%), and negative regulation of protein phosphorylation (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="45-60" id="s2459.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="286-292" id="s2459.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2459.e0" e2="s2459.e1" id="s2459.p0" relation="true"/>
  </sentence>
  <sentence id="s2460" text="Here, we determine that somatic mutations in phosphorylation (44%), phosphatidylinositol 3-kinase signaling (17%), positive regulation of blood vessel endothelial cell migration (15%), and negative regulation of protein phosphorylation (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="68-107" id="s2460.e0" ontology_id="GO_0014065" text="phosphatidylinositol 3-kinase signaling" type="GO"/>
    <entity charOffset="286-292" id="s2460.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2460.e0" e2="s2460.e1" id="s2460.p0" relation="true"/>
  </sentence>
  <sentence id="s2461" text="Here, we determine that somatic mutations in phosphorylation (44%), phosphatidylinositol 3-kinase signaling (17%), positive regulation of blood vessel endothelial cell migration (15%), and negative regulation of protein phosphorylation (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="115-177" id="s2461.e0" ontology_id="GO_0043536" text="positive regulation of blood vessel endothelial cell migration" type="GO"/>
    <entity charOffset="286-292" id="s2461.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2461.e0" e2="s2461.e1" id="s2461.p0" relation="false"/>
  </sentence>
  <sentence id="s2462" text="Here, we determine that somatic mutations in phosphorylation (44%), phosphatidylinositol 3-kinase signaling (17%), positive regulation of blood vessel endothelial cell migration (15%), and negative regulation of protein phosphorylation (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.">
    <entity charOffset="189-235" id="s2462.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="286-292" id="s2462.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2462.e0" e2="s2462.e1" id="s2462.p0" relation="true"/>
  </sentence>
  <sentence id="s2463" text="Collectively, these findings advance our understanding of phosphorylation impactful mutations in breast cancer and have important implications for PI3K-targeted therapy in precision oncology">
    <entity charOffset="58-73" id="s2463.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="104-110" id="s2463.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2463.e0" e2="s2463.e1" id="s2463.p0" relation="true"/>
  </sentence>
  <sentence id="s2464" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="82-125" id="s2464.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="146-158" id="s2464.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2464.e0" e2="s2464.e1" id="s2464.p0" relation="false"/>
  </sentence>
  <sentence id="s2465" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="82-125" id="s2465.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="163-171" id="s2465.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2465.e0" e2="s2465.e1" id="s2465.p0" relation="true"/>
  </sentence>
  <sentence id="s2466" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="82-125" id="s2466.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="436-441" id="s2466.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s2466.e0" e2="s2466.e1" id="s2466.p0" relation="false"/>
  </sentence>
  <sentence id="s2467" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="82-125" id="s2467.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="215-228" id="s2467.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s2467.e0" e2="s2467.e1" id="s2467.p0" relation="false"/>
  </sentence>
  <sentence id="s2468" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="146-158" id="s2468.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="248-310" id="s2468.e1" ontology_id="GO_0032088" text="negative regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s2468.e0" e2="s2468.e1" id="s2468.p0" relation="false"/>
  </sentence>
  <sentence id="s2469" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="146-158" id="s2469.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="361-403" id="s2469.e1" ontology_id="GO_0070159" text="mitochondrial threonyl-tRNA aminoacylation" type="GO"/>
    <pair e1="s2469.e0" e2="s2469.e1" id="s2469.p0" relation="false"/>
  </sentence>
  <sentence id="s2470" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="163-171" id="s2470.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="248-310" id="s2470.e1" ontology_id="GO_0032088" text="negative regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s2470.e0" e2="s2470.e1" id="s2470.p0" relation="false"/>
  </sentence>
  <sentence id="s2471" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="163-171" id="s2471.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="361-403" id="s2471.e1" ontology_id="GO_0070159" text="mitochondrial threonyl-tRNA aminoacylation" type="GO"/>
    <pair e1="s2471.e0" e2="s2471.e1" id="s2471.p0" relation="false"/>
  </sentence>
  <sentence id="s2472" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="215-228" id="s2472.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="248-310" id="s2472.e1" ontology_id="GO_0032088" text="negative regulation of NF-kappaB transcription factor activity" type="GO"/>
    <pair e1="s2472.e0" e2="s2472.e1" id="s2472.p0" relation="false"/>
  </sentence>
  <sentence id="s2473" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="215-228" id="s2473.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="361-403" id="s2473.e1" ontology_id="GO_0070159" text="mitochondrial threonyl-tRNA aminoacylation" type="GO"/>
    <pair e1="s2473.e0" e2="s2473.e1" id="s2473.p0" relation="false"/>
  </sentence>
  <sentence id="s2474" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="248-310" id="s2474.e0" ontology_id="GO_0032088" text="negative regulation of NF-kappaB transcription factor activity" type="GO"/>
    <entity charOffset="436-441" id="s2474.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s2474.e0" e2="s2474.e1" id="s2474.p0" relation="false"/>
  </sentence>
  <sentence id="s2475" text="By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.">
    <entity charOffset="361-403" id="s2475.e0" ontology_id="GO_0070159" text="mitochondrial threonyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="436-441" id="s2475.e1" ontology_id="HP_0025287" text="axial" type="HP"/>
    <pair e1="s2475.e0" e2="s2475.e1" id="s2475.p0" relation="false"/>
  </sentence>
  <sentence id="s2476" text="Expression of the corresponding wild-type transcripts in immortalized mutant fibroblasts rescued the biochemical impairment of mitochondrial respiration and yeast modeling of the tRNA aminoacylation for protein translation mutation confirmed its pathogenic role.">
    <entity charOffset="127-140" id="s2476.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="179-222" id="s2476.e1" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <pair e1="s2476.e0" e2="s2476.e1" id="s2476.p0" relation="false"/>
  </sentence>
  <sentence id="s2477" text="Our study reports the first mutations in the tRNA aminoacylation for protein translation and mitochondrial threonyl-tRNA aminoacylation genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.">
    <entity charOffset="45-88" id="s2477.e0" ontology_id="GO_0006418" text="tRNA aminoacylation for protein translation" type="GO"/>
    <entity charOffset="262-278" id="s2477.e1" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <pair e1="s2477.e0" e2="s2477.e1" id="s2477.p0" relation="false"/>
  </sentence>
  <sentence id="s2478" text="Our study reports the first mutations in the tRNA aminoacylation for protein translation and mitochondrial threonyl-tRNA aminoacylation genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.">
    <entity charOffset="93-135" id="s2478.e0" ontology_id="GO_0070159" text="mitochondrial threonyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="262-278" id="s2478.e1" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <pair e1="s2478.e0" e2="s2478.e1" id="s2478.p0" relation="false"/>
  </sentence>
  <sentence id="s2479" text="De novo monoallelic mutations in the adenylate cyclase-activating dopamine receptor signaling pathway gene, encoding a  subunit of heterotrimeric G proteins, cause a newly recognized disorder with the typical clinical picture of severe developmental delay/intellectual disability, hypotonia and extrapyramidal symptoms.">
    <entity charOffset="37-101" id="s2479.e0" ontology_id="GO_0007191" text="adenylate cyclase-activating dopamine receptor signaling pathway" type="GO"/>
    <entity charOffset="237-256" id="s2479.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2479.e0" e2="s2479.e1" id="s2479.p0" relation="true"/>
  </sentence>
  <sentence id="s2480" text="De novo monoallelic mutations in the adenylate cyclase-activating dopamine receptor signaling pathway gene, encoding a  subunit of heterotrimeric G proteins, cause a newly recognized disorder with the typical clinical picture of severe developmental delay/intellectual disability, hypotonia and extrapyramidal symptoms.">
    <entity charOffset="37-101" id="s2480.e0" ontology_id="GO_0007191" text="adenylate cyclase-activating dopamine receptor signaling pathway" type="GO"/>
    <entity charOffset="257-280" id="s2480.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2480.e0" e2="s2480.e1" id="s2480.p0" relation="true"/>
  </sentence>
  <sentence id="s2481" text="We describe another case of the condition with manifestations of cutaneous mastocytosis associated with a novel do novo mutation adenylate cyclase-activating dopamine receptor signaling pathwayNM_001282539.1: c.230G&amp;gt;T; p.(Gly77Val).">
    <entity charOffset="65-87" id="s2481.e0" ontology_id="HP_0200151" text="cutaneous mastocytosis" type="HP"/>
    <entity charOffset="129-193" id="s2481.e1" ontology_id="GO_0007191" text="adenylate cyclase-activating dopamine receptor signaling pathway" type="GO"/>
    <pair e1="s2481.e0" e2="s2481.e1" id="s2481.p0" relation="false"/>
  </sentence>
  <sentence id="s2482" text="Similarly, homozygous loss-of-function mutations in xenobiotic metabolic process, one of the major RA-metabolizing enzymes, cause advanced bone age, premature epiphyseal fusion, and craniosynostosis.">
    <entity charOffset="52-80" id="s2482.e0" ontology_id="GO_0006805" text="xenobiotic metabolic process" type="GO"/>
    <entity charOffset="182-198" id="s2482.e1" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <pair e1="s2482.e0" e2="s2482.e1" id="s2482.p0" relation="true"/>
  </sentence>
  <sentence id="s2483" text="Mutations in the extracellular matrix organization gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or glomerular basement membrane development are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.">
    <entity charOffset="17-50" id="s2483.e0" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <entity charOffset="212-231" id="s2483.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2483.e0" e2="s2483.e1" id="s2483.p0" relation="false"/>
  </sentence>
  <sentence id="s2484" text="Mutations in the extracellular matrix organization gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or glomerular basement membrane development are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.">
    <entity charOffset="151-191" id="s2484.e0" ontology_id="GO_0032836" text="glomerular basement membrane development" type="GO"/>
    <entity charOffset="212-231" id="s2484.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2484.e0" e2="s2484.e1" id="s2484.p0" relation="true"/>
  </sentence>
  <sentence id="s2485" text="This result suggests that COL4A3 and COL4A4 digenic mutations in interleukin-7-mediated signaling pathway mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown">
    <entity charOffset="65-105" id="s2485.e0" ontology_id="GO_0038111" text="interleukin-7-mediated signaling pathway" type="GO"/>
    <entity charOffset="138-149" id="s2485.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s2485.e0" e2="s2485.e1" id="s2485.p0" relation="false"/>
  </sentence>
  <sentence id="s2486" text="The schizophrenia-associated gene GRIN2A (glutamate ionotropic receptor NMDA muscle organ development subunit 2a) codes for a protein subunit of the NMDA (N-methyl-D-aspartate) receptor that underlies central aspects of human cognition.">
    <entity charOffset="4-17" id="s2486.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="77-101" id="s2486.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2486.e0" e2="s2486.e1" id="s2486.p0" relation="false"/>
  </sentence>
  <sentence id="s2487" text="The results also suggest that some schizophrenia-related alleles may be subject to cognitive tradeoffs involving both positive and negative effects on psychological phenomuscle organ developments, which may help to explain the maintenance of psychiatric-disorder risk alleles in human populations">
    <entity charOffset="35-48" id="s2487.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="170-194" id="s2487.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2487.e0" e2="s2487.e1" id="s2487.p0" relation="false"/>
  </sentence>
  <sentence id="s2488" text="The most significant association with childhood brain tumor risk was for IVS1-401G&amp;gt;C in the somatic diversification of immunoglobulins gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&amp;gt;C of CASP14 was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).">
    <entity charOffset="54-59" id="s2488.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="95-137" id="s2488.e1" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <pair e1="s2488.e0" e2="s2488.e1" id="s2488.p0" relation="false"/>
  </sentence>
  <sentence id="s2489" text="We concluded that genetic polymorphisms in somatic diversification of immunoglobulins and CASP14 are associated with risk for brain tumor in Korean children.">
    <entity charOffset="43-85" id="s2489.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="132-137" id="s2489.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2489.e0" e2="s2489.e1" id="s2489.p0" relation="false"/>
  </sentence>
  <sentence id="s2490" text="Clinical trials have revealed that inhibition of sonic Hedgehog (SHH) signaling or histone deacetylase (negative regulation of transcription by RNA polymerase II) holds promise as a treatment for liver cancer.">
    <entity charOffset="104-161" id="s2490.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="202-208" id="s2490.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2490.e0" e2="s2490.e1" id="s2490.p0" relation="false"/>
  </sentence>
  <sentence id="s2491" text="The results revealed that the dual use of the SHH inhibitor and the negative regulation of transcription by RNA polymerase II inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver cancer cells.">
    <entity charOffset="68-125" id="s2491.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="216-222" id="s2491.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2491.e0" e2="s2491.e1" id="s2491.p0" relation="false"/>
  </sentence>
  <sentence id="s2492" text="Genetic variation in the neutrophil degranulation/regulation of cell growth region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.">
    <entity charOffset="25-49" id="s2492.e0" ontology_id="GO_0043312" text="neutrophil degranulation" type="GO"/>
    <entity charOffset="176-182" id="s2492.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2492.e0" e2="s2492.e1" id="s2492.p0" relation="true"/>
  </sentence>
  <sentence id="s2493" text="Genetic variation in the neutrophil degranulation/regulation of cell growth region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.">
    <entity charOffset="25-49" id="s2493.e0" ontology_id="GO_0043312" text="neutrophil degranulation" type="GO"/>
    <entity charOffset="130-165" id="s2493.e1" ontology_id="HP_0006739" text="squamous cell carcinoma of the skin" type="HP"/>
    <pair e1="s2493.e0" e2="s2493.e1" id="s2493.p0" relation="false"/>
  </sentence>
  <sentence id="s2494" text="Genetic variation in the neutrophil degranulation/regulation of cell growth region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.">
    <entity charOffset="50-75" id="s2494.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="176-182" id="s2494.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2494.e0" e2="s2494.e1" id="s2494.p0" relation="true"/>
  </sentence>
  <sentence id="s2495" text="Genetic variation in the neutrophil degranulation/regulation of cell growth region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.">
    <entity charOffset="50-75" id="s2495.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="130-165" id="s2495.e1" ontology_id="HP_0006739" text="squamous cell carcinoma of the skin" type="HP"/>
    <pair e1="s2495.e0" e2="s2495.e1" id="s2495.p0" relation="false"/>
  </sentence>
  <sentence id="s2496" text="Here, we have tested the hypothesis that the common regulation of cell growth SNP rs7208422 is associated with high-risk HPV infection and risk of head and neck squamous cell carcinoma (HNSCC).">
    <entity charOffset="52-77" id="s2496.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="161-184" id="s2496.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s2496.e0" e2="s2496.e1" id="s2496.p0" relation="true"/>
  </sentence>
  <sentence id="s2497" text="The negative regulation of transcription by RNA polymerase II mutant epidermis development have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.">
    <entity charOffset="4-61" id="s2497.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="158-172" id="s2497.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s2497.e0" e2="s2497.e1" id="s2497.p0" relation="true"/>
  </sentence>
  <sentence id="s2498" text="The negative regulation of transcription by RNA polymerase II mutant epidermis development have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.">
    <entity charOffset="4-61" id="s2498.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="219-225" id="s2498.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2498.e0" e2="s2498.e1" id="s2498.p0" relation="false"/>
  </sentence>
  <sentence id="s2499" text="The negative regulation of transcription by RNA polymerase II mutant epidermis development have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.">
    <entity charOffset="69-90" id="s2499.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="158-172" id="s2499.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s2499.e0" e2="s2499.e1" id="s2499.p0" relation="false"/>
  </sentence>
  <sentence id="s2500" text="The negative regulation of transcription by RNA polymerase II mutant epidermis development have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.">
    <entity charOffset="69-90" id="s2500.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="219-225" id="s2500.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2500.e0" e2="s2500.e1" id="s2500.p0" relation="false"/>
  </sentence>
  <sentence id="s2501" text="positive regulation of cell proliferation signalling from the prechordal plate and ventral midline of the diencephalon is required for appropriate division of the eyefield and forebrain, with mutation in a number of pathway components associated with Holoprosencephaly, a clinically heterogeneous developmental defect characterized by a failure of the early forebrain vesicle to divide into distinct halves.">
    <entity charOffset="0-41" id="s2501.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="283-296" id="s2501.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2501.e0" e2="s2501.e1" id="s2501.p0" relation="false"/>
  </sentence>
  <sentence id="s2502" text="In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of chromatin organization (joint p-value: 3.6x10-06) and pyrimidine nucleoside biosynthetic process (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).">
    <entity charOffset="107-113" id="s2502.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="141-163" id="s2502.e1" ontology_id="GO_0006325" text="chromatin organization" type="GO"/>
    <pair e1="s2502.e0" e2="s2502.e1" id="s2502.p0" relation="false"/>
  </sentence>
  <sentence id="s2503" text="In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of chromatin organization (joint p-value: 3.6x10-06) and pyrimidine nucleoside biosynthetic process (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).">
    <entity charOffset="107-113" id="s2503.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="195-237" id="s2503.e1" ontology_id="GO_0046134" text="pyrimidine nucleoside biosynthetic process" type="GO"/>
    <pair e1="s2503.e0" e2="s2503.e1" id="s2503.p0" relation="false"/>
  </sentence>
  <sentence id="s2504" text="While genome-wide association studies (GWAS) have implicated chromatin organization and protein export from nucleus in breast cancer risk, they have not identified the remaining three genes.">
    <entity charOffset="61-83" id="s2504.e0" ontology_id="GO_0006325" text="chromatin organization" type="GO"/>
    <entity charOffset="126-132" id="s2504.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2504.e0" e2="s2504.e1" id="s2504.p0" relation="false"/>
  </sentence>
  <sentence id="s2505" text="While genome-wide association studies (GWAS) have implicated chromatin organization and protein export from nucleus in breast cancer risk, they have not identified the remaining three genes.">
    <entity charOffset="88-115" id="s2505.e0" ontology_id="GO_0006611" text="protein export from nucleus" type="GO"/>
    <entity charOffset="126-132" id="s2505.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2505.e0" e2="s2505.e1" id="s2505.p0" relation="false"/>
  </sentence>
  <sentence id="s2506" text="Collectively, negative regulation of regulatory T cell differentiationL supports the induction of durable, antigen-specific Th17/Th1-mediated immunity in vivo, establishing a vaccination platform to enhance CD4&lt;sup&gt;+&lt;/sup&gt; T cell-mediated antitumor immunity and providing a crucial component of an effective cancer vaccine">
    <entity charOffset="14-70" id="s2506.e0" ontology_id="GO_0045590" text="negative regulation of regulatory T cell differentiation" type="GO"/>
    <entity charOffset="308-314" id="s2506.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2506.e0" e2="s2506.e1" id="s2506.p0" relation="true"/>
  </sentence>
  <sentence id="s2507" text="Collectively, negative regulation of regulatory T cell differentiationL supports the induction of durable, antigen-specific Th17/Th1-mediated immunity in vivo, establishing a vaccination platform to enhance CD4&lt;sup&gt;+&lt;/sup&gt; T cell-mediated antitumor immunity and providing a crucial component of an effective cancer vaccine">
    <entity charOffset="14-70" id="s2507.e0" ontology_id="GO_0045590" text="negative regulation of regulatory T cell differentiation" type="GO"/>
    <entity charOffset="243-248" id="s2507.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2507.e0" e2="s2507.e1" id="s2507.p0" relation="true"/>
  </sentence>
  <sentence id="s2508" text="Muscarinic acetylcholine receptor M3 (G protein-coupled acetylcholine receptor signaling pathway) was reported as a key receptor in different cancer types.">
    <entity charOffset="38-96" id="s2508.e0" ontology_id="GO_0007213" text="G protein-coupled acetylcholine receptor signaling pathway" type="GO"/>
    <entity charOffset="142-148" id="s2508.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2508.e0" e2="s2508.e1" id="s2508.p0" relation="false"/>
  </sentence>
  <sentence id="s2509" text="&lt;i&gt;G protein-coupled acetylcholine receptor signaling pathway&lt;/i&gt; is located at 1q42-43 which was reported to associate with bladder cancer.">
    <entity charOffset="3-61" id="s2509.e0" ontology_id="GO_0007213" text="G protein-coupled acetylcholine receptor signaling pathway" type="GO"/>
    <entity charOffset="133-139" id="s2509.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2509.e0" e2="s2509.e1" id="s2509.p0" relation="false"/>
  </sentence>
  <sentence id="s2510" text="Our study attempted to delineate whether genetic variants of &lt;i&gt;G protein-coupled acetylcholine receptor signaling pathway&lt;/i&gt; contribute to bladder cancer in Chinese Han population in south Taiwan.">
    <entity charOffset="64-122" id="s2510.e0" ontology_id="GO_0007213" text="G protein-coupled acetylcholine receptor signaling pathway" type="GO"/>
    <entity charOffset="149-155" id="s2510.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2510.e0" e2="s2510.e1" id="s2510.p0" relation="false"/>
  </sentence>
  <sentence id="s2511" text="To our knowledge, this is the first genetic association study that reveals the genetic contribution of &lt;i&gt;G protein-coupled acetylcholine receptor signaling pathway&lt;/i&gt; gene in bladder cancer etiology">
    <entity charOffset="106-164" id="s2511.e0" ontology_id="GO_0007213" text="G protein-coupled acetylcholine receptor signaling pathway" type="GO"/>
    <entity charOffset="185-191" id="s2511.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2511.e0" e2="s2511.e1" id="s2511.p0" relation="false"/>
  </sentence>
  <sentence id="s2512" text="Fuchs endothelial corneal dystrophy (extracellular matrix organization) is the most common late-onset, vision-threatening corneal dystrophy in the United States, affecting about 4% of the population.">
    <entity charOffset="18-35" id="s2512.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="37-70" id="s2512.e1" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <pair e1="s2512.e0" e2="s2512.e1" id="s2512.p0" relation="true"/>
  </sentence>
  <sentence id="s2513" text="Advanced extracellular matrix organization involves a thickening of the cornea from stromal edema and changes in Descemet membrane.">
    <entity charOffset="9-42" id="s2513.e0" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <entity charOffset="92-97" id="s2513.e1" ontology_id="HP_0000969" text="edema" type="HP"/>
    <pair e1="s2513.e0" e2="s2513.e1" id="s2513.p0" relation="true"/>
  </sentence>
  <sentence id="s2514" text="Gentranscription by RNA polymerase IIlized epilepsies, particularly the idiopathic or genetic generalized epilepsies (GGEs), represent some of the most common epilepsies.">
    <entity charOffset="3-37" id="s2514.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="43-53" id="s2514.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s2514.e0" e2="s2514.e1" id="s2514.p0" relation="false"/>
  </sentence>
  <sentence id="s2515" text="The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, SCN1B, inhibitory synapse assembly, and GABRA1.">
    <entity charOffset="101-135" id="s2515.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="141-151" id="s2515.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s2515.e0" e2="s2515.e1" id="s2515.p0" relation="false"/>
  </sentence>
  <sentence id="s2516" text="The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, SCN1B, inhibitory synapse assembly, and GABRA1.">
    <entity charOffset="141-151" id="s2516.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="306-366" id="s2516.e1" ontology_id="GO_0086002" text="cardiac muscle cell action potential involved in contraction" type="GO"/>
    <pair e1="s2516.e0" e2="s2516.e1" id="s2516.p0" relation="true"/>
  </sentence>
  <sentence id="s2517" text="The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, SCN1B, inhibitory synapse assembly, and GABRA1.">
    <entity charOffset="141-151" id="s2517.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="375-402" id="s2517.e1" ontology_id="GO_1904862" text="inhibitory synapse assembly" type="GO"/>
    <pair e1="s2517.e0" e2="s2517.e1" id="s2517.p0" relation="true"/>
  </sentence>
  <sentence id="s2518" text="Genes for epileptic encephalopathies such as protein-containing complex assembly were rediscovered in GGE, highlighting the biological continuum between different epilepsies.">
    <entity charOffset="20-36" id="s2518.e0" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <entity charOffset="45-80" id="s2518.e1" ontology_id="GO_0065003" text="protein-containing complex assembly" type="GO"/>
    <pair e1="s2518.e0" e2="s2518.e1" id="s2518.p0" relation="true"/>
  </sentence>
  <sentence id="s2519" text="Genes for epileptic encephalopathies such as protein-containing complex assembly were rediscovered in GGE, highlighting the biological continuum between different epilepsies.">
    <entity charOffset="45-80" id="s2519.e0" ontology_id="GO_0065003" text="protein-containing complex assembly" type="GO"/>
    <entity charOffset="163-173" id="s2519.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s2519.e0" e2="s2519.e1" id="s2519.p0" relation="true"/>
  </sentence>
  <sentence id="s2520" text="However, the role of circRNAs in age-related cataract (mRNA splice site selection), the leading cause of visual impairment worldwide, is still unknown.">
    <entity charOffset="45-53" id="s2520.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="55-81" id="s2520.e1" ontology_id="GO_0006376" text="mRNA splice site selection" type="GO"/>
    <pair e1="s2520.e0" e2="s2520.e1" id="s2520.p0" relation="false"/>
  </sentence>
  <sentence id="s2521" text="However, the role of circRNAs in age-related cataract (mRNA splice site selection), the leading cause of visual impairment worldwide, is still unknown.">
    <entity charOffset="55-81" id="s2521.e0" ontology_id="GO_0006376" text="mRNA splice site selection" type="GO"/>
    <entity charOffset="105-122" id="s2521.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s2521.e0" e2="s2521.e1" id="s2521.p0" relation="false"/>
  </sentence>
  <sentence id="s2522" text="The short-rib polydactyly syndromes (muscle contractionS) are autosomal recessively inherited, genetically heterogeneous skeletal ciliopathies.">
    <entity charOffset="14-25" id="s2522.e0" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <entity charOffset="37-55" id="s2522.e1" ontology_id="GO_0006936" text="muscle contraction" type="GO"/>
    <pair e1="s2522.e0" e2="s2522.e1" id="s2522.p0" relation="false"/>
  </sentence>
  <sentence id="s2523" text="The short-rib polydactyly syndromes (muscle contractionS) are autosomal recessively inherited, genetically heterogeneous skeletal ciliopathies.">
    <entity charOffset="37-55" id="s2523.e0" ontology_id="GO_0006936" text="muscle contraction" type="GO"/>
    <entity charOffset="107-120" id="s2523.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2523.e0" e2="s2523.e1" id="s2523.p0" relation="false"/>
  </sentence>
  <sentence id="s2524" text="Here, we report that variants in protein complex oligomerization result in progressive childhood encephalopathy.">
    <entity charOffset="33-64" id="s2524.e0" ontology_id="GO_0051259" text="protein complex oligomerization" type="GO"/>
    <entity charOffset="97-111" id="s2524.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s2524.e0" e2="s2524.e1" id="s2524.p0" relation="true"/>
  </sentence>
  <sentence id="s2525" text="Specifically, ADHFE1, positive regulation of cardiac muscle hypertrophy, and protein folding were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.">
    <entity charOffset="22-71" id="s2525.e0" ontology_id="GO_0010613" text="positive regulation of cardiac muscle hypertrophy" type="GO"/>
    <entity charOffset="141-147" id="s2525.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2525.e0" e2="s2525.e1" id="s2525.p0" relation="false"/>
  </sentence>
  <sentence id="s2526" text="Specifically, ADHFE1, positive regulation of cardiac muscle hypertrophy, and protein folding were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.">
    <entity charOffset="77-92" id="s2526.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="141-147" id="s2526.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2526.e0" e2="s2526.e1" id="s2526.p0" relation="false"/>
  </sentence>
  <sentence id="s2527" text="The pH-sensing receptor ovarian cancer G protein-coupled receptor 1 (inflammatory response; inflammatory response) is expressed in the gut.">
    <entity charOffset="32-38" id="s2527.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="69-90" id="s2527.e1" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <pair e1="s2527.e0" e2="s2527.e1" id="s2527.p0" relation="false"/>
  </sentence>
  <sentence id="s2528" text="The pH-sensing receptor ovarian cancer G protein-coupled receptor 1 (inflammatory response; inflammatory response) is expressed in the gut.">
    <entity charOffset="32-38" id="s2528.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="92-113" id="s2528.e1" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <pair e1="s2528.e0" e2="s2528.e1" id="s2528.p0" relation="false"/>
  </sentence>
  <sentence id="s2529" text="Congenital hypogonadotrophic hypogonadism (CHH) is a challenging inherited endocrine disorder characterised by absent or incomplete pubertal development and infertility as a result of the low action/secretion of the hypothalamic gonadotrophin-releasing hormone (signal transduction).">
    <entity charOffset="29-41" id="s2529.e0" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <entity charOffset="262-281" id="s2529.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s2529.e0" e2="s2529.e1" id="s2529.p0" relation="true"/>
  </sentence>
  <sentence id="s2530" text="Previously, a homozygous missense mutation in mRNA export from nucleus in the Hutterite population was reported in association with syndromic intellectual disability.">
    <entity charOffset="46-70" id="s2530.e0" ontology_id="GO_0006406" text="mRNA export from nucleus" type="GO"/>
    <entity charOffset="142-165" id="s2530.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2530.e0" e2="s2530.e1" id="s2530.p0" relation="true"/>
  </sentence>
  <sentence id="s2531" text="Our results expand the mutational and clinical spectrum of this rare disease, confirm that mRNA export from nucleus is an intellectual disability causing gene, while providing insight into the importance of the THO complex in neurodevelopment">
    <entity charOffset="91-115" id="s2531.e0" ontology_id="GO_0006406" text="mRNA export from nucleus" type="GO"/>
    <entity charOffset="122-145" id="s2531.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2531.e0" e2="s2531.e1" id="s2531.p0" relation="true"/>
  </sentence>
  <sentence id="s2532" text="Our study demonstrated that AURKA rs1047972 TT and (CC+CT) genomuscle organ developments were significantly associated with an increased risk of gastric cancer.">
    <entity charOffset="65-89" id="s2532.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="155-161" id="s2532.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2532.e0" e2="s2532.e1" id="s2532.p0" relation="false"/>
  </sentence>
  <sentence id="s2533" text="Malfunction of mutant protein farnesylation proteins triggers a severe form of Leber congenital amaurosis and leads to blindness.">
    <entity charOffset="22-43" id="s2533.e0" ontology_id="GO_0018343" text="protein farnesylation" type="GO"/>
    <entity charOffset="119-128" id="s2533.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s2533.e0" e2="s2533.e1" id="s2533.p0" relation="true"/>
  </sentence>
  <sentence id="s2534" text="Several mouse models have been described for this gene; epidermis development heterozygous for loss-of-function defects display a rapidly progressive high-frequency hearing impairment.">
    <entity charOffset="56-77" id="s2534.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="165-183" id="s2534.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s2534.e0" e2="s2534.e1" id="s2534.p0" relation="false"/>
  </sentence>
  <sentence id="s2535" text="Up to now cellular calcium ion homeostasis has only been reported as a modifier, or in a digenic mechanism with calcium ion transport for hearing impairment in humans.">
    <entity charOffset="10-42" id="s2535.e0" ontology_id="GO_0006874" text="cellular calcium ion homeostasis" type="GO"/>
    <entity charOffset="138-156" id="s2535.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s2535.e0" e2="s2535.e1" id="s2535.p0" relation="false"/>
  </sentence>
  <sentence id="s2536" text="Up to now cellular calcium ion homeostasis has only been reported as a modifier, or in a digenic mechanism with calcium ion transport for hearing impairment in humans.">
    <entity charOffset="112-133" id="s2536.e0" ontology_id="GO_0006816" text="calcium ion transport" type="GO"/>
    <entity charOffset="138-156" id="s2536.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s2536.e0" e2="s2536.e1" id="s2536.p0" relation="true"/>
  </sentence>
  <sentence id="s2537" text="Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and calcium ion transport, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2">
    <entity charOffset="11-30" id="s2537.e0" ontology_id="HP_0010984" text="digenic inheritance" type="HP"/>
    <entity charOffset="128-149" id="s2537.e1" ontology_id="GO_0006816" text="calcium ion transport" type="GO"/>
    <pair e1="s2537.e0" e2="s2537.e1" id="s2537.p0" relation="false"/>
  </sentence>
  <sentence id="s2538" text="Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and calcium ion transport, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2">
    <entity charOffset="42-60" id="s2538.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="128-149" id="s2538.e1" ontology_id="GO_0006816" text="calcium ion transport" type="GO"/>
    <pair e1="s2538.e0" e2="s2538.e1" id="s2538.p0" relation="true"/>
  </sentence>
  <sentence id="s2539" text="Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic glycogen catabolic process triplet expansion in the regulation of ferrochelatase activity gene, leading to reduced expression of the mitochondrial protein frataxin.">
    <entity charOffset="13-19" id="s2539.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="81-107" id="s2539.e1" ontology_id="GO_0005980" text="glycogen catabolic process" type="GO"/>
    <pair e1="s2539.e0" e2="s2539.e1" id="s2539.p0" relation="false"/>
  </sentence>
  <sentence id="s2540" text="Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic glycogen catabolic process triplet expansion in the regulation of ferrochelatase activity gene, leading to reduced expression of the mitochondrial protein frataxin.">
    <entity charOffset="13-19" id="s2540.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="133-170" id="s2540.e1" ontology_id="GO_0010722" text="regulation of ferrochelatase activity" type="GO"/>
    <pair e1="s2540.e0" e2="s2540.e1" id="s2540.p0" relation="true"/>
  </sentence>
  <sentence id="s2541" text="Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic glycogen catabolic process triplet expansion in the regulation of ferrochelatase activity gene, leading to reduced expression of the mitochondrial protein frataxin.">
    <entity charOffset="31-50" id="s2541.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="81-107" id="s2541.e1" ontology_id="GO_0005980" text="glycogen catabolic process" type="GO"/>
    <pair e1="s2541.e0" e2="s2541.e1" id="s2541.p0" relation="true"/>
  </sentence>
  <sentence id="s2542" text="Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic glycogen catabolic process triplet expansion in the regulation of ferrochelatase activity gene, leading to reduced expression of the mitochondrial protein frataxin.">
    <entity charOffset="31-50" id="s2542.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="133-170" id="s2542.e1" ontology_id="GO_0010722" text="regulation of ferrochelatase activity" type="GO"/>
    <pair e1="s2542.e0" e2="s2542.e1" id="s2542.p0" relation="true"/>
  </sentence>
  <sentence id="s2543" text="epithelial to mesenchymal transition-positive regulation of transcription by RNA polymerase II promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.">
    <entity charOffset="0-36" id="s2543.e0" ontology_id="GO_0001837" text="epithelial to mesenchymal transition" type="GO"/>
    <entity charOffset="106-111" id="s2543.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2543.e0" e2="s2543.e1" id="s2543.p0" relation="false"/>
  </sentence>
  <sentence id="s2544" text="epithelial to mesenchymal transition-positive regulation of transcription by RNA polymerase II promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.">
    <entity charOffset="37-94" id="s2544.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="180-186" id="s2544.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2544.e0" e2="s2544.e1" id="s2544.p0" relation="true"/>
  </sentence>
  <sentence id="s2545" text="epithelial to mesenchymal transition-positive regulation of transcription by RNA polymerase II promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.">
    <entity charOffset="37-94" id="s2545.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="106-111" id="s2545.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2545.e0" e2="s2545.e1" id="s2545.p0" relation="true"/>
  </sentence>
  <sentence id="s2546" text="Focal epilepsies, where seizures initiate in spatially limited networks, are the most frequent epilepsy muscle organ development, accounting for two-thirds of patients.">
    <entity charOffset="95-103" id="s2546.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="104-128" id="s2546.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2546.e0" e2="s2546.e1" id="s2546.p0" relation="false"/>
  </sentence>
  <sentence id="s2547" text="Brain somatic mutations in the gene encoding regulation of cell growth (regulation of cell growth) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.">
    <entity charOffset="45-70" id="s2547.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="134-152" id="s2547.e1" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <pair e1="s2547.e0" e2="s2547.e1" id="s2547.p0" relation="true"/>
  </sentence>
  <sentence id="s2548" text="Brain somatic mutations in the gene encoding regulation of cell growth (regulation of cell growth) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.">
    <entity charOffset="45-70" id="s2548.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="202-220" id="s2548.e1" ontology_id="HP_0007206" text="hemimegalencephaly" type="HP"/>
    <pair e1="s2548.e0" e2="s2548.e1" id="s2548.p0" relation="true"/>
  </sentence>
  <sentence id="s2549" text="Brain somatic mutations in the gene encoding regulation of cell growth (regulation of cell growth) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.">
    <entity charOffset="72-97" id="s2549.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="134-152" id="s2549.e1" ontology_id="HP_0002539" text="cortical dysplasia" type="HP"/>
    <pair e1="s2549.e0" e2="s2549.e1" id="s2549.p0" relation="true"/>
  </sentence>
  <sentence id="s2550" text="In subgroup analysis, compared with PD patients with initial symptom of tremor and mitochondrion organization, the positive regulation of glucose transmembrane transport allele frequency of ribosomal large subunit export from nucleus rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.">
    <entity charOffset="83-109" id="s2550.e0" ontology_id="GO_0007005" text="mitochondrion organization" type="GO"/>
    <entity charOffset="294-306" id="s2550.e1" ontology_id="HP_0002067" text="bradykinesia" type="HP"/>
    <pair e1="s2550.e0" e2="s2550.e1" id="s2550.p0" relation="false"/>
  </sentence>
  <sentence id="s2551" text="In subgroup analysis, compared with PD patients with initial symptom of tremor and mitochondrion organization, the positive regulation of glucose transmembrane transport allele frequency of ribosomal large subunit export from nucleus rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.">
    <entity charOffset="115-169" id="s2551.e0" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <entity charOffset="294-306" id="s2551.e1" ontology_id="HP_0002067" text="bradykinesia" type="HP"/>
    <pair e1="s2551.e0" e2="s2551.e1" id="s2551.p0" relation="false"/>
  </sentence>
  <sentence id="s2552" text="In subgroup analysis, compared with PD patients with initial symptom of tremor and mitochondrion organization, the positive regulation of glucose transmembrane transport allele frequency of ribosomal large subunit export from nucleus rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.">
    <entity charOffset="190-233" id="s2552.e0" ontology_id="GO_0000055" text="ribosomal large subunit export from nucleus" type="GO"/>
    <entity charOffset="294-306" id="s2552.e1" ontology_id="HP_0002067" text="bradykinesia" type="HP"/>
    <pair e1="s2552.e0" e2="s2552.e1" id="s2552.p0" relation="false"/>
  </sentence>
  <sentence id="s2553" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, extracellular matrix disassembly, PFN1, mitotic cytokinesis, CFN1) associated with loss of double-strand break repair via homologous recombination function.">
    <entity charOffset="60-65" id="s2553.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="299-354" id="s2553.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2553.e0" e2="s2553.e1" id="s2553.p0" relation="true"/>
  </sentence>
  <sentence id="s2554" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, extracellular matrix disassembly, PFN1, mitotic cytokinesis, CFN1) associated with loss of double-strand break repair via homologous recombination function.">
    <entity charOffset="60-65" id="s2554.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="208-240" id="s2554.e1" ontology_id="GO_0022617" text="extracellular matrix disassembly" type="GO"/>
    <pair e1="s2554.e0" e2="s2554.e1" id="s2554.p0" relation="false"/>
  </sentence>
  <sentence id="s2555" text="We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, extracellular matrix disassembly, PFN1, mitotic cytokinesis, CFN1) associated with loss of double-strand break repair via homologous recombination function.">
    <entity charOffset="60-65" id="s2555.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="248-267" id="s2555.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s2555.e0" e2="s2555.e1" id="s2555.p0" relation="false"/>
  </sentence>
  <sentence id="s2556" text="By immunohistochemistry of ovarian tumors with double-strand break repair via homologous recombination(+/+) and BRCA1(null) status, we further verified our proteomic-based finding of elevated negative regulation of actin filament polymerization expression associated with BRCA1 deficiency.">
    <entity charOffset="35-40" id="s2556.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="47-102" id="s2556.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s2556.e0" e2="s2556.e1" id="s2556.p0" relation="true"/>
  </sentence>
  <sentence id="s2557" text="By immunohistochemistry of ovarian tumors with double-strand break repair via homologous recombination(+/+) and BRCA1(null) status, we further verified our proteomic-based finding of elevated negative regulation of actin filament polymerization expression associated with BRCA1 deficiency.">
    <entity charOffset="35-40" id="s2557.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="192-244" id="s2557.e1" ontology_id="GO_0030837" text="negative regulation of actin filament polymerization" type="GO"/>
    <pair e1="s2557.e0" e2="s2557.e1" id="s2557.p0" relation="false"/>
  </sentence>
  <sentence id="s2558" text="Finally, we established a causal link between negative regulation of actin filament polymerization and double-strand break repair via homologous recombination-induced changes in cell migration thus uncovering a novel mechanistic basis for BRCA1-dependent regulation of ovarian cancer cell migration.">
    <entity charOffset="46-98" id="s2558.e0" ontology_id="GO_0030837" text="negative regulation of actin filament polymerization" type="GO"/>
    <entity charOffset="277-283" id="s2558.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2558.e0" e2="s2558.e1" id="s2558.p0" relation="false"/>
  </sentence>
  <sentence id="s2559" text="Finally, we established a causal link between negative regulation of actin filament polymerization and double-strand break repair via homologous recombination-induced changes in cell migration thus uncovering a novel mechanistic basis for BRCA1-dependent regulation of ovarian cancer cell migration.">
    <entity charOffset="103-158" id="s2559.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="277-283" id="s2559.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2559.e0" e2="s2559.e1" id="s2559.p0" relation="true"/>
  </sentence>
  <sentence id="s2560" text="Mutations in Ankyrin repeat and sterile alpha motif domain containing 6 (biological_process) play a causative role in renal cyst formation in the PKD/Mhm(cy/+) rat model of polycystic kidney disease and in nephronophthisis in humans.">
    <entity charOffset="73-91" id="s2560.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="118-128" id="s2560.e1" ontology_id="HP_0000107" text="renal cyst" type="HP"/>
    <pair e1="s2560.e0" e2="s2560.e1" id="s2560.p0" relation="true"/>
  </sentence>
  <sentence id="s2561" text="A network of protein partners of biological_process is emerging and their functional characterization provides important clues to understand the role of ANKS6 in renal biology and in mechanisms involved in the formation of renal cysts.">
    <entity charOffset="33-51" id="s2561.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="223-233" id="s2561.e1" ontology_id="HP_0000107" text="renal cyst" type="HP"/>
    <pair e1="s2561.e0" e2="s2561.e1" id="s2561.p0" relation="true"/>
  </sentence>
  <sentence id="s2562" text="Upregulated LINC00963 led to elevated expression of protein homooligomerization through inhibiting protein polyubiquitination-608, which consequently promoted melanoma malignant progression.">
    <entity charOffset="52-79" id="s2562.e0" ontology_id="GO_0051260" text="protein homooligomerization" type="GO"/>
    <entity charOffset="159-167" id="s2562.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2562.e0" e2="s2562.e1" id="s2562.p0" relation="false"/>
  </sentence>
  <sentence id="s2563" text="Upregulated LINC00963 led to elevated expression of protein homooligomerization through inhibiting protein polyubiquitination-608, which consequently promoted melanoma malignant progression.">
    <entity charOffset="99-125" id="s2563.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="159-167" id="s2563.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2563.e0" e2="s2563.e1" id="s2563.p0" relation="false"/>
  </sentence>
  <sentence id="s2564" text="Taken together, our results illustrated that LINC00963-protein polyubiquitination-608-NACC1 pathway might be a potential target for melanoma therapy">
    <entity charOffset="55-81" id="s2564.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="132-140" id="s2564.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s2564.e0" e2="s2564.e1" id="s2564.p0" relation="false"/>
  </sentence>
  <sentence id="s2565" text="We recently reported that centrosomal protein 164 (cilium assembly) regulates both cilia and the DNA cellular protein catabolic process response in the autosomal recessive polycystic kidney disease nephronophthisis.">
    <entity charOffset="51-66" id="s2565.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="152-171" id="s2565.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2565.e0" e2="s2565.e1" id="s2565.p0" relation="true"/>
  </sentence>
  <sentence id="s2566" text="We recently reported that centrosomal protein 164 (cilium assembly) regulates both cilia and the DNA cellular protein catabolic process response in the autosomal recessive polycystic kidney disease nephronophthisis.">
    <entity charOffset="101-135" id="s2566.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="152-171" id="s2566.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2566.e0" e2="s2566.e1" id="s2566.p0" relation="false"/>
  </sentence>
  <sentence id="s2567" text="Jeune asphyxiating thoracic dystrophy (JATD) is a skeletal dysplasia characterized by a small thoracic biological_process and a range of skeletal and extra-skeletal anomalies.">
    <entity charOffset="50-68" id="s2567.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="103-121" id="s2567.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s2567.e0" e2="s2567.e1" id="s2567.p0" relation="false"/>
  </sentence>
  <sentence id="s2568" text="Inhibition of the positive regulation of centriole elongation ortholog in zebrafish produced pleiotropic phenotypes characteristic of cilia defects including abnormal body curvature, hydrocephalus, otolith defects and abnormal renal, head and craniofacial development.">
    <entity charOffset="18-61" id="s2568.e0" ontology_id="GO_1903724" text="positive regulation of centriole elongation" type="GO"/>
    <entity charOffset="183-196" id="s2568.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s2568.e0" e2="s2568.e1" id="s2568.p0" relation="true"/>
  </sentence>
  <sentence id="s2569" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-140" id="s2569.e0" ontology_id="GO_0030166" text="proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="400-416" id="s2569.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s2569.e0" e2="s2569.e1" id="s2569.p0" relation="false"/>
  </sentence>
  <sentence id="s2570" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-140" id="s2570.e0" ontology_id="GO_0030166" text="proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="418-428" id="s2570.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s2570.e0" e2="s2570.e1" id="s2570.p0" relation="false"/>
  </sentence>
  <sentence id="s2571" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-140" id="s2571.e0" ontology_id="GO_0030166" text="proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="430-439" id="s2571.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2571.e0" e2="s2571.e1" id="s2571.p0" relation="false"/>
  </sentence>
  <sentence id="s2572" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="107-140" id="s2572.e0" ontology_id="GO_0030166" text="proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="452-460" id="s2572.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2572.e0" e2="s2572.e1" id="s2572.p0" relation="true"/>
  </sentence>
  <sentence id="s2573" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="142-191" id="s2573.e0" ontology_id="GO_0015012" text="heparan sulfate proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="441-450" id="s2573.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s2573.e0" e2="s2573.e1" id="s2573.p0" relation="true"/>
  </sentence>
  <sentence id="s2574" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="142-191" id="s2574.e0" ontology_id="GO_0015012" text="heparan sulfate proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="430-439" id="s2574.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2574.e0" e2="s2574.e1" id="s2574.p0" relation="true"/>
  </sentence>
  <sentence id="s2575" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="142-191" id="s2575.e0" ontology_id="GO_0015012" text="heparan sulfate proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="452-460" id="s2575.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2575.e0" e2="s2575.e1" id="s2575.p0" relation="false"/>
  </sentence>
  <sentence id="s2576" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="142-191" id="s2576.e0" ontology_id="GO_0015012" text="heparan sulfate proteoglycan biosynthetic process" type="GO"/>
    <entity charOffset="499-517" id="s2576.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s2576.e0" e2="s2576.e1" id="s2576.p0" relation="true"/>
  </sentence>
  <sentence id="s2577" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="193-231" id="s2577.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="400-416" id="s2577.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s2577.e0" e2="s2577.e1" id="s2577.p0" relation="false"/>
  </sentence>
  <sentence id="s2578" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="193-231" id="s2578.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="441-450" id="s2578.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s2578.e0" e2="s2578.e1" id="s2578.p0" relation="false"/>
  </sentence>
  <sentence id="s2579" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="193-231" id="s2579.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="418-428" id="s2579.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s2579.e0" e2="s2579.e1" id="s2579.p0" relation="false"/>
  </sentence>
  <sentence id="s2580" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="193-231" id="s2580.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="430-439" id="s2580.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2580.e0" e2="s2580.e1" id="s2580.p0" relation="false"/>
  </sentence>
  <sentence id="s2581" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="193-231" id="s2581.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="452-460" id="s2581.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2581.e0" e2="s2581.e1" id="s2581.p0" relation="false"/>
  </sentence>
  <sentence id="s2582" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="193-231" id="s2582.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="499-517" id="s2582.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s2582.e0" e2="s2582.e1" id="s2582.p0" relation="false"/>
  </sentence>
  <sentence id="s2583" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="233-271" id="s2583.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="400-416" id="s2583.e1" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <pair e1="s2583.e0" e2="s2583.e1" id="s2583.p0" relation="false"/>
  </sentence>
  <sentence id="s2584" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="233-271" id="s2584.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="441-450" id="s2584.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s2584.e0" e2="s2584.e1" id="s2584.p0" relation="false"/>
  </sentence>
  <sentence id="s2585" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="233-271" id="s2585.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="430-439" id="s2585.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2585.e0" e2="s2585.e1" id="s2585.p0" relation="false"/>
  </sentence>
  <sentence id="s2586" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="233-271" id="s2586.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="452-460" id="s2586.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2586.e0" e2="s2586.e1" id="s2586.p0" relation="false"/>
  </sentence>
  <sentence id="s2587" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="233-271" id="s2587.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="499-517" id="s2587.e1" ontology_id="HP_0000541" text="retinal detachment" type="HP"/>
    <pair e1="s2587.e0" e2="s2587.e1" id="s2587.p0" relation="false"/>
  </sentence>
  <sentence id="s2588" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="277-315" id="s2588.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="441-450" id="s2588.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s2588.e0" e2="s2588.e1" id="s2588.p0" relation="false"/>
  </sentence>
  <sentence id="s2589" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="277-315" id="s2589.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="418-428" id="s2589.e1" ontology_id="HP_0000486" text="strabismus" type="HP"/>
    <pair e1="s2589.e0" e2="s2589.e1" id="s2589.p0" relation="true"/>
  </sentence>
  <sentence id="s2590" text="The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.">
    <entity charOffset="277-315" id="s2590.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="430-439" id="s2590.e1" ontology_id="HP_0000639" text="nystagmus" type="HP"/>
    <pair e1="s2590.e0" e2="s2590.e1" id="s2590.p0" relation="false"/>
  </sentence>
  <sentence id="s2591" text="The corneal clouding and cataracts in this patient may thus have been caused by her glycosaminoglycan biosynthetic process mutation, but the colobomas are a novel phenotypic finding.">
    <entity charOffset="4-20" id="s2591.e0" ontology_id="HP_0007957" text="corneal clouding" type="HP"/>
    <entity charOffset="84-122" id="s2591.e1" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <pair e1="s2591.e0" e2="s2591.e1" id="s2591.p0" relation="false"/>
  </sentence>
  <sentence id="s2592" text="The corneal clouding and cataracts in this patient may thus have been caused by her glycosaminoglycan biosynthetic process mutation, but the colobomas are a novel phenotypic finding.">
    <entity charOffset="25-34" id="s2592.e0" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <entity charOffset="84-122" id="s2592.e1" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <pair e1="s2592.e0" e2="s2592.e1" id="s2592.p0" relation="false"/>
  </sentence>
  <sentence id="s2593" text="Mitochondrial dysfunction and epithelial-to-mesenchymal transition (cytokine production) play important roles in cancer development and metastasis.">
    <entity charOffset="68-87" id="s2593.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="113-119" id="s2593.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2593.e0" e2="s2593.e1" id="s2593.p0" relation="true"/>
  </sentence>
  <sentence id="s2594" text="However, very little is known about the connection between mitochondrial dysfunction and cytokine production.">
    <entity charOffset="59-84" id="s2594.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="89-108" id="s2594.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s2594.e0" e2="s2594.e1" id="s2594.p0" relation="false"/>
  </sentence>
  <sentence id="s2595" text="translational elongation expression level was positively correlated with that of E-cadherin and decreased significantly during the progression of human lung cancer.">
    <entity charOffset="0-24" id="s2595.e0" ontology_id="GO_0006414" text="translational elongation" type="GO"/>
    <entity charOffset="157-163" id="s2595.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2595.e0" e2="s2595.e1" id="s2595.p0" relation="false"/>
  </sentence>
  <sentence id="s2596" text="Mechanistically, translational elongation knockdown activated AMPK and phosphorylated GSK3 and increased the nuclear accumulation of -catenin, leading to the induction of cytokine production and increased migration and metastasis of A549 lung cancer cells.">
    <entity charOffset="17-41" id="s2596.e0" ontology_id="GO_0006414" text="translational elongation" type="GO"/>
    <entity charOffset="245-251" id="s2596.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2596.e0" e2="s2596.e1" id="s2596.p0" relation="false"/>
  </sentence>
  <sentence id="s2597" text="Mechanistically, translational elongation knockdown activated AMPK and phosphorylated GSK3 and increased the nuclear accumulation of -catenin, leading to the induction of cytokine production and increased migration and metastasis of A549 lung cancer cells.">
    <entity charOffset="173-192" id="s2597.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="245-251" id="s2597.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2597.e0" e2="s2597.e1" id="s2597.p0" relation="true"/>
  </sentence>
  <sentence id="s2598" text="Although translational elongation knockdown also induced cytokine production of MCF7 breast cancer cells, the underlying mechanism appeared somewhat different from that in lung cancer cells.">
    <entity charOffset="9-33" id="s2598.e0" ontology_id="GO_0006414" text="translational elongation" type="GO"/>
    <entity charOffset="92-98" id="s2598.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2598.e0" e2="s2598.e1" id="s2598.p0" relation="false"/>
  </sentence>
  <sentence id="s2599" text="Although translational elongation knockdown also induced cytokine production of MCF7 breast cancer cells, the underlying mechanism appeared somewhat different from that in lung cancer cells.">
    <entity charOffset="57-76" id="s2599.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="92-98" id="s2599.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2599.e0" e2="s2599.e1" id="s2599.p0" relation="true"/>
  </sentence>
  <sentence id="s2600" text="Our work identifies translational elongation as a novel regulator of cytokine production and suggests a molecular link between mitochondrial dysfunction and EMT induction.">
    <entity charOffset="20-44" id="s2600.e0" ontology_id="GO_0006414" text="translational elongation" type="GO"/>
    <entity charOffset="127-152" id="s2600.e1" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <pair e1="s2600.e0" e2="s2600.e1" id="s2600.p0" relation="false"/>
  </sentence>
  <sentence id="s2601" text="Our work identifies translational elongation as a novel regulator of cytokine production and suggests a molecular link between mitochondrial dysfunction and EMT induction.">
    <entity charOffset="69-88" id="s2601.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="127-152" id="s2601.e1" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <pair e1="s2601.e0" e2="s2601.e1" id="s2601.p0" relation="false"/>
  </sentence>
  <sentence id="s2602" text="In parallel, we recently reported that &lt;i&gt;Cc2d1a&lt;/i&gt;-deficient epidermis development present with cognitive and social deficits, hyperactivity and anxiety.">
    <entity charOffset="63-84" id="s2602.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="129-142" id="s2602.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s2602.e0" e2="s2602.e1" id="s2602.p0" relation="false"/>
  </sentence>
  <sentence id="s2603" text="We generated &lt;i&gt;Cc2d1b&lt;/i&gt; knockout (KO), &lt;i&gt;Cc2d1a/1b&lt;/i&gt; double heterozygous and double KO epidermis development, then performed behavioral studies to analyze learning and memory, social interactions, anxiety, and hyperactivity.">
    <entity charOffset="93-114" id="s2603.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="216-229" id="s2603.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s2603.e0" e2="s2603.e1" id="s2603.p0" relation="false"/>
  </sentence>
  <sentence id="s2604" text="Cervical cancer is the fourth most common malignancy among women worldwide, and continued research to discover biomarkers or therapeutic targets will somatic diversification of immunoglobulins early diagnosis and treatment of this cancer.">
    <entity charOffset="9-15" id="s2604.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="150-192" id="s2604.e1" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <pair e1="s2604.e0" e2="s2604.e1" id="s2604.p0" relation="false"/>
  </sentence>
  <sentence id="s2605" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: post-translational protein modification, SYCP2, KIF4A, regulation of cytokinesis, DNA topological change, regulation of autophagy, microtubule bundle formation, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2605.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="101-140" id="s2605.e1" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <pair e1="s2605.e0" e2="s2605.e1" id="s2605.p0" relation="false"/>
  </sentence>
  <sentence id="s2606" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: post-translational protein modification, SYCP2, KIF4A, regulation of cytokinesis, DNA topological change, regulation of autophagy, microtubule bundle formation, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2606.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="156-181" id="s2606.e1" ontology_id="GO_0032465" text="regulation of cytokinesis" type="GO"/>
    <pair e1="s2606.e0" e2="s2606.e1" id="s2606.p0" relation="false"/>
  </sentence>
  <sentence id="s2607" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: post-translational protein modification, SYCP2, KIF4A, regulation of cytokinesis, DNA topological change, regulation of autophagy, microtubule bundle formation, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2607.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="183-205" id="s2607.e1" ontology_id="GO_0006265" text="DNA topological change" type="GO"/>
    <pair e1="s2607.e0" e2="s2607.e1" id="s2607.p0" relation="true"/>
  </sentence>
  <sentence id="s2608" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: post-translational protein modification, SYCP2, KIF4A, regulation of cytokinesis, DNA topological change, regulation of autophagy, microtubule bundle formation, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2608.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="207-230" id="s2608.e1" ontology_id="GO_0010506" text="regulation of autophagy" type="GO"/>
    <pair e1="s2608.e0" e2="s2608.e1" id="s2608.p0" relation="false"/>
  </sentence>
  <sentence id="s2609" text="We have identified nine genes of interest that appear to be involved in cervical cancer development: post-translational protein modification, SYCP2, KIF4A, regulation of cytokinesis, DNA topological change, regulation of autophagy, microtubule bundle formation, MCM2, and APOBEC3B.">
    <entity charOffset="81-87" id="s2609.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="232-260" id="s2609.e1" ontology_id="GO_0001578" text="microtubule bundle formation" type="GO"/>
    <pair e1="s2609.e0" e2="s2609.e1" id="s2609.p0" relation="false"/>
  </sentence>
  <sentence id="s2610" text="Furthermore, gene ontology (GO) and co-expression analysis of these differentially expressed genes indicated that post-translational protein modification may play a core role in cervical cancer development.">
    <entity charOffset="114-153" id="s2610.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="187-193" id="s2610.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2610.e0" e2="s2610.e1" id="s2610.p0" relation="false"/>
  </sentence>
  <sentence id="s2611" text="Finally, we validated these observations by investigating post-translational protein modification expression in cervical cancer tissue and serum samples.">
    <entity charOffset="58-97" id="s2611.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="121-127" id="s2611.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2611.e0" e2="s2611.e1" id="s2611.p0" relation="false"/>
  </sentence>
  <sentence id="s2612" text="The diagnostic specificity of serum post-translational protein modification in cervical cancer occurrence was also compared with other high incidence diseases.">
    <entity charOffset="36-75" id="s2612.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="88-94" id="s2612.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2612.e0" e2="s2612.e1" id="s2612.p0" relation="false"/>
  </sentence>
  <sentence id="s2613" text="All of these data indicate that post-translational protein modification may be a novel cancer predictive marker and a potential therapeutic target for tumor development and progression in cervical cancer">
    <entity charOffset="32-71" id="s2613.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="87-93" id="s2613.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2613.e0" e2="s2613.e1" id="s2613.p0" relation="false"/>
  </sentence>
  <sentence id="s2614" text="All of these data indicate that post-translational protein modification may be a novel cancer predictive marker and a potential therapeutic target for tumor development and progression in cervical cancer">
    <entity charOffset="32-71" id="s2614.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="151-156" id="s2614.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2614.e0" e2="s2614.e1" id="s2614.p0" relation="false"/>
  </sentence>
  <sentence id="s2615" text="Here, we causally link a previously unreported missense mutation in biological_process (c.1249G&amp;gt;A, p.D417N), encoding one of the neuron-specific -tubulin isotype II, to a disorder characterized by progressive spastic paraplegia, peripheral sensory-motor polyneuropathy and ataxia.">
    <entity charOffset="68-86" id="s2615.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="277-283" id="s2615.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s2615.e0" e2="s2615.e1" id="s2615.p0" relation="false"/>
  </sentence>
  <sentence id="s2616" text="We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (negative regulation of transcription by RNA polymerase II), whose expression was induced in the human neuroblastoma cell line TGW expressing regulation of cell adhesion by neural crest cell migration stimulation and was also detected in mouse metanephric kidney.">
    <entity charOffset="136-193" id="s2616.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="238-251" id="s2616.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s2616.e0" e2="s2616.e1" id="s2616.p0" relation="false"/>
  </sentence>
  <sentence id="s2617" text="We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (negative regulation of transcription by RNA polymerase II), whose expression was induced in the human neuroblastoma cell line TGW expressing regulation of cell adhesion by neural crest cell migration stimulation and was also detected in mouse metanephric kidney.">
    <entity charOffset="238-251" id="s2617.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="308-335" id="s2617.e1" ontology_id="GO_0001755" text="neural crest cell migration" type="GO"/>
    <pair e1="s2617.e0" e2="s2617.e1" id="s2617.p0" relation="true"/>
  </sentence>
  <sentence id="s2618" text="We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (negative regulation of transcription by RNA polymerase II), whose expression was induced in the human neuroblastoma cell line TGW expressing regulation of cell adhesion by neural crest cell migration stimulation and was also detected in mouse metanephric kidney.">
    <entity charOffset="238-251" id="s2618.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="277-304" id="s2618.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s2618.e0" e2="s2618.e1" id="s2618.p0" relation="true"/>
  </sentence>
  <sentence id="s2619" text="In addition, negative regulation of transcription by RNA polymerase II expression was undetectable or very low in most cases of renal cell carcinomas and Wilms tumors.">
    <entity charOffset="13-70" id="s2619.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="128-149" id="s2619.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s2619.e0" e2="s2619.e1" id="s2619.p0" relation="false"/>
  </sentence>
  <sentence id="s2620" text="In addition, negative regulation of transcription by RNA polymerase II expression was undetectable or very low in most cases of renal cell carcinomas and Wilms tumors.">
    <entity charOffset="13-70" id="s2620.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="160-166" id="s2620.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2620.e0" e2="s2620.e1" id="s2620.p0" relation="false"/>
  </sentence>
  <sentence id="s2621" text="Objective Hearing loss (lipid metabolic process) is the most common sensory-neural defect and the most heterogeneous trait in humans, with the involvement of &amp;gt;100 genes, which make a molecular diagnosis problematic.">
    <entity charOffset="24-47" id="s2621.e0" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <entity charOffset="103-116" id="s2621.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2621.e0" e2="s2621.e1" id="s2621.p0" relation="false"/>
  </sentence>
  <sentence id="s2622" text="Results Clinical evaluations suggested autosomal recessive nonsyndromic lipid metabolic process.">
    <entity charOffset="39-58" id="s2622.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="72-95" id="s2622.e1" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <pair e1="s2622.e0" e2="s2622.e1" id="s2622.p0" relation="true"/>
  </sentence>
  <sentence id="s2623" text="Overall, our findings establish RASSF4 as a tumor-suppressive mRNA splicing, via spliceosome in MM and provide a mechanistic rationale for combining trametinib with negative regulation of transcription by RNA polymerase II inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.&lt;b&gt;Significance:&lt;/b&gt; These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.">
    <entity charOffset="44-49" id="s2623.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="62-92" id="s2623.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s2623.e0" e2="s2623.e1" id="s2623.p0" relation="false"/>
  </sentence>
  <sentence id="s2624" text="Overall, our findings establish RASSF4 as a tumor-suppressive mRNA splicing, via spliceosome in MM and provide a mechanistic rationale for combining trametinib with negative regulation of transcription by RNA polymerase II inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.&lt;b&gt;Significance:&lt;/b&gt; These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.">
    <entity charOffset="44-49" id="s2624.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="165-222" id="s2624.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2624.e0" e2="s2624.e1" id="s2624.p0" relation="false"/>
  </sentence>
  <sentence id="s2625" text="ADP transport is one of the nuclear genes responsible of autosomal dominant progressive external ophthalmoplegia (adPEO) with mitochondrial DNA multiple deletions.">
    <entity charOffset="0-13" id="s2625.e0" ontology_id="GO_0015866" text="ADP transport" type="GO"/>
    <entity charOffset="76-87" id="s2625.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s2625.e0" e2="s2625.e1" id="s2625.p0" relation="true"/>
  </sentence>
  <sentence id="s2626" text="ADP transport is one of the nuclear genes responsible of autosomal dominant progressive external ophthalmoplegia (adPEO) with mitochondrial DNA multiple deletions.">
    <entity charOffset="0-13" id="s2626.e0" ontology_id="GO_0015866" text="ADP transport" type="GO"/>
    <entity charOffset="97-112" id="s2626.e1" ontology_id="HP_0000602" text="ophthalmoplegia" type="HP"/>
    <pair e1="s2626.e0" e2="s2626.e1" id="s2626.p0" relation="true"/>
  </sentence>
  <sentence id="s2627" text="Further studies are needed to assess the prevalence of central neurological manifestations in ADP transport mitochondrial disease">
    <entity charOffset="55-62" id="s2627.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="94-107" id="s2627.e1" ontology_id="GO_0015866" text="ADP transport" type="GO"/>
    <pair e1="s2627.e0" e2="s2627.e1" id="s2627.p0" relation="false"/>
  </sentence>
  <sentence id="s2628" text="Thus we conclude that the hearing loss in the family described in this report is caused by a novel missense mutation in biological_process.">
    <entity charOffset="26-38" id="s2628.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="120-138" id="s2628.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s2628.e0" e2="s2628.e1" id="s2628.p0" relation="true"/>
  </sentence>
  <sentence id="s2629" text="While there has been growing interest in the homodimeric gene products of regulation of cellular respiration (regulation of cellular respiration) and regulation of autophagy (regulation of autophagy), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="74-108" id="s2629.e0" ontology_id="GO_0043457" text="regulation of cellular respiration" type="GO"/>
    <entity charOffset="294-300" id="s2629.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2629.e0" e2="s2629.e1" id="s2629.p0" relation="false"/>
  </sentence>
  <sentence id="s2630" text="While there has been growing interest in the homodimeric gene products of regulation of cellular respiration (regulation of cellular respiration) and regulation of autophagy (regulation of autophagy), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="110-144" id="s2630.e0" ontology_id="GO_0043457" text="regulation of cellular respiration" type="GO"/>
    <entity charOffset="294-300" id="s2630.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2630.e0" e2="s2630.e1" id="s2630.p0" relation="false"/>
  </sentence>
  <sentence id="s2631" text="While there has been growing interest in the homodimeric gene products of regulation of cellular respiration (regulation of cellular respiration) and regulation of autophagy (regulation of autophagy), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="150-173" id="s2631.e0" ontology_id="GO_0010506" text="regulation of autophagy" type="GO"/>
    <entity charOffset="294-300" id="s2631.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2631.e0" e2="s2631.e1" id="s2631.p0" relation="false"/>
  </sentence>
  <sentence id="s2632" text="While there has been growing interest in the homodimeric gene products of regulation of cellular respiration (regulation of cellular respiration) and regulation of autophagy (regulation of autophagy), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.">
    <entity charOffset="175-198" id="s2632.e0" ontology_id="GO_0010506" text="regulation of autophagy" type="GO"/>
    <entity charOffset="294-300" id="s2632.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2632.e0" e2="s2632.e1" id="s2632.p0" relation="false"/>
  </sentence>
  <sentence id="s2633" text="Thus loss of Arp2/3 complex-mediated actin nucleation produces a unique set of platelet abnormalities, and is associated with haematopoietic/immune symptoms affecting cell lineages where this isoform predominates.">
    <entity charOffset="13-53" id="s2633.e0" ontology_id="GO_0034314" text="Arp2/3 complex-mediated actin nucleation" type="GO"/>
    <entity charOffset="79-101" id="s2633.e1" ontology_id="HP_0001872" text="platelet abnormalities" type="HP"/>
    <pair e1="s2633.e0" e2="s2633.e1" id="s2633.p0" relation="true"/>
  </sentence>
  <sentence id="s2634" text="RAD51C and strand invasion have been defined as susceptibility genes for hereditary breast and ovarian cancer syndrome in several studies.">
    <entity charOffset="11-26" id="s2634.e0" ontology_id="GO_0042148" text="strand invasion" type="GO"/>
    <entity charOffset="103-109" id="s2634.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2634.e0" e2="s2634.e1" id="s2634.p0" relation="true"/>
  </sentence>
  <sentence id="s2635" text="The DNA repair pathogenic variant c.404G&amp;gt;A was identified in a breast and ovarian cancer family (0.7%), while the strand invasion pathogenic variant c.694C&amp;gt;T was described in an ovarian cancer family (1.3%).">
    <entity charOffset="4-14" id="s2635.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="87-93" id="s2635.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2635.e0" e2="s2635.e1" id="s2635.p0" relation="true"/>
  </sentence>
  <sentence id="s2636" text="The DNA repair pathogenic variant c.404G&amp;gt;A was identified in a breast and ovarian cancer family (0.7%), while the strand invasion pathogenic variant c.694C&amp;gt;T was described in an ovarian cancer family (1.3%).">
    <entity charOffset="87-93" id="s2636.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="119-134" id="s2636.e1" ontology_id="GO_0042148" text="strand invasion" type="GO"/>
    <pair e1="s2636.e0" e2="s2636.e1" id="s2636.p0" relation="true"/>
  </sentence>
  <sentence id="s2637" text="These results increase our knowledge about the DNA repair and strand invasion mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian cancer syndrome">
    <entity charOffset="47-57" id="s2637.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="238-244" id="s2637.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2637.e0" e2="s2637.e1" id="s2637.p0" relation="true"/>
  </sentence>
  <sentence id="s2638" text="These results increase our knowledge about the DNA repair and strand invasion mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian cancer syndrome">
    <entity charOffset="62-77" id="s2638.e0" ontology_id="GO_0042148" text="strand invasion" type="GO"/>
    <entity charOffset="238-244" id="s2638.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2638.e0" e2="s2638.e1" id="s2638.p0" relation="true"/>
  </sentence>
  <sentence id="s2639" text="Fc-histone H3 acetylation receptor-IIb (FcRIIb) and its ligand are reported to be associated with obesity and muscle organ development 2 diabetes mellitus (T2DM).">
    <entity charOffset="3-25" id="s2639.e0" ontology_id="GO_0043966" text="histone H3 acetylation" type="GO"/>
    <entity charOffset="99-106" id="s2639.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2639.e0" e2="s2639.e1" id="s2639.p0" relation="false"/>
  </sentence>
  <sentence id="s2640" text="Fc-histone H3 acetylation receptor-IIb (FcRIIb) and its ligand are reported to be associated with obesity and muscle organ development 2 diabetes mellitus (T2DM).">
    <entity charOffset="99-106" id="s2640.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="111-135" id="s2640.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2640.e0" e2="s2640.e1" id="s2640.p0" relation="false"/>
  </sentence>
  <sentence id="s2641" text="mitotic chromosome condensation functions as a tumor suppressor gene and has been reported in pancreatic tumor cells.">
    <entity charOffset="0-31" id="s2641.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="47-52" id="s2641.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2641.e0" e2="s2641.e1" id="s2641.p0" relation="false"/>
  </sentence>
  <sentence id="s2642" text="Here, we examined the expression level of mitotic chromosome condensation in human response to hydroperoxide tissues and renal tumor cells by real-time quantitative RT-PCR and western blot.">
    <entity charOffset="42-73" id="s2642.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="127-132" id="s2642.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2642.e0" e2="s2642.e1" id="s2642.p0" relation="false"/>
  </sentence>
  <sentence id="s2643" text="Here, we examined the expression level of mitotic chromosome condensation in human response to hydroperoxide tissues and renal tumor cells by real-time quantitative RT-PCR and western blot.">
    <entity charOffset="83-108" id="s2643.e0" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <entity charOffset="127-132" id="s2643.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2643.e0" e2="s2643.e1" id="s2643.p0" relation="false"/>
  </sentence>
  <sentence id="s2644" text="We found that the expression level of mitotic chromosome condensation is significantly lower in RCC tissues and renal tumor cells compared with adjacent non-tumorous tissues and normal renal cells.">
    <entity charOffset="38-69" id="s2644.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="118-123" id="s2644.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2644.e0" e2="s2644.e1" id="s2644.p0" relation="false"/>
  </sentence>
  <sentence id="s2645" text="Interestingly, overexpression of mitotic chromosome condensation using a eukaryotic plasmid inhibited the proliferation of renal tumor cells in vitro and the growth of renal tumor in vivo.">
    <entity charOffset="33-64" id="s2645.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="129-134" id="s2645.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2645.e0" e2="s2645.e1" id="s2645.p0" relation="false"/>
  </sentence>
  <sentence id="s2646" text="Thus, our results demonstrate that mitotic chromosome condensation functions as a tumor suppressor gene in renal cells and may be a useful target for treatment of RCC">
    <entity charOffset="35-66" id="s2646.e0" ontology_id="GO_0007076" text="mitotic chromosome condensation" type="GO"/>
    <entity charOffset="82-87" id="s2646.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2646.e0" e2="s2646.e1" id="s2646.p0" relation="false"/>
  </sentence>
  <sentence id="s2647" text="The common Ser96Ala human genetic variant of regulation of heart rate strongly correlates with life-threatening ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy.">
    <entity charOffset="45-69" id="s2647.e0" ontology_id="GO_0002027" text="regulation of heart rate" type="GO"/>
    <entity charOffset="112-135" id="s2647.e1" ontology_id="HP_0004308" text="ventricular arrhythmias" type="HP"/>
    <pair e1="s2647.e0" e2="s2647.e1" id="s2647.p0" relation="false"/>
  </sentence>
  <sentence id="s2648" text="In humans, phosphorylation mutations cause widespread retinal degeneration: early dysfunction and loss of rod and cone photoreceptors in the outer retina and, progressively, death of cells in the inner retina.">
    <entity charOffset="11-26" id="s2648.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="54-74" id="s2648.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2648.e0" e2="s2648.e1" id="s2648.p0" relation="false"/>
  </sentence>
  <sentence id="s2649" text="Chylomicron retention disease (positive regulation of transcription by RNA polymerase II) is a rare autosomal recessive hereditary hypocholesterolemic disorder.">
    <entity charOffset="31-88" id="s2649.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="100-119" id="s2649.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2649.e0" e2="s2649.e1" id="s2649.p0" relation="true"/>
  </sentence>
  <sentence id="s2650" text="Heterotaxy, a birth defect involving left-right patterning defects, and primary ciliary dyskinesia (motile cilium assembly), a sinopulmonary disease with dyskinetic/immotile cilia in the airway are seemingly disparate diseases.">
    <entity charOffset="80-98" id="s2650.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="100-122" id="s2650.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s2650.e0" e2="s2650.e1" id="s2650.p0" relation="true"/>
  </sentence>
  <sentence id="s2651" text="The negative regulation of transcription by RNA polymerase II of NOX2 and ROS on cancer development is only partly explored.">
    <entity charOffset="4-61" id="s2651.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="81-87" id="s2651.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2651.e0" e2="s2651.e1" id="s2651.p0" relation="false"/>
  </sentence>
  <sentence id="s2652" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, Cybb, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="98-126" id="s2652.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="481-486" id="s2652.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2652.e0" e2="s2652.e1" id="s2652.p0" relation="false"/>
  </sentence>
  <sentence id="s2653" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, Cybb, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="136-163" id="s2653.e0" ontology_id="GO_0017004" text="cytochrome complex assembly" type="GO"/>
    <entity charOffset="481-486" id="s2653.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2653.e0" e2="s2653.e1" id="s2653.p0" relation="false"/>
  </sentence>
  <sentence id="s2654" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, Cybb, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="171-200" id="s2654.e0" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <entity charOffset="481-486" id="s2654.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2654.e0" e2="s2654.e1" id="s2654.p0" relation="false"/>
  </sentence>
  <sentence id="s2655" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, Cybb, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="202-297" id="s2655.e0" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <entity charOffset="481-486" id="s2655.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2655.e0" e2="s2655.e1" id="s2655.p0" relation="false"/>
  </sentence>
  <sentence id="s2656" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, Cybb, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
    <entity charOffset="302-397" id="s2656.e0" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <entity charOffset="481-486" id="s2656.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2656.e0" e2="s2656.e1" id="s2656.p0" relation="false"/>
  </sentence>
  <sentence id="s2657" text="p.(Arg320His) mutation in the protein tetramerization gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.">
    <entity charOffset="30-53" id="s2657.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="134-143" id="s2657.e1" ontology_id="HP_0001336" text="myoclonus" type="HP"/>
    <pair e1="s2657.e0" e2="s2657.e1" id="s2657.p0" relation="true"/>
  </sentence>
  <sentence id="s2658" text="p.(Arg320His) mutation in the protein tetramerization gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.">
    <entity charOffset="30-53" id="s2658.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="237-245" id="s2658.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2658.e0" e2="s2658.e1" id="s2658.p0" relation="true"/>
  </sentence>
  <sentence id="s2659" text="As previously observed in the mutant mouse carrying a disrupted protein tetramerization gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present intellectual disability without seizure and epilepsy">
    <entity charOffset="64-87" id="s2659.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="183-206" id="s2659.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2659.e0" e2="s2659.e1" id="s2659.p0" relation="false"/>
  </sentence>
  <sentence id="s2660" text="No significant associations were detected between these SNPs and schizophrenia in Han Chinese and the positive regulation of antibacterial peptide production data set.">
    <entity charOffset="65-78" id="s2660.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="102-157" id="s2660.e1" ontology_id="GO_0002803" text="positive regulation of antibacterial peptide production" type="GO"/>
    <pair e1="s2660.e0" e2="s2660.e1" id="s2660.p0" relation="false"/>
  </sentence>
  <sentence id="s2661" text="However, we observed nominal significant associations of 2 SNPs in the apoptotic mitochondrial changes gene and 4 SNPs in the response to oxidative stress gene with early onset schizophrenia (EOS), but none of these associations survived the Bonferroni correction.">
    <entity charOffset="71-102" id="s2661.e0" ontology_id="GO_0008637" text="apoptotic mitochondrial changes" type="GO"/>
    <entity charOffset="177-190" id="s2661.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2661.e0" e2="s2661.e1" id="s2661.p0" relation="false"/>
  </sentence>
  <sentence id="s2662" text="However, we observed nominal significant associations of 2 SNPs in the apoptotic mitochondrial changes gene and 4 SNPs in the response to oxidative stress gene with early onset schizophrenia (EOS), but none of these associations survived the Bonferroni correction.">
    <entity charOffset="126-154" id="s2662.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="177-190" id="s2662.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2662.e0" e2="s2662.e1" id="s2662.p0" relation="false"/>
  </sentence>
  <sentence id="s2663" text="We initially selected 6 fluoropyrimidine metabolism-related genes (thymine catabolic process, ORPT, TYMS, pyrimidine nucleoside metabolic process, TK1, and TK2) and 3 radiotherapy response-related genes (protein-containing complex assembly, HIF-1, and HIF-2) as targets for gene expression identification in 60 chemotaxis cancer specimens.">
    <entity charOffset="67-92" id="s2663.e0" ontology_id="GO_0006210" text="thymine catabolic process" type="GO"/>
    <entity charOffset="324-330" id="s2663.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2663.e0" e2="s2663.e1" id="s2663.p0" relation="false"/>
  </sentence>
  <sentence id="s2664" text="We initially selected 6 fluoropyrimidine metabolism-related genes (thymine catabolic process, ORPT, TYMS, pyrimidine nucleoside metabolic process, TK1, and TK2) and 3 radiotherapy response-related genes (protein-containing complex assembly, HIF-1, and HIF-2) as targets for gene expression identification in 60 chemotaxis cancer specimens.">
    <entity charOffset="106-145" id="s2664.e0" ontology_id="GO_0006213" text="pyrimidine nucleoside metabolic process" type="GO"/>
    <entity charOffset="324-330" id="s2664.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2664.e0" e2="s2664.e1" id="s2664.p0" relation="false"/>
  </sentence>
  <sentence id="s2665" text="We initially selected 6 fluoropyrimidine metabolism-related genes (thymine catabolic process, ORPT, TYMS, pyrimidine nucleoside metabolic process, TK1, and TK2) and 3 radiotherapy response-related genes (protein-containing complex assembly, HIF-1, and HIF-2) as targets for gene expression identification in 60 chemotaxis cancer specimens.">
    <entity charOffset="204-239" id="s2665.e0" ontology_id="GO_0065003" text="protein-containing complex assembly" type="GO"/>
    <entity charOffset="324-330" id="s2665.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2665.e0" e2="s2665.e1" id="s2665.p0" relation="false"/>
  </sentence>
  <sentence id="s2666" text="We initially selected 6 fluoropyrimidine metabolism-related genes (thymine catabolic process, ORPT, TYMS, pyrimidine nucleoside metabolic process, TK1, and TK2) and 3 radiotherapy response-related genes (protein-containing complex assembly, HIF-1, and HIF-2) as targets for gene expression identification in 60 chemotaxis cancer specimens.">
    <entity charOffset="313-323" id="s2666.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="324-330" id="s2666.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2666.e0" e2="s2666.e1" id="s2666.p0" relation="false"/>
  </sentence>
  <sentence id="s2667" text="After CCRT, 39 of 60 (65%) chemotaxis patients were classified as responders (pathological tumor regression grade 2 ~ 4).">
    <entity charOffset="27-37" id="s2667.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="91-96" id="s2667.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2667.e0" e2="s2667.e1" id="s2667.p0" relation="false"/>
  </sentence>
  <sentence id="s2668" text="We aimed to identify the genetic cause of the devastating neurodegenerative disease amyotrophic lateral sclerosis (ALS) in a German family with two affected individuals, and to assess the prevalence of variants in the identified risk gene, phosphatidylinositol biosynthetic process, in a central European ALS cohort.">
    <entity charOffset="58-83" id="s2668.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="240-281" id="s2668.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="s2668.e0" e2="s2668.e1" id="s2668.p0" relation="true"/>
  </sentence>
  <sentence id="s2669" text="Additionally, novel or rare heterozygous phosphatidylinositol biosynthetic process missense variants predicted to be deleterious were detected in five sporadic signal transduction patients revealing an overall FIG4 variant frequency of 3% in our cohort.">
    <entity charOffset="41-82" id="s2669.e0" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <entity charOffset="151-159" id="s2669.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2669.e0" e2="s2669.e1" id="s2669.p0" relation="false"/>
  </sentence>
  <sentence id="s2670" text="Additionally, novel or rare heterozygous phosphatidylinositol biosynthetic process missense variants predicted to be deleterious were detected in five sporadic signal transduction patients revealing an overall FIG4 variant frequency of 3% in our cohort.">
    <entity charOffset="151-159" id="s2670.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="160-179" id="s2670.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s2670.e0" e2="s2670.e1" id="s2670.p0" relation="false"/>
  </sentence>
  <sentence id="s2671" text="Four of six variants identified were previously associated with signal transduction or the motor and sensory neuropathy Charcot-Marie-Tooth disease muscle organ development 4J (phosphatidylinositol biosynthetic process), whereas two variants were novel.">
    <entity charOffset="64-83" id="s2671.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="109-119" id="s2671.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2671.e0" e2="s2671.e1" id="s2671.p0" relation="false"/>
  </sentence>
  <sentence id="s2672" text="Four of six variants identified were previously associated with signal transduction or the motor and sensory neuropathy Charcot-Marie-Tooth disease muscle organ development 4J (phosphatidylinositol biosynthetic process), whereas two variants were novel.">
    <entity charOffset="109-119" id="s2672.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="148-172" id="s2672.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2672.e0" e2="s2672.e1" id="s2672.p0" relation="false"/>
  </sentence>
  <sentence id="s2673" text="Four of six variants identified were previously associated with signal transduction or the motor and sensory neuropathy Charcot-Marie-Tooth disease muscle organ development 4J (phosphatidylinositol biosynthetic process), whereas two variants were novel.">
    <entity charOffset="109-119" id="s2673.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="177-218" id="s2673.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="s2673.e0" e2="s2673.e1" id="s2673.p0" relation="true"/>
  </sentence>
  <sentence id="s2674" text="negative regulation of transcription by RNA polymerase II, a major transcription factor in transforming growth factor- (TGF-) signaling, plays critical roles in both tumor-suppressive and pro-oncogenic functions.">
    <entity charOffset="0-57" id="s2674.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="168-173" id="s2674.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2674.e0" e2="s2674.e1" id="s2674.p0" relation="false"/>
  </sentence>
  <sentence id="s2675" text="However, recent discoveries of negative regulation of transcription by RNA polymerase II-interacting molecules that preferentially bind phosphorylated Smad3 linker serine/threonine residues have shown a multitude of signal transductions that either enhance or suppress TGF- responses associated with Smad3 turnover or cancer progression.">
    <entity charOffset="31-88" id="s2675.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="319-325" id="s2675.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2675.e0" e2="s2675.e1" id="s2675.p0" relation="false"/>
  </sentence>
  <sentence id="s2676" text="Recessive mutations in the secreted metalloprotease proteolysis cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.">
    <entity charOffset="52-63" id="s2676.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="70-84" id="s2676.e1" ontology_id="HP_0001083" text="ectopia lentis" type="HP"/>
    <pair e1="s2676.e0" e2="s2676.e1" id="s2676.p0" relation="true"/>
  </sentence>
  <sentence id="s2677" text="Recessive mutations in the secreted metalloprotease proteolysis cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.">
    <entity charOffset="52-63" id="s2677.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="172-180" id="s2677.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2677.e0" e2="s2677.e1" id="s2677.p0" relation="true"/>
  </sentence>
  <sentence id="s2678" text="We investigated the effects of heightened levels of catecholamine catabolic process on dopamine-regulated motor behaviors and molecular alterations in a mouse model of dyskinesia.">
    <entity charOffset="52-83" id="s2678.e0" ontology_id="GO_0042424" text="catecholamine catabolic process" type="GO"/>
    <entity charOffset="168-178" id="s2678.e1" ontology_id="HP_0100660" text="dyskinesia" type="HP"/>
    <pair e1="s2678.e0" e2="s2678.e1" id="s2678.p0" relation="false"/>
  </sentence>
  <sentence id="s2679" text="l-DOPA-induced dyskinesia was exacerbated in TG epidermis development without altering l-DOPA motor efficacy as determined by contralateral rotations or motor coordination.">
    <entity charOffset="15-25" id="s2679.e0" ontology_id="HP_0100660" text="dyskinesia" type="HP"/>
    <entity charOffset="48-69" id="s2679.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2679.e0" e2="s2679.e1" id="s2679.p0" relation="false"/>
  </sentence>
  <sentence id="s2680" text="Our results demonstrate that human catecholamine catabolic process overexpression confers a heightened susceptibility to l-DOPA-induced dyskinesia and alters molecular and neurochemical responses in the lesioned striatum of mice">
    <entity charOffset="35-66" id="s2680.e0" ontology_id="GO_0042424" text="catecholamine catabolic process" type="GO"/>
    <entity charOffset="136-146" id="s2680.e1" ontology_id="HP_0100660" text="dyskinesia" type="HP"/>
    <pair e1="s2680.e0" e2="s2680.e1" id="s2680.p0" relation="false"/>
  </sentence>
  <sentence id="s2681" text="regulation of ARF protein signal transductions display resistance to frontline cancer treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse.">
    <entity charOffset="0-45" id="s2681.e0" ontology_id="GO_0032012" text="regulation of ARF protein signal transduction" type="GO"/>
    <entity charOffset="135-140" id="s2681.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2681.e0" e2="s2681.e1" id="s2681.p0" relation="false"/>
  </sentence>
  <sentence id="s2682" text="regulation of ARF protein signal transductions display resistance to frontline cancer treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse.">
    <entity charOffset="0-45" id="s2682.e0" ontology_id="GO_0032012" text="regulation of ARF protein signal transduction" type="GO"/>
    <entity charOffset="79-85" id="s2682.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2682.e0" e2="s2682.e1" id="s2682.p0" relation="false"/>
  </sentence>
  <sentence id="s2683" text="Here we identify a novel mechanism of NOTCH regulation and regulation of ARF protein signal transduction induction in breast cancer via the miR-106b-25 miRNA cluster.">
    <entity charOffset="59-104" id="s2683.e0" ontology_id="GO_0032012" text="regulation of ARF protein signal transduction" type="GO"/>
    <entity charOffset="125-131" id="s2683.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2683.e0" e2="s2683.e1" id="s2683.p0" relation="false"/>
  </sentence>
  <sentence id="s2684" text="We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, regulation of membrane depolarization.">
    <entity charOffset="75-81" id="s2684.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="231-268" id="s2684.e1" ontology_id="GO_0003254" text="regulation of membrane depolarization" type="GO"/>
    <pair e1="s2684.e0" e2="s2684.e1" id="s2684.p0" relation="false"/>
  </sentence>
  <sentence id="s2685" text="We further show that upregulation of cell cycle arrest is necessary for regulation of ARF protein signal transduction induction downstream of protein polyubiquitination-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
    <entity charOffset="37-54" id="s2685.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="206-212" id="s2685.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2685.e0" e2="s2685.e1" id="s2685.p0" relation="true"/>
  </sentence>
  <sentence id="s2686" text="We further show that upregulation of cell cycle arrest is necessary for regulation of ARF protein signal transduction induction downstream of protein polyubiquitination-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
    <entity charOffset="72-117" id="s2686.e0" ontology_id="GO_0032012" text="regulation of ARF protein signal transduction" type="GO"/>
    <entity charOffset="206-212" id="s2686.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2686.e0" e2="s2686.e1" id="s2686.p0" relation="false"/>
  </sentence>
  <sentence id="s2687" text="We further show that upregulation of cell cycle arrest is necessary for regulation of ARF protein signal transduction induction downstream of protein polyubiquitination-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
    <entity charOffset="142-168" id="s2687.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="206-212" id="s2687.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2687.e0" e2="s2687.e1" id="s2687.p0" relation="false"/>
  </sentence>
  <sentence id="s2688" text="Importantly, we demonstrate a significant positive correlation between miR-106b-25 and cell cycle arrest protein, yet a significant inverse correlation between miR-106b-25 and NEDD4L mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.">
    <entity charOffset="87-104" id="s2688.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="204-210" id="s2688.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2688.e0" e2="s2688.e1" id="s2688.p0" relation="true"/>
  </sentence>
  <sentence id="s2689" text="These data expand our knowledge of the mechanisms underlying NOTCH activation and regulation of ARF protein signal transduction induction in breast cancer, and may provide new avenues for the development of therapies targeting this resistant subset of tumor cells">
    <entity charOffset="82-127" id="s2689.e0" ontology_id="GO_0032012" text="regulation of ARF protein signal transduction" type="GO"/>
    <entity charOffset="148-154" id="s2689.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2689.e0" e2="s2689.e1" id="s2689.p0" relation="false"/>
  </sentence>
  <sentence id="s2690" text="Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including positive regulation of endothelial cell differentiation, biological_process, negative regulation of transcription by RNA polymerase II and ZNF367.">
    <entity charOffset="96-102" id="s2690.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-169" id="s2690.e1" ontology_id="GO_0045603" text="positive regulation of endothelial cell differentiation" type="GO"/>
    <pair e1="s2690.e0" e2="s2690.e1" id="s2690.p0" relation="false"/>
  </sentence>
  <sentence id="s2691" text="Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including positive regulation of endothelial cell differentiation, biological_process, negative regulation of transcription by RNA polymerase II and ZNF367.">
    <entity charOffset="96-102" id="s2691.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="171-189" id="s2691.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s2691.e0" e2="s2691.e1" id="s2691.p0" relation="false"/>
  </sentence>
  <sentence id="s2692" text="Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including positive regulation of endothelial cell differentiation, biological_process, negative regulation of transcription by RNA polymerase II and ZNF367.">
    <entity charOffset="96-102" id="s2692.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="191-248" id="s2692.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2692.e0" e2="s2692.e1" id="s2692.p0" relation="false"/>
  </sentence>
  <sentence id="s2693" text="Next-generation sequencing (NGS) of the genetic information of cancer cells has revolutionized the field of cancer biology, including prostate cancer (mitochondrial transport).">
    <entity charOffset="63-69" id="s2693.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="151-174" id="s2693.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s2693.e0" e2="s2693.e1" id="s2693.p0" relation="false"/>
  </sentence>
  <sentence id="s2694" text="With its highly heterogeneous nature, mitochondrial transport continues to pose a tremendous challenge in terms of diagnosis and prognosis.">
    <entity charOffset="16-29" id="s2694.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="38-61" id="s2694.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s2694.e0" e2="s2694.e1" id="s2694.p0" relation="false"/>
  </sentence>
  <sentence id="s2695" text="We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human signal transduction (signal transduction(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade.">
    <entity charOffset="167-186" id="s2695.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="223-228" id="s2695.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2695.e0" e2="s2695.e1" id="s2695.p0" relation="true"/>
  </sentence>
  <sentence id="s2696" text="We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human signal transduction (signal transduction(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade.">
    <entity charOffset="188-207" id="s2696.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="223-228" id="s2696.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2696.e0" e2="s2696.e1" id="s2696.p0" relation="true"/>
  </sentence>
  <sentence id="s2697" text="The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of transcription by RNA polymerase II, positive regulation of mitochondrial translation and biological_process, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.">
    <entity charOffset="45-50" id="s2697.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="136-170" id="s2697.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2697.e0" e2="s2697.e1" id="s2697.p0" relation="false"/>
  </sentence>
  <sentence id="s2698" text="The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of transcription by RNA polymerase II, positive regulation of mitochondrial translation and biological_process, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.">
    <entity charOffset="45-50" id="s2698.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="172-220" id="s2698.e1" ontology_id="GO_0070131" text="positive regulation of mitochondrial translation" type="GO"/>
    <pair e1="s2698.e0" e2="s2698.e1" id="s2698.p0" relation="false"/>
  </sentence>
  <sentence id="s2699" text="The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of transcription by RNA polymerase II, positive regulation of mitochondrial translation and biological_process, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.">
    <entity charOffset="45-50" id="s2699.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="225-243" id="s2699.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s2699.e0" e2="s2699.e1" id="s2699.p0" relation="false"/>
  </sentence>
  <sentence id="s2700" text="Genetic studies have identified a homozygous truncation mutation in endosome to lysosome transport that causes hypertonia in mice.">
    <entity charOffset="68-98" id="s2700.e0" ontology_id="GO_0008333" text="endosome to lysosome transport" type="GO"/>
    <entity charOffset="111-121" id="s2700.e1" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <pair e1="s2700.e0" e2="s2700.e1" id="s2700.p0" relation="true"/>
  </sentence>
  <sentence id="s2701" text="Moreover, elevated endosome to lysosome transport protein expression is associated with several types of cancers and variants in Trak1 are linked to childhood absence epilepsy in humans.">
    <entity charOffset="19-49" id="s2701.e0" ontology_id="GO_0008333" text="endosome to lysosome transport" type="GO"/>
    <entity charOffset="167-175" id="s2701.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s2701.e0" e2="s2701.e1" id="s2701.p0" relation="true"/>
  </sentence>
  <sentence id="s2702" text="Biological activities of compounds 3-7 towards human cancer cells, generation of precursor metabolites and energy-2, ROCK1, and interleukin-4-mediated signaling pathway were evaluated">
    <entity charOffset="53-59" id="s2702.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-113" id="s2702.e1" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <pair e1="s2702.e0" e2="s2702.e1" id="s2702.p0" relation="false"/>
  </sentence>
  <sentence id="s2703" text="Biological activities of compounds 3-7 towards human cancer cells, generation of precursor metabolites and energy-2, ROCK1, and interleukin-4-mediated signaling pathway were evaluated">
    <entity charOffset="53-59" id="s2703.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="128-168" id="s2703.e1" ontology_id="GO_0035771" text="interleukin-4-mediated signaling pathway" type="GO"/>
    <pair e1="s2703.e0" e2="s2703.e1" id="s2703.p0" relation="false"/>
  </sentence>
  <sentence id="s2704" text="In this work, we functionally characterize two breast cancer associated genes, the proteasome 26S subunit ATPase 3 interacting protein (reciprocal meiotic recombination) and the epithelial-stromal interaction 1 (biological_process), to explore their potential apoptotic role in breast cancer.">
    <entity charOffset="54-60" id="s2704.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="136-168" id="s2704.e1" ontology_id="GO_0007131" text="reciprocal meiotic recombination" type="GO"/>
    <pair e1="s2704.e0" e2="s2704.e1" id="s2704.p0" relation="false"/>
  </sentence>
  <sentence id="s2705" text="In this work, we functionally characterize two breast cancer associated genes, the proteasome 26S subunit ATPase 3 interacting protein (reciprocal meiotic recombination) and the epithelial-stromal interaction 1 (biological_process), to explore their potential apoptotic role in breast cancer.">
    <entity charOffset="54-60" id="s2705.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="212-230" id="s2705.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s2705.e0" e2="s2705.e1" id="s2705.p0" relation="false"/>
  </sentence>
  <sentence id="s2706" text="Based on the generated interaction network, we examine several apoptotic markers to determine the effect of reciprocal meiotic recombination and EPSTI1 gene expression modulation in two different human breast cancer cell lines to suggest potential molecular mechanisms to unveil their role in the disease.">
    <entity charOffset="108-140" id="s2706.e0" ontology_id="GO_0007131" text="reciprocal meiotic recombination" type="GO"/>
    <entity charOffset="209-215" id="s2706.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2706.e0" e2="s2706.e1" id="s2706.p0" relation="false"/>
  </sentence>
  <sentence id="s2707" text="Our results show that reciprocal meiotic recombination and biological_process are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast cancer cell lines, highlighting them as potential therapeutic targets.">
    <entity charOffset="22-54" id="s2707.e0" ontology_id="GO_0007131" text="reciprocal meiotic recombination" type="GO"/>
    <entity charOffset="188-194" id="s2707.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2707.e0" e2="s2707.e1" id="s2707.p0" relation="false"/>
  </sentence>
  <sentence id="s2708" text="Our results show that reciprocal meiotic recombination and biological_process are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast cancer cell lines, highlighting them as potential therapeutic targets.">
    <entity charOffset="59-77" id="s2708.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="188-194" id="s2708.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2708.e0" e2="s2708.e1" id="s2708.p0" relation="false"/>
  </sentence>
  <sentence id="s2709" text="Here we demonstrate association of variants in the mitochondrial asparaginyl-tRNA synthetase asparaginyl-tRNA aminoacylation with human hearing loss and Leigh syndrome.">
    <entity charOffset="93-124" id="s2709.e0" ontology_id="GO_0006421" text="asparaginyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="136-148" id="s2709.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2709.e0" e2="s2709.e1" id="s2709.p0" relation="false"/>
  </sentence>
  <sentence id="s2710" text="p.Asn381Ser also disrupts dimerization of asparaginyl-tRNA aminoacylation, while the hearing loss p.Val213Phe variant has no effect on NARS2 oligomerization.">
    <entity charOffset="42-73" id="s2710.e0" ontology_id="GO_0006421" text="asparaginyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="85-97" id="s2710.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2710.e0" e2="s2710.e1" id="s2710.p0" relation="false"/>
  </sentence>
  <sentence id="s2711" text="Primary ciliary dyskinesia (motile cilium assembly) is an autosomal-recessive disease due to functional or ultra-structural defects of motile cilia.">
    <entity charOffset="8-26" id="s2711.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-50" id="s2711.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s2711.e0" e2="s2711.e1" id="s2711.p0" relation="true"/>
  </sentence>
  <sentence id="s2712" text="The extracellular matrix (platelet degranulation) is a known factor in tumor invasion, and differences in the ECM of nontumor brain and glioblastoma has been proven.">
    <entity charOffset="26-48" id="s2712.e0" ontology_id="GO_0002576" text="platelet degranulation" type="GO"/>
    <entity charOffset="71-76" id="s2712.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2712.e0" e2="s2712.e1" id="s2712.p0" relation="false"/>
  </sentence>
  <sentence id="s2713" text="The extracellular matrix (platelet degranulation) is a known factor in tumor invasion, and differences in the ECM of nontumor brain and glioblastoma has been proven.">
    <entity charOffset="26-48" id="s2713.e0" ontology_id="GO_0002576" text="platelet degranulation" type="GO"/>
    <entity charOffset="136-148" id="s2713.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s2713.e0" e2="s2713.e1" id="s2713.p0" relation="false"/>
  </sentence>
  <sentence id="s2714" text="This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&amp;gt;G [p.(His 107 peptidyl-tyrosine phosphorylation)] mutation in &lt;i&gt;TUBA1A&lt;/i&gt; gene, and the clinical aspects and neuroimaging features of &amp;quot;lissencephaly syndrome&amp;quot; are summarized.">
    <entity charOffset="64-76" id="s2714.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="208-241" id="s2714.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s2714.e0" e2="s2714.e1" id="s2714.p0" relation="false"/>
  </sentence>
  <sentence id="s2715" text="This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&amp;gt;G [p.(His 107 peptidyl-tyrosine phosphorylation)] mutation in &lt;i&gt;TUBA1A&lt;/i&gt; gene, and the clinical aspects and neuroimaging features of &amp;quot;lissencephaly syndrome&amp;quot; are summarized.">
    <entity charOffset="83-102" id="s2715.e0" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <entity charOffset="208-241" id="s2715.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s2715.e0" e2="s2715.e1" id="s2715.p0" relation="false"/>
  </sentence>
  <sentence id="s2716" text="This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&amp;gt;G [p.(His 107 peptidyl-tyrosine phosphorylation)] mutation in &lt;i&gt;TUBA1A&lt;/i&gt; gene, and the clinical aspects and neuroimaging features of &amp;quot;lissencephaly syndrome&amp;quot; are summarized.">
    <entity charOffset="114-122" id="s2716.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="208-241" id="s2716.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s2716.e0" e2="s2716.e1" id="s2716.p0" relation="false"/>
  </sentence>
  <sentence id="s2717" text="This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&amp;gt;G [p.(His 107 peptidyl-tyrosine phosphorylation)] mutation in &lt;i&gt;TUBA1A&lt;/i&gt; gene, and the clinical aspects and neuroimaging features of &amp;quot;lissencephaly syndrome&amp;quot; are summarized.">
    <entity charOffset="135-154" id="s2717.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="208-241" id="s2717.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s2717.e0" e2="s2717.e1" id="s2717.p0" relation="false"/>
  </sentence>
  <sentence id="s2718" text="Serine biosynthesis defects result from deficiencies in L-serine biosynthetic process, PSAT, or antimicrobial humoral response and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with intellectual disability at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.">
    <entity charOffset="56-85" id="s2718.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="289-312" id="s2718.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2718.e0" e2="s2718.e1" id="s2718.p0" relation="true"/>
  </sentence>
  <sentence id="s2719" text="Serine biosynthesis defects result from deficiencies in L-serine biosynthetic process, PSAT, or antimicrobial humoral response and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with intellectual disability at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.">
    <entity charOffset="96-126" id="s2719.e0" ontology_id="GO_0019730" text="antimicrobial humoral response" type="GO"/>
    <entity charOffset="289-312" id="s2719.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2719.e0" e2="s2719.e1" id="s2719.p0" relation="false"/>
  </sentence>
  <sentence id="s2720" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in L-serine biosynthetic process.">
    <entity charOffset="49-61" id="s2720.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="182-211" id="s2720.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="s2720.e0" e2="s2720.e1" id="s2720.p0" relation="true"/>
  </sentence>
  <sentence id="s2721" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in L-serine biosynthetic process.">
    <entity charOffset="88-96" id="s2721.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="182-211" id="s2721.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="s2721.e0" e2="s2721.e1" id="s2721.p0" relation="true"/>
  </sentence>
  <sentence id="s2722" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in L-serine biosynthetic process.">
    <entity charOffset="112-122" id="s2722.e0" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <entity charOffset="182-211" id="s2722.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="s2722.e0" e2="s2722.e1" id="s2722.p0" relation="true"/>
  </sentence>
  <sentence id="s2723" text="In a family with sensory neuropathy with loss of pain perception and destruction of the pedal skeleton we report a missense mutation in a highly conserved amino acid residue of atlastin GTPase 3 (protein homooligomerization), an endoplasmic reticulum-shaping GTPase.">
    <entity charOffset="25-35" id="s2723.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="196-223" id="s2723.e1" ontology_id="GO_0051260" text="protein homooligomerization" type="GO"/>
    <pair e1="s2723.e0" e2="s2723.e1" id="s2723.p0" relation="true"/>
  </sentence>
  <sentence id="s2724" text="ATL3 is a paralogue of endoplasmic reticulum organization, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory neuropathy.">
    <entity charOffset="23-57" id="s2724.e0" ontology_id="GO_0007029" text="endoplasmic reticulum organization" type="GO"/>
    <entity charOffset="162-172" id="s2724.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2724.e0" e2="s2724.e1" id="s2724.p0" relation="true"/>
  </sentence>
  <sentence id="s2725" text="Succinate dehydrogenase subunit B and D (tricarboxylic acid cycle and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (Ptricarboxylic acid cycle).">
    <entity charOffset="41-65" id="s2725.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="155-168" id="s2725.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s2725.e0" e2="s2725.e1" id="s2725.p0" relation="true"/>
  </sentence>
  <sentence id="s2726" text="Succinate dehydrogenase subunit B and D (tricarboxylic acid cycle and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (Ptricarboxylic acid cycle).">
    <entity charOffset="155-168" id="s2726.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="171-195" id="s2726.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s2726.e0" e2="s2726.e1" id="s2726.p0" relation="true"/>
  </sentence>
  <sentence id="s2727" text="In SDHB-related syndrome, Ptricarboxylic acid cycle maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).">
    <entity charOffset="27-51" id="s2727.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="149-154" id="s2727.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2727.e0" e2="s2727.e1" id="s2727.p0" relation="true"/>
  </sentence>
  <sentence id="s2728" text="However, when tricarboxylic acid cycle-tumors give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with tricarboxylic acid cycle counterparts (p = 0.17 vs 0.89).">
    <entity charOffset="14-38" id="s2728.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="39-44" id="s2728.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2728.e0" e2="s2728.e1" id="s2728.p0" relation="true"/>
  </sentence>
  <sentence id="s2729" text="However, when tricarboxylic acid cycle-tumors give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with tricarboxylic acid cycle counterparts (p = 0.17 vs 0.89).">
    <entity charOffset="39-44" id="s2729.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="162-186" id="s2729.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s2729.e0" e2="s2729.e1" id="s2729.p0" relation="true"/>
  </sentence>
  <sentence id="s2730" text="These findings align with data suggesting that tricarboxylic acid cycle-related PPGL require less genetic events for tumor initiation and maintenance compared to those related to tricarboxylic acid cycle, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.">
    <entity charOffset="47-71" id="s2730.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="117-122" id="s2730.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2730.e0" e2="s2730.e1" id="s2730.p0" relation="true"/>
  </sentence>
  <sentence id="s2731" text="These findings align with data suggesting that tricarboxylic acid cycle-related PPGL require less genetic events for tumor initiation and maintenance compared to those related to tricarboxylic acid cycle, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.">
    <entity charOffset="117-122" id="s2731.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="179-203" id="s2731.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s2731.e0" e2="s2731.e1" id="s2731.p0" relation="true"/>
  </sentence>
  <sentence id="s2732" text="By contrast, the higher number of genetic abnormalities required for tumor initiation and maintenance in tricarboxylic acid cycle PPGL result in a lower penetrance of PGL, but when cells give rise to metastases they are assumed to be better adapted to sustain survival.">
    <entity charOffset="69-74" id="s2732.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="105-129" id="s2732.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s2732.e0" e2="s2732.e1" id="s2732.p0" relation="true"/>
  </sentence>
  <sentence id="s2733" text="In our study, the protein expression of Na&lt;sub&gt;V&lt;/sub&gt;1.3, Na&lt;sub&gt;V&lt;/sub&gt;1.6 and negative regulation of endothelial cell proliferation was significantly increased in the tumor compared to control tissue, while the level of p-CaMKII/CaMKII was significantly decreased in the tumor group as determined by Western Blotting and immunohistochemistry.">
    <entity charOffset="81-134" id="s2733.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="170-175" id="s2733.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2733.e0" e2="s2733.e1" id="s2733.p0" relation="true"/>
  </sentence>
  <sentence id="s2734" text="Furthermore, double-labeling immunofluorescence results showed that Na&lt;sub&gt;V&lt;/sub&gt;1.3/Na&lt;sub&gt;V&lt;/sub&gt;1.6 and negative regulation of endothelial cell proliferation co-localization was significantly increased in the tumor group compared to control tissue.">
    <entity charOffset="108-161" id="s2734.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="213-218" id="s2734.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2734.e0" e2="s2734.e1" id="s2734.p0" relation="true"/>
  </sentence>
  <sentence id="s2735" text="This study represents the first evidence of the abnormal changes in VGSCs subtypes and negative regulation of endothelial cell proliferation/CaMKII pathway in human brain low-grade astrocytoma, providing new potential targets for molecular therapies of this disease">
    <entity charOffset="87-140" id="s2735.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="181-192" id="s2735.e1" ontology_id="HP_0009592" text="astrocytoma" type="HP"/>
    <pair e1="s2735.e0" e2="s2735.e1" id="s2735.p0" relation="false"/>
  </sentence>
  <sentence id="s2736" text="Membrane transporters (such as ABCs, SLCs and ATPases) coenzyme A biosynthetic process in carcinogenesis and chemoresistance development, but their relevance for prognosis of epithelial ovarian cancer (EOC) remains poorly understood.">
    <entity charOffset="55-86" id="s2736.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="194-200" id="s2736.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2736.e0" e2="s2736.e1" id="s2736.p0" relation="false"/>
  </sentence>
  <sentence id="s2737" text="We found that KLK10 was significantly overexpressed in tissues of pancreatic intraepithelial neoplasia (PanIN) and PDAC from Pdx1-Cre; LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt; epidermis development (KC) and Pdx1-Cre; LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt;; LSL-Trp53&lt;sup&gt;R172H/+&lt;/sup&gt; mice (KPC) by immunohistochemical analysis.">
    <entity charOffset="93-102" id="s2737.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="161-182" id="s2737.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2737.e0" e2="s2737.e1" id="s2737.p0" relation="false"/>
  </sentence>
  <sentence id="s2738" text="Mutations in the membrane frizzled-related protein (embryo development ending in birth or egg hatching/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.">
    <entity charOffset="52-102" id="s2738.e0" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <entity charOffset="229-243" id="s2738.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s2738.e0" e2="s2738.e1" id="s2738.p0" relation="true"/>
  </sentence>
  <sentence id="s2739" text="In embryo development ending in birth or egg hatchingrd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (retinoid metabolic process, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, receptor guanylyl cyclase signaling pathway, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and actin cytoskeleton organization).">
    <entity charOffset="3-53" id="s2739.e0" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <entity charOffset="153-173" id="s2739.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2739.e0" e2="s2739.e1" id="s2739.p0" relation="true"/>
  </sentence>
  <sentence id="s2740" text="In embryo development ending in birth or egg hatchingrd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (retinoid metabolic process, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, receptor guanylyl cyclase signaling pathway, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and actin cytoskeleton organization).">
    <entity charOffset="153-173" id="s2740.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="217-243" id="s2740.e1" ontology_id="GO_0001523" text="retinoid metabolic process" type="GO"/>
    <pair e1="s2740.e0" e2="s2740.e1" id="s2740.p0" relation="false"/>
  </sentence>
  <sentence id="s2741" text="In embryo development ending in birth or egg hatchingrd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (retinoid metabolic process, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, receptor guanylyl cyclase signaling pathway, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and actin cytoskeleton organization).">
    <entity charOffset="153-173" id="s2741.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="276-320" id="s2741.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s2741.e0" e2="s2741.e1" id="s2741.p0" relation="false"/>
  </sentence>
  <sentence id="s2742" text="In embryo development ending in birth or egg hatchingrd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (retinoid metabolic process, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, receptor guanylyl cyclase signaling pathway, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and actin cytoskeleton organization).">
    <entity charOffset="153-173" id="s2742.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="322-365" id="s2742.e1" ontology_id="GO_0007168" text="receptor guanylyl cyclase signaling pathway" type="GO"/>
    <pair e1="s2742.e0" e2="s2742.e1" id="s2742.p0" relation="false"/>
  </sentence>
  <sentence id="s2743" text="In embryo development ending in birth or egg hatchingrd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (retinoid metabolic process, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, receptor guanylyl cyclase signaling pathway, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and actin cytoskeleton organization).">
    <entity charOffset="153-173" id="s2743.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="424-455" id="s2743.e1" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <pair e1="s2743.e0" e2="s2743.e1" id="s2743.p0" relation="false"/>
  </sentence>
  <sentence id="s2744" text="Transcripts of camera-type eye development, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in embryo development ending in birth or egg hatchingrd6 eyes by 17-fold.">
    <entity charOffset="15-42" id="s2744.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="101-115" id="s2744.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s2744.e0" e2="s2744.e1" id="s2744.p0" relation="true"/>
  </sentence>
  <sentence id="s2745" text="Transcripts of camera-type eye development, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in embryo development ending in birth or egg hatchingrd6 eyes by 17-fold.">
    <entity charOffset="15-42" id="s2745.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="81-89" id="s2745.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s2745.e0" e2="s2745.e1" id="s2745.p0" relation="true"/>
  </sentence>
  <sentence id="s2746" text="Transcripts of camera-type eye development, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in embryo development ending in birth or egg hatchingrd6 eyes by 17-fold.">
    <entity charOffset="15-42" id="s2746.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="120-126" id="s2746.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s2746.e0" e2="s2746.e1" id="s2746.p0" relation="false"/>
  </sentence>
  <sentence id="s2747" text="Transcripts of camera-type eye development, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in embryo development ending in birth or egg hatchingrd6 eyes by 17-fold.">
    <entity charOffset="81-89" id="s2747.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="146-196" id="s2747.e1" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <pair e1="s2747.e0" e2="s2747.e1" id="s2747.p0" relation="true"/>
  </sentence>
  <sentence id="s2748" text="Transcripts of camera-type eye development, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in embryo development ending in birth or egg hatchingrd6 eyes by 17-fold.">
    <entity charOffset="120-126" id="s2748.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="146-196" id="s2748.e1" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <pair e1="s2748.e0" e2="s2748.e1" id="s2748.p0" relation="false"/>
  </sentence>
  <sentence id="s2749" text="Prostate cancer (mitochondrial transport) is a leading cause of cancerassociated mortality in negative regulation of phosphatase activity; however, the factors that contribute to disease development have yet to be fully elucidated.">
    <entity charOffset="9-15" id="s2749.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="17-40" id="s2749.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s2749.e0" e2="s2749.e1" id="s2749.p0" relation="false"/>
  </sentence>
  <sentence id="s2750" text="Prostate cancer (mitochondrial transport) is a leading cause of cancerassociated mortality in negative regulation of phosphatase activity; however, the factors that contribute to disease development have yet to be fully elucidated.">
    <entity charOffset="9-15" id="s2750.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="95-138" id="s2750.e1" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <pair e1="s2750.e0" e2="s2750.e1" id="s2750.p0" relation="false"/>
  </sentence>
  <sentence id="s2751" text="Biallelic mutations in heme biosynthetic process cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia.">
    <entity charOffset="23-48" id="s2751.e0" ontology_id="GO_0006783" text="heme biosynthetic process" type="GO"/>
    <entity charOffset="137-160" id="s2751.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2751.e0" e2="s2751.e1" id="s2751.p0" relation="false"/>
  </sentence>
  <sentence id="s2752" text="Biallelic mutations in heme biosynthetic process cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia.">
    <entity charOffset="23-48" id="s2752.e0" ontology_id="GO_0006783" text="heme biosynthetic process" type="GO"/>
    <entity charOffset="181-199" id="s2752.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s2752.e0" e2="s2752.e1" id="s2752.p0" relation="true"/>
  </sentence>
  <sentence id="s2753" text="Gorlin syndrome is a rare multisystem inherited disorder which can predispose to basal cell carcinomas (BCCs), childhood medulloblastomas in addition to various developmental abnormalities; the majority of cases are due to mutations in the positive regulation of cholesterol efflux gene.">
    <entity charOffset="121-137" id="s2753.e0" ontology_id="HP_0002885" text="medulloblastomas" type="HP"/>
    <entity charOffset="240-281" id="s2753.e1" ontology_id="GO_0010875" text="positive regulation of cholesterol efflux" type="GO"/>
    <pair e1="s2753.e0" e2="s2753.e1" id="s2753.p0" relation="true"/>
  </sentence>
  <sentence id="s2754" text="Certain phenotypic features have been identified as being more prevalent in individuals with a negative regulation of transcription by RNA polymerase II mutation such as childhood medulloblastoma, infundibulocystic BCCs and trichoepitheliomas.">
    <entity charOffset="95-152" id="s2754.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="180-195" id="s2754.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s2754.e0" e2="s2754.e1" id="s2754.p0" relation="true"/>
  </sentence>
  <sentence id="s2755" text="Certain phenotypic features have been identified as being more prevalent in individuals with a negative regulation of transcription by RNA polymerase II mutation such as childhood medulloblastoma, infundibulocystic BCCs and trichoepitheliomas.">
    <entity charOffset="95-152" id="s2755.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="224-242" id="s2755.e1" ontology_id="HP_0025367" text="trichoepitheliomas" type="HP"/>
    <pair e1="s2755.e0" e2="s2755.e1" id="s2755.p0" relation="false"/>
  </sentence>
  <sentence id="s2756" text="Recently hamartomatous skin lesions have also been noted in families with childhood medulloblastoma, a &amp;quot;Gorlin like&amp;quot; phenotype and a negative regulation of transcription by RNA polymerase II mutation.">
    <entity charOffset="84-99" id="s2756.e0" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <entity charOffset="143-200" id="s2756.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2756.e0" e2="s2756.e1" id="s2756.p0" relation="true"/>
  </sentence>
  <sentence id="s2757" text="We used Cregulation of insulin secretion-C to investigate long-range interactions at three breast cancer gene deserts mapping to 2q35, 8q24.21, and 9q31.2.">
    <entity charOffset="9-40" id="s2757.e0" ontology_id="GO_0050796" text="regulation of insulin secretion" type="GO"/>
    <entity charOffset="98-104" id="s2757.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2757.e0" e2="s2757.e1" id="s2757.p0" relation="false"/>
  </sentence>
  <sentence id="s2758" text="Both RPE65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating T cell costimulation-induced retinal degeneration.">
    <entity charOffset="137-157" id="s2758.e0" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <entity charOffset="166-186" id="s2758.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2758.e0" e2="s2758.e1" id="s2758.p0" relation="false"/>
  </sentence>
  <sentence id="s2759" text="The genes with the highest number of hypermethylated CpG sites in INRG M tumors are transcription, RNA-templated, PCDHGA4, DLX5, and skeletal system development-AS1.">
    <entity charOffset="73-78" id="s2759.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-112" id="s2759.e1" ontology_id="GO_0001172" text="transcription, RNA-templated" type="GO"/>
    <pair e1="s2759.e0" e2="s2759.e1" id="s2759.p0" relation="true"/>
  </sentence>
  <sentence id="s2760" text="The genes with the highest number of hypermethylated CpG sites in INRG M tumors are transcription, RNA-templated, PCDHGA4, DLX5, and skeletal system development-AS1.">
    <entity charOffset="73-78" id="s2760.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="133-160" id="s2760.e1" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="s2760.e0" e2="s2760.e1" id="s2760.p0" relation="false"/>
  </sentence>
  <sentence id="s2761" text="For validation, we used a negative regulation of transcription, DNA-templated of independent tumors previously analyzed with the Illumina 27K methylation arrays, which confirmed the differentially methylated sites.">
    <entity charOffset="26-77" id="s2761.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="93-98" id="s2761.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2761.e0" e2="s2761.e1" id="s2761.p0" relation="false"/>
  </sentence>
  <sentence id="s2762" text="Mutations in the phosphatidylcholine biosynthetic process gene have been recently linked to two different phenotypes: one characterized by spondylometaphyseal dysplasia and cone-rod dystrophy (SMD-CRD) and the other by congenital lipodystrophy, severe fatty liver disease, and reduced HDL cholesterol without any retinal or skeletal involvement.">
    <entity charOffset="17-57" id="s2762.e0" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <entity charOffset="139-168" id="s2762.e1" ontology_id="HP_0002657" text="spondylometaphyseal dysplasia" type="HP"/>
    <pair e1="s2762.e0" e2="s2762.e1" id="s2762.p0" relation="true"/>
  </sentence>
  <sentence id="s2763" text="Mutations in the phosphatidylcholine biosynthetic process gene have been recently linked to two different phenotypes: one characterized by spondylometaphyseal dysplasia and cone-rod dystrophy (SMD-CRD) and the other by congenital lipodystrophy, severe fatty liver disease, and reduced HDL cholesterol without any retinal or skeletal involvement.">
    <entity charOffset="17-57" id="s2763.e0" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <entity charOffset="230-243" id="s2763.e1" ontology_id="HP_0009125" text="lipodystrophy" type="HP"/>
    <pair e1="s2763.e0" e2="s2763.e1" id="s2763.p0" relation="false"/>
  </sentence>
  <sentence id="s2764" text="This is the first report showing that the phosphatidylcholine biosynthetic process gene can be responsible for isolated forms of retinal dystrophy, particularly without any skeletal involvement, thus further expanding the phenotypic spectrum induced by mutations in this gene">
    <entity charOffset="42-82" id="s2764.e0" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <entity charOffset="129-146" id="s2764.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s2764.e0" e2="s2764.e1" id="s2764.p0" relation="true"/>
  </sentence>
  <sentence id="s2765" text="The majority of causative genetic variants identified thus far are inherited in an autosomal recessive manner and impact key cellular pathways such as mitosis, DNA cellular protein catabolic process response and repair, apoptosis and splicing.">
    <entity charOffset="83-102" id="s2765.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="164-198" id="s2765.e1" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <pair e1="s2765.e0" e2="s2765.e1" id="s2765.p0" relation="false"/>
  </sentence>
  <sentence id="s2766" text="Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (mRNA splicing, via spliceosome) gene (NG_021310.2:g.6126G&amp;gt;A, NM_015698.4:c.331+5G&amp;gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).">
    <entity charOffset="88-118" id="s2766.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="326-338" id="s2766.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2766.e0" e2="s2766.e1" id="s2766.p0" relation="true"/>
  </sentence>
  <sentence id="s2767" text="Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (mRNA splicing, via spliceosome) gene (NG_021310.2:g.6126G&amp;gt;A, NM_015698.4:c.331+5G&amp;gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).">
    <entity charOffset="88-118" id="s2767.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="343-374" id="s2767.e1" ontology_id="HP_0001511" text="intrauterine growth restriction" type="HP"/>
    <pair e1="s2767.e0" e2="s2767.e1" id="s2767.p0" relation="true"/>
  </sentence>
  <sentence id="s2768" text="Based on our and published data we propose that the mRNA splicing, via spliceosome gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenomuscle organ development characterised by microcephaly and IUGR">
    <entity charOffset="52-82" id="s2768.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="221-233" id="s2768.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2768.e0" e2="s2768.e1" id="s2768.p0" relation="true"/>
  </sentence>
  <sentence id="s2769" text="Based on our and published data we propose that the mRNA splicing, via spliceosome gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenomuscle organ development characterised by microcephaly and IUGR">
    <entity charOffset="179-203" id="s2769.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="221-233" id="s2769.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2769.e0" e2="s2769.e1" id="s2769.p0" relation="false"/>
  </sentence>
  <sentence id="s2770" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-158" id="s2770.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="198-213" id="s2770.e1" ontology_id="HP_0000787" text="nephrolithiasis" type="HP"/>
    <pair e1="s2770.e0" e2="s2770.e1" id="s2770.p0" relation="false"/>
  </sentence>
  <sentence id="s2771" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-158" id="s2771.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="278-299" id="s2771.e1" ontology_id="HP_0000169" text="gingival fibromatosis" type="HP"/>
    <pair e1="s2771.e0" e2="s2771.e1" id="s2771.p0" relation="false"/>
  </sentence>
  <sentence id="s2772" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-158" id="s2772.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="310-330" id="s2772.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s2772.e0" e2="s2772.e1" id="s2772.p0" relation="true"/>
  </sentence>
  <sentence id="s2773" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="112-158" id="s2773.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="342-352" id="s2773.e1" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <pair e1="s2773.e0" e2="s2773.e1" id="s2773.p0" relation="false"/>
  </sentence>
  <sentence id="s2774" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="180-196" id="s2774.e0" ontology_id="HP_0000121" text="nephrocalcinosis" type="HP"/>
    <entity charOffset="252-276" id="s2774.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2774.e0" e2="s2774.e1" id="s2774.p0" relation="false"/>
  </sentence>
  <sentence id="s2775" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="198-213" id="s2775.e0" ontology_id="HP_0000787" text="nephrolithiasis" type="HP"/>
    <entity charOffset="252-276" id="s2775.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2775.e0" e2="s2775.e1" id="s2775.p0" relation="false"/>
  </sentence>
  <sentence id="s2776" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="252-276" id="s2776.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="310-330" id="s2776.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s2776.e0" e2="s2776.e1" id="s2776.p0" relation="false"/>
  </sentence>
  <sentence id="s2777" text="Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.">
    <entity charOffset="252-276" id="s2777.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="342-352" id="s2777.e1" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <pair e1="s2777.e0" e2="s2777.e1" id="s2777.p0" relation="false"/>
  </sentence>
  <sentence id="s2778" text="Very recently, double-strand break repair via homologous recombination has been established as a new FA gene raising the question of its implication in breast cancer risk.">
    <entity charOffset="15-70" id="s2778.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="159-165" id="s2778.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2778.e0" e2="s2778.e1" id="s2778.p0" relation="true"/>
  </sentence>
  <sentence id="s2779" text="This study aimed at answering this question sequencing the entire coding region of double-strand break repair via homologous recombination in 526 familial breast cancer cases from Italy.">
    <entity charOffset="83-138" id="s2779.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="162-168" id="s2779.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2779.e0" e2="s2779.e1" id="s2779.p0" relation="true"/>
  </sentence>
  <sentence id="s2780" text="Our results indicate that testing for double-strand break repair via homologous recombination germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population">
    <entity charOffset="38-93" id="s2780.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="196-202" id="s2780.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2780.e0" e2="s2780.e1" id="s2780.p0" relation="true"/>
  </sentence>
  <sentence id="s2781" text="Here we show, using whole-exome and cancer gene panel sequencing of 79 aGCTs from two independent cohorts, that truncating mutation of the histone lysine methyltransferase gene KMT2D (also known as histone H3-K4 methylation) is a recurrent somatic event in aGCT.">
    <entity charOffset="36-42" id="s2781.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="198-223" id="s2781.e1" ontology_id="GO_0051568" text="histone H3-K4 methylation" type="GO"/>
    <pair e1="s2781.e0" e2="s2781.e1" id="s2781.p0" relation="false"/>
  </sentence>
  <sentence id="s2782" text="Moreover, Adenomatous polyposis coli 2 (APC2), a tumor suppressor and a negative regulator of Wnt signaling, was found to be the direct target of protein polyubiquitination-3648.">
    <entity charOffset="49-54" id="s2782.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="146-172" id="s2782.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s2782.e0" e2="s2782.e1" id="s2782.p0" relation="false"/>
  </sentence>
  <sentence id="s2783" text="Exome sequencing of superior coloboma patients identified rare variants in a Bone Morphogenetic Protein (Bmp) receptor (protein phosphorylation) and T-box transcription factor (negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="29-37" id="s2783.e0" ontology_id="HP_0000589" text="coloboma" type="HP"/>
    <entity charOffset="120-143" id="s2783.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s2783.e0" e2="s2783.e1" id="s2783.p0" relation="false"/>
  </sentence>
  <sentence id="s2784" text="Exome sequencing of superior coloboma patients identified rare variants in a Bone Morphogenetic Protein (Bmp) receptor (protein phosphorylation) and T-box transcription factor (negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="29-37" id="s2784.e0" ontology_id="HP_0000589" text="coloboma" type="HP"/>
    <entity charOffset="177-234" id="s2784.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2784.e0" e2="s2784.e1" id="s2784.p0" relation="false"/>
  </sentence>
  <sentence id="s2785" text="We found that positive regulation of transcription by RNA polymerase II is significantly upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.">
    <entity charOffset="14-71" id="s2785.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="104-128" id="s2785.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s2785.e0" e2="s2785.e1" id="s2785.p0" relation="false"/>
  </sentence>
  <sentence id="s2786" text="We found that positive regulation of transcription by RNA polymerase II is significantly upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.">
    <entity charOffset="14-71" id="s2786.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="168-174" id="s2786.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2786.e0" e2="s2786.e1" id="s2786.p0" relation="false"/>
  </sentence>
  <sentence id="s2787" text="We found that positive regulation of transcription by RNA polymerase II is significantly upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.">
    <entity charOffset="14-71" id="s2787.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="208-213" id="s2787.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2787.e0" e2="s2787.e1" id="s2787.p0" relation="false"/>
  </sentence>
  <sentence id="s2788" text="We found that positive regulation of transcription by RNA polymerase II is significantly upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.">
    <entity charOffset="130-166" id="s2788.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="168-174" id="s2788.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s2788.e0" e2="s2788.e1" id="s2788.p0" relation="false"/>
  </sentence>
  <sentence id="s2789" text="We performed exome sequencing in a large family affected by an autosomal-dominant form of mild syndromic ID with ptosis, growth retardation, and hypotonia, and we identified an inherited 2bp deletion causing a frameshift in histone H3 acetylation (c.1052_1053del) in five affected family members.">
    <entity charOffset="113-119" id="s2789.e0" ontology_id="HP_0000508" text="ptosis" type="HP"/>
    <entity charOffset="225-247" id="s2789.e1" ontology_id="GO_0043966" text="histone H3 acetylation" type="GO"/>
    <pair e1="s2789.e0" e2="s2789.e1" id="s2789.p0" relation="true"/>
  </sentence>
  <sentence id="s2790" text="We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as ptosis and blepharophimosis, are mostly driven by histone H3 acetylation haploinsufficiency">
    <entity charOffset="144-160" id="s2790.e0" ontology_id="HP_0000581" text="blepharophimosis" type="HP"/>
    <entity charOffset="183-205" id="s2790.e1" ontology_id="GO_0043966" text="histone H3 acetylation" type="GO"/>
    <pair e1="s2790.e0" e2="s2790.e1" id="s2790.p0" relation="true"/>
  </sentence>
  <sentence id="s2791" text="Primary hyperoxaluria muscle organ development 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease.">
    <entity charOffset="8-21" id="s2791.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="22-46" id="s2791.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2791.e0" e2="s2791.e1" id="s2791.p0" relation="false"/>
  </sentence>
  <sentence id="s2792" text="Primary hyperoxaluria muscle organ development 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease.">
    <entity charOffset="22-46" id="s2792.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="113-125" id="s2792.e1" ontology_id="HP_0000787" text="renal stones" type="HP"/>
    <pair e1="s2792.e0" e2="s2792.e1" id="s2792.p0" relation="false"/>
  </sentence>
  <sentence id="s2793" text="Primary hyperoxaluria muscle organ development 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease.">
    <entity charOffset="22-46" id="s2793.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="127-143" id="s2793.e1" ontology_id="HP_0000121" text="nephrocalcinosis" type="HP"/>
    <pair e1="s2793.e0" e2="s2793.e1" id="s2793.p0" relation="false"/>
  </sentence>
  <sentence id="s2794" text="Our results reveal that current SZ diagnoses aggregate over at least two disease subtypes: one part resembles high intelligence and bipolar disorder (cellular response to glucose starvation), while the other part is a cognitive disorder that is independent of BIP">
    <entity charOffset="132-148" id="s2794.e0" ontology_id="HP_0007302" text="bipolar disorder" type="HP"/>
    <entity charOffset="150-189" id="s2794.e1" ontology_id="GO_0042149" text="cellular response to glucose starvation" type="GO"/>
    <pair e1="s2794.e0" e2="s2794.e1" id="s2794.p0" relation="false"/>
  </sentence>
  <sentence id="s2795" text="In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins regulation of protein phosphorylation and cellular response to unfolded protein and investigate the functional consequences of newly discovered variants.">
    <entity charOffset="54-60" id="s2795.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="142-179" id="s2795.e1" ontology_id="GO_0001932" text="regulation of protein phosphorylation" type="GO"/>
    <pair e1="s2795.e0" e2="s2795.e1" id="s2795.p0" relation="false"/>
  </sentence>
  <sentence id="s2796" text="In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins regulation of protein phosphorylation and cellular response to unfolded protein and investigate the functional consequences of newly discovered variants.">
    <entity charOffset="78-88" id="s2796.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="142-179" id="s2796.e1" ontology_id="GO_0001932" text="regulation of protein phosphorylation" type="GO"/>
    <pair e1="s2796.e0" e2="s2796.e1" id="s2796.p0" relation="true"/>
  </sentence>
  <sentence id="s2797" text="In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins regulation of protein phosphorylation and cellular response to unfolded protein and investigate the functional consequences of newly discovered variants.">
    <entity charOffset="78-88" id="s2797.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="184-221" id="s2797.e1" ontology_id="GO_0034620" text="cellular response to unfolded protein" type="GO"/>
    <pair e1="s2797.e0" e2="s2797.e1" id="s2797.p0" relation="true"/>
  </sentence>
  <sentence id="s2798" text="Among 510 unrelated patients with distal motor neuropathy, we identified mutations in regulation of protein phosphorylation (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.">
    <entity charOffset="34-40" id="s2798.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="86-123" id="s2798.e1" ontology_id="GO_0001932" text="regulation of protein phosphorylation" type="GO"/>
    <pair e1="s2798.e0" e2="s2798.e1" id="s2798.p0" relation="false"/>
  </sentence>
  <sentence id="s2799" text="Among 510 unrelated patients with distal motor neuropathy, we identified mutations in regulation of protein phosphorylation (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.">
    <entity charOffset="47-57" id="s2799.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="86-123" id="s2799.e1" ontology_id="GO_0001932" text="regulation of protein phosphorylation" type="GO"/>
    <pair e1="s2799.e0" e2="s2799.e1" id="s2799.p0" relation="true"/>
  </sentence>
  <sentence id="s2800" text="We demonstrate that regulation of protein phosphorylation and HSPB8 mutations are a major cause of inherited motor axonal neuropathy.">
    <entity charOffset="20-57" id="s2800.e0" ontology_id="GO_0001932" text="regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="122-132" id="s2800.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s2800.e0" e2="s2800.e1" id="s2800.p0" relation="true"/>
  </sentence>
  <sentence id="s2801" text="In this study, we aimed to assess the independent prognostic value of protein polyubiquitination-361-3p in terms of overall survival (OS) and recurrence-free survival (RFS) in cervical cancer, as well as its possible regulative network.">
    <entity charOffset="70-96" id="s2801.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="185-191" id="s2801.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2801.e0" e2="s2801.e1" id="s2801.p0" relation="false"/>
  </sentence>
  <sentence id="s2802" text="Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of mRNA export from nucleus and DNA replication in hematological neoplasms and overexpression of NUP88 in a variety of human cancers.">
    <entity charOffset="92-116" id="s2802.e0" ontology_id="GO_0006406" text="mRNA export from nucleus" type="GO"/>
    <entity charOffset="154-163" id="s2802.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s2802.e0" e2="s2802.e1" id="s2802.p0" relation="true"/>
  </sentence>
  <sentence id="s2803" text="Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of mRNA export from nucleus and DNA replication in hematological neoplasms and overexpression of NUP88 in a variety of human cancers.">
    <entity charOffset="121-136" id="s2803.e0" ontology_id="GO_0006260" text="DNA replication" type="GO"/>
    <entity charOffset="154-163" id="s2803.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s2803.e0" e2="s2803.e1" id="s2803.p0" relation="false"/>
  </sentence>
  <sentence id="s2804" text="Inherited mutations in protein acetylation, encoding the catalytic subunit of the major N-terminal acetylation complex NatA have been associated with diverse, syndromic X-linked recessive disorders, whereas de novo missense mutations have been reported in one male and one female individual with severe intellectual disability but otherwise unspecific phenotypes.">
    <entity charOffset="23-42" id="s2804.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="303-326" id="s2804.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2804.e0" e2="s2804.e1" id="s2804.p0" relation="true"/>
  </sentence>
  <sentence id="s2805" text="The core phenotype of X-linked protein acetylation-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-50" id="s2805.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="162-185" id="s2805.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2805.e0" e2="s2805.e1" id="s2805.p0" relation="true"/>
  </sentence>
  <sentence id="s2806" text="The core phenotype of X-linked protein acetylation-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-50" id="s2806.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="187-211" id="s2806.e1" ontology_id="HP_0008897" text="postnatal growth failure" type="HP"/>
    <pair e1="s2806.e0" e2="s2806.e1" id="s2806.p0" relation="true"/>
  </sentence>
  <sentence id="s2807" text="The core phenotype of X-linked protein acetylation-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.">
    <entity charOffset="31-50" id="s2807.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="224-236" id="s2807.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2807.e0" e2="s2807.e1" id="s2807.p0" relation="true"/>
  </sentence>
  <sentence id="s2808" text="Broad adenylate cyclase-activating G protein-coupled receptor signaling pathway methylation abnormalities are also observed in most sporadic PHP1B (sporPHP1B) cases.">
    <entity charOffset="6-79" id="s2808.e0" ontology_id="GO_0007189" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="132-140" id="s2808.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2808.e0" e2="s2808.e1" id="s2808.p0" relation="true"/>
  </sentence>
  <sentence id="s2809" text="We now investigated 23 Japanese sporPHP1B cases, who presented with hypocalcemia, hyperphosphatemia, elevated negative regulation of transcription by RNA polymerase II levels, and occasionally with TSH elevations and mild AHO features.">
    <entity charOffset="68-80" id="s2809.e0" ontology_id="HP_0002901" text="hypocalcemia" type="HP"/>
    <entity charOffset="110-167" id="s2809.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2809.e0" e2="s2809.e1" id="s2809.p0" relation="true"/>
  </sentence>
  <sentence id="s2810" text="We now investigated 23 Japanese sporPHP1B cases, who presented with hypocalcemia, hyperphosphatemia, elevated negative regulation of transcription by RNA polymerase II levels, and occasionally with TSH elevations and mild AHO features.">
    <entity charOffset="82-99" id="s2810.e0" ontology_id="HP_0002905" text="hyperphosphatemia" type="HP"/>
    <entity charOffset="110-167" id="s2810.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2810.e0" e2="s2810.e1" id="s2810.p0" relation="true"/>
  </sentence>
  <sentence id="s2811" text="Cases were reviewed for consanguinity, multicellular organism development, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).">
    <entity charOffset="39-73" id="s2811.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="172-192" id="s2811.e1" ontology_id="HP_0011968" text="feeding difficulties" type="HP"/>
    <pair e1="s2811.e0" e2="s2811.e1" id="s2811.p0" relation="false"/>
  </sentence>
  <sentence id="s2812" text="Cases were reviewed for consanguinity, multicellular organism development, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).">
    <entity charOffset="39-73" id="s2812.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="210-222" id="s2812.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2812.e0" e2="s2812.e1" id="s2812.p0" relation="false"/>
  </sentence>
  <sentence id="s2813" text="Cases were reviewed for consanguinity, multicellular organism development, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).">
    <entity charOffset="39-73" id="s2813.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="420-438" id="s2813.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s2813.e0" e2="s2813.e1" id="s2813.p0" relation="false"/>
  </sentence>
  <sentence id="s2814" text="The quality of care for LTC residents with intracellular protein transport is heterogeneous in regard to both the facility and the patient.">
    <entity charOffset="43-74" id="s2814.e0" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <entity charOffset="78-91" id="s2814.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s2814.e0" e2="s2814.e1" id="s2814.p0" relation="false"/>
  </sentence>
  <sentence id="s2815" text="To investigate the direct effects of this SNP in the heterogeneous cellular context of the brain, we generated humanized transgenic epidermis development using a design that maximized the local transcriptional landscape of the human adenylate cyclase-inhibiting serotonin receptor signaling pathway gene while also controlling for effects of genomic insertion location.">
    <entity charOffset="53-66" id="s2815.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="132-153" id="s2815.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2815.e0" e2="s2815.e1" id="s2815.p0" relation="false"/>
  </sentence>
  <sentence id="s2816" text="To investigate the direct effects of this SNP in the heterogeneous cellular context of the brain, we generated humanized transgenic epidermis development using a design that maximized the local transcriptional landscape of the human adenylate cyclase-inhibiting serotonin receptor signaling pathway gene while also controlling for effects of genomic insertion location.">
    <entity charOffset="53-66" id="s2816.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="233-298" id="s2816.e1" ontology_id="GO_0007198" text="adenylate cyclase-inhibiting serotonin receptor signaling pathway" type="GO"/>
    <pair e1="s2816.e0" e2="s2816.e1" id="s2816.p0" relation="false"/>
  </sentence>
  <sentence id="s2817" text="De novo negative regulation of B cell apoptotic process mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.">
    <entity charOffset="8-55" id="s2817.e0" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <entity charOffset="92-115" id="s2817.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2817.e0" e2="s2817.e1" id="s2817.p0" relation="true"/>
  </sentence>
  <sentence id="s2818" text="De novo negative regulation of B cell apoptotic process mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.">
    <entity charOffset="8-55" id="s2818.e0" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <entity charOffset="122-133" id="s2818.e1" ontology_id="HP_0001270" text="motor delay" type="HP"/>
    <pair e1="s2818.e0" e2="s2818.e1" id="s2818.p0" relation="true"/>
  </sentence>
  <sentence id="s2819" text="De novo negative regulation of B cell apoptotic process mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.">
    <entity charOffset="8-55" id="s2819.e0" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <entity charOffset="176-195" id="s2819.e1" ontology_id="HP_0000750" text="speech difficulties" type="HP"/>
    <pair e1="s2819.e0" e2="s2819.e1" id="s2819.p0" relation="true"/>
  </sentence>
  <sentence id="s2820" text="By whole exome sequencing we identified a de novo splicing mutation in negative regulation of B cell apoptotic process in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with trigonocephaly.">
    <entity charOffset="71-118" id="s2820.e0" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <entity charOffset="224-238" id="s2820.e1" ontology_id="HP_0000243" text="trigonocephaly" type="HP"/>
    <pair e1="s2820.e0" e2="s2820.e1" id="s2820.p0" relation="false"/>
  </sentence>
  <sentence id="s2821" text="The patient reported here shares speech difficulties, intellectual disability and autistic features with other negative regulation of B cell apoptotic process syndrome patients, and thus the diagnosis for this patient should be changed.">
    <entity charOffset="33-52" id="s2821.e0" ontology_id="HP_0000750" text="speech difficulties" type="HP"/>
    <entity charOffset="111-158" id="s2821.e1" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <pair e1="s2821.e0" e2="s2821.e1" id="s2821.p0" relation="true"/>
  </sentence>
  <sentence id="s2822" text="The patient reported here shares speech difficulties, intellectual disability and autistic features with other negative regulation of B cell apoptotic process syndrome patients, and thus the diagnosis for this patient should be changed.">
    <entity charOffset="54-77" id="s2822.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="111-158" id="s2822.e1" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <pair e1="s2822.e0" e2="s2822.e1" id="s2822.p0" relation="true"/>
  </sentence>
  <sentence id="s2823" text="Finally, since trigonocephaly has not been previously reported in negative regulation of B cell apoptotic process syndrome, it remains to be proved whether it may be associated with the FOXP1 mutation">
    <entity charOffset="15-29" id="s2823.e0" ontology_id="HP_0000243" text="trigonocephaly" type="HP"/>
    <entity charOffset="66-113" id="s2823.e1" ontology_id="GO_0002903" text="negative regulation of B cell apoptotic process" type="GO"/>
    <pair e1="s2823.e0" e2="s2823.e1" id="s2823.p0" relation="false"/>
  </sentence>
  <sentence id="s2824" text="Epithelial-stromal angiogenesis dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (quaternary ammonium group transport) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.">
    <entity charOffset="19-31" id="s2824.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="196-215" id="s2824.e1" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <pair e1="s2824.e0" e2="s2824.e1" id="s2824.p0" relation="true"/>
  </sentence>
  <sentence id="s2825" text="Epithelial-stromal angiogenesis dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (quaternary ammonium group transport) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.">
    <entity charOffset="19-31" id="s2825.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="53-70" id="s2825.e1" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <pair e1="s2825.e0" e2="s2825.e1" id="s2825.p0" relation="true"/>
  </sentence>
  <sentence id="s2826" text="Epithelial-stromal angiogenesis dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (quaternary ammonium group transport) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.">
    <entity charOffset="53-70" id="s2826.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="103-138" id="s2826.e1" ontology_id="GO_0015697" text="quaternary ammonium group transport" type="GO"/>
    <pair e1="s2826.e0" e2="s2826.e1" id="s2826.p0" relation="false"/>
  </sentence>
  <sentence id="s2827" text="Epithelial-stromal angiogenesis dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (quaternary ammonium group transport) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.">
    <entity charOffset="103-138" id="s2827.e0" ontology_id="GO_0015697" text="quaternary ammonium group transport" type="GO"/>
    <entity charOffset="196-215" id="s2827.e1" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <pair e1="s2827.e0" e2="s2827.e1" id="s2827.p0" relation="false"/>
  </sentence>
  <sentence id="s2828" text="Recessive mutations in WD repeat domain 62 (mitotic spindle organization) cause microcephaly and a wide spectrum of severe brain malformations.">
    <entity charOffset="44-72" id="s2828.e0" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <entity charOffset="80-92" id="s2828.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s2828.e0" e2="s2828.e1" id="s2828.p0" relation="true"/>
  </sentence>
  <sentence id="s2829" text="As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="36-87" id="s2829.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="138-151" id="s2829.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2829.e0" e2="s2829.e1" id="s2829.p0" relation="false"/>
  </sentence>
  <sentence id="s2830" text="As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="138-151" id="s2830.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="284-338" id="s2830.e1" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <pair e1="s2830.e0" e2="s2830.e1" id="s2830.p0" relation="false"/>
  </sentence>
  <sentence id="s2831" text="As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="138-151" id="s2831.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="358-390" id="s2831.e1" ontology_id="GO_1902476" text="chloride transmembrane transport" type="GO"/>
    <pair e1="s2831.e0" e2="s2831.e1" id="s2831.p0" relation="false"/>
  </sentence>
  <sentence id="s2832" text="As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="138-151" id="s2832.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="392-456" id="s2832.e1" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <pair e1="s2832.e0" e2="s2832.e1" id="s2832.p0" relation="false"/>
  </sentence>
  <sentence id="s2833" text="As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="138-151" id="s2833.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="495-565" id="s2833.e1" ontology_id="GO_0002474" text="antigen processing and presentation of peptide antigen via MHC class I" type="GO"/>
    <pair e1="s2833.e0" e2="s2833.e1" id="s2833.p0" relation="false"/>
  </sentence>
  <sentence id="s2834" text="As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="138-151" id="s2834.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="567-585" id="s2834.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s2834.e0" e2="s2834.e1" id="s2834.p0" relation="false"/>
  </sentence>
  <sentence id="s2835" text="As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="138-151" id="s2835.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="587-644" id="s2835.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2835.e0" e2="s2835.e1" id="s2835.p0" relation="false"/>
  </sentence>
  <sentence id="s2836" text="In our study, we identified a negative regulation of transcription, DNA-templated of susceptibility genes that had been missed in single-marker GWAS, and our findings could promote the study of the genetic mechanisms in schizophrenia.">
    <entity charOffset="30-81" id="s2836.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="220-233" id="s2836.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2836.e0" e2="s2836.e1" id="s2836.p0" relation="false"/>
  </sentence>
  <sentence id="s2837" text="This work associates missense mutations in NGolgi organizationE3 with an autosomal recessive chromosome breakage syndrome that leads to defective T and B cell function and acute respiratory distress syndrome in early childhood">
    <entity charOffset="44-62" id="s2837.e0" ontology_id="GO_0007030" text="Golgi organization" type="GO"/>
    <entity charOffset="73-92" id="s2837.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2837.e0" e2="s2837.e1" id="s2837.p0" relation="true"/>
  </sentence>
  <sentence id="s2838" text="Chronic hepatitis B virus (HBV) infection is partly responsible for hepatitis, fatty liver disease and hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="103-127" id="s2838.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="129-165" id="s2838.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s2838.e0" e2="s2838.e1" id="s2838.p0" relation="false"/>
  </sentence>
  <sentence id="s2839" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in multicellular organism development steroid hormone pathways (FN1, CCDC170, transcription by RNA polymerase II, Golgi organization and G protein-coupled receptor signaling pathway).">
    <entity charOffset="111-124" id="s2839.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="188-222" id="s2839.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s2839.e0" e2="s2839.e1" id="s2839.p0" relation="false"/>
  </sentence>
  <sentence id="s2840" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in multicellular organism development steroid hormone pathways (FN1, CCDC170, transcription by RNA polymerase II, Golgi organization and G protein-coupled receptor signaling pathway).">
    <entity charOffset="111-124" id="s2840.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="263-297" id="s2840.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s2840.e0" e2="s2840.e1" id="s2840.p0" relation="false"/>
  </sentence>
  <sentence id="s2841" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in multicellular organism development steroid hormone pathways (FN1, CCDC170, transcription by RNA polymerase II, Golgi organization and G protein-coupled receptor signaling pathway).">
    <entity charOffset="111-124" id="s2841.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="299-317" id="s2841.e1" ontology_id="GO_0007030" text="Golgi organization" type="GO"/>
    <pair e1="s2841.e0" e2="s2841.e1" id="s2841.p0" relation="false"/>
  </sentence>
  <sentence id="s2842" text="In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&amp;lt;5  10&lt;sup&gt;-8&lt;/sup&gt;), implicating genes involved in multicellular organism development steroid hormone pathways (FN1, CCDC170, transcription by RNA polymerase II, Golgi organization and G protein-coupled receptor signaling pathway).">
    <entity charOffset="111-124" id="s2842.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="322-366" id="s2842.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s2842.e0" e2="s2842.e1" id="s2842.p0" relation="false"/>
  </sentence>
  <sentence id="s2843" text="Conditional analysis identified five secondary association signals, including two at the transcription by RNA polymerase II locus, resulting in 19 independent single nucleotide polymorphisms (SNPs) robustly associated with endometriosis, which together explain up to 5.19% of variance in endometriosis.">
    <entity charOffset="89-123" id="s2843.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="223-236" id="s2843.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2843.e0" e2="s2843.e1" id="s2843.p0" relation="false"/>
  </sentence>
  <sentence id="s2844" text="However, analogous advanced treatments are not available for patients with lung squamous cell carcinoma (lung negative regulation of peptidase activity).">
    <entity charOffset="80-103" id="s2844.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="110-151" id="s2844.e1" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <pair e1="s2844.e0" e2="s2844.e1" id="s2844.p0" relation="false"/>
  </sentence>
  <sentence id="s2845" text="However, the negative regulation of transcription by RNA polymerase II of protein polyubiquitination-145-3p (the passenger strand) on cancer cells is still ambiguous.">
    <entity charOffset="13-70" id="s2845.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="134-140" id="s2845.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2845.e0" e2="s2845.e1" id="s2845.p0" relation="false"/>
  </sentence>
  <sentence id="s2846" text="However, the negative regulation of transcription by RNA polymerase II of protein polyubiquitination-145-3p (the passenger strand) on cancer cells is still ambiguous.">
    <entity charOffset="74-100" id="s2846.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="134-140" id="s2846.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2846.e0" e2="s2846.e1" id="s2846.p0" relation="false"/>
  </sentence>
  <sentence id="s2847" text="Expression levels of protein polyubiquitination-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.">
    <entity charOffset="21-47" id="s2847.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="255-260" id="s2847.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2847.e0" e2="s2847.e1" id="s2847.p0" relation="false"/>
  </sentence>
  <sentence id="s2848" text="Expression levels of protein polyubiquitination-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.">
    <entity charOffset="21-47" id="s2848.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="95-101" id="s2848.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2848.e0" e2="s2848.e1" id="s2848.p0" relation="false"/>
  </sentence>
  <sentence id="s2849" text="Taken together, both strands of protein polyubiquitination-145, miR-145-5p and miR-145-3p are functional and play pivotal roles as antitumor miRNAs in lung SCC">
    <entity charOffset="32-58" id="s2849.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="135-140" id="s2849.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2849.e0" e2="s2849.e1" id="s2849.p0" relation="false"/>
  </sentence>
  <sentence id="s2850" text="On comparing cytoskeletal anchoring at nuclear membrane and BRCA1 localization in the ovarian cancer cell lines SKOV-3 and Caov-3, Nesprin-2 and BRCA1 were localized to the NE envelope and the nucleus in SKOV-3, respectively, and to the cytoplasm in Caov-3 cells.">
    <entity charOffset="13-55" id="s2850.e0" ontology_id="GO_0090286" text="cytoskeletal anchoring at nuclear membrane" type="GO"/>
    <entity charOffset="94-100" id="s2850.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2850.e0" e2="s2850.e1" id="s2850.p0" relation="false"/>
  </sentence>
  <sentence id="s2851" text="steroid biosynthetic process defects result in congenital adrenal hyperplasia (CAH), an autosomal recessive disorder characterized by impaired adrenal steroidogenesis.">
    <entity charOffset="0-28" id="s2851.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="58-77" id="s2851.e1" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <pair e1="s2851.e0" e2="s2851.e1" id="s2851.p0" relation="true"/>
  </sentence>
  <sentence id="s2852" text="The hallmarks of this disease are macular drusen, carbohydrate metabolic process alterations, and geographic atrophy (GA).">
    <entity charOffset="50-80" id="s2852.e0" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <entity charOffset="98-116" id="s2852.e1" ontology_id="HP_0031609" text="geographic atrophy" type="HP"/>
    <pair e1="s2852.e0" e2="s2852.e1" id="s2852.p0" relation="false"/>
  </sentence>
  <sentence id="s2853" text="Complete identification of genes related to one muscle organ development of cancer facilitates earlier diagnosis and effective treatments.">
    <entity charOffset="48-72" id="s2853.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="76-82" id="s2853.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2853.e0" e2="s2853.e1" id="s2853.p0" relation="false"/>
  </sentence>
  <sentence id="s2854" text="This is the first study to investigate the effect of vitamin D receptor ( negative regulation of transcription by RNA polymerase II) gene single-nucleotide polymorphisms on the clinicopathologic features of papillary thyroid cancer in Turkey.">
    <entity charOffset="74-131" id="s2854.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="225-231" id="s2854.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2854.e0" e2="s2854.e1" id="s2854.p0" relation="false"/>
  </sentence>
  <sentence id="s2855" text="negative regulation of transcription by RNA polymerase II gene polymorphisms BsmI, ApaI, and TaqI did not differ between the papillary thyroid cancer group and control group (p&amp;gt;0.05, each).">
    <entity charOffset="0-57" id="s2855.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="143-149" id="s2855.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2855.e0" e2="s2855.e1" id="s2855.p0" relation="false"/>
  </sentence>
  <sentence id="s2856" text="negative regulation of transcription by RNA polymerase II gene FokI T allele and TT genotype correlated with aggressiveness of papillary thyroid cancer; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer">
    <entity charOffset="0-57" id="s2856.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="145-151" id="s2856.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2856.e0" e2="s2856.e1" id="s2856.p0" relation="false"/>
  </sentence>
  <sentence id="s2857" text="negative regulation of transcription by RNA polymerase II gene FokI T allele and TT genotype correlated with aggressiveness of papillary thyroid cancer; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer">
    <entity charOffset="0-57" id="s2857.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="109-123" id="s2857.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s2857.e0" e2="s2857.e1" id="s2857.p0" relation="false"/>
  </sentence>
  <sentence id="s2858" text="After 1year, because of worsening in multicellular organism development orientation and the onset of dressing apraxia, he was referred to our memory clinic.">
    <entity charOffset="38-72" id="s2858.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="111-118" id="s2858.e1" ontology_id="HP_0002186" text="apraxia" type="HP"/>
    <pair e1="s2858.e0" e2="s2858.e1" id="s2858.p0" relation="false"/>
  </sentence>
  <sentence id="s2859" text="Pathway analyses demonstrated that methylation levels associated with age and BMI are overrepresented among genes involved in cancer, muscle organ development 2 diabetes and cardiovascular disease.">
    <entity charOffset="126-132" id="s2859.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="134-158" id="s2859.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2859.e0" e2="s2859.e1" id="s2859.p0" relation="false"/>
  </sentence>
  <sentence id="s2860" text="Pathway analyses demonstrated that methylation levels associated with age and BMI are overrepresented among genes involved in cancer, muscle organ development 2 diabetes and cardiovascular disease.">
    <entity charOffset="134-158" id="s2860.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="174-196" id="s2860.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s2860.e0" e2="s2860.e1" id="s2860.p0" relation="true"/>
  </sentence>
  <sentence id="s2861" text="Our results highlight the negative regulation of transcription by RNA polymerase II of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, muscle organ development 2 diabetes and cancer in human adipose tissue.">
    <entity charOffset="26-83" id="s2861.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="202-208" id="s2861.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2861.e0" e2="s2861.e1" id="s2861.p0" relation="false"/>
  </sentence>
  <sentence id="s2862" text="Our results highlight the negative regulation of transcription by RNA polymerase II of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, muscle organ development 2 diabetes and cancer in human adipose tissue.">
    <entity charOffset="26-83" id="s2862.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="153-160" id="s2862.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s2862.e0" e2="s2862.e1" id="s2862.p0" relation="false"/>
  </sentence>
  <sentence id="s2863" text="Our results highlight the negative regulation of transcription by RNA polymerase II of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, muscle organ development 2 diabetes and cancer in human adipose tissue.">
    <entity charOffset="153-160" id="s2863.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="162-186" id="s2863.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s2863.e0" e2="s2863.e1" id="s2863.p0" relation="false"/>
  </sentence>
  <sentence id="s2864" text="Our results highlight the negative regulation of transcription by RNA polymerase II of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, muscle organ development 2 diabetes and cancer in human adipose tissue.">
    <entity charOffset="162-186" id="s2864.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="202-208" id="s2864.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2864.e0" e2="s2864.e1" id="s2864.p0" relation="false"/>
  </sentence>
  <sentence id="s2865" text="Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (asparagine catabolic process via L-aspartate), severe developmental delay, intellectual disability, and seizures.">
    <entity charOffset="16-33" id="s2865.e0" ontology_id="HP_0003155" text="hyperphosphatasia" type="HP"/>
    <entity charOffset="170-214" id="s2865.e1" ontology_id="GO_0033345" text="asparagine catabolic process via L-aspartate" type="GO"/>
    <pair e1="s2865.e0" e2="s2865.e1" id="s2865.p0" relation="false"/>
  </sentence>
  <sentence id="s2866" text="Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (asparagine catabolic process via L-aspartate), severe developmental delay, intellectual disability, and seizures.">
    <entity charOffset="77-96" id="s2866.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="170-214" id="s2866.e1" ontology_id="GO_0033345" text="asparagine catabolic process via L-aspartate" type="GO"/>
    <pair e1="s2866.e0" e2="s2866.e1" id="s2866.p0" relation="false"/>
  </sentence>
  <sentence id="s2867" text="Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (asparagine catabolic process via L-aspartate), severe developmental delay, intellectual disability, and seizures.">
    <entity charOffset="170-214" id="s2867.e0" ontology_id="GO_0033345" text="asparagine catabolic process via L-aspartate" type="GO"/>
    <entity charOffset="245-268" id="s2867.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2867.e0" e2="s2867.e1" id="s2867.p0" relation="false"/>
  </sentence>
  <sentence id="s2868" text="We performed whole-exome sequencing of a patient with severe intellectual disability, distinctive facial appearance, fragile nails, and persistent increased serum levels of asparagine catabolic process via L-aspartate.">
    <entity charOffset="117-130" id="s2868.e0" ontology_id="HP_0001808" text="fragile nails" type="HP"/>
    <entity charOffset="173-217" id="s2868.e1" ontology_id="GO_0033345" text="asparagine catabolic process via L-aspartate" type="GO"/>
    <pair e1="s2868.e0" e2="s2868.e1" id="s2868.p0" relation="false"/>
  </sentence>
  <sentence id="s2869" text="Nonsynonymous changes or frameshift mutations in preassembly of GPI anchor in ER membrane have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-89" id="s2869.e0" ontology_id="GO_0016254" text="preassembly of GPI anchor in ER membrane" type="GO"/>
    <entity charOffset="151-170" id="s2869.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2869.e0" e2="s2869.e1" id="s2869.p0" relation="true"/>
  </sentence>
  <sentence id="s2870" text="Nonsynonymous changes or frameshift mutations in preassembly of GPI anchor in ER membrane have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-89" id="s2870.e0" ontology_id="GO_0016254" text="preassembly of GPI anchor in ER membrane" type="GO"/>
    <entity charOffset="282-305" id="s2870.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s2870.e0" e2="s2870.e1" id="s2870.p0" relation="true"/>
  </sentence>
  <sentence id="s2871" text="Nonsynonymous changes or frameshift mutations in preassembly of GPI anchor in ER membrane have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-89" id="s2871.e0" ontology_id="GO_0016254" text="preassembly of GPI anchor in ER membrane" type="GO"/>
    <entity charOffset="197-206" id="s2871.e1" ontology_id="HP_0000589" text="colobomas" type="HP"/>
    <pair e1="s2871.e0" e2="s2871.e1" id="s2871.p0" relation="true"/>
  </sentence>
  <sentence id="s2872" text="Nonsynonymous changes or frameshift mutations in preassembly of GPI anchor in ER membrane have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-89" id="s2872.e0" ontology_id="GO_0016254" text="preassembly of GPI anchor in ER membrane" type="GO"/>
    <entity charOffset="208-232" id="s2872.e1" ontology_id="HP_0001627" text="congenital heart defects" type="HP"/>
    <pair e1="s2872.e0" e2="s2872.e1" id="s2872.p0" relation="true"/>
  </sentence>
  <sentence id="s2873" text="Nonsynonymous changes or frameshift mutations in preassembly of GPI anchor in ER membrane have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.">
    <entity charOffset="49-89" id="s2873.e0" ontology_id="GO_0016254" text="preassembly of GPI anchor in ER membrane" type="GO"/>
    <entity charOffset="246-255" id="s2873.e1" ontology_id="HP_0025279" text="migratory" type="HP"/>
    <pair e1="s2873.e0" e2="s2873.e1" id="s2873.p0" relation="false"/>
  </sentence>
  <sentence id="s2874" text="The tumor suppressor characteristics of cyclindependent kinase 10 (peptidyl-threonine phosphorylation) in nasopharyngeal carcinoma and breast cancer have been previously demonstrated.">
    <entity charOffset="4-9" id="s2874.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="68-102" id="s2874.e1" ontology_id="GO_0018107" text="peptidyl-threonine phosphorylation" type="GO"/>
    <pair e1="s2874.e0" e2="s2874.e1" id="s2874.p0" relation="false"/>
  </sentence>
  <sentence id="s2875" text="In the present study the expression status of peptidyl-threonine phosphorylation and its prognostic significance in gastric cancer was determined, as well as its role in cell proliferation and invasion.">
    <entity charOffset="46-80" id="s2875.e0" ontology_id="GO_0018107" text="peptidyl-threonine phosphorylation" type="GO"/>
    <entity charOffset="124-130" id="s2875.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2875.e0" e2="s2875.e1" id="s2875.p0" relation="false"/>
  </sentence>
  <sentence id="s2876" text="Immunoblot analysis revealed that peptidyl-threonine phosphorylation protein expression was notably decreased in gastric cancer compared with normal tissues.">
    <entity charOffset="34-68" id="s2876.e0" ontology_id="GO_0018107" text="peptidyl-threonine phosphorylation" type="GO"/>
    <entity charOffset="121-127" id="s2876.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2876.e0" e2="s2876.e1" id="s2876.p0" relation="false"/>
  </sentence>
  <sentence id="s2877" text="Immunohistochemistry demonstrated that the loss of peptidyl-threonine phosphorylation expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced tumor stage (P&amp;lt;0.001), frequent lymph node metastasis (P&amp;lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&amp;lt;0.001).">
    <entity charOffset="51-85" id="s2877.e0" ontology_id="GO_0018107" text="peptidyl-threonine phosphorylation" type="GO"/>
    <entity charOffset="145-151" id="s2877.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2877.e0" e2="s2877.e1" id="s2877.p0" relation="false"/>
  </sentence>
  <sentence id="s2878" text="To date, over 150 disease-associated variants in establishment or maintenance of cell polarity have been described, resulting in a range of retinal disease phenotypes including Leber congenital amaurosis and retinitis pigmentosa.">
    <entity charOffset="49-94" id="s2878.e0" ontology_id="GO_0007163" text="establishment or maintenance of cell polarity" type="GO"/>
    <entity charOffset="140-155" id="s2878.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s2878.e0" e2="s2878.e1" id="s2878.p0" relation="true"/>
  </sentence>
  <sentence id="s2879" text="Genome-wide association studies have identified genomic loci, whose single-nucleotide polymorphisms (SNPs) predispose to prostate cancer (mitochondrial transport).">
    <entity charOffset="130-136" id="s2879.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="138-161" id="s2879.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s2879.e0" e2="s2879.e1" id="s2879.p0" relation="false"/>
  </sentence>
  <sentence id="s2880" text="Higher melanophilin level in prostate tissue of patients with a favorable mitochondrial transport risk profile points out a tumor-suppressive effect.">
    <entity charOffset="74-97" id="s2880.e0" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <entity charOffset="124-129" id="s2880.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2880.e0" e2="s2880.e1" id="s2880.p0" relation="false"/>
  </sentence>
  <sentence id="s2881" text="cation transport encoding the beta subunit of the cyclic nucleotide-gated ion channel in cone photoreceptors is the major achromatopsia gene.">
    <entity charOffset="0-16" id="s2881.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="122-135" id="s2881.e1" ontology_id="HP_0011516" text="achromatopsia" type="HP"/>
    <pair e1="s2881.e0" e2="s2881.e1" id="s2881.p0" relation="true"/>
  </sentence>
  <sentence id="s2882" text="Here, we present a comprehensive spectrum of cation transport mutations and their prevalence in a cohort of 1074 independent families clinically diagnosed with achromatopsia.">
    <entity charOffset="45-61" id="s2882.e0" ontology_id="GO_0006812" text="cation transport" type="GO"/>
    <entity charOffset="160-173" id="s2882.e1" ontology_id="HP_0011516" text="achromatopsia" type="HP"/>
    <pair e1="s2882.e0" e2="s2882.e1" id="s2882.p0" relation="true"/>
  </sentence>
  <sentence id="s2883" text="A frequently reported cellular response to interleukin-4ing is that effects from common genetic variation are associated with a schizophrenia-related structural endophenotype.">
    <entity charOffset="22-56" id="s2883.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="128-141" id="s2883.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2883.e0" e2="s2883.e1" id="s2883.p0" relation="false"/>
  </sentence>
  <sentence id="s2884" text="However, the prevalence and spectrum of positive regulation of transcription, DNA-templated mutations associated with sporadic DCM remain to be evaluated.">
    <entity charOffset="40-91" id="s2884.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="118-126" id="s2884.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2884.e0" e2="s2884.e1" id="s2884.p0" relation="false"/>
  </sentence>
  <sentence id="s2885" text="In this study, the coding regions and flanking introns of the positive regulation of transcription, DNA-templated gene, which encodes a cardiac transcription factor pivotal for cardiac development and structural remodeling, were sequenced in 210 unrelated patients with sporadic adult-onset DCM.">
    <entity charOffset="62-113" id="s2885.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="270-278" id="s2885.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2885.e0" e2="s2885.e1" id="s2885.p0" relation="false"/>
  </sentence>
  <sentence id="s2886" text="As a result, two novel heterozygous positive regulation of transcription, DNA-templated mutations, p.R139W and p.E167X, were identified in 2 unrelated patients with sporadic adult-onset DCM, with a mutational prevalence of approximately 0.95%.">
    <entity charOffset="36-87" id="s2886.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="165-173" id="s2886.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2886.e0" e2="s2886.e1" id="s2886.p0" relation="false"/>
  </sentence>
  <sentence id="s2887" text="This study is the first to associate positive regulation of transcription, DNA-templated loss-of-function mutations with enhanced susceptibility to sporadic DCM, which provides novel insight into the molecular etiology underpinning DCM, and suggests the potential implications for the genetic counseling and personalized treatment of the DCM patients">
    <entity charOffset="37-88" id="s2887.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="148-156" id="s2887.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2887.e0" e2="s2887.e1" id="s2887.p0" relation="false"/>
  </sentence>
  <sentence id="s2888" text="The autosomal recessive disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either biotin metabolic process or PCCB genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.">
    <entity charOffset="4-23" id="s2888.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="228-252" id="s2888.e1" ontology_id="GO_0006768" text="biotin metabolic process" type="GO"/>
    <pair e1="s2888.e0" e2="s2888.e1" id="s2888.p0" relation="true"/>
  </sentence>
  <sentence id="s2889" text="Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an positive regulation of cell proliferation-independent method to detect CTCs in the GPI anchor metabolic processipheral blood of NB patients.">
    <entity charOffset="44-49" id="s2889.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="123-164" id="s2889.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s2889.e0" e2="s2889.e1" id="s2889.p0" relation="true"/>
  </sentence>
  <sentence id="s2890" text="Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an positive regulation of cell proliferation-independent method to detect CTCs in the GPI anchor metabolic processipheral blood of NB patients.">
    <entity charOffset="44-49" id="s2890.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="206-234" id="s2890.e1" ontology_id="GO_0006505" text="GPI anchor metabolic process" type="GO"/>
    <pair e1="s2890.e0" e2="s2890.e1" id="s2890.p0" relation="false"/>
  </sentence>
  <sentence id="s2891" text="Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an positive regulation of cell proliferation-independent method to detect CTCs in the GPI anchor metabolic processipheral blood of NB patients.">
    <entity charOffset="62-75" id="s2891.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="123-164" id="s2891.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s2891.e0" e2="s2891.e1" id="s2891.p0" relation="true"/>
  </sentence>
  <sentence id="s2892" text="Mutations in regulation of membrane potential lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (regulation of membrane potential), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="13-45" id="s2892.e0" ontology_id="GO_0042391" text="regulation of membrane potential" type="GO"/>
    <entity charOffset="119-149" id="s2892.e1" ontology_id="HP_0006785" text="limb girdle muscular dystrophy" type="HP"/>
    <pair e1="s2892.e0" e2="s2892.e1" id="s2892.p0" relation="false"/>
  </sentence>
  <sentence id="s2893" text="Mutations in regulation of membrane potential lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (regulation of membrane potential), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="13-45" id="s2893.e0" ontology_id="GO_0042391" text="regulation of membrane potential" type="GO"/>
    <entity charOffset="219-225" id="s2893.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s2893.e0" e2="s2893.e1" id="s2893.p0" relation="false"/>
  </sentence>
  <sentence id="s2894" text="Mutations in regulation of membrane potential lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (regulation of membrane potential), rippling muscle disease, distal myopathy and isolated hyperCKemia.">
    <entity charOffset="159-191" id="s2894.e0" ontology_id="GO_0042391" text="regulation of membrane potential" type="GO"/>
    <entity charOffset="219-225" id="s2894.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s2894.e0" e2="s2894.e1" id="s2894.p0" relation="false"/>
  </sentence>
  <sentence id="s2895" text="This case series demonstrates that exercise intolerance, myalgia and rhabdomyolysis may be caused by regulation of membrane potential mutations and broadens the phenotypic spectrum of caveolinopathies.">
    <entity charOffset="69-83" id="s2895.e0" ontology_id="HP_0003201" text="rhabdomyolysis" type="HP"/>
    <entity charOffset="101-133" id="s2895.e1" ontology_id="GO_0042391" text="regulation of membrane potential" type="GO"/>
    <pair e1="s2895.e0" e2="s2895.e1" id="s2895.p0" relation="false"/>
  </sentence>
  <sentence id="s2896" text="The expression of the ID2, skeletal system development and positive regulation of endothelial cell migration genes was compared between the endometrium of women without endometriosis in the proliferative phase of their menstrual cycle and the eutopic and ectopic endometrium of women with endometriosis in the proliferative phase.">
    <entity charOffset="27-54" id="s2896.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="169-182" id="s2896.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2896.e0" e2="s2896.e1" id="s2896.p0" relation="false"/>
  </sentence>
  <sentence id="s2897" text="The expression of the ID2, skeletal system development and positive regulation of endothelial cell migration genes was compared between the endometrium of women without endometriosis in the proliferative phase of their menstrual cycle and the eutopic and ectopic endometrium of women with endometriosis in the proliferative phase.">
    <entity charOffset="59-108" id="s2897.e0" ontology_id="GO_0010595" text="positive regulation of endothelial cell migration" type="GO"/>
    <entity charOffset="169-182" id="s2897.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s2897.e0" e2="s2897.e1" id="s2897.p0" relation="false"/>
  </sentence>
  <sentence id="s2898" text="The ID2 gene expression was increased in the most advanced stage of endometriosis and in ovarian endometriomas, the PRELP was more expressed in peritoneal lesions, and the positive regulation of endothelial cell migration was highly expressed in both peritoneal and endometrioma lesions.">
    <entity charOffset="68-81" id="s2898.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="172-221" id="s2898.e1" ontology_id="GO_0010595" text="positive regulation of endothelial cell migration" type="GO"/>
    <pair e1="s2898.e0" e2="s2898.e1" id="s2898.p0" relation="false"/>
  </sentence>
  <sentence id="s2899" text="Epidermal growth factor receptor (positive regulation of protein phosphorylation) mutation is prevalently expressed in lung adenocarcinoma cases and acts as one of the major driving oncogenes.">
    <entity charOffset="34-80" id="s2899.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="119-138" id="s2899.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s2899.e0" e2="s2899.e1" id="s2899.p0" relation="false"/>
  </sentence>
  <sentence id="s2900" text="positive regulation of protein phosphorylation tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs.">
    <entity charOffset="0-46" id="s2900.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="206-211" id="s2900.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2900.e0" e2="s2900.e1" id="s2900.p0" relation="true"/>
  </sentence>
  <sentence id="s2901" text="Recently, cellular protein modification process-associate protein (regulation of cell cycle) has been reported to promote multiple cancer cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance.">
    <entity charOffset="10-47" id="s2901.e0" ontology_id="GO_0006464" text="cellular protein modification process" type="GO"/>
    <entity charOffset="131-137" id="s2901.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2901.e0" e2="s2901.e1" id="s2901.p0" relation="false"/>
  </sentence>
  <sentence id="s2902" text="Recently, cellular protein modification process-associate protein (regulation of cell cycle) has been reported to promote multiple cancer cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance.">
    <entity charOffset="67-91" id="s2902.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="131-137" id="s2902.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2902.e0" e2="s2902.e1" id="s2902.p0" relation="false"/>
  </sentence>
  <sentence id="s2903" text="This study investigated the roles of regulation of cell cycle in TKI-resistant lung adenocarcinoma.">
    <entity charOffset="37-61" id="s2903.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="79-98" id="s2903.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s2903.e0" e2="s2903.e1" id="s2903.p0" relation="false"/>
  </sentence>
  <sentence id="s2904" text="With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation epidermis development and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="13-37" id="s2904.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="140-145" id="s2904.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2904.e0" e2="s2904.e1" id="s2904.p0" relation="false"/>
  </sentence>
  <sentence id="s2905" text="With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation epidermis development and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="13-37" id="s2905.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="354-360" id="s2905.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2905.e0" e2="s2905.e1" id="s2905.p0" relation="false"/>
  </sentence>
  <sentence id="s2906" text="With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation epidermis development and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="140-145" id="s2906.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="199-220" id="s2906.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s2906.e0" e2="s2906.e1" id="s2906.p0" relation="false"/>
  </sentence>
  <sentence id="s2907" text="With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation epidermis development and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="154-198" id="s2907.e0" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <entity charOffset="354-360" id="s2907.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2907.e0" e2="s2907.e1" id="s2907.p0" relation="false"/>
  </sentence>
  <sentence id="s2908" text="With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation epidermis development and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="199-220" id="s2908.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="354-360" id="s2908.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2908.e0" e2="s2908.e1" id="s2908.p0" relation="false"/>
  </sentence>
  <sentence id="s2909" text="With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation epidermis development and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.">
    <entity charOffset="244-290" id="s2909.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="354-360" id="s2909.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2909.e0" e2="s2909.e1" id="s2909.p0" relation="true"/>
  </sentence>
  <sentence id="s2910" text="Progressive rod-cone degeneration (visual perception) is a canine retinal disease that maps to the centromeric positive regulation of protein phosphorylation of CFA9 in a region of synteny with the distal part of HSA17q.">
    <entity charOffset="35-52" id="s2910.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="66-81" id="s2910.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s2910.e0" e2="s2910.e1" id="s2910.p0" relation="true"/>
  </sentence>
  <sentence id="s2911" text="Progressive rod-cone degeneration (visual perception) is a canine retinal disease that maps to the centromeric positive regulation of protein phosphorylation of CFA9 in a region of synteny with the distal part of HSA17q.">
    <entity charOffset="66-81" id="s2911.e0" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <entity charOffset="111-157" id="s2911.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s2911.e0" e2="s2911.e1" id="s2911.p0" relation="true"/>
  </sentence>
  <sentence id="s2912" text="The transcriptional coactivator peroxisome proliferator-activated receptor-histone H3 acetylation coactivator 1-alpha (positive regulation of antibacterial peptide production-1) has been linked to multiple neurological and psychiatric disorders including schizophrenia, but its involvement in the pathophysiology of these disorders is unclear.">
    <entity charOffset="75-97" id="s2912.e0" ontology_id="GO_0043966" text="histone H3 acetylation" type="GO"/>
    <entity charOffset="256-269" id="s2912.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2912.e0" e2="s2912.e1" id="s2912.p0" relation="false"/>
  </sentence>
  <sentence id="s2913" text="The transcriptional coactivator peroxisome proliferator-activated receptor-histone H3 acetylation coactivator 1-alpha (positive regulation of antibacterial peptide production-1) has been linked to multiple neurological and psychiatric disorders including schizophrenia, but its involvement in the pathophysiology of these disorders is unclear.">
    <entity charOffset="119-174" id="s2913.e0" ontology_id="GO_0002803" text="positive regulation of antibacterial peptide production" type="GO"/>
    <entity charOffset="256-269" id="s2913.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2913.e0" e2="s2913.e1" id="s2913.p0" relation="false"/>
  </sentence>
  <sentence id="s2914" text="We measured the mRNA expression of positive regulation of antibacterial peptide production-1 and these transcripts in postmortem cortical tissue from control and schizophrenia patients and found a reduction in PGC-1-dependent transcripts without a change in PGC-1.">
    <entity charOffset="35-90" id="s2914.e0" ontology_id="GO_0002803" text="positive regulation of antibacterial peptide production" type="GO"/>
    <entity charOffset="163-176" id="s2914.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2914.e0" e2="s2914.e1" id="s2914.p0" relation="false"/>
  </sentence>
  <sentence id="s2915" text="While control subjects with high positive regulation of antibacterial peptide production-1 expression exhibited high PV and Nefh expression, schizophrenia subjects with high PGC-1 expression did not, suggesting dissociation between PGC-1 expression and these targets in schizophrenia.">
    <entity charOffset="33-88" id="s2915.e0" ontology_id="GO_0002803" text="positive regulation of antibacterial peptide production" type="GO"/>
    <entity charOffset="142-155" id="s2915.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2915.e0" e2="s2915.e1" id="s2915.p0" relation="false"/>
  </sentence>
  <sentence id="s2916" text="negative regulation of transcription, DNA-templated-1 mRNA expression was reduced in schizophrenia, and its transcript levels predicted that of positive regulation of antibacterial peptide production-1-dependent targets in schizophrenia.">
    <entity charOffset="0-51" id="s2916.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="85-98" id="s2916.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2916.e0" e2="s2916.e1" id="s2916.p0" relation="false"/>
  </sentence>
  <sentence id="s2917" text="negative regulation of transcription, DNA-templated-1 mRNA expression was reduced in schizophrenia, and its transcript levels predicted that of positive regulation of antibacterial peptide production-1-dependent targets in schizophrenia.">
    <entity charOffset="85-98" id="s2917.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="144-199" id="s2917.e1" ontology_id="GO_0002803" text="positive regulation of antibacterial peptide production" type="GO"/>
    <pair e1="s2917.e0" e2="s2917.e1" id="s2917.p0" relation="false"/>
  </sentence>
  <sentence id="s2918" text="Interestingly, the positive correlation between positive regulation of antibacterial peptide production-1 and PV, Syt2, or exocytosis expression was lost in schizophrenia patients with low negative regulation of transcription, DNA-templated-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.">
    <entity charOffset="48-103" id="s2918.e0" ontology_id="GO_0002803" text="positive regulation of antibacterial peptide production" type="GO"/>
    <entity charOffset="158-171" id="s2918.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2918.e0" e2="s2918.e1" id="s2918.p0" relation="false"/>
  </sentence>
  <sentence id="s2919" text="Interestingly, the positive correlation between positive regulation of antibacterial peptide production-1 and PV, Syt2, or exocytosis expression was lost in schizophrenia patients with low negative regulation of transcription, DNA-templated-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.">
    <entity charOffset="124-134" id="s2919.e0" ontology_id="GO_0006887" text="exocytosis" type="GO"/>
    <entity charOffset="158-171" id="s2919.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s2919.e0" e2="s2919.e1" id="s2919.p0" relation="false"/>
  </sentence>
  <sentence id="s2920" text="Interestingly, the positive correlation between positive regulation of antibacterial peptide production-1 and PV, Syt2, or exocytosis expression was lost in schizophrenia patients with low negative regulation of transcription, DNA-templated-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.">
    <entity charOffset="158-171" id="s2920.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="190-241" id="s2920.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s2920.e0" e2="s2920.e1" id="s2920.p0" relation="false"/>
  </sentence>
  <sentence id="s2921" text="These data suggest that schizophrenia involves a disruption in positive regulation of antibacterial peptide production-1 and/or negative regulation of transcription, DNA-templated-1-associated transcriptional programs in the cortex and that approaches to enhance the activity of PGC-1 or transcriptional regulators like NRF-1 should be considered with the goal of restoring normal gene programs and improving cortical function">
    <entity charOffset="24-37" id="s2921.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="63-118" id="s2921.e1" ontology_id="GO_0002803" text="positive regulation of antibacterial peptide production" type="GO"/>
    <pair e1="s2921.e0" e2="s2921.e1" id="s2921.p0" relation="false"/>
  </sentence>
  <sentence id="s2922" text="These data suggest that schizophrenia involves a disruption in positive regulation of antibacterial peptide production-1 and/or negative regulation of transcription, DNA-templated-1-associated transcriptional programs in the cortex and that approaches to enhance the activity of PGC-1 or transcriptional regulators like NRF-1 should be considered with the goal of restoring normal gene programs and improving cortical function">
    <entity charOffset="24-37" id="s2922.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="129-180" id="s2922.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s2922.e0" e2="s2922.e1" id="s2922.p0" relation="false"/>
  </sentence>
  <sentence id="s2923" text="Mutations in double-strand break repair via homologous recombination are implicated in cancer development and in a severe congenital inflammatory disease known as Aicardi-Goutires syndrome.">
    <entity charOffset="13-68" id="s2923.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="87-93" id="s2923.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2923.e0" e2="s2923.e1" id="s2923.p0" relation="false"/>
  </sentence>
  <sentence id="s2924" text="The mechanism by which double-strand break repair via homologous recombination protects against cancer and chronic inflammation is unknown.">
    <entity charOffset="23-78" id="s2924.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="96-102" id="s2924.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2924.e0" e2="s2924.e1" id="s2924.p0" relation="false"/>
  </sentence>
  <sentence id="s2925" text="This includes the first two genes linked to recessively inherited isolated dystonia, that is, positive regulation of cytosolic calcium ion concentration (hippocalcin) and COL6A3 (collagen VI alpha 3).">
    <entity charOffset="75-83" id="s2925.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="94-152" id="s2925.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s2925.e0" e2="s2925.e1" id="s2925.p0" relation="true"/>
  </sentence>
  <sentence id="s2926" text="The novel myoclonus-dystonia genes KCTD17 and modulation of chemical synaptic transmission also implicate abnormal calcium signaling in dystonia.">
    <entity charOffset="20-28" id="s2926.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="46-90" id="s2926.e1" ontology_id="GO_0050804" text="modulation of chemical synaptic transmission" type="GO"/>
    <pair e1="s2926.e0" e2="s2926.e1" id="s2926.p0" relation="true"/>
  </sentence>
  <sentence id="s2927" text="Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in GCH1, TH, positive regulation of cytosolic calcium ion concentration, or to heterozygous negative regulation of microtubule polymerization mutations.">
    <entity charOffset="95-103" id="s2927.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="173-231" id="s2927.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s2927.e0" e2="s2927.e1" id="s2927.p0" relation="false"/>
  </sentence>
  <sentence id="s2928" text="Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in GCH1, TH, positive regulation of cytosolic calcium ion concentration, or to heterozygous negative regulation of microtubule polymerization mutations.">
    <entity charOffset="95-103" id="s2928.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="252-301" id="s2928.e1" ontology_id="GO_0031115" text="negative regulation of microtubule polymerization" type="GO"/>
    <pair e1="s2928.e0" e2="s2928.e1" id="s2928.p0" relation="true"/>
  </sentence>
  <sentence id="s2929" text="MESP2, mesoderm development and inactivation of MAPK activity genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.">
    <entity charOffset="7-27" id="s2929.e0" ontology_id="GO_0007498" text="mesoderm development" type="GO"/>
    <entity charOffset="138-147" id="s2929.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s2929.e0" e2="s2929.e1" id="s2929.p0" relation="true"/>
  </sentence>
  <sentence id="s2930" text="MESP2, mesoderm development and inactivation of MAPK activity genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.">
    <entity charOffset="32-61" id="s2930.e0" ontology_id="GO_0000188" text="inactivation of MAPK activity" type="GO"/>
    <entity charOffset="138-147" id="s2930.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s2930.e0" e2="s2930.e1" id="s2930.p0" relation="false"/>
  </sentence>
  <sentence id="s2931" text="regulation of transcription by RNA polymerase II, HES7 and inactivation of MAPK activity genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population">
    <entity charOffset="0-48" id="s2931.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="142-150" id="s2931.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2931.e0" e2="s2931.e1" id="s2931.p0" relation="false"/>
  </sentence>
  <sentence id="s2932" text="regulation of transcription by RNA polymerase II, HES7 and inactivation of MAPK activity genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population">
    <entity charOffset="59-88" id="s2932.e0" ontology_id="GO_0000188" text="inactivation of MAPK activity" type="GO"/>
    <entity charOffset="142-150" id="s2932.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s2932.e0" e2="s2932.e1" id="s2932.p0" relation="false"/>
  </sentence>
  <sentence id="s2933" text="Somatic defects at five loci, WT1, protein polyubiquitination, positive regulation of protein ubiquitination, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.">
    <entity charOffset="35-61" id="s2933.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="171-176" id="s2933.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2933.e0" e2="s2933.e1" id="s2933.p0" relation="true"/>
  </sentence>
  <sentence id="s2934" text="Somatic defects at five loci, WT1, protein polyubiquitination, positive regulation of protein ubiquitination, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.">
    <entity charOffset="35-61" id="s2934.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="209-215" id="s2934.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2934.e0" e2="s2934.e1" id="s2934.p0" relation="true"/>
  </sentence>
  <sentence id="s2935" text="Somatic defects at five loci, WT1, protein polyubiquitination, positive regulation of protein ubiquitination, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.">
    <entity charOffset="63-108" id="s2935.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="171-176" id="s2935.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2935.e0" e2="s2935.e1" id="s2935.p0" relation="false"/>
  </sentence>
  <sentence id="s2936" text="Somatic defects at five loci, WT1, protein polyubiquitination, positive regulation of protein ubiquitination, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.">
    <entity charOffset="63-108" id="s2936.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="209-215" id="s2936.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2936.e0" e2="s2936.e1" id="s2936.p0" relation="false"/>
  </sentence>
  <sentence id="s2937" text="We identified mutations of WTX in 32%, protein polyubiquitination in 15%, WT1 in 12% and TP53 in 5% of tumors.">
    <entity charOffset="39-65" id="s2937.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="103-108" id="s2937.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2937.e0" e2="s2937.e1" id="s2937.p0" relation="true"/>
  </sentence>
  <sentence id="s2938" text="Group 1 tumors (63%) were defined as 11p15-mutant and WT1-normal; a third also had positive regulation of protein ubiquitination mutations.">
    <entity charOffset="8-13" id="s2938.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="83-128" id="s2938.e1" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <pair e1="s2938.e0" e2="s2938.e1" id="s2938.p0" relation="false"/>
  </sentence>
  <sentence id="s2939" text="Here, we determine that non-canonical IKK-lymphocyte differentiation pathway activation of KRAS-mutant tumor cells mediates MPE development and this is fueled by host-provided interleukin IL-1.">
    <entity charOffset="43-69" id="s2939.e0" ontology_id="GO_0030098" text="lymphocyte differentiation" type="GO"/>
    <entity charOffset="104-109" id="s2939.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2939.e0" e2="s2939.e1" id="s2939.p0" relation="false"/>
  </sentence>
  <sentence id="s2940" text="Indeed, IKK is required for the MPE-competence of positive regulation of protein phosphorylation-mutant tumor cells by activating non-canonical peripheral nervous system development-B signaling.">
    <entity charOffset="51-97" id="s2940.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="105-110" id="s2940.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2940.e0" e2="s2940.e1" id="s2940.p0" relation="true"/>
  </sentence>
  <sentence id="s2941" text="Indeed, IKK is required for the MPE-competence of positive regulation of protein phosphorylation-mutant tumor cells by activating non-canonical peripheral nervous system development-B signaling.">
    <entity charOffset="105-110" id="s2941.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="145-182" id="s2941.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s2941.e0" e2="s2941.e1" id="s2941.p0" relation="false"/>
  </sentence>
  <sentence id="s2942" text="Importantly, IL-1-mediated peripheral nervous system development-B induction in positive regulation of protein phosphorylation-mutant tumor cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKK, a strategy that overcomes drug resistance to individual treatments.">
    <entity charOffset="28-65" id="s2942.e0" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <entity charOffset="136-141" id="s2942.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2942.e0" e2="s2942.e1" id="s2942.p0" relation="false"/>
  </sentence>
  <sentence id="s2943" text="Importantly, IL-1-mediated peripheral nervous system development-B induction in positive regulation of protein phosphorylation-mutant tumor cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKK, a strategy that overcomes drug resistance to individual treatments.">
    <entity charOffset="82-128" id="s2943.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="136-141" id="s2943.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2943.e0" e2="s2943.e1" id="s2943.p0" relation="true"/>
  </sentence>
  <sentence id="s2944" text="These experiments identify a role for mitofusins in directly regulating mitochondrial transport and offer important insight into the cell muscle organ development specificity and molecular mechanisms of axonal degeneration in microtubule-based movement and dominant optic atrophy">
    <entity charOffset="138-162" id="s2944.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="203-222" id="s2944.e1" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <pair e1="s2944.e0" e2="s2944.e1" id="s2944.p0" relation="false"/>
  </sentence>
  <sentence id="s2945" text="These experiments identify a role for mitofusins in directly regulating mitochondrial transport and offer important insight into the cell muscle organ development specificity and molecular mechanisms of axonal degeneration in microtubule-based movement and dominant optic atrophy">
    <entity charOffset="203-222" id="s2945.e0" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <entity charOffset="226-252" id="s2945.e1" ontology_id="GO_0007018" text="microtubule-based movement" type="GO"/>
    <pair e1="s2945.e0" e2="s2945.e1" id="s2945.p0" relation="false"/>
  </sentence>
  <sentence id="s2946" text="In a consanguineous Saudi family segregating Usher syndrome muscle organ development 1 (USH1), NGS of genes for Usher syndrome, deafness and retinal dystrophy and subsequent whole-exome sequencing each failed to identify a mutation.">
    <entity charOffset="60-84" id="s2946.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="128-136" id="s2946.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2946.e0" e2="s2946.e1" id="s2946.p0" relation="false"/>
  </sentence>
  <sentence id="s2947" text="In a consanguineous Saudi family segregating Usher syndrome muscle organ development 1 (USH1), NGS of genes for Usher syndrome, deafness and retinal dystrophy and subsequent whole-exome sequencing each failed to identify a mutation.">
    <entity charOffset="60-84" id="s2947.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="141-158" id="s2947.e1" ontology_id="HP_0000556" text="retinal dystrophy" type="HP"/>
    <pair e1="s2947.e0" e2="s2947.e1" id="s2947.p0" relation="false"/>
  </sentence>
  <sentence id="s2948" text="Loss of positive regulation of transcription by RNA polymerase II contributes to the aggressive phenotype of glioblastoma through regulation of poor prognosis-associated signatures.">
    <entity charOffset="8-65" id="s2948.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="109-121" id="s2948.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s2948.e0" e2="s2948.e1" id="s2948.p0" relation="false"/>
  </sentence>
  <sentence id="s2949" text="Restitution of positive regulation of transcription by RNA polymerase II expression reverses the phenotype and impairs tumor-forming ability.">
    <entity charOffset="15-72" id="s2949.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="119-124" id="s2949.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2949.e0" e2="s2949.e1" id="s2949.p0" relation="false"/>
  </sentence>
  <sentence id="s2950" text="These results indicate that positive regulation of transcription by RNA polymerase II functions as a tumor suppressor in GBM through the regulation of genes associated with phenotypically aggressive properties.&lt;b&gt;Implications:&lt;/b&gt; This study characterizes the role of the putative tumor suppressor ZBTB18 and its regulation by promoter hypermethylation, which appears to be a common mechanism to silence ZBTB18 in the mesenchymal subtype of GBM and provides a new mechanistic opportunity to specifically target this tumor subclass.">
    <entity charOffset="28-85" id="s2950.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="101-106" id="s2950.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2950.e0" e2="s2950.e1" id="s2950.p0" relation="false"/>
  </sentence>
  <sentence id="s2951" text="Mutations in cilium assembly lead to diseases ranging from isolated retinal degeneration to severe syndromic ciliopathies.">
    <entity charOffset="13-28" id="s2951.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="68-88" id="s2951.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2951.e0" e2="s2951.e1" id="s2951.p0" relation="true"/>
  </sentence>
  <sentence id="s2952" text="In this study, we created a mouse model of cilium assembly-associated retinal degeneration to investigate the ocular disease mechanism.">
    <entity charOffset="43-58" id="s2952.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="70-90" id="s2952.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s2952.e0" e2="s2952.e1" id="s2952.p0" relation="true"/>
  </sentence>
  <sentence id="s2953" text="We investigated molecular mechanisms of degeneration and show that cilium assembly protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, regulation of transcription by RNA polymerase II), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (osteoblast differentiation).">
    <entity charOffset="67-82" id="s2953.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="325-331" id="s2953.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2953.e0" e2="s2953.e1" id="s2953.p0" relation="false"/>
  </sentence>
  <sentence id="s2954" text="We investigated molecular mechanisms of degeneration and show that cilium assembly protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, regulation of transcription by RNA polymerase II), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (osteoblast differentiation).">
    <entity charOffset="190-238" id="s2954.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="325-331" id="s2954.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s2954.e0" e2="s2954.e1" id="s2954.p0" relation="false"/>
  </sentence>
  <sentence id="s2955" text="We investigated molecular mechanisms of degeneration and show that cilium assembly protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, regulation of transcription by RNA polymerase II), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (osteoblast differentiation).">
    <entity charOffset="325-331" id="s2955.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="369-395" id="s2955.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s2955.e0" e2="s2955.e1" id="s2955.p0" relation="false"/>
  </sentence>
  <sentence id="s2956" text="This mouse model exhibits key features of the retinal phenotype observed in patients with cilium assembly-associated blindness and can be used for in vivo testing of ciliopathy therapies">
    <entity charOffset="90-105" id="s2956.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="117-126" id="s2956.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s2956.e0" e2="s2956.e1" id="s2956.p0" relation="true"/>
  </sentence>
  <sentence id="s2957" text="Age-related hearing impairment (regulation of cyclin-dependent protein serine/threonine kinase activity), one of the most common sensory disorders, can be mitigated, but not cured or eliminated.">
    <entity charOffset="12-30" id="s2957.e0" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <entity charOffset="32-103" id="s2957.e1" ontology_id="GO_0000079" text="regulation of cyclin-dependent protein serine/threonine kinase activity" type="GO"/>
    <pair e1="s2957.e0" e2="s2957.e1" id="s2957.p0" relation="false"/>
  </sentence>
  <sentence id="s2958" text="The latter SNP lies just outside exon 8 and is highly correlated (r2 = 0.96) with the missense SNP rs5756795 in exon 7 of positive regulation of substrate adhesion-dependent cell spreading, a gene previously associated with prelingual nonsyndromic hearing loss.">
    <entity charOffset="122-188" id="s2958.e0" ontology_id="GO_1900026" text="positive regulation of substrate adhesion-dependent cell spreading" type="GO"/>
    <entity charOffset="248-260" id="s2958.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2958.e0" e2="s2958.e1" id="s2958.p0" relation="true"/>
  </sentence>
  <sentence id="s2959" text="We also tested variants within exons of 132 other previously-identified hearing loss genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in protein homooligomerization, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (mitotic spindle organization; p = 0.0019); and rs9493627 (missense change in visual perception, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).">
    <entity charOffset="72-84" id="s2959.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="179-206" id="s2959.e1" ontology_id="GO_0051260" text="protein homooligomerization" type="GO"/>
    <pair e1="s2959.e0" e2="s2959.e1" id="s2959.p0" relation="true"/>
  </sentence>
  <sentence id="s2960" text="We also tested variants within exons of 132 other previously-identified hearing loss genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in protein homooligomerization, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (mitotic spindle organization; p = 0.0019); and rs9493627 (missense change in visual perception, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).">
    <entity charOffset="72-84" id="s2960.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="351-379" id="s2960.e1" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <pair e1="s2960.e0" e2="s2960.e1" id="s2960.p0" relation="false"/>
  </sentence>
  <sentence id="s2961" text="We also tested variants within exons of 132 other previously-identified hearing loss genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in protein homooligomerization, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (mitotic spindle organization; p = 0.0019); and rs9493627 (missense change in visual perception, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).">
    <entity charOffset="72-84" id="s2961.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="428-445" id="s2961.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s2961.e0" e2="s2961.e1" id="s2961.p0" relation="true"/>
  </sentence>
  <sentence id="s2962" text="These data suggest a previously unrecognized mechanism by which EBNALP coactivates transcription through subverting of negative regulation of transcription by RNA polymerase II and thus affects the expression of LCL genes regulated by a broad range of host TFs.&lt;b&gt;IMPORTANCE&lt;/b&gt; Epstein-Barr virus was the first human DNA tumor virus discovered over 50 years ago.">
    <entity charOffset="119-176" id="s2962.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="322-327" id="s2962.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s2962.e0" e2="s2962.e1" id="s2962.p0" relation="true"/>
  </sentence>
  <sentence id="s2963" text="Physical deconditioning is associated with the development of chronic diseases, including muscle organ development 2 diabetes and cardiovascular disease.">
    <entity charOffset="90-114" id="s2963.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="130-152" id="s2963.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s2963.e0" e2="s2963.e1" id="s2963.p0" relation="true"/>
  </sentence>
  <sentence id="s2964" text="Pompe disease, also called muscle organ development II glycogen storage disease, is a rare autosomal recessive inherited disease caused by the storage of glycogen in lysosome due to acid -glucosidase (GAA) deficiency, with the most severe conditions in the skeletal muscle, the myocardium, and the smooth muscle.">
    <entity charOffset="27-51" id="s2964.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="91-110" id="s2964.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s2964.e0" e2="s2964.e1" id="s2964.p0" relation="true"/>
  </sentence>
  <sentence id="s2965" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="22-58" id="s2965.e0" ontology_id="GO_0018146" text="keratan sulfate biosynthetic process" type="GO"/>
    <entity charOffset="233-251" id="s2965.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s2965.e0" e2="s2965.e1" id="s2965.p0" relation="true"/>
  </sentence>
  <sentence id="s2966" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="22-58" id="s2966.e0" ontology_id="GO_0018146" text="keratan sulfate biosynthetic process" type="GO"/>
    <entity charOffset="677-690" id="s2966.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2966.e0" e2="s2966.e1" id="s2966.p0" relation="true"/>
  </sentence>
  <sentence id="s2967" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="60-111" id="s2967.e0" ontology_id="GO_0008543" text="fibroblast growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="233-251" id="s2967.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s2967.e0" e2="s2967.e1" id="s2967.p0" relation="true"/>
  </sentence>
  <sentence id="s2968" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="60-111" id="s2968.e0" ontology_id="GO_0008543" text="fibroblast growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="677-690" id="s2968.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2968.e0" e2="s2968.e1" id="s2968.p0" relation="true"/>
  </sentence>
  <sentence id="s2969" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="113-151" id="s2969.e0" ontology_id="GO_0033673" text="negative regulation of kinase activity" type="GO"/>
    <entity charOffset="233-251" id="s2969.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s2969.e0" e2="s2969.e1" id="s2969.p0" relation="false"/>
  </sentence>
  <sentence id="s2970" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="157-214" id="s2970.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="233-251" id="s2970.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s2970.e0" e2="s2970.e1" id="s2970.p0" relation="false"/>
  </sentence>
  <sentence id="s2971" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="157-214" id="s2971.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="677-690" id="s2971.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2971.e0" e2="s2971.e1" id="s2971.p0" relation="true"/>
  </sentence>
  <sentence id="s2972" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="233-251" id="s2972.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="270-343" id="s2972.e1" ontology_id="GO_0007189" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s2972.e0" e2="s2972.e1" id="s2972.p0" relation="false"/>
  </sentence>
  <sentence id="s2973" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="233-251" id="s2973.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="395-432" id="s2973.e1" ontology_id="GO_0032870" text="cellular response to hormone stimulus" type="GO"/>
    <pair e1="s2973.e0" e2="s2973.e1" id="s2973.p0" relation="false"/>
  </sentence>
  <sentence id="s2974" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="233-251" id="s2974.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="457-472" id="s2974.e1" ontology_id="GO_0001775" text="cell activation" type="GO"/>
    <pair e1="s2974.e0" e2="s2974.e1" id="s2974.p0" relation="false"/>
  </sentence>
  <sentence id="s2975" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="233-251" id="s2975.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="474-493" id="s2975.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s2975.e0" e2="s2975.e1" id="s2975.p0" relation="false"/>
  </sentence>
  <sentence id="s2976" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="233-251" id="s2976.e0" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <entity charOffset="345-392" id="s2976.e1" ontology_id="GO_0002092" text="positive regulation of receptor internalization" type="GO"/>
    <pair e1="s2976.e0" e2="s2976.e1" id="s2976.p0" relation="false"/>
  </sentence>
  <sentence id="s2977" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="345-392" id="s2977.e0" ontology_id="GO_0002092" text="positive regulation of receptor internalization" type="GO"/>
    <entity charOffset="677-690" id="s2977.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2977.e0" e2="s2977.e1" id="s2977.p0" relation="true"/>
  </sentence>
  <sentence id="s2978" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="395-432" id="s2978.e0" ontology_id="GO_0032870" text="cellular response to hormone stimulus" type="GO"/>
    <entity charOffset="677-690" id="s2978.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2978.e0" e2="s2978.e1" id="s2978.p0" relation="true"/>
  </sentence>
  <sentence id="s2979" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="434-455" id="s2979.e0" ontology_id="GO_0032355" text="response to estradiol" type="GO"/>
    <entity charOffset="677-690" id="s2979.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2979.e0" e2="s2979.e1" id="s2979.p0" relation="true"/>
  </sentence>
  <sentence id="s2980" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="457-472" id="s2980.e0" ontology_id="GO_0001775" text="cell activation" type="GO"/>
    <entity charOffset="677-690" id="s2980.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2980.e0" e2="s2980.e1" id="s2980.p0" relation="true"/>
  </sentence>
  <sentence id="s2981" text="Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).">
    <entity charOffset="474-493" id="s2981.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="677-690" id="s2981.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s2981.e0" e2="s2981.e1" id="s2981.p0" relation="false"/>
  </sentence>
  <sentence id="s2982" text="In mice, cognition (also known as Jxc1) is critical for patterning of the organ of Corti; one of our patients has a subclinical cochlear hearing loss but no gross cochlear abnormalities.">
    <entity charOffset="9-18" id="s2982.e0" ontology_id="GO_0050890" text="cognition" type="GO"/>
    <entity charOffset="137-149" id="s2982.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s2982.e0" e2="s2982.e1" id="s2982.p0" relation="false"/>
  </sentence>
  <sentence id="s2983" text="Our study showed that targeted NGS is an effective tool for diagnosis of genetic deafness and that p.G141R in &lt;i&gt;ILDR1&lt;/i&gt; may be a relatively frequent mutation for protein homooligomerization in Chinese Hans">
    <entity charOffset="81-89" id="s2983.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="165-192" id="s2983.e1" ontology_id="GO_0051260" text="protein homooligomerization" type="GO"/>
    <pair e1="s2983.e0" e2="s2983.e1" id="s2983.p0" relation="true"/>
  </sentence>
  <sentence id="s2984" text="Several studies have investigated single nucleotide polymorphisms (SNPs) in a number of genes associated with the susceptibility to or severity and outcome of community-acquired pneumonia (positive regulation of transcription elongation from RNA polymerase II promoter), but no research has yet been conducted on the role of IRF5 gene polymorphisms in CAP.">
    <entity charOffset="178-187" id="s2984.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="189-268" id="s2984.e1" ontology_id="GO_0032968" text="positive regulation of transcription elongation from RNA polymerase II promoter" type="GO"/>
    <pair e1="s2984.e0" e2="s2984.e1" id="s2984.p0" relation="false"/>
  </sentence>
  <sentence id="s2985" text="Ectodermal dysplasia-9 (ED-9) is a congenital condition characterized by hypotrichosis and natural killer cell activation involved in immune response dystrophy without other disorders, and anatomical structure morphogenesis is a pathogenic gene for ED-9.">
    <entity charOffset="73-86" id="s2985.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="91-149" id="s2985.e1" ontology_id="GO_0002323" text="natural killer cell activation involved in immune response" type="GO"/>
    <pair e1="s2985.e0" e2="s2985.e1" id="s2985.p0" relation="false"/>
  </sentence>
  <sentence id="s2986" text="Ectodermal dysplasia-9 (ED-9) is a congenital condition characterized by hypotrichosis and natural killer cell activation involved in immune response dystrophy without other disorders, and anatomical structure morphogenesis is a pathogenic gene for ED-9.">
    <entity charOffset="73-86" id="s2986.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="189-223" id="s2986.e1" ontology_id="GO_0009653" text="anatomical structure morphogenesis" type="GO"/>
    <pair e1="s2986.e0" e2="s2986.e1" id="s2986.p0" relation="true"/>
  </sentence>
  <sentence id="s2987" text="Furthermore, microRNA-22 targeted Ras protein signal transduction proto-oncogene, GTPase (NRAS) in breast cancer cells.">
    <entity charOffset="34-65" id="s2987.e0" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <entity charOffset="106-112" id="s2987.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s2987.e0" e2="s2987.e1" id="s2987.p0" relation="true"/>
  </sentence>
  <sentence id="s2988" text="Moreover, microRNA-22 sensitized breast cancer cells to paclitaxel by regulation of Ras protein signal transduction.">
    <entity charOffset="40-46" id="s2988.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="84-115" id="s2988.e1" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <pair e1="s2988.e0" e2="s2988.e1" id="s2988.p0" relation="true"/>
  </sentence>
  <sentence id="s2989" text="RT-PCR analysis showed that the overall transcriptional activity of the main HS biosynthesis-involved genes (&lt;i&gt;EXT1&lt;/i&gt;, &lt;i&gt;EXT2&lt;/i&gt;, &lt;i&gt;NDST1&lt;/i&gt;, &lt;i&gt;NDST2&lt;/i&gt;, &lt;i&gt;GLCE&lt;/i&gt;, &lt;i&gt;HS2ST1&lt;/i&gt;, &lt;i&gt;HS3ST1&lt;/i&gt;, &lt;i&gt;HS3ST2&lt;/i&gt;, &lt;i&gt;HS6ST1&lt;/i&gt;, &lt;i&gt;HS6ST2&lt;/i&gt;, &lt;i&gt;SULF1&lt;/i&gt;, &lt;i&gt;SULF2&lt;/i&gt;, &lt;i&gt;cell-matrix adhesion&lt;/i&gt;) was decreased by 1.5-2-fold in Grade II-III glioma (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01) and by 3-fold in Grade IV glioma (glioblastoma multiforme, GBM) (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05), as compared with the para-tumourous tissue.">
    <entity charOffset="282-302" id="s2989.e0" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <entity charOffset="492-498" id="s2989.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2989.e0" e2="s2989.e1" id="s2989.p0" relation="false"/>
  </sentence>
  <sentence id="s2990" text="Heparanase (&lt;i&gt;cell-matrix adhesion&lt;/i&gt;) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.">
    <entity charOffset="15-35" id="s2990.e0" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <entity charOffset="145-151" id="s2990.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s2990.e0" e2="s2990.e1" id="s2990.p0" relation="false"/>
  </sentence>
  <sentence id="s2991" text="Mutations in the activation of MAPK activity gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.">
    <entity charOffset="17-44" id="s2991.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="197-205" id="s2991.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s2991.e0" e2="s2991.e1" id="s2991.p0" relation="true"/>
  </sentence>
  <sentence id="s2992" text="Mutations in the activation of MAPK activity gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.">
    <entity charOffset="17-44" id="s2992.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="252-271" id="s2992.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s2992.e0" e2="s2992.e1" id="s2992.p0" relation="true"/>
  </sentence>
  <sentence id="s2993" text="Mutations in the activation of MAPK activity gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.">
    <entity charOffset="17-44" id="s2993.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="277-292" id="s2993.e1" ontology_id="HP_0003128" text="lactic acidosis" type="HP"/>
    <pair e1="s2993.e0" e2="s2993.e1" id="s2993.p0" relation="false"/>
  </sentence>
  <sentence id="s2994" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s2994.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="54-77" id="s2994.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s2994.e0" e2="s2994.e1" id="s2994.p0" relation="true"/>
  </sentence>
  <sentence id="s2995" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s2995.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="85-124" id="s2995.e1" ontology_id="GO_0014065" text="phosphatidylinositol 3-kinase signaling" type="GO"/>
    <pair e1="s2995.e0" e2="s2995.e1" id="s2995.p0" relation="true"/>
  </sentence>
  <sentence id="s2996" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s2996.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="126-167" id="s2996.e1" ontology_id="GO_0010875" text="positive regulation of cholesterol efflux" type="GO"/>
    <pair e1="s2996.e0" e2="s2996.e1" id="s2996.p0" relation="true"/>
  </sentence>
  <sentence id="s2997" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s2997.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="169-215" id="s2997.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s2997.e0" e2="s2997.e1" id="s2997.p0" relation="true"/>
  </sentence>
  <sentence id="s2998" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s2998.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="217-251" id="s2998.e1" ontology_id="GO_0006211" text="5-methylcytosine catabolic process" type="GO"/>
    <pair e1="s2998.e0" e2="s2998.e1" id="s2998.p0" relation="true"/>
  </sentence>
  <sentence id="s2999" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s2999.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="308-334" id="s2999.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s2999.e0" e2="s2999.e1" id="s2999.p0" relation="true"/>
  </sentence>
  <sentence id="s3000" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s3000.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="336-355" id="s3000.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s3000.e0" e2="s3000.e1" id="s3000.p0" relation="true"/>
  </sentence>
  <sentence id="s3001" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s3001.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="382-407" id="s3001.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s3001.e0" e2="s3001.e1" id="s3001.p0" relation="false"/>
  </sentence>
  <sentence id="s3002" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s3002.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="409-450" id="s3002.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s3002.e0" e2="s3002.e1" id="s3002.p0" relation="true"/>
  </sentence>
  <sentence id="s3003" text="The 21 genes comprised 8 tumor suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).">
    <entity charOffset="25-30" id="s3003.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="461-496" id="s3003.e1" ontology_id="GO_0035335" text="peptidyl-tyrosine dephosphorylation" type="GO"/>
    <pair e1="s3003.e0" e2="s3003.e1" id="s3003.p0" relation="true"/>
  </sentence>
  <sentence id="s3004" text="We believe that this study will shed new T cell costimulation on fundamental aspects for understanding the molecular pathogenesis of endometrial cancer and may aid in the development of new targeted therapies.">
    <entity charOffset="41-61" id="s3004.e0" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <entity charOffset="145-151" id="s3004.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3004.e0" e2="s3004.e1" id="s3004.p0" relation="false"/>
  </sentence>
  <sentence id="s3005" text="Vegetarian and vegan diets have increased worldwide in the last decades, according to the knowledge that they might prevent coronary heart disease, cancer, and muscle organ development 2 diabetes.">
    <entity charOffset="148-154" id="s3005.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="160-184" id="s3005.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3005.e0" e2="s3005.e1" id="s3005.p0" relation="false"/>
  </sentence>
  <sentence id="s3006" text="Necropsy revealed extensive granulomatous pneumonia, from which inner cell mass cell proliferation was isolated and identified as a member of LAM3/F11 lineage; a common lineage found in humans in South Africa.">
    <entity charOffset="42-51" id="s3006.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="64-98" id="s3006.e1" ontology_id="GO_0001833" text="inner cell mass cell proliferation" type="GO"/>
    <pair e1="s3006.e0" e2="s3006.e1" id="s3006.p0" relation="false"/>
  </sentence>
  <sentence id="s3007" text="Herein, we report 3 patients with heterozygous constitutional phosphorylation of RNA polymerase II C-terminal domain mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked cardiac anomalies.">
    <entity charOffset="62-116" id="s3007.e0" ontology_id="GO_0070816" text="phosphorylation of RNA polymerase II C-terminal domain" type="GO"/>
    <entity charOffset="189-212" id="s3007.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3007.e0" e2="s3007.e1" id="s3007.p0" relation="true"/>
  </sentence>
  <sentence id="s3008" text="Herein, we report 3 patients with heterozygous constitutional phosphorylation of RNA polymerase II C-terminal domain mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked cardiac anomalies.">
    <entity charOffset="62-116" id="s3008.e0" ontology_id="GO_0070816" text="phosphorylation of RNA polymerase II C-terminal domain" type="GO"/>
    <entity charOffset="245-262" id="s3008.e1" ontology_id="HP_0001627" text="cardiac anomalies" type="HP"/>
    <pair e1="s3008.e0" e2="s3008.e1" id="s3008.p0" relation="true"/>
  </sentence>
  <sentence id="s3009" text="Exposure to BMAA has been implicated in the development of neurodegenerative diseases including amyotrophic lateral sclerosis (signal transduction), Alzheimer's disease (AD) and Parkinson's disease (PD).">
    <entity charOffset="59-85" id="s3009.e0" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <entity charOffset="127-146" id="s3009.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s3009.e0" e2="s3009.e1" id="s3009.p0" relation="false"/>
  </sentence>
  <sentence id="s3010" text="The present study aimed to identify novel intervertebral disc degeneration (extracellular matrix organization)associated long noncoding (lnc)RNAs and genes.">
    <entity charOffset="42-74" id="s3010.e0" ontology_id="HP_0008419" text="intervertebral disc degeneration" type="HP"/>
    <entity charOffset="76-109" id="s3010.e1" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <pair e1="s3010.e0" e2="s3010.e1" id="s3010.p0" relation="false"/>
  </sentence>
  <sentence id="s3011" text="&lt;b&gt;Objective:&lt;/b&gt; To study the association between Thymidine Phosphorylase (pyrimidine nucleoside metabolic process) genetic variation and clinical outcomes and safety of postoperative colorectal cancer (CRC) patients.">
    <entity charOffset="76-115" id="s3011.e0" ontology_id="GO_0006213" text="pyrimidine nucleoside metabolic process" type="GO"/>
    <entity charOffset="196-202" id="s3011.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3011.e0" e2="s3011.e1" id="s3011.p0" relation="false"/>
  </sentence>
  <sentence id="s3012" text="Additionally, of the 87 postoperative tissue specimens, the results showed that the expression of pyrimidine nucleoside metabolic process in cancer tissues of the patients with CT or TT genomuscle organ developments were significantly higher than those of the wild type CC genotype patients (&lt;i&gt;P&lt;/i&gt;=0.019).">
    <entity charOffset="98-137" id="s3012.e0" ontology_id="GO_0006213" text="pyrimidine nucleoside metabolic process" type="GO"/>
    <entity charOffset="141-147" id="s3012.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3012.e0" e2="s3012.e1" id="s3012.p0" relation="false"/>
  </sentence>
  <sentence id="s3013" text="Additionally, of the 87 postoperative tissue specimens, the results showed that the expression of pyrimidine nucleoside metabolic process in cancer tissues of the patients with CT or TT genomuscle organ developments were significantly higher than those of the wild type CC genotype patients (&lt;i&gt;P&lt;/i&gt;=0.019).">
    <entity charOffset="141-147" id="s3013.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="190-214" id="s3013.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3013.e0" e2="s3013.e1" id="s3013.p0" relation="false"/>
  </sentence>
  <sentence id="s3014" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.">
    <entity charOffset="39-47" id="s3014.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="170-192" id="s3014.e1" ontology_id="GO_0000303" text="response to superoxide" type="GO"/>
    <pair e1="s3014.e0" e2="s3014.e1" id="s3014.p0" relation="false"/>
  </sentence>
  <sentence id="s3015" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.">
    <entity charOffset="39-47" id="s3015.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="203-215" id="s3015.e1" ontology_id="GO_0008380" text="RNA splicing" type="GO"/>
    <pair e1="s3015.e0" e2="s3015.e1" id="s3015.p0" relation="false"/>
  </sentence>
  <sentence id="s3016" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.">
    <entity charOffset="39-47" id="s3016.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="217-259" id="s3016.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3016.e0" e2="s3016.e1" id="s3016.p0" relation="false"/>
  </sentence>
  <sentence id="s3017" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.">
    <entity charOffset="39-47" id="s3017.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="266-302" id="s3017.e1" ontology_id="GO_0039702" text="viral budding via host ESCRT complex" type="GO"/>
    <pair e1="s3017.e0" e2="s3017.e1" id="s3017.p0" relation="false"/>
  </sentence>
  <sentence id="s3018" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.">
    <entity charOffset="39-47" id="s3018.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="304-351" id="s3018.e1" ontology_id="GO_0002091" text="negative regulation of receptor internalization" type="GO"/>
    <pair e1="s3018.e0" e2="s3018.e1" id="s3018.p0" relation="false"/>
  </sentence>
  <sentence id="s3019" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.">
    <entity charOffset="39-47" id="s3019.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="353-376" id="s3019.e1" ontology_id="GO_0055085" text="transmembrane transport" type="GO"/>
    <pair e1="s3019.e0" e2="s3019.e1" id="s3019.p0" relation="false"/>
  </sentence>
  <sentence id="s3020" text="To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.">
    <entity charOffset="39-47" id="s3020.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="378-405" id="s3020.e1" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <pair e1="s3020.e0" e2="s3020.e1" id="s3020.p0" relation="false"/>
  </sentence>
  <sentence id="s3021" text="Most of the available anticancer drugs are designed to coenzyme A biosynthetic process on specific targets by altering the activity of involved transporters and genes.">
    <entity charOffset="26-32" id="s3021.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="55-86" id="s3021.e1" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <pair e1="s3021.e0" e2="s3021.e1" id="s3021.p0" relation="false"/>
  </sentence>
  <sentence id="s3022" text="We used Cytoscape network analysis and Search tool for retrieval of intercoenzyme A biosynthetic processing genes/ proteins (STRING) to study the possible interactions to show the links between the antioxidants, antibiotics, anti-inflammatory and antimitotic agents and their targets for their possible use in cancer.">
    <entity charOffset="73-104" id="s3022.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="310-316" id="s3022.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3022.e0" e2="s3022.e1" id="s3022.p0" relation="false"/>
  </sentence>
  <sentence id="s3023" text="Crisponi syndrome (CS)/cold-induced sweating syndrome muscle organ development 1 (positive regulation of cell proliferation) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.">
    <entity charOffset="54-78" id="s3023.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="307-327" id="s3023.e1" ontology_id="HP_0011968" text="feeding difficulties" type="HP"/>
    <pair e1="s3023.e0" e2="s3023.e1" id="s3023.p0" relation="false"/>
  </sentence>
  <sentence id="s3024" text="Crisponi syndrome (CS)/cold-induced sweating syndrome muscle organ development 1 (positive regulation of cell proliferation) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.">
    <entity charOffset="82-123" id="s3024.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="290-302" id="s3024.e1" ontology_id="HP_0001945" text="hyperthermia" type="HP"/>
    <pair e1="s3024.e0" e2="s3024.e1" id="s3024.p0" relation="true"/>
  </sentence>
  <sentence id="s3025" text="Crisponi syndrome (CS)/cold-induced sweating syndrome muscle organ development 1 (positive regulation of cell proliferation) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.">
    <entity charOffset="82-123" id="s3025.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="352-361" id="s3025.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s3025.e0" e2="s3025.e1" id="s3025.p0" relation="true"/>
  </sentence>
  <sentence id="s3026" text="Although these data further support the pathogenic role of protein ubiquitination mutations in a CS/CISS1-like phenomuscle organ development, they do not explain all their clinical manifestations and highlight the high phenotypic heterogeneity associated with mutations in KLHL7.">
    <entity charOffset="59-81" id="s3026.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="230-243" id="s3026.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s3026.e0" e2="s3026.e1" id="s3026.p0" relation="false"/>
  </sentence>
  <sentence id="s3027" text="Although these data further support the pathogenic role of protein ubiquitination mutations in a CS/CISS1-like phenomuscle organ development, they do not explain all their clinical manifestations and highlight the high phenotypic heterogeneity associated with mutations in KLHL7.">
    <entity charOffset="116-140" id="s3027.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="230-243" id="s3027.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s3027.e0" e2="s3027.e1" id="s3027.p0" relation="false"/>
  </sentence>
  <sentence id="s3028" text="In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(negative regulation of transcription, DNA-templated) and negative regulation of transcription by RNA polymerase II homeobox1(MSX1) genes in 9subjects.">
    <entity charOffset="82-92" id="s3028.e0" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <entity charOffset="155-206" id="s3028.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3028.e0" e2="s3028.e1" id="s3028.p0" relation="false"/>
  </sentence>
  <sentence id="s3029" text="In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(negative regulation of transcription, DNA-templated) and negative regulation of transcription by RNA polymerase II homeobox1(MSX1) genes in 9subjects.">
    <entity charOffset="82-92" id="s3029.e0" ontology_id="HP_0000668" text="hypodontia" type="HP"/>
    <entity charOffset="212-269" id="s3029.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3029.e0" e2="s3029.e1" id="s3029.p0" relation="false"/>
  </sentence>
  <sentence id="s3030" text="Overall, our study confirmed the major role played by canonical Wnt signaling pathway in tooth agenesis and the genetic heterogeneity of this disease.">
    <entity charOffset="54-85" id="s3030.e0" ontology_id="GO_0060070" text="canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="120-133" id="s3030.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s3030.e0" e2="s3030.e1" id="s3030.p0" relation="false"/>
  </sentence>
  <sentence id="s3031" text="Mutations in positive regulation of cell proliferation have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome muscle organ development 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.">
    <entity charOffset="13-54" id="s3031.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="81-100" id="s3031.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3031.e0" e2="s3031.e1" id="s3031.p0" relation="true"/>
  </sentence>
  <sentence id="s3032" text="Mutations in positive regulation of cell proliferation have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome muscle organ development 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.">
    <entity charOffset="13-54" id="s3032.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="242-262" id="s3032.e1" ontology_id="HP_0011968" text="feeding difficulties" type="HP"/>
    <pair e1="s3032.e0" e2="s3032.e1" id="s3032.p0" relation="true"/>
  </sentence>
  <sentence id="s3033" text="Mutations in positive regulation of cell proliferation have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome muscle organ development 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.">
    <entity charOffset="81-100" id="s3033.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="144-168" id="s3033.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3033.e0" e2="s3033.e1" id="s3033.p0" relation="true"/>
  </sentence>
  <sentence id="s3034" text="Mutations in positive regulation of cell proliferation have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome muscle organ development 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.">
    <entity charOffset="144-168" id="s3034.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="242-262" id="s3034.e1" ontology_id="HP_0011968" text="feeding difficulties" type="HP"/>
    <pair e1="s3034.e0" e2="s3034.e1" id="s3034.p0" relation="false"/>
  </sentence>
  <sentence id="s3035" text="Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in &lt;i&gt;cytoskeleton organization&lt;/i&gt;/S&lt;i&gt;cyl3&lt;/i&gt; double-deficient epidermis development than in &lt;i&gt;Scyl1&lt;/i&gt;-deficient mice.">
    <entity charOffset="61-75" id="s3035.e0" ontology_id="HP_0003202" text="muscle wasting" type="HP"/>
    <entity charOffset="210-235" id="s3035.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s3035.e0" e2="s3035.e1" id="s3035.p0" relation="false"/>
  </sentence>
  <sentence id="s3036" text="Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in &lt;i&gt;cytoskeleton organization&lt;/i&gt;/S&lt;i&gt;cyl3&lt;/i&gt; double-deficient epidermis development than in &lt;i&gt;Scyl1&lt;/i&gt;-deficient mice.">
    <entity charOffset="61-75" id="s3036.e0" ontology_id="HP_0003202" text="muscle wasting" type="HP"/>
    <entity charOffset="270-291" id="s3036.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3036.e0" e2="s3036.e1" id="s3036.p0" relation="false"/>
  </sentence>
  <sentence id="s3037" text="Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in &lt;i&gt;cytoskeleton organization&lt;/i&gt;/S&lt;i&gt;cyl3&lt;/i&gt; double-deficient epidermis development than in &lt;i&gt;Scyl1&lt;/i&gt;-deficient mice.">
    <entity charOffset="97-122" id="s3037.e0" ontology_id="HP_0007373" text="motor neuron degeneration" type="HP"/>
    <entity charOffset="210-235" id="s3037.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s3037.e0" e2="s3037.e1" id="s3037.p0" relation="false"/>
  </sentence>
  <sentence id="s3038" text="Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) epidermis development.">
    <entity charOffset="48-78" id="s3038.e0" ontology_id="GO_0002009" text="morphogenesis of an epithelium" type="GO"/>
    <entity charOffset="139-153" id="s3038.e1" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <pair e1="s3038.e0" e2="s3038.e1" id="s3038.p0" relation="false"/>
  </sentence>
  <sentence id="s3039" text="Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) epidermis development.">
    <entity charOffset="129-138" id="s3039.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="198-228" id="s3039.e1" ontology_id="GO_0002009" text="morphogenesis of an epithelium" type="GO"/>
    <pair e1="s3039.e0" e2="s3039.e1" id="s3039.p0" relation="false"/>
  </sentence>
  <sentence id="s3040" text="Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) epidermis development.">
    <entity charOffset="129-138" id="s3040.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="237-258" id="s3040.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3040.e0" e2="s3040.e1" id="s3040.p0" relation="false"/>
  </sentence>
  <sentence id="s3041" text="Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) epidermis development.">
    <entity charOffset="139-153" id="s3041.e0" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <entity charOffset="237-258" id="s3041.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3041.e0" e2="s3041.e1" id="s3041.p0" relation="false"/>
  </sentence>
  <sentence id="s3042" text="This prevented renal agenesis in morphogenesis of an epithelium(bl/bl) epidermis development, permitting kidney development and postnatal survival.">
    <entity charOffset="15-29" id="s3042.e0" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <entity charOffset="33-63" id="s3042.e1" ontology_id="GO_0002009" text="morphogenesis of an epithelium" type="GO"/>
    <pair e1="s3042.e0" e2="s3042.e1" id="s3042.p0" relation="false"/>
  </sentence>
  <sentence id="s3043" text="This prevented renal agenesis in morphogenesis of an epithelium(bl/bl) epidermis development, permitting kidney development and postnatal survival.">
    <entity charOffset="15-29" id="s3043.e0" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <entity charOffset="71-92" id="s3043.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3043.e0" e2="s3043.e1" id="s3043.p0" relation="false"/>
  </sentence>
  <sentence id="s3044" text="Developmental and epileptic encephalopathy with hypsarrhythmia is present in most patients with galactose metabolic process variants, and is drug-resistant in the majority of cases.">
    <entity charOffset="28-42" id="s3044.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="96-123" id="s3044.e1" ontology_id="GO_0006012" text="galactose metabolic process" type="GO"/>
    <pair e1="s3044.e0" e2="s3044.e1" id="s3044.p0" relation="true"/>
  </sentence>
  <sentence id="s3045" text="Developmental and epileptic encephalopathy with hypsarrhythmia is present in most patients with galactose metabolic process variants, and is drug-resistant in the majority of cases.">
    <entity charOffset="48-62" id="s3045.e0" ontology_id="HP_0002521" text="hypsarrhythmia" type="HP"/>
    <entity charOffset="96-123" id="s3045.e1" ontology_id="GO_0006012" text="galactose metabolic process" type="GO"/>
    <pair e1="s3045.e0" e2="s3045.e1" id="s3045.p0" relation="true"/>
  </sentence>
  <sentence id="s3046" text="The positive regulation of cysteine-type endopeptidase activity involved in apoptotic process co-receptor activation of MAPK activity is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.">
    <entity charOffset="4-93" id="s3046.e0" ontology_id="GO_0043280" text="positive regulation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="267-276" id="s3046.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s3046.e0" e2="s3046.e1" id="s3046.p0" relation="true"/>
  </sentence>
  <sentence id="s3047" text="The positive regulation of cysteine-type endopeptidase activity involved in apoptotic process co-receptor activation of MAPK activity is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.">
    <entity charOffset="4-93" id="s3047.e0" ontology_id="GO_0043280" text="positive regulation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="383-389" id="s3047.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3047.e0" e2="s3047.e1" id="s3047.p0" relation="true"/>
  </sentence>
  <sentence id="s3048" text="The positive regulation of cysteine-type endopeptidase activity involved in apoptotic process co-receptor activation of MAPK activity is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.">
    <entity charOffset="106-133" id="s3048.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="383-389" id="s3048.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3048.e0" e2="s3048.e1" id="s3048.p0" relation="true"/>
  </sentence>
  <sentence id="s3049" text="Here we investigated methylation of the activation of MAPK activity promoter in mouse germ cells and human germ cell cancer and correlated this with the level of activation of MAPK activity protein expression.">
    <entity charOffset="40-67" id="s3049.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="117-123" id="s3049.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3049.e0" e2="s3049.e1" id="s3049.p0" relation="true"/>
  </sentence>
  <sentence id="s3050" text="Here we investigated methylation of the activation of MAPK activity promoter in mouse germ cells and human germ cell cancer and correlated this with the level of activation of MAPK activity protein expression.">
    <entity charOffset="117-123" id="s3050.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="162-189" id="s3050.e1" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <pair e1="s3050.e0" e2="s3050.e1" id="s3050.p0" relation="true"/>
  </sentence>
  <sentence id="s3051" text="activation of MAPK activity protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk cAMP biosynthetic process tumor and seminomas.">
    <entity charOffset="0-27" id="s3051.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="72-81" id="s3051.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s3051.e0" e2="s3051.e1" id="s3051.p0" relation="true"/>
  </sentence>
  <sentence id="s3052" text="activation of MAPK activity protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk cAMP biosynthetic process tumor and seminomas.">
    <entity charOffset="0-27" id="s3052.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="153-158" id="s3052.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3052.e0" e2="s3052.e1" id="s3052.p0" relation="true"/>
  </sentence>
  <sentence id="s3053" text="activation of MAPK activity protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk cAMP biosynthetic process tumor and seminomas.">
    <entity charOffset="72-81" id="s3053.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="127-152" id="s3053.e1" ontology_id="GO_0006171" text="cAMP biosynthetic process" type="GO"/>
    <pair e1="s3053.e0" e2="s3053.e1" id="s3053.p0" relation="false"/>
  </sentence>
  <sentence id="s3054" text="activation of MAPK activity protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk cAMP biosynthetic process tumor and seminomas.">
    <entity charOffset="127-152" id="s3054.e0" ontology_id="GO_0006171" text="cAMP biosynthetic process" type="GO"/>
    <entity charOffset="153-158" id="s3054.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3054.e0" e2="s3054.e1" id="s3054.p0" relation="false"/>
  </sentence>
  <sentence id="s3055" text="Further, cleaved activation of MAPK activity was detected in media from seminoma and embryonal carcinoma cell lines, suggesting that cleaved CRIPTO may provide diagnostic indication of germ cell cancer.">
    <entity charOffset="17-44" id="s3055.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="195-201" id="s3055.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3055.e0" e2="s3055.e1" id="s3055.p0" relation="true"/>
  </sentence>
  <sentence id="s3056" text="Accordingly, activation of MAPK activity was detectable in serum from 6/15 patients with embryonal carcinoma, 5/15 patients with seminoma, 4/5 patients with germ cell neoplasia in situ cells only and in 1/15 control patients.">
    <entity charOffset="13-40" id="s3056.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="167-176" id="s3056.e1" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <pair e1="s3056.e0" e2="s3056.e1" id="s3056.p0" relation="true"/>
  </sentence>
  <sentence id="s3057" text="These findings suggest that activation of MAPK activity expression may be a useful serological marker for diagnostic and/or prognostic purposes during germ cell cancer management.">
    <entity charOffset="28-55" id="s3057.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="161-167" id="s3057.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3057.e0" e2="s3057.e1" id="s3057.p0" relation="true"/>
  </sentence>
  <sentence id="s3058" text="We report the case of a patient with &lt;i&gt;attachment of GPI anchor to protein&lt;/i&gt; mutations who experienced recurrent aseptic meningitis 121 times over 16 years before developing paroxysmal nocturnal haemoglobinuria (PNH).">
    <entity charOffset="40-75" id="s3058.e0" ontology_id="GO_0016255" text="attachment of GPI anchor to protein" type="GO"/>
    <entity charOffset="177-213" id="s3058.e1" ontology_id="HP_0004818" text="paroxysmal nocturnal haemoglobinuria" type="HP"/>
    <pair e1="s3058.e0" e2="s3058.e1" id="s3058.p0" relation="true"/>
  </sentence>
  <sentence id="s3059" text="Targeted expression of a human glycoprotein catabolic process transgene to tissues involved in ecdysteroidogenesis, &lt;i&gt;e.g.&lt;/i&gt;, prothoracic gland, also partially rescues global developmental delay in mutant homozygotes.">
    <entity charOffset="31-61" id="s3059.e0" ontology_id="GO_0006516" text="glycoprotein catabolic process" type="GO"/>
    <entity charOffset="178-197" id="s3059.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3059.e0" e2="s3059.e1" id="s3059.p0" relation="true"/>
  </sentence>
  <sentence id="s3060" text="The most common and severe form, primary hyperoxaluria Type I, is due to the deficit of liver peroxisomal alanine/glyoxylate aminotransferase (glyoxylate catabolic process).">
    <entity charOffset="41-54" id="s3060.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="143-171" id="s3060.e1" ontology_id="GO_0009436" text="glyoxylate catabolic process" type="GO"/>
    <pair e1="s3060.e0" e2="s3060.e1" id="s3060.p0" relation="true"/>
  </sentence>
  <sentence id="s3061" text="Primary hyperoxaluria muscle organ development II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (glyoxylate metabolic process) and 4-hydroxy-2-oxoglutarate aldolase (4-hydroxyproline catabolic process), respectively.">
    <entity charOffset="8-21" id="s3061.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="22-46" id="s3061.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3061.e0" e2="s3061.e1" id="s3061.p0" relation="false"/>
  </sentence>
  <sentence id="s3062" text="Primary hyperoxaluria muscle organ development II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (glyoxylate metabolic process) and 4-hydroxy-2-oxoglutarate aldolase (4-hydroxyproline catabolic process), respectively.">
    <entity charOffset="8-21" id="s3062.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="159-187" id="s3062.e1" ontology_id="GO_0046487" text="glyoxylate metabolic process" type="GO"/>
    <pair e1="s3062.e0" e2="s3062.e1" id="s3062.p0" relation="true"/>
  </sentence>
  <sentence id="s3063" text="Primary hyperoxaluria muscle organ development II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (glyoxylate metabolic process) and 4-hydroxy-2-oxoglutarate aldolase (4-hydroxyproline catabolic process), respectively.">
    <entity charOffset="8-21" id="s3063.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="228-262" id="s3063.e1" ontology_id="GO_0019470" text="4-hydroxyproline catabolic process" type="GO"/>
    <pair e1="s3063.e0" e2="s3063.e1" id="s3063.p0" relation="true"/>
  </sentence>
  <sentence id="s3064" text="Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (lipid metabolic process) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic hypoglycemia, metabolic acidosis and hyperammonemia.">
    <entity charOffset="52-75" id="s3064.e0" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <entity charOffset="259-271" id="s3064.e1" ontology_id="HP_0001943" text="hypoglycemia" type="HP"/>
    <pair e1="s3064.e0" e2="s3064.e1" id="s3064.p0" relation="true"/>
  </sentence>
  <sentence id="s3065" text="Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (lipid metabolic process) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic hypoglycemia, metabolic acidosis and hyperammonemia.">
    <entity charOffset="52-75" id="s3065.e0" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <entity charOffset="296-310" id="s3065.e1" ontology_id="HP_0001987" text="hyperammonemia" type="HP"/>
    <pair e1="s3065.e0" e2="s3065.e1" id="s3065.p0" relation="true"/>
  </sentence>
  <sentence id="s3066" text="This autosomal recessive disease is caused by mutations in the gene encoding barttin, ion transmembrane transport, an essential subunit of the positive regulation of cell proliferation-K chloride channels expressed in renal and inner ear epithelia.">
    <entity charOffset="5-24" id="s3066.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="86-113" id="s3066.e1" ontology_id="GO_0034220" text="ion transmembrane transport" type="GO"/>
    <pair e1="s3066.e0" e2="s3066.e1" id="s3066.p0" relation="true"/>
  </sentence>
  <sentence id="s3067" text="This autosomal recessive disease is caused by mutations in the gene encoding barttin, ion transmembrane transport, an essential subunit of the positive regulation of cell proliferation-K chloride channels expressed in renal and inner ear epithelia.">
    <entity charOffset="5-24" id="s3067.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="143-184" id="s3067.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s3067.e0" e2="s3067.e1" id="s3067.p0" relation="true"/>
  </sentence>
  <sentence id="s3068" text="Previous work has demonstrated the effectiveness of inhibiting DNA damage checkpoint with small-molecule inhibitors, but the role of CHK1 mediated DDR in medulloblastoma is unknown.">
    <entity charOffset="63-84" id="s3068.e0" ontology_id="GO_0000077" text="DNA damage checkpoint" type="GO"/>
    <entity charOffset="154-169" id="s3068.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s3068.e0" e2="s3068.e1" id="s3068.p0" relation="false"/>
  </sentence>
  <sentence id="s3069" text="Overall, our results demonstrate that small-molecule inhibition of DNA damage checkpoint in combination with, cisplatin, is more advantageous than either treatment alone, especially for Group 3 medulloblastoma, and therefore this combined therapeutic approach serves as an avenue for further investigation">
    <entity charOffset="67-88" id="s3069.e0" ontology_id="GO_0000077" text="DNA damage checkpoint" type="GO"/>
    <entity charOffset="194-209" id="s3069.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s3069.e0" e2="s3069.e1" id="s3069.p0" relation="false"/>
  </sentence>
  <sentence id="s3070" text="We evaluated whether methylation of tumor-suppressor genes (TSGs) would classify non-muscle-invasive (inflammatory response) bladder cancer subgroups and predict outcome.">
    <entity charOffset="102-123" id="s3070.e0" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <entity charOffset="133-139" id="s3070.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3070.e0" e2="s3070.e1" id="s3070.p0" relation="false"/>
  </sentence>
  <sentence id="s3071" text="A retrospective design included the following paraffin-embedded primary inflammatory response tumor types (n = 251): biological_process low grade (LG) (n = 79), pT1LG (n = 81), and pT1 high grade (HG) (n = 91).">
    <entity charOffset="72-93" id="s3071.e0" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <entity charOffset="94-99" id="s3071.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3071.e0" e2="s3071.e1" id="s3071.p0" relation="false"/>
  </sentence>
  <sentence id="s3072" text="A retrospective design included the following paraffin-embedded primary inflammatory response tumor types (n = 251): biological_process low grade (LG) (n = 79), pT1LG (n = 81), and pT1 high grade (HG) (n = 91).">
    <entity charOffset="94-99" id="s3072.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="117-135" id="s3072.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3072.e0" e2="s3072.e1" id="s3072.p0" relation="false"/>
  </sentence>
  <sentence id="s3073" text="Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="41-69" id="s3073.e0" ontology_id="GO_0001913" text="T cell mediated cytotoxicity" type="GO"/>
    <entity charOffset="250-255" id="s3073.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3073.e0" e2="s3073.e1" id="s3073.p0" relation="false"/>
  </sentence>
  <sentence id="s3074" text="Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="79-115" id="s3074.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="250-255" id="s3074.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3074.e0" e2="s3074.e1" id="s3074.p0" relation="false"/>
  </sentence>
  <sentence id="s3075" text="Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="117-139" id="s3075.e0" ontology_id="GO_0002040" text="sprouting angiogenesis" type="GO"/>
    <entity charOffset="250-255" id="s3075.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3075.e0" e2="s3075.e1" id="s3075.p0" relation="false"/>
  </sentence>
  <sentence id="s3076" text="Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="151-208" id="s3076.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="250-255" id="s3076.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3076.e0" e2="s3076.e1" id="s3076.p0" relation="false"/>
  </sentence>
  <sentence id="s3077" text="Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="220-238" id="s3077.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="250-255" id="s3077.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3077.e0" e2="s3077.e1" id="s3077.p0" relation="false"/>
  </sentence>
  <sentence id="s3078" text="Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="250-255" id="s3078.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="333-356" id="s3078.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s3078.e0" e2="s3078.e1" id="s3078.p0" relation="true"/>
  </sentence>
  <sentence id="s3079" text="Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.">
    <entity charOffset="250-255" id="s3079.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="291-317" id="s3079.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s3079.e0" e2="s3079.e1" id="s3079.p0" relation="false"/>
  </sentence>
  <sentence id="s3080" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="59-81" id="s3080.e0" ontology_id="HP_0007166" text="paroxysmal dyskinesias" type="HP"/>
    <entity charOffset="231-272" id="s3080.e1" ontology_id="GO_0050884" text="neuromuscular process controlling posture" type="GO"/>
    <pair e1="s3080.e0" e2="s3080.e1" id="s3080.p0" relation="true"/>
  </sentence>
  <sentence id="s3081" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="59-81" id="s3081.e0" ontology_id="HP_0007166" text="paroxysmal dyskinesias" type="HP"/>
    <entity charOffset="315-373" id="s3081.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s3081.e0" e2="s3081.e1" id="s3081.p0" relation="false"/>
  </sentence>
  <sentence id="s3082" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="83-106" id="s3082.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="149-157" id="s3082.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3082.e0" e2="s3082.e1" id="s3082.p0" relation="false"/>
  </sentence>
  <sentence id="s3083" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="83-106" id="s3083.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="451-459" id="s3083.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s3083.e0" e2="s3083.e1" id="s3083.p0" relation="false"/>
  </sentence>
  <sentence id="s3084" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="83-106" id="s3084.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="460-466" id="s3084.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3084.e0" e2="s3084.e1" id="s3084.p0" relation="false"/>
  </sentence>
  <sentence id="s3085" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="149-157" id="s3085.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="315-373" id="s3085.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s3085.e0" e2="s3085.e1" id="s3085.p0" relation="true"/>
  </sentence>
  <sentence id="s3086" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="149-157" id="s3086.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="374-398" id="s3086.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3086.e0" e2="s3086.e1" id="s3086.p0" relation="false"/>
  </sentence>
  <sentence id="s3087" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="231-272" id="s3087.e0" ontology_id="GO_0050884" text="neuromuscular process controlling posture" type="GO"/>
    <entity charOffset="451-459" id="s3087.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s3087.e0" e2="s3087.e1" id="s3087.p0" relation="false"/>
  </sentence>
  <sentence id="s3088" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="231-272" id="s3088.e0" ontology_id="GO_0050884" text="neuromuscular process controlling posture" type="GO"/>
    <entity charOffset="460-466" id="s3088.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3088.e0" e2="s3088.e1" id="s3088.p0" relation="true"/>
  </sentence>
  <sentence id="s3089" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="315-373" id="s3089.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="451-459" id="s3089.e1" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <pair e1="s3089.e0" e2="s3089.e1" id="s3089.p0" relation="false"/>
  </sentence>
  <sentence id="s3090" text="Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.">
    <entity charOffset="374-398" id="s3090.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="460-466" id="s3090.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3090.e0" e2="s3090.e1" id="s3090.p0" relation="false"/>
  </sentence>
  <sentence id="s3091" text="cell proliferation encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes.">
    <entity charOffset="0-18" id="s3091.e0" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <entity charOffset="51-56" id="s3091.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3091.e0" e2="s3091.e1" id="s3091.p0" relation="false"/>
  </sentence>
  <sentence id="s3092" text="Herein, we report biallelic pathogenic variants in cell proliferation in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features.">
    <entity charOffset="51-69" id="s3092.e0" ontology_id="GO_0008283" text="cell proliferation" type="GO"/>
    <entity charOffset="124-147" id="s3092.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3092.e0" e2="s3092.e1" id="s3092.p0" relation="true"/>
  </sentence>
  <sentence id="s3093" text="Chorea-acanthocytosis (autophagy), a neurodegenerative disease, results from loss-of-function-mutations of the chorein-encoding gene VPS13A.">
    <entity charOffset="23-32" id="s3093.e0" ontology_id="GO_0006914" text="autophagy" type="GO"/>
    <entity charOffset="37-62" id="s3093.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s3093.e0" e2="s3093.e1" id="s3093.p0" relation="false"/>
  </sentence>
  <sentence id="s3094" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="72-78" id="s3094.e0" ontology_id="HP_0002072" text="chorea" type="HP"/>
    <entity charOffset="157-224" id="s3094.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s3094.e0" e2="s3094.e1" id="s3094.p0" relation="false"/>
  </sentence>
  <sentence id="s3095" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="80-92" id="s3095.e0" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <entity charOffset="157-224" id="s3095.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s3095.e0" e2="s3095.e1" id="s3095.p0" relation="false"/>
  </sentence>
  <sentence id="s3096" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="123-133" id="s3096.e0" ontology_id="HP_0001260" text="dysarthria" type="HP"/>
    <entity charOffset="157-224" id="s3096.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s3096.e0" e2="s3096.e1" id="s3096.p0" relation="false"/>
  </sentence>
  <sentence id="s3097" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="157-224" id="s3097.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="305-313" id="s3097.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s3097.e0" e2="s3097.e1" id="s3097.p0" relation="false"/>
  </sentence>
  <sentence id="s3098" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="157-224" id="s3098.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="315-335" id="s3098.e1" ontology_id="HP_0100543" text="cognitive impairment" type="HP"/>
    <pair e1="s3098.e0" e2="s3098.e1" id="s3098.p0" relation="false"/>
  </sentence>
  <sentence id="s3099" text="Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and nuclear-transcribed mRNA catabolic process, nonsense-mediated decay biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.">
    <entity charOffset="157-224" id="s3099.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="341-359" id="s3099.e1" ontology_id="HP_0000708" text="behavioral changes" type="HP"/>
    <pair e1="s3099.e0" e2="s3099.e1" id="s3099.p0" relation="false"/>
  </sentence>
  <sentence id="s3100" text="Chorein, regulation of cell growth, store-operated calcium entry and SOCE further confer survival of tumor cells.">
    <entity charOffset="9-34" id="s3100.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="101-106" id="s3100.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3100.e0" e2="s3100.e1" id="s3100.p0" relation="false"/>
  </sentence>
  <sentence id="s3101" text="Chorein, regulation of cell growth, store-operated calcium entry and SOCE further confer survival of tumor cells.">
    <entity charOffset="36-64" id="s3101.e0" ontology_id="GO_0002115" text="store-operated calcium entry" type="GO"/>
    <entity charOffset="101-106" id="s3101.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3101.e0" e2="s3101.e1" id="s3101.p0" relation="false"/>
  </sentence>
  <sentence id="s3102" text="Disruption of outflow tract septum morphogenesis induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma.">
    <entity charOffset="14-48" id="s3102.e0" ontology_id="GO_0003148" text="outflow tract septum morphogenesis" type="GO"/>
    <entity charOffset="114-119" id="s3102.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3102.e0" e2="s3102.e1" id="s3102.p0" relation="true"/>
  </sentence>
  <sentence id="s3103" text="Disruption of outflow tract septum morphogenesis induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma.">
    <entity charOffset="14-48" id="s3103.e0" ontology_id="GO_0003148" text="outflow tract septum morphogenesis" type="GO"/>
    <entity charOffset="151-163" id="s3103.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s3103.e0" e2="s3103.e1" id="s3103.p0" relation="false"/>
  </sentence>
  <sentence id="s3104" text="Our study supports the targeting of outflow tract septum morphogenesis to break this GSC-specific autocrine/paracrine loop in order to improve glioblastoma treatment, potentially with a high therapeutic index.">
    <entity charOffset="36-70" id="s3104.e0" ontology_id="GO_0003148" text="outflow tract septum morphogenesis" type="GO"/>
    <entity charOffset="143-155" id="s3104.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s3104.e0" e2="s3104.e1" id="s3104.p0" relation="false"/>
  </sentence>
  <sentence id="s3105" text="Here we identified six different de novo missense mutations in mitochondrial large ribosomal subunit assembly in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.">
    <entity charOffset="63-109" id="s3105.e0" ontology_id="GO_1902775" text="mitochondrial large ribosomal subunit assembly" type="GO"/>
    <entity charOffset="161-180" id="s3105.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3105.e0" e2="s3105.e1" id="s3105.p0" relation="true"/>
  </sentence>
  <sentence id="s3106" text="Here we identified six different de novo missense mutations in mitochondrial large ribosomal subunit assembly in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.">
    <entity charOffset="63-109" id="s3106.e0" ontology_id="GO_1902775" text="mitochondrial large ribosomal subunit assembly" type="GO"/>
    <entity charOffset="188-211" id="s3106.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3106.e0" e2="s3106.e1" id="s3106.p0" relation="true"/>
  </sentence>
  <sentence id="s3107" text="Here we identified six different de novo missense mutations in mitochondrial large ribosomal subunit assembly in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.">
    <entity charOffset="63-109" id="s3107.e0" ontology_id="GO_1902775" text="mitochondrial large ribosomal subunit assembly" type="GO"/>
    <entity charOffset="225-242" id="s3107.e1" ontology_id="HP_0002167" text="speech impairment" type="HP"/>
    <pair e1="s3107.e0" e2="s3107.e1" id="s3107.p0" relation="true"/>
  </sentence>
  <sentence id="s3108" text="Here we identified six different de novo missense mutations in mitochondrial large ribosomal subunit assembly in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.">
    <entity charOffset="63-109" id="s3108.e0" ontology_id="GO_1902775" text="mitochondrial large ribosomal subunit assembly" type="GO"/>
    <entity charOffset="247-265" id="s3108.e1" ontology_id="HP_0001288" text="gait abnormalities" type="HP"/>
    <pair e1="s3108.e0" e2="s3108.e1" id="s3108.p0" relation="true"/>
  </sentence>
  <sentence id="s3109" text="Review of exome sequencing data of the proband and her unaffected son for 40 known genes causing congenital nonsyndromic cataracts revealed two variants, namely c.139G&amp;gt;A (p.Asp47Asn; D47N) in the &lt;i&gt;gap junction-mediated intercellular transport&lt;/i&gt; gene and c.2036C&amp;gt;T in the &lt;i&gt;FYCO1&lt;/i&gt; gene to be potentially pathogenic.">
    <entity charOffset="121-129" id="s3109.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="202-247" id="s3109.e1" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <pair e1="s3109.e0" e2="s3109.e1" id="s3109.p0" relation="true"/>
  </sentence>
  <sentence id="s3110" text="The mutation c.139G&amp;gt;A in the &lt;i&gt;gap junction-mediated intercellular transport&lt;/i&gt; gene detected in the present study was also previously reported in Caucasian and Chinese families but with different phenotypes, i.e. nuclear and nuclear pulverulent cataracts.">
    <entity charOffset="35-80" id="s3110.e0" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <entity charOffset="251-259" id="s3110.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s3110.e0" e2="s3110.e1" id="s3110.p0" relation="true"/>
  </sentence>
  <sentence id="s3111" text="Biallelic pathogenic variants in protein polyubiquitination are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia.">
    <entity charOffset="33-59" id="s3111.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="180-195" id="s3111.e1" ontology_id="HP_0003128" text="lactic acidemia" type="HP"/>
    <pair e1="s3111.e0" e2="s3111.e1" id="s3111.p0" relation="true"/>
  </sentence>
  <sentence id="s3112" text="Biallelic pathogenic variants in protein polyubiquitination are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia.">
    <entity charOffset="33-59" id="s3112.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="197-216" id="s3112.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3112.e0" e2="s3112.e1" id="s3112.p0" relation="true"/>
  </sentence>
  <sentence id="s3113" text="Human placenta-derived mesenchymal stem cell (hPMSC) transplantation has a potential to restore ovarian dysfunction associated with premature ovarian failure (female gamete generation), while the exact function of the Treg cells in the transplantation still needs to be further investigated.">
    <entity charOffset="132-157" id="s3113.e0" ontology_id="HP_0008209" text="premature ovarian failure" type="HP"/>
    <entity charOffset="159-183" id="s3113.e1" ontology_id="GO_0007292" text="female gamete generation" type="GO"/>
    <pair e1="s3113.e0" e2="s3113.e1" id="s3113.p0" relation="true"/>
  </sentence>
  <sentence id="s3114" text="Chudley-McCullough syndrome (actin filament organization) is a rare autosomal recessive disorder characterized by sensorineural deafness, agenesis of the corpus callosum, frontal polymicrogyria, interhemispheric cyst, and ventricular enlargement.">
    <entity charOffset="29-56" id="s3114.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="128-136" id="s3114.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3114.e0" e2="s3114.e1" id="s3114.p0" relation="false"/>
  </sentence>
  <sentence id="s3115" text="Chudley-McCullough syndrome (actin filament organization) is a rare autosomal recessive disorder characterized by sensorineural deafness, agenesis of the corpus callosum, frontal polymicrogyria, interhemispheric cyst, and ventricular enlargement.">
    <entity charOffset="29-56" id="s3115.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="138-169" id="s3115.e1" ontology_id="HP_0001274" text="agenesis of the corpus callosum" type="HP"/>
    <pair e1="s3115.e0" e2="s3115.e1" id="s3115.p0" relation="false"/>
  </sentence>
  <sentence id="s3116" text="The combination of sensorineural hearing loss and partial agenesis of the corpus callosum is a highly recognizable clinico-radiological entity that should prompt mutational analysis of the establishment of mitotic spindle orientation gene.">
    <entity charOffset="33-45" id="s3116.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="189-233" id="s3116.e1" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <pair e1="s3116.e0" e2="s3116.e1" id="s3116.p0" relation="true"/>
  </sentence>
  <sentence id="s3117" text="Aberrant expression of receptor intercoenzyme A biosynthetic processing protein kinase 4 (morphogenesis of an epithelium), a crucial regulatory protein of Wnt/-catenin signaling, has recently been reported to be involved in several cancers.">
    <entity charOffset="37-68" id="s3117.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="233-239" id="s3117.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3117.e0" e2="s3117.e1" id="s3117.p0" relation="false"/>
  </sentence>
  <sentence id="s3118" text="Aberrant expression of receptor intercoenzyme A biosynthetic processing protein kinase 4 (morphogenesis of an epithelium), a crucial regulatory protein of Wnt/-catenin signaling, has recently been reported to be involved in several cancers.">
    <entity charOffset="90-120" id="s3118.e0" ontology_id="GO_0002009" text="morphogenesis of an epithelium" type="GO"/>
    <entity charOffset="233-239" id="s3118.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3118.e0" e2="s3118.e1" id="s3118.p0" relation="false"/>
  </sentence>
  <sentence id="s3119" text="Knockdown of morphogenesis of an epithelium reduced cell migration and invasion via inhibition of Vimentin, MMP2 and Fibronectin expression in cervical cancer cells.">
    <entity charOffset="13-43" id="s3119.e0" ontology_id="GO_0002009" text="morphogenesis of an epithelium" type="GO"/>
    <entity charOffset="152-158" id="s3119.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3119.e0" e2="s3119.e1" id="s3119.p0" relation="false"/>
  </sentence>
  <sentence id="s3120" text="Molecular diagnosis is consistent with the genetic heterogeneity of the guanine salvage gene responsible for guanine salvage deficiency.">
    <entity charOffset="51-64" id="s3120.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="109-124" id="s3120.e1" ontology_id="GO_0006178" text="guanine salvage" type="GO"/>
    <pair e1="s3120.e0" e2="s3120.e1" id="s3120.p0" relation="false"/>
  </sentence>
  <sentence id="s3121" text="Molecular diagnosis is consistent with the genetic heterogeneity of the guanine salvage gene responsible for guanine salvage deficiency.">
    <entity charOffset="51-64" id="s3121.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="72-87" id="s3121.e1" ontology_id="GO_0006178" text="guanine salvage" type="GO"/>
    <pair e1="s3121.e0" e2="s3121.e1" id="s3121.p0" relation="false"/>
  </sentence>
  <sentence id="s3122" text="Single large-scale mitochondrial DNA deletions disorders are classified into three main phenotypes with frequent clinical overlap: Pearson marrow-pancreas syndrome (regulation of lipid kinase activity), Kearns-Sayre syndrome (KSS) and chronic progressive external ophtalmoplegia (PEO).">
    <entity charOffset="165-200" id="s3122.e0" ontology_id="GO_0043550" text="regulation of lipid kinase activity" type="GO"/>
    <entity charOffset="243-254" id="s3122.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s3122.e0" e2="s3122.e1" id="s3122.p0" relation="false"/>
  </sentence>
  <sentence id="s3123" text="We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (intracellular protein transport; P=9.3  10(-4)), peripheral artery disease (biological_process; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).">
    <entity charOffset="50-56" id="s3123.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="118-149" id="s3123.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s3123.e0" e2="s3123.e1" id="s3123.p0" relation="false"/>
  </sentence>
  <sentence id="s3124" text="We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (intracellular protein transport; P=9.3  10(-4)), peripheral artery disease (biological_process; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).">
    <entity charOffset="50-56" id="s3124.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="195-213" id="s3124.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3124.e0" e2="s3124.e1" id="s3124.p0" relation="false"/>
  </sentence>
  <sentence id="s3125" text="We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (intracellular protein transport; P=9.3  10(-4)), peripheral artery disease (biological_process; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).">
    <entity charOffset="118-149" id="s3125.e0" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <entity charOffset="238-254" id="s3125.e1" ontology_id="HP_0004942" text="aortic aneurysms" type="HP"/>
    <pair e1="s3125.e0" e2="s3125.e1" id="s3125.p0" relation="false"/>
  </sentence>
  <sentence id="s3126" text="Although open hERG1 channels did not interact as strongly with &lt;sub&gt;1&lt;/sub&gt; integrins as did closed channels, current flow through hERG1 channels was necessary to activate the integrin-dependent phosphorylation of Tyr&lt;sup&gt;397&lt;/sup&gt; in focal adhesion kinase (transforming growth factor beta receptor signaling pathway) in both normal and cancer cells.">
    <entity charOffset="259-317" id="s3126.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="338-344" id="s3126.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3126.e0" e2="s3126.e1" id="s3126.p0" relation="false"/>
  </sentence>
  <sentence id="s3127" text="Likewise, HCV replication is severely impaired within hepatocellular carcinoma (phosphatidylinositol phosphorylation) tissue in vivo, but the mechanisms responsible for this restriction are presently unknown.">
    <entity charOffset="54-78" id="s3127.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="80-116" id="s3127.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s3127.e0" e2="s3127.e1" id="s3127.p0" relation="false"/>
  </sentence>
  <sentence id="s3128" text="Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary phosphatidylinositol phosphorylation tissue, as a host factor that interacts with CLDN1 and cell-cell junction organization and regulates their cellular localization.">
    <entity charOffset="18-23" id="s3128.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="213-244" id="s3128.e1" ontology_id="GO_0045216" text="cell-cell junction organization" type="GO"/>
    <pair e1="s3128.e0" e2="s3128.e1" id="s3128.p0" relation="false"/>
  </sentence>
  <sentence id="s3129" text="Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary phosphatidylinositol phosphorylation tissue, as a host factor that interacts with CLDN1 and cell-cell junction organization and regulates their cellular localization.">
    <entity charOffset="18-23" id="s3129.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="121-157" id="s3129.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s3129.e0" e2="s3129.e1" id="s3129.p0" relation="false"/>
  </sentence>
  <sentence id="s3130" text="To better understand the biological role of this factor, we generated mitochondrial proton-transporting ATP synthase complex assembly-deficient mice and found that the homozygous Tmem70-/- knockouts exhibited profound growth retardation and embryonic lethality at 9.5 days post coitum.">
    <entity charOffset="70-133" id="s3130.e0" ontology_id="GO_0033615" text="mitochondrial proton-transporting ATP synthase complex assembly" type="GO"/>
    <entity charOffset="209-217" id="s3130.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s3130.e0" e2="s3130.e1" id="s3130.p0" relation="false"/>
  </sentence>
  <sentence id="s3131" text="We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia muscle organ development 31 (biological_process) who had dystonia.">
    <entity charOffset="84-90" id="s3131.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="91-115" id="s3131.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3131.e0" e2="s3131.e1" id="s3131.p0" relation="false"/>
  </sentence>
  <sentence id="s3132" text="We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia muscle organ development 31 (biological_process) who had dystonia.">
    <entity charOffset="84-90" id="s3132.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="120-138" id="s3132.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3132.e0" e2="s3132.e1" id="s3132.p0" relation="true"/>
  </sentence>
  <sentence id="s3133" text="We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia muscle organ development 31 (biological_process) who had dystonia.">
    <entity charOffset="91-115" id="s3133.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="148-156" id="s3133.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s3133.e0" e2="s3133.e1" id="s3133.p0" relation="false"/>
  </sentence>
  <sentence id="s3134" text="On the basis of his symptoms, we diagnosed him as spinocerebellar degeneration (quaternary ammonium group transport), and prescribed taltirelin hydrate.">
    <entity charOffset="50-78" id="s3134.e0" ontology_id="HP_0002503" text="spinocerebellar degeneration" type="HP"/>
    <entity charOffset="80-115" id="s3134.e1" ontology_id="GO_0015697" text="quaternary ammonium group transport" type="GO"/>
    <pair e1="s3134.e0" e2="s3134.e1" id="s3134.p0" relation="false"/>
  </sentence>
  <sentence id="s3135" text="And left hallux moved involuntarily toward the top surface of the foot at negative regulation of transcription by RNA polymerase II, that is dystonia.">
    <entity charOffset="74-131" id="s3135.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="141-149" id="s3135.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s3135.e0" e2="s3135.e1" id="s3135.p0" relation="false"/>
  </sentence>
  <sentence id="s3136" text="Our case report support clinical heterogeneity of biological_process, and highlight the importance of considering this muscle organ development in patients with dystonia and ataxia.">
    <entity charOffset="33-46" id="s3136.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="119-143" id="s3136.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3136.e0" e2="s3136.e1" id="s3136.p0" relation="false"/>
  </sentence>
  <sentence id="s3137" text="Our case report support clinical heterogeneity of biological_process, and highlight the importance of considering this muscle organ development in patients with dystonia and ataxia.">
    <entity charOffset="33-46" id="s3137.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="50-68" id="s3137.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3137.e0" e2="s3137.e1" id="s3137.p0" relation="false"/>
  </sentence>
  <sentence id="s3138" text="Our case report support clinical heterogeneity of biological_process, and highlight the importance of considering this muscle organ development in patients with dystonia and ataxia.">
    <entity charOffset="50-68" id="s3138.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="174-180" id="s3138.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3138.e0" e2="s3138.e1" id="s3138.p0" relation="true"/>
  </sentence>
  <sentence id="s3139" text="Our case report support clinical heterogeneity of biological_process, and highlight the importance of considering this muscle organ development in patients with dystonia and ataxia.">
    <entity charOffset="50-68" id="s3139.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="161-169" id="s3139.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s3139.e0" e2="s3139.e1" id="s3139.p0" relation="false"/>
  </sentence>
  <sentence id="s3140" text="Our case report support clinical heterogeneity of biological_process, and highlight the importance of considering this muscle organ development in patients with dystonia and ataxia.">
    <entity charOffset="119-143" id="s3140.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="174-180" id="s3140.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3140.e0" e2="s3140.e1" id="s3140.p0" relation="false"/>
  </sentence>
  <sentence id="s3141" text="Our case report support clinical heterogeneity of biological_process, and highlight the importance of considering this muscle organ development in patients with dystonia and ataxia.">
    <entity charOffset="119-143" id="s3141.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="161-169" id="s3141.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s3141.e0" e2="s3141.e1" id="s3141.p0" relation="false"/>
  </sentence>
  <sentence id="s3142" text="Patients with the combination of dystonia and ataxia and a family history of a neurodegenerative disorder should be tested for biological_process.">
    <entity charOffset="33-41" id="s3142.e0" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <entity charOffset="127-145" id="s3142.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3142.e0" e2="s3142.e1" id="s3142.p0" relation="false"/>
  </sentence>
  <sentence id="s3143" text="Mutations in positive regulation of transcription by RNA polymerase II and oxidative phosphorylation were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="13-70" id="s3143.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="147-173" id="s3143.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3143.e0" e2="s3143.e1" id="s3143.p0" relation="false"/>
  </sentence>
  <sentence id="s3144" text="Mutations in positive regulation of transcription by RNA polymerase II and oxidative phosphorylation were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="13-70" id="s3144.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="240-263" id="s3144.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3144.e0" e2="s3144.e1" id="s3144.p0" relation="false"/>
  </sentence>
  <sentence id="s3145" text="Mutations in positive regulation of transcription by RNA polymerase II and oxidative phosphorylation were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="75-100" id="s3145.e0" ontology_id="GO_0006119" text="oxidative phosphorylation" type="GO"/>
    <entity charOffset="240-263" id="s3145.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s3145.e0" e2="s3145.e1" id="s3145.p0" relation="true"/>
  </sentence>
  <sentence id="s3146" text="None of the patients showed positive regulation of transcription by RNA polymerase II mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in oxidative phosphorylation.">
    <entity charOffset="28-85" id="s3146.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="107-115" id="s3146.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3146.e0" e2="s3146.e1" id="s3146.p0" relation="false"/>
  </sentence>
  <sentence id="s3147" text="None of the patients showed positive regulation of transcription by RNA polymerase II mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in oxidative phosphorylation.">
    <entity charOffset="107-115" id="s3147.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="173-198" id="s3147.e1" ontology_id="GO_0006119" text="oxidative phosphorylation" type="GO"/>
    <pair e1="s3147.e0" e2="s3147.e1" id="s3147.p0" relation="false"/>
  </sentence>
  <sentence id="s3148" text="Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="27-64" id="s3148.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="428-433" id="s3148.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3148.e0" e2="s3148.e1" id="s3148.p0" relation="true"/>
  </sentence>
  <sentence id="s3149" text="Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="66-103" id="s3149.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="428-433" id="s3149.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3149.e0" e2="s3149.e1" id="s3149.p0" relation="true"/>
  </sentence>
  <sentence id="s3150" text="Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="112-158" id="s3150.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="428-433" id="s3150.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3150.e0" e2="s3150.e1" id="s3150.p0" relation="true"/>
  </sentence>
  <sentence id="s3151" text="Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="167-179" id="s3151.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="428-433" id="s3151.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3151.e0" e2="s3151.e1" id="s3151.p0" relation="false"/>
  </sentence>
  <sentence id="s3152" text="Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="188-246" id="s3152.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="428-433" id="s3152.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3152.e0" e2="s3152.e1" id="s3152.p0" relation="false"/>
  </sentence>
  <sentence id="s3153" text="Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="258-285" id="s3153.e0" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <entity charOffset="428-433" id="s3153.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3153.e0" e2="s3153.e1" id="s3153.p0" relation="true"/>
  </sentence>
  <sentence id="s3154" text="Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.">
    <entity charOffset="339-366" id="s3154.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="428-433" id="s3154.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3154.e0" e2="s3154.e1" id="s3154.p0" relation="true"/>
  </sentence>
  <sentence id="s3155" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (protein polyubiquitination, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="153-176" id="s3155.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="178-204" id="s3155.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s3155.e0" e2="s3155.e1" id="s3155.p0" relation="true"/>
  </sentence>
  <sentence id="s3156" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (protein polyubiquitination, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="153-176" id="s3156.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="206-224" id="s3156.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3156.e0" e2="s3156.e1" id="s3156.p0" relation="false"/>
  </sentence>
  <sentence id="s3157" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (protein polyubiquitination, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="153-176" id="s3157.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="301-331" id="s3157.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s3157.e0" e2="s3157.e1" id="s3157.p0" relation="true"/>
  </sentence>
  <sentence id="s3158" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (protein polyubiquitination, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="178-204" id="s3158.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="255-281" id="s3158.e1" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <pair e1="s3158.e0" e2="s3158.e1" id="s3158.p0" relation="false"/>
  </sentence>
  <sentence id="s3159" text="The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (protein polyubiquitination, biological_process), including a gene coding for mandibulofacial dysostosis with microcephaly (mRNA splicing, via spliceosome).">
    <entity charOffset="178-204" id="s3159.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="287-299" id="s3159.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3159.e0" e2="s3159.e1" id="s3159.p0" relation="false"/>
  </sentence>
  <sentence id="s3160" text="Based on our findings we conclude that for new patients with Kabuki-like phenotypes it is possible to choose a specific molecular testing approach that has the highest detection rate for a given histone H3-K4 methylation-Kabuki score, thus fostering more precise patient diagnosis and improved management in these genetically- and phenotypically heterogeneous clinical entities">
    <entity charOffset="195-220" id="s3160.e0" ontology_id="GO_0051568" text="histone H3-K4 methylation" type="GO"/>
    <entity charOffset="346-359" id="s3160.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3160.e0" e2="s3160.e1" id="s3160.p0" relation="false"/>
  </sentence>
  <sentence id="s3161" text="Mutations in the elongation of very long chain fatty acid 4 (fatty acid elongation, saturated fatty acid) gene cause Stargardt macular dystrophy 3 (fatty acid elongation, saturated fatty acid), a rare, juvenile-onset, autosomal dominant form of macular degeneration.">
    <entity charOffset="61-104" id="s3161.e0" ontology_id="GO_0019367" text="fatty acid elongation, saturated fatty acid" type="GO"/>
    <entity charOffset="127-144" id="s3161.e1" ontology_id="HP_0007754" text="macular dystrophy" type="HP"/>
    <pair e1="s3161.e0" e2="s3161.e1" id="s3161.p0" relation="true"/>
  </sentence>
  <sentence id="s3162" text="Mutations in the elongation of very long chain fatty acid 4 (fatty acid elongation, saturated fatty acid) gene cause Stargardt macular dystrophy 3 (fatty acid elongation, saturated fatty acid), a rare, juvenile-onset, autosomal dominant form of macular degeneration.">
    <entity charOffset="61-104" id="s3162.e0" ontology_id="GO_0019367" text="fatty acid elongation, saturated fatty acid" type="GO"/>
    <entity charOffset="245-265" id="s3162.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s3162.e0" e2="s3162.e1" id="s3162.p0" relation="true"/>
  </sentence>
  <sentence id="s3163" text="Mutations in the elongation of very long chain fatty acid 4 (fatty acid elongation, saturated fatty acid) gene cause Stargardt macular dystrophy 3 (fatty acid elongation, saturated fatty acid), a rare, juvenile-onset, autosomal dominant form of macular degeneration.">
    <entity charOffset="127-144" id="s3163.e0" ontology_id="HP_0007754" text="macular dystrophy" type="HP"/>
    <entity charOffset="148-191" id="s3163.e1" ontology_id="GO_0019367" text="fatty acid elongation, saturated fatty acid" type="GO"/>
    <pair e1="s3163.e0" e2="s3163.e1" id="s3163.p0" relation="true"/>
  </sentence>
  <sentence id="s3164" text="Mutations in the elongation of very long chain fatty acid 4 (fatty acid elongation, saturated fatty acid) gene cause Stargardt macular dystrophy 3 (fatty acid elongation, saturated fatty acid), a rare, juvenile-onset, autosomal dominant form of macular degeneration.">
    <entity charOffset="148-191" id="s3164.e0" ontology_id="GO_0019367" text="fatty acid elongation, saturated fatty acid" type="GO"/>
    <entity charOffset="245-265" id="s3164.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s3164.e0" e2="s3164.e1" id="s3164.p0" relation="true"/>
  </sentence>
  <sentence id="s3165" text="However, this reduction in positive regulation of cell migration-VLC-PUFA content in the all-cone retina had no negative regulation of transcription by RNA polymerase II on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;fatty acid elongation, saturated fatty acid epidermis development.">
    <entity charOffset="27-64" id="s3165.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="219-239" id="s3165.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s3165.e0" e2="s3165.e1" id="s3165.p0" relation="false"/>
  </sentence>
  <sentence id="s3166" text="However, this reduction in positive regulation of cell migration-VLC-PUFA content in the all-cone retina had no negative regulation of transcription by RNA polymerase II on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;fatty acid elongation, saturated fatty acid epidermis development.">
    <entity charOffset="112-169" id="s3166.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="219-239" id="s3166.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s3166.e0" e2="s3166.e1" id="s3166.p0" relation="false"/>
  </sentence>
  <sentence id="s3167" text="However, this reduction in positive regulation of cell migration-VLC-PUFA content in the all-cone retina had no negative regulation of transcription by RNA polymerase II on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;fatty acid elongation, saturated fatty acid epidermis development.">
    <entity charOffset="219-239" id="s3167.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="303-324" id="s3167.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3167.e0" e2="s3167.e1" id="s3167.p0" relation="false"/>
  </sentence>
  <sentence id="s3168" text="However, this reduction in positive regulation of cell migration-VLC-PUFA content in the all-cone retina had no negative regulation of transcription by RNA polymerase II on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;fatty acid elongation, saturated fatty acid epidermis development.">
    <entity charOffset="219-239" id="s3168.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="259-302" id="s3168.e1" ontology_id="GO_0019367" text="fatty acid elongation, saturated fatty acid" type="GO"/>
    <pair e1="s3168.e0" e2="s3168.e1" id="s3168.p0" relation="true"/>
  </sentence>
  <sentence id="s3169" text="In OSCC samples, a high negative regulation of transcription by RNA polymerase II expression was associated with tumour size but not with prognosis.">
    <entity charOffset="24-81" id="s3169.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="113-119" id="s3169.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3169.e0" e2="s3169.e1" id="s3169.p0" relation="true"/>
  </sentence>
  <sentence id="s3170" text="Both display heterotaxy, cardiopulmonary malformations and cystic kidneys, a syndrome also characteristic of mutations in negative regulation of canonical Wnt signaling pathway and negative regulation of canonical Wnt signaling pathway, the other known components of the IC.">
    <entity charOffset="59-73" id="s3170.e0" ontology_id="HP_0000107" text="cystic kidneys" type="HP"/>
    <entity charOffset="122-176" id="s3170.e1" ontology_id="GO_0090090" text="negative regulation of canonical Wnt signaling pathway" type="GO"/>
    <pair e1="s3170.e0" e2="s3170.e1" id="s3170.p0" relation="true"/>
  </sentence>
  <sentence id="s3171" text="Both display heterotaxy, cardiopulmonary malformations and cystic kidneys, a syndrome also characteristic of mutations in negative regulation of canonical Wnt signaling pathway and negative regulation of canonical Wnt signaling pathway, the other known components of the IC.">
    <entity charOffset="59-73" id="s3171.e0" ontology_id="HP_0000107" text="cystic kidneys" type="HP"/>
    <entity charOffset="181-235" id="s3171.e1" ontology_id="GO_0090090" text="negative regulation of canonical Wnt signaling pathway" type="GO"/>
    <pair e1="s3171.e0" e2="s3171.e1" id="s3171.p0" relation="true"/>
  </sentence>
  <sentence id="s3172" text="Despite the identification of several oncogenic driver mutations leading to constitutive JAK-STAT activation, the cellular and molecular biology of myeloproliferative neoplasms (proteolysis) remains incompletely understood.">
    <entity charOffset="167-176" id="s3172.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="178-189" id="s3172.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s3172.e0" e2="s3172.e1" id="s3172.p0" relation="false"/>
  </sentence>
  <sentence id="s3173" text="Our results reveal a novel genetic regulation of lipid kinase activity-like mouse model and identify a tumor suppressor role for &lt;i&gt;NOL3&lt;/i&gt; in the pathogenesis of myeloid malignancies">
    <entity charOffset="35-70" id="s3173.e0" ontology_id="GO_0043550" text="regulation of lipid kinase activity" type="GO"/>
    <entity charOffset="103-108" id="s3173.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3173.e0" e2="s3173.e1" id="s3173.p0" relation="false"/>
  </sentence>
  <sentence id="s3174" text="cytoskeleton organization is therefore a new gene implicated in the etiology of XLMR associated with macrocephaly and may cause disease by altering intracellular signaling pathways affecting cellular proliferation">
    <entity charOffset="0-25" id="s3174.e0" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <entity charOffset="101-113" id="s3174.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s3174.e0" e2="s3174.e1" id="s3174.p0" relation="true"/>
  </sentence>
  <sentence id="s3175" text="Hereditary angioedema (HAE), due to cytoskeleton organization-inhibitor deficiency, is a rare autosomal dominant and potentially life-threatening disease characterised by recurrent oedema attacks of skin, mucosa and viscera.">
    <entity charOffset="11-21" id="s3175.e0" ontology_id="HP_0100665" text="angioedema" type="HP"/>
    <entity charOffset="36-61" id="s3175.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s3175.e0" e2="s3175.e1" id="s3175.p0" relation="false"/>
  </sentence>
  <sentence id="s3176" text="Due to the rarity and the nucleosome disassembly that symptoms of HAE imitate other forms of angioedema and other conditions, HAE may be misdiagnosed, especially in emergency settings.">
    <entity charOffset="26-48" id="s3176.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="93-103" id="s3176.e1" ontology_id="HP_0100665" text="angioedema" type="HP"/>
    <pair e1="s3176.e0" e2="s3176.e1" id="s3176.p0" relation="false"/>
  </sentence>
  <sentence id="s3177" text="Rarely, patients with severe, salt-wasting CAH have deletions of steroid biosynthetic process that extend into collagen metabolic process, resulting in a &amp;quot;contiguous gene syndrome&amp;quot; consisting of CAH and EDS.">
    <entity charOffset="65-93" id="s3177.e0" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <entity charOffset="160-184" id="s3177.e1" ontology_id="HP_0001466" text="contiguous gene syndrome" type="HP"/>
    <pair e1="s3177.e0" e2="s3177.e1" id="s3177.p0" relation="false"/>
  </sentence>
  <sentence id="s3178" text="Rarely, patients with severe, salt-wasting CAH have deletions of steroid biosynthetic process that extend into collagen metabolic process, resulting in a &amp;quot;contiguous gene syndrome&amp;quot; consisting of CAH and EDS.">
    <entity charOffset="111-137" id="s3178.e0" ontology_id="GO_0032963" text="collagen metabolic process" type="GO"/>
    <entity charOffset="160-184" id="s3178.e1" ontology_id="HP_0001466" text="contiguous gene syndrome" type="HP"/>
    <pair e1="s3178.e0" e2="s3178.e1" id="s3178.p0" relation="false"/>
  </sentence>
  <sentence id="s3179" text="Reliable biomarkers for renal cell carcinoma (response to hydroperoxide) have yet to be determined.">
    <entity charOffset="24-44" id="s3179.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="46-71" id="s3179.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s3179.e0" e2="s3179.e1" id="s3179.p0" relation="false"/>
  </sentence>
  <sentence id="s3180" text="Meningiomas may be classified as neurofibromin 2 (negative regulation of cell proliferation)-associated and non-NF2 meningiomas depending on the presence or absence of molecular alterations in the &lt;i&gt;NF2&lt;/i&gt; gene.">
    <entity charOffset="50-91" id="s3180.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="116-127" id="s3180.e1" ontology_id="HP_0002858" text="meningiomas" type="HP"/>
    <pair e1="s3180.e0" e2="s3180.e1" id="s3180.p0" relation="true"/>
  </sentence>
  <sentence id="s3181" text="In humans, &lt;i&gt;negative regulation of cell proliferation&lt;/i&gt; is the gene responsible for the disease neurofibromatosis muscle organ development II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="14-55" id="s3181.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="189-195" id="s3181.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3181.e0" e2="s3181.e1" id="s3181.p0" relation="true"/>
  </sentence>
  <sentence id="s3182" text="In humans, &lt;i&gt;negative regulation of cell proliferation&lt;/i&gt; is the gene responsible for the disease neurofibromatosis muscle organ development II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="14-55" id="s3182.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="230-240" id="s3182.e1" ontology_id="HP_0002858" text="meningioma" type="HP"/>
    <pair e1="s3182.e0" e2="s3182.e1" id="s3182.p0" relation="true"/>
  </sentence>
  <sentence id="s3183" text="In humans, &lt;i&gt;negative regulation of cell proliferation&lt;/i&gt; is the gene responsible for the disease neurofibromatosis muscle organ development II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="118-142" id="s3183.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="189-195" id="s3183.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3183.e0" e2="s3183.e1" id="s3183.p0" relation="false"/>
  </sentence>
  <sentence id="s3184" text="In humans, &lt;i&gt;negative regulation of cell proliferation&lt;/i&gt; is the gene responsible for the disease neurofibromatosis muscle organ development II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.">
    <entity charOffset="118-142" id="s3184.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="230-240" id="s3184.e1" ontology_id="HP_0002858" text="meningioma" type="HP"/>
    <pair e1="s3184.e0" e2="s3184.e1" id="s3184.p0" relation="false"/>
  </sentence>
  <sentence id="s3185" text="&lt;i&gt;Drosophila&lt;/i&gt; positive regulation of cell-matrix adhesion is involved in biological_process, tumor suppression and Hippo (Hpo) signaling, which is associated with Mer.">
    <entity charOffset="18-61" id="s3185.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="97-102" id="s3185.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3185.e0" e2="s3185.e1" id="s3185.p0" relation="false"/>
  </sentence>
  <sentence id="s3186" text="&lt;i&gt;Drosophila&lt;/i&gt; positive regulation of cell-matrix adhesion is involved in biological_process, tumor suppression and Hippo (Hpo) signaling, which is associated with Mer.">
    <entity charOffset="77-95" id="s3186.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="97-102" id="s3186.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3186.e0" e2="s3186.e1" id="s3186.p0" relation="false"/>
  </sentence>
  <sentence id="s3187" text="We have been investigating the pancreas specific transcription factor, 1a cre-recombinase; blood vessel morphogenesis-stop-lox- Kristen rat sarcoma, glycine to aspartic acid at the 12 codon (Ptf1a&lt;sup&gt;cre/+&lt;/sup&gt;;LSL-Kras&lt;sup&gt;G12D/+&lt;/sup&gt;) mouse strain as a model of human pancreatic cancer.">
    <entity charOffset="91-117" id="s3187.e0" ontology_id="GO_0048514" text="blood vessel morphogenesis" type="GO"/>
    <entity charOffset="284-290" id="s3187.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3187.e0" e2="s3187.e1" id="s3187.p0" relation="false"/>
  </sentence>
  <sentence id="s3188" text="Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the KRT3 or visual perception genes, which encode the cytoskeletal protein keratins K3 and K12, respectively.">
    <entity charOffset="20-37" id="s3188.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="140-157" id="s3188.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s3188.e0" e2="s3188.e1" id="s3188.p0" relation="true"/>
  </sentence>
  <sentence id="s3189" text="Although no overt changes in corneal opacity were detected by slit-regulation of autophagy examination, the corneas of homozygous mutant mice exhibited histological and ultrastructural epithelial cell fragility phenotypes.">
    <entity charOffset="29-44" id="s3189.e0" ontology_id="HP_0007957" text="corneal opacity" type="HP"/>
    <entity charOffset="67-90" id="s3189.e1" ontology_id="GO_0010506" text="regulation of autophagy" type="GO"/>
    <pair e1="s3189.e0" e2="s3189.e1" id="s3189.p0" relation="false"/>
  </sentence>
  <sentence id="s3190" text="Although the most severe phenotype is observed in the homozygous epidermis development, this model will still provide a test-bed for therapies not only for corneal dystrophies but also for other keratinopathies caused by similar mutations.">
    <entity charOffset="65-86" id="s3190.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="156-175" id="s3190.e1" ontology_id="HP_0001131" text="corneal dystrophies" type="HP"/>
    <pair e1="s3190.e0" e2="s3190.e1" id="s3190.p0" relation="false"/>
  </sentence>
  <sentence id="s3191" text="We present a 22-year old male with hypotonia, developmental delay, seizure disorder, and dysmorphic facial features who enrolled in our rare disease research center at 18 years of age, where exome sequencing revealed a novel, likely pathogenic variant in the regulation of postsynaptic neurotransmitter receptor internalization gene.">
    <entity charOffset="46-65" id="s3191.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="259-327" id="s3191.e1" ontology_id="GO_0099149" text="regulation of postsynaptic neurotransmitter receptor internalization" type="GO"/>
    <pair e1="s3191.e0" e2="s3191.e1" id="s3191.p0" relation="true"/>
  </sentence>
  <sentence id="s3192" text="We present a 22-year old male with hypotonia, developmental delay, seizure disorder, and dysmorphic facial features who enrolled in our rare disease research center at 18 years of age, where exome sequencing revealed a novel, likely pathogenic variant in the regulation of postsynaptic neurotransmitter receptor internalization gene.">
    <entity charOffset="67-74" id="s3192.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="259-327" id="s3192.e1" ontology_id="GO_0099149" text="regulation of postsynaptic neurotransmitter receptor internalization" type="GO"/>
    <pair e1="s3192.e0" e2="s3192.e1" id="s3192.p0" relation="true"/>
  </sentence>
  <sentence id="s3193" text="These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with regulation of postsynaptic neurotransmitter receptor internalization variants.">
    <entity charOffset="152-179" id="s3193.e0" ontology_id="HP_0000119" text="genitourinary abnormalities" type="HP"/>
    <entity charOffset="299-367" id="s3193.e1" ontology_id="GO_0099149" text="regulation of postsynaptic neurotransmitter receptor internalization" type="GO"/>
    <pair e1="s3193.e0" e2="s3193.e1" id="s3193.p0" relation="true"/>
  </sentence>
  <sentence id="s3194" text="These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with regulation of postsynaptic neurotransmitter receptor internalization variants.">
    <entity charOffset="186-205" id="s3194.e0" ontology_id="HP_0000046" text="hypoplastic scrotum" type="HP"/>
    <entity charOffset="299-367" id="s3194.e1" ontology_id="GO_0099149" text="regulation of postsynaptic neurotransmitter receptor internalization" type="GO"/>
    <pair e1="s3194.e0" e2="s3194.e1" id="s3194.p0" relation="true"/>
  </sentence>
  <sentence id="s3195" text="These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with regulation of postsynaptic neurotransmitter receptor internalization variants.">
    <entity charOffset="207-219" id="s3195.e0" ontology_id="HP_0030260" text="microphallus" type="HP"/>
    <entity charOffset="299-367" id="s3195.e1" ontology_id="GO_0099149" text="regulation of postsynaptic neurotransmitter receptor internalization" type="GO"/>
    <pair e1="s3195.e0" e2="s3195.e1" id="s3195.p0" relation="true"/>
  </sentence>
  <sentence id="s3196" text="Biallelic mutations in IRE1-mediated unfolded protein response cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.">
    <entity charOffset="23-62" id="s3196.e0" ontology_id="GO_0036498" text="IRE1-mediated unfolded protein response" type="GO"/>
    <entity charOffset="147-161" id="s3196.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s3196.e0" e2="s3196.e1" id="s3196.p0" relation="true"/>
  </sentence>
  <sentence id="s3197" text="Biallelic mutations in IRE1-mediated unfolded protein response cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.">
    <entity charOffset="23-62" id="s3197.e0" ontology_id="GO_0036498" text="IRE1-mediated unfolded protein response" type="GO"/>
    <entity charOffset="163-171" id="s3197.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s3197.e0" e2="s3197.e1" id="s3197.p0" relation="true"/>
  </sentence>
  <sentence id="s3198" text="Biallelic mutations in IRE1-mediated unfolded protein response cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.">
    <entity charOffset="23-62" id="s3198.e0" ontology_id="GO_0036498" text="IRE1-mediated unfolded protein response" type="GO"/>
    <entity charOffset="177-189" id="s3198.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3198.e0" e2="s3198.e1" id="s3198.p0" relation="true"/>
  </sentence>
  <sentence id="s3199" text="We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild hearing loss, decreased muscle cell adhesion mediated by integrin, and a dissection of the celiac artery at age 41.">
    <entity charOffset="107-120" id="s3199.e0" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <entity charOffset="158-192" id="s3199.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s3199.e0" e2="s3199.e1" id="s3199.p0" relation="true"/>
  </sentence>
  <sentence id="s3200" text="We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild hearing loss, decreased muscle cell adhesion mediated by integrin, and a dissection of the celiac artery at age 41.">
    <entity charOffset="127-139" id="s3200.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="158-192" id="s3200.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s3200.e0" e2="s3200.e1" id="s3200.p0" relation="true"/>
  </sentence>
  <sentence id="s3201" text="cell cycle arrest is a p53 target gene with DNA binding function and represents a highly plausible candidate breast cancer predisposition gene.">
    <entity charOffset="0-17" id="s3201.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="116-122" id="s3201.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3201.e0" e2="s3201.e1" id="s3201.p0" relation="true"/>
  </sentence>
  <sentence id="s3202" text="A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for double-strand break repair via homologous recombination and mitotic cytokinesis mutations and in 1/84 sporadic breast cancer cases.">
    <entity charOffset="188-243" id="s3202.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="306-312" id="s3202.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3202.e0" e2="s3202.e1" id="s3202.p0" relation="true"/>
  </sentence>
  <sentence id="s3203" text="A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for double-strand break repair via homologous recombination and mitotic cytokinesis mutations and in 1/84 sporadic breast cancer cases.">
    <entity charOffset="188-243" id="s3203.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="290-298" id="s3203.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3203.e0" e2="s3203.e1" id="s3203.p0" relation="false"/>
  </sentence>
  <sentence id="s3204" text="A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for double-strand break repair via homologous recombination and mitotic cytokinesis mutations and in 1/84 sporadic breast cancer cases.">
    <entity charOffset="248-267" id="s3204.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="306-312" id="s3204.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3204.e0" e2="s3204.e1" id="s3204.p0" relation="true"/>
  </sentence>
  <sentence id="s3205" text="A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for double-strand break repair via homologous recombination and mitotic cytokinesis mutations and in 1/84 sporadic breast cancer cases.">
    <entity charOffset="248-267" id="s3205.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="290-298" id="s3205.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3205.e0" e2="s3205.e1" id="s3205.p0" relation="false"/>
  </sentence>
  <sentence id="s3206" text="However, the variant was also detected in 2/182 families with known double-strand break repair via homologous recombination or mitotic cytokinesis mutations and in 2/464 non-cancer controls.">
    <entity charOffset="68-123" id="s3206.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="174-180" id="s3206.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3206.e0" e2="s3206.e1" id="s3206.p0" relation="true"/>
  </sentence>
  <sentence id="s3207" text="However, the variant was also detected in 2/182 families with known double-strand break repair via homologous recombination or mitotic cytokinesis mutations and in 2/464 non-cancer controls.">
    <entity charOffset="127-146" id="s3207.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="174-180" id="s3207.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3207.e0" e2="s3207.e1" id="s3207.p0" relation="true"/>
  </sentence>
  <sentence id="s3208" text="Our data suggest that pathogenic mutations in cell cycle arrest are rare in breast cancer families and the c.339_340delAG variant does not represent a high-penetrance breast cancer risk allele">
    <entity charOffset="46-63" id="s3208.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="83-89" id="s3208.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3208.e0" e2="s3208.e1" id="s3208.p0" relation="true"/>
  </sentence>
  <sentence id="s3209" text="To address this negative regulation of cell-matrix adhesion, we performed a longitudinal exome-wide association study to identify susceptibility loci for obesity and MetS in a Japanese population.">
    <entity charOffset="16-59" id="s3209.e0" ontology_id="GO_0001953" text="negative regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="154-161" id="s3209.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3209.e0" e2="s3209.e1" id="s3209.p0" relation="false"/>
  </sentence>
  <sentence id="s3210" text="The association of single nucleotide polymorphisms (SNPs) with body cell adhesion mediated by integrin index (BMI) or the prevalence of obesity and MetS was examined in a generalized estimating equation model.">
    <entity charOffset="68-102" id="s3210.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="136-143" id="s3210.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3210.e0" e2="s3210.e1" id="s3210.p0" relation="false"/>
  </sentence>
  <sentence id="s3211" text="Consistent with a role in transition zone function, mutation of mouse smoothened signaling pathway disrupts the localization of proteins including smoothened signaling pathway and protein processing involved in protein targeting to mitochondrion to cilia, resulting in phenotypes characteristic of cilium assembly such as polydactyly and kidney cysts.">
    <entity charOffset="70-98" id="s3211.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="322-333" id="s3211.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s3211.e0" e2="s3211.e1" id="s3211.p0" relation="true"/>
  </sentence>
  <sentence id="s3212" text="Consistent with a role in transition zone function, mutation of mouse smoothened signaling pathway disrupts the localization of proteins including smoothened signaling pathway and protein processing involved in protein targeting to mitochondrion to cilia, resulting in phenotypes characteristic of cilium assembly such as polydactyly and kidney cysts.">
    <entity charOffset="147-175" id="s3212.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="322-333" id="s3212.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s3212.e0" e2="s3212.e1" id="s3212.p0" relation="true"/>
  </sentence>
  <sentence id="s3213" text="Consistent with a role in transition zone function, mutation of mouse smoothened signaling pathway disrupts the localization of proteins including smoothened signaling pathway and protein processing involved in protein targeting to mitochondrion to cilia, resulting in phenotypes characteristic of cilium assembly such as polydactyly and kidney cysts.">
    <entity charOffset="180-245" id="s3213.e0" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <entity charOffset="322-333" id="s3213.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s3213.e0" e2="s3213.e1" id="s3213.p0" relation="false"/>
  </sentence>
  <sentence id="s3214" text="Consistent with a role in transition zone function, mutation of mouse smoothened signaling pathway disrupts the localization of proteins including smoothened signaling pathway and protein processing involved in protein targeting to mitochondrion to cilia, resulting in phenotypes characteristic of cilium assembly such as polydactyly and kidney cysts.">
    <entity charOffset="298-313" id="s3214.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="322-333" id="s3214.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s3214.e0" e2="s3214.e1" id="s3214.p0" relation="true"/>
  </sentence>
  <sentence id="s3215" text="Testing for high-risk (hr) muscle organ developments of human papillomavirus (HPV) is highly sensitive as a screening test of high-grade cervical intraepithelial neoplastic (CIN2/3) disease, the precursor of cervical cancer.">
    <entity charOffset="27-51" id="s3215.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="217-223" id="s3215.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3215.e0" e2="s3215.e1" id="s3215.p0" relation="false"/>
  </sentence>
  <sentence id="s3216" text="regulation of cell proliferation, a new member of the cell division cycle associated family of genes, is involved in embryonic development and dysregulated in various types of human cancer.">
    <entity charOffset="0-32" id="s3216.e0" ontology_id="GO_0042127" text="regulation of cell proliferation" type="GO"/>
    <entity charOffset="182-188" id="s3216.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3216.e0" e2="s3216.e1" id="s3216.p0" relation="false"/>
  </sentence>
  <sentence id="s3217" text="Furthermore, regulation of cell proliferation increased the expression of negative regulation of transcription by RNA polymerase II, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.">
    <entity charOffset="13-45" id="s3217.e0" ontology_id="GO_0042127" text="regulation of cell proliferation" type="GO"/>
    <entity charOffset="163-169" id="s3217.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3217.e0" e2="s3217.e1" id="s3217.p0" relation="false"/>
  </sentence>
  <sentence id="s3218" text="Furthermore, regulation of cell proliferation increased the expression of negative regulation of transcription by RNA polymerase II, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.">
    <entity charOffset="13-45" id="s3218.e0" ontology_id="GO_0042127" text="regulation of cell proliferation" type="GO"/>
    <entity charOffset="190-195" id="s3218.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3218.e0" e2="s3218.e1" id="s3218.p0" relation="false"/>
  </sentence>
  <sentence id="s3219" text="Furthermore, regulation of cell proliferation increased the expression of negative regulation of transcription by RNA polymerase II, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.">
    <entity charOffset="74-131" id="s3219.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="163-169" id="s3219.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3219.e0" e2="s3219.e1" id="s3219.p0" relation="false"/>
  </sentence>
  <sentence id="s3220" text="double-strand break repair is one of the essential proteins of this pathway and single-nucleotide polymorphisms (SNPs) of this gene are reported to be associated with cancer risks.">
    <entity charOffset="0-26" id="s3220.e0" ontology_id="GO_0006302" text="double-strand break repair" type="GO"/>
    <entity charOffset="167-173" id="s3220.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3220.e0" e2="s3220.e1" id="s3220.p0" relation="true"/>
  </sentence>
  <sentence id="s3221" text="the Partner and localizer of BRCA2 (double-strand break repair via homologous recombination) gene and risk of breast cancer.">
    <entity charOffset="36-91" id="s3221.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="117-123" id="s3221.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3221.e0" e2="s3221.e1" id="s3221.p0" relation="true"/>
  </sentence>
  <sentence id="s3222" text="the association between SNPs in the double-strand break repair via homologous recombination gene and the susceptibility to breast cancer.">
    <entity charOffset="36-91" id="s3222.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="130-136" id="s3222.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3222.e0" e2="s3222.e1" id="s3222.p0" relation="true"/>
  </sentence>
  <sentence id="s3223" text="Since wonegative regulation of phosphatase activity with breast cancer and men and women with other disorders are often treated with androgen catabolic process inhibitors (AI), these populations might be especially vulnerable to cognitive deficits due to low neuroE2 synthesis, i.e., synthesis of E2 directly within the brain.">
    <entity charOffset="8-51" id="s3223.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="64-70" id="s3223.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3223.e0" e2="s3223.e1" id="s3223.p0" relation="false"/>
  </sentence>
  <sentence id="s3224" text="Since wonegative regulation of phosphatase activity with breast cancer and men and women with other disorders are often treated with androgen catabolic process inhibitors (AI), these populations might be especially vulnerable to cognitive deficits due to low neuroE2 synthesis, i.e., synthesis of E2 directly within the brain.">
    <entity charOffset="64-70" id="s3224.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="133-159" id="s3224.e1" ontology_id="GO_0006710" text="androgen catabolic process" type="GO"/>
    <pair e1="s3224.e0" e2="s3224.e1" id="s3224.p0" relation="false"/>
  </sentence>
  <sentence id="s3225" text="This study investigated the role of potassium channel gene &lt;i&gt;(potassium ion transmembrane transport)&lt;/i&gt; polymorphisms in high myopia.">
    <entity charOffset="63-100" id="s3225.e0" ontology_id="GO_0071805" text="potassium ion transmembrane transport" type="GO"/>
    <entity charOffset="128-134" id="s3225.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s3225.e0" e2="s3225.e1" id="s3225.p0" relation="false"/>
  </sentence>
  <sentence id="s3226" text="Five tag single-nucleotide polymorphisms (SNPs) of &lt;i&gt;potassium ion transmembrane transport&lt;/i&gt; were genotyped, and association testing with high myopia was conducted using logistic regression analysis adjusted for multicellular organism development and age to give &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;asym&lt;/sub&gt; values, and multiple comparisons were corrected by permutation test to give &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;emp&lt;/sub&gt; values.">
    <entity charOffset="54-91" id="s3226.e0" ontology_id="GO_0071805" text="potassium ion transmembrane transport" type="GO"/>
    <entity charOffset="146-152" id="s3226.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s3226.e0" e2="s3226.e1" id="s3226.p0" relation="false"/>
  </sentence>
  <sentence id="s3227" text="Five tag single-nucleotide polymorphisms (SNPs) of &lt;i&gt;potassium ion transmembrane transport&lt;/i&gt; were genotyped, and association testing with high myopia was conducted using logistic regression analysis adjusted for multicellular organism development and age to give &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;asym&lt;/sub&gt; values, and multiple comparisons were corrected by permutation test to give &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;emp&lt;/sub&gt; values.">
    <entity charOffset="146-152" id="s3227.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="215-249" id="s3227.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s3227.e0" e2="s3227.e1" id="s3227.p0" relation="false"/>
  </sentence>
  <sentence id="s3228" text="The SNP rs7744813, previously shown to be associated with refractive error and myopia in two GWAS, showed an odds ratio of 0.75 (95% CI 0.63-0.90; &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;emp&lt;/sub&gt; = 0.0058) for the positive regulation of glucose transmembrane transport allele.">
    <entity charOffset="79-85" id="s3228.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="188-242" id="s3228.e1" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <pair e1="s3228.e0" e2="s3228.e1" id="s3228.p0" relation="false"/>
  </sentence>
  <sentence id="s3229" text="Our data support the involvement of &lt;i&gt;potassium ion transmembrane transport&lt;/i&gt; gene polymorphisms in the genetic susceptibility to high myopia and further exploration of &lt;i&gt;KCNQ5&lt;/i&gt; as a risk factor for high myopia">
    <entity charOffset="39-76" id="s3229.e0" ontology_id="GO_0071805" text="potassium ion transmembrane transport" type="GO"/>
    <entity charOffset="138-144" id="s3229.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s3229.e0" e2="s3229.e1" id="s3229.p0" relation="false"/>
  </sentence>
  <sentence id="s3230" text="Clinical features of affected individuals with LGD variants in N-terminal protein amino acid acetylation include variable levels of intellectual disability, delayed speech and motor milestones, and autism spectrum disorder.">
    <entity charOffset="63-104" id="s3230.e0" ontology_id="GO_0006474" text="N-terminal protein amino acid acetylation" type="GO"/>
    <entity charOffset="198-204" id="s3230.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3230.e0" e2="s3230.e1" id="s3230.p0" relation="false"/>
  </sentence>
  <sentence id="s3231" text="Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving N-terminal protein amino acid acetylation and surrounding genes can present with mild intellectual disability, mild dysmorphic features, motor delays, and decreased growth.">
    <entity charOffset="117-158" id="s3231.e0" ontology_id="GO_0006474" text="N-terminal protein amino acid acetylation" type="GO"/>
    <entity charOffset="203-226" id="s3231.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3231.e0" e2="s3231.e1" id="s3231.p0" relation="true"/>
  </sentence>
  <sentence id="s3232" text="Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving N-terminal protein amino acid acetylation and surrounding genes can present with mild intellectual disability, mild dysmorphic features, motor delays, and decreased growth.">
    <entity charOffset="117-158" id="s3232.e0" ontology_id="GO_0006474" text="N-terminal protein amino acid acetylation" type="GO"/>
    <entity charOffset="254-266" id="s3232.e1" ontology_id="HP_0001270" text="motor delays" type="HP"/>
    <pair e1="s3232.e0" e2="s3232.e1" id="s3232.p0" relation="false"/>
  </sentence>
  <sentence id="s3233" text="Twenty-one genes showed single or cross-cancer associations, including novel associations of succinate metabolic process in melanoma and double-strand break repair via homologous recombination in stomach adenocarcinoma.">
    <entity charOffset="40-46" id="s3233.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="93-120" id="s3233.e1" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <pair e1="s3233.e0" e2="s3233.e1" id="s3233.p0" relation="true"/>
  </sentence>
  <sentence id="s3234" text="Twenty-one genes showed single or cross-cancer associations, including novel associations of succinate metabolic process in melanoma and double-strand break repair via homologous recombination in stomach adenocarcinoma.">
    <entity charOffset="40-46" id="s3234.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-192" id="s3234.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s3234.e0" e2="s3234.e1" id="s3234.p0" relation="true"/>
  </sentence>
  <sentence id="s3235" text="Twenty-one genes showed single or cross-cancer associations, including novel associations of succinate metabolic process in melanoma and double-strand break repair via homologous recombination in stomach adenocarcinoma.">
    <entity charOffset="124-132" id="s3235.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="137-192" id="s3235.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s3235.e0" e2="s3235.e1" id="s3235.p0" relation="true"/>
  </sentence>
  <sentence id="s3236" text="The 659 predisposition variants and 18 additional large deletions in tumor suppressors, including protein phosphorylation, double-strand break repair via homologous recombination, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events.">
    <entity charOffset="69-74" id="s3236.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="98-121" id="s3236.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s3236.e0" e2="s3236.e1" id="s3236.p0" relation="true"/>
  </sentence>
  <sentence id="s3237" text="The 659 predisposition variants and 18 additional large deletions in tumor suppressors, including protein phosphorylation, double-strand break repair via homologous recombination, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events.">
    <entity charOffset="69-74" id="s3237.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="123-178" id="s3237.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s3237.e0" e2="s3237.e1" id="s3237.p0" relation="true"/>
  </sentence>
  <sentence id="s3238" text="Williams-Beuren syndrome (outflow tract morphogenesis, no.OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome7q11.23 and characterized by cardiovascular malformations, mental retardation, and a specific facial dysmorphism.">
    <entity charOffset="26-53" id="s3238.e0" ontology_id="GO_0003151" text="outflow tract morphogenesis" type="GO"/>
    <entity charOffset="180-208" id="s3238.e1" ontology_id="HP_0030680" text="cardiovascular malformations" type="HP"/>
    <pair e1="s3238.e0" e2="s3238.e1" id="s3238.p0" relation="true"/>
  </sentence>
  <sentence id="s3239" text="Williams-Beuren syndrome (outflow tract morphogenesis, no.OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome7q11.23 and characterized by cardiovascular malformations, mental retardation, and a specific facial dysmorphism.">
    <entity charOffset="26-53" id="s3239.e0" ontology_id="GO_0003151" text="outflow tract morphogenesis" type="GO"/>
    <entity charOffset="245-263" id="s3239.e1" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <pair e1="s3239.e0" e2="s3239.e1" id="s3239.p0" relation="true"/>
  </sentence>
  <sentence id="s3240" text="While the patient showed features overlapping with the reported phenotype, such as a short stature and small hands and feet, he also presented with additional features like cleft nuclear-transcribed mRNA catabolic process, nonsense-mediated decay and palate and an aberrant right subclavian artery.">
    <entity charOffset="85-98" id="s3240.e0" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <entity charOffset="179-246" id="s3240.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s3240.e0" e2="s3240.e1" id="s3240.p0" relation="false"/>
  </sentence>
  <sentence id="s3241" text="The aim of this study was to look for genetic causes of Currarino Syndrome in sporadic patients after ruling out other causes, like chromosome aberrations, disease-causing variants in possible regulation of transcription by RNA polymerase II cooperating transcription factors and aberrant methylation in the promoter of the MNX1 gene.">
    <entity charOffset="78-86" id="s3241.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="193-241" id="s3241.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3241.e0" e2="s3241.e1" id="s3241.p0" relation="false"/>
  </sentence>
  <sentence id="s3242" text="Genetic analysis of a large Indian family with an autosomal dominant cataract phenotype allowed us to identify a novel cataract gene, visual perception.">
    <entity charOffset="69-77" id="s3242.e0" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <entity charOffset="134-151" id="s3242.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s3242.e0" e2="s3242.e1" id="s3242.p0" relation="true"/>
  </sentence>
  <sentence id="s3243" text="Considering that CRYBA4 associates with visual perception and that the latter protein has been implicated in microphthalmia, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).">
    <entity charOffset="40-57" id="s3243.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="109-123" id="s3243.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s3243.e0" e2="s3243.e1" id="s3243.p0" relation="false"/>
  </sentence>
  <sentence id="s3244" text="This is the first report linking mutations in visual perception to cataractogenesis and microphthalmia">
    <entity charOffset="46-63" id="s3244.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="67-75" id="s3244.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s3244.e0" e2="s3244.e1" id="s3244.p0" relation="true"/>
  </sentence>
  <sentence id="s3245" text="protein polyubiquitination-122, the expression of which is regulated by several transcription factors, such as natural killer cell differentiation, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.">
    <entity charOffset="0-26" id="s3245.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="219-243" id="s3245.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3245.e0" e2="s3245.e1" id="s3245.p0" relation="false"/>
  </sentence>
  <sentence id="s3246" text="protein polyubiquitination-122, the expression of which is regulated by several transcription factors, such as natural killer cell differentiation, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.">
    <entity charOffset="111-146" id="s3246.e0" ontology_id="GO_0001779" text="natural killer cell differentiation" type="GO"/>
    <entity charOffset="219-243" id="s3246.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3246.e0" e2="s3246.e1" id="s3246.p0" relation="false"/>
  </sentence>
  <sentence id="s3247" text="Lower serum protein polyubiquitination-122 is a unique feature of natural killer cell differentiation-protein phosphorylation patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients">
    <entity charOffset="12-38" id="s3247.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="192-200" id="s3247.e1" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="s3247.e0" e2="s3247.e1" id="s3247.p0" relation="false"/>
  </sentence>
  <sentence id="s3248" text="Lower serum protein polyubiquitination-122 is a unique feature of natural killer cell differentiation-protein phosphorylation patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients">
    <entity charOffset="66-101" id="s3248.e0" ontology_id="GO_0001779" text="natural killer cell differentiation" type="GO"/>
    <entity charOffset="192-200" id="s3248.e1" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="s3248.e0" e2="s3248.e1" id="s3248.p0" relation="true"/>
  </sentence>
  <sentence id="s3249" text="Lower serum protein polyubiquitination-122 is a unique feature of natural killer cell differentiation-protein phosphorylation patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients">
    <entity charOffset="102-125" id="s3249.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="192-200" id="s3249.e1" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="s3249.e0" e2="s3249.e1" id="s3249.p0" relation="false"/>
  </sentence>
  <sentence id="s3250" text="In the present article, we review current evidence supporting the role of fatty acid metabolic process in thymic egress, inflammation, and cancer.">
    <entity charOffset="74-102" id="s3250.e0" ontology_id="GO_0006631" text="fatty acid metabolic process" type="GO"/>
    <entity charOffset="139-145" id="s3250.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3250.e0" e2="s3250.e1" id="s3250.p0" relation="false"/>
  </sentence>
  <sentence id="s3251" text="These 294 differentially expressed genes and non-coding RNA transcripts provide here a negative regulation of transcription, DNA-templated to specifically define skull base chordomas and to identify novel and potentially important targets for diagnosis, prognosis, and therapy of this cancer.">
    <entity charOffset="87-138" id="s3251.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="173-182" id="s3251.e1" ontology_id="HP_0010762" text="chordomas" type="HP"/>
    <pair e1="s3251.e0" e2="s3251.e1" id="s3251.p0" relation="false"/>
  </sentence>
  <sentence id="s3252" text="Therefore, quantification of glioma extracellular L-phenylalanine catabolic process (pHe) is of crucial importance.">
    <entity charOffset="29-35" id="s3252.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="50-83" id="s3252.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s3252.e0" e2="s3252.e1" id="s3252.p0" relation="false"/>
  </sentence>
  <sentence id="s3253" text="This study is focused on the application of the YbHPDO3A (ytterbium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane) probe for in vivo glioma L-phenylalanine catabolic processe quantification using chemical exchange saturation transfer (CEST)-MRI and its correlation with tumor metabolism assessed by immunohistochemistry.">
    <entity charOffset="142-148" id="s3253.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="149-182" id="s3253.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s3253.e0" e2="s3253.e1" id="s3253.p0" relation="false"/>
  </sentence>
  <sentence id="s3254" text="In vivo MRI sequences consisted of T&lt;sub&gt;2w&lt;/sub&gt; for tumor localization, T&lt;sub&gt;2w&lt;/sub&gt; * to assess YbHPDO3A biodistribution by exploiting its magnetic susceptibility effect and CEST for glioma L-phenylalanine catabolic processe mapping.">
    <entity charOffset="54-59" id="s3254.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="195-228" id="s3254.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s3254.e0" e2="s3254.e1" id="s3254.p0" relation="false"/>
  </sentence>
  <sentence id="s3255" text="These immunohistochemical results are consistent with our L-phenylalanine catabolic processe mapping (Pearson correlation coefficient&amp;gt;0.70) and provide evidence for the feasibility of the CEST-MRI method with the YbHPDO3A probe for glioma pHe quantification at 4.7T.">
    <entity charOffset="58-91" id="s3255.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="237-243" id="s3255.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3255.e0" e2="s3255.e1" id="s3255.p0" relation="false"/>
  </sentence>
  <sentence id="s3256" text="Blocking the expression of regulation of transcription by RNA polymerase II, female gamete generation, and RDX significantly inhibits breast cancer cell migration induced by let-7b repression.">
    <entity charOffset="27-75" id="s3256.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="141-147" id="s3256.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3256.e0" e2="s3256.e1" id="s3256.p0" relation="false"/>
  </sentence>
  <sentence id="s3257" text="Blocking the expression of regulation of transcription by RNA polymerase II, female gamete generation, and RDX significantly inhibits breast cancer cell migration induced by let-7b repression.">
    <entity charOffset="77-101" id="s3257.e0" ontology_id="GO_0007292" text="female gamete generation" type="GO"/>
    <entity charOffset="141-147" id="s3257.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3257.e0" e2="s3257.e1" id="s3257.p0" relation="false"/>
  </sentence>
  <sentence id="s3258" text="In an unrelated sporadic case of CGHT, we identified a 1.3 Mb nodal signaling pathway deletion of chr17q24.2-q24.3 encompassing negative regulation of macrophage derived foam cell differentiation and found that ABCA5 levels are dramatically reduced throughout patient hair follicles.">
    <entity charOffset="16-24" id="s3258.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="128-195" id="s3258.e1" ontology_id="GO_0010745" text="negative regulation of macrophage derived foam cell differentiation" type="GO"/>
    <pair e1="s3258.e0" e2="s3258.e1" id="s3258.p0" relation="false"/>
  </sentence>
  <sentence id="s3259" text="In an unrelated sporadic case of CGHT, we identified a 1.3 Mb nodal signaling pathway deletion of chr17q24.2-q24.3 encompassing negative regulation of macrophage derived foam cell differentiation and found that ABCA5 levels are dramatically reduced throughout patient hair follicles.">
    <entity charOffset="16-24" id="s3259.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="62-85" id="s3259.e1" ontology_id="GO_0038092" text="nodal signaling pathway" type="GO"/>
    <pair e1="s3259.e0" e2="s3259.e1" id="s3259.p0" relation="false"/>
  </sentence>
  <sentence id="s3260" text="A previous study recently described two consanguineous families in which homozygous mutations of double-strand break repair via homologous recombination were responsible for POI and short stature.">
    <entity charOffset="97-152" id="s3260.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="182-195" id="s3260.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3260.e0" e2="s3260.e1" id="s3260.p0" relation="true"/>
  </sentence>
  <sentence id="s3261" text="Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of glycogen catabolic process trinucleotide repeats in the first intron of the regulation of ferrochelatase activity gene, which encodes for the mitochondrial frataxin protein.">
    <entity charOffset="11-17" id="s3261.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="125-151" id="s3261.e1" ontology_id="GO_0005980" text="glycogen catabolic process" type="GO"/>
    <pair e1="s3261.e0" e2="s3261.e1" id="s3261.p0" relation="false"/>
  </sentence>
  <sentence id="s3262" text="Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of glycogen catabolic process trinucleotide repeats in the first intron of the regulation of ferrochelatase activity gene, which encodes for the mitochondrial frataxin protein.">
    <entity charOffset="11-17" id="s3262.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="201-238" id="s3262.e1" ontology_id="GO_0010722" text="regulation of ferrochelatase activity" type="GO"/>
    <pair e1="s3262.e0" e2="s3262.e1" id="s3262.p0" relation="true"/>
  </sentence>
  <sentence id="s3263" text="The aim of the study was to understand the role of axon guidance-homophilic cell adhesion via plasma membrane adhesion molecules/2-CDC42 signalling pathways in development of breast cancer (BC).">
    <entity charOffset="51-64" id="s3263.e0" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <entity charOffset="182-188" id="s3263.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3263.e0" e2="s3263.e1" id="s3263.p0" relation="false"/>
  </sentence>
  <sentence id="s3264" text="The aim of the study was to understand the role of axon guidance-homophilic cell adhesion via plasma membrane adhesion molecules/2-CDC42 signalling pathways in development of breast cancer (BC).">
    <entity charOffset="65-128" id="s3264.e0" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <entity charOffset="182-188" id="s3264.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3264.e0" e2="s3264.e1" id="s3264.p0" relation="false"/>
  </sentence>
  <sentence id="s3265" text="Significantly, higher alteration of axon guidance locus was observed in triple negative breast cancer (TNBC) over signal transduction subtype (P = 0.0014).">
    <entity charOffset="36-49" id="s3265.e0" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <entity charOffset="95-101" id="s3265.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3265.e0" e2="s3265.e1" id="s3265.p0" relation="false"/>
  </sentence>
  <sentence id="s3266" text="Significantly, higher alteration of axon guidance locus was observed in triple negative breast cancer (TNBC) over signal transduction subtype (P = 0.0014).">
    <entity charOffset="95-101" id="s3266.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-133" id="s3266.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s3266.e0" e2="s3266.e1" id="s3266.p0" relation="true"/>
  </sentence>
  <sentence id="s3267" text="Results indicate the importance of axon guidance-homophilic cell adhesion via plasma membrane adhesion molecules-actin cytoskeleton organization signalling pathway in predicting tumour progression.">
    <entity charOffset="35-48" id="s3267.e0" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <entity charOffset="178-184" id="s3267.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3267.e0" e2="s3267.e1" id="s3267.p0" relation="false"/>
  </sentence>
  <sentence id="s3268" text="Results indicate the importance of axon guidance-homophilic cell adhesion via plasma membrane adhesion molecules-actin cytoskeleton organization signalling pathway in predicting tumour progression.">
    <entity charOffset="49-112" id="s3268.e0" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <entity charOffset="178-184" id="s3268.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3268.e0" e2="s3268.e1" id="s3268.p0" relation="false"/>
  </sentence>
  <sentence id="s3269" text="Results indicate the importance of axon guidance-homophilic cell adhesion via plasma membrane adhesion molecules-actin cytoskeleton organization signalling pathway in predicting tumour progression.">
    <entity charOffset="113-144" id="s3269.e0" ontology_id="GO_0030036" text="actin cytoskeleton organization" type="GO"/>
    <entity charOffset="178-184" id="s3269.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3269.e0" e2="s3269.e1" id="s3269.p0" relation="false"/>
  </sentence>
  <sentence id="s3270" text="The lack of good molecular markers for diagnosis as well as treatment assessment has rendered the hepatocellular carcinoma (phosphatidylinositol phosphorylation) a major challenge in health care.">
    <entity charOffset="98-122" id="s3270.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="124-160" id="s3270.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s3270.e0" e2="s3270.e1" id="s3270.p0" relation="false"/>
  </sentence>
  <sentence id="s3271" text="An analysis approach combing supervised significant analysis of microarray (SAM), prediction analysis of microarray (protein ubiquitination), and unsupervised hierarchical cluster methodologies statistically determined 211 upregulated and 78 downregulated genes between liver cancer and non-cancer liver tissues, and demonstrated &amp;gt; or = 93% accuracy in classifying the tissue samples.">
    <entity charOffset="117-139" id="s3271.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="276-282" id="s3271.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3271.e0" e2="s3271.e1" id="s3271.p0" relation="false"/>
  </sentence>
  <sentence id="s3272" text="Numerous genes found in this study were also differentially expressed in human phosphatidylinositol phosphorylation and many other human cancers including breast, prostate and lung cancers, etc., serving as tumor suppressors, promoters, prognostic markers or chemotherapy targets.">
    <entity charOffset="79-115" id="s3272.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="137-143" id="s3272.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3272.e0" e2="s3272.e1" id="s3272.p0" relation="false"/>
  </sentence>
  <sentence id="s3273" text="Additionally, multivariate logistic regression analysis identified that the mutant genotype of rs4148323 in the UGT1A1 gene, carbohydrate metabolic process incompatibility, G6PD deficiency, and SS genotype at rs1805173 locus of the HO-1 gene were genetic risk factors of neonatal hyperbilirubinemia.">
    <entity charOffset="125-155" id="s3273.e0" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <entity charOffset="280-298" id="s3273.e1" ontology_id="HP_0002904" text="hyperbilirubinemia" type="HP"/>
    <pair e1="s3273.e0" e2="s3273.e1" id="s3273.p0" relation="false"/>
  </sentence>
  <sentence id="s3274" text="mitochondrial calcium ion transmembrane transport protein was detected in 107 TNBC, 42 ductal carcinoma in situ (DCIS) and 65 adjacent non-tumor breast tissues using immunohistochemical (IHC) staining.">
    <entity charOffset="0-49" id="s3274.e0" ontology_id="GO_0006851" text="mitochondrial calcium ion transmembrane transport" type="GO"/>
    <entity charOffset="139-144" id="s3274.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3274.e0" e2="s3274.e1" id="s3274.p0" relation="true"/>
  </sentence>
  <sentence id="s3275" text="In humans and epidermis development hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="14-35" id="s3275.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="158-169" id="s3275.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s3275.e0" e2="s3275.e1" id="s3275.p0" relation="false"/>
  </sentence>
  <sentence id="s3276" text="In humans and epidermis development hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="14-35" id="s3276.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="368-380" id="s3276.e1" ontology_id="HP_0000135" text="hypogonadism" type="HP"/>
    <pair e1="s3276.e0" e2="s3276.e1" id="s3276.p0" relation="false"/>
  </sentence>
  <sentence id="s3277" text="In humans and epidermis development hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="36-61" id="s3277.e0" ontology_id="GO_0001942" text="hair follicle development" type="GO"/>
    <entity charOffset="158-169" id="s3277.e1" ontology_id="HP_0010442" text="polydactyly" type="HP"/>
    <pair e1="s3277.e0" e2="s3277.e1" id="s3277.p0" relation="false"/>
  </sentence>
  <sentence id="s3278" text="In humans and epidermis development hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="36-61" id="s3278.e0" ontology_id="GO_0001942" text="hair follicle development" type="GO"/>
    <entity charOffset="266-274" id="s3278.e1" ontology_id="HP_0001596" text="alopecia" type="HP"/>
    <pair e1="s3278.e0" e2="s3278.e1" id="s3278.p0" relation="true"/>
  </sentence>
  <sentence id="s3279" text="In humans and epidermis development hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="36-61" id="s3279.e0" ontology_id="GO_0001942" text="hair follicle development" type="GO"/>
    <entity charOffset="284-300" id="s3279.e1" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <pair e1="s3279.e0" e2="s3279.e1" id="s3279.p0" relation="true"/>
  </sentence>
  <sentence id="s3280" text="In humans and epidermis development hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.">
    <entity charOffset="36-61" id="s3280.e0" ontology_id="GO_0001942" text="hair follicle development" type="GO"/>
    <entity charOffset="302-315" id="s3280.e1" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <pair e1="s3280.e0" e2="s3280.e1" id="s3280.p0" relation="true"/>
  </sentence>
  <sentence id="s3281" text="By using exome and capillary sequencing, we here identify biallelic biological_process mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.">
    <entity charOffset="68-86" id="s3281.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="299-323" id="s3281.e1" ontology_id="HP_0000252" text="small head circumference" type="HP"/>
    <pair e1="s3281.e0" e2="s3281.e1" id="s3281.p0" relation="true"/>
  </sentence>
  <sentence id="s3282" text="By using exome and capillary sequencing, we here identify biallelic biological_process mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.">
    <entity charOffset="68-86" id="s3282.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="325-344" id="s3282.e1" ontology_id="HP_0001999" text="facial dysmorphisms" type="HP"/>
    <pair e1="s3282.e0" e2="s3282.e1" id="s3282.p0" relation="true"/>
  </sentence>
  <sentence id="s3283" text="Brain MRI showed diffuse leukoencephalopathy, suggesting transcription initiation from RNA polymerase II promoter.">
    <entity charOffset="25-44" id="s3283.e0" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <entity charOffset="57-113" id="s3283.e1" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <pair e1="s3283.e0" e2="s3283.e1" id="s3283.p0" relation="true"/>
  </sentence>
  <sentence id="s3284" text="5'-Aza-2'-deoxycytidine (5-Aza-neuron migration) is a demethylating drug that causes genome-wide hypomethylation resulting in the expression of several tumor suppressor genes causing growth arrest of cancer cells.">
    <entity charOffset="31-47" id="s3284.e0" ontology_id="GO_0001764" text="neuron migration" type="GO"/>
    <entity charOffset="152-157" id="s3284.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3284.e0" e2="s3284.e1" id="s3284.p0" relation="false"/>
  </sentence>
  <sentence id="s3285" text="Induction of p53 by 5-Aza-neuron migration was tested in vitro using cancer cells.">
    <entity charOffset="26-42" id="s3285.e0" ontology_id="GO_0001764" text="neuron migration" type="GO"/>
    <entity charOffset="69-75" id="s3285.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3285.e0" e2="s3285.e1" id="s3285.p0" relation="false"/>
  </sentence>
  <sentence id="s3286" text="Through genetic mapping of disease loci and whole-exome sequencing in four unrelated multiplex families presenting with severe AMC, we identified biallelic loss-of-function mutations in regulation of myelination (leucine-rich glioma-inactivated 4).">
    <entity charOffset="186-211" id="s3286.e0" ontology_id="GO_0031641" text="regulation of myelination" type="GO"/>
    <entity charOffset="226-232" id="s3286.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3286.e0" e2="s3286.e1" id="s3286.p0" relation="false"/>
  </sentence>
  <sentence id="s3287" text="This is consistent with previous studies reporting arthrogryposis in regulation of myelination-deficient mice due to peripheral hypomyelination.">
    <entity charOffset="51-65" id="s3287.e0" ontology_id="HP_0002804" text="arthrogryposis" type="HP"/>
    <entity charOffset="69-94" id="s3287.e1" ontology_id="GO_0031641" text="regulation of myelination" type="GO"/>
    <pair e1="s3287.e0" e2="s3287.e1" id="s3287.p0" relation="true"/>
  </sentence>
  <sentence id="s3288" text="Genetic reduction of cAMP biosynthetic process also ameliorates autism-related symptoms including repetitive behaviour, defective social interaction and audiogenic seizures.">
    <entity charOffset="21-46" id="s3288.e0" ontology_id="GO_0006171" text="cAMP biosynthetic process" type="GO"/>
    <entity charOffset="64-70" id="s3288.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3288.e0" e2="s3288.e1" id="s3288.p0" relation="false"/>
  </sentence>
  <sentence id="s3289" text="Limb-girdle muscular dystrophies (LGMD) are a highly heterogeneous group of muscle disorders, which first affect the voluntary muscles of the negative regulation of signal transduction and shoulder areas.">
    <entity charOffset="53-66" id="s3289.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="142-184" id="s3289.e1" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <pair e1="s3289.e0" e2="s3289.e1" id="s3289.p0" relation="false"/>
  </sentence>
  <sentence id="s3290" text="The autosomal recessive forms (proteolysis) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (protein polyubiquitination), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (protein O-linked mannosylation), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (protein O-linked mannosylation), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s3290.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="31-42" id="s3290.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s3290.e0" e2="s3290.e1" id="s3290.p0" relation="true"/>
  </sentence>
  <sentence id="s3291" text="The autosomal recessive forms (proteolysis) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (protein polyubiquitination), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (protein O-linked mannosylation), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (protein O-linked mannosylation), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s3291.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="214-240" id="s3291.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s3291.e0" e2="s3291.e1" id="s3291.p0" relation="true"/>
  </sentence>
  <sentence id="s3292" text="The autosomal recessive forms (proteolysis) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (protein polyubiquitination), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (protein O-linked mannosylation), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (protein O-linked mannosylation), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s3292.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="282-312" id="s3292.e1" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <pair e1="s3292.e0" e2="s3292.e1" id="s3292.p0" relation="true"/>
  </sentence>
  <sentence id="s3293" text="The autosomal recessive forms (proteolysis) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (protein polyubiquitination), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (protein O-linked mannosylation), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (protein O-linked mannosylation), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)">
    <entity charOffset="4-23" id="s3293.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="363-393" id="s3293.e1" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <pair e1="s3293.e0" e2="s3293.e1" id="s3293.p0" relation="true"/>
  </sentence>
  <sentence id="s3294" text="The high-risk HPV muscle organ developments (HR HPV) account for approximately 5% of the global burden of cancer and thus cause high morbidity and mortality.">
    <entity charOffset="18-42" id="s3294.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="106-112" id="s3294.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3294.e0" e2="s3294.e1" id="s3294.p0" relation="false"/>
  </sentence>
  <sentence id="s3295" text="Our data indicate that 5-hmC might serve as a metastasis marker for cancer and that the decreased expression of methylation-dependent chromatin silencing is likely one of the mechanisms of genome instability underlying 5-hmC loss in cancer">
    <entity charOffset="68-74" id="s3295.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="112-153" id="s3295.e1" ontology_id="GO_0006346" text="methylation-dependent chromatin silencing" type="GO"/>
    <pair e1="s3295.e0" e2="s3295.e1" id="s3295.p0" relation="false"/>
  </sentence>
  <sentence id="s3296" text="It has been reported that functionally distinct cancer stem cells (CSCs) exist in human bladder cancer (intracellular signal transduction).">
    <entity charOffset="48-54" id="s3296.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-137" id="s3296.e1" ontology_id="GO_0035556" text="intracellular signal transduction" type="GO"/>
    <pair e1="s3296.e0" e2="s3296.e1" id="s3296.p0" relation="true"/>
  </sentence>
  <sentence id="s3297" text="Sox2 expression is absent in normal urothelial cells, but it begins to be expressed in pre-neoplastic bladder tumors and continues to be expressed in invasive mouse intracellular signal transduction.">
    <entity charOffset="110-116" id="s3297.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="165-198" id="s3297.e1" ontology_id="GO_0035556" text="intracellular signal transduction" type="GO"/>
    <pair e1="s3297.e0" e2="s3297.e1" id="s3297.p0" relation="true"/>
  </sentence>
  <sentence id="s3298" text="Using s as a reporter of osteoblast differentiation transcriptional expression, we demonstrated that Sox2-expressing cells mark a subpopulation of tumor cells that fuel the growth of established intracellular signal transduction.">
    <entity charOffset="25-51" id="s3298.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="147-152" id="s3298.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3298.e0" e2="s3298.e1" id="s3298.p0" relation="true"/>
  </sentence>
  <sentence id="s3299" text="Using s as a reporter of osteoblast differentiation transcriptional expression, we demonstrated that Sox2-expressing cells mark a subpopulation of tumor cells that fuel the growth of established intracellular signal transduction.">
    <entity charOffset="147-152" id="s3299.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="195-228" id="s3299.e1" ontology_id="GO_0035556" text="intracellular signal transduction" type="GO"/>
    <pair e1="s3299.e0" e2="s3299.e1" id="s3299.p0" relation="true"/>
  </sentence>
  <sentence id="s3300" text="Response rates in both treatment cilium assemblys were less than 5% in the overall population and in the liposarcoma subgroup.">
    <entity charOffset="33-48" id="s3300.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="105-116" id="s3300.e1" ontology_id="HP_0012034" text="liposarcoma" type="HP"/>
    <pair e1="s3300.e0" e2="s3300.e1" id="s3300.p0" relation="false"/>
  </sentence>
  <sentence id="s3301" text="epidermis development and KRT6 (KRT6A, KRT6B &amp;amp; KRT6C) gene expression was assessed in publically available serous ovarian cancer data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.">
    <entity charOffset="0-21" id="s3301.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="126-132" id="s3301.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3301.e0" e2="s3301.e1" id="s3301.p0" relation="true"/>
  </sentence>
  <sentence id="s3302" text="Survival analyses showed that high epidermis development mRNA in stage III/IV serous ovarian cancers was significantly associated with reduced progression-free (HR 1.38, P &amp;lt; 0.0001) and overall survival (HR 1.28, P = 0.013) whilst high keratinization mRNA was only associated with reduced progression-free survival (HR 1.2, P = 0.031).">
    <entity charOffset="35-56" id="s3302.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="93-99" id="s3302.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3302.e0" e2="s3302.e1" id="s3302.p0" relation="true"/>
  </sentence>
  <sentence id="s3303" text="Survival analyses showed that high epidermis development mRNA in stage III/IV serous ovarian cancers was significantly associated with reduced progression-free (HR 1.38, P &amp;lt; 0.0001) and overall survival (HR 1.28, P = 0.013) whilst high keratinization mRNA was only associated with reduced progression-free survival (HR 1.2, P = 0.031).">
    <entity charOffset="93-99" id="s3303.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="239-253" id="s3303.e1" ontology_id="GO_0031424" text="keratinization" type="GO"/>
    <pair e1="s3303.e0" e2="s3303.e1" id="s3303.p0" relation="false"/>
  </sentence>
  <sentence id="s3304" text="KRT5 but not keratinizationC mRNA expression was increased in chemotherapy resistant primary serous ovarian cancer cells compared to chemotherapy sensitive cells.">
    <entity charOffset="13-27" id="s3304.e0" ontology_id="GO_0031424" text="keratinization" type="GO"/>
    <entity charOffset="108-114" id="s3304.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3304.e0" e2="s3304.e1" id="s3304.p0" relation="false"/>
  </sentence>
  <sentence id="s3305" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, protein phosphorylation, regulation of transcription, DNA-templated, RAF1, and interleukin-2-mediated signaling pathway might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="71-94" id="s3305.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="235-254" id="s3305.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s3305.e0" e2="s3305.e1" id="s3305.p0" relation="false"/>
  </sentence>
  <sentence id="s3306" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, protein phosphorylation, regulation of transcription, DNA-templated, RAF1, and interleukin-2-mediated signaling pathway might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="96-138" id="s3306.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="235-254" id="s3306.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s3306.e0" e2="s3306.e1" id="s3306.p0" relation="false"/>
  </sentence>
  <sentence id="s3307" text="Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, protein phosphorylation, regulation of transcription, DNA-templated, RAF1, and interleukin-2-mediated signaling pathway might be associated with the development of lung adenocarcinoma.">
    <entity charOffset="150-190" id="s3307.e0" ontology_id="GO_0038110" text="interleukin-2-mediated signaling pathway" type="GO"/>
    <entity charOffset="235-254" id="s3307.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s3307.e0" e2="s3307.e1" id="s3307.p0" relation="false"/>
  </sentence>
  <sentence id="s3308" text="Patients with physical findings suggestive of Treacher Collins syndrome (regulation of translation) or mandibulofacial dysostosis (MFD) and macrocytic anemia diagnostic of Diamond-Blackfan anemia (monocyte chemotaxis) have been reported.">
    <entity charOffset="73-98" id="s3308.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="103-129" id="s3308.e1" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <pair e1="s3308.e0" e2="s3308.e1" id="s3308.p0" relation="false"/>
  </sentence>
  <sentence id="s3309" text="Patients with physical findings suggestive of Treacher Collins syndrome (regulation of translation) or mandibulofacial dysostosis (MFD) and macrocytic anemia diagnostic of Diamond-Blackfan anemia (monocyte chemotaxis) have been reported.">
    <entity charOffset="103-129" id="s3309.e0" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <entity charOffset="197-216" id="s3309.e1" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <pair e1="s3309.e0" e2="s3309.e1" id="s3309.p0" relation="false"/>
  </sentence>
  <sentence id="s3310" text="We conclude that the phenotype combining features of regulation of translation with monocyte chemotaxis is genetically heterogeneous.">
    <entity charOffset="53-78" id="s3310.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="119-132" id="s3310.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3310.e0" e2="s3310.e1" id="s3310.p0" relation="false"/>
  </sentence>
  <sentence id="s3311" text="We conclude that the phenotype combining features of regulation of translation with monocyte chemotaxis is genetically heterogeneous.">
    <entity charOffset="84-103" id="s3311.e0" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <entity charOffset="119-132" id="s3311.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3311.e0" e2="s3311.e1" id="s3311.p0" relation="false"/>
  </sentence>
  <sentence id="s3312" text="In vitro head and neck cancer studies have demonstrated that epidermal growth factor receptor kinase substrate 8 (regulation of cell shape) overexpression contributes to squamous carcinogenesis.">
    <entity charOffset="23-29" id="s3312.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-138" id="s3312.e1" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <pair e1="s3312.e0" e2="s3312.e1" id="s3312.p0" relation="false"/>
  </sentence>
  <sentence id="s3313" text="We then correlated our findings with clinicopathologic data including tumor-node-metastasis stage, p16 status, age, multicellular organism development, and smoking and alcohol history.">
    <entity charOffset="70-75" id="s3313.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="116-150" id="s3313.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s3313.e0" e2="s3313.e1" id="s3313.p0" relation="false"/>
  </sentence>
  <sentence id="s3314" text="In conclusion, our data offer in vivo support that, in HNSCCs, regulation of cell shape is involved in tumor invasion but not necessarily the development of regional LN metastasis.">
    <entity charOffset="63-87" id="s3314.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="103-108" id="s3314.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3314.e0" e2="s3314.e1" id="s3314.p0" relation="false"/>
  </sentence>
  <sentence id="s3315" text="A case with cellular response to histamine (C.905A&amp;gt;G) had seizure controlled for 3 mouths.">
    <entity charOffset="12-42" id="s3315.e0" ontology_id="GO_0071420" text="cellular response to histamine" type="GO"/>
    <entity charOffset="61-68" id="s3315.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s3315.e0" e2="s3315.e1" id="s3315.p0" relation="true"/>
  </sentence>
  <sentence id="s3316" text="Pedigree analysis in the Haflinger breed supports a simple recessive mode of inheritance and a genome-wide association study (N=23) identified a 1.5 Mb locus on ECA12 significantly associated with limbal negative regulation of peptidase activity (P&lt;sub&gt;corrected&lt;/sub&gt; = 0.04).">
    <entity charOffset="69-88" id="s3316.e0" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <entity charOffset="206-247" id="s3316.e1" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <pair e1="s3316.e0" e2="s3316.e1" id="s3316.p0" relation="false"/>
  </sentence>
  <sentence id="s3317" text="Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous negative regulation of peptidase activity and melanomas, is explained by mutations in DDB2.">
    <entity charOffset="145-186" id="s3317.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="191-200" id="s3317.e1" ontology_id="HP_0002861" text="melanomas" type="HP"/>
    <pair e1="s3317.e0" e2="s3317.e1" id="s3317.p0" relation="false"/>
  </sentence>
  <sentence id="s3318" text="The knock out animals were protected from HFD induced obesity, positive regulation of cell-matrix adhesionty liver and insulin resistance.">
    <entity charOffset="54-61" id="s3318.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="63-106" id="s3318.e1" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s3318.e0" e2="s3318.e1" id="s3318.p0" relation="false"/>
  </sentence>
  <sentence id="s3319" text="Here, using a microarray screen, we found that knocking down DNA repair in human neuroblastoma cells results in down-regulation of microRNA-221 (protein polyubiquitination-221).">
    <entity charOffset="61-71" id="s3319.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="81-94" id="s3319.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s3319.e0" e2="s3319.e1" id="s3319.p0" relation="false"/>
  </sentence>
  <sentence id="s3320" text="Here, using a microarray screen, we found that knocking down DNA repair in human neuroblastoma cells results in down-regulation of microRNA-221 (protein polyubiquitination-221).">
    <entity charOffset="81-94" id="s3320.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="145-171" id="s3320.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s3320.e0" e2="s3320.e1" id="s3320.p0" relation="false"/>
  </sentence>
  <sentence id="s3321" text="Gap junction beta-1 (cell-cell signaling) gene mutations affecting the gap junction protein connexin32 (Cx32) cause the X-linked Charcot-Marie-Tooth disease (CMT1X), a common inherited neuropathy.">
    <entity charOffset="21-40" id="s3321.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="185-195" id="s3321.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3321.e0" e2="s3321.e1" id="s3321.p0" relation="true"/>
  </sentence>
  <sentence id="s3322" text="Mutations in the glucosylceramidase beta (glucosylceramide catabolic process) gene are strongly associated with neurodegenerative diseases marked by protein aggregation.">
    <entity charOffset="42-76" id="s3322.e0" ontology_id="GO_0006680" text="glucosylceramide catabolic process" type="GO"/>
    <entity charOffset="112-137" id="s3322.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s3322.e0" e2="s3322.e1" id="s3322.p0" relation="false"/>
  </sentence>
  <sentence id="s3323" text="Of the included 24 CNS patients with hemangioblastoma (14 intracranial and 10 spinal hemangioblastomas), 5 patients (20.8%) were diagnosed with Von Hippel-Lindau disease (protein ubiquitination).">
    <entity charOffset="37-53" id="s3323.e0" ontology_id="HP_0010797" text="hemangioblastoma" type="HP"/>
    <entity charOffset="171-193" id="s3323.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s3323.e0" e2="s3323.e1" id="s3323.p0" relation="true"/>
  </sentence>
  <sentence id="s3324" text="We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a negative regulation of transcription, DNA-templated-like presentation.">
    <entity charOffset="60-72" id="s3324.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="187-238" id="s3324.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3324.e0" e2="s3324.e1" id="s3324.p0" relation="true"/>
  </sentence>
  <sentence id="s3325" text="We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a negative regulation of transcription, DNA-templated-like presentation.">
    <entity charOffset="130-146" id="s3325.e0" ontology_id="HP_0002120" text="cortical atrophy" type="HP"/>
    <entity charOffset="187-238" id="s3325.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3325.e0" e2="s3325.e1" id="s3325.p0" relation="true"/>
  </sentence>
  <sentence id="s3326" text="The regulation of the post-mitotic neural survival activity of negative regulation of I-kappaB kinase/NF-kappaB signaling depends critically on an interaction with FOXG1, a gene shown to be involved in a postnatal microcephaly syndrome.">
    <entity charOffset="63-121" id="s3326.e0" ontology_id="GO_0043124" text="negative regulation of I-kappaB kinase/NF-kappaB signaling" type="GO"/>
    <entity charOffset="214-226" id="s3326.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3326.e0" e2="s3326.e1" id="s3326.p0" relation="false"/>
  </sentence>
  <sentence id="s3327" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely DNA repair, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.">
    <entity charOffset="93-116" id="s3327.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="286-292" id="s3327.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3327.e0" e2="s3327.e1" id="s3327.p0" relation="true"/>
  </sentence>
  <sentence id="s3328" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely DNA repair, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.">
    <entity charOffset="121-163" id="s3328.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="286-292" id="s3328.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3328.e0" e2="s3328.e1" id="s3328.p0" relation="true"/>
  </sentence>
  <sentence id="s3329" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely DNA repair, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.">
    <entity charOffset="286-292" id="s3329.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="334-344" id="s3329.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s3329.e0" e2="s3329.e1" id="s3329.p0" relation="true"/>
  </sentence>
  <sentence id="s3330" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely DNA repair, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.">
    <entity charOffset="286-292" id="s3330.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="346-373" id="s3330.e1" ontology_id="GO_0010332" text="response to gamma radiation" type="GO"/>
    <pair e1="s3330.e0" e2="s3330.e1" id="s3330.p0" relation="true"/>
  </sentence>
  <sentence id="s3331" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely DNA repair, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.">
    <entity charOffset="286-292" id="s3331.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="375-420" id="s3331.e1" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <pair e1="s3331.e0" e2="s3331.e1" id="s3331.p0" relation="true"/>
  </sentence>
  <sentence id="s3332" text="We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely DNA repair, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.">
    <entity charOffset="286-292" id="s3332.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="422-473" id="s3332.e1" ontology_id="GO_0008543" text="fibroblast growth factor receptor signaling pathway" type="GO"/>
    <pair e1="s3332.e0" e2="s3332.e1" id="s3332.p0" relation="true"/>
  </sentence>
  <sentence id="s3333" text="Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &amp;quot;likely pathogenic&amp;quot; missense variants in protein phosphorylation, mitochondrial translational elongation, regulation of transcription, DNA-templated and TP53.">
    <entity charOffset="121-127" id="s3333.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="269-292" id="s3333.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s3333.e0" e2="s3333.e1" id="s3333.p0" relation="true"/>
  </sentence>
  <sentence id="s3334" text="Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &amp;quot;likely pathogenic&amp;quot; missense variants in protein phosphorylation, mitochondrial translational elongation, regulation of transcription, DNA-templated and TP53.">
    <entity charOffset="121-127" id="s3334.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="334-376" id="s3334.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3334.e0" e2="s3334.e1" id="s3334.p0" relation="true"/>
  </sentence>
  <sentence id="s3335" text="Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &amp;quot;likely pathogenic&amp;quot; missense variants in protein phosphorylation, mitochondrial translational elongation, regulation of transcription, DNA-templated and TP53.">
    <entity charOffset="121-127" id="s3335.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="294-332" id="s3335.e1" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <pair e1="s3335.e0" e2="s3335.e1" id="s3335.p0" relation="false"/>
  </sentence>
  <sentence id="s3336" text="Homeobox A11 (skeletal system development) is one of the hypermethylated genes in breast cancer and its function in breast tumorigenesis remains elusive.">
    <entity charOffset="14-41" id="s3336.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="89-95" id="s3336.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3336.e0" e2="s3336.e1" id="s3336.p0" relation="false"/>
  </sentence>
  <sentence id="s3337" text="Homeobox A11 (skeletal system development) is one of the hypermethylated genes in breast cancer and its function in breast tumorigenesis remains elusive.">
    <entity charOffset="14-41" id="s3337.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="123-128" id="s3337.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3337.e0" e2="s3337.e1" id="s3337.p0" relation="false"/>
  </sentence>
  <sentence id="s3338" text="In this study, we analyzed the methylation status of skeletal system development in 264 paired breast cancer and normal tissue as well as in matched serum samples by MethyLight assay.">
    <entity charOffset="53-80" id="s3338.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="102-108" id="s3338.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3338.e0" e2="s3338.e1" id="s3338.p0" relation="false"/>
  </sentence>
  <sentence id="s3339" text="Further, the function of skeletal system development in breast tumorigenesis was analyzed by cell proliferation and migration assays.">
    <entity charOffset="25-52" id="s3339.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="63-68" id="s3339.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3339.e0" e2="s3339.e1" id="s3339.p0" relation="false"/>
  </sentence>
  <sentence id="s3340" text="We found that skeletal system development was hypermethylated in cancer tissues (45.08%), especially in invasive ductal carcinomas (P&amp;lt;0.001), patients with a family history of cancer (P=0.033), cases with metastatic lymph nodes (P=0.004) and P53 positive group (P=0.017).">
    <entity charOffset="14-41" id="s3340.e0" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <entity charOffset="65-71" id="s3340.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3340.e0" e2="s3340.e1" id="s3340.p0" relation="false"/>
  </sentence>
  <sentence id="s3341" text="These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-phosphatidylcholine biosynthetic process syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.">
    <entity charOffset="24-30" id="s3341.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="80-120" id="s3341.e1" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <pair e1="s3341.e0" e2="s3341.e1" id="s3341.p0" relation="false"/>
  </sentence>
  <sentence id="s3342" text="These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-phosphatidylcholine biosynthetic process syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.">
    <entity charOffset="50-63" id="s3342.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="80-120" id="s3342.e1" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <pair e1="s3342.e0" e2="s3342.e1" id="s3342.p0" relation="false"/>
  </sentence>
  <sentence id="s3343" text="These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-phosphatidylcholine biosynthetic process syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.">
    <entity charOffset="65-71" id="s3343.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="80-120" id="s3343.e1" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <pair e1="s3343.e0" e2="s3343.e1" id="s3343.p0" relation="false"/>
  </sentence>
  <sentence id="s3344" text="These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-phosphatidylcholine biosynthetic process syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.">
    <entity charOffset="80-120" id="s3344.e0" ontology_id="GO_0006656" text="phosphatidylcholine biosynthetic process" type="GO"/>
    <entity charOffset="148-156" id="s3344.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s3344.e0" e2="s3344.e1" id="s3344.p0" relation="false"/>
  </sentence>
  <sentence id="s3345" text="Primary ciliary dyskinesia (motile cilium assembly) is an autosomal recessive disease characterized by chronic respiratory infections of the upper and lower airways, hypofertility, and, in approximately half of the cases, situs inversus.">
    <entity charOffset="28-50" id="s3345.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="58-77" id="s3345.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3345.e0" e2="s3345.e1" id="s3345.p0" relation="true"/>
  </sentence>
  <sentence id="s3346" text="Interestingly, protein insertion into membrane mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy muscle organ development V (dHMN-V).">
    <entity charOffset="15-46" id="s3346.e0" ontology_id="GO_0051205" text="protein insertion into membrane" type="GO"/>
    <entity charOffset="150-168" id="s3346.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s3346.e0" e2="s3346.e1" id="s3346.p0" relation="true"/>
  </sentence>
  <sentence id="s3347" text="Interestingly, protein insertion into membrane mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy muscle organ development V (dHMN-V).">
    <entity charOffset="150-168" id="s3347.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="214-238" id="s3347.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3347.e0" e2="s3347.e1" id="s3347.p0" relation="false"/>
  </sentence>
  <sentence id="s3348" text="Interestingly, protein insertion into membrane mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy muscle organ development V (dHMN-V).">
    <entity charOffset="203-213" id="s3348.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="214-238" id="s3348.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3348.e0" e2="s3348.e1" id="s3348.p0" relation="false"/>
  </sentence>
  <sentence id="s3349" text="In 20/23 cases, MDRnegative regulation of gene expression BSI occurred during neutropenia.">
    <entity charOffset="19-57" id="s3349.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="78-89" id="s3349.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s3349.e0" e2="s3349.e1" id="s3349.p0" relation="false"/>
  </sentence>
  <sentence id="s3350" text="MDR rectal colonization occurs in 6.5% of haematological inpatients and predicts a 16% probability of MDRnegative regulation of gene expression BSI, particularly during neutropenia, as well as a higher probability of unfavourable outcomes in positive regulation of cytosolic calcium ion concentration-rel BSIs.">
    <entity charOffset="105-143" id="s3350.e0" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <entity charOffset="169-180" id="s3350.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s3350.e0" e2="s3350.e1" id="s3350.p0" relation="false"/>
  </sentence>
  <sentence id="s3351" text="MDR rectal colonization occurs in 6.5% of haematological inpatients and predicts a 16% probability of MDRnegative regulation of gene expression BSI, particularly during neutropenia, as well as a higher probability of unfavourable outcomes in positive regulation of cytosolic calcium ion concentration-rel BSIs.">
    <entity charOffset="169-180" id="s3351.e0" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <entity charOffset="242-300" id="s3351.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s3351.e0" e2="s3351.e1" id="s3351.p0" relation="false"/>
  </sentence>
  <sentence id="s3352" text="Solute carrier family 34 member 2 (phosphate ion transport) is a well-known sodium-dependent phosphate transporter that has recently been linked to cancer development.">
    <entity charOffset="35-58" id="s3352.e0" ontology_id="GO_0006817" text="phosphate ion transport" type="GO"/>
    <entity charOffset="148-154" id="s3352.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3352.e0" e2="s3352.e1" id="s3352.p0" relation="false"/>
  </sentence>
  <sentence id="s3353" text="Our results indicate that the protein expression level of pyrimidine nucleotide metabolic process in pancreatic cancer tissue is a good predictor of PFS, and thus dCK may be the chloride transport biomarker of dFdC sensitivity in pancreatic cancer patients treated with dFdC, although other proteins would also contribute to dFdC-sensitivity at the cellular level in vivo and in vitro.">
    <entity charOffset="58-97" id="s3353.e0" ontology_id="GO_0006220" text="pyrimidine nucleotide metabolic process" type="GO"/>
    <entity charOffset="112-118" id="s3353.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3353.e0" e2="s3353.e1" id="s3353.p0" relation="false"/>
  </sentence>
  <sentence id="s3354" text="Our results indicate that the protein expression level of pyrimidine nucleotide metabolic process in pancreatic cancer tissue is a good predictor of PFS, and thus dCK may be the chloride transport biomarker of dFdC sensitivity in pancreatic cancer patients treated with dFdC, although other proteins would also contribute to dFdC-sensitivity at the cellular level in vivo and in vitro.">
    <entity charOffset="112-118" id="s3354.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="178-196" id="s3354.e1" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <pair e1="s3354.e0" e2="s3354.e1" id="s3354.p0" relation="false"/>
  </sentence>
  <sentence id="s3355" text="Our recent determination of a microRNA (protein polyubiquitinationNA) expresmelanosome organizationon signature in prostate cancer (mitochondrial transport) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.">
    <entity charOffset="40-66" id="s3355.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="124-130" id="s3355.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3355.e0" e2="s3355.e1" id="s3355.p0" relation="false"/>
  </sentence>
  <sentence id="s3356" text="Our recent determination of a microRNA (protein polyubiquitinationNA) expresmelanosome organizationon signature in prostate cancer (mitochondrial transport) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.">
    <entity charOffset="76-99" id="s3356.e0" ontology_id="GO_0032438" text="melanosome organization" type="GO"/>
    <entity charOffset="124-130" id="s3356.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3356.e0" e2="s3356.e1" id="s3356.p0" relation="false"/>
  </sentence>
  <sentence id="s3357" text="Our recent determination of a microRNA (protein polyubiquitinationNA) expresmelanosome organizationon signature in prostate cancer (mitochondrial transport) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.">
    <entity charOffset="124-130" id="s3357.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="132-155" id="s3357.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s3357.e0" e2="s3357.e1" id="s3357.p0" relation="false"/>
  </sentence>
  <sentence id="s3358" text="Here we describe the approaches and methods used to identify nucleosome disassembly mutations, which drive development of the rare ovarian cancer, small cell carcinoma of the ovary, hypercalcemic muscle organ development (SCCOHT), and point to the broader relevance of this paradigm for future research in rare cancers">
    <entity charOffset="61-83" id="s3358.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="139-145" id="s3358.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3358.e0" e2="s3358.e1" id="s3358.p0" relation="false"/>
  </sentence>
  <sentence id="s3359" text="Here we describe the approaches and methods used to identify nucleosome disassembly mutations, which drive development of the rare ovarian cancer, small cell carcinoma of the ovary, hypercalcemic muscle organ development (SCCOHT), and point to the broader relevance of this paradigm for future research in rare cancers">
    <entity charOffset="139-145" id="s3359.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="196-220" id="s3359.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3359.e0" e2="s3359.e1" id="s3359.p0" relation="false"/>
  </sentence>
  <sentence id="s3360" text="We show that morpholino-mediated negative regulation of protein kinase activity loss of function in the zebrafish results in shortened body axis, microphthalmia with disorganized lens, microcephaly, reduced touch-evoked motility, and highly disorganized myofibers.">
    <entity charOffset="33-79" id="s3360.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="146-160" id="s3360.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s3360.e0" e2="s3360.e1" id="s3360.p0" relation="false"/>
  </sentence>
  <sentence id="s3361" text="We show that morpholino-mediated negative regulation of protein kinase activity loss of function in the zebrafish results in shortened body axis, microphthalmia with disorganized lens, microcephaly, reduced touch-evoked motility, and highly disorganized myofibers.">
    <entity charOffset="33-79" id="s3361.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="185-197" id="s3361.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3361.e0" e2="s3361.e1" id="s3361.p0" relation="true"/>
  </sentence>
  <sentence id="s3362" text="Altogether these data demonstrate that mutations in negative regulation of protein kinase activity cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability">
    <entity charOffset="52-98" id="s3362.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="151-164" id="s3362.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3362.e0" e2="s3362.e1" id="s3362.p0" relation="true"/>
  </sentence>
  <sentence id="s3363" text="Bardet-Biedl syndrome (visual perception) is a rare ciliopathy disorder that is clinically and genetically heterogeneous with 18 known genes.">
    <entity charOffset="23-40" id="s3363.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="107-120" id="s3363.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3363.e0" e2="s3363.e1" id="s3363.p0" relation="false"/>
  </sentence>
  <sentence id="s3364" text="After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-neuropeptide signaling pathway addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA cellular protein catabolic process repair mechanisms firstly anti-PARPs, inhibitory molecules of negative regulation of transcription by RNA polymerase II, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the negative regulation of apoptotic process promoter.">
    <entity charOffset="97-127" id="s3364.e0" ontology_id="GO_0007218" text="neuropeptide signaling pathway" type="GO"/>
    <entity charOffset="174-180" id="s3364.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3364.e0" e2="s3364.e1" id="s3364.p0" relation="false"/>
  </sentence>
  <sentence id="s3365" text="After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-neuropeptide signaling pathway addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA cellular protein catabolic process repair mechanisms firstly anti-PARPs, inhibitory molecules of negative regulation of transcription by RNA polymerase II, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the negative regulation of apoptotic process promoter.">
    <entity charOffset="174-180" id="s3365.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="218-252" id="s3365.e1" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <pair e1="s3365.e0" e2="s3365.e1" id="s3365.p0" relation="false"/>
  </sentence>
  <sentence id="s3366" text="After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-neuropeptide signaling pathway addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA cellular protein catabolic process repair mechanisms firstly anti-PARPs, inhibitory molecules of negative regulation of transcription by RNA polymerase II, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the negative regulation of apoptotic process promoter.">
    <entity charOffset="174-180" id="s3366.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="315-372" id="s3366.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3366.e0" e2="s3366.e1" id="s3366.p0" relation="false"/>
  </sentence>
  <sentence id="s3367" text="After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-neuropeptide signaling pathway addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA cellular protein catabolic process repair mechanisms firstly anti-PARPs, inhibitory molecules of negative regulation of transcription by RNA polymerase II, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the negative regulation of apoptotic process promoter.">
    <entity charOffset="174-180" id="s3367.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="536-576" id="s3367.e1" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <pair e1="s3367.e0" e2="s3367.e1" id="s3367.p0" relation="true"/>
  </sentence>
  <sentence id="s3368" text="An analysis of human SCLC specimens revealed that negative regulation by host of viral transcription is expressed exclusively in variant SCLC tumors that lack expression of neuroendocrine markers and instead express markers of a chemosensory lineage known as tuft cells.">
    <entity charOffset="50-100" id="s3368.e0" ontology_id="GO_0043922" text="negative regulation by host of viral transcription" type="GO"/>
    <entity charOffset="142-147" id="s3368.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3368.e0" e2="s3368.e1" id="s3368.p0" relation="false"/>
  </sentence>
  <sentence id="s3369" text="Moreover, we show that most SCLC tumors can be classified into one of three lineages based on the expression of negative regulation by host of viral transcription, ASCL1, or NEUROD1.">
    <entity charOffset="33-38" id="s3369.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="112-162" id="s3369.e1" ontology_id="GO_0043922" text="negative regulation by host of viral transcription" type="GO"/>
    <pair e1="s3369.e0" e2="s3369.e1" id="s3369.p0" relation="false"/>
  </sentence>
  <sentence id="s3370" text="The study was conducted to determine the effect of DHA on the distribution of apelin receptor signaling pathway and apelin receptor (APJ) in the central nervous system in 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP)-induced PD model.">
    <entity charOffset="78-111" id="s3370.e0" ontology_id="GO_0060183" text="apelin receptor signaling pathway" type="GO"/>
    <entity charOffset="145-152" id="s3370.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s3370.e0" e2="s3370.e1" id="s3370.p0" relation="false"/>
  </sentence>
  <sentence id="s3371" text="Epithelial-mesenchymal transition (cytokine production) is a process whereby epithelial cells assume mesenchymal characteristics to facilitate cancer metastasis.">
    <entity charOffset="35-54" id="s3371.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="143-149" id="s3371.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3371.e0" e2="s3371.e1" id="s3371.p0" relation="true"/>
  </sentence>
  <sentence id="s3372" text="However, cytokine production also contributes to the initiation and development of primary tumors.">
    <entity charOffset="9-28" id="s3372.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="91-97" id="s3372.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3372.e0" e2="s3372.e1" id="s3372.p0" relation="true"/>
  </sentence>
  <sentence id="s3373" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="0-28" id="s3373.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="46-59" id="s3373.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3373.e0" e2="s3373.e1" id="s3373.p0" relation="false"/>
  </sentence>
  <sentence id="s3374" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="0-28" id="s3374.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="225-244" id="s3374.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3374.e0" e2="s3374.e1" id="s3374.p0" relation="false"/>
  </sentence>
  <sentence id="s3375" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="46-59" id="s3375.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="286-313" id="s3375.e1" ontology_id="GO_0017004" text="cytochrome complex assembly" type="GO"/>
    <pair e1="s3375.e0" e2="s3375.e1" id="s3375.p0" relation="false"/>
  </sentence>
  <sentence id="s3376" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="46-59" id="s3376.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="351-446" id="s3376.e1" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <pair e1="s3376.e0" e2="s3376.e1" id="s3376.p0" relation="false"/>
  </sentence>
  <sentence id="s3377" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="46-59" id="s3377.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="466-561" id="s3377.e1" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <pair e1="s3377.e0" e2="s3377.e1" id="s3377.p0" relation="false"/>
  </sentence>
  <sentence id="s3378" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="136-164" id="s3378.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="225-244" id="s3378.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3378.e0" e2="s3378.e1" id="s3378.p0" relation="false"/>
  </sentence>
  <sentence id="s3379" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="225-244" id="s3379.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="351-446" id="s3379.e1" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <pair e1="s3379.e0" e2="s3379.e1" id="s3379.p0" relation="true"/>
  </sentence>
  <sentence id="s3380" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.">
    <entity charOffset="225-244" id="s3380.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="466-561" id="s3380.e1" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <pair e1="s3380.e0" e2="s3380.e1" id="s3380.p0" relation="true"/>
  </sentence>
  <sentence id="s3381" text="In this study, we evaluated the clinical, laboratory and genetic findings and the prognostic effects of molecular inheritance of our 24 superoxide metabolic process cases (14 XR, 10 autosomal recessive-AR).">
    <entity charOffset="136-164" id="s3381.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="182-201" id="s3381.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3381.e0" e2="s3381.e1" id="s3381.p0" relation="false"/>
  </sentence>
  <sentence id="s3382" text="We describe a multigenerational Saudi family with an autosomal dominant form of hypohidrotic ectodermal dysplasia in which positional mapping and exome sequencing identified a novel variant in regulation of epidermal cell division that fully segregates with the phenotype.">
    <entity charOffset="93-113" id="s3382.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="193-230" id="s3382.e1" ontology_id="GO_0010482" text="regulation of epidermal cell division" type="GO"/>
    <pair e1="s3382.e0" e2="s3382.e1" id="s3382.p0" relation="false"/>
  </sentence>
  <sentence id="s3383" text="In a unique case from a consanguineous union presenting with overgrowth, macrocephaly, retinal coloboma, large thumbs, severe varicose veins and learning disabilities, exome sequencing identified a homozygous nonsense platelet aggregation variant.">
    <entity charOffset="73-85" id="s3383.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="218-238" id="s3383.e1" ontology_id="GO_0070527" text="platelet aggregation" type="GO"/>
    <pair e1="s3383.e0" e2="s3383.e1" id="s3383.p0" relation="true"/>
  </sentence>
  <sentence id="s3384" text="In a unique case from a consanguineous union presenting with overgrowth, macrocephaly, retinal coloboma, large thumbs, severe varicose veins and learning disabilities, exome sequencing identified a homozygous nonsense platelet aggregation variant.">
    <entity charOffset="87-103" id="s3384.e0" ontology_id="HP_0000480" text="retinal coloboma" type="HP"/>
    <entity charOffset="218-238" id="s3384.e1" ontology_id="GO_0070527" text="platelet aggregation" type="GO"/>
    <pair e1="s3384.e0" e2="s3384.e1" id="s3384.p0" relation="false"/>
  </sentence>
  <sentence id="s3385" text="Spinocerebellar ataxia type 17 (transcription by RNA polymerase II) is caused by CAG repeat expansion in the TATA-box binding protein gene.">
    <entity charOffset="16-22" id="s3385.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="32-66" id="s3385.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3385.e0" e2="s3385.e1" id="s3385.p0" relation="true"/>
  </sentence>
  <sentence id="s3386" text="The lifestyle gradually transformed from Bedouin life to urban sedentary life, along with a negative regulation of transcription by RNA polymerase II increase in obesity and other comorbidities.">
    <entity charOffset="92-149" id="s3386.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="162-169" id="s3386.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3386.e0" e2="s3386.e1" id="s3386.p0" relation="false"/>
  </sentence>
  <sentence id="s3387" text="The percentage of autosomal recessive forms due to mutations in proteolysis, protein peptidyl-prolyl isomerization, protein folding, negative regulation of angiogenesis, and positive regulation of cell proliferation was unusually high (48%).">
    <entity charOffset="18-37" id="s3387.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="64-75" id="s3387.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s3387.e0" e2="s3387.e1" id="s3387.p0" relation="true"/>
  </sentence>
  <sentence id="s3388" text="The percentage of autosomal recessive forms due to mutations in proteolysis, protein peptidyl-prolyl isomerization, protein folding, negative regulation of angiogenesis, and positive regulation of cell proliferation was unusually high (48%).">
    <entity charOffset="18-37" id="s3388.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="77-114" id="s3388.e1" ontology_id="GO_0000413" text="protein peptidyl-prolyl isomerization" type="GO"/>
    <pair e1="s3388.e0" e2="s3388.e1" id="s3388.p0" relation="true"/>
  </sentence>
  <sentence id="s3389" text="The percentage of autosomal recessive forms due to mutations in proteolysis, protein peptidyl-prolyl isomerization, protein folding, negative regulation of angiogenesis, and positive regulation of cell proliferation was unusually high (48%).">
    <entity charOffset="18-37" id="s3389.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="116-131" id="s3389.e1" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <pair e1="s3389.e0" e2="s3389.e1" id="s3389.p0" relation="true"/>
  </sentence>
  <sentence id="s3390" text="The percentage of autosomal recessive forms due to mutations in proteolysis, protein peptidyl-prolyl isomerization, protein folding, negative regulation of angiogenesis, and positive regulation of cell proliferation was unusually high (48%).">
    <entity charOffset="18-37" id="s3390.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="133-168" id="s3390.e1" ontology_id="GO_0016525" text="negative regulation of angiogenesis" type="GO"/>
    <pair e1="s3390.e0" e2="s3390.e1" id="s3390.p0" relation="true"/>
  </sentence>
  <sentence id="s3391" text="The percentage of autosomal recessive forms due to mutations in proteolysis, protein peptidyl-prolyl isomerization, protein folding, negative regulation of angiogenesis, and positive regulation of cell proliferation was unusually high (48%).">
    <entity charOffset="18-37" id="s3391.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="174-215" id="s3391.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s3391.e0" e2="s3391.e1" id="s3391.p0" relation="true"/>
  </sentence>
  <sentence id="s3392" text="Estrogens and estrogen receptors (ERs), such as ER and ER, prolactin (negative regulation of endothelial cell proliferation) and prolactin receptor (PRLR) have been reported to be involved in the physiopathology of uterine cervical cancer (UCC).">
    <entity charOffset="72-125" id="s3392.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="234-240" id="s3392.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3392.e0" e2="s3392.e1" id="s3392.p0" relation="false"/>
  </sentence>
  <sentence id="s3393" text="The results revealed that ER, ER, negative regulation of endothelial cell proliferationR and Ki67 expression levels were increased during the progression of cancer.">
    <entity charOffset="36-89" id="s3393.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="159-165" id="s3393.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3393.e0" e2="s3393.e1" id="s3393.p0" relation="false"/>
  </sentence>
  <sentence id="s3394" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="16-70" id="s3394.e0" ontology_id="GO_0090090" text="negative regulation of canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="202-221" id="s3394.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3394.e0" e2="s3394.e1" id="s3394.p0" relation="true"/>
  </sentence>
  <sentence id="s3395" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="16-70" id="s3395.e0" ontology_id="GO_0090090" text="negative regulation of canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="222-229" id="s3395.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s3395.e0" e2="s3395.e1" id="s3395.p0" relation="false"/>
  </sentence>
  <sentence id="s3396" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="66-81" id="s3396.e0" ontology_id="GO_0035329" text="hippo signaling" type="GO"/>
    <entity charOffset="222-229" id="s3396.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s3396.e0" e2="s3396.e1" id="s3396.p0" relation="false"/>
  </sentence>
  <sentence id="s3397" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="16-70" id="s3397.e0" ontology_id="GO_0090090" text="negative regulation of canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="249-260" id="s3397.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s3397.e0" e2="s3397.e1" id="s3397.p0" relation="false"/>
  </sentence>
  <sentence id="s3398" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="113-137" id="s3398.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="202-221" id="s3398.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3398.e0" e2="s3398.e1" id="s3398.p0" relation="true"/>
  </sentence>
  <sentence id="s3399" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="113-137" id="s3399.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="222-229" id="s3399.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s3399.e0" e2="s3399.e1" id="s3399.p0" relation="false"/>
  </sentence>
  <sentence id="s3400" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="113-137" id="s3400.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="249-260" id="s3400.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s3400.e0" e2="s3400.e1" id="s3400.p0" relation="false"/>
  </sentence>
  <sentence id="s3401" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="142-196" id="s3401.e0" ontology_id="GO_0090090" text="negative regulation of canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="202-221" id="s3401.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3401.e0" e2="s3401.e1" id="s3401.p0" relation="true"/>
  </sentence>
  <sentence id="s3402" text="Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial nephropathy.">
    <entity charOffset="142-196" id="s3402.e0" ontology_id="GO_0090090" text="negative regulation of canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="222-229" id="s3402.e1" ontology_id="HP_0011010" text="chronic" type="HP"/>
    <pair e1="s3402.e0" e2="s3402.e1" id="s3402.p0" relation="false"/>
  </sentence>
  <sentence id="s3403" text="The zinc transporter cellular response to zinc ion starvation influences epithelial cell morphology and migration in various cancers; however, its role in regulating cell invasion and chemotherapeutic resistance in human lung cancer is not yet clear.">
    <entity charOffset="21-61" id="s3403.e0" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <entity charOffset="125-131" id="s3403.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3403.e0" e2="s3403.e1" id="s3403.p0" relation="false"/>
  </sentence>
  <sentence id="s3404" text="Here, integrated analysis of gene expression in non-small cell lung cancer revealed that cellular response to zinc ion starvation expression is significantly correlated with increased tumour size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).">
    <entity charOffset="68-74" id="s3404.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="89-129" id="s3404.e1" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <pair e1="s3404.e0" e2="s3404.e1" id="s3404.p0" relation="false"/>
  </sentence>
  <sentence id="s3405" text="cellular response to zinc ion starvation silencing by lentivirus-mediated shRNA blocked human lung cancer cell epithelial-mesenchymal transition and metastasis in vitro and in vivo, respectively.">
    <entity charOffset="0-40" id="s3405.e0" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <entity charOffset="99-105" id="s3405.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3405.e0" e2="s3405.e1" id="s3405.p0" relation="false"/>
  </sentence>
  <sentence id="s3406" text="Moreover, cellular response to zinc ion starvation knockdown enhanced cancer cell sensitivity to cisplatin-induced death by inhibiting stemness in lung cancer cells.">
    <entity charOffset="10-50" id="s3406.e0" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <entity charOffset="70-76" id="s3406.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3406.e0" e2="s3406.e1" id="s3406.p0" relation="false"/>
  </sentence>
  <sentence id="s3407" text="Collectively, these data suggest that cellular response to zinc ion starvation may be a novel therapeutic target and predictive marker of tumour metastasis in non-small cell lung cancer">
    <entity charOffset="38-78" id="s3407.e0" ontology_id="GO_0034224" text="cellular response to zinc ion starvation" type="GO"/>
    <entity charOffset="138-144" id="s3407.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3407.e0" e2="s3407.e1" id="s3407.p0" relation="false"/>
  </sentence>
  <sentence id="s3408" text="Biallelic biological_process mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.">
    <entity charOffset="10-28" id="s3408.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="71-92" id="s3408.e1" ontology_id="HP_0004923" text="hyperphenylalaninemia" type="HP"/>
    <pair e1="s3408.e0" e2="s3408.e1" id="s3408.p0" relation="false"/>
  </sentence>
  <sentence id="s3409" text="Biallelic biological_process mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.">
    <entity charOffset="10-28" id="s3409.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="94-118" id="s3409.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s3409.e0" e2="s3409.e1" id="s3409.p0" relation="true"/>
  </sentence>
  <sentence id="s3410" text="Biallelic biological_process mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.">
    <entity charOffset="10-28" id="s3410.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="124-132" id="s3410.e1" ontology_id="HP_0001332" text="dystonia" type="HP"/>
    <pair e1="s3410.e0" e2="s3410.e1" id="s3410.p0" relation="true"/>
  </sentence>
  <sentence id="s3411" text="We identified biological_process homozygous null variants (c.187A&amp;gt;T;p.K63* and c.79-2A&amp;gt;G;p.V27Wfs*14) in two kindreds with early-onset parkinsonism.">
    <entity charOffset="14-32" id="s3411.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="141-153" id="s3411.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s3411.e0" e2="s3411.e1" id="s3411.p0" relation="true"/>
  </sentence>
  <sentence id="s3412" text="Our results suggest that biological_process mutations (absent in 500 early-onset patients with Parkinson's disease) rarely cause dopa-responsive nonprogressive parkinsonism in adulthood, but broaden the clinical spectrum of DNAJC12 deficiency.">
    <entity charOffset="25-43" id="s3412.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="160-172" id="s3412.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s3412.e0" e2="s3412.e1" id="s3412.p0" relation="true"/>
  </sentence>
  <sentence id="s3413" text="Our results suggest that biological_process mutations (absent in 500 early-onset patients with Parkinson's disease) rarely cause dopa-responsive nonprogressive parkinsonism in adulthood, but broaden the clinical spectrum of DNAJC12 deficiency.">
    <entity charOffset="25-43" id="s3413.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="145-159" id="s3413.e1" ontology_id="HP_0003680" text="nonprogressive" type="HP"/>
    <pair e1="s3413.e0" e2="s3413.e1" id="s3413.p0" relation="false"/>
  </sentence>
  <sentence id="s3414" text="Mutations of &lt;i&gt;lysosome organization&lt;/i&gt;/&lt;i&gt;lysosome organization&lt;/i&gt; have been implicated in inherited deafness in both humans and mice.">
    <entity charOffset="16-37" id="s3414.e0" ontology_id="GO_0007040" text="lysosome organization" type="GO"/>
    <entity charOffset="105-113" id="s3414.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3414.e0" e2="s3414.e1" id="s3414.p0" relation="true"/>
  </sentence>
  <sentence id="s3415" text="Mutations of &lt;i&gt;lysosome organization&lt;/i&gt;/&lt;i&gt;lysosome organization&lt;/i&gt; have been implicated in inherited deafness in both humans and mice.">
    <entity charOffset="45-66" id="s3415.e0" ontology_id="GO_0007040" text="lysosome organization" type="GO"/>
    <entity charOffset="105-113" id="s3415.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3415.e0" e2="s3415.e1" id="s3415.p0" relation="true"/>
  </sentence>
  <sentence id="s3416" text="This study also identified a de novo c.3015_3027dup frameshift mutation predicting p.Lys1010Glnfs*57 in neurofilament bundle assembly from a microtubule-based movement family with an atypical clinical symptom of prominent proximal weakness.">
    <entity charOffset="104-133" id="s3416.e0" ontology_id="GO_0033693" text="neurofilament bundle assembly" type="GO"/>
    <entity charOffset="222-230" id="s3416.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s3416.e0" e2="s3416.e1" id="s3416.p0" relation="false"/>
  </sentence>
  <sentence id="s3417" text="This study also identified a de novo c.3015_3027dup frameshift mutation predicting p.Lys1010Glnfs*57 in neurofilament bundle assembly from a microtubule-based movement family with an atypical clinical symptom of prominent proximal weakness.">
    <entity charOffset="141-167" id="s3417.e0" ontology_id="GO_0007018" text="microtubule-based movement" type="GO"/>
    <entity charOffset="222-230" id="s3417.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s3417.e0" e2="s3417.e1" id="s3417.p0" relation="false"/>
  </sentence>
  <sentence id="s3418" text="Therefore, this study suggests that the lysosome localization loss and translational elongations by the 3' UTR of the neurofilament bundle assembly mutations may be a relatively frequent genetic cause of axonal peripheral neuropathy with the specific characteristics of proximal dominant weakness">
    <entity charOffset="40-61" id="s3418.e0" ontology_id="GO_0032418" text="lysosome localization" type="GO"/>
    <entity charOffset="270-278" id="s3418.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s3418.e0" e2="s3418.e1" id="s3418.p0" relation="false"/>
  </sentence>
  <sentence id="s3419" text="Therefore, this study suggests that the lysosome localization loss and translational elongations by the 3' UTR of the neurofilament bundle assembly mutations may be a relatively frequent genetic cause of axonal peripheral neuropathy with the specific characteristics of proximal dominant weakness">
    <entity charOffset="118-147" id="s3419.e0" ontology_id="GO_0033693" text="neurofilament bundle assembly" type="GO"/>
    <entity charOffset="270-278" id="s3419.e1" ontology_id="HP_0012840" text="proximal" type="HP"/>
    <pair e1="s3419.e0" e2="s3419.e1" id="s3419.p0" relation="false"/>
  </sentence>
  <sentence id="s3420" text="&lt;b&gt;Rationale:&lt;/b&gt; Oncogenic regulation of transcription, DNA-templated signaling activation and 3p22-21.3 locus alteration are common in multiple tumors, especially carcinomas of the nasopharynx, esophagus and lung.">
    <entity charOffset="28-70" id="s3420.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="146-152" id="s3420.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3420.e0" e2="s3420.e1" id="s3420.p0" relation="true"/>
  </sentence>
  <sentence id="s3421" text="&lt;i&gt;negative regulation of cell proliferation&lt;/i&gt; was frequently downregulated in ESCC, lung and NPC cell lines and primary tumors, but was readily expressed in normal tissues and immortalized normal epithelial cells, with mutations rarely detected.">
    <entity charOffset="3-44" id="s3421.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="123-129" id="s3421.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3421.e0" e2="s3421.e1" id="s3421.p0" relation="true"/>
  </sentence>
  <sentence id="s3422" text="&lt;i&gt;negative regulation of cell proliferation&lt;/i&gt; methylation was frequently detected in ESCC tumors and correlated with lymph node metastasis, tumor recurrence and progression, with &lt;i&gt;DLEC1&lt;/i&gt; as the most frequently methylated among the established 3p22.2 tumor suppressors (&lt;i&gt;RASSF1A, PLCD1&lt;/i&gt; and &lt;i&gt;ZMYND10/BLU&lt;/i&gt;).">
    <entity charOffset="3-44" id="s3422.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="93-99" id="s3422.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3422.e0" e2="s3422.e1" id="s3422.p0" relation="true"/>
  </sentence>
  <sentence id="s3423" text="Mutations in the Pejvakin (biological_process) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.">
    <entity charOffset="27-45" id="s3423.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="137-147" id="s3423.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3423.e0" e2="s3423.e1" id="s3423.p0" relation="false"/>
  </sentence>
  <sentence id="s3424" text="Here, we demonstrate that epidermis development with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.">
    <entity charOffset="26-47" id="s3424.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="211-223" id="s3424.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s3424.e0" e2="s3424.e1" id="s3424.p0" relation="false"/>
  </sentence>
  <sentence id="s3425" text="Here, we demonstrate that epidermis development with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.">
    <entity charOffset="26-47" id="s3425.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="202-210" id="s3425.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s3425.e0" e2="s3425.e1" id="s3425.p0" relation="false"/>
  </sentence>
  <sentence id="s3426" text="In humans, recessive and dominant response to vitamin D mutations cause hypophosphatasia (HPP), a metabolic bone disease with highly heterogeneous clinical manifestations, ranging from lethal perinatal hypomineralization to a relatively mild dental disease.">
    <entity charOffset="34-55" id="s3426.e0" ontology_id="GO_0033280" text="response to vitamin D" type="GO"/>
    <entity charOffset="133-146" id="s3426.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3426.e0" e2="s3426.e1" id="s3426.p0" relation="false"/>
  </sentence>
  <sentence id="s3427" text="Lactate dehydrogenase-A (pyruvate metabolic process) can promote Warburg effect to produce lactate and Adenosine Triphosphate (ATP) in aerobic condition, which contributes to oncogenesis metastasis and drug resistance in various cancers.">
    <entity charOffset="25-51" id="s3427.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="229-235" id="s3427.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3427.e0" e2="s3427.e1" id="s3427.p0" relation="false"/>
  </sentence>
  <sentence id="s3428" text="We determined that pyruvate metabolic process was over-expressed in GBC tumor tissues compared with normal tissues, which was also an independent prognostic factor for the overall survival of GBC patients by tissue microarrays analysis.">
    <entity charOffset="19-45" id="s3428.e0" ontology_id="GO_0006090" text="pyruvate metabolic process" type="GO"/>
    <entity charOffset="72-77" id="s3428.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3428.e0" e2="s3428.e1" id="s3428.p0" relation="false"/>
  </sentence>
  <sentence id="s3429" text="The SNPs rs2124437 (RASGRP3), rs1335022 (protein retention in ER lumen), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (ubiquitin-dependent protein catabolic process) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="41-70" id="s3429.e0" ontology_id="GO_0006621" text="protein retention in ER lumen" type="GO"/>
    <entity charOffset="229-235" id="s3429.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3429.e0" e2="s3429.e1" id="s3429.p0" relation="false"/>
  </sentence>
  <sentence id="s3430" text="The SNPs rs2124437 (RASGRP3), rs1335022 (protein retention in ER lumen), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (ubiquitin-dependent protein catabolic process) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.">
    <entity charOffset="126-171" id="s3430.e0" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <entity charOffset="229-235" id="s3430.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3430.e0" e2="s3430.e1" id="s3430.p0" relation="false"/>
  </sentence>
  <sentence id="s3431" text="A significant association of the SNPs in oral cancer was observed in MAPK cascade AA (rs2124437) (p&amp;lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), protein retention in ER lumen TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), G protein-coupled receptor signaling pathway CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&amp;lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.">
    <entity charOffset="46-52" id="s3431.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="69-81" id="s3431.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s3431.e0" e2="s3431.e1" id="s3431.p0" relation="false"/>
  </sentence>
  <sentence id="s3432" text="A significant association of the SNPs in oral cancer was observed in MAPK cascade AA (rs2124437) (p&amp;lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), protein retention in ER lumen TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), G protein-coupled receptor signaling pathway CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&amp;lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.">
    <entity charOffset="46-52" id="s3432.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="163-192" id="s3432.e1" ontology_id="GO_0006621" text="protein retention in ER lumen" type="GO"/>
    <pair e1="s3432.e0" e2="s3432.e1" id="s3432.p0" relation="false"/>
  </sentence>
  <sentence id="s3433" text="A significant association of the SNPs in oral cancer was observed in MAPK cascade AA (rs2124437) (p&amp;lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), protein retention in ER lumen TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), G protein-coupled receptor signaling pathway CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&amp;lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.">
    <entity charOffset="46-52" id="s3433.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="249-293" id="s3433.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s3433.e0" e2="s3433.e1" id="s3433.p0" relation="false"/>
  </sentence>
  <sentence id="s3434" text="Phosphatase and tensin homolog (negative regulation of protein phosphorylation) is a wellknown tumor suppressor and serves a vital role in cancer progression.">
    <entity charOffset="32-78" id="s3434.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="140-146" id="s3434.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3434.e0" e2="s3434.e1" id="s3434.p0" relation="true"/>
  </sentence>
  <sentence id="s3435" text="Phosphatase and tensin homolog (negative regulation of protein phosphorylation) is a wellknown tumor suppressor and serves a vital role in cancer progression.">
    <entity charOffset="32-78" id="s3435.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="96-101" id="s3435.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3435.e0" e2="s3435.e1" id="s3435.p0" relation="true"/>
  </sentence>
  <sentence id="s3436" text="blood vessel development mutations have been found to be responsible for Tricho-Dento-Osseous (TDO) syndrome, characterized by kinky hair, thin-pitted enamel and increased bone density.">
    <entity charOffset="0-24" id="s3436.e0" ontology_id="GO_0001568" text="blood vessel development" type="GO"/>
    <entity charOffset="162-184" id="s3436.e1" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <pair e1="s3436.e0" e2="s3436.e1" id="s3436.p0" relation="true"/>
  </sentence>
  <sentence id="s3437" text="Here we show that the blood vessel development mutation (c.533A&amp;gt;G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a tryptophan catabolic process to kynurenine patient, providing a molecular explanation for abnormal increased bone density.">
    <entity charOffset="22-46" id="s3437.e0" ontology_id="GO_0001568" text="blood vessel development" type="GO"/>
    <entity charOffset="279-301" id="s3437.e1" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <pair e1="s3437.e0" e2="s3437.e1" id="s3437.p0" relation="true"/>
  </sentence>
  <sentence id="s3438" text="Here we show that the blood vessel development mutation (c.533A&amp;gt;G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a tryptophan catabolic process to kynurenine patient, providing a molecular explanation for abnormal increased bone density.">
    <entity charOffset="180-222" id="s3438.e0" ontology_id="GO_0019441" text="tryptophan catabolic process to kynurenine" type="GO"/>
    <entity charOffset="279-301" id="s3438.e1" ontology_id="HP_0011001" text="increased bone density" type="HP"/>
    <pair e1="s3438.e0" e2="s3438.e1" id="s3438.p0" relation="false"/>
  </sentence>
  <sentence id="s3439" text="The discovery of mutations in genes encoding the metabolic enzymes isocitrate dehydrogenase (IDH), succinate dehydrogenase (choline catabolic process), and fumarate hydratase (FH) has expanded our understanding not only of altered metabolic pathways but also epigenetic dysregulation in cancer.">
    <entity charOffset="124-149" id="s3439.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="287-293" id="s3439.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3439.e0" e2="s3439.e1" id="s3439.p0" relation="false"/>
  </sentence>
  <sentence id="s3440" text="In contrast, choline catabolic process and FH act as tumor suppressors and genomic inactivation results in succinate and fumarate accumulation, respectively.">
    <entity charOffset="13-38" id="s3440.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="53-58" id="s3440.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3440.e0" e2="s3440.e1" id="s3440.p0" relation="false"/>
  </sentence>
  <sentence id="s3441" text="choline catabolic process deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).">
    <entity charOffset="0-25" id="s3441.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="277-282" id="s3441.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3441.e0" e2="s3441.e1" id="s3441.p0" relation="false"/>
  </sentence>
  <sentence id="s3442" text="choline catabolic process deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).">
    <entity charOffset="0-25" id="s3442.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="156-172" id="s3442.e1" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <pair e1="s3442.e0" e2="s3442.e1" id="s3442.p0" relation="false"/>
  </sentence>
  <sentence id="s3443" text="choline catabolic process deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).">
    <entity charOffset="0-25" id="s3443.e0" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <entity charOffset="142-155" id="s3443.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s3443.e0" e2="s3443.e1" id="s3443.p0" relation="false"/>
  </sentence>
  <sentence id="s3444" text="In contrast, patients with the non-hereditary Carney triad, including paraganglioma, GIST, and pulmonary chondroma, usually lack germline choline catabolic process mutations and instead show epigenetic SDH complex inactivation through SDHC promoter methylation.">
    <entity charOffset="70-83" id="s3444.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="138-163" id="s3444.e1" ontology_id="GO_0042426" text="choline catabolic process" type="GO"/>
    <pair e1="s3444.e0" e2="s3444.e1" id="s3444.p0" relation="false"/>
  </sentence>
  <sentence id="s3445" text="&lt;b&gt;Objective:&lt;/b&gt; To investigate the significance of negative regulation of osteoblast differentiation in glioma and whether it is involved in the malignant transformation of glioma by epithelial-mesenchymal transition (EMT).">
    <entity charOffset="53-102" id="s3445.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="106-112" id="s3445.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3445.e0" e2="s3445.e1" id="s3445.p0" relation="false"/>
  </sentence>
  <sentence id="s3446" text="&lt;b&gt;Methods:&lt;/b&gt; Using immunohistochemical method detected the expression level of negative regulation of osteoblast differentiation in 60 cases of gliomas (including WHO grades ,  and , each for 20 cases) and 20 cases of non-tumor brain tissues.">
    <entity charOffset="82-131" id="s3446.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="147-153" id="s3446.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3446.e0" e2="s3446.e1" id="s3446.p0" relation="false"/>
  </sentence>
  <sentence id="s3447" text="&lt;b&gt;Results:&lt;/b&gt; Immunohistochemistry results showed that the percentages of negative regulation of osteoblast differentiation expression in glioma was 90%(54/60) compared with 30%(6/20) in non-tumor brain tissues(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="76-125" id="s3447.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="140-146" id="s3447.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3447.e0" e2="s3447.e1" id="s3447.p0" relation="false"/>
  </sentence>
  <sentence id="s3448" text="&lt;b&gt;Results:&lt;/b&gt; Immunohistochemistry results showed that the percentages of negative regulation of osteoblast differentiation expression in glioma was 90%(54/60) compared with 30%(6/20) in non-tumor brain tissues(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="76-125" id="s3448.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="193-198" id="s3448.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3448.e0" e2="s3448.e1" id="s3448.p0" relation="false"/>
  </sentence>
  <sentence id="s3449" text="Real-time fluorescence quantitative PCR and Western blot showed that the expression level of negative regulation of transcription, DNA-templated 2 in gliomas was significantly higher than that in para-cancerous tissues (&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01), and those in WHO grades  and  gliomas were significantly higher than that in WHO grade  glioma (&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="93-144" id="s3449.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="150-156" id="s3449.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3449.e0" e2="s3449.e1" id="s3449.p0" relation="false"/>
  </sentence>
  <sentence id="s3450" text="The expression of N-cadherin and vimentin was positively associated with negative regulation of osteoblast differentiation in glioma(&lt;i&gt;r&lt;/i&gt;=0.971, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.01; &lt;i&gt;r&lt;/i&gt;=0.968, &lt;i&gt;P&lt;/i&gt;&amp;lt;0.01).">
    <entity charOffset="73-122" id="s3450.e0" ontology_id="GO_0045668" text="negative regulation of osteoblast differentiation" type="GO"/>
    <entity charOffset="126-132" id="s3450.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3450.e0" e2="s3450.e1" id="s3450.p0" relation="false"/>
  </sentence>
  <sentence id="s3451" text="Global-genome nucleotide excision repair (GG-NER) prevents ultraviolet (UV) light-induced skin cancer by removing mutagenic cyclobutane pyrimidine dimers (sensory perception of sounds).">
    <entity charOffset="95-101" id="s3451.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="155-182" id="s3451.e1" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <pair e1="s3451.e0" e2="s3451.e1" id="s3451.p0" relation="false"/>
  </sentence>
  <sentence id="s3452" text="Superficial tissue homeostasis-positive fibroblastic tumor is a recently described soft-tissue tumor entity.">
    <entity charOffset="12-30" id="s3452.e0" ontology_id="GO_0001894" text="tissue homeostasis" type="GO"/>
    <entity charOffset="53-58" id="s3452.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3452.e0" e2="s3452.e1" id="s3452.p0" relation="false"/>
  </sentence>
  <sentence id="s3453" text="A 48 year-old-male presented with a gradually increasing soft-tissue cell adhesion mediated by integrin in his right forearm of 2 years' duration, along with multiple subcutaneous soft-tissue nodular lesions, and reminiscent of lipomas over his body.">
    <entity charOffset="69-103" id="s3453.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="228-235" id="s3453.e1" ontology_id="HP_0012032" text="lipomas" type="HP"/>
    <pair e1="s3453.e0" e2="s3453.e1" id="s3453.p0" relation="false"/>
  </sentence>
  <sentence id="s3454" text="Microscopic sections showed a circumscribed tumor in the dermis and subcutaneous positive regulation of cell-matrix adhesion, composed of spindle cells, inflammatory cells, including lymphocytes, plasma cells, and eosinophils, along with interspersed markedly pleomorphic giant cells containing moderate-to-abundant &amp;quot;glassy&amp;quot; cytoplasm, vesicular nuclei, exhibiting prominent nucleoli, and intranuclear pseudoinclusions.">
    <entity charOffset="44-49" id="s3454.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="81-124" id="s3454.e1" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s3454.e0" e2="s3454.e1" id="s3454.p0" relation="false"/>
  </sentence>
  <sentence id="s3455" text="By immunohistochemistry, the tumor cells were diffusely positive for tissue homeostasis while negative for cytokeratin (CK), pan CK (AE1/AE3), S100 protein, CD30, and CD31.">
    <entity charOffset="29-34" id="s3455.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="69-87" id="s3455.e1" ontology_id="GO_0001894" text="tissue homeostasis" type="GO"/>
    <pair e1="s3455.e0" e2="s3455.e1" id="s3455.p0" relation="false"/>
  </sentence>
  <sentence id="s3456" text="Diagnosis of superficial tissue homeostasis-positive fibroblastic tumor was offered.">
    <entity charOffset="25-43" id="s3456.e0" ontology_id="GO_0001894" text="tissue homeostasis" type="GO"/>
    <entity charOffset="66-71" id="s3456.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3456.e0" e2="s3456.e1" id="s3456.p0" relation="false"/>
  </sentence>
  <sentence id="s3457" text="Fluorescence in situ hybridisation (superoxide metabolic process) targeting specific genes has been used as an ancillary method for differential diagnosis of melanocytic tumours, but most previous studies have focused on non-acral lesions which may have genetic alterations different from acral lesions.">
    <entity charOffset="36-64" id="s3457.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="170-177" id="s3457.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s3457.e0" e2="s3457.e1" id="s3457.p0" relation="false"/>
  </sentence>
  <sentence id="s3458" text="We evaluated use of multi-site superoxide metabolic process in the diagnosis of acral melanoma in a series of 82 acral melanocytic tumours.">
    <entity charOffset="31-59" id="s3458.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="131-138" id="s3458.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s3458.e0" e2="s3458.e1" id="s3458.p0" relation="false"/>
  </sentence>
  <sentence id="s3459" text="We evaluated use of multi-site superoxide metabolic process in the diagnosis of acral melanoma in a series of 82 acral melanocytic tumours.">
    <entity charOffset="31-59" id="s3459.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="80-85" id="s3459.e1" ontology_id="HP_0025292" text="acral" type="HP"/>
    <pair e1="s3459.e0" e2="s3459.e1" id="s3459.p0" relation="false"/>
  </sentence>
  <sentence id="s3460" text="In 44 primary acral melanomas, sensitivity was 70.5% (31/44) using probe negative regulation of transcription, DNA-templated 1 alone, and 59.1% (26/44) using probe set 2 alone.">
    <entity charOffset="14-19" id="s3460.e0" ontology_id="HP_0025292" text="acral" type="HP"/>
    <entity charOffset="73-124" id="s3460.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3460.e0" e2="s3460.e1" id="s3460.p0" relation="false"/>
  </sentence>
  <sentence id="s3461" text="Recessive mutations in positive regulation of protein phosphorylation cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-69" id="s3461.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="92-100" id="s3461.e1" ontology_id="HP_0002063" text="rigidity" type="HP"/>
    <pair e1="s3461.e0" e2="s3461.e1" id="s3461.p0" relation="true"/>
  </sentence>
  <sentence id="s3462" text="Recessive mutations in positive regulation of protein phosphorylation cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-69" id="s3462.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="105-115" id="s3462.e1" ontology_id="HP_0030651" text="multifocal" type="HP"/>
    <pair e1="s3462.e0" e2="s3462.e1" id="s3462.p0" relation="false"/>
  </sentence>
  <sentence id="s3463" text="Recessive mutations in positive regulation of protein phosphorylation cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-69" id="s3463.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="116-123" id="s3463.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s3463.e0" e2="s3463.e1" id="s3463.p0" relation="true"/>
  </sentence>
  <sentence id="s3464" text="Recessive mutations in positive regulation of protein phosphorylation cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-69" id="s3464.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="172-184" id="s3464.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3464.e0" e2="s3464.e1" id="s3464.p0" relation="true"/>
  </sentence>
  <sentence id="s3465" text="Recessive mutations in positive regulation of protein phosphorylation cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-69" id="s3465.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="186-196" id="s3465.e1" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <pair e1="s3465.e0" e2="s3465.e1" id="s3465.p0" relation="true"/>
  </sentence>
  <sentence id="s3466" text="Mildly affected individuals with positive regulation of protein phosphorylation mutations show that BRAT1 must be considered as a cause in childhood refractory epilepsy and microcephaly with survival beyond infancy.">
    <entity charOffset="33-79" id="s3466.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="173-185" id="s3466.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3466.e0" e2="s3466.e1" id="s3466.p0" relation="true"/>
  </sentence>
  <sentence id="s3467" text="Mildly affected individuals with positive regulation of protein phosphorylation mutations show that BRAT1 must be considered as a cause in childhood refractory epilepsy and microcephaly with survival beyond infancy.">
    <entity charOffset="33-79" id="s3467.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="160-168" id="s3467.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3467.e0" e2="s3467.e1" id="s3467.p0" relation="true"/>
  </sentence>
  <sentence id="s3468" text="Moreover, we demonstrated that pharmacological inhibition of 15-L-serine biosynthetic process enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the oxidation-reduction process-positive subset in both human PDAC cells and tumor cells of Kras&lt;sup&gt;LSL-G12D/+&lt;/sup&gt;; Ptf1a&lt;sup&gt;Cre/+&lt;/sup&gt; (KC) mice.">
    <entity charOffset="64-93" id="s3468.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="272-277" id="s3468.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3468.e0" e2="s3468.e1" id="s3468.p0" relation="false"/>
  </sentence>
  <sentence id="s3469" text="Moreover, we demonstrated that pharmacological inhibition of 15-L-serine biosynthetic process enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the oxidation-reduction process-positive subset in both human PDAC cells and tumor cells of Kras&lt;sup&gt;LSL-G12D/+&lt;/sup&gt;; Ptf1a&lt;sup&gt;Cre/+&lt;/sup&gt; (KC) mice.">
    <entity charOffset="199-226" id="s3469.e0" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <entity charOffset="272-277" id="s3469.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3469.e0" e2="s3469.e1" id="s3469.p0" relation="false"/>
  </sentence>
  <sentence id="s3470" text="Finally, ATRA replacement suppressed 15-L-serine biosynthetic process inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated oxidation-reduction process activity in tumor cells isolated from the pancreas of 15-L-serine biosynthetic process&lt;sup&gt;-/-&lt;/sup&gt; KC mice.">
    <entity charOffset="40-69" id="s3470.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="89-94" id="s3470.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3470.e0" e2="s3470.e1" id="s3470.p0" relation="false"/>
  </sentence>
  <sentence id="s3471" text="Finally, ATRA replacement suppressed 15-L-serine biosynthetic process inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated oxidation-reduction process activity in tumor cells isolated from the pancreas of 15-L-serine biosynthetic process&lt;sup&gt;-/-&lt;/sup&gt; KC mice.">
    <entity charOffset="89-94" id="s3471.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="234-263" id="s3471.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="s3471.e0" e2="s3471.e1" id="s3471.p0" relation="false"/>
  </sentence>
  <sentence id="s3472" text="Finally, ATRA replacement suppressed 15-L-serine biosynthetic process inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated oxidation-reduction process activity in tumor cells isolated from the pancreas of 15-L-serine biosynthetic process&lt;sup&gt;-/-&lt;/sup&gt; KC mice.">
    <entity charOffset="89-94" id="s3472.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="149-176" id="s3472.e1" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <pair e1="s3472.e0" e2="s3472.e1" id="s3472.p0" relation="false"/>
  </sentence>
  <sentence id="s3473" text="These findings provide evidence that 15-L-serine biosynthetic process inhibition enhances positive regulation of protein phosphorylation-driven tumor progression via ATRA depletion in the pancreas.">
    <entity charOffset="40-69" id="s3473.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="144-149" id="s3473.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3473.e0" e2="s3473.e1" id="s3473.p0" relation="false"/>
  </sentence>
  <sentence id="s3474" text="These findings provide evidence that 15-L-serine biosynthetic process inhibition enhances positive regulation of protein phosphorylation-driven tumor progression via ATRA depletion in the pancreas.">
    <entity charOffset="90-136" id="s3474.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="144-149" id="s3474.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3474.e0" e2="s3474.e1" id="s3474.p0" relation="true"/>
  </sentence>
  <sentence id="s3475" text="Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&amp;gt;A, negative regulation of translation 829C&amp;gt;T, regulation of histone methylation 677C&amp;gt;T, MTHFR 1298A&amp;gt;C, and nucleobase-containing compound metabolic process 347C&amp;gt;G.">
    <entity charOffset="33-45" id="s3475.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="135-169" id="s3475.e1" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <pair e1="s3475.e0" e2="s3475.e1" id="s3475.p0" relation="false"/>
  </sentence>
  <sentence id="s3476" text="Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&amp;gt;A, negative regulation of translation 829C&amp;gt;T, regulation of histone methylation 677C&amp;gt;T, MTHFR 1298A&amp;gt;C, and nucleobase-containing compound metabolic process 347C&amp;gt;G.">
    <entity charOffset="33-45" id="s3476.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="181-214" id="s3476.e1" ontology_id="GO_0031060" text="regulation of histone methylation" type="GO"/>
    <pair e1="s3476.e0" e2="s3476.e1" id="s3476.p0" relation="false"/>
  </sentence>
  <sentence id="s3477" text="Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&amp;gt;A, negative regulation of translation 829C&amp;gt;T, regulation of histone methylation 677C&amp;gt;T, MTHFR 1298A&amp;gt;C, and nucleobase-containing compound metabolic process 347C&amp;gt;G.">
    <entity charOffset="33-45" id="s3477.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="248-296" id="s3477.e1" ontology_id="GO_0006139" text="nucleobase-containing compound metabolic process" type="GO"/>
    <pair e1="s3477.e0" e2="s3477.e1" id="s3477.p0" relation="false"/>
  </sentence>
  <sentence id="s3478" text="Even though the role of single nucleotide polymorphisms of nucleobase-containing compound metabolic process in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&amp;gt;G polymorphism may influence the levels of adenosine after lactation treatment, which may affect the histologic response of osteosarcoma.">
    <entity charOffset="59-107" id="s3478.e0" ontology_id="GO_0006139" text="nucleobase-containing compound metabolic process" type="GO"/>
    <entity charOffset="319-331" id="s3478.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s3478.e0" e2="s3478.e1" id="s3478.p0" relation="false"/>
  </sentence>
  <sentence id="s3479" text="Even though the role of single nucleotide polymorphisms of nucleobase-containing compound metabolic process in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&amp;gt;G polymorphism may influence the levels of adenosine after lactation treatment, which may affect the histologic response of osteosarcoma.">
    <entity charOffset="59-107" id="s3479.e0" ontology_id="GO_0006139" text="nucleobase-containing compound metabolic process" type="GO"/>
    <entity charOffset="132-137" id="s3479.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3479.e0" e2="s3479.e1" id="s3479.p0" relation="false"/>
  </sentence>
  <sentence id="s3480" text="Even though the role of single nucleotide polymorphisms of nucleobase-containing compound metabolic process in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&amp;gt;G polymorphism may influence the levels of adenosine after lactation treatment, which may affect the histologic response of osteosarcoma.">
    <entity charOffset="132-137" id="s3480.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="254-263" id="s3480.e1" ontology_id="GO_0007595" text="lactation" type="GO"/>
    <pair e1="s3480.e0" e2="s3480.e1" id="s3480.p0" relation="false"/>
  </sentence>
  <sentence id="s3481" text="Even though the role of single nucleotide polymorphisms of nucleobase-containing compound metabolic process in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&amp;gt;G polymorphism may influence the levels of adenosine after lactation treatment, which may affect the histologic response of osteosarcoma.">
    <entity charOffset="254-263" id="s3481.e0" ontology_id="GO_0007595" text="lactation" type="GO"/>
    <entity charOffset="319-331" id="s3481.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s3481.e0" e2="s3481.e1" id="s3481.p0" relation="false"/>
  </sentence>
  <sentence id="s3482" text="A recent syndromic condition with craniofacial dysmorphisms, comprising congenital ocular defect and neurodevelopmental delay named Helsmoortel-glycoprotein biosynthetic process der Aa Syndrome (HVDAS) (OMIM#615873), has been described and molecularly defined, identifying pathogenic mutations in the regulation of transcription by RNA polymerase II gene (OMIM#611386) as biological cause.">
    <entity charOffset="101-125" id="s3482.e0" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <entity charOffset="144-177" id="s3482.e1" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <pair e1="s3482.e0" e2="s3482.e1" id="s3482.p0" relation="false"/>
  </sentence>
  <sentence id="s3483" text="A recent syndromic condition with craniofacial dysmorphisms, comprising congenital ocular defect and neurodevelopmental delay named Helsmoortel-glycoprotein biosynthetic process der Aa Syndrome (HVDAS) (OMIM#615873), has been described and molecularly defined, identifying pathogenic mutations in the regulation of transcription by RNA polymerase II gene (OMIM#611386) as biological cause.">
    <entity charOffset="101-125" id="s3483.e0" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <entity charOffset="301-349" id="s3483.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3483.e0" e2="s3483.e1" id="s3483.p0" relation="true"/>
  </sentence>
  <sentence id="s3484" text="We report on two children, displaying intellectual disability (ID) and peculiar congenital eyes anomalies, both carrying a de novo nonsense mutation in the regulation of transcription by RNA polymerase II gene.">
    <entity charOffset="38-61" id="s3484.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="156-204" id="s3484.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3484.e0" e2="s3484.e1" id="s3484.p0" relation="true"/>
  </sentence>
  <sentence id="s3485" text="Genes involved in tissue development, differentiation, and oncogenesis such as protein refolding, HES5, negative regulation of transcription by RNA polymerase II, diet induced thermogenesis, positive regulation of transcription, DNA-templated, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="79-96" id="s3485.e0" ontology_id="GO_0042026" text="protein refolding" type="GO"/>
    <entity charOffset="392-408" id="s3485.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s3485.e0" e2="s3485.e1" id="s3485.p0" relation="false"/>
  </sentence>
  <sentence id="s3486" text="Genes involved in tissue development, differentiation, and oncogenesis such as protein refolding, HES5, negative regulation of transcription by RNA polymerase II, diet induced thermogenesis, positive regulation of transcription, DNA-templated, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="104-161" id="s3486.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="392-408" id="s3486.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s3486.e0" e2="s3486.e1" id="s3486.p0" relation="false"/>
  </sentence>
  <sentence id="s3487" text="Genes involved in tissue development, differentiation, and oncogenesis such as protein refolding, HES5, negative regulation of transcription by RNA polymerase II, diet induced thermogenesis, positive regulation of transcription, DNA-templated, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="163-189" id="s3487.e0" ontology_id="GO_0002024" text="diet induced thermogenesis" type="GO"/>
    <entity charOffset="392-408" id="s3487.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s3487.e0" e2="s3487.e1" id="s3487.p0" relation="false"/>
  </sentence>
  <sentence id="s3488" text="Genes involved in tissue development, differentiation, and oncogenesis such as protein refolding, HES5, negative regulation of transcription by RNA polymerase II, diet induced thermogenesis, positive regulation of transcription, DNA-templated, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.">
    <entity charOffset="191-242" id="s3488.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="392-408" id="s3488.e1" ontology_id="HP_0002859" text="rhabdomyosarcoma" type="HP"/>
    <pair e1="s3488.e0" e2="s3488.e1" id="s3488.p0" relation="false"/>
  </sentence>
  <sentence id="s3489" text="Partial loss-of-function variants in the positive regulation of antigen processing and presentation of peptide antigen via MHC class II immune receptor are associated with increased risk for Alzheimer's disease (AD) and other forms of neurodegenerative disease, but the molecular bases for these connections are unknown.">
    <entity charOffset="41-135" id="s3489.e0" ontology_id="GO_0002588" text="positive regulation of antigen processing and presentation of peptide antigen via MHC class II" type="GO"/>
    <entity charOffset="235-260" id="s3489.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s3489.e0" e2="s3489.e1" id="s3489.p0" relation="true"/>
  </sentence>
  <sentence id="s3490" text="Excess accumulation of endogenous all-trans-retinal (atRAL) contributes to degeneration of the retinal pigment epithelium (carbohydrate metabolic process) and photoreceptor cells, and plays a role in the etiologies of age-related macular degeneration (AMD) and Stargardt's disease.">
    <entity charOffset="123-153" id="s3490.e0" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <entity charOffset="230-250" id="s3490.e1" ontology_id="HP_0000608" text="macular degeneration" type="HP"/>
    <pair e1="s3490.e0" e2="s3490.e1" id="s3490.p0" relation="false"/>
  </sentence>
  <sentence id="s3491" text="Progressive retinal atrophy (signal transduction) is the canine equivalent of retinitis pigmentosa (RP).">
    <entity charOffset="12-27" id="s3491.e0" ontology_id="HP_0001105" text="retinal atrophy" type="HP"/>
    <entity charOffset="29-48" id="s3491.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s3491.e0" e2="s3491.e1" id="s3491.p0" relation="false"/>
  </sentence>
  <sentence id="s3492" text="Therefore, we evaluated the roles of peptidyl-serine phosphorylation, regulation of double-strand break repair via homologous recombination, and phosphorylated SIRT6 and their relationships in breast carcinoma.">
    <entity charOffset="37-68" id="s3492.e0" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <entity charOffset="193-209" id="s3492.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s3492.e0" e2="s3492.e1" id="s3492.p0" relation="false"/>
  </sentence>
  <sentence id="s3493" text="Therefore, we evaluated the roles of peptidyl-serine phosphorylation, regulation of double-strand break repair via homologous recombination, and phosphorylated SIRT6 and their relationships in breast carcinoma.">
    <entity charOffset="70-139" id="s3493.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="193-209" id="s3493.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s3493.e0" e2="s3493.e1" id="s3493.p0" relation="false"/>
  </sentence>
  <sentence id="s3494" text="Inhibition of peptidyl-serine phosphorylation decreased the proliferative and invasive activity of cancer cells.">
    <entity charOffset="14-45" id="s3494.e0" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <entity charOffset="99-105" id="s3494.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3494.e0" e2="s3494.e1" id="s3494.p0" relation="false"/>
  </sentence>
  <sentence id="s3495" text="Knockdown of regulation of double-strand break repair via homologous recombination decreased the proliferation and invasiveness of cancer cells.">
    <entity charOffset="13-82" id="s3495.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="131-137" id="s3495.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3495.e0" e2="s3495.e1" id="s3495.p0" relation="false"/>
  </sentence>
  <sentence id="s3496" text="Glioblastoma (GBM) is the most prevalent and lethal muscle organ development of primary malignant brain tumour.">
    <entity charOffset="52-76" id="s3496.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="104-110" id="s3496.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3496.e0" e2="s3496.e1" id="s3496.p0" relation="false"/>
  </sentence>
  <sentence id="s3497" text="We found that protein polyubiquitination-UL112-3p expression was significantly elevated in GBM, and its expression levels were highly associated with glioma size, differentiation, WHO stage and the overall and disease-free survival of patients.">
    <entity charOffset="14-40" id="s3497.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="150-156" id="s3497.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s3497.e0" e2="s3497.e1" id="s3497.p0" relation="false"/>
  </sentence>
  <sentence id="s3498" text="This study identifies a negative regulation of transcription, DNA-templated of candidate genes and their potential regulatory variants, and provides additional evidence showing the role of long-range chromatin interactions in prostate cancer etiology">
    <entity charOffset="24-75" id="s3498.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="235-241" id="s3498.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3498.e0" e2="s3498.e1" id="s3498.p0" relation="false"/>
  </sentence>
  <sentence id="s3499" text="Herein, we performed comparative quantitative proteomics on whole plasma sampled from patients with stable angina (inflammatory response), acute myocardial infarction (MI), and healthy control subjects (protein catabolic process).">
    <entity charOffset="115-136" id="s3499.e0" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <entity charOffset="145-166" id="s3499.e1" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <pair e1="s3499.e0" e2="s3499.e1" id="s3499.p0" relation="false"/>
  </sentence>
  <sentence id="s3500" text="Herein, we performed comparative quantitative proteomics on whole plasma sampled from patients with stable angina (inflammatory response), acute myocardial infarction (MI), and healthy control subjects (protein catabolic process).">
    <entity charOffset="145-166" id="s3500.e0" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <entity charOffset="203-228" id="s3500.e1" ontology_id="GO_0030163" text="protein catabolic process" type="GO"/>
    <pair e1="s3500.e0" e2="s3500.e1" id="s3500.p0" relation="false"/>
  </sentence>
  <sentence id="s3501" text="It is caused by recessive mutations in &lt;i&gt;platelet formation&lt;/i&gt;, resulting in macrothrombocytopenia and myelofibrosis.">
    <entity charOffset="42-60" id="s3501.e0" ontology_id="GO_0030220" text="platelet formation" type="GO"/>
    <entity charOffset="79-100" id="s3501.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s3501.e0" e2="s3501.e1" id="s3501.p0" relation="false"/>
  </sentence>
  <sentence id="s3502" text="Despite promising therapeutic avenues, there is currently no effective treatment for Duchenne muscular dystrophy (peptide biosynthetic process), a lethal monogenic disorder caused by the loss of the large cytoskeletal protein, dystrophin.">
    <entity charOffset="94-112" id="s3502.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="114-142" id="s3502.e1" ontology_id="GO_0043043" text="peptide biosynthetic process" type="GO"/>
    <pair e1="s3502.e0" e2="s3502.e1" id="s3502.p0" relation="true"/>
  </sentence>
  <sentence id="s3503" text="The 18 new diagnoses made with WGS included structural and non-exonic sequence variants not detectable with whole-exome sequencing, and confirmed recent disease associations with the genes GPI anchor biosynthetic process, RNU4ATAC, negative regulation of fat cell differentiation, and UNC13A.ConclusionWGS as a primary clinical test provided a higher diagnostic yield than conventional genetic testing in a clinically heterogeneous cohort">
    <entity charOffset="189-220" id="s3503.e0" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <entity charOffset="418-431" id="s3503.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3503.e0" e2="s3503.e1" id="s3503.p0" relation="false"/>
  </sentence>
  <sentence id="s3504" text="The 18 new diagnoses made with WGS included structural and non-exonic sequence variants not detectable with whole-exome sequencing, and confirmed recent disease associations with the genes GPI anchor biosynthetic process, RNU4ATAC, negative regulation of fat cell differentiation, and UNC13A.ConclusionWGS as a primary clinical test provided a higher diagnostic yield than conventional genetic testing in a clinically heterogeneous cohort">
    <entity charOffset="232-279" id="s3504.e0" ontology_id="GO_0045599" text="negative regulation of fat cell differentiation" type="GO"/>
    <entity charOffset="418-431" id="s3504.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3504.e0" e2="s3504.e1" id="s3504.p0" relation="false"/>
  </sentence>
  <sentence id="s3505" text="However, mutation screening of these genes revealed two mutated alleles in only just over half of our cilium assembly cohort (46 families), suggesting an even greater level of genetic heterogeneity.">
    <entity charOffset="102-117" id="s3505.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="184-197" id="s3505.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s3505.e0" e2="s3505.e1" id="s3505.p0" relation="false"/>
  </sentence>
  <sentence id="s3506" text="The fetus inherited an additional likely pathogenic novel missense change to a second cilium assembly gene, CEP290; p.R2210C, suggesting oligogenic inheritance in this disorder">
    <entity charOffset="86-101" id="s3506.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="137-159" id="s3506.e1" ontology_id="HP_0010983" text="oligogenic inheritance" type="HP"/>
    <pair e1="s3506.e0" e2="s3506.e1" id="s3506.p0" relation="false"/>
  </sentence>
  <sentence id="s3507" text="Loss of negative regulation of transcription by RNA polymerase II function in humans and mice leads to the development of several pathologies, including neonatal diabetes and congenital hypothyroidism, polycystic kidney disease, and infertility.">
    <entity charOffset="8-65" id="s3507.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="186-200" id="s3507.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s3507.e0" e2="s3507.e1" id="s3507.p0" relation="true"/>
  </sentence>
  <sentence id="s3508" text="Single nucleotide polymorphisms in negative regulation of transcription by RNA polymerase II genes have been associated with increased risk of several diseases, including type 1 and type 2 diabetes, glaucoma, and neurological disorders.">
    <entity charOffset="35-92" id="s3508.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="199-207" id="s3508.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s3508.e0" e2="s3508.e1" id="s3508.p0" relation="true"/>
  </sentence>
  <sentence id="s3509" text="The proband carried the two kinds of mutations and expressed various clinical manifestations of heart failure and had history of ventricular tachycardia, paraxial atrial fibrillation, pacemaker implantation, electrocardiogram showed right bundle branch block and echocardiography examination evidenced thickened interventricular septum (23.3 mm) and telomere maintenance and reduced wall motion of these segments.">
    <entity charOffset="129-152" id="s3509.e0" ontology_id="HP_0004756" text="ventricular tachycardia" type="HP"/>
    <entity charOffset="350-370" id="s3509.e1" ontology_id="GO_0000723" text="telomere maintenance" type="GO"/>
    <pair e1="s3509.e0" e2="s3509.e1" id="s3509.p0" relation="false"/>
  </sentence>
  <sentence id="s3510" text="Homozygous, loss of function variants in G protein-coupled receptor signaling pathway was initially implicated in autosomal recessive IGD; however, most IGD-associated PROKR2 variants are heterozygous.">
    <entity charOffset="41-85" id="s3510.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="114-133" id="s3510.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3510.e0" e2="s3510.e1" id="s3510.p0" relation="true"/>
  </sentence>
  <sentence id="s3511" text="Hyperpolarization-coenzyme A biosynthetic processivated cyclic nucleotide-gated channels (HCN) can act as pacemakers in the brain making them strong candidates for driving aberrant hypersynchronous network activity seen in epilepsy.">
    <entity charOffset="18-49" id="s3511.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="223-231" id="s3511.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3511.e0" e2="s3511.e1" id="s3511.p0" relation="false"/>
  </sentence>
  <sentence id="s3512" text="However, only recently have genetic studies demonstrated sequence variation in HCN1 and cellular response to cAMP genes associated with human epilepsy.">
    <entity charOffset="88-113" id="s3512.e0" ontology_id="GO_0071320" text="cellular response to cAMP" type="GO"/>
    <entity charOffset="142-150" id="s3512.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s3512.e0" e2="s3512.e1" id="s3512.p0" relation="false"/>
  </sentence>
  <sentence id="s3513" text="These include a triple proline deletion in cellular response to cAMP that increases channel function and occurs more often in patients with febrile seizure syndromes.">
    <entity charOffset="43-68" id="s3513.e0" ontology_id="GO_0071320" text="cellular response to cAMP" type="GO"/>
    <entity charOffset="148-155" id="s3513.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s3513.e0" e2="s3513.e1" id="s3513.p0" relation="false"/>
  </sentence>
  <sentence id="s3514" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).">
    <entity charOffset="160-191" id="s3514.e0" ontology_id="GO_1902358" text="sulfate transmembrane transport" type="GO"/>
    <entity charOffset="356-375" id="s3514.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3514.e0" e2="s3514.e1" id="s3514.p0" relation="true"/>
  </sentence>
  <sentence id="s3515" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).">
    <entity charOffset="268-286" id="s3515.e0" ontology_id="GO_0048240" text="sperm capacitation" type="GO"/>
    <entity charOffset="347-355" id="s3515.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3515.e0" e2="s3515.e1" id="s3515.p0" relation="false"/>
  </sentence>
  <sentence id="s3516" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).">
    <entity charOffset="268-286" id="s3516.e0" ontology_id="GO_0048240" text="sperm capacitation" type="GO"/>
    <entity charOffset="356-375" id="s3516.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3516.e0" e2="s3516.e1" id="s3516.p0" relation="true"/>
  </sentence>
  <sentence id="s3517" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).">
    <entity charOffset="347-355" id="s3517.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="406-422" id="s3517.e1" ontology_id="GO_0006885" text="regulation of pH" type="GO"/>
    <pair e1="s3517.e0" e2="s3517.e1" id="s3517.p0" relation="true"/>
  </sentence>
  <sentence id="s3518" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).">
    <entity charOffset="356-375" id="s3518.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="376-400" id="s3518.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3518.e0" e2="s3518.e1" id="s3518.p0" relation="true"/>
  </sentence>
  <sentence id="s3519" text="A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).">
    <entity charOffset="356-375" id="s3519.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="406-422" id="s3519.e1" ontology_id="GO_0006885" text="regulation of pH" type="GO"/>
    <pair e1="s3519.e0" e2="s3519.e1" id="s3519.p0" relation="true"/>
  </sentence>
  <sentence id="s3520" text="To identify other possible transcriptional targets of positive regulation of antibacterial peptide production-1 in neural tissue, we conducted a microarray on neuroblastoma cells overexpressing PGC-1, mined results for genes with physiological relevance to interneurons, and measured cortical gene and protein expression of these genes in epidermis development with underexpression and overexpression of PGC-1.">
    <entity charOffset="54-109" id="s3520.e0" ontology_id="GO_0002803" text="positive regulation of antibacterial peptide production" type="GO"/>
    <entity charOffset="160-173" id="s3520.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s3520.e0" e2="s3520.e1" id="s3520.p0" relation="false"/>
  </sentence>
  <sentence id="s3521" text="To identify other possible transcriptional targets of positive regulation of antibacterial peptide production-1 in neural tissue, we conducted a microarray on neuroblastoma cells overexpressing PGC-1, mined results for genes with physiological relevance to interneurons, and measured cortical gene and protein expression of these genes in epidermis development with underexpression and overexpression of PGC-1.">
    <entity charOffset="160-173" id="s3521.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="341-362" id="s3521.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3521.e0" e2="s3521.e1" id="s3521.p0" relation="false"/>
  </sentence>
  <sentence id="s3522" text="In order to investigate essential molecular causes for hearing loss and mutation frequency of deafness-related genes, 1315 newborns who did not pass the Newborn Hearing Screening (biological_process) (audio-no-pass) and 1000 random-selected infants were subjected to detection for 101 hotspot mutations in 18 common deafness-related genes.">
    <entity charOffset="94-102" id="s3522.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="180-198" id="s3522.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3522.e0" e2="s3522.e1" id="s3522.p0" relation="false"/>
  </sentence>
  <sentence id="s3523" text="Treacher Collins syndrome (regulation of translation, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-52" id="s3523.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="85-111" id="s3523.e1" ontology_id="HP_0005321" text="mandibulofacial dysostosis" type="HP"/>
    <pair e1="s3523.e0" e2="s3523.e1" id="s3523.p0" relation="false"/>
  </sentence>
  <sentence id="s3524" text="Treacher Collins syndrome (regulation of translation, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-52" id="s3524.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="170-186" id="s3524.e1" ontology_id="HP_0000272" text="malar hypoplasia" type="HP"/>
    <pair e1="s3524.e0" e2="s3524.e1" id="s3524.p0" relation="true"/>
  </sentence>
  <sentence id="s3525" text="Treacher Collins syndrome (regulation of translation, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-52" id="s3525.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="218-233" id="s3525.e1" ontology_id="HP_0000377" text="dysplastic ears" type="HP"/>
    <pair e1="s3525.e0" e2="s3525.e1" id="s3525.p0" relation="true"/>
  </sentence>
  <sentence id="s3526" text="Treacher Collins syndrome (regulation of translation, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.">
    <entity charOffset="27-52" id="s3526.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="266-274" id="s3526.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s3526.e0" e2="s3526.e1" id="s3526.p0" relation="true"/>
  </sentence>
  <sentence id="s3527" text="Here we describe three unrelated patients showing clinical features overlapping with regulation of translation, but who in addition have developmental delay, microcephaly and a distinct facial gestalt.">
    <entity charOffset="85-110" id="s3527.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="158-170" id="s3527.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3527.e0" e2="s3527.e1" id="s3527.p0" relation="false"/>
  </sentence>
  <sentence id="s3528" text="Because of the distinct ear anomalies and the hearing loss a cell fate determination mutation was taken into account.">
    <entity charOffset="46-58" id="s3528.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="61-84" id="s3528.e1" ontology_id="GO_0001709" text="cell fate determination" type="GO"/>
    <pair e1="s3528.e0" e2="s3528.e1" id="s3528.p0" relation="true"/>
  </sentence>
  <sentence id="s3529" text="We and others have recently demonstrated that peptidyl-tyrosine phosphorylation is a key mediator of growth, invasion, and metastasis, and therefore represents a promising therapeutic target in thyroid cancer.">
    <entity charOffset="46-79" id="s3529.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="202-208" id="s3529.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3529.e0" e2="s3529.e1" id="s3529.p0" relation="true"/>
  </sentence>
  <sentence id="s3530" text="Consistently, eye development deficiency associates with neural tube defects and coloboma, a congenital eye disease.">
    <entity charOffset="14-29" id="s3530.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="57-76" id="s3530.e1" ontology_id="HP_0045005" text="neural tube defects" type="HP"/>
    <pair e1="s3530.e0" e2="s3530.e1" id="s3530.p0" relation="false"/>
  </sentence>
  <sentence id="s3531" text="Consistently, eye development deficiency associates with neural tube defects and coloboma, a congenital eye disease.">
    <entity charOffset="14-29" id="s3531.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="81-89" id="s3531.e1" ontology_id="HP_0000589" text="coloboma" type="HP"/>
    <pair e1="s3531.e0" e2="s3531.e1" id="s3531.p0" relation="true"/>
  </sentence>
  <sentence id="s3532" text="Relevant to cancer, clinical studies indicate that eye development is deregulated in various cancers and is a specific biomarker for Synovial Sarcoma.">
    <entity charOffset="12-18" id="s3532.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="51-66" id="s3532.e1" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <pair e1="s3532.e0" e2="s3532.e1" id="s3532.p0" relation="false"/>
  </sentence>
  <sentence id="s3533" text="We specifically discuss the role of SALL2 in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 tumor suppressor and negative regulation of transcription by RNA polymerase II oncogene.">
    <entity charOffset="218-223" id="s3533.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="239-296" id="s3533.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3533.e0" e2="s3533.e1" id="s3533.p0" relation="true"/>
  </sentence>
  <sentence id="s3534" text="Special attention is given to p53-independent eye development regulation of pro-apoptotic genes BAX and proteasomal protein catabolic process, and the implication of these findings on the apoptotic response of cancer cells to therapy.">
    <entity charOffset="46-61" id="s3534.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="210-216" id="s3534.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3534.e0" e2="s3534.e1" id="s3534.p0" relation="false"/>
  </sentence>
  <sentence id="s3535" text="Special attention is given to p53-independent eye development regulation of pro-apoptotic genes BAX and proteasomal protein catabolic process, and the implication of these findings on the apoptotic response of cancer cells to therapy.">
    <entity charOffset="104-141" id="s3535.e0" ontology_id="GO_0010498" text="proteasomal protein catabolic process" type="GO"/>
    <entity charOffset="210-216" id="s3535.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3535.e0" e2="s3535.e1" id="s3535.p0" relation="false"/>
  </sentence>
  <sentence id="s3536" text="Analysis using Gene negative regulation of transcription, DNA-templated Enrichment Analysis (GSEA) software revealed significant enrichment for 197proteins from the CM of lung cancer samples in maternalplacental interface expression profiles for a midterm placenta with strong invasiveness relative to RNA expression profiles for a human fullterm placenta after delivery.">
    <entity charOffset="20-71" id="s3536.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="177-183" id="s3536.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3536.e0" e2="s3536.e1" id="s3536.p0" relation="false"/>
  </sentence>
  <sentence id="s3537" text="Signs and symptoms are blisters, skin fragility, erosions hyGPI anchor metabolic processpigmentation, sclerodermoid plaques.">
    <entity charOffset="33-47" id="s3537.e0" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <entity charOffset="60-88" id="s3537.e1" ontology_id="GO_0006505" text="GPI anchor metabolic process" type="GO"/>
    <pair e1="s3537.e0" e2="s3537.e1" id="s3537.p0" relation="false"/>
  </sentence>
  <sentence id="s3538" text="In keeping with a tumor suppressive role of protein ubiquitination in human gastric cancer, we cellular response to interleukin-4 an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.">
    <entity charOffset="18-23" id="s3538.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="44-66" id="s3538.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s3538.e0" e2="s3538.e1" id="s3538.p0" relation="false"/>
  </sentence>
  <sentence id="s3539" text="In keeping with a tumor suppressive role of protein ubiquitination in human gastric cancer, we cellular response to interleukin-4 an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.">
    <entity charOffset="18-23" id="s3539.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="95-129" id="s3539.e1" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <pair e1="s3539.e0" e2="s3539.e1" id="s3539.p0" relation="false"/>
  </sentence>
  <sentence id="s3540" text="In keeping with a tumor suppressive role of protein ubiquitination in human gastric cancer, we cellular response to interleukin-4 an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.">
    <entity charOffset="44-66" id="s3540.e0" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <entity charOffset="84-90" id="s3540.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3540.e0" e2="s3540.e1" id="s3540.p0" relation="false"/>
  </sentence>
  <sentence id="s3541" text="In keeping with a tumor suppressive role of protein ubiquitination in human gastric cancer, we cellular response to interleukin-4 an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.">
    <entity charOffset="84-90" id="s3541.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="95-129" id="s3541.e1" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <pair e1="s3541.e0" e2="s3541.e1" id="s3541.p0" relation="false"/>
  </sentence>
  <sentence id="s3542" text="Mechanistically, we cellular response to interleukin-4 that stabilization of nucleosome disassembly in gastric cancer cells suppresses E-integrin-mediated signaling pathway expression, subsequently promoting gastric cancer metastasis.">
    <entity charOffset="20-54" id="s3542.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="111-117" id="s3542.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3542.e0" e2="s3542.e1" id="s3542.p0" relation="false"/>
  </sentence>
  <sentence id="s3543" text="Mechanistically, we cellular response to interleukin-4 that stabilization of nucleosome disassembly in gastric cancer cells suppresses E-integrin-mediated signaling pathway expression, subsequently promoting gastric cancer metastasis.">
    <entity charOffset="77-99" id="s3543.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="111-117" id="s3543.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3543.e0" e2="s3543.e1" id="s3543.p0" relation="false"/>
  </sentence>
  <sentence id="s3544" text="Mechanistically, we cellular response to interleukin-4 that stabilization of nucleosome disassembly in gastric cancer cells suppresses E-integrin-mediated signaling pathway expression, subsequently promoting gastric cancer metastasis.">
    <entity charOffset="111-117" id="s3544.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-172" id="s3544.e1" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <pair e1="s3544.e0" e2="s3544.e1" id="s3544.p0" relation="false"/>
  </sentence>
  <sentence id="s3545" text="Hence, this previously unknown FBW7/nucleosome disassembly signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric cancers">
    <entity charOffset="36-58" id="s3545.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="170-176" id="s3545.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3545.e0" e2="s3545.e1" id="s3545.p0" relation="false"/>
  </sentence>
  <sentence id="s3546" text="A panel of hypermethylated genes including cellular response to DNA damage stimulus, osteoblast differentiation, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, chromatin organization, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="43-83" id="s3546.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="261-267" id="s3546.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3546.e0" e2="s3546.e1" id="s3546.p0" relation="true"/>
  </sentence>
  <sentence id="s3547" text="A panel of hypermethylated genes including cellular response to DNA damage stimulus, osteoblast differentiation, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, chromatin organization, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="85-111" id="s3547.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="261-267" id="s3547.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3547.e0" e2="s3547.e1" id="s3547.p0" relation="false"/>
  </sentence>
  <sentence id="s3548" text="A panel of hypermethylated genes including cellular response to DNA damage stimulus, osteoblast differentiation, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, chromatin organization, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="126-153" id="s3548.e0" ontology_id="GO_0042118" text="endothelial cell activation" type="GO"/>
    <entity charOffset="261-267" id="s3548.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3548.e0" e2="s3548.e1" id="s3548.p0" relation="false"/>
  </sentence>
  <sentence id="s3549" text="A panel of hypermethylated genes including cellular response to DNA damage stimulus, osteoblast differentiation, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, chromatin organization, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="167-207" id="s3549.e0" ontology_id="GO_0035771" text="interleukin-4-mediated signaling pathway" type="GO"/>
    <entity charOffset="261-267" id="s3549.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3549.e0" e2="s3549.e1" id="s3549.p0" relation="false"/>
  </sentence>
  <sentence id="s3550" text="A panel of hypermethylated genes including cellular response to DNA damage stimulus, osteoblast differentiation, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, chromatin organization, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.">
    <entity charOffset="216-238" id="s3550.e0" ontology_id="GO_0006325" text="chromatin organization" type="GO"/>
    <entity charOffset="261-267" id="s3550.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3550.e0" e2="s3550.e1" id="s3550.p0" relation="false"/>
  </sentence>
  <sentence id="s3551" text="Genome-wide association studies have identified loci at 15q25 (iron ion transport) and 4q22 (regulation of small GTPase mediated signal transduction), associated with lung cancer (LC) and chronic obstructive pulmonary disease (intracellular protein transport).">
    <entity charOffset="63-81" id="s3551.e0" ontology_id="GO_0006826" text="iron ion transport" type="GO"/>
    <entity charOffset="172-178" id="s3551.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3551.e0" e2="s3551.e1" id="s3551.p0" relation="false"/>
  </sentence>
  <sentence id="s3552" text="Genome-wide association studies have identified loci at 15q25 (iron ion transport) and 4q22 (regulation of small GTPase mediated signal transduction), associated with lung cancer (LC) and chronic obstructive pulmonary disease (intracellular protein transport).">
    <entity charOffset="93-148" id="s3552.e0" ontology_id="GO_0051056" text="regulation of small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="172-178" id="s3552.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3552.e0" e2="s3552.e1" id="s3552.p0" relation="false"/>
  </sentence>
  <sentence id="s3553" text="Genome-wide association studies have identified loci at 15q25 (iron ion transport) and 4q22 (regulation of small GTPase mediated signal transduction), associated with lung cancer (LC) and chronic obstructive pulmonary disease (intracellular protein transport).">
    <entity charOffset="172-178" id="s3553.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="227-258" id="s3553.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s3553.e0" e2="s3553.e1" id="s3553.p0" relation="false"/>
  </sentence>
  <sentence id="s3554" text="Further experiments demonstrated that the biological_process ceRNA sequestered miR-30c-2-3p from binding its targets protein phosphorylation and transforming growth factor beta receptor signaling pathway mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.">
    <entity charOffset="42-60" id="s3554.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="283-288" id="s3554.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3554.e0" e2="s3554.e1" id="s3554.p0" relation="false"/>
  </sentence>
  <sentence id="s3555" text="Further experiments demonstrated that the biological_process ceRNA sequestered miR-30c-2-3p from binding its targets protein phosphorylation and transforming growth factor beta receptor signaling pathway mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.">
    <entity charOffset="117-140" id="s3555.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="283-288" id="s3555.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3555.e0" e2="s3555.e1" id="s3555.p0" relation="true"/>
  </sentence>
  <sentence id="s3556" text="Further experiments demonstrated that the biological_process ceRNA sequestered miR-30c-2-3p from binding its targets protein phosphorylation and transforming growth factor beta receptor signaling pathway mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.">
    <entity charOffset="145-203" id="s3556.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="283-288" id="s3556.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3556.e0" e2="s3556.e1" id="s3556.p0" relation="false"/>
  </sentence>
  <sentence id="s3557" text="The dopamine hypothesis of schizophrenia is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, synapse assembly or catecholamine catabolic process are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s3557.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="57-79" id="s3557.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s3557.e0" e2="s3557.e1" id="s3557.p0" relation="false"/>
  </sentence>
  <sentence id="s3558" text="The dopamine hypothesis of schizophrenia is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, synapse assembly or catecholamine catabolic process are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s3558.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="161-225" id="s3558.e1" ontology_id="GO_0007195" text="adenylate cyclase-inhibiting dopamine receptor signaling pathway" type="GO"/>
    <pair e1="s3558.e0" e2="s3558.e1" id="s3558.p0" relation="false"/>
  </sentence>
  <sentence id="s3559" text="The dopamine hypothesis of schizophrenia is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, synapse assembly or catecholamine catabolic process are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s3559.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="227-269" id="s3559.e1" ontology_id="GO_0002031" text="G protein-coupled receptor internalization" type="GO"/>
    <pair e1="s3559.e0" e2="s3559.e1" id="s3559.p0" relation="false"/>
  </sentence>
  <sentence id="s3560" text="The dopamine hypothesis of schizophrenia is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, synapse assembly or catecholamine catabolic process are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s3560.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="271-329" id="s3560.e1" ontology_id="GO_0032515" text="negative regulation of phosphoprotein phosphatase activity" type="GO"/>
    <pair e1="s3560.e0" e2="s3560.e1" id="s3560.p0" relation="false"/>
  </sentence>
  <sentence id="s3561" text="The dopamine hypothesis of schizophrenia is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, synapse assembly or catecholamine catabolic process are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s3561.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="331-347" id="s3561.e1" ontology_id="GO_0007416" text="synapse assembly" type="GO"/>
    <pair e1="s3561.e0" e2="s3561.e1" id="s3561.p0" relation="false"/>
  </sentence>
  <sentence id="s3562" text="The dopamine hypothesis of schizophrenia is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, synapse assembly or catecholamine catabolic process are closely related to dopaminergic system functioning.">
    <entity charOffset="27-40" id="s3562.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="351-382" id="s3562.e1" ontology_id="GO_0042424" text="catecholamine catabolic process" type="GO"/>
    <pair e1="s3562.e0" e2="s3562.e1" id="s3562.p0" relation="true"/>
  </sentence>
  <sentence id="s3563" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).">
    <entity charOffset="32-45" id="s3563.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="203-226" id="s3563.e1" ontology_id="GO_0001504" text="neurotransmitter uptake" type="GO"/>
    <pair e1="s3563.e0" e2="s3563.e1" id="s3563.p0" relation="false"/>
  </sentence>
  <sentence id="s3564" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).">
    <entity charOffset="32-45" id="s3564.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="228-263" id="s3564.e1" ontology_id="GO_0015813" text="L-glutamate transmembrane transport" type="GO"/>
    <pair e1="s3564.e0" e2="s3564.e1" id="s3564.p0" relation="false"/>
  </sentence>
  <sentence id="s3565" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).">
    <entity charOffset="32-45" id="s3565.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="264-282" id="s3565.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3565.e0" e2="s3565.e1" id="s3565.p0" relation="false"/>
  </sentence>
  <sentence id="s3566" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).">
    <entity charOffset="32-45" id="s3566.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="284-303" id="s3566.e1" ontology_id="GO_0045471" text="response to ethanol" type="GO"/>
    <pair e1="s3566.e0" e2="s3566.e1" id="s3566.p0" relation="false"/>
  </sentence>
  <sentence id="s3567" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).">
    <entity charOffset="32-45" id="s3567.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="305-343" id="s3567.e1" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <pair e1="s3567.e0" e2="s3567.e1" id="s3567.p0" relation="false"/>
  </sentence>
  <sentence id="s3568" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).">
    <entity charOffset="32-45" id="s3568.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="358-387" id="s3568.e1" ontology_id="GO_0031175" text="neuron projection development" type="GO"/>
    <pair e1="s3568.e0" e2="s3568.e1" id="s3568.p0" relation="false"/>
  </sentence>
  <sentence id="s3569" text="The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).">
    <entity charOffset="32-45" id="s3569.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="403-447" id="s3569.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s3569.e0" e2="s3569.e1" id="s3569.p0" relation="false"/>
  </sentence>
  <sentence id="s3570" text="However, to the chloride transport of our knowledge, the role of regulation of transcription by RNA polymerase II in human colorectal cancer (CRC) is still unclear.">
    <entity charOffset="16-34" id="s3570.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="134-140" id="s3570.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3570.e0" e2="s3570.e1" id="s3570.p0" relation="false"/>
  </sentence>
  <sentence id="s3571" text="However, to the chloride transport of our knowledge, the role of regulation of transcription by RNA polymerase II in human colorectal cancer (CRC) is still unclear.">
    <entity charOffset="65-113" id="s3571.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="134-140" id="s3571.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3571.e0" e2="s3571.e1" id="s3571.p0" relation="false"/>
  </sentence>
  <sentence id="s3572" text="Overexpression of regulation of transcription by RNA polymerase II significantly inhibited the proliferation in vitro and CRC tumor growth in nude mice.">
    <entity charOffset="18-66" id="s3572.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="126-131" id="s3572.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3572.e0" e2="s3572.e1" id="s3572.p0" relation="false"/>
  </sentence>
  <sentence id="s3573" text="Taken together, our study demonstrates that regulation of transcription by RNA polymerase II inhibits proliferation and tumorigenesis through inactivation of the Wnt/-catenin pathway in CRC cells.">
    <entity charOffset="44-92" id="s3573.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="120-125" id="s3573.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3573.e0" e2="s3573.e1" id="s3573.p0" relation="false"/>
  </sentence>
  <sentence id="s3574" text="Heritability-based analyses are demonstrating strong links between migraine and other neuropsychiatric disorders and brain phenotypes, highT cell costimulationing genetic links between migraine and major depressive disorder and attention-deficit hyperactivity disorder, among others.">
    <entity charOffset="139-159" id="s3574.e0" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <entity charOffset="246-259" id="s3574.e1" ontology_id="HP_0000752" text="hyperactivity" type="HP"/>
    <pair e1="s3574.e0" e2="s3574.e1" id="s3574.p0" relation="false"/>
  </sentence>
  <sentence id="s3575" text="In signal transduction, motor neuron degeneration first becomes evident at the motor nerve terminals in neuromuscular junctions (NMJs), the cholinergic synapse between motor neuron and skeletal muscle; degeneration then progresses proximally, implicating the NMJ as a therapeutic target.">
    <entity charOffset="3-22" id="s3575.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="24-49" id="s3575.e1" ontology_id="HP_0007373" text="motor neuron degeneration" type="HP"/>
    <pair e1="s3575.e0" e2="s3575.e1" id="s3575.p0" relation="false"/>
  </sentence>
  <sentence id="s3576" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of biological_process as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s3576.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="158-176" id="s3576.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3576.e0" e2="s3576.e1" id="s3576.p0" relation="false"/>
  </sentence>
  <sentence id="s3577" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of biological_process as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s3577.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="116-137" id="s3577.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3577.e0" e2="s3577.e1" id="s3577.p0" relation="false"/>
  </sentence>
  <sentence id="s3578" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of biological_process as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s3578.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="229-240" id="s3578.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s3578.e0" e2="s3578.e1" id="s3578.p0" relation="false"/>
  </sentence>
  <sentence id="s3579" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of biological_process as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s3579.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="242-268" id="s3579.e1" ontology_id="GO_0030574" text="collagen catabolic process" type="GO"/>
    <pair e1="s3579.e0" e2="s3579.e1" id="s3579.p0" relation="false"/>
  </sentence>
  <sentence id="s3580" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of biological_process as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s3580.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="270-323" id="s3580.e1" ontology_id="GO_0001938" text="positive regulation of endothelial cell proliferation" type="GO"/>
    <pair e1="s3580.e0" e2="s3580.e1" id="s3580.p0" relation="false"/>
  </sentence>
  <sentence id="s3581" text="Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of biological_process as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.">
    <entity charOffset="22-48" id="s3581.e0" ontology_id="HP_0011496" text="corneal neovascularization" type="HP"/>
    <entity charOffset="325-366" id="s3581.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s3581.e0" e2="s3581.e1" id="s3581.p0" relation="false"/>
  </sentence>
  <sentence id="s3582" text="This work provides a relevant hydrocephalus mouse model and demonstrates that &lt;i&gt;ubiquitin-dependent protein catabolic process&lt;/i&gt; is essential to maintain integrity of the ependyma">
    <entity charOffset="30-43" id="s3582.e0" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <entity charOffset="81-126" id="s3582.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s3582.e0" e2="s3582.e1" id="s3582.p0" relation="false"/>
  </sentence>
  <sentence id="s3583" text="These epidermis development displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function ion homeostasis.">
    <entity charOffset="6-27" id="s3583.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="52-64" id="s3583.e1" ontology_id="HP_0002153" text="hyperkalemia" type="HP"/>
    <pair e1="s3583.e0" e2="s3583.e1" id="s3583.p0" relation="false"/>
  </sentence>
  <sentence id="s3584" text="These epidermis development displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function ion homeostasis.">
    <entity charOffset="38-50" id="s3584.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="182-197" id="s3584.e1" ontology_id="GO_0050801" text="ion homeostasis" type="GO"/>
    <pair e1="s3584.e0" e2="s3584.e1" id="s3584.p0" relation="true"/>
  </sentence>
  <sentence id="s3585" text="These epidermis development displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function ion homeostasis.">
    <entity charOffset="52-64" id="s3585.e0" ontology_id="HP_0002153" text="hyperkalemia" type="HP"/>
    <entity charOffset="182-197" id="s3585.e1" ontology_id="GO_0050801" text="ion homeostasis" type="GO"/>
    <pair e1="s3585.e0" e2="s3585.e1" id="s3585.p0" relation="true"/>
  </sentence>
  <sentence id="s3586" text="We discover that proline catabolism via proline dehydrogenase (positive regulation of cell death) supports growth of breast cancer cells in 3D culture.">
    <entity charOffset="63-96" id="s3586.e0" ontology_id="GO_0010942" text="positive regulation of cell death" type="GO"/>
    <entity charOffset="124-130" id="s3586.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3586.e0" e2="s3586.e1" id="s3586.p0" relation="false"/>
  </sentence>
  <sentence id="s3587" text="In particular, we find that positive regulation of cell death expression and proline catabolism is increased in metastases compared to primary breast cancers of patients and mice.">
    <entity charOffset="28-61" id="s3587.e0" ontology_id="GO_0010942" text="positive regulation of cell death" type="GO"/>
    <entity charOffset="150-156" id="s3587.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3587.e0" e2="s3587.e1" id="s3587.p0" relation="false"/>
  </sentence>
  <sentence id="s3588" text="We describe a neurological disorder with epilepsy and prominent choreoathetosis caused by biallelic pathogenic variants in regulation of glutamate receptor signaling pathway, which encodes an AMPA receptor outer-core protein.">
    <entity charOffset="41-49" id="s3588.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="123-173" id="s3588.e1" ontology_id="GO_1900449" text="regulation of glutamate receptor signaling pathway" type="GO"/>
    <pair e1="s3588.e0" e2="s3588.e1" id="s3588.p0" relation="true"/>
  </sentence>
  <sentence id="s3589" text="Expression of miR-17-92a miRNAs caused decreased cell proliferation, reduced activation of positive regulation of protein phosphorylation and MAP kinases, delayed tumorigenicity and reduced tumor growth in animals.">
    <entity charOffset="91-137" id="s3589.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="163-168" id="s3589.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3589.e0" e2="s3589.e1" id="s3589.p0" relation="true"/>
  </sentence>
  <sentence id="s3590" text="Progressive retinal atrophy (signal transduction) is the collective name of a class of hereditary retinal dystrophies in the dog and is often described as the equivalent of retinitis pigmentosa in humans.">
    <entity charOffset="12-27" id="s3590.e0" ontology_id="HP_0001105" text="retinal atrophy" type="HP"/>
    <entity charOffset="29-48" id="s3590.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s3590.e0" e2="s3590.e1" id="s3590.p0" relation="false"/>
  </sentence>
  <sentence id="s3591" text="Progressive retinal atrophy (signal transduction) is the collective name of a class of hereditary retinal dystrophies in the dog and is often described as the equivalent of retinitis pigmentosa in humans.">
    <entity charOffset="29-48" id="s3591.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="98-117" id="s3591.e1" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <pair e1="s3591.e0" e2="s3591.e1" id="s3591.p0" relation="false"/>
  </sentence>
  <sentence id="s3592" text="signal transduction is characterized by visual impairment due to degeneration of the photoreceptors in the retina, usually leading to blindness.">
    <entity charOffset="0-19" id="s3592.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="40-57" id="s3592.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s3592.e0" e2="s3592.e1" id="s3592.p0" relation="false"/>
  </sentence>
  <sentence id="s3593" text="signal transduction is characterized by visual impairment due to degeneration of the photoreceptors in the retina, usually leading to blindness.">
    <entity charOffset="0-19" id="s3593.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="134-143" id="s3593.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s3593.e0" e2="s3593.e1" id="s3593.p0" relation="false"/>
  </sentence>
  <sentence id="s3594" text="signal transduction has been reported in dogs from more than 100 breeds and can be genetically heterogeneous both between and within breeds.">
    <entity charOffset="0-19" id="s3594.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="95-108" id="s3594.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3594.e0" e2="s3594.e1" id="s3594.p0" relation="false"/>
  </sentence>
  <sentence id="s3595" text="The study indicated genetic heterogeneity as the mutation was present in all signal transduction-affected individuals in one large family of Shelties, whereas some other cases in the studied Sheltie population were not associated with this rhodopsin mediated signaling pathway mutation.">
    <entity charOffset="28-41" id="s3595.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="77-96" id="s3595.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s3595.e0" e2="s3595.e1" id="s3595.p0" relation="false"/>
  </sentence>
  <sentence id="s3596" text="The study indicated genetic heterogeneity as the mutation was present in all signal transduction-affected individuals in one large family of Shelties, whereas some other cases in the studied Sheltie population were not associated with this rhodopsin mediated signaling pathway mutation.">
    <entity charOffset="28-41" id="s3596.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="240-276" id="s3596.e1" ontology_id="GO_0016056" text="rhodopsin mediated signaling pathway" type="GO"/>
    <pair e1="s3596.e0" e2="s3596.e1" id="s3596.p0" relation="false"/>
  </sentence>
  <sentence id="s3597" text="To this positive regulation of protein phosphorylation, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against cellular calcium ion homeostasis.">
    <entity charOffset="8-54" id="s3597.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="78-86" id="s3597.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3597.e0" e2="s3597.e1" id="s3597.p0" relation="false"/>
  </sentence>
  <sentence id="s3598" text="To this positive regulation of protein phosphorylation, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against cellular calcium ion homeostasis.">
    <entity charOffset="8-54" id="s3598.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="91-104" id="s3598.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s3598.e0" e2="s3598.e1" id="s3598.p0" relation="false"/>
  </sentence>
  <sentence id="s3599" text="To this positive regulation of protein phosphorylation, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against cellular calcium ion homeostasis.">
    <entity charOffset="78-86" id="s3599.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="143-167" id="s3599.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3599.e0" e2="s3599.e1" id="s3599.p0" relation="false"/>
  </sentence>
  <sentence id="s3600" text="To this positive regulation of protein phosphorylation, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against cellular calcium ion homeostasis.">
    <entity charOffset="78-86" id="s3600.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="246-278" id="s3600.e1" ontology_id="GO_0006874" text="cellular calcium ion homeostasis" type="GO"/>
    <pair e1="s3600.e0" e2="s3600.e1" id="s3600.p0" relation="false"/>
  </sentence>
  <sentence id="s3601" text="To this positive regulation of protein phosphorylation, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against cellular calcium ion homeostasis.">
    <entity charOffset="91-104" id="s3601.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="246-278" id="s3601.e1" ontology_id="GO_0006874" text="cellular calcium ion homeostasis" type="GO"/>
    <pair e1="s3601.e0" e2="s3601.e1" id="s3601.p0" relation="false"/>
  </sentence>
  <sentence id="s3602" text="Reactive oxygen species (regulation of cell growth) play a vital role in the pathogenesis of many cardiovascular diseases.">
    <entity charOffset="25-50" id="s3602.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="98-120" id="s3602.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s3602.e0" e2="s3602.e1" id="s3602.p0" relation="false"/>
  </sentence>
  <sentence id="s3603" text="Promyelocytic leukemia (response to hypoxia) is a pleiotropic tumor suppressor, but its role in tumor microenvironment regulation is poorly characterized.">
    <entity charOffset="24-43" id="s3603.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="62-67" id="s3603.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3603.e0" e2="s3603.e1" id="s3603.p0" relation="false"/>
  </sentence>
  <sentence id="s3604" text="response to hypoxia is frequently downregulated in many cancer types, including lung cancer.">
    <entity charOffset="0-19" id="s3604.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="56-62" id="s3604.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3604.e0" e2="s3604.e1" id="s3604.p0" relation="false"/>
  </sentence>
  <sentence id="s3605" text="Clinically, this response to hypoxia degradation pathway is hyperactivated in lung cancer and correlates with poor prognosis.">
    <entity charOffset="17-36" id="s3605.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="83-89" id="s3605.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3605.e0" e2="s3605.e1" id="s3605.p0" relation="false"/>
  </sentence>
  <sentence id="s3606" text="The tRNA modification/response to hypoxia axis induces a negative regulation of transcription, DNA-templated of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (positive regulation of DNA binding), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="4-21" id="s3606.e0" ontology_id="GO_0006400" text="tRNA modification" type="GO"/>
    <entity charOffset="372-378" id="s3606.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3606.e0" e2="s3606.e1" id="s3606.p0" relation="false"/>
  </sentence>
  <sentence id="s3607" text="The tRNA modification/response to hypoxia axis induces a negative regulation of transcription, DNA-templated of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (positive regulation of DNA binding), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="22-41" id="s3607.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="372-378" id="s3607.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3607.e0" e2="s3607.e1" id="s3607.p0" relation="false"/>
  </sentence>
  <sentence id="s3608" text="The tRNA modification/response to hypoxia axis induces a negative regulation of transcription, DNA-templated of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (positive regulation of DNA binding), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="57-108" id="s3608.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="372-378" id="s3608.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3608.e0" e2="s3608.e1" id="s3608.p0" relation="false"/>
  </sentence>
  <sentence id="s3609" text="The tRNA modification/response to hypoxia axis induces a negative regulation of transcription, DNA-templated of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (positive regulation of DNA binding), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.">
    <entity charOffset="209-243" id="s3609.e0" ontology_id="GO_0043388" text="positive regulation of DNA binding" type="GO"/>
    <entity charOffset="372-378" id="s3609.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3609.e0" e2="s3609.e1" id="s3609.p0" relation="false"/>
  </sentence>
  <sentence id="s3610" text="In xenograft and genetically engineered mouse models, the tRNA modification/PML axis elevates intratumoral Tregs and M2-like macrophages and reduces CD8+ T cells to promote lung tumor growth.">
    <entity charOffset="58-75" id="s3610.e0" ontology_id="GO_0006400" text="tRNA modification" type="GO"/>
    <entity charOffset="99-104" id="s3610.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3610.e0" e2="s3610.e1" id="s3610.p0" relation="false"/>
  </sentence>
  <sentence id="s3611" text="Our study identifies tRNA modification as an oncoprotein that negatively regulates response to hypoxia via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="21-38" id="s3611.e0" ontology_id="GO_0006400" text="tRNA modification" type="GO"/>
    <entity charOffset="209-214" id="s3611.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3611.e0" e2="s3611.e1" id="s3611.p0" relation="false"/>
  </sentence>
  <sentence id="s3612" text="Our study identifies tRNA modification as an oncoprotein that negatively regulates response to hypoxia via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="21-38" id="s3612.e0" ontology_id="GO_0006400" text="tRNA modification" type="GO"/>
    <entity charOffset="138-144" id="s3612.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3612.e0" e2="s3612.e1" id="s3612.p0" relation="false"/>
  </sentence>
  <sentence id="s3613" text="Our study identifies tRNA modification as an oncoprotein that negatively regulates response to hypoxia via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation">
    <entity charOffset="83-102" id="s3613.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="138-144" id="s3613.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3613.e0" e2="s3613.e1" id="s3613.p0" relation="false"/>
  </sentence>
  <sentence id="s3614" text="Loss-of-function mutations of ATP-dependent chromatin remodeling have recently been defined to cause a recognizable syndrome with intellectual disability (ID).">
    <entity charOffset="30-64" id="s3614.e0" ontology_id="GO_0043044" text="ATP-dependent chromatin remodeling" type="GO"/>
    <entity charOffset="130-153" id="s3614.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3614.e0" e2="s3614.e1" id="s3614.p0" relation="true"/>
  </sentence>
  <sentence id="s3615" text="We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped prolyl-tRNA aminoacylation, and clinodactyly.">
    <entity charOffset="52-71" id="s3615.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="193-219" id="s3615.e1" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <pair e1="s3615.e0" e2="s3615.e1" id="s3615.p0" relation="true"/>
  </sentence>
  <sentence id="s3616" text="We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped prolyl-tRNA aminoacylation, and clinodactyly.">
    <entity charOffset="118-142" id="s3616.e0" ontology_id="HP_0045025" text="small palpebral fissures" type="HP"/>
    <entity charOffset="193-219" id="s3616.e1" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <pair e1="s3616.e0" e2="s3616.e1" id="s3616.p0" relation="false"/>
  </sentence>
  <sentence id="s3617" text="We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped prolyl-tRNA aminoacylation, and clinodactyly.">
    <entity charOffset="193-219" id="s3617.e0" ontology_id="GO_0006433" text="prolyl-tRNA aminoacylation" type="GO"/>
    <entity charOffset="225-237" id="s3617.e1" ontology_id="HP_0030084" text="clinodactyly" type="HP"/>
    <pair e1="s3617.e0" e2="s3617.e1" id="s3617.p0" relation="false"/>
  </sentence>
  <sentence id="s3618" text="X-linked retinitis pigmentosa (XLRP) caused by mutations in the visual perception gene is an early onset and severe cause of blindness.">
    <entity charOffset="64-81" id="s3618.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="125-134" id="s3618.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s3618.e0" e2="s3618.e1" id="s3618.p0" relation="true"/>
  </sentence>
  <sentence id="s3619" text="protein phosphorylation overexpression promotes tumorigenesis and is associated with poor prognosis in several cancers.">
    <entity charOffset="0-23" id="s3619.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="48-53" id="s3619.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3619.e0" e2="s3619.e1" id="s3619.p0" relation="false"/>
  </sentence>
  <sentence id="s3620" text="Increased protein phosphorylation expression during the late pathological stage has been detected in the Oncomine liver dataset and hepatocellular carcinoma (phosphatidylinositol phosphorylation) specimens.">
    <entity charOffset="10-33" id="s3620.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="132-156" id="s3620.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3620.e0" e2="s3620.e1" id="s3620.p0" relation="false"/>
  </sentence>
  <sentence id="s3621" text="Increased protein phosphorylation expression during the late pathological stage has been detected in the Oncomine liver dataset and hepatocellular carcinoma (phosphatidylinositol phosphorylation) specimens.">
    <entity charOffset="132-156" id="s3621.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="158-194" id="s3621.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s3621.e0" e2="s3621.e1" id="s3621.p0" relation="false"/>
  </sentence>
  <sentence id="s3622" text="However, the precise roles and mechanisms of protein phosphorylation in liver cancer progression remain largely unknown.">
    <entity charOffset="45-68" id="s3622.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="78-84" id="s3622.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3622.e0" e2="s3622.e1" id="s3622.p0" relation="false"/>
  </sentence>
  <sentence id="s3623" text="Results from the current study showed that protein phosphorylation mediates tumor growth, metastasis and angiogenesis in vivo.">
    <entity charOffset="43-66" id="s3623.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="76-81" id="s3623.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3623.e0" e2="s3623.e1" id="s3623.p0" relation="false"/>
  </sentence>
  <sentence id="s3624" text="Moreover, protein phosphorylation mediated liver cancer cell migration via ppositive regulation of protein phosphorylation/peripheral nervous system development-B signaling and matrix metalloproteinase (MMP) activation.">
    <entity charOffset="10-33" id="s3624.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="49-55" id="s3624.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3624.e0" e2="s3624.e1" id="s3624.p0" relation="false"/>
  </sentence>
  <sentence id="s3625" text="Moreover, protein phosphorylation mediated liver cancer cell migration via ppositive regulation of protein phosphorylation/peripheral nervous system development-B signaling and matrix metalloproteinase (MMP) activation.">
    <entity charOffset="49-55" id="s3625.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="76-122" id="s3625.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s3625.e0" e2="s3625.e1" id="s3625.p0" relation="true"/>
  </sentence>
  <sentence id="s3626" text="Moreover, protein phosphorylation mediated liver cancer cell migration via ppositive regulation of protein phosphorylation/peripheral nervous system development-B signaling and matrix metalloproteinase (MMP) activation.">
    <entity charOffset="49-55" id="s3626.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="123-160" id="s3626.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s3626.e0" e2="s3626.e1" id="s3626.p0" relation="false"/>
  </sentence>
  <sentence id="s3627" text="Tenascin-C (response to wounding), an extracellular matrix glycoprotein, has been implicated in progression of various types of cancer.">
    <entity charOffset="12-32" id="s3627.e0" ontology_id="GO_0009611" text="response to wounding" type="GO"/>
    <entity charOffset="128-134" id="s3627.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3627.e0" e2="s3627.e1" id="s3627.p0" relation="false"/>
  </sentence>
  <sentence id="s3628" text="However, few reports exist on response to wounding expression in gastrointestinal stromal tumors (GISTs).">
    <entity charOffset="30-50" id="s3628.e0" ontology_id="GO_0009611" text="response to wounding" type="GO"/>
    <entity charOffset="90-96" id="s3628.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3628.e0" e2="s3628.e1" id="s3628.p0" relation="false"/>
  </sentence>
  <sentence id="s3629" text="The response to wounding mRNA and protein levels were found to significantly downregulated in tumors without progression compared to those tumors which occurred tumor progression during the follow-up period (P&amp;lt;.05).">
    <entity charOffset="4-24" id="s3629.e0" ontology_id="GO_0009611" text="response to wounding" type="GO"/>
    <entity charOffset="94-100" id="s3629.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3629.e0" e2="s3629.e1" id="s3629.p0" relation="false"/>
  </sentence>
  <sentence id="s3630" text="The response to wounding mRNA and protein levels were found to significantly downregulated in tumors without progression compared to those tumors which occurred tumor progression during the follow-up period (P&amp;lt;.05).">
    <entity charOffset="4-24" id="s3630.e0" ontology_id="GO_0009611" text="response to wounding" type="GO"/>
    <entity charOffset="161-166" id="s3630.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3630.e0" e2="s3630.e1" id="s3630.p0" relation="false"/>
  </sentence>
  <sentence id="s3631" text="As for the prognostic analysis, it revealed that tumor size, mitotic count, surgical margins, multivisceral resection, and response to wounding expression were independent predictors of PFS for gastric GISTs (P&amp;lt;.05).">
    <entity charOffset="49-54" id="s3631.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="123-143" id="s3631.e1" ontology_id="GO_0009611" text="response to wounding" type="GO"/>
    <pair e1="s3631.e0" e2="s3631.e1" id="s3631.p0" relation="false"/>
  </sentence>
  <sentence id="s3632" text="Primary ciliary dyskinesia (motile cilium assembly) is a clinical rare peculiar disorder, mainly featured by respiratory infection, tympanitis, nasosinusitis, and male infertility.">
    <entity charOffset="8-26" id="s3632.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-50" id="s3632.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s3632.e0" e2="s3632.e1" id="s3632.p0" relation="true"/>
  </sentence>
  <sentence id="s3633" text="In contrast, among the factors supporting the resistance in negative regulation of phosphatase activity can be an elevated concentration of MP-positive regulation of receptor-mediated endocytosis which, together with the coexistence of hypertriglyceridemia, may constitute an important mechanism of resistance to clopidogrel">
    <entity charOffset="60-103" id="s3633.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="236-256" id="s3633.e1" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <pair e1="s3633.e0" e2="s3633.e1" id="s3633.p0" relation="false"/>
  </sentence>
  <sentence id="s3634" text="In contrast, among the factors supporting the resistance in negative regulation of phosphatase activity can be an elevated concentration of MP-positive regulation of receptor-mediated endocytosis which, together with the coexistence of hypertriglyceridemia, may constitute an important mechanism of resistance to clopidogrel">
    <entity charOffset="143-195" id="s3634.e0" ontology_id="GO_0048260" text="positive regulation of receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="236-256" id="s3634.e1" ontology_id="HP_0002155" text="hypertriglyceridemia" type="HP"/>
    <pair e1="s3634.e0" e2="s3634.e1" id="s3634.p0" relation="false"/>
  </sentence>
  <sentence id="s3635" text="The authors report here a brief summary of findings from 12 lines of genetically engineered epidermis development that presented with autosomal recessive congenital hydrocephalus.">
    <entity charOffset="92-113" id="s3635.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="165-178" id="s3635.e1" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <pair e1="s3635.e0" e2="s3635.e1" id="s3635.p0" relation="false"/>
  </sentence>
  <sentence id="s3636" text="The authors report here a brief summary of findings from 12 lines of genetically engineered epidermis development that presented with autosomal recessive congenital hydrocephalus.">
    <entity charOffset="92-113" id="s3636.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="134-153" id="s3636.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3636.e0" e2="s3636.e1" id="s3636.p0" relation="true"/>
  </sentence>
  <sentence id="s3637" text="Even though the direct relevance of mouse models to hydrocephalus in humans remains uncertain, the high prevalence of familial patterns of inheritance for congenital hydrocephalus in humans suggests that identification of genes responsible for development of hydrocephalus in epidermis development may lead to the identification of homologous modifier genes and susceptibility alleles in humans.">
    <entity charOffset="52-65" id="s3637.e0" ontology_id="HP_0000238" text="hydrocephalus" type="HP"/>
    <entity charOffset="276-297" id="s3637.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3637.e0" e2="s3637.e1" id="s3637.p0" relation="false"/>
  </sentence>
  <sentence id="s3638" text="A hypomorphic variant in cellular copper ion homeostasis was previously reported in association with a familial case of syndromic X-linked intellectual disability, which shows phenotypic overlap with RSS/3C syndrome.">
    <entity charOffset="25-56" id="s3638.e0" ontology_id="GO_0006878" text="cellular copper ion homeostasis" type="GO"/>
    <entity charOffset="139-162" id="s3638.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3638.e0" e2="s3638.e1" id="s3638.p0" relation="true"/>
  </sentence>
  <sentence id="s3639" text="Small cell lung cancer (SCLC) is the most aggressive muscle organ development of lung cancer.">
    <entity charOffset="16-22" id="s3639.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="53-77" id="s3639.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3639.e0" e2="s3639.e1" id="s3639.p0" relation="false"/>
  </sentence>
  <sentence id="s3640" text="In particular, the TMEM132D, MAPK cascade and protein transport genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.">
    <entity charOffset="29-41" id="s3640.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="121-127" id="s3640.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3640.e0" e2="s3640.e1" id="s3640.p0" relation="false"/>
  </sentence>
  <sentence id="s3641" text="In particular, the TMEM132D, MAPK cascade and protein transport genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.">
    <entity charOffset="46-63" id="s3641.e0" ontology_id="GO_0015031" text="protein transport" type="GO"/>
    <entity charOffset="121-127" id="s3641.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3641.e0" e2="s3641.e1" id="s3641.p0" relation="false"/>
  </sentence>
  <sentence id="s3642" text="We found that the expression of chromosome segregation mRNA was relatively low in normal tissues, but was upregulated in 82% of hepatocellular carcinoma (phosphatidylinositol phosphorylation), and correlated with elevated alpha-fetoprotein and early disease onset of HCC.">
    <entity charOffset="32-54" id="s3642.e0" ontology_id="GO_0007059" text="chromosome segregation" type="GO"/>
    <entity charOffset="128-152" id="s3642.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3642.e0" e2="s3642.e1" id="s3642.p0" relation="false"/>
  </sentence>
  <sentence id="s3643" text="We found that the expression of chromosome segregation mRNA was relatively low in normal tissues, but was upregulated in 82% of hepatocellular carcinoma (phosphatidylinositol phosphorylation), and correlated with elevated alpha-fetoprotein and early disease onset of HCC.">
    <entity charOffset="128-152" id="s3643.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="154-190" id="s3643.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s3643.e0" e2="s3643.e1" id="s3643.p0" relation="false"/>
  </sentence>
  <sentence id="s3644" text="Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by osteoblast differentiation, OPTN and protein phosphorylation mutations.">
    <entity charOffset="94-102" id="s3644.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="156-182" id="s3644.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s3644.e0" e2="s3644.e1" id="s3644.p0" relation="true"/>
  </sentence>
  <sentence id="s3645" text="Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by osteoblast differentiation, OPTN and protein phosphorylation mutations.">
    <entity charOffset="94-102" id="s3645.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="193-216" id="s3645.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s3645.e0" e2="s3645.e1" id="s3645.p0" relation="false"/>
  </sentence>
  <sentence id="s3646" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3646.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="136-157" id="s3646.e1" ontology_id="GO_0007040" text="lysosome organization" type="GO"/>
    <pair e1="s3646.e0" e2="s3646.e1" id="s3646.p0" relation="false"/>
  </sentence>
  <sentence id="s3647" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3647.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="159-192" id="s3647.e1" ontology_id="GO_0009966" text="regulation of signal transduction" type="GO"/>
    <pair e1="s3647.e0" e2="s3647.e1" id="s3647.p0" relation="false"/>
  </sentence>
  <sentence id="s3648" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3648.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="194-223" id="s3648.e1" ontology_id="GO_0019673" text="GDP-mannose metabolic process" type="GO"/>
    <pair e1="s3648.e0" e2="s3648.e1" id="s3648.p0" relation="false"/>
  </sentence>
  <sentence id="s3649" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3649.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="225-246" id="s3649.e1" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <pair e1="s3649.e0" e2="s3649.e1" id="s3649.p0" relation="false"/>
  </sentence>
  <sentence id="s3650" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3650.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="256-274" id="s3650.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s3650.e0" e2="s3650.e1" id="s3650.p0" relation="false"/>
  </sentence>
  <sentence id="s3651" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3651.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="292-307" id="s3651.e1" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <pair e1="s3651.e0" e2="s3651.e1" id="s3651.p0" relation="true"/>
  </sentence>
  <sentence id="s3652" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3652.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="309-356" id="s3652.e1" ontology_id="GO_0002091" text="negative regulation of receptor internalization" type="GO"/>
    <pair e1="s3652.e0" e2="s3652.e1" id="s3652.p0" relation="false"/>
  </sentence>
  <sentence id="s3653" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3653.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="405-425" id="s3653.e1" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <pair e1="s3653.e0" e2="s3653.e1" id="s3653.p0" relation="false"/>
  </sentence>
  <sentence id="s3654" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3654.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="440-460" id="s3654.e1" ontology_id="GO_0007160" text="cell-matrix adhesion" type="GO"/>
    <pair e1="s3654.e0" e2="s3654.e1" id="s3654.p0" relation="false"/>
  </sentence>
  <sentence id="s3655" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3655.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="462-493" id="s3655.e1" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <pair e1="s3655.e0" e2="s3655.e1" id="s3655.p0" relation="false"/>
  </sentence>
  <sentence id="s3656" text="Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).">
    <entity charOffset="60-68" id="s3656.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="544-602" id="s3656.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s3656.e0" e2="s3656.e1" id="s3656.p0" relation="false"/>
  </sentence>
  <sentence id="s3657" text="In total sixteen genomic regions have been associated with POAG (including the normal tension glaucoma (transcription initiation from RNA polymerase II promoter) subgroup), 8 with PACG and 2 with XFS.">
    <entity charOffset="94-102" id="s3657.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="104-160" id="s3657.e1" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <pair e1="s3657.e0" e2="s3657.e1" id="s3657.p0" relation="false"/>
  </sentence>
  <sentence id="s3658" text="Recent studies reported germline variants in telomere maintenance via telomerase in melanoma families.">
    <entity charOffset="45-80" id="s3658.e0" ontology_id="GO_0007004" text="telomere maintenance via telomerase" type="GO"/>
    <entity charOffset="84-92" id="s3658.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s3658.e0" e2="s3658.e1" id="s3658.p0" relation="true"/>
  </sentence>
  <sentence id="s3659" text="So, in conclusion, melanoma associated telomere maintenance via telomerase germline variants seem to be rare.">
    <entity charOffset="19-27" id="s3659.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="39-74" id="s3659.e1" ontology_id="GO_0007004" text="telomere maintenance via telomerase" type="GO"/>
    <pair e1="s3659.e0" e2="s3659.e1" id="s3659.p0" relation="true"/>
  </sentence>
  <sentence id="s3660" text="The classical mammalian isoforms of PLD are N-glycan processing and PLD2, and the levels of both mRNA were higher at the primary tumor sites than in normal kidney tissues.">
    <entity charOffset="44-63" id="s3660.e0" ontology_id="GO_0006491" text="N-glycan processing" type="GO"/>
    <entity charOffset="129-134" id="s3660.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3660.e0" e2="s3660.e1" id="s3660.p0" relation="false"/>
  </sentence>
  <sentence id="s3661" text="Notably, shRNA-mediated knockdown of PLD2 suppressed the growth and invasion of tumors in establishment of mitotic spindle orientation mouse xenograft models.">
    <entity charOffset="80-85" id="s3661.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="90-134" id="s3661.e1" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <pair e1="s3661.e0" e2="s3661.e1" id="s3661.p0" relation="false"/>
  </sentence>
  <sentence id="s3662" text="As for genes relating to the tumor invasion of phosphatidic acid biosynthetic process, we found that angiogenin (ANG) was positively regulated by PLD2.">
    <entity charOffset="29-34" id="s3662.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="47-85" id="s3662.e1" ontology_id="GO_0006654" text="phosphatidic acid biosynthetic process" type="GO"/>
    <pair e1="s3662.e0" e2="s3662.e1" id="s3662.p0" relation="false"/>
  </sentence>
  <sentence id="s3663" text="In nucleosome disassembly, the expression levels of angiogenesis were elevated in tumor tissues as compared with normal kidney and the inhibition of ANG activity with a neutralizing antibody significantly suppressed tumor invasion.">
    <entity charOffset="3-25" id="s3663.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="82-87" id="s3663.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3663.e0" e2="s3663.e1" id="s3663.p0" relation="false"/>
  </sentence>
  <sentence id="s3664" text="In nucleosome disassembly, the expression levels of angiogenesis were elevated in tumor tissues as compared with normal kidney and the inhibition of ANG activity with a neutralizing antibody significantly suppressed tumor invasion.">
    <entity charOffset="52-64" id="s3664.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="82-87" id="s3664.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3664.e0" e2="s3664.e1" id="s3664.p0" relation="false"/>
  </sentence>
  <sentence id="s3665" text="We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="44-70" id="s3665.e0" ontology_id="GO_0008045" text="motor neuron axon guidance" type="GO"/>
    <entity charOffset="325-351" id="s3665.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3665.e0" e2="s3665.e1" id="s3665.p0" relation="false"/>
  </sentence>
  <sentence id="s3666" text="We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="72-87" id="s3666.e0" ontology_id="GO_0006094" text="gluconeogenesis" type="GO"/>
    <entity charOffset="325-351" id="s3666.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3666.e0" e2="s3666.e1" id="s3666.p0" relation="false"/>
  </sentence>
  <sentence id="s3667" text="We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="89-134" id="s3667.e0" ontology_id="GO_0045666" text="positive regulation of neuron differentiation" type="GO"/>
    <entity charOffset="325-351" id="s3667.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3667.e0" e2="s3667.e1" id="s3667.p0" relation="false"/>
  </sentence>
  <sentence id="s3668" text="We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="142-170" id="s3668.e0" ontology_id="GO_0071918" text="urea transmembrane transport" type="GO"/>
    <entity charOffset="325-351" id="s3668.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3668.e0" e2="s3668.e1" id="s3668.p0" relation="false"/>
  </sentence>
  <sentence id="s3669" text="We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="172-198" id="s3669.e0" ontology_id="GO_0007269" text="neurotransmitter secretion" type="GO"/>
    <entity charOffset="325-351" id="s3669.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3669.e0" e2="s3669.e1" id="s3669.p0" relation="false"/>
  </sentence>
  <sentence id="s3670" text="We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three neurodegenerative diseases.">
    <entity charOffset="203-293" id="s3670.e0" ontology_id="GO_0035774" text="positive regulation of insulin secretion involved in cellular response to glucose stimulus" type="GO"/>
    <entity charOffset="325-351" id="s3670.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3670.e0" e2="s3670.e1" id="s3670.p0" relation="false"/>
  </sentence>
  <sentence id="s3671" text="Ectodysplasin-A2 (positive regulation of NF-kappaB transcription factor activity) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (positive regulation of JNK cascade).">
    <entity charOffset="18-80" id="s3671.e0" ontology_id="GO_0051092" text="positive regulation of NF-kappaB transcription factor activity" type="GO"/>
    <entity charOffset="119-124" id="s3671.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3671.e0" e2="s3671.e1" id="s3671.p0" relation="false"/>
  </sentence>
  <sentence id="s3672" text="Ectodysplasin-A2 (positive regulation of NF-kappaB transcription factor activity) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (positive regulation of JNK cascade).">
    <entity charOffset="119-124" id="s3672.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="207-241" id="s3672.e1" ontology_id="GO_0046330" text="positive regulation of JNK cascade" type="GO"/>
    <pair e1="s3672.e0" e2="s3672.e1" id="s3672.p0" relation="false"/>
  </sentence>
  <sentence id="s3673" text="Ectodysplasin-A2 (positive regulation of NF-kappaB transcription factor activity) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (positive regulation of JNK cascade).">
    <entity charOffset="176-196" id="s3673.e0" ontology_id="HP_0000968" text="ectodermal dysplasia" type="HP"/>
    <entity charOffset="207-241" id="s3673.e1" ontology_id="GO_0046330" text="positive regulation of JNK cascade" type="GO"/>
    <pair e1="s3673.e0" e2="s3673.e1" id="s3673.p0" relation="false"/>
  </sentence>
  <sentence id="s3674" text="Limb girdle muscular dystrophy muscle organ development 2G (cardiac muscle hypertrophy) is caused by mutations in the cardiac muscle hypertrophy gene.">
    <entity charOffset="12-30" id="s3674.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="31-55" id="s3674.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3674.e0" e2="s3674.e1" id="s3674.p0" relation="true"/>
  </sentence>
  <sentence id="s3675" text="Limb girdle muscular dystrophy muscle organ development 2G (cardiac muscle hypertrophy) is caused by mutations in the cardiac muscle hypertrophy gene.">
    <entity charOffset="12-30" id="s3675.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="61-87" id="s3675.e1" ontology_id="GO_0003300" text="cardiac muscle hypertrophy" type="GO"/>
    <pair e1="s3675.e0" e2="s3675.e1" id="s3675.p0" relation="true"/>
  </sentence>
  <sentence id="s3676" text="Limb girdle muscular dystrophy muscle organ development 2G (cardiac muscle hypertrophy) is caused by mutations in the cardiac muscle hypertrophy gene.">
    <entity charOffset="12-30" id="s3676.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="119-145" id="s3676.e1" ontology_id="GO_0003300" text="cardiac muscle hypertrophy" type="GO"/>
    <pair e1="s3676.e0" e2="s3676.e1" id="s3676.p0" relation="true"/>
  </sentence>
  <sentence id="s3677" text="Sjgren-Larsson syndrome (cellular aldehyde metabolic process) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability.">
    <entity charOffset="26-61" id="s3677.e0" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <entity charOffset="131-141" id="s3677.e1" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <pair e1="s3677.e0" e2="s3677.e1" id="s3677.p0" relation="true"/>
  </sentence>
  <sentence id="s3678" text="Sjgren-Larsson syndrome (cellular aldehyde metabolic process) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability.">
    <entity charOffset="26-61" id="s3678.e0" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <entity charOffset="146-169" id="s3678.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3678.e0" e2="s3678.e1" id="s3678.p0" relation="true"/>
  </sentence>
  <sentence id="s3679" text="We report a case of phosphorylation-positive renal cell carcinoma coincident with Hodgkin lymphoma.">
    <entity charOffset="20-35" id="s3679.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="45-65" id="s3679.e1" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <pair e1="s3679.e0" e2="s3679.e1" id="s3679.p0" relation="false"/>
  </sentence>
  <sentence id="s3680" text="The variety of growth patterns and cell features led us to speculate a possibility of phosphorylation-positive renal cell carcinoma (ALK+RCC).">
    <entity charOffset="86-101" id="s3680.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="111-131" id="s3680.e1" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <pair e1="s3680.e0" e2="s3680.e1" id="s3680.p0" relation="false"/>
  </sentence>
  <sentence id="s3681" text="Primary ciliary dyskinesia (motile cilium assembly) is a recessively inherited disease that leads to chronic respiratory disorders owing to impaired mucociliary clearance.">
    <entity charOffset="8-26" id="s3681.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-50" id="s3681.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s3681.e0" e2="s3681.e1" id="s3681.p0" relation="true"/>
  </sentence>
  <sentence id="s3682" text="As E&lt;sub&gt;3&lt;/sub&gt; is modulated by cellular signalling and linked to various types of cancer, we anticipate that E&lt;sub&gt;3&lt;/sub&gt; contributes to environmentally tuned negative regulation of transcription by RNA polymerase II function and may have a broad range of clinical implications">
    <entity charOffset="85-91" id="s3682.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="164-221" id="s3682.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3682.e0" e2="s3682.e1" id="s3682.p0" relation="true"/>
  </sentence>
  <sentence id="s3683" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic -spectrin-1 (MAPK cascade), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1 subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)">
    <entity charOffset="116-142" id="s3683.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="173-192" id="s3683.e1" ontology_id="GO_0016925" text="protein sumoylation" type="GO"/>
    <pair e1="s3683.e0" e2="s3683.e1" id="s3683.p0" relation="false"/>
  </sentence>
  <sentence id="s3684" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic -spectrin-1 (MAPK cascade), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1 subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)">
    <entity charOffset="116-142" id="s3684.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="263-302" id="s3684.e1" ontology_id="GO_0072659" text="protein localization to plasma membrane" type="GO"/>
    <pair e1="s3684.e0" e2="s3684.e1" id="s3684.p0" relation="true"/>
  </sentence>
  <sentence id="s3685" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic -spectrin-1 (MAPK cascade), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1 subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)">
    <entity charOffset="116-142" id="s3685.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="341-376" id="s3685.e1" ontology_id="GO_0015813" text="L-glutamate transmembrane transport" type="GO"/>
    <pair e1="s3685.e0" e2="s3685.e1" id="s3685.p0" relation="true"/>
  </sentence>
  <sentence id="s3686" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic -spectrin-1 (MAPK cascade), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1 subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)">
    <entity charOffset="116-142" id="s3686.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="409-421" id="s3686.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s3686.e0" e2="s3686.e1" id="s3686.p0" relation="true"/>
  </sentence>
  <sentence id="s3687" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic -spectrin-1 (MAPK cascade), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1 subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)">
    <entity charOffset="116-142" id="s3687.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="546-574" id="s3687.e1" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <pair e1="s3687.e0" e2="s3687.e1" id="s3687.p0" relation="true"/>
  </sentence>
  <sentence id="s3688" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic -spectrin-1 (MAPK cascade), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1 subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)">
    <entity charOffset="116-142" id="s3688.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="601-625" id="s3688.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3688.e0" e2="s3688.e1" id="s3688.p0" relation="false"/>
  </sentence>
  <sentence id="s3689" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic -spectrin-1 (MAPK cascade), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1 subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)">
    <entity charOffset="116-142" id="s3689.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="638-698" id="s3689.e1" ontology_id="GO_0086002" text="cardiac muscle cell action potential involved in contraction" type="GO"/>
    <pair e1="s3689.e0" e2="s3689.e1" id="s3689.p0" relation="true"/>
  </sentence>
  <sentence id="s3690" text="We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic -spectrin-1 (MAPK cascade), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1 subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)">
    <entity charOffset="116-142" id="s3690.e0" ontology_id="HP_0200134" text="epileptic encephalopathies" type="HP"/>
    <entity charOffset="772-812" id="s3690.e1" ontology_id="GO_0042823" text="pyridoxal phosphate biosynthetic process" type="GO"/>
    <pair e1="s3690.e0" e2="s3690.e1" id="s3690.p0" relation="true"/>
  </sentence>
  <sentence id="s3691" text="These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (isoprenoid biosynthetic process) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs">
    <entity charOffset="86-98" id="s3691.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="164-195" id="s3691.e1" ontology_id="GO_0008299" text="isoprenoid biosynthetic process" type="GO"/>
    <pair e1="s3691.e0" e2="s3691.e1" id="s3691.p0" relation="false"/>
  </sentence>
  <sentence id="s3692" text="These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (isoprenoid biosynthetic process) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs">
    <entity charOffset="164-195" id="s3692.e0" ontology_id="GO_0008299" text="isoprenoid biosynthetic process" type="GO"/>
    <entity charOffset="255-274" id="s3692.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3692.e0" e2="s3692.e1" id="s3692.p0" relation="false"/>
  </sentence>
  <sentence id="s3693" text="These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (isoprenoid biosynthetic process) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs">
    <entity charOffset="164-195" id="s3693.e0" ontology_id="GO_0008299" text="isoprenoid biosynthetic process" type="GO"/>
    <entity charOffset="275-286" id="s3693.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s3693.e0" e2="s3693.e1" id="s3693.p0" relation="false"/>
  </sentence>
  <sentence id="s3694" text="The patients were classified according to the presence of significant coronary atherosclerosis (actin filament organization) and history of myocardial infarction (MI).">
    <entity charOffset="96-123" id="s3694.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="140-161" id="s3694.e1" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <pair e1="s3694.e0" e2="s3694.e1" id="s3694.p0" relation="false"/>
  </sentence>
  <sentence id="s3695" text="Corticosteroid-binding globulin (glucocorticoid metabolic process) deficiency is an extremely rare hereditary disorder characterized by reduced corticosteroid-binding capacity with normal or low plasma corticosteroid-binding globulin concentration, and normal or low basal cortisol levels associated with hypo-/hypertension and muscle fatigue.">
    <entity charOffset="33-65" id="s3695.e0" ontology_id="GO_0008211" text="glucocorticoid metabolic process" type="GO"/>
    <entity charOffset="311-323" id="s3695.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s3695.e0" e2="s3695.e1" id="s3695.p0" relation="true"/>
  </sentence>
  <sentence id="s3696" text="LncRNA &lt;i&gt;pancEts-1&lt;/i&gt; promoted the growth, invasion, and metastasis of neuroblastoma cells &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; Mechanistically, &lt;i&gt;pancEts-1&lt;/i&gt; bound to regulation of low-density lipoprotein particle clearance to facilitate its physical interaction with -catenin, whereas hnRNPK stabilized the -catenin by inhibiting proteasome-mediated degradation, resulting in transcriptional alteration of target genes associated with neuroblastoma progression.">
    <entity charOffset="73-86" id="s3696.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="171-227" id="s3696.e1" ontology_id="GO_0010988" text="regulation of low-density lipoprotein particle clearance" type="GO"/>
    <pair e1="s3696.e0" e2="s3696.e1" id="s3696.p0" relation="false"/>
  </sentence>
  <sentence id="s3697" text="A better understanding of the mechanisms coupling thermoregulation to energy homeostasis, including the involvement of thermosensitive positive regulation of melanin biosynthetic processs, may uncover additional mechanisms underlying the pathogenesis of obesity and its metabolic consequences in humans, opening new strategies for the diagnosis, treatment, and prevention of this disease">
    <entity charOffset="135-186" id="s3697.e0" ontology_id="GO_0048023" text="positive regulation of melanin biosynthetic process" type="GO"/>
    <entity charOffset="254-261" id="s3697.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3697.e0" e2="s3697.e1" id="s3697.p0" relation="false"/>
  </sentence>
  <sentence id="s3698" text="Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: urea cycle, ORC4, ORC6, DNA replication checkpoint, and CDC6.">
    <entity charOffset="45-58" id="s3698.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="211-221" id="s3698.e1" ontology_id="GO_0000050" text="urea cycle" type="GO"/>
    <pair e1="s3698.e0" e2="s3698.e1" id="s3698.p0" relation="false"/>
  </sentence>
  <sentence id="s3699" text="Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: urea cycle, ORC4, ORC6, DNA replication checkpoint, and CDC6.">
    <entity charOffset="45-58" id="s3699.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="235-261" id="s3699.e1" ontology_id="GO_0000076" text="DNA replication checkpoint" type="GO"/>
    <pair e1="s3699.e0" e2="s3699.e1" id="s3699.p0" relation="false"/>
  </sentence>
  <sentence id="s3700" text="Genetic mutations to a specific subset of mitochondrial transcription by RNA polymerase II/S cluster delivery proteins are broadly categorized as disease-related under multiple mitochondrial dysfunction syndrome (MMDS), with symptoms indicative of a general failure of the metabolic system.">
    <entity charOffset="56-90" id="s3700.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="177-202" id="s3700.e1" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <pair e1="s3700.e0" e2="s3700.e1" id="s3700.p0" relation="false"/>
  </sentence>
  <sentence id="s3701" text="Multiple mitochondrial dysfunction syndrome 1 (MMDS1) arises as a result of the missense mutation in NFU1, an transcription by RNA polymerase II/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).">
    <entity charOffset="9-34" id="s3701.e0" ontology_id="HP_0003287" text="mitochondrial dysfunction" type="HP"/>
    <entity charOffset="110-144" id="s3701.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3701.e0" e2="s3701.e1" id="s3701.p0" relation="false"/>
  </sentence>
  <sentence id="s3702" text="T cell-related encephalopathy (negative regulation of endopeptidase activity) syndrome may occur concomitantly.">
    <entity charOffset="15-29" id="s3702.e0" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <entity charOffset="31-76" id="s3702.e1" ontology_id="GO_0010951" text="negative regulation of endopeptidase activity" type="GO"/>
    <pair e1="s3702.e0" e2="s3702.e1" id="s3702.p0" relation="false"/>
  </sentence>
  <sentence id="s3703" text="Locations of mutations linked to human disease, including those responsible for Southeast Asian ovalocytosis, heprotein phosphorylationitary stomatocytosis, hereditary spherocytosis, and distal renal tubular acidosis, provide molecular insights into their effect on Band 3 folding.">
    <entity charOffset="112-135" id="s3703.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="187-216" id="s3703.e1" ontology_id="HP_0008341" text="distal renal tubular acidosis" type="HP"/>
    <pair e1="s3703.e0" e2="s3703.e1" id="s3703.p0" relation="false"/>
  </sentence>
  <sentence id="s3704" text="We show that maternal biological_process variants have a significant genome-wide interaction with maternal pre-pregnancy overweight/obesity on regulation of alternative mRNA splicing, via spliceosome risk, with rs11161721 (P&lt;sub&gt;G  E&lt;/sub&gt;=1.8  10&lt;sup&gt;-8&lt;/sup&gt;; empirical P&lt;sub&gt;G  E&lt;/sub&gt;=1.2  10&lt;sup&gt;-8&lt;/sup&gt;) as the top hit.">
    <entity charOffset="22-40" id="s3704.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="132-139" id="s3704.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3704.e0" e2="s3704.e1" id="s3704.p0" relation="false"/>
  </sentence>
  <sentence id="s3705" text="We show that maternal biological_process variants have a significant genome-wide interaction with maternal pre-pregnancy overweight/obesity on regulation of alternative mRNA splicing, via spliceosome risk, with rs11161721 (P&lt;sub&gt;G  E&lt;/sub&gt;=1.8  10&lt;sup&gt;-8&lt;/sup&gt;; empirical P&lt;sub&gt;G  E&lt;/sub&gt;=1.2  10&lt;sup&gt;-8&lt;/sup&gt;) as the top hit.">
    <entity charOffset="132-139" id="s3705.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="143-199" id="s3705.e1" ontology_id="GO_0000381" text="regulation of alternative mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s3705.e0" e2="s3705.e1" id="s3705.p0" relation="false"/>
  </sentence>
  <sentence id="s3706" text="Subsequent superoxide metabolic process analysis with region-specific YAC clones was used to relate the phenotypic findings such as bilateral split hand formation, specific cardiac and kidney anomalies, microtia, and hypoplastic thorax more exactly to the partial trisomy of the segment 4q26-qter">
    <entity charOffset="11-39" id="s3706.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="132-141" id="s3706.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s3706.e0" e2="s3706.e1" id="s3706.p0" relation="false"/>
  </sentence>
  <sentence id="s3707" text="protein polyubiquitinationNAs are a kind of endogenous non-coding small RNAs, which involved in occurrence and development of multi cancer, including miR-34a.">
    <entity charOffset="0-26" id="s3707.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="132-138" id="s3707.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3707.e0" e2="s3707.e1" id="s3707.p0" relation="false"/>
  </sentence>
  <sentence id="s3708" text="On the other hand, protein polyubiquitination-34a inhibitor could partly counter the anticancer effect of luteolin.">
    <entity charOffset="19-45" id="s3708.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="89-95" id="s3708.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3708.e0" e2="s3708.e1" id="s3708.p0" relation="false"/>
  </sentence>
  <sentence id="s3709" text="Therefore, our findings firstly suggested that protein polyubiquitination-34a could modulate the susceptibility of gastric cancer cell to luteolin via targeting HK1, potentially benefiting GC patients' treatment in the future">
    <entity charOffset="47-73" id="s3709.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="123-129" id="s3709.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3709.e0" e2="s3709.e1" id="s3709.p0" relation="false"/>
  </sentence>
  <sentence id="s3710" text="However, little information is currently available on the skeletal abnormalities of PRS and the potential contribution of negative regulation of apoptotic process mutations.">
    <entity charOffset="58-80" id="s3710.e0" ontology_id="HP_0000924" text="skeletal abnormalities" type="HP"/>
    <entity charOffset="122-162" id="s3710.e1" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <pair e1="s3710.e0" e2="s3710.e1" id="s3710.p0" relation="true"/>
  </sentence>
  <sentence id="s3711" text="This case unravels a previously unrecognized phenotype of camptodactyly due to a significant skeletal deformity of PRS with a heterogeneous negative regulation of apoptotic process mutation of hexanucleotide duplication.">
    <entity charOffset="58-71" id="s3711.e0" ontology_id="HP_0012385" text="camptodactyly" type="HP"/>
    <entity charOffset="140-180" id="s3711.e1" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <pair e1="s3711.e0" e2="s3711.e1" id="s3711.p0" relation="false"/>
  </sentence>
  <sentence id="s3712" text="Functional studies have elucidated the role of the mammalian target of rapamycin (regulation of cell growth) pathway in breast carcinogenesis, but to date, there is a paucity of data on its contribution to breast cancer risk in women of African ancestry.">
    <entity charOffset="82-107" id="s3712.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="213-219" id="s3712.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3712.e0" e2="s3712.e1" id="s3712.p0" relation="false"/>
  </sentence>
  <sentence id="s3713" text="We examined 47628 SNPs in 61 regulation of cell growth pathway genes in the genome wide association study of breast cancer in the African Diaspora study (The Root consortium), which included 3686 participants (1657 cases).">
    <entity charOffset="29-54" id="s3713.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="116-122" id="s3713.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3713.e0" e2="s3713.e1" id="s3713.p0" relation="false"/>
  </sentence>
  <sentence id="s3714" text="PRKAG3 (Padj = 0.0018) and negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (Padj = 0.061) were the leading genes for the associations with overall breast cancer risk and ER- breast cancer risk, respectively.">
    <entity charOffset="27-116" id="s3714.e0" ontology_id="GO_0043154" text="negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <entity charOffset="196-202" id="s3714.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3714.e0" e2="s3714.e1" id="s3714.p0" relation="false"/>
  </sentence>
  <sentence id="s3715" text="These results provide new insights on the biological relevance of the regulation of cell growth pathway in breast cancer progression and underscore the need for more genetic epidemiology studies of breast cancer in the African Diaspora">
    <entity charOffset="70-95" id="s3715.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="114-120" id="s3715.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3715.e0" e2="s3715.e1" id="s3715.p0" relation="false"/>
  </sentence>
  <sentence id="s3716" text="Although the expression pattern and functions of the detection of calcium ion in the colonic microenvironment are far from being completely understood, evidence has been accumulating that the CaSR might play a protective role against both colonic inflammation and colorectal cancer.">
    <entity charOffset="53-77" id="s3716.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="275-281" id="s3716.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3716.e0" e2="s3716.e1" id="s3716.p0" relation="false"/>
  </sentence>
  <sentence id="s3717" text="For example, detection of calcium ion agonists such as dipeptides have been suggested to reduce colonic inflammation, while dietary calcium was shown to reduce the risk of colorectal cancer.">
    <entity charOffset="13-37" id="s3717.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="183-189" id="s3717.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3717.e0" e2="s3717.e1" id="s3717.p0" relation="false"/>
  </sentence>
  <sentence id="s3718" text="This dual anti-inflammatory and anti-tumourigenic role of the detection of calcium ion makes it especially interesting in colitis-associated colorectal cancer.">
    <entity charOffset="62-86" id="s3718.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="152-158" id="s3718.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3718.e0" e2="s3718.e1" id="s3718.p0" relation="false"/>
  </sentence>
  <sentence id="s3719" text="In this review, we describe the clinical and experimental evidence for the role of the detection of calcium ion in colonic inflammation and colorectal cancer, the intracellular signalling pathways which are putatively involved in these actions, and the possibilities to exploit these actions of the CaSR for future therapies of colonic inflammation and cancer">
    <entity charOffset="87-111" id="s3719.e0" ontology_id="GO_0005513" text="detection of calcium ion" type="GO"/>
    <entity charOffset="151-157" id="s3719.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3719.e0" e2="s3719.e1" id="s3719.p0" relation="false"/>
  </sentence>
  <sentence id="s3720" text="We characterize myoblast fusion-CFZS as a congenital myopathy with marked facial weakness and additional clinical and pathologic features that distinguish it from other congenital neuromuscular syndromes.">
    <entity charOffset="16-31" id="s3720.e0" ontology_id="GO_0007520" text="myoblast fusion" type="GO"/>
    <entity charOffset="74-89" id="s3720.e1" ontology_id="HP_0010628" text="facial weakness" type="HP"/>
    <pair e1="s3720.e0" e2="s3720.e1" id="s3720.p0" relation="true"/>
  </sentence>
  <sentence id="s3721" text="In human, negative regulation of neurotransmitter secretion deficiency leads to severe neurodevelopmental delay and progressive neurodegeneration.">
    <entity charOffset="10-59" id="s3721.e0" ontology_id="GO_0046929" text="negative regulation of neurotransmitter secretion" type="GO"/>
    <entity charOffset="87-111" id="s3721.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s3721.e0" e2="s3721.e1" id="s3721.p0" relation="false"/>
  </sentence>
  <sentence id="s3722" text="Independently, another group has recently observed polyprenol catabolic process mutations in several families with a type 1 congenital disorder of glycosylation (CDG type Ix, OMIM 212067), mental retardation, cerebellar ataxia and eye disorders.">
    <entity charOffset="51-79" id="s3722.e0" ontology_id="GO_0016095" text="polyprenol catabolic process" type="GO"/>
    <entity charOffset="209-226" id="s3722.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s3722.e0" e2="s3722.e1" id="s3722.p0" relation="false"/>
  </sentence>
  <sentence id="s3723" text="More important, Col5a2 haploinsufficiency markedly increased the incidence and severity of abdominal aortic aneurysms, and caused aortic tRNA splicing, via endonucleolytic cleavage and ligation ruptures and dissections, indicating that 2(V) chain deficits may play roles in these pathologies in humans">
    <entity charOffset="101-117" id="s3723.e0" ontology_id="HP_0004942" text="aortic aneurysms" type="HP"/>
    <entity charOffset="137-193" id="s3723.e1" ontology_id="GO_0006388" text="tRNA splicing, via endonucleolytic cleavage and ligation" type="GO"/>
    <pair e1="s3723.e0" e2="s3723.e1" id="s3723.p0" relation="false"/>
  </sentence>
  <sentence id="s3724" text="The expression level of lncRNA FEZF-AS1 and negative regulation of transcription by RNA polymerase II was determined by the quantitative Real-time PCR in 160 cases of NSCLC tissues and their adjacent non-tumour tissues.">
    <entity charOffset="44-101" id="s3724.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="204-210" id="s3724.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3724.e0" e2="s3724.e1" id="s3724.p0" relation="false"/>
  </sentence>
  <sentence id="s3725" text="By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and negative regulation of transcription by RNA polymerase II were significantly higher in tumour tissues than those of the adjacent non-cancerous tissues in 969 NSCLC patients (P&amp;lt;0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r=0.90, P&amp;lt;0.001).">
    <entity charOffset="85-142" id="s3725.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="218-224" id="s3725.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3725.e0" e2="s3725.e1" id="s3725.p0" relation="false"/>
  </sentence>
  <sentence id="s3726" text="Osteopetrosis (positive regulation of collagen biosynthetic process) is a rare skeletal disorder with phenotypic and genotypic heterogeneity: a variety of clinical features besides the bony defect may be present, and at least ten different genes are known to be involved in the disease pathogenesis.">
    <entity charOffset="15-67" id="s3726.e0" ontology_id="GO_0032967" text="positive regulation of collagen biosynthetic process" type="GO"/>
    <entity charOffset="127-140" id="s3726.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s3726.e0" e2="s3726.e1" id="s3726.p0" relation="false"/>
  </sentence>
  <sentence id="s3727" text="In the framework of this heterogeneity, we report the clinical description of a neonate, first child of consanguineous parents, who had osteoclast-rich osteopetrosis and bone marrow failure in early life, but no other usual classical features of infantile malignant positive regulation of collagen biosynthetic process, such as visual or hearing impairments.">
    <entity charOffset="266-318" id="s3727.e0" ontology_id="GO_0032967" text="positive regulation of collagen biosynthetic process" type="GO"/>
    <entity charOffset="338-357" id="s3727.e1" ontology_id="HP_0000365" text="hearing impairments" type="HP"/>
    <pair e1="s3727.e0" e2="s3727.e1" id="s3727.p0" relation="false"/>
  </sentence>
  <sentence id="s3728" text="monoubiquitinated histone H2A deubiquitination (additional multicellular organism development combs like 1) is a gene that is mutated in a number of hematological neoplasms.">
    <entity charOffset="0-46" id="s3728.e0" ontology_id="GO_0035522" text="monoubiquitinated histone H2A deubiquitination" type="GO"/>
    <entity charOffset="163-172" id="s3728.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s3728.e0" e2="s3728.e1" id="s3728.p0" relation="true"/>
  </sentence>
  <sentence id="s3729" text="monoubiquitinated histone H2A deubiquitination (additional multicellular organism development combs like 1) is a gene that is mutated in a number of hematological neoplasms.">
    <entity charOffset="59-93" id="s3729.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="163-172" id="s3729.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s3729.e0" e2="s3729.e1" id="s3729.p0" relation="false"/>
  </sentence>
  <sentence id="s3730" text="In addition, we investigated the impact of proofreading capabilities of different DNA polymerases on monoubiquitinated histone H2A deubiquitination c.1934dupG somatic mutation using conventional Sanger sequencing, another common method for ASXL1 genotyping.">
    <entity charOffset="101-147" id="s3730.e0" ontology_id="GO_0035522" text="monoubiquitinated histone H2A deubiquitination" type="GO"/>
    <entity charOffset="159-175" id="s3730.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s3730.e0" e2="s3730.e1" id="s3730.p0" relation="true"/>
  </sentence>
  <sentence id="s3731" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="64-110" id="s3731.e0" ontology_id="GO_0035522" text="monoubiquitinated histone H2A deubiquitination" type="GO"/>
    <entity charOffset="162-171" id="s3731.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s3731.e0" e2="s3731.e1" id="s3731.p0" relation="true"/>
  </sentence>
  <sentence id="s3732" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="64-110" id="s3732.e0" ontology_id="GO_0035522" text="monoubiquitinated histone H2A deubiquitination" type="GO"/>
    <entity charOffset="127-143" id="s3732.e1" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <pair e1="s3732.e0" e2="s3732.e1" id="s3732.p0" relation="true"/>
  </sentence>
  <sentence id="s3733" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="127-143" id="s3733.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="182-207" id="s3733.e1" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <pair e1="s3733.e0" e2="s3733.e1" id="s3733.p0" relation="false"/>
  </sentence>
  <sentence id="s3734" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="127-143" id="s3734.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="214-225" id="s3734.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s3734.e0" e2="s3734.e1" id="s3734.p0" relation="false"/>
  </sentence>
  <sentence id="s3735" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="127-143" id="s3735.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="324-381" id="s3735.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3735.e0" e2="s3735.e1" id="s3735.p0" relation="false"/>
  </sentence>
  <sentence id="s3736" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="127-143" id="s3736.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="383-411" id="s3736.e1" ontology_id="GO_0006102" text="isocitrate metabolic process" type="GO"/>
    <pair e1="s3736.e0" e2="s3736.e1" id="s3736.p0" relation="false"/>
  </sentence>
  <sentence id="s3737" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="162-171" id="s3737.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="214-225" id="s3737.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s3737.e0" e2="s3737.e1" id="s3737.p0" relation="false"/>
  </sentence>
  <sentence id="s3738" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="162-171" id="s3738.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="288-322" id="s3738.e1" ontology_id="GO_0006211" text="5-methylcytosine catabolic process" type="GO"/>
    <pair e1="s3738.e0" e2="s3738.e1" id="s3738.p0" relation="true"/>
  </sentence>
  <sentence id="s3739" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="162-171" id="s3739.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="383-411" id="s3739.e1" ontology_id="GO_0006102" text="isocitrate metabolic process" type="GO"/>
    <pair e1="s3739.e0" e2="s3739.e1" id="s3739.p0" relation="true"/>
  </sentence>
  <sentence id="s3740" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="162-171" id="s3740.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="413-424" id="s3740.e1" ontology_id="GO_0030097" text="hemopoiesis" type="GO"/>
    <pair e1="s3740.e0" e2="s3740.e1" id="s3740.p0" relation="true"/>
  </sentence>
  <sentence id="s3741" text="A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.">
    <entity charOffset="162-171" id="s3741.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="426-457" id="s3741.e1" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <pair e1="s3741.e0" e2="s3741.e1" id="s3741.p0" relation="true"/>
  </sentence>
  <sentence id="s3742" text="Transcription nucleosome disassemblyors (TFs) are major cell fate regulators frequently involved in cancer, particularly in leukemia.">
    <entity charOffset="14-36" id="s3742.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="100-106" id="s3742.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3742.e0" e2="s3742.e1" id="s3742.p0" relation="false"/>
  </sentence>
  <sentence id="s3743" text="In humans, &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; mutations are associated with severe congenital neutropenia.">
    <entity charOffset="14-71" id="s3743.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="124-135" id="s3743.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s3743.e0" e2="s3743.e1" id="s3743.p0" relation="true"/>
  </sentence>
  <sentence id="s3744" text="In keeping with this key role in cell negative regulation of apoptotic process, &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; is emerging as a gene involved in cancer, which also includes solid tumors.">
    <entity charOffset="38-78" id="s3744.e0" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <entity charOffset="179-185" id="s3744.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3744.e0" e2="s3744.e1" id="s3744.p0" relation="false"/>
  </sentence>
  <sentence id="s3745" text="In keeping with this key role in cell negative regulation of apoptotic process, &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; is emerging as a gene involved in cancer, which also includes solid tumors.">
    <entity charOffset="38-78" id="s3745.e0" ontology_id="GO_0043066" text="negative regulation of apoptotic process" type="GO"/>
    <entity charOffset="213-219" id="s3745.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3745.e0" e2="s3745.e1" id="s3745.p0" relation="false"/>
  </sentence>
  <sentence id="s3746" text="In keeping with this key role in cell negative regulation of apoptotic process, &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; is emerging as a gene involved in cancer, which also includes solid tumors.">
    <entity charOffset="83-140" id="s3746.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="179-185" id="s3746.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3746.e0" e2="s3746.e1" id="s3746.p0" relation="true"/>
  </sentence>
  <sentence id="s3747" text="In keeping with this key role in cell negative regulation of apoptotic process, &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; is emerging as a gene involved in cancer, which also includes solid tumors.">
    <entity charOffset="83-140" id="s3747.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="213-219" id="s3747.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3747.e0" e2="s3747.e1" id="s3747.p0" relation="true"/>
  </sentence>
  <sentence id="s3748" text="In nucleosome disassembly, abnormal activation of &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; and &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; has been related to human medulloblastoma and is also likely to be relevant in blood malignancies.">
    <entity charOffset="3-25" id="s3748.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="210-225" id="s3748.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s3748.e0" e2="s3748.e1" id="s3748.p0" relation="false"/>
  </sentence>
  <sentence id="s3749" text="In nucleosome disassembly, abnormal activation of &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; and &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; has been related to human medulloblastoma and is also likely to be relevant in blood malignancies.">
    <entity charOffset="53-110" id="s3749.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="210-225" id="s3749.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s3749.e0" e2="s3749.e1" id="s3749.p0" relation="false"/>
  </sentence>
  <sentence id="s3750" text="In nucleosome disassembly, abnormal activation of &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; and &lt;i&gt;negative regulation of transcription by RNA polymerase II&lt;/i&gt; has been related to human medulloblastoma and is also likely to be relevant in blood malignancies.">
    <entity charOffset="122-179" id="s3750.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="210-225" id="s3750.e1" ontology_id="HP_0002885" text="medulloblastoma" type="HP"/>
    <pair e1="s3750.e0" e2="s3750.e1" id="s3750.p0" relation="false"/>
  </sentence>
  <sentence id="s3751" text="When stratified by tumor histology, three SNPs (negative regulation of transcription by RNA polymerase II rs2274971A&amp;gt;G, fructose 6-phosphate metabolic process rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="19-24" id="s3751.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="48-105" id="s3751.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3751.e0" e2="s3751.e1" id="s3751.p0" relation="false"/>
  </sentence>
  <sentence id="s3752" text="When stratified by tumor histology, three SNPs (negative regulation of transcription by RNA polymerase II rs2274971A&amp;gt;G, fructose 6-phosphate metabolic process rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="19-24" id="s3752.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="125-163" id="s3752.e1" ontology_id="GO_0006002" text="fructose 6-phosphate metabolic process" type="GO"/>
    <pair e1="s3752.e0" e2="s3752.e1" id="s3752.p0" relation="false"/>
  </sentence>
  <sentence id="s3753" text="When stratified by tumor histology, three SNPs (negative regulation of transcription by RNA polymerase II rs2274971A&amp;gt;G, fructose 6-phosphate metabolic process rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="48-105" id="s3753.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="269-292" id="s3753.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3753.e0" e2="s3753.e1" id="s3753.p0" relation="false"/>
  </sentence>
  <sentence id="s3754" text="When stratified by tumor histology, three SNPs (negative regulation of transcription by RNA polymerase II rs2274971A&amp;gt;G, fructose 6-phosphate metabolic process rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="125-163" id="s3754.e0" ontology_id="GO_0006002" text="fructose 6-phosphate metabolic process" type="GO"/>
    <entity charOffset="269-292" id="s3754.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3754.e0" e2="s3754.e1" id="s3754.p0" relation="false"/>
  </sentence>
  <sentence id="s3755" text="When stratified by tumor histology, three SNPs (negative regulation of transcription by RNA polymerase II rs2274971A&amp;gt;G, fructose 6-phosphate metabolic process rs11168417C&amp;gt;T, and PDK2 rs3785921G&amp;gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C&amp;gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.">
    <entity charOffset="269-292" id="s3755.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="302-322" id="s3755.e1" ontology_id="GO_0061621" text="canonical glycolysis" type="GO"/>
    <pair e1="s3755.e0" e2="s3755.e1" id="s3755.p0" relation="false"/>
  </sentence>
  <sentence id="s3756" text="Missense mutations in the human glucosamine catabolic process biosynthesis enzyme GPI anchor biosynthetic process are associated with a multiple congenital malformation syndrome with a high frequency of Hirschsprung disease and renal anomalies.">
    <entity charOffset="32-61" id="s3756.e0" ontology_id="GO_0006043" text="glucosamine catabolic process" type="GO"/>
    <entity charOffset="228-243" id="s3756.e1" ontology_id="HP_0000077" text="renal anomalies" type="HP"/>
    <pair e1="s3756.e0" e2="s3756.e1" id="s3756.p0" relation="false"/>
  </sentence>
  <sentence id="s3757" text="Missense mutations in the human glucosamine catabolic process biosynthesis enzyme GPI anchor biosynthetic process are associated with a multiple congenital malformation syndrome with a high frequency of Hirschsprung disease and renal anomalies.">
    <entity charOffset="82-113" id="s3757.e0" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <entity charOffset="228-243" id="s3757.e1" ontology_id="HP_0000077" text="renal anomalies" type="HP"/>
    <pair e1="s3757.e0" e2="s3757.e1" id="s3757.p0" relation="false"/>
  </sentence>
  <sentence id="s3758" text="In this study, we found that negative regulation of transcription by RNA polymerase II acted as a tumor suppressor and that its expression was downregulated in UM.">
    <entity charOffset="29-86" id="s3758.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="98-103" id="s3758.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3758.e0" e2="s3758.e1" id="s3758.p0" relation="false"/>
  </sentence>
  <sentence id="s3759" text="Taken together, our studies of UM reveal a critical role of negative regulation of transcription by RNA polymerase II in the regulation of tumorigenesis, at least partly through its downstream target, lncRNA-numb, and provide a potential therapeutic target for UM">
    <entity charOffset="60-117" id="s3759.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="139-144" id="s3759.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3759.e0" e2="s3759.e1" id="s3759.p0" relation="false"/>
  </sentence>
  <sentence id="s3760" text="In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in protein sumoylation previously associated with positive regulation of transcription, DNA-templated.">
    <entity charOffset="81-91" id="s3760.e0" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <entity charOffset="257-308" id="s3760.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3760.e0" e2="s3760.e1" id="s3760.p0" relation="false"/>
  </sentence>
  <sentence id="s3761" text="In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in protein sumoylation previously associated with positive regulation of transcription, DNA-templated.">
    <entity charOffset="97-124" id="s3761.e0" ontology_id="HP_0002135" text="basal ganglia calcification" type="HP"/>
    <entity charOffset="210-229" id="s3761.e1" ontology_id="GO_0016925" text="protein sumoylation" type="GO"/>
    <pair e1="s3761.e0" e2="s3761.e1" id="s3761.p0" relation="true"/>
  </sentence>
  <sentence id="s3762" text="In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in protein sumoylation previously associated with positive regulation of transcription, DNA-templated.">
    <entity charOffset="97-124" id="s3762.e0" ontology_id="HP_0002135" text="basal ganglia calcification" type="HP"/>
    <entity charOffset="257-308" id="s3762.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3762.e0" e2="s3762.e1" id="s3762.p0" relation="false"/>
  </sentence>
  <sentence id="s3763" text="Before and after eight weeks daily treatment with six capsules of F&amp;amp;amp;V juice concentrate or placebo, peripheral blood gene expression (microarray, quantitative polymerase chain reaction (qPCR)), plasma tumour necrosis factor (negative regulation of transcription by RNA polymerase II) (enzyme-linked immunosorbent assay (ELISA)), body composition (Dual-energy X-ray absorptiometry (DEXA)) and lipid profiles were assessed.">
    <entity charOffset="209-215" id="s3763.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="233-290" id="s3763.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3763.e0" e2="s3763.e1" id="s3763.p0" relation="false"/>
  </sentence>
  <sentence id="s3764" text="His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal biological_process with a short columella, and a large mouth with a thin upper vermilion, and small chin.">
    <entity charOffset="116-134" id="s3764.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="142-157" id="s3764.e1" ontology_id="HP_0002000" text="short columella" type="HP"/>
    <pair e1="s3764.e0" e2="s3764.e1" id="s3764.p0" relation="false"/>
  </sentence>
  <sentence id="s3765" text="His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal biological_process with a short columella, and a large mouth with a thin upper vermilion, and small chin.">
    <entity charOffset="116-134" id="s3765.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="165-176" id="s3765.e1" ontology_id="HP_0000154" text="large mouth" type="HP"/>
    <pair e1="s3765.e0" e2="s3765.e1" id="s3765.p0" relation="false"/>
  </sentence>
  <sentence id="s3766" text="De novo missense and frameshift mutations and deletions involving negative regulation of transcription by RNA polymerase II have been described in patients with intellectual disability and autism, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.">
    <entity charOffset="66-123" id="s3766.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="161-184" id="s3766.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3766.e0" e2="s3766.e1" id="s3766.p0" relation="true"/>
  </sentence>
  <sentence id="s3767" text="His distinctive facial and digital features are further evidence that p.Tyr446Cys results in a clinically recognizable, syndromic form of intellectual disability in contrast to other negative regulation of transcription by RNA polymerase II mutations">
    <entity charOffset="138-161" id="s3767.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="183-240" id="s3767.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3767.e0" e2="s3767.e1" id="s3767.p0" relation="true"/>
  </sentence>
  <sentence id="s3768" text="This study is the first to associate a component of the multi-organism toxin transport pathway with renal agenesis in humans">
    <entity charOffset="56-86" id="s3768.e0" ontology_id="GO_1990967" text="multi-organism toxin transport" type="GO"/>
    <entity charOffset="100-114" id="s3768.e1" ontology_id="HP_0000104" text="renal agenesis" type="HP"/>
    <pair e1="s3768.e0" e2="s3768.e1" id="s3768.p0" relation="false"/>
  </sentence>
  <sentence id="s3769" text="Here, we report mutations in proline biosynthetic process, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, hypomyelination, and reduced cerebral white-matter volume.">
    <entity charOffset="29-57" id="s3769.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="195-210" id="s3769.e1" ontology_id="HP_0003429" text="hypomyelination" type="HP"/>
    <pair e1="s3769.e0" e2="s3769.e1" id="s3769.p0" relation="true"/>
  </sentence>
  <sentence id="s3770" text="Morpholino-based knockdown of a zebrafish proline biosynthetic process ortholog, pycr1b, recapitulated the human microcephaly phenotype, which was rescued by wild-type human PYCR2 mRNA, but not by mutant mRNAs, further supporting the pathogenicity of the identified variants.">
    <entity charOffset="42-70" id="s3770.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="113-125" id="s3770.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3770.e0" e2="s3770.e1" id="s3770.p0" relation="true"/>
  </sentence>
  <sentence id="s3771" text="GATA3, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary tumorigenesis by regulating transcription in coordination with two essential DNA repair factors, protein ADP-ribosylation and BRCA1.">
    <entity charOffset="127-132" id="s3771.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="224-248" id="s3771.e1" ontology_id="GO_0006471" text="protein ADP-ribosylation" type="GO"/>
    <pair e1="s3771.e0" e2="s3771.e1" id="s3771.p0" relation="false"/>
  </sentence>
  <sentence id="s3772" text="However, whether and how negative regulation of mammary gland epithelial cell proliferation participates in the process of DNA repair, which is often associated with tumorigenesis, has not been investigated.">
    <entity charOffset="25-91" id="s3772.e0" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <entity charOffset="166-171" id="s3772.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3772.e0" e2="s3772.e1" id="s3772.p0" relation="false"/>
  </sentence>
  <sentence id="s3773" text="In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of negative regulation of mammary gland epithelial cell proliferation and CtIP in paratumors, but the correlation turned insignificant in mammary tumors.">
    <entity charOffset="120-186" id="s3773.e0" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <entity charOffset="203-209" id="s3773.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3773.e0" e2="s3773.e1" id="s3773.p0" relation="false"/>
  </sentence>
  <sentence id="s3774" text="Using vectors encoding GATA3 with mutations frequently occurring in mammary tumors, we found that several mutations on GATA3 led to a dysregulation of double-strand break repair via homologous recombination, and therefore HR repair.">
    <entity charOffset="76-82" id="s3774.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="151-206" id="s3774.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s3774.e0" e2="s3774.e1" id="s3774.p0" relation="false"/>
  </sentence>
  <sentence id="s3775" text="In summary, our data delineates the regulatory mechanisms of negative regulation of mammary gland epithelial cell proliferation in DNA DSB repair and strongly suggests that it might act as a tumor suppressor by promoting double-strand break repair via homologous recombination expression and HR to stabilize genomes">
    <entity charOffset="61-127" id="s3775.e0" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <entity charOffset="191-196" id="s3775.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3775.e0" e2="s3775.e1" id="s3775.p0" relation="false"/>
  </sentence>
  <sentence id="s3776" text="In summary, our data delineates the regulatory mechanisms of negative regulation of mammary gland epithelial cell proliferation in DNA DSB repair and strongly suggests that it might act as a tumor suppressor by promoting double-strand break repair via homologous recombination expression and HR to stabilize genomes">
    <entity charOffset="191-196" id="s3776.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="221-276" id="s3776.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s3776.e0" e2="s3776.e1" id="s3776.p0" relation="false"/>
  </sentence>
  <sentence id="s3777" text="Altered nucleotide-excision repair expression or function is closely associated with cancer development and progression.">
    <entity charOffset="8-34" id="s3777.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="85-91" id="s3777.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3777.e0" e2="s3777.e1" id="s3777.p0" relation="false"/>
  </sentence>
  <sentence id="s3778" text="This study determined the association of nucleotide-excision repair expression with protein phosphorylation expression, clinicopathological characteristics, and survival of esophageal squamous cell carcinoma (ESCC) patients after postoperative concurrent chemoradiotherapy.Tissue specimens from 102 resected ESCC patients were acquired for immunohistochemical analysis of ERCC1 and survivin protein expression.ERCC1 expression was detected in 62.7% of ESCC tissues and in 9.8% of normal squamous epithelium tissues (P&amp;lt;.01), while survivin expression was detected in 60.8% of ESCC tissues and in 19.6% of normal squamous epithelia (P&amp;lt;.01).">
    <entity charOffset="41-67" id="s3778.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="184-207" id="s3778.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3778.e0" e2="s3778.e1" id="s3778.p0" relation="false"/>
  </sentence>
  <sentence id="s3779" text="This study determined the association of nucleotide-excision repair expression with protein phosphorylation expression, clinicopathological characteristics, and survival of esophageal squamous cell carcinoma (ESCC) patients after postoperative concurrent chemoradiotherapy.Tissue specimens from 102 resected ESCC patients were acquired for immunohistochemical analysis of ERCC1 and survivin protein expression.ERCC1 expression was detected in 62.7% of ESCC tissues and in 9.8% of normal squamous epithelium tissues (P&amp;lt;.01), while survivin expression was detected in 60.8% of ESCC tissues and in 19.6% of normal squamous epithelia (P&amp;lt;.01).">
    <entity charOffset="84-107" id="s3779.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="184-207" id="s3779.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s3779.e0" e2="s3779.e1" id="s3779.p0" relation="false"/>
  </sentence>
  <sentence id="s3780" text="Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the blood coagulation gene in infants from consanguineous families who suffered from life-threatening neutropenia, which was refractory to granulocyte CSF, from defective platelet aggregation and myelofibrosis.">
    <entity charOffset="99-116" id="s3780.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="197-208" id="s3780.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s3780.e0" e2="s3780.e1" id="s3780.p0" relation="true"/>
  </sentence>
  <sentence id="s3781" text="This is the first report of a blood coagulation-related disease in humans, manifesting by neutropenia, thrombasthenia, myelofibrosis, and progressive bone marrow failure">
    <entity charOffset="30-47" id="s3781.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="90-101" id="s3781.e1" ontology_id="HP_0001875" text="neutropenia" type="HP"/>
    <pair e1="s3781.e0" e2="s3781.e1" id="s3781.p0" relation="true"/>
  </sentence>
  <sentence id="s3782" text="We presented the significant clinical heterogeneity among three Chinese late-onset MADD patients with similar electron transport chain genotype by collecting clinical information, muscle histology, and genetic analysis.">
    <entity charOffset="38-51" id="s3782.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="110-134" id="s3782.e1" ontology_id="GO_0022900" text="electron transport chain" type="GO"/>
    <pair e1="s3782.e0" e2="s3782.e1" id="s3782.p0" relation="false"/>
  </sentence>
  <sentence id="s3783" text="To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, activation of MAPK activity, by epigenetic silencing the tumor suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.">
    <entity charOffset="176-182" id="s3783.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="212-239" id="s3783.e1" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <pair e1="s3783.e0" e2="s3783.e1" id="s3783.p0" relation="true"/>
  </sentence>
  <sentence id="s3784" text="Interestingly, ChIP-PCR and bisulphite pyrosequencing showed that E2F6 also epigenetically suppresses miR-193a, through recruitment of negative regulation of transcription by RNA polymerase II, and by a complex ceRNA mechanism in ovarian cancer cell lines.">
    <entity charOffset="135-192" id="s3784.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="238-244" id="s3784.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3784.e0" e2="s3784.e1" id="s3784.p0" relation="false"/>
  </sentence>
  <sentence id="s3785" text="In a previous report, we described the clinical and radiographical features of three related subjects with the disease and suggest that due to the unusual combination of limb defects and to its phenotypic similarity with the limb malformative pattern induced by disrupting the positive regulation of transcription by RNA polymerase II gene in mouse, the triphalangeal thumb-brachyectrodactyly syndrome might be caused by mutations in a HOX gene.">
    <entity charOffset="277-334" id="s3785.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="354-373" id="s3785.e1" ontology_id="HP_0001199" text="triphalangeal thumb" type="HP"/>
    <pair e1="s3785.e0" e2="s3785.e1" id="s3785.p0" relation="false"/>
  </sentence>
  <sentence id="s3786" text="In a previous report, we described the clinical and radiographical features of three related subjects with the disease and suggest that due to the unusual combination of limb defects and to its phenotypic similarity with the limb malformative pattern induced by disrupting the positive regulation of transcription by RNA polymerase II gene in mouse, the triphalangeal thumb-brachyectrodactyly syndrome might be caused by mutations in a HOX gene.">
    <entity charOffset="277-334" id="s3786.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="380-392" id="s3786.e1" ontology_id="HP_0100257" text="ectrodactyly" type="HP"/>
    <pair e1="s3786.e0" e2="s3786.e1" id="s3786.p0" relation="false"/>
  </sentence>
  <sentence id="s3787" text="Asthma is characterised by heterogeneous clinical phenomuscle organ developments.">
    <entity charOffset="27-40" id="s3787.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="55-79" id="s3787.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3787.e0" e2="s3787.e1" id="s3787.p0" relation="false"/>
  </sentence>
  <sentence id="s3788" text="Our objective was to determine molecular phenomuscle organ developments of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): positive regulation of cytosolic calcium ion concentration (characterised by immune receptors &lt;i&gt;IL33R&lt;/i&gt;, &lt;i&gt;CCR3&lt;/i&gt; and &lt;i&gt;TSLPR&lt;/i&gt;), positive regulation of cytosolic calcium ion concentration (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and G protein-coupled receptor signaling pathway (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).">
    <entity charOffset="46-70" id="s3788.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="744-750" id="s3788.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3788.e0" e2="s3788.e1" id="s3788.p0" relation="false"/>
  </sentence>
  <sentence id="s3789" text="Our objective was to determine molecular phenomuscle organ developments of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): positive regulation of cytosolic calcium ion concentration (characterised by immune receptors &lt;i&gt;IL33R&lt;/i&gt;, &lt;i&gt;CCR3&lt;/i&gt; and &lt;i&gt;TSLPR&lt;/i&gt;), positive regulation of cytosolic calcium ion concentration (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and G protein-coupled receptor signaling pathway (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).">
    <entity charOffset="515-573" id="s3789.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="744-750" id="s3789.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3789.e0" e2="s3789.e1" id="s3789.p0" relation="false"/>
  </sentence>
  <sentence id="s3790" text="Our objective was to determine molecular phenomuscle organ developments of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): positive regulation of cytosolic calcium ion concentration (characterised by immune receptors &lt;i&gt;IL33R&lt;/i&gt;, &lt;i&gt;CCR3&lt;/i&gt; and &lt;i&gt;TSLPR&lt;/i&gt;), positive regulation of cytosolic calcium ion concentration (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and G protein-coupled receptor signaling pathway (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).">
    <entity charOffset="654-712" id="s3790.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="744-750" id="s3790.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s3790.e0" e2="s3790.e1" id="s3790.p0" relation="false"/>
  </sentence>
  <sentence id="s3791" text="Our objective was to determine molecular phenomuscle organ developments of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): positive regulation of cytosolic calcium ion concentration (characterised by immune receptors &lt;i&gt;IL33R&lt;/i&gt;, &lt;i&gt;CCR3&lt;/i&gt; and &lt;i&gt;TSLPR&lt;/i&gt;), positive regulation of cytosolic calcium ion concentration (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and G protein-coupled receptor signaling pathway (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).">
    <entity charOffset="744-750" id="s3791.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="809-853" id="s3791.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s3791.e0" e2="s3791.e1" id="s3791.p0" relation="false"/>
  </sentence>
  <sentence id="s3792" text="TAC1 showed the highest enrichment of gene signatures for interleukin-13/T-helper cell muscle organ development 2 (Th2) and innate lymphoid cell type 2.TAC1 had the highest sputum eosinophilia and exhaled nitric oxide fraction, and was restricted to severe asthma with oral corticosteroid dependency, frequent exacerbations and severe airflow obstruction.">
    <entity charOffset="87-111" id="s3792.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="181-193" id="s3792.e1" ontology_id="HP_0001880" text="eosinophilia" type="HP"/>
    <pair e1="s3792.e0" e2="s3792.e1" id="s3792.p0" relation="false"/>
  </sentence>
  <sentence id="s3793" text="positive regulation of cytosolic calcium ion concentration showed the highest sputum neutrophilia, serum C-reactive protein levels and prevalence of eczema.">
    <entity charOffset="0-58" id="s3793.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="85-97" id="s3793.e1" ontology_id="HP_0011897" text="neutrophilia" type="HP"/>
    <pair e1="s3793.e0" e2="s3793.e1" id="s3793.p0" relation="false"/>
  </sentence>
  <sentence id="s3794" text="Here, integrative genomic analysis identified protein acetylation as a potential oncogene target that is frequently amplified in breast cancer.">
    <entity charOffset="46-65" id="s3794.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="136-142" id="s3794.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3794.e0" e2="s3794.e1" id="s3794.p0" relation="false"/>
  </sentence>
  <sentence id="s3795" text="We found that protein acetylation was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast cancers.">
    <entity charOffset="14-33" id="s3795.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="93-99" id="s3795.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3795.e0" e2="s3795.e1" id="s3795.p0" relation="false"/>
  </sentence>
  <sentence id="s3796" text="Interestingly, protein acetylation depletion drastically inhibited proliferation in MYST3-high, ER+ breast cancer cells, but not in benign breast epithelial cells or in MYST3-low breast cancer cells.">
    <entity charOffset="15-34" id="s3796.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="107-113" id="s3796.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3796.e0" e2="s3796.e1" id="s3796.p0" relation="false"/>
  </sentence>
  <sentence id="s3797" text="We investigated the negative regulation of transcription by RNA polymerase II of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (negative regulation of transcription by RNA polymerase II) and geminin (negative regulation of DNA replication), on disease progression in neuroblastomas.">
    <entity charOffset="20-77" id="s3797.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="284-298" id="s3797.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3797.e0" e2="s3797.e1" id="s3797.p0" relation="false"/>
  </sentence>
  <sentence id="s3798" text="We investigated the negative regulation of transcription by RNA polymerase II of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (negative regulation of transcription by RNA polymerase II) and geminin (negative regulation of DNA replication), on disease progression in neuroblastomas.">
    <entity charOffset="145-202" id="s3798.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="284-298" id="s3798.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3798.e0" e2="s3798.e1" id="s3798.p0" relation="false"/>
  </sentence>
  <sentence id="s3799" text="We investigated the negative regulation of transcription by RNA polymerase II of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (negative regulation of transcription by RNA polymerase II) and geminin (negative regulation of DNA replication), on disease progression in neuroblastomas.">
    <entity charOffset="217-255" id="s3799.e0" ontology_id="GO_0008156" text="negative regulation of DNA replication" type="GO"/>
    <entity charOffset="284-298" id="s3799.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3799.e0" e2="s3799.e1" id="s3799.p0" relation="false"/>
  </sentence>
  <sentence id="s3800" text="The expression of negative regulation of transcription by RNA polymerase II and negative regulation of DNA replication was studied by immunostaining 84 neuroblastomas.">
    <entity charOffset="18-75" id="s3800.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="152-166" id="s3800.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3800.e0" e2="s3800.e1" id="s3800.p0" relation="false"/>
  </sentence>
  <sentence id="s3801" text="The expression of negative regulation of transcription by RNA polymerase II and negative regulation of DNA replication was studied by immunostaining 84 neuroblastomas.">
    <entity charOffset="80-118" id="s3801.e0" ontology_id="GO_0008156" text="negative regulation of DNA replication" type="GO"/>
    <entity charOffset="152-166" id="s3801.e1" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <pair e1="s3801.e0" e2="s3801.e1" id="s3801.p0" relation="false"/>
  </sentence>
  <sentence id="s3802" text="The PI for both markers was significantly higher in neuroblastomas from patients with unfavorable clinical (high-risk group, advanced stage, age 18 months at presentation, primary abdominal compared to extra-abdominal sites), biological (positive regulation of gene expression amplification, 1p deletion, 17q gain), and pathological (undifferentiated or poorly differentiated status, high mitosis-karyorrhexis index, [MKI], unfavorable histology) factors.">
    <entity charOffset="52-66" id="s3802.e0" ontology_id="HP_0003006" text="neuroblastomas" type="HP"/>
    <entity charOffset="239-277" id="s3802.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s3802.e0" e2="s3802.e1" id="s3802.p0" relation="false"/>
  </sentence>
  <sentence id="s3803" text="Recent studies have revealed severe cases of microcephaly resulting from human mutations in the establishment of mitotic spindle orientation gene, which is involved in the regulation of cytoplasmic dynein.">
    <entity charOffset="45-57" id="s3803.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="96-140" id="s3803.e1" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <pair e1="s3803.e0" e2="s3803.e1" id="s3803.p0" relation="true"/>
  </sentence>
  <sentence id="s3804" text="These results reveal that the severity of establishment of mitotic spindle orientation-associated microcephaly results not from defects in mitosis, but rather the inability of neural progenitors to ever reach this stage">
    <entity charOffset="42-86" id="s3804.e0" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <entity charOffset="98-110" id="s3804.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3804.e0" e2="s3804.e1" id="s3804.p0" relation="true"/>
  </sentence>
  <sentence id="s3805" text="By whole-exome sequencing, recessive protein-truncating mutations in mRNA splicing, via spliceosome were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.">
    <entity charOffset="69-99" id="s3805.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="213-226" id="s3805.e1" ontology_id="HP_0001156" text="brachydactyly" type="HP"/>
    <pair e1="s3805.e0" e2="s3805.e1" id="s3805.p0" relation="true"/>
  </sentence>
  <sentence id="s3806" text="Remarkably, variable expressivity of the human phenotype can be recapitulated in mRNA splicing, via spliceosome mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout epidermis development while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.">
    <entity charOffset="12-33" id="s3806.e0" ontology_id="HP_0003828" text="variable expressivity" type="HP"/>
    <entity charOffset="81-111" id="s3806.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s3806.e0" e2="s3806.e1" id="s3806.p0" relation="false"/>
  </sentence>
  <sentence id="s3807" text="Remarkably, variable expressivity of the human phenotype can be recapitulated in mRNA splicing, via spliceosome mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout epidermis development while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.">
    <entity charOffset="12-33" id="s3807.e0" ontology_id="HP_0003828" text="variable expressivity" type="HP"/>
    <entity charOffset="217-238" id="s3807.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s3807.e0" e2="s3807.e1" id="s3807.p0" relation="false"/>
  </sentence>
  <sentence id="s3808" text="Remarkably, variable expressivity of the human phenotype can be recapitulated in mRNA splicing, via spliceosome mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout epidermis development while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.">
    <entity charOffset="217-238" id="s3808.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="308-328" id="s3808.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s3808.e0" e2="s3808.e1" id="s3808.p0" relation="false"/>
  </sentence>
  <sentence id="s3809" text="The tumor suppressor gene TP53 is mutated exclusively with the epithelial cell development, positive regulation of protein phosphorylation, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="4-9" id="s3809.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="63-90" id="s3809.e1" ontology_id="GO_0002064" text="epithelial cell development" type="GO"/>
    <pair e1="s3809.e0" e2="s3809.e1" id="s3809.p0" relation="false"/>
  </sentence>
  <sentence id="s3810" text="The tumor suppressor gene TP53 is mutated exclusively with the epithelial cell development, positive regulation of protein phosphorylation, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="4-9" id="s3810.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="92-138" id="s3810.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s3810.e0" e2="s3810.e1" id="s3810.p0" relation="true"/>
  </sentence>
  <sentence id="s3811" text="The tumor suppressor gene TP53 is mutated exclusively with the epithelial cell development, positive regulation of protein phosphorylation, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="4-9" id="s3811.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="144-190" id="s3811.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s3811.e0" e2="s3811.e1" id="s3811.p0" relation="true"/>
  </sentence>
  <sentence id="s3812" text="The tumor suppressor gene TP53 is mutated exclusively with the epithelial cell development, positive regulation of protein phosphorylation, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="63-90" id="s3812.e0" ontology_id="GO_0002064" text="epithelial cell development" type="GO"/>
    <entity charOffset="239-245" id="s3812.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3812.e0" e2="s3812.e1" id="s3812.p0" relation="false"/>
  </sentence>
  <sentence id="s3813" text="The tumor suppressor gene TP53 is mutated exclusively with the epithelial cell development, positive regulation of protein phosphorylation, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="92-138" id="s3813.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="239-245" id="s3813.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3813.e0" e2="s3813.e1" id="s3813.p0" relation="true"/>
  </sentence>
  <sentence id="s3814" text="The tumor suppressor gene TP53 is mutated exclusively with the epithelial cell development, positive regulation of protein phosphorylation, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.">
    <entity charOffset="144-190" id="s3814.e0" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="239-245" id="s3814.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3814.e0" e2="s3814.e1" id="s3814.p0" relation="true"/>
  </sentence>
  <sentence id="s3815" text="We use the BMI- and obesity-associated DNA dealkylation involved in DNA repair locus as a subject as it poses an illustrative example on the value of these resources.">
    <entity charOffset="20-27" id="s3815.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="39-78" id="s3815.e1" ontology_id="GO_0006307" text="DNA dealkylation involved in DNA repair" type="GO"/>
    <pair e1="s3815.e0" e2="s3815.e1" id="s3815.p0" relation="true"/>
  </sentence>
  <sentence id="s3816" text="Polo-Like Kinase 1 (G2/M transition of mitotic cell cycle), a serine-threonine kinase that is often overexpressed across multiple tumor types, is one of the key regulators of CIN and is considered as a potential therapeutic target.">
    <entity charOffset="20-57" id="s3816.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="130-135" id="s3816.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3816.e0" e2="s3816.e1" id="s3816.p0" relation="false"/>
  </sentence>
  <sentence id="s3817" text="Rather than directly inhibiting G2/M transition of mitotic cell cycle, we found that inhibition of PP2A causes selective lethality to PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells.">
    <entity charOffset="32-69" id="s3817.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="183-195" id="s3817.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s3817.e0" e2="s3817.e1" id="s3817.p0" relation="false"/>
  </sentence>
  <sentence id="s3818" text="Rather than directly inhibiting G2/M transition of mitotic cell cycle, we found that inhibition of PP2A causes selective lethality to PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells.">
    <entity charOffset="32-69" id="s3818.e0" ontology_id="GO_0000086" text="G2/M transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="210-216" id="s3818.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3818.e0" e2="s3818.e1" id="s3818.p0" relation="false"/>
  </sentence>
  <sentence id="s3819" text="Anaplastic thyroid cancer (protein phosphorylation) is associated with poor prognosis and is often untreatable.">
    <entity charOffset="19-25" id="s3819.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="27-50" id="s3819.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s3819.e0" e2="s3819.e1" id="s3819.p0" relation="true"/>
  </sentence>
  <sentence id="s3820" text="Tumor proliferation promoted by the regulation of protein polyubiquitinationNA expression can be regulated in thyroid cancer by upregulating transforming growth factor-1 (TGF-1), which is thought to interact with protein targeting to membrane.">
    <entity charOffset="50-76" id="s3820.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="118-124" id="s3820.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3820.e0" e2="s3820.e1" id="s3820.p0" relation="false"/>
  </sentence>
  <sentence id="s3821" text="Tumor proliferation promoted by the regulation of protein polyubiquitinationNA expression can be regulated in thyroid cancer by upregulating transforming growth factor-1 (TGF-1), which is thought to interact with protein targeting to membrane.">
    <entity charOffset="118-124" id="s3821.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="215-244" id="s3821.e1" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <pair e1="s3821.e0" e2="s3821.e1" id="s3821.p0" relation="false"/>
  </sentence>
  <sentence id="s3822" text="When compared with adjacent non-tumor tissues, we found that protein polyubiquitination-483 was upregulated and protein targeting to membrane was downregulated in 80 thyroid tumor samples.">
    <entity charOffset="32-37" id="s3822.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="112-141" id="s3822.e1" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <pair e1="s3822.e0" e2="s3822.e1" id="s3822.p0" relation="false"/>
  </sentence>
  <sentence id="s3823" text="When compared with adjacent non-tumor tissues, we found that protein polyubiquitination-483 was upregulated and protein targeting to membrane was downregulated in 80 thyroid tumor samples.">
    <entity charOffset="32-37" id="s3823.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="61-87" id="s3823.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s3823.e0" e2="s3823.e1" id="s3823.p0" relation="false"/>
  </sentence>
  <sentence id="s3824" text="Our previous studies reported gastric cancer cells are insensitive to positive regulation of apoptotic process.">
    <entity charOffset="38-44" id="s3824.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="70-110" id="s3824.e1" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <pair e1="s3824.e0" e2="s3824.e1" id="s3824.p0" relation="false"/>
  </sentence>
  <sentence id="s3825" text="However, whether -elemene could enhance anti-cancer effects of positive regulation of apoptotic process on gastric cancer cells is unknown.">
    <entity charOffset="46-52" id="s3825.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="64-104" id="s3825.e1" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <pair e1="s3825.e0" e2="s3825.e1" id="s3825.p0" relation="false"/>
  </sentence>
  <sentence id="s3826" text="In our present study, -elemene prevented gastric cancer cell viability in dose-dependent manner, and when combined with positive regulation of apoptotic process, obviously inhibited proliferation and promoted apoptosis in gastric cancer cells.">
    <entity charOffset="50-56" id="s3826.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="121-161" id="s3826.e1" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <pair e1="s3826.e0" e2="s3826.e1" id="s3826.p0" relation="false"/>
  </sentence>
  <sentence id="s3827" text="Our results suggest that -elemene increases the sensitivity of gastric cancer cells to positive regulation of apoptotic process partially by promoting the formation of DISC in lipid rafts">
    <entity charOffset="72-78" id="s3827.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-128" id="s3827.e1" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <pair e1="s3827.e0" e2="s3827.e1" id="s3827.p0" relation="false"/>
  </sentence>
  <sentence id="s3828" text="&lt;i&gt;Background:&lt;/i&gt; regulation of cell cycle/positive regulation of cell proliferation have been reported to be highly expressed in malignant tumors.">
    <entity charOffset="19-43" id="s3828.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="141-147" id="s3828.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3828.e0" e2="s3828.e1" id="s3828.p0" relation="false"/>
  </sentence>
  <sentence id="s3829" text="&lt;i&gt;Background:&lt;/i&gt; regulation of cell cycle/positive regulation of cell proliferation have been reported to be highly expressed in malignant tumors.">
    <entity charOffset="44-85" id="s3829.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="141-147" id="s3829.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3829.e0" e2="s3829.e1" id="s3829.p0" relation="false"/>
  </sentence>
  <sentence id="s3830" text="This research was aimed to study the expression of positive regulation of cell proliferation/regulation of cell cycle protein in malignant melanoma and to investigate its relationship to the clinicopathology and prognosis of patients with malignant melanoma.">
    <entity charOffset="51-92" id="s3830.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="129-147" id="s3830.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3830.e0" e2="s3830.e1" id="s3830.p0" relation="false"/>
  </sentence>
  <sentence id="s3831" text="This research was aimed to study the expression of positive regulation of cell proliferation/regulation of cell cycle protein in malignant melanoma and to investigate its relationship to the clinicopathology and prognosis of patients with malignant melanoma.">
    <entity charOffset="93-117" id="s3831.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="129-147" id="s3831.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3831.e0" e2="s3831.e1" id="s3831.p0" relation="false"/>
  </sentence>
  <sentence id="s3832" text="Relationship between positive regulation of cell proliferation/regulation of cell cycle and clinical data of malignant melanoma were analyzed.">
    <entity charOffset="21-62" id="s3832.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="109-127" id="s3832.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3832.e0" e2="s3832.e1" id="s3832.p0" relation="false"/>
  </sentence>
  <sentence id="s3833" text="Relationship between positive regulation of cell proliferation/regulation of cell cycle and clinical data of malignant melanoma were analyzed.">
    <entity charOffset="63-87" id="s3833.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="109-127" id="s3833.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3833.e0" e2="s3833.e1" id="s3833.p0" relation="false"/>
  </sentence>
  <sentence id="s3834" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of positive regulation of cell proliferation and regulation of cell cycle in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and regulation of transcription by RNA polymerase III stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="48-89" id="s3834.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="122-140" id="s3834.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3834.e0" e2="s3834.e1" id="s3834.p0" relation="false"/>
  </sentence>
  <sentence id="s3835" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of positive regulation of cell proliferation and regulation of cell cycle in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and regulation of transcription by RNA polymerase III stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="94-118" id="s3835.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="122-140" id="s3835.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3835.e0" e2="s3835.e1" id="s3835.p0" relation="false"/>
  </sentence>
  <sentence id="s3836" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of positive regulation of cell proliferation and regulation of cell cycle in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and regulation of transcription by RNA polymerase III stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="122-140" id="s3836.e0" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <entity charOffset="489-538" id="s3836.e1" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <pair e1="s3836.e0" e2="s3836.e1" id="s3836.p0" relation="false"/>
  </sentence>
  <sentence id="s3837" text="&lt;i&gt;Results:&lt;/i&gt; The number of positive cells of positive regulation of cell proliferation and regulation of cell cycle in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &amp;lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and regulation of transcription by RNA polymerase III stages (P &amp;lt;0.05), and increased with TNM staging.">
    <entity charOffset="141-146" id="s3837.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="489-538" id="s3837.e1" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <pair e1="s3837.e0" e2="s3837.e1" id="s3837.p0" relation="false"/>
  </sentence>
  <sentence id="s3838" text="High expression of positive regulation of cell proliferation/regulation of cell cycle significantly reduced the postoperative survival rate in patients with malignant melanoma.">
    <entity charOffset="19-60" id="s3838.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="157-175" id="s3838.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3838.e0" e2="s3838.e1" id="s3838.p0" relation="false"/>
  </sentence>
  <sentence id="s3839" text="High expression of positive regulation of cell proliferation/regulation of cell cycle significantly reduced the postoperative survival rate in patients with malignant melanoma.">
    <entity charOffset="61-85" id="s3839.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="157-175" id="s3839.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3839.e0" e2="s3839.e1" id="s3839.p0" relation="false"/>
  </sentence>
  <sentence id="s3840" text="&lt;i&gt;Conclusion:&lt;/i&gt; positive regulation of cell proliferation/regulation of cell cycle is highly expressed in malignant melanoma tumor tissues.">
    <entity charOffset="19-60" id="s3840.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="109-127" id="s3840.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3840.e0" e2="s3840.e1" id="s3840.p0" relation="false"/>
  </sentence>
  <sentence id="s3841" text="&lt;i&gt;Conclusion:&lt;/i&gt; positive regulation of cell proliferation/regulation of cell cycle is highly expressed in malignant melanoma tumor tissues.">
    <entity charOffset="19-60" id="s3841.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="128-133" id="s3841.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3841.e0" e2="s3841.e1" id="s3841.p0" relation="false"/>
  </sentence>
  <sentence id="s3842" text="&lt;i&gt;Conclusion:&lt;/i&gt; positive regulation of cell proliferation/regulation of cell cycle is highly expressed in malignant melanoma tumor tissues.">
    <entity charOffset="61-85" id="s3842.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="109-127" id="s3842.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3842.e0" e2="s3842.e1" id="s3842.p0" relation="false"/>
  </sentence>
  <sentence id="s3843" text="&lt;i&gt;Conclusion:&lt;/i&gt; positive regulation of cell proliferation/regulation of cell cycle is highly expressed in malignant melanoma tumor tissues.">
    <entity charOffset="61-85" id="s3843.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="128-133" id="s3843.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3843.e0" e2="s3843.e1" id="s3843.p0" relation="false"/>
  </sentence>
  <sentence id="s3844" text="The high expression of positive regulation of cell proliferation/regulation of cell cycle promotes the progression of malignant melanoma and affects the postoperative survival of patients">
    <entity charOffset="23-64" id="s3844.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="118-136" id="s3844.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3844.e0" e2="s3844.e1" id="s3844.p0" relation="false"/>
  </sentence>
  <sentence id="s3845" text="The high expression of positive regulation of cell proliferation/regulation of cell cycle promotes the progression of malignant melanoma and affects the postoperative survival of patients">
    <entity charOffset="65-89" id="s3845.e0" ontology_id="GO_0051726" text="regulation of cell cycle" type="GO"/>
    <entity charOffset="118-136" id="s3845.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s3845.e0" e2="s3845.e1" id="s3845.p0" relation="false"/>
  </sentence>
  <sentence id="s3846" text="Few studies have examined the roles of CRELD1 and positive regulation of transcription, DNA-templated in cardiac abnormalities or their association with pulmonary artery histopathology.">
    <entity charOffset="50-101" id="s3846.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="105-126" id="s3846.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s3846.e0" e2="s3846.e1" id="s3846.p0" relation="true"/>
  </sentence>
  <sentence id="s3847" text="Children with DS have an elevated risk of pulmonary arterial hypertension (L-phenylalanine catabolic process).">
    <entity charOffset="42-73" id="s3847.e0" ontology_id="HP_0002092" text="pulmonary arterial hypertension" type="HP"/>
    <entity charOffset="75-108" id="s3847.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s3847.e0" e2="s3847.e1" id="s3847.p0" relation="false"/>
  </sentence>
  <sentence id="s3848" text="Addition of exogenous SLURP1 (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor- (TNF-)-stimulated human umbilical cord vascular endothelial cell (HUVEC) centrosome cycle formation.">
    <entity charOffset="136-141" id="s3848.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="234-250" id="s3848.e1" ontology_id="GO_0007098" text="centrosome cycle" type="GO"/>
    <pair e1="s3848.e0" e2="s3848.e1" id="s3848.p0" relation="false"/>
  </sentence>
  <sentence id="s3849" text="Therefore, we performed this preliminary clinical study to investigate the possible association between 2 adipokines, C1q/tumor necrosis factor-related protein-3 and -5 (CTRP-3 and CTRP-5), with lung function and other markers of inflammation in intracellular protein transport.">
    <entity charOffset="122-127" id="s3849.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="246-277" id="s3849.e1" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <pair e1="s3849.e0" e2="s3849.e1" id="s3849.p0" relation="false"/>
  </sentence>
  <sentence id="s3850" text="Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in anion transport, ossification, and ATP6V1B1 genes and the clinical phenotype.">
    <entity charOffset="88-117" id="s3850.e0" ontology_id="HP_0008341" text="distal renal tubular acidosis" type="HP"/>
    <entity charOffset="166-181" id="s3850.e1" ontology_id="GO_0006820" text="anion transport" type="GO"/>
    <pair e1="s3850.e0" e2="s3850.e1" id="s3850.p0" relation="true"/>
  </sentence>
  <sentence id="s3851" text="Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in anion transport, ossification, and ATP6V1B1 genes and the clinical phenotype.">
    <entity charOffset="88-117" id="s3851.e0" ontology_id="HP_0008341" text="distal renal tubular acidosis" type="HP"/>
    <entity charOffset="183-195" id="s3851.e1" ontology_id="GO_0001503" text="ossification" type="GO"/>
    <pair e1="s3851.e0" e2="s3851.e1" id="s3851.p0" relation="true"/>
  </sentence>
  <sentence id="s3852" text="Their phosphorylation activity has also linked them to the development of neurodegenerative diseases like Alzheimer's disease, amyotrophic lateral sclerosis or spinocerebellar ataxia muscle organ development 11.">
    <entity charOffset="74-100" id="s3852.e0" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <entity charOffset="183-207" id="s3852.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3852.e0" e2="s3852.e1" id="s3852.p0" relation="false"/>
  </sentence>
  <sentence id="s3853" text="Their phosphorylation activity has also linked them to the development of neurodegenerative diseases like Alzheimer's disease, amyotrophic lateral sclerosis or spinocerebellar ataxia muscle organ development 11.">
    <entity charOffset="176-182" id="s3853.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="183-207" id="s3853.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3853.e0" e2="s3853.e1" id="s3853.p0" relation="false"/>
  </sentence>
  <sentence id="s3854" text="The final analysis of all this information led us to propose peptidyl-serine phosphorylation as a new target for the treatment of neurodegenerative diseases and its selective inhibitors as potential effective drugs for the treatment of these severe unmet disorders">
    <entity charOffset="61-92" id="s3854.e0" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <entity charOffset="130-156" id="s3854.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s3854.e0" e2="s3854.e1" id="s3854.p0" relation="false"/>
  </sentence>
  <sentence id="s3855" text="Differently from other digestive malignancies, gastric cancer (vitamin D metabolic process) carcinogenesis seems more heterogeneous and unclear.">
    <entity charOffset="55-61" id="s3855.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="63-90" id="s3855.e1" ontology_id="GO_0042359" text="vitamin D metabolic process" type="GO"/>
    <pair e1="s3855.e0" e2="s3855.e1" id="s3855.p0" relation="false"/>
  </sentence>
  <sentence id="s3856" text="Differently from other digestive malignancies, gastric cancer (vitamin D metabolic process) carcinogenesis seems more heterogeneous and unclear.">
    <entity charOffset="63-90" id="s3856.e0" ontology_id="GO_0042359" text="vitamin D metabolic process" type="GO"/>
    <entity charOffset="118-131" id="s3856.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3856.e0" e2="s3856.e1" id="s3856.p0" relation="false"/>
  </sentence>
  <sentence id="s3857" text="In the case of vitamin D metabolic process, in fact, several cytological and molecular works have already demonstrated GJ to be an interesting biological material for improving clinicopathologic and prognostic knowledge of this cancer.">
    <entity charOffset="15-42" id="s3857.e0" ontology_id="GO_0042359" text="vitamin D metabolic process" type="GO"/>
    <entity charOffset="228-234" id="s3857.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3857.e0" e2="s3857.e1" id="s3857.p0" relation="false"/>
  </sentence>
  <sentence id="s3858" text="In 2003, a new syndrome was described in the Sephardi Jewish population, named progressive cerebello-cerebral atrophy (biotin metabolic process) based on the typical neuroradiological findings.">
    <entity charOffset="101-117" id="s3858.e0" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <entity charOffset="119-143" id="s3858.e1" ontology_id="GO_0006768" text="biotin metabolic process" type="GO"/>
    <pair e1="s3858.e0" e2="s3858.e1" id="s3858.p0" relation="true"/>
  </sentence>
  <sentence id="s3859" text="As a reason why the present case showed lethal phenomuscle organ development despite the in-frame deletion mutation, rapid degradation of neo-synthesized 6 protein and/or impaired transport of integrin were suggested from previous reports, and the lack of localization of integrin 64 to the epidermal basement membrane resulted in skin fragility.">
    <entity charOffset="52-76" id="s3859.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="334-348" id="s3859.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s3859.e0" e2="s3859.e1" id="s3859.p0" relation="false"/>
  </sentence>
  <sentence id="s3860" text="The tumors were characterized by immunohistochemistry for pituitary hormones, cytokeratins, positive regulation of I-kappaB kinase/NF-kappaB signaling, and the neuronal markers mRNA processing, neurofilaments (NFP), and MAP2.">
    <entity charOffset="4-10" id="s3860.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="92-150" id="s3860.e1" ontology_id="GO_0043123" text="positive regulation of I-kappaB kinase/NF-kappaB signaling" type="GO"/>
    <pair e1="s3860.e0" e2="s3860.e1" id="s3860.p0" relation="false"/>
  </sentence>
  <sentence id="s3861" text="The tumors were characterized by immunohistochemistry for pituitary hormones, cytokeratins, positive regulation of I-kappaB kinase/NF-kappaB signaling, and the neuronal markers mRNA processing, neurofilaments (NFP), and MAP2.">
    <entity charOffset="4-10" id="s3861.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="177-192" id="s3861.e1" ontology_id="GO_0006397" text="mRNA processing" type="GO"/>
    <pair e1="s3861.e0" e2="s3861.e1" id="s3861.p0" relation="false"/>
  </sentence>
  <sentence id="s3862" text="Double-labeling immunohistochemistry for positive regulation of I-kappaB kinase/NF-kappaB signaling/GH, Pit-1/NFP, Pit-1/MAP2, and NeuN/GH was performed in 9/10 tumors.">
    <entity charOffset="41-99" id="s3862.e0" ontology_id="GO_0043123" text="positive regulation of I-kappaB kinase/NF-kappaB signaling" type="GO"/>
    <entity charOffset="161-167" id="s3862.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3862.e0" e2="s3862.e1" id="s3862.p0" relation="false"/>
  </sentence>
  <sentence id="s3863" text="These epidermis development develop prostate tumors similar to a subset of poor outcome, treatment-associated human PC tumors.">
    <entity charOffset="6-27" id="s3863.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="45-51" id="s3863.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3863.e0" e2="s3863.e1" id="s3863.p0" relation="false"/>
  </sentence>
  <sentence id="s3864" text="Correlation analysis using microarray data from (signal transduction  PWK/PhJ) F2 prostate tumors identified 35 metastasis-associated transcripts within the two loci.">
    <entity charOffset="49-68" id="s3864.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="92-98" id="s3864.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3864.e0" e2="s3864.e1" id="s3864.p0" relation="false"/>
  </sentence>
  <sentence id="s3865" text="A protective effect was observed for the fetal regulation of cyclin-dependent protein serine/threonine kinase activity SNP on cleft palate only, opposite in direction to the effect on CLO.">
    <entity charOffset="47-118" id="s3865.e0" ontology_id="GO_0000079" text="regulation of cyclin-dependent protein serine/threonine kinase activity" type="GO"/>
    <entity charOffset="126-138" id="s3865.e1" ontology_id="HP_0000175" text="cleft palate" type="HP"/>
    <pair e1="s3865.e0" e2="s3865.e1" id="s3865.p0" relation="false"/>
  </sentence>
  <sentence id="s3866" text="This study investigates the soluble factors released by tumor-associated dendritic cells (TADCs) responsible for increasing cancer stem cell (CSC) properties, cell mobility, and epithelial-to-mesenchymal transition (cytokine production).">
    <entity charOffset="124-130" id="s3866.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="216-235" id="s3866.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s3866.e0" e2="s3866.e1" id="s3866.p0" relation="true"/>
  </sentence>
  <sentence id="s3867" text="Dendritic cells (DCs) of colon cancer patients were collected for phenotype and chemotaxis expression by flow cytometry and Luminex assays.">
    <entity charOffset="31-37" id="s3867.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="80-90" id="s3867.e1" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <pair e1="s3867.e0" e2="s3867.e1" id="s3867.p0" relation="false"/>
  </sentence>
  <sentence id="s3868" text="The transcriptome of chemotaxis-treated cancer cells was established by next generation sequencing.">
    <entity charOffset="21-31" id="s3868.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="40-46" id="s3868.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3868.e0" e2="s3868.e1" id="s3868.p0" relation="false"/>
  </sentence>
  <sentence id="s3869" text="Additionally, CXCL1 increases the metastatic ability of a cancer by enhancing cell migration, matrix metalloproteinase-7 expression and cytokine production.">
    <entity charOffset="58-64" id="s3869.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="136-155" id="s3869.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s3869.e0" e2="s3869.e1" id="s3869.p0" relation="true"/>
  </sentence>
  <sentence id="s3870" text="The enhanced chemotaxis expression in DCs is also noted in mice transplanted with colon cancer cells.">
    <entity charOffset="13-23" id="s3870.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="88-94" id="s3870.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3870.e0" e2="s3870.e1" id="s3870.p0" relation="false"/>
  </sentence>
  <sentence id="s3871" text="Concurrently, chemotaxis displays a specific microRNA (protein polyubiquitination) upregulated by the prototypical colon cancer onco-miR miR-105.">
    <entity charOffset="14-24" id="s3871.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="121-127" id="s3871.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3871.e0" e2="s3871.e1" id="s3871.p0" relation="false"/>
  </sentence>
  <sentence id="s3872" text="Concurrently, chemotaxis displays a specific microRNA (protein polyubiquitination) upregulated by the prototypical colon cancer onco-miR miR-105.">
    <entity charOffset="55-81" id="s3872.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="121-127" id="s3872.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3872.e0" e2="s3872.e1" id="s3872.p0" relation="false"/>
  </sentence>
  <sentence id="s3873" text="Analysis of publicly available data reveals chemotaxis-driven oncogenes and protein polyubiquitination-105 have a negative prognostic impact on the outcome of colon cancer.">
    <entity charOffset="44-54" id="s3873.e0" ontology_id="GO_0006935" text="chemotaxis" type="GO"/>
    <entity charOffset="165-171" id="s3873.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3873.e0" e2="s3873.e1" id="s3873.p0" relation="false"/>
  </sentence>
  <sentence id="s3874" text="Analysis of publicly available data reveals chemotaxis-driven oncogenes and protein polyubiquitination-105 have a negative prognostic impact on the outcome of colon cancer.">
    <entity charOffset="76-102" id="s3874.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="165-171" id="s3874.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3874.e0" e2="s3874.e1" id="s3874.p0" relation="false"/>
  </sentence>
  <sentence id="s3875" text="Recently, a missense mutation (R7S) in yet another member of this family, response to unfolded protein, was found to cause an axonal motor neuropathy (distal hereditary motor neuropathy type 2C, dHMN2C).">
    <entity charOffset="74-102" id="s3875.e0" ontology_id="GO_0006986" text="response to unfolded protein" type="GO"/>
    <entity charOffset="139-149" id="s3875.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3875.e0" e2="s3875.e1" id="s3875.p0" relation="true"/>
  </sentence>
  <sentence id="s3876" text="WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (membrane protein ectodomain proteolysis, membrane protein ectodomain proteolysis), lysosomal (proteolysis, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.">
    <entity charOffset="111-150" id="s3876.e0" ontology_id="GO_0006509" text="membrane protein ectodomain proteolysis" type="GO"/>
    <entity charOffset="404-412" id="s3876.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3876.e0" e2="s3876.e1" id="s3876.p0" relation="true"/>
  </sentence>
  <sentence id="s3877" text="WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (membrane protein ectodomain proteolysis, membrane protein ectodomain proteolysis), lysosomal (proteolysis, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.">
    <entity charOffset="152-191" id="s3877.e0" ontology_id="GO_0006509" text="membrane protein ectodomain proteolysis" type="GO"/>
    <entity charOffset="404-412" id="s3877.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3877.e0" e2="s3877.e1" id="s3877.p0" relation="false"/>
  </sentence>
  <sentence id="s3878" text="WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (membrane protein ectodomain proteolysis, membrane protein ectodomain proteolysis), lysosomal (proteolysis, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.">
    <entity charOffset="205-216" id="s3878.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="404-412" id="s3878.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s3878.e0" e2="s3878.e1" id="s3878.p0" relation="false"/>
  </sentence>
  <sentence id="s3879" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="97-115" id="s3879.e0" ontology_id="GO_0098609" text="cell-cell adhesion" type="GO"/>
    <entity charOffset="363-382" id="s3879.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3879.e0" e2="s3879.e1" id="s3879.p0" relation="true"/>
  </sentence>
  <sentence id="s3880" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="97-115" id="s3880.e0" ontology_id="GO_0098609" text="cell-cell adhesion" type="GO"/>
    <entity charOffset="229-242" id="s3880.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s3880.e0" e2="s3880.e1" id="s3880.p0" relation="true"/>
  </sentence>
  <sentence id="s3881" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="117-161" id="s3881.e0" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="229-242" id="s3881.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s3881.e0" e2="s3881.e1" id="s3881.p0" relation="true"/>
  </sentence>
  <sentence id="s3882" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="166-193" id="s3882.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="363-382" id="s3882.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3882.e0" e2="s3882.e1" id="s3882.p0" relation="false"/>
  </sentence>
  <sentence id="s3883" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="166-193" id="s3883.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="229-242" id="s3883.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s3883.e0" e2="s3883.e1" id="s3883.p0" relation="true"/>
  </sentence>
  <sentence id="s3884" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="229-242" id="s3884.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="266-280" id="s3884.e1" ontology_id="GO_0031424" text="keratinization" type="GO"/>
    <pair e1="s3884.e0" e2="s3884.e1" id="s3884.p0" relation="true"/>
  </sentence>
  <sentence id="s3885" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="229-242" id="s3885.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="282-305" id="s3885.e1" ontology_id="GO_0016042" text="lipid catabolic process" type="GO"/>
    <pair e1="s3885.e0" e2="s3885.e1" id="s3885.p0" relation="true"/>
  </sentence>
  <sentence id="s3886" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="229-242" id="s3886.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="310-354" id="s3886.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s3886.e0" e2="s3886.e1" id="s3886.p0" relation="true"/>
  </sentence>
  <sentence id="s3887" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="229-242" id="s3887.e0" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <entity charOffset="440-464" id="s3887.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3887.e0" e2="s3887.e1" id="s3887.p0" relation="false"/>
  </sentence>
  <sentence id="s3888" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="266-280" id="s3888.e0" ontology_id="GO_0031424" text="keratinization" type="GO"/>
    <entity charOffset="363-382" id="s3888.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3888.e0" e2="s3888.e1" id="s3888.p0" relation="true"/>
  </sentence>
  <sentence id="s3889" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="282-305" id="s3889.e0" ontology_id="GO_0016042" text="lipid catabolic process" type="GO"/>
    <entity charOffset="363-382" id="s3889.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3889.e0" e2="s3889.e1" id="s3889.p0" relation="true"/>
  </sentence>
  <sentence id="s3890" text="These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.">
    <entity charOffset="363-382" id="s3890.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="440-464" id="s3890.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3890.e0" e2="s3890.e1" id="s3890.p0" relation="true"/>
  </sentence>
  <sentence id="s3891" text="Peripheral neuropathy (G protein-coupled receptor signaling pathway) remains one of the most frequent side-effects experienced by patients who receive these novel agents.">
    <entity charOffset="11-21" id="s3891.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="23-67" id="s3891.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s3891.e0" e2="s3891.e1" id="s3891.p0" relation="false"/>
  </sentence>
  <sentence id="s3892" text="A growing body of literature indicates that YY1 is overexpressed in multiple cancer muscle organ developments and that increased YY1 levels correlate with poor clinical outcomes in many cancers.">
    <entity charOffset="77-83" id="s3892.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="84-108" id="s3892.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3892.e0" e2="s3892.e1" id="s3892.p0" relation="false"/>
  </sentence>
  <sentence id="s3893" text="However, the role of YY1 in the promotion or suppression of tumor growth remains controversial and its regulatory effects may be tumor cell muscle organ development dependent at least in experimental systems.">
    <entity charOffset="60-65" id="s3893.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="140-164" id="s3893.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3893.e0" e2="s3893.e1" id="s3893.p0" relation="false"/>
  </sentence>
  <sentence id="s3894" text="This review highlights recent advances in our understanding of regulatory insights involving YY1 function in a range of cancer muscle organ developments.">
    <entity charOffset="120-126" id="s3894.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-151" id="s3894.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3894.e0" e2="s3894.e1" id="s3894.p0" relation="false"/>
  </sentence>
  <sentence id="s3895" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular regulation of cell growth and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving negative regulation of T cell mediated cytotoxicity, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="s3895.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="251-276" id="s3895.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s3895.e0" e2="s3895.e1" id="s3895.p0" relation="false"/>
  </sentence>
  <sentence id="s3896" text="For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular regulation of cell growth and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving negative regulation of T cell mediated cytotoxicity, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.">
    <entity charOffset="28-33" id="s3896.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="458-509" id="s3896.e1" ontology_id="GO_0001915" text="negative regulation of T cell mediated cytotoxicity" type="GO"/>
    <pair e1="s3896.e0" e2="s3896.e1" id="s3896.p0" relation="false"/>
  </sentence>
  <sentence id="s3897" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor double-strand break repair via homologous recombination, increased B cell apoptotic process transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of osteoblast differentiation overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="s3897.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="103-158" id="s3897.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s3897.e0" e2="s3897.e1" id="s3897.p0" relation="true"/>
  </sentence>
  <sentence id="s3898" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor double-strand break repair via homologous recombination, increased B cell apoptotic process transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of osteoblast differentiation overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="s3898.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="170-194" id="s3898.e1" ontology_id="GO_0001783" text="B cell apoptotic process" type="GO"/>
    <pair e1="s3898.e0" e2="s3898.e1" id="s3898.p0" relation="false"/>
  </sentence>
  <sentence id="s3899" text="On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor double-strand break repair via homologous recombination, increased B cell apoptotic process transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of osteoblast differentiation overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.">
    <entity charOffset="19-24" id="s3899.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="429-455" id="s3899.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s3899.e0" e2="s3899.e1" id="s3899.p0" relation="true"/>
  </sentence>
  <sentence id="s3900" text="YY1 expression is associated with that of cancer stem cell markers osteoblast differentiation, positive regulation of ubiquitin-protein transferase activity and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.">
    <entity charOffset="42-48" id="s3900.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-93" id="s3900.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s3900.e0" e2="s3900.e1" id="s3900.p0" relation="true"/>
  </sentence>
  <sentence id="s3901" text="YY1 expression is associated with that of cancer stem cell markers osteoblast differentiation, positive regulation of ubiquitin-protein transferase activity and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.">
    <entity charOffset="42-48" id="s3901.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="95-156" id="s3901.e1" ontology_id="GO_0051443" text="positive regulation of ubiquitin-protein transferase activity" type="GO"/>
    <pair e1="s3901.e0" e2="s3901.e1" id="s3901.p0" relation="false"/>
  </sentence>
  <sentence id="s3902" text="Intraepithelial neoplasia in FGPs, referred to as FGP with dysplasia, is often seen in patients with familial adenomatous polyposis (proteolysis).">
    <entity charOffset="16-25" id="s3902.e0" ontology_id="HP_0002664" text="neoplasia" type="HP"/>
    <entity charOffset="133-144" id="s3902.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s3902.e0" e2="s3902.e1" id="s3902.p0" relation="false"/>
  </sentence>
  <sentence id="s3903" text="In sporadic FGPs, low-grade dysplasia (LGD) is rare, and high-grade dysplasia (L-phenylalanine catabolic process) or carcinoma arising from sporadic FGPs is extremely rare.">
    <entity charOffset="79-112" id="s3903.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="117-126" id="s3903.e1" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <pair e1="s3903.e0" e2="s3903.e1" id="s3903.p0" relation="false"/>
  </sentence>
  <sentence id="s3904" text="In the present case, a sporadic FGP with LGD did not develop into invasive carcinoma, but contained foci of L-phenylalanine catabolic process 14 years after diagnosis.">
    <entity charOffset="23-31" id="s3904.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="108-141" id="s3904.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s3904.e0" e2="s3904.e1" id="s3904.p0" relation="false"/>
  </sentence>
  <sentence id="s3905" text="The pathological diagnosis of the resected specimen was FGP with L-phenylalanine catabolic process mixed in LGD, with no invasive carcinoma.">
    <entity charOffset="65-98" id="s3905.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="130-139" id="s3905.e1" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <pair e1="s3905.e0" e2="s3905.e1" id="s3905.p0" relation="false"/>
  </sentence>
  <sentence id="s3906" text="We find that anion transport-mediated VRAC is augmented in hypertrophic murine and human adipocytes in the setting of obesity.">
    <entity charOffset="13-28" id="s3906.e0" ontology_id="GO_0006820" text="anion transport" type="GO"/>
    <entity charOffset="118-125" id="s3906.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s3906.e0" e2="s3906.e1" id="s3906.p0" relation="false"/>
  </sentence>
  <sentence id="s3907" text="Molecular genetic tests for episodic ataxia muscle organ development 2 (EA2) usually target only the specific calcium channel gene (&lt;i&gt;CACNA1A&lt;/i&gt;) that is known to cause EA2.">
    <entity charOffset="28-36" id="s3907.e0" ontology_id="HP_0025303" text="episodic" type="HP"/>
    <entity charOffset="44-68" id="s3907.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3907.e0" e2="s3907.e1" id="s3907.p0" relation="false"/>
  </sentence>
  <sentence id="s3908" text="Molecular genetic tests for episodic ataxia muscle organ development 2 (EA2) usually target only the specific calcium channel gene (&lt;i&gt;CACNA1A&lt;/i&gt;) that is known to cause EA2.">
    <entity charOffset="37-43" id="s3908.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="44-68" id="s3908.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3908.e0" e2="s3908.e1" id="s3908.p0" relation="false"/>
  </sentence>
  <sentence id="s3909" text="Here we present a case of a proband with a complex episodic ataxias (EA)/seizure phenomuscle organ development with an EA-affected father; and an unaffected mother, all negative for &lt;i&gt;CACNA1A&lt;/i&gt; gene mutations.">
    <entity charOffset="60-66" id="s3909.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="86-110" id="s3909.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3909.e0" e2="s3909.e1" id="s3909.p0" relation="false"/>
  </sentence>
  <sentence id="s3910" text="Here we present a case of a proband with a complex episodic ataxias (EA)/seizure phenomuscle organ development with an EA-affected father; and an unaffected mother, all negative for &lt;i&gt;CACNA1A&lt;/i&gt; gene mutations.">
    <entity charOffset="73-80" id="s3910.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="86-110" id="s3910.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s3910.e0" e2="s3910.e1" id="s3910.p0" relation="false"/>
  </sentence>
  <sentence id="s3911" text="The negative regulation of fat cell differentiation was studied by whole-exome sequencing to identify candidate genes responsible for causing the complex EA/seizure phenotype.">
    <entity charOffset="4-51" id="s3911.e0" ontology_id="GO_0045599" text="negative regulation of fat cell differentiation" type="GO"/>
    <entity charOffset="157-164" id="s3911.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s3911.e0" e2="s3911.e1" id="s3911.p0" relation="true"/>
  </sentence>
  <sentence id="s3912" text="We identified a recurrent de novo regulation of cell growth c.1582C&amp;gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.">
    <entity charOffset="34-59" id="s3912.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="189-208" id="s3912.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s3912.e0" e2="s3912.e1" id="s3912.p0" relation="true"/>
  </sentence>
  <sentence id="s3913" text="We identified a recurrent de novo regulation of cell growth c.1582C&amp;gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.">
    <entity charOffset="34-59" id="s3913.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="221-234" id="s3913.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s3913.e0" e2="s3913.e1" id="s3913.p0" relation="true"/>
  </sentence>
  <sentence id="s3914" text="We identified a recurrent de novo regulation of cell growth c.1582C&amp;gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.">
    <entity charOffset="34-59" id="s3914.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="243-253" id="s3914.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s3914.e0" e2="s3914.e1" id="s3914.p0" relation="true"/>
  </sentence>
  <sentence id="s3915" text="We identified a recurrent de novo regulation of cell growth c.1582C&amp;gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.">
    <entity charOffset="34-59" id="s3915.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="272-286" id="s3915.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s3915.e0" e2="s3915.e1" id="s3915.p0" relation="true"/>
  </sentence>
  <sentence id="s3916" text="Hepatocyte growth factor (neutrophil apoptotic process)/c-MET signaling plays an important role in cell proliferation, survival, migration and motility of cancer cells.">
    <entity charOffset="26-54" id="s3916.e0" ontology_id="GO_0001781" text="neutrophil apoptotic process" type="GO"/>
    <entity charOffset="155-161" id="s3916.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3916.e0" e2="s3916.e1" id="s3916.p0" relation="false"/>
  </sentence>
  <sentence id="s3917" text="The scope of the present review is to recapitulate and review the evidence of negative regulation of cell-cell adhesion participation in cancer development and progression, exploring the clinical, biological and functional descriptions of the involvement of this protein in diverse neoplasias.">
    <entity charOffset="78-119" id="s3917.e0" ontology_id="GO_0022408" text="negative regulation of cell-cell adhesion" type="GO"/>
    <entity charOffset="137-143" id="s3917.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3917.e0" e2="s3917.e1" id="s3917.p0" relation="false"/>
  </sentence>
  <sentence id="s3918" text="The scope of the present review is to recapitulate and review the evidence of negative regulation of cell-cell adhesion participation in cancer development and progression, exploring the clinical, biological and functional descriptions of the involvement of this protein in diverse neoplasias.">
    <entity charOffset="78-119" id="s3918.e0" ontology_id="GO_0022408" text="negative regulation of cell-cell adhesion" type="GO"/>
    <entity charOffset="282-292" id="s3918.e1" ontology_id="HP_0002664" text="neoplasias" type="HP"/>
    <pair e1="s3918.e0" e2="s3918.e1" id="s3918.p0" relation="false"/>
  </sentence>
  <sentence id="s3919" text="Most studies are in agreement as to the belief that, in a large range of human cancers, the negative regulation of cell-cell adhesion gene promoter is frequently methylated, resulting in the epigenetic silence of this gene.">
    <entity charOffset="79-85" id="s3919.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="92-133" id="s3919.e1" ontology_id="GO_0022408" text="negative regulation of cell-cell adhesion" type="GO"/>
    <pair e1="s3919.e0" e2="s3919.e1" id="s3919.p0" relation="false"/>
  </sentence>
  <sentence id="s3920" text="Functional assays indicate that SPINT2 reactivation ameliorates the malignant phenomuscle organ development, specifically reducing cell viability, migration and invasion in diverse cancer cell lines.">
    <entity charOffset="83-107" id="s3920.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="181-187" id="s3920.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3920.e0" e2="s3920.e1" id="s3920.p0" relation="false"/>
  </sentence>
  <sentence id="s3921" text="In sum, the negative regulation of cell-cell adhesion gene is epigenetically silenced or downregulated in human cancers, altering the balance of neutrophil apoptotic process activation/inhibition ratio, which contributes to cancer development and progression">
    <entity charOffset="12-53" id="s3921.e0" ontology_id="GO_0022408" text="negative regulation of cell-cell adhesion" type="GO"/>
    <entity charOffset="112-118" id="s3921.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3921.e0" e2="s3921.e1" id="s3921.p0" relation="false"/>
  </sentence>
  <sentence id="s3922" text="In sum, the negative regulation of cell-cell adhesion gene is epigenetically silenced or downregulated in human cancers, altering the balance of neutrophil apoptotic process activation/inhibition ratio, which contributes to cancer development and progression">
    <entity charOffset="112-118" id="s3922.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="145-173" id="s3922.e1" ontology_id="GO_0001781" text="neutrophil apoptotic process" type="GO"/>
    <pair e1="s3922.e0" e2="s3922.e1" id="s3922.p0" relation="false"/>
  </sentence>
  <sentence id="s3923" text="Further, epidermis development heterozygous for either Magoh or Rbm8a exhibit aberrant neurogenesis and microcephaly.">
    <entity charOffset="9-30" id="s3923.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="104-116" id="s3923.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3923.e0" e2="s3923.e1" id="s3923.p0" relation="false"/>
  </sentence>
  <sentence id="s3924" text="Using a new conditional allele, we first show that mRNA splicing, via spliceosome haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay and Rbm8a mutant mice.">
    <entity charOffset="51-81" id="s3924.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="139-151" id="s3924.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s3924.e0" e2="s3924.e1" id="s3924.p0" relation="false"/>
  </sentence>
  <sentence id="s3925" text="Using a new conditional allele, we first show that mRNA splicing, via spliceosome haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay and Rbm8a mutant mice.">
    <entity charOffset="139-151" id="s3925.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="155-222" id="s3925.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s3925.e0" e2="s3925.e1" id="s3925.p0" relation="false"/>
  </sentence>
  <sentence id="s3926" text="GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi muscle organ development aminoaciduria, cholestasis, iron overload, profound lactic acidosis, and early death.">
    <entity charOffset="106-130" id="s3926.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="174-182" id="s3926.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s3926.e0" e2="s3926.e1" id="s3926.p0" relation="false"/>
  </sentence>
  <sentence id="s3927" text="GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi muscle organ development aminoaciduria, cholestasis, iron overload, profound lactic acidosis, and early death.">
    <entity charOffset="106-130" id="s3927.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="131-144" id="s3927.e1" ontology_id="HP_0003355" text="aminoaciduria" type="HP"/>
    <pair e1="s3927.e0" e2="s3927.e1" id="s3927.p0" relation="false"/>
  </sentence>
  <sentence id="s3928" text="The clinical presentation of both patients was initially thought to be suggestive of Lin-Gettig syndrome (glycosaminoglycan biosynthetic process), a multiple malformation syndrome associated with craniosynostosis that was initially reported in two brothers in 1990, with a third patient reported in 2003.">
    <entity charOffset="106-144" id="s3928.e0" ontology_id="GO_0006024" text="glycosaminoglycan biosynthetic process" type="GO"/>
    <entity charOffset="196-212" id="s3928.e1" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <pair e1="s3928.e0" e2="s3928.e1" id="s3928.p0" relation="false"/>
  </sentence>
  <sentence id="s3929" text="We show that craniosynostosis, which has not been previously reported in association with histone acetylation mutations, may be part of the genitopatellar/Say Barber Biesecker Young Simpson spectrum.">
    <entity charOffset="13-29" id="s3929.e0" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <entity charOffset="90-109" id="s3929.e1" ontology_id="GO_0016573" text="histone acetylation" type="GO"/>
    <pair e1="s3929.e0" e2="s3929.e1" id="s3929.p0" relation="false"/>
  </sentence>
  <sentence id="s3930" text="Here we report that positive regulation of protein ubiquitination ubiquitylates and triggers degradation of the tumor-suppressive sirtuin regulation of double-strand break repair via homologous recombination in hepatocellular carcinoma.">
    <entity charOffset="20-65" id="s3930.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="112-117" id="s3930.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3930.e0" e2="s3930.e1" id="s3930.p0" relation="false"/>
  </sentence>
  <sentence id="s3931" text="Here we report that positive regulation of protein ubiquitination ubiquitylates and triggers degradation of the tumor-suppressive sirtuin regulation of double-strand break repair via homologous recombination in hepatocellular carcinoma.">
    <entity charOffset="20-65" id="s3931.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="211-235" id="s3931.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3931.e0" e2="s3931.e1" id="s3931.p0" relation="false"/>
  </sentence>
  <sentence id="s3932" text="Here we report that positive regulation of protein ubiquitination ubiquitylates and triggers degradation of the tumor-suppressive sirtuin regulation of double-strand break repair via homologous recombination in hepatocellular carcinoma.">
    <entity charOffset="112-117" id="s3932.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="138-207" id="s3932.e1" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s3932.e0" e2="s3932.e1" id="s3932.p0" relation="false"/>
  </sentence>
  <sentence id="s3933" text="Here we report that positive regulation of protein ubiquitination ubiquitylates and triggers degradation of the tumor-suppressive sirtuin regulation of double-strand break repair via homologous recombination in hepatocellular carcinoma.">
    <entity charOffset="138-207" id="s3933.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="211-235" id="s3933.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3933.e0" e2="s3933.e1" id="s3933.p0" relation="false"/>
  </sentence>
  <sentence id="s3934" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of positive regulation of receptor recycling were critical for positive regulation of protein ubiquitination-mediated tumorigenesis.">
    <entity charOffset="19-43" id="s3934.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="154-199" id="s3934.e1" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <pair e1="s3934.e0" e2="s3934.e1" id="s3934.p0" relation="false"/>
  </sentence>
  <sentence id="s3935" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of positive regulation of receptor recycling were critical for positive regulation of protein ubiquitination-mediated tumorigenesis.">
    <entity charOffset="19-43" id="s3935.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="94-135" id="s3935.e1" ontology_id="GO_0001921" text="positive regulation of receptor recycling" type="GO"/>
    <pair e1="s3935.e0" e2="s3935.e1" id="s3935.p0" relation="false"/>
  </sentence>
  <sentence id="s3936" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of positive regulation of receptor recycling were critical for positive regulation of protein ubiquitination-mediated tumorigenesis.">
    <entity charOffset="94-135" id="s3936.e0" ontology_id="GO_0001921" text="positive regulation of receptor recycling" type="GO"/>
    <entity charOffset="209-214" id="s3936.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3936.e0" e2="s3936.e1" id="s3936.p0" relation="false"/>
  </sentence>
  <sentence id="s3937" text="In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of positive regulation of receptor recycling were critical for positive regulation of protein ubiquitination-mediated tumorigenesis.">
    <entity charOffset="154-199" id="s3937.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="209-214" id="s3937.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3937.e0" e2="s3937.e1" id="s3937.p0" relation="false"/>
  </sentence>
  <sentence id="s3938" text="Furthermore, in clinical specimens, increased positive regulation of protein ubiquitination levels correlated with reduced regulation of double-strand break repair via homologous recombination levels and elevated positive regulation of receptor recycling levels in increasing tumor grades.">
    <entity charOffset="46-91" id="s3938.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="276-281" id="s3938.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3938.e0" e2="s3938.e1" id="s3938.p0" relation="false"/>
  </sentence>
  <sentence id="s3939" text="Furthermore, in clinical specimens, increased positive regulation of protein ubiquitination levels correlated with reduced regulation of double-strand break repair via homologous recombination levels and elevated positive regulation of receptor recycling levels in increasing tumor grades.">
    <entity charOffset="123-192" id="s3939.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="276-281" id="s3939.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3939.e0" e2="s3939.e1" id="s3939.p0" relation="false"/>
  </sentence>
  <sentence id="s3940" text="Furthermore, in clinical specimens, increased positive regulation of protein ubiquitination levels correlated with reduced regulation of double-strand break repair via homologous recombination levels and elevated positive regulation of receptor recycling levels in increasing tumor grades.">
    <entity charOffset="213-254" id="s3940.e0" ontology_id="GO_0001921" text="positive regulation of receptor recycling" type="GO"/>
    <entity charOffset="276-281" id="s3940.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3940.e0" e2="s3940.e1" id="s3940.p0" relation="false"/>
  </sentence>
  <sentence id="s3941" text="Overall, our findings show how the tumor suppressor regulation of double-strand break repair via homologous recombination is regulated in hepatocellular carcinoma and establish the mechanism underlying positive regulation of protein ubiquitination-mediated tumorigenesis in this disease.&lt;b&gt;Significance:&lt;/b&gt; These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.">
    <entity charOffset="35-40" id="s3941.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="202-247" id="s3941.e1" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <pair e1="s3941.e0" e2="s3941.e1" id="s3941.p0" relation="false"/>
  </sentence>
  <sentence id="s3942" text="Overall, our findings show how the tumor suppressor regulation of double-strand break repair via homologous recombination is regulated in hepatocellular carcinoma and establish the mechanism underlying positive regulation of protein ubiquitination-mediated tumorigenesis in this disease.&lt;b&gt;Significance:&lt;/b&gt; These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.">
    <entity charOffset="52-121" id="s3942.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="138-162" id="s3942.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s3942.e0" e2="s3942.e1" id="s3942.p0" relation="false"/>
  </sentence>
  <sentence id="s3943" text="Several studies have shown that reproductive factors, such as age at natural negative regulation of phosphatase activityopause, parity and polycystic ovarian syndrome (PCOS), may play a role in the development of heart failure.">
    <entity charOffset="77-120" id="s3943.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="213-226" id="s3943.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s3943.e0" e2="s3943.e1" id="s3943.p0" relation="false"/>
  </sentence>
  <sentence id="s3944" text="However, age at negative regulation of phosphatase activityarche, gestational diabetes and PCOS were found to be genetically linked to risk factors for heart failure, such as atrial fibrillation, diabetes and smoking.">
    <entity charOffset="16-59" id="s3944.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="152-165" id="s3944.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s3944.e0" e2="s3944.e1" id="s3944.p0" relation="false"/>
  </sentence>
  <sentence id="s3945" text="Corresponding implicated genes, such as protein phosphorylation, ErbB3, MKL2, glucose homeostasis and protein phosphorylation, may explain the associations between reproductive factors and heart failure.">
    <entity charOffset="40-63" id="s3945.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="189-202" id="s3945.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s3945.e0" e2="s3945.e1" id="s3945.p0" relation="true"/>
  </sentence>
  <sentence id="s3946" text="Corresponding implicated genes, such as protein phosphorylation, ErbB3, MKL2, glucose homeostasis and protein phosphorylation, may explain the associations between reproductive factors and heart failure.">
    <entity charOffset="78-97" id="s3946.e0" ontology_id="GO_0042593" text="glucose homeostasis" type="GO"/>
    <entity charOffset="189-202" id="s3946.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s3946.e0" e2="s3946.e1" id="s3946.p0" relation="false"/>
  </sentence>
  <sentence id="s3947" text="Corresponding implicated genes, such as protein phosphorylation, ErbB3, MKL2, glucose homeostasis and protein phosphorylation, may explain the associations between reproductive factors and heart failure.">
    <entity charOffset="102-125" id="s3947.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="189-202" id="s3947.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s3947.e0" e2="s3947.e1" id="s3947.p0" relation="false"/>
  </sentence>
  <sentence id="s3948" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor regulation of transcription by RNA polymerase II that interacts with NONO/p54NRB, a survival factor.">
    <entity charOffset="48-54" id="s3948.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="207-255" id="s3948.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3948.e0" e2="s3948.e1" id="s3948.p0" relation="true"/>
  </sentence>
  <sentence id="s3949" text="Also, two somatic heterozygous activation of innate immune response mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).">
    <entity charOffset="31-67" id="s3949.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="110-116" id="s3949.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s3949.e0" e2="s3949.e1" id="s3949.p0" relation="false"/>
  </sentence>
  <sentence id="s3950" text="Our studies implicate therapeutic strategies for either reducing -cell proliferation in insulinomas or alleviating normal -cell deficiency in diabetes through the modulation of regulation of transcription by RNA polymerase II phosphorylation">
    <entity charOffset="89-100" id="s3950.e0" ontology_id="HP_0012197" text="insulinomas" type="HP"/>
    <entity charOffset="179-227" id="s3950.e1" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3950.e0" e2="s3950.e1" id="s3950.p0" relation="false"/>
  </sentence>
  <sentence id="s3951" text="In a large Scottish pedigree, a balanced translocation t (1;11)(q42.1;q14.3) disrupting the microtubule cytoskeleton organization and DISC2 genes segregates with major mental illness, including schizophrenia and depression.">
    <entity charOffset="92-129" id="s3951.e0" ontology_id="GO_0000226" text="microtubule cytoskeleton organization" type="GO"/>
    <entity charOffset="194-207" id="s3951.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3951.e0" e2="s3951.e1" id="s3951.p0" relation="false"/>
  </sentence>
  <sentence id="s3952" text="A frame-shift carboxyl-terminal deletion was reported in microtubule cytoskeleton organization in an American family with schizophrenia, but subsequently found in two controls.">
    <entity charOffset="57-94" id="s3952.e0" ontology_id="GO_0000226" text="microtubule cytoskeleton organization" type="GO"/>
    <entity charOffset="122-135" id="s3952.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s3952.e0" e2="s3952.e1" id="s3952.p0" relation="false"/>
  </sentence>
  <sentence id="s3953" text="Hirschsprung disease (endothelin receptor signaling pathway) is a congenital and heterogeneous disorder characterized by the absence of intramural nervous plexuses along variable lengths of the hindgut.">
    <entity charOffset="22-59" id="s3953.e0" ontology_id="GO_0086100" text="endothelin receptor signaling pathway" type="GO"/>
    <entity charOffset="81-94" id="s3953.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s3953.e0" e2="s3953.e1" id="s3953.p0" relation="true"/>
  </sentence>
  <sentence id="s3954" text="To discover additional risk loci, we performed a GWAS of 123 sporadic endothelin receptor signaling pathway patients and 432 unaffected controls using a large-scale platform with coverage of over 1 million polymorphic markers.">
    <entity charOffset="61-69" id="s3954.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="70-107" id="s3954.e1" ontology_id="GO_0086100" text="endothelin receptor signaling pathway" type="GO"/>
    <pair e1="s3954.e0" e2="s3954.e1" id="s3954.p0" relation="false"/>
  </sentence>
  <sentence id="s3955" text="Smith-Magenis syndrome (positive regulation of transcription, DNA-templated), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene.">
    <entity charOffset="24-75" id="s3955.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="146-169" id="s3955.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s3955.e0" e2="s3955.e1" id="s3955.p0" relation="true"/>
  </sentence>
  <sentence id="s3956" text="We cellular response to interleukin-4 NF1 mutations in neuroblastoma cell lines and in primary tumors.">
    <entity charOffset="3-37" id="s3956.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="55-68" id="s3956.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s3956.e0" e2="s3956.e1" id="s3956.p0" relation="false"/>
  </sentence>
  <sentence id="s3957" text="Our study aimed to investigate the relationship between single nucleotide polymorphisms (SNPs) of claudin 10 (regulation of ion transport) (rs1325774, rs7333503, rs3751334) and breast cancer and the clinical characteristics of patients.A total of 104 patients with breast cancer and 118 healthy controls were recruited in our study between 2013 and 2015.">
    <entity charOffset="110-137" id="s3957.e0" ontology_id="GO_0043269" text="regulation of ion transport" type="GO"/>
    <entity charOffset="184-190" id="s3957.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3957.e0" e2="s3957.e1" id="s3957.p0" relation="false"/>
  </sentence>
  <sentence id="s3958" text="The expression level of regulation of ion transport was reduced in breast cancer tissues compared with normal breast tissues according to the analysis of The Cancer Genome Atlas (TCGA) data through GEPIA.Our results suggest that the polymorphism of rs1325774 associate with increase the breast cancer risk.">
    <entity charOffset="24-51" id="s3958.e0" ontology_id="GO_0043269" text="regulation of ion transport" type="GO"/>
    <entity charOffset="74-80" id="s3958.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3958.e0" e2="s3958.e1" id="s3958.p0" relation="false"/>
  </sentence>
  <sentence id="s3959" text="This report identifies the implication of apoptotic process in human pathology and highlights the first description of a ciliary transport defect in OFDS, extending the genetic heterogeneity of this subgroup of ciliopathies">
    <entity charOffset="42-59" id="s3959.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="177-190" id="s3959.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s3959.e0" e2="s3959.e1" id="s3959.p0" relation="false"/>
  </sentence>
  <sentence id="s3960" text="Recessively inherited, pathogenic defects in cellular response to oxidative stress have been previously reported to underlie cerebral, ocular, dental, auricular and skeletal anomalies (CODAS) syndrome, a complex multisystemic and developmental disorder.">
    <entity charOffset="45-82" id="s3960.e0" ontology_id="GO_0034599" text="cellular response to oxidative stress" type="GO"/>
    <entity charOffset="165-183" id="s3960.e1" ontology_id="HP_0000924" text="skeletal anomalies" type="HP"/>
    <pair e1="s3960.e0" e2="s3960.e1" id="s3960.p0" relation="true"/>
  </sentence>
  <sentence id="s3961" text="We have applied whole exome sequencing to a patient with congenital lactic acidosis, muscle weakness, profound deficiencies in mitochondrial oxidative phosphorylation associated with loss of mtDNA copy number and MRI abnormalities consistent with Leigh syndrome, identifying biallelic variants in the cellular response to oxidative stress (NM_004793.3) gene; c.1693T&amp;gt;C predicting p.(Tyr565His) and c.2197G&amp;gt;A predicting p.(Glu733Lys); no evidence of the classical skeletal or dental defects observed in CODAS syndrome patients were noted in our patient.">
    <entity charOffset="75-83" id="s3961.e0" ontology_id="HP_0001941" text="acidosis" type="HP"/>
    <entity charOffset="301-338" id="s3961.e1" ontology_id="GO_0034599" text="cellular response to oxidative stress" type="GO"/>
    <pair e1="s3961.e0" e2="s3961.e1" id="s3961.p0" relation="false"/>
  </sentence>
  <sentence id="s3962" text="Among these genes, mutations in double-strand break repair gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (double-strand break repair), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).">
    <entity charOffset="32-58" id="s3962.e0" ontology_id="GO_0006302" text="double-strand break repair" type="GO"/>
    <entity charOffset="230-236" id="s3962.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3962.e0" e2="s3962.e1" id="s3962.p0" relation="false"/>
  </sentence>
  <sentence id="s3963" text="Among these genes, mutations in double-strand break repair gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (double-strand break repair), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).">
    <entity charOffset="130-153" id="s3963.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="155-181" id="s3963.e1" ontology_id="GO_0006302" text="double-strand break repair" type="GO"/>
    <pair e1="s3963.e0" e2="s3963.e1" id="s3963.p0" relation="true"/>
  </sentence>
  <sentence id="s3964" text="Among these genes, mutations in double-strand break repair gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (double-strand break repair), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).">
    <entity charOffset="155-181" id="s3964.e0" ontology_id="GO_0006302" text="double-strand break repair" type="GO"/>
    <entity charOffset="230-236" id="s3964.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3964.e0" e2="s3964.e1" id="s3964.p0" relation="false"/>
  </sentence>
  <sentence id="s3965" text="These subjects share a negative regulation of transcription, DNA-templated of common facial features that include a prominent maxilla and upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay that readily reveal the upper gingiva, widely spaced teeth, and a broad nasal tip.">
    <entity charOffset="23-74" id="s3965.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="251-270" id="s3965.e1" ontology_id="HP_0000687" text="widely spaced teeth" type="HP"/>
    <pair e1="s3965.e0" e2="s3965.e1" id="s3965.p0" relation="false"/>
  </sentence>
  <sentence id="s3966" text="These subjects share a negative regulation of transcription, DNA-templated of common facial features that include a prominent maxilla and upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay that readily reveal the upper gingiva, widely spaced teeth, and a broad nasal tip.">
    <entity charOffset="144-211" id="s3966.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="251-270" id="s3966.e1" ontology_id="HP_0000687" text="widely spaced teeth" type="HP"/>
    <pair e1="s3966.e0" e2="s3966.e1" id="s3966.p0" relation="false"/>
  </sentence>
  <sentence id="s3967" text="Grossly, the neoplasm was lobulated, with a fleshy positive regulation of dendrite morphogenesis surface and a diameter ranging between 0.8 and 8cm (mean 3.4cm).">
    <entity charOffset="13-21" id="s3967.e0" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <entity charOffset="51-96" id="s3967.e1" ontology_id="GO_0050775" text="positive regulation of dendrite morphogenesis" type="GO"/>
    <pair e1="s3967.e0" e2="s3967.e1" id="s3967.p0" relation="false"/>
  </sentence>
  <sentence id="s3968" text="Primary ciliary dyskinesia (motile cilium assembly) can manifest in the neonatal period with severe respiratory distress.">
    <entity charOffset="8-26" id="s3968.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-50" id="s3968.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s3968.e0" e2="s3968.e1" id="s3968.p0" relation="true"/>
  </sentence>
  <sentence id="s3969" text="We describe a child with PCD who presented at term with severe neonatal respiratory distress, persistent right upper negative regulation of protein kinase activity collapse and failure to thrive who underwent lobectomy prior to the diagnosis of PCD at the age of 3 years.">
    <entity charOffset="117-163" id="s3969.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="177-194" id="s3969.e1" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <pair e1="s3969.e0" e2="s3969.e1" id="s3969.p0" relation="false"/>
  </sentence>
  <sentence id="s3970" text="Their expression changes were further validated in U2positive regulation of stress-activated MAPK cascade osteosarcoma cell lines and hOB normal cell lines through quantitative PCR (qPCR) and consistent result with microarray analysis was obtained.">
    <entity charOffset="53-105" id="s3970.e0" ontology_id="GO_0032874" text="positive regulation of stress-activated MAPK cascade" type="GO"/>
    <entity charOffset="106-118" id="s3970.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s3970.e0" e2="s3970.e1" id="s3970.p0" relation="false"/>
  </sentence>
  <sentence id="s3971" text="We chose to study protein transport-branching involved in blood vessel morphogenesis rather than wild muscle organ development branching involved in blood vessel morphogenesis because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="18-35" id="s3971.e0" ontology_id="GO_0015031" text="protein transport" type="GO"/>
    <entity charOffset="396-401" id="s3971.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3971.e0" e2="s3971.e1" id="s3971.p0" relation="false"/>
  </sentence>
  <sentence id="s3972" text="We chose to study protein transport-branching involved in blood vessel morphogenesis rather than wild muscle organ development branching involved in blood vessel morphogenesis because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="36-84" id="s3972.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="396-401" id="s3972.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3972.e0" e2="s3972.e1" id="s3972.p0" relation="false"/>
  </sentence>
  <sentence id="s3973" text="We chose to study protein transport-branching involved in blood vessel morphogenesis rather than wild muscle organ development branching involved in blood vessel morphogenesis because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="102-126" id="s3973.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="396-401" id="s3973.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3973.e0" e2="s3973.e1" id="s3973.p0" relation="false"/>
  </sentence>
  <sentence id="s3974" text="We chose to study protein transport-branching involved in blood vessel morphogenesis rather than wild muscle organ development branching involved in blood vessel morphogenesis because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.">
    <entity charOffset="127-175" id="s3974.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="396-401" id="s3974.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3974.e0" e2="s3974.e1" id="s3974.p0" relation="false"/>
  </sentence>
  <sentence id="s3975" text="We generated calpain-1 knockout Townes sickle (SSCKO) epidermis development to investigate the role of calpain-1 in steady state and hypoxia/reoxygenation (H/R)-induced sickle platelet activation and aggregation, clot retraction, and pulmonary arterial hypertension.">
    <entity charOffset="54-75" id="s3975.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="234-265" id="s3975.e1" ontology_id="HP_0002092" text="pulmonary arterial hypertension" type="HP"/>
    <pair e1="s3975.e0" e2="s3975.e1" id="s3975.p0" relation="false"/>
  </sentence>
  <sentence id="s3976" text="To investigate the role of homotypic cell-cell adhesion variants with putative transcription regulatory function in the etiology of autism, we performed a family-based association study in 410 Chinese Han trios.">
    <entity charOffset="27-55" id="s3976.e0" ontology_id="GO_0034109" text="homotypic cell-cell adhesion" type="GO"/>
    <entity charOffset="132-138" id="s3976.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s3976.e0" e2="s3976.e1" id="s3976.p0" relation="false"/>
  </sentence>
  <sentence id="s3977" text="Alterations in regulation of cell growth signaling are involved both in cancer progression and in osteoclast differentiation.">
    <entity charOffset="15-40" id="s3977.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="72-78" id="s3977.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3977.e0" e2="s3977.e1" id="s3977.p0" relation="false"/>
  </sentence>
  <sentence id="s3978" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as negative regulation of transcription, DNA-templated, ATXN2, ATXN3, ATXN7, CACNA1A and transcription by RNA polymerase II, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s3978.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="78-129" id="s3978.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s3978.e0" e2="s3978.e1" id="s3978.p0" relation="true"/>
  </sentence>
  <sentence id="s3979" text="While polyglutamine ataxias, linked to CAG repeat expansions in genes such as negative regulation of transcription, DNA-templated, ATXN2, ATXN3, ATXN7, CACNA1A and transcription by RNA polymerase II, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.">
    <entity charOffset="20-27" id="s3979.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="164-198" id="s3979.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s3979.e0" e2="s3979.e1" id="s3979.p0" relation="true"/>
  </sentence>
  <sentence id="s3980" text="Clinical comparisons showed that ataxias due to channelopathies had a significantly earlier age at onset with an average of 24.6 years, versus 40.9 years for polyglutamine expansion spinocerebellar ataxias and 37.8 years for regulation of mitochondrial membrane permeability-related forms (P = 0.001).">
    <entity charOffset="33-40" id="s3980.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="225-274" id="s3980.e1" ontology_id="GO_0046902" text="regulation of mitochondrial membrane permeability" type="GO"/>
    <pair e1="s3980.e0" e2="s3980.e1" id="s3980.p0" relation="true"/>
  </sentence>
  <sentence id="s3981" text="Similar differences were found among a single gene group, comparing 23 patients with positive regulation of cytosolic calcium ion concentration expansions (spinocerebellar ataxia 6) to 22 patients with CACNA1A point mutations, which had lower average age at onset (25.2 versus 47.3 years) with longer disease duration (18.7 versus 10.9), but lower severity indexes (0.39 versus 0.44), indicating slower progression of the disease.">
    <entity charOffset="85-143" id="s3981.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="172-178" id="s3981.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3981.e0" e2="s3981.e1" id="s3981.p0" relation="true"/>
  </sentence>
  <sentence id="s3982" text="In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed positive regulation of cytosolic calcium ion concentration and regulation of mitochondrial membrane permeability as major ataxia genes.">
    <entity charOffset="138-145" id="s3982.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="161-219" id="s3982.e1" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <pair e1="s3982.e0" e2="s3982.e1" id="s3982.p0" relation="true"/>
  </sentence>
  <sentence id="s3983" text="In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed positive regulation of cytosolic calcium ion concentration and regulation of mitochondrial membrane permeability as major ataxia genes.">
    <entity charOffset="138-145" id="s3983.e0" ontology_id="HP_0001251" text="ataxias" type="HP"/>
    <entity charOffset="224-273" id="s3983.e1" ontology_id="GO_0046902" text="regulation of mitochondrial membrane permeability" type="GO"/>
    <pair e1="s3983.e0" e2="s3983.e1" id="s3983.p0" relation="true"/>
  </sentence>
  <sentence id="s3984" text="In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed positive regulation of cytosolic calcium ion concentration and regulation of mitochondrial membrane permeability as major ataxia genes.">
    <entity charOffset="161-219" id="s3984.e0" ontology_id="GO_0007204" text="positive regulation of cytosolic calcium ion concentration" type="GO"/>
    <entity charOffset="283-289" id="s3984.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s3984.e0" e2="s3984.e1" id="s3984.p0" relation="true"/>
  </sentence>
  <sentence id="s3985" text="regulation of synapse assemblyKs and SSH promote cancer cell invasion and metastasis and represent novel anti-cancer targets.">
    <entity charOffset="0-30" id="s3985.e0" ontology_id="GO_0051963" text="regulation of synapse assembly" type="GO"/>
    <entity charOffset="49-55" id="s3985.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3985.e0" e2="s3985.e1" id="s3985.p0" relation="false"/>
  </sentence>
  <sentence id="s3986" text="We show that active cofilin, regulation of synapse assemblyK1, LIMK2, and SSH1 are overexpressed in human CRC and are associated with tumor progression parameters.">
    <entity charOffset="29-59" id="s3986.e0" ontology_id="GO_0051963" text="regulation of synapse assembly" type="GO"/>
    <entity charOffset="134-139" id="s3986.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3986.e0" e2="s3986.e1" id="s3986.p0" relation="false"/>
  </sentence>
  <sentence id="s3987" text="In addition, immunofluorescence analysis showed increased expression of active cofilin, regulation of synapse assemblyK1, LIMK2, and regulation of cellular protein metabolic process in HT29 colon cancer cells resistant to 5-fluorouracil compared to parental HT29 cells.">
    <entity charOffset="88-118" id="s3987.e0" ontology_id="GO_0051963" text="regulation of synapse assembly" type="GO"/>
    <entity charOffset="196-202" id="s3987.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3987.e0" e2="s3987.e1" id="s3987.p0" relation="false"/>
  </sentence>
  <sentence id="s3988" text="In addition, immunofluorescence analysis showed increased expression of active cofilin, regulation of synapse assemblyK1, LIMK2, and regulation of cellular protein metabolic process in HT29 colon cancer cells resistant to 5-fluorouracil compared to parental HT29 cells.">
    <entity charOffset="133-181" id="s3988.e0" ontology_id="GO_0032268" text="regulation of cellular protein metabolic process" type="GO"/>
    <entity charOffset="196-202" id="s3988.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s3988.e0" e2="s3988.e1" id="s3988.p0" relation="false"/>
  </sentence>
  <sentence id="s3989" text="Our results suggest that F-actin regulators LIMK/cofilin pathway and regulation of cellular protein metabolic process are associated with CRC progression and chemoresistance representing promising tumor biomarkers and therapeutic targets in CRC">
    <entity charOffset="69-117" id="s3989.e0" ontology_id="GO_0032268" text="regulation of cellular protein metabolic process" type="GO"/>
    <entity charOffset="197-202" id="s3989.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s3989.e0" e2="s3989.e1" id="s3989.p0" relation="false"/>
  </sentence>
  <sentence id="s3990" text="We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the signal transduction gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.">
    <entity charOffset="108-127" id="s3990.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="150-168" id="s3990.e1" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <pair e1="s3990.e0" e2="s3990.e1" id="s3990.p0" relation="false"/>
  </sentence>
  <sentence id="s3991" text="We also describe a mouse model harboring a knockdown mutation in the murine signal transduction gene that shared several of the phenotypic elements observed in the signal transduction-deficient human including facial dysmorphism, growth restriction and retinal deposits.">
    <entity charOffset="76-95" id="s3991.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="210-228" id="s3991.e1" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <pair e1="s3991.e0" e2="s3991.e1" id="s3991.p0" relation="false"/>
  </sentence>
  <sentence id="s3992" text="We also describe a mouse model harboring a knockdown mutation in the murine signal transduction gene that shared several of the phenotypic elements observed in the signal transduction-deficient human including facial dysmorphism, growth restriction and retinal deposits.">
    <entity charOffset="164-183" id="s3992.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="210-228" id="s3992.e1" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <pair e1="s3992.e0" e2="s3992.e1" id="s3992.p0" relation="false"/>
  </sentence>
  <sentence id="s3993" text="Heritable pulmonary arterial hypertension (HPAH) is a rare but severe complication of protein phosphorylation.">
    <entity charOffset="10-41" id="s3993.e0" ontology_id="HP_0002092" text="pulmonary arterial hypertension" type="HP"/>
    <entity charOffset="86-109" id="s3993.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s3993.e0" e2="s3993.e1" id="s3993.p0" relation="true"/>
  </sentence>
  <sentence id="s3994" text="The mutations in both lipid catabolic process and LPAR6/P2RY5 are responsible for autosomal recessive woolly hair with or without hypotrichosis (ARWH/HT).">
    <entity charOffset="22-45" id="s3994.e0" ontology_id="GO_0016042" text="lipid catabolic process" type="GO"/>
    <entity charOffset="130-143" id="s3994.e1" ontology_id="HP_0001006" text="hypotrichosis" type="HP"/>
    <pair e1="s3994.e0" e2="s3994.e1" id="s3994.p0" relation="true"/>
  </sentence>
  <sentence id="s3995" text="The mutations in both lipid catabolic process and LPAR6/P2RY5 are responsible for autosomal recessive woolly hair with or without hypotrichosis (ARWH/HT).">
    <entity charOffset="22-45" id="s3995.e0" ontology_id="GO_0016042" text="lipid catabolic process" type="GO"/>
    <entity charOffset="82-101" id="s3995.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3995.e0" e2="s3995.e1" id="s3995.p0" relation="true"/>
  </sentence>
  <sentence id="s3996" text="The main objective of this study is to provide a brief version of the Spanish translation of the detection of chemical stimulus involved in sensory perception of bitter taste, across a sample consisting of 465 main familial caregivers (85.2% female, n = 396) between 27 and 67 years old ([Formula: see text] = 44.13; SD = 5.35) of paediatric patients between 9 and 18 years old ([Formula: see text] = 12.10, SD = 2.20; 56.8% men, n = 264) diagnosed with diabetes mellitus muscle organ development I (20.9% of the sample; n = 97), short stature (32.5% of the sample; n = 151), or a chronic respiratory disease (asthma, cystic fibrosis, bronchiolitis obliterans and bronchiectasis) (46.6% of the sample; n = 217).">
    <entity charOffset="97-174" id="s3996.e0" ontology_id="GO_0001580" text="detection of chemical stimulus involved in sensory perception of bitter taste" type="GO"/>
    <entity charOffset="530-543" id="s3996.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3996.e0" e2="s3996.e1" id="s3996.p0" relation="false"/>
  </sentence>
  <sentence id="s3997" text="The main objective of this study is to provide a brief version of the Spanish translation of the detection of chemical stimulus involved in sensory perception of bitter taste, across a sample consisting of 465 main familial caregivers (85.2% female, n = 396) between 27 and 67 years old ([Formula: see text] = 44.13; SD = 5.35) of paediatric patients between 9 and 18 years old ([Formula: see text] = 12.10, SD = 2.20; 56.8% men, n = 264) diagnosed with diabetes mellitus muscle organ development I (20.9% of the sample; n = 97), short stature (32.5% of the sample; n = 151), or a chronic respiratory disease (asthma, cystic fibrosis, bronchiolitis obliterans and bronchiectasis) (46.6% of the sample; n = 217).">
    <entity charOffset="472-496" id="s3997.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="530-543" id="s3997.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s3997.e0" e2="s3997.e1" id="s3997.p0" relation="false"/>
  </sentence>
  <sentence id="s3998" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="173-185" id="s3998.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="600-619" id="s3998.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3998.e0" e2="s3998.e1" id="s3998.p0" relation="false"/>
  </sentence>
  <sentence id="s3999" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="187-228" id="s3999.e0" ontology_id="GO_0001921" text="positive regulation of receptor recycling" type="GO"/>
    <entity charOffset="600-619" id="s3999.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s3999.e0" e2="s3999.e1" id="s3999.p0" relation="false"/>
  </sentence>
  <sentence id="s4000" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="230-268" id="s4000.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="600-619" id="s4000.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4000.e0" e2="s4000.e1" id="s4000.p0" relation="false"/>
  </sentence>
  <sentence id="s4001" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="270-310" id="s4001.e0" ontology_id="GO_0006729" text="tetrahydrobiopterin biosynthetic process" type="GO"/>
    <entity charOffset="600-619" id="s4001.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4001.e0" e2="s4001.e1" id="s4001.p0" relation="true"/>
  </sentence>
  <sentence id="s4002" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="312-359" id="s4002.e0" ontology_id="GO_0002091" text="negative regulation of receptor internalization" type="GO"/>
    <entity charOffset="600-619" id="s4002.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4002.e0" e2="s4002.e1" id="s4002.p0" relation="false"/>
  </sentence>
  <sentence id="s4003" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="361-382" id="s4003.e0" ontology_id="GO_0007032" text="endosome organization" type="GO"/>
    <entity charOffset="600-619" id="s4003.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4003.e0" e2="s4003.e1" id="s4003.p0" relation="false"/>
  </sentence>
  <sentence id="s4004" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="384-410" id="s4004.e0" ontology_id="GO_0048489" text="synaptic vesicle transport" type="GO"/>
    <entity charOffset="600-619" id="s4004.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4004.e0" e2="s4004.e1" id="s4004.p0" relation="false"/>
  </sentence>
  <sentence id="s4005" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="420-431" id="s4005.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="600-619" id="s4005.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4005.e0" e2="s4005.e1" id="s4005.p0" relation="true"/>
  </sentence>
  <sentence id="s4006" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="433-448" id="s4006.e0" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <entity charOffset="600-619" id="s4006.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4006.e0" e2="s4006.e1" id="s4006.p0" relation="false"/>
  </sentence>
  <sentence id="s4007" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="450-489" id="s4007.e0" ontology_id="GO_1905612" text="positive regulation of mRNA cap binding" type="GO"/>
    <entity charOffset="600-619" id="s4007.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4007.e0" e2="s4007.e1" id="s4007.p0" relation="false"/>
  </sentence>
  <sentence id="s4008" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="498-555" id="s4008.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="600-619" id="s4008.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4008.e0" e2="s4008.e1" id="s4008.p0" relation="false"/>
  </sentence>
  <sentence id="s4009" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="561-595" id="s4009.e0" ontology_id="GO_0006680" text="glucosylceramide catabolic process" type="GO"/>
    <entity charOffset="600-619" id="s4009.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4009.e0" e2="s4009.e1" id="s4009.p0" relation="true"/>
  </sentence>
  <sentence id="s4010" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4010.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="638-664" id="s4010.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s4010.e0" e2="s4010.e1" id="s4010.p0" relation="true"/>
  </sentence>
  <sentence id="s4011" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4011.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="666-712" id="s4011.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4011.e0" e2="s4011.e1" id="s4011.p0" relation="true"/>
  </sentence>
  <sentence id="s4012" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4012.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="719-751" id="s4012.e1" ontology_id="GO_0006874" text="cellular calcium ion homeostasis" type="GO"/>
    <pair e1="s4012.e0" e2="s4012.e1" id="s4012.p0" relation="true"/>
  </sentence>
  <sentence id="s4013" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4013.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="761-806" id="s4013.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s4013.e0" e2="s4013.e1" id="s4013.p0" relation="true"/>
  </sentence>
  <sentence id="s4014" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4014.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="808-834" id="s4014.e1" ontology_id="GO_0016191" text="synaptic vesicle uncoating" type="GO"/>
    <pair e1="s4014.e0" e2="s4014.e1" id="s4014.p0" relation="true"/>
  </sentence>
  <sentence id="s4015" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4015.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="836-874" id="s4015.e1" ontology_id="GO_0046856" text="phosphatidylinositol dephosphorylation" type="GO"/>
    <pair e1="s4015.e0" e2="s4015.e1" id="s4015.p0" relation="true"/>
  </sentence>
  <sentence id="s4016" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4016.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="883-909" id="s4016.e1" ontology_id="GO_0007005" text="mitochondrion organization" type="GO"/>
    <pair e1="s4016.e0" e2="s4016.e1" id="s4016.p0" relation="true"/>
  </sentence>
  <sentence id="s4017" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4017.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="911-948" id="s4017.e1" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <pair e1="s4017.e0" e2="s4017.e1" id="s4017.p0" relation="false"/>
  </sentence>
  <sentence id="s4018" text="We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or autosomal recessive (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.">
    <entity charOffset="600-619" id="s4018.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="954-972" id="s4018.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4018.e0" e2="s4018.e1" id="s4018.p0" relation="false"/>
  </sentence>
  <sentence id="s4019" text="Duplication in interleukin-12-mediated signaling pathway encoding lamin B1 causes autosomal dominant leukodystrophy and mutations in biological_process encoding lamin B2 are associated with acquired partial lipodystrophy.">
    <entity charOffset="15-56" id="s4019.e0" ontology_id="GO_0035722" text="interleukin-12-mediated signaling pathway" type="GO"/>
    <entity charOffset="101-115" id="s4019.e1" ontology_id="HP_0002415" text="leukodystrophy" type="HP"/>
    <pair e1="s4019.e0" e2="s4019.e1" id="s4019.p0" relation="true"/>
  </sentence>
  <sentence id="s4020" text="Duplication in interleukin-12-mediated signaling pathway encoding lamin B1 causes autosomal dominant leukodystrophy and mutations in biological_process encoding lamin B2 are associated with acquired partial lipodystrophy.">
    <entity charOffset="101-115" id="s4020.e0" ontology_id="HP_0002415" text="leukodystrophy" type="HP"/>
    <entity charOffset="133-151" id="s4020.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4020.e0" e2="s4020.e1" id="s4020.p0" relation="false"/>
  </sentence>
  <sentence id="s4021" text="In this study, we found that tumor suppressor candidate3(magnesium ion transport) was downregulated in temozolomide-resistant U87MG cells(U87MG-res cells) and its restoration sensitized U87MG-res cells to temozolomide.">
    <entity charOffset="29-34" id="s4021.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="59-82" id="s4021.e1" ontology_id="GO_0015693" text="magnesium ion transport" type="GO"/>
    <pair e1="s4021.e0" e2="s4021.e1" id="s4021.p0" relation="false"/>
  </sentence>
  <sentence id="s4022" text="protein polyubiquitination132 was upregulated in the U87MG-res cells and its overexpression induced temozolomide resistance and the formation of cancer stem cell phenotypes in the U87MG cells.">
    <entity charOffset="0-26" id="s4022.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="146-152" id="s4022.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4022.e0" e2="s4022.e1" id="s4022.p0" relation="false"/>
  </sentence>
  <sentence id="s4023" text="Thus, our data indicate that protein polyubiquitination-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting magnesium ion transport in glioblastoma">
    <entity charOffset="29-55" id="s4023.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="122-128" id="s4023.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4023.e0" e2="s4023.e1" id="s4023.p0" relation="false"/>
  </sentence>
  <sentence id="s4024" text="Thus, our data indicate that protein polyubiquitination-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting magnesium ion transport in glioblastoma">
    <entity charOffset="122-128" id="s4024.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="163-186" id="s4024.e1" ontology_id="GO_0015693" text="magnesium ion transport" type="GO"/>
    <pair e1="s4024.e0" e2="s4024.e1" id="s4024.p0" relation="false"/>
  </sentence>
  <sentence id="s4025" text="We hypothesized that newly identified genetic risk factors for the general African American population could also negative regulation of transcription by RNA polymerase II laboratory biomarkers known to contribute to the clinical disease expression of SCA, including variants influencing the white blood cell count and the development of albuminuria and abnormal glomerular filtration rate.">
    <entity charOffset="114-171" id="s4025.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="338-349" id="s4025.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s4025.e0" e2="s4025.e1" id="s4025.p0" relation="false"/>
  </sentence>
  <sentence id="s4026" text="To investigate the mechanism by which the -crystallin mutations negative regulation of intracellular transport-R49C and negative regulation of intracellular transport-R120G lead to cataract formation, we determined whether these mutations cause an altered expression of specific transcripts in the lens at an early postnatal age by RNA-seq analysis.">
    <entity charOffset="65-111" id="s4026.e0" ontology_id="GO_0032387" text="negative regulation of intracellular transport" type="GO"/>
    <entity charOffset="182-190" id="s4026.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s4026.e0" e2="s4026.e1" id="s4026.p0" relation="true"/>
  </sentence>
  <sentence id="s4027" text="To investigate the mechanism by which the -crystallin mutations negative regulation of intracellular transport-R49C and negative regulation of intracellular transport-R120G lead to cataract formation, we determined whether these mutations cause an altered expression of specific transcripts in the lens at an early postnatal age by RNA-seq analysis.">
    <entity charOffset="121-167" id="s4027.e0" ontology_id="GO_0032387" text="negative regulation of intracellular transport" type="GO"/>
    <entity charOffset="182-190" id="s4027.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s4027.e0" e2="s4027.e1" id="s4027.p0" relation="true"/>
  </sentence>
  <sentence id="s4028" text="Taken together, these findings offer additional insight into the early transcriptional changes caused by negative regulation of intracellular transport and negative regulation of intracellular transport mutations associated with autosomal dominant human cataracts, and indicate that the transcript levels of certain genes are affected by the expression of mutant -crystallin in vivo">
    <entity charOffset="105-151" id="s4028.e0" ontology_id="GO_0032387" text="negative regulation of intracellular transport" type="GO"/>
    <entity charOffset="254-263" id="s4028.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s4028.e0" e2="s4028.e1" id="s4028.p0" relation="true"/>
  </sentence>
  <sentence id="s4029" text="Taken together, these findings offer additional insight into the early transcriptional changes caused by negative regulation of intracellular transport and negative regulation of intracellular transport mutations associated with autosomal dominant human cataracts, and indicate that the transcript levels of certain genes are affected by the expression of mutant -crystallin in vivo">
    <entity charOffset="156-202" id="s4029.e0" ontology_id="GO_0032387" text="negative regulation of intracellular transport" type="GO"/>
    <entity charOffset="254-263" id="s4029.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s4029.e0" e2="s4029.e1" id="s4029.p0" relation="true"/>
  </sentence>
  <sentence id="s4030" text="However, the underlying mechanisms involved in hepatocellular carcinoma (phosphatidylinositol phosphorylation) progression remain poorly understood.">
    <entity charOffset="47-71" id="s4030.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="73-109" id="s4030.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4030.e0" e2="s4030.e1" id="s4030.p0" relation="false"/>
  </sentence>
  <sentence id="s4031" text="Surprisingly, germline variants in endosomal vesicle fusion or SAMD9L were present in 17% of primary microtubule-based process patients, and these variants were routinely lost in the tumor cells by chromosomal deletions (e.g., monosomy 7) or copy number neutral loss of heterozygosity (CN-LOH).">
    <entity charOffset="35-59" id="s4031.e0" ontology_id="GO_0034058" text="endosomal vesicle fusion" type="GO"/>
    <entity charOffset="183-188" id="s4031.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4031.e0" e2="s4031.e1" id="s4031.p0" relation="true"/>
  </sentence>
  <sentence id="s4032" text="Surprisingly, germline variants in endosomal vesicle fusion or SAMD9L were present in 17% of primary microtubule-based process patients, and these variants were routinely lost in the tumor cells by chromosomal deletions (e.g., monosomy 7) or copy number neutral loss of heterozygosity (CN-LOH).">
    <entity charOffset="101-126" id="s4032.e0" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <entity charOffset="183-188" id="s4032.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4032.e0" e2="s4032.e1" id="s4032.p0" relation="false"/>
  </sentence>
  <sentence id="s4033" text="Amyotrophic lateral sclerosis (signal transduction) is a fatal neurodegenerative disease.">
    <entity charOffset="31-50" id="s4033.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="63-88" id="s4033.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s4033.e0" e2="s4033.e1" id="s4033.p0" relation="false"/>
  </sentence>
  <sentence id="s4034" text="Progressive and systemic loss of motor neurons with gliosis in the central nervous system (CNS) is a neuropathological hallmark of signal transduction.">
    <entity charOffset="67-74" id="s4034.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="131-150" id="s4034.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s4034.e0" e2="s4034.e1" id="s4034.p0" relation="false"/>
  </sentence>
  <sentence id="s4035" text="Anti-mRNA splicing, via spliceosome antibodies were also observed in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and Sjgren's syndrome (SS) patients at a positive rate of 17.3, 14.5, and 10.1% respectively.">
    <entity charOffset="5-35" id="s4035.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="105-125" id="s4035.e1" ontology_id="HP_0001370" text="rheumatoid arthritis" type="HP"/>
    <pair e1="s4035.e0" e2="s4035.e1" id="s4035.p0" relation="false"/>
  </sentence>
  <sentence id="s4036" text="The Aicardi-Goutires syndrome (negative regulation of cell-matrix adhesion) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon  activity.">
    <entity charOffset="32-75" id="s4036.e0" ontology_id="GO_0001953" text="negative regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="241-267" id="s4036.e1" ontology_id="HP_0002514" text="intracranial calcification" type="HP"/>
    <pair e1="s4036.e0" e2="s4036.e1" id="s4036.p0" relation="false"/>
  </sentence>
  <sentence id="s4037" text="The Aicardi-Goutires syndrome (negative regulation of cell-matrix adhesion) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon  activity.">
    <entity charOffset="32-75" id="s4037.e0" ontology_id="GO_0001953" text="negative regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="269-288" id="s4037.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s4037.e0" e2="s4037.e1" id="s4037.p0" relation="false"/>
  </sentence>
  <sentence id="s4038" text="The Aicardi-Goutires syndrome (negative regulation of cell-matrix adhesion) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon  activity.">
    <entity charOffset="32-75" id="s4038.e0" ontology_id="GO_0001953" text="negative regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="294-310" id="s4038.e1" ontology_id="HP_0002059" text="cerebral atrophy" type="HP"/>
    <pair e1="s4038.e0" e2="s4038.e1" id="s4038.p0" relation="false"/>
  </sentence>
  <sentence id="s4039" text="Wnt transgenic epidermis development provide convincing evidence that Wnt signaling is involved in breast cancer initiation and progression, which is further strengthened by observations on human clinical breast cancer patients and studies on in vitro cultured human breast cancer cells.">
    <entity charOffset="15-36" id="s4039.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="106-112" id="s4039.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4039.e0" e2="s4039.e1" id="s4039.p0" relation="false"/>
  </sentence>
  <sentence id="s4040" text="Objective clinical response was 19% (one confirmed partial response (PR) in small cell lung cancer (SCLC) and two unconfirmed); stable disease (SD) was 6% for a disease control rate (xylulose metabolic process) of 25%.">
    <entity charOffset="92-98" id="s4040.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="183-209" id="s4040.e1" ontology_id="GO_0005997" text="xylulose metabolic process" type="GO"/>
    <pair e1="s4040.e0" e2="s4040.e1" id="s4040.p0" relation="false"/>
  </sentence>
  <sentence id="s4041" text="Genetic discoveries have established the importance of MAPK cascade for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia muscle organ development 2 (MAPK cascade) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.">
    <entity charOffset="55-67" id="s4041.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="273-279" id="s4041.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4041.e0" e2="s4041.e1" id="s4041.p0" relation="true"/>
  </sentence>
  <sentence id="s4042" text="Genetic discoveries have established the importance of MAPK cascade for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia muscle organ development 2 (MAPK cascade) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.">
    <entity charOffset="166-190" id="s4042.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="273-279" id="s4042.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4042.e0" e2="s4042.e1" id="s4042.p0" relation="false"/>
  </sentence>
  <sentence id="s4043" text="Genetic discoveries have established the importance of MAPK cascade for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia muscle organ development 2 (MAPK cascade) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.">
    <entity charOffset="194-206" id="s4043.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="273-279" id="s4043.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4043.e0" e2="s4043.e1" id="s4043.p0" relation="true"/>
  </sentence>
  <sentence id="s4044" text="Over the last decade, altered RNA regulation and aberrant RNA-binding protein function have emerged as a central theme in motor neuron disease pathogenesis, with evidence suggesting that sporadic signal transduction disease pathology may overlap with the molecular pathology uncovered in familial ALS.">
    <entity charOffset="187-195" id="s4044.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="196-215" id="s4044.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s4044.e0" e2="s4044.e1" id="s4044.p0" relation="false"/>
  </sentence>
  <sentence id="s4045" text="While we do not yet know which MAPK cascade activities are most critical to neurodegeneration, our evolving understanding of SETX function will undoubtedly be crucial for not only understanding the role of SETX in signal transduction and ataxia disease pathogenesis, but also for delineating the mechanistic biology of fundamentally important molecular processes in the cell">
    <entity charOffset="31-43" id="s4045.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="238-244" id="s4045.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4045.e0" e2="s4045.e1" id="s4045.p0" relation="true"/>
  </sentence>
  <sentence id="s4046" text="While we do not yet know which MAPK cascade activities are most critical to neurodegeneration, our evolving understanding of SETX function will undoubtedly be crucial for not only understanding the role of SETX in signal transduction and ataxia disease pathogenesis, but also for delineating the mechanistic biology of fundamentally important molecular processes in the cell">
    <entity charOffset="214-233" id="s4046.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="238-244" id="s4046.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4046.e0" e2="s4046.e1" id="s4046.p0" relation="false"/>
  </sentence>
  <sentence id="s4047" text="Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (negative regulation of epithelial cell proliferation 146255) under the acronym negative regulation of mammary gland epithelial cell proliferation.">
    <entity charOffset="31-49" id="s4047.e0" ontology_id="HP_0000829" text="hypoparathyroidism" type="HP"/>
    <entity charOffset="212-278" id="s4047.e1" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <pair e1="s4047.e0" e2="s4047.e1" id="s4047.p0" relation="true"/>
  </sentence>
  <sentence id="s4048" text="Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (negative regulation of epithelial cell proliferation 146255) under the acronym negative regulation of mammary gland epithelial cell proliferation.">
    <entity charOffset="51-59" id="s4048.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="133-185" id="s4048.e1" ontology_id="GO_0050680" text="negative regulation of epithelial cell proliferation" type="GO"/>
    <pair e1="s4048.e0" e2="s4048.e1" id="s4048.p0" relation="false"/>
  </sentence>
  <sentence id="s4049" text="Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (negative regulation of epithelial cell proliferation 146255) under the acronym negative regulation of mammary gland epithelial cell proliferation.">
    <entity charOffset="51-59" id="s4049.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="212-278" id="s4049.e1" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <pair e1="s4049.e0" e2="s4049.e1" id="s4049.p0" relation="true"/>
  </sentence>
  <sentence id="s4050" text="Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (negative regulation of epithelial cell proliferation 146255) under the acronym negative regulation of mammary gland epithelial cell proliferation.">
    <entity charOffset="65-80" id="s4050.e0" ontology_id="HP_0000110" text="renal dysplasia" type="HP"/>
    <entity charOffset="212-278" id="s4050.e1" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <pair e1="s4050.e0" e2="s4050.e1" id="s4050.p0" relation="true"/>
  </sentence>
  <sentence id="s4051" text="Hemizygosity of the distal region, designated negative regulation of mammary gland epithelial cell proliferation1, can cause hypoparathyroidism and in addition sensorineuronal deafness and renal dysplasia/insufficiency or a subset of this triad">
    <entity charOffset="46-112" id="s4051.e0" ontology_id="GO_0033600" text="negative regulation of mammary gland epithelial cell proliferation" type="GO"/>
    <entity charOffset="189-204" id="s4051.e1" ontology_id="HP_0000110" text="renal dysplasia" type="HP"/>
    <pair e1="s4051.e0" e2="s4051.e1" id="s4051.p0" relation="true"/>
  </sentence>
  <sentence id="s4052" text="A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of protein polyubiquitination, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="50-107" id="s4052.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="263-279" id="s4052.e1" ontology_id="HP_0002023" text="imperforate anus" type="HP"/>
    <pair e1="s4052.e0" e2="s4052.e1" id="s4052.p0" relation="true"/>
  </sentence>
  <sentence id="s4053" text="A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of protein polyubiquitination, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="50-107" id="s4053.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="345-358" id="s4053.e1" ontology_id="HP_0000598" text="ear anomalies" type="HP"/>
    <pair e1="s4053.e0" e2="s4053.e1" id="s4053.p0" relation="true"/>
  </sentence>
  <sentence id="s4054" text="A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of protein polyubiquitination, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="123-149" id="s4054.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="263-279" id="s4054.e1" ontology_id="HP_0002023" text="imperforate anus" type="HP"/>
    <pair e1="s4054.e0" e2="s4054.e1" id="s4054.p0" relation="false"/>
  </sentence>
  <sentence id="s4055" text="A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of protein polyubiquitination, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="123-149" id="s4055.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="345-358" id="s4055.e1" ontology_id="HP_0000598" text="ear anomalies" type="HP"/>
    <pair e1="s4055.e0" e2="s4055.e1" id="s4055.p0" relation="true"/>
  </sentence>
  <sentence id="s4056" text="A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of protein polyubiquitination, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="154-211" id="s4056.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="263-279" id="s4056.e1" ontology_id="HP_0002023" text="imperforate anus" type="HP"/>
    <pair e1="s4056.e0" e2="s4056.e1" id="s4056.p0" relation="true"/>
  </sentence>
  <sentence id="s4057" text="A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of protein polyubiquitination, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.">
    <entity charOffset="154-211" id="s4057.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="345-358" id="s4057.e1" ontology_id="HP_0000598" text="ear anomalies" type="HP"/>
    <pair e1="s4057.e0" e2="s4057.e1" id="s4057.p0" relation="true"/>
  </sentence>
  <sentence id="s4058" text="The negative regulation of transcription by RNA polymerase II c.1256G&amp;gt;A;p.Trp419&lt;sup&gt;*&lt;/sup&gt; variant segregated appropriately in the family consistent with an autosomal dominant mode of inheritance.">
    <entity charOffset="4-61" id="s4058.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="181-200" id="s4058.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s4058.e0" e2="s4058.e1" id="s4058.p0" relation="false"/>
  </sentence>
  <sentence id="s4059" text="negative regulation of transcription by RNA polymerase II is a member of the Wnt-signaling pathway, and epidermis development homozygous for null alleles display multiple congenital anomalies including absent anus with blind-ending colon and genitourinary malformations.">
    <entity charOffset="0-57" id="s4059.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="202-213" id="s4059.e1" ontology_id="HP_0002023" text="absent anus" type="HP"/>
    <pair e1="s4059.e0" e2="s4059.e1" id="s4059.p0" relation="true"/>
  </sentence>
  <sentence id="s4060" text="negative regulation of transcription by RNA polymerase II is a member of the Wnt-signaling pathway, and epidermis development homozygous for null alleles display multiple congenital anomalies including absent anus with blind-ending colon and genitourinary malformations.">
    <entity charOffset="104-125" id="s4060.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="202-213" id="s4060.e1" ontology_id="HP_0002023" text="absent anus" type="HP"/>
    <pair e1="s4060.e0" e2="s4060.e1" id="s4060.p0" relation="false"/>
  </sentence>
  <sentence id="s4061" text="To examine if CRC patients have altered decorin levels, expression of decorin and its target genes, endothelial cell morphogenesis and vascular endothelial growth factor A (negative regulation of transcription by RNA polymerase II), were analyzed in their tumors.">
    <entity charOffset="100-130" id="s4061.e0" ontology_id="GO_0001886" text="endothelial cell morphogenesis" type="GO"/>
    <entity charOffset="256-262" id="s4061.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4061.e0" e2="s4061.e1" id="s4061.p0" relation="true"/>
  </sentence>
  <sentence id="s4062" text="To examine if CRC patients have altered decorin levels, expression of decorin and its target genes, endothelial cell morphogenesis and vascular endothelial growth factor A (negative regulation of transcription by RNA polymerase II), were analyzed in their tumors.">
    <entity charOffset="173-230" id="s4062.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="256-262" id="s4062.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4062.e0" e2="s4062.e1" id="s4062.p0" relation="false"/>
  </sentence>
  <sentence id="s4063" text="Compared to normal tissues, decorin expression was reduced in CRC patients' tumors, while there were increased Met and negative regulation of transcription by RNA polymerase II levels.">
    <entity charOffset="76-82" id="s4063.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="119-176" id="s4063.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4063.e0" e2="s4063.e1" id="s4063.p0" relation="false"/>
  </sentence>
  <sentence id="s4064" text="Mutations in a proline-rich-repeat region (angiotensin maturation) of regulation of macroautophagy cause amyotrophic lateral sclerosis (signal transduction)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.">
    <entity charOffset="43-65" id="s4064.e0" ontology_id="GO_0002003" text="angiotensin maturation" type="GO"/>
    <entity charOffset="157-180" id="s4064.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4064.e0" e2="s4064.e1" id="s4064.p0" relation="false"/>
  </sentence>
  <sentence id="s4065" text="Mutations in a proline-rich-repeat region (angiotensin maturation) of regulation of macroautophagy cause amyotrophic lateral sclerosis (signal transduction)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.">
    <entity charOffset="70-98" id="s4065.e0" ontology_id="GO_0016241" text="regulation of macroautophagy" type="GO"/>
    <entity charOffset="157-180" id="s4065.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4065.e0" e2="s4065.e1" id="s4065.p0" relation="true"/>
  </sentence>
  <sentence id="s4066" text="Mutations in a proline-rich-repeat region (angiotensin maturation) of regulation of macroautophagy cause amyotrophic lateral sclerosis (signal transduction)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.">
    <entity charOffset="136-155" id="s4066.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="157-180" id="s4066.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4066.e0" e2="s4066.e1" id="s4066.p0" relation="false"/>
  </sentence>
  <sentence id="s4067" text="positive regulation of GTPase activity-related intellectual disability is caused by mutations in the gene encoding the p21-activated kinase (PAK) protein.">
    <entity charOffset="0-38" id="s4067.e0" ontology_id="GO_0043547" text="positive regulation of GTPase activity" type="GO"/>
    <entity charOffset="47-70" id="s4067.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4067.e0" e2="s4067.e1" id="s4067.p0" relation="false"/>
  </sentence>
  <sentence id="s4068" text="The authors report a patient with a novel positive regulation of GTPase activity mutation, who presented with intellectual disability, severe automutilation, and epilepsy.">
    <entity charOffset="42-80" id="s4068.e0" ontology_id="GO_0043547" text="positive regulation of GTPase activity" type="GO"/>
    <entity charOffset="162-170" id="s4068.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4068.e0" e2="s4068.e1" id="s4068.p0" relation="false"/>
  </sentence>
  <sentence id="s4069" text="This is the first case of positive regulation of GTPase activity-related intellectual disability presenting with severe self-injury with improvement following treatment.">
    <entity charOffset="26-64" id="s4069.e0" ontology_id="GO_0043547" text="positive regulation of GTPase activity" type="GO"/>
    <entity charOffset="73-96" id="s4069.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4069.e0" e2="s4069.e1" id="s4069.p0" relation="false"/>
  </sentence>
  <sentence id="s4070" text="Spinal muscular atrophy (spliceosomal snRNP assembly) is a lethal autosomal recessive neurological disease characterized by selective degeneration of motor neurons in the spinal cord.">
    <entity charOffset="25-52" id="s4070.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="66-85" id="s4070.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4070.e0" e2="s4070.e1" id="s4070.p0" relation="true"/>
  </sentence>
  <sentence id="s4071" text="Previous studies have shown that c-apoptotic process is overexpressed in cases of aggressive bladder cancer (intracellular signal transduction).">
    <entity charOffset="35-52" id="s4071.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="101-107" id="s4071.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4071.e0" e2="s4071.e1" id="s4071.p0" relation="false"/>
  </sentence>
  <sentence id="s4072" text="Previous studies have shown that c-apoptotic process is overexpressed in cases of aggressive bladder cancer (intracellular signal transduction).">
    <entity charOffset="101-107" id="s4072.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="109-142" id="s4072.e1" ontology_id="GO_0035556" text="intracellular signal transduction" type="GO"/>
    <pair e1="s4072.e0" e2="s4072.e1" id="s4072.p0" relation="true"/>
  </sentence>
  <sentence id="s4073" text="We also highlight Rac protein signal transduction as another compelling candidate in a large family with autosomal dominant mild intellectual disability that fully segregates with a heterozygous truncating variant.">
    <entity charOffset="18-49" id="s4073.e0" ontology_id="GO_0016601" text="Rac protein signal transduction" type="GO"/>
    <entity charOffset="129-152" id="s4073.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4073.e0" e2="s4073.e1" id="s4073.p0" relation="false"/>
  </sentence>
  <sentence id="s4074" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s4074.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="143-182" id="s4074.e1" ontology_id="GO_0006285" text="base-excision repair, AP site formation" type="GO"/>
    <pair e1="s4074.e0" e2="s4074.e1" id="s4074.p0" relation="true"/>
  </sentence>
  <sentence id="s4075" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s4075.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="184-251" id="s4075.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s4075.e0" e2="s4075.e1" id="s4075.p0" relation="false"/>
  </sentence>
  <sentence id="s4076" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s4076.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="260-300" id="s4076.e1" ontology_id="GO_0033683" text="nucleotide-excision repair, DNA incision" type="GO"/>
    <pair e1="s4076.e0" e2="s4076.e1" id="s4076.p0" relation="true"/>
  </sentence>
  <sentence id="s4077" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s4077.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="314-363" id="s4077.e1" ontology_id="GO_0008608" text="attachment of spindle microtubules to kinetochore" type="GO"/>
    <pair e1="s4077.e0" e2="s4077.e1" id="s4077.p0" relation="true"/>
  </sentence>
  <sentence id="s4078" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s4078.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="365-387" id="s4078.e1" ontology_id="GO_0014029" text="neural crest formation" type="GO"/>
    <pair e1="s4078.e0" e2="s4078.e1" id="s4078.p0" relation="false"/>
  </sentence>
  <sentence id="s4079" text="High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.">
    <entity charOffset="107-113" id="s4079.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="393-418" id="s4079.e1" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <pair e1="s4079.e0" e2="s4079.e1" id="s4079.p0" relation="false"/>
  </sentence>
  <sentence id="s4080" text="Pyridoxine-dependent epilepsy (cellular aldehyde metabolic process) is a rare disease characterized by mutations in the lysine degradation gene &lt;i&gt;ALDH7A1&lt;/i&gt; leading to recurrent neonatal seizures, which are uniquely alleviated by high doses of pyridoxine or pyridoxal 5'-phosphate (vitamin B6 vitamers).">
    <entity charOffset="21-29" id="s4080.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="31-66" id="s4080.e1" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <pair e1="s4080.e0" e2="s4080.e1" id="s4080.p0" relation="true"/>
  </sentence>
  <sentence id="s4081" text="Pyridoxine-dependent epilepsy (cellular aldehyde metabolic process) is a rare disease characterized by mutations in the lysine degradation gene &lt;i&gt;ALDH7A1&lt;/i&gt; leading to recurrent neonatal seizures, which are uniquely alleviated by high doses of pyridoxine or pyridoxal 5'-phosphate (vitamin B6 vitamers).">
    <entity charOffset="31-66" id="s4081.e0" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <entity charOffset="189-197" id="s4081.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s4081.e0" e2="s4081.e1" id="s4081.p0" relation="true"/>
  </sentence>
  <sentence id="s4082" text="Remarkably, as is the case in human cellular aldehyde metabolic process, the seizures show an almost immediate sensitivity to pyridoxine and pyridoxal 5'-phosphate, with a resulting extension of the life span.">
    <entity charOffset="36-71" id="s4082.e0" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <entity charOffset="77-85" id="s4082.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s4082.e0" e2="s4082.e1" id="s4082.p0" relation="true"/>
  </sentence>
  <sentence id="s4083" text="Impaired lysine degradation with accumulation of cellular aldehyde metabolic process biomarkers, B6 deficiency, and low -aminobutyric acid levels were observed in the &lt;i&gt;cellular aldehyde metabolic process&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; larvae, which may play a significant role in the seizure phenotype and PDE pathogenesis.">
    <entity charOffset="49-84" id="s4083.e0" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <entity charOffset="274-281" id="s4083.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4083.e0" e2="s4083.e1" id="s4083.p0" relation="true"/>
  </sentence>
  <sentence id="s4084" text="Impaired lysine degradation with accumulation of cellular aldehyde metabolic process biomarkers, B6 deficiency, and low -aminobutyric acid levels were observed in the &lt;i&gt;cellular aldehyde metabolic process&lt;/i&gt;&lt;sup&gt;-/-&lt;/sup&gt; larvae, which may play a significant role in the seizure phenotype and PDE pathogenesis.">
    <entity charOffset="171-206" id="s4084.e0" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <entity charOffset="274-281" id="s4084.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4084.e0" e2="s4084.e1" id="s4084.p0" relation="true"/>
  </sentence>
  <sentence id="s4085" text="cellular calcium ion homeostasis mutations are rare cause of autosomal recessive juvenile-onset Parkinson disease.">
    <entity charOffset="0-32" id="s4085.e0" ontology_id="GO_0006874" text="cellular calcium ion homeostasis" type="GO"/>
    <entity charOffset="61-80" id="s4085.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4085.e0" e2="s4085.e1" id="s4085.p0" relation="true"/>
  </sentence>
  <sentence id="s4086" text="The postsynaptic density (PSD) contains a complex negative regulation of transcription, DNA-templated of proteins of known relevance to neuropsychiatric disorders, and schizophrenia specifically.">
    <entity charOffset="50-101" id="s4086.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="168-181" id="s4086.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4086.e0" e2="s4086.e1" id="s4086.p0" relation="false"/>
  </sentence>
  <sentence id="s4087" text="Both single-gene and gene-negative regulation of transcription, DNA-templated enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of negative regulation of transcription by RNA polymerase II and MAPK3, and enrichment of our PSD proteome.">
    <entity charOffset="26-77" id="s4087.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="147-160" id="s4087.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4087.e0" e2="s4087.e1" id="s4087.p0" relation="false"/>
  </sentence>
  <sentence id="s4088" text="Both single-gene and gene-negative regulation of transcription, DNA-templated enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of negative regulation of transcription by RNA polymerase II and MAPK3, and enrichment of our PSD proteome.">
    <entity charOffset="147-160" id="s4088.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="244-301" id="s4088.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4088.e0" e2="s4088.e1" id="s4088.p0" relation="false"/>
  </sentence>
  <sentence id="s4089" text="GRACILE Syndrome, is an autosomal recessive disease presenting with growth retardation, severe lactic acidosis, Fanconi muscle organ development tubulopathy, cholestasis, iron overload and early death without any dysmorphological or neurological features.">
    <entity charOffset="95-110" id="s4089.e0" ontology_id="HP_0003128" text="lactic acidosis" type="HP"/>
    <entity charOffset="120-144" id="s4089.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4089.e0" e2="s4089.e1" id="s4089.p0" relation="false"/>
  </sentence>
  <sentence id="s4090" text="The importance of positive regulation of protein phosphorylation coenzyme A biosynthetic processions in human physiology is strengthened by the rarity of modifying mutations in their genes and by the devastating impact caused by these mutations on growth and development and in disorders such as cancer.">
    <entity charOffset="18-64" id="s4090.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="296-302" id="s4090.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4090.e0" e2="s4090.e1" id="s4090.p0" relation="true"/>
  </sentence>
  <sentence id="s4091" text="The importance of positive regulation of protein phosphorylation coenzyme A biosynthetic processions in human physiology is strengthened by the rarity of modifying mutations in their genes and by the devastating impact caused by these mutations on growth and development and in disorders such as cancer.">
    <entity charOffset="65-96" id="s4091.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="296-302" id="s4091.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4091.e0" e2="s4091.e1" id="s4091.p0" relation="false"/>
  </sentence>
  <sentence id="s4092" text="By negative regulation of fat cell differentiation exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.">
    <entity charOffset="3-50" id="s4092.e0" ontology_id="GO_0045599" text="negative regulation of fat cell differentiation" type="GO"/>
    <entity charOffset="219-231" id="s4092.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4092.e0" e2="s4092.e1" id="s4092.p0" relation="false"/>
  </sentence>
  <sentence id="s4093" text="By negative regulation of fat cell differentiation exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.">
    <entity charOffset="3-50" id="s4093.e0" ontology_id="GO_0045599" text="negative regulation of fat cell differentiation" type="GO"/>
    <entity charOffset="262-271" id="s4093.e1" ontology_id="HP_0410030" text="cleft lip" type="HP"/>
    <pair e1="s4093.e0" e2="s4093.e1" id="s4093.p0" relation="false"/>
  </sentence>
  <sentence id="s4094" text="By negative regulation of fat cell differentiation exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.">
    <entity charOffset="3-50" id="s4094.e0" ontology_id="GO_0045599" text="negative regulation of fat cell differentiation" type="GO"/>
    <entity charOffset="320-333" id="s4094.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s4094.e0" e2="s4094.e1" id="s4094.p0" relation="false"/>
  </sentence>
  <sentence id="s4095" text="In Japan, 26 mutations in the endoplasmic reticulum calcium ion homeostasis gene in 7 pedigrees and 19 sporadic cases with DD have been reported, among which one pedigree and one sporadic case were accompanied by neuropsychiatric symptoms.">
    <entity charOffset="30-75" id="s4095.e0" ontology_id="GO_0032469" text="endoplasmic reticulum calcium ion homeostasis" type="GO"/>
    <entity charOffset="103-111" id="s4095.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4095.e0" e2="s4095.e1" id="s4095.p0" relation="false"/>
  </sentence>
  <sentence id="s4096" text="Zinc finger protein 687 (regulation of transcription by RNA polymerase II), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell tumor of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in cancer.">
    <entity charOffset="25-73" id="s4096.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="177-182" id="s4096.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4096.e0" e2="s4096.e1" id="s4096.p0" relation="false"/>
  </sentence>
  <sentence id="s4097" text="Herein, we report that regulation of transcription by RNA polymerase II was markedly upregulated in hepatocellular carcinoma (HCC) cell lines and HCC tissues, and was significantly correlated with relapse-free survival in HCC.">
    <entity charOffset="23-71" id="s4097.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="100-124" id="s4097.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s4097.e0" e2="s4097.e1" id="s4097.p0" relation="false"/>
  </sentence>
  <sentence id="s4098" text="regulation of transcription by RNA polymerase II overexpression greatly enhanced phosphatidylinositol phosphorylation cell capability for tumorsphere formation, invasion and chemoresistance in vitro, whereas inhibiting ZNF687 reduced these capabilities and inhibited HCC cell tumorigenic capability in vivo.">
    <entity charOffset="0-48" id="s4098.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="138-143" id="s4098.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4098.e0" e2="s4098.e1" id="s4098.p0" relation="false"/>
  </sentence>
  <sentence id="s4099" text="regulation of transcription by RNA polymerase II overexpression greatly enhanced phosphatidylinositol phosphorylation cell capability for tumorsphere formation, invasion and chemoresistance in vitro, whereas inhibiting ZNF687 reduced these capabilities and inhibited HCC cell tumorigenic capability in vivo.">
    <entity charOffset="81-117" id="s4099.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="138-143" id="s4099.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4099.e0" e2="s4099.e1" id="s4099.p0" relation="false"/>
  </sentence>
  <sentence id="s4100" text="Importantly, extreme limiting dilution analysis revealed that even 1  10&lt;sup&gt;2&lt;/sup&gt; regulation of transcription by RNA polymerase II-transduced cells could form tumors in vivo, indicating that ZNF687 contributes to phosphatidylinositol phosphorylation recurrence.">
    <entity charOffset="86-134" id="s4100.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="163-168" id="s4100.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4100.e0" e2="s4100.e1" id="s4100.p0" relation="false"/>
  </sentence>
  <sentence id="s4101" text="Importantly, extreme limiting dilution analysis revealed that even 1  10&lt;sup&gt;2&lt;/sup&gt; regulation of transcription by RNA polymerase II-transduced cells could form tumors in vivo, indicating that ZNF687 contributes to phosphatidylinositol phosphorylation recurrence.">
    <entity charOffset="163-168" id="s4101.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="217-253" id="s4101.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4101.e0" e2="s4101.e1" id="s4101.p0" relation="false"/>
  </sentence>
  <sentence id="s4102" text="Further in vitro and in vivo results demonstrated that regulation of cell shape was associated with proliferation and metastasis of pancreatic cancer cells.">
    <entity charOffset="55-79" id="s4102.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="143-149" id="s4102.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4102.e0" e2="s4102.e1" id="s4102.p0" relation="false"/>
  </sentence>
  <sentence id="s4103" text="Mechanistically, the role of regulation of cell shape in pancreatic cancer might attribute to its regulation of c-Myc, HIF1 and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.">
    <entity charOffset="29-53" id="s4103.e0" ontology_id="GO_0008360" text="regulation of cell shape" type="GO"/>
    <entity charOffset="68-74" id="s4103.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4103.e0" e2="s4103.e1" id="s4103.p0" relation="false"/>
  </sentence>
  <sentence id="s4104" text="Here, we report that hypoxia-inducible factor (HIF-1) and cancer-associated fibroblasts (CAFs)-secreted TGF-2 converge to activate the expression of hedgehog transcription factor smoothened signaling pathway in CSCs, resulting in increased stemness/dedifferentiation and intrinsic resistance to chemotherapy.">
    <entity charOffset="59-65" id="s4104.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="181-209" id="s4104.e1" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <pair e1="s4104.e0" e2="s4104.e1" id="s4104.p0" relation="true"/>
  </sentence>
  <sentence id="s4105" text="Importantly, high expression levels of HIF-1/TGF-2/smoothened signaling pathway correlated robustly with the patient relapse following chemotherapy, highlighting a potential biomarker and therapeutic target for chemoresistance in colorectal cancer.">
    <entity charOffset="53-81" id="s4105.e0" ontology_id="GO_0007224" text="smoothened signaling pathway" type="GO"/>
    <entity charOffset="243-249" id="s4105.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4105.e0" e2="s4105.e1" id="s4105.p0" relation="true"/>
  </sentence>
  <sentence id="s4106" text="The aim of this study was to investigate the expression of the long intergenic non-protein coding RNA 665 (LINC00665) gene and the cell cycle in hepatocellular carcinoma (phosphatidylinositol phosphorylation) using database analysis including The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and quantitative real-time polymerase chain reaction (qPCR).">
    <entity charOffset="145-169" id="s4106.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="171-207" id="s4106.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4106.e0" e2="s4106.e1" id="s4106.p0" relation="false"/>
  </sentence>
  <sentence id="s4107" text="RESULTS Overexpression of LINC00665 in patients with phosphatidylinositol phosphorylation was significantly associated with gender, tumor grade, stage, and tumor cell type.">
    <entity charOffset="53-89" id="s4107.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="132-137" id="s4107.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4107.e0" e2="s4107.e1" id="s4107.p0" relation="false"/>
  </sentence>
  <sentence id="s4108" text="However, the ectopic expression of G protein-coupled receptor signaling pathway was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).">
    <entity charOffset="35-79" id="s4108.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="232-239" id="s4108.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s4108.e0" e2="s4108.e1" id="s4108.p0" relation="false"/>
  </sentence>
  <sentence id="s4109" text="However, the ectopic expression of G protein-coupled receptor signaling pathway was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).">
    <entity charOffset="35-79" id="s4109.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="113-118" id="s4109.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4109.e0" e2="s4109.e1" id="s4109.p0" relation="false"/>
  </sentence>
  <sentence id="s4110" text="The possible involvement of G protein-coupled receptor signaling pathway in tumor progression and the use of FSHR examination for diagnostic purposes is also reviewed.">
    <entity charOffset="28-72" id="s4110.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="76-81" id="s4110.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4110.e0" e2="s4110.e1" id="s4110.p0" relation="false"/>
  </sentence>
  <sentence id="s4111" text="All three and two patients with negative regulation of transcription by RNA polymerase II variants had hypothyroidism and developmental delay, respectively.">
    <entity charOffset="32-89" id="s4111.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="103-117" id="s4111.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s4111.e0" e2="s4111.e1" id="s4111.p0" relation="true"/>
  </sentence>
  <sentence id="s4112" text="All three and two patients with negative regulation of transcription by RNA polymerase II variants had hypothyroidism and developmental delay, respectively.">
    <entity charOffset="32-89" id="s4112.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="122-141" id="s4112.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4112.e0" e2="s4112.e1" id="s4112.p0" relation="true"/>
  </sentence>
  <sentence id="s4113" text="Similarly, SEPT4 has lymphoid and non-lymphoid forms; mitotic cytokinesis has lymphoid and central nervous system (CNS) forms; and mitotic cytokinesis and protein heterooligomerization are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.">
    <entity charOffset="54-73" id="s4113.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="91-98" id="s4113.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s4113.e0" e2="s4113.e1" id="s4113.p0" relation="false"/>
  </sentence>
  <sentence id="s4114" text="Similarly, SEPT4 has lymphoid and non-lymphoid forms; mitotic cytokinesis has lymphoid and central nervous system (CNS) forms; and mitotic cytokinesis and protein heterooligomerization are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.">
    <entity charOffset="91-98" id="s4114.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="131-150" id="s4114.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s4114.e0" e2="s4114.e1" id="s4114.p0" relation="false"/>
  </sentence>
  <sentence id="s4115" text="Similarly, SEPT4 has lymphoid and non-lymphoid forms; mitotic cytokinesis has lymphoid and central nervous system (CNS) forms; and mitotic cytokinesis and protein heterooligomerization are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.">
    <entity charOffset="91-98" id="s4115.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="155-184" id="s4115.e1" ontology_id="GO_0051291" text="protein heterooligomerization" type="GO"/>
    <pair e1="s4115.e0" e2="s4115.e1" id="s4115.p0" relation="false"/>
  </sentence>
  <sentence id="s4116" text="Overexpression of negative regulation of transcription by RNA polymerase II and SERPINH1 was observed in clinical specimens of lung cancer and fibrotic lesions.">
    <entity charOffset="18-75" id="s4116.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="132-138" id="s4116.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4116.e0" e2="s4116.e1" id="s4116.p0" relation="false"/>
  </sentence>
  <sentence id="s4117" text="Downregulation of miR-29a caused overexpression of negative regulation of transcription by RNA polymerase II and SERPINH1 in lung cancer and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases">
    <entity charOffset="51-108" id="s4117.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="130-136" id="s4117.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4117.e0" e2="s4117.e1" id="s4117.p0" relation="false"/>
  </sentence>
  <sentence id="s4118" text="The reported enamel abnormality in negative regulation of cold-induced thermogenesis mutation carriers could be attributed to a half dose effect of the laminin 3 chain (haploinsufficiency)">
    <entity charOffset="13-31" id="s4118.e0" ontology_id="HP_0000682" text="enamel abnormality" type="HP"/>
    <entity charOffset="35-84" id="s4118.e1" ontology_id="GO_0120163" text="negative regulation of cold-induced thermogenesis" type="GO"/>
    <pair e1="s4118.e0" e2="s4118.e1" id="s4118.p0" relation="false"/>
  </sentence>
  <sentence id="s4119" text="Low-density lipoprotein receptor-related protein 4 (kidney development) is a multi-functional protein implicated in bone, kidney and neurological diseases including Cenani-Lenz syndactyly (CLS), sclerosteosis, osteoporosis, congenital myasthenic syndrome and myasthenia gravis.">
    <entity charOffset="52-70" id="s4119.e0" ontology_id="GO_0001822" text="kidney development" type="GO"/>
    <entity charOffset="177-187" id="s4119.e1" ontology_id="HP_0001159" text="syndactyly" type="HP"/>
    <pair e1="s4119.e0" e2="s4119.e1" id="s4119.p0" relation="true"/>
  </sentence>
  <sentence id="s4120" text="The clinical phenomuscle organ development of CMT1A is determined by the degree of axonal loss, and patients suffer from progressive muscle weakness and impaired sensation.">
    <entity charOffset="18-42" id="s4120.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="83-94" id="s4120.e1" ontology_id="HP_0003447" text="axonal loss" type="HP"/>
    <pair e1="s4120.e0" e2="s4120.e1" id="s4120.p0" relation="false"/>
  </sentence>
  <sentence id="s4121" text="This study supports heterogeneity for skeletal system development-like phenotypes and sorting these out will help to define the biological pathway and genetic contributors">
    <entity charOffset="20-33" id="s4121.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="38-65" id="s4121.e1" ontology_id="GO_0001501" text="skeletal system development" type="GO"/>
    <pair e1="s4121.e0" e2="s4121.e1" id="s4121.p0" relation="false"/>
  </sentence>
  <sentence id="s4122" text="BACKGROUND Previous research found that dolichol-linked oligosaccharide biosynthetic process is associated with cervical cancer, but the role of ALG3 in breast cancer was still unknown.">
    <entity charOffset="40-92" id="s4122.e0" ontology_id="GO_0006488" text="dolichol-linked oligosaccharide biosynthetic process" type="GO"/>
    <entity charOffset="121-127" id="s4122.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4122.e0" e2="s4122.e1" id="s4122.p0" relation="false"/>
  </sentence>
  <sentence id="s4123" text="MATERIAL AND METHODS The expression of dolichol-linked oligosaccharide biosynthetic process in breast carcinoma tissues was determined by immunochemistry.">
    <entity charOffset="39-91" id="s4123.e0" ontology_id="GO_0006488" text="dolichol-linked oligosaccharide biosynthetic process" type="GO"/>
    <entity charOffset="95-111" id="s4123.e1" ontology_id="HP_0003002" text="breast carcinoma" type="HP"/>
    <pair e1="s4123.e0" e2="s4123.e1" id="s4123.p0" relation="false"/>
  </sentence>
  <sentence id="s4124" text="dolichol-linked oligosaccharide biosynthetic process expression was significantly increased in cancer samples with advanced stages (stage III/IV) compared with those in the early stages of disease (stage I/II) (p&amp;lt;0.05).">
    <entity charOffset="0-52" id="s4124.e0" ontology_id="GO_0006488" text="dolichol-linked oligosaccharide biosynthetic process" type="GO"/>
    <entity charOffset="95-101" id="s4124.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4124.e0" e2="s4124.e1" id="s4124.p0" relation="false"/>
  </sentence>
  <sentence id="s4125" text="The staining intensity of dolichol-linked oligosaccharide biosynthetic process was significantly correlated to the tumor grade (grades 2-3 versus 1, p&amp;lt;0.05).">
    <entity charOffset="26-78" id="s4125.e0" ontology_id="GO_0006488" text="dolichol-linked oligosaccharide biosynthetic process" type="GO"/>
    <entity charOffset="115-120" id="s4125.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4125.e0" e2="s4125.e1" id="s4125.p0" relation="false"/>
  </sentence>
  <sentence id="s4126" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="30-73" id="s4126.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="676-690" id="s4126.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s4126.e0" e2="s4126.e1" id="s4126.p0" relation="false"/>
  </sentence>
  <sentence id="s4127" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="30-73" id="s4127.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="692-700" id="s4127.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4127.e0" e2="s4127.e1" id="s4127.p0" relation="false"/>
  </sentence>
  <sentence id="s4128" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="30-73" id="s4128.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="706-718" id="s4128.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4128.e0" e2="s4128.e1" id="s4128.p0" relation="false"/>
  </sentence>
  <sentence id="s4129" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="123-166" id="s4129.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="692-700" id="s4129.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4129.e0" e2="s4129.e1" id="s4129.p0" relation="false"/>
  </sentence>
  <sentence id="s4130" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="123-166" id="s4130.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="706-718" id="s4130.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4130.e0" e2="s4130.e1" id="s4130.p0" relation="false"/>
  </sentence>
  <sentence id="s4131" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="204-258" id="s4131.e0" ontology_id="GO_0033539" text="fatty acid beta-oxidation using acyl-CoA dehydrogenase" type="GO"/>
    <entity charOffset="692-700" id="s4131.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4131.e0" e2="s4131.e1" id="s4131.p0" relation="true"/>
  </sentence>
  <sentence id="s4132" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="204-258" id="s4132.e0" ontology_id="GO_0033539" text="fatty acid beta-oxidation using acyl-CoA dehydrogenase" type="GO"/>
    <entity charOffset="706-718" id="s4132.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4132.e0" e2="s4132.e1" id="s4132.p0" relation="false"/>
  </sentence>
  <sentence id="s4133" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="273-316" id="s4133.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="676-690" id="s4133.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s4133.e0" e2="s4133.e1" id="s4133.p0" relation="false"/>
  </sentence>
  <sentence id="s4134" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="273-316" id="s4134.e0" ontology_id="GO_0009083" text="branched-chain amino acid catabolic process" type="GO"/>
    <entity charOffset="706-718" id="s4134.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4134.e0" e2="s4134.e1" id="s4134.p0" relation="false"/>
  </sentence>
  <sentence id="s4135" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="357-389" id="s4135.e0" ontology_id="GO_0006695" text="cholesterol biosynthetic process" type="GO"/>
    <entity charOffset="676-690" id="s4135.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s4135.e0" e2="s4135.e1" id="s4135.p0" relation="false"/>
  </sentence>
  <sentence id="s4136" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="357-389" id="s4136.e0" ontology_id="GO_0006695" text="cholesterol biosynthetic process" type="GO"/>
    <entity charOffset="692-700" id="s4136.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4136.e0" e2="s4136.e1" id="s4136.p0" relation="false"/>
  </sentence>
  <sentence id="s4137" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="357-389" id="s4137.e0" ontology_id="GO_0006695" text="cholesterol biosynthetic process" type="GO"/>
    <entity charOffset="706-718" id="s4137.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4137.e0" e2="s4137.e1" id="s4137.p0" relation="true"/>
  </sentence>
  <sentence id="s4138" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="420-457" id="s4138.e0" ontology_id="GO_0019216" text="regulation of lipid metabolic process" type="GO"/>
    <entity charOffset="692-700" id="s4138.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4138.e0" e2="s4138.e1" id="s4138.p0" relation="false"/>
  </sentence>
  <sentence id="s4139" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="420-457" id="s4139.e0" ontology_id="GO_0019216" text="regulation of lipid metabolic process" type="GO"/>
    <entity charOffset="706-718" id="s4139.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4139.e0" e2="s4139.e1" id="s4139.p0" relation="false"/>
  </sentence>
  <sentence id="s4140" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="514-541" id="s4140.e0" ontology_id="GO_0051289" text="protein homotetramerization" type="GO"/>
    <entity charOffset="676-690" id="s4140.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s4140.e0" e2="s4140.e1" id="s4140.p0" relation="false"/>
  </sentence>
  <sentence id="s4141" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="595-634" id="s4141.e0" ontology_id="GO_0036498" text="IRE1-mediated unfolded protein response" type="GO"/>
    <entity charOffset="676-690" id="s4141.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s4141.e0" e2="s4141.e1" id="s4141.p0" relation="true"/>
  </sentence>
  <sentence id="s4142" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="595-634" id="s4142.e0" ontology_id="GO_0036498" text="IRE1-mediated unfolded protein response" type="GO"/>
    <entity charOffset="692-700" id="s4142.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4142.e0" e2="s4142.e1" id="s4142.p0" relation="true"/>
  </sentence>
  <sentence id="s4143" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="595-634" id="s4143.e0" ontology_id="GO_0036498" text="IRE1-mediated unfolded protein response" type="GO"/>
    <entity charOffset="706-718" id="s4143.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4143.e0" e2="s4143.e1" id="s4143.p0" relation="true"/>
  </sentence>
  <sentence id="s4144" text="The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschtter-Tnz syndrome).">
    <entity charOffset="692-700" id="s4144.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="732-749" id="s4144.e1" ontology_id="GO_0007420" text="brain development" type="GO"/>
    <pair e1="s4144.e0" e2="s4144.e1" id="s4144.p0" relation="false"/>
  </sentence>
  <sentence id="s4145" text="Homozygous null mutation of tumor suppressor &lt;i&gt;WWOX/negative regulation of Wnt signaling pathway&lt;/i&gt; gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, epidermis development and rats.">
    <entity charOffset="28-33" id="s4145.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="53-97" id="s4145.e1" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <pair e1="s4145.e0" e2="s4145.e1" id="s4145.p0" relation="true"/>
  </sentence>
  <sentence id="s4146" text="Homozygous null mutation of tumor suppressor &lt;i&gt;WWOX/negative regulation of Wnt signaling pathway&lt;/i&gt; gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, epidermis development and rats.">
    <entity charOffset="28-33" id="s4146.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="203-224" id="s4146.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4146.e0" e2="s4146.e1" id="s4146.p0" relation="false"/>
  </sentence>
  <sentence id="s4147" text="&lt;i&gt;In vitro&lt;/i&gt; analysis revealed that knockdown of negative regulation of Wnt signaling pathway protein in neuroblastoma cells results in aggregation of TRAPPC6A, I-kappaB kinase/NF-kappaB signaling, amyloid , and microtubule cytoskeleton organization in a sequential manner.">
    <entity charOffset="52-96" id="s4147.e0" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="108-121" id="s4147.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s4147.e0" e2="s4147.e1" id="s4147.p0" relation="false"/>
  </sentence>
  <sentence id="s4148" text="&lt;i&gt;In vitro&lt;/i&gt; analysis revealed that knockdown of negative regulation of Wnt signaling pathway protein in neuroblastoma cells results in aggregation of TRAPPC6A, I-kappaB kinase/NF-kappaB signaling, amyloid , and microtubule cytoskeleton organization in a sequential manner.">
    <entity charOffset="108-121" id="s4148.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="165-200" id="s4148.e1" ontology_id="GO_0007249" text="I-kappaB kinase/NF-kappaB signaling" type="GO"/>
    <pair e1="s4148.e0" e2="s4148.e1" id="s4148.p0" relation="false"/>
  </sentence>
  <sentence id="s4149" text="&lt;i&gt;In vitro&lt;/i&gt; analysis revealed that knockdown of negative regulation of Wnt signaling pathway protein in neuroblastoma cells results in aggregation of TRAPPC6A, I-kappaB kinase/NF-kappaB signaling, amyloid , and microtubule cytoskeleton organization in a sequential manner.">
    <entity charOffset="108-121" id="s4149.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="217-254" id="s4149.e1" ontology_id="GO_0000226" text="microtubule cytoskeleton organization" type="GO"/>
    <pair e1="s4149.e0" e2="s4149.e1" id="s4149.p0" relation="false"/>
  </sentence>
  <sentence id="s4150" text="Down-regulation of negative regulation of transcription by RNA polymerase II has been found in various tumor cell lines.">
    <entity charOffset="19-76" id="s4150.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="103-108" id="s4150.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4150.e0" e2="s4150.e1" id="s4150.p0" relation="false"/>
  </sentence>
  <sentence id="s4151" text="There has been virtually no tissue study on the expression of PLZF in prostate cancer (mitochondrial transport).">
    <entity charOffset="79-85" id="s4151.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="87-110" id="s4151.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s4151.e0" e2="s4151.e1" id="s4151.p0" relation="false"/>
  </sentence>
  <sentence id="s4152" text="mitochondrial transport is a heterogeneous disease, most of which are indolent and non-lethal.">
    <entity charOffset="0-23" id="s4152.e0" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <entity charOffset="29-42" id="s4152.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4152.e0" e2="s4152.e1" id="s4152.p0" relation="false"/>
  </sentence>
  <sentence id="s4153" text="This study aimed to investigate the expression of negative regulation of transcription by RNA polymerase II by immunohistochemistry in different grade as well as metastatic PCa and to correlate the alteration of PLZF expression with PCa aggressiveness.">
    <entity charOffset="50-107" id="s4153.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="237-251" id="s4153.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s4153.e0" e2="s4153.e1" id="s4153.p0" relation="false"/>
  </sentence>
  <sentence id="s4154" text="These data demonstrated that down-regulation of negative regulation of transcription by RNA polymerase II is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for mitochondrial transport aggressiveness and metastasis in the personalized care of PCa.">
    <entity charOffset="48-105" id="s4154.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="144-149" id="s4154.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4154.e0" e2="s4154.e1" id="s4154.p0" relation="false"/>
  </sentence>
  <sentence id="s4155" text="These data demonstrated that down-regulation of negative regulation of transcription by RNA polymerase II is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for mitochondrial transport aggressiveness and metastasis in the personalized care of PCa.">
    <entity charOffset="48-105" id="s4155.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="297-311" id="s4155.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s4155.e0" e2="s4155.e1" id="s4155.p0" relation="false"/>
  </sentence>
  <sentence id="s4156" text="These data demonstrated that down-regulation of negative regulation of transcription by RNA polymerase II is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for mitochondrial transport aggressiveness and metastasis in the personalized care of PCa.">
    <entity charOffset="144-149" id="s4156.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="273-296" id="s4156.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s4156.e0" e2="s4156.e1" id="s4156.p0" relation="false"/>
  </sentence>
  <sentence id="s4157" text="These data demonstrated that down-regulation of negative regulation of transcription by RNA polymerase II is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for mitochondrial transport aggressiveness and metastasis in the personalized care of PCa.">
    <entity charOffset="273-296" id="s4157.e0" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <entity charOffset="297-311" id="s4157.e1" ontology_id="HP_0000718" text="aggressiveness" type="HP"/>
    <pair e1="s4157.e0" e2="s4157.e1" id="s4157.p0" relation="false"/>
  </sentence>
  <sentence id="s4158" text="Abnormalities in nucleic acid processing are associated with the development of amyotrophic lateral sclerosis (signal transduction) and frontotemporal dementia (FTD).">
    <entity charOffset="111-130" id="s4158.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="136-159" id="s4158.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4158.e0" e2="s4158.e1" id="s4158.p0" relation="false"/>
  </sentence>
  <sentence id="s4159" text="Mutations in &lt;i&gt;Matrin 3&lt;/i&gt; (&lt;i&gt;activation of innate immune response&lt;/i&gt;), a poorly understood DNA- and RNA-binding protein, cause familial signal transduction/FTD, and MATR3 pathology is a feature of sporadic disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis.">
    <entity charOffset="33-69" id="s4159.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="202-210" id="s4159.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4159.e0" e2="s4159.e1" id="s4159.p0" relation="false"/>
  </sentence>
  <sentence id="s4160" text="Mutations in &lt;i&gt;Matrin 3&lt;/i&gt; (&lt;i&gt;activation of innate immune response&lt;/i&gt;), a poorly understood DNA- and RNA-binding protein, cause familial signal transduction/FTD, and MATR3 pathology is a feature of sporadic disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis.">
    <entity charOffset="141-160" id="s4160.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="202-210" id="s4160.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4160.e0" e2="s4160.e1" id="s4160.p0" relation="false"/>
  </sentence>
  <sentence id="s4161" text="Peroxisome biogenesis disorders (PBD) are a heterogeneous group of disorders due to proteolysis genes mutations, with a broad clinical spectrum comprising severe neonatal disease to mild presentation.">
    <entity charOffset="44-57" id="s4161.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="84-95" id="s4161.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s4161.e0" e2="s4161.e1" id="s4161.p0" relation="false"/>
  </sentence>
  <sentence id="s4162" text="MicroRNA-200a (protein polyubiquitination-200a) is frequently downregulated in most cancer types and plays an important role in carcinogenesis and cancer progression.">
    <entity charOffset="15-41" id="s4162.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="84-90" id="s4162.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4162.e0" e2="s4162.e1" id="s4162.p0" relation="false"/>
  </sentence>
  <sentence id="s4163" text="In this study, we determined that protein polyubiquitination-200a was downregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) tissues and cell lines, consistent with the results of our previous study.">
    <entity charOffset="34-60" id="s4163.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="87-111" id="s4163.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s4163.e0" e2="s4163.e1" id="s4163.p0" relation="false"/>
  </sentence>
  <sentence id="s4164" text="In this study, we determined that protein polyubiquitination-200a was downregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) tissues and cell lines, consistent with the results of our previous study.">
    <entity charOffset="87-111" id="s4164.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="113-149" id="s4164.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4164.e0" e2="s4164.e1" id="s4164.p0" relation="false"/>
  </sentence>
  <sentence id="s4165" text="Taken together, these data provide novel information for comprehending the tumor-suppressive role of protein polyubiquitination-200a in phosphatidylinositol phosphorylation pathogenesis through inhibition of GAB1 translation">
    <entity charOffset="75-80" id="s4165.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="101-127" id="s4165.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s4165.e0" e2="s4165.e1" id="s4165.p0" relation="false"/>
  </sentence>
  <sentence id="s4166" text="Taken together, these data provide novel information for comprehending the tumor-suppressive role of protein polyubiquitination-200a in phosphatidylinositol phosphorylation pathogenesis through inhibition of GAB1 translation">
    <entity charOffset="75-80" id="s4166.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="136-172" id="s4166.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4166.e0" e2="s4166.e1" id="s4166.p0" relation="false"/>
  </sentence>
  <sentence id="s4167" text="Moreover, myostatin inhibitors are known to promote muscle regeneration and ameliorate fibrosis in animal models of Duchenne muscular dystrophy (peptide biosynthetic process), a human disease characterized by chronic muscle degeneration.">
    <entity charOffset="125-143" id="s4167.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="145-173" id="s4167.e1" ontology_id="GO_0043043" text="peptide biosynthetic process" type="GO"/>
    <pair e1="s4167.e0" e2="s4167.e1" id="s4167.p0" relation="true"/>
  </sentence>
  <sentence id="s4168" text="The ability of positive regulation of B cell proliferation to promote proliferation and differentiation of activated T cells fueled present attempts to modulate this immune checkpoint to reinforce antitumor immunity.">
    <entity charOffset="15-58" id="s4168.e0" ontology_id="GO_0030890" text="positive regulation of B cell proliferation" type="GO"/>
    <entity charOffset="201-206" id="s4168.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4168.e0" e2="s4168.e1" id="s4168.p0" relation="true"/>
  </sentence>
  <sentence id="s4169" text="The data presented thus not only identify the yet unknown involvement of positive regulation of B cell proliferation/OX40L in ALL pathophysiology and NK cell immunosurveillance but also point to the necessity to thoroughly consider the consequences of modulating the OX40/OX40L molecule system beyond its effects on T cells when developing OX40-targeting approaches for cancer immunotherapy">
    <entity charOffset="73-116" id="s4169.e0" ontology_id="GO_0030890" text="positive regulation of B cell proliferation" type="GO"/>
    <entity charOffset="370-376" id="s4169.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4169.e0" e2="s4169.e1" id="s4169.p0" relation="true"/>
  </sentence>
  <sentence id="s4170" text="Mutations in positive regulation of protein phosphorylation, a mitochondrially targeted serine/threonine kinase, cause autosomal recessive Parkinson's disease (PD).">
    <entity charOffset="13-59" id="s4170.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="119-138" id="s4170.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4170.e0" e2="s4170.e1" id="s4170.p0" relation="true"/>
  </sentence>
  <sentence id="s4171" text="We show that signaling through herpes virus entry mediator (T cell costimulation), a member of the tumor necrosis factor (negative regulation of transcription by RNA polymerase II) receptor superfamily, in ILC3 is important for host defense against oral infection with the bacterial pathogen Yersinia enterocolitica.">
    <entity charOffset="60-80" id="s4171.e0" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <entity charOffset="99-104" id="s4171.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4171.e0" e2="s4171.e1" id="s4171.p0" relation="false"/>
  </sentence>
  <sentence id="s4172" text="We show that signaling through herpes virus entry mediator (T cell costimulation), a member of the tumor necrosis factor (negative regulation of transcription by RNA polymerase II) receptor superfamily, in ILC3 is important for host defense against oral infection with the bacterial pathogen Yersinia enterocolitica.">
    <entity charOffset="99-104" id="s4172.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="122-179" id="s4172.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4172.e0" e2="s4172.e1" id="s4172.p0" relation="false"/>
  </sentence>
  <sentence id="s4173" text="Introduction Despite some new treatment possibilities, the improvement in survival rate for hepatocellular carcinoma (phosphatidylinositol phosphorylation) patients is still poor due to late diagnosis.">
    <entity charOffset="92-116" id="s4173.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="118-154" id="s4173.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4173.e0" e2="s4173.e1" id="s4173.p0" relation="false"/>
  </sentence>
  <sentence id="s4174" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="152-198" id="s4174.e0" ontology_id="GO_0030200" text="heparan sulfate proteoglycan catabolic process" type="GO"/>
    <entity charOffset="264-287" id="s4174.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s4174.e0" e2="s4174.e1" id="s4174.p0" relation="false"/>
  </sentence>
  <sentence id="s4175" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="220-261" id="s4175.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="264-287" id="s4175.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s4175.e0" e2="s4175.e1" id="s4175.p0" relation="false"/>
  </sentence>
  <sentence id="s4176" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="264-287" id="s4176.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="434-470" id="s4176.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4176.e0" e2="s4176.e1" id="s4176.p0" relation="false"/>
  </sentence>
  <sentence id="s4177" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="264-287" id="s4177.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="299-340" id="s4177.e1" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <pair e1="s4177.e0" e2="s4177.e1" id="s4177.p0" relation="false"/>
  </sentence>
  <sentence id="s4178" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="264-287" id="s4178.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="372-400" id="s4178.e1" ontology_id="GO_0001781" text="neutrophil apoptotic process" type="GO"/>
    <pair e1="s4178.e0" e2="s4178.e1" id="s4178.p0" relation="false"/>
  </sentence>
  <sentence id="s4179" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="299-340" id="s4179.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="415-421" id="s4179.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4179.e0" e2="s4179.e1" id="s4179.p0" relation="false"/>
  </sentence>
  <sentence id="s4180" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="372-400" id="s4180.e0" ontology_id="GO_0001781" text="neutrophil apoptotic process" type="GO"/>
    <entity charOffset="415-421" id="s4180.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4180.e0" e2="s4180.e1" id="s4180.p0" relation="false"/>
  </sentence>
  <sentence id="s4181" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="415-421" id="s4181.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="434-470" id="s4181.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4181.e0" e2="s4181.e1" id="s4181.p0" relation="false"/>
  </sentence>
  <sentence id="s4182" text="The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.">
    <entity charOffset="415-421" id="s4182.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="515-533" id="s4182.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4182.e0" e2="s4182.e1" id="s4182.p0" relation="false"/>
  </sentence>
  <sentence id="s4183" text="The 'chloride transport' combination of tumour markers in our study includes all tested markers with AUC of 0.967.">
    <entity charOffset="5-23" id="s4183.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="40-46" id="s4183.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4183.e0" e2="s4183.e1" id="s4183.p0" relation="false"/>
  </sentence>
  <sentence id="s4184" text="Conclusion While novel diagnostic tumour markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing phosphatidylinositol phosphorylation in biological_process.">
    <entity charOffset="34-40" id="s4184.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="176-212" id="s4184.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4184.e0" e2="s4184.e1" id="s4184.p0" relation="false"/>
  </sentence>
  <sentence id="s4185" text="Conclusion While novel diagnostic tumour markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing phosphatidylinositol phosphorylation in biological_process.">
    <entity charOffset="34-40" id="s4185.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="216-234" id="s4185.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4185.e0" e2="s4185.e1" id="s4185.p0" relation="false"/>
  </sentence>
  <sentence id="s4186" text="Furthermore, probably the future is in finding the chloride transport optimal combination of tumour markers for diagnosing phosphatidylinositol phosphorylation based on cost-effectiveness">
    <entity charOffset="51-69" id="s4186.e0" ontology_id="GO_0006821" text="chloride transport" type="GO"/>
    <entity charOffset="93-99" id="s4186.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4186.e0" e2="s4186.e1" id="s4186.p0" relation="false"/>
  </sentence>
  <sentence id="s4187" text="Furthermore, probably the future is in finding the chloride transport optimal combination of tumour markers for diagnosing phosphatidylinositol phosphorylation based on cost-effectiveness">
    <entity charOffset="93-99" id="s4187.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="123-159" id="s4187.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4187.e0" e2="s4187.e1" id="s4187.p0" relation="false"/>
  </sentence>
  <sentence id="s4188" text="Based on screening results, five unique genes (ether lipid biosynthetic process, protein sumoylation, negative regulation of cell-cell adhesion, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a protein phosphorylation mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="47-79" id="s4188.e0" ontology_id="GO_0008611" text="ether lipid biosynthetic process" type="GO"/>
    <entity charOffset="293-301" id="s4188.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4188.e0" e2="s4188.e1" id="s4188.p0" relation="false"/>
  </sentence>
  <sentence id="s4189" text="Based on screening results, five unique genes (ether lipid biosynthetic process, protein sumoylation, negative regulation of cell-cell adhesion, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a protein phosphorylation mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="81-100" id="s4189.e0" ontology_id="GO_0016925" text="protein sumoylation" type="GO"/>
    <entity charOffset="293-301" id="s4189.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4189.e0" e2="s4189.e1" id="s4189.p0" relation="false"/>
  </sentence>
  <sentence id="s4190" text="Based on screening results, five unique genes (ether lipid biosynthetic process, protein sumoylation, negative regulation of cell-cell adhesion, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a protein phosphorylation mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="102-143" id="s4190.e0" ontology_id="GO_0022408" text="negative regulation of cell-cell adhesion" type="GO"/>
    <entity charOffset="293-301" id="s4190.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4190.e0" e2="s4190.e1" id="s4190.p0" relation="false"/>
  </sentence>
  <sentence id="s4191" text="Based on screening results, five unique genes (ether lipid biosynthetic process, protein sumoylation, negative regulation of cell-cell adhesion, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a protein phosphorylation mutated melanoma line (P&amp;lt;0.001).">
    <entity charOffset="261-284" id="s4191.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="293-301" id="s4191.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4191.e0" e2="s4191.e1" id="s4191.p0" relation="true"/>
  </sentence>
  <sentence id="s4192" text="Our findings indicate that GNPAT, protein sumoylation, negative regulation of cell-cell adhesion, FLI1, and regulation of transcription, DNA-templated play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="34-53" id="s4192.e0" ontology_id="GO_0016925" text="protein sumoylation" type="GO"/>
    <entity charOffset="223-231" id="s4192.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4192.e0" e2="s4192.e1" id="s4192.p0" relation="false"/>
  </sentence>
  <sentence id="s4193" text="Our findings indicate that GNPAT, protein sumoylation, negative regulation of cell-cell adhesion, FLI1, and regulation of transcription, DNA-templated play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="55-96" id="s4193.e0" ontology_id="GO_0022408" text="negative regulation of cell-cell adhesion" type="GO"/>
    <entity charOffset="223-231" id="s4193.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4193.e0" e2="s4193.e1" id="s4193.p0" relation="false"/>
  </sentence>
  <sentence id="s4194" text="Our findings indicate that GNPAT, protein sumoylation, negative regulation of cell-cell adhesion, FLI1, and regulation of transcription, DNA-templated play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control">
    <entity charOffset="108-150" id="s4194.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="223-231" id="s4194.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4194.e0" e2="s4194.e1" id="s4194.p0" relation="false"/>
  </sentence>
  <sentence id="s4195" text="We conducted a interleukin-7-mediated signaling pathway-expression quantitative trait loci (cis-eQTL) analysis using normal or tumor breast transcriptome data from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), The Cancer Genome Atlas (TCGA), and the Genotype-Tissue Expression (GTEx) project.">
    <entity charOffset="15-55" id="s4195.e0" ontology_id="GO_0038111" text="interleukin-7-mediated signaling pathway" type="GO"/>
    <entity charOffset="127-132" id="s4195.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4195.e0" e2="s4195.e1" id="s4195.p0" relation="false"/>
  </sentence>
  <sentence id="s4196" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that telomere maintenance, apoptotic process, and protein modification by small protein conjugation played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="52-58" id="s4196.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="124-141" id="s4196.e1" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <pair e1="s4196.e0" e2="s4196.e1" id="s4196.p0" relation="false"/>
  </sentence>
  <sentence id="s4197" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that telomere maintenance, apoptotic process, and protein modification by small protein conjugation played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="52-58" id="s4197.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="147-196" id="s4197.e1" ontology_id="GO_0032446" text="protein modification by small protein conjugation" type="GO"/>
    <pair e1="s4197.e0" e2="s4197.e1" id="s4197.p0" relation="false"/>
  </sentence>
  <sentence id="s4198" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that telomere maintenance, apoptotic process, and protein modification by small protein conjugation played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="102-122" id="s4198.e0" ontology_id="GO_0000723" text="telomere maintenance" type="GO"/>
    <entity charOffset="227-232" id="s4198.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4198.e0" e2="s4198.e1" id="s4198.p0" relation="false"/>
  </sentence>
  <sentence id="s4199" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that telomere maintenance, apoptotic process, and protein modification by small protein conjugation played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="124-141" id="s4199.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="227-232" id="s4199.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4199.e0" e2="s4199.e1" id="s4199.p0" relation="false"/>
  </sentence>
  <sentence id="s4200" text="Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that telomere maintenance, apoptotic process, and protein modification by small protein conjugation played a vital role in breast tumorigenesis via certain disruption of cell behaviors.">
    <entity charOffset="147-196" id="s4200.e0" ontology_id="GO_0032446" text="protein modification by small protein conjugation" type="GO"/>
    <entity charOffset="227-232" id="s4200.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4200.e0" e2="s4200.e1" id="s4200.p0" relation="false"/>
  </sentence>
  <sentence id="s4201" text="Identification of novel genetic and epigenetic alterations is required for optimal stratification of patients with hepatocellular carcinoma (phosphatidylinositol phosphorylation) at risk for recurrence and adverse prognosis.">
    <entity charOffset="115-139" id="s4201.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="141-177" id="s4201.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4201.e0" e2="s4201.e1" id="s4201.p0" relation="false"/>
  </sentence>
  <sentence id="s4202" text="ubiquinone biosynthetic process is a putative tumor suppressor, and promoter hypermethylation is a key regulatory mechanism in HCC.">
    <entity charOffset="0-31" id="s4202.e0" ontology_id="GO_0006744" text="ubiquinone biosynthetic process" type="GO"/>
    <entity charOffset="46-51" id="s4202.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4202.e0" e2="s4202.e1" id="s4202.p0" relation="false"/>
  </sentence>
  <sentence id="s4203" text="Mutations in regulation of macroautophagy have been associated with rare cases of X-linked juvenile and adult forms of amyotrophic lateral sclerosis (signal transduction) and ALS linked to frontotemporal dementia (FTD).">
    <entity charOffset="13-41" id="s4203.e0" ontology_id="GO_0016241" text="regulation of macroautophagy" type="GO"/>
    <entity charOffset="189-212" id="s4203.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4203.e0" e2="s4203.e1" id="s4203.p0" relation="true"/>
  </sentence>
  <sentence id="s4204" text="Mutations in regulation of macroautophagy have been associated with rare cases of X-linked juvenile and adult forms of amyotrophic lateral sclerosis (signal transduction) and ALS linked to frontotemporal dementia (FTD).">
    <entity charOffset="150-169" id="s4204.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="189-212" id="s4204.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4204.e0" e2="s4204.e1" id="s4204.p0" relation="false"/>
  </sentence>
  <sentence id="s4205" text="Here, we report 1 known (c.1489C&amp;gt;T, p.Pro497Ser, P497S) and 3 novel (c.1481C&amp;gt;T, p.Pro494Leu, P494L; c.1498C&amp;gt;T, p.Pro500Ser, P500S; and c.1516C&amp;gt;G, p.Pro506Ala, P506A) missense mutations in the PXX domain of UBQLN2 in familial motor neuron diseases including signal transduction and spastic paraplegia (SP).">
    <entity charOffset="269-288" id="s4205.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="293-311" id="s4205.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s4205.e0" e2="s4205.e1" id="s4205.p0" relation="false"/>
  </sentence>
  <sentence id="s4206" text="A novel missense mutation (c.1462G&amp;gt;A, p.Ala488Thr, A488T) adjacent to this hotspot regulation of macroautophagy domain was identified in a sporadic case of ALS.">
    <entity charOffset="86-114" id="s4206.e0" ontology_id="GO_0016241" text="regulation of macroautophagy" type="GO"/>
    <entity charOffset="142-150" id="s4206.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s4206.e0" e2="s4206.e1" id="s4206.p0" relation="false"/>
  </sentence>
  <sentence id="s4207" text="Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (glycogen metabolic process), and X-linked (PHKA2, PDHA1, OTC, and creatine transmembrane transport) disorders.">
    <entity charOffset="64-83" id="s4207.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="85-111" id="s4207.e1" ontology_id="GO_0005977" text="glycogen metabolic process" type="GO"/>
    <pair e1="s4207.e0" e2="s4207.e1" id="s4207.p0" relation="true"/>
  </sentence>
  <sentence id="s4208" text="Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (glycogen metabolic process), and X-linked (PHKA2, PDHA1, OTC, and creatine transmembrane transport) disorders.">
    <entity charOffset="64-83" id="s4208.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="151-183" id="s4208.e1" ontology_id="GO_0015881" text="creatine transmembrane transport" type="GO"/>
    <pair e1="s4208.e0" e2="s4208.e1" id="s4208.p0" relation="false"/>
  </sentence>
  <sentence id="s4209" text="mitochondrion organization is an autosomal recessive generalized connective tissue disorder associated with extreme corneal thinning and a high risk of corneal rupture.">
    <entity charOffset="0-26" id="s4209.e0" ontology_id="GO_0007005" text="mitochondrion organization" type="GO"/>
    <entity charOffset="33-52" id="s4209.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4209.e0" e2="s4209.e1" id="s4209.p0" relation="true"/>
  </sentence>
  <sentence id="s4210" text="We hypothesized that heterozygous variants in negative regulation of transcription by RNA polymerase II and regulation of transcription by RNA polymerase II predispose to the development of isolated keratoconus.">
    <entity charOffset="46-103" id="s4210.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="199-210" id="s4210.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s4210.e0" e2="s4210.e1" id="s4210.p0" relation="true"/>
  </sentence>
  <sentence id="s4211" text="We hypothesized that heterozygous variants in negative regulation of transcription by RNA polymerase II and regulation of transcription by RNA polymerase II predispose to the development of isolated keratoconus.">
    <entity charOffset="108-156" id="s4211.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="199-210" id="s4211.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s4211.e0" e2="s4211.e1" id="s4211.p0" relation="true"/>
  </sentence>
  <sentence id="s4212" text="We found a significant enrichment of potentially pathologic heterozygous alleles in regulation of transcription by RNA polymerase II associated with the development of keratoconus (P = 0.00102) resulting in a relative risk of 12.0.">
    <entity charOffset="84-132" id="s4212.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="168-179" id="s4212.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s4212.e0" e2="s4212.e1" id="s4212.p0" relation="true"/>
  </sentence>
  <sentence id="s4213" text="This enrichment of rare potentially pathogenic alleles in regulation of transcription by RNA polymerase II in 12.5% of keratoconus patients represents a significant mutational load and highlights ZNF469 as the most significant genetic factor responsible for keratoconus identified to date.">
    <entity charOffset="58-106" id="s4213.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="119-130" id="s4213.e1" ontology_id="HP_0000563" text="keratoconus" type="HP"/>
    <pair e1="s4213.e0" e2="s4213.e1" id="s4213.p0" relation="true"/>
  </sentence>
  <sentence id="s4214" text="Integration of cell culture genomes, transcriptomes and tumour phenotypes with functional studies and human data reveals additional widespread effects of oncogenic dosage variation on cell morphology and plasticity, histopathology and clinical outcome, with the highest positive regulation of protein phosphorylation&lt;sup&gt;MUT&lt;/sup&gt; levels underlying aggressive undifferentiated phenotypes.">
    <entity charOffset="56-62" id="s4214.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="270-316" id="s4214.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4214.e0" e2="s4214.e1" id="s4214.p0" relation="true"/>
  </sentence>
  <sentence id="s4215" text="Mechanistically, different oncogenic gains and dosages evolve along distinct evolutionary routes, licensed by defined allelic states and/or combinations of hallmark tumour suppressor alterations (G1/S transition of mitotic cell cycle, Trp53, Tgf-pathway).">
    <entity charOffset="165-171" id="s4215.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="196-233" id="s4215.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s4215.e0" e2="s4215.e1" id="s4215.p0" relation="true"/>
  </sentence>
  <sentence id="s4216" text="Risdiplam (RG7916; RO7034067) is an orally administered, small-molecule &lt;i&gt;mRNA splicing, via spliceosome2&lt;/i&gt; pre-mRNA splicing modifier that distributes into the central nervous system (CNS) and peripheral tissues.">
    <entity charOffset="75-105" id="s4216.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="164-171" id="s4216.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s4216.e0" e2="s4216.e1" id="s4216.p0" relation="false"/>
  </sentence>
  <sentence id="s4217" text="Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (negative regulation of tumor necrosis factor production)-independent macronodular adrenal hyperplasia, is a rare muscle organ development of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.">
    <entity charOffset="21-40" id="s4217.e0" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <entity charOffset="141-196" id="s4217.e1" ontology_id="GO_0032720" text="negative regulation of tumor necrosis factor production" type="GO"/>
    <pair e1="s4217.e0" e2="s4217.e1" id="s4217.p0" relation="false"/>
  </sentence>
  <sentence id="s4218" text="Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (negative regulation of tumor necrosis factor production)-independent macronodular adrenal hyperplasia, is a rare muscle organ development of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.">
    <entity charOffset="21-40" id="s4218.e0" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <entity charOffset="254-278" id="s4218.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4218.e0" e2="s4218.e1" id="s4218.p0" relation="false"/>
  </sentence>
  <sentence id="s4219" text="Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (negative regulation of tumor necrosis factor production)-independent macronodular adrenal hyperplasia, is a rare muscle organ development of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.">
    <entity charOffset="75-84" id="s4219.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="141-196" id="s4219.e1" ontology_id="GO_0032720" text="negative regulation of tumor necrosis factor production" type="GO"/>
    <pair e1="s4219.e0" e2="s4219.e1" id="s4219.p0" relation="false"/>
  </sentence>
  <sentence id="s4220" text="Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (negative regulation of tumor necrosis factor production)-independent macronodular adrenal hyperplasia, is a rare muscle organ development of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.">
    <entity charOffset="75-84" id="s4220.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="254-278" id="s4220.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4220.e0" e2="s4220.e1" id="s4220.p0" relation="false"/>
  </sentence>
  <sentence id="s4221" text="In addition, haploid clone of tumor DNA was confirmed by germline mutation and somaticmutation, which suggested the pathogenic mechanism of &amp;quot;two-hit-model.&amp;quot; biological_process was the causative gene of AIMAH pedigrees.">
    <entity charOffset="30-35" id="s4221.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="167-185" id="s4221.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4221.e0" e2="s4221.e1" id="s4221.p0" relation="true"/>
  </sentence>
  <sentence id="s4222" text="Whereas the majority of mammalian cells carry no more than two centrosomes GPI anchor metabolic process cell, exceptions to this rule apply in certain specialized tissues and in select disease states, including cancer.">
    <entity charOffset="75-103" id="s4222.e0" ontology_id="GO_0006505" text="GPI anchor metabolic process" type="GO"/>
    <entity charOffset="211-217" id="s4222.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4222.e0" e2="s4222.e1" id="s4222.p0" relation="false"/>
  </sentence>
  <sentence id="s4223" text="Extensive IDS gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire regulation of gene expression gene, and epilepsy developed in only one of them.">
    <entity charOffset="136-165" id="s4223.e0" ontology_id="GO_0010468" text="regulation of gene expression" type="GO"/>
    <entity charOffset="176-184" id="s4223.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4223.e0" e2="s4223.e1" id="s4223.p0" relation="false"/>
  </sentence>
  <sentence id="s4224" text="Wide allelic heterogeneity was noted, with large gene alterations (e.g. glycosaminoglycan catabolic process/IDSP1 gene inversions, partial to extensive IDS deletions, and one chimeric IDS-IDSP1 allele) that occurred at higher frequencies than previously reported (36% vs 18.9-29%).">
    <entity charOffset="13-26" id="s4224.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="72-107" id="s4224.e1" ontology_id="GO_0006027" text="glycosaminoglycan catabolic process" type="GO"/>
    <pair e1="s4224.e0" e2="s4224.e1" id="s4224.p0" relation="false"/>
  </sentence>
  <sentence id="s4225" text="Our findings suggest a wide allelic heterogeneity in Mexican MPSII patients; DNA microarray analysis contributes to further delineation of the resulting phenomuscle organ development for glycosaminoglycan catabolic process and neighboring loci deletions">
    <entity charOffset="36-49" id="s4225.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="158-182" id="s4225.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4225.e0" e2="s4225.e1" id="s4225.p0" relation="false"/>
  </sentence>
  <sentence id="s4226" text="Our findings suggest a wide allelic heterogeneity in Mexican MPSII patients; DNA microarray analysis contributes to further delineation of the resulting phenomuscle organ development for glycosaminoglycan catabolic process and neighboring loci deletions">
    <entity charOffset="36-49" id="s4226.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="187-222" id="s4226.e1" ontology_id="GO_0006027" text="glycosaminoglycan catabolic process" type="GO"/>
    <pair e1="s4226.e0" e2="s4226.e1" id="s4226.p0" relation="false"/>
  </sentence>
  <sentence id="s4227" text="Norepinephrine transporter (negative regulation of transcription, DNA-templated) transfection leads to significant uptake of iodine-131-labeled metaiodobenzylguanidine (&lt;sup&gt;131&lt;/sup&gt;I-MIBG) in non-neuroendocrine tumors.">
    <entity charOffset="28-79" id="s4227.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="213-219" id="s4227.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4227.e0" e2="s4227.e1" id="s4227.p0" relation="false"/>
  </sentence>
  <sentence id="s4228" text="We evaluated the uptake and efflux of &lt;sup&gt;131&lt;/sup&gt;I-MIBG both in vitro and in vivo in epidermis development bearing transfected tumors.">
    <entity charOffset="88-109" id="s4228.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="130-136" id="s4228.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4228.e0" e2="s4228.e1" id="s4228.p0" relation="false"/>
  </sentence>
  <sentence id="s4229" text="In vivo exGPI anchor metabolic processiments were performed in establishment of mitotic spindle orientation epidermis development bearing transfected tumors; results revealed that negative regulation of transcription, DNA-templated-VMAT2-coexpressing tumors had longer &lt;sup&gt;131&lt;/sup&gt;I-MIBG retention time than NET-expressing tumors.">
    <entity charOffset="10-38" id="s4229.e0" ontology_id="GO_0006505" text="GPI anchor metabolic process" type="GO"/>
    <entity charOffset="150-156" id="s4229.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4229.e0" e2="s4229.e1" id="s4229.p0" relation="false"/>
  </sentence>
  <sentence id="s4230" text="In vivo exGPI anchor metabolic processiments were performed in establishment of mitotic spindle orientation epidermis development bearing transfected tumors; results revealed that negative regulation of transcription, DNA-templated-VMAT2-coexpressing tumors had longer &lt;sup&gt;131&lt;/sup&gt;I-MIBG retention time than NET-expressing tumors.">
    <entity charOffset="63-107" id="s4230.e0" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <entity charOffset="150-156" id="s4230.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4230.e0" e2="s4230.e1" id="s4230.p0" relation="false"/>
  </sentence>
  <sentence id="s4231" text="In vivo exGPI anchor metabolic processiments were performed in establishment of mitotic spindle orientation epidermis development bearing transfected tumors; results revealed that negative regulation of transcription, DNA-templated-VMAT2-coexpressing tumors had longer &lt;sup&gt;131&lt;/sup&gt;I-MIBG retention time than NET-expressing tumors.">
    <entity charOffset="108-129" id="s4231.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="150-156" id="s4231.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4231.e0" e2="s4231.e1" id="s4231.p0" relation="false"/>
  </sentence>
  <sentence id="s4232" text="In vivo exGPI anchor metabolic processiments were performed in establishment of mitotic spindle orientation epidermis development bearing transfected tumors; results revealed that negative regulation of transcription, DNA-templated-VMAT2-coexpressing tumors had longer &lt;sup&gt;131&lt;/sup&gt;I-MIBG retention time than NET-expressing tumors.">
    <entity charOffset="150-156" id="s4232.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="180-231" id="s4232.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4232.e0" e2="s4232.e1" id="s4232.p0" relation="false"/>
  </sentence>
  <sentence id="s4233" text="Meanwhile, negative regulation of transcription, DNA-templated-chemical synaptic transmission-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose GPI anchor metabolic process gram of tissue 24 h after &lt;sup&gt;131&lt;/sup&gt;I-MIBG administration.">
    <entity charOffset="11-62" id="s4233.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="126-132" id="s4233.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4233.e0" e2="s4233.e1" id="s4233.p0" relation="false"/>
  </sentence>
  <sentence id="s4234" text="Meanwhile, negative regulation of transcription, DNA-templated-chemical synaptic transmission-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose GPI anchor metabolic process gram of tissue 24 h after &lt;sup&gt;131&lt;/sup&gt;I-MIBG administration.">
    <entity charOffset="63-93" id="s4234.e0" ontology_id="GO_0007268" text="chemical synaptic transmission" type="GO"/>
    <entity charOffset="126-132" id="s4234.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4234.e0" e2="s4234.e1" id="s4234.p0" relation="false"/>
  </sentence>
  <sentence id="s4235" text="Meanwhile, negative regulation of transcription, DNA-templated-chemical synaptic transmission-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose GPI anchor metabolic process gram of tissue 24 h after &lt;sup&gt;131&lt;/sup&gt;I-MIBG administration.">
    <entity charOffset="126-132" id="s4235.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="195-223" id="s4235.e1" ontology_id="GO_0006505" text="GPI anchor metabolic process" type="GO"/>
    <pair e1="s4235.e0" e2="s4235.e1" id="s4235.p0" relation="false"/>
  </sentence>
  <sentence id="s4236" text="&lt;b&gt;Result:&lt;/b&gt; Three mutant genes (peptidyl-tyrosine dephosphorylation gene in chromosome 12, Ras protein signal transduction gene in chromosome 1 and activation of MAPKK activity gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.">
    <entity charOffset="35-70" id="s4236.e0" ontology_id="GO_0035335" text="peptidyl-tyrosine dephosphorylation" type="GO"/>
    <entity charOffset="268-282" id="s4236.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s4236.e0" e2="s4236.e1" id="s4236.p0" relation="true"/>
  </sentence>
  <sentence id="s4237" text="&lt;b&gt;Result:&lt;/b&gt; Three mutant genes (peptidyl-tyrosine dephosphorylation gene in chromosome 12, Ras protein signal transduction gene in chromosome 1 and activation of MAPKK activity gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.">
    <entity charOffset="94-125" id="s4237.e0" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <entity charOffset="268-282" id="s4237.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s4237.e0" e2="s4237.e1" id="s4237.p0" relation="true"/>
  </sentence>
  <sentence id="s4238" text="&lt;b&gt;Result:&lt;/b&gt; Three mutant genes (peptidyl-tyrosine dephosphorylation gene in chromosome 12, Ras protein signal transduction gene in chromosome 1 and activation of MAPKK activity gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.">
    <entity charOffset="151-179" id="s4238.e0" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <entity charOffset="268-282" id="s4238.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s4238.e0" e2="s4238.e1" id="s4238.p0" relation="true"/>
  </sentence>
  <sentence id="s4239" text="The reported hypertrophic cardiomyopathy relevant genes sarcomere organization, MYH6 and MYBP3 had also been found in case 1 and 2.">
    <entity charOffset="26-40" id="s4239.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="56-78" id="s4239.e1" ontology_id="GO_0045214" text="sarcomere organization" type="GO"/>
    <pair e1="s4239.e0" e2="s4239.e1" id="s4239.p0" relation="true"/>
  </sentence>
  <sentence id="s4240" text="A total of 3128 people participated and were divided into 5 groups: healthy controls, natural clearance, chronic hepatitis B(CHB), liver cirrhosis and hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="151-175" id="s4240.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="177-213" id="s4240.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4240.e0" e2="s4240.e1" id="s4240.p0" relation="false"/>
  </sentence>
  <sentence id="s4241" text="Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3mRNA splicing, via spliceosome genes (intracellular sequestering of iron ion, GRM1 and negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="79-85" id="s4241.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="305-335" id="s4241.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s4241.e0" e2="s4241.e1" id="s4241.p0" relation="false"/>
  </sentence>
  <sentence id="s4242" text="Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3mRNA splicing, via spliceosome genes (intracellular sequestering of iron ion, GRM1 and negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="79-85" id="s4242.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="343-381" id="s4242.e1" ontology_id="GO_0006880" text="intracellular sequestering of iron ion" type="GO"/>
    <pair e1="s4242.e0" e2="s4242.e1" id="s4242.p0" relation="false"/>
  </sentence>
  <sentence id="s4243" text="Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3mRNA splicing, via spliceosome genes (intracellular sequestering of iron ion, GRM1 and negative regulation of transcription by RNA polymerase II).">
    <entity charOffset="79-85" id="s4243.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="392-449" id="s4243.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4243.e0" e2="s4243.e1" id="s4243.p0" relation="true"/>
  </sentence>
  <sentence id="s4244" text="As a result, patients with histone succinylation suffer from severe bacterial infections and impaired wound healing, accompanied by neutrophilia.">
    <entity charOffset="27-48" id="s4244.e0" ontology_id="GO_0106077" text="histone succinylation" type="GO"/>
    <entity charOffset="132-144" id="s4244.e1" ontology_id="HP_0011897" text="neutrophilia" type="HP"/>
    <pair e1="s4244.e0" e2="s4244.e1" id="s4244.p0" relation="false"/>
  </sentence>
  <sentence id="s4245" text="But the role of definitive hemopoiesis in breast cancer remains unclear.">
    <entity charOffset="16-38" id="s4245.e0" ontology_id="GO_0060216" text="definitive hemopoiesis" type="GO"/>
    <entity charOffset="49-55" id="s4245.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4245.e0" e2="s4245.e1" id="s4245.p0" relation="false"/>
  </sentence>
  <sentence id="s4246" text="Functionally, definitive hemopoiesis overexpression accelerated breast cancer cell proliferation and migration, while an opposite effect was observed when MFAP5 was knocked down.">
    <entity charOffset="14-36" id="s4246.e0" ontology_id="GO_0060216" text="definitive hemopoiesis" type="GO"/>
    <entity charOffset="71-77" id="s4246.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4246.e0" e2="s4246.e1" id="s4246.p0" relation="false"/>
  </sentence>
  <sentence id="s4247" text="These findings may provide a better understanding about the mechanism of breast cancer and suggest that definitive hemopoiesis may be a potential prognostic biomarker and therapeutic target for breast cancer, especially for bone metastasis of breast cancer">
    <entity charOffset="80-86" id="s4247.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="104-126" id="s4247.e1" ontology_id="GO_0060216" text="definitive hemopoiesis" type="GO"/>
    <pair e1="s4247.e0" e2="s4247.e1" id="s4247.p0" relation="false"/>
  </sentence>
  <sentence id="s4248" text="In the gene expression and network-level information, we revealed significant alterations of molecules related to response to hypoxia and metabolic pathways in the hypoxic-conditioned lung cancer cells.">
    <entity charOffset="114-133" id="s4248.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="189-195" id="s4248.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4248.e0" e2="s4248.e1" id="s4248.p0" relation="false"/>
  </sentence>
  <sentence id="s4249" text="We also observed that glycogen biosynthetic process and HK2 are downstream of response to hypoxia pathway important in hypoxia-conditioned lung cancer cell.">
    <entity charOffset="22-51" id="s4249.e0" ontology_id="GO_0005978" text="glycogen biosynthetic process" type="GO"/>
    <entity charOffset="144-150" id="s4249.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4249.e0" e2="s4249.e1" id="s4249.p0" relation="false"/>
  </sentence>
  <sentence id="s4250" text="We also observed that glycogen biosynthetic process and HK2 are downstream of response to hypoxia pathway important in hypoxia-conditioned lung cancer cell.">
    <entity charOffset="78-97" id="s4250.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="144-150" id="s4250.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4250.e0" e2="s4250.e1" id="s4250.p0" relation="false"/>
  </sentence>
  <sentence id="s4251" text="Furthermore, we used publicly available datasets to validate that the late-stage lung adenocarcinoma patients showed higher expression HK2 and glycogen biosynthetic process than early-stage ones.">
    <entity charOffset="81-100" id="s4251.e0" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <entity charOffset="143-172" id="s4251.e1" ontology_id="GO_0005978" text="glycogen biosynthetic process" type="GO"/>
    <pair e1="s4251.e0" e2="s4251.e1" id="s4251.p0" relation="false"/>
  </sentence>
  <sentence id="s4252" text="Interestingly, dysregulated expression of KDM4 members is involved in the progression of several cancer types and plays a role in the DNA cellular protein catabolic process response; however, the gene expression profile and the importance of KDM4 members in CLL are still unknown.">
    <entity charOffset="97-103" id="s4252.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="138-172" id="s4252.e1" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <pair e1="s4252.e0" e2="s4252.e1" id="s4252.p0" relation="false"/>
  </sentence>
  <sentence id="s4253" text="In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), positive regulation of gene expression, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, protein-DNA complex disassembly, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE">
    <entity charOffset="177-244" id="s4253.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="393-398" id="s4253.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4253.e0" e2="s4253.e1" id="s4253.p0" relation="false"/>
  </sentence>
  <sentence id="s4254" text="In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), positive regulation of gene expression, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, protein-DNA complex disassembly, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE">
    <entity charOffset="247-285" id="s4254.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="393-398" id="s4254.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4254.e0" e2="s4254.e1" id="s4254.p0" relation="true"/>
  </sentence>
  <sentence id="s4255" text="In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), positive regulation of gene expression, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, protein-DNA complex disassembly, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE">
    <entity charOffset="287-354" id="s4255.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="393-398" id="s4255.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4255.e0" e2="s4255.e1" id="s4255.p0" relation="false"/>
  </sentence>
  <sentence id="s4256" text="In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), positive regulation of gene expression, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, protein-DNA complex disassembly, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE">
    <entity charOffset="356-387" id="s4256.e0" ontology_id="GO_0032986" text="protein-DNA complex disassembly" type="GO"/>
    <entity charOffset="393-398" id="s4256.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4256.e0" e2="s4256.e1" id="s4256.p0" relation="false"/>
  </sentence>
  <sentence id="s4257" text="The sisters reported here display the distinguishing clinical features of sister chromatid cohesion: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.">
    <entity charOffset="74-99" id="s4257.e0" ontology_id="GO_0007062" text="sister chromatid cohesion" type="GO"/>
    <entity charOffset="141-153" id="s4257.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s4257.e0" e2="s4257.e1" id="s4257.p0" relation="true"/>
  </sentence>
  <sentence id="s4258" text="The sisters reported here display the distinguishing clinical features of sister chromatid cohesion: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.">
    <entity charOffset="74-99" id="s4258.e0" ontology_id="GO_0007062" text="sister chromatid cohesion" type="GO"/>
    <entity charOffset="155-178" id="s4258.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4258.e0" e2="s4258.e1" id="s4258.p0" relation="true"/>
  </sentence>
  <sentence id="s4259" text="The sisters reported here display the distinguishing clinical features of sister chromatid cohesion: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.">
    <entity charOffset="74-99" id="s4259.e0" ontology_id="GO_0007062" text="sister chromatid cohesion" type="GO"/>
    <entity charOffset="194-206" id="s4259.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4259.e0" e2="s4259.e1" id="s4259.p0" relation="true"/>
  </sentence>
  <sentence id="s4260" text="Schwartz-Jampel syndrome type 1 (receptor-mediated endocytosis) is a rare autosomal recessive disease caused by mutations in the gene heparan sulfate proteoglycan 2 (receptor-mediated endocytosis; also known as basement membranespecific heparin sulfate).">
    <entity charOffset="33-62" id="s4260.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="74-93" id="s4260.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4260.e0" e2="s4260.e1" id="s4260.p0" relation="true"/>
  </sentence>
  <sentence id="s4261" text="Schwartz-Jampel syndrome type 1 (receptor-mediated endocytosis) is a rare autosomal recessive disease caused by mutations in the gene heparan sulfate proteoglycan 2 (receptor-mediated endocytosis; also known as basement membranespecific heparin sulfate).">
    <entity charOffset="74-93" id="s4261.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="166-195" id="s4261.e1" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <pair e1="s4261.e0" e2="s4261.e1" id="s4261.p0" relation="true"/>
  </sentence>
  <sentence id="s4262" text="The key clinical features of the patient with receptor-mediated endocytosis included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="46-75" id="s4262.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="85-98" id="s4262.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s4262.e0" e2="s4262.e1" id="s4262.p0" relation="true"/>
  </sentence>
  <sentence id="s4263" text="The key clinical features of the patient with receptor-mediated endocytosis included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="46-75" id="s4263.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="106-118" id="s4263.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s4263.e0" e2="s4263.e1" id="s4263.p0" relation="true"/>
  </sentence>
  <sentence id="s4264" text="The key clinical features of the patient with receptor-mediated endocytosis included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="46-75" id="s4264.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="139-147" id="s4264.e1" ontology_id="HP_0002486" text="myotonia" type="HP"/>
    <pair e1="s4264.e0" e2="s4264.e1" id="s4264.p0" relation="true"/>
  </sentence>
  <sentence id="s4265" text="The key clinical features of the patient with receptor-mediated endocytosis included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="106-118" id="s4265.e0" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <entity charOffset="189-218" id="s4265.e1" ontology_id="GO_0036297" text="interstrand cross-link repair" type="GO"/>
    <pair e1="s4265.e0" e2="s4265.e1" id="s4265.p0" relation="false"/>
  </sentence>
  <sentence id="s4266" text="The key clinical features of the patient with receptor-mediated endocytosis included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.">
    <entity charOffset="139-147" id="s4266.e0" ontology_id="HP_0002486" text="myotonia" type="HP"/>
    <entity charOffset="189-218" id="s4266.e1" ontology_id="GO_0036297" text="interstrand cross-link repair" type="GO"/>
    <pair e1="s4266.e0" e2="s4266.e1" id="s4266.p0" relation="false"/>
  </sentence>
  <sentence id="s4267" text="In nucleosome disassembly, cells which simultaneously express both sets of markers have the highest tumor initiating capacity.">
    <entity charOffset="3-25" id="s4267.e0" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <entity charOffset="100-105" id="s4267.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4267.e0" e2="s4267.e1" id="s4267.p0" relation="false"/>
  </sentence>
  <sentence id="s4268" text="In ALDH&lt;sup&gt;+&lt;/sup&gt;CD24&lt;sup&gt;-&lt;/sup&gt;CD44&lt;sup&gt;+&lt;/sup&gt; BCSCs, we identified P4HA2, leukotriene metabolic process and RAB40B as potential prognostic markers, which were virtually related to the status of BCSCs and tumor growth in TNBC cells">
    <entity charOffset="80-109" id="s4268.e0" ontology_id="GO_0006691" text="leukotriene metabolic process" type="GO"/>
    <entity charOffset="210-215" id="s4268.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4268.e0" e2="s4268.e1" id="s4268.p0" relation="false"/>
  </sentence>
  <sentence id="s4269" text="Missense mutations in sodium ion transport (p.Leu1342Pro) and KCNQ2 (p.Ala306Thr) were found in two patients with no history of epilepsy before the onset of ISs.">
    <entity charOffset="22-42" id="s4269.e0" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <entity charOffset="128-136" id="s4269.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4269.e0" e2="s4269.e1" id="s4269.p0" relation="true"/>
  </sentence>
  <sentence id="s4270" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="12-36" id="s4270.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="265-284" id="s4270.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4270.e0" e2="s4270.e1" id="s4270.p0" relation="false"/>
  </sentence>
  <sentence id="s4271" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="12-36" id="s4271.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="333-345" id="s4271.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s4271.e0" e2="s4271.e1" id="s4271.p0" relation="false"/>
  </sentence>
  <sentence id="s4272" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="12-36" id="s4272.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="361-374" id="s4272.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s4272.e0" e2="s4272.e1" id="s4272.p0" relation="false"/>
  </sentence>
  <sentence id="s4273" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="120-135" id="s4273.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="265-284" id="s4273.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4273.e0" e2="s4273.e1" id="s4273.p0" relation="true"/>
  </sentence>
  <sentence id="s4274" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="120-135" id="s4274.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="297-315" id="s4274.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s4274.e0" e2="s4274.e1" id="s4274.p0" relation="false"/>
  </sentence>
  <sentence id="s4275" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="139-169" id="s4275.e0" ontology_id="GO_0090149" text="mitochondrial membrane fission" type="GO"/>
    <entity charOffset="265-284" id="s4275.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4275.e0" e2="s4275.e1" id="s4275.p0" relation="true"/>
  </sentence>
  <sentence id="s4276" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="139-169" id="s4276.e0" ontology_id="GO_0090149" text="mitochondrial membrane fission" type="GO"/>
    <entity charOffset="297-315" id="s4276.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s4276.e0" e2="s4276.e1" id="s4276.p0" relation="false"/>
  </sentence>
  <sentence id="s4277" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="139-169" id="s4277.e0" ontology_id="GO_0090149" text="mitochondrial membrane fission" type="GO"/>
    <entity charOffset="361-374" id="s4277.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s4277.e0" e2="s4277.e1" id="s4277.p0" relation="true"/>
  </sentence>
  <sentence id="s4278" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="187-214" id="s4278.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="265-284" id="s4278.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4278.e0" e2="s4278.e1" id="s4278.p0" relation="false"/>
  </sentence>
  <sentence id="s4279" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="187-214" id="s4279.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="333-345" id="s4279.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s4279.e0" e2="s4279.e1" id="s4279.p0" relation="false"/>
  </sentence>
  <sentence id="s4280" text="The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.">
    <entity charOffset="187-214" id="s4280.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="361-374" id="s4280.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s4280.e0" e2="s4280.e1" id="s4280.p0" relation="false"/>
  </sentence>
  <sentence id="s4281" text="Mutations with milder presentation (homozygous p.D132A/rRNA processing or VRK1) may display additionally signs of upper motor neuron impairment, dystonia or ataxia and die at age between 5 and 18 years.">
    <entity charOffset="55-70" id="s4281.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="157-163" id="s4281.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4281.e0" e2="s4281.e1" id="s4281.p0" relation="false"/>
  </sentence>
  <sentence id="s4282" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, fatty acid beta-oxidation using acyl-CoA dehydrogenase and G protein-coupled receptor signaling pathway as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.">
    <entity charOffset="23-28" id="s4282.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="196-250" id="s4282.e1" ontology_id="GO_0033539" text="fatty acid beta-oxidation using acyl-CoA dehydrogenase" type="GO"/>
    <pair e1="s4282.e0" e2="s4282.e1" id="s4282.p0" relation="false"/>
  </sentence>
  <sentence id="s4283" text="Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, fatty acid beta-oxidation using acyl-CoA dehydrogenase and G protein-coupled receptor signaling pathway as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.">
    <entity charOffset="23-28" id="s4283.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="255-299" id="s4283.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s4283.e0" e2="s4283.e1" id="s4283.p0" relation="false"/>
  </sentence>
  <sentence id="s4284" text="Reported susceptibility SNPs for narcolepsy in the Japanese population, carnitine shuttle (carnitine palmitoyltransferase 1B), TRA@ (T-cell receptor alpha) and P2RY11 (purinergic receptor P2Y, G-protein coupled, 11), were found to explain 0.8% of narcolepsy onset (P&lt;sub&gt;whole genome without HLA-DQB1*06:02&lt;/sub&gt;=9.74  10&lt;sup&gt;-2&lt;/sup&gt;).">
    <entity charOffset="33-43" id="s4284.e0" ontology_id="HP_0030050" text="narcolepsy" type="HP"/>
    <entity charOffset="72-89" id="s4284.e1" ontology_id="GO_0006853" text="carnitine shuttle" type="GO"/>
    <pair e1="s4284.e0" e2="s4284.e1" id="s4284.p0" relation="false"/>
  </sentence>
  <sentence id="s4285" text="In addition, splicing variants of biological_process mRNA is associated with a variety of cancers and Alzheimer's disease, and mutations of the CIZ1 gene lead to cervical dystonia.">
    <entity charOffset="34-52" id="s4285.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="162-179" id="s4285.e1" ontology_id="HP_0000473" text="cervical dystonia" type="HP"/>
    <pair e1="s4285.e0" e2="s4285.e1" id="s4285.p0" relation="true"/>
  </sentence>
  <sentence id="s4286" text="The clinical history for migraine and hypertension was collected; genomic DNA was charcoenzyme A biosynthetic processerized for a panel of 33 SNPs encoding proteins involved in ionic transport.">
    <entity charOffset="38-50" id="s4286.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="86-117" id="s4286.e1" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <pair e1="s4286.e0" e2="s4286.e1" id="s4286.p0" relation="false"/>
  </sentence>
  <sentence id="s4287" text="A putative tumor suppressor outer dynein arm assembly mapped on the chromosomal 3p21 region, is frequently lost in human tumors including nasopharyngeal carcinoma (NPC).">
    <entity charOffset="11-16" id="s4287.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="28-53" id="s4287.e1" ontology_id="GO_0036158" text="outer dynein arm assembly" type="GO"/>
    <pair e1="s4287.e0" e2="s4287.e1" id="s4287.p0" relation="false"/>
  </sentence>
  <sentence id="s4288" text="To explore the underlying mechanism of tumor suppression by BLU, its potential to promote apoptosis induced by positive regulation of apoptotic process, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.">
    <entity charOffset="39-44" id="s4288.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="111-151" id="s4288.e1" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <pair e1="s4288.e0" e2="s4288.e1" id="s4288.p0" relation="false"/>
  </sentence>
  <sentence id="s4289" text="In conclusion, outer dynein arm assembly suppressed tumor formation by strengthening the antitumor immunity">
    <entity charOffset="15-40" id="s4289.e0" ontology_id="GO_0036158" text="outer dynein arm assembly" type="GO"/>
    <entity charOffset="52-57" id="s4289.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4289.e0" e2="s4289.e1" id="s4289.p0" relation="false"/>
  </sentence>
  <sentence id="s4290" text="Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (ER to Golgi vesicle-mediated transport), retinoic acid early transcript 1E (natural killer cell mediated cytotoxicity), and V-positive regulation of protein phosphorylation murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.">
    <entity charOffset="159-197" id="s4290.e0" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <entity charOffset="452-462" id="s4290.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s4290.e0" e2="s4290.e1" id="s4290.p0" relation="false"/>
  </sentence>
  <sentence id="s4291" text="Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (ER to Golgi vesicle-mediated transport), retinoic acid early transcript 1E (natural killer cell mediated cytotoxicity), and V-positive regulation of protein phosphorylation murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.">
    <entity charOffset="235-276" id="s4291.e0" ontology_id="GO_0042267" text="natural killer cell mediated cytotoxicity" type="GO"/>
    <entity charOffset="452-462" id="s4291.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s4291.e0" e2="s4291.e1" id="s4291.p0" relation="false"/>
  </sentence>
  <sentence id="s4292" text="Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (ER to Golgi vesicle-mediated transport), retinoic acid early transcript 1E (natural killer cell mediated cytotoxicity), and V-positive regulation of protein phosphorylation murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.">
    <entity charOffset="285-331" id="s4292.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="452-462" id="s4292.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s4292.e0" e2="s4292.e1" id="s4292.p0" relation="false"/>
  </sentence>
  <sentence id="s4293" text="No clinical replication cohort is available, so we validated the role of one of these targets, positive regulation of blood vessel endothelial cell migration, in a pneumococcal meningitis mouse model.">
    <entity charOffset="95-157" id="s4293.e0" ontology_id="GO_0043536" text="positive regulation of blood vessel endothelial cell migration" type="GO"/>
    <entity charOffset="177-187" id="s4293.e1" ontology_id="HP_0001287" text="meningitis" type="HP"/>
    <pair e1="s4293.e0" e2="s4293.e1" id="s4293.p0" relation="false"/>
  </sentence>
  <sentence id="s4294" text="Here we identify a negative regulation of transcription, DNA-templated of genes that is highly expressed in breast cancer bone metastasis and activated by negative regulation of transcription by RNA polymerase II.">
    <entity charOffset="19-70" id="s4294.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="115-121" id="s4294.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4294.e0" e2="s4294.e1" id="s4294.p0" relation="false"/>
  </sentence>
  <sentence id="s4295" text="Here we identify a negative regulation of transcription, DNA-templated of genes that is highly expressed in breast cancer bone metastasis and activated by negative regulation of transcription by RNA polymerase II.">
    <entity charOffset="115-121" id="s4295.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="155-212" id="s4295.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4295.e0" e2="s4295.e1" id="s4295.p0" relation="false"/>
  </sentence>
  <sentence id="s4296" text="We here demonstrate that the expression of negative regulation of transcription by RNA polymerase II and BMP-inhibitors is correlated with bone metastasis, but not with brain or lung metastasis of breast cancer patients.">
    <entity charOffset="43-100" id="s4296.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="204-210" id="s4296.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4296.e0" e2="s4296.e1" id="s4296.p0" relation="false"/>
  </sentence>
  <sentence id="s4297" text="These findings suggest that ZEB1 is not only driving cytokine production, but also contributes to the formation of osteolytic bone metastases in breast cancer.">
    <entity charOffset="53-72" id="s4297.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="152-158" id="s4297.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4297.e0" e2="s4297.e1" id="s4297.p0" relation="true"/>
  </sentence>
  <sentence id="s4298" text="Identifying the central and peripheral vestibular mechanisms responsible for pathology can aid in management of peptidyl-tyrosine phosphorylation.">
    <entity charOffset="28-38" id="s4298.e0" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <entity charOffset="112-145" id="s4298.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s4298.e0" e2="s4298.e1" id="s4298.p0" relation="false"/>
  </sentence>
  <sentence id="s4299" text="We therefore examined whether maternal or fetal folate status, together with indices of placental folate transport, were modulated by either maternal pre-pregnancy body cell adhesion mediated by integrin index (BMI i.e., overweight: 25  BMI &amp;lt; 30 or obesity: BMI  30 kg/m) and/or gestational diabetes mellitus (GD).">
    <entity charOffset="169-203" id="s4299.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="253-260" id="s4299.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4299.e0" e2="s4299.e1" id="s4299.p0" relation="false"/>
  </sentence>
  <sentence id="s4300" text="5-20% of melanoma families have germline mutations in the G1/S transition of mitotic cell cycle gene.">
    <entity charOffset="9-17" id="s4300.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="58-95" id="s4300.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s4300.e0" e2="s4300.e1" id="s4300.p0" relation="true"/>
  </sentence>
  <sentence id="s4301" text="In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, telomere maintenance via telomerase, telomere maintenance and TERF2IP.">
    <entity charOffset="23-31" id="s4301.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="106-141" id="s4301.e1" ontology_id="GO_0007004" text="telomere maintenance via telomerase" type="GO"/>
    <pair e1="s4301.e0" e2="s4301.e1" id="s4301.p0" relation="true"/>
  </sentence>
  <sentence id="s4302" text="In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, telomere maintenance via telomerase, telomere maintenance and TERF2IP.">
    <entity charOffset="23-31" id="s4302.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="143-163" id="s4302.e1" ontology_id="GO_0000723" text="telomere maintenance" type="GO"/>
    <pair e1="s4302.e0" e2="s4302.e1" id="s4302.p0" relation="true"/>
  </sentence>
  <sentence id="s4303" text="In some families with multiple cases of uveal and cutaneous melanoma (including a few Swedish families), mutations in the positive regulation of sodium ion transport gene have been found.">
    <entity charOffset="60-68" id="s4303.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="122-165" id="s4303.e1" ontology_id="GO_0010765" text="positive regulation of sodium ion transport" type="GO"/>
    <pair e1="s4303.e0" e2="s4303.e1" id="s4303.p0" relation="false"/>
  </sentence>
  <sentence id="s4304" text="In genes that regulate cellular pigmentation pathways, including MC1R, protein targeting to membrane, positive regulation of interleukin-10 biosynthetic process, TYR, TYRP1 and OCA, there are different common variants that determine complexion negative regulation of transcription by RNA polymerase II, and those variants are also associated with different risks of melanoma.">
    <entity charOffset="71-100" id="s4304.e0" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <entity charOffset="366-374" id="s4304.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4304.e0" e2="s4304.e1" id="s4304.p0" relation="false"/>
  </sentence>
  <sentence id="s4305" text="In genes that regulate cellular pigmentation pathways, including MC1R, protein targeting to membrane, positive regulation of interleukin-10 biosynthetic process, TYR, TYRP1 and OCA, there are different common variants that determine complexion negative regulation of transcription by RNA polymerase II, and those variants are also associated with different risks of melanoma.">
    <entity charOffset="102-160" id="s4305.e0" ontology_id="GO_0045082" text="positive regulation of interleukin-10 biosynthetic process" type="GO"/>
    <entity charOffset="366-374" id="s4305.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4305.e0" e2="s4305.e1" id="s4305.p0" relation="false"/>
  </sentence>
  <sentence id="s4306" text="In genes that regulate cellular pigmentation pathways, including MC1R, protein targeting to membrane, positive regulation of interleukin-10 biosynthetic process, TYR, TYRP1 and OCA, there are different common variants that determine complexion negative regulation of transcription by RNA polymerase II, and those variants are also associated with different risks of melanoma.">
    <entity charOffset="244-301" id="s4306.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="366-374" id="s4306.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s4306.e0" e2="s4306.e1" id="s4306.p0" relation="false"/>
  </sentence>
  <sentence id="s4307" text="Individuals with known mutations in tumor suppressor genes such as CDKN2A and positive regulation of sodium ion transport require, in addition, follow up for other cancers">
    <entity charOffset="36-41" id="s4307.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="78-121" id="s4307.e1" ontology_id="GO_0010765" text="positive regulation of sodium ion transport" type="GO"/>
    <pair e1="s4307.e0" e2="s4307.e1" id="s4307.p0" relation="false"/>
  </sentence>
  <sentence id="s4308" text="BACKGROUND Latent transforming growth factor b binding protein 2 (supramolecular fiber organization) is proven to be associated with platelet degranulation and involved in the advancement of several kinds of cancer.">
    <entity charOffset="66-99" id="s4308.e0" ontology_id="GO_0097435" text="supramolecular fiber organization" type="GO"/>
    <entity charOffset="208-214" id="s4308.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4308.e0" e2="s4308.e1" id="s4308.p0" relation="false"/>
  </sentence>
  <sentence id="s4309" text="BACKGROUND Latent transforming growth factor b binding protein 2 (supramolecular fiber organization) is proven to be associated with platelet degranulation and involved in the advancement of several kinds of cancer.">
    <entity charOffset="133-155" id="s4309.e0" ontology_id="GO_0002576" text="platelet degranulation" type="GO"/>
    <entity charOffset="208-214" id="s4309.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4309.e0" e2="s4309.e1" id="s4309.p0" relation="false"/>
  </sentence>
  <sentence id="s4310" text="Vitamin-B&lt;sub&gt;6&lt;/sub&gt;-dependent epilepsies are a heterogenous group of treatable disorders due to mutations in several genes (&lt;i&gt;ALDH7A1, pyridoxal phosphate biosynthetic process, ALPL&lt;/i&gt; or &lt;i&gt;ALDH4A1&lt;/i&gt;).">
    <entity charOffset="32-42" id="s4310.e0" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <entity charOffset="138-178" id="s4310.e1" ontology_id="GO_0042823" text="pyridoxal phosphate biosynthetic process" type="GO"/>
    <pair e1="s4310.e0" e2="s4310.e1" id="s4310.p0" relation="true"/>
  </sentence>
  <sentence id="s4311" text="In neonatal seizures, defects in &lt;i&gt;ALDH7A1 and pyridoxal phosphate biosynthetic process&lt;/i&gt; explain a major fraction of cases.">
    <entity charOffset="12-20" id="s4311.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="48-88" id="s4311.e1" ontology_id="GO_0042823" text="pyridoxal phosphate biosynthetic process" type="GO"/>
    <pair e1="s4311.e0" e2="s4311.e1" id="s4311.p0" relation="true"/>
  </sentence>
  <sentence id="s4312" text="Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in skeletal muscle contraction as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).">
    <entity charOffset="79-106" id="s4312.e0" ontology_id="GO_0003009" text="skeletal muscle contraction" type="GO"/>
    <entity charOffset="231-243" id="s4312.e1" ontology_id="HP_0000175" text="cleft palate" type="HP"/>
    <pair e1="s4312.e0" e2="s4312.e1" id="s4312.p0" relation="true"/>
  </sentence>
  <sentence id="s4313" text="Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in skeletal muscle contraction as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).">
    <entity charOffset="79-106" id="s4313.e0" ontology_id="GO_0003009" text="skeletal muscle contraction" type="GO"/>
    <entity charOffset="245-258" id="s4313.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s4313.e0" e2="s4313.e1" id="s4313.p0" relation="true"/>
  </sentence>
  <sentence id="s4314" text="Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in skeletal muscle contraction as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).">
    <entity charOffset="79-106" id="s4314.e0" ontology_id="GO_0003009" text="skeletal muscle contraction" type="GO"/>
    <entity charOffset="260-266" id="s4314.e1" ontology_id="HP_0000508" text="ptosis" type="HP"/>
    <pair e1="s4314.e0" e2="s4314.e1" id="s4314.p0" relation="true"/>
  </sentence>
  <sentence id="s4315" text="Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in skeletal muscle contraction as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).">
    <entity charOffset="79-106" id="s4315.e0" ontology_id="GO_0003009" text="skeletal muscle contraction" type="GO"/>
    <entity charOffset="268-282" id="s4315.e1" ontology_id="HP_0002751" text="kyphoscoliosis" type="HP"/>
    <pair e1="s4315.e0" e2="s4315.e1" id="s4315.p0" relation="true"/>
  </sentence>
  <sentence id="s4316" text="Mutations affecting human ER to Golgi vesicle-mediated transport, intra-Golgi vesicle-mediated transport and retrograde vesicle-mediated transport, Golgi to ER-ER to Golgi vesicle-mediated transport cause monogenic forms of inherited, autosomal recessive protein glycosylation.">
    <entity charOffset="26-64" id="s4316.e0" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <entity charOffset="235-254" id="s4316.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4316.e0" e2="s4316.e1" id="s4316.p0" relation="true"/>
  </sentence>
  <sentence id="s4317" text="Mutations affecting human ER to Golgi vesicle-mediated transport, intra-Golgi vesicle-mediated transport and retrograde vesicle-mediated transport, Golgi to ER-ER to Golgi vesicle-mediated transport cause monogenic forms of inherited, autosomal recessive protein glycosylation.">
    <entity charOffset="66-104" id="s4317.e0" ontology_id="GO_0006891" text="intra-Golgi vesicle-mediated transport" type="GO"/>
    <entity charOffset="235-254" id="s4317.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4317.e0" e2="s4317.e1" id="s4317.p0" relation="true"/>
  </sentence>
  <sentence id="s4318" text="Mutations affecting human ER to Golgi vesicle-mediated transport, intra-Golgi vesicle-mediated transport and retrograde vesicle-mediated transport, Golgi to ER-ER to Golgi vesicle-mediated transport cause monogenic forms of inherited, autosomal recessive protein glycosylation.">
    <entity charOffset="109-159" id="s4318.e0" ontology_id="GO_0006890" text="retrograde vesicle-mediated transport, Golgi to ER" type="GO"/>
    <entity charOffset="235-254" id="s4318.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4318.e0" e2="s4318.e1" id="s4318.p0" relation="true"/>
  </sentence>
  <sentence id="s4319" text="Mutations affecting human ER to Golgi vesicle-mediated transport, intra-Golgi vesicle-mediated transport and retrograde vesicle-mediated transport, Golgi to ER-ER to Golgi vesicle-mediated transport cause monogenic forms of inherited, autosomal recessive protein glycosylation.">
    <entity charOffset="160-198" id="s4319.e0" ontology_id="GO_0006888" text="ER to Golgi vesicle-mediated transport" type="GO"/>
    <entity charOffset="235-254" id="s4319.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4319.e0" e2="s4319.e1" id="s4319.p0" relation="true"/>
  </sentence>
  <sentence id="s4320" text="Mutations affecting human ER to Golgi vesicle-mediated transport, intra-Golgi vesicle-mediated transport and retrograde vesicle-mediated transport, Golgi to ER-ER to Golgi vesicle-mediated transport cause monogenic forms of inherited, autosomal recessive protein glycosylation.">
    <entity charOffset="235-254" id="s4320.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="255-276" id="s4320.e1" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <pair e1="s4320.e0" e2="s4320.e1" id="s4320.p0" relation="true"/>
  </sentence>
  <sentence id="s4321" text="Minichromosome maintenance protein 5 (G1/S transition of mitotic cell cycle) has been suggested overexpressed in cervical cancer, but the clinical value and biological function of MCM5 in cervical cancer is still unknown.">
    <entity charOffset="38-75" id="s4321.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="122-128" id="s4321.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4321.e0" e2="s4321.e1" id="s4321.p0" relation="false"/>
  </sentence>
  <sentence id="s4322" text="In our study, G1/S transition of mitotic cell cycle mRNA and protein were significantly overexpressed in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical squamous cell carcinoma tissues and cell lines.">
    <entity charOffset="14-51" id="s4322.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="114-120" id="s4322.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4322.e0" e2="s4322.e1" id="s4322.p0" relation="false"/>
  </sentence>
  <sentence id="s4323" text="In our study, G1/S transition of mitotic cell cycle mRNA and protein were significantly overexpressed in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical squamous cell carcinoma tissues and cell lines.">
    <entity charOffset="14-51" id="s4323.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="303-326" id="s4323.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s4323.e0" e2="s4323.e1" id="s4323.p0" relation="false"/>
  </sentence>
  <sentence id="s4324" text="We tried to elucidate the role of three 3p21.3 TSGs: negative regulation of cell proliferation, cell adhesion and mismatch repair, in non-small cell lung cancer (NSCLC).">
    <entity charOffset="53-94" id="s4324.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="154-160" id="s4324.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4324.e0" e2="s4324.e1" id="s4324.p0" relation="true"/>
  </sentence>
  <sentence id="s4325" text="We tried to elucidate the role of three 3p21.3 TSGs: negative regulation of cell proliferation, cell adhesion and mismatch repair, in non-small cell lung cancer (NSCLC).">
    <entity charOffset="96-109" id="s4325.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="154-160" id="s4325.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4325.e0" e2="s4325.e1" id="s4325.p0" relation="false"/>
  </sentence>
  <sentence id="s4326" text="We tried to elucidate the role of three 3p21.3 TSGs: negative regulation of cell proliferation, cell adhesion and mismatch repair, in non-small cell lung cancer (NSCLC).">
    <entity charOffset="114-129" id="s4326.e0" ontology_id="GO_0006298" text="mismatch repair" type="GO"/>
    <entity charOffset="154-160" id="s4326.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4326.e0" e2="s4326.e1" id="s4326.p0" relation="true"/>
  </sentence>
  <sentence id="s4327" text="In case of negative regulation of cell proliferation and ITGA9, expression levels were decreased in 71-78% of tumor samples and significantly different between tumor and normal tissues (P=0.0001).">
    <entity charOffset="11-52" id="s4327.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="111-116" id="s4327.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4327.e0" e2="s4327.e1" id="s4327.p0" relation="true"/>
  </sentence>
  <sentence id="s4328" text="cell adhesion could also be regarded as a diagnostic marker differentiating NSCLC subtypes, as its expression level was significantly lower in squamous cell carcinoma (P=0.001).">
    <entity charOffset="0-13" id="s4328.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="143-166" id="s4328.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s4328.e0" e2="s4328.e1" id="s4328.p0" relation="false"/>
  </sentence>
  <sentence id="s4329" text="A negative regulation of transcription, DNA-templated of ten plasma and serum samples from subjects with multiple sclerosis, narcolepsy, and without any disease diagnosis were profiled on a peptide array representing the whole proteome, hosting 2.2 million 12-mer peptides with a six amino acid lateral shift.">
    <entity charOffset="2-53" id="s4329.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="125-135" id="s4329.e1" ontology_id="HP_0030050" text="narcolepsy" type="HP"/>
    <pair e1="s4329.e0" e2="s4329.e1" id="s4329.p0" relation="false"/>
  </sentence>
  <sentence id="s4330" text="The presented workflow employed three different peptide microarray formats to discover and resolve the epitopes of human autoantibodies and revealed two potentially new autoantigens: activation of MAPKK activity in multiple sclerosis and NRXN1 in narcolepsy.">
    <entity charOffset="183-211" id="s4330.e0" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <entity charOffset="247-257" id="s4330.e1" ontology_id="HP_0030050" text="narcolepsy" type="HP"/>
    <pair e1="s4330.e0" e2="s4330.e1" id="s4330.p0" relation="false"/>
  </sentence>
  <sentence id="s4331" text="protein glycosylation-CDG is an autosomal recessive disease with a large phenotypic spectrum, and is associated with mutations in the &lt;i&gt;PMM2&lt;/i&gt; gene.">
    <entity charOffset="0-21" id="s4331.e0" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <entity charOffset="32-51" id="s4331.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4331.e0" e2="s4331.e1" id="s4331.p0" relation="true"/>
  </sentence>
  <sentence id="s4332" text="Recently, autosomal recessive loss-of-function mutations in EXPH5 (encoding exophilin-5, also known as keratinocyte development, a protein involved in intracellular vesicle transport) were identified in a new mechanobullous disease resembling a form of epidermolysis bullosa simplex (EBS).">
    <entity charOffset="10-29" id="s4332.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="103-127" id="s4332.e1" ontology_id="GO_0003334" text="keratinocyte development" type="GO"/>
    <pair e1="s4332.e0" e2="s4332.e1" id="s4332.p0" relation="true"/>
  </sentence>
  <sentence id="s4333" text="This case represents the third pedigree with keratinocyte development mutations resulting in inherited skin fragility.">
    <entity charOffset="45-69" id="s4333.e0" ontology_id="GO_0003334" text="keratinocyte development" type="GO"/>
    <entity charOffset="103-117" id="s4333.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s4333.e0" e2="s4333.e1" id="s4333.p0" relation="true"/>
  </sentence>
  <sentence id="s4334" text="Epilepsy with mental retardation limited to females (homophilic cell adhesion via plasma membrane adhesion molecules) is a syndrome characterized by early onset heat-sensitive epilepsy of infancy or early childhood and generally limited to females, which previously reported that the integrin-mediated signaling pathway gene superfamily subtype protocadherin 19 (PCDH19) gene is its pathogenic gene.">
    <entity charOffset="53-116" id="s4334.e0" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <entity charOffset="176-184" id="s4334.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4334.e0" e2="s4334.e1" id="s4334.p0" relation="true"/>
  </sentence>
  <sentence id="s4335" text="Epilepsy with mental retardation limited to females (homophilic cell adhesion via plasma membrane adhesion molecules) is a syndrome characterized by early onset heat-sensitive epilepsy of infancy or early childhood and generally limited to females, which previously reported that the integrin-mediated signaling pathway gene superfamily subtype protocadherin 19 (PCDH19) gene is its pathogenic gene.">
    <entity charOffset="176-184" id="s4335.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="284-319" id="s4335.e1" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <pair e1="s4335.e0" e2="s4335.e1" id="s4335.p0" relation="false"/>
  </sentence>
  <sentence id="s4336" text="Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo homophilic cell adhesion via plasma membrane adhesion molecules gene mutations were found in their epilepsy gene protein polyubiquitination sequencing.">
    <entity charOffset="24-30" id="s4336.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="189-252" id="s4336.e1" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <pair e1="s4336.e0" e2="s4336.e1" id="s4336.p0" relation="false"/>
  </sentence>
  <sentence id="s4337" text="Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo homophilic cell adhesion via plasma membrane adhesion molecules gene mutations were found in their epilepsy gene protein polyubiquitination sequencing.">
    <entity charOffset="24-30" id="s4337.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="302-328" id="s4337.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s4337.e0" e2="s4337.e1" id="s4337.p0" relation="false"/>
  </sentence>
  <sentence id="s4338" text="Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the positive regulation of transforming growth factor beta1 production gene.">
    <entity charOffset="51-70" id="s4338.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="147-213" id="s4338.e1" ontology_id="GO_0032914" text="positive regulation of transforming growth factor beta1 production" type="GO"/>
    <pair e1="s4338.e0" e2="s4338.e1" id="s4338.p0" relation="true"/>
  </sentence>
  <sentence id="s4339" text="Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the positive regulation of transforming growth factor beta1 production gene.">
    <entity charOffset="79-103" id="s4339.e0" ontology_id="HP_0000982" text="palmoplantar keratoderma" type="HP"/>
    <entity charOffset="147-213" id="s4339.e1" ontology_id="GO_0032914" text="positive regulation of transforming growth factor beta1 production" type="GO"/>
    <pair e1="s4339.e0" e2="s4339.e1" id="s4339.p0" relation="true"/>
  </sentence>
  <sentence id="s4340" text="Gastrointestinal stromal tumors (GISTs) are the most common muscle organ development of mesenchymal tumor of the digestive tract.">
    <entity charOffset="25-31" id="s4340.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="60-84" id="s4340.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4340.e0" e2="s4340.e1" id="s4340.p0" relation="false"/>
  </sentence>
  <sentence id="s4341" text="Gastrointestinal stromal tumors (GISTs) are the most common muscle organ development of mesenchymal tumor of the digestive tract.">
    <entity charOffset="60-84" id="s4341.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="100-105" id="s4341.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4341.e0" e2="s4341.e1" id="s4341.p0" relation="false"/>
  </sentence>
  <sentence id="s4342" text="Dysregulated protein polyubiquitinationNAs are involved in various muscle organ developments of human disease, including cancer.">
    <entity charOffset="13-39" id="s4342.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="121-127" id="s4342.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4342.e0" e2="s4342.e1" id="s4342.p0" relation="false"/>
  </sentence>
  <sentence id="s4343" text="Dysregulated protein polyubiquitinationNAs are involved in various muscle organ developments of human disease, including cancer.">
    <entity charOffset="67-91" id="s4343.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="121-127" id="s4343.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4343.e0" e2="s4343.e1" id="s4343.p0" relation="false"/>
  </sentence>
  <sentence id="s4344" text="Breast tissue and blood from patients with invasive breast cancer (n=38) and benign breast disease (n=30) were compared with those from healthy individuals (n=36), matched with the cancer patients by age at diagnosis, ethnicity, body cell adhesion mediated by integrin index, menopausal status and familial history of cancer.">
    <entity charOffset="59-65" id="s4344.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="240-274" id="s4344.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s4344.e0" e2="s4344.e1" id="s4344.p0" relation="false"/>
  </sentence>
  <sentence id="s4345" text="Tumor-specific methylation changes at positive regulation of cell proliferation protein deubiquitination2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, regulation of cyclin-dependent protein serine/threonine kinase activity DMR in 36%, negative regulation of Wnt signaling pathway ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="38-79" id="s4345.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="130-136" id="s4345.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4345.e0" e2="s4345.e1" id="s4345.p0" relation="true"/>
  </sentence>
  <sentence id="s4346" text="Tumor-specific methylation changes at positive regulation of cell proliferation protein deubiquitination2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, regulation of cyclin-dependent protein serine/threonine kinase activity DMR in 36%, negative regulation of Wnt signaling pathway ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="80-104" id="s4346.e0" ontology_id="GO_0016579" text="protein deubiquitination" type="GO"/>
    <entity charOffset="130-136" id="s4346.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4346.e0" e2="s4346.e1" id="s4346.p0" relation="false"/>
  </sentence>
  <sentence id="s4347" text="Tumor-specific methylation changes at positive regulation of cell proliferation protein deubiquitination2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, regulation of cyclin-dependent protein serine/threonine kinase activity DMR in 36%, negative regulation of Wnt signaling pathway ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="130-136" id="s4347.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="165-236" id="s4347.e1" ontology_id="GO_0000079" text="regulation of cyclin-dependent protein serine/threonine kinase activity" type="GO"/>
    <pair e1="s4347.e0" e2="s4347.e1" id="s4347.p0" relation="false"/>
  </sentence>
  <sentence id="s4348" text="Tumor-specific methylation changes at positive regulation of cell proliferation protein deubiquitination2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, regulation of cyclin-dependent protein serine/threonine kinase activity DMR in 36%, negative regulation of Wnt signaling pathway ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.">
    <entity charOffset="130-136" id="s4348.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="249-293" id="s4348.e1" ontology_id="GO_0030178" text="negative regulation of Wnt signaling pathway" type="GO"/>
    <pair e1="s4348.e0" e2="s4348.e1" id="s4348.p0" relation="false"/>
  </sentence>
  <sentence id="s4349" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, response to virus, and starch catabolic process), the JAK/STAT cascade, and epigenetic modifiers (response to estrogen, histone H2A monoubiquitination, nucleosome disassembly, and EP300).">
    <entity charOffset="133-138" id="s4349.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="158-175" id="s4349.e1" ontology_id="GO_0009615" text="response to virus" type="GO"/>
    <pair e1="s4349.e0" e2="s4349.e1" id="s4349.p0" relation="false"/>
  </sentence>
  <sentence id="s4350" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, response to virus, and starch catabolic process), the JAK/STAT cascade, and epigenetic modifiers (response to estrogen, histone H2A monoubiquitination, nucleosome disassembly, and EP300).">
    <entity charOffset="133-138" id="s4350.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="181-205" id="s4350.e1" ontology_id="GO_0005983" text="starch catabolic process" type="GO"/>
    <pair e1="s4350.e0" e2="s4350.e1" id="s4350.p0" relation="false"/>
  </sentence>
  <sentence id="s4351" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, response to virus, and starch catabolic process), the JAK/STAT cascade, and epigenetic modifiers (response to estrogen, histone H2A monoubiquitination, nucleosome disassembly, and EP300).">
    <entity charOffset="133-138" id="s4351.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="256-276" id="s4351.e1" ontology_id="GO_0043627" text="response to estrogen" type="GO"/>
    <pair e1="s4351.e0" e2="s4351.e1" id="s4351.p0" relation="false"/>
  </sentence>
  <sentence id="s4352" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, response to virus, and starch catabolic process), the JAK/STAT cascade, and epigenetic modifiers (response to estrogen, histone H2A monoubiquitination, nucleosome disassembly, and EP300).">
    <entity charOffset="133-138" id="s4352.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="278-308" id="s4352.e1" ontology_id="GO_0035518" text="histone H2A monoubiquitination" type="GO"/>
    <pair e1="s4352.e0" e2="s4352.e1" id="s4352.p0" relation="false"/>
  </sentence>
  <sentence id="s4353" text="This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, response to virus, and starch catabolic process), the JAK/STAT cascade, and epigenetic modifiers (response to estrogen, histone H2A monoubiquitination, nucleosome disassembly, and EP300).">
    <entity charOffset="133-138" id="s4353.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="310-332" id="s4353.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s4353.e0" e2="s4353.e1" id="s4353.p0" relation="false"/>
  </sentence>
  <sentence id="s4354" text="Auditory neuropathy is a muscle organ development of hearing loss that constitutes a change in the conduct of the auditory stimulus by the involvement of inner hair cells or auditory nerve synapses.">
    <entity charOffset="25-49" id="s4354.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="53-65" id="s4354.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4354.e0" e2="s4354.e1" id="s4354.p0" relation="false"/>
  </sentence>
  <sentence id="s4355" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="61-71" id="s4355.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="144-171" id="s4355.e1" ontology_id="GO_0016079" text="synaptic vesicle exocytosis" type="GO"/>
    <pair e1="s4355.e0" e2="s4355.e1" id="s4355.p0" relation="false"/>
  </sentence>
  <sentence id="s4356" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="61-71" id="s4356.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="238-256" id="s4356.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4356.e0" e2="s4356.e1" id="s4356.p0" relation="false"/>
  </sentence>
  <sentence id="s4357" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="61-71" id="s4357.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="388-413" id="s4357.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s4357.e0" e2="s4357.e1" id="s4357.p0" relation="false"/>
  </sentence>
  <sentence id="s4358" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="110-118" id="s4358.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="144-171" id="s4358.e1" ontology_id="GO_0016079" text="synaptic vesicle exocytosis" type="GO"/>
    <pair e1="s4358.e0" e2="s4358.e1" id="s4358.p0" relation="true"/>
  </sentence>
  <sentence id="s4359" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="110-118" id="s4359.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="238-256" id="s4359.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4359.e0" e2="s4359.e1" id="s4359.p0" relation="true"/>
  </sentence>
  <sentence id="s4360" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="144-171" id="s4360.e0" ontology_id="GO_0016079" text="synaptic vesicle exocytosis" type="GO"/>
    <entity charOffset="301-312" id="s4360.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s4360.e0" e2="s4360.e1" id="s4360.p0" relation="false"/>
  </sentence>
  <sentence id="s4361" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="238-256" id="s4361.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="301-312" id="s4361.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s4361.e0" e2="s4361.e1" id="s4361.p0" relation="false"/>
  </sentence>
  <sentence id="s4362" text="At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosomeX.">
    <entity charOffset="301-312" id="s4362.e0" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <entity charOffset="388-413" id="s4362.e1" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <pair e1="s4362.e0" e2="s4362.e1" id="s4362.p0" relation="false"/>
  </sentence>
  <sentence id="s4363" text="synaptic vesicle exocytosis gene mutations exert a significant role in auditory neuropathy.">
    <entity charOffset="0-27" id="s4363.e0" ontology_id="GO_0016079" text="synaptic vesicle exocytosis" type="GO"/>
    <entity charOffset="80-90" id="s4363.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s4363.e0" e2="s4363.e1" id="s4363.p0" relation="false"/>
  </sentence>
  <sentence id="s4364" text="The identification of genetic alterations responsible for auditory neuropathy is one of the challenges contributing to understand the molecular bases of the different phenomuscle organ developments of hearing loss.">
    <entity charOffset="67-77" id="s4364.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="172-196" id="s4364.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4364.e0" e2="s4364.e1" id="s4364.p0" relation="false"/>
  </sentence>
  <sentence id="s4365" text="The identification of genetic alterations responsible for auditory neuropathy is one of the challenges contributing to understand the molecular bases of the different phenomuscle organ developments of hearing loss.">
    <entity charOffset="172-196" id="s4365.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="201-213" id="s4365.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4365.e0" e2="s4365.e1" id="s4365.p0" relation="false"/>
  </sentence>
  <sentence id="s4366" text="Thus, the present study aimed to investigate molecular changes in the synaptic vesicle exocytosis gene in patients with auditory neuropathy, and to develop a DNA chip for the molecular diagnosis of auditory neuropathy using mass spectrometry for genotyping.">
    <entity charOffset="70-97" id="s4366.e0" ontology_id="GO_0016079" text="synaptic vesicle exocytosis" type="GO"/>
    <entity charOffset="129-139" id="s4366.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s4366.e0" e2="s4366.e1" id="s4366.p0" relation="false"/>
  </sentence>
  <sentence id="s4367" text="Genetic alterations were investigated in 47patients with hearing loss and clinical diagnosis of auditory neuropathy, and the c.35delG mutation in the gap junction-mediated intercellular transport gene was identified in three homozygous patients, and the heterozygous parents of one of these cases.">
    <entity charOffset="58-70" id="s4367.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="151-196" id="s4367.e1" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <pair e1="s4367.e0" e2="s4367.e1" id="s4367.p0" relation="true"/>
  </sentence>
  <sentence id="s4368" text="Genetic alterations were investigated in 47patients with hearing loss and clinical diagnosis of auditory neuropathy, and the c.35delG mutation in the gap junction-mediated intercellular transport gene was identified in three homozygous patients, and the heterozygous parents of one of these cases.">
    <entity charOffset="106-116" id="s4368.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="151-196" id="s4368.e1" ontology_id="GO_1990349" text="gap junction-mediated intercellular transport" type="GO"/>
    <pair e1="s4368.e0" e2="s4368.e1" id="s4368.p0" relation="false"/>
  </sentence>
  <sentence id="s4369" text="Several candidate genes for obesity and T2D (e.g., insulin receptor signaling pathway and VEGFA) were differentially expressed in discordant twins.">
    <entity charOffset="28-35" id="s4369.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="51-85" id="s4369.e1" ontology_id="GO_0008286" text="insulin receptor signaling pathway" type="GO"/>
    <pair e1="s4369.e0" e2="s4369.e1" id="s4369.p0" relation="false"/>
  </sentence>
  <sentence id="s4370" text="The sensory perception of sound locus harbors sensory perception of sound mutations in which have been reported in a few families with deafness.">
    <entity charOffset="4-31" id="s4370.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="135-143" id="s4370.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s4370.e0" e2="s4370.e1" id="s4370.p0" relation="true"/>
  </sentence>
  <sentence id="s4371" text="The sensory perception of sound locus harbors sensory perception of sound mutations in which have been reported in a few families with deafness.">
    <entity charOffset="46-73" id="s4371.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="135-143" id="s4371.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s4371.e0" e2="s4371.e1" id="s4371.p0" relation="true"/>
  </sentence>
  <sentence id="s4372" text="Four frameshift mutations in sensory perception of sound have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.">
    <entity charOffset="29-56" id="s4372.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="106-114" id="s4372.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s4372.e0" e2="s4372.e1" id="s4372.p0" relation="false"/>
  </sentence>
  <sentence id="s4373" text="Four frameshift mutations in sensory perception of sound have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.">
    <entity charOffset="29-56" id="s4373.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="115-127" id="s4373.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4373.e0" e2="s4373.e1" id="s4373.p0" relation="true"/>
  </sentence>
  <sentence id="s4374" text="Four frameshift mutations in sensory perception of sound have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.">
    <entity charOffset="29-56" id="s4374.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="217-228" id="s4374.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s4374.e0" e2="s4374.e1" id="s4374.p0" relation="false"/>
  </sentence>
  <sentence id="s4375" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="21-56" id="s4375.e0" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <entity charOffset="100-110" id="s4375.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s4375.e0" e2="s4375.e1" id="s4375.p0" relation="true"/>
  </sentence>
  <sentence id="s4376" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="21-56" id="s4376.e0" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <entity charOffset="281-287" id="s4376.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4376.e0" e2="s4376.e1" id="s4376.p0" relation="false"/>
  </sentence>
  <sentence id="s4377" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="100-110" id="s4377.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="111-135" id="s4377.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4377.e0" e2="s4377.e1" id="s4377.p0" relation="false"/>
  </sentence>
  <sentence id="s4378" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="100-110" id="s4378.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="197-242" id="s4378.e1" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <pair e1="s4378.e0" e2="s4378.e1" id="s4378.p0" relation="false"/>
  </sentence>
  <sentence id="s4379" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="111-135" id="s4379.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="262-270" id="s4379.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s4379.e0" e2="s4379.e1" id="s4379.p0" relation="false"/>
  </sentence>
  <sentence id="s4380" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="111-135" id="s4380.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="281-287" id="s4380.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4380.e0" e2="s4380.e1" id="s4380.p0" relation="false"/>
  </sentence>
  <sentence id="s4381" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="139-174" id="s4381.e0" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <entity charOffset="262-270" id="s4381.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s4381.e0" e2="s4381.e1" id="s4381.p0" relation="true"/>
  </sentence>
  <sentence id="s4382" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="139-174" id="s4382.e0" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <entity charOffset="281-287" id="s4382.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4382.e0" e2="s4382.e1" id="s4382.p0" relation="false"/>
  </sentence>
  <sentence id="s4383" text="The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.">
    <entity charOffset="197-242" id="s4383.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="262-270" id="s4383.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s4383.e0" e2="s4383.e1" id="s4383.p0" relation="false"/>
  </sentence>
  <sentence id="s4384" text="Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding pyrimidine nucleoside metabolic process in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases.">
    <entity charOffset="123-141" id="s4384.e0" ontology_id="HP_0002204" text="pulmonary embolism" type="HP"/>
    <entity charOffset="157-196" id="s4384.e1" ontology_id="GO_0006213" text="pyrimidine nucleoside metabolic process" type="GO"/>
    <pair e1="s4384.e0" e2="s4384.e1" id="s4384.p0" relation="false"/>
  </sentence>
  <sentence id="s4385" text="Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding pyrimidine nucleoside metabolic process in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases.">
    <entity charOffset="157-196" id="s4385.e0" ontology_id="GO_0006213" text="pyrimidine nucleoside metabolic process" type="GO"/>
    <entity charOffset="268-291" id="s4385.e1" ontology_id="HP_0001626" text="cardiovascular diseases" type="HP"/>
    <pair e1="s4385.e0" e2="s4385.e1" id="s4385.p0" relation="false"/>
  </sentence>
  <sentence id="s4386" text="A total of nine non-coding variants on 11q13.5 predispose negative regulation of phosphatase activity to prostate cancer (PrCa). rs200331695 within the EMSY intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.">
    <entity charOffset="58-101" id="s4386.e0" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <entity charOffset="114-120" id="s4386.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4386.e0" e2="s4386.e1" id="s4386.p0" relation="false"/>
  </sentence>
  <sentence id="s4387" text="The results were validated in a second tumor negative regulation of transcription, DNA-templated (n=41), in lymphoblastoid cell lines (LCLs) (n=38), and using the GTEx Portal.">
    <entity charOffset="39-44" id="s4387.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="45-96" id="s4387.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4387.e0" e2="s4387.e1" id="s4387.p0" relation="false"/>
  </sentence>
  <sentence id="s4388" text="The findings indicate the functionality of the PrCa death-predisposing SNPs rs143975731, rs12277366, rs2155225, and rs2155222 as triglyceride biosynthetic process regulators in prostate tumors.">
    <entity charOffset="129-162" id="s4388.e0" ontology_id="GO_0019432" text="triglyceride biosynthetic process" type="GO"/>
    <entity charOffset="186-192" id="s4388.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4388.e0" e2="s4388.e1" id="s4388.p0" relation="false"/>
  </sentence>
  <sentence id="s4389" text="The mechanistic target of rapamycin (regulation of cell growth) is an established therapeutic target in renal cell carcinoma (response to hydroperoxide).">
    <entity charOffset="37-62" id="s4389.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="104-124" id="s4389.e1" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <pair e1="s4389.e0" e2="s4389.e1" id="s4389.p0" relation="false"/>
  </sentence>
  <sentence id="s4390" text="The mechanistic target of rapamycin (regulation of cell growth) is an established therapeutic target in renal cell carcinoma (response to hydroperoxide).">
    <entity charOffset="104-124" id="s4390.e0" ontology_id="HP_0005584" text="renal cell carcinoma" type="HP"/>
    <entity charOffset="126-151" id="s4390.e1" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <pair e1="s4390.e0" e2="s4390.e1" id="s4390.p0" relation="false"/>
  </sentence>
  <sentence id="s4391" text="We identified six patients with metastatic response to hydroperoxide who initially responded to regulation of cell growth inhibitor therapy and then progressed, and had pre-treatment and post-treatment tumor samples available for analysis.">
    <entity charOffset="43-68" id="s4391.e0" ontology_id="GO_0033194" text="response to hydroperoxide" type="GO"/>
    <entity charOffset="202-207" id="s4391.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4391.e0" e2="s4391.e1" id="s4391.p0" relation="false"/>
  </sentence>
  <sentence id="s4392" text="We identified six patients with metastatic response to hydroperoxide who initially responded to regulation of cell growth inhibitor therapy and then progressed, and had pre-treatment and post-treatment tumor samples available for analysis.">
    <entity charOffset="96-121" id="s4392.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="202-207" id="s4392.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4392.e0" e2="s4392.e1" id="s4392.p0" relation="false"/>
  </sentence>
  <sentence id="s4393" text="Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated translational initiation-positive regulation of Wnt signaling pathway and PTPRK-positive regulation of Wnt signaling pathway chromosome rearrangements in vivo.">
    <entity charOffset="123-129" id="s4393.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="141-165" id="s4393.e1" ontology_id="GO_0006413" text="translational initiation" type="GO"/>
    <pair e1="s4393.e0" e2="s4393.e1" id="s4393.p0" relation="false"/>
  </sentence>
  <sentence id="s4394" text="Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated translational initiation-positive regulation of Wnt signaling pathway and PTPRK-positive regulation of Wnt signaling pathway chromosome rearrangements in vivo.">
    <entity charOffset="123-129" id="s4394.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="166-210" id="s4394.e1" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <pair e1="s4394.e0" e2="s4394.e1" id="s4394.p0" relation="false"/>
  </sentence>
  <sentence id="s4395" text="Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated translational initiation-positive regulation of Wnt signaling pathway and PTPRK-positive regulation of Wnt signaling pathway chromosome rearrangements in vivo.">
    <entity charOffset="123-129" id="s4395.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="221-265" id="s4395.e1" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <pair e1="s4395.e0" e2="s4395.e1" id="s4395.p0" relation="false"/>
  </sentence>
  <sentence id="s4396" text="We show that both positive regulation of Wnt signaling pathway and Rspo3 fusion events are sufficient to initiate hyperplasia and tumour development in vivo, without additional cooperating genetic events.">
    <entity charOffset="18-62" id="s4396.e0" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="130-136" id="s4396.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4396.e0" e2="s4396.e1" id="s4396.p0" relation="false"/>
  </sentence>
  <sentence id="s4397" text="Altogether, our study provides direct evidence that endogenous positive regulation of Wnt signaling pathway and positive regulation of Wnt signaling pathway chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers">
    <entity charOffset="63-107" id="s4397.e0" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="209-215" id="s4397.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4397.e0" e2="s4397.e1" id="s4397.p0" relation="false"/>
  </sentence>
  <sentence id="s4398" text="Altogether, our study provides direct evidence that endogenous positive regulation of Wnt signaling pathway and positive regulation of Wnt signaling pathway chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers">
    <entity charOffset="112-156" id="s4398.e0" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="306-312" id="s4398.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4398.e0" e2="s4398.e1" id="s4398.p0" relation="false"/>
  </sentence>
  <sentence id="s4399" text="Altogether, our study provides direct evidence that endogenous positive regulation of Wnt signaling pathway and positive regulation of Wnt signaling pathway chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers">
    <entity charOffset="112-156" id="s4399.e0" ontology_id="GO_0030177" text="positive regulation of Wnt signaling pathway" type="GO"/>
    <entity charOffset="209-215" id="s4399.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4399.e0" e2="s4399.e1" id="s4399.p0" relation="false"/>
  </sentence>
  <sentence id="s4400" text="In respect to achalasia, circadian regulation of gene expression-oral endoscopic myotomy (ureteric bud development) which was developed in Japan, has become an alternative to the traditional Heller's myotomy.">
    <entity charOffset="14-23" id="s4400.e0" ontology_id="HP_0002571" text="achalasia" type="HP"/>
    <entity charOffset="25-64" id="s4400.e1" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <pair e1="s4400.e0" e2="s4400.e1" id="s4400.p0" relation="false"/>
  </sentence>
  <sentence id="s4401" text="In respect to achalasia, circadian regulation of gene expression-oral endoscopic myotomy (ureteric bud development) which was developed in Japan, has become an alternative to the traditional Heller's myotomy.">
    <entity charOffset="14-23" id="s4401.e0" ontology_id="HP_0002571" text="achalasia" type="HP"/>
    <entity charOffset="90-114" id="s4401.e1" ontology_id="GO_0001657" text="ureteric bud development" type="GO"/>
    <pair e1="s4401.e0" e2="s4401.e1" id="s4401.p0" relation="false"/>
  </sentence>
  <sentence id="s4402" text="In regard to BE, endoscopic submucosal dissection (glutathione derivative biosynthetic process) which is well established in Asia, is now becoming more mainstream in the West for the treatment of BE with high grade dysplasia, as well as early esophageal cancer.">
    <entity charOffset="51-94" id="s4402.e0" ontology_id="GO_1901687" text="glutathione derivative biosynthetic process" type="GO"/>
    <entity charOffset="254-260" id="s4402.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4402.e0" e2="s4402.e1" id="s4402.p0" relation="false"/>
  </sentence>
  <sentence id="s4403" text="Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, glutathione derivative biosynthetic process and full thickness resection (FTR) can excise these lesions &lt;i&gt;en-bloc&lt;/i&gt; and endoscopic suturing is now used to close large defects and circadian regulation of gene expressionforations.">
    <entity charOffset="40-46" id="s4403.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="274-313" id="s4403.e1" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <pair e1="s4403.e0" e2="s4403.e1" id="s4403.p0" relation="false"/>
  </sentence>
  <sentence id="s4404" text="Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, glutathione derivative biosynthetic process and full thickness resection (FTR) can excise these lesions &lt;i&gt;en-bloc&lt;/i&gt; and endoscopic suturing is now used to close large defects and circadian regulation of gene expressionforations.">
    <entity charOffset="40-46" id="s4404.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="92-135" id="s4404.e1" ontology_id="GO_1901687" text="glutathione derivative biosynthetic process" type="GO"/>
    <pair e1="s4404.e0" e2="s4404.e1" id="s4404.p0" relation="false"/>
  </sentence>
  <sentence id="s4405" text="Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, glutathione derivative biosynthetic process and full thickness resection (FTR) can excise these lesions &lt;i&gt;en-bloc&lt;/i&gt; and endoscopic suturing is now used to close large defects and circadian regulation of gene expressionforations.">
    <entity charOffset="62-68" id="s4405.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="274-313" id="s4405.e1" ontology_id="GO_0032922" text="circadian regulation of gene expression" type="GO"/>
    <pair e1="s4405.e0" e2="s4405.e1" id="s4405.p0" relation="false"/>
  </sentence>
  <sentence id="s4406" text="Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, glutathione derivative biosynthetic process and full thickness resection (FTR) can excise these lesions &lt;i&gt;en-bloc&lt;/i&gt; and endoscopic suturing is now used to close large defects and circadian regulation of gene expressionforations.">
    <entity charOffset="62-68" id="s4406.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="92-135" id="s4406.e1" ontology_id="GO_1901687" text="glutathione derivative biosynthetic process" type="GO"/>
    <pair e1="s4406.e0" e2="s4406.e1" id="s4406.p0" relation="false"/>
  </sentence>
  <sentence id="s4407" text="Amyotrophic lateral sclerosis (signal transduction) is a complex neurodegenerative disease, characterized genetically by a disproportionately large contribution of rare genetic variation.">
    <entity charOffset="31-50" id="s4407.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="65-90" id="s4407.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s4407.e0" e2="s4407.e1" id="s4407.p0" relation="false"/>
  </sentence>
  <sentence id="s4408" text="&lt;i&gt;GPX2&lt;/i&gt; and &lt;i&gt;TXNRD3&lt;/i&gt; showed a higher expression and &lt;i&gt;GPX3&lt;/i&gt;, &lt;i&gt;platelet degranulation&lt;/i&gt;, &lt;i&gt;SELENOS&lt;/i&gt;, and &lt;i&gt;SEPHS2&lt;/i&gt; exhibited a lower expression in the disease tissue from adenomas and both cancer groups (&lt;i&gt;p&lt;/i&gt;-values from 0.023 to &amp;lt;0.001).">
    <entity charOffset="77-99" id="s4408.e0" ontology_id="GO_0002576" text="platelet degranulation" type="GO"/>
    <entity charOffset="213-219" id="s4408.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4408.e0" e2="s4408.e1" id="s4408.p0" relation="false"/>
  </sentence>
  <sentence id="s4409" text="Myelodysplastic syndromes (microtubule-based process) in children and adolescents are a rare heterogeneous group of clonal stem cell disorders.">
    <entity charOffset="27-52" id="s4409.e0" ontology_id="GO_0007017" text="microtubule-based process" type="GO"/>
    <entity charOffset="93-106" id="s4409.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4409.e0" e2="s4409.e1" id="s4409.p0" relation="false"/>
  </sentence>
  <sentence id="s4410" text="The roles of positive regulation of cell proliferation in human breast cancer remains elusive.">
    <entity charOffset="13-54" id="s4410.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="71-77" id="s4410.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4410.e0" e2="s4410.e1" id="s4410.p0" relation="false"/>
  </sentence>
  <sentence id="s4411" text="Here we report that positive regulation of cell proliferation acts as an oncogenic protein in human breast cancer.">
    <entity charOffset="20-61" id="s4411.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="107-113" id="s4411.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4411.e0" e2="s4411.e1" id="s4411.p0" relation="false"/>
  </sentence>
  <sentence id="s4412" text="We analyzed the expression of positive regulation of cell proliferation in 148 patients with breast cancer.">
    <entity charOffset="30-71" id="s4412.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="100-106" id="s4412.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4412.e0" e2="s4412.e1" id="s4412.p0" relation="false"/>
  </sentence>
  <sentence id="s4413" text="The mRNA and protein levels of positive regulation of cell proliferation are significantly up-regulated in human breast cancer compared with matched adjacent non-cancer tissues.">
    <entity charOffset="31-72" id="s4413.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="120-126" id="s4413.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4413.e0" e2="s4413.e1" id="s4413.p0" relation="false"/>
  </sentence>
  <sentence id="s4414" text="Lentivirus-mediated knockdown of positive regulation of cell proliferation represses in vitro proliferation and colony formation and in vivo growth of breast cancer cells, whereas STX3 overexpression promotes the growth of breast cancer cells in vitro and in vivo.">
    <entity charOffset="33-74" id="s4414.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="158-164" id="s4414.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4414.e0" e2="s4414.e1" id="s4414.p0" relation="false"/>
  </sentence>
  <sentence id="s4415" text="We cellular response to interleukin-4 that positive regulation of cell proliferation promotes the proliferation of breast cancer cells by increasing the activation of the Akt-regulation of cell growth signaling, and Akt inhibitor Ipatasertib or positive regulation of keratinocyte proliferation-2206 represses STX3 effects on the growth of breast cancer cells.">
    <entity charOffset="3-37" id="s4415.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="122-128" id="s4415.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4415.e0" e2="s4415.e1" id="s4415.p0" relation="false"/>
  </sentence>
  <sentence id="s4416" text="We cellular response to interleukin-4 that positive regulation of cell proliferation promotes the proliferation of breast cancer cells by increasing the activation of the Akt-regulation of cell growth signaling, and Akt inhibitor Ipatasertib or positive regulation of keratinocyte proliferation-2206 represses STX3 effects on the growth of breast cancer cells.">
    <entity charOffset="43-84" id="s4416.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="122-128" id="s4416.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4416.e0" e2="s4416.e1" id="s4416.p0" relation="false"/>
  </sentence>
  <sentence id="s4417" text="We cellular response to interleukin-4 that positive regulation of cell proliferation promotes the proliferation of breast cancer cells by increasing the activation of the Akt-regulation of cell growth signaling, and Akt inhibitor Ipatasertib or positive regulation of keratinocyte proliferation-2206 represses STX3 effects on the growth of breast cancer cells.">
    <entity charOffset="122-128" id="s4417.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="175-200" id="s4417.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s4417.e0" e2="s4417.e1" id="s4417.p0" relation="false"/>
  </sentence>
  <sentence id="s4418" text="We cellular response to interleukin-4 that positive regulation of cell proliferation promotes the proliferation of breast cancer cells by increasing the activation of the Akt-regulation of cell growth signaling, and Akt inhibitor Ipatasertib or positive regulation of keratinocyte proliferation-2206 represses STX3 effects on the growth of breast cancer cells.">
    <entity charOffset="122-128" id="s4418.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="245-294" id="s4418.e1" ontology_id="GO_0010838" text="positive regulation of keratinocyte proliferation" type="GO"/>
    <pair e1="s4418.e0" e2="s4418.e1" id="s4418.p0" relation="false"/>
  </sentence>
  <sentence id="s4419" text="Therefore, positive regulation of cell proliferation promotes the growth of breast cancer cells by regulating the negative regulation of protein phosphorylation-phosphorylation-Akt-mTOR signaling">
    <entity charOffset="11-52" id="s4419.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="83-89" id="s4419.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4419.e0" e2="s4419.e1" id="s4419.p0" relation="false"/>
  </sentence>
  <sentence id="s4420" text="Therefore, positive regulation of cell proliferation promotes the growth of breast cancer cells by regulating the negative regulation of protein phosphorylation-phosphorylation-Akt-mTOR signaling">
    <entity charOffset="83-89" id="s4420.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-160" id="s4420.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4420.e0" e2="s4420.e1" id="s4420.p0" relation="true"/>
  </sentence>
  <sentence id="s4421" text="Therefore, positive regulation of cell proliferation promotes the growth of breast cancer cells by regulating the negative regulation of protein phosphorylation-phosphorylation-Akt-mTOR signaling">
    <entity charOffset="83-89" id="s4421.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="161-176" id="s4421.e1" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <pair e1="s4421.e0" e2="s4421.e1" id="s4421.p0" relation="true"/>
  </sentence>
  <sentence id="s4422" text="No differences were found in age, multicellular organism development, mean arterial pressure, heart rate, HDL, cirrhosis etiology, degree of alcohol consumption, encephalopathy, variceal bleeding history, or hepatocellular carcinoma between patients with or without adrenal insufficiency.">
    <entity charOffset="34-68" id="s4422.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="162-176" id="s4422.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s4422.e0" e2="s4422.e1" id="s4422.p0" relation="false"/>
  </sentence>
  <sentence id="s4423" text="However, HoFH is clinically heterogeneous, reflecting residual low-density lipoprotein receptor (intestinal cholesterol absorption) activity.">
    <entity charOffset="28-41" id="s4423.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="97-130" id="s4423.e1" ontology_id="GO_0030299" text="intestinal cholesterol absorption" type="GO"/>
    <pair e1="s4423.e0" e2="s4423.e1" id="s4423.p0" relation="false"/>
  </sentence>
  <sentence id="s4424" text="Here, we show that TILs from epidermis development deleted in protocadherin-18 had enhanced antitumor activity and that coblockade of PD-1 and protocadherin-18 in wild-type mice significantly enhanced TIL effector phase function.">
    <entity charOffset="29-50" id="s4424.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="96-101" id="s4424.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4424.e0" e2="s4424.e1" id="s4424.p0" relation="false"/>
  </sentence>
  <sentence id="s4425" text="We report on an 8-year-old girl born to consanguineous Iraqi parents presenting with slowly progressive encephalomyopathy, severe failure to thrive, significant delays in verbal and communicative skills and bilateral retinal cherry protein phosphorylation spots on fundoscopy.">
    <entity charOffset="130-147" id="s4425.e0" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <entity charOffset="232-255" id="s4425.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s4425.e0" e2="s4425.e1" id="s4425.p0" relation="false"/>
  </sentence>
  <sentence id="s4426" text="We report on an 8-year-old girl born to consanguineous Iraqi parents presenting with slowly progressive encephalomyopathy, severe failure to thrive, significant delays in verbal and communicative skills and bilateral retinal cherry protein phosphorylation spots on fundoscopy.">
    <entity charOffset="207-216" id="s4426.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="232-255" id="s4426.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s4426.e0" e2="s4426.e1" id="s4426.p0" relation="false"/>
  </sentence>
  <sentence id="s4427" text="The bilateral retinal cherry protein phosphorylation spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with mitochondrial respiratory chain complex III assembly mutations.">
    <entity charOffset="4-13" id="s4427.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="194-246" id="s4427.e1" ontology_id="GO_0034551" text="mitochondrial respiratory chain complex III assembly" type="GO"/>
    <pair e1="s4427.e0" e2="s4427.e1" id="s4427.p0" relation="false"/>
  </sentence>
  <sentence id="s4428" text="The bilateral retinal cherry protein phosphorylation spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with mitochondrial respiratory chain complex III assembly mutations.">
    <entity charOffset="29-52" id="s4428.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="63-80" id="s4428.e1" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <pair e1="s4428.e0" e2="s4428.e1" id="s4428.p0" relation="false"/>
  </sentence>
  <sentence id="s4429" text="The bilateral retinal cherry protein phosphorylation spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with mitochondrial respiratory chain complex III assembly mutations.">
    <entity charOffset="63-80" id="s4429.e0" ontology_id="HP_0001508" text="failure to thrive" type="HP"/>
    <entity charOffset="194-246" id="s4429.e1" ontology_id="GO_0034551" text="mitochondrial respiratory chain complex III assembly" type="GO"/>
    <pair e1="s4429.e0" e2="s4429.e1" id="s4429.p0" relation="false"/>
  </sentence>
  <sentence id="s4430" text="We performed a clinical, neurophysiological (in vivo electroencephalography-auditory-evoked related potentials) and genetic (whole-exome sequencing) follow-up analysis of two families with known deleterious negative regulation of excitatory postsynaptic potential gene mutations (either truncating or overexpressing) present in individuals with ASD and/or with intellectual disability (ID).">
    <entity charOffset="207-263" id="s4430.e0" ontology_id="GO_0090394" text="negative regulation of excitatory postsynaptic potential" type="GO"/>
    <entity charOffset="361-384" id="s4430.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4430.e0" e2="s4430.e1" id="s4430.p0" relation="true"/>
  </sentence>
  <sentence id="s4431" text="Recently, defects of positive regulation of glycolytic process, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and autism.">
    <entity charOffset="21-62" id="s4431.e0" ontology_id="GO_0045821" text="positive regulation of glycolytic process" type="GO"/>
    <entity charOffset="211-234" id="s4431.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4431.e0" e2="s4431.e1" id="s4431.p0" relation="true"/>
  </sentence>
  <sentence id="s4432" text="Recently, defects of positive regulation of glycolytic process, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and autism.">
    <entity charOffset="21-62" id="s4432.e0" ontology_id="GO_0045821" text="positive regulation of glycolytic process" type="GO"/>
    <entity charOffset="239-245" id="s4432.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s4432.e0" e2="s4432.e1" id="s4432.p0" relation="true"/>
  </sentence>
  <sentence id="s4433" text="Two positive regulation of glycolytic process single nucleotide variants, located at the N-terminal and central regions of the protein and potentially conferring autism risk, altered dendritic spine morphology.">
    <entity charOffset="4-45" id="s4433.e0" ontology_id="GO_0045821" text="positive regulation of glycolytic process" type="GO"/>
    <entity charOffset="162-168" id="s4433.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s4433.e0" e2="s4433.e1" id="s4433.p0" relation="true"/>
  </sentence>
  <sentence id="s4434" text="In contrast, a single nucleotide variant identified in patients with intellectual disability and located at the C-terminus of positive regulation of glycolytic process affected dendritic arborization and dendritic length but had no effect on dendritic spine morphology.">
    <entity charOffset="69-92" id="s4434.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="126-167" id="s4434.e1" ontology_id="GO_0045821" text="positive regulation of glycolytic process" type="GO"/>
    <pair e1="s4434.e0" e2="s4434.e1" id="s4434.p0" relation="true"/>
  </sentence>
  <sentence id="s4435" text="Genetic workup confirmed the clinical diagnosis of camptodactyly-arthropathy-coxa vara-pericarditis (immune response) syndrome CACP syndrome and also revealed a rare mutation in the causative gene">
    <entity charOffset="51-64" id="s4435.e0" ontology_id="HP_0012385" text="camptodactyly" type="HP"/>
    <entity charOffset="101-116" id="s4435.e1" ontology_id="GO_0006955" text="immune response" type="GO"/>
    <pair e1="s4435.e0" e2="s4435.e1" id="s4435.p0" relation="true"/>
  </sentence>
  <sentence id="s4436" text="Deficits in protein polyubiquitinationNA biogenesis have been linked to neurological deficits in humans, and widespread changes in miRNA levels occur in epilepsy, traumatic brain injury, and in response to less dramatic brain insults in rodent models.">
    <entity charOffset="12-38" id="s4436.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="153-161" id="s4436.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4436.e0" e2="s4436.e1" id="s4436.p0" relation="false"/>
  </sentence>
  <sentence id="s4437" text="Recently, microdeletions encompassing &lt;i&gt;MIR137HG&lt;/i&gt;, the host gene which encodes the protein polyubiquitinationNA miR-137, have been linked to autism and intellectual disability, and genome wide association studies have linked this locus to schizophrenia.">
    <entity charOffset="87-113" id="s4437.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="145-151" id="s4437.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s4437.e0" e2="s4437.e1" id="s4437.p0" relation="false"/>
  </sentence>
  <sentence id="s4438" text="Recently, microdeletions encompassing &lt;i&gt;MIR137HG&lt;/i&gt;, the host gene which encodes the protein polyubiquitinationNA miR-137, have been linked to autism and intellectual disability, and genome wide association studies have linked this locus to schizophrenia.">
    <entity charOffset="87-113" id="s4438.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="156-179" id="s4438.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4438.e0" e2="s4438.e1" id="s4438.p0" relation="false"/>
  </sentence>
  <sentence id="s4439" text="Molecular biomarkers in blood are needed to somatic diversification of immunoglobulins the early diagnosis and clinical assessment of glioblastoma (GBM).">
    <entity charOffset="44-86" id="s4439.e0" ontology_id="GO_0016445" text="somatic diversification of immunoglobulins" type="GO"/>
    <entity charOffset="134-146" id="s4439.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s4439.e0" e2="s4439.e1" id="s4439.p0" relation="false"/>
  </sentence>
  <sentence id="s4440" text="The plasma concentrations of neutrophil degranulation, positive regulation of gene expression, and C9 showed significant positive correlations with tumor size (R2 = 0.534, 0.495, and 0.452, respectively)">
    <entity charOffset="29-53" id="s4440.e0" ontology_id="GO_0043312" text="neutrophil degranulation" type="GO"/>
    <entity charOffset="148-153" id="s4440.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4440.e0" e2="s4440.e1" id="s4440.p0" relation="false"/>
  </sentence>
  <sentence id="s4441" text="The plasma concentrations of neutrophil degranulation, positive regulation of gene expression, and C9 showed significant positive correlations with tumor size (R2 = 0.534, 0.495, and 0.452, respectively)">
    <entity charOffset="55-93" id="s4441.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="148-153" id="s4441.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4441.e0" e2="s4441.e1" id="s4441.p0" relation="false"/>
  </sentence>
  <sentence id="s4442" text="Hepatocellular carcinoma (phosphatidylinositol phosphorylation) is an aggressive and deadly cancer.">
    <entity charOffset="26-62" id="s4442.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="92-98" id="s4442.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4442.e0" e2="s4442.e1" id="s4442.p0" relation="false"/>
  </sentence>
  <sentence id="s4443" text="We compared the early transcriptome profile between DKD-resistant C57BL/6J and DKD-susceptible DBA/2J (D2) glomeruli and demonstrated a significant downregulation of essential mitochondrial genes in glomeruli from diabetic D2 epidermis development, but not in C57BL/6J, with comparable hyperglycemia.">
    <entity charOffset="226-247" id="s4443.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="286-299" id="s4443.e1" ontology_id="HP_0003074" text="hyperglycemia" type="HP"/>
    <pair e1="s4443.e0" e2="s4443.e1" id="s4443.p0" relation="false"/>
  </sentence>
  <sentence id="s4444" text="Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by negative regulation of transcription by RNA polymerase II-Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis">
    <entity charOffset="102-159" id="s4444.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="358-369" id="s4444.e1" ontology_id="HP_0012592" text="albuminuria" type="HP"/>
    <pair e1="s4444.e0" e2="s4444.e1" id="s4444.p0" relation="false"/>
  </sentence>
  <sentence id="s4445" text="The deleted in colorectal cancer (DCC) gene encodes the netrin-1 (substrate-dependent cell migration, cell extension) receptor DCC, a transmembrane protein required for the guidance of commissural axons.">
    <entity charOffset="26-32" id="s4445.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="66-116" id="s4445.e1" ontology_id="GO_0006930" text="substrate-dependent cell migration, cell extension" type="GO"/>
    <pair e1="s4445.e0" e2="s4445.e1" id="s4445.p0" relation="false"/>
  </sentence>
  <sentence id="s4446" text="Germline regulation of neuron death mutations disrupt the development of predominantly commissural tracts in the central nervous system (CNS) and cause a spectrum of neurological disorders.">
    <entity charOffset="9-35" id="s4446.e0" ontology_id="GO_1901214" text="regulation of neuron death" type="GO"/>
    <entity charOffset="113-120" id="s4446.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s4446.e0" e2="s4446.e1" id="s4446.p0" relation="false"/>
  </sentence>
  <sentence id="s4447" text="It is a genetic disorder caused by a mutation in the dysferlin gene (monocyte activation involved in immune response) with an autosomal recessive mode of inheritance.">
    <entity charOffset="69-116" id="s4447.e0" ontology_id="GO_0002280" text="monocyte activation involved in immune response" type="GO"/>
    <entity charOffset="146-165" id="s4447.e1" ontology_id="HP_0000005" text="mode of inheritance" type="HP"/>
    <pair e1="s4447.e0" e2="s4447.e1" id="s4447.p0" relation="false"/>
  </sentence>
  <sentence id="s4448" text="In this article, we report a case of Limb-girdle muscular dystrophy type 2B with a rare homozygous duplication c.164dupA, p.(Ile57Hisfs*8) (rs863225020) in monocyte activation involved in immune response in a Saudi patient.">
    <entity charOffset="49-67" id="s4448.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="156-203" id="s4448.e1" ontology_id="GO_0002280" text="monocyte activation involved in immune response" type="GO"/>
    <pair e1="s4448.e0" e2="s4448.e1" id="s4448.p0" relation="true"/>
  </sentence>
  <sentence id="s4449" text="Our results therefore confirm the protein tetramerizationR423H allele as causative for SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant inheritance, congenital onset, and disease pathology">
    <entity charOffset="34-57" id="s4449.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="186-197" id="s4449.e1" ontology_id="HP_0000005" text="inheritance" type="HP"/>
    <pair e1="s4449.e0" e2="s4449.e1" id="s4449.p0" relation="false"/>
  </sentence>
  <sentence id="s4450" text="Besides, previous evidence suggested that morphogenesis of a polarized epithelium expression was changed in schizophrenia patients.">
    <entity charOffset="42-81" id="s4450.e0" ontology_id="GO_0001738" text="morphogenesis of a polarized epithelium" type="GO"/>
    <entity charOffset="108-121" id="s4450.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4450.e0" e2="s4450.e1" id="s4450.p0" relation="false"/>
  </sentence>
  <sentence id="s4451" text="Furthermore, association signal between morphogenesis of a polarized epithelium variants and schizophrenia has been reported in several European samples.">
    <entity charOffset="40-79" id="s4451.e0" ontology_id="GO_0001738" text="morphogenesis of a polarized epithelium" type="GO"/>
    <entity charOffset="93-106" id="s4451.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4451.e0" e2="s4451.e1" id="s4451.p0" relation="false"/>
  </sentence>
  <sentence id="s4452" text="These results suggested that morphogenesis of a polarized epithelium is likely a risk gene for schizophrenia, at least in European populations.">
    <entity charOffset="29-68" id="s4452.e0" ontology_id="GO_0001738" text="morphogenesis of a polarized epithelium" type="GO"/>
    <entity charOffset="95-108" id="s4452.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4452.e0" e2="s4452.e1" id="s4452.p0" relation="false"/>
  </sentence>
  <sentence id="s4453" text="Pathogenic mutations have been identified in the nervous system development (nervous system development) and visual perception (visual perception) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.">
    <entity charOffset="49-75" id="s4453.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="250-256" id="s4453.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4453.e0" e2="s4453.e1" id="s4453.p0" relation="false"/>
  </sentence>
  <sentence id="s4454" text="Pathogenic mutations have been identified in the nervous system development (nervous system development) and visual perception (visual perception) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.">
    <entity charOffset="77-103" id="s4454.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="250-256" id="s4454.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4454.e0" e2="s4454.e1" id="s4454.p0" relation="false"/>
  </sentence>
  <sentence id="s4455" text="Pathogenic mutations have been identified in the nervous system development (nervous system development) and visual perception (visual perception) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.">
    <entity charOffset="109-126" id="s4455.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="250-256" id="s4455.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4455.e0" e2="s4455.e1" id="s4455.p0" relation="true"/>
  </sentence>
  <sentence id="s4456" text="Pathogenic mutations have been identified in the nervous system development (nervous system development) and visual perception (visual perception) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.">
    <entity charOffset="128-145" id="s4456.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="250-256" id="s4456.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4456.e0" e2="s4456.e1" id="s4456.p0" relation="true"/>
  </sentence>
  <sentence id="s4457" text="Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, negative regulation of transcription by RNA polymerase II or Twist.">
    <entity charOffset="112-118" id="s4457.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="268-325" id="s4457.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4457.e0" e2="s4457.e1" id="s4457.p0" relation="true"/>
  </sentence>
  <sentence id="s4458" text="PDT is a promising new modality in the treatment of cancers, which employs the interaction between a tumor-localizing photosensitizer and light of an appropriate wavelength to bring about regulation of cell growth-induced cell death.">
    <entity charOffset="101-106" id="s4458.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="188-213" id="s4458.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s4458.e0" e2="s4458.e1" id="s4458.p0" relation="false"/>
  </sentence>
  <sentence id="s4459" text="In vivo multispectral fluorescent imaging, the EGFP-mitochondrial translational elongation conjugated nanoparticles showed significantly higher accumulation in tumor tissues than non-conjugated ones.">
    <entity charOffset="52-90" id="s4459.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="160-165" id="s4459.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4459.e0" e2="s4459.e1" id="s4459.p0" relation="false"/>
  </sentence>
  <sentence id="s4460" text="Tumor tissue slides further presented that EGFP-mitochondrial translational elongation conjugated nanoparticles showed significantly higher accumulation in tumor vasculature than non-conjugated ones.">
    <entity charOffset="48-86" id="s4460.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="156-161" id="s4460.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4460.e0" e2="s4460.e1" id="s4460.p0" relation="false"/>
  </sentence>
  <sentence id="s4461" text="These promising results indicated that PDT enhanced EGFP-mitochondrial translational elongationmodified PEG-PLGA nanoparticle accumulation in tumor vaculature.">
    <entity charOffset="57-95" id="s4461.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="142-147" id="s4461.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4461.e0" e2="s4461.e1" id="s4461.p0" relation="false"/>
  </sentence>
  <sentence id="s4462" text="A combination of both EGFP-mitochondrial translational elongation modification and PDT provided a positive feed-back target effect to tumor vessels and might have a great potential for tumor therapy">
    <entity charOffset="27-65" id="s4462.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="134-139" id="s4462.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4462.e0" e2="s4462.e1" id="s4462.p0" relation="false"/>
  </sentence>
  <sentence id="s4463" text="Here we show that a series of transcription factors, including C/EBP, regulation of transcription, DNA-templated, and negative regulation of transcription by RNA polymerase II, could act as potential modulators of histone methylation in tumor cells.">
    <entity charOffset="71-113" id="s4463.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="238-243" id="s4463.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4463.e0" e2="s4463.e1" id="s4463.p0" relation="false"/>
  </sentence>
  <sentence id="s4464" text="Here we show that a series of transcription factors, including C/EBP, regulation of transcription, DNA-templated, and negative regulation of transcription by RNA polymerase II, could act as potential modulators of histone methylation in tumor cells.">
    <entity charOffset="119-176" id="s4464.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="238-243" id="s4464.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4464.e0" e2="s4464.e1" id="s4464.p0" relation="true"/>
  </sentence>
  <sentence id="s4465" text="Of note, C/EBP, an independent prognostic fcoenzyme A biosynthetic processor for patients with ovarian cancer, mediates an important mechanism through which epigenetic enzyme modifies groups of functionally related genes in a context-dependent manner.">
    <entity charOffset="44-75" id="s4465.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="104-110" id="s4465.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4465.e0" e2="s4465.e1" id="s4465.p0" relation="false"/>
  </sentence>
  <sentence id="s4466" text="Here, we report two novel positive regulation of guanylate cyclase activity (the gene for guanylate cyclase activating protein 1) mutations identified in unrelated Spanish families affected by autosomal dominant retinal degeneration (adRD) with cone and rod involvement.">
    <entity charOffset="26-75" id="s4466.e0" ontology_id="GO_0031284" text="positive regulation of guanylate cyclase activity" type="GO"/>
    <entity charOffset="212-232" id="s4466.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s4466.e0" e2="s4466.e1" id="s4466.p0" relation="true"/>
  </sentence>
  <sentence id="s4467" text="The expression of positive regulation of gene expression in nonsmall cell lung cancer (NSCLC) remains unclear.">
    <entity charOffset="18-56" id="s4467.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="80-86" id="s4467.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4467.e0" e2="s4467.e1" id="s4467.p0" relation="false"/>
  </sentence>
  <sentence id="s4468" text="Therefore, positive regulation of gene expression expression was detected in clinical specimens using quantum dots (QDs)immunohistochemistry (IHC) and lung cancer cell lines by quantitative realtime polymerase chain reaction.">
    <entity charOffset="11-49" id="s4468.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="157-163" id="s4468.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4468.e0" e2="s4468.e1" id="s4468.p0" relation="false"/>
  </sentence>
  <sentence id="s4469" text="The protein levels of positive regulation of gene expression were decreased in the tumor tissues of NSCLC patients and lung cancer cell lines.">
    <entity charOffset="22-60" id="s4469.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="124-130" id="s4469.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4469.e0" e2="s4469.e1" id="s4469.p0" relation="false"/>
  </sentence>
  <sentence id="s4470" text="The protein levels of positive regulation of gene expression were decreased in the tumor tissues of NSCLC patients and lung cancer cell lines.">
    <entity charOffset="22-60" id="s4470.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="83-88" id="s4470.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4470.e0" e2="s4470.e1" id="s4470.p0" relation="false"/>
  </sentence>
  <sentence id="s4471" text="Adolescent idiopathic scoliosis (oxidation-reduction process) and pectus excavatum (PE) are common pediatric musculoskeletal disorders.">
    <entity charOffset="22-31" id="s4471.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="33-60" id="s4471.e1" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <pair e1="s4471.e0" e2="s4471.e1" id="s4471.p0" relation="false"/>
  </sentence>
  <sentence id="s4472" text="Adolescent idiopathic scoliosis (oxidation-reduction process) and pectus excavatum (PE) are common pediatric musculoskeletal disorders.">
    <entity charOffset="33-60" id="s4472.e0" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <entity charOffset="66-82" id="s4472.e1" ontology_id="HP_0000767" text="pectus excavatum" type="HP"/>
    <pair e1="s4472.e0" e2="s4472.e1" id="s4472.p0" relation="false"/>
  </sentence>
  <sentence id="s4473" text="Silencing expression of G1/S transition of mitotic cell cycle, transforming growth factor beta receptor signaling pathway and regulation of transcription, DNA-templated in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.">
    <entity charOffset="24-61" id="s4473.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="187-193" id="s4473.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4473.e0" e2="s4473.e1" id="s4473.p0" relation="true"/>
  </sentence>
  <sentence id="s4474" text="Silencing expression of G1/S transition of mitotic cell cycle, transforming growth factor beta receptor signaling pathway and regulation of transcription, DNA-templated in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.">
    <entity charOffset="63-121" id="s4474.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="187-193" id="s4474.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4474.e0" e2="s4474.e1" id="s4474.p0" relation="false"/>
  </sentence>
  <sentence id="s4475" text="Silencing expression of G1/S transition of mitotic cell cycle, transforming growth factor beta receptor signaling pathway and regulation of transcription, DNA-templated in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.">
    <entity charOffset="126-168" id="s4475.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="187-193" id="s4475.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4475.e0" e2="s4475.e1" id="s4475.p0" relation="false"/>
  </sentence>
  <sentence id="s4476" text="Our study identified a unique gene signature - G1/S transition of mitotic cell cycle, transforming growth factor beta receptor signaling pathway and regulation of transcription, DNA-templated - which may be involved in oral cancer lymph node metastasis">
    <entity charOffset="47-84" id="s4476.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="224-230" id="s4476.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4476.e0" e2="s4476.e1" id="s4476.p0" relation="true"/>
  </sentence>
  <sentence id="s4477" text="Our study identified a unique gene signature - G1/S transition of mitotic cell cycle, transforming growth factor beta receptor signaling pathway and regulation of transcription, DNA-templated - which may be involved in oral cancer lymph node metastasis">
    <entity charOffset="86-144" id="s4477.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="224-230" id="s4477.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4477.e0" e2="s4477.e1" id="s4477.p0" relation="false"/>
  </sentence>
  <sentence id="s4478" text="Our study identified a unique gene signature - G1/S transition of mitotic cell cycle, transforming growth factor beta receptor signaling pathway and regulation of transcription, DNA-templated - which may be involved in oral cancer lymph node metastasis">
    <entity charOffset="149-191" id="s4478.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="224-230" id="s4478.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4478.e0" e2="s4478.e1" id="s4478.p0" relation="false"/>
  </sentence>
  <sentence id="s4479" text="Inhibitory immune receptors, such as negative regulation of signal transduction, dampen inflammation and are important for resolving inflammation, but their role in obesity is unknown.">
    <entity charOffset="37-79" id="s4479.e0" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <entity charOffset="165-172" id="s4479.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4479.e0" e2="s4479.e1" id="s4479.p0" relation="false"/>
  </sentence>
  <sentence id="s4480" text="We show that obesity in humans correlates with reduced expression of adipose tissue negative regulation of signal transduction.">
    <entity charOffset="13-20" id="s4480.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="84-126" id="s4480.e1" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <pair e1="s4480.e0" e2="s4480.e1" id="s4480.p0" relation="false"/>
  </sentence>
  <sentence id="s4481" text="Co-housing with wild-type animals, antibiotic treatment, or germ-free condition was sufficient to restrain inflammation, obesity, and insulin tolerance in negative regulation of signal transduction&lt;sup&gt;-/-&lt;/sup&gt; epidermis development, implicating the microbiota.">
    <entity charOffset="121-128" id="s4481.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="155-197" id="s4481.e1" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <pair e1="s4481.e0" e2="s4481.e1" id="s4481.p0" relation="false"/>
  </sentence>
  <sentence id="s4482" text="Co-housing with wild-type animals, antibiotic treatment, or germ-free condition was sufficient to restrain inflammation, obesity, and insulin tolerance in negative regulation of signal transduction&lt;sup&gt;-/-&lt;/sup&gt; epidermis development, implicating the microbiota.">
    <entity charOffset="121-128" id="s4482.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="212-233" id="s4482.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4482.e0" e2="s4482.e1" id="s4482.p0" relation="false"/>
  </sentence>
  <sentence id="s4483" text="HFD-fed negative regulation of signal transduction&lt;sup&gt;-/-&lt;/sup&gt; epidermis development display dysbiosis marked by increased obesity-associated Erysipelotrichaceae, but reduced Lachnospiraceae family and the associated enzymes required for short-chain fatty acid (SCFA) synthesis.">
    <entity charOffset="8-50" id="s4483.e0" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <entity charOffset="125-132" id="s4483.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4483.e0" e2="s4483.e1" id="s4483.p0" relation="false"/>
  </sentence>
  <sentence id="s4484" text="HFD-fed negative regulation of signal transduction&lt;sup&gt;-/-&lt;/sup&gt; epidermis development display dysbiosis marked by increased obesity-associated Erysipelotrichaceae, but reduced Lachnospiraceae family and the associated enzymes required for short-chain fatty acid (SCFA) synthesis.">
    <entity charOffset="65-86" id="s4484.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="125-132" id="s4484.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4484.e0" e2="s4484.e1" id="s4484.p0" relation="false"/>
  </sentence>
  <sentence id="s4485" text="These findings reveal that negative regulation of signal transduction reduces HFD-induced obesity by maintaining beneficial microbiota">
    <entity charOffset="27-69" id="s4485.e0" ontology_id="GO_0009968" text="negative regulation of signal transduction" type="GO"/>
    <entity charOffset="90-97" id="s4485.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4485.e0" e2="s4485.e1" id="s4485.p0" relation="false"/>
  </sentence>
  <sentence id="s4486" text="The presence of positive regulation of glucose transmembrane transport loss-of-function variants in negative regulation of transcription by RNA polymerase II predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).">
    <entity charOffset="16-70" id="s4486.e0" ontology_id="GO_0010828" text="positive regulation of glucose transmembrane transport" type="GO"/>
    <entity charOffset="229-238" id="s4486.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s4486.e0" e2="s4486.e1" id="s4486.p0" relation="false"/>
  </sentence>
  <sentence id="s4487" text="The presence of positive regulation of glucose transmembrane transport loss-of-function variants in negative regulation of transcription by RNA polymerase II predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).">
    <entity charOffset="100-157" id="s4487.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="196-204" id="s4487.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s4487.e0" e2="s4487.e1" id="s4487.p0" relation="true"/>
  </sentence>
  <sentence id="s4488" text="The presence of positive regulation of glucose transmembrane transport loss-of-function variants in negative regulation of transcription by RNA polymerase II predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).">
    <entity charOffset="100-157" id="s4488.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="229-238" id="s4488.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s4488.e0" e2="s4488.e1" id="s4488.p0" relation="true"/>
  </sentence>
  <sentence id="s4489" text="A major susceptibility locus, HIVAN1, was previously mapped to chromosome 3A1-A3 in a cross between TgFVB and transcription initiation from RNA polymerase I promoter/EiJ (CAST) strains, and introgression of a 51.9 Mb segment encompassing HIVAN1 from CAST into TgFVB resulted in accelerated development of nephropathy.">
    <entity charOffset="110-165" id="s4489.e0" ontology_id="GO_0006361" text="transcription initiation from RNA polymerase I promoter" type="GO"/>
    <entity charOffset="305-316" id="s4489.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s4489.e0" e2="s4489.e1" id="s4489.p0" relation="false"/>
  </sentence>
  <sentence id="s4490" text="Of these, craniofacial suture morphogenesis, cellular response to starvation, and Setd7 have been implicated in the pathogenesis of nephropathy.">
    <entity charOffset="10-43" id="s4490.e0" ontology_id="GO_0097094" text="craniofacial suture morphogenesis" type="GO"/>
    <entity charOffset="132-143" id="s4490.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s4490.e0" e2="s4490.e1" id="s4490.p0" relation="false"/>
  </sentence>
  <sentence id="s4491" text="Of these, craniofacial suture morphogenesis, cellular response to starvation, and Setd7 have been implicated in the pathogenesis of nephropathy.">
    <entity charOffset="45-76" id="s4491.e0" ontology_id="GO_0009267" text="cellular response to starvation" type="GO"/>
    <entity charOffset="132-143" id="s4491.e1" ontology_id="HP_0000112" text="nephropathy" type="HP"/>
    <pair e1="s4491.e0" e2="s4491.e1" id="s4491.p0" relation="false"/>
  </sentence>
  <sentence id="s4492" text="We report a new (fifth) patient with the cblJ disorder who presented at 7 days of age with poor feeding, hypotonia, methylmalonic aciduria, and elevated plasma homocysteine and harbored the mutations c.1667_1668delAG [p.Glu556Glyfs*27] and c.1295G&amp;gt;A [p.Arg432Gln] in the &lt;i&gt;cobalamin metabolic process&lt;/i&gt; gene.">
    <entity charOffset="116-138" id="s4492.e0" ontology_id="HP_0012120" text="methylmalonic aciduria" type="HP"/>
    <entity charOffset="277-304" id="s4492.e1" ontology_id="GO_0009235" text="cobalamin metabolic process" type="GO"/>
    <pair e1="s4492.e0" e2="s4492.e1" id="s4492.p0" relation="true"/>
  </sentence>
  <sentence id="s4493" text="The sterile alpha motif (SAM) domain of the protein biological_process, a protein-protein interaction domain, is responsible for autosomal dominant polycystic kidney disease.">
    <entity charOffset="52-70" id="s4493.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="159-173" id="s4493.e1" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <pair e1="s4493.e0" e2="s4493.e1" id="s4493.p0" relation="true"/>
  </sentence>
  <sentence id="s4494" text="Oral-facial-digital syndromes (OFDS) gather rare genetic disorders characterised by facial, oral and digital abnormalities associated with a wide range of additional features (polycystic kidney disease, cerebral malformations and several others) to delineate a growing list of OFDS submuscle organ developments.">
    <entity charOffset="187-201" id="s4494.e0" ontology_id="HP_0000077" text="kidney disease" type="HP"/>
    <entity charOffset="285-309" id="s4494.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4494.e0" e2="s4494.e1" id="s4494.p0" relation="false"/>
  </sentence>
  <sentence id="s4495" text="Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing positive regulation of cell proliferation (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in epidermis development using a combination of a mutagen followed by chronic pulmonary inflammation.">
    <entity charOffset="141-182" id="s4495.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="309-315" id="s4495.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4495.e0" e2="s4495.e1" id="s4495.p0" relation="false"/>
  </sentence>
  <sentence id="s4496" text="Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing positive regulation of cell proliferation (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in epidermis development using a combination of a mutagen followed by chronic pulmonary inflammation.">
    <entity charOffset="141-182" id="s4496.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="265-271" id="s4496.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4496.e0" e2="s4496.e1" id="s4496.p0" relation="false"/>
  </sentence>
  <sentence id="s4497" text="Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing positive regulation of cell proliferation (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in epidermis development using a combination of a mutagen followed by chronic pulmonary inflammation.">
    <entity charOffset="265-271" id="s4497.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="329-350" id="s4497.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4497.e0" e2="s4497.e1" id="s4497.p0" relation="false"/>
  </sentence>
  <sentence id="s4498" text="Examination of tumor-infiltrating immune cells from epidermis development vaccinated with the positive regulation of cell proliferation-expressing exosomes showed robust tumor-reactive CD8&lt;sup&gt;+&lt;/sup&gt; T effector responses, Th1 cytokine responses, and higher CD8&lt;sup&gt;+&lt;/sup&gt; T effector/CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt;Foxp3&lt;sup&gt;+&lt;/sup&gt; T regulatory cell ratio in the tumors.">
    <entity charOffset="15-20" id="s4498.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="52-73" id="s4498.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4498.e0" e2="s4498.e1" id="s4498.p0" relation="false"/>
  </sentence>
  <sentence id="s4499" text="Examination of tumor-infiltrating immune cells from epidermis development vaccinated with the positive regulation of cell proliferation-expressing exosomes showed robust tumor-reactive CD8&lt;sup&gt;+&lt;/sup&gt; T effector responses, Th1 cytokine responses, and higher CD8&lt;sup&gt;+&lt;/sup&gt; T effector/CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt;Foxp3&lt;sup&gt;+&lt;/sup&gt; T regulatory cell ratio in the tumors.">
    <entity charOffset="52-73" id="s4499.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="365-371" id="s4499.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4499.e0" e2="s4499.e1" id="s4499.p0" relation="false"/>
  </sentence>
  <sentence id="s4500" text="Examination of tumor-infiltrating immune cells from epidermis development vaccinated with the positive regulation of cell proliferation-expressing exosomes showed robust tumor-reactive CD8&lt;sup&gt;+&lt;/sup&gt; T effector responses, Th1 cytokine responses, and higher CD8&lt;sup&gt;+&lt;/sup&gt; T effector/CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt;Foxp3&lt;sup&gt;+&lt;/sup&gt; T regulatory cell ratio in the tumors.">
    <entity charOffset="94-135" id="s4500.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="365-371" id="s4500.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4500.e0" e2="s4500.e1" id="s4500.p0" relation="false"/>
  </sentence>
  <sentence id="s4501" text="Deleted in lung and esophageal cancer 1 (negative regulation of cell proliferation) is a tumor suppressor gene with reduced transcriptional activity and promoter hypermethylation in various cancers, including colorectal cancer.">
    <entity charOffset="31-37" id="s4501.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="41-82" id="s4501.e1" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <pair e1="s4501.e0" e2="s4501.e1" id="s4501.p0" relation="true"/>
  </sentence>
  <sentence id="s4502" text="Deleted in lung and esophageal cancer 1 (negative regulation of cell proliferation) is a tumor suppressor gene with reduced transcriptional activity and promoter hypermethylation in various cancers, including colorectal cancer.">
    <entity charOffset="41-82" id="s4502.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="89-94" id="s4502.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4502.e0" e2="s4502.e1" id="s4502.p0" relation="true"/>
  </sentence>
  <sentence id="s4503" text="Here we cellular response to interleukin-4, launching from Drosophila models of amyotrophic lateral sclerosis and frontotemporal dementia, that RNA splicing impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler covalent chromatin modification to chromatin.">
    <entity charOffset="8-42" id="s4503.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="114-137" id="s4503.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4503.e0" e2="s4503.e1" id="s4503.p0" relation="false"/>
  </sentence>
  <sentence id="s4504" text="Here we cellular response to interleukin-4, launching from Drosophila models of amyotrophic lateral sclerosis and frontotemporal dementia, that RNA splicing impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler covalent chromatin modification to chromatin.">
    <entity charOffset="114-137" id="s4504.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="144-156" id="s4504.e1" ontology_id="GO_0008380" text="RNA splicing" type="GO"/>
    <pair e1="s4504.e0" e2="s4504.e1" id="s4504.p0" relation="true"/>
  </sentence>
  <sentence id="s4505" text="Here we cellular response to interleukin-4, launching from Drosophila models of amyotrophic lateral sclerosis and frontotemporal dementia, that RNA splicing impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler covalent chromatin modification to chromatin.">
    <entity charOffset="114-137" id="s4505.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="296-327" id="s4505.e1" ontology_id="GO_0016569" text="covalent chromatin modification" type="GO"/>
    <pair e1="s4505.e0" e2="s4505.e1" id="s4505.p0" relation="false"/>
  </sentence>
  <sentence id="s4506" text="Enhancing chromatin dynamics may be a treatment approach to amyotrophic lateral scleorosis (signal transduction)/frontotemporal dementia (FTD)">
    <entity charOffset="92-111" id="s4506.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="113-136" id="s4506.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4506.e0" e2="s4506.e1" id="s4506.p0" relation="false"/>
  </sentence>
  <sentence id="s4507" text="For instance, mutations in both biological_process and visual perception cause cataract in humans.">
    <entity charOffset="32-50" id="s4507.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="79-87" id="s4507.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s4507.e0" e2="s4507.e1" id="s4507.p0" relation="true"/>
  </sentence>
  <sentence id="s4508" text="For instance, mutations in both biological_process and visual perception cause cataract in humans.">
    <entity charOffset="55-72" id="s4508.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="79-87" id="s4508.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s4508.e0" e2="s4508.e1" id="s4508.p0" relation="true"/>
  </sentence>
  <sentence id="s4509" text="In the case-control analysis, the rs9607195 A&amp;gt;G on intergenic area 250kb away from the ISX gene and the rs12738007 A&amp;gt;G on the intron of the fatty acid metabolic process gene were the most strongly associated SNPs with the risk of schizophrenia (P=6.210(-8) , OR=0.50 and P=3.710(-7) , OR=2.39, respectively).">
    <entity charOffset="147-175" id="s4509.e0" ontology_id="GO_0006631" text="fatty acid metabolic process" type="GO"/>
    <entity charOffset="237-250" id="s4509.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4509.e0" e2="s4509.e1" id="s4509.p0" relation="false"/>
  </sentence>
  <sentence id="s4510" text="In subsequent fine-mapping analysis, 6 SNPs of fatty acid metabolic process were genotyped with 310 schizophrenia patients and 604 control subjects.">
    <entity charOffset="47-75" id="s4510.e0" ontology_id="GO_0006631" text="fatty acid metabolic process" type="GO"/>
    <entity charOffset="100-113" id="s4510.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4510.e0" e2="s4510.e1" id="s4510.p0" relation="false"/>
  </sentence>
  <sentence id="s4511" text="Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, protein-containing complex assembly, BIRC5, and anaphase-promoting complex-dependent catabolic process, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s4511.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-123" id="s4511.e1" ontology_id="GO_0065003" text="protein-containing complex assembly" type="GO"/>
    <pair e1="s4511.e0" e2="s4511.e1" id="s4511.p0" relation="false"/>
  </sentence>
  <sentence id="s4512" text="Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, protein-containing complex assembly, BIRC5, and anaphase-promoting complex-dependent catabolic process, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.">
    <entity charOffset="47-53" id="s4512.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="136-190" id="s4512.e1" ontology_id="GO_0031145" text="anaphase-promoting complex-dependent catabolic process" type="GO"/>
    <pair e1="s4512.e0" e2="s4512.e1" id="s4512.p0" relation="false"/>
  </sentence>
  <sentence id="s4513" text="Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including positive regulation of protein phosphorylation and inactivation of tumor suppressors, such as TP53, transforming growth factor beta receptor signaling pathway and CDKN2A.">
    <entity charOffset="151-157" id="s4513.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="269-327" id="s4513.e1" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <pair e1="s4513.e0" e2="s4513.e1" id="s4513.p0" relation="true"/>
  </sentence>
  <sentence id="s4514" text="Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including positive regulation of protein phosphorylation and inactivation of tumor suppressors, such as TP53, transforming growth factor beta receptor signaling pathway and CDKN2A.">
    <entity charOffset="169-215" id="s4514.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="236-241" id="s4514.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4514.e0" e2="s4514.e1" id="s4514.p0" relation="true"/>
  </sentence>
  <sentence id="s4515" text="However, siRNA-based therapeutics interstrand cross-link repair important challenges, including rapid serum degradation, poor tumor cell uptake and cellular uptake, leading to off-target effects.">
    <entity charOffset="34-63" id="s4515.e0" ontology_id="GO_0036297" text="interstrand cross-link repair" type="GO"/>
    <entity charOffset="126-131" id="s4515.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4515.e0" e2="s4515.e1" id="s4515.p0" relation="true"/>
  </sentence>
  <sentence id="s4516" text="Therefore, there is a G protein-coupled receptor signaling pathway need for the development of safe and effective nanoparticles for better tumor-specific delivery of anti-cancer therapeutics.">
    <entity charOffset="22-66" id="s4516.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="171-177" id="s4516.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4516.e0" e2="s4516.e1" id="s4516.p0" relation="false"/>
  </sentence>
  <sentence id="s4517" text="Therefore, there is a G protein-coupled receptor signaling pathway need for the development of safe and effective nanoparticles for better tumor-specific delivery of anti-cancer therapeutics.">
    <entity charOffset="22-66" id="s4517.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="139-144" id="s4517.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4517.e0" e2="s4517.e1" id="s4517.p0" relation="false"/>
  </sentence>
  <sentence id="s4518" text="We show that tumour cells specifically induce cell cycle arrest activity in mesenchymal stromal cells (MSCs) required for the transcription of the complement factor C1q.">
    <entity charOffset="13-19" id="s4518.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="46-63" id="s4518.e1" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <pair e1="s4518.e0" e2="s4518.e1" id="s4518.p0" relation="false"/>
  </sentence>
  <sentence id="s4519" text="cell cycle arrest activation in the microenvironment is a pre-requisite for the activation of canonical Wnt signalling in tumour cells">
    <entity charOffset="0-17" id="s4519.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="122-128" id="s4519.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4519.e0" e2="s4519.e1" id="s4519.p0" relation="false"/>
  </sentence>
  <sentence id="s4520" text="Posterior microphthalmos (PM) is a relatively infrequent muscle organ development of microphthalmos where posterior segment is predominantly affected with normal anterior segment measurements.">
    <entity charOffset="10-24" id="s4520.e0" ontology_id="HP_0000568" text="microphthalmos" type="HP"/>
    <entity charOffset="57-81" id="s4520.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4520.e0" e2="s4520.e1" id="s4520.p0" relation="false"/>
  </sentence>
  <sentence id="s4521" text="We here report that (-)-epigallocatechin gallate (EGCG) inhibited programmed cell death ligand 1 (PD-L1) expression in nonsmall-cell lung cancer cells, induced by both interferon (IFN)- and epidermal growth factor (angiogenesis).">
    <entity charOffset="139-145" id="s4521.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="217-229" id="s4521.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s4521.e0" e2="s4521.e1" id="s4521.p0" relation="false"/>
  </sentence>
  <sentence id="s4522" text="Furthermore, 0.3% GTE in drinking water reduced the average number of tumors per mouse from 4.1  0.5 to 2.6  0.4 and the percentage of PD-L1 positive cells from 9.6% to 2.9%, a decrease of 70%, in lung tumors of A/J epidermis development given a single intraperitoneal injection of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).">
    <entity charOffset="70-76" id="s4522.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="218-239" id="s4522.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4522.e0" e2="s4522.e1" id="s4522.p0" relation="false"/>
  </sentence>
  <sentence id="s4523" text="In co-culture exGPI anchor metabolic processiments using F10-OVA melanoma cells and tumor-specific CD3+ T cells, EGCG reduced &lt;i&gt;PD-L1&lt;/i&gt; mRNA expression about 30% in F10-OVA cells and restored &lt;i&gt;interleukin-2&lt;/i&gt; mRNA expression in tumor-specific CD3+ T cells.">
    <entity charOffset="16-44" id="s4523.e0" ontology_id="GO_0006505" text="GPI anchor metabolic process" type="GO"/>
    <entity charOffset="84-89" id="s4523.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4523.e0" e2="s4523.e1" id="s4523.p0" relation="false"/>
  </sentence>
  <sentence id="s4524" text="We identified 22 genes including cellular response to DNA damage stimulus, KRAS, TP53, adenylate cyclase-activating G protein-coupled receptor signaling pathway, NRAS, transforming growth factor beta receptor signaling pathway, ARID2, and phosphorylation with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="33-73" id="s4524.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="288-294" id="s4524.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4524.e0" e2="s4524.e1" id="s4524.p0" relation="true"/>
  </sentence>
  <sentence id="s4525" text="We identified 22 genes including cellular response to DNA damage stimulus, KRAS, TP53, adenylate cyclase-activating G protein-coupled receptor signaling pathway, NRAS, transforming growth factor beta receptor signaling pathway, ARID2, and phosphorylation with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="87-160" id="s4525.e0" ontology_id="GO_0007189" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="288-294" id="s4525.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4525.e0" e2="s4525.e1" id="s4525.p0" relation="true"/>
  </sentence>
  <sentence id="s4526" text="We identified 22 genes including cellular response to DNA damage stimulus, KRAS, TP53, adenylate cyclase-activating G protein-coupled receptor signaling pathway, NRAS, transforming growth factor beta receptor signaling pathway, ARID2, and phosphorylation with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="168-226" id="s4526.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="288-294" id="s4526.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4526.e0" e2="s4526.e1" id="s4526.p0" relation="true"/>
  </sentence>
  <sentence id="s4527" text="We identified 22 genes including cellular response to DNA damage stimulus, KRAS, TP53, adenylate cyclase-activating G protein-coupled receptor signaling pathway, NRAS, transforming growth factor beta receptor signaling pathway, ARID2, and phosphorylation with non-silent mutations in the cancer Census Genes.">
    <entity charOffset="239-254" id="s4527.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="288-294" id="s4527.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4527.e0" e2="s4527.e1" id="s4527.p0" relation="true"/>
  </sentence>
  <sentence id="s4528" text="Five HGCAs harbored either mono-allelic (four HGCAs) or bi-allelic (one HGCA) transforming growth factor beta receptor signaling pathway mutation or 18q loss that had been known as early carcinoma-specific changes.">
    <entity charOffset="78-136" id="s4528.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="187-196" id="s4528.e1" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <pair e1="s4528.e0" e2="s4528.e1" id="s4528.p0" relation="false"/>
  </sentence>
  <sentence id="s4529" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4529.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="81-127" id="s4529.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4529.e0" e2="s4529.e1" id="s4529.p0" relation="false"/>
  </sentence>
  <sentence id="s4530" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4530.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="138-211" id="s4530.e1" ontology_id="GO_0007189" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s4530.e0" e2="s4530.e1" id="s4530.p0" relation="false"/>
  </sentence>
  <sentence id="s4531" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4531.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="425-447" id="s4531.e1" ontology_id="GO_0006337" text="nucleosome disassembly" type="GO"/>
    <pair e1="s4531.e0" e2="s4531.e1" id="s4531.p0" relation="false"/>
  </sentence>
  <sentence id="s4532" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4532.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="262-287" id="s4532.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s4532.e0" e2="s4532.e1" id="s4532.p0" relation="false"/>
  </sentence>
  <sentence id="s4533" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4533.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="289-326" id="s4533.e1" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <pair e1="s4533.e0" e2="s4533.e1" id="s4533.p0" relation="false"/>
  </sentence>
  <sentence id="s4534" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4534.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="334-357" id="s4534.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s4534.e0" e2="s4534.e1" id="s4534.p0" relation="false"/>
  </sentence>
  <sentence id="s4535" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4535.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="359-416" id="s4535.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4535.e0" e2="s4535.e1" id="s4535.p0" relation="false"/>
  </sentence>
  <sentence id="s4536" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4536.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="449-476" id="s4536.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s4536.e0" e2="s4536.e1" id="s4536.p0" relation="false"/>
  </sentence>
  <sentence id="s4537" text="Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.">
    <entity charOffset="58-67" id="s4537.e0" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <entity charOffset="481-521" id="s4537.e1" ontology_id="GO_0071260" text="cellular response to mechanical stimulus" type="GO"/>
    <pair e1="s4537.e0" e2="s4537.e1" id="s4537.p0" relation="false"/>
  </sentence>
  <sentence id="s4538" text="PITPNM3, known as a human homologue of the Drosophila retinal degeneration B (phospholipid transport), lacks the N-terminal PIT domain needed for transport of phospholipids, renewal of photoreceptors membrane and providing the electroretinogram (ERG) response to light.">
    <entity charOffset="54-74" id="s4538.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="78-100" id="s4538.e1" ontology_id="GO_0015914" text="phospholipid transport" type="GO"/>
    <pair e1="s4538.e0" e2="s4538.e1" id="s4538.p0" relation="false"/>
  </sentence>
  <sentence id="s4539" text="Intravascular lithotripsy (response to UV-B) with the Shockwave system has recently been evaluated as a familiar angioplasty-balloon-based but effective technique for the management of arterial calcification.">
    <entity charOffset="27-43" id="s4539.e0" ontology_id="GO_0010224" text="response to UV-B" type="GO"/>
    <entity charOffset="186-208" id="s4539.e1" ontology_id="HP_0003207" text="arterial calcification" type="HP"/>
    <pair e1="s4539.e0" e2="s4539.e1" id="s4539.p0" relation="false"/>
  </sentence>
  <sentence id="s4540" text="The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVHI), pulmonary vascular remodeling, serum tumor necrosis factor  (TNF), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first fatty acid biosynthetic process injection.">
    <entity charOffset="51-74" id="s4540.e0" ontology_id="HP_0001714" text="ventricular hypertrophy" type="HP"/>
    <entity charOffset="248-279" id="s4540.e1" ontology_id="GO_0006633" text="fatty acid biosynthetic process" type="GO"/>
    <pair e1="s4540.e0" e2="s4540.e1" id="s4540.p0" relation="false"/>
  </sentence>
  <sentence id="s4541" text="The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVHI), pulmonary vascular remodeling, serum tumor necrosis factor  (TNF), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first fatty acid biosynthetic process injection.">
    <entity charOffset="126-131" id="s4541.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="248-279" id="s4541.e1" ontology_id="GO_0006633" text="fatty acid biosynthetic process" type="GO"/>
    <pair e1="s4541.e0" e2="s4541.e1" id="s4541.p0" relation="false"/>
  </sentence>
  <sentence id="s4542" text="We describe an infant with the phenomuscle organ development of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.">
    <entity charOffset="36-60" id="s4542.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="113-125" id="s4542.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s4542.e0" e2="s4542.e1" id="s4542.p0" relation="false"/>
  </sentence>
  <sentence id="s4543" text="We describe an infant with the phenomuscle organ development of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.">
    <entity charOffset="36-60" id="s4543.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="138-151" id="s4543.e1" ontology_id="HP_0012385" text="camptodactyly" type="HP"/>
    <pair e1="s4543.e0" e2="s4543.e1" id="s4543.p0" relation="false"/>
  </sentence>
  <sentence id="s4544" text="We describe an infant with the phenomuscle organ development of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.">
    <entity charOffset="36-60" id="s4544.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="160-171" id="s4544.e1" ontology_id="HP_0001270" text="motor delay" type="HP"/>
    <pair e1="s4544.e0" e2="s4544.e1" id="s4544.p0" relation="false"/>
  </sentence>
  <sentence id="s4545" text="Neurofibromatosis muscle organ development 2 (NF2) is a tumor-forming disease of the nervous system caused by deletion or by loss-of-function mutations in NF2, encoding the tumor suppressing protein neurofibromin 2 (also known as schwannomin or negative regulation of cell proliferation).">
    <entity charOffset="18-42" id="s4545.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="56-61" id="s4545.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4545.e0" e2="s4545.e1" id="s4545.p0" relation="false"/>
  </sentence>
  <sentence id="s4546" text="Neurofibromatosis muscle organ development 2 (NF2) is a tumor-forming disease of the nervous system caused by deletion or by loss-of-function mutations in NF2, encoding the tumor suppressing protein neurofibromin 2 (also known as schwannomin or negative regulation of cell proliferation).">
    <entity charOffset="56-61" id="s4546.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="245-286" id="s4546.e1" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <pair e1="s4546.e0" e2="s4546.e1" id="s4546.p0" relation="true"/>
  </sentence>
  <sentence id="s4547" text="The correlation of the tumor-suppressive function and conformation (open or closed) of neurofibromin 2 has been subject to much speculation, often based on extrapolation from other cellular response to oxidative stress proteins, and controversy.">
    <entity charOffset="23-28" id="s4547.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="181-218" id="s4547.e1" ontology_id="GO_0034599" text="cellular response to oxidative stress" type="GO"/>
    <pair e1="s4547.e0" e2="s4547.e1" id="s4547.p0" relation="false"/>
  </sentence>
  <sentence id="s4548" text="These data suggest cyclic purine nucleotide metabolic process-related PCH as a potentially treatable early-onset neurodegenerative disease.">
    <entity charOffset="19-61" id="s4548.e0" ontology_id="GO_0052652" text="cyclic purine nucleotide metabolic process" type="GO"/>
    <entity charOffset="113-138" id="s4548.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s4548.e0" e2="s4548.e1" id="s4548.p0" relation="false"/>
  </sentence>
  <sentence id="s4549" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RNA processing, UFSP1), gluco-metabolic phenomuscle organ developments (e.g. INPP5E, endocytic recycling, ERAP2, post-translational protein modification), and obesity (e.g. negative regulation of tumor necrosis factor production, response to ischemia).">
    <entity charOffset="103-117" id="s4549.e0" ontology_id="GO_0006396" text="RNA processing" type="GO"/>
    <entity charOffset="262-269" id="s4549.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4549.e0" e2="s4549.e1" id="s4549.p0" relation="false"/>
  </sentence>
  <sentence id="s4550" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RNA processing, UFSP1), gluco-metabolic phenomuscle organ developments (e.g. INPP5E, endocytic recycling, ERAP2, post-translational protein modification), and obesity (e.g. negative regulation of tumor necrosis factor production, response to ischemia).">
    <entity charOffset="148-172" id="s4550.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="262-269" id="s4550.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4550.e0" e2="s4550.e1" id="s4550.p0" relation="false"/>
  </sentence>
  <sentence id="s4551" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RNA processing, UFSP1), gluco-metabolic phenomuscle organ developments (e.g. INPP5E, endocytic recycling, ERAP2, post-translational protein modification), and obesity (e.g. negative regulation of tumor necrosis factor production, response to ischemia).">
    <entity charOffset="188-207" id="s4551.e0" ontology_id="GO_0032456" text="endocytic recycling" type="GO"/>
    <entity charOffset="262-269" id="s4551.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4551.e0" e2="s4551.e1" id="s4551.p0" relation="false"/>
  </sentence>
  <sentence id="s4552" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RNA processing, UFSP1), gluco-metabolic phenomuscle organ developments (e.g. INPP5E, endocytic recycling, ERAP2, post-translational protein modification), and obesity (e.g. negative regulation of tumor necrosis factor production, response to ischemia).">
    <entity charOffset="216-255" id="s4552.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="262-269" id="s4552.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4552.e0" e2="s4552.e1" id="s4552.p0" relation="false"/>
  </sentence>
  <sentence id="s4553" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RNA processing, UFSP1), gluco-metabolic phenomuscle organ developments (e.g. INPP5E, endocytic recycling, ERAP2, post-translational protein modification), and obesity (e.g. negative regulation of tumor necrosis factor production, response to ischemia).">
    <entity charOffset="262-269" id="s4553.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="276-331" id="s4553.e1" ontology_id="GO_0032720" text="negative regulation of tumor necrosis factor production" type="GO"/>
    <pair e1="s4553.e0" e2="s4553.e1" id="s4553.p0" relation="true"/>
  </sentence>
  <sentence id="s4554" text="Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RNA processing, UFSP1), gluco-metabolic phenomuscle organ developments (e.g. INPP5E, endocytic recycling, ERAP2, post-translational protein modification), and obesity (e.g. negative regulation of tumor necrosis factor production, response to ischemia).">
    <entity charOffset="262-269" id="s4554.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="333-353" id="s4554.e1" ontology_id="GO_0002931" text="response to ischemia" type="GO"/>
    <pair e1="s4554.e0" e2="s4554.e1" id="s4554.p0" relation="false"/>
  </sentence>
  <sentence id="s4555" text="Single-gene variant analysis showed significant associations of the TT genotype of lipid hydroxylation and the rare GG genotype of transcription-coupled nucleotide-excision repair with bladder cancer susceptibility (OR=1.34, 95% CI 1.22-1.40, P&amp;lt;0.0001).">
    <entity charOffset="83-102" id="s4555.e0" ontology_id="GO_0002933" text="lipid hydroxylation" type="GO"/>
    <entity charOffset="193-199" id="s4555.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4555.e0" e2="s4555.e1" id="s4555.p0" relation="false"/>
  </sentence>
  <sentence id="s4556" text="Single-gene variant analysis showed significant associations of the TT genotype of lipid hydroxylation and the rare GG genotype of transcription-coupled nucleotide-excision repair with bladder cancer susceptibility (OR=1.34, 95% CI 1.22-1.40, P&amp;lt;0.0001).">
    <entity charOffset="131-179" id="s4556.e0" ontology_id="GO_0006283" text="transcription-coupled nucleotide-excision repair" type="GO"/>
    <entity charOffset="193-199" id="s4556.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4556.e0" e2="s4556.e1" id="s4556.p0" relation="true"/>
  </sentence>
  <sentence id="s4557" text="Although Sur8 has been shown to be a scaffold protein of the Ras-angiogenesis pathway, its interaction with other signaling pathways and its involvement in tumor malignancy has not been reported.">
    <entity charOffset="65-77" id="s4557.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="156-161" id="s4557.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4557.e0" e2="s4557.e1" id="s4557.p0" relation="false"/>
  </sentence>
  <sentence id="s4558" text="At surgery, the cell adhesion mediated by integrin was located within the epineurium, could be bluntly dissected from the nerve fascicles, and was suspected to be a schwannoma.">
    <entity charOffset="16-50" id="s4558.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="165-175" id="s4558.e1" ontology_id="HP_0100008" text="schwannoma" type="HP"/>
    <pair e1="s4558.e0" e2="s4558.e1" id="s4558.p0" relation="false"/>
  </sentence>
  <sentence id="s4559" text="Fluorescence in situ hybridization, with a break-apart probe strategy, demonstrated regulation of transcription, DNA-templated rearrangement, consistent in this morphological context with the low-grade fibromyxoid sarcoma-associated FUS-CREB3L2 or FUS-CREB3L1 fusions.">
    <entity charOffset="84-126" id="s4559.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="214-221" id="s4559.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s4559.e0" e2="s4559.e1" id="s4559.p0" relation="false"/>
  </sentence>
  <sentence id="s4560" text="We conducted a large-scale genome-wide association study of erectile dysfunction in 36,649 negative regulation of phosphatase activity in the multiethnic Kaiser Permanente Northern California Genetic Epidemiology Research in Adult Health and Aging cohort.">
    <entity charOffset="60-80" id="s4560.e0" ontology_id="HP_0000802" text="erectile dysfunction" type="HP"/>
    <entity charOffset="91-134" id="s4560.e1" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <pair e1="s4560.e0" e2="s4560.e1" id="s4560.p0" relation="false"/>
  </sentence>
  <sentence id="s4561" text="The association replicated in the UK Biobank sample (odds ratio = 1.25, &lt;i&gt;P&lt;/i&gt; = 6.8  10&lt;sup&gt;-14&lt;/sup&gt;), and the effect is independent of known erectile dysfunction risk factors, including body cell adhesion mediated by integrin index (BMI).">
    <entity charOffset="147-167" id="s4561.e0" ontology_id="HP_0000802" text="erectile dysfunction" type="HP"/>
    <entity charOffset="197-231" id="s4561.e1" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <pair e1="s4561.e0" e2="s4561.e1" id="s4561.p0" relation="false"/>
  </sentence>
  <sentence id="s4562" text="Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (spliceosomal tri-snRNP complex assembly, PRPF8, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited retinal degeneration.">
    <entity charOffset="82-121" id="s4562.e0" ontology_id="GO_0000244" text="spliceosomal tri-snRNP complex assembly" type="GO"/>
    <entity charOffset="215-235" id="s4562.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s4562.e0" e2="s4562.e1" id="s4562.p0" relation="false"/>
  </sentence>
  <sentence id="s4563" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="111-157" id="s4563.e0" ontology_id="GO_0051353" text="positive regulation of oxidoreductase activity" type="GO"/>
    <entity charOffset="566-578" id="s4563.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s4563.e0" e2="s4563.e1" id="s4563.p0" relation="false"/>
  </sentence>
  <sentence id="s4564" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="111-157" id="s4564.e0" ontology_id="GO_0051353" text="positive regulation of oxidoreductase activity" type="GO"/>
    <entity charOffset="606-615" id="s4564.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s4564.e0" e2="s4564.e1" id="s4564.p0" relation="true"/>
  </sentence>
  <sentence id="s4565" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="271-292" id="s4565.e0" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <entity charOffset="566-578" id="s4565.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s4565.e0" e2="s4565.e1" id="s4565.p0" relation="false"/>
  </sentence>
  <sentence id="s4566" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="271-292" id="s4566.e0" ontology_id="GO_0006486" text="protein glycosylation" type="GO"/>
    <entity charOffset="606-615" id="s4566.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s4566.e0" e2="s4566.e1" id="s4566.p0" relation="false"/>
  </sentence>
  <sentence id="s4567" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4567.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="617-647" id="s4567.e1" ontology_id="GO_0051017" text="actin filament bundle assembly" type="GO"/>
    <pair e1="s4567.e0" e2="s4567.e1" id="s4567.p0" relation="false"/>
  </sentence>
  <sentence id="s4568" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4568.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="674-698" id="s4568.e1" ontology_id="GO_0006406" text="mRNA export from nucleus" type="GO"/>
    <pair e1="s4568.e0" e2="s4568.e1" id="s4568.p0" relation="false"/>
  </sentence>
  <sentence id="s4569" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4569.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="713-754" id="s4569.e1" ontology_id="GO_0007264" text="small GTPase mediated signal transduction" type="GO"/>
    <pair e1="s4569.e0" e2="s4569.e1" id="s4569.p0" relation="false"/>
  </sentence>
  <sentence id="s4570" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4570.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="836-866" id="s4570.e1" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <pair e1="s4570.e0" e2="s4570.e1" id="s4570.p0" relation="false"/>
  </sentence>
  <sentence id="s4571" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4571.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="934-963" id="s4571.e1" ontology_id="GO_0018125" text="peptidyl-cysteine methylation" type="GO"/>
    <pair e1="s4571.e0" e2="s4571.e1" id="s4571.p0" relation="false"/>
  </sentence>
  <sentence id="s4572" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4572.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="977-1004" id="s4572.e1" ontology_id="GO_0031069" text="hair follicle morphogenesis" type="GO"/>
    <pair e1="s4572.e0" e2="s4572.e1" id="s4572.p0" relation="false"/>
  </sentence>
  <sentence id="s4573" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4573.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1008-1035" id="s4573.e1" ontology_id="GO_0031069" text="hair follicle morphogenesis" type="GO"/>
    <pair e1="s4573.e0" e2="s4573.e1" id="s4573.p0" relation="false"/>
  </sentence>
  <sentence id="s4574" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4574.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1349-1441" id="s4574.e1" ontology_id="GO_0098696" text="regulation of neurotransmitter receptor localization to postsynaptic specialization membrane" type="GO"/>
    <pair e1="s4574.e0" e2="s4574.e1" id="s4574.p0" relation="true"/>
  </sentence>
  <sentence id="s4575" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4575.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1653-1697" id="s4575.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s4575.e0" e2="s4575.e1" id="s4575.p0" relation="false"/>
  </sentence>
  <sentence id="s4576" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4576.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1738-1792" id="s4576.e1" ontology_id="GO_0046579" text="positive regulation of Ras protein signal transduction" type="GO"/>
    <pair e1="s4576.e0" e2="s4576.e1" id="s4576.p0" relation="true"/>
  </sentence>
  <sentence id="s4577" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4577.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1795-1826" id="s4577.e1" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <pair e1="s4577.e0" e2="s4577.e1" id="s4577.p0" relation="true"/>
  </sentence>
  <sentence id="s4578" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="566-578" id="s4578.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="1932-1960" id="s4578.e1" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <pair e1="s4578.e0" e2="s4578.e1" id="s4578.p0" relation="true"/>
  </sentence>
  <sentence id="s4579" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4579.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="617-647" id="s4579.e1" ontology_id="GO_0051017" text="actin filament bundle assembly" type="GO"/>
    <pair e1="s4579.e0" e2="s4579.e1" id="s4579.p0" relation="false"/>
  </sentence>
  <sentence id="s4580" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4580.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="674-698" id="s4580.e1" ontology_id="GO_0006406" text="mRNA export from nucleus" type="GO"/>
    <pair e1="s4580.e0" e2="s4580.e1" id="s4580.p0" relation="false"/>
  </sentence>
  <sentence id="s4581" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4581.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="713-754" id="s4581.e1" ontology_id="GO_0007264" text="small GTPase mediated signal transduction" type="GO"/>
    <pair e1="s4581.e0" e2="s4581.e1" id="s4581.p0" relation="true"/>
  </sentence>
  <sentence id="s4582" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4582.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="836-866" id="s4582.e1" ontology_id="GO_0005975" text="carbohydrate metabolic process" type="GO"/>
    <pair e1="s4582.e0" e2="s4582.e1" id="s4582.p0" relation="false"/>
  </sentence>
  <sentence id="s4583" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4583.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="934-963" id="s4583.e1" ontology_id="GO_0018125" text="peptidyl-cysteine methylation" type="GO"/>
    <pair e1="s4583.e0" e2="s4583.e1" id="s4583.p0" relation="false"/>
  </sentence>
  <sentence id="s4584" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4584.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="977-1004" id="s4584.e1" ontology_id="GO_0031069" text="hair follicle morphogenesis" type="GO"/>
    <pair e1="s4584.e0" e2="s4584.e1" id="s4584.p0" relation="true"/>
  </sentence>
  <sentence id="s4585" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4585.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1008-1035" id="s4585.e1" ontology_id="GO_0031069" text="hair follicle morphogenesis" type="GO"/>
    <pair e1="s4585.e0" e2="s4585.e1" id="s4585.p0" relation="true"/>
  </sentence>
  <sentence id="s4586" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4586.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1185-1220" id="s4586.e1" ontology_id="GO_0035335" text="peptidyl-tyrosine dephosphorylation" type="GO"/>
    <pair e1="s4586.e0" e2="s4586.e1" id="s4586.p0" relation="true"/>
  </sentence>
  <sentence id="s4587" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4587.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1232-1324" id="s4587.e1" ontology_id="GO_0098696" text="regulation of neurotransmitter receptor localization to postsynaptic specialization membrane" type="GO"/>
    <pair e1="s4587.e0" e2="s4587.e1" id="s4587.p0" relation="true"/>
  </sentence>
  <sentence id="s4588" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4588.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1349-1441" id="s4588.e1" ontology_id="GO_0098696" text="regulation of neurotransmitter receptor localization to postsynaptic specialization membrane" type="GO"/>
    <pair e1="s4588.e0" e2="s4588.e1" id="s4588.p0" relation="true"/>
  </sentence>
  <sentence id="s4589" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4589.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1491-1514" id="s4589.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s4589.e0" e2="s4589.e1" id="s4589.p0" relation="true"/>
  </sentence>
  <sentence id="s4590" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4590.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1525-1571" id="s4590.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4590.e0" e2="s4590.e1" id="s4590.p0" relation="true"/>
  </sentence>
  <sentence id="s4591" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4591.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1653-1697" id="s4591.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s4591.e0" e2="s4591.e1" id="s4591.p0" relation="true"/>
  </sentence>
  <sentence id="s4592" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4592.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1795-1826" id="s4592.e1" ontology_id="GO_0007265" text="Ras protein signal transduction" type="GO"/>
    <pair e1="s4592.e0" e2="s4592.e1" id="s4592.p0" relation="true"/>
  </sentence>
  <sentence id="s4593" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4593.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1862-1890" id="s4593.e1" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <pair e1="s4593.e0" e2="s4593.e1" id="s4593.p0" relation="true"/>
  </sentence>
  <sentence id="s4594" text="Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.">
    <entity charOffset="606-615" id="s4594.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="1932-1960" id="s4594.e1" ontology_id="GO_0000186" text="activation of MAPKK activity" type="GO"/>
    <pair e1="s4594.e0" e2="s4594.e1" id="s4594.p0" relation="true"/>
  </sentence>
  <sentence id="s4595" text="According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 spastic paraplegia 7 (SPG7) variant is associated with CAD as it bypasses the regulation of tyrosine phosphorylation of proteolysis and enhances the processing and maturation of SPG7 protein.">
    <entity charOffset="115-133" id="s4595.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="235-246" id="s4595.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s4595.e0" e2="s4595.e1" id="s4595.p0" relation="false"/>
  </sentence>
  <sentence id="s4596" text="Deafness genes, which harbor pathogenic mutations that have been identified in families with hereditary hearing loss, are commonly expressed in the auditory positive regulation of protein phosphorylation organ or the cochlea and may contribute to normal hearing function, yet some of the mouse models carrying these mutations fail to recapitulate the hearing loss phenotype.">
    <entity charOffset="104-116" id="s4596.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="157-203" id="s4596.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4596.e0" e2="s4596.e1" id="s4596.p0" relation="false"/>
  </sentence>
  <sentence id="s4597" text="In this study, we cellular response to interleukin-4 that distinct expression patterns of those deafness genes in the cochlea of a non-human primate, the common marmoset (Callithrix jacchus).">
    <entity charOffset="18-52" id="s4597.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="96-104" id="s4597.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s4597.e0" e2="s4597.e1" id="s4597.p0" relation="false"/>
  </sentence>
  <sentence id="s4598" text="The deafness genes in utero embryonic development, CRYM, epidermis development, DFNA5, and ossification were expressed in marmoset cochleae in patterns different from those in mouse cochleae.">
    <entity charOffset="4-12" id="s4598.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="19-49" id="s4598.e1" ontology_id="GO_0001701" text="in utero embryonic development" type="GO"/>
    <pair e1="s4598.e0" e2="s4598.e1" id="s4598.p0" relation="true"/>
  </sentence>
  <sentence id="s4599" text="The deafness genes in utero embryonic development, CRYM, epidermis development, DFNA5, and ossification were expressed in marmoset cochleae in patterns different from those in mouse cochleae.">
    <entity charOffset="4-12" id="s4599.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="57-78" id="s4599.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4599.e0" e2="s4599.e1" id="s4599.p0" relation="true"/>
  </sentence>
  <sentence id="s4600" text="The deafness genes in utero embryonic development, CRYM, epidermis development, DFNA5, and ossification were expressed in marmoset cochleae in patterns different from those in mouse cochleae.">
    <entity charOffset="4-12" id="s4600.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="91-103" id="s4600.e1" ontology_id="GO_0001503" text="ossification" type="GO"/>
    <pair e1="s4600.e0" e2="s4600.e1" id="s4600.p0" relation="true"/>
  </sentence>
  <sentence id="s4601" text="We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic TDP-43 protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from sporadic FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or negative regulation of protein phosphorylation repeat expansion mutations (FTLD-TDP-C9+).">
    <entity charOffset="232-240" id="s4601.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="301-347" id="s4601.e1" ontology_id="GO_0001933" text="negative regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4601.e0" e2="s4601.e1" id="s4601.p0" relation="false"/>
  </sentence>
  <sentence id="s4602" text="Circulating soluble peptide hormone processing has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.">
    <entity charOffset="20-46" id="s4602.e0" ontology_id="GO_0016486" text="peptide hormone processing" type="GO"/>
    <entity charOffset="92-115" id="s4602.e1" ontology_id="HP_0001626" text="cardiovascular diseases" type="HP"/>
    <pair e1="s4602.e0" e2="s4602.e1" id="s4602.p0" relation="false"/>
  </sentence>
  <sentence id="s4603" text="Circulating soluble peptide hormone processing has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.">
    <entity charOffset="20-46" id="s4603.e0" ontology_id="GO_0016486" text="peptide hormone processing" type="GO"/>
    <entity charOffset="125-137" id="s4603.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s4603.e0" e2="s4603.e1" id="s4603.p0" relation="false"/>
  </sentence>
  <sentence id="s4604" text="Circulating soluble peptide hormone processing has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.">
    <entity charOffset="20-46" id="s4604.e0" ontology_id="GO_0016486" text="peptide hormone processing" type="GO"/>
    <entity charOffset="139-152" id="s4604.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s4604.e0" e2="s4604.e1" id="s4604.p0" relation="false"/>
  </sentence>
  <sentence id="s4605" text="Circulating soluble peptide hormone processing has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.">
    <entity charOffset="20-46" id="s4605.e0" ontology_id="GO_0016486" text="peptide hormone processing" type="GO"/>
    <entity charOffset="154-175" id="s4605.e1" ontology_id="HP_0001658" text="myocardial infarction" type="HP"/>
    <pair e1="s4605.e0" e2="s4605.e1" id="s4605.p0" relation="false"/>
  </sentence>
  <sentence id="s4606" text="Through gene negative regulation of transcription, DNA-templated enrichment analysis and bi-clustering, we also found that most of the differential expressed lncRNAs were closely associated with mitochondrial functions (e.g. mitochondrion organization, P=3.2110&lt;sup&gt;-17&lt;/sup&gt;; mitochondrial ATP synthesis coupled electron transport, P=1.7310&lt;sup&gt;-19&lt;/sup&gt; and mitochondrial membrane organization, P=4.0410&lt;sup&gt;-8&lt;/sup&gt;).">
    <entity charOffset="13-64" id="s4606.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="195-208" id="s4606.e1" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <pair e1="s4606.e0" e2="s4606.e1" id="s4606.p0" relation="false"/>
  </sentence>
  <sentence id="s4607" text="Absence epilepsy (AE) is a common muscle organ development of genetic generalized epilepsy (GGE), particularly in children.">
    <entity charOffset="8-16" id="s4607.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="34-58" id="s4607.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4607.e0" e2="s4607.e1" id="s4607.p0" relation="false"/>
  </sentence>
  <sentence id="s4608" text="By creating new Pcnxl2 frameshift alleles using TALEN mutagenesis, we show that Pcnxl2 deficiency is responsible for mitigating the seizure phenomuscle organ development - making Pcnxl2 the first known modifier gene for absence seizures in any species.">
    <entity charOffset="132-139" id="s4608.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="145-169" id="s4608.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4608.e0" e2="s4608.e1" id="s4608.p0" relation="false"/>
  </sentence>
  <sentence id="s4609" text="Together these new findings expand our knowledge of how natural variation modulates seizures, and highlights the feasibility of characterizing and validating modifiers in mouse strains and substrains in the post-genome sequence transcription by RNA polymerase II.">
    <entity charOffset="84-92" id="s4609.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="228-262" id="s4609.e1" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4609.e0" e2="s4609.e1" id="s4609.p0" relation="false"/>
  </sentence>
  <sentence id="s4610" text="The activation of innate immune response gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (signal transduction).">
    <entity charOffset="4-40" id="s4610.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="70-76" id="s4610.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s4610.e0" e2="s4610.e1" id="s4610.p0" relation="false"/>
  </sentence>
  <sentence id="s4611" text="The activation of innate immune response gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (signal transduction).">
    <entity charOffset="4-40" id="s4611.e0" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <entity charOffset="77-85" id="s4611.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4611.e0" e2="s4611.e1" id="s4611.p0" relation="false"/>
  </sentence>
  <sentence id="s4612" text="The activation of innate immune response gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (signal transduction).">
    <entity charOffset="77-85" id="s4612.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="121-140" id="s4612.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s4612.e0" e2="s4612.e1" id="s4612.p0" relation="false"/>
  </sentence>
  <sentence id="s4613" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="38-44" id="s4613.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="183-240" id="s4613.e1" ontology_id="GO_0006121" text="mitochondrial electron transport, succinate to ubiquinone" type="GO"/>
    <pair e1="s4613.e0" e2="s4613.e1" id="s4613.p0" relation="true"/>
  </sentence>
  <sentence id="s4614" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="38-44" id="s4614.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="242-269" id="s4614.e1" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <pair e1="s4614.e0" e2="s4614.e1" id="s4614.p0" relation="true"/>
  </sentence>
  <sentence id="s4615" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="38-44" id="s4615.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="271-295" id="s4615.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s4615.e0" e2="s4615.e1" id="s4615.p0" relation="true"/>
  </sentence>
  <sentence id="s4616" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="46-62" id="s4616.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="144-171" id="s4616.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s4616.e0" e2="s4616.e1" id="s4616.p0" relation="true"/>
  </sentence>
  <sentence id="s4617" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="46-62" id="s4617.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="183-240" id="s4617.e1" ontology_id="GO_0006121" text="mitochondrial electron transport, succinate to ubiquinone" type="GO"/>
    <pair e1="s4617.e0" e2="s4617.e1" id="s4617.p0" relation="true"/>
  </sentence>
  <sentence id="s4618" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="46-62" id="s4618.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="242-269" id="s4618.e1" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <pair e1="s4618.e0" e2="s4618.e1" id="s4618.p0" relation="true"/>
  </sentence>
  <sentence id="s4619" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="46-62" id="s4619.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="271-295" id="s4619.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s4619.e0" e2="s4619.e1" id="s4619.p0" relation="true"/>
  </sentence>
  <sentence id="s4620" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="46-62" id="s4620.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="297-321" id="s4620.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s4620.e0" e2="s4620.e1" id="s4620.p0" relation="true"/>
  </sentence>
  <sentence id="s4621" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="46-62" id="s4621.e0" ontology_id="HP_0002666" text="pheochromocytoma" type="HP"/>
    <entity charOffset="323-347" id="s4621.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s4621.e0" e2="s4621.e1" id="s4621.p0" relation="true"/>
  </sentence>
  <sentence id="s4622" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="68-81" id="s4622.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="242-269" id="s4622.e1" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <pair e1="s4622.e0" e2="s4622.e1" id="s4622.p0" relation="true"/>
  </sentence>
  <sentence id="s4623" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="68-81" id="s4623.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="271-295" id="s4623.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s4623.e0" e2="s4623.e1" id="s4623.p0" relation="true"/>
  </sentence>
  <sentence id="s4624" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="68-81" id="s4624.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="297-321" id="s4624.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s4624.e0" e2="s4624.e1" id="s4624.p0" relation="true"/>
  </sentence>
  <sentence id="s4625" text="A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.">
    <entity charOffset="68-81" id="s4625.e0" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <entity charOffset="349-390" id="s4625.e1" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <pair e1="s4625.e0" e2="s4625.e1" id="s4625.p0" relation="true"/>
  </sentence>
  <sentence id="s4626" text="Using whole-exome sequencing (WES), we identified four de novo variants in protein dephosphorylation in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.">
    <entity charOffset="75-100" id="s4626.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="148-171" id="s4626.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4626.e0" e2="s4626.e1" id="s4626.p0" relation="true"/>
  </sentence>
  <sentence id="s4627" text="Using whole-exome sequencing (WES), we identified four de novo variants in protein dephosphorylation in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.">
    <entity charOffset="75-100" id="s4627.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="230-236" id="s4627.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s4627.e0" e2="s4627.e1" id="s4627.p0" relation="false"/>
  </sentence>
  <sentence id="s4628" text="Using whole-exome sequencing (WES), we identified four de novo variants in protein dephosphorylation in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.">
    <entity charOffset="75-100" id="s4628.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="256-268" id="s4628.e1" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <pair e1="s4628.e0" e2="s4628.e1" id="s4628.p0" relation="true"/>
  </sentence>
  <sentence id="s4629" text="Using whole-exome sequencing (WES), we identified four de novo variants in protein dephosphorylation in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.">
    <entity charOffset="75-100" id="s4629.e0" ontology_id="GO_0006470" text="protein dephosphorylation" type="GO"/>
    <entity charOffset="281-289" id="s4629.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s4629.e0" e2="s4629.e1" id="s4629.p0" relation="true"/>
  </sentence>
  <sentence id="s4630" text="Our current study found that phosphoserine aminotransferase 1 (L-serine biosynthetic process), an enzyme catalyzing serine biosynthesis, was significantly up-regulated in non-small cell lung cancer (NSCLC) and was involved in the regulation of E2F activity.">
    <entity charOffset="63-92" id="s4630.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="191-197" id="s4630.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4630.e0" e2="s4630.e1" id="s4630.p0" relation="false"/>
  </sentence>
  <sentence id="s4631" text="Loss- and gain-of-function experiments demonstrated that L-serine biosynthetic process promoted cell cycle progression, cell proliferation and tumorigenesis.">
    <entity charOffset="57-86" id="s4631.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="143-148" id="s4631.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4631.e0" e2="s4631.e1" id="s4631.p0" relation="false"/>
  </sentence>
  <sentence id="s4632" text="Correlation analysis showed that L-serine biosynthetic process expression positively correlated with the levels of phosphorylated GSK-3, cyclin D1 and phosphorylated Rb in NSCLC primary tumors.">
    <entity charOffset="33-62" id="s4632.e0" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <entity charOffset="187-192" id="s4632.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4632.e0" e2="s4632.e1" id="s4632.p0" relation="false"/>
  </sentence>
  <sentence id="s4633" text="A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, response to hypoxia, was in a focal (frontal negative regulation of protein kinase activity)-onset syndrome.">
    <entity charOffset="99-107" id="s4633.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="207-253" id="s4633.e1" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <pair e1="s4633.e0" e2="s4633.e1" id="s4633.p0" relation="false"/>
  </sentence>
  <sentence id="s4634" text="A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, response to hypoxia, was in a focal (frontal negative regulation of protein kinase activity)-onset syndrome.">
    <entity charOffset="136-144" id="s4634.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="162-181" id="s4634.e1" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <pair e1="s4634.e0" e2="s4634.e1" id="s4634.p0" relation="true"/>
  </sentence>
  <sentence id="s4635" text="A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, response to hypoxia, was in a focal (frontal negative regulation of protein kinase activity)-onset syndrome.">
    <entity charOffset="136-144" id="s4635.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="207-253" id="s4635.e1" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <pair e1="s4635.e0" e2="s4635.e1" id="s4635.p0" relation="false"/>
  </sentence>
  <sentence id="s4636" text="The reason why response to hypoxia causes focal-onset seizures is unknown.">
    <entity charOffset="15-34" id="s4636.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="54-62" id="s4636.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s4636.e0" e2="s4636.e1" id="s4636.p0" relation="true"/>
  </sentence>
  <sentence id="s4637" text="Recently, the second focal (temporal negative regulation of protein kinase activity)-onset epilepsy gene, axon guidance (unknown function), was discovered.">
    <entity charOffset="37-83" id="s4637.e0" ontology_id="GO_0006469" text="negative regulation of protein kinase activity" type="GO"/>
    <entity charOffset="91-99" id="s4637.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4637.e0" e2="s4637.e1" id="s4637.p0" relation="false"/>
  </sentence>
  <sentence id="s4638" text="Recently, the second focal (temporal negative regulation of protein kinase activity)-onset epilepsy gene, axon guidance (unknown function), was discovered.">
    <entity charOffset="91-99" id="s4638.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="106-119" id="s4638.e1" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <pair e1="s4638.e0" e2="s4638.e1" id="s4638.p0" relation="true"/>
  </sentence>
  <sentence id="s4639" text="response to hypoxia led the way to mutation identifications in 15 ion channel genes, most causing primarily generalized epilepsies.">
    <entity charOffset="0-19" id="s4639.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="120-130" id="s4639.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s4639.e0" e2="s4639.e1" id="s4639.p0" relation="true"/>
  </sentence>
  <sentence id="s4640" text="Mutations in the mitotic cytokinesis gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized epilepsies) and single nucleotide polymorphisms in the BRD2 gene (unknown function) and the malic enzyme 2 (ME2) gene.">
    <entity charOffset="17-36" id="s4640.e0" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <entity charOffset="181-191" id="s4640.e1" ontology_id="HP_0001250" text="epilepsies" type="HP"/>
    <pair e1="s4640.e0" e2="s4640.e1" id="s4640.p0" relation="true"/>
  </sentence>
  <sentence id="s4641" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, inhibitory synapse assembly, response to ethanol, potassium ion transmembrane transport, negative regulation of gene expression, homophilic cell adhesion via plasma membrane adhesion molecules, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s4641.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="462-489" id="s4641.e1" ontology_id="GO_1904862" text="inhibitory synapse assembly" type="GO"/>
    <pair e1="s4641.e0" e2="s4641.e1" id="s4641.p0" relation="true"/>
  </sentence>
  <sentence id="s4642" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, inhibitory synapse assembly, response to ethanol, potassium ion transmembrane transport, negative regulation of gene expression, homophilic cell adhesion via plasma membrane adhesion molecules, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s4642.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="491-510" id="s4642.e1" ontology_id="GO_0045471" text="response to ethanol" type="GO"/>
    <pair e1="s4642.e0" e2="s4642.e1" id="s4642.p0" relation="true"/>
  </sentence>
  <sentence id="s4643" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, inhibitory synapse assembly, response to ethanol, potassium ion transmembrane transport, negative regulation of gene expression, homophilic cell adhesion via plasma membrane adhesion molecules, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s4643.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="512-549" id="s4643.e1" ontology_id="GO_0071805" text="potassium ion transmembrane transport" type="GO"/>
    <pair e1="s4643.e0" e2="s4643.e1" id="s4643.p0" relation="true"/>
  </sentence>
  <sentence id="s4644" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, inhibitory synapse assembly, response to ethanol, potassium ion transmembrane transport, negative regulation of gene expression, homophilic cell adhesion via plasma membrane adhesion molecules, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s4644.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="551-589" id="s4644.e1" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <pair e1="s4644.e0" e2="s4644.e1" id="s4644.p0" relation="true"/>
  </sentence>
  <sentence id="s4645" text="The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, inhibitory synapse assembly, response to ethanol, potassium ion transmembrane transport, negative regulation of gene expression, homophilic cell adhesion via plasma membrane adhesion molecules, SCN1A, or SCN2A).">
    <entity charOffset="133-141" id="s4645.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="591-654" id="s4645.e1" ontology_id="GO_0007156" text="homophilic cell adhesion via plasma membrane adhesion molecules" type="GO"/>
    <pair e1="s4645.e0" e2="s4645.e1" id="s4645.p0" relation="true"/>
  </sentence>
  <sentence id="s4646" text="However, unconditioned NRGS epidermis development developed less clinically relevant disease, with CDXs forming solid tumors throughout the body, whereas unconditioned NRG mice were incapable of efficiently supporting PDX or human hematopoietic stem cell engraftment.">
    <entity charOffset="28-49" id="s4646.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="118-124" id="s4646.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4646.e0" e2="s4646.e1" id="s4646.p0" relation="false"/>
  </sentence>
  <sentence id="s4647" text="Thus, research directed at expanding our current understanding of transcriptional corepressors could negative regulation of transcription by RNA polymerase II the future development of new cancer diagnostics, prognostics, and therapies.">
    <entity charOffset="101-158" id="s4647.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="189-195" id="s4647.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4647.e0" e2="s4647.e1" id="s4647.p0" relation="false"/>
  </sentence>
  <sentence id="s4648" text="Importantly, the role of negative regulation of transcription by RNA polymerase II overexpression in adult tissues in promoting the progression of multiple cancer types through their ability to modulate the transcription of developmental genes ectopically is explored.">
    <entity charOffset="25-82" id="s4648.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="156-162" id="s4648.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4648.e0" e2="s4648.e1" id="s4648.p0" relation="true"/>
  </sentence>
  <sentence id="s4649" text="negative regulation of transcription by RNA polymerase II overexpression is known to be protumorigenic and affects the regulation of gene networks associated with &amp;quot;cancer hallmarks&amp;quot; and malignant behavior, including increased cell survival, proliferation, migration, invasion, and the epithelial-mesenchymal transition.">
    <entity charOffset="0-57" id="s4649.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="169-175" id="s4649.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4649.e0" e2="s4649.e1" id="s4649.p0" relation="true"/>
  </sentence>
  <sentence id="s4650" text="negative regulation of transcription by RNA polymerase II overexpression is known to be protumorigenic and affects the regulation of gene networks associated with &amp;quot;cancer hallmarks&amp;quot; and malignant behavior, including increased cell survival, proliferation, migration, invasion, and the epithelial-mesenchymal transition.">
    <entity charOffset="0-57" id="s4650.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="91-96" id="s4650.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4650.e0" e2="s4650.e1" id="s4650.p0" relation="true"/>
  </sentence>
  <sentence id="s4651" text="As a transcriptional regulator of broad developmental processes capable of promoting malignant growth in adult tissues, therapeutically targeting the negative regulation of transcription by RNA polymerase II corepressor has the potential to be an effective method for the treatment of diverse tumor types.">
    <entity charOffset="150-207" id="s4651.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="293-298" id="s4651.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4651.e0" e2="s4651.e1" id="s4651.p0" relation="true"/>
  </sentence>
  <sentence id="s4652" text="Fanconi anemia (regulation of ferrochelatase activity) is a rare disease characterized by bone marrow failure, developmental abnormalities, and increased cancer risk that is caused by defective repair of DNA interstrand crosslinks (ICLs).">
    <entity charOffset="16-53" id="s4652.e0" ontology_id="GO_0010722" text="regulation of ferrochelatase activity" type="GO"/>
    <entity charOffset="154-160" id="s4652.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4652.e0" e2="s4652.e1" id="s4652.p0" relation="false"/>
  </sentence>
  <sentence id="s4653" text="Progressive retinal atrophy (signal transduction) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness.">
    <entity charOffset="12-27" id="s4653.e0" ontology_id="HP_0001105" text="retinal atrophy" type="HP"/>
    <entity charOffset="29-48" id="s4653.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s4653.e0" e2="s4653.e1" id="s4653.p0" relation="false"/>
  </sentence>
  <sentence id="s4654" text="Progressive retinal atrophy (signal transduction) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness.">
    <entity charOffset="29-48" id="s4654.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="246-255" id="s4654.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s4654.e0" e2="s4654.e1" id="s4654.p0" relation="false"/>
  </sentence>
  <sentence id="s4655" text="Mutations in the GPI anchor biosynthetic process gene cause hyperphosphatasia mental retardation syndrome-3.">
    <entity charOffset="17-48" id="s4655.e0" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <entity charOffset="60-77" id="s4655.e1" ontology_id="HP_0003155" text="hyperphosphatasia" type="HP"/>
    <pair e1="s4655.e0" e2="s4655.e1" id="s4655.p0" relation="true"/>
  </sentence>
  <sentence id="s4656" text="The genetic diagnosis is difficult owing to the large genetic heterogeneity of the 6p21.3 region, which contains the steroid biosynthetic process gene, especially with respect to the use of new-generation techniques of sequencing.">
    <entity charOffset="62-75" id="s4656.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="117-145" id="s4656.e1" ontology_id="GO_0006694" text="steroid biosynthetic process" type="GO"/>
    <pair e1="s4656.e0" e2="s4656.e1" id="s4656.p0" relation="false"/>
  </sentence>
  <sentence id="s4657" text="This study aimed to elucidate the potential functional mechanism of miR-135b-5p in migration, invasion and epithelial-to-mesenchymal transition (cytokine production) of pancreatic cancer cells.">
    <entity charOffset="145-164" id="s4657.e0" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <entity charOffset="180-186" id="s4657.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4657.e0" e2="s4657.e1" id="s4657.p0" relation="true"/>
  </sentence>
  <sentence id="s4658" text="By real-time PCR and analysis of GEO database, we determined the up-regulated expression of protein polyubiquitination-135b-5p in pancreatic cancer tissues and cell lines.">
    <entity charOffset="92-118" id="s4658.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="141-147" id="s4658.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4658.e0" e2="s4658.e1" id="s4658.p0" relation="false"/>
  </sentence>
  <sentence id="s4659" text="Functionally, Transwell assays indicated that protein polyubiquitination-135b-5p was a promoter for migration and invasion of pancreatic cancer cells.">
    <entity charOffset="46-72" id="s4659.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="137-143" id="s4659.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4659.e0" e2="s4659.e1" id="s4659.p0" relation="false"/>
  </sentence>
  <sentence id="s4660" text="Additionally, immunohistochemistry staining and Western blot showed that highly expressed protein polyubiquitination-135b-5p accelerated EMT process of pancreatic cancer cells.">
    <entity charOffset="90-116" id="s4660.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="163-169" id="s4660.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4660.e0" e2="s4660.e1" id="s4660.p0" relation="false"/>
  </sentence>
  <sentence id="s4661" text="Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of protein polyubiquitination-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and cytokine production.">
    <entity charOffset="146-172" id="s4661.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="195-201" id="s4661.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4661.e0" e2="s4661.e1" id="s4661.p0" relation="false"/>
  </sentence>
  <sentence id="s4662" text="Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of protein polyubiquitination-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and cytokine production.">
    <entity charOffset="146-172" id="s4662.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="263-268" id="s4662.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4662.e0" e2="s4662.e1" id="s4662.p0" relation="false"/>
  </sentence>
  <sentence id="s4663" text="Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of protein polyubiquitination-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and cytokine production.">
    <entity charOffset="263-268" id="s4663.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="299-318" id="s4663.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s4663.e0" e2="s4663.e1" id="s4663.p0" relation="true"/>
  </sentence>
  <sentence id="s4664" text="In conclusion, protein polyubiquitination-135b-5p, maybe a novel therapeutic target for pancreatic cancer, promoted migration, invasion and cytokine production of pancreatic cancer cells by targeting NR3C2">
    <entity charOffset="15-41" id="s4664.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="99-105" id="s4664.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4664.e0" e2="s4664.e1" id="s4664.p0" relation="false"/>
  </sentence>
  <sentence id="s4665" text="In conclusion, protein polyubiquitination-135b-5p, maybe a novel therapeutic target for pancreatic cancer, promoted migration, invasion and cytokine production of pancreatic cancer cells by targeting NR3C2">
    <entity charOffset="99-105" id="s4665.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="140-159" id="s4665.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s4665.e0" e2="s4665.e1" id="s4665.p0" relation="true"/>
  </sentence>
  <sentence id="s4666" text="Similar to the human phenotype, &lt;i&gt;negative regulation of actin filament depolymerization&lt;/i&gt;-deficient epidermis development displayed reduced cholesterol absorption and were resistant to diet-induced hypercholesterolemia.">
    <entity charOffset="35-89" id="s4666.e0" ontology_id="GO_0030835" text="negative regulation of actin filament depolymerization" type="GO"/>
    <entity charOffset="202-222" id="s4666.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s4666.e0" e2="s4666.e1" id="s4666.p0" relation="false"/>
  </sentence>
  <sentence id="s4667" text="Similar to the human phenotype, &lt;i&gt;negative regulation of actin filament depolymerization&lt;/i&gt;-deficient epidermis development displayed reduced cholesterol absorption and were resistant to diet-induced hypercholesterolemia.">
    <entity charOffset="104-125" id="s4667.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="202-222" id="s4667.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s4667.e0" e2="s4667.e1" id="s4667.p0" relation="false"/>
  </sentence>
  <sentence id="s4668" text="Dominantly inherited digitotalar dysmorphism (regulation of cellular amino acid metabolic process), which is characterised by flexion contractures of digits and 'rocker-bottom' feet due to a vertical talus, was first described in a South African family of European stock in 1972.">
    <entity charOffset="46-97" id="s4668.e0" ontology_id="GO_0006521" text="regulation of cellular amino acid metabolic process" type="GO"/>
    <entity charOffset="134-146" id="s4668.e1" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <pair e1="s4668.e0" e2="s4668.e1" id="s4668.p0" relation="false"/>
  </sentence>
  <sentence id="s4669" text="Dominantly inherited digitotalar dysmorphism (regulation of cellular amino acid metabolic process), which is characterised by flexion contractures of digits and 'rocker-bottom' feet due to a vertical talus, was first described in a South African family of European stock in 1972.">
    <entity charOffset="46-97" id="s4669.e0" ontology_id="GO_0006521" text="regulation of cellular amino acid metabolic process" type="GO"/>
    <entity charOffset="191-205" id="s4669.e1" ontology_id="HP_0001838" text="vertical talus" type="HP"/>
    <pair e1="s4669.e0" e2="s4669.e1" id="s4669.p0" relation="false"/>
  </sentence>
  <sentence id="s4670" text="Transplantation of mitotic cell cycle checkpoint photoreceptors, derived either from neonatal retinae or pluripotent stem cells (PSCs), can restore rod-mediated visual function in murine models of inherited blindness.">
    <entity charOffset="19-48" id="s4670.e0" ontology_id="GO_0007093" text="mitotic cell cycle checkpoint" type="GO"/>
    <entity charOffset="207-216" id="s4670.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s4670.e0" e2="s4670.e1" id="s4670.p0" relation="false"/>
  </sentence>
  <sentence id="s4671" text="The human Shwachman-Diamond syndrome (mitotic spindle organization) is an autosomal recessive disease caused by mutations in a highly conserved ribosome assembly factor mitotic spindle organization.">
    <entity charOffset="38-66" id="s4671.e0" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <entity charOffset="74-93" id="s4671.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4671.e0" e2="s4671.e1" id="s4671.p0" relation="true"/>
  </sentence>
  <sentence id="s4672" text="The human Shwachman-Diamond syndrome (mitotic spindle organization) is an autosomal recessive disease caused by mutations in a highly conserved ribosome assembly factor mitotic spindle organization.">
    <entity charOffset="74-93" id="s4672.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="169-197" id="s4672.e1" ontology_id="GO_0007052" text="mitotic spindle organization" type="GO"/>
    <pair e1="s4672.e0" e2="s4672.e1" id="s4672.p0" relation="true"/>
  </sentence>
  <sentence id="s4673" text="Besides dramatic metabolic alterations, cancer cells display severe changes in the protein acetylation phenotype with likely consequences in tumor progression and treatment response.">
    <entity charOffset="83-102" id="s4673.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="141-146" id="s4673.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4673.e0" e2="s4673.e1" id="s4673.p0" relation="false"/>
  </sentence>
  <sentence id="s4674" text="In this study, we use a comprehensive systems-driven approach to investigate the effect of protein acetylation disruption on metabolic pathways and its negative regulation of transcription by RNA polymerase II on drug response in a cellular model of colon cancer progression.">
    <entity charOffset="91-110" id="s4674.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="256-262" id="s4674.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4674.e0" e2="s4674.e1" id="s4674.p0" relation="false"/>
  </sentence>
  <sentence id="s4675" text="In this study, we use a comprehensive systems-driven approach to investigate the effect of protein acetylation disruption on metabolic pathways and its negative regulation of transcription by RNA polymerase II on drug response in a cellular model of colon cancer progression.">
    <entity charOffset="152-209" id="s4675.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="256-262" id="s4675.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4675.e0" e2="s4675.e1" id="s4675.p0" relation="false"/>
  </sentence>
  <sentence id="s4676" text="A mapping of the expression data to a comprehensive genome-scale reconstruction of human metabolism allowed for the in-depth functional characterization of 24h-oscillating transcripts and pointed to a protein acetylation-driven metabolic reprogramming in tumorigenesis.">
    <entity charOffset="202-221" id="s4676.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="256-261" id="s4676.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4676.e0" e2="s4676.e1" id="s4676.p0" relation="false"/>
  </sentence>
  <sentence id="s4677" text="We further identified a reciprocal connection of hexose metabolic process to the protein acetylation in the primary tumor, which is lost in the metastatic cells.">
    <entity charOffset="49-73" id="s4677.e0" ontology_id="GO_0019318" text="hexose metabolic process" type="GO"/>
    <entity charOffset="116-121" id="s4677.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4677.e0" e2="s4677.e1" id="s4677.p0" relation="false"/>
  </sentence>
  <sentence id="s4678" text="We further identified a reciprocal connection of hexose metabolic process to the protein acetylation in the primary tumor, which is lost in the metastatic cells.">
    <entity charOffset="81-100" id="s4678.e0" ontology_id="GO_0006473" text="protein acetylation" type="GO"/>
    <entity charOffset="116-121" id="s4678.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4678.e0" e2="s4678.e1" id="s4678.p0" relation="false"/>
  </sentence>
  <sentence id="s4679" text="Joubert syndrome exhibits genetic heterogeneity, with mutations identified in more than 30 genes, including protein processing involved in protein targeting to mitochondrion, a gene encoding inositol polyphosphate 5-phosphatase E, which is important in the development and stability of the primary cilium.">
    <entity charOffset="34-47" id="s4679.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="108-173" id="s4679.e1" ontology_id="GO_0006627" text="protein processing involved in protein targeting to mitochondrion" type="GO"/>
    <pair e1="s4679.e0" e2="s4679.e1" id="s4679.p0" relation="false"/>
  </sentence>
  <sentence id="s4680" text="A pathogenic R474Q mutation of axon guidance, which does not exceptionallyaffect either the secretion or the central nervous system development binding, is located in the LGI1-LGI1 interface and disrupts the higher-order assembly of the LGI1-ADAM22 complex in vitro and in a mouse model for familial epilepsy.">
    <entity charOffset="31-44" id="s4680.e0" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <entity charOffset="301-309" id="s4680.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4680.e0" e2="s4680.e1" id="s4680.p0" relation="true"/>
  </sentence>
  <sentence id="s4681" text="A pathogenic R474Q mutation of axon guidance, which does not exceptionallyaffect either the secretion or the central nervous system development binding, is located in the LGI1-LGI1 interface and disrupts the higher-order assembly of the LGI1-ADAM22 complex in vitro and in a mouse model for familial epilepsy.">
    <entity charOffset="110-144" id="s4681.e0" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <entity charOffset="301-309" id="s4681.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4681.e0" e2="s4681.e1" id="s4681.p0" relation="true"/>
  </sentence>
  <sentence id="s4682" text="Haplotype GAT for G protein-coupled glutamate receptor signaling pathway markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high myopia.">
    <entity charOffset="18-72" id="s4682.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="310-316" id="s4682.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s4682.e0" e2="s4682.e1" id="s4682.p0" relation="true"/>
  </sentence>
  <sentence id="s4683" text="The mechanism of G protein-coupled glutamate receptor signaling pathway in the development of high myopia need to be further investigated.">
    <entity charOffset="17-71" id="s4683.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="99-105" id="s4683.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s4683.e0" e2="s4683.e1" id="s4683.p0" relation="true"/>
  </sentence>
  <sentence id="s4684" text="Aminoacyl-tRNA synthetase complex (negative regulation of cell proliferation)-interacting multifunctional protein 1 (negative regulation of endothelial cell proliferation) is a cytokine that is known to amplify the actions of tumor necrosis factor- and to be involved in microglial activation and neuronal death.">
    <entity charOffset="35-76" id="s4684.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="226-231" id="s4684.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4684.e0" e2="s4684.e1" id="s4684.p0" relation="false"/>
  </sentence>
  <sentence id="s4685" text="Aminoacyl-tRNA synthetase complex (negative regulation of cell proliferation)-interacting multifunctional protein 1 (negative regulation of endothelial cell proliferation) is a cytokine that is known to amplify the actions of tumor necrosis factor- and to be involved in microglial activation and neuronal death.">
    <entity charOffset="117-170" id="s4685.e0" ontology_id="GO_0001937" text="negative regulation of endothelial cell proliferation" type="GO"/>
    <entity charOffset="226-231" id="s4685.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4685.e0" e2="s4685.e1" id="s4685.p0" relation="false"/>
  </sentence>
  <sentence id="s4686" text="To personalize nutrition, the purpose of this study was to examine five key genes in the folate metabolism pathway, and dietary parameters and related inttranscription by RNA polymerase IIctive parameters as predictors of colorectal cancer (CRC) by measuring the healthy eating index (HEI) in multiethnic families.">
    <entity charOffset="154-188" id="s4686.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="233-239" id="s4686.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4686.e0" e2="s4686.e1" id="s4686.p0" relation="false"/>
  </sentence>
  <sentence id="s4687" text="Additional predictors included age, as well as gender and the interaction of &lt;i&gt;MTHFR&lt;/i&gt; 677 with overweight status (measured by body cell adhesion mediated by integrin index) in predicting CRC, with the cancer group having more negative regulation of phosphatase activity and overweight cases.">
    <entity charOffset="135-169" id="s4687.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="205-211" id="s4687.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4687.e0" e2="s4687.e1" id="s4687.p0" relation="false"/>
  </sentence>
  <sentence id="s4688" text="Additional predictors included age, as well as gender and the interaction of &lt;i&gt;MTHFR&lt;/i&gt; 677 with overweight status (measured by body cell adhesion mediated by integrin index) in predicting CRC, with the cancer group having more negative regulation of phosphatase activity and overweight cases.">
    <entity charOffset="205-211" id="s4688.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="230-273" id="s4688.e1" ontology_id="GO_0010923" text="negative regulation of phosphatase activity" type="GO"/>
    <pair e1="s4688.e0" e2="s4688.e1" id="s4688.p0" relation="false"/>
  </sentence>
  <sentence id="s4689" text="The molecular chaperone positive regulation of protein phosphorylation is overexpressed in prostate cancer (mitochondrial transport) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression.">
    <entity charOffset="24-70" id="s4689.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="100-106" id="s4689.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4689.e0" e2="s4689.e1" id="s4689.p0" relation="false"/>
  </sentence>
  <sentence id="s4690" text="The molecular chaperone positive regulation of protein phosphorylation is overexpressed in prostate cancer (mitochondrial transport) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression.">
    <entity charOffset="100-106" id="s4690.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="108-131" id="s4690.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s4690.e0" e2="s4690.e1" id="s4690.p0" relation="false"/>
  </sentence>
  <sentence id="s4691" text="This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="64-121" id="s4691.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="284-290" id="s4691.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4691.e0" e2="s4691.e1" id="s4691.p0" relation="false"/>
  </sentence>
  <sentence id="s4692" text="This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="64-121" id="s4692.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="301-324" id="s4692.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s4692.e0" e2="s4692.e1" id="s4692.p0" relation="false"/>
  </sentence>
  <sentence id="s4693" text="This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="122-160" id="s4693.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="284-290" id="s4693.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4693.e0" e2="s4693.e1" id="s4693.p0" relation="false"/>
  </sentence>
  <sentence id="s4694" text="This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.">
    <entity charOffset="122-160" id="s4694.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="329-347" id="s4694.e1" ontology_id="HP_0002861" text="malignant melanoma" type="HP"/>
    <pair e1="s4694.e0" e2="s4694.e1" id="s4694.p0" relation="false"/>
  </sentence>
  <sentence id="s4695" text="Across the years the regulation of cyclin-dependent protein serine/threonine kinase activity have been increasingly implicated in the development of obesity, diabetes and its complications.">
    <entity charOffset="21-92" id="s4695.e0" ontology_id="GO_0000079" text="regulation of cyclin-dependent protein serine/threonine kinase activity" type="GO"/>
    <entity charOffset="149-156" id="s4695.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4695.e0" e2="s4695.e1" id="s4695.p0" relation="false"/>
  </sentence>
  <sentence id="s4696" text="Key steps where regulation of cyclin-dependent protein serine/threonine kinase activity may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where positive regulation of cell differentiation inhibits positive regulation of cell-matrix adhesion cell differentiation in vitro and multicellular organism development may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.">
    <entity charOffset="16-87" id="s4696.e0" ontology_id="GO_0000079" text="regulation of cyclin-dependent protein serine/threonine kinase activity" type="GO"/>
    <entity charOffset="138-145" id="s4696.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4696.e0" e2="s4696.e1" id="s4696.p0" relation="false"/>
  </sentence>
  <sentence id="s4697" text="Key steps where regulation of cyclin-dependent protein serine/threonine kinase activity may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where positive regulation of cell differentiation inhibits positive regulation of cell-matrix adhesion cell differentiation in vitro and multicellular organism development may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.">
    <entity charOffset="138-145" id="s4697.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="176-219" id="s4697.e1" ontology_id="GO_0045597" text="positive regulation of cell differentiation" type="GO"/>
    <pair e1="s4697.e0" e2="s4697.e1" id="s4697.p0" relation="false"/>
  </sentence>
  <sentence id="s4698" text="Key steps where regulation of cyclin-dependent protein serine/threonine kinase activity may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where positive regulation of cell differentiation inhibits positive regulation of cell-matrix adhesion cell differentiation in vitro and multicellular organism development may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.">
    <entity charOffset="138-145" id="s4698.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="229-272" id="s4698.e1" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <pair e1="s4698.e0" e2="s4698.e1" id="s4698.p0" relation="false"/>
  </sentence>
  <sentence id="s4699" text="Key steps where regulation of cyclin-dependent protein serine/threonine kinase activity may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where positive regulation of cell differentiation inhibits positive regulation of cell-matrix adhesion cell differentiation in vitro and multicellular organism development may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.">
    <entity charOffset="138-145" id="s4699.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="307-341" id="s4699.e1" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <pair e1="s4699.e0" e2="s4699.e1" id="s4699.p0" relation="false"/>
  </sentence>
  <sentence id="s4700" text="Taken together, we show here that mutations leading either to hematopoietic stem cell migration haploinsufficiency or to a truncated BCL11B protein clinically cause a non-syndromic neurodevelopmental delay.">
    <entity charOffset="62-95" id="s4700.e0" ontology_id="GO_0035701" text="hematopoietic stem cell migration" type="GO"/>
    <entity charOffset="186-205" id="s4700.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4700.e0" e2="s4700.e1" id="s4700.p0" relation="true"/>
  </sentence>
  <sentence id="s4701" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in phosphatidylinositol phosphorylation cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (cytokine production) regulatory proteins E-integrin-mediated signaling pathway, N-cadherin, Fibronectin, Snail and negative regulation of transcription by RNA polymerase II; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s4701.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="67-103" id="s4701.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4701.e0" e2="s4701.e1" id="s4701.p0" relation="false"/>
  </sentence>
  <sentence id="s4702" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in phosphatidylinositol phosphorylation cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (cytokine production) regulatory proteins E-integrin-mediated signaling pathway, N-cadherin, Fibronectin, Snail and negative regulation of transcription by RNA polymerase II; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s4702.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="340-359" id="s4702.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s4702.e0" e2="s4702.e1" id="s4702.p0" relation="true"/>
  </sentence>
  <sentence id="s4703" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in phosphatidylinositol phosphorylation cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (cytokine production) regulatory proteins E-integrin-mediated signaling pathway, N-cadherin, Fibronectin, Snail and negative regulation of transcription by RNA polymerase II; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s4703.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="383-418" id="s4703.e1" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <pair e1="s4703.e0" e2="s4703.e1" id="s4703.p0" relation="false"/>
  </sentence>
  <sentence id="s4704" text="TCIRG1 knockdown suppressed tumor cell growth and proliferation in phosphatidylinositol phosphorylation cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (cytokine production) regulatory proteins E-integrin-mediated signaling pathway, N-cadherin, Fibronectin, Snail and negative regulation of transcription by RNA polymerase II; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.">
    <entity charOffset="28-33" id="s4704.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="455-512" id="s4704.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4704.e0" e2="s4704.e1" id="s4704.p0" relation="true"/>
  </sentence>
  <sentence id="s4705" text="For individual RP patients, our study may help to predict time-courses for G protein-coupled receptor signaling pathway-related retinal degeneration and thereby facilitate the definition of a window-of-opportunity for clinical interventions.">
    <entity charOffset="75-119" id="s4705.e0" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="128-148" id="s4705.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s4705.e0" e2="s4705.e1" id="s4705.p0" relation="false"/>
  </sentence>
  <sentence id="s4706" text="Some aspects of the disease are now well known, such as nephrocalcinosis and craniosynostosis, related to the natural course of the disease, which persisted despite the negative regulation of transcription, DNA-templated.">
    <entity charOffset="56-72" id="s4706.e0" ontology_id="HP_0000121" text="nephrocalcinosis" type="HP"/>
    <entity charOffset="169-220" id="s4706.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4706.e0" e2="s4706.e1" id="s4706.p0" relation="false"/>
  </sentence>
  <sentence id="s4707" text="Some aspects of the disease are now well known, such as nephrocalcinosis and craniosynostosis, related to the natural course of the disease, which persisted despite the negative regulation of transcription, DNA-templated.">
    <entity charOffset="77-93" id="s4707.e0" ontology_id="HP_0001363" text="craniosynostosis" type="HP"/>
    <entity charOffset="169-220" id="s4707.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4707.e0" e2="s4707.e1" id="s4707.p0" relation="false"/>
  </sentence>
  <sentence id="s4708" text="protein phosphorylation is known to be responsible for autosomal dominant brachydactyly and autosomal recessive acromesomelic chondrodysplasia.">
    <entity charOffset="0-23" id="s4708.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="74-87" id="s4708.e1" ontology_id="HP_0001156" text="brachydactyly" type="HP"/>
    <pair e1="s4708.e0" e2="s4708.e1" id="s4708.p0" relation="true"/>
  </sentence>
  <sentence id="s4709" text="protein phosphorylation is known to be responsible for autosomal dominant brachydactyly and autosomal recessive acromesomelic chondrodysplasia.">
    <entity charOffset="0-23" id="s4709.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="92-111" id="s4709.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4709.e0" e2="s4709.e1" id="s4709.p0" relation="true"/>
  </sentence>
  <sentence id="s4710" text="This study establishes cellular response to oxidative stress variants as a cause of early-onset myopathy and uses biospecimens and cell lines, yeast, and zebrafish models to elucidate the fundamental role of PYROXD1 in skeletal muscle.">
    <entity charOffset="23-60" id="s4710.e0" ontology_id="GO_0034599" text="cellular response to oxidative stress" type="GO"/>
    <entity charOffset="96-104" id="s4710.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4710.e0" e2="s4710.e1" id="s4710.p0" relation="false"/>
  </sentence>
  <sentence id="s4711" text="We characterize variants in the oxidoreductase cellular response to oxidative stress as a cause of early-onset myopathy with distinctive histopathology and introduce altered redox regulation as a primary cause of congenital muscle disease">
    <entity charOffset="47-84" id="s4711.e0" ontology_id="GO_0034599" text="cellular response to oxidative stress" type="GO"/>
    <entity charOffset="111-119" id="s4711.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4711.e0" e2="s4711.e1" id="s4711.p0" relation="false"/>
  </sentence>
  <sentence id="s4712" text="Mutations of phosphatidylinositol biosynthetic process result in the inherited disorders Charcot-Marie-Tooth disease muscle organ development 4J, Yunis-Varn syndrome, and polymicrogyria with seizures.">
    <entity charOffset="13-54" id="s4712.e0" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <entity charOffset="192-200" id="s4712.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s4712.e0" e2="s4712.e1" id="s4712.p0" relation="true"/>
  </sentence>
  <sentence id="s4713" text="Mutations of phosphatidylinositol biosynthetic process result in the inherited disorders Charcot-Marie-Tooth disease muscle organ development 4J, Yunis-Varn syndrome, and polymicrogyria with seizures.">
    <entity charOffset="117-141" id="s4713.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="192-200" id="s4713.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s4713.e0" e2="s4713.e1" id="s4713.p0" relation="false"/>
  </sentence>
  <sentence id="s4714" text="Raptor-cKO epidermis development developed hearing loss considerably more slowly than WT littermates.">
    <entity charOffset="11-32" id="s4714.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="43-55" id="s4714.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4714.e0" e2="s4714.e1" id="s4714.p0" relation="false"/>
  </sentence>
  <sentence id="s4715" text="Conversely, regulation of translation loss led to the early-onset death of cochlear hair cells and consequently accelerated hearing loss.">
    <entity charOffset="12-37" id="s4715.e0" ontology_id="GO_0006417" text="regulation of translation" type="GO"/>
    <entity charOffset="124-136" id="s4715.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s4715.e0" e2="s4715.e1" id="s4715.p0" relation="false"/>
  </sentence>
  <sentence id="s4716" text="negative regulation of transcription by RNA polymerase II deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy and late-onset progressive external ophthalmoplegia">
    <entity charOffset="0-57" id="s4716.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="212-220" id="s4716.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4716.e0" e2="s4716.e1" id="s4716.p0" relation="true"/>
  </sentence>
  <sentence id="s4717" text="negative regulation of transcription by RNA polymerase II deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy and late-onset progressive external ophthalmoplegia">
    <entity charOffset="0-57" id="s4717.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="236-247" id="s4717.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s4717.e0" e2="s4717.e1" id="s4717.p0" relation="false"/>
  </sentence>
  <sentence id="s4718" text="Planar cell polarity (biological_process) signaling has been shown in different studies to either promote or inhibit the malignancy of breast cancer.">
    <entity charOffset="22-40" id="s4718.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="142-148" id="s4718.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4718.e0" e2="s4718.e1" id="s4718.p0" relation="false"/>
  </sentence>
  <sentence id="s4719" text="We thus provide evidence that biological_process signaling can coenzyme A biosynthetic process in a context dependent manner to promote breast cancer progression.">
    <entity charOffset="30-48" id="s4719.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="143-149" id="s4719.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4719.e0" e2="s4719.e1" id="s4719.p0" relation="false"/>
  </sentence>
  <sentence id="s4720" text="We thus provide evidence that biological_process signaling can coenzyme A biosynthetic process in a context dependent manner to promote breast cancer progression.">
    <entity charOffset="63-94" id="s4720.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="143-149" id="s4720.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4720.e0" e2="s4720.e1" id="s4720.p0" relation="false"/>
  </sentence>
  <sentence id="s4721" text="The mutational analysis of the whole mitochondrial DNA revealed the presence of m.1555A&amp;gt;G mutation in MT-RNR1 gene associated to the m.8527A&amp;gt;G (p.M&amp;gt;V) and the m.8392C&amp;gt;T (p.136P&amp;gt;S) variations in the mitochondrial biological_process gene in patient1 and his family members with variable phenotype including hearing impairment.">
    <entity charOffset="227-245" id="s4721.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="320-338" id="s4721.e1" ontology_id="HP_0000365" text="hearing impairment" type="HP"/>
    <pair e1="s4721.e0" e2="s4721.e1" id="s4721.p0" relation="false"/>
  </sentence>
  <sentence id="s4722" text="Herewith we provide a biological and pathophysiological characterization of the immunological layer of cancerous (mitochondrial transport) versus benign (BPH) disease, derived from antibody profiling on protein microarrays">
    <entity charOffset="103-109" id="s4722.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="114-137" id="s4722.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s4722.e0" e2="s4722.e1" id="s4722.p0" relation="false"/>
  </sentence>
  <sentence id="s4723" text="Prostate cancer (mitochondrial transport) is one of the most common types of cancer in the urinary system in men.">
    <entity charOffset="9-15" id="s4723.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="17-40" id="s4723.e1" ontology_id="GO_0006839" text="mitochondrial transport" type="GO"/>
    <pair e1="s4723.e0" e2="s4723.e1" id="s4723.p0" relation="false"/>
  </sentence>
  <sentence id="s4724" text="These tumors often exhibit a plasmablastic morphology, a finding which prompted our interest in looking for phosphorylation fusions in plasma cell neoplasms.">
    <entity charOffset="6-12" id="s4724.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="108-123" id="s4724.e1" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <pair e1="s4724.e0" e2="s4724.e1" id="s4724.p0" relation="true"/>
  </sentence>
  <sentence id="s4725" text="These tumors often exhibit a plasmablastic morphology, a finding which prompted our interest in looking for phosphorylation fusions in plasma cell neoplasms.">
    <entity charOffset="108-123" id="s4725.e0" ontology_id="GO_0016310" text="phosphorylation" type="GO"/>
    <entity charOffset="147-156" id="s4725.e1" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <pair e1="s4725.e0" e2="s4725.e1" id="s4725.p0" relation="true"/>
  </sentence>
  <sentence id="s4726" text="Biallelic loss-of-function mutations in myeloid leukocyte activation and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).">
    <entity charOffset="40-68" id="s4726.e0" ontology_id="GO_0002274" text="myeloid leukocyte activation" type="GO"/>
    <entity charOffset="127-150" id="s4726.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4726.e0" e2="s4726.e1" id="s4726.p0" relation="false"/>
  </sentence>
  <sentence id="s4727" text="Biallelic loss-of-function mutations in myeloid leukocyte activation and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).">
    <entity charOffset="40-68" id="s4727.e0" ontology_id="GO_0002274" text="myeloid leukocyte activation" type="GO"/>
    <entity charOffset="233-252" id="s4727.e1" ontology_id="HP_0002352" text="leukoencephalopathy" type="HP"/>
    <pair e1="s4727.e0" e2="s4727.e1" id="s4727.p0" relation="true"/>
  </sentence>
  <sentence id="s4728" text="The toxic subcellular accumulation of lipids predisposes several human metabolic syndromes, including obesity, muscle organ development 2 diabetes, and some forms of neurodegeneration.">
    <entity charOffset="102-109" id="s4728.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="111-135" id="s4728.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4728.e0" e2="s4728.e1" id="s4728.p0" relation="false"/>
  </sentence>
  <sentence id="s4729" text="Bcl2-associated athanogene 3 (extrinsic apoptotic signaling pathway via death domain receptors) mutations have been reported to cause the myofibrillar myopathy (MFM) which shows progressive limb muscle weakness, respiratory failure, and cardiomyopathy.">
    <entity charOffset="30-94" id="s4729.e0" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <entity charOffset="151-159" id="s4729.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4729.e0" e2="s4729.e1" id="s4729.p0" relation="true"/>
  </sentence>
  <sentence id="s4730" text="We aimed to cellular response to interleukin-4 the genetic cause of Korean patients with sensory motor polyneuropathy, myopathy and rigid spine.">
    <entity charOffset="12-46" id="s4730.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="103-117" id="s4730.e1" ontology_id="HP_0001271" text="polyneuropathy" type="HP"/>
    <pair e1="s4730.e0" e2="s4730.e1" id="s4730.p0" relation="false"/>
  </sentence>
  <sentence id="s4731" text="We aimed to cellular response to interleukin-4 the genetic cause of Korean patients with sensory motor polyneuropathy, myopathy and rigid spine.">
    <entity charOffset="12-46" id="s4731.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="119-127" id="s4731.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4731.e0" e2="s4731.e1" id="s4731.p0" relation="false"/>
  </sentence>
  <sentence id="s4732" text="We found extrinsic apoptotic signaling pathway via death domain receptors mutation in one patient with neuropathy, myopathy and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.">
    <entity charOffset="9-73" id="s4732.e0" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <entity charOffset="115-123" id="s4732.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4732.e0" e2="s4732.e1" id="s4732.p0" relation="true"/>
  </sentence>
  <sentence id="s4733" text="She showed an axonal sensory-motor polyneuropathy like Charcot-Marie-Tooth disease (CMT), myopathy, rigid spine and respiratory dysfunction; however, she did not show any cardiomyopathy, which is a common symptom in extrinsic apoptotic signaling pathway via death domain receptors mutation.">
    <entity charOffset="35-49" id="s4733.e0" ontology_id="HP_0001271" text="polyneuropathy" type="HP"/>
    <entity charOffset="216-280" id="s4733.e1" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <pair e1="s4733.e0" e2="s4733.e1" id="s4733.p0" relation="false"/>
  </sentence>
  <sentence id="s4734" text="We described a extrinsic apoptotic signaling pathway via death domain receptors mutation patient with atypical phenotype of CMT and myopathy, and those are expected to broaden the clinical spectrum of the disease and help to diagnose it">
    <entity charOffset="15-79" id="s4734.e0" ontology_id="GO_0008625" text="extrinsic apoptotic signaling pathway via death domain receptors" type="GO"/>
    <entity charOffset="132-140" id="s4734.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4734.e0" e2="s4734.e1" id="s4734.p0" relation="true"/>
  </sentence>
  <sentence id="s4735" text="Mutations in eight of them (ubiquinone biosynthetic process, PDSS2, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="28-59" id="s4735.e0" ontology_id="GO_0006744" text="ubiquinone biosynthetic process" type="GO"/>
    <entity charOffset="227-240" id="s4735.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4735.e0" e2="s4735.e1" id="s4735.p0" relation="false"/>
  </sentence>
  <sentence id="s4736" text="Mutations in eight of them (ubiquinone biosynthetic process, PDSS2, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="68-99" id="s4736.e0" ontology_id="GO_0006744" text="ubiquinone biosynthetic process" type="GO"/>
    <entity charOffset="227-240" id="s4736.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4736.e0" e2="s4736.e1" id="s4736.p0" relation="false"/>
  </sentence>
  <sentence id="s4737" text="Mutations in eight of them (ubiquinone biosynthetic process, PDSS2, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="101-132" id="s4737.e0" ontology_id="GO_0006744" text="ubiquinone biosynthetic process" type="GO"/>
    <entity charOffset="227-240" id="s4737.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4737.e0" e2="s4737.e1" id="s4737.p0" relation="false"/>
  </sentence>
  <sentence id="s4738" text="Mutations in eight of them (ubiquinone biosynthetic process, PDSS2, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.">
    <entity charOffset="134-165" id="s4738.e0" ontology_id="GO_0006744" text="ubiquinone biosynthetic process" type="GO"/>
    <entity charOffset="227-240" id="s4738.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4738.e0" e2="s4738.e1" id="s4738.p0" relation="false"/>
  </sentence>
  <sentence id="s4739" text="Uncorrected refrcoenzyme A biosynthetic processive errors constitute the most common cause of vision loss and second leading cause of blindness worldwide.">
    <entity charOffset="16-47" id="s4739.e0" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <entity charOffset="134-143" id="s4739.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s4739.e0" e2="s4739.e1" id="s4739.p0" relation="false"/>
  </sentence>
  <sentence id="s4740" text="We have previously identified a role for the secreted serine protease camera-type eye development in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refrcoenzyme A biosynthetic processive development.">
    <entity charOffset="70-97" id="s4740.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="192-201" id="s4740.e1" ontology_id="HP_0000540" text="hyperopia" type="HP"/>
    <pair e1="s4740.e0" e2="s4740.e1" id="s4740.p0" relation="true"/>
  </sentence>
  <sentence id="s4741" text="We have previously identified a role for the secreted serine protease camera-type eye development in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refrcoenzyme A biosynthetic processive development.">
    <entity charOffset="206-212" id="s4741.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="249-280" id="s4741.e1" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <pair e1="s4741.e0" e2="s4741.e1" id="s4741.p0" relation="false"/>
  </sentence>
  <sentence id="s4742" text="Here, we use a combination of genetic mouse models to demonstrate that camera-type eye development mutations leading to reduced ocular size and hyperopia coenzyme A biosynthetic process via a loss of function mechanism.">
    <entity charOffset="71-98" id="s4742.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="144-153" id="s4742.e1" ontology_id="HP_0000540" text="hyperopia" type="HP"/>
    <pair e1="s4742.e0" e2="s4742.e1" id="s4742.p0" relation="true"/>
  </sentence>
  <sentence id="s4743" text="Here, we use a combination of genetic mouse models to demonstrate that camera-type eye development mutations leading to reduced ocular size and hyperopia coenzyme A biosynthetic process via a loss of function mechanism.">
    <entity charOffset="144-153" id="s4743.e0" ontology_id="HP_0000540" text="hyperopia" type="HP"/>
    <entity charOffset="154-185" id="s4743.e1" ontology_id="GO_0015937" text="coenzyme A biosynthetic process" type="GO"/>
    <pair e1="s4743.e0" e2="s4743.e1" id="s4743.p0" relation="false"/>
  </sentence>
  <sentence id="s4744" text="Overall, our findings identify camera-type eye development as a potential therapeutic target for modulating ocular growth aimed at preventing or slowing down myopia, which is reaching epidemic proportions">
    <entity charOffset="31-58" id="s4744.e0" ontology_id="GO_0043010" text="camera-type eye development" type="GO"/>
    <entity charOffset="158-164" id="s4744.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s4744.e0" e2="s4744.e1" id="s4744.p0" relation="false"/>
  </sentence>
  <sentence id="s4745" text="Primary hyperoxaluria (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly the kidney, leading to recurrent lithiasis, nephrocalcinosis and positive regulation of protein phosphorylation stage renal disease (ESRD).">
    <entity charOffset="8-21" id="s4745.e0" ontology_id="HP_0003159" text="hyperoxaluria" type="HP"/>
    <entity charOffset="320-366" id="s4745.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4745.e0" e2="s4745.e1" id="s4745.p0" relation="false"/>
  </sentence>
  <sentence id="s4746" text="Primary hyperoxaluria (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly the kidney, leading to recurrent lithiasis, nephrocalcinosis and positive regulation of protein phosphorylation stage renal disease (ESRD).">
    <entity charOffset="299-315" id="s4746.e0" ontology_id="HP_0000121" text="nephrocalcinosis" type="HP"/>
    <entity charOffset="320-366" id="s4746.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s4746.e0" e2="s4746.e1" id="s4746.p0" relation="false"/>
  </sentence>
  <sentence id="s4747" text="Their seizures started within the first day and could not be controlled by pyridoxine or pyridoxal-5'-phosphate (substantia nigra development) completely.">
    <entity charOffset="6-14" id="s4747.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="113-141" id="s4747.e1" ontology_id="GO_0021762" text="substantia nigra development" type="GO"/>
    <pair e1="s4747.e0" e2="s4747.e1" id="s4747.p0" relation="true"/>
  </sentence>
  <sentence id="s4748" text="With particular relevance for muscle physiology, mutations in protein polyubiquitination are associated with autosomal recessive Limb-Girdle Muscular Dystrophy 2H, a muscle-wasting disease with variable clinical spectrum ranging from almost asymptomatic to wheelchair-bound patients.">
    <entity charOffset="62-88" id="s4748.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="109-128" id="s4748.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4748.e0" e2="s4748.e1" id="s4748.p0" relation="true"/>
  </sentence>
  <sentence id="s4749" text="In this review, we will focus on the ability of TRIM32 to protein phosphorylation specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or tumour suppressive role for TRIM32 in the context of different types of cancer">
    <entity charOffset="58-81" id="s4749.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="303-309" id="s4749.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4749.e0" e2="s4749.e1" id="s4749.p0" relation="false"/>
  </sentence>
  <sentence id="s4750" text="Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disease caused by expansion of a stem cell that harbors a somatic mutation in &lt;i&gt;GPI anchor biosynthetic process&lt;/i&gt; PIGA mutant blood cells are deficient in the complement regulator proteins CD55 and CD59, making them susceptible to intravascular hemolysis due to a failure to regulate the cellular response to DNA damage stimulus on erythrocytes.">
    <entity charOffset="126-142" id="s4750.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="359-399" id="s4750.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s4750.e0" e2="s4750.e1" id="s4750.p0" relation="true"/>
  </sentence>
  <sentence id="s4751" text="Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disease caused by expansion of a stem cell that harbors a somatic mutation in &lt;i&gt;GPI anchor biosynthetic process&lt;/i&gt; PIGA mutant blood cells are deficient in the complement regulator proteins CD55 and CD59, making them susceptible to intravascular hemolysis due to a failure to regulate the cellular response to DNA damage stimulus on erythrocytes.">
    <entity charOffset="126-142" id="s4751.e0" ontology_id="HP_0001428" text="somatic mutation" type="HP"/>
    <entity charOffset="149-180" id="s4751.e1" ontology_id="GO_0006506" text="GPI anchor biosynthetic process" type="GO"/>
    <pair e1="s4751.e0" e2="s4751.e1" id="s4751.p0" relation="true"/>
  </sentence>
  <sentence id="s4752" text="the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the T cell costimulation sensitivity and adaptation in intact rods; 2. functional differences between positive regulation of guanylate cyclase activity and receptor guanylyl cyclase signaling pathway in intact rod photoreceptors; and 3. whether positive regulation of guanylate cyclase activity mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies">
    <entity charOffset="75-95" id="s4752.e0" ontology_id="GO_0031295" text="T cell costimulation" type="GO"/>
    <entity charOffset="409-424" id="s4752.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s4752.e0" e2="s4752.e1" id="s4752.p0" relation="false"/>
  </sentence>
  <sentence id="s4753" text="the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the T cell costimulation sensitivity and adaptation in intact rods; 2. functional differences between positive regulation of guanylate cyclase activity and receptor guanylyl cyclase signaling pathway in intact rod photoreceptors; and 3. whether positive regulation of guanylate cyclase activity mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies">
    <entity charOffset="173-222" id="s4753.e0" ontology_id="GO_0031284" text="positive regulation of guanylate cyclase activity" type="GO"/>
    <entity charOffset="409-424" id="s4753.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s4753.e0" e2="s4753.e1" id="s4753.p0" relation="true"/>
  </sentence>
  <sentence id="s4754" text="the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the T cell costimulation sensitivity and adaptation in intact rods; 2. functional differences between positive regulation of guanylate cyclase activity and receptor guanylyl cyclase signaling pathway in intact rod photoreceptors; and 3. whether positive regulation of guanylate cyclase activity mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies">
    <entity charOffset="227-270" id="s4754.e0" ontology_id="GO_0007168" text="receptor guanylyl cyclase signaling pathway" type="GO"/>
    <entity charOffset="409-424" id="s4754.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s4754.e0" e2="s4754.e1" id="s4754.p0" relation="true"/>
  </sentence>
  <sentence id="s4755" text="the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the T cell costimulation sensitivity and adaptation in intact rods; 2. functional differences between positive regulation of guanylate cyclase activity and receptor guanylyl cyclase signaling pathway in intact rod photoreceptors; and 3. whether positive regulation of guanylate cyclase activity mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies">
    <entity charOffset="316-365" id="s4755.e0" ontology_id="GO_0031284" text="positive regulation of guanylate cyclase activity" type="GO"/>
    <entity charOffset="409-424" id="s4755.e1" ontology_id="HP_0000479" text="retinal disease" type="HP"/>
    <pair e1="s4755.e0" e2="s4755.e1" id="s4755.p0" relation="true"/>
  </sentence>
  <sentence id="s4756" text="Pyridoxine dependent epilepsy (cellular aldehyde metabolic process) is a rare autosomal recessive neurometabolic disorder.">
    <entity charOffset="21-29" id="s4756.e0" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <entity charOffset="31-66" id="s4756.e1" ontology_id="GO_0006081" text="cellular aldehyde metabolic process" type="GO"/>
    <pair e1="s4756.e0" e2="s4756.e1" id="s4756.p0" relation="true"/>
  </sentence>
  <sentence id="s4757" text="Mice with a neuronal deletion of Arv1 recapitulated the human phenomuscle organ development, exhibiting seizures and a severe survival defect in adulthood.">
    <entity charOffset="67-91" id="s4757.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="104-111" id="s4757.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s4757.e0" e2="s4757.e1" id="s4757.p0" relation="false"/>
  </sentence>
  <sentence id="s4758" text="Our data support regulation of intracellular cholesterol transport deficiency as a cause of autosomal recessive epileptic encephalopathy">
    <entity charOffset="17-66" id="s4758.e0" ontology_id="GO_0032383" text="regulation of intracellular cholesterol transport" type="GO"/>
    <entity charOffset="92-111" id="s4758.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4758.e0" e2="s4758.e1" id="s4758.p0" relation="true"/>
  </sentence>
  <sentence id="s4759" text="The major question to be solved is the genetic basis of bilateral adrenal hyperplasia (positive regulation of proteolysis).">
    <entity charOffset="56-65" id="s4759.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="87-121" id="s4759.e1" ontology_id="GO_0045862" text="positive regulation of proteolysis" type="GO"/>
    <pair e1="s4759.e0" e2="s4759.e1" id="s4759.p0" relation="false"/>
  </sentence>
  <sentence id="s4760" text="The major question to be solved is the genetic basis of bilateral adrenal hyperplasia (positive regulation of proteolysis).">
    <entity charOffset="66-85" id="s4760.e0" ontology_id="HP_0008221" text="adrenal hyperplasia" type="HP"/>
    <entity charOffset="87-121" id="s4760.e1" ontology_id="GO_0045862" text="positive regulation of proteolysis" type="GO"/>
    <pair e1="s4760.e0" e2="s4760.e1" id="s4760.p0" relation="false"/>
  </sentence>
  <sentence id="s4761" text="Myotonic dystrophy 1 (protein phosphorylation) is a multisystem disorder primarily affecting the central nervous system, heart and skeletal muscle.">
    <entity charOffset="22-45" id="s4761.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="97-104" id="s4761.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s4761.e0" e2="s4761.e1" id="s4761.p0" relation="false"/>
  </sentence>
  <sentence id="s4762" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (collagen fibril organization), DFNB66, and ion transport.">
    <entity charOffset="58-77" id="s4762.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="226-254" id="s4762.e1" ontology_id="GO_0030199" text="collagen fibril organization" type="GO"/>
    <pair e1="s4762.e0" e2="s4762.e1" id="s4762.p0" relation="true"/>
  </sentence>
  <sentence id="s4763" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (collagen fibril organization), DFNB66, and ion transport.">
    <entity charOffset="58-77" id="s4763.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="269-282" id="s4763.e1" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <pair e1="s4763.e0" e2="s4763.e1" id="s4763.p0" relation="true"/>
  </sentence>
  <sentence id="s4764" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (collagen fibril organization), DFNB66, and ion transport.">
    <entity charOffset="91-103" id="s4764.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="226-254" id="s4764.e1" ontology_id="GO_0030199" text="collagen fibril organization" type="GO"/>
    <pair e1="s4764.e0" e2="s4764.e1" id="s4764.p0" relation="true"/>
  </sentence>
  <sentence id="s4765" text="In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (collagen fibril organization), DFNB66, and ion transport.">
    <entity charOffset="91-103" id="s4765.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="269-282" id="s4765.e1" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <pair e1="s4765.e0" e2="s4765.e1" id="s4765.p0" relation="true"/>
  </sentence>
  <sentence id="s4766" text="Fine mapping excluded collagen fibril organization and subsequently homozygous mutations were identified in the lipoma negative regulation of transcription by RNA polymerase II fusion partner-like 5 (LHFPL5) gene, also named protein-containing complex assembly membrane protein of hair cell stereocilia (ion transport) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two ion transport-linked families from Pakistan.">
    <entity charOffset="22-50" id="s4766.e0" ontology_id="GO_0030199" text="collagen fibril organization" type="GO"/>
    <entity charOffset="112-118" id="s4766.e1" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <pair e1="s4766.e0" e2="s4766.e1" id="s4766.p0" relation="false"/>
  </sentence>
  <sentence id="s4767" text="Fine mapping excluded collagen fibril organization and subsequently homozygous mutations were identified in the lipoma negative regulation of transcription by RNA polymerase II fusion partner-like 5 (LHFPL5) gene, also named protein-containing complex assembly membrane protein of hair cell stereocilia (ion transport) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two ion transport-linked families from Pakistan.">
    <entity charOffset="112-118" id="s4767.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="119-176" id="s4767.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4767.e0" e2="s4767.e1" id="s4767.p0" relation="false"/>
  </sentence>
  <sentence id="s4768" text="Fine mapping excluded collagen fibril organization and subsequently homozygous mutations were identified in the lipoma negative regulation of transcription by RNA polymerase II fusion partner-like 5 (LHFPL5) gene, also named protein-containing complex assembly membrane protein of hair cell stereocilia (ion transport) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two ion transport-linked families from Pakistan.">
    <entity charOffset="112-118" id="s4768.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="225-260" id="s4768.e1" ontology_id="GO_0065003" text="protein-containing complex assembly" type="GO"/>
    <pair e1="s4768.e0" e2="s4768.e1" id="s4768.p0" relation="false"/>
  </sentence>
  <sentence id="s4769" text="Fine mapping excluded collagen fibril organization and subsequently homozygous mutations were identified in the lipoma negative regulation of transcription by RNA polymerase II fusion partner-like 5 (LHFPL5) gene, also named protein-containing complex assembly membrane protein of hair cell stereocilia (ion transport) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two ion transport-linked families from Pakistan.">
    <entity charOffset="112-118" id="s4769.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="304-317" id="s4769.e1" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <pair e1="s4769.e0" e2="s4769.e1" id="s4769.p0" relation="false"/>
  </sentence>
  <sentence id="s4770" text="Fine mapping excluded collagen fibril organization and subsequently homozygous mutations were identified in the lipoma negative regulation of transcription by RNA polymerase II fusion partner-like 5 (LHFPL5) gene, also named protein-containing complex assembly membrane protein of hair cell stereocilia (ion transport) gene, which was recently shown to be mutated in the &amp;quot;hurry scurry&amp;quot; mouse and in two ion transport-linked families from Pakistan.">
    <entity charOffset="112-118" id="s4770.e0" ontology_id="HP_0012032" text="lipoma" type="HP"/>
    <entity charOffset="413-426" id="s4770.e1" ontology_id="GO_0006811" text="ion transport" type="GO"/>
    <pair e1="s4770.e0" e2="s4770.e1" id="s4770.p0" relation="false"/>
  </sentence>
  <sentence id="s4771" text="Thus, the geographic imbalance in colorectal cancer, in part, may reflect chronic exposure to ST-producing organisms that restore digestion signaling silenced by hormone loss during transformation.">
    <entity charOffset="45-51" id="s4771.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="130-139" id="s4771.e1" ontology_id="GO_0007586" text="digestion" type="GO"/>
    <pair e1="s4771.e0" e2="s4771.e1" id="s4771.p0" relation="false"/>
  </sentence>
  <sentence id="s4772" text="Moreover, epidermis development colonized with ST-producing &lt;i&gt;E. coli&lt;/i&gt; exhibited a 50% reduction in carcinogen-induced colorectal tumor burden.">
    <entity charOffset="10-31" id="s4772.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="134-139" id="s4772.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4772.e0" e2="s4772.e1" id="s4772.p0" relation="false"/>
  </sentence>
  <sentence id="s4773" text="Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare tumors with distinct sets of morphological features, both characterized by maintenance of gastrointestinal epithelium immunoreactivity.">
    <entity charOffset="22-29" id="s4773.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="168-210" id="s4773.e1" ontology_id="GO_0030277" text="maintenance of gastrointestinal epithelium" type="GO"/>
    <pair e1="s4773.e0" e2="s4773.e1" id="s4773.p0" relation="false"/>
  </sentence>
  <sentence id="s4774" text="In the largest study of hybrid LGFMS-SEF tumors to date, all cases exhibited regulation of transcription, DNA-templated rearrangements, a similar genetic profile to LGFMS.">
    <entity charOffset="41-47" id="s4774.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="77-119" id="s4774.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4774.e0" e2="s4774.e1" id="s4774.p0" relation="false"/>
  </sentence>
  <sentence id="s4775" text="Fusion gene detection using a next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) was performed on both the primary renal tumor that showed the morphology of a LGFMS, and a cervical metastasis that showed the morphology of MAPK cascade.">
    <entity charOffset="170-175" id="s4775.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="271-283" id="s4775.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s4775.e0" e2="s4775.e1" id="s4775.p0" relation="false"/>
  </sentence>
  <sentence id="s4776" text="We show that hypermethylation of p16/Ink4a and p19/Arf in CNT- and asbestos-induced inflammatory lesions precedes mesothelioma; this results in silencing of G1/S transition of mitotic cell cycle (Ink4a/Arf) and loss of p16 and p19 protein, consistent with epigenetic alterations playing a gatekeeper role in cancer.">
    <entity charOffset="157-194" id="s4776.e0" ontology_id="GO_0000082" text="G1/S transition of mitotic cell cycle" type="GO"/>
    <entity charOffset="308-314" id="s4776.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4776.e0" e2="s4776.e1" id="s4776.p0" relation="true"/>
  </sentence>
  <sentence id="s4777" text="B cell-associated protein 31 (positive regulation of retrograde protein transport, ER to cytosol) was shown to participate in the apoptosis, and to be an immunotherapy target and a, prognostic factor for cancer, but its role in CRC has not been elucidated.">
    <entity charOffset="30-96" id="s4777.e0" ontology_id="GO_1904154" text="positive regulation of retrograde protein transport, ER to cytosol" type="GO"/>
    <entity charOffset="204-210" id="s4777.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4777.e0" e2="s4777.e1" id="s4777.p0" relation="false"/>
  </sentence>
  <sentence id="s4778" text="Gain-of-function mutations in negative regulation of protein secretion underlie Tylosis with oesophageal cancer (negative regulation of protein secretion), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6.">
    <entity charOffset="30-70" id="s4778.e0" ontology_id="GO_0050709" text="negative regulation of protein secretion" type="GO"/>
    <entity charOffset="105-111" id="s4778.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4778.e0" e2="s4778.e1" id="s4778.p0" relation="true"/>
  </sentence>
  <sentence id="s4779" text="Gain-of-function mutations in negative regulation of protein secretion underlie Tylosis with oesophageal cancer (negative regulation of protein secretion), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6.">
    <entity charOffset="105-111" id="s4779.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="113-153" id="s4779.e1" ontology_id="GO_0050709" text="negative regulation of protein secretion" type="GO"/>
    <pair e1="s4779.e0" e2="s4779.e1" id="s4779.p0" relation="true"/>
  </sentence>
  <sentence id="s4780" text="Autosomal recessive spastic ataxia of Charlevoix-Saguenay (negative regulation of inclusion body assembly) is a neurodegenerative disease that is caused by mutations in the &lt;i&gt;SACS&lt;/i&gt; gene.">
    <entity charOffset="28-34" id="s4780.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="59-105" id="s4780.e1" ontology_id="GO_0090084" text="negative regulation of inclusion body assembly" type="GO"/>
    <pair e1="s4780.e0" e2="s4780.e1" id="s4780.p0" relation="true"/>
  </sentence>
  <sentence id="s4781" text="Levels of serum CysC might become elevated regardless of renal function, and CysC-positive regulation of protein phosphorylation might become unpredictable during the active phase of tumors.">
    <entity charOffset="82-128" id="s4781.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="183-188" id="s4781.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4781.e0" e2="s4781.e1" id="s4781.p0" relation="true"/>
  </sentence>
  <sentence id="s4782" text="In addition, conditions such as Gitelman's syndrome, distal renal tubular acidosis and pseudohypoaldosteronism muscle organ development II, as well as a mitochondrial defect associated with hypomagnesaemia, all change the renal handling of divalent cations.">
    <entity charOffset="53-82" id="s4782.e0" ontology_id="HP_0008341" text="distal renal tubular acidosis" type="HP"/>
    <entity charOffset="111-135" id="s4782.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4782.e0" e2="s4782.e1" id="s4782.p0" relation="false"/>
  </sentence>
  <sentence id="s4783" text="In addition, conditions such as Gitelman's syndrome, distal renal tubular acidosis and pseudohypoaldosteronism muscle organ development II, as well as a mitochondrial defect associated with hypomagnesaemia, all change the renal handling of divalent cations.">
    <entity charOffset="87-110" id="s4783.e0" ontology_id="HP_0008242" text="pseudohypoaldosteronism" type="HP"/>
    <entity charOffset="111-135" id="s4783.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4783.e0" e2="s4783.e1" id="s4783.p0" relation="false"/>
  </sentence>
  <sentence id="s4784" text="The second most frequently mutated gene, histone methyltransferase &lt;i&gt;regulation of double-strand break repair via homologous recombination&lt;/i&gt;, has known roles in multiple cancers, but has not previously been strongly implicated in osteosarcoma.">
    <entity charOffset="70-139" id="s4784.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="233-245" id="s4784.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s4784.e0" e2="s4784.e1" id="s4784.p0" relation="false"/>
  </sentence>
  <sentence id="s4785" text="The second most frequently mutated gene, histone methyltransferase &lt;i&gt;regulation of double-strand break repair via homologous recombination&lt;/i&gt;, has known roles in multiple cancers, but has not previously been strongly implicated in osteosarcoma.">
    <entity charOffset="70-139" id="s4785.e0" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="173-179" id="s4785.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4785.e0" e2="s4785.e1" id="s4785.p0" relation="true"/>
  </sentence>
  <sentence id="s4786" text="This study points to the likely importance of histone modifications in osteosarcoma and highlights the strong genetic similarities between human and dog osteosarcoma, suggesting that canine osteosarcoma may serve as an excellent model for developing treatment strategies in both species.&lt;b&gt;Significance:&lt;/b&gt; Canine osteosarcoma genomics identify regulation of double-strand break repair via homologous recombination as a possible oncogenic driver of osteosarcoma, and findings establish the canine model as a useful comparative model for the corresponding human disease.">
    <entity charOffset="71-83" id="s4786.e0" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <entity charOffset="346-415" id="s4786.e1" ontology_id="GO_0010569" text="regulation of double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s4786.e0" e2="s4786.e1" id="s4786.p0" relation="false"/>
  </sentence>
  <sentence id="s4787" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="0-28" id="s4787.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="46-59" id="s4787.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4787.e0" e2="s4787.e1" id="s4787.p0" relation="false"/>
  </sentence>
  <sentence id="s4788" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="0-28" id="s4788.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="210-229" id="s4788.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4788.e0" e2="s4788.e1" id="s4788.p0" relation="false"/>
  </sentence>
  <sentence id="s4789" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="46-59" id="s4789.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="136-164" id="s4789.e1" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <pair e1="s4789.e0" e2="s4789.e1" id="s4789.p0" relation="false"/>
  </sentence>
  <sentence id="s4790" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="46-59" id="s4790.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="277-306" id="s4790.e1" ontology_id="GO_0006612" text="protein targeting to membrane" type="GO"/>
    <pair e1="s4790.e0" e2="s4790.e1" id="s4790.p0" relation="false"/>
  </sentence>
  <sentence id="s4791" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="46-59" id="s4791.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="308-403" id="s4791.e1" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <pair e1="s4791.e0" e2="s4791.e1" id="s4791.p0" relation="false"/>
  </sentence>
  <sentence id="s4792" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="136-164" id="s4792.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="210-229" id="s4792.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4792.e0" e2="s4792.e1" id="s4792.p0" relation="false"/>
  </sentence>
  <sentence id="s4793" text="superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.">
    <entity charOffset="210-229" id="s4793.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="308-403" id="s4793.e1" ontology_id="GO_0002479" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" type="GO"/>
    <pair e1="s4793.e0" e2="s4793.e1" id="s4793.p0" relation="true"/>
  </sentence>
  <sentence id="s4794" text="Triple-negative breast cancer (TNBC), lacking the steroid hormone receptors ER and PR and the oncoprotein signal transduction, is characterized by its aggressive pattern and insensitivity to endocrine and HER2-directed therapy.">
    <entity charOffset="23-29" id="s4794.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="106-125" id="s4794.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s4794.e0" e2="s4794.e1" id="s4794.p0" relation="true"/>
  </sentence>
  <sentence id="s4795" text="amelogenesis protein is localized in the cytoplasm of tumor and stroma cells.">
    <entity charOffset="0-12" id="s4795.e0" ontology_id="GO_0097186" text="amelogenesis" type="GO"/>
    <entity charOffset="54-59" id="s4795.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4795.e0" e2="s4795.e1" id="s4795.p0" relation="false"/>
  </sentence>
  <sentence id="s4796" text="In this patient cohort, elevated stroma cell amelogenesis expression, but not tumor cell KLK4 expression, is predictive for poor disease-free survival by univariate analysis (hazard ratio: 2.26, p=0.001) and multivariable analysis (hazard ratio: 2.12, p&amp;lt;0.01).">
    <entity charOffset="45-57" id="s4796.e0" ontology_id="GO_0097186" text="amelogenesis" type="GO"/>
    <entity charOffset="78-83" id="s4796.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4796.e0" e2="s4796.e1" id="s4796.p0" relation="false"/>
  </sentence>
  <sentence id="s4797" text="Using exome sequencing, we discovered missense mutations in transcription by RNA polymerase II, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).">
    <entity charOffset="60-94" id="s4797.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="302-315" id="s4797.e1" ontology_id="HP_0000280" text="coarse facies" type="HP"/>
    <pair e1="s4797.e0" e2="s4797.e1" id="s4797.p0" relation="true"/>
  </sentence>
  <sentence id="s4798" text="Using exome sequencing, we discovered missense mutations in transcription by RNA polymerase II, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).">
    <entity charOffset="60-94" id="s4798.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="344-351" id="s4798.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s4798.e0" e2="s4798.e1" id="s4798.p0" relation="true"/>
  </sentence>
  <sentence id="s4799" text="Using exome sequencing, we discovered missense mutations in transcription by RNA polymerase II, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).">
    <entity charOffset="60-94" id="s4799.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="391-404" id="s4799.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s4799.e0" e2="s4799.e1" id="s4799.p0" relation="true"/>
  </sentence>
  <sentence id="s4800" text="Primary ciliary dyskinesia (motile cilium assembly) is a genetically heterogeneous, autosomal-recessive disorder, characterized by oto-sino-pulmonary disease and situs abnormalities.">
    <entity charOffset="8-26" id="s4800.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-50" id="s4800.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s4800.e0" e2="s4800.e1" id="s4800.p0" relation="true"/>
  </sentence>
  <sentence id="s4801" text="These results revealed that mutations in cilium movement are a cause of ciliary dysmotility and motile cilium assembly and further demonstrate the utility of exome sequencing to identify genetic causes in heterogeneous recessive disorders">
    <entity charOffset="41-56" id="s4801.e0" ontology_id="GO_0003341" text="cilium movement" type="GO"/>
    <entity charOffset="205-218" id="s4801.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4801.e0" e2="s4801.e1" id="s4801.p0" relation="false"/>
  </sentence>
  <sentence id="s4802" text="These results revealed that mutations in cilium movement are a cause of ciliary dysmotility and motile cilium assembly and further demonstrate the utility of exome sequencing to identify genetic causes in heterogeneous recessive disorders">
    <entity charOffset="96-118" id="s4802.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="205-218" id="s4802.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4802.e0" e2="s4802.e1" id="s4802.p0" relation="false"/>
  </sentence>
  <sentence id="s4803" text="Prion proteins (positive regulation of peptidyl-tyrosine phosphorylation and acrosome reaction), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.">
    <entity charOffset="16-72" id="s4803.e0" ontology_id="GO_0050731" text="positive regulation of peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="162-178" id="s4803.e1" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <pair e1="s4803.e0" e2="s4803.e1" id="s4803.p0" relation="true"/>
  </sentence>
  <sentence id="s4804" text="Prion proteins (positive regulation of peptidyl-tyrosine phosphorylation and acrosome reaction), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.">
    <entity charOffset="16-72" id="s4804.e0" ontology_id="GO_0050731" text="positive regulation of peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="255-260" id="s4804.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4804.e0" e2="s4804.e1" id="s4804.p0" relation="false"/>
  </sentence>
  <sentence id="s4805" text="Prion proteins (positive regulation of peptidyl-tyrosine phosphorylation and acrosome reaction), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.">
    <entity charOffset="77-94" id="s4805.e0" ontology_id="GO_0007340" text="acrosome reaction" type="GO"/>
    <entity charOffset="162-178" id="s4805.e1" ontology_id="HP_0001298" text="encephalopathies" type="HP"/>
    <pair e1="s4805.e0" e2="s4805.e1" id="s4805.p0" relation="false"/>
  </sentence>
  <sentence id="s4806" text="Prion proteins (positive regulation of peptidyl-tyrosine phosphorylation and acrosome reaction), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.">
    <entity charOffset="77-94" id="s4806.e0" ontology_id="GO_0007340" text="acrosome reaction" type="GO"/>
    <entity charOffset="255-260" id="s4806.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4806.e0" e2="s4806.e1" id="s4806.p0" relation="false"/>
  </sentence>
  <sentence id="s4807" text="PRNP and acrosome reaction are significantly over-expressed in osteosarcoma.">
    <entity charOffset="9-26" id="s4807.e0" ontology_id="GO_0007340" text="acrosome reaction" type="GO"/>
    <entity charOffset="63-75" id="s4807.e1" ontology_id="HP_0002669" text="osteosarcoma" type="HP"/>
    <pair e1="s4807.e0" e2="s4807.e1" id="s4807.p0" relation="false"/>
  </sentence>
  <sentence id="s4808" text="positive regulation of peptidyl-tyrosine phosphorylation and PRND appear involved with some important genes related to tumorigenesis and apoptosis.">
    <entity charOffset="0-56" id="s4808.e0" ontology_id="GO_0050731" text="positive regulation of peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="119-124" id="s4808.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4808.e0" e2="s4808.e1" id="s4808.p0" relation="false"/>
  </sentence>
  <sentence id="s4809" text="Promoter CpG island hypermethylation is an important mechanism for inactivating key cellular enzymes that mediate epigenetic processes in hepatitis-related hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="156-180" id="s4809.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="182-218" id="s4809.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4809.e0" e2="s4809.e1" id="s4809.p0" relation="false"/>
  </sentence>
  <sentence id="s4810" text="Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in RNA processing.">
    <entity charOffset="42-61" id="s4810.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="219-233" id="s4810.e1" ontology_id="GO_0006396" text="RNA processing" type="GO"/>
    <pair e1="s4810.e0" e2="s4810.e1" id="s4810.p0" relation="true"/>
  </sentence>
  <sentence id="s4811" text="By comparing these two additional cases with those previously reported, we strengthen the key features of AS: severe growth restriction, severe intellectual disability and some distinguishing facial features such as broad nose, malar hypoplasia, wide mouth, full lips and abnormally negative regulation of transcription, DNA-templated teeth.">
    <entity charOffset="228-244" id="s4811.e0" ontology_id="HP_0000272" text="malar hypoplasia" type="HP"/>
    <entity charOffset="283-334" id="s4811.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4811.e0" e2="s4811.e1" id="s4811.p0" relation="false"/>
  </sentence>
  <sentence id="s4812" text="By comparing these two additional cases with those previously reported, we strengthen the key features of AS: severe growth restriction, severe intellectual disability and some distinguishing facial features such as broad nose, malar hypoplasia, wide mouth, full lips and abnormally negative regulation of transcription, DNA-templated teeth.">
    <entity charOffset="246-256" id="s4812.e0" ontology_id="HP_0000154" text="wide mouth" type="HP"/>
    <entity charOffset="283-334" id="s4812.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4812.e0" e2="s4812.e1" id="s4812.p0" relation="true"/>
  </sentence>
  <sentence id="s4813" text="In this study, we performed exome-wide association studies(EWASs) to identify genetic variants that confer susceptibility to ischemic stroke, intracerebral hemorrhage(ICH), or subarachnoid hemorrhage(regulation of blood pressure).">
    <entity charOffset="143-167" id="s4813.e0" ontology_id="HP_0001342" text="intracerebral hemorrhage" type="HP"/>
    <entity charOffset="203-231" id="s4813.e1" ontology_id="GO_0008217" text="regulation of blood pressure" type="GO"/>
    <pair e1="s4813.e0" e2="s4813.e1" id="s4813.p0" relation="false"/>
  </sentence>
  <sentence id="s4814" text="Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of proteolysis(P=0.0024; odds ratio, 0.37), rs2292661 of protein folding (P=0.0054; odds ratio, 0.35) and rs191885206 of very long-chain fatty acid metabolic process (P=0.0082; odds ratio, 2.60)] were related(P&amp;lt;0.01) to ischemic stroke.">
    <entity charOffset="68-102" id="s4814.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="125-137" id="s4814.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s4814.e0" e2="s4814.e1" id="s4814.p0" relation="false"/>
  </sentence>
  <sentence id="s4815" text="Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of proteolysis(P=0.0024; odds ratio, 0.37), rs2292661 of protein folding (P=0.0054; odds ratio, 0.35) and rs191885206 of very long-chain fatty acid metabolic process (P=0.0082; odds ratio, 2.60)] were related(P&amp;lt;0.01) to ischemic stroke.">
    <entity charOffset="125-137" id="s4815.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="256-267" id="s4815.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s4815.e0" e2="s4815.e1" id="s4815.p0" relation="false"/>
  </sentence>
  <sentence id="s4816" text="Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of proteolysis(P=0.0024; odds ratio, 0.37), rs2292661 of protein folding (P=0.0054; odds ratio, 0.35) and rs191885206 of very long-chain fatty acid metabolic process (P=0.0082; odds ratio, 2.60)] were related(P&amp;lt;0.01) to ischemic stroke.">
    <entity charOffset="125-137" id="s4816.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="311-326" id="s4816.e1" ontology_id="GO_0006457" text="protein folding" type="GO"/>
    <pair e1="s4816.e0" e2="s4816.e1" id="s4816.p0" relation="false"/>
  </sentence>
  <sentence id="s4817" text="Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of proteolysis(P=0.0024; odds ratio, 0.37), rs2292661 of protein folding (P=0.0054; odds ratio, 0.35) and rs191885206 of very long-chain fatty acid metabolic process (P=0.0082; odds ratio, 2.60)] were related(P&amp;lt;0.01) to ischemic stroke.">
    <entity charOffset="125-137" id="s4817.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="375-419" id="s4817.e1" ontology_id="GO_0000038" text="very long-chain fatty acid metabolic process" type="GO"/>
    <pair e1="s4817.e0" e2="s4817.e1" id="s4817.p0" relation="false"/>
  </sentence>
  <sentence id="s4818" text="Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of hypertension revealed that rs138533962 of peptidyl-tyrosine phosphorylation (P&amp;lt;1.0x10-23; odds ratio, 111.3) was significantly (P&amp;lt;2.60x10-4) associated with ICH and that rs117564807 of hemidesmosome assembly (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&amp;lt;0.0010) associated with regulation of blood pressure.">
    <entity charOffset="68-102" id="s4818.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="125-137" id="s4818.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s4818.e0" e2="s4818.e1" id="s4818.p0" relation="false"/>
  </sentence>
  <sentence id="s4819" text="Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of hypertension revealed that rs138533962 of peptidyl-tyrosine phosphorylation (P&amp;lt;1.0x10-23; odds ratio, 111.3) was significantly (P&amp;lt;2.60x10-4) associated with ICH and that rs117564807 of hemidesmosome assembly (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&amp;lt;0.0010) associated with regulation of blood pressure.">
    <entity charOffset="125-137" id="s4819.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="421-449" id="s4819.e1" ontology_id="GO_0008217" text="regulation of blood pressure" type="GO"/>
    <pair e1="s4819.e0" e2="s4819.e1" id="s4819.p0" relation="false"/>
  </sentence>
  <sentence id="s4820" text="Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of hypertension revealed that rs138533962 of peptidyl-tyrosine phosphorylation (P&amp;lt;1.0x10-23; odds ratio, 111.3) was significantly (P&amp;lt;2.60x10-4) associated with ICH and that rs117564807 of hemidesmosome assembly (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&amp;lt;0.0010) associated with regulation of blood pressure.">
    <entity charOffset="125-137" id="s4820.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="167-200" id="s4820.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s4820.e0" e2="s4820.e1" id="s4820.p0" relation="false"/>
  </sentence>
  <sentence id="s4821" text="Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of hypertension revealed that rs138533962 of peptidyl-tyrosine phosphorylation (P&amp;lt;1.0x10-23; odds ratio, 111.3) was significantly (P&amp;lt;2.60x10-4) associated with ICH and that rs117564807 of hemidesmosome assembly (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&amp;lt;0.0010) associated with regulation of blood pressure.">
    <entity charOffset="125-137" id="s4821.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="316-338" id="s4821.e1" ontology_id="GO_0031581" text="hemidesmosome assembly" type="GO"/>
    <pair e1="s4821.e0" e2="s4821.e1" id="s4821.p0" relation="false"/>
  </sentence>
  <sentence id="s4822" text="We identified the first de novo variant in response to hypoxia (c.2984A&amp;gt;G (p.(N995S)))-encoding the BK channel-that causes epilepsy, but not paroxysmal dyskinesia, in two independent families.">
    <entity charOffset="43-62" id="s4822.e0" ontology_id="GO_0001666" text="response to hypoxia" type="GO"/>
    <entity charOffset="129-137" id="s4822.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4822.e0" e2="s4822.e1" id="s4822.p0" relation="true"/>
  </sentence>
  <sentence id="s4823" text="Amyotrophic lateral sclerosis (signal transduction) and frontotemporal dementia (FTD) are neurodegenerative diseases that overlap in their clinical presentation, pathology and genetics, and likely represent a spectrum of one underlying disease.">
    <entity charOffset="31-50" id="s4823.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="56-79" id="s4823.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4823.e0" e2="s4823.e1" id="s4823.p0" relation="false"/>
  </sentence>
  <sentence id="s4824" text="While mutations in Golgi calcium ion transport are known to cause human 'congenital disorders of glycosylation', a recessive autosomal metabolic disease, the potential association of this protein with human cancer development has not been explored to date.">
    <entity charOffset="19-46" id="s4824.e0" ontology_id="GO_0032472" text="Golgi calcium ion transport" type="GO"/>
    <entity charOffset="207-213" id="s4824.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4824.e0" e2="s4824.e1" id="s4824.p0" relation="false"/>
  </sentence>
  <sentence id="s4825" text="In the present study, we revealed that Golgi calcium ion transport is overexpressed in HCC and its depletion weakens the invasive activity of cancer cells through suppression of matrix metalloproteinase2 (MMP2) expression.">
    <entity charOffset="39-66" id="s4825.e0" ontology_id="GO_0032472" text="Golgi calcium ion transport" type="GO"/>
    <entity charOffset="142-148" id="s4825.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4825.e0" e2="s4825.e1" id="s4825.p0" relation="false"/>
  </sentence>
  <sentence id="s4826" text="The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined negative regulation of transcription by RNA polymerase II and protein polyubiquitination and/or BCL6 rearrangements (double-hit, DH).">
    <entity charOffset="76-85" id="s4826.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="161-218" id="s4826.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s4826.e0" e2="s4826.e1" id="s4826.p0" relation="true"/>
  </sentence>
  <sentence id="s4827" text="The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined negative regulation of transcription by RNA polymerase II and protein polyubiquitination and/or BCL6 rearrangements (double-hit, DH).">
    <entity charOffset="76-85" id="s4827.e0" ontology_id="HP_0002664" text="neoplasms" type="HP"/>
    <entity charOffset="223-249" id="s4827.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s4827.e0" e2="s4827.e1" id="s4827.p0" relation="true"/>
  </sentence>
  <sentence id="s4828" text="The significance of the ubiquitin-proteasome system (heme biosynthetic process) for protein degradation has been highlighted in the context of neurodegenerative diseases, including retinal dystrophies.">
    <entity charOffset="53-78" id="s4828.e0" ontology_id="GO_0006783" text="heme biosynthetic process" type="GO"/>
    <entity charOffset="143-169" id="s4828.e1" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <pair e1="s4828.e0" e2="s4828.e1" id="s4828.p0" relation="false"/>
  </sentence>
  <sentence id="s4829" text="The significance of the ubiquitin-proteasome system (heme biosynthetic process) for protein degradation has been highlighted in the context of neurodegenerative diseases, including retinal dystrophies.">
    <entity charOffset="53-78" id="s4829.e0" ontology_id="GO_0006783" text="heme biosynthetic process" type="GO"/>
    <entity charOffset="181-200" id="s4829.e1" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <pair e1="s4829.e0" e2="s4829.e1" id="s4829.p0" relation="false"/>
  </sentence>
  <sentence id="s4830" text="The encoded protein, complexin 1, is crucially involved in neuronal synaptic regulation, and homozygous exocytosis knockout epidermis development have the earliest known onset of ataxia seen in a mouse model.">
    <entity charOffset="104-114" id="s4830.e0" ontology_id="GO_0006887" text="exocytosis" type="GO"/>
    <entity charOffset="179-185" id="s4830.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4830.e0" e2="s4830.e1" id="s4830.p0" relation="false"/>
  </sentence>
  <sentence id="s4831" text="The encoded protein, complexin 1, is crucially involved in neuronal synaptic regulation, and homozygous exocytosis knockout epidermis development have the earliest known onset of ataxia seen in a mouse model.">
    <entity charOffset="124-145" id="s4831.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="179-185" id="s4831.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s4831.e0" e2="s4831.e1" id="s4831.p0" relation="false"/>
  </sentence>
  <sentence id="s4832" text="Recently, a homozygous truncating variant in exocytosis was suggested to be causative for migrating epilepsy and structural brain abnormalities.">
    <entity charOffset="45-55" id="s4832.e0" ontology_id="GO_0006887" text="exocytosis" type="GO"/>
    <entity charOffset="100-108" id="s4832.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4832.e0" e2="s4832.e1" id="s4832.p0" relation="true"/>
  </sentence>
  <sentence id="s4833" text="However, the currently limited knowledge on exocytosis suggests that loss of complexin 1 function may lead to a complex but variable clinical phenotype, and our findings encourage further investigations of CPLX1 in patients with ID, developmental delay and myoclonic epilepsy to unravel the phenotypic spectrum of carriers of CPLX1 variants">
    <entity charOffset="44-54" id="s4833.e0" ontology_id="GO_0006887" text="exocytosis" type="GO"/>
    <entity charOffset="233-252" id="s4833.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s4833.e0" e2="s4833.e1" id="s4833.p0" relation="true"/>
  </sentence>
  <sentence id="s4834" text="However, the currently limited knowledge on exocytosis suggests that loss of complexin 1 function may lead to a complex but variable clinical phenotype, and our findings encourage further investigations of CPLX1 in patients with ID, developmental delay and myoclonic epilepsy to unravel the phenotypic spectrum of carriers of CPLX1 variants">
    <entity charOffset="44-54" id="s4834.e0" ontology_id="GO_0006887" text="exocytosis" type="GO"/>
    <entity charOffset="267-275" id="s4834.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s4834.e0" e2="s4834.e1" id="s4834.p0" relation="true"/>
  </sentence>
  <sentence id="s4835" text="Defects in Membrane Frizzled-related Protein (embryo development ending in birth or egg hatching) cause autosomal recessive retinitis pigmentosa (biological_process).">
    <entity charOffset="46-96" id="s4835.e0" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <entity charOffset="104-123" id="s4835.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4835.e0" e2="s4835.e1" id="s4835.p0" relation="true"/>
  </sentence>
  <sentence id="s4836" text="Defects in Membrane Frizzled-related Protein (embryo development ending in birth or egg hatching) cause autosomal recessive retinitis pigmentosa (biological_process).">
    <entity charOffset="104-123" id="s4836.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="146-164" id="s4836.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4836.e0" e2="s4836.e1" id="s4836.p0" relation="false"/>
  </sentence>
  <sentence id="s4837" text="Cystinosis is an autosomal recessive lysosomal storage disease caused by mutations in glutathione metabolic process.">
    <entity charOffset="17-36" id="s4837.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="86-115" id="s4837.e1" ontology_id="GO_0006749" text="glutathione metabolic process" type="GO"/>
    <pair e1="s4837.e0" e2="s4837.e1" id="s4837.p0" relation="true"/>
  </sentence>
  <sentence id="s4838" text="Here, we hypothesize that proline biosynthetic process might be a novel prognostic biomarker and therapeutic target for breast cancer.">
    <entity charOffset="26-54" id="s4838.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="127-133" id="s4838.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4838.e0" e2="s4838.e1" id="s4838.p0" relation="false"/>
  </sentence>
  <sentence id="s4839" text="In this study, breast cancer tissue samples were obtained from Zhejiang University (ZJU negative regulation of transcription, DNA-templated).">
    <entity charOffset="22-28" id="s4839.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="88-139" id="s4839.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4839.e0" e2="s4839.e1" id="s4839.p0" relation="false"/>
  </sentence>
  <sentence id="s4840" text="The prognostic significance and performance of proline biosynthetic process mRNA were validated on 13 worldwide independent microarray data negative regulation of transcription, DNA-templateds, composed of 2500 assessable breast cancer cases.">
    <entity charOffset="47-75" id="s4840.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="229-235" id="s4840.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4840.e0" e2="s4840.e1" id="s4840.p0" relation="false"/>
  </sentence>
  <sentence id="s4841" text="The prognostic significance and performance of proline biosynthetic process mRNA were validated on 13 worldwide independent microarray data negative regulation of transcription, DNA-templateds, composed of 2500 assessable breast cancer cases.">
    <entity charOffset="140-191" id="s4841.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="229-235" id="s4841.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4841.e0" e2="s4841.e1" id="s4841.p0" relation="false"/>
  </sentence>
  <sentence id="s4842" text="Our findings revealed that both proline biosynthetic process mRNA and protein expression were significantly associated with tumor size, grade and invasive molecular subtypes of breast cancers.">
    <entity charOffset="32-60" id="s4842.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="184-190" id="s4842.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4842.e0" e2="s4842.e1" id="s4842.p0" relation="false"/>
  </sentence>
  <sentence id="s4843" text="Our findings revealed that both proline biosynthetic process mRNA and protein expression were significantly associated with tumor size, grade and invasive molecular subtypes of breast cancers.">
    <entity charOffset="32-60" id="s4843.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="124-129" id="s4843.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4843.e0" e2="s4843.e1" id="s4843.p0" relation="false"/>
  </sentence>
  <sentence id="s4844" text="Further population study also validated that chemotherapy significantly improved survival in early-stage breast cancer patients with low proline biosynthetic process expression levels.">
    <entity charOffset="112-118" id="s4844.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="137-165" id="s4844.e1" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <pair e1="s4844.e0" e2="s4844.e1" id="s4844.p0" relation="false"/>
  </sentence>
  <sentence id="s4845" text="Therefore, proline biosynthetic process might serve as a prognostic biomaker for either ER-positive or ER-negative breast cancer subtypes and can also be a potential target for breast cancer therapy">
    <entity charOffset="11-39" id="s4845.e0" ontology_id="GO_0006561" text="proline biosynthetic process" type="GO"/>
    <entity charOffset="122-128" id="s4845.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4845.e0" e2="s4845.e1" id="s4845.p0" relation="false"/>
  </sentence>
  <sentence id="s4846" text="clathrin coat assembly is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.">
    <entity charOffset="0-22" id="s4846.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="56-75" id="s4846.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4846.e0" e2="s4846.e1" id="s4846.p0" relation="false"/>
  </sentence>
  <sentence id="s4847" text="clathrin coat assembly is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.">
    <entity charOffset="0-22" id="s4847.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="111-130" id="s4847.e1" ontology_id="HP_0000556" text="retinal dystrophies" type="HP"/>
    <pair e1="s4847.e0" e2="s4847.e1" id="s4847.p0" relation="false"/>
  </sentence>
  <sentence id="s4848" text="clathrin coat assembly is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.">
    <entity charOffset="0-22" id="s4848.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="231-248" id="s4848.e1" ontology_id="HP_0000505" text="visual impairment" type="HP"/>
    <pair e1="s4848.e0" e2="s4848.e1" id="s4848.p0" relation="false"/>
  </sentence>
  <sentence id="s4849" text="Here we have studied eleven consanguineous clathrin coat assembly and one autosomal recessive RP (arRP) south Indian families to know the prevalence of mutations in known genes and also to know the involvement of novel loci, if any.">
    <entity charOffset="43-65" id="s4849.e0" ontology_id="GO_0048268" text="clathrin coat assembly" type="GO"/>
    <entity charOffset="74-93" id="s4849.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4849.e0" e2="s4849.e1" id="s4849.p0" relation="false"/>
  </sentence>
  <sentence id="s4850" text="Amyotrophic lateral sclerosis (signal transduction) is the major adult-onset motor neuron disease, and is clinisister chromatid cohesiony, pathologically, and genetically associated with frontotemporal dementia, the second cause of dementia in the elderly.">
    <entity charOffset="31-50" id="s4850.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="187-210" id="s4850.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4850.e0" e2="s4850.e1" id="s4850.p0" relation="false"/>
  </sentence>
  <sentence id="s4851" text="Amyotrophic lateral sclerosis (signal transduction) is the major adult-onset motor neuron disease, and is clinisister chromatid cohesiony, pathologically, and genetically associated with frontotemporal dementia, the second cause of dementia in the elderly.">
    <entity charOffset="111-136" id="s4851.e0" ontology_id="GO_0007062" text="sister chromatid cohesion" type="GO"/>
    <entity charOffset="187-210" id="s4851.e1" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="s4851.e0" e2="s4851.e1" id="s4851.p0" relation="false"/>
  </sentence>
  <sentence id="s4852" text="In response to surgical induction of endometriosis, Klf11-/- female epidermis development develop significant fibrosis in contrast to wild-type mice.">
    <entity charOffset="37-50" id="s4852.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="68-89" id="s4852.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4852.e0" e2="s4852.e1" id="s4852.p0" relation="false"/>
  </sentence>
  <sentence id="s4853" text="Pulmonary veno-occlusive disease (PVOD) is a rare and fatal cause of pulmonary arterial hypertension (L-phenylalanine catabolic process).">
    <entity charOffset="69-100" id="s4853.e0" ontology_id="HP_0002092" text="pulmonary arterial hypertension" type="HP"/>
    <entity charOffset="102-135" id="s4853.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s4853.e0" e2="s4853.e1" id="s4853.p0" relation="false"/>
  </sentence>
  <sentence id="s4854" text="Here, we reported a sporadic PVOD patient evidenced by pathology and regulation of translational initiation by eIF2 alpha phosphorylation biallelic mutation.">
    <entity charOffset="20-28" id="s4854.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="69-137" id="s4854.e1" ontology_id="GO_0010998" text="regulation of translational initiation by eIF2 alpha phosphorylation" type="GO"/>
    <pair e1="s4854.e0" e2="s4854.e1" id="s4854.p0" relation="false"/>
  </sentence>
  <sentence id="s4855" text="Germline regulation of transcription, DNA-templated mutations confer increased cancer risk, for breast and other types, which is variable depending on the specific mutation.">
    <entity charOffset="9-51" id="s4855.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="79-85" id="s4855.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4855.e0" e2="s4855.e1" id="s4855.p0" relation="true"/>
  </sentence>
  <sentence id="s4856" text="Popliteal pterygium syndrome shares features with glycoprotein biosynthetic process der Woude syndrome but, in addition, is characterized by genital anomalies, syndactyly of fingers and toes, and toenail dysplasia.">
    <entity charOffset="50-83" id="s4856.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="141-158" id="s4856.e1" ontology_id="HP_0000078" text="genital anomalies" type="HP"/>
    <pair e1="s4856.e0" e2="s4856.e1" id="s4856.p0" relation="false"/>
  </sentence>
  <sentence id="s4857" text="Popliteal pterygium syndrome shares features with glycoprotein biosynthetic process der Woude syndrome but, in addition, is characterized by genital anomalies, syndactyly of fingers and toes, and toenail dysplasia.">
    <entity charOffset="50-83" id="s4857.e0" ontology_id="GO_0009101" text="glycoprotein biosynthetic process" type="GO"/>
    <entity charOffset="196-213" id="s4857.e1" ontology_id="HP_0100797" text="toenail dysplasia" type="HP"/>
    <pair e1="s4857.e0" e2="s4857.e1" id="s4857.p0" relation="false"/>
  </sentence>
  <sentence id="s4858" text="Renal manifestations of multiple myeloma (MM) including transcription initiation from RNA polymerase I promoter nephropathy, amyloidosis, and renal calcification have been widely recognized.">
    <entity charOffset="24-40" id="s4858.e0" ontology_id="HP_0006775" text="multiple myeloma" type="HP"/>
    <entity charOffset="56-111" id="s4858.e1" ontology_id="GO_0006361" text="transcription initiation from RNA polymerase I promoter" type="GO"/>
    <pair e1="s4858.e0" e2="s4858.e1" id="s4858.p0" relation="false"/>
  </sentence>
  <sentence id="s4859" text="Based on the elastic negative regulation of transcription, DNA-templated, 33 genes out of 1381 genes related to bladder cancer were selected.">
    <entity charOffset="21-72" id="s4859.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="120-126" id="s4859.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4859.e0" e2="s4859.e1" id="s4859.p0" relation="false"/>
  </sentence>
  <sentence id="s4860" text="Patients with receptor-mediated endocytosis show &amp;lt;50% of normal activity and those with the rare autosomal recessive harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the CPOX reaction.">
    <entity charOffset="14-43" id="s4860.e0" ontology_id="GO_0006898" text="receptor-mediated endocytosis" type="GO"/>
    <entity charOffset="100-119" id="s4860.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4860.e0" e2="s4860.e1" id="s4860.p0" relation="false"/>
  </sentence>
  <sentence id="s4861" text="histone H3-K9 demethylation knockdown inhibits proliferation and promotes the apoptosis of ALL cells invitro as well as attenuates tumor growth invivo.">
    <entity charOffset="0-27" id="s4861.e0" ontology_id="GO_0033169" text="histone H3-K9 demethylation" type="GO"/>
    <entity charOffset="132-137" id="s4861.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4861.e0" e2="s4861.e1" id="s4861.p0" relation="false"/>
  </sentence>
  <sentence id="s4862" text="The membrane-type frizzled-related protein (embryo development ending in birth or egg hatching) is the only gene so far reported implicated in autosomal recessive, non-syndromic and syndromic forms of PM.">
    <entity charOffset="44-94" id="s4862.e0" ontology_id="GO_0009792" text="embryo development ending in birth or egg hatching" type="GO"/>
    <entity charOffset="143-162" id="s4862.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s4862.e0" e2="s4862.e1" id="s4862.p0" relation="true"/>
  </sentence>
  <sentence id="s4863" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (regulation of transcription by RNA polymerase II, transcription initiation from RNA polymerase II promoter, positive regulation of gene expression, SOX2, visual perception-3 and visual perception) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="114-162" id="s4863.e0" ontology_id="GO_0006357" text="regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="387-401" id="s4863.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s4863.e0" e2="s4863.e1" id="s4863.p0" relation="true"/>
  </sentence>
  <sentence id="s4864" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (regulation of transcription by RNA polymerase II, transcription initiation from RNA polymerase II promoter, positive regulation of gene expression, SOX2, visual perception-3 and visual perception) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="164-220" id="s4864.e0" ontology_id="GO_0006367" text="transcription initiation from RNA polymerase II promoter" type="GO"/>
    <entity charOffset="387-401" id="s4864.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s4864.e0" e2="s4864.e1" id="s4864.p0" relation="false"/>
  </sentence>
  <sentence id="s4865" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (regulation of transcription by RNA polymerase II, transcription initiation from RNA polymerase II promoter, positive regulation of gene expression, SOX2, visual perception-3 and visual perception) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="222-260" id="s4865.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="387-401" id="s4865.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s4865.e0" e2="s4865.e1" id="s4865.p0" relation="true"/>
  </sentence>
  <sentence id="s4866" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (regulation of transcription by RNA polymerase II, transcription initiation from RNA polymerase II promoter, positive regulation of gene expression, SOX2, visual perception-3 and visual perception) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="268-285" id="s4866.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="387-401" id="s4866.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s4866.e0" e2="s4866.e1" id="s4866.p0" relation="false"/>
  </sentence>
  <sentence id="s4867" text="To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (regulation of transcription by RNA polymerase II, transcription initiation from RNA polymerase II promoter, positive regulation of gene expression, SOX2, visual perception-3 and visual perception) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.">
    <entity charOffset="292-309" id="s4867.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="387-401" id="s4867.e1" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <pair e1="s4867.e0" e2="s4867.e1" id="s4867.p0" relation="false"/>
  </sentence>
  <sentence id="s4868" text="MATERIAL AND METHODS We analyzed BC microarray studies GSE37751, GSE7390, and GSE21653 to investigate the expression of positive regulation of cell proliferation gene between BC patients and their normal counterparts and the relationship between FGF5 expression and age, tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, clinical risk group according to spermatogenesis criteria, clinical risk group according to Veridex signature, distant metastasis-free survival (DMFS), time to distant metastasis (TDM), disease-free survival (DFS), and overall survival (OS) of BC patients.">
    <entity charOffset="120-161" id="s4868.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="271-276" id="s4868.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4868.e0" e2="s4868.e1" id="s4868.p0" relation="false"/>
  </sentence>
  <sentence id="s4869" text="MATERIAL AND METHODS We analyzed BC microarray studies GSE37751, GSE7390, and GSE21653 to investigate the expression of positive regulation of cell proliferation gene between BC patients and their normal counterparts and the relationship between FGF5 expression and age, tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, clinical risk group according to spermatogenesis criteria, clinical risk group according to Veridex signature, distant metastasis-free survival (DMFS), time to distant metastasis (TDM), disease-free survival (DFS), and overall survival (OS) of BC patients.">
    <entity charOffset="271-276" id="s4869.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="416-431" id="s4869.e1" ontology_id="GO_0007283" text="spermatogenesis" type="GO"/>
    <pair e1="s4869.e0" e2="s4869.e1" id="s4869.p0" relation="false"/>
  </sentence>
  <sentence id="s4870" text="BC patients in the positive regulation of cell proliferation low-expression group were correlated with better clinical characteristics, including tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, NPI criteria and Veridex signature, DMFS, TDM, and DFS compared with those in the FGF5 high-expression cohort.">
    <entity charOffset="19-60" id="s4870.e0" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <entity charOffset="146-151" id="s4870.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4870.e0" e2="s4870.e1" id="s4870.p0" relation="false"/>
  </sentence>
  <sentence id="s4871" text="The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (TNF-)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (phagocytosis), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the cell cycle arrest group compared to the PBS group.">
    <entity charOffset="95-100" id="s4871.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="529-546" id="s4871.e1" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <pair e1="s4871.e0" e2="s4871.e1" id="s4871.p0" relation="false"/>
  </sentence>
  <sentence id="s4872" text="The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (TNF-)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (phagocytosis), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the cell cycle arrest group compared to the PBS group.">
    <entity charOffset="95-100" id="s4872.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="233-245" id="s4872.e1" ontology_id="GO_0006909" text="phagocytosis" type="GO"/>
    <pair e1="s4872.e0" e2="s4872.e1" id="s4872.p0" relation="false"/>
  </sentence>
  <sentence id="s4873" text="regulation of phosphate transport excess induces hypophosphatemia via impaired phosphate reabsorption in the renal proximal tubules and decreased phosphate absorption in the intestines.">
    <entity charOffset="0-33" id="s4873.e0" ontology_id="GO_0010966" text="regulation of phosphate transport" type="GO"/>
    <entity charOffset="49-65" id="s4873.e1" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <pair e1="s4873.e0" e2="s4873.e1" id="s4873.p0" relation="true"/>
  </sentence>
  <sentence id="s4874" text="Among these diseases, X-linked hypophosphatemia (proteolysis), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (proteolysis) gene, is the most prevalent form of genetic regulation of phosphate transport-related hypophosphatemic rickets.">
    <entity charOffset="31-47" id="s4874.e0" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <entity charOffset="223-256" id="s4874.e1" ontology_id="GO_0010966" text="regulation of phosphate transport" type="GO"/>
    <pair e1="s4874.e0" e2="s4874.e1" id="s4874.p0" relation="true"/>
  </sentence>
  <sentence id="s4875" text="Among these diseases, X-linked hypophosphatemia (proteolysis), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (proteolysis) gene, is the most prevalent form of genetic regulation of phosphate transport-related hypophosphatemic rickets.">
    <entity charOffset="31-47" id="s4875.e0" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <entity charOffset="49-60" id="s4875.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s4875.e0" e2="s4875.e1" id="s4875.p0" relation="true"/>
  </sentence>
  <sentence id="s4876" text="Among these diseases, X-linked hypophosphatemia (proteolysis), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (proteolysis) gene, is the most prevalent form of genetic regulation of phosphate transport-related hypophosphatemic rickets.">
    <entity charOffset="31-47" id="s4876.e0" ontology_id="HP_0002148" text="hypophosphatemia" type="HP"/>
    <entity charOffset="166-177" id="s4876.e1" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <pair e1="s4876.e0" e2="s4876.e1" id="s4876.p0" relation="true"/>
  </sentence>
  <sentence id="s4877" text="Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, acetyl-CoA biosynthetic process) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.">
    <entity charOffset="52-83" id="s4877.e0" ontology_id="GO_0006085" text="acetyl-CoA biosynthetic process" type="GO"/>
    <entity charOffset="217-225" id="s4877.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s4877.e0" e2="s4877.e1" id="s4877.p0" relation="true"/>
  </sentence>
  <sentence id="s4878" text="Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, acetyl-CoA biosynthetic process) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.">
    <entity charOffset="52-83" id="s4878.e0" ontology_id="GO_0006085" text="acetyl-CoA biosynthetic process" type="GO"/>
    <entity charOffset="227-241" id="s4878.e1" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <pair e1="s4878.e0" e2="s4878.e1" id="s4878.p0" relation="true"/>
  </sentence>
  <sentence id="s4879" text="This case of malonic aciduria with cardiomyopathy demonstrates improvement in cardiac function attributable to polysaccharide digestion-restricted/MCT-supplemented diet">
    <entity charOffset="35-49" id="s4879.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="111-135" id="s4879.e1" ontology_id="GO_0044245" text="polysaccharide digestion" type="GO"/>
    <pair e1="s4879.e0" e2="s4879.e1" id="s4879.p0" relation="false"/>
  </sentence>
  <sentence id="s4880" text="Among the 363 outbreaks with a confirmed infectious etiology, 212 (58%) were caused by Cryptosporidium (which causes predominantly gastrointestinal illness), 57 (16%) by Legionella (which causes Legionnaires' disease, a severe pneumonia, and Pontiac fever, a milder illness with flu-like symptoms), and 47 (13%) by Pseudomonas (which causes folliculitis [&amp;quot;hot intraciliary transport rash&amp;quot;] and otitis externa [&amp;quot;swimmers' ear&amp;quot;]).">
    <entity charOffset="227-236" id="s4880.e0" ontology_id="HP_0002090" text="pneumonia" type="HP"/>
    <entity charOffset="365-387" id="s4880.e1" ontology_id="GO_0042073" text="intraciliary transport" type="GO"/>
    <pair e1="s4880.e0" e2="s4880.e1" id="s4880.p0" relation="false"/>
  </sentence>
  <sentence id="s4881" text="The regulation of transcription, DNA-templated-MC was also validated against measurements and simulations in heterogeneous phantoms created by placing lung or bone slabs in a water phantom.">
    <entity charOffset="4-46" id="s4881.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="109-122" id="s4881.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4881.e0" e2="s4881.e1" id="s4881.p0" relation="true"/>
  </sentence>
  <sentence id="s4882" text="The regulation of transcription, DNA-templated-MC algorithm demonstrated improved dosimetric accuracy over the RS-PBA in the presence of homogenous, heterogeneous and anthropomorphic phantoms.">
    <entity charOffset="4-46" id="s4882.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="149-162" id="s4882.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4882.e0" e2="s4882.e1" id="s4882.p0" relation="true"/>
  </sentence>
  <sentence id="s4883" text="We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in adenylate cyclase-activating G protein-coupled receptor signaling pathway, which were sometimes found with accelerated growth rather than short stature as described previously.">
    <entity charOffset="102-175" id="s4883.e0" ontology_id="GO_0007189" text="adenylate cyclase-activating G protein-coupled receptor signaling pathway" type="GO"/>
    <entity charOffset="240-253" id="s4883.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s4883.e0" e2="s4883.e1" id="s4883.p0" relation="true"/>
  </sentence>
  <sentence id="s4884" text="Further validation in cohorts with severe obesity and engineering the variants in model organisms will be needed to explore whether human variants in angiogenesis and other genes that lead to obesity when deleted in epidermis development, do contribute to obesity.">
    <entity charOffset="42-49" id="s4884.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="150-162" id="s4884.e1" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <pair e1="s4884.e0" e2="s4884.e1" id="s4884.p0" relation="false"/>
  </sentence>
  <sentence id="s4885" text="Further validation in cohorts with severe obesity and engineering the variants in model organisms will be needed to explore whether human variants in angiogenesis and other genes that lead to obesity when deleted in epidermis development, do contribute to obesity.">
    <entity charOffset="42-49" id="s4885.e0" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <entity charOffset="216-237" id="s4885.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4885.e0" e2="s4885.e1" id="s4885.p0" relation="false"/>
  </sentence>
  <sentence id="s4886" text="The condition was initially termed actin filament bundle assembly syndrome (macrocephaly, alopecia, cutis laxa, and scoliosis), based on the clinical features of the first identified family; however, with the expansion of the clinical phenotype in additional families, it was subsequently coined small GTPase mediated signal transduction syndrome.">
    <entity charOffset="35-65" id="s4886.e0" ontology_id="GO_0051017" text="actin filament bundle assembly" type="GO"/>
    <entity charOffset="116-125" id="s4886.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s4886.e0" e2="s4886.e1" id="s4886.p0" relation="false"/>
  </sentence>
  <sentence id="s4887" text="The condition was initially termed actin filament bundle assembly syndrome (macrocephaly, alopecia, cutis laxa, and scoliosis), based on the clinical features of the first identified family; however, with the expansion of the clinical phenotype in additional families, it was subsequently coined small GTPase mediated signal transduction syndrome.">
    <entity charOffset="116-125" id="s4887.e0" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <entity charOffset="296-337" id="s4887.e1" ontology_id="GO_0007264" text="small GTPase mediated signal transduction" type="GO"/>
    <pair e1="s4887.e0" e2="s4887.e1" id="s4887.p0" relation="true"/>
  </sentence>
  <sentence id="s4888" text="Patients with small GTPase mediated signal transduction syndrome present phenotypic overlap with other conditions, including EDS (especially the dermatosparaxis and kyphoscoliosis subtypes).">
    <entity charOffset="14-55" id="s4888.e0" ontology_id="GO_0007264" text="small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="170-179" id="s4888.e1" ontology_id="HP_0002650" text="scoliosis" type="HP"/>
    <pair e1="s4888.e0" e2="s4888.e1" id="s4888.p0" relation="true"/>
  </sentence>
  <sentence id="s4889" text="Besides the hallmark features, this patient also presents problems not previously associated with small GTPase mediated signal transduction syndrome, including cervical vertebral fusion, mild hearing loss, and colonic fibrosis.">
    <entity charOffset="98-139" id="s4889.e0" ontology_id="GO_0007264" text="small GTPase mediated signal transduction" type="GO"/>
    <entity charOffset="160-185" id="s4889.e1" ontology_id="HP_0002949" text="cervical vertebral fusion" type="HP"/>
    <pair e1="s4889.e0" e2="s4889.e1" id="s4889.p0" relation="false"/>
  </sentence>
  <sentence id="s4890" text="Fragile X syndrome (FXS), the leading cause of inherited forms of mental retardation and autism, is caused by the transcriptional silencing of regulation of alternative mRNA splicing, via spliceosome encoding the fragile X mental retardation protein (regulation of alternative mRNA splicing, via spliceosome).">
    <entity charOffset="89-95" id="s4890.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="143-199" id="s4890.e1" ontology_id="GO_0000381" text="regulation of alternative mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s4890.e0" e2="s4890.e1" id="s4890.p0" relation="true"/>
  </sentence>
  <sentence id="s4891" text="Fragile X syndrome (FXS), the leading cause of inherited forms of mental retardation and autism, is caused by the transcriptional silencing of regulation of alternative mRNA splicing, via spliceosome encoding the fragile X mental retardation protein (regulation of alternative mRNA splicing, via spliceosome).">
    <entity charOffset="89-95" id="s4891.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="251-307" id="s4891.e1" ontology_id="GO_0000381" text="regulation of alternative mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s4891.e0" e2="s4891.e1" id="s4891.p0" relation="true"/>
  </sentence>
  <sentence id="s4892" text="Patients with potassium ion transport imprinting syndrome demonstrate congenital hypotonia, variable cleft palate, normal MRIs and EEGs, delayed development, and feeding problems.">
    <entity charOffset="14-37" id="s4892.e0" ontology_id="GO_0006813" text="potassium ion transport" type="GO"/>
    <entity charOffset="101-113" id="s4892.e1" ontology_id="HP_0000175" text="cleft palate" type="HP"/>
    <pair e1="s4892.e0" e2="s4892.e1" id="s4892.p0" relation="true"/>
  </sentence>
  <sentence id="s4893" text="Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, short philtrum, tented upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, palatal abnormalities, and small mandible.">
    <entity charOffset="66-86" id="s4893.e0" ontology_id="HP_0000341" text="bitemporal narrowing" type="HP"/>
    <entity charOffset="117-184" id="s4893.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s4893.e0" e2="s4893.e1" id="s4893.p0" relation="false"/>
  </sentence>
  <sentence id="s4894" text="Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, short philtrum, tented upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, palatal abnormalities, and small mandible.">
    <entity charOffset="88-102" id="s4894.e0" ontology_id="HP_0000322" text="short philtrum" type="HP"/>
    <entity charOffset="117-184" id="s4894.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s4894.e0" e2="s4894.e1" id="s4894.p0" relation="false"/>
  </sentence>
  <sentence id="s4895" text="Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, short philtrum, tented upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, palatal abnormalities, and small mandible.">
    <entity charOffset="117-184" id="s4895.e0" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <entity charOffset="213-227" id="s4895.e1" ontology_id="HP_0000347" text="small mandible" type="HP"/>
    <pair e1="s4895.e0" e2="s4895.e1" id="s4895.p0" relation="false"/>
  </sentence>
  <sentence id="s4896" text="In clinical practices, the therapeutic outcomes and prognosis of hepatocellular carcinoma (phosphatidylinositol phosphorylation) patients with different tumor numbers after surgery are very different; however, the underlying mechanisms of the tumorigenesis and development of HCC with different tumor numbers are still not well understood.">
    <entity charOffset="65-89" id="s4896.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="91-127" id="s4896.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4896.e0" e2="s4896.e1" id="s4896.p0" relation="false"/>
  </sentence>
  <sentence id="s4897" text="In clinical practices, the therapeutic outcomes and prognosis of hepatocellular carcinoma (phosphatidylinositol phosphorylation) patients with different tumor numbers after surgery are very different; however, the underlying mechanisms of the tumorigenesis and development of HCC with different tumor numbers are still not well understood.">
    <entity charOffset="91-127" id="s4897.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="153-158" id="s4897.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4897.e0" e2="s4897.e1" id="s4897.p0" relation="false"/>
  </sentence>
  <sentence id="s4898" text="These information revealed that there might be different molecular mechanisms of the tumorigenesis and development of the phosphatidylinositol phosphorylation with single and multiple lesions.">
    <entity charOffset="85-90" id="s4898.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="122-158" id="s4898.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4898.e0" e2="s4898.e1" id="s4898.p0" relation="false"/>
  </sentence>
  <sentence id="s4899" text="The spontaneous mutant mouse staggerer, with an ataxic gait caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades protein ubiquitination to result from homozygous intragenic Rora deletions.">
    <entity charOffset="48-59" id="s4899.e0" ontology_id="HP_0002066" text="ataxic gait" type="HP"/>
    <entity charOffset="145-167" id="s4899.e1" ontology_id="GO_0016567" text="protein ubiquitination" type="GO"/>
    <pair e1="s4899.e0" e2="s4899.e1" id="s4899.p0" relation="false"/>
  </sentence>
  <sentence id="s4900" text="Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving regulation of transcription, DNA-templated in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.">
    <entity charOffset="308-350" id="s4900.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="400-424" id="s4900.e1" ontology_id="HP_0012758" text="neurodevelopmental delay" type="HP"/>
    <pair e1="s4900.e0" e2="s4900.e1" id="s4900.p0" relation="true"/>
  </sentence>
  <sentence id="s4901" text="Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving regulation of transcription, DNA-templated in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.">
    <entity charOffset="308-350" id="s4901.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="488-505" id="s4901.e1" ontology_id="HP_0001251" text="cerebellar ataxia" type="HP"/>
    <pair e1="s4901.e0" e2="s4901.e1" id="s4901.p0" relation="true"/>
  </sentence>
  <sentence id="s4902" text="The clinical presentation was severe, early-onset, progressive spliceosomal snRNP assembly-like motor neuronopathy, cerebellar atrophy, and in one affected individual, congenital fractures of the long bones.">
    <entity charOffset="63-90" id="s4902.e0" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <entity charOffset="116-134" id="s4902.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s4902.e0" e2="s4902.e1" id="s4902.p0" relation="false"/>
  </sentence>
  <sentence id="s4903" text="In summary, we show that variants in nuclear-transcribed mRNA catabolic process result in a neurological syndrome combining cerebellar atrophy and spinal motoneuronopathy, thus expanding the list of human exosomopathies">
    <entity charOffset="37-79" id="s4903.e0" ontology_id="GO_0000956" text="nuclear-transcribed mRNA catabolic process" type="GO"/>
    <entity charOffset="124-142" id="s4903.e1" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <pair e1="s4903.e0" e2="s4903.e1" id="s4903.p0" relation="true"/>
  </sentence>
  <sentence id="s4904" text="Additionally, despite mitochondrial fission affecting mitochondrial functionality, and hence being of great importance to cellular function, the GDAP1associated Charcot-Marie-Tooth disease is mainly characterized by axonal degeneration.">
    <entity charOffset="22-43" id="s4904.e0" ontology_id="GO_0000266" text="mitochondrial fission" type="GO"/>
    <entity charOffset="217-236" id="s4904.e1" ontology_id="HP_0040078" text="axonal degeneration" type="HP"/>
    <pair e1="s4904.e0" e2="s4904.e1" id="s4904.p0" relation="true"/>
  </sentence>
  <sentence id="s4905" text="Gastric stump cancer (neural crest cell fate specification) is a carcinoma arising from the remnant stomach following gastric surgery for benign or malignant disease, and is more common in men.">
    <entity charOffset="22-58" id="s4905.e0" ontology_id="GO_0014036" text="neural crest cell fate specification" type="GO"/>
    <entity charOffset="65-74" id="s4905.e1" ontology_id="HP_0030731" text="carcinoma" type="HP"/>
    <pair e1="s4905.e0" e2="s4905.e1" id="s4905.p0" relation="false"/>
  </sentence>
  <sentence id="s4906" text="Treatments in neural crest cell fate specification and primary gastric cancer are the same and include resection of the lesion and radical lymph node dissection.">
    <entity charOffset="14-50" id="s4906.e0" ontology_id="GO_0014036" text="neural crest cell fate specification" type="GO"/>
    <entity charOffset="71-77" id="s4906.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4906.e0" e2="s4906.e1" id="s4906.p0" relation="false"/>
  </sentence>
  <sentence id="s4907" text="Here, we examined the effects of protein monoubiquitination on the progression of gastric cancer.">
    <entity charOffset="33-59" id="s4907.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="90-96" id="s4907.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4907.e0" e2="s4907.e1" id="s4907.p0" relation="true"/>
  </sentence>
  <sentence id="s4908" text="protein monoubiquitination was highly expressed in gastric tumors and gastric cancer cells.">
    <entity charOffset="0-26" id="s4908.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="59-65" id="s4908.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4908.e0" e2="s4908.e1" id="s4908.p0" relation="true"/>
  </sentence>
  <sentence id="s4909" text="Suppression of protein monoubiquitination also attenuated the invasive and metastatic abilities of gastric cancer cells by altering expression of epithelial-mesenchymal transition (cytokine production)-related factors.">
    <entity charOffset="15-41" id="s4909.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="107-113" id="s4909.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4909.e0" e2="s4909.e1" id="s4909.p0" relation="true"/>
  </sentence>
  <sentence id="s4910" text="Suppression of protein monoubiquitination also attenuated the invasive and metastatic abilities of gastric cancer cells by altering expression of epithelial-mesenchymal transition (cytokine production)-related factors.">
    <entity charOffset="107-113" id="s4910.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="181-200" id="s4910.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s4910.e0" e2="s4910.e1" id="s4910.p0" relation="true"/>
  </sentence>
  <sentence id="s4911" text="A xenograft model in which nude epidermis development were injected with protein monoubiquitination knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.">
    <entity charOffset="32-53" id="s4911.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="124-130" id="s4911.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4911.e0" e2="s4911.e1" id="s4911.p0" relation="false"/>
  </sentence>
  <sentence id="s4912" text="A xenograft model in which nude epidermis development were injected with protein monoubiquitination knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.">
    <entity charOffset="32-53" id="s4912.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="188-193" id="s4912.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4912.e0" e2="s4912.e1" id="s4912.p0" relation="false"/>
  </sentence>
  <sentence id="s4913" text="A xenograft model in which nude epidermis development were injected with protein monoubiquitination knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.">
    <entity charOffset="73-99" id="s4913.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="124-130" id="s4913.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4913.e0" e2="s4913.e1" id="s4913.p0" relation="true"/>
  </sentence>
  <sentence id="s4914" text="A xenograft model in which nude epidermis development were injected with protein monoubiquitination knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.">
    <entity charOffset="73-99" id="s4914.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="188-193" id="s4914.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4914.e0" e2="s4914.e1" id="s4914.p0" relation="true"/>
  </sentence>
  <sentence id="s4915" text="These results suggest that protein monoubiquitination plays a critical role in gastric cancer, and that it may serve as a useful prognostic biomarker and therapeutic target in gastric cancer patients">
    <entity charOffset="27-53" id="s4915.e0" ontology_id="GO_0006513" text="protein monoubiquitination" type="GO"/>
    <entity charOffset="87-93" id="s4915.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4915.e0" e2="s4915.e1" id="s4915.p0" relation="true"/>
  </sentence>
  <sentence id="s4916" text="We investigated glioma-associated oncogene protein-1 (osteoblast differentiation-1) expression in human esophageal carcinoma tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.">
    <entity charOffset="16-22" id="s4916.e0" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <entity charOffset="54-80" id="s4916.e1" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <pair e1="s4916.e0" e2="s4916.e1" id="s4916.p0" relation="false"/>
  </sentence>
  <sentence id="s4917" text="MATERIAL AND METHODS osteoblast differentiation-1 in tumor tissue was measured by immunohistochemistry (IHC).">
    <entity charOffset="21-47" id="s4917.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="53-58" id="s4917.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4917.e0" e2="s4917.e1" id="s4917.p0" relation="true"/>
  </sentence>
  <sentence id="s4918" text="Despite their clinical heterogeneity, which remains an open question, laminopathies are commonly caused by mutations in the positive regulation of cell aging gene, encoding the nuclear proteins Lamin A and C.">
    <entity charOffset="23-36" id="s4918.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="124-157" id="s4918.e1" ontology_id="GO_0090343" text="positive regulation of cell aging" type="GO"/>
    <pair e1="s4918.e0" e2="s4918.e1" id="s4918.p0" relation="true"/>
  </sentence>
  <sentence id="s4919" text="Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in mitochondrial tRNA modification.">
    <entity charOffset="16-28" id="s4919.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="88-119" id="s4919.e1" ontology_id="GO_0070900" text="mitochondrial tRNA modification" type="GO"/>
    <pair e1="s4919.e0" e2="s4919.e1" id="s4919.p0" relation="false"/>
  </sentence>
  <sentence id="s4920" text="Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in mitochondrial tRNA modification.">
    <entity charOffset="30-49" id="s4920.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="88-119" id="s4920.e1" ontology_id="GO_0070900" text="mitochondrial tRNA modification" type="GO"/>
    <pair e1="s4920.e0" e2="s4920.e1" id="s4920.p0" relation="true"/>
  </sentence>
  <sentence id="s4921" text="Diamond-Blackfan anemia (monocyte chemotaxis), an inherited bone marrow failure syndrome characterized by anemia that usually presents before the first birthday or in early childhood, is associated with birth defects and an increased risk of cancer.">
    <entity charOffset="25-44" id="s4921.e0" ontology_id="GO_0002548" text="monocyte chemotaxis" type="GO"/>
    <entity charOffset="242-248" id="s4921.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4921.e0" e2="s4921.e1" id="s4921.p0" relation="true"/>
  </sentence>
  <sentence id="s4922" text="MIR22HG is an lncRNA that contributes to the initiation and progression of many human cancers, including hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="105-129" id="s4922.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="131-167" id="s4922.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4922.e0" e2="s4922.e1" id="s4922.p0" relation="false"/>
  </sentence>
  <sentence id="s4923" text="We report that MIR22HG was downregulated in 120 phosphatidylinositol phosphorylation samples compared with adjacent nontumor liver tissues.">
    <entity charOffset="48-84" id="s4923.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="119-124" id="s4923.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4923.e0" e2="s4923.e1" id="s4923.p0" relation="false"/>
  </sentence>
  <sentence id="s4924" text="The sonic Hedgehog/osteoblast differentiation signaling pathway (HH) is critical for maintaining tissue polarity in development and contributes to tumor stemness.">
    <entity charOffset="19-45" id="s4924.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="147-152" id="s4924.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4924.e0" e2="s4924.e1" id="s4924.p0" relation="true"/>
  </sentence>
  <sentence id="s4925" text="Important factors osteoblast differentiation1 and GLI2 were always expressed, only exceptionally one of them was lowered, suggesting the functionality of HH in all tumors tested.">
    <entity charOffset="18-44" id="s4925.e0" ontology_id="GO_0001649" text="osteoblast differentiation" type="GO"/>
    <entity charOffset="164-169" id="s4925.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4925.e0" e2="s4925.e1" id="s4925.p0" relation="true"/>
  </sentence>
  <sentence id="s4926" text="Progression of prostate cancer (PC) to castration-recurrent growth (CRPC) remains dependent on sustained expression and transcriptional activity of the androgen receptor (oxidation-reduction process).">
    <entity charOffset="24-30" id="s4926.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="171-198" id="s4926.e1" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <pair e1="s4926.e0" e2="s4926.e1" id="s4926.p0" relation="false"/>
  </sentence>
  <sentence id="s4927" text="By comparing the peptidyl-tyrosine phosphorylation-induced oxidation-reduction process-cistrome and/or transcriptome in LNCaP to those in CRPC and LuCaP35.1 tumors, we identified an 11-gene Src-regulated CRPC signature consisting of AR-dependent, AR binding site (ARBS)-associated genes whose expression is altered by DHT in LNCaP[Src527F] but not in LNCaP cells.">
    <entity charOffset="17-50" id="s4927.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="157-163" id="s4927.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4927.e0" e2="s4927.e1" id="s4927.p0" relation="true"/>
  </sentence>
  <sentence id="s4928" text="By comparing the peptidyl-tyrosine phosphorylation-induced oxidation-reduction process-cistrome and/or transcriptome in LNCaP to those in CRPC and LuCaP35.1 tumors, we identified an 11-gene Src-regulated CRPC signature consisting of AR-dependent, AR binding site (ARBS)-associated genes whose expression is altered by DHT in LNCaP[Src527F] but not in LNCaP cells.">
    <entity charOffset="59-86" id="s4928.e0" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <entity charOffset="157-163" id="s4928.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s4928.e0" e2="s4928.e1" id="s4928.p0" relation="false"/>
  </sentence>
  <sentence id="s4929" text="In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and interleukin-7-mediated signaling pathway boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and TEK tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral positive regulation of cell proliferation repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.">
    <entity charOffset="34-42" id="s4929.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="165-205" id="s4929.e1" ontology_id="GO_0038111" text="interleukin-7-mediated signaling pathway" type="GO"/>
    <pair e1="s4929.e0" e2="s4929.e1" id="s4929.p0" relation="false"/>
  </sentence>
  <sentence id="s4930" text="In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and interleukin-7-mediated signaling pathway boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and TEK tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral positive regulation of cell proliferation repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.">
    <entity charOffset="34-42" id="s4930.e0" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <entity charOffset="782-823" id="s4930.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s4930.e0" e2="s4930.e1" id="s4930.p0" relation="false"/>
  </sentence>
  <sentence id="s4931" text="Mutation in negative regulation of transcription by RNA polymerase I causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.">
    <entity charOffset="12-68" id="s4931.e0" ontology_id="GO_0016479" text="negative regulation of transcription by RNA polymerase I" type="GO"/>
    <entity charOffset="113-131" id="s4931.e1" ontology_id="HP_0002652" text="skeletal dysplasia" type="HP"/>
    <pair e1="s4931.e0" e2="s4931.e1" id="s4931.p0" relation="true"/>
  </sentence>
  <sentence id="s4932" text="Mutation in negative regulation of transcription by RNA polymerase I causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.">
    <entity charOffset="12-68" id="s4932.e0" ontology_id="GO_0016479" text="negative regulation of transcription by RNA polymerase I" type="GO"/>
    <entity charOffset="194-217" id="s4932.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4932.e0" e2="s4932.e1" id="s4932.p0" relation="true"/>
  </sentence>
  <sentence id="s4933" text="Mutation in negative regulation of transcription by RNA polymerase I causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.">
    <entity charOffset="12-68" id="s4933.e0" ontology_id="GO_0016479" text="negative regulation of transcription by RNA polymerase I" type="GO"/>
    <entity charOffset="222-244" id="s4933.e1" ontology_id="HP_0005214" text="intestinal obstruction" type="HP"/>
    <pair e1="s4933.e0" e2="s4933.e1" id="s4933.p0" relation="false"/>
  </sentence>
  <sentence id="s4934" text="Reviewing the emerging dataset, we underline this unanticipated phenotypic consequence of pathogenic negative regulation of transcription by RNA polymerase I mutation-associated pulmonary disease.Conclusion: From the emerging data, we suggest that while reviewing complex cases with a sustained oxygen requirement against a clincial background of cardiac concerns or intestinal obstruction to have a high index of suspicion for FLNA related pathology and to instigate early MRI brain scan and FLNA mutation analysis.">
    <entity charOffset="101-157" id="s4934.e0" ontology_id="GO_0016479" text="negative regulation of transcription by RNA polymerase I" type="GO"/>
    <entity charOffset="367-389" id="s4934.e1" ontology_id="HP_0005214" text="intestinal obstruction" type="HP"/>
    <pair e1="s4934.e0" e2="s4934.e1" id="s4934.p0" relation="false"/>
  </sentence>
  <sentence id="s4935" text="The expression of CD133, oxidation-reduction process and positive regulation of canonical Wnt signaling pathway was found to be positive in 55.6, 47.2 and 78.9% of the primary tumour samples, respectively.">
    <entity charOffset="25-52" id="s4935.e0" ontology_id="GO_0055114" text="oxidation-reduction process" type="GO"/>
    <entity charOffset="176-182" id="s4935.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4935.e0" e2="s4935.e1" id="s4935.p0" relation="false"/>
  </sentence>
  <sentence id="s4936" text="The expression of CD133, oxidation-reduction process and positive regulation of canonical Wnt signaling pathway was found to be positive in 55.6, 47.2 and 78.9% of the primary tumour samples, respectively.">
    <entity charOffset="57-111" id="s4936.e0" ontology_id="GO_0090263" text="positive regulation of canonical Wnt signaling pathway" type="GO"/>
    <entity charOffset="176-182" id="s4936.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4936.e0" e2="s4936.e1" id="s4936.p0" relation="false"/>
  </sentence>
  <sentence id="s4937" text="The present study intended to identify the association between three severe muscle organ developments of gynecological cancer, specifically ovarian cancer, cervical cancer and endometrial cancer, and to identify the connective driver genes, microRNAs (miRNAs) and biological processes associated with these types of gynecological cancer.">
    <entity charOffset="76-100" id="s4937.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="119-125" id="s4937.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4937.e0" e2="s4937.e1" id="s4937.p0" relation="false"/>
  </sentence>
  <sentence id="s4938" text="In the present study, individual driver genes for each muscle organ development of cancer were identified using integrated analysis of multiple microarray data.">
    <entity charOffset="55-79" id="s4938.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="83-89" id="s4938.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4938.e0" e2="s4938.e1" id="s4938.p0" relation="false"/>
  </sentence>
  <sentence id="s4939" text="Survival analysis revealed that the expression of cellular response to DNA damage stimulus, proteolysis, positive regulation of epithelial to mesenchymal transition and transforming growth factor beta receptor signaling pathway was associated with the prognosis of the aforementioned gynecological cancer muscle organ developments.">
    <entity charOffset="50-90" id="s4939.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="298-304" id="s4939.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4939.e0" e2="s4939.e1" id="s4939.p0" relation="false"/>
  </sentence>
  <sentence id="s4940" text="Survival analysis revealed that the expression of cellular response to DNA damage stimulus, proteolysis, positive regulation of epithelial to mesenchymal transition and transforming growth factor beta receptor signaling pathway was associated with the prognosis of the aforementioned gynecological cancer muscle organ developments.">
    <entity charOffset="92-103" id="s4940.e0" ontology_id="GO_0006508" text="proteolysis" type="GO"/>
    <entity charOffset="298-304" id="s4940.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4940.e0" e2="s4940.e1" id="s4940.p0" relation="false"/>
  </sentence>
  <sentence id="s4941" text="Survival analysis revealed that the expression of cellular response to DNA damage stimulus, proteolysis, positive regulation of epithelial to mesenchymal transition and transforming growth factor beta receptor signaling pathway was associated with the prognosis of the aforementioned gynecological cancer muscle organ developments.">
    <entity charOffset="105-164" id="s4941.e0" ontology_id="GO_0010718" text="positive regulation of epithelial to mesenchymal transition" type="GO"/>
    <entity charOffset="298-304" id="s4941.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4941.e0" e2="s4941.e1" id="s4941.p0" relation="true"/>
  </sentence>
  <sentence id="s4942" text="Survival analysis revealed that the expression of cellular response to DNA damage stimulus, proteolysis, positive regulation of epithelial to mesenchymal transition and transforming growth factor beta receptor signaling pathway was associated with the prognosis of the aforementioned gynecological cancer muscle organ developments.">
    <entity charOffset="169-227" id="s4942.e0" ontology_id="GO_0007179" text="transforming growth factor beta receptor signaling pathway" type="GO"/>
    <entity charOffset="298-304" id="s4942.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4942.e0" e2="s4942.e1" id="s4942.p0" relation="false"/>
  </sentence>
  <sentence id="s4943" text="Survival analysis revealed that the expression of cellular response to DNA damage stimulus, proteolysis, positive regulation of epithelial to mesenchymal transition and transforming growth factor beta receptor signaling pathway was associated with the prognosis of the aforementioned gynecological cancer muscle organ developments.">
    <entity charOffset="298-304" id="s4943.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="305-329" id="s4943.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s4943.e0" e2="s4943.e1" id="s4943.p0" relation="false"/>
  </sentence>
  <sentence id="s4944" text="In conclusion, the present study demonstrated a connection model across three muscle organ developments of gynecological cancer, which was useful in identifying potential diagnostic markers and novel therapeutic targets, in addition to in aiding the prediction of the development of cancer as it progresses">
    <entity charOffset="78-102" id="s4944.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="121-127" id="s4944.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4944.e0" e2="s4944.e1" id="s4944.p0" relation="false"/>
  </sentence>
  <sentence id="s4945" text="In the single-locus analysis, two variants, the MAPK cascade rs1805794 (OR 1.42, 95% CI 1.15-1.76, P = 0.001), and DNA repair rs1048771 (OR 1.61, 95% CI 1.17-2.22, P = 0.002) were significantly associated with glioma risk.">
    <entity charOffset="48-60" id="s4945.e0" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <entity charOffset="210-216" id="s4945.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s4945.e0" e2="s4945.e1" id="s4945.p0" relation="false"/>
  </sentence>
  <sentence id="s4946" text="In the single-locus analysis, two variants, the MAPK cascade rs1805794 (OR 1.42, 95% CI 1.15-1.76, P = 0.001), and DNA repair rs1048771 (OR 1.61, 95% CI 1.17-2.22, P = 0.002) were significantly associated with glioma risk.">
    <entity charOffset="115-125" id="s4946.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="210-216" id="s4946.e1" ontology_id="HP_0009733" text="glioma" type="HP"/>
    <pair e1="s4946.e0" e2="s4946.e1" id="s4946.p0" relation="false"/>
  </sentence>
  <sentence id="s4947" text="Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with multicellular organism developmentual dimorphism of hepatocellular carcinoma (phosphatidylinositol phosphorylation) risk.">
    <entity charOffset="136-170" id="s4947.e0" ontology_id="GO_0007275" text="multicellular organism development" type="GO"/>
    <entity charOffset="188-212" id="s4947.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s4947.e0" e2="s4947.e1" id="s4947.p0" relation="false"/>
  </sentence>
  <sentence id="s4948" text="Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with multicellular organism developmentual dimorphism of hepatocellular carcinoma (phosphatidylinositol phosphorylation) risk.">
    <entity charOffset="188-212" id="s4948.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="214-250" id="s4948.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4948.e0" e2="s4948.e1" id="s4948.p0" relation="false"/>
  </sentence>
  <sentence id="s4949" text="Moreover, results from our real-time quantitative polymerase chain reaction (qPCR) using 72 normal liver tissues adjacent to the tumors showed that glucocorticoid metabolic process expression was significantly different among different genotypes of this variant (GG versus CC: P = 0.032; Group test: P = 0.060).">
    <entity charOffset="129-135" id="s4949.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="148-180" id="s4949.e1" ontology_id="GO_0008211" text="glucocorticoid metabolic process" type="GO"/>
    <pair e1="s4949.e0" e2="s4949.e1" id="s4949.p0" relation="false"/>
  </sentence>
  <sentence id="s4950" text="Limb girdle muscular dystrophy type 2I (LGMD2I) is a progressive disorder caused by mutations in the FuKutin-Related Protein gene (protein O-linked mannosylation).">
    <entity charOffset="12-30" id="s4950.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="131-161" id="s4950.e1" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <pair e1="s4950.e0" e2="s4950.e1" id="s4950.p0" relation="true"/>
  </sentence>
  <sentence id="s4951" text="protein O-linked mannosylation displays clinical heterogeneity with onset of severe symptoms in early childhood to mild calf and thigh hypertrophy in the second or third decade.">
    <entity charOffset="0-30" id="s4951.e0" ontology_id="GO_0035269" text="protein O-linked mannosylation" type="GO"/>
    <entity charOffset="49-62" id="s4951.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s4951.e0" e2="s4951.e1" id="s4951.p0" relation="true"/>
  </sentence>
  <sentence id="s4952" text="Knockout of genes encoding metabotropic glutamate receptor 5 (G protein-coupled glutamate receptor signaling pathway) or its endogenous regulators, such as Norbin, induce a schizophrenia-like phenotype in rodents, suggesting dysregulation of mGluR5 in schizophrenia.">
    <entity charOffset="62-116" id="s4952.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="173-186" id="s4952.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4952.e0" e2="s4952.e1" id="s4952.p0" relation="false"/>
  </sentence>
  <sentence id="s4953" text="We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (biological_process), and Preso1 (positive regulation of synapse structural plasticity), which regulate mGluR5 localization, internalization and signaling.">
    <entity charOffset="113-126" id="s4953.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="291-309" id="s4953.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s4953.e0" e2="s4953.e1" id="s4953.p0" relation="false"/>
  </sentence>
  <sentence id="s4954" text="We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (biological_process), and Preso1 (positive regulation of synapse structural plasticity), which regulate mGluR5 localization, internalization and signaling.">
    <entity charOffset="113-126" id="s4954.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="324-376" id="s4954.e1" ontology_id="GO_0051835" text="positive regulation of synapse structural plasticity" type="GO"/>
    <pair e1="s4954.e0" e2="s4954.e1" id="s4954.p0" relation="false"/>
  </sentence>
  <sentence id="s4955" text="G protein-coupled glutamate receptor signaling pathway protein was significantly associated with mGluR5 mRNA and mGluR5 endogenous regulators in control subjects, but these associations were lost in schizophrenia subjects.">
    <entity charOffset="0-54" id="s4955.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="199-212" id="s4955.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4955.e0" e2="s4955.e1" id="s4955.p0" relation="false"/>
  </sentence>
  <sentence id="s4956" text="The results from our study provide compelling evidence that G protein-coupled glutamate receptor signaling pathway regulation is altered in schizophrenia, likely contributing to the altered glutamatergic signaling that is associated with the disorder">
    <entity charOffset="60-114" id="s4956.e0" ontology_id="GO_0007216" text="G protein-coupled glutamate receptor signaling pathway" type="GO"/>
    <entity charOffset="140-153" id="s4956.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s4956.e0" e2="s4956.e1" id="s4956.p0" relation="false"/>
  </sentence>
  <sentence id="s4957" text="Whereas transcription by RNA polymerase II heterozygote epidermis development have no detectable cardiac defects, loss of a Klf13 allele in cell-cell signaling heterozygote mice significantly increases the penetrance of cell-cell signaling-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.">
    <entity charOffset="8-42" id="s4957.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="250-271" id="s4957.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s4957.e0" e2="s4957.e1" id="s4957.p0" relation="false"/>
  </sentence>
  <sentence id="s4958" text="Whereas transcription by RNA polymerase II heterozygote epidermis development have no detectable cardiac defects, loss of a Klf13 allele in cell-cell signaling heterozygote mice significantly increases the penetrance of cell-cell signaling-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.">
    <entity charOffset="56-77" id="s4958.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="250-271" id="s4958.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s4958.e0" e2="s4958.e1" id="s4958.p0" relation="false"/>
  </sentence>
  <sentence id="s4959" text="Whereas transcription by RNA polymerase II heterozygote epidermis development have no detectable cardiac defects, loss of a Klf13 allele in cell-cell signaling heterozygote mice significantly increases the penetrance of cell-cell signaling-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.">
    <entity charOffset="140-159" id="s4959.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="250-271" id="s4959.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s4959.e0" e2="s4959.e1" id="s4959.p0" relation="true"/>
  </sentence>
  <sentence id="s4960" text="Whereas transcription by RNA polymerase II heterozygote epidermis development have no detectable cardiac defects, loss of a Klf13 allele in cell-cell signaling heterozygote mice significantly increases the penetrance of cell-cell signaling-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.">
    <entity charOffset="220-239" id="s4960.e0" ontology_id="GO_0007267" text="cell-cell signaling" type="GO"/>
    <entity charOffset="250-271" id="s4960.e1" ontology_id="HP_0001627" text="cardiac abnormalities" type="HP"/>
    <pair e1="s4960.e0" e2="s4960.e1" id="s4960.p0" relation="true"/>
  </sentence>
  <sentence id="s4961" text="Mutations in the positive regulation of stress-activated MAPK cascade gene have been associated with the X-linked form of Opitz Syndrome, a developmental disorder characterized by midline defects and intellectual disability.">
    <entity charOffset="17-69" id="s4961.e0" ontology_id="GO_0032874" text="positive regulation of stress-activated MAPK cascade" type="GO"/>
    <entity charOffset="200-223" id="s4961.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s4961.e0" e2="s4961.e1" id="s4961.p0" relation="false"/>
  </sentence>
  <sentence id="s4962" text="Next, using histone succinylation-1 colon cancer cells inducibly expressing SASS6, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes.">
    <entity charOffset="12-33" id="s4962.e0" ontology_id="GO_0106077" text="histone succinylation" type="GO"/>
    <entity charOffset="42-48" id="s4962.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4962.e0" e2="s4962.e1" id="s4962.p0" relation="false"/>
  </sentence>
  <sentence id="s4963" text="centriole replication upregulation in colon cancer was also revealed in the Cancer Genome Atlas (TCGA) data and was shown to be an independent predictor of poor survival (multivariate analysis: hazard ratio, 2.805; 95% confidence interval, 1.2447.512; P=0.0112).">
    <entity charOffset="0-21" id="s4963.e0" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <entity charOffset="44-50" id="s4963.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4963.e0" e2="s4963.e1" id="s4963.p0" relation="false"/>
  </sentence>
  <sentence id="s4964" text="Finally, further analysis of the TCGA data demonstrated centriole replication upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.">
    <entity charOffset="56-77" id="s4964.e0" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <entity charOffset="121-127" id="s4964.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4964.e0" e2="s4964.e1" id="s4964.p0" relation="false"/>
  </sentence>
  <sentence id="s4965" text="Finally, further analysis of the TCGA data demonstrated centriole replication upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.">
    <entity charOffset="56-77" id="s4965.e0" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <entity charOffset="287-306" id="s4965.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s4965.e0" e2="s4965.e1" id="s4965.p0" relation="false"/>
  </sentence>
  <sentence id="s4966" text="Our present findings revealed that the upregulation of centriole replication expression is involved in the pathogenesis of CRC and is associated with a poor prognosis among patients with colon cancer.">
    <entity charOffset="55-76" id="s4966.e0" ontology_id="GO_0007099" text="centriole replication" type="GO"/>
    <entity charOffset="193-199" id="s4966.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4966.e0" e2="s4966.e1" id="s4966.p0" relation="false"/>
  </sentence>
  <sentence id="s4967" text="Squamous cell carcinoma (negative regulation of peptidase activity) can progress to malignant metastatic cancer, including an aggressive subtype known as spindle cell carcinoma (spSCC). spSCC formation involves epithelial-to-mesenchymal transition (EMT), yet the molecular basis of this event remains unknown.">
    <entity charOffset="25-66" id="s4967.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="105-111" id="s4967.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4967.e0" e2="s4967.e1" id="s4967.p0" relation="false"/>
  </sentence>
  <sentence id="s4968" text="Here, we show that human spSCC tumours also feature strong nuclear localisation of YAP and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in epidermis development.">
    <entity charOffset="31-38" id="s4968.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="229-250" id="s4968.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s4968.e0" e2="s4968.e1" id="s4968.p0" relation="false"/>
  </sentence>
  <sentence id="s4969" text="spnegative regulation of peptidase activity tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo cytokine production to generate spSCC.">
    <entity charOffset="2-43" id="s4969.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="44-51" id="s4969.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s4969.e0" e2="s4969.e1" id="s4969.p0" relation="false"/>
  </sentence>
  <sentence id="s4970" text="spnegative regulation of peptidase activity tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo cytokine production to generate spSCC.">
    <entity charOffset="2-43" id="s4970.e0" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <entity charOffset="105-111" id="s4970.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s4970.e0" e2="s4970.e1" id="s4970.p0" relation="false"/>
  </sentence>
  <sentence id="s4971" text="spnegative regulation of peptidase activity tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo cytokine production to generate spSCC.">
    <entity charOffset="44-51" id="s4971.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="148-167" id="s4971.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s4971.e0" e2="s4971.e1" id="s4971.p0" relation="true"/>
  </sentence>
  <sentence id="s4972" text="spnegative regulation of peptidase activity tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo cytokine production to generate spSCC.">
    <entity charOffset="105-111" id="s4972.e0" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <entity charOffset="148-167" id="s4972.e1" ontology_id="GO_0001816" text="cytokine production" type="GO"/>
    <pair e1="s4972.e0" e2="s4972.e1" id="s4972.p0" relation="true"/>
  </sentence>
  <sentence id="s4973" text="Group 1 pulmonary hypertension or pulmonary arterial hypertension (L-phenylalanine catabolic process) is a rare disease characterized by proliferation and occlusion of small pulmonary arterioles, leading to progressive elevation of pulmonary artery pressure and pulmonary vascular resistance, and right ventricular failure.">
    <entity charOffset="67-100" id="s4973.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="297-322" id="s4973.e1" ontology_id="HP_0001708" text="right ventricular failure" type="HP"/>
    <pair e1="s4973.e0" e2="s4973.e1" id="s4973.p0" relation="false"/>
  </sentence>
  <sentence id="s4974" text="L-phenylalanine catabolic process in children is much more heterogeneous than in adults, and can be associated with several genetic syndromes, congenital heart disease, pulmonary disease, and vascular disease.">
    <entity charOffset="0-33" id="s4974.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="59-72" id="s4974.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s4974.e0" e2="s4974.e1" id="s4974.p0" relation="false"/>
  </sentence>
  <sentence id="s4975" text="The aim of our study was to determine the negative regulation of transcription by RNA polymerase II of genetic polymorphisms in the caspase (CASP) genes on prognosis of hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="42-99" id="s4975.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="169-193" id="s4975.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s4975.e0" e2="s4975.e1" id="s4975.p0" relation="false"/>
  </sentence>
  <sentence id="s4976" text="The aim of our study was to determine the negative regulation of transcription by RNA polymerase II of genetic polymorphisms in the caspase (CASP) genes on prognosis of hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="169-193" id="s4976.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="195-231" id="s4976.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s4976.e0" e2="s4976.e1" id="s4976.p0" relation="false"/>
  </sentence>
  <sentence id="s4977" text="We genotyped 7 potentially functional polymorphisms in protein stabilization3, CASP7, CASP8, CASP9, CASP10 genes in 362 phosphatidylinositol phosphorylation patients of receiving surgical resection of HCC tumor.">
    <entity charOffset="55-76" id="s4977.e0" ontology_id="GO_0050821" text="protein stabilization" type="GO"/>
    <entity charOffset="205-210" id="s4977.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4977.e0" e2="s4977.e1" id="s4977.p0" relation="false"/>
  </sentence>
  <sentence id="s4978" text="We genotyped 7 potentially functional polymorphisms in protein stabilization3, CASP7, CASP8, CASP9, CASP10 genes in 362 phosphatidylinositol phosphorylation patients of receiving surgical resection of HCC tumor.">
    <entity charOffset="120-156" id="s4978.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="205-210" id="s4978.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4978.e0" e2="s4978.e1" id="s4978.p0" relation="false"/>
  </sentence>
  <sentence id="s4979" text="In cancer, elevated positive regulation of protein ubiquitination expression has been associated with malignancy, poor prognosis, and treatment resistance.">
    <entity charOffset="3-9" id="s4979.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="20-65" id="s4979.e1" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <pair e1="s4979.e0" e2="s4979.e1" id="s4979.p0" relation="true"/>
  </sentence>
  <sentence id="s4980" text="positive regulation of protein ubiquitination has previously been proposed to promote tumor growth through suppression of autophagy.">
    <entity charOffset="0-45" id="s4980.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="86-91" id="s4980.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s4980.e0" e2="s4980.e1" id="s4980.p0" relation="true"/>
  </sentence>
  <sentence id="s4981" text="In this study, we examined the expression of positive regulation of protein ubiquitination and p62, two critical mediators of autophagy, in breast and colon cancer.">
    <entity charOffset="45-90" id="s4981.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="157-163" id="s4981.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4981.e0" e2="s4981.e1" id="s4981.p0" relation="true"/>
  </sentence>
  <sentence id="s4982" text="We observed a negative correlation between positive regulation of protein ubiquitination and p62 expression in normal and cancer tissues of breast and colon, and that the ratio of XIAP and p62 expression determines the cancer phenotype.">
    <entity charOffset="43-88" id="s4982.e0" ontology_id="GO_0031398" text="positive regulation of protein ubiquitination" type="GO"/>
    <entity charOffset="122-128" id="s4982.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4982.e0" e2="s4982.e1" id="s4982.p0" relation="true"/>
  </sentence>
  <sentence id="s4983" text="Mutations in branching involved in blood vessel morphogenesis have been reported in schizencephaly and porencephaly combined with microbleeds or calcifications, often associated with ocular and renal abnormalities, myopathy, elevated creatine kinase levels and haemolytic anaemia.">
    <entity charOffset="13-61" id="s4983.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="84-98" id="s4983.e1" ontology_id="HP_0010636" text="schizencephaly" type="HP"/>
    <pair e1="s4983.e0" e2="s4983.e1" id="s4983.p0" relation="true"/>
  </sentence>
  <sentence id="s4984" text="Mutations in branching involved in blood vessel morphogenesis have been reported in schizencephaly and porencephaly combined with microbleeds or calcifications, often associated with ocular and renal abnormalities, myopathy, elevated creatine kinase levels and haemolytic anaemia.">
    <entity charOffset="13-61" id="s4984.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="215-223" id="s4984.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s4984.e0" e2="s4984.e1" id="s4984.p0" relation="false"/>
  </sentence>
  <sentence id="s4985" text="In this study, we aimed to clarify the phenotypic spectrum of branching involved in blood vessel morphogenesis/A2 mutations in the context of cortical malformations that include schizencephaly, polymicrogyria and/or heterotopia">
    <entity charOffset="62-110" id="s4985.e0" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <entity charOffset="194-208" id="s4985.e1" ontology_id="HP_0002126" text="polymicrogyria" type="HP"/>
    <pair e1="s4985.e0" e2="s4985.e1" id="s4985.p0" relation="true"/>
  </sentence>
  <sentence id="s4986" text="The colonic expression of response to manganese ion is decreased in ulcerative colitis (UC) patients at baseline who progress to cancer.">
    <entity charOffset="26-51" id="s4986.e0" ontology_id="GO_0010042" text="response to manganese ion" type="GO"/>
    <entity charOffset="129-135" id="s4986.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4986.e0" e2="s4986.e1" id="s4986.p0" relation="false"/>
  </sentence>
  <sentence id="s4987" text="Our study identifies urine D2HG and tissue response to manganese ion expression as biomarkers to identify patients at risk for progressing from colitis to cancer.">
    <entity charOffset="43-68" id="s4987.e0" ontology_id="GO_0010042" text="response to manganese ion" type="GO"/>
    <entity charOffset="155-161" id="s4987.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4987.e0" e2="s4987.e1" id="s4987.p0" relation="false"/>
  </sentence>
  <sentence id="s4988" text="Craniofrontonasal syndrome (cell adhesion) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, hypertelorism, and a bifid nasal tip.">
    <entity charOffset="28-41" id="s4988.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="120-133" id="s4988.e1" ontology_id="HP_0000248" text="brachycephaly" type="HP"/>
    <pair e1="s4988.e0" e2="s4988.e1" id="s4988.p0" relation="true"/>
  </sentence>
  <sentence id="s4989" text="Craniofrontonasal syndrome (cell adhesion) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, hypertelorism, and a bifid nasal tip.">
    <entity charOffset="28-41" id="s4989.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="135-148" id="s4989.e1" ontology_id="HP_0000316" text="hypertelorism" type="HP"/>
    <pair e1="s4989.e0" e2="s4989.e1" id="s4989.p0" relation="true"/>
  </sentence>
  <sentence id="s4990" text="Duchenne muscular dystrophy (peptide biosynthetic process) is characterized by a severe and progressive destruction of muscle fibers associated with altered Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis.">
    <entity charOffset="9-27" id="s4990.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="29-57" id="s4990.e1" ontology_id="GO_0043043" text="peptide biosynthetic process" type="GO"/>
    <pair e1="s4990.e0" e2="s4990.e1" id="s4990.p0" relation="true"/>
  </sentence>
  <sentence id="s4991" text="Spinocerebellar ataxia type 1 (negative regulation of transcription, DNA-templated) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein negative regulation of transcription, DNA-templated.">
    <entity charOffset="16-22" id="s4991.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="31-82" id="s4991.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4991.e0" e2="s4991.e1" id="s4991.p0" relation="true"/>
  </sentence>
  <sentence id="s4992" text="Spinocerebellar ataxia type 1 (negative regulation of transcription, DNA-templated) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein negative regulation of transcription, DNA-templated.">
    <entity charOffset="16-22" id="s4992.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="212-263" id="s4992.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s4992.e0" e2="s4992.e1" id="s4992.p0" relation="true"/>
  </sentence>
  <sentence id="s4993" text="positive regulation of transcription, DNA-templated expression and molecular mechanisms by which PAX6 modifies the migration capacity of breast cancer cells">
    <entity charOffset="0-51" id="s4993.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="144-150" id="s4993.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4993.e0" e2="s4993.e1" id="s4993.p0" relation="true"/>
  </sentence>
  <sentence id="s4994" text="The genetic study by panels of known genes associated with tubulointerstitial disease allowed us to discover autosomal dominant distal renal tubular acidosis associated with a de novo mutation in exon 14 of the anion transport gene, which would have been impossible to diagnose clinically due to the advanced nature of the kidney disease when it was discovered">
    <entity charOffset="128-134" id="s4994.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="211-226" id="s4994.e1" ontology_id="GO_0006820" text="anion transport" type="GO"/>
    <pair e1="s4994.e0" e2="s4994.e1" id="s4994.p0" relation="false"/>
  </sentence>
  <sentence id="s4995" text="The genetic study by panels of known genes associated with tubulointerstitial disease allowed us to discover autosomal dominant distal renal tubular acidosis associated with a de novo mutation in exon 14 of the anion transport gene, which would have been impossible to diagnose clinically due to the advanced nature of the kidney disease when it was discovered">
    <entity charOffset="135-157" id="s4995.e0" ontology_id="HP_0001947" text="renal tubular acidosis" type="HP"/>
    <entity charOffset="211-226" id="s4995.e1" ontology_id="GO_0006820" text="anion transport" type="GO"/>
    <pair e1="s4995.e0" e2="s4995.e1" id="s4995.p0" relation="true"/>
  </sentence>
  <sentence id="s4996" text="Functional studies support intraocular pressure-related influences of cytoskeleton organization and LMX1B, with certain Lmx1b mutations causing high IOP and glaucoma resembling POAG in mice.">
    <entity charOffset="70-95" id="s4996.e0" ontology_id="GO_0007010" text="cytoskeleton organization" type="GO"/>
    <entity charOffset="157-165" id="s4996.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s4996.e0" e2="s4996.e1" id="s4996.p0" relation="false"/>
  </sentence>
  <sentence id="s4997" text="Aberrant expression of the sodium channel gene (sodium ion transport) has been proposed to disrupt cardiac action potential and cause human cardiac arrhythmias, but the mechanisms of SCN5A gene regulation and dysregulation still remain largely unexplored.">
    <entity charOffset="48-68" id="s4997.e0" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <entity charOffset="140-159" id="s4997.e1" ontology_id="HP_0011675" text="cardiac arrhythmias" type="HP"/>
    <pair e1="s4997.e0" e2="s4997.e1" id="s4997.p0" relation="true"/>
  </sentence>
  <sentence id="s4998" text="This study aimed to evaluate the interactions between single nucleotide polymorphisms of response to oxidative stress (rs1917799) and protein polyubiquitination (rs158572 and rs158916) in gastric cancer and its precancerous diseases.">
    <entity charOffset="89-117" id="s4998.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="196-202" id="s4998.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4998.e0" e2="s4998.e1" id="s4998.p0" relation="true"/>
  </sentence>
  <sentence id="s4999" text="This study aimed to evaluate the interactions between single nucleotide polymorphisms of response to oxidative stress (rs1917799) and protein polyubiquitination (rs158572 and rs158916) in gastric cancer and its precancerous diseases.">
    <entity charOffset="134-160" id="s4999.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="196-202" id="s4999.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s4999.e0" e2="s4999.e1" id="s4999.p0" relation="false"/>
  </sentence>
  <sentence id="s5000" text="response to oxidative stress rs1917799 also showed a significant interaction with ERCC8 rs158916 to reduce gastric cancer risk.">
    <entity charOffset="0-28" id="s5000.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="115-121" id="s5000.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5000.e0" e2="s5000.e1" id="s5000.p0" relation="true"/>
  </sentence>
  <sentence id="s5001" text="The expressions of response to oxidative stress, protein polyubiquitination and ERCC6-ERCC8 combination have similarities that higher positivity was observed in chronic superficial gastritis compared with chronic atrophic gastritis and gastric cancer.">
    <entity charOffset="19-47" id="s5001.e0" ontology_id="GO_0006979" text="response to oxidative stress" type="GO"/>
    <entity charOffset="244-250" id="s5001.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5001.e0" e2="s5001.e1" id="s5001.p0" relation="true"/>
  </sentence>
  <sentence id="s5002" text="The expressions of response to oxidative stress, protein polyubiquitination and ERCC6-ERCC8 combination have similarities that higher positivity was observed in chronic superficial gastritis compared with chronic atrophic gastritis and gastric cancer.">
    <entity charOffset="49-75" id="s5002.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="244-250" id="s5002.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5002.e0" e2="s5002.e1" id="s5002.p0" relation="false"/>
  </sentence>
  <sentence id="s5003" text="phosphatidylserine catabolic process mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.">
    <entity charOffset="0-36" id="s5003.e0" ontology_id="GO_0006660" text="phosphatidylserine catabolic process" type="GO"/>
    <entity charOffset="108-120" id="s5003.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s5003.e0" e2="s5003.e1" id="s5003.p0" relation="true"/>
  </sentence>
  <sentence id="s5004" text="phosphatidylserine catabolic process mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.">
    <entity charOffset="0-36" id="s5004.e0" ontology_id="GO_0006660" text="phosphatidylserine catabolic process" type="GO"/>
    <entity charOffset="168-176" id="s5004.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s5004.e0" e2="s5004.e1" id="s5004.p0" relation="true"/>
  </sentence>
  <sentence id="s5005" text="Of these five genes, the brain expressed peptidyl-serine phosphorylation gene constitutes a good candidate for the developmental delay, while the cellular homeostasis gene, involved in mitochondrial trafficking, might underlie the hypotonia and the excessive fatigue">
    <entity charOffset="41-72" id="s5005.e0" ontology_id="GO_0018105" text="peptidyl-serine phosphorylation" type="GO"/>
    <entity charOffset="115-134" id="s5005.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s5005.e0" e2="s5005.e1" id="s5005.p0" relation="false"/>
  </sentence>
  <sentence id="s5006" text="Of these five genes, the brain expressed peptidyl-serine phosphorylation gene constitutes a good candidate for the developmental delay, while the cellular homeostasis gene, involved in mitochondrial trafficking, might underlie the hypotonia and the excessive fatigue">
    <entity charOffset="115-134" id="s5006.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="146-166" id="s5006.e1" ontology_id="GO_0019725" text="cellular homeostasis" type="GO"/>
    <pair e1="s5006.e0" e2="s5006.e1" id="s5006.p0" relation="false"/>
  </sentence>
  <sentence id="s5007" text="BRAF mutations occur in about 40-45% of all papillary thyroid carcinomas (biological_processs) and of which 99.7% is the BRAFV600E mutation.">
    <entity charOffset="44-72" id="s5007.e0" ontology_id="HP_0002895" text="papillary thyroid carcinomas" type="HP"/>
    <entity charOffset="74-92" id="s5007.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s5007.e0" e2="s5007.e1" id="s5007.p0" relation="false"/>
  </sentence>
  <sentence id="s5008" text="A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/cell surface receptor signaling pathway signaling in the development of biological_processs.">
    <entity charOffset="82-96" id="s5008.e0" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <entity charOffset="279-318" id="s5008.e1" ontology_id="GO_0007166" text="cell surface receptor signaling pathway" type="GO"/>
    <pair e1="s5008.e0" e2="s5008.e1" id="s5008.p0" relation="true"/>
  </sentence>
  <sentence id="s5009" text="A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/cell surface receptor signaling pathway signaling in the development of biological_processs.">
    <entity charOffset="82-96" id="s5009.e0" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <entity charOffset="351-369" id="s5009.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s5009.e0" e2="s5009.e1" id="s5009.p0" relation="false"/>
  </sentence>
  <sentence id="s5010" text="A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/cell surface receptor signaling pathway signaling in the development of biological_processs.">
    <entity charOffset="183-188" id="s5010.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="279-318" id="s5010.e1" ontology_id="GO_0007166" text="cell surface receptor signaling pathway" type="GO"/>
    <pair e1="s5010.e0" e2="s5010.e1" id="s5010.p0" relation="false"/>
  </sentence>
  <sentence id="s5011" text="A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/cell surface receptor signaling pathway signaling in the development of biological_processs.">
    <entity charOffset="183-188" id="s5011.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="351-369" id="s5011.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s5011.e0" e2="s5011.e1" id="s5011.p0" relation="false"/>
  </sentence>
  <sentence id="s5012" text="BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), response to estrogen (70%), and regulation of megakaryocyte differentiation (90%) mutations by exome sequencing, similar to human MIBC.">
    <entity charOffset="4-10" id="s5012.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="127-147" id="s5012.e1" ontology_id="GO_0043627" text="response to estrogen" type="GO"/>
    <pair e1="s5012.e0" e2="s5012.e1" id="s5012.p0" relation="false"/>
  </sentence>
  <sentence id="s5013" text="BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), response to estrogen (70%), and regulation of megakaryocyte differentiation (90%) mutations by exome sequencing, similar to human MIBC.">
    <entity charOffset="53-59" id="s5013.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="127-147" id="s5013.e1" ontology_id="GO_0043627" text="response to estrogen" type="GO"/>
    <pair e1="s5013.e0" e2="s5013.e1" id="s5013.p0" relation="false"/>
  </sentence>
  <sentence id="s5014" text="BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), response to estrogen (70%), and regulation of megakaryocyte differentiation (90%) mutations by exome sequencing, similar to human MIBC.">
    <entity charOffset="53-59" id="s5014.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="159-202" id="s5014.e1" ontology_id="GO_0045652" text="regulation of megakaryocyte differentiation" type="GO"/>
    <pair e1="s5014.e0" e2="s5014.e1" id="s5014.p0" relation="false"/>
  </sentence>
  <sentence id="s5015" text="Here, we report that mitotic spindle assembly checkpoint is highly overexpressed in multiple lung adenocarcinoma cell lines and tumor tissues.">
    <entity charOffset="21-56" id="s5015.e0" ontology_id="GO_0007094" text="mitotic spindle assembly checkpoint" type="GO"/>
    <entity charOffset="93-112" id="s5015.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s5015.e0" e2="s5015.e1" id="s5015.p0" relation="false"/>
  </sentence>
  <sentence id="s5016" text="Clinically, mitotic spindle assembly checkpoint expression is positively associated with tumor size, T-stage, and N-stage, and Kaplan-Meier analysis revealed that heightened TRIP13 expression is associated with lower overall survival.">
    <entity charOffset="12-47" id="s5016.e0" ontology_id="GO_0007094" text="mitotic spindle assembly checkpoint" type="GO"/>
    <entity charOffset="89-94" id="s5016.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5016.e0" e2="s5016.e1" id="s5016.p0" relation="true"/>
  </sentence>
  <sentence id="s5017" text="mitotic spindle assembly checkpoint promotes lung adenocarcinoma cell proliferation, clonogenicity, and migration while inhibiting apoptosis and G2/M phase shift invitro.">
    <entity charOffset="0-35" id="s5017.e0" ontology_id="GO_0007094" text="mitotic spindle assembly checkpoint" type="GO"/>
    <entity charOffset="45-64" id="s5017.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s5017.e0" e2="s5017.e1" id="s5017.p0" relation="false"/>
  </sentence>
  <sentence id="s5018" text="Accordingly, mitotic spindle assembly checkpoint-silenced xenograft tumors displayed significant growth inhibition invivo.">
    <entity charOffset="13-48" id="s5018.e0" ontology_id="GO_0007094" text="mitotic spindle assembly checkpoint" type="GO"/>
    <entity charOffset="68-73" id="s5018.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5018.e0" e2="s5018.e1" id="s5018.p0" relation="true"/>
  </sentence>
  <sentence id="s5019" text="In conclusion, heightened mitotic spindle assembly checkpoint expression appears to promote lung adenocarcinoma tumor progression and displays potential as a therapeutic target or biomarker for lung adenocarcinoma">
    <entity charOffset="26-61" id="s5019.e0" ontology_id="GO_0007094" text="mitotic spindle assembly checkpoint" type="GO"/>
    <entity charOffset="92-111" id="s5019.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s5019.e0" e2="s5019.e1" id="s5019.p0" relation="false"/>
  </sentence>
  <sentence id="s5020" text="In conclusion, heightened mitotic spindle assembly checkpoint expression appears to promote lung adenocarcinoma tumor progression and displays potential as a therapeutic target or biomarker for lung adenocarcinoma">
    <entity charOffset="26-61" id="s5020.e0" ontology_id="GO_0007094" text="mitotic spindle assembly checkpoint" type="GO"/>
    <entity charOffset="112-117" id="s5020.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5020.e0" e2="s5020.e1" id="s5020.p0" relation="true"/>
  </sentence>
  <sentence id="s5021" text="Bartter syndrome muscle organ development 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (&lt;i&gt;excretion&lt;/i&gt;), which encodes the positive regulation of cell proliferation-Kb chloride channel involved in NaCl reabsorption in the renal tubule.">
    <entity charOffset="17-41" id="s5021.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="60-73" id="s5021.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s5021.e0" e2="s5021.e1" id="s5021.p0" relation="false"/>
  </sentence>
  <sentence id="s5022" text="Bartter syndrome muscle organ development 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (&lt;i&gt;excretion&lt;/i&gt;), which encodes the positive regulation of cell proliferation-Kb chloride channel involved in NaCl reabsorption in the renal tubule.">
    <entity charOffset="60-73" id="s5022.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="179-188" id="s5022.e1" ontology_id="GO_0007588" text="excretion" type="GO"/>
    <pair e1="s5022.e0" e2="s5022.e1" id="s5022.p0" relation="true"/>
  </sentence>
  <sentence id="s5023" text="Bartter syndrome muscle organ development 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (&lt;i&gt;excretion&lt;/i&gt;), which encodes the positive regulation of cell proliferation-Kb chloride channel involved in NaCl reabsorption in the renal tubule.">
    <entity charOffset="60-73" id="s5023.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="213-254" id="s5023.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s5023.e0" e2="s5023.e1" id="s5023.p0" relation="false"/>
  </sentence>
  <sentence id="s5024" text="Among patients, 29.5% had a phenomuscle organ development of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).">
    <entity charOffset="33-57" id="s5024.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="214-228" id="s5024.e1" ontology_id="HP_0002150" text="hypercalciuria" type="HP"/>
    <pair e1="s5024.e0" e2="s5024.e1" id="s5024.p0" relation="false"/>
  </sentence>
  <sentence id="s5025" text="Among patients, 29.5% had a phenomuscle organ development of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).">
    <entity charOffset="33-57" id="s5025.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="310-321" id="s5025.e1" ontology_id="HP_0002900" text="hypokalemia" type="HP"/>
    <pair e1="s5025.e0" e2="s5025.e1" id="s5025.p0" relation="false"/>
  </sentence>
  <sentence id="s5026" text="Among patients, 29.5% had a phenomuscle organ development of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).">
    <entity charOffset="33-57" id="s5026.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="327-341" id="s5026.e1" ontology_id="HP_0002917" text="hypomagnesemia" type="HP"/>
    <pair e1="s5026.e0" e2="s5026.e1" id="s5026.p0" relation="false"/>
  </sentence>
  <sentence id="s5027" text="Among patients, 29.5% had a phenomuscle organ development of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).">
    <entity charOffset="33-57" id="s5027.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="349-362" id="s5027.e1" ontology_id="HP_0003127" text="hypocalciuria" type="HP"/>
    <pair e1="s5027.e0" e2="s5027.e1" id="s5027.p0" relation="false"/>
  </sentence>
  <sentence id="s5028" text="Our findings imply that microcephaly is a variable phenomuscle organ development in nucleus organization-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease">
    <entity charOffset="56-80" id="s5028.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="169-192" id="s5028.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5028.e0" e2="s5028.e1" id="s5028.p0" relation="false"/>
  </sentence>
  <sentence id="s5029" text="Our findings imply that microcephaly is a variable phenomuscle organ development in nucleus organization-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease">
    <entity charOffset="56-80" id="s5029.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="197-218" id="s5029.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s5029.e0" e2="s5029.e1" id="s5029.p0" relation="false"/>
  </sentence>
  <sentence id="s5030" text="Our findings imply that microcephaly is a variable phenomuscle organ development in nucleus organization-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease">
    <entity charOffset="84-104" id="s5030.e0" ontology_id="GO_0006997" text="nucleus organization" type="GO"/>
    <entity charOffset="169-192" id="s5030.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5030.e0" e2="s5030.e1" id="s5030.p0" relation="true"/>
  </sentence>
  <sentence id="s5031" text="Our findings imply that microcephaly is a variable phenomuscle organ development in nucleus organization-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease">
    <entity charOffset="84-104" id="s5031.e0" ontology_id="GO_0006997" text="nucleus organization" type="GO"/>
    <entity charOffset="197-218" id="s5031.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s5031.e0" e2="s5031.e1" id="s5031.p0" relation="false"/>
  </sentence>
  <sentence id="s5032" text="Two rare pathogenic variants were identified in the collagen catabolic process gene: one in a sporadic case and another was found to segregate in a family with six affected individuals with CD.">
    <entity charOffset="52-78" id="s5032.e0" ontology_id="GO_0030574" text="collagen catabolic process" type="GO"/>
    <entity charOffset="94-102" id="s5032.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5032.e0" e2="s5032.e1" id="s5032.p0" relation="false"/>
  </sentence>
  <sentence id="s5033" text="Mutations in heat shock transcription factor 4 (regulation of transcription, DNA-templated) have been associated with cataract; however, the mechanisms regarding how mutations in HSF4 cause cataract are still obscure.">
    <entity charOffset="48-90" id="s5033.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="118-126" id="s5033.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s5033.e0" e2="s5033.e1" id="s5033.p0" relation="true"/>
  </sentence>
  <sentence id="s5034" text="The mutant zebrasuperoxide metabolic process developed an early-onset cataract with multiple developmental defects in lens.">
    <entity charOffset="16-44" id="s5034.e0" ontology_id="GO_0006801" text="superoxide metabolic process" type="GO"/>
    <entity charOffset="70-78" id="s5034.e1" ontology_id="HP_0000518" text="cataract" type="HP"/>
    <pair e1="s5034.e0" e2="s5034.e1" id="s5034.p0" relation="false"/>
  </sentence>
  <sentence id="s5035" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(negative regulation of peptidase activity) of the tongue: the vascular endothelial growth factor(negative regulation of transcription by RNA polymerase II)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(myeloid dendritic cell chemotaxis); neuropilin(positive regulation of neurogenesis)1 and NRP2; and semaphorin 3E(branching involved in blood vessel morphogenesis).">
    <entity charOffset="119-142" id="s5035.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="144-185" id="s5035.e1" ontology_id="GO_0010466" text="negative regulation of peptidase activity" type="GO"/>
    <pair e1="s5035.e0" e2="s5035.e1" id="s5035.p0" relation="false"/>
  </sentence>
  <sentence id="s5036" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(negative regulation of peptidase activity) of the tongue: the vascular endothelial growth factor(negative regulation of transcription by RNA polymerase II)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(myeloid dendritic cell chemotaxis); neuropilin(positive regulation of neurogenesis)1 and NRP2; and semaphorin 3E(branching involved in blood vessel morphogenesis).">
    <entity charOffset="119-142" id="s5036.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="242-299" id="s5036.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5036.e0" e2="s5036.e1" id="s5036.p0" relation="false"/>
  </sentence>
  <sentence id="s5037" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(negative regulation of peptidase activity) of the tongue: the vascular endothelial growth factor(negative regulation of transcription by RNA polymerase II)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(myeloid dendritic cell chemotaxis); neuropilin(positive regulation of neurogenesis)1 and NRP2; and semaphorin 3E(branching involved in blood vessel morphogenesis).">
    <entity charOffset="119-142" id="s5037.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="430-463" id="s5037.e1" ontology_id="GO_0002408" text="myeloid dendritic cell chemotaxis" type="GO"/>
    <pair e1="s5037.e0" e2="s5037.e1" id="s5037.p0" relation="false"/>
  </sentence>
  <sentence id="s5038" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(negative regulation of peptidase activity) of the tongue: the vascular endothelial growth factor(negative regulation of transcription by RNA polymerase II)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(myeloid dendritic cell chemotaxis); neuropilin(positive regulation of neurogenesis)1 and NRP2; and semaphorin 3E(branching involved in blood vessel morphogenesis).">
    <entity charOffset="119-142" id="s5038.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="478-513" id="s5038.e1" ontology_id="GO_0050769" text="positive regulation of neurogenesis" type="GO"/>
    <pair e1="s5038.e0" e2="s5038.e1" id="s5038.p0" relation="false"/>
  </sentence>
  <sentence id="s5039" text="The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(negative regulation of peptidase activity) of the tongue: the vascular endothelial growth factor(negative regulation of transcription by RNA polymerase II)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(myeloid dendritic cell chemotaxis); neuropilin(positive regulation of neurogenesis)1 and NRP2; and semaphorin 3E(branching involved in blood vessel morphogenesis).">
    <entity charOffset="119-142" id="s5039.e0" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <entity charOffset="545-593" id="s5039.e1" ontology_id="GO_0001569" text="branching involved in blood vessel morphogenesis" type="GO"/>
    <pair e1="s5039.e0" e2="s5039.e1" id="s5039.p0" relation="false"/>
  </sentence>
  <sentence id="s5040" text="Subsequent quantitative PCR experiments confirmed that I-kappaB phosphorylation, CKS2, female pregnancy, and an protein phosphorylation (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.">
    <entity charOffset="55-79" id="s5040.e0" ontology_id="GO_0007252" text="I-kappaB phosphorylation" type="GO"/>
    <entity charOffset="221-227" id="s5040.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5040.e0" e2="s5040.e1" id="s5040.p0" relation="false"/>
  </sentence>
  <sentence id="s5041" text="Subsequent quantitative PCR experiments confirmed that I-kappaB phosphorylation, CKS2, female pregnancy, and an protein phosphorylation (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.">
    <entity charOffset="87-103" id="s5041.e0" ontology_id="GO_0007565" text="female pregnancy" type="GO"/>
    <entity charOffset="221-227" id="s5041.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5041.e0" e2="s5041.e1" id="s5041.p0" relation="false"/>
  </sentence>
  <sentence id="s5042" text="Subsequent quantitative PCR experiments confirmed that I-kappaB phosphorylation, CKS2, female pregnancy, and an protein phosphorylation (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.">
    <entity charOffset="112-135" id="s5042.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="221-227" id="s5042.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5042.e0" e2="s5042.e1" id="s5042.p0" relation="true"/>
  </sentence>
  <sentence id="s5043" text="We investigated this issue by analyzing the expression patterns of regulation of presynapse assembly, APP-processing secretases, and APP metabolites in mitochondria separated from human neuroblastoma SH-SY5Y cells and those expressing Swedish mutant APP.">
    <entity charOffset="67-100" id="s5043.e0" ontology_id="GO_1905606" text="regulation of presynapse assembly" type="GO"/>
    <entity charOffset="186-199" id="s5043.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s5043.e0" e2="s5043.e1" id="s5043.p0" relation="false"/>
  </sentence>
  <sentence id="s5044" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="130-151" id="s5044.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="253-267" id="s5044.e1" ontology_id="HP_0002311" text="incoordination" type="HP"/>
    <pair e1="s5044.e0" e2="s5044.e1" id="s5044.p0" relation="false"/>
  </sentence>
  <sentence id="s5045" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="130-151" id="s5045.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="272-282" id="s5045.e1" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <pair e1="s5045.e0" e2="s5045.e1" id="s5045.p0" relation="false"/>
  </sentence>
  <sentence id="s5046" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="253-267" id="s5046.e0" ontology_id="HP_0002311" text="incoordination" type="HP"/>
    <entity charOffset="324-343" id="s5046.e1" ontology_id="GO_0015844" text="monoamine transport" type="GO"/>
    <pair e1="s5046.e0" e2="s5046.e1" id="s5046.p0" relation="false"/>
  </sentence>
  <sentence id="s5047" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="253-267" id="s5047.e0" ontology_id="HP_0002311" text="incoordination" type="HP"/>
    <entity charOffset="345-387" id="s5047.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s5047.e0" e2="s5047.e1" id="s5047.p0" relation="false"/>
  </sentence>
  <sentence id="s5048" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="253-267" id="s5048.e0" ontology_id="HP_0002311" text="incoordination" type="HP"/>
    <entity charOffset="419-454" id="s5048.e1" ontology_id="GO_0002088" text="lens development in camera-type eye" type="GO"/>
    <pair e1="s5048.e0" e2="s5048.e1" id="s5048.p0" relation="false"/>
  </sentence>
  <sentence id="s5049" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="272-282" id="s5049.e0" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <entity charOffset="324-343" id="s5049.e1" ontology_id="GO_0015844" text="monoamine transport" type="GO"/>
    <pair e1="s5049.e0" e2="s5049.e1" id="s5049.p0" relation="false"/>
  </sentence>
  <sentence id="s5050" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="272-282" id="s5050.e0" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <entity charOffset="345-387" id="s5050.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s5050.e0" e2="s5050.e1" id="s5050.p0" relation="false"/>
  </sentence>
  <sentence id="s5051" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="272-282" id="s5051.e0" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <entity charOffset="389-417" id="s5051.e1" ontology_id="GO_0006351" text="transcription, DNA-templated" type="GO"/>
    <pair e1="s5051.e0" e2="s5051.e1" id="s5051.p0" relation="false"/>
  </sentence>
  <sentence id="s5052" text="Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).">
    <entity charOffset="272-282" id="s5052.e0" ontology_id="HP_0000733" text="stereotypy" type="HP"/>
    <entity charOffset="419-454" id="s5052.e1" ontology_id="GO_0002088" text="lens development in camera-type eye" type="GO"/>
    <pair e1="s5052.e0" e2="s5052.e1" id="s5052.p0" relation="false"/>
  </sentence>
  <sentence id="s5053" text="The neurophenotype of these GFAP.HMOX1&lt;sup&gt;8.5-19m&lt;/sup&gt; epidermis development is highly consistent with parkinsonism and differs dramatically from the schizophrenia-like features previously documented in younger GFAP.HMOX1&lt;sup&gt;0-12m&lt;/sup&gt; mice.">
    <entity charOffset="57-78" id="s5053.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="105-117" id="s5053.e1" ontology_id="HP_0001300" text="parkinsonism" type="HP"/>
    <pair e1="s5053.e0" e2="s5053.e1" id="s5053.p0" relation="false"/>
  </sentence>
  <sentence id="s5054" text="A key aspect of several adult lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (intracellular protein transport), including emphysema, is aberrant tissue repair, which leads to an accumulation of cellular protein catabolic process and impaired respiratory function.">
    <entity charOffset="132-163" id="s5054.e0" ontology_id="GO_0006886" text="intracellular protein transport" type="GO"/>
    <entity charOffset="176-185" id="s5054.e1" ontology_id="HP_0002097" text="emphysema" type="HP"/>
    <pair e1="s5054.e0" e2="s5054.e1" id="s5054.p0" relation="false"/>
  </sentence>
  <sentence id="s5055" text="A key aspect of several adult lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (intracellular protein transport), including emphysema, is aberrant tissue repair, which leads to an accumulation of cellular protein catabolic process and impaired respiratory function.">
    <entity charOffset="176-185" id="s5055.e0" ontology_id="HP_0002097" text="emphysema" type="HP"/>
    <entity charOffset="248-282" id="s5055.e1" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <pair e1="s5055.e0" e2="s5055.e1" id="s5055.p0" relation="false"/>
  </sentence>
  <sentence id="s5056" text="In addition, we show that &lt;i&gt;Vangl2&lt;sup&gt;Lp/+&lt;/sup&gt;&lt;/i&gt; lungs exhibit many of the hallmarks of tissue cellular protein catabolic process, including an altered macrophage population, abnormal elastin deposition and elevated levels of the elastin-modifying enzyme, &lt;i&gt;Mmp12&lt;/i&gt;, all of which are observed in emphysema.">
    <entity charOffset="101-135" id="s5056.e0" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <entity charOffset="305-314" id="s5056.e1" ontology_id="HP_0002097" text="emphysema" type="HP"/>
    <pair e1="s5056.e0" e2="s5056.e1" id="s5056.p0" relation="false"/>
  </sentence>
  <sentence id="s5057" text="Finally, we show that biological_process genes &lt;i&gt;VANGL2&lt;/i&gt; and &lt;i&gt;SCRIB&lt;/i&gt; are significantly downregulated in lung tissue from patients with emphysema.">
    <entity charOffset="22-40" id="s5057.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="144-153" id="s5057.e1" ontology_id="HP_0002097" text="emphysema" type="HP"/>
    <pair e1="s5057.e0" e2="s5057.e1" id="s5057.p0" relation="false"/>
  </sentence>
  <sentence id="s5058" text="Schnyder corneal dystrophy (quaternary ammonium group transport) is a rare autosomal dominant disease in humans, characterized by abnormal deposition of cholesterol and phospholipids in cornea caused by mutations in the UbiA prenyltransferase domain containing 1 (vitamin K biosynthetic process) gene.">
    <entity charOffset="9-26" id="s5058.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="28-63" id="s5058.e1" ontology_id="GO_0015697" text="quaternary ammonium group transport" type="GO"/>
    <pair e1="s5058.e0" e2="s5058.e1" id="s5058.p0" relation="false"/>
  </sentence>
  <sentence id="s5059" text="Schnyder corneal dystrophy (quaternary ammonium group transport) is a rare autosomal dominant disease in humans, characterized by abnormal deposition of cholesterol and phospholipids in cornea caused by mutations in the UbiA prenyltransferase domain containing 1 (vitamin K biosynthetic process) gene.">
    <entity charOffset="9-26" id="s5059.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="264-294" id="s5059.e1" ontology_id="GO_0042371" text="vitamin K biosynthetic process" type="GO"/>
    <pair e1="s5059.e0" e2="s5059.e1" id="s5059.p0" relation="true"/>
  </sentence>
  <sentence id="s5060" text="To further characterize CD164 as a potential biomarker for malignant CD4&lt;sup&gt;+&lt;/sup&gt; T cells, CD164&lt;sup&gt;+&lt;/sup&gt; and CD164&lt;sup&gt;-&lt;/sup&gt;CD4&lt;sup&gt;+&lt;/sup&gt; T cells isolated from patients with high-circulating tumor burden, B2 stage, and medium/low tumor burden, protein localization to cilium-B0 stage, were assessed for the expression of genes reported to differentiate SS from normal controls, and associated with malignancy and poor prognosis.">
    <entity charOffset="202-207" id="s5060.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="255-285" id="s5060.e1" ontology_id="GO_0061512" text="protein localization to cilium" type="GO"/>
    <pair e1="s5060.e0" e2="s5060.e1" id="s5060.p0" relation="false"/>
  </sentence>
  <sentence id="s5061" text="Patients with autosomal dominant vibratory urticaria have localized hives and systemic manifestations in response to dermal vibration, with coincident degranulation of antigen receptor-mediated signaling pathway cells and increased histamine levels in serum.">
    <entity charOffset="43-52" id="s5061.e0" ontology_id="HP_0001025" text="urticaria" type="HP"/>
    <entity charOffset="168-211" id="s5061.e1" ontology_id="GO_0050851" text="antigen receptor-mediated signaling pathway" type="GO"/>
    <pair e1="s5061.e0" e2="s5061.e1" id="s5061.p0" relation="false"/>
  </sentence>
  <sentence id="s5062" text="We identified a previously unknown missense substitution in cell adhesion (also known as EMR2), which was predicted to result in the replacement of cysteine with tyrosine at amino acid position 492 (p.C492Y), as the only nonsynonymous variant cosegregating with vibratory urticaria in two large kindreds.">
    <entity charOffset="60-73" id="s5062.e0" ontology_id="GO_0007155" text="cell adhesion" type="GO"/>
    <entity charOffset="272-281" id="s5062.e1" ontology_id="HP_0001025" text="urticaria" type="HP"/>
    <pair e1="s5062.e0" e2="s5062.e1" id="s5062.p0" relation="true"/>
  </sentence>
  <sentence id="s5063" text="Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, immunoglobulin production involved in immunoglobulin mediated immune response), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, G protein-coupled receptor signaling pathway-TRIM5).">
    <entity charOffset="20-26" id="s5063.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="86-163" id="s5063.e1" ontology_id="GO_0002381" text="immunoglobulin production involved in immunoglobulin mediated immune response" type="GO"/>
    <pair e1="s5063.e0" e2="s5063.e1" id="s5063.p0" relation="false"/>
  </sentence>
  <sentence id="s5064" text="Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, immunoglobulin production involved in immunoglobulin mediated immune response), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, G protein-coupled receptor signaling pathway-TRIM5).">
    <entity charOffset="20-26" id="s5064.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="219-263" id="s5064.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s5064.e0" e2="s5064.e1" id="s5064.p0" relation="false"/>
  </sentence>
  <sentence id="s5065" text="Oral cancer was associated with two new regions, 2p23.3 (rs6547741, biological_process) and 9q34.12 (rs928674, extracellular matrix organization), and with known cancer-related loci-9p21.3 (rs8181047, regulation of cyclin-dependent protein serine/threonine kinase activity-AS1) and 5p15.33 (rs10462706, apoptotic process).">
    <entity charOffset="5-11" id="s5065.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="68-86" id="s5065.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s5065.e0" e2="s5065.e1" id="s5065.p0" relation="false"/>
  </sentence>
  <sentence id="s5066" text="Oral cancer was associated with two new regions, 2p23.3 (rs6547741, biological_process) and 9q34.12 (rs928674, extracellular matrix organization), and with known cancer-related loci-9p21.3 (rs8181047, regulation of cyclin-dependent protein serine/threonine kinase activity-AS1) and 5p15.33 (rs10462706, apoptotic process).">
    <entity charOffset="5-11" id="s5066.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="111-144" id="s5066.e1" ontology_id="GO_0030198" text="extracellular matrix organization" type="GO"/>
    <pair e1="s5066.e0" e2="s5066.e1" id="s5066.p0" relation="false"/>
  </sentence>
  <sentence id="s5067" text="Oral cancer was associated with two new regions, 2p23.3 (rs6547741, biological_process) and 9q34.12 (rs928674, extracellular matrix organization), and with known cancer-related loci-9p21.3 (rs8181047, regulation of cyclin-dependent protein serine/threonine kinase activity-AS1) and 5p15.33 (rs10462706, apoptotic process).">
    <entity charOffset="5-11" id="s5067.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="201-272" id="s5067.e1" ontology_id="GO_0000079" text="regulation of cyclin-dependent protein serine/threonine kinase activity" type="GO"/>
    <pair e1="s5067.e0" e2="s5067.e1" id="s5067.p0" relation="true"/>
  </sentence>
  <sentence id="s5068" text="Oral cancer was associated with two new regions, 2p23.3 (rs6547741, biological_process) and 9q34.12 (rs928674, extracellular matrix organization), and with known cancer-related loci-9p21.3 (rs8181047, regulation of cyclin-dependent protein serine/threonine kinase activity-AS1) and 5p15.33 (rs10462706, apoptotic process).">
    <entity charOffset="5-11" id="s5068.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="303-320" id="s5068.e1" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <pair e1="s5068.e0" e2="s5068.e1" id="s5068.p0" relation="false"/>
  </sentence>
  <sentence id="s5069" text="We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), mitotic cytokinesis (3), DNA repair (1), DNA repair (1)].">
    <entity charOffset="149-155" id="s5069.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="261-280" id="s5069.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s5069.e0" e2="s5069.e1" id="s5069.p0" relation="true"/>
  </sentence>
  <sentence id="s5070" text="We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), mitotic cytokinesis (3), DNA repair (1), DNA repair (1)].">
    <entity charOffset="149-155" id="s5070.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="286-296" id="s5070.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s5070.e0" e2="s5070.e1" id="s5070.p0" relation="true"/>
  </sentence>
  <sentence id="s5071" text="We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), mitotic cytokinesis (3), DNA repair (1), DNA repair (1)].">
    <entity charOffset="149-155" id="s5071.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="302-312" id="s5071.e1" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <pair e1="s5071.e0" e2="s5071.e1" id="s5071.p0" relation="true"/>
  </sentence>
  <sentence id="s5072" text="The contiguous deletion of positive regulation of transcription, DNA-templated and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="27-78" id="s5072.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="223-235" id="s5072.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s5072.e0" e2="s5072.e1" id="s5072.p0" relation="true"/>
  </sentence>
  <sentence id="s5073" text="The contiguous deletion of positive regulation of transcription, DNA-templated and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="27-78" id="s5073.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="266-274" id="s5073.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s5073.e0" e2="s5073.e1" id="s5073.p0" relation="true"/>
  </sentence>
  <sentence id="s5074" text="The contiguous deletion of positive regulation of transcription, DNA-templated and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="118-165" id="s5074.e0" ontology_id="GO_1990830" text="cellular response to leukemia inhibitory factor" type="GO"/>
    <entity charOffset="237-260" id="s5074.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5074.e0" e2="s5074.e1" id="s5074.p0" relation="false"/>
  </sentence>
  <sentence id="s5075" text="The contiguous deletion of positive regulation of transcription, DNA-templated and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.">
    <entity charOffset="118-165" id="s5075.e0" ontology_id="GO_1990830" text="cellular response to leukemia inhibitory factor" type="GO"/>
    <entity charOffset="266-274" id="s5075.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s5075.e0" e2="s5075.e1" id="s5075.p0" relation="false"/>
  </sentence>
  <sentence id="s5076" text="This familial study demonstrates that a deficiency in one of two MAO genes may not lead to psychomotor delay, and deletion of cellular response to leukemia inhibitory factor may not cause epilepsy.">
    <entity charOffset="126-173" id="s5076.e0" ontology_id="GO_1990830" text="cellular response to leukemia inhibitory factor" type="GO"/>
    <entity charOffset="188-196" id="s5076.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s5076.e0" e2="s5076.e1" id="s5076.p0" relation="false"/>
  </sentence>
  <sentence id="s5077" text="Main subtypes of the disease are pseudohypoparathyroidism 1b (sex determination1b) and pseudohypoparathyroidism 1a (PHP1a).">
    <entity charOffset="33-57" id="s5077.e0" ontology_id="HP_0000852" text="pseudohypoparathyroidism" type="HP"/>
    <entity charOffset="62-79" id="s5077.e1" ontology_id="GO_0007530" text="sex determination" type="GO"/>
    <pair e1="s5077.e0" e2="s5077.e1" id="s5077.p0" relation="false"/>
  </sentence>
  <sentence id="s5078" text="Since this is an atypical but previously described rare presentation of sex determination1b, we reemphasize retrograde transport, endosome to Golgi deletions and PHP1b as a rare cause for early onset obesity and macrosomia.">
    <entity charOffset="72-89" id="s5078.e0" ontology_id="GO_0007530" text="sex determination" type="GO"/>
    <entity charOffset="212-222" id="s5078.e1" ontology_id="HP_0001520" text="macrosomia" type="HP"/>
    <pair e1="s5078.e0" e2="s5078.e1" id="s5078.p0" relation="false"/>
  </sentence>
  <sentence id="s5079" text="Since this is an atypical but previously described rare presentation of sex determination1b, we reemphasize retrograde transport, endosome to Golgi deletions and PHP1b as a rare cause for early onset obesity and macrosomia.">
    <entity charOffset="72-89" id="s5079.e0" ontology_id="GO_0007530" text="sex determination" type="GO"/>
    <entity charOffset="200-207" id="s5079.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s5079.e0" e2="s5079.e1" id="s5079.p0" relation="true"/>
  </sentence>
  <sentence id="s5080" text="Since this is an atypical but previously described rare presentation of sex determination1b, we reemphasize retrograde transport, endosome to Golgi deletions and PHP1b as a rare cause for early onset obesity and macrosomia.">
    <entity charOffset="108-147" id="s5080.e0" ontology_id="GO_0042147" text="retrograde transport, endosome to Golgi" type="GO"/>
    <entity charOffset="212-222" id="s5080.e1" ontology_id="HP_0001520" text="macrosomia" type="HP"/>
    <pair e1="s5080.e0" e2="s5080.e1" id="s5080.p0" relation="false"/>
  </sentence>
  <sentence id="s5081" text="Here, we identified three families with mutations in transmembrane transport, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.">
    <entity charOffset="53-76" id="s5081.e0" ontology_id="GO_0055085" text="transmembrane transport" type="GO"/>
    <entity charOffset="146-155" id="s5081.e1" ontology_id="HP_0000518" text="cataracts" type="HP"/>
    <pair e1="s5081.e0" e2="s5081.e1" id="s5081.p0" relation="false"/>
  </sentence>
  <sentence id="s5082" text="In one of the families with additional cardiomyopathy and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in chromatin remodeling, encoding the lysine acetyltransferase 2B, with negative regulation of transcription by RNA polymerase II on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum.">
    <entity charOffset="39-53" id="s5082.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="136-156" id="s5082.e1" ontology_id="GO_0006338" text="chromatin remodeling" type="GO"/>
    <pair e1="s5082.e0" e2="s5082.e1" id="s5082.p0" relation="false"/>
  </sentence>
  <sentence id="s5083" text="In one of the families with additional cardiomyopathy and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in chromatin remodeling, encoding the lysine acetyltransferase 2B, with negative regulation of transcription by RNA polymerase II on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum.">
    <entity charOffset="39-53" id="s5083.e0" ontology_id="HP_0001638" text="cardiomyopathy" type="HP"/>
    <entity charOffset="205-262" id="s5083.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5083.e0" e2="s5083.e1" id="s5083.p0" relation="false"/>
  </sentence>
  <sentence id="s5084" text="Colorectal cancer cell lines with protein polyubiquitination methylation demonstrated increased sensitivity to irinotecan.">
    <entity charOffset="11-17" id="s5084.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="34-60" id="s5084.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s5084.e0" e2="s5084.e1" id="s5084.p0" relation="false"/>
  </sentence>
  <sentence id="s5085" text="The autosomal recessive neurodegenerative disease spinal muscular atrophy (spliceosomal snRNP assembly) results from low levels of survival motor neuron (mRNA splicing, via spliceosome) protein; however, it is unclear how reduced SMN promotes SMA development.">
    <entity charOffset="4-23" id="s5085.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="75-102" id="s5085.e1" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <pair e1="s5085.e0" e2="s5085.e1" id="s5085.p0" relation="true"/>
  </sentence>
  <sentence id="s5086" text="The autosomal recessive neurodegenerative disease spinal muscular atrophy (spliceosomal snRNP assembly) results from low levels of survival motor neuron (mRNA splicing, via spliceosome) protein; however, it is unclear how reduced SMN promotes SMA development.">
    <entity charOffset="4-23" id="s5086.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="154-184" id="s5086.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s5086.e0" e2="s5086.e1" id="s5086.p0" relation="false"/>
  </sentence>
  <sentence id="s5087" text="The autosomal recessive neurodegenerative disease spinal muscular atrophy (spliceosomal snRNP assembly) results from low levels of survival motor neuron (mRNA splicing, via spliceosome) protein; however, it is unclear how reduced SMN promotes SMA development.">
    <entity charOffset="24-49" id="s5087.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="75-102" id="s5087.e1" ontology_id="GO_0000387" text="spliceosomal snRNP assembly" type="GO"/>
    <pair e1="s5087.e0" e2="s5087.e1" id="s5087.p0" relation="false"/>
  </sentence>
  <sentence id="s5088" text="The autosomal recessive neurodegenerative disease spinal muscular atrophy (spliceosomal snRNP assembly) results from low levels of survival motor neuron (mRNA splicing, via spliceosome) protein; however, it is unclear how reduced SMN promotes SMA development.">
    <entity charOffset="24-49" id="s5088.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="154-184" id="s5088.e1" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <pair e1="s5088.e0" e2="s5088.e1" id="s5088.p0" relation="false"/>
  </sentence>
  <sentence id="s5089" text="Aberrant expression of different family members of the positive regulation of cell-matrix adhesion/ephrin system, which comprises the Eph receptors (Ephs) and their ligands (ephrins), has been implicated in various malignancies including breast cancer.">
    <entity charOffset="55-98" id="s5089.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="245-251" id="s5089.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5089.e0" e2="s5089.e1" id="s5089.p0" relation="false"/>
  </sentence>
  <sentence id="s5090" text="This review reflects the existing positive regulation of cell-matrix adhesion/ephrin literature while focusing on breast cancer heterogeneity.">
    <entity charOffset="34-77" id="s5090.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="128-141" id="s5090.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s5090.e0" e2="s5090.e1" id="s5090.p0" relation="false"/>
  </sentence>
  <sentence id="s5091" text="Hormone positive, signal transduction positive and triple negative breast cancer (TNBC) cell lines, xenografts/mutant animal models and patient samples are examined separately as, in humans, they represent entities with differences in prognosis and treatment.">
    <entity charOffset="18-37" id="s5091.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="74-80" id="s5091.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5091.e0" e2="s5091.e1" id="s5091.p0" relation="true"/>
  </sentence>
  <sentence id="s5092" text="positive regulation of cell-matrix adhesionA2, EphB4 and EphB6 are the members most extensively studied in breast cancer.">
    <entity charOffset="0-43" id="s5092.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="114-120" id="s5092.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5092.e0" e2="s5092.e1" id="s5092.p0" relation="false"/>
  </sentence>
  <sentence id="s5093" text="Existing research points to the potential use of various positive regulation of cell-matrix adhesion/ephrin members as biomarkers for assessing prognosis and selecting the most suitable thtranscription by RNA polymerase IIpeutic strategies in variable clinical scenarios, also for overcoming drug resistance, in the era of breast cancer heterogeneity">
    <entity charOffset="57-100" id="s5093.e0" ontology_id="GO_0001954" text="positive regulation of cell-matrix adhesion" type="GO"/>
    <entity charOffset="330-336" id="s5093.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5093.e0" e2="s5093.e1" id="s5093.p0" relation="false"/>
  </sentence>
  <sentence id="s5094" text="Existing research points to the potential use of various positive regulation of cell-matrix adhesion/ephrin members as biomarkers for assessing prognosis and selecting the most suitable thtranscription by RNA polymerase IIpeutic strategies in variable clinical scenarios, also for overcoming drug resistance, in the era of breast cancer heterogeneity">
    <entity charOffset="188-222" id="s5094.e0" ontology_id="GO_0006366" text="transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="330-336" id="s5094.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5094.e0" e2="s5094.e1" id="s5094.p0" relation="false"/>
  </sentence>
  <sentence id="s5095" text="Further, high activation of NF-kappaB-inducing kinase activity expression level was correlated with higher tumor stage, lymph node metastasis, myometrial invasion, and lower survival rate.">
    <entity charOffset="14-62" id="s5095.e0" ontology_id="GO_0007250" text="activation of NF-kappaB-inducing kinase activity" type="GO"/>
    <entity charOffset="107-112" id="s5095.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5095.e0" e2="s5095.e1" id="s5095.p0" relation="false"/>
  </sentence>
  <sentence id="s5096" text="These collective data indicated that activation of NF-kappaB-inducing kinase activity overexpression promotes EC tumorigenesis by activating mitotic cell cycle and cell division pathways, and IRAK1 may serve as a promising therapeutic strategy for EC">
    <entity charOffset="37-85" id="s5096.e0" ontology_id="GO_0007250" text="activation of NF-kappaB-inducing kinase activity" type="GO"/>
    <entity charOffset="113-118" id="s5096.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5096.e0" e2="s5096.e1" id="s5096.p0" relation="false"/>
  </sentence>
  <sentence id="s5097" text="More importantly, overexpression of mitochondrial translational elongation-L could increase tumorigenic potential of regulation of low-density lipoprotein particle clearance-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.">
    <entity charOffset="36-74" id="s5097.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="183-189" id="s5097.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5097.e0" e2="s5097.e1" id="s5097.p0" relation="false"/>
  </sentence>
  <sentence id="s5098" text="More importantly, overexpression of mitochondrial translational elongation-L could increase tumorigenic potential of regulation of low-density lipoprotein particle clearance-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.">
    <entity charOffset="92-97" id="s5098.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="117-173" id="s5098.e1" ontology_id="GO_0010988" text="regulation of low-density lipoprotein particle clearance" type="GO"/>
    <pair e1="s5098.e0" e2="s5098.e1" id="s5098.p0" relation="false"/>
  </sentence>
  <sentence id="s5099" text="More importantly, overexpression of mitochondrial translational elongation-L could increase tumorigenic potential of regulation of low-density lipoprotein particle clearance-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.">
    <entity charOffset="117-173" id="s5099.e0" ontology_id="GO_0010988" text="regulation of low-density lipoprotein particle clearance" type="GO"/>
    <entity charOffset="183-189" id="s5099.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5099.e0" e2="s5099.e1" id="s5099.p0" relation="false"/>
  </sentence>
  <sentence id="s5100" text="Finally, we found that inclusion of mitochondrial translational elongation exon 3 was promoted in human colorectal cancer tissues and this was correlated with regulation of low-density lipoprotein particle clearance levels.">
    <entity charOffset="36-74" id="s5100.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="115-121" id="s5100.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5100.e0" e2="s5100.e1" id="s5100.p0" relation="false"/>
  </sentence>
  <sentence id="s5101" text="Finally, we found that inclusion of mitochondrial translational elongation exon 3 was promoted in human colorectal cancer tissues and this was correlated with regulation of low-density lipoprotein particle clearance levels.">
    <entity charOffset="115-121" id="s5101.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="159-215" id="s5101.e1" ontology_id="GO_0010988" text="regulation of low-density lipoprotein particle clearance" type="GO"/>
    <pair e1="s5101.e0" e2="s5101.e1" id="s5101.p0" relation="false"/>
  </sentence>
  <sentence id="s5102" text="In summary, our findings underscore the biological significance of mitochondrial translational elongation-L and regulation of low-density lipoprotein particle clearance in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells">
    <entity charOffset="67-105" id="s5102.e0" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <entity charOffset="176-181" id="s5102.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5102.e0" e2="s5102.e1" id="s5102.p0" relation="false"/>
  </sentence>
  <sentence id="s5103" text="In summary, our findings underscore the biological significance of mitochondrial translational elongation-L and regulation of low-density lipoprotein particle clearance in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells">
    <entity charOffset="112-168" id="s5103.e0" ontology_id="GO_0010988" text="regulation of low-density lipoprotein particle clearance" type="GO"/>
    <entity charOffset="269-275" id="s5103.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5103.e0" e2="s5103.e1" id="s5103.p0" relation="false"/>
  </sentence>
  <sentence id="s5104" text="In summary, our findings underscore the biological significance of mitochondrial translational elongation-L and regulation of low-density lipoprotein particle clearance in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells">
    <entity charOffset="112-168" id="s5104.e0" ontology_id="GO_0010988" text="regulation of low-density lipoprotein particle clearance" type="GO"/>
    <entity charOffset="176-181" id="s5104.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5104.e0" e2="s5104.e1" id="s5104.p0" relation="false"/>
  </sentence>
  <sentence id="s5105" text="Glutaric aciduria type I (regulation of apoptotic process-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).">
    <entity charOffset="26-57" id="s5105.e0" ontology_id="GO_0042981" text="regulation of apoptotic process" type="GO"/>
    <entity charOffset="71-87" id="s5105.e1" ontology_id="HP_0001992" text="organic aciduria" type="HP"/>
    <pair e1="s5105.e0" e2="s5105.e1" id="s5105.p0" relation="false"/>
  </sentence>
  <sentence id="s5106" text="Glutaric aciduria type I (regulation of apoptotic process-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).">
    <entity charOffset="26-57" id="s5106.e0" ontology_id="GO_0042981" text="regulation of apoptotic process" type="GO"/>
    <entity charOffset="102-121" id="s5106.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5106.e0" e2="s5106.e1" id="s5106.p0" relation="false"/>
  </sentence>
  <sentence id="s5107" text="Disruption of blood coagulation has previously been implicated in the causation of intellectual disability (but not aniridia).">
    <entity charOffset="14-31" id="s5107.e0" ontology_id="GO_0007596" text="blood coagulation" type="GO"/>
    <entity charOffset="83-106" id="s5107.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5107.e0" e2="s5107.e1" id="s5107.p0" relation="true"/>
  </sentence>
  <sentence id="s5108" text="In functional assays performed with RNA knockdown, loss of protein secretion attenuated aggressive phenotypes in glioma cells, including cell proliferation, invasion, and sphere formation in vitro and tumor growth in vivo.">
    <entity charOffset="59-76" id="s5108.e0" ontology_id="GO_0009306" text="protein secretion" type="GO"/>
    <entity charOffset="201-206" id="s5108.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5108.e0" e2="s5108.e1" id="s5108.p0" relation="false"/>
  </sentence>
  <sentence id="s5109" text="The correlations between the expressions of cell migration with clinicopathologic features,E-cadherin and Vimentin expression were analyzed.&lt;b&gt;Result:&lt;/b&gt;CTHRC1 protein expression levels in papillary thyroid carcinoma tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(&lt;i&gt;P&lt;/i&gt;&amp;lt;0.05).">
    <entity charOffset="44-58" id="s5109.e0" ontology_id="GO_0016477" text="cell migration" type="GO"/>
    <entity charOffset="190-217" id="s5109.e1" ontology_id="HP_0002895" text="papillary thyroid carcinoma" type="HP"/>
    <pair e1="s5109.e0" e2="s5109.e1" id="s5109.p0" relation="false"/>
  </sentence>
  <sentence id="s5110" text="Congenital erythropoietic porphyria (CEP) is an inborn error of heme biosynthesis characterized by uroporphyrinogen III synthase (uroporphyrinogen III biosynthetic process) deficiency resulting in deleterious porphyrin accumulation in blood cells responsible for hemolytic anemia and cutaneous photosensitivity.">
    <entity charOffset="130-171" id="s5110.e0" ontology_id="GO_0006780" text="uroporphyrinogen III biosynthetic process" type="GO"/>
    <entity charOffset="284-310" id="s5110.e1" ontology_id="HP_0000992" text="cutaneous photosensitivity" type="HP"/>
    <pair e1="s5110.e0" e2="s5110.e1" id="s5110.p0" relation="true"/>
  </sentence>
  <sentence id="s5111" text="In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, eye development, negative regulation of cell proliferation and negative regulation of very-low-density lipoprotein particle clearance, in a cohort of 187 independent Chinese patients with high myopia.">
    <entity charOffset="122-137" id="s5111.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="315-321" id="s5111.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s5111.e0" e2="s5111.e1" id="s5111.p0" relation="true"/>
  </sentence>
  <sentence id="s5112" text="In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, eye development, negative regulation of cell proliferation and negative regulation of very-low-density lipoprotein particle clearance, in a cohort of 187 independent Chinese patients with high myopia.">
    <entity charOffset="139-180" id="s5112.e0" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <entity charOffset="315-321" id="s5112.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s5112.e0" e2="s5112.e1" id="s5112.p0" relation="true"/>
  </sentence>
  <sentence id="s5113" text="In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, eye development, negative regulation of cell proliferation and negative regulation of very-low-density lipoprotein particle clearance, in a cohort of 187 independent Chinese patients with high myopia.">
    <entity charOffset="185-255" id="s5113.e0" ontology_id="GO_0010916" text="negative regulation of very-low-density lipoprotein particle clearance" type="GO"/>
    <entity charOffset="315-321" id="s5113.e1" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <pair e1="s5113.e0" e2="s5113.e1" id="s5113.p0" relation="true"/>
  </sentence>
  <sentence id="s5114" text="The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (protein phosphorylation) and ATM and Rad3-related (actin cytoskeleton reorganization), and proteins with double-strand break repair via homologous recombination COOH-terminal (BRCT) domains.">
    <entity charOffset="107-113" id="s5114.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="138-161" id="s5114.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s5114.e0" e2="s5114.e1" id="s5114.p0" relation="true"/>
  </sentence>
  <sentence id="s5115" text="The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (protein phosphorylation) and ATM and Rad3-related (actin cytoskeleton reorganization), and proteins with double-strand break repair via homologous recombination COOH-terminal (BRCT) domains.">
    <entity charOffset="107-113" id="s5115.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="189-222" id="s5115.e1" ontology_id="GO_0031532" text="actin cytoskeleton reorganization" type="GO"/>
    <pair e1="s5115.e0" e2="s5115.e1" id="s5115.p0" relation="false"/>
  </sentence>
  <sentence id="s5116" text="The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (protein phosphorylation) and ATM and Rad3-related (actin cytoskeleton reorganization), and proteins with double-strand break repair via homologous recombination COOH-terminal (BRCT) domains.">
    <entity charOffset="107-113" id="s5116.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="243-298" id="s5116.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s5116.e0" e2="s5116.e1" id="s5116.p0" relation="false"/>
  </sentence>
  <sentence id="s5117" text="Single marker-based association tests for corneal astigmatism identified four genome-wide significant loci (P&amp;lt;510&lt;sup&gt;-8&lt;/sup&gt;) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), HERC2/OCA2 (15q13.1) and ubiquitin-dependent protein catabolic process/TSPAN10 (17q25.3).">
    <entity charOffset="50-61" id="s5117.e0" ontology_id="HP_0000483" text="astigmatism" type="HP"/>
    <entity charOffset="212-257" id="s5117.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s5117.e0" e2="s5117.e1" id="s5117.p0" relation="false"/>
  </sentence>
  <sentence id="s5118" text="Three of these loci also demonstrated genome-wide significant association with refractive astigmatism: LINC00340, cellular response to DNA damage stimulus/OCA2 and ubiquitin-dependent protein catabolic process/TSPAN10.">
    <entity charOffset="90-101" id="s5118.e0" ontology_id="HP_0000483" text="astigmatism" type="HP"/>
    <entity charOffset="114-154" id="s5118.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s5118.e0" e2="s5118.e1" id="s5118.p0" relation="false"/>
  </sentence>
  <sentence id="s5119" text="Three of these loci also demonstrated genome-wide significant association with refractive astigmatism: LINC00340, cellular response to DNA damage stimulus/OCA2 and ubiquitin-dependent protein catabolic process/TSPAN10.">
    <entity charOffset="90-101" id="s5119.e0" ontology_id="HP_0000483" text="astigmatism" type="HP"/>
    <entity charOffset="164-209" id="s5119.e1" ontology_id="GO_0006511" text="ubiquitin-dependent protein catabolic process" type="GO"/>
    <pair e1="s5119.e0" e2="s5119.e1" id="s5119.p0" relation="false"/>
  </sentence>
  <sentence id="s5120" text="These loci have previously demonstrated association with axial length (ZC3H11B), myopia (NPLOC4), spherical equivalent refractive error (LINC00340) and eye colour (cellular response to DNA damage stimulus).">
    <entity charOffset="81-87" id="s5120.e0" ontology_id="HP_0000545" text="myopia" type="HP"/>
    <entity charOffset="164-204" id="s5120.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s5120.e0" e2="s5120.e1" id="s5120.p0" relation="true"/>
  </sentence>
  <sentence id="s5121" text="Importantly, cardiac positive regulation of DNA damage response, signal transduction by p53 class mediator has been shown to be highly induced in various cardiomyopathies and in heart failure, although it is still unclear what negative regulation of transcription by RNA polymerase II this may have on the pathophysiology of heart failure.">
    <entity charOffset="21-106" id="s5121.e0" ontology_id="GO_0043517" text="positive regulation of DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <entity charOffset="178-191" id="s5121.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s5121.e0" e2="s5121.e1" id="s5121.p0" relation="false"/>
  </sentence>
  <sentence id="s5122" text="Importantly, cardiac positive regulation of DNA damage response, signal transduction by p53 class mediator has been shown to be highly induced in various cardiomyopathies and in heart failure, although it is still unclear what negative regulation of transcription by RNA polymerase II this may have on the pathophysiology of heart failure.">
    <entity charOffset="178-191" id="s5122.e0" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <entity charOffset="227-284" id="s5122.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5122.e0" e2="s5122.e1" id="s5122.p0" relation="false"/>
  </sentence>
  <sentence id="s5123" text="reproductive process mRNA was measured in 121 tumor samples of soft tissue sarcoma patients using quantitative real-time PCR.">
    <entity charOffset="0-20" id="s5123.e0" ontology_id="GO_0022414" text="reproductive process" type="GO"/>
    <entity charOffset="46-51" id="s5123.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5123.e0" e2="s5123.e1" id="s5123.p0" relation="true"/>
  </sentence>
  <sentence id="s5124" text="reproductive process protein was evaluated in 52 tumor samples by ELISA.">
    <entity charOffset="0-20" id="s5124.e0" ontology_id="GO_0022414" text="reproductive process" type="GO"/>
    <entity charOffset="49-54" id="s5124.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5124.e0" e2="s5124.e1" id="s5124.p0" relation="true"/>
  </sentence>
  <sentence id="s5125" text="Low reproductive process mRNA expression was correlated with a worsened patients' disease-specific survival in Kaplan-Meier analyses (mean patient survival was 25 vs. 96 months; &lt;i&gt;p&lt;/i&gt; = 0.013), especially in high-stage tumors.">
    <entity charOffset="4-24" id="s5125.e0" ontology_id="GO_0022414" text="reproductive process" type="GO"/>
    <entity charOffset="222-227" id="s5125.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5125.e0" e2="s5125.e1" id="s5125.p0" relation="true"/>
  </sentence>
  <sentence id="s5126" text="A decreased reproductive process expression is a negative prognostic factor for soft tissue sarcoma patients.">
    <entity charOffset="12-32" id="s5126.e0" ontology_id="GO_0022414" text="reproductive process" type="GO"/>
    <entity charOffset="92-99" id="s5126.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s5126.e0" e2="s5126.e1" id="s5126.p0" relation="true"/>
  </sentence>
  <sentence id="s5127" text="reproductive process may be an interesting candidate gene for the further exploration of soft tissue sarcoma negative regulation of transcription by RNA polymerase II and progression">
    <entity charOffset="0-20" id="s5127.e0" ontology_id="GO_0022414" text="reproductive process" type="GO"/>
    <entity charOffset="101-108" id="s5127.e1" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <pair e1="s5127.e0" e2="s5127.e1" id="s5127.p0" relation="true"/>
  </sentence>
  <sentence id="s5128" text="reproductive process may be an interesting candidate gene for the further exploration of soft tissue sarcoma negative regulation of transcription by RNA polymerase II and progression">
    <entity charOffset="101-108" id="s5128.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="109-166" id="s5128.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5128.e0" e2="s5128.e1" id="s5128.p0" relation="false"/>
  </sentence>
  <sentence id="s5129" text="In this study, we found that negative regulation of axon regeneration protein level was positively related to InternationalFederationof Gynecology and Obstetrics (FIGO) stage and LASS2-negative tumors showed significant association with longer disease-free survival (DFS) and overall survival (OS) in ovarian cancer patients.">
    <entity charOffset="29-69" id="s5129.e0" ontology_id="GO_0048681" text="negative regulation of axon regeneration" type="GO"/>
    <entity charOffset="196-202" id="s5129.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5129.e0" e2="s5129.e1" id="s5129.p0" relation="false"/>
  </sentence>
  <sentence id="s5130" text="In this study, we found that negative regulation of axon regeneration protein level was positively related to InternationalFederationof Gynecology and Obstetrics (FIGO) stage and LASS2-negative tumors showed significant association with longer disease-free survival (DFS) and overall survival (OS) in ovarian cancer patients.">
    <entity charOffset="29-69" id="s5130.e0" ontology_id="GO_0048681" text="negative regulation of axon regeneration" type="GO"/>
    <entity charOffset="311-317" id="s5130.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5130.e0" e2="s5130.e1" id="s5130.p0" relation="false"/>
  </sentence>
  <sentence id="s5131" text="The heterogeneous expression of negative regulation of axon regeneration had been exhibited in diverse ovarian cancer cells.">
    <entity charOffset="4-17" id="s5131.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="32-72" id="s5131.e1" ontology_id="GO_0048681" text="negative regulation of axon regeneration" type="GO"/>
    <pair e1="s5131.e0" e2="s5131.e1" id="s5131.p0" relation="false"/>
  </sentence>
  <sentence id="s5132" text="The heterogeneous expression of negative regulation of axon regeneration had been exhibited in diverse ovarian cancer cells.">
    <entity charOffset="32-72" id="s5132.e0" ontology_id="GO_0048681" text="negative regulation of axon regeneration" type="GO"/>
    <entity charOffset="111-117" id="s5132.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5132.e0" e2="s5132.e1" id="s5132.p0" relation="false"/>
  </sentence>
  <sentence id="s5133" text="A significantly lower messenger RNA (mRNA) and protein level of negative regulation of axon regeneration was seen in 3AO cell compared with those in other types of ovarian cancer cells.">
    <entity charOffset="64-104" id="s5133.e0" ontology_id="GO_0048681" text="negative regulation of axon regeneration" type="GO"/>
    <entity charOffset="172-178" id="s5133.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5133.e0" e2="s5133.e1" id="s5133.p0" relation="false"/>
  </sentence>
  <sentence id="s5134" text="The oncogenic capacity of negative regulation of axon regeneration in ovarian cancer may be mediated by increased expression of YAP/TAZ.">
    <entity charOffset="26-66" id="s5134.e0" ontology_id="GO_0048681" text="negative regulation of axon regeneration" type="GO"/>
    <entity charOffset="78-84" id="s5134.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5134.e0" e2="s5134.e1" id="s5134.p0" relation="false"/>
  </sentence>
  <sentence id="s5135" text="Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy muscle organ development 2 (microtubule-based movement).">
    <entity charOffset="17-43" id="s5135.e0" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <entity charOffset="94-112" id="s5135.e1" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <pair e1="s5135.e0" e2="s5135.e1" id="s5135.p0" relation="true"/>
  </sentence>
  <sentence id="s5136" text="Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy muscle organ development 2 (microtubule-based movement).">
    <entity charOffset="17-43" id="s5136.e0" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <entity charOffset="160-170" id="s5136.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s5136.e0" e2="s5136.e1" id="s5136.p0" relation="true"/>
  </sentence>
  <sentence id="s5137" text="Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy muscle organ development 2 (microtubule-based movement).">
    <entity charOffset="94-112" id="s5137.e0" ontology_id="HP_0001258" text="spastic paraplegia" type="HP"/>
    <entity charOffset="171-195" id="s5137.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5137.e0" e2="s5137.e1" id="s5137.p0" relation="false"/>
  </sentence>
  <sentence id="s5138" text="Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy muscle organ development 2 (microtubule-based movement).">
    <entity charOffset="149-159" id="s5138.e0" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <entity charOffset="171-195" id="s5138.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5138.e0" e2="s5138.e1" id="s5138.p0" relation="false"/>
  </sentence>
  <sentence id="s5139" text="Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy muscle organ development 2 (microtubule-based movement).">
    <entity charOffset="149-159" id="s5139.e0" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <entity charOffset="199-225" id="s5139.e1" ontology_id="GO_0007018" text="microtubule-based movement" type="GO"/>
    <pair e1="s5139.e0" e2="s5139.e1" id="s5139.p0" relation="false"/>
  </sentence>
  <sentence id="s5140" text="Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy muscle organ development 2 (microtubule-based movement).">
    <entity charOffset="160-170" id="s5140.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="199-225" id="s5140.e1" ontology_id="GO_0007018" text="microtubule-based movement" type="GO"/>
    <pair e1="s5140.e0" e2="s5140.e1" id="s5140.p0" relation="true"/>
  </sentence>
  <sentence id="s5141" text="The p.Arg204Trp mutation was identified from a CMT2 patient with additional complex phenomuscle organ developments of HSP, ataxia, fatigability and pyramidal sign, but the p.Arg280His and p.Leu588Pro mutations were identified in each axonal CMT2 patient.">
    <entity charOffset="89-113" id="s5141.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="123-129" id="s5141.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s5141.e0" e2="s5141.e1" id="s5141.p0" relation="false"/>
  </sentence>
  <sentence id="s5142" text="As the first report in Korea, this study identified three KIF5A mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenomuscle organ development.">
    <entity charOffset="108-118" id="s5142.e0" ontology_id="HP_0030646" text="peripheral" type="HP"/>
    <entity charOffset="159-183" id="s5142.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5142.e0" e2="s5142.e1" id="s5142.p0" relation="false"/>
  </sentence>
  <sentence id="s5143" text="Backgorund: Sanjad-Sakati syndrome (SSS) is a rare autosomal recessive disease caused by a deletion mutation (155-166del) in exon 3 of the post-chaperonin tubulin folding pathway gene on chromosome 1q42-43.">
    <entity charOffset="51-70" id="s5143.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="139-178" id="s5143.e1" ontology_id="GO_0007023" text="post-chaperonin tubulin folding pathway" type="GO"/>
    <pair e1="s5143.e0" e2="s5143.e1" id="s5143.p0" relation="true"/>
  </sentence>
  <sentence id="s5144" text="production of siRNA involved in RNA interference is an RNase III endoribonuclease central to miRNA biogenesis, and germline &lt;i&gt;DICER1&lt;/i&gt; mutations result in a cancer predisposition syndrome, associated with an increased risk of many tumor types.">
    <entity charOffset="0-48" id="s5144.e0" ontology_id="GO_0030422" text="production of siRNA involved in RNA interference" type="GO"/>
    <entity charOffset="160-166" id="s5144.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5144.e0" e2="s5144.e1" id="s5144.p0" relation="true"/>
  </sentence>
  <sentence id="s5145" text="production of siRNA involved in RNA interference is an RNase III endoribonuclease central to miRNA biogenesis, and germline &lt;i&gt;DICER1&lt;/i&gt; mutations result in a cancer predisposition syndrome, associated with an increased risk of many tumor types.">
    <entity charOffset="0-48" id="s5145.e0" ontology_id="GO_0030422" text="production of siRNA involved in RNA interference" type="GO"/>
    <entity charOffset="234-239" id="s5145.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5145.e0" e2="s5145.e1" id="s5145.p0" relation="true"/>
  </sentence>
  <sentence id="s5146" text="Angiosarcomas in &lt;i&gt;aP2-Cre;production of siRNA involved in RNA interference&lt;sup&gt;Flox/-&lt;/sup&gt;&lt;/i&gt; epidermis development histologically and genetically resemble human angiosarcoma.">
    <entity charOffset="5-12" id="s5146.e0" ontology_id="HP_0100242" text="sarcoma" type="HP"/>
    <entity charOffset="28-76" id="s5146.e1" ontology_id="GO_0030422" text="production of siRNA involved in RNA interference" type="GO"/>
    <pair e1="s5146.e0" e2="s5146.e1" id="s5146.p0" relation="true"/>
  </sentence>
  <sentence id="s5147" text="Angiosarcomas in &lt;i&gt;aP2-Cre;production of siRNA involved in RNA interference&lt;sup&gt;Flox/-&lt;/sup&gt;&lt;/i&gt; epidermis development histologically and genetically resemble human angiosarcoma.">
    <entity charOffset="28-76" id="s5147.e0" ontology_id="GO_0030422" text="production of siRNA involved in RNA interference" type="GO"/>
    <entity charOffset="166-178" id="s5147.e1" ontology_id="HP_0200058" text="angiosarcoma" type="HP"/>
    <pair e1="s5147.e0" e2="s5147.e1" id="s5147.p0" relation="false"/>
  </sentence>
  <sentence id="s5148" text="Angiosarcomas in &lt;i&gt;aP2-Cre;production of siRNA involved in RNA interference&lt;sup&gt;Flox/-&lt;/sup&gt;&lt;/i&gt; epidermis development histologically and genetically resemble human angiosarcoma.">
    <entity charOffset="98-119" id="s5148.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="166-178" id="s5148.e1" ontology_id="HP_0200058" text="angiosarcoma" type="HP"/>
    <pair e1="s5148.e0" e2="s5148.e1" id="s5148.p0" relation="false"/>
  </sentence>
  <sentence id="s5149" text="These studies illustrate that production of siRNA involved in RNA interference can function as a traditional loss-of-function tumor suppressor gene, and they provide a fully penetrant animal model for the study of angiosarcoma development and metastasis.">
    <entity charOffset="30-78" id="s5149.e0" ontology_id="GO_0030422" text="production of siRNA involved in RNA interference" type="GO"/>
    <entity charOffset="214-226" id="s5149.e1" ontology_id="HP_0200058" text="angiosarcoma" type="HP"/>
    <pair e1="s5149.e0" e2="s5149.e1" id="s5149.p0" relation="false"/>
  </sentence>
  <sentence id="s5150" text="The original tumor harbors mutations in negative regulation of cell proliferation, while the second harbors mutations in KDM5C.">
    <entity charOffset="13-18" id="s5150.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="40-81" id="s5150.e1" ontology_id="GO_0008285" text="negative regulation of cell proliferation" type="GO"/>
    <pair e1="s5150.e0" e2="s5150.e1" id="s5150.p0" relation="false"/>
  </sentence>
  <sentence id="s5151" text="In this study, we reported the identification of Calcium Binding Protein 39-Like (cell cycle arrest) as a novel regulator of tumor metabolism in GC.">
    <entity charOffset="82-99" id="s5151.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="125-130" id="s5151.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5151.e0" e2="s5151.e1" id="s5151.p0" relation="false"/>
  </sentence>
  <sentence id="s5152" text="protein phosphorylation-lipid biosynthetic process activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the cell cycle arrest-silenced cells.">
    <entity charOffset="0-23" id="s5152.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="83-88" id="s5152.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5152.e0" e2="s5152.e1" id="s5152.p0" relation="true"/>
  </sentence>
  <sentence id="s5153" text="protein phosphorylation-lipid biosynthetic process activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the cell cycle arrest-silenced cells.">
    <entity charOffset="24-50" id="s5153.e0" ontology_id="GO_0008610" text="lipid biosynthetic process" type="GO"/>
    <entity charOffset="83-88" id="s5153.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5153.e0" e2="s5153.e1" id="s5153.p0" relation="false"/>
  </sentence>
  <sentence id="s5154" text="protein phosphorylation-lipid biosynthetic process activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the cell cycle arrest-silenced cells.">
    <entity charOffset="83-88" id="s5154.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="167-184" id="s5154.e1" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <pair e1="s5154.e0" e2="s5154.e1" id="s5154.p0" relation="false"/>
  </sentence>
  <sentence id="s5155" text="Moreover, knockdown of protein phosphorylation reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-lipid biosynthetic process.">
    <entity charOffset="23-46" id="s5155.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="108-113" id="s5155.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5155.e0" e2="s5155.e1" id="s5155.p0" relation="true"/>
  </sentence>
  <sentence id="s5156" text="Moreover, knockdown of protein phosphorylation reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-lipid biosynthetic process.">
    <entity charOffset="108-113" id="s5156.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="153-179" id="s5156.e1" ontology_id="GO_0008610" text="lipid biosynthetic process" type="GO"/>
    <pair e1="s5156.e0" e2="s5156.e1" id="s5156.p0" relation="false"/>
  </sentence>
  <sentence id="s5157" text="Our data demonstrate that cell cycle arrest is a novel tumor suppressor which suppresses tumorigenesis by promoting protein phosphorylation-AMPK-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.">
    <entity charOffset="26-43" id="s5157.e0" ontology_id="GO_0007050" text="cell cycle arrest" type="GO"/>
    <entity charOffset="55-60" id="s5157.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5157.e0" e2="s5157.e1" id="s5157.p0" relation="false"/>
  </sentence>
  <sentence id="s5158" text="Our data demonstrate that cell cycle arrest is a novel tumor suppressor which suppresses tumorigenesis by promoting protein phosphorylation-AMPK-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.">
    <entity charOffset="55-60" id="s5158.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="116-139" id="s5158.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s5158.e0" e2="s5158.e1" id="s5158.p0" relation="true"/>
  </sentence>
  <sentence id="s5159" text="of dorsal root ganglion development gene (one of the netrin-1 receptors) in colorectal cancer patients of Kashmiri population (North India).">
    <entity charOffset="3-35" id="s5159.e0" ontology_id="GO_1990791" text="dorsal root ganglion development" type="GO"/>
    <entity charOffset="87-93" id="s5159.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5159.e0" e2="s5159.e1" id="s5159.p0" relation="false"/>
  </sentence>
  <sentence id="s5160" text="Results: dorsal root ganglion development promoter hypermethylation was significantly found to be associated with colorectal cancer cases">
    <entity charOffset="9-41" id="s5160.e0" ontology_id="GO_1990791" text="dorsal root ganglion development" type="GO"/>
    <entity charOffset="125-131" id="s5160.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5160.e0" e2="s5160.e1" id="s5160.p0" relation="false"/>
  </sentence>
  <sentence id="s5161" text="One hundred and forty-eight negative regulation of regulatory T cell differentiation mutation carriers have been reported; patients showed hypogammaglobulinemia, recurrent infectious diseases, various autoimmune diseases, and lymphocytic infiltration into multiple organs.">
    <entity charOffset="28-84" id="s5161.e0" ontology_id="GO_0045590" text="negative regulation of regulatory T cell differentiation" type="GO"/>
    <entity charOffset="139-160" id="s5161.e1" ontology_id="HP_0004313" text="hypogammaglobulinemia" type="HP"/>
    <pair e1="s5161.e0" e2="s5161.e1" id="s5161.p0" relation="true"/>
  </sentence>
  <sentence id="s5162" text="We also functionally characterized two visual perception mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases.">
    <entity charOffset="39-56" id="s5162.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="126-135" id="s5162.e1" ontology_id="HP_0000618" text="blindness" type="HP"/>
    <pair e1="s5162.e0" e2="s5162.e1" id="s5162.p0" relation="false"/>
  </sentence>
  <sentence id="s5163" text="We also functionally characterized two visual perception mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases.">
    <entity charOffset="39-56" id="s5163.e0" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <entity charOffset="176-192" id="s5163.e1" ontology_id="HP_0000479" text="retinal diseases" type="HP"/>
    <pair e1="s5163.e0" e2="s5163.e1" id="s5163.p0" relation="true"/>
  </sentence>
  <sentence id="s5164" text="Bartter syndrome (BS) is a hereditary condition transmitted as an autosomal recessive (Bartter muscle organ development 1 to 4) or dominant trait (Bartter type 5).">
    <entity charOffset="66-85" id="s5164.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="95-119" id="s5164.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5164.e0" e2="s5164.e1" id="s5164.p0" relation="true"/>
  </sentence>
  <sentence id="s5165" text="Here we presented a case (BS muscle organ development ) of a 17 years old female presented with polyhydramnios, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).">
    <entity charOffset="29-53" id="s5165.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="97-111" id="s5165.e1" ontology_id="HP_0001561" text="polyhydramnios" type="HP"/>
    <pair e1="s5165.e0" e2="s5165.e1" id="s5165.p0" relation="false"/>
  </sentence>
  <sentence id="s5166" text="Here we presented a case (BS muscle organ development ) of a 17 years old female presented with polyhydramnios, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).">
    <entity charOffset="29-53" id="s5166.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="113-121" id="s5166.e1" ontology_id="HP_0000103" text="polyuria" type="HP"/>
    <pair e1="s5166.e0" e2="s5166.e1" id="s5166.p0" relation="false"/>
  </sentence>
  <sentence id="s5167" text="We demonstrate the presence of either biallelic loss of Hippo pathway tumor suppressor genes (negative regulation of cytokine production) and/or evidence of alteration of Hippo pathway genes in 85% of samples.">
    <entity charOffset="70-75" id="s5167.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="94-136" id="s5167.e1" ontology_id="GO_0001818" text="negative regulation of cytokine production" type="GO"/>
    <pair e1="s5167.e0" e2="s5167.e1" id="s5167.p0" relation="false"/>
  </sentence>
  <sentence id="s5168" text="Moreover, the novel mutation, p.R414C, adds up to the literature for the infantile-onset form of autosomal recessive ataxia associated with vesicle-mediated transport.">
    <entity charOffset="97-116" id="s5168.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="140-166" id="s5168.e1" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <pair e1="s5168.e0" e2="s5168.e1" id="s5168.p0" relation="true"/>
  </sentence>
  <sentence id="s5169" text="Moreover, the novel mutation, p.R414C, adds up to the literature for the infantile-onset form of autosomal recessive ataxia associated with vesicle-mediated transport.">
    <entity charOffset="117-123" id="s5169.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="140-166" id="s5169.e1" ontology_id="GO_0016192" text="vesicle-mediated transport" type="GO"/>
    <pair e1="s5169.e0" e2="s5169.e1" id="s5169.p0" relation="true"/>
  </sentence>
  <sentence id="s5170" text="The Rb tumor suppressor gene performs a critical role in controlling cell proliferation and tumorigenesis; it recruits negative regulation of transcription by RNA polymerase II protein into the E2F complexes to repress transcription.">
    <entity charOffset="7-12" id="s5170.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="119-176" id="s5170.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5170.e0" e2="s5170.e1" id="s5170.p0" relation="false"/>
  </sentence>
  <sentence id="s5171" text="In this study, we demonstrate that mRNA splicing, via spliceosome, RB and negative regulation of transcription by RNA polymerase II were significantly expressed in same lung cancer tissues in a tissue microarray (TMA) containing 300 non-small cell lung cancers (NSCLC).">
    <entity charOffset="35-65" id="s5171.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="174-180" id="s5171.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5171.e0" e2="s5171.e1" id="s5171.p0" relation="false"/>
  </sentence>
  <sentence id="s5172" text="In this study, we demonstrate that mRNA splicing, via spliceosome, RB and negative regulation of transcription by RNA polymerase II were significantly expressed in same lung cancer tissues in a tissue microarray (TMA) containing 300 non-small cell lung cancers (NSCLC).">
    <entity charOffset="74-131" id="s5172.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="174-180" id="s5172.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5172.e0" e2="s5172.e1" id="s5172.p0" relation="false"/>
  </sentence>
  <sentence id="s5173" text="High expression level of mRNA splicing, via spliceosome in tumor patients was significantly correlated with poor prognosis in NSCLC (log-rank P for OS = 0.01, log-rank P for DFS = 0.001).">
    <entity charOffset="25-55" id="s5173.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="59-64" id="s5173.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5173.e0" e2="s5173.e1" id="s5173.p0" relation="false"/>
  </sentence>
  <sentence id="s5174" text="Knockdown of mRNA splicing, via spliceosome reduced colony formation ability of lung cancer cells.">
    <entity charOffset="13-43" id="s5174.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="85-91" id="s5174.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5174.e0" e2="s5174.e1" id="s5174.p0" relation="false"/>
  </sentence>
  <sentence id="s5175" text="These findings may indicate the involvement of mRNA splicing, via spliceosome in progression of lung cancer by regulating the RB/negative regulation of transcription by RNA polymerase II interaction">
    <entity charOffset="47-77" id="s5175.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="101-107" id="s5175.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5175.e0" e2="s5175.e1" id="s5175.p0" relation="false"/>
  </sentence>
  <sentence id="s5176" text="These findings may indicate the involvement of mRNA splicing, via spliceosome in progression of lung cancer by regulating the RB/negative regulation of transcription by RNA polymerase II interaction">
    <entity charOffset="101-107" id="s5176.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="129-186" id="s5176.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5176.e0" e2="s5176.e1" id="s5176.p0" relation="false"/>
  </sentence>
  <sentence id="s5177" text="3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including positive regulation of cell proliferation, visual perception, intracellular cholesterol transport and QIL1/MIC13">
    <entity charOffset="74-87" id="s5177.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="138-179" id="s5177.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s5177.e0" e2="s5177.e1" id="s5177.p0" relation="false"/>
  </sentence>
  <sentence id="s5178" text="3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including positive regulation of cell proliferation, visual perception, intracellular cholesterol transport and QIL1/MIC13">
    <entity charOffset="74-87" id="s5178.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="181-198" id="s5178.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s5178.e0" e2="s5178.e1" id="s5178.p0" relation="false"/>
  </sentence>
  <sentence id="s5179" text="3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including positive regulation of cell proliferation, visual perception, intracellular cholesterol transport and QIL1/MIC13">
    <entity charOffset="74-87" id="s5179.e0" ontology_id="HP_0001427" text="mitochondrial" type="HP"/>
    <entity charOffset="200-235" id="s5179.e1" ontology_id="GO_0032367" text="intracellular cholesterol transport" type="GO"/>
    <pair e1="s5179.e0" e2="s5179.e1" id="s5179.p0" relation="false"/>
  </sentence>
  <sentence id="s5180" text="Glioblastoma multiforme (GBM) is a highly malignant muscle organ development of brain tumor found in humans.">
    <entity charOffset="52-76" id="s5180.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="86-91" id="s5180.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5180.e0" e2="s5180.e1" id="s5180.p0" relation="false"/>
  </sentence>
  <sentence id="s5181" text="Additional plasma and 52 brain tissues obtained from patients with gliomas were used to validate the association rate of serum amyloid A1 (activation of MAPK activity) in different grades of gliomas and its distribution in tumors.">
    <entity charOffset="67-74" id="s5181.e0" ontology_id="HP_0009733" text="gliomas" type="HP"/>
    <entity charOffset="139-166" id="s5181.e1" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <pair e1="s5181.e0" e2="s5181.e1" id="s5181.p0" relation="false"/>
  </sentence>
  <sentence id="s5182" text="Additional plasma and 52 brain tissues obtained from patients with gliomas were used to validate the association rate of serum amyloid A1 (activation of MAPK activity) in different grades of gliomas and its distribution in tumors.">
    <entity charOffset="139-166" id="s5182.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="223-228" id="s5182.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5182.e0" e2="s5182.e1" id="s5182.p0" relation="false"/>
  </sentence>
  <sentence id="s5183" text="Microarray database analysis further validated the coefficient of activation of MAPK activity levels in gliomas.">
    <entity charOffset="66-93" id="s5183.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="104-111" id="s5183.e1" ontology_id="HP_0009733" text="gliomas" type="HP"/>
    <pair e1="s5183.e0" e2="s5183.e1" id="s5183.p0" relation="false"/>
  </sentence>
  <sentence id="s5184" text="Magnetic resonance imaging and tumor region-specific microarray analysis identified a correlation between activation of MAPK activity and GBM cell infiltration in patients.">
    <entity charOffset="31-36" id="s5184.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="106-133" id="s5184.e1" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <pair e1="s5184.e0" e2="s5184.e1" id="s5184.p0" relation="false"/>
  </sentence>
  <sentence id="s5185" text="In summary, our results demonstrate that activation of MAPK activity in combination with integrin V and 3 can serve as an indicator of high glioblastoma risk.">
    <entity charOffset="41-68" id="s5185.e0" ontology_id="GO_0000187" text="activation of MAPK activity" type="GO"/>
    <entity charOffset="142-154" id="s5185.e1" ontology_id="HP_0012174" text="glioblastoma" type="HP"/>
    <pair e1="s5185.e0" e2="s5185.e1" id="s5185.p0" relation="false"/>
  </sentence>
  <sentence id="s5186" text="cDNA-encoded FLAG-tagged human wildtype cellular iron ion homeostasis (&lt;i&gt;a&lt;/i&gt;2) and ossification (&lt;i&gt;a&lt;/i&gt;4) subunits and their mutants, &lt;i&gt;a&lt;/i&gt;2&lt;sup&gt;P405L&lt;/sup&gt; (causing cutis laxa), and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;R449H&lt;/sup&gt; and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;G820R&lt;/sup&gt; (causing renal tubular acidosis, dRTA), were transiently expressed in peptidyl-tyrosine phosphorylation 293 cells.">
    <entity charOffset="40-69" id="s5186.e0" ontology_id="GO_0006879" text="cellular iron ion homeostasis" type="GO"/>
    <entity charOffset="256-278" id="s5186.e1" ontology_id="HP_0001947" text="renal tubular acidosis" type="HP"/>
    <pair e1="s5186.e0" e2="s5186.e1" id="s5186.p0" relation="false"/>
  </sentence>
  <sentence id="s5187" text="cDNA-encoded FLAG-tagged human wildtype cellular iron ion homeostasis (&lt;i&gt;a&lt;/i&gt;2) and ossification (&lt;i&gt;a&lt;/i&gt;4) subunits and their mutants, &lt;i&gt;a&lt;/i&gt;2&lt;sup&gt;P405L&lt;/sup&gt; (causing cutis laxa), and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;R449H&lt;/sup&gt; and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;G820R&lt;/sup&gt; (causing renal tubular acidosis, dRTA), were transiently expressed in peptidyl-tyrosine phosphorylation 293 cells.">
    <entity charOffset="86-98" id="s5187.e0" ontology_id="GO_0001503" text="ossification" type="GO"/>
    <entity charOffset="256-278" id="s5187.e1" ontology_id="HP_0001947" text="renal tubular acidosis" type="HP"/>
    <pair e1="s5187.e0" e2="s5187.e1" id="s5187.p0" relation="true"/>
  </sentence>
  <sentence id="s5188" text="cDNA-encoded FLAG-tagged human wildtype cellular iron ion homeostasis (&lt;i&gt;a&lt;/i&gt;2) and ossification (&lt;i&gt;a&lt;/i&gt;4) subunits and their mutants, &lt;i&gt;a&lt;/i&gt;2&lt;sup&gt;P405L&lt;/sup&gt; (causing cutis laxa), and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;R449H&lt;/sup&gt; and &lt;i&gt;a&lt;/i&gt;4&lt;sup&gt;G820R&lt;/sup&gt; (causing renal tubular acidosis, dRTA), were transiently expressed in peptidyl-tyrosine phosphorylation 293 cells.">
    <entity charOffset="256-278" id="s5188.e0" ontology_id="HP_0001947" text="renal tubular acidosis" type="HP"/>
    <entity charOffset="317-350" id="s5188.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s5188.e0" e2="s5188.e1" id="s5188.p0" relation="false"/>
  </sentence>
  <sentence id="s5189" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="7-26" id="s5189.e0" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <entity charOffset="317-384" id="s5189.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5189.e0" e2="s5189.e1" id="s5189.p0" relation="false"/>
  </sentence>
  <sentence id="s5190" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="43-55" id="s5190.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="317-384" id="s5190.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5190.e0" e2="s5190.e1" id="s5190.p0" relation="false"/>
  </sentence>
  <sentence id="s5191" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="77-88" id="s5191.e0" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <entity charOffset="317-384" id="s5191.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5191.e0" e2="s5191.e1" id="s5191.p0" relation="false"/>
  </sentence>
  <sentence id="s5192" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="89-95" id="s5192.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="317-384" id="s5192.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5192.e0" e2="s5192.e1" id="s5192.p0" relation="false"/>
  </sentence>
  <sentence id="s5193" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="97-103" id="s5193.e0" ontology_id="HP_0012839" text="distal" type="HP"/>
    <entity charOffset="317-384" id="s5193.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5193.e0" e2="s5193.e1" id="s5193.p0" relation="false"/>
  </sentence>
  <sentence id="s5194" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="131-143" id="s5194.e0" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <entity charOffset="317-384" id="s5194.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5194.e0" e2="s5194.e1" id="s5194.p0" relation="false"/>
  </sentence>
  <sentence id="s5195" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="172-182" id="s5195.e0" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <entity charOffset="317-384" id="s5195.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5195.e0" e2="s5195.e1" id="s5195.p0" relation="false"/>
  </sentence>
  <sentence id="s5196" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="202-214" id="s5196.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="317-384" id="s5196.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5196.e0" e2="s5196.e1" id="s5196.p0" relation="false"/>
  </sentence>
  <sentence id="s5197" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="251-269" id="s5197.e0" ontology_id="HP_0001999" text="facial dysmorphism" type="HP"/>
    <entity charOffset="317-384" id="s5197.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5197.e0" e2="s5197.e1" id="s5197.p0" relation="false"/>
  </sentence>
  <sentence id="s5198" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="275-293" id="s5198.e0" ontology_id="HP_0000316" text="widely spaced eyes" type="HP"/>
    <entity charOffset="317-384" id="s5198.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5198.e0" e2="s5198.e1" id="s5198.p0" relation="false"/>
  </sentence>
  <sentence id="s5199" text="Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.">
    <entity charOffset="295-304" id="s5199.e0" ontology_id="HP_0000577" text="exotropia" type="HP"/>
    <entity charOffset="317-384" id="s5199.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5199.e0" e2="s5199.e1" id="s5199.p0" relation="false"/>
  </sentence>
  <sentence id="s5200" text="Our findings expand the clinical phenotype and further demonstrate the clinical heterogeneity related to negative regulation of gene expression variants">
    <entity charOffset="80-93" id="s5200.e0" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <entity charOffset="105-143" id="s5200.e1" ontology_id="GO_0010629" text="negative regulation of gene expression" type="GO"/>
    <pair e1="s5200.e0" e2="s5200.e1" id="s5200.p0" relation="false"/>
  </sentence>
  <sentence id="s5201" text="Keratitis-ichthyosis-deafness (sister chromatid cohesion) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene.">
    <entity charOffset="21-29" id="s5201.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="31-56" id="s5201.e1" ontology_id="GO_0007062" text="sister chromatid cohesion" type="GO"/>
    <pair e1="s5201.e0" e2="s5201.e1" id="s5201.p0" relation="false"/>
  </sentence>
  <sentence id="s5202" text="Although DNA strand renaturationR2 has been linked to human cancer, its role in cervical cancer remains unknown.">
    <entity charOffset="9-32" id="s5202.e0" ontology_id="GO_0000733" text="DNA strand renaturation" type="GO"/>
    <entity charOffset="60-66" id="s5202.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5202.e0" e2="s5202.e1" id="s5202.p0" relation="true"/>
  </sentence>
  <sentence id="s5203" text="In this study, we investigated the expression and clinical significance of DNA strand renaturationR2 in early-stage cervical cancer.">
    <entity charOffset="75-98" id="s5203.e0" ontology_id="GO_0000733" text="DNA strand renaturation" type="GO"/>
    <entity charOffset="125-131" id="s5203.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5203.e0" e2="s5203.e1" id="s5203.p0" relation="true"/>
  </sentence>
  <sentence id="s5204" text="DNA strand renaturationR2 expression is significantly upregulated at both mRNA and protein levels in cervical cancer cells and tissues, compared with that in matched normal cervical cells and tissues, respectively.">
    <entity charOffset="0-23" id="s5204.e0" ontology_id="GO_0000733" text="DNA strand renaturation" type="GO"/>
    <entity charOffset="110-116" id="s5204.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5204.e0" e2="s5204.e1" id="s5204.p0" relation="true"/>
  </sentence>
  <sentence id="s5205" text="Patients with high DNA strand renaturationR2 expression have a shorter overall survival (OS) and disease-free survival (DFS). p53R2 is an independent factor for predicting OS and DFS of cervical cancer patients.">
    <entity charOffset="19-42" id="s5205.e0" ontology_id="GO_0000733" text="DNA strand renaturation" type="GO"/>
    <entity charOffset="195-201" id="s5205.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5205.e0" e2="s5205.e1" id="s5205.p0" relation="true"/>
  </sentence>
  <sentence id="s5206" text="We further show that DNA strand renaturationR2 is important for oncogenic growth, migration and invasion in cervical cancer cells.">
    <entity charOffset="21-44" id="s5206.e0" ontology_id="GO_0000733" text="DNA strand renaturation" type="GO"/>
    <entity charOffset="117-123" id="s5206.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5206.e0" e2="s5206.e1" id="s5206.p0" relation="true"/>
  </sentence>
  <sentence id="s5207" text="In conclusion, our study demonstrates for the first time that DNA strand renaturationR2 protein is overexpressed in early-stage cervical cancer and unravels some unconventional oncogenic functions of p53R2. p53R2 may be a useful prognostic biomarker and therapeutic target for cervical cancer">
    <entity charOffset="62-85" id="s5207.e0" ontology_id="GO_0000733" text="DNA strand renaturation" type="GO"/>
    <entity charOffset="137-143" id="s5207.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5207.e0" e2="s5207.e1" id="s5207.p0" relation="true"/>
  </sentence>
  <sentence id="s5208" text="regulation of transcription, DNA-templated (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.">
    <entity charOffset="0-42" id="s5208.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="120-134" id="s5208.e1" ontology_id="HP_0000053" text="macroorchidism" type="HP"/>
    <pair e1="s5208.e0" e2="s5208.e1" id="s5208.p0" relation="false"/>
  </sentence>
  <sentence id="s5209" text="Based on a patient with a full deletion of regulation of transcription, DNA-templated clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion.">
    <entity charOffset="43-85" id="s5209.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="179-193" id="s5209.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s5209.e0" e2="s5209.e1" id="s5209.p0" relation="true"/>
  </sentence>
  <sentence id="s5210" text="Based on a patient with a full deletion of regulation of transcription, DNA-templated clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion.">
    <entity charOffset="43-85" id="s5210.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="198-212" id="s5210.e1" ontology_id="HP_0000053" text="macroorchidism" type="HP"/>
    <pair e1="s5210.e0" e2="s5210.e1" id="s5210.p0" relation="false"/>
  </sentence>
  <sentence id="s5211" text="In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in regulation of transcription, DNA-templated deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary">
    <entity charOffset="59-66" id="s5211.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="104-146" id="s5211.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s5211.e0" e2="s5211.e1" id="s5211.p0" relation="false"/>
  </sentence>
  <sentence id="s5212" text="In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in regulation of transcription, DNA-templated deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary">
    <entity charOffset="67-81" id="s5212.e0" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <entity charOffset="104-146" id="s5212.e1" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s5212.e0" e2="s5212.e1" id="s5212.p0" relation="true"/>
  </sentence>
  <sentence id="s5213" text="The mitochondrial protein mitochondrial membrane fission has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth muscle organ development 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="26-56" id="s5213.e0" ontology_id="GO_0090149" text="mitochondrial membrane fission" type="GO"/>
    <entity charOffset="280-286" id="s5213.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s5213.e0" e2="s5213.e1" id="s5213.p0" relation="true"/>
  </sentence>
  <sentence id="s5214" text="The mitochondrial protein mitochondrial membrane fission has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth muscle organ development 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="179-192" id="s5214.e0" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <entity charOffset="214-238" id="s5214.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5214.e0" e2="s5214.e1" id="s5214.p0" relation="false"/>
  </sentence>
  <sentence id="s5215" text="The mitochondrial protein mitochondrial membrane fission has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth muscle organ development 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="214-238" id="s5215.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="280-286" id="s5215.e1" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <pair e1="s5215.e0" e2="s5215.e1" id="s5215.p0" relation="false"/>
  </sentence>
  <sentence id="s5216" text="The mitochondrial protein mitochondrial membrane fission has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth muscle organ development 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.">
    <entity charOffset="214-238" id="s5216.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="314-335" id="s5216.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s5216.e0" e2="s5216.e1" id="s5216.p0" relation="false"/>
  </sentence>
  <sentence id="s5217" text="Mutant epidermis development manifest the main clinical features identified in patients, including ataxia, optic atrophy and cerebellar hypoplasia, which were completely rescued by expression of the human ortholog.">
    <entity charOffset="7-28" id="s5217.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="107-120" id="s5217.e1" ontology_id="HP_0000648" text="optic atrophy" type="HP"/>
    <pair e1="s5217.e0" e2="s5217.e1" id="s5217.p0" relation="false"/>
  </sentence>
  <sentence id="s5218" text="Mutant epidermis development manifest the main clinical features identified in patients, including ataxia, optic atrophy and cerebellar hypoplasia, which were completely rescued by expression of the human ortholog.">
    <entity charOffset="7-28" id="s5218.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="125-146" id="s5218.e1" ontology_id="HP_0001321" text="cerebellar hypoplasia" type="HP"/>
    <pair e1="s5218.e0" e2="s5218.e1" id="s5218.p0" relation="false"/>
  </sentence>
  <sentence id="s5219" text="The dystrobrevin-binding protein 1 (neuron projection development) gene is a candidate risk factor for schizophrenia and has been associated with cognitive ability in both patient populations and healthy controls.">
    <entity charOffset="36-65" id="s5219.e0" ontology_id="GO_0031175" text="neuron projection development" type="GO"/>
    <entity charOffset="103-116" id="s5219.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s5219.e0" e2="s5219.e1" id="s5219.p0" relation="false"/>
  </sentence>
  <sentence id="s5220" text="neuron projection development encodes neuron projection development protein, which is localized to synaptic sites and is reduced in the prefrontal cortex and hippocampus of patients with schizophrenia, indicating a potential role in schizophrenia etiology.">
    <entity charOffset="0-29" id="s5220.e0" ontology_id="GO_0031175" text="neuron projection development" type="GO"/>
    <entity charOffset="187-200" id="s5220.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s5220.e0" e2="s5220.e1" id="s5220.p0" relation="false"/>
  </sentence>
  <sentence id="s5221" text="neuron projection development encodes neuron projection development protein, which is localized to synaptic sites and is reduced in the prefrontal cortex and hippocampus of patients with schizophrenia, indicating a potential role in schizophrenia etiology.">
    <entity charOffset="38-67" id="s5221.e0" ontology_id="GO_0031175" text="neuron projection development" type="GO"/>
    <entity charOffset="187-200" id="s5221.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s5221.e0" e2="s5221.e1" id="s5221.p0" relation="false"/>
  </sentence>
  <sentence id="s5222" text="The purpose of these recommendations is to answer the following question: in case of deeply infiltrating endometriosis associated infertility, what is the best therapeutic strategy? First-line surgery and then in vitro fertilization (sodium ion transport) in case of persistent infertility or first-line IVF, without surgery? After exhaustive literature analysis, we suggest the following recommendations: studies focusing on spontaneous fertility of infertile patients with deeply infiltrating endometriosis found spontaneous pregnancy rates about 10%.">
    <entity charOffset="105-118" id="s5222.e0" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <entity charOffset="234-254" id="s5222.e1" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <pair e1="s5222.e0" e2="s5222.e1" id="s5222.p0" relation="false"/>
  </sentence>
  <sentence id="s5223" text="First-line sodium ion transport is a good option in case of no operated deeply infiltrating endometriosis associated infertility.">
    <entity charOffset="11-31" id="s5223.e0" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <entity charOffset="92-105" id="s5223.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s5223.e0" e2="s5223.e1" id="s5223.p0" relation="false"/>
  </sentence>
  <sentence id="s5224" text="The use of sodium ion transport in the indication &amp;quot;deep infiltrating endometriosis&amp;quot; allows satisfactory pregnancy rates without significant risk, regarding disease progression or oocyte retrieval procedure morbidity">
    <entity charOffset="11-31" id="s5224.e0" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <entity charOffset="74-87" id="s5224.e1" ontology_id="HP_0030127" text="endometriosis" type="HP"/>
    <pair e1="s5224.e0" e2="s5224.e1" id="s5224.p0" relation="false"/>
  </sentence>
  <sentence id="s5225" text="In addition, p-BS/GS can occur as a result of other inherited diseases such as cystic fibrosis, autosomal dominant hypocalcemia, Dent disease, or congenital chloride diarrhea (negative regulation of transcription, DNA-templated).">
    <entity charOffset="115-127" id="s5225.e0" ontology_id="HP_0002901" text="hypocalcemia" type="HP"/>
    <entity charOffset="176-227" id="s5225.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s5225.e0" e2="s5225.e1" id="s5225.p0" relation="false"/>
  </sentence>
  <sentence id="s5226" text="Insufficient signaling through one or more of these metabolite-sensing GPCRs likely contributes to human diseases such as asthma, food allergies, muscle organ development 1 and type 2 diabetes, hepatic steatosis, cardiovascular disease, and inflammatory bowel diseases">
    <entity charOffset="146-170" id="s5226.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="202-211" id="s5226.e1" ontology_id="HP_0001397" text="steatosis" type="HP"/>
    <pair e1="s5226.e0" e2="s5226.e1" id="s5226.p0" relation="false"/>
  </sentence>
  <sentence id="s5227" text="Insufficient signaling through one or more of these metabolite-sensing GPCRs likely contributes to human diseases such as asthma, food allergies, muscle organ development 1 and type 2 diabetes, hepatic steatosis, cardiovascular disease, and inflammatory bowel diseases">
    <entity charOffset="146-170" id="s5227.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="213-235" id="s5227.e1" ontology_id="HP_0001626" text="cardiovascular disease" type="HP"/>
    <pair e1="s5227.e0" e2="s5227.e1" id="s5227.p0" relation="true"/>
  </sentence>
  <sentence id="s5228" text="Large-scale tumor sequencing has revolutionized the identification of somatic driver alterations but has had limited negative regulation of transcription by RNA polymerase II on the identification of cancer predisposition genes (CPGs).">
    <entity charOffset="12-17" id="s5228.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="117-174" id="s5228.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5228.e0" e2="s5228.e1" id="s5228.p0" relation="false"/>
  </sentence>
  <sentence id="s5229" text="Applied to ~10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier positive regulation of transcription, DNA-templated -that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH).">
    <entity charOffset="19-24" id="s5229.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="115-166" id="s5229.e1" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s5229.e0" e2="s5229.e1" id="s5229.p0" relation="true"/>
  </sentence>
  <sentence id="s5230" text="Applied to ~10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier positive regulation of transcription, DNA-templated -that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH).">
    <entity charOffset="115-166" id="s5230.e0" ontology_id="GO_0045893" text="positive regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="188-194" id="s5230.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5230.e0" e2="s5230.e1" id="s5230.p0" relation="true"/>
  </sentence>
  <sentence id="s5231" text="We report a girl with consanguineous parents presenting as collodion baby with contractures of the G protein-coupled receptor signaling pathway joints and palmoplantar hyperlinearity.">
    <entity charOffset="79-91" id="s5231.e0" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <entity charOffset="99-143" id="s5231.e1" ontology_id="GO_0007186" text="G protein-coupled receptor signaling pathway" type="GO"/>
    <pair e1="s5231.e0" e2="s5231.e1" id="s5231.p0" relation="false"/>
  </sentence>
  <sentence id="s5232" text="Pulmonary arterial hypertension (L-phenylalanine catabolic process) is a progressive disease characterised by increased pulmonary vascular resistance and pulmonary artery remodelling as result of increased vascular tone and vascular cell proliferation, respectively.">
    <entity charOffset="33-66" id="s5232.e0" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <entity charOffset="110-149" id="s5232.e1" ontology_id="HP_0005317" text="increased pulmonary vascular resistance" type="HP"/>
    <pair e1="s5232.e0" e2="s5232.e1" id="s5232.p0" relation="false"/>
  </sentence>
  <sentence id="s5233" text="Jalili syndrome (JS) is an autosomal recessive disease characterized by a combination of cone-rode retinal dytrophy (positive regulation of transcription by RNA polymerase II) and amelogenesis imperfect (AI).">
    <entity charOffset="27-46" id="s5233.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="117-174" id="s5233.e1" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5233.e0" e2="s5233.e1" id="s5233.p0" relation="true"/>
  </sentence>
  <sentence id="s5234" text="However, the associations between regulation of mitotic recombination germline mutations and the survival and risk of breast cancer have not been fully elucidated.">
    <entity charOffset="34-69" id="s5234.e0" ontology_id="GO_0000019" text="regulation of mitotic recombination" type="GO"/>
    <entity charOffset="125-131" id="s5234.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5234.e0" e2="s5234.e1" id="s5234.p0" relation="true"/>
  </sentence>
  <sentence id="s5235" text="Here, we aimed to investigate the clinical impact of regulation of mitotic recombination germline mutations in a large cohort of unselected breast cancer patients.">
    <entity charOffset="53-88" id="s5235.e0" ontology_id="GO_0000019" text="regulation of mitotic recombination" type="GO"/>
    <entity charOffset="147-153" id="s5235.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5235.e0" e2="s5235.e1" id="s5235.p0" relation="true"/>
  </sentence>
  <sentence id="s5236" text="In our study, regulation of mitotic recombination germline mutations were determined using next-generation sequencing in 7657 consecutive unselected breast cancer patients without BRCA1/2 mutations.">
    <entity charOffset="14-49" id="s5236.e0" ontology_id="GO_0000019" text="regulation of mitotic recombination" type="GO"/>
    <entity charOffset="156-162" id="s5236.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5236.e0" e2="s5236.e1" id="s5236.p0" relation="true"/>
  </sentence>
  <sentence id="s5237" text="Our study suggested that regulation of mitotic recombination germline mutations are not associated with an increased risk of breast cancer, but patients with RAD50 germline mutations have unfavourable survival compared to patients without these mutations">
    <entity charOffset="25-60" id="s5237.e0" ontology_id="GO_0000019" text="regulation of mitotic recombination" type="GO"/>
    <entity charOffset="132-138" id="s5237.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5237.e0" e2="s5237.e1" id="s5237.p0" relation="true"/>
  </sentence>
  <sentence id="s5238" text="In summary, our results reveal that rare loss-of-function variants in biological_process increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern">
    <entity charOffset="70-88" id="s5238.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="170-189" id="s5238.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s5238.e0" e2="s5238.e1" id="s5238.p0" relation="false"/>
  </sentence>
  <sentence id="s5239" text="In summary, our results reveal that rare loss-of-function variants in biological_process increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern">
    <entity charOffset="70-88" id="s5239.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="136-144" id="s5239.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s5239.e0" e2="s5239.e1" id="s5239.p0" relation="false"/>
  </sentence>
  <sentence id="s5240" text="Mutations in the gene encoding the nuclear matrix protein Matrin 3 have been found in familial cases of signal transduction, as well as autosomal dominant distal myopathy with vocal cord and pharyngeal weakness.">
    <entity charOffset="104-123" id="s5240.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="155-161" id="s5240.e1" ontology_id="HP_0012839" text="distal" type="HP"/>
    <pair e1="s5240.e0" e2="s5240.e1" id="s5240.p0" relation="false"/>
  </sentence>
  <sentence id="s5241" text="Mutations in the gene encoding the nuclear matrix protein Matrin 3 have been found in familial cases of signal transduction, as well as autosomal dominant distal myopathy with vocal cord and pharyngeal weakness.">
    <entity charOffset="104-123" id="s5241.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="162-170" id="s5241.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s5241.e0" e2="s5241.e1" id="s5241.p0" relation="false"/>
  </sentence>
  <sentence id="s5242" text="We previously found that spinal cord and muscle, organs involved in either signal transduction or distal myopathy, have relatively lower levels of Matrin 3 compared to the brain and other peripheral organs in the murine system.">
    <entity charOffset="75-94" id="s5242.e0" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <entity charOffset="105-113" id="s5242.e1" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <pair e1="s5242.e0" e2="s5242.e1" id="s5242.p0" relation="false"/>
  </sentence>
  <sentence id="s5243" text="CONCLUSIONS Our findings indicate that resveratrol induces apoptosis via HIF-1/regulation of cell growth/p53 signaling in prostate cancer cells and may be a useful therapeutic agent against prostate cancer">
    <entity charOffset="80-105" id="s5243.e0" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <entity charOffset="132-138" id="s5243.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5243.e0" e2="s5243.e1" id="s5243.p0" relation="false"/>
  </sentence>
  <sentence id="s5244" text="Canine antigen receptor-mediated signaling pathway cell tumours (CMCT) are one of the most common skin tumours in dogs with a major negative regulation of transcription by RNA polymerase II on canine health.">
    <entity charOffset="7-50" id="s5244.e0" ontology_id="GO_0050851" text="antigen receptor-mediated signaling pathway" type="GO"/>
    <entity charOffset="56-63" id="s5244.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s5244.e0" e2="s5244.e1" id="s5244.p0" relation="false"/>
  </sentence>
  <sentence id="s5245" text="Canine antigen receptor-mediated signaling pathway cell tumours (CMCT) are one of the most common skin tumours in dogs with a major negative regulation of transcription by RNA polymerase II on canine health.">
    <entity charOffset="56-63" id="s5245.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="132-189" id="s5245.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5245.e0" e2="s5245.e1" id="s5245.p0" relation="false"/>
  </sentence>
  <sentence id="s5246" text="BACKGROUND regulation of cell adhesion rearrangements have been reported in 30% of papillary thyroid carcinomas and 1-2% of non-small cell lung cancer (NSCLC).">
    <entity charOffset="11-38" id="s5246.e0" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <entity charOffset="83-111" id="s5246.e1" ontology_id="HP_0002895" text="papillary thyroid carcinomas" type="HP"/>
    <pair e1="s5246.e0" e2="s5246.e1" id="s5246.p0" relation="false"/>
  </sentence>
  <sentence id="s5247" text="In this investigation we assessed the positivity rate of regulation of cell adhesion gene rearrangement in primary and metastatic non-small cell lung cancer and explored their relationships.">
    <entity charOffset="57-84" id="s5247.e0" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <entity charOffset="150-156" id="s5247.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5247.e0" e2="s5247.e1" id="s5247.p0" relation="true"/>
  </sentence>
  <sentence id="s5248" text="The regulation of cell adhesion rearrangement uniformity in metastatic lymph nodes and tumor specimens were contrasted and the relationships between RET rearrangement and patients' clinical features were investigated.">
    <entity charOffset="4-31" id="s5248.e0" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <entity charOffset="87-92" id="s5248.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5248.e0" e2="s5248.e1" id="s5248.p0" relation="true"/>
  </sentence>
  <sentence id="s5249" text="Among the 246 paired cases, 3 (1.22%) cases of primary tumor had identified regulation of cell adhesion rearrangement and 2 (0.81%) cases of metastases had identified RET rearrangement.">
    <entity charOffset="55-60" id="s5249.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="76-103" id="s5249.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s5249.e0" e2="s5249.e1" id="s5249.p0" relation="true"/>
  </sentence>
  <sentence id="s5250" text="CONCLUSIONS The results of this research indicate that the metastases of non-small cell lung cancer can predict regulation of cell adhesion rearrangement of the primary tumor tissue in the majority of cases.">
    <entity charOffset="93-99" id="s5250.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="112-139" id="s5250.e1" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <pair e1="s5250.e0" e2="s5250.e1" id="s5250.p0" relation="true"/>
  </sentence>
  <sentence id="s5251" text="CONCLUSIONS The results of this research indicate that the metastases of non-small cell lung cancer can predict regulation of cell adhesion rearrangement of the primary tumor tissue in the majority of cases.">
    <entity charOffset="112-139" id="s5251.e0" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <entity charOffset="169-174" id="s5251.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5251.e0" e2="s5251.e1" id="s5251.p0" relation="true"/>
  </sentence>
  <sentence id="s5252" text="Testing for regulation of cell adhesion rearrangement in metastases can be used as an alternative to testing of primary tumor tissue if it is inaccessible">
    <entity charOffset="12-39" id="s5252.e0" ontology_id="GO_0030155" text="regulation of cell adhesion" type="GO"/>
    <entity charOffset="120-125" id="s5252.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5252.e0" e2="s5252.e1" id="s5252.p0" relation="true"/>
  </sentence>
  <sentence id="s5253" text="We further replicated pleiotropic associations of glycogen biosynthetic process in a childhood obesity study (n=482) and in a gestational diabetes study (n=1710), respectively.">
    <entity charOffset="50-79" id="s5253.e0" ontology_id="GO_0005978" text="glycogen biosynthetic process" type="GO"/>
    <entity charOffset="95-102" id="s5253.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s5253.e0" e2="s5253.e1" id="s5253.p0" relation="false"/>
  </sentence>
  <sentence id="s5254" text="Here we have investigated the effects of depletion of positive regulation of apoptotic process on the mRNA, microRNA and protein expression profiles in prostate and breast cancers and melanoma.">
    <entity charOffset="54-94" id="s5254.e0" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <entity charOffset="184-192" id="s5254.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s5254.e0" e2="s5254.e1" id="s5254.p0" relation="false"/>
  </sentence>
  <sentence id="s5255" text="Depending on the tumor cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s5255.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="345-382" id="s5255.e1" ontology_id="GO_0007422" text="peripheral nervous system development" type="GO"/>
    <pair e1="s5255.e0" e2="s5255.e1" id="s5255.p0" relation="false"/>
  </sentence>
  <sentence id="s5256" text="Depending on the tumor cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s5256.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="28-52" id="s5256.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5256.e0" e2="s5256.e1" id="s5256.p0" relation="false"/>
  </sentence>
  <sentence id="s5257" text="Depending on the tumor cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s5257.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="209-242" id="s5257.e1" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <pair e1="s5257.e0" e2="s5257.e1" id="s5257.p0" relation="false"/>
  </sentence>
  <sentence id="s5258" text="Depending on the tumor cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s5258.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="274-297" id="s5258.e1" ontology_id="GO_0001659" text="temperature homeostasis" type="GO"/>
    <pair e1="s5258.e0" e2="s5258.e1" id="s5258.p0" relation="false"/>
  </sentence>
  <sentence id="s5259" text="Depending on the tumor cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s5259.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="395-425" id="s5259.e1" ontology_id="GO_0001886" text="endothelial cell morphogenesis" type="GO"/>
    <pair e1="s5259.e0" e2="s5259.e1" id="s5259.p0" relation="true"/>
  </sentence>
  <sentence id="s5260" text="Depending on the tumor cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s5260.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="434-480" id="s5260.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s5260.e0" e2="s5260.e1" id="s5260.p0" relation="true"/>
  </sentence>
  <sentence id="s5261" text="Depending on the tumor cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.">
    <entity charOffset="17-22" id="s5261.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="489-501" id="s5261.e1" ontology_id="GO_0001503" text="ossification" type="GO"/>
    <pair e1="s5261.e0" e2="s5261.e1" id="s5261.p0" relation="false"/>
  </sentence>
  <sentence id="s5262" text="positive regulation of apoptotic process-centric molecules were found to be predominately implicated in the hypoxia-inducible factor-1 (HIF-1) signaling pathway, and cancer and development signaling networks.">
    <entity charOffset="0-40" id="s5262.e0" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <entity charOffset="168-174" id="s5262.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5262.e0" e2="s5262.e1" id="s5262.p0" relation="false"/>
  </sentence>
  <sentence id="s5263" text="Thus positive regulation of apoptotic process seems to regulate the cell survival and cancer progression processes in a multifaceted manner.">
    <entity charOffset="5-45" id="s5263.e0" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <entity charOffset="86-92" id="s5263.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5263.e0" e2="s5263.e1" id="s5263.p0" relation="false"/>
  </sentence>
  <sentence id="s5264" text="We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with signal transduction and healthy control subjects.">
    <entity charOffset="54-72" id="s5264.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="315-323" id="s5264.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5264.e0" e2="s5264.e1" id="s5264.p0" relation="false"/>
  </sentence>
  <sentence id="s5265" text="We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with signal transduction and healthy control subjects.">
    <entity charOffset="82-99" id="s5265.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="315-323" id="s5265.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5265.e0" e2="s5265.e1" id="s5265.p0" relation="false"/>
  </sentence>
  <sentence id="s5266" text="We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with signal transduction and healthy control subjects.">
    <entity charOffset="101-116" id="s5266.e0" ontology_id="GO_0006364" text="rRNA processing" type="GO"/>
    <entity charOffset="315-323" id="s5266.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5266.e0" e2="s5266.e1" id="s5266.p0" relation="false"/>
  </sentence>
  <sentence id="s5267" text="We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with signal transduction and healthy control subjects.">
    <entity charOffset="118-141" id="s5267.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="315-323" id="s5267.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5267.e0" e2="s5267.e1" id="s5267.p0" relation="false"/>
  </sentence>
  <sentence id="s5268" text="We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with signal transduction and healthy control subjects.">
    <entity charOffset="147-213" id="s5268.e0" ontology_id="GO_0060314" text="regulation of ryanodine-sensitive calcium-release channel activity" type="GO"/>
    <entity charOffset="315-323" id="s5268.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5268.e0" e2="s5268.e1" id="s5268.p0" relation="false"/>
  </sentence>
  <sentence id="s5269" text="We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with signal transduction and healthy control subjects.">
    <entity charOffset="315-323" id="s5269.e0" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="338-357" id="s5269.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s5269.e0" e2="s5269.e1" id="s5269.p0" relation="false"/>
  </sentence>
  <sentence id="s5270" text="Cyclooxygenase (generation of precursor metabolites and energy)-2 is upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="16-62" id="s5270.e0" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <entity charOffset="84-108" id="s5270.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s5270.e0" e2="s5270.e1" id="s5270.p0" relation="false"/>
  </sentence>
  <sentence id="s5271" text="Cyclooxygenase (generation of precursor metabolites and energy)-2 is upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation).">
    <entity charOffset="84-108" id="s5271.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="110-146" id="s5271.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s5271.e0" e2="s5271.e1" id="s5271.p0" relation="false"/>
  </sentence>
  <sentence id="s5272" text="Bio-functional investigation revealed that LTBP1 inhibited cell proliferation in phosphatidylinositol phosphorylation cell lines, suggesting its potential role as a tumor suppressor in HCC.">
    <entity charOffset="81-117" id="s5272.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="165-170" id="s5272.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5272.e0" e2="s5272.e1" id="s5272.p0" relation="false"/>
  </sentence>
  <sentence id="s5273" text="In conclusion, this study demonstrated for the first time that enhanced generation of precursor metabolites and energy-2 expression in hepatocytes is sufficient to induce phosphatidylinositol phosphorylation through inducing promoter hypermethylation by reducing TET1, silencing tumor-suppressive genes and activating key oncogenic pathways.">
    <entity charOffset="72-118" id="s5273.e0" ontology_id="GO_0006091" text="generation of precursor metabolites and energy" type="GO"/>
    <entity charOffset="279-284" id="s5273.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5273.e0" e2="s5273.e1" id="s5273.p0" relation="false"/>
  </sentence>
  <sentence id="s5274" text="In conclusion, this study demonstrated for the first time that enhanced generation of precursor metabolites and energy-2 expression in hepatocytes is sufficient to induce phosphatidylinositol phosphorylation through inducing promoter hypermethylation by reducing TET1, silencing tumor-suppressive genes and activating key oncogenic pathways.">
    <entity charOffset="171-207" id="s5274.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="279-284" id="s5274.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5274.e0" e2="s5274.e1" id="s5274.p0" relation="false"/>
  </sentence>
  <sentence id="s5275" text="This mutation was also found in a second unrelated family with the same clinical phenotype, while no germline or somatic &lt;i&gt;inflammatory response&lt;/i&gt; mutations were identified in nine patients with sporadic insulinomatosis.">
    <entity charOffset="124-145" id="s5275.e0" ontology_id="GO_0006954" text="inflammatory response" type="GO"/>
    <entity charOffset="198-206" id="s5275.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5275.e0" e2="s5275.e1" id="s5275.p0" relation="false"/>
  </sentence>
  <sentence id="s5276" text="Nephronophthisis (NPHP), Joubert (JBTS), and Meckel-Gruber (cilium assembly) syndromes are autosomal-recessive ciliopathies presenting with cystic kidneys, retinal degeneration, and cerebellar/neural tube malformation.">
    <entity charOffset="60-75" id="s5276.e0" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <entity charOffset="156-176" id="s5276.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s5276.e0" e2="s5276.e1" id="s5276.p0" relation="false"/>
  </sentence>
  <sentence id="s5277" text="This study investigated the angiogenesis gene mutation muscle organ developments in outpatients clinically diagnosed with granular corneal dystrophy (GCD) prior to phototherapeutic keratectomy (positive regulation of endothelial cell migration), also calculated the mutation rate of subjects with normal corneas, but positive family history.">
    <entity charOffset="28-40" id="s5277.e0" ontology_id="GO_0001525" text="angiogenesis" type="GO"/>
    <entity charOffset="131-148" id="s5277.e1" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <pair e1="s5277.e0" e2="s5277.e1" id="s5277.p0" relation="true"/>
  </sentence>
  <sentence id="s5278" text="This study investigated the angiogenesis gene mutation muscle organ developments in outpatients clinically diagnosed with granular corneal dystrophy (GCD) prior to phototherapeutic keratectomy (positive regulation of endothelial cell migration), also calculated the mutation rate of subjects with normal corneas, but positive family history.">
    <entity charOffset="55-79" id="s5278.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="131-148" id="s5278.e1" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <pair e1="s5278.e0" e2="s5278.e1" id="s5278.p0" relation="false"/>
  </sentence>
  <sentence id="s5279" text="This study investigated the angiogenesis gene mutation muscle organ developments in outpatients clinically diagnosed with granular corneal dystrophy (GCD) prior to phototherapeutic keratectomy (positive regulation of endothelial cell migration), also calculated the mutation rate of subjects with normal corneas, but positive family history.">
    <entity charOffset="131-148" id="s5279.e0" ontology_id="HP_0001131" text="corneal dystrophy" type="HP"/>
    <entity charOffset="194-243" id="s5279.e1" ontology_id="GO_0010595" text="positive regulation of endothelial cell migration" type="GO"/>
    <pair e1="s5279.e0" e2="s5279.e1" id="s5279.p0" relation="false"/>
  </sentence>
  <sentence id="s5280" text="In this study, we expand the genotype-phenotype repertoire of protein tetramerization by describing the novel protein tetramerization deletion p.Pro583_Pro585del highlighting the allelic heterogeneity observed in SCA13 patients.">
    <entity charOffset="62-85" id="s5280.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="187-200" id="s5280.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s5280.e0" e2="s5280.e1" id="s5280.p0" relation="false"/>
  </sentence>
  <sentence id="s5281" text="In this study, we expand the genotype-phenotype repertoire of protein tetramerization by describing the novel protein tetramerization deletion p.Pro583_Pro585del highlighting the allelic heterogeneity observed in SCA13 patients.">
    <entity charOffset="110-133" id="s5281.e0" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <entity charOffset="187-200" id="s5281.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="s5281.e0" e2="s5281.e1" id="s5281.p0" relation="false"/>
  </sentence>
  <sentence id="s5282" text="We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of profound spasticity not previously associated with the protein tetramerization phenotype.">
    <entity charOffset="122-132" id="s5282.e0" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <entity charOffset="168-191" id="s5282.e1" ontology_id="GO_0051262" text="protein tetramerization" type="GO"/>
    <pair e1="s5282.e0" e2="s5282.e1" id="s5282.p0" relation="false"/>
  </sentence>
  <sentence id="s5283" text="Primary ciliary dyskinesia (motile cilium assembly) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.">
    <entity charOffset="8-26" id="s5283.e0" ontology_id="HP_0012265" text="ciliary dyskinesia" type="HP"/>
    <entity charOffset="28-50" id="s5283.e1" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <pair e1="s5283.e0" e2="s5283.e1" id="s5283.p0" relation="true"/>
  </sentence>
  <sentence id="s5284" text="Primary ciliary dyskinesia (motile cilium assembly) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.">
    <entity charOffset="28-50" id="s5284.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="63-82" id="s5284.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5284.e0" e2="s5284.e1" id="s5284.p0" relation="true"/>
  </sentence>
  <sentence id="s5285" text="Primary ciliary dyskinesia (motile cilium assembly) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.">
    <entity charOffset="28-50" id="s5285.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="217-228" id="s5285.e1" ontology_id="HP_0030853" text="heterotaxia" type="HP"/>
    <pair e1="s5285.e0" e2="s5285.e1" id="s5285.p0" relation="false"/>
  </sentence>
  <sentence id="s5286" text="Primary ciliary dyskinesia (motile cilium assembly) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.">
    <entity charOffset="28-50" id="s5286.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="233-256" id="s5286.e1" ontology_id="HP_0012206" text="abnormal sperm motility" type="HP"/>
    <pair e1="s5286.e0" e2="s5286.e1" id="s5286.p0" relation="false"/>
  </sentence>
  <sentence id="s5287" text="Here, with a comprehensive literature review, we report a couple with an infertility history of 9years and three unsuccessful sodium ion transport treatments, where male partner has Kartagener's Syndrome, a subtype of PCD, displaying recurrent respiratory infections, dextrocardia and total asthenozoospermia.">
    <entity charOffset="127-147" id="s5287.e0" ontology_id="GO_0006814" text="sodium ion transport" type="GO"/>
    <entity charOffset="269-281" id="s5287.e1" ontology_id="HP_0001651" text="dextrocardia" type="HP"/>
    <pair e1="s5287.e0" e2="s5287.e1" id="s5287.p0" relation="false"/>
  </sentence>
  <sentence id="s5288" text="Mutations in four genes (intestinal cholesterol absorption, positive regulation of macrophage derived foam cell differentiation, negative regulation of receptor recycling and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.">
    <entity charOffset="25-58" id="s5288.e0" ontology_id="GO_0030299" text="intestinal cholesterol absorption" type="GO"/>
    <entity charOffset="232-252" id="s5288.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s5288.e0" e2="s5288.e1" id="s5288.p0" relation="true"/>
  </sentence>
  <sentence id="s5289" text="Mutations in four genes (intestinal cholesterol absorption, positive regulation of macrophage derived foam cell differentiation, negative regulation of receptor recycling and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.">
    <entity charOffset="60-127" id="s5289.e0" ontology_id="GO_0010744" text="positive regulation of macrophage derived foam cell differentiation" type="GO"/>
    <entity charOffset="232-252" id="s5289.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s5289.e0" e2="s5289.e1" id="s5289.p0" relation="true"/>
  </sentence>
  <sentence id="s5290" text="Mutations in four genes (intestinal cholesterol absorption, positive regulation of macrophage derived foam cell differentiation, negative regulation of receptor recycling and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.">
    <entity charOffset="129-170" id="s5290.e0" ontology_id="GO_0001920" text="negative regulation of receptor recycling" type="GO"/>
    <entity charOffset="232-252" id="s5290.e1" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <pair e1="s5290.e0" e2="s5290.e1" id="s5290.p0" relation="true"/>
  </sentence>
  <sentence id="s5291" text="Nearly 80 genes involved in lipid metabolism (encoding structural components of lipoproteins, lipoprotein receptors and related proteins, enzymes, lipid transporters, lipid transfer proteins, and activators or inhibitors of protein function and gene transcription) with single nucleotide variants (SNVs) that are recognized to be associated with hypercholesterolemia and serum lipid negative regulation of transcription by RNA polymerase II in genome-wide association studies and candidate gene studies were identified.">
    <entity charOffset="346-366" id="s5291.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="383-440" id="s5291.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5291.e0" e2="s5291.e1" id="s5291.p0" relation="false"/>
  </sentence>
  <sentence id="s5292" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="92-119" id="s5292.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="710-729" id="s5292.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5292.e0" e2="s5292.e1" id="s5292.p0" relation="false"/>
  </sentence>
  <sentence id="s5293" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="92-119" id="s5293.e0" ontology_id="GO_0007015" text="actin filament organization" type="GO"/>
    <entity charOffset="826-847" id="s5293.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5293.e0" e2="s5293.e1" id="s5293.p0" relation="false"/>
  </sentence>
  <sentence id="s5294" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="121-160" id="s5294.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="710-729" id="s5294.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5294.e0" e2="s5294.e1" id="s5294.p0" relation="false"/>
  </sentence>
  <sentence id="s5295" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="121-160" id="s5295.e0" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <entity charOffset="826-847" id="s5295.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5295.e0" e2="s5295.e1" id="s5295.p0" relation="false"/>
  </sentence>
  <sentence id="s5296" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="162-217" id="s5296.e0" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <entity charOffset="826-847" id="s5296.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5296.e0" e2="s5296.e1" id="s5296.p0" relation="false"/>
  </sentence>
  <sentence id="s5297" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="219-260" id="s5297.e0" ontology_id="GO_0018242" text="protein O-linked glycosylation via serine" type="GO"/>
    <entity charOffset="710-729" id="s5297.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5297.e0" e2="s5297.e1" id="s5297.p0" relation="false"/>
  </sentence>
  <sentence id="s5298" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="219-260" id="s5298.e0" ontology_id="GO_0018242" text="protein O-linked glycosylation via serine" type="GO"/>
    <entity charOffset="826-847" id="s5298.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5298.e0" e2="s5298.e1" id="s5298.p0" relation="false"/>
  </sentence>
  <sentence id="s5299" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="267-285" id="s5299.e0" ontology_id="GO_0006829" text="zinc ion transport" type="GO"/>
    <entity charOffset="710-729" id="s5299.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5299.e0" e2="s5299.e1" id="s5299.p0" relation="false"/>
  </sentence>
  <sentence id="s5300" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="287-305" id="s5300.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="710-729" id="s5300.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5300.e0" e2="s5300.e1" id="s5300.p0" relation="false"/>
  </sentence>
  <sentence id="s5301" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="287-305" id="s5301.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="826-847" id="s5301.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5301.e0" e2="s5301.e1" id="s5301.p0" relation="false"/>
  </sentence>
  <sentence id="s5302" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="307-325" id="s5302.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="710-729" id="s5302.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5302.e0" e2="s5302.e1" id="s5302.p0" relation="false"/>
  </sentence>
  <sentence id="s5303" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="307-325" id="s5303.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="826-847" id="s5303.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5303.e0" e2="s5303.e1" id="s5303.p0" relation="false"/>
  </sentence>
  <sentence id="s5304" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="327-367" id="s5304.e0" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <entity charOffset="826-847" id="s5304.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5304.e0" e2="s5304.e1" id="s5304.p0" relation="false"/>
  </sentence>
  <sentence id="s5305" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="383-413" id="s5305.e0" ontology_id="GO_0000398" text="mRNA splicing, via spliceosome" type="GO"/>
    <entity charOffset="710-729" id="s5305.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5305.e0" e2="s5305.e1" id="s5305.p0" relation="false"/>
  </sentence>
  <sentence id="s5306" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="415-448" id="s5306.e0" ontology_id="GO_0015721" text="bile acid and bile salt transport" type="GO"/>
    <entity charOffset="710-729" id="s5306.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5306.e0" e2="s5306.e1" id="s5306.p0" relation="false"/>
  </sentence>
  <sentence id="s5307" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="415-448" id="s5307.e0" ontology_id="GO_0015721" text="bile acid and bile salt transport" type="GO"/>
    <entity charOffset="826-847" id="s5307.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5307.e0" e2="s5307.e1" id="s5307.p0" relation="false"/>
  </sentence>
  <sentence id="s5308" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="450-465" id="s5308.e0" ontology_id="GO_0001654" text="eye development" type="GO"/>
    <entity charOffset="826-847" id="s5308.e1" ontology_id="HP_0040185" text="macrothrombocytopenia" type="HP"/>
    <pair e1="s5308.e0" e2="s5308.e1" id="s5308.p0" relation="false"/>
  </sentence>
  <sentence id="s5309" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="475-495" id="s5309.e0" ontology_id="GO_0007338" text="single fertilization" type="GO"/>
    <entity charOffset="710-729" id="s5309.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5309.e0" e2="s5309.e1" id="s5309.p0" relation="false"/>
  </sentence>
  <sentence id="s5310" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="499-550" id="s5310.e0" ontology_id="GO_0033617" text="mitochondrial respiratory chain complex IV assembly" type="GO"/>
    <entity charOffset="710-729" id="s5310.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5310.e0" e2="s5310.e1" id="s5310.p0" relation="false"/>
  </sentence>
  <sentence id="s5311" text="Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.">
    <entity charOffset="552-596" id="s5311.e0" ontology_id="GO_0070373" text="negative regulation of ERK1 and ERK2 cascade" type="GO"/>
    <entity charOffset="710-729" id="s5311.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5311.e0" e2="s5311.e1" id="s5311.p0" relation="false"/>
  </sentence>
  <sentence id="s5312" text="Our case presented the specific characteristics: macrocephaly, midline cleft-nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, cleft palate, polydactyly of both hands and feet but without occipitoschisis, considered as the pathognomonic sign of the syndrome.">
    <entity charOffset="49-61" id="s5312.e0" ontology_id="HP_0000256" text="macrocephaly" type="HP"/>
    <entity charOffset="77-144" id="s5312.e1" ontology_id="GO_0000184" text="nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" type="GO"/>
    <pair e1="s5312.e0" e2="s5312.e1" id="s5312.p0" relation="false"/>
  </sentence>
  <sentence id="s5313" text="Leiomyoma of deep soft tissue is a rare muscle organ development of benign smooth muscle tumor that mostly occurs in the retroperitoneum or abdominal cavity of women, and about which very little genetic information exists.">
    <entity charOffset="40-64" id="s5313.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="89-94" id="s5313.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5313.e0" e2="s5313.e1" id="s5313.p0" relation="false"/>
  </sentence>
  <sentence id="s5314" text="G-banding showed that three tumors carried rearrangements of the long cilium assembly of chromosome 12, three others had 8q rearrangements, the 7th tumor had deletion of the long arm of chromosome 7, del(7)(q22), and the 8th had aberrations of chromosome bands 3q21~23 and 11q21~22.">
    <entity charOffset="28-33" id="s5314.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="70-85" id="s5314.e1" ontology_id="GO_0060271" text="cilium assembly" type="GO"/>
    <pair e1="s5314.e0" e2="s5314.e1" id="s5314.p0" relation="false"/>
  </sentence>
  <sentence id="s5315" text="In the leiomyomas with 12q rearrangements, both HMGA2 and positive regulation of transcription by RNA polymerase II were expressed whereas in the tumors with 8q aberrations, only PLAG1 was expressed.">
    <entity charOffset="58-115" id="s5315.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="146-151" id="s5315.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5315.e0" e2="s5315.e1" id="s5315.p0" relation="true"/>
  </sentence>
  <sentence id="s5316" text="In two tumors with 12q rearrangements, RPSAP52 on 12q14.3 was fused with non-coding RNA (accession number XR_944195) from 14q32.2 or MAPK cascade from14q24.1.">
    <entity charOffset="7-12" id="s5316.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="133-145" id="s5316.e1" ontology_id="GO_0000165" text="MAPK cascade" type="GO"/>
    <pair e1="s5316.e0" e2="s5316.e1" id="s5316.p0" relation="false"/>
  </sentence>
  <sentence id="s5317" text="We recently found that phosphatidic acid biosynthetic process is a principal triglyceride hydrolase in the central nervous system (CNS) and that genetic deletion of this enzyme in mice leads to ectopic lipid droplet (positive regulation of macroautophagy) accumulation in neurons throughout the brain.">
    <entity charOffset="23-61" id="s5317.e0" ontology_id="GO_0006654" text="phosphatidic acid biosynthetic process" type="GO"/>
    <entity charOffset="107-114" id="s5317.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s5317.e0" e2="s5317.e1" id="s5317.p0" relation="false"/>
  </sentence>
  <sentence id="s5318" text="We recently found that phosphatidic acid biosynthetic process is a principal triglyceride hydrolase in the central nervous system (CNS) and that genetic deletion of this enzyme in mice leads to ectopic lipid droplet (positive regulation of macroautophagy) accumulation in neurons throughout the brain.">
    <entity charOffset="107-114" id="s5318.e0" ontology_id="HP_0030645" text="central" type="HP"/>
    <entity charOffset="217-254" id="s5318.e1" ontology_id="GO_0016239" text="positive regulation of macroautophagy" type="GO"/>
    <pair e1="s5318.e0" e2="s5318.e1" id="s5318.p0" relation="false"/>
  </sentence>
  <sentence id="s5319" text="We confirmed the association between cognition and schizophrenia through individual genotyping of 1,400 subjects.">
    <entity charOffset="37-46" id="s5319.e0" ontology_id="GO_0050890" text="cognition" type="GO"/>
    <entity charOffset="51-64" id="s5319.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s5319.e0" e2="s5319.e1" id="s5319.p0" relation="false"/>
  </sentence>
  <sentence id="s5320" text="In a gene expression analysis the risk allele of a coding SNP associated with schizophrenia was found to be associated with a reduced expression of cognition.">
    <entity charOffset="78-91" id="s5320.e0" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <entity charOffset="148-157" id="s5320.e1" ontology_id="GO_0050890" text="cognition" type="GO"/>
    <pair e1="s5320.e0" e2="s5320.e1" id="s5320.p0" relation="false"/>
  </sentence>
  <sentence id="s5321" text="The genetic and functional evidences here reported suggest a possible role of the cognition gene in the pathology of schizophrenia and also in the therapeutic effects of antipsychotic drugs">
    <entity charOffset="82-91" id="s5321.e0" ontology_id="GO_0050890" text="cognition" type="GO"/>
    <entity charOffset="117-130" id="s5321.e1" ontology_id="HP_0100753" text="schizophrenia" type="HP"/>
    <pair e1="s5321.e0" e2="s5321.e1" id="s5321.p0" relation="false"/>
  </sentence>
  <sentence id="s5322" text="Mechanical compression induced protein polyubiquitination-9 downregulation by DNA methylation-dependent promoter methylation in the MDA-MB-231 and biological_process-474 breast cancer cell lines and in cancer-associated fibroblasts.">
    <entity charOffset="31-57" id="s5322.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="177-183" id="s5322.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5322.e0" e2="s5322.e1" id="s5322.p0" relation="false"/>
  </sentence>
  <sentence id="s5323" text="Mechanical compression induced protein polyubiquitination-9 downregulation by DNA methylation-dependent promoter methylation in the MDA-MB-231 and biological_process-474 breast cancer cell lines and in cancer-associated fibroblasts.">
    <entity charOffset="78-93" id="s5323.e0" ontology_id="GO_0006306" text="DNA methylation" type="GO"/>
    <entity charOffset="177-183" id="s5323.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5323.e0" e2="s5323.e1" id="s5323.p0" relation="true"/>
  </sentence>
  <sentence id="s5324" text="Mechanical compression induced protein polyubiquitination-9 downregulation by DNA methylation-dependent promoter methylation in the MDA-MB-231 and biological_process-474 breast cancer cell lines and in cancer-associated fibroblasts.">
    <entity charOffset="147-165" id="s5324.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="177-183" id="s5324.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5324.e0" e2="s5324.e1" id="s5324.p0" relation="false"/>
  </sentence>
  <sentence id="s5325" text="This paper deals with the molecular investigation of Waardenburg syndrome (WS) in a sample of 49 clinically diagnosed probands (most from southeastern Brazil), 24 of them having the muscle organ development 1 (WS1) variant (10 familial and 14 isolated cases) and 25 being affected by the type 2 (WS2) variant (five familial and 20 isolated cases).">
    <entity charOffset="182-206" id="s5325.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="243-257" id="s5325.e1" ontology_id="HP_0003745" text="isolated cases" type="HP"/>
    <pair e1="s5325.e0" e2="s5325.e1" id="s5325.p0" relation="false"/>
  </sentence>
  <sentence id="s5326" text="Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the negative regulation of microtubule depolymerization gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.">
    <entity charOffset="106-157" id="s5326.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="243-255" id="s5326.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s5326.e0" e2="s5326.e1" id="s5326.p0" relation="true"/>
  </sentence>
  <sentence id="s5327" text="Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the negative regulation of microtubule depolymerization gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.">
    <entity charOffset="106-157" id="s5327.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="257-270" id="s5327.e1" ontology_id="HP_0001339" text="lissencephaly" type="HP"/>
    <pair e1="s5327.e0" e2="s5327.e1" id="s5327.p0" relation="true"/>
  </sentence>
  <sentence id="s5328" text="Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the negative regulation of microtubule depolymerization gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.">
    <entity charOffset="106-157" id="s5328.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="272-285" id="s5328.e1" ontology_id="HP_0004322" text="short stature" type="HP"/>
    <pair e1="s5328.e0" e2="s5328.e1" id="s5328.p0" relation="false"/>
  </sentence>
  <sentence id="s5329" text="Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the negative regulation of microtubule depolymerization gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.">
    <entity charOffset="106-157" id="s5329.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="307-327" id="s5329.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s5329.e0" e2="s5329.e1" id="s5329.p0" relation="false"/>
  </sentence>
  <sentence id="s5330" text="Homozygous and compound heterozygous mutations in negative regulation of microtubule depolymerization have very recently been described as a cause of microcephaly with brain malformations and seizures.">
    <entity charOffset="50-101" id="s5330.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="150-162" id="s5330.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s5330.e0" e2="s5330.e1" id="s5330.p0" relation="true"/>
  </sentence>
  <sentence id="s5331" text="Homozygous and compound heterozygous mutations in negative regulation of microtubule depolymerization have very recently been described as a cause of microcephaly with brain malformations and seizures.">
    <entity charOffset="50-101" id="s5331.e0" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <entity charOffset="192-200" id="s5331.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s5331.e0" e2="s5331.e1" id="s5331.p0" relation="true"/>
  </sentence>
  <sentence id="s5332" text="Interestingly, de novo loss-of-function and missense variants in histone H3-K4 demethylation were identified in patients with intellectual disability (ID) and autism spectrum disorder (ASD) but also in unaffected individuals.">
    <entity charOffset="65-92" id="s5332.e0" ontology_id="GO_0034720" text="histone H3-K4 demethylation" type="GO"/>
    <entity charOffset="159-165" id="s5332.e1" ontology_id="HP_0000717" text="autism" type="HP"/>
    <pair e1="s5332.e0" e2="s5332.e1" id="s5332.p0" relation="false"/>
  </sentence>
  <sentence id="s5333" text="The c.808+1G&amp;gt;A variant was identified in a boy with mild ID and autism negative regulation of transcription by RNA polymerase II and is associated with a significant reduced histone H3-K4 demethylation mRNA expression without alteration of its H3K4me3 pattern.">
    <entity charOffset="71-77" id="s5333.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="181-208" id="s5333.e1" ontology_id="GO_0034720" text="histone H3-K4 demethylation" type="GO"/>
    <pair e1="s5333.e0" e2="s5333.e1" id="s5333.p0" relation="false"/>
  </sentence>
  <sentence id="s5334" text="The c.808+1G&amp;gt;A variant was identified in a boy with mild ID and autism negative regulation of transcription by RNA polymerase II and is associated with a significant reduced histone H3-K4 demethylation mRNA expression without alteration of its H3K4me3 pattern.">
    <entity charOffset="71-77" id="s5334.e0" ontology_id="HP_0000717" text="autism" type="HP"/>
    <entity charOffset="78-135" id="s5334.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5334.e0" e2="s5334.e1" id="s5334.p0" relation="false"/>
  </sentence>
  <sentence id="s5335" text="Our data reinforces the recent observation that the histone H3-K4 demethylation haploinsufficiency is not a mechanism involved in intellectual disability and that KDM5B disorder associated with LOF variants is a recessive disorder.">
    <entity charOffset="52-79" id="s5335.e0" ontology_id="GO_0034720" text="histone H3-K4 demethylation" type="GO"/>
    <entity charOffset="130-153" id="s5335.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5335.e0" e2="s5335.e1" id="s5335.p0" relation="false"/>
  </sentence>
  <sentence id="s5336" text="Proteomic analysis of 12 tumours from an regulation of cell growth-driven hepatocellular carcinoma mouse model revealed that positive regulation of DNA binding and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="25-32" id="s5336.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="41-66" id="s5336.e1" ontology_id="GO_0001558" text="regulation of cell growth" type="GO"/>
    <pair e1="s5336.e0" e2="s5336.e1" id="s5336.p0" relation="false"/>
  </sentence>
  <sentence id="s5337" text="Proteomic analysis of 12 tumours from an regulation of cell growth-driven hepatocellular carcinoma mouse model revealed that positive regulation of DNA binding and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="25-32" id="s5337.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="125-159" id="s5337.e1" ontology_id="GO_0043388" text="positive regulation of DNA binding" type="GO"/>
    <pair e1="s5337.e0" e2="s5337.e1" id="s5337.p0" relation="true"/>
  </sentence>
  <sentence id="s5338" text="Proteomic analysis of 12 tumours from an regulation of cell growth-driven hepatocellular carcinoma mouse model revealed that positive regulation of DNA binding and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="25-32" id="s5338.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="164-202" id="s5338.e1" ontology_id="GO_0006165" text="nucleoside diphosphate phosphorylation" type="GO"/>
    <pair e1="s5338.e0" e2="s5338.e1" id="s5338.p0" relation="false"/>
  </sentence>
  <sentence id="s5339" text="Proteomic analysis of 12 tumours from an regulation of cell growth-driven hepatocellular carcinoma mouse model revealed that positive regulation of DNA binding and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.">
    <entity charOffset="74-98" id="s5339.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="125-159" id="s5339.e1" ontology_id="GO_0043388" text="positive regulation of DNA binding" type="GO"/>
    <pair e1="s5339.e0" e2="s5339.e1" id="s5339.p0" relation="false"/>
  </sentence>
  <sentence id="s5340" text="Conversely, expression of the putative histidine phosphatase phosphate-containing compound metabolic process was downregulated specifically in the tumours.">
    <entity charOffset="61-108" id="s5340.e0" ontology_id="GO_0006796" text="phosphate-containing compound metabolic process" type="GO"/>
    <entity charOffset="147-154" id="s5340.e1" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <pair e1="s5340.e0" e2="s5340.e1" id="s5340.p0" relation="false"/>
  </sentence>
  <sentence id="s5341" text="Sustained, hepatic expression of phosphate-containing compound metabolic process in the hepatocellular carcinoma mouse model reduced tumour burden and prevented the loss of liver function.">
    <entity charOffset="33-80" id="s5341.e0" ontology_id="GO_0006796" text="phosphate-containing compound metabolic process" type="GO"/>
    <entity charOffset="88-112" id="s5341.e1" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="s5341.e0" e2="s5341.e1" id="s5341.p0" relation="false"/>
  </sentence>
  <sentence id="s5342" text="Sustained, hepatic expression of phosphate-containing compound metabolic process in the hepatocellular carcinoma mouse model reduced tumour burden and prevented the loss of liver function.">
    <entity charOffset="33-80" id="s5342.e0" ontology_id="GO_0006796" text="phosphate-containing compound metabolic process" type="GO"/>
    <entity charOffset="133-139" id="s5342.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s5342.e0" e2="s5342.e1" id="s5342.p0" relation="false"/>
  </sentence>
  <sentence id="s5343" text="Finally, in patients with hepatocellular carcinoma, low expression of phosphate-containing compound metabolic process correlated with increased tumour severity and reduced overall survival.">
    <entity charOffset="70-117" id="s5343.e0" ontology_id="GO_0006796" text="phosphate-containing compound metabolic process" type="GO"/>
    <entity charOffset="144-150" id="s5343.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s5343.e0" e2="s5343.e1" id="s5343.p0" relation="false"/>
  </sentence>
  <sentence id="s5344" text="Thus, phosphate-containing compound metabolic process is a protein histidine phosphatase and tumour suppressor, suggesting that deregulated histidine phosphorylation is oncogenic">
    <entity charOffset="6-53" id="s5344.e0" ontology_id="GO_0006796" text="phosphate-containing compound metabolic process" type="GO"/>
    <entity charOffset="93-99" id="s5344.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s5344.e0" e2="s5344.e1" id="s5344.p0" relation="false"/>
  </sentence>
  <sentence id="s5345" text="protein hydroxylation knockdown in MDA-MB-231 breast cancer cells significantly impeded cell proliferation and resulted in the accumulation of G1 and G2/M cells by decreasing the mRNA levels of G1/S transition- and G2/M-related transcription factors and their target genes.">
    <entity charOffset="0-21" id="s5345.e0" ontology_id="GO_0018126" text="protein hydroxylation" type="GO"/>
    <entity charOffset="53-59" id="s5345.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5345.e0" e2="s5345.e1" id="s5345.p0" relation="false"/>
  </sentence>
  <sentence id="s5346" text="We also confirmed that protein hydroxylation is highly expressed in breast cancer tissues by bioinformatic analysis and immunohistochemistry.">
    <entity charOffset="23-44" id="s5346.e0" ontology_id="GO_0018126" text="protein hydroxylation" type="GO"/>
    <entity charOffset="75-81" id="s5346.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5346.e0" e2="s5346.e1" id="s5346.p0" relation="false"/>
  </sentence>
  <sentence id="s5347" text="Thus, we propose that protein hydroxylation is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.">
    <entity charOffset="22-43" id="s5347.e0" ontology_id="GO_0018126" text="protein hydroxylation" type="GO"/>
    <entity charOffset="67-73" id="s5347.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5347.e0" e2="s5347.e1" id="s5347.p0" relation="false"/>
  </sentence>
  <sentence id="s5348" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (protein phosphorylation, MAPK10, protein phosphorylation, protein phosphorylation, MAPK1, cellular response to transforming growth factor beta stimulus and VEGF), were calculated.">
    <entity charOffset="201-207" id="s5348.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="221-244" id="s5348.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s5348.e0" e2="s5348.e1" id="s5348.p0" relation="false"/>
  </sentence>
  <sentence id="s5349" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (protein phosphorylation, MAPK10, protein phosphorylation, protein phosphorylation, MAPK1, cellular response to transforming growth factor beta stimulus and VEGF), were calculated.">
    <entity charOffset="201-207" id="s5349.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="254-277" id="s5349.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s5349.e0" e2="s5349.e1" id="s5349.p0" relation="false"/>
  </sentence>
  <sentence id="s5350" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (protein phosphorylation, MAPK10, protein phosphorylation, protein phosphorylation, MAPK1, cellular response to transforming growth factor beta stimulus and VEGF), were calculated.">
    <entity charOffset="201-207" id="s5350.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="279-302" id="s5350.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s5350.e0" e2="s5350.e1" id="s5350.p0" relation="false"/>
  </sentence>
  <sentence id="s5351" text="To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (protein phosphorylation, MAPK10, protein phosphorylation, protein phosphorylation, MAPK1, cellular response to transforming growth factor beta stimulus and VEGF), were calculated.">
    <entity charOffset="201-207" id="s5351.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="311-372" id="s5351.e1" ontology_id="GO_0071560" text="cellular response to transforming growth factor beta stimulus" type="GO"/>
    <pair e1="s5351.e0" e2="s5351.e1" id="s5351.p0" relation="false"/>
  </sentence>
  <sentence id="s5352" text="The cause was identified in only 7 patients and included methylmalonic aciduria, meningoencephalitis, perinatal hypoxic-ischemic injury, large genomic deletion on chromosome 7q21, translocase of inner mitochondrial membrane 8 homolog A (nervous system development) mutation (Mohr-Tranebjaerg syndrome), and chromosome 2 open reading frame 37 (post-translational protein modification) mutation (Woodhouse-Sakati syndrome).">
    <entity charOffset="57-79" id="s5352.e0" ontology_id="HP_0012120" text="methylmalonic aciduria" type="HP"/>
    <entity charOffset="237-263" id="s5352.e1" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <pair e1="s5352.e0" e2="s5352.e1" id="s5352.p0" relation="false"/>
  </sentence>
  <sentence id="s5353" text="The cause was identified in only 7 patients and included methylmalonic aciduria, meningoencephalitis, perinatal hypoxic-ischemic injury, large genomic deletion on chromosome 7q21, translocase of inner mitochondrial membrane 8 homolog A (nervous system development) mutation (Mohr-Tranebjaerg syndrome), and chromosome 2 open reading frame 37 (post-translational protein modification) mutation (Woodhouse-Sakati syndrome).">
    <entity charOffset="57-79" id="s5353.e0" ontology_id="HP_0012120" text="methylmalonic aciduria" type="HP"/>
    <entity charOffset="343-382" id="s5353.e1" ontology_id="GO_0043687" text="post-translational protein modification" type="GO"/>
    <pair e1="s5353.e0" e2="s5353.e1" id="s5353.p0" relation="false"/>
  </sentence>
  <sentence id="s5354" text="A large, complex, and robust gene network containing well-known lung cancer-related genes, including positive regulation of protein phosphorylation and transcription, RNA-templated, was identified from combined gene lists for lung adenocarcinoma.">
    <entity charOffset="69-75" id="s5354.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="101-147" id="s5354.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s5354.e0" e2="s5354.e1" id="s5354.p0" relation="true"/>
  </sentence>
  <sentence id="s5355" text="A large, complex, and robust gene network containing well-known lung cancer-related genes, including positive regulation of protein phosphorylation and transcription, RNA-templated, was identified from combined gene lists for lung adenocarcinoma.">
    <entity charOffset="152-180" id="s5355.e0" ontology_id="GO_0001172" text="transcription, RNA-templated" type="GO"/>
    <entity charOffset="226-245" id="s5355.e1" ontology_id="HP_0030078" text="lung adenocarcinoma" type="HP"/>
    <pair e1="s5355.e0" e2="s5355.e1" id="s5355.p0" relation="false"/>
  </sentence>
  <sentence id="s5356" text="Intracerebroventricular infusion of Hm1a rescues Dravet syndrome epidermis development from seizures and premature death.">
    <entity charOffset="65-86" id="s5356.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="92-100" id="s5356.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s5356.e0" e2="s5356.e1" id="s5356.p0" relation="false"/>
  </sentence>
  <sentence id="s5357" text="Here we found that perilipin-1 (lipid metabolic process) mRNA expression is significantly downregulated in human breast cancer.">
    <entity charOffset="32-55" id="s5357.e0" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <entity charOffset="120-126" id="s5357.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5357.e0" e2="s5357.e1" id="s5357.p0" relation="false"/>
  </sentence>
  <sentence id="s5358" text="Further Cox proportional hazard models analysis revealed that the reduced expression of lipid metabolic process is an independent predictor of overall survival in estrogen receptor positive (p &amp;lt; 0.0001, HR = 0.87, 95% CI = 0.81-0.92, N = 3,600) and luminal A-subtype (p = 0.02, HR = 0.88, 95% CI = 0.78-0.98, N = 1,469) breast cancer patients.">
    <entity charOffset="88-111" id="s5358.e0" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <entity charOffset="330-336" id="s5358.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5358.e0" e2="s5358.e1" id="s5358.p0" relation="false"/>
  </sentence>
  <sentence id="s5359" text="We also demonstrated that the exogenous expression of lipid metabolic process in human breast cancer MCF-7 and MDA-MB-231 cells significantly inhibits cell proliferation, migration, invasion and in vivo tumorigenesis in mice.">
    <entity charOffset="54-77" id="s5359.e0" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <entity charOffset="94-100" id="s5359.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5359.e0" e2="s5359.e1" id="s5359.p0" relation="false"/>
  </sentence>
  <sentence id="s5360" text="Together, these data provide novel insights into a prognostic significance of lipid metabolic process in human breast cancer and reveal a potentially new gene therapy target for breast cancer">
    <entity charOffset="78-101" id="s5360.e0" ontology_id="GO_0006629" text="lipid metabolic process" type="GO"/>
    <entity charOffset="118-124" id="s5360.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5360.e0" e2="s5360.e1" id="s5360.p0" relation="false"/>
  </sentence>
  <sentence id="s5361" text="We investigated the negative regulation of transcription by RNA polymerase II of these polymorphisms on the clinical outcome of 103 patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with a platinum compound, fluorouracil and cetuximab as palliative first-line therapy.">
    <entity charOffset="20-77" id="s5361.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="170-193" id="s5361.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s5361.e0" e2="s5361.e1" id="s5361.p0" relation="false"/>
  </sentence>
  <sentence id="s5362" text="Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&amp;gt;C, p.V378L) action potential mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.">
    <entity charOffset="93-109" id="s5362.e0" ontology_id="GO_0001508" text="action potential" type="GO"/>
    <entity charOffset="144-163" id="s5362.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s5362.e0" e2="s5362.e1" id="s5362.p0" relation="true"/>
  </sentence>
  <sentence id="s5363" text="Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&amp;gt;C, p.V378L) action potential mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.">
    <entity charOffset="93-109" id="s5363.e0" ontology_id="GO_0001508" text="action potential" type="GO"/>
    <entity charOffset="165-188" id="s5363.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5363.e0" e2="s5363.e1" id="s5363.p0" relation="true"/>
  </sentence>
  <sentence id="s5364" text="We present a case of a patient with long-standing hyperpigmented macules and erythematous papules over his chest, abdomen, back and positive regulation of neuron projection development, suggestive of Dowling-Degos disease (DDD).">
    <entity charOffset="50-72" id="s5364.e0" ontology_id="HP_0001034" text="hyperpigmented macules" type="HP"/>
    <entity charOffset="132-184" id="s5364.e1" ontology_id="GO_0010976" text="positive regulation of neuron projection development" type="GO"/>
    <pair e1="s5364.e0" e2="s5364.e1" id="s5364.p0" relation="false"/>
  </sentence>
  <sentence id="s5365" text="Although mutations in the gene encoding tricellulin are known to cause deafness in humans (sensory perception of sound) and mice, the influence of its systemic deletion in vivo remains unknown.">
    <entity charOffset="71-79" id="s5365.e0" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <entity charOffset="91-118" id="s5365.e1" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <pair e1="s5365.e0" e2="s5365.e1" id="s5365.p0" relation="true"/>
  </sentence>
  <sentence id="s5366" text="When we generated tricellulin-knockout mice (sensory perception of sound(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (mitochondrion organization); however, their body size and overall appearance were normal.">
    <entity charOffset="45-72" id="s5366.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="112-123" id="s5366.e1" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <pair e1="s5366.e0" e2="s5366.e1" id="s5366.p0" relation="false"/>
  </sentence>
  <sentence id="s5367" text="When we generated tricellulin-knockout mice (sensory perception of sound(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (mitochondrion organization); however, their body size and overall appearance were normal.">
    <entity charOffset="45-72" id="s5367.e0" ontology_id="GO_0007605" text="sensory perception of sound" type="GO"/>
    <entity charOffset="124-136" id="s5367.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s5367.e0" e2="s5367.e1" id="s5367.p0" relation="true"/>
  </sentence>
  <sentence id="s5368" text="When we generated tricellulin-knockout mice (sensory perception of sound(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (mitochondrion organization); however, their body size and overall appearance were normal.">
    <entity charOffset="112-123" id="s5368.e0" ontology_id="HP_0003676" text="progressive" type="HP"/>
    <entity charOffset="185-211" id="s5368.e1" ontology_id="GO_0007005" text="mitochondrion organization" type="GO"/>
    <pair e1="s5368.e0" e2="s5368.e1" id="s5368.p0" relation="false"/>
  </sentence>
  <sentence id="s5369" text="Spinocerebellar ataxia muscle organ development 11 (negative regulation of microtubule depolymerization) is a rare, dominantly inherited human ataxia characterized by atrophy of Purkinje neurons in the cerebellum.">
    <entity charOffset="16-22" id="s5369.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="23-47" id="s5369.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5369.e0" e2="s5369.e1" id="s5369.p0" relation="false"/>
  </sentence>
  <sentence id="s5370" text="Spinocerebellar ataxia muscle organ development 11 (negative regulation of microtubule depolymerization) is a rare, dominantly inherited human ataxia characterized by atrophy of Purkinje neurons in the cerebellum.">
    <entity charOffset="16-22" id="s5370.e0" ontology_id="HP_0001251" text="ataxia" type="HP"/>
    <entity charOffset="52-103" id="s5370.e1" ontology_id="GO_0007026" text="negative regulation of microtubule depolymerization" type="GO"/>
    <pair e1="s5370.e0" e2="s5370.e1" id="s5370.p0" relation="true"/>
  </sentence>
  <sentence id="s5371" text="Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the negative regulation of lipopolysaccharide-mediated signaling pathway features include primary microcephaly and profound global developmental delay.">
    <entity charOffset="185-253" id="s5371.e0" ontology_id="GO_0031665" text="negative regulation of lipopolysaccharide-mediated signaling pathway" type="GO"/>
    <entity charOffset="279-291" id="s5371.e1" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <pair e1="s5371.e0" e2="s5371.e1" id="s5371.p0" relation="false"/>
  </sentence>
  <sentence id="s5372" text="Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the negative regulation of lipopolysaccharide-mediated signaling pathway features include primary microcephaly and profound global developmental delay.">
    <entity charOffset="185-253" id="s5372.e0" ontology_id="GO_0031665" text="negative regulation of lipopolysaccharide-mediated signaling pathway" type="GO"/>
    <entity charOffset="296-304" id="s5372.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s5372.e0" e2="s5372.e1" id="s5372.p0" relation="false"/>
  </sentence>
  <sentence id="s5373" text="Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the negative regulation of lipopolysaccharide-mediated signaling pathway features include primary microcephaly and profound global developmental delay.">
    <entity charOffset="185-253" id="s5373.e0" ontology_id="GO_0031665" text="negative regulation of lipopolysaccharide-mediated signaling pathway" type="GO"/>
    <entity charOffset="312-331" id="s5373.e1" ontology_id="HP_0001263" text="developmental delay" type="HP"/>
    <pair e1="s5373.e0" e2="s5373.e1" id="s5373.p0" relation="false"/>
  </sentence>
  <sentence id="s5374" text="However, the biological function and mechanism of glyceraldehyde-3-phosphate biosynthetic process in cancer remain largely unknown.">
    <entity charOffset="50-97" id="s5374.e0" ontology_id="GO_0046166" text="glyceraldehyde-3-phosphate biosynthetic process" type="GO"/>
    <entity charOffset="101-107" id="s5374.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5374.e0" e2="s5374.e1" id="s5374.p0" relation="false"/>
  </sentence>
  <sentence id="s5375" text="In this study, we have found that TPI1 expression was greatly decreased in clinical phosphatidylinositol phosphorylation samples, positively correlated with overall survival, and negatively associated with histological differentiation, tumor size and organ metastasis.">
    <entity charOffset="84-120" id="s5375.e0" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <entity charOffset="236-241" id="s5375.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5375.e0" e2="s5375.e1" id="s5375.p0" relation="false"/>
  </sentence>
  <sentence id="s5376" text="Moreover, overexpression of glyceraldehyde-3-phosphate biosynthetic process led to slowed tumor growth and decreased tumor weight invivo.">
    <entity charOffset="28-75" id="s5376.e0" ontology_id="GO_0046166" text="glyceraldehyde-3-phosphate biosynthetic process" type="GO"/>
    <entity charOffset="90-95" id="s5376.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5376.e0" e2="s5376.e1" id="s5376.p0" relation="false"/>
  </sentence>
  <sentence id="s5377" text="Therefore, our data suggested that glyceraldehyde-3-phosphate biosynthetic process functioned as a tumor suppressor in phosphatidylinositol phosphorylation and might serve as a potential therapeutic target for the treatment of HCC">
    <entity charOffset="35-82" id="s5377.e0" ontology_id="GO_0046166" text="glyceraldehyde-3-phosphate biosynthetic process" type="GO"/>
    <entity charOffset="99-104" id="s5377.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5377.e0" e2="s5377.e1" id="s5377.p0" relation="false"/>
  </sentence>
  <sentence id="s5378" text="Therefore, our data suggested that glyceraldehyde-3-phosphate biosynthetic process functioned as a tumor suppressor in phosphatidylinositol phosphorylation and might serve as a potential therapeutic target for the treatment of HCC">
    <entity charOffset="99-104" id="s5378.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="119-155" id="s5378.e1" ontology_id="GO_0046854" text="phosphatidylinositol phosphorylation" type="GO"/>
    <pair e1="s5378.e0" e2="s5378.e1" id="s5378.p0" relation="false"/>
  </sentence>
  <sentence id="s5379" text="We also found that multiple cancers are genetically correlated with non-cancer negative regulation of transcription by RNA polymerase II including smoking, psychiatric diseases and metabolic characteristics.">
    <entity charOffset="28-34" id="s5379.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="79-136" id="s5379.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5379.e0" e2="s5379.e1" id="s5379.p0" relation="false"/>
  </sentence>
  <sentence id="s5380" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s5380.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="127-155" id="s5380.e1" ontology_id="GO_0001172" text="transcription, RNA-templated" type="GO"/>
    <pair e1="s5380.e0" e2="s5380.e1" id="s5380.p0" relation="true"/>
  </sentence>
  <sentence id="s5381" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s5381.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="184-207" id="s5381.e1" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <pair e1="s5381.e0" e2="s5381.e1" id="s5381.p0" relation="true"/>
  </sentence>
  <sentence id="s5382" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s5382.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="307-364" id="s5382.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5382.e0" e2="s5382.e1" id="s5382.p0" relation="false"/>
  </sentence>
  <sentence id="s5383" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s5383.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="432-450" id="s5383.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s5383.e0" e2="s5383.e1" id="s5383.p0" relation="false"/>
  </sentence>
  <sentence id="s5384" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="85-91" id="s5384.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="462-502" id="s5384.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s5384.e0" e2="s5384.e1" id="s5384.p0" relation="false"/>
  </sentence>
  <sentence id="s5385" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="184-207" id="s5385.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="391-397" id="s5385.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5385.e0" e2="s5385.e1" id="s5385.p0" relation="true"/>
  </sentence>
  <sentence id="s5386" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="391-397" id="s5386.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="432-450" id="s5386.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s5386.e0" e2="s5386.e1" id="s5386.p0" relation="false"/>
  </sentence>
  <sentence id="s5387" text="Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).">
    <entity charOffset="391-397" id="s5387.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="462-502" id="s5387.e1" ontology_id="GO_0006974" text="cellular response to DNA damage stimulus" type="GO"/>
    <pair e1="s5387.e0" e2="s5387.e1" id="s5387.p0" relation="false"/>
  </sentence>
  <sentence id="s5388" text="In the present case, magnetic resonance imaging (MRI) obtained during infancy revealed symmetric lesions in the substantia nigra of a patient with Leigh syndrome with an mitochondrial respiratory chain complex I assembly mutation; lesions of the bilateral putamen and brainstem were subsequently observed.">
    <entity charOffset="170-220" id="s5388.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="246-255" id="s5388.e1" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <pair e1="s5388.e0" e2="s5388.e1" id="s5388.p0" relation="false"/>
  </sentence>
  <sentence id="s5389" text="We provide functional evidence to support the pathogenicity of these mitochondrial respiratory chain complex I assembly variants, including evidence of founder effects for both variants, and establish defects within this gene as a cause of complex I deficiency in association with either pure myopathy in adulthood or, in one individual, a severe multisystem presentation (chronic renal failure andcardiomyopathy) in infancy.">
    <entity charOffset="69-119" id="s5389.e0" ontology_id="GO_0032981" text="mitochondrial respiratory chain complex I assembly" type="GO"/>
    <entity charOffset="381-394" id="s5389.e1" ontology_id="HP_0000083" text="renal failure" type="HP"/>
    <pair e1="s5389.e0" e2="s5389.e1" id="s5389.p0" relation="false"/>
  </sentence>
  <sentence id="s5390" text="negative regulation of transcription by RNA polymerase II, a member of the T-box family of transcription factors, contributes directly to tumor formation, migration, and invasion.">
    <entity charOffset="0-57" id="s5390.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="138-143" id="s5390.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5390.e0" e2="s5390.e1" id="s5390.p0" relation="false"/>
  </sentence>
  <sentence id="s5391" text="negative regulation of transcription by RNA polymerase II expression was positively associated with multiple tumor nodes, venous infiltration, and advanced regulation of transcription by RNA polymerase III tumor stage.">
    <entity charOffset="0-57" id="s5391.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="109-114" id="s5391.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5391.e0" e2="s5391.e1" id="s5391.p0" relation="false"/>
  </sentence>
  <sentence id="s5392" text="negative regulation of transcription by RNA polymerase II expression was positively associated with multiple tumor nodes, venous infiltration, and advanced regulation of transcription by RNA polymerase III tumor stage.">
    <entity charOffset="109-114" id="s5392.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="156-205" id="s5392.e1" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <pair e1="s5392.e0" e2="s5392.e1" id="s5392.p0" relation="false"/>
  </sentence>
  <sentence id="s5393" text="There is increasing evidence of a clinical, neuropathological and genetic overlap between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (signal transduction).">
    <entity charOffset="90-113" id="s5393.e0" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <entity charOffset="155-174" id="s5393.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s5393.e0" e2="s5393.e1" id="s5393.p0" relation="false"/>
  </sentence>
  <sentence id="s5394" text="A better understanding of protein exit from endoplasmic reticulum gene expression, during the pathogenesis of hepatic insulin resistance, could ultimately provide new avenues for therapies for metabolic syndrome, obesity, and type-2 diabetes mellitus, disorders whose worldwide incidences are increasing drastically">
    <entity charOffset="26-65" id="s5394.e0" ontology_id="GO_0032527" text="protein exit from endoplasmic reticulum" type="GO"/>
    <entity charOffset="213-220" id="s5394.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s5394.e0" e2="s5394.e1" id="s5394.p0" relation="false"/>
  </sentence>
  <sentence id="s5395" text="Using whole-exome sequencing, we identified biallelic mutations in seizure threshold 2 (corpus callosum morphogenesis) in both affected children.">
    <entity charOffset="67-74" id="s5395.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="88-117" id="s5395.e1" ontology_id="GO_0021540" text="corpus callosum morphogenesis" type="GO"/>
    <pair e1="s5395.e0" e2="s5395.e1" id="s5395.p0" relation="true"/>
  </sentence>
  <sentence id="s5396" text="Although the molecular role of the peroxisomal protein corpus callosum morphogenesis in neuronal excitability and brain development remains to be defined, corpus callosum morphogenesis has been shown to influence seizure threshold and epileptogenesis in epidermis development, consistent with our findings in humans.">
    <entity charOffset="55-84" id="s5396.e0" ontology_id="GO_0021540" text="corpus callosum morphogenesis" type="GO"/>
    <entity charOffset="213-220" id="s5396.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5396.e0" e2="s5396.e1" id="s5396.p0" relation="true"/>
  </sentence>
  <sentence id="s5397" text="Although the molecular role of the peroxisomal protein corpus callosum morphogenesis in neuronal excitability and brain development remains to be defined, corpus callosum morphogenesis has been shown to influence seizure threshold and epileptogenesis in epidermis development, consistent with our findings in humans.">
    <entity charOffset="155-184" id="s5397.e0" ontology_id="GO_0021540" text="corpus callosum morphogenesis" type="GO"/>
    <entity charOffset="213-220" id="s5397.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5397.e0" e2="s5397.e1" id="s5397.p0" relation="true"/>
  </sentence>
  <sentence id="s5398" text="Although the molecular role of the peroxisomal protein corpus callosum morphogenesis in neuronal excitability and brain development remains to be defined, corpus callosum morphogenesis has been shown to influence seizure threshold and epileptogenesis in epidermis development, consistent with our findings in humans.">
    <entity charOffset="213-220" id="s5398.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="254-275" id="s5398.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s5398.e0" e2="s5398.e1" id="s5398.p0" relation="false"/>
  </sentence>
  <sentence id="s5399" text="We conclude that mutations in corpus callosum morphogenesis cause a severe muscle organ development of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.">
    <entity charOffset="30-59" id="s5399.e0" ontology_id="GO_0021540" text="corpus callosum morphogenesis" type="GO"/>
    <entity charOffset="133-147" id="s5399.e1" ontology_id="HP_0001298" text="encephalopathy" type="HP"/>
    <pair e1="s5399.e0" e2="s5399.e1" id="s5399.p0" relation="true"/>
  </sentence>
  <sentence id="s5400" text="We conclude that mutations in corpus callosum morphogenesis cause a severe muscle organ development of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.">
    <entity charOffset="30-59" id="s5400.e0" ontology_id="GO_0021540" text="corpus callosum morphogenesis" type="GO"/>
    <entity charOffset="165-172" id="s5400.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5400.e0" e2="s5400.e1" id="s5400.p0" relation="true"/>
  </sentence>
  <sentence id="s5401" text="We conclude that mutations in corpus callosum morphogenesis cause a severe muscle organ development of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.">
    <entity charOffset="75-99" id="s5401.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="165-172" id="s5401.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5401.e0" e2="s5401.e1" id="s5401.p0" relation="false"/>
  </sentence>
  <sentence id="s5402" text="Here, we found that cervical cancer cells undergo massive death by negative regulation of transcription by RNA polymerase II knockdown, but this effect is reversed by SIRT1 restoration.">
    <entity charOffset="29-35" id="s5402.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="67-124" id="s5402.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5402.e0" e2="s5402.e1" id="s5402.p0" relation="false"/>
  </sentence>
  <sentence id="s5403" text="Interestingly, pyroptotic death signaling in negative regulation of transcription by RNA polymerase II-knocked-down cells was transmitted to nave cervical cancer cells, which was mediated by extracellular vesicles carrying activation of innate immune response inflammasome proteins.">
    <entity charOffset="45-102" id="s5403.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="156-162" id="s5403.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5403.e0" e2="s5403.e1" id="s5403.p0" relation="false"/>
  </sentence>
  <sentence id="s5404" text="Interestingly, pyroptotic death signaling in negative regulation of transcription by RNA polymerase II-knocked-down cells was transmitted to nave cervical cancer cells, which was mediated by extracellular vesicles carrying activation of innate immune response inflammasome proteins.">
    <entity charOffset="156-162" id="s5404.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="224-260" id="s5404.e1" ontology_id="GO_0002218" text="activation of innate immune response" type="GO"/>
    <pair e1="s5404.e0" e2="s5404.e1" id="s5404.p0" relation="false"/>
  </sentence>
  <sentence id="s5405" text="Immunohistochemical analyses showed that negative regulation of transcription by RNA polymerase II expression correlated with poor clinical outcomes in cervical cancer.">
    <entity charOffset="41-98" id="s5405.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="161-167" id="s5405.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5405.e0" e2="s5405.e1" id="s5405.p0" relation="false"/>
  </sentence>
  <sentence id="s5406" text="In conclusion, negative regulation of transcription by RNA polymerase II enabled HPV-infected cervical cancer cells to continue growing by nullifying AIM2 inflammasome-mediated immunity.">
    <entity charOffset="15-72" id="s5406.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="103-109" id="s5406.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5406.e0" e2="s5406.e1" id="s5406.p0" relation="false"/>
  </sentence>
  <sentence id="s5407" text="Without negative regulation of transcription by RNA polymerase II, cervical cancer cells could no longer survive because of the derepression of the AIM2 inflammasome.">
    <entity charOffset="8-65" id="s5407.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="76-82" id="s5407.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5407.e0" e2="s5407.e1" id="s5407.p0" relation="false"/>
  </sentence>
  <sentence id="s5408" text="Clinicopathologic features such as menarche age, body cell adhesion mediated by integrin index, personal cancer history, grade, and histologic muscle organ development were compared between the 2 groups.">
    <entity charOffset="54-88" id="s5408.e0" ontology_id="GO_0033627" text="cell adhesion mediated by integrin" type="GO"/>
    <entity charOffset="105-111" id="s5408.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5408.e0" e2="s5408.e1" id="s5408.p0" relation="false"/>
  </sentence>
  <sentence id="s5409" text="Clinicopathologic features such as menarche age, body cell adhesion mediated by integrin index, personal cancer history, grade, and histologic muscle organ development were compared between the 2 groups.">
    <entity charOffset="105-111" id="s5409.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="143-167" id="s5409.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5409.e0" e2="s5409.e1" id="s5409.p0" relation="false"/>
  </sentence>
  <sentence id="s5410" text="Univariate (Pearson Chi-squared test, Fisher exact test, T test, Wilcoxon positive regulation of DNA-binding transcription factor activity sum test, logistic regression) statistics and stepwise multivariate logistic regression were used to identify factors associated with PFH in the analysis.Among young patients with EC, the PFH group had younger age-of-onset age of endometrial cancer (40 years) (odds ratio [OR] = 2.21, 95% confidence interval [95% CI]: 1.01-4.82) than the NFH group.">
    <entity charOffset="74-138" id="s5410.e0" ontology_id="GO_0051091" text="positive regulation of DNA-binding transcription factor activity" type="GO"/>
    <entity charOffset="381-387" id="s5410.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5410.e0" e2="s5410.e1" id="s5410.p0" relation="false"/>
  </sentence>
  <sentence id="s5411" text="Colorectal, lung, endometrial, breast, and hepatocellular carcinoma accounted for 58.6% of all cancer muscle organ developments among 1st- and 2nd-degree relatives.">
    <entity charOffset="43-67" id="s5411.e0" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <entity charOffset="102-126" id="s5411.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5411.e0" e2="s5411.e1" id="s5411.p0" relation="false"/>
  </sentence>
  <sentence id="s5412" text="Colorectal, lung, endometrial, breast, and hepatocellular carcinoma accounted for 58.6% of all cancer muscle organ developments among 1st- and 2nd-degree relatives.">
    <entity charOffset="95-101" id="s5412.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="102-126" id="s5412.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5412.e0" e2="s5412.e1" id="s5412.p0" relation="false"/>
  </sentence>
  <sentence id="s5413" text="Our study identifies negative regulation of transcription by RNA polymerase II as a key regulator of TSH/cell surface receptor signaling pathway-mediated thyroid hormone biosynthesis and proliferation of thyroid follicular cells and uncovers a mechanism by which GLIS3 deficiency causes neonatal hypothyroidism and prevents goiter development">
    <entity charOffset="21-78" id="s5413.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="296-310" id="s5413.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s5413.e0" e2="s5413.e1" id="s5413.p0" relation="true"/>
  </sentence>
  <sentence id="s5414" text="Our study identifies negative regulation of transcription by RNA polymerase II as a key regulator of TSH/cell surface receptor signaling pathway-mediated thyroid hormone biosynthesis and proliferation of thyroid follicular cells and uncovers a mechanism by which GLIS3 deficiency causes neonatal hypothyroidism and prevents goiter development">
    <entity charOffset="105-144" id="s5414.e0" ontology_id="GO_0007166" text="cell surface receptor signaling pathway" type="GO"/>
    <entity charOffset="296-310" id="s5414.e1" ontology_id="HP_0000821" text="hypothyroidism" type="HP"/>
    <pair e1="s5414.e0" e2="s5414.e1" id="s5414.p0" relation="true"/>
  </sentence>
  <sentence id="s5415" text="Appraisal of the present case against previously reported patients indicate that keratinocyte development mutations result in a distinctive skin fragility phenotype, with minimal blistering compared with other forms of basal EBS">
    <entity charOffset="81-105" id="s5415.e0" ontology_id="GO_0003334" text="keratinocyte development" type="GO"/>
    <entity charOffset="140-154" id="s5415.e1" ontology_id="HP_0001030" text="skin fragility" type="HP"/>
    <pair e1="s5415.e0" e2="s5415.e1" id="s5415.p0" relation="true"/>
  </sentence>
  <sentence id="s5416" text="In this study, we investigated the expression of activation of JUN kinase activity in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron cellular protein catabolic process induced by KA.">
    <entity charOffset="49-82" id="s5416.e0" ontology_id="GO_0007257" text="activation of JUN kinase activity" type="GO"/>
    <entity charOffset="100-108" id="s5416.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="s5416.e0" e2="s5416.e1" id="s5416.p0" relation="false"/>
  </sentence>
  <sentence id="s5417" text="In this study, we investigated the expression of activation of JUN kinase activity in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron cellular protein catabolic process induced by KA.">
    <entity charOffset="49-82" id="s5417.e0" ontology_id="GO_0007257" text="activation of JUN kinase activity" type="GO"/>
    <entity charOffset="174-182" id="s5417.e1" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <pair e1="s5417.e0" e2="s5417.e1" id="s5417.p0" relation="false"/>
  </sentence>
  <sentence id="s5418" text="In this study, we investigated the expression of activation of JUN kinase activity in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron cellular protein catabolic process induced by KA.">
    <entity charOffset="174-182" id="s5418.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="282-316" id="s5418.e1" ontology_id="GO_0044257" text="cellular protein catabolic process" type="GO"/>
    <pair e1="s5418.e0" e2="s5418.e1" id="s5418.p0" relation="false"/>
  </sentence>
  <sentence id="s5419" text="We found that activation of JUN kinase activity was markedly increased in TLE patients and a mouse model of epileptic seizures; epidermis development underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.">
    <entity charOffset="14-47" id="s5419.e0" ontology_id="GO_0007257" text="activation of JUN kinase activity" type="GO"/>
    <entity charOffset="259-266" id="s5419.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5419.e0" e2="s5419.e1" id="s5419.p0" relation="false"/>
  </sentence>
  <sentence id="s5420" text="We found that activation of JUN kinase activity was markedly increased in TLE patients and a mouse model of epileptic seizures; epidermis development underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.">
    <entity charOffset="118-126" id="s5420.e0" ontology_id="HP_0001250" text="seizures" type="HP"/>
    <entity charOffset="128-149" id="s5420.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s5420.e0" e2="s5420.e1" id="s5420.p0" relation="false"/>
  </sentence>
  <sentence id="s5421" text="We found that activation of JUN kinase activity was markedly increased in TLE patients and a mouse model of epileptic seizures; epidermis development underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.">
    <entity charOffset="128-149" id="s5421.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="259-266" id="s5421.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5421.e0" e2="s5421.e1" id="s5421.p0" relation="false"/>
  </sentence>
  <sentence id="s5422" text="Subsequently, a decreased activation of protein phosphorylation following seizure induction was observed in epidermis development underexpressing activation of JUN kinase activity, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.">
    <entity charOffset="40-63" id="s5422.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="74-81" id="s5422.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5422.e0" e2="s5422.e1" id="s5422.p0" relation="false"/>
  </sentence>
  <sentence id="s5423" text="Subsequently, a decreased activation of protein phosphorylation following seizure induction was observed in epidermis development underexpressing activation of JUN kinase activity, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.">
    <entity charOffset="74-81" id="s5423.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="146-179" id="s5423.e1" ontology_id="GO_0007257" text="activation of JUN kinase activity" type="GO"/>
    <pair e1="s5423.e0" e2="s5423.e1" id="s5423.p0" relation="false"/>
  </sentence>
  <sentence id="s5424" text="Subsequently, a decreased activation of protein phosphorylation following seizure induction was observed in epidermis development underexpressing activation of JUN kinase activity, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.">
    <entity charOffset="74-81" id="s5424.e0" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <entity charOffset="108-129" id="s5424.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s5424.e0" e2="s5424.e1" id="s5424.p0" relation="false"/>
  </sentence>
  <sentence id="s5425" text="We also found that epidermis development underexpressing activation of JUN kinase activity exhibited a delayed pentylenetetrazole (PTZ)-induced kindling seizure process">
    <entity charOffset="19-40" id="s5425.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="153-160" id="s5425.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5425.e0" e2="s5425.e1" id="s5425.p0" relation="false"/>
  </sentence>
  <sentence id="s5426" text="We also found that epidermis development underexpressing activation of JUN kinase activity exhibited a delayed pentylenetetrazole (PTZ)-induced kindling seizure process">
    <entity charOffset="57-90" id="s5426.e0" ontology_id="GO_0007257" text="activation of JUN kinase activity" type="GO"/>
    <entity charOffset="153-160" id="s5426.e1" ontology_id="HP_0001250" text="seizure" type="HP"/>
    <pair e1="s5426.e0" e2="s5426.e1" id="s5426.p0" relation="false"/>
  </sentence>
  <sentence id="s5427" text="Cerebral, ocular, dental, auricular, skeletal (CODAS) syndrome is a rare autosomal recessive multisystem disorder caused by mutations in cellular response to oxidative stress.">
    <entity charOffset="73-92" id="s5427.e0" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <entity charOffset="137-174" id="s5427.e1" ontology_id="GO_0034599" text="cellular response to oxidative stress" type="GO"/>
    <pair e1="s5427.e0" e2="s5427.e1" id="s5427.p0" relation="true"/>
  </sentence>
  <sentence id="s5428" text="We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on positive regulation of cell proliferation-weighted images.">
    <entity charOffset="79-102" id="s5428.e0" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <entity charOffset="263-304" id="s5428.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s5428.e0" e2="s5428.e1" id="s5428.p0" relation="false"/>
  </sentence>
  <sentence id="s5429" text="We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on positive regulation of cell proliferation-weighted images.">
    <entity charOffset="115-124" id="s5429.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="263-304" id="s5429.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s5429.e0" e2="s5429.e1" id="s5429.p0" relation="false"/>
  </sentence>
  <sentence id="s5430" text="We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on positive regulation of cell proliferation-weighted images.">
    <entity charOffset="136-146" id="s5430.e0" ontology_id="HP_0001257" text="spasticity" type="HP"/>
    <entity charOffset="263-304" id="s5430.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s5430.e0" e2="s5430.e1" id="s5430.p0" relation="false"/>
  </sentence>
  <sentence id="s5431" text="We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on positive regulation of cell proliferation-weighted images.">
    <entity charOffset="196-214" id="s5431.e0" ontology_id="HP_0001272" text="cerebellar atrophy" type="HP"/>
    <entity charOffset="263-304" id="s5431.e1" ontology_id="GO_0008284" text="positive regulation of cell proliferation" type="GO"/>
    <pair e1="s5431.e0" e2="s5431.e1" id="s5431.p0" relation="false"/>
  </sentence>
  <sentence id="s5432" text="Here, we investigated whether synonymous changes could affect expression of the potassium voltage-gated channel subfamily H member 2 (&lt;i&gt;KCNH2&lt;/i&gt;) gene, encoding the human ether-a-go-go-related gene (cellular response to drug) ion channel, which is linked to hereditary cardiac arrhythmia.">
    <entity charOffset="201-226" id="s5432.e0" ontology_id="GO_0035690" text="cellular response to drug" type="GO"/>
    <entity charOffset="271-289" id="s5432.e1" ontology_id="HP_0011675" text="cardiac arrhythmia" type="HP"/>
    <pair e1="s5432.e0" e2="s5432.e1" id="s5432.p0" relation="true"/>
  </sentence>
  <sentence id="s5433" text="Urofacial syndrome (glycosaminoglycan catabolic process) is an autosomal recessive disease with severe dysfunctional urination including urinary incontinence (UI).">
    <entity charOffset="20-55" id="s5433.e0" ontology_id="GO_0006027" text="glycosaminoglycan catabolic process" type="GO"/>
    <entity charOffset="63-82" id="s5433.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5433.e0" e2="s5433.e1" id="s5433.p0" relation="true"/>
  </sentence>
  <sentence id="s5434" text="Ltd), a vascular positive regulation of protein phosphorylationothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase inhibitor, has been proven to be safe and to significantly prolong survival in advanced chemotherapy-refractory gastric cancer.">
    <entity charOffset="17-63" id="s5434.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="243-249" id="s5434.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5434.e0" e2="s5434.e1" id="s5434.p0" relation="true"/>
  </sentence>
  <sentence id="s5435" text="Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), positive regulation of gene expression (p=.0165) mitotic cytokinesis (p=.0206), and MTAP (p=.0393).">
    <entity charOffset="17-25" id="s5435.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="108-146" id="s5435.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s5435.e0" e2="s5435.e1" id="s5435.p0" relation="true"/>
  </sentence>
  <sentence id="s5436" text="Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), positive regulation of gene expression (p=.0165) mitotic cytokinesis (p=.0206), and MTAP (p=.0393).">
    <entity charOffset="17-25" id="s5436.e0" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <entity charOffset="159-178" id="s5436.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s5436.e0" e2="s5436.e1" id="s5436.p0" relation="true"/>
  </sentence>
  <sentence id="s5437" text="We also observed a suggestive association for DNA repair (p=.002), a gene previously implicated in melanoma survival.">
    <entity charOffset="46-56" id="s5437.e0" ontology_id="GO_0006281" text="DNA repair" type="GO"/>
    <entity charOffset="101-109" id="s5437.e1" ontology_id="HP_0002861" text="melanoma" type="HP"/>
    <pair e1="s5437.e0" e2="s5437.e1" id="s5437.p0" relation="false"/>
  </sentence>
  <sentence id="s5438" text="Although MC1R carriers were represented proportionally among the four molecular tumor submuscle organ developments, these individuals accounted for 69% of ultraviolet (UV) radiation mutational signatures among triple-wild type tumors (p=.040), highlighting the increased sensitivity to UV exposure among individuals with loss-of-function variants in MC1R">
    <entity charOffset="80-85" id="s5438.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="89-113" id="s5438.e1" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <pair e1="s5438.e0" e2="s5438.e1" id="s5438.p0" relation="false"/>
  </sentence>
  <sentence id="s5439" text="We confirmed that this nonsense DNA damage response, signal transduction by p53 class mediator mutation segregated with deafness in this family.">
    <entity charOffset="32-94" id="s5439.e0" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <entity charOffset="120-128" id="s5439.e1" ontology_id="HP_0000365" text="deafness" type="HP"/>
    <pair e1="s5439.e0" e2="s5439.e1" id="s5439.p0" relation="true"/>
  </sentence>
  <sentence id="s5440" text="In conclusion, we described a novel nonsense DNA damage response, signal transduction by p53 class mediator mutation that was responsible for the hearing loss in a Brazilian family.">
    <entity charOffset="45-107" id="s5440.e0" ontology_id="GO_0030330" text="DNA damage response, signal transduction by p53 class mediator" type="GO"/>
    <entity charOffset="146-158" id="s5440.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s5440.e0" e2="s5440.e1" id="s5440.p0" relation="true"/>
  </sentence>
  <sentence id="s5441" text="Human bladder cancer (intracellular signal transduction) is one of the most commonly diagnosed malignancies worldwide.">
    <entity charOffset="14-20" id="s5441.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="22-55" id="s5441.e1" ontology_id="GO_0035556" text="intracellular signal transduction" type="GO"/>
    <pair e1="s5441.e0" e2="s5441.e1" id="s5441.p0" relation="true"/>
  </sentence>
  <sentence id="s5442" text="nervous system development is a small nuclear protein associated with intellectual disability and neural development in humans.">
    <entity charOffset="0-26" id="s5442.e0" ontology_id="GO_0007399" text="nervous system development" type="GO"/>
    <entity charOffset="70-93" id="s5442.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5442.e0" e2="s5442.e1" id="s5442.p0" relation="true"/>
  </sentence>
  <sentence id="s5443" text="We show here that histone deacetylation depletion in MYCN-driven neuroblastoma cell lines strongly induces cell death, mostly mediated by apoptotic programs.">
    <entity charOffset="18-39" id="s5443.e0" ontology_id="GO_0016575" text="histone deacetylation" type="GO"/>
    <entity charOffset="65-78" id="s5443.e1" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <pair e1="s5443.e0" e2="s5443.e1" id="s5443.p0" relation="false"/>
  </sentence>
  <sentence id="s5444" text="Our study identified a group of cell cycle-promoting genes regulated by histone deacetylation, being both predictors of unfavorable patient outcome and essential for tumor cell viability.">
    <entity charOffset="72-93" id="s5444.e0" ontology_id="GO_0016575" text="histone deacetylation" type="GO"/>
    <entity charOffset="166-171" id="s5444.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5444.e0" e2="s5444.e1" id="s5444.p0" relation="false"/>
  </sentence>
  <sentence id="s5445" text="Mutations in GJB2 or apoptotic process and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -hearing loss syndromes were not detected by Sanger sequencing.">
    <entity charOffset="21-38" id="s5445.e0" ontology_id="GO_0006915" text="apoptotic process" type="GO"/>
    <entity charOffset="155-167" id="s5445.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s5445.e0" e2="s5445.e1" id="s5445.p0" relation="true"/>
  </sentence>
  <sentence id="s5446" text="Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of peptidyl-threonine dephosphorylation substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.">
    <entity charOffset="13-18" id="s5446.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="84-120" id="s5446.e1" ontology_id="GO_0035970" text="peptidyl-threonine dephosphorylation" type="GO"/>
    <pair e1="s5446.e0" e2="s5446.e1" id="s5446.p0" relation="true"/>
  </sentence>
  <sentence id="s5447" text="To retrospectively analyze and quantitatively correlate UGT1A1 (bilirubin UDP- glucuronosyltransferase gene) genomuscle organ developments and unconjugated hyperbilirubinemia (UCH) phenotypes among Chinese children.We retrospectively reviewed UCH patients, quantitatively analyzed genotype-phenotype correlation by comparing with healthy controls.">
    <entity charOffset="113-137" id="s5447.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="156-174" id="s5447.e1" ontology_id="HP_0002904" text="hyperbilirubinemia" type="HP"/>
    <pair e1="s5447.e0" e2="s5447.e1" id="s5447.p0" relation="false"/>
  </sentence>
  <sentence id="s5448" text="Although fatty acid beta-oxidation is responsible for X-linked fatty acid beta-oxidation (X-fatty acid beta-oxidation), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="9-34" id="s5448.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="280-297" id="s5448.e1" ontology_id="HP_0001410" text="liver dysfunction" type="HP"/>
    <pair e1="s5448.e0" e2="s5448.e1" id="s5448.p0" relation="false"/>
  </sentence>
  <sentence id="s5449" text="Although fatty acid beta-oxidation is responsible for X-linked fatty acid beta-oxidation (X-fatty acid beta-oxidation), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="9-34" id="s5449.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="299-310" id="s5449.e1" ontology_id="HP_0001396" text="cholestasis" type="HP"/>
    <pair e1="s5449.e0" e2="s5449.e1" id="s5449.p0" relation="false"/>
  </sentence>
  <sentence id="s5450" text="Although fatty acid beta-oxidation is responsible for X-linked fatty acid beta-oxidation (X-fatty acid beta-oxidation), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="63-88" id="s5450.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="299-310" id="s5450.e1" ontology_id="HP_0001396" text="cholestasis" type="HP"/>
    <pair e1="s5450.e0" e2="s5450.e1" id="s5450.p0" relation="false"/>
  </sentence>
  <sentence id="s5451" text="Although fatty acid beta-oxidation is responsible for X-linked fatty acid beta-oxidation (X-fatty acid beta-oxidation), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="92-117" id="s5451.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="280-297" id="s5451.e1" ontology_id="HP_0001410" text="liver dysfunction" type="HP"/>
    <pair e1="s5451.e0" e2="s5451.e1" id="s5451.p0" relation="false"/>
  </sentence>
  <sentence id="s5452" text="Although fatty acid beta-oxidation is responsible for X-linked fatty acid beta-oxidation (X-fatty acid beta-oxidation), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.">
    <entity charOffset="92-117" id="s5452.e0" ontology_id="GO_0006635" text="fatty acid beta-oxidation" type="GO"/>
    <entity charOffset="299-310" id="s5452.e1" ontology_id="HP_0001396" text="cholestasis" type="HP"/>
    <pair e1="s5452.e0" e2="s5452.e1" id="s5452.p0" relation="false"/>
  </sentence>
  <sentence id="s5453" text="Lastly, a syndromic form of motile cilium assembly with retinal degeneration results in normal ciliary ultrastructure through mutations in the visual perception gene.">
    <entity charOffset="28-50" id="s5453.e0" ontology_id="GO_0044458" text="motile cilium assembly" type="GO"/>
    <entity charOffset="56-76" id="s5453.e1" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <pair e1="s5453.e0" e2="s5453.e1" id="s5453.p0" relation="false"/>
  </sentence>
  <sentence id="s5454" text="Lastly, a syndromic form of motile cilium assembly with retinal degeneration results in normal ciliary ultrastructure through mutations in the visual perception gene.">
    <entity charOffset="56-76" id="s5454.e0" ontology_id="HP_0000546" text="retinal degeneration" type="HP"/>
    <entity charOffset="143-160" id="s5454.e1" ontology_id="GO_0007601" text="visual perception" type="GO"/>
    <pair e1="s5454.e0" e2="s5454.e1" id="s5454.p0" relation="true"/>
  </sentence>
  <sentence id="s5455" text="Mutations and post-translational modifications of negative regulation of ATPase activity may lead to dilated cardiomyopathy (DCM) and heart failure.">
    <entity charOffset="50-88" id="s5455.e0" ontology_id="GO_0032780" text="negative regulation of ATPase activity" type="GO"/>
    <entity charOffset="134-147" id="s5455.e1" ontology_id="HP_0001635" text="heart failure" type="HP"/>
    <pair e1="s5455.e0" e2="s5455.e1" id="s5455.p0" relation="true"/>
  </sentence>
  <sentence id="s5456" text="Here we cellular response to interleukin-4 that a lymphocyte lineage-restricted transcription factor, positive regulation of transcription by RNA polymerase II, is frequently expressed in human lung cancer tissues.">
    <entity charOffset="8-42" id="s5456.e0" ontology_id="GO_0071353" text="cellular response to interleukin-4" type="GO"/>
    <entity charOffset="199-205" id="s5456.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5456.e0" e2="s5456.e1" id="s5456.p0" relation="false"/>
  </sentence>
  <sentence id="s5457" text="Here we cellular response to interleukin-4 that a lymphocyte lineage-restricted transcription factor, positive regulation of transcription by RNA polymerase II, is frequently expressed in human lung cancer tissues.">
    <entity charOffset="102-159" id="s5457.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="199-205" id="s5457.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5457.e0" e2="s5457.e1" id="s5457.p0" relation="true"/>
  </sentence>
  <sentence id="s5458" text="The Spi-B-expressing cancer cells coexpressed vimentin but repressed E-integrin-mediated signaling pathway and exhibited invasive behavior.">
    <entity charOffset="21-27" id="s5458.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="71-106" id="s5458.e1" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <pair e1="s5458.e0" e2="s5458.e1" id="s5458.p0" relation="false"/>
  </sentence>
  <sentence id="s5459" text="Increased positive regulation of transcription by RNA polymerase II expression was associated with tumor grade, lymphatic metastasis, and short overall survival.">
    <entity charOffset="10-67" id="s5459.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="99-104" id="s5459.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5459.e0" e2="s5459.e1" id="s5459.p0" relation="true"/>
  </sentence>
  <sentence id="s5460" text="These data suggest that positive regulation of transcription by RNA polymerase II participates in mesenchymal invasion, linking epithelial cancer metastasis with a lymphatic transcriptional program.">
    <entity charOffset="24-81" id="s5460.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="139-145" id="s5460.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5460.e0" e2="s5460.e1" id="s5460.p0" relation="true"/>
  </sentence>
  <sentence id="s5461" text="Global gene expression profiling studies were carried out using cancer cells and surrogate tissues, such as whole blood and skin, to identify genes that are modulated by central nervous system development family proteins.">
    <entity charOffset="64-70" id="s5461.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="170-204" id="s5461.e1" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <pair e1="s5461.e0" e2="s5461.e1" id="s5461.p0" relation="false"/>
  </sentence>
  <sentence id="s5462" text="Candidate markers were further characterized for concentration- and time-dependent responses to the central nervous system development inhibitor ABBV-075 in vitro and in vivo negative regulation of transcription by RNA polymerase II was found to be the only gene that exhibited robust and consistent modulation by BET inhibitors across multiple cancer indications and surrogate tissues.">
    <entity charOffset="100-134" id="s5462.e0" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <entity charOffset="345-351" id="s5462.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5462.e0" e2="s5462.e1" id="s5462.p0" relation="false"/>
  </sentence>
  <sentence id="s5463" text="Candidate markers were further characterized for concentration- and time-dependent responses to the central nervous system development inhibitor ABBV-075 in vitro and in vivo negative regulation of transcription by RNA polymerase II was found to be the only gene that exhibited robust and consistent modulation by BET inhibitors across multiple cancer indications and surrogate tissues.">
    <entity charOffset="175-232" id="s5463.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="345-351" id="s5463.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5463.e0" e2="s5463.e1" id="s5463.p0" relation="false"/>
  </sentence>
  <sentence id="s5464" text="Markers such as positive regulation of neuron projection development, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="16-68" id="s5464.e0" ontology_id="GO_0010976" text="positive regulation of neuron projection development" type="GO"/>
    <entity charOffset="191-197" id="s5464.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5464.e0" e2="s5464.e1" id="s5464.p0" relation="false"/>
  </sentence>
  <sentence id="s5465" text="Markers such as positive regulation of neuron projection development, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="16-68" id="s5465.e0" ontology_id="GO_0010976" text="positive regulation of neuron projection development" type="GO"/>
    <entity charOffset="223-229" id="s5465.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5465.e0" e2="s5465.e1" id="s5465.p0" relation="false"/>
  </sentence>
  <sentence id="s5466" text="Markers such as positive regulation of neuron projection development, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="70-88" id="s5466.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="191-197" id="s5466.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5466.e0" e2="s5466.e1" id="s5466.p0" relation="false"/>
  </sentence>
  <sentence id="s5467" text="Markers such as positive regulation of neuron projection development, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.">
    <entity charOffset="94-131" id="s5467.e0" ontology_id="GO_0030336" text="negative regulation of cell migration" type="GO"/>
    <entity charOffset="191-197" id="s5467.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5467.e0" e2="s5467.e1" id="s5467.p0" relation="false"/>
  </sentence>
  <sentence id="s5468" text="Significant downregulation of negative regulation of transcription by RNA polymerase II, a well-publicized target of central nervous system development inhibitors, was largely restricted to hematologic cancer cell lines.">
    <entity charOffset="30-87" id="s5468.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="202-208" id="s5468.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5468.e0" e2="s5468.e1" id="s5468.p0" relation="true"/>
  </sentence>
  <sentence id="s5469" text="Significant downregulation of negative regulation of transcription by RNA polymerase II, a well-publicized target of central nervous system development inhibitors, was largely restricted to hematologic cancer cell lines.">
    <entity charOffset="117-151" id="s5469.e0" ontology_id="GO_0007417" text="central nervous system development" type="GO"/>
    <entity charOffset="202-208" id="s5469.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5469.e0" e2="s5469.e1" id="s5469.p0" relation="false"/>
  </sentence>
  <sentence id="s5470" text="Until recently, four loci (purine nucleobase metabolic process, DFN3, DFN4, and striated muscle contraction) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.">
    <entity charOffset="27-62" id="s5470.e0" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <entity charOffset="154-166" id="s5470.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s5470.e0" e2="s5470.e1" id="s5470.p0" relation="true"/>
  </sentence>
  <sentence id="s5471" text="Until recently, four loci (purine nucleobase metabolic process, DFN3, DFN4, and striated muscle contraction) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.">
    <entity charOffset="80-107" id="s5471.e0" ontology_id="GO_0006941" text="striated muscle contraction" type="GO"/>
    <entity charOffset="154-166" id="s5471.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s5471.e0" e2="s5471.e1" id="s5471.p0" relation="true"/>
  </sentence>
  <sentence id="s5472" text="In addition to the cochlea morphogenesis gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, purine nucleobase metabolic process, has recently been identified to be the causative gene of purine nucleobase metabolic process (purine nucleobase metabolic process).">
    <entity charOffset="19-40" id="s5472.e0" ontology_id="GO_0090103" text="cochlea morphogenesis" type="GO"/>
    <entity charOffset="116-128" id="s5472.e1" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <pair e1="s5472.e0" e2="s5472.e1" id="s5472.p0" relation="true"/>
  </sentence>
  <sentence id="s5473" text="In addition to the cochlea morphogenesis gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, purine nucleobase metabolic process, has recently been identified to be the causative gene of purine nucleobase metabolic process (purine nucleobase metabolic process).">
    <entity charOffset="116-128" id="s5473.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="276-311" id="s5473.e1" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <pair e1="s5473.e0" e2="s5473.e1" id="s5473.p0" relation="true"/>
  </sentence>
  <sentence id="s5474" text="In addition to the cochlea morphogenesis gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, purine nucleobase metabolic process, has recently been identified to be the causative gene of purine nucleobase metabolic process (purine nucleobase metabolic process).">
    <entity charOffset="116-128" id="s5474.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="145-180" id="s5474.e1" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <pair e1="s5474.e0" e2="s5474.e1" id="s5474.p0" relation="true"/>
  </sentence>
  <sentence id="s5475" text="In addition to the cochlea morphogenesis gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, purine nucleobase metabolic process, has recently been identified to be the causative gene of purine nucleobase metabolic process (purine nucleobase metabolic process).">
    <entity charOffset="116-128" id="s5475.e0" ontology_id="HP_0000365" text="hearing loss" type="HP"/>
    <entity charOffset="239-274" id="s5475.e1" ontology_id="GO_0006144" text="purine nucleobase metabolic process" type="GO"/>
    <pair e1="s5475.e0" e2="s5475.e1" id="s5475.p0" relation="true"/>
  </sentence>
  <sentence id="s5476" text="Bone morphogenetic protein7(positive regulation of gene expression), a member of the BMP family of signaling molecules, has been implicated in various types of cancer, particularly prostate cancer and breast cancer.">
    <entity charOffset="30-68" id="s5476.e0" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <entity charOffset="162-168" id="s5476.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5476.e0" e2="s5476.e1" id="s5476.p0" relation="false"/>
  </sentence>
  <sentence id="s5477" text="80.5% of luminal-type tumours developed bone metastasis as opposed to 41.7% of basal and 55.6% of signal transduction-like tumours.">
    <entity charOffset="23-30" id="s5477.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="101-120" id="s5477.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="s5477.e0" e2="s5477.e1" id="s5477.p0" relation="true"/>
  </sentence>
  <sentence id="s5478" text="A novel 15-gene signature identified 82.4% of the tumours with bone metastasis, 85.2% of the tumours which had bone metastasis as first site of metastasis and 100% of the ones with bone metastasis only (p 9.99e-09), in the training negative regulation of transcription, DNA-templated.">
    <entity charOffset="51-58" id="s5478.e0" ontology_id="HP_0002664" text="tumours" type="HP"/>
    <entity charOffset="235-286" id="s5478.e1" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <pair e1="s5478.e0" e2="s5478.e1" id="s5478.p0" relation="false"/>
  </sentence>
  <sentence id="s5479" text="The expression levels of the up-regulated genes (regulation of translational initiation, retina homeostasis and PH-4) were also found to be correlated to epithelial to mesenchymal transition status of the tumour.">
    <entity charOffset="49-87" id="s5479.e0" ontology_id="GO_0006446" text="regulation of translational initiation" type="GO"/>
    <entity charOffset="205-211" id="s5479.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s5479.e0" e2="s5479.e1" id="s5479.p0" relation="false"/>
  </sentence>
  <sentence id="s5480" text="The expression levels of the up-regulated genes (regulation of translational initiation, retina homeostasis and PH-4) were also found to be correlated to epithelial to mesenchymal transition status of the tumour.">
    <entity charOffset="89-107" id="s5480.e0" ontology_id="GO_0001895" text="retina homeostasis" type="GO"/>
    <entity charOffset="205-211" id="s5480.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s5480.e0" e2="s5480.e1" id="s5480.p0" relation="false"/>
  </sentence>
  <sentence id="s5481" text="regulation of proteolysis was identified as a genetic modifier of muscular dystrophy in mice and humans.">
    <entity charOffset="0-25" id="s5481.e0" ontology_id="GO_0030162" text="regulation of proteolysis" type="GO"/>
    <entity charOffset="66-84" id="s5481.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s5481.e0" e2="s5481.e1" id="s5481.p0" relation="false"/>
  </sentence>
  <sentence id="s5482" text="An in-frame insertion polymorphism in the murine regulation of proteolysis gene associates with partial protection against muscular dystrophy.">
    <entity charOffset="49-74" id="s5482.e0" ontology_id="GO_0030162" text="regulation of proteolysis" type="GO"/>
    <entity charOffset="123-141" id="s5482.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s5482.e0" e2="s5482.e1" id="s5482.p0" relation="false"/>
  </sentence>
  <sentence id="s5483" text="In humans, nonsynonymous single nucleotide polymorphisms in regulation of proteolysis associate with prolonged ambulation in Duchenne muscular dystrophy.">
    <entity charOffset="60-85" id="s5483.e0" ontology_id="GO_0030162" text="regulation of proteolysis" type="GO"/>
    <entity charOffset="134-152" id="s5483.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s5483.e0" e2="s5483.e1" id="s5483.p0" relation="false"/>
  </sentence>
  <sentence id="s5484" text="In order to assess the effects of regulation of proteolysis in muscular dystrophy, LTBP4 overexpressing epidermis development were bred to mdx mice, a model of Duchenne muscular dystrophy.">
    <entity charOffset="34-59" id="s5484.e0" ontology_id="GO_0030162" text="regulation of proteolysis" type="GO"/>
    <entity charOffset="63-81" id="s5484.e1" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <pair e1="s5484.e0" e2="s5484.e1" id="s5484.p0" relation="false"/>
  </sentence>
  <sentence id="s5485" text="In order to assess the effects of regulation of proteolysis in muscular dystrophy, LTBP4 overexpressing epidermis development were bred to mdx mice, a model of Duchenne muscular dystrophy.">
    <entity charOffset="63-81" id="s5485.e0" ontology_id="HP_0003560" text="muscular dystrophy" type="HP"/>
    <entity charOffset="104-125" id="s5485.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s5485.e0" e2="s5485.e1" id="s5485.p0" relation="false"/>
  </sentence>
  <sentence id="s5486" text="Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and phosphatidylinositol biosynthetic process (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.">
    <entity charOffset="104-112" id="s5486.e0" ontology_id="HP_0003198" text="myopathy" type="HP"/>
    <entity charOffset="171-212" id="s5486.e1" ontology_id="GO_0006661" text="phosphatidylinositol biosynthetic process" type="GO"/>
    <pair e1="s5486.e0" e2="s5486.e1" id="s5486.p0" relation="true"/>
  </sentence>
  <sentence id="s5487" text="a small fraction of the breast cancer burden, mutations in the double-strand break repair via homologous recombination and mitotic cytokinesis genes are known to confer a high">
    <entity charOffset="31-37" id="s5487.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="63-118" id="s5487.e1" ontology_id="GO_0000724" text="double-strand break repair via homologous recombination" type="GO"/>
    <pair e1="s5487.e0" e2="s5487.e1" id="s5487.p0" relation="true"/>
  </sentence>
  <sentence id="s5488" text="a small fraction of the breast cancer burden, mutations in the double-strand break repair via homologous recombination and mitotic cytokinesis genes are known to confer a high">
    <entity charOffset="31-37" id="s5488.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="123-142" id="s5488.e1" ontology_id="GO_0000281" text="mitotic cytokinesis" type="GO"/>
    <pair e1="s5488.e0" e2="s5488.e1" id="s5488.p0" relation="true"/>
  </sentence>
  <sentence id="s5489" text="studies have shown that mutations in the regulation of transcription, DNA-templated gene are involved in breast cancer susceptibility due to its impact">
    <entity charOffset="41-83" id="s5489.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="112-118" id="s5489.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5489.e0" e2="s5489.e1" id="s5489.p0" relation="true"/>
  </sentence>
  <sentence id="s5490" text="germline mutations in regulation of transcription, DNA-templated gene (c.1100delC, R145W and I157T) in breast cancers in Rwanda.">
    <entity charOffset="22-64" id="s5490.e0" ontology_id="GO_0006355" text="regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="110-116" id="s5490.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5490.e0" e2="s5490.e1" id="s5490.p0" relation="true"/>
  </sentence>
  <sentence id="s5491" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed mitochondrial translational elongation rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), transcription-coupled nucleotide-excision repair rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s5491.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="132-170" id="s5491.e1" ontology_id="GO_0070125" text="mitochondrial translational elongation" type="GO"/>
    <pair e1="s5491.e0" e2="s5491.e1" id="s5491.p0" relation="false"/>
  </sentence>
  <sentence id="s5492" text="Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed mitochondrial translational elongation rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), transcription-coupled nucleotide-excision repair rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.">
    <entity charOffset="49-55" id="s5492.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="306-354" id="s5492.e1" ontology_id="GO_0006283" text="transcription-coupled nucleotide-excision repair" type="GO"/>
    <pair e1="s5492.e0" e2="s5492.e1" id="s5492.p0" relation="true"/>
  </sentence>
  <sentence id="s5493" text="We found that rs1042752-located in the 3'-UTR of POU2AF1, which plays a vital role in lymphomagenesis-actin filament polymerization significantly associated with lymphoma risk in a case-control study with 793 patients and 939 controls.">
    <entity charOffset="86-94" id="s5493.e0" ontology_id="HP_0002665" text="lymphoma" type="HP"/>
    <entity charOffset="102-131" id="s5493.e1" ontology_id="GO_0030041" text="actin filament polymerization" type="GO"/>
    <pair e1="s5493.e0" e2="s5493.e1" id="s5493.p0" relation="true"/>
  </sentence>
  <sentence id="s5494" text="Cystinuria is a heterogeneous, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: SLC3A1 and neutral amino acid transport.">
    <entity charOffset="16-29" id="s5494.e0" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <entity charOffset="130-158" id="s5494.e1" ontology_id="GO_0015804" text="neutral amino acid transport" type="GO"/>
    <pair e1="s5494.e0" e2="s5494.e1" id="s5494.p0" relation="false"/>
  </sentence>
  <sentence id="s5495" text="We report 83 patients affected by cystinuria: 44 presented prenatally with a establishment of mitotic spindle orientation (HEC group) and 39 with a classical postnatal form (CC group).">
    <entity charOffset="34-44" id="s5495.e0" ontology_id="HP_0003131" text="cystinuria" type="HP"/>
    <entity charOffset="77-121" id="s5495.e1" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <pair e1="s5495.e0" e2="s5495.e1" id="s5495.p0" relation="false"/>
  </sentence>
  <sentence id="s5496" text="This study shows a relationship between genotype and the clinical form of cystinuria, suggesting that only the patients with the most severe mutations presented with an establishment of mitotic spindle orientation.">
    <entity charOffset="74-84" id="s5496.e0" ontology_id="HP_0003131" text="cystinuria" type="HP"/>
    <entity charOffset="169-213" id="s5496.e1" ontology_id="GO_0000132" text="establishment of mitotic spindle orientation" type="GO"/>
    <pair e1="s5496.e0" e2="s5496.e1" id="s5496.p0" relation="false"/>
  </sentence>
  <sentence id="s5497" text="PM were loaded with a siRNA against positive regulation of cell migration, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy.">
    <entity charOffset="36-73" id="s5497.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="116-122" id="s5497.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5497.e0" e2="s5497.e1" id="s5497.p0" relation="false"/>
  </sentence>
  <sentence id="s5498" text="PM were loaded with a siRNA against positive regulation of cell migration, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy.">
    <entity charOffset="36-73" id="s5498.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="123-128" id="s5498.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5498.e0" e2="s5498.e1" id="s5498.p0" relation="false"/>
  </sentence>
  <sentence id="s5499" text="Efficacy of sipositive regulation of cell migration-PM was validated in CSC isolated from two breast cancer cell lines: MCF-7 and Triple Negative MDA-MB-231 corresponding to an aggressive subtype of breast cancer.">
    <entity charOffset="14-51" id="s5499.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="101-107" id="s5499.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5499.e0" e2="s5499.e1" id="s5499.p0" relation="false"/>
  </sentence>
  <sentence id="s5500" text="These results prompt positive regulation of cell migration inhibition as a powerful therapeutic target against CSC and pave the way to the appearance of more effective nanomedicine-based gene therapies aimed to prevent CSC-related tumor recurrence">
    <entity charOffset="21-58" id="s5500.e0" ontology_id="GO_0030335" text="positive regulation of cell migration" type="GO"/>
    <entity charOffset="231-236" id="s5500.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="s5500.e0" e2="s5500.e1" id="s5500.p0" relation="false"/>
  </sentence>
  <sentence id="s5501" text="These studies suggest that compound 4d behaves well in lowering body weight and maintaining energy expenditure without a chance of hyperglycaemia, 4d has strong clinical potential as an efficient biological_process-1/GCGR agonist in the prevention and treatment of obesity and dyslipidemia">
    <entity charOffset="196-214" id="s5501.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="265-272" id="s5501.e1" ontology_id="HP_0001513" text="obesity" type="HP"/>
    <pair e1="s5501.e0" e2="s5501.e1" id="s5501.p0" relation="false"/>
  </sentence>
  <sentence id="s5502" text="Finally, we reveal that papillary craniopharyngioma (biological_process), a benign human pituitary tumour harbouring &lt;i&gt;BRAF p.V600E&lt;/i&gt; also contains Sox2&lt;sup&gt;+&lt;/sup&gt; cells with sustained proliferative capacity and disrupted pituitary differentiation.">
    <entity charOffset="53-71" id="s5502.e0" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <entity charOffset="99-105" id="s5502.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="s5502.e0" e2="s5502.e1" id="s5502.p0" relation="false"/>
  </sentence>
  <sentence id="s5503" text="response to calcium ion mutation results in a heterogeneous phenotype and care should be taken in categorization and treatment of these patients.">
    <entity charOffset="0-23" id="s5503.e0" ontology_id="GO_0051592" text="response to calcium ion" type="GO"/>
    <entity charOffset="46-59" id="s5503.e1" ontology_id="HP_0001425" text="heterogeneous" type="HP"/>
    <pair e1="s5503.e0" e2="s5503.e1" id="s5503.p0" relation="false"/>
  </sentence>
  <sentence id="s5504" text="We conducted further optimization of dual enzymatic inhibitions towards FGFR1 and peptidyl-tyrosine phosphorylation, two important kinases in lung squamous cell carcinoma.">
    <entity charOffset="82-115" id="s5504.e0" ontology_id="GO_0018108" text="peptidyl-tyrosine phosphorylation" type="GO"/>
    <entity charOffset="147-170" id="s5504.e1" ontology_id="HP_0002860" text="squamous cell carcinoma" type="HP"/>
    <pair e1="s5504.e0" e2="s5504.e1" id="s5504.p0" relation="false"/>
  </sentence>
  <sentence id="s5505" text="Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (intestinal cholesterol absorption) mutations and results in an increased risk of early-onset cardiovascular disease due to marked elevation of LDL cholesterol (LDL-C) in blood.">
    <entity charOffset="9-29" id="s5505.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="89-122" id="s5505.e1" ontology_id="GO_0030299" text="intestinal cholesterol absorption" type="GO"/>
    <pair e1="s5505.e0" e2="s5505.e1" id="s5505.p0" relation="true"/>
  </sentence>
  <sentence id="s5506" text="Statins are the first line of lipid-lowering drugs for treating FH and other types of hypercholesterolemia, but new approaches are emerging, in particular negative regulation of receptor recycling antibodies, which are now being tested in clinical trials.">
    <entity charOffset="86-106" id="s5506.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="155-196" id="s5506.e1" ontology_id="GO_0001920" text="negative regulation of receptor recycling" type="GO"/>
    <pair e1="s5506.e0" e2="s5506.e1" id="s5506.p0" relation="true"/>
  </sentence>
  <sentence id="s5507" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without positive regulation of gene expression amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="57-71" id="s5507.e0" ontology_id="HP_0000243" text="trigonocephaly" type="HP"/>
    <entity charOffset="242-280" id="s5507.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s5507.e0" e2="s5507.e1" id="s5507.p0" relation="false"/>
  </sentence>
  <sentence id="s5508" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without positive regulation of gene expression amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="114-126" id="s5508.e0" ontology_id="HP_0000601" text="hypotelorism" type="HP"/>
    <entity charOffset="242-280" id="s5508.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s5508.e0" e2="s5508.e1" id="s5508.p0" relation="false"/>
  </sentence>
  <sentence id="s5509" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without positive regulation of gene expression amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="158-170" id="s5509.e0" ontology_id="HP_0000347" text="micrognathia" type="HP"/>
    <entity charOffset="242-280" id="s5509.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s5509.e0" e2="s5509.e1" id="s5509.p0" relation="true"/>
  </sentence>
  <sentence id="s5510" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without positive regulation of gene expression amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="183-199" id="s5510.e0" ontology_id="HP_0000286" text="epicanthal folds" type="HP"/>
    <entity charOffset="242-280" id="s5510.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s5510.e0" e2="s5510.e1" id="s5510.p0" relation="true"/>
  </sentence>
  <sentence id="s5511" text="Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without positive regulation of gene expression amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.">
    <entity charOffset="220-233" id="s5511.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="242-280" id="s5511.e1" ontology_id="GO_0010628" text="positive regulation of gene expression" type="GO"/>
    <pair e1="s5511.e0" e2="s5511.e1" id="s5511.p0" relation="false"/>
  </sentence>
  <sentence id="s5512" text="Human-induced neuronal progenitor cells (iNPCs) carrying dominant and recessive diadenosine tetraphosphate biosynthetic process mutations showed alterations of mitochondrial proteins, which were more prominent in iNPCs with dominant, neuropathy-causing mutations.">
    <entity charOffset="80-127" id="s5512.e0" ontology_id="GO_0015966" text="diadenosine tetraphosphate biosynthetic process" type="GO"/>
    <entity charOffset="234-244" id="s5512.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s5512.e0" e2="s5512.e1" id="s5512.p0" relation="true"/>
  </sentence>
  <sentence id="s5513" text="Our data suggest that altered mitochondria-associated endoplasmic reticulum (ER) membranes (muscle organ development) may be important disease mechanisms leading to neuropathy in this condition">
    <entity charOffset="92-116" id="s5513.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="165-175" id="s5513.e1" ontology_id="HP_0009830" text="neuropathy" type="HP"/>
    <pair e1="s5513.e0" e2="s5513.e1" id="s5513.p0" relation="false"/>
  </sentence>
  <sentence id="s5514" text="Mucopolysaccharidosis muscle organ development IIIA (MPSIIIA), also known as Sanfilippo A syndrome, is an inherited neurodegenerative disease caused by mutations in the lysosomal enzyme, N-sulfoglucosamine sulfohydrolase (glycosaminoglycan catabolic process), also known as sulfamidase.">
    <entity charOffset="22-46" id="s5514.e0" ontology_id="GO_0007517" text="muscle organ development" type="GO"/>
    <entity charOffset="116-141" id="s5514.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="s5514.e0" e2="s5514.e1" id="s5514.p0" relation="false"/>
  </sentence>
  <sentence id="s5515" text="Mucopolysaccharidosis muscle organ development IIIA (MPSIIIA), also known as Sanfilippo A syndrome, is an inherited neurodegenerative disease caused by mutations in the lysosomal enzyme, N-sulfoglucosamine sulfohydrolase (glycosaminoglycan catabolic process), also known as sulfamidase.">
    <entity charOffset="116-141" id="s5515.e0" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <entity charOffset="222-257" id="s5515.e1" ontology_id="GO_0006027" text="glycosaminoglycan catabolic process" type="GO"/>
    <pair e1="s5515.e0" e2="s5515.e1" id="s5515.p0" relation="false"/>
  </sentence>
  <sentence id="s5516" text="Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced mice are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a tumor-associated antigen (e.g. ERBB2 or regulation of canonical Wnt signaling pathway) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.">
    <entity charOffset="228-233" id="s5516.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="268-313" id="s5516.e1" ontology_id="GO_0060828" text="regulation of canonical Wnt signaling pathway" type="GO"/>
    <pair e1="s5516.e0" e2="s5516.e1" id="s5516.p0" relation="true"/>
  </sentence>
  <sentence id="s5517" text="Mutations in human positive regulation of apoptotic process, encoding an ADAMTS-like protein which has been implicated in fibrillin microfibril biogenesis, cause ectopia lentis (EL) and EL et pupillae.">
    <entity charOffset="19-59" id="s5517.e0" ontology_id="GO_0043065" text="positive regulation of apoptotic process" type="GO"/>
    <entity charOffset="162-176" id="s5517.e1" ontology_id="HP_0001083" text="ectopia lentis" type="HP"/>
    <pair e1="s5517.e0" e2="s5517.e1" id="s5517.p0" relation="true"/>
  </sentence>
  <sentence id="s5518" text="positive regulation of transcription by RNA polymerase II-induced skin tumors were subjected to mutation screening, which identified genetic changes in regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (7/40, 17.5%) and Tp53 (2/40, 5%), but not in protein polyubiquitination, a commonly mutated gene in PhIP-induced colon tumors.">
    <entity charOffset="0-57" id="s5518.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="71-77" id="s5518.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5518.e0" e2="s5518.e1" id="s5518.p0" relation="false"/>
  </sentence>
  <sentence id="s5519" text="positive regulation of transcription by RNA polymerase II-induced skin tumors were subjected to mutation screening, which identified genetic changes in regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (7/40, 17.5%) and Tp53 (2/40, 5%), but not in protein polyubiquitination, a commonly mutated gene in PhIP-induced colon tumors.">
    <entity charOffset="71-77" id="s5519.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="152-244" id="s5519.e1" ontology_id="GO_0098696" text="regulation of neurotransmitter receptor localization to postsynaptic specialization membrane" type="GO"/>
    <pair e1="s5519.e0" e2="s5519.e1" id="s5519.p0" relation="true"/>
  </sentence>
  <sentence id="s5520" text="positive regulation of transcription by RNA polymerase II-induced skin tumors were subjected to mutation screening, which identified genetic changes in regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (7/40, 17.5%) and Tp53 (2/40, 5%), but not in protein polyubiquitination, a commonly mutated gene in PhIP-induced colon tumors.">
    <entity charOffset="71-77" id="s5520.e0" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <entity charOffset="291-317" id="s5520.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s5520.e0" e2="s5520.e1" id="s5520.p0" relation="true"/>
  </sentence>
  <sentence id="s5521" text="Despite the absence of protein polyubiquitination mutations, -catenin was overexpressed in nuclear and plasma membrane fractions from positive regulation of transcription by RNA polymerase II-induced skin tumors, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts.">
    <entity charOffset="23-49" id="s5521.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="206-212" id="s5521.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5521.e0" e2="s5521.e1" id="s5521.p0" relation="true"/>
  </sentence>
  <sentence id="s5522" text="Despite the absence of protein polyubiquitination mutations, -catenin was overexpressed in nuclear and plasma membrane fractions from positive regulation of transcription by RNA polymerase II-induced skin tumors, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts.">
    <entity charOffset="135-192" id="s5522.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="206-212" id="s5522.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5522.e0" e2="s5522.e1" id="s5522.p0" relation="false"/>
  </sentence>
  <sentence id="s5523" text="Real-time RT-PCR revealed that p120-catenin isoforms 1 and 4 were upregulated in positive regulation of transcription by RNA polymerase II-induced skin tumors, whereas p120-catenin isoform 3 was expressed uniformly, compared with adjacent normal-looking tissue.">
    <entity charOffset="81-138" id="s5523.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="152-158" id="s5523.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5523.e0" e2="s5523.e1" id="s5523.p0" relation="false"/>
  </sentence>
  <sentence id="s5524" text="Co-immunoprecipitation experiments identified associations of -catenin with p120-catenin isoforms in positive regulation of transcription by RNA polymerase II-induced skin tumors and human cancer cell lines.">
    <entity charOffset="102-159" id="s5524.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="173-179" id="s5524.e1" ontology_id="HP_0002664" text="tumors" type="HP"/>
    <pair e1="s5524.e0" e2="s5524.e1" id="s5524.p0" relation="false"/>
  </sentence>
  <sentence id="s5525" text="Co-immunoprecipitation experiments identified associations of -catenin with p120-catenin isoforms in positive regulation of transcription by RNA polymerase II-induced skin tumors and human cancer cell lines.">
    <entity charOffset="102-159" id="s5525.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="190-196" id="s5525.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5525.e0" e2="s5525.e1" id="s5525.p0" relation="false"/>
  </sentence>
  <sentence id="s5526" text="In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or axon guidance being the most common.">
    <entity charOffset="27-39" id="s5526.e0" ontology_id="HP_0000528" text="anophthalmia" type="HP"/>
    <entity charOffset="206-219" id="s5526.e1" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <pair e1="s5526.e0" e2="s5526.e1" id="s5526.p0" relation="true"/>
  </sentence>
  <sentence id="s5527" text="In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or axon guidance being the most common.">
    <entity charOffset="50-64" id="s5527.e0" ontology_id="HP_0000568" text="microphthalmia" type="HP"/>
    <entity charOffset="206-219" id="s5527.e1" ontology_id="GO_0007411" text="axon guidance" type="GO"/>
    <pair e1="s5527.e0" e2="s5527.e1" id="s5527.p0" relation="true"/>
  </sentence>
  <sentence id="s5528" text="After its downregulation in neuroblastoma cells and in brains of biological_process-deficient epidermis development, membrane protein ectodomain proteolysis and regulation of presynapse assembly levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.">
    <entity charOffset="28-41" id="s5528.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="117-156" id="s5528.e1" ontology_id="GO_0006509" text="membrane protein ectodomain proteolysis" type="GO"/>
    <pair e1="s5528.e0" e2="s5528.e1" id="s5528.p0" relation="false"/>
  </sentence>
  <sentence id="s5529" text="After its downregulation in neuroblastoma cells and in brains of biological_process-deficient epidermis development, membrane protein ectodomain proteolysis and regulation of presynapse assembly levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.">
    <entity charOffset="28-41" id="s5529.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="161-194" id="s5529.e1" ontology_id="GO_1905606" text="regulation of presynapse assembly" type="GO"/>
    <pair e1="s5529.e0" e2="s5529.e1" id="s5529.p0" relation="false"/>
  </sentence>
  <sentence id="s5530" text="After its downregulation in neuroblastoma cells and in brains of biological_process-deficient epidermis development, membrane protein ectodomain proteolysis and regulation of presynapse assembly levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.">
    <entity charOffset="28-41" id="s5530.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="65-83" id="s5530.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s5530.e0" e2="s5530.e1" id="s5530.p0" relation="false"/>
  </sentence>
  <sentence id="s5531" text="After its downregulation in neuroblastoma cells and in brains of biological_process-deficient epidermis development, membrane protein ectodomain proteolysis and regulation of presynapse assembly levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.">
    <entity charOffset="28-41" id="s5531.e0" ontology_id="HP_0003006" text="neuroblastoma" type="HP"/>
    <entity charOffset="94-115" id="s5531.e1" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <pair e1="s5531.e0" e2="s5531.e1" id="s5531.p0" relation="false"/>
  </sentence>
  <sentence id="s5532" text="Deregulated monoubiquitination of histone H2B (H2Bub1), mainly catalyzed by E3 ubiquitin-protein ligase protein polyubiquitination/RNF40 complex, may play an important role in cancer.">
    <entity charOffset="104-130" id="s5532.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="176-182" id="s5532.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5532.e0" e2="s5532.e1" id="s5532.p0" relation="false"/>
  </sentence>
  <sentence id="s5533" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as positive regulation of protein phosphorylation, E2F1/2, HOXA1, protein polyubiquitination modifying factor (negative regulation of autophagy), Met, and negative regulation of transcription by RNA polymerase II; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, integrin-mediated signaling pathway, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s5533.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="109-155" id="s5533.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="s5533.e0" e2="s5533.e1" id="s5533.p0" relation="false"/>
  </sentence>
  <sentence id="s5534" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as positive regulation of protein phosphorylation, E2F1/2, HOXA1, protein polyubiquitination modifying factor (negative regulation of autophagy), Met, and negative regulation of transcription by RNA polymerase II; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, integrin-mediated signaling pathway, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s5534.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="172-198" id="s5534.e1" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <pair e1="s5534.e0" e2="s5534.e1" id="s5534.p0" relation="true"/>
  </sentence>
  <sentence id="s5535" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as positive regulation of protein phosphorylation, E2F1/2, HOXA1, protein polyubiquitination modifying factor (negative regulation of autophagy), Met, and negative regulation of transcription by RNA polymerase II; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, integrin-mediated signaling pathway, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s5535.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="217-249" id="s5535.e1" ontology_id="GO_0010507" text="negative regulation of autophagy" type="GO"/>
    <pair e1="s5535.e0" e2="s5535.e1" id="s5535.p0" relation="false"/>
  </sentence>
  <sentence id="s5536" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as positive regulation of protein phosphorylation, E2F1/2, HOXA1, protein polyubiquitination modifying factor (negative regulation of autophagy), Met, and negative regulation of transcription by RNA polymerase II; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, integrin-mediated signaling pathway, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s5536.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="261-318" id="s5536.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <pair e1="s5536.e0" e2="s5536.e1" id="s5536.p0" relation="true"/>
  </sentence>
  <sentence id="s5537" text="Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as positive regulation of protein phosphorylation, E2F1/2, HOXA1, protein polyubiquitination modifying factor (negative regulation of autophagy), Met, and negative regulation of transcription by RNA polymerase II; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, integrin-mediated signaling pathway, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.">
    <entity charOffset="78-83" id="s5537.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="423-458" id="s5537.e1" ontology_id="GO_0007229" text="integrin-mediated signaling pathway" type="GO"/>
    <pair e1="s5537.e0" e2="s5537.e1" id="s5537.p0" relation="false"/>
  </sentence>
  <sentence id="s5538" text="Moreover, protein polyubiquitination knockdown dramatically suppresses terminal squamous differentiation of cultured bronchial epithelial cells, and significantly enhances proliferation, migration, invasion, and cisplatin resistance of lung cancer cells.">
    <entity charOffset="10-36" id="s5538.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="241-247" id="s5538.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5538.e0" e2="s5538.e1" id="s5538.p0" relation="false"/>
  </sentence>
  <sentence id="s5539" text="Consistent with our description of this pathway and the phenotype of patients with FGD1 mutations, epidermis development with a targeted deletion of protein phosphorylation displayed multiple skeletal defects, including dental abnormalities, deficient calvarial mineralization, and reduced bone mass.">
    <entity charOffset="99-120" id="s5539.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="220-240" id="s5539.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s5539.e0" e2="s5539.e1" id="s5539.p0" relation="false"/>
  </sentence>
  <sentence id="s5540" text="Consistent with our description of this pathway and the phenotype of patients with FGD1 mutations, epidermis development with a targeted deletion of protein phosphorylation displayed multiple skeletal defects, including dental abnormalities, deficient calvarial mineralization, and reduced bone mass.">
    <entity charOffset="149-172" id="s5540.e0" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="220-240" id="s5540.e1" ontology_id="HP_0000164" text="dental abnormalities" type="HP"/>
    <pair e1="s5540.e0" e2="s5540.e1" id="s5540.p0" relation="false"/>
  </sentence>
  <sentence id="s5541" text="Very recently, negative regulation of translation mutations were reported to cause intellectual disability with growth retardation.">
    <entity charOffset="15-49" id="s5541.e0" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <entity charOffset="83-106" id="s5541.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5541.e0" e2="s5541.e1" id="s5541.p0" relation="false"/>
  </sentence>
  <sentence id="s5542" text="We describe two families in which two different homozygous negative regulation of translation mutations (missense and frameshift deletion) segregate with a phenotype comprising intellectual disability and progressive microcephaly.">
    <entity charOffset="59-93" id="s5542.e0" ontology_id="GO_0017148" text="negative regulation of translation" type="GO"/>
    <entity charOffset="177-200" id="s5542.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
    <pair e1="s5542.e0" e2="s5542.e1" id="s5542.p0" relation="false"/>
  </sentence>
  <sentence id="s5543" text="Bowen-Conradi syndrome (mitochondrion organization) is an autosomal-recessive disorder characterized by severely impaired prenatal and postnatal growth, profound psychomotor retardation, and death in early childhood.">
    <entity charOffset="24-50" id="s5543.e0" ontology_id="GO_0007005" text="mitochondrion organization" type="GO"/>
    <entity charOffset="153-161" id="s5543.e1" ontology_id="HP_0012829" text="profound" type="HP"/>
    <pair e1="s5543.e0" e2="s5543.e1" id="s5543.p0" relation="false"/>
  </sentence>
  <sentence id="s5544" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="12-17" id="s5544.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="147-174" id="s5544.e1" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <pair e1="s5544.e0" e2="s5544.e1" id="s5544.p0" relation="true"/>
  </sentence>
  <sentence id="s5545" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="12-17" id="s5545.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="176-200" id="s5545.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s5545.e0" e2="s5545.e1" id="s5545.p0" relation="true"/>
  </sentence>
  <sentence id="s5546" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="12-17" id="s5546.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="228-252" id="s5546.e1" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <pair e1="s5546.e0" e2="s5546.e1" id="s5546.p0" relation="true"/>
  </sentence>
  <sentence id="s5547" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="147-174" id="s5547.e0" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <entity charOffset="338-351" id="s5547.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s5547.e0" e2="s5547.e1" id="s5547.p0" relation="true"/>
  </sentence>
  <sentence id="s5548" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="147-174" id="s5548.e0" ontology_id="GO_0006105" text="succinate metabolic process" type="GO"/>
    <entity charOffset="352-369" id="s5548.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s5548.e0" e2="s5548.e1" id="s5548.p0" relation="true"/>
  </sentence>
  <sentence id="s5549" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="202-226" id="s5549.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="352-369" id="s5549.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s5549.e0" e2="s5549.e1" id="s5549.p0" relation="true"/>
  </sentence>
  <sentence id="s5550" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="202-226" id="s5550.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="390-411" id="s5550.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s5550.e0" e2="s5550.e1" id="s5550.p0" relation="true"/>
  </sentence>
  <sentence id="s5551" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="228-252" id="s5551.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="338-351" id="s5551.e1" ontology_id="HP_0002668" text="paraganglioma" type="HP"/>
    <pair e1="s5551.e0" e2="s5551.e1" id="s5551.p0" relation="true"/>
  </sentence>
  <sentence id="s5552" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="228-252" id="s5552.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="352-369" id="s5552.e1" ontology_id="HP_0002666" text="pheochromocytomas" type="HP"/>
    <pair e1="s5552.e0" e2="s5552.e1" id="s5552.p0" relation="true"/>
  </sentence>
  <sentence id="s5553" text="An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).">
    <entity charOffset="228-252" id="s5553.e0" ontology_id="GO_0006099" text="tricarboxylic acid cycle" type="GO"/>
    <entity charOffset="390-411" id="s5553.e1" ontology_id="HP_0005584" text="renal cell carcinomas" type="HP"/>
    <pair e1="s5553.e0" e2="s5553.e1" id="s5553.p0" relation="true"/>
  </sentence>
  <sentence id="s5554" text="We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in hematopoietic progenitor cell differentiation, biological_process and leukocyte differentiation with larger effects (&amp;gt;1.5 mm Hg/allele) than common variants.">
    <entity charOffset="40-52" id="s5554.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="145-190" id="s5554.e1" ontology_id="GO_0002244" text="hematopoietic progenitor cell differentiation" type="GO"/>
    <pair e1="s5554.e0" e2="s5554.e1" id="s5554.p0" relation="false"/>
  </sentence>
  <sentence id="s5555" text="We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in hematopoietic progenitor cell differentiation, biological_process and leukocyte differentiation with larger effects (&amp;gt;1.5 mm Hg/allele) than common variants.">
    <entity charOffset="40-52" id="s5555.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="192-210" id="s5555.e1" ontology_id="GO_0008150" text="biological_process" type="GO"/>
    <pair e1="s5555.e0" e2="s5555.e1" id="s5555.p0" relation="false"/>
  </sentence>
  <sentence id="s5556" text="We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in hematopoietic progenitor cell differentiation, biological_process and leukocyte differentiation with larger effects (&amp;gt;1.5 mm Hg/allele) than common variants.">
    <entity charOffset="40-52" id="s5556.e0" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <entity charOffset="215-240" id="s5556.e1" ontology_id="GO_0002521" text="leukocyte differentiation" type="GO"/>
    <pair e1="s5556.e0" e2="s5556.e1" id="s5556.p0" relation="false"/>
  </sentence>
  <sentence id="s5557" text="Our data extend the spectrum of allelic variation underlying blood pressure negative regulation of transcription by RNA polymerase II and hypertension, provide new insights into the pathophysiology of hypertension and indicate new targets for clinical intervention">
    <entity charOffset="76-133" id="s5557.e0" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="138-150" id="s5557.e1" ontology_id="HP_0000822" text="hypertension" type="HP"/>
    <pair e1="s5557.e0" e2="s5557.e1" id="s5557.p0" relation="false"/>
  </sentence>
  <sentence id="s5558" text="Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 regulation of the force of heart contraction gene variant, and the 71098693 epithelial cell development gene variant were found to be significantly associated with sporadic ASD (P&amp;lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&amp;lt;510^-4).">
    <entity charOffset="90-134" id="s5558.e0" ontology_id="GO_0002026" text="regulation of the force of heart contraction" type="GO"/>
    <entity charOffset="254-262" id="s5558.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5558.e0" e2="s5558.e1" id="s5558.p0" relation="false"/>
  </sentence>
  <sentence id="s5559" text="Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 regulation of the force of heart contraction gene variant, and the 71098693 epithelial cell development gene variant were found to be significantly associated with sporadic ASD (P&amp;lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&amp;lt;510^-4).">
    <entity charOffset="166-193" id="s5559.e0" ontology_id="GO_0002064" text="epithelial cell development" type="GO"/>
    <entity charOffset="254-262" id="s5559.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5559.e0" e2="s5559.e1" id="s5559.p0" relation="false"/>
  </sentence>
  <sentence id="s5560" text="CONCLUSIONS This was the first study that demonstrated variants in negative regulation of transcription, DNA-templated and epithelial cell development associated with sporadic ASD, and supported the use of WES and bioinformatics analysis to identify disease-associated mutations">
    <entity charOffset="67-118" id="s5560.e0" ontology_id="GO_0045892" text="negative regulation of transcription, DNA-templated" type="GO"/>
    <entity charOffset="167-175" id="s5560.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5560.e0" e2="s5560.e1" id="s5560.p0" relation="false"/>
  </sentence>
  <sentence id="s5561" text="CONCLUSIONS This was the first study that demonstrated variants in negative regulation of transcription, DNA-templated and epithelial cell development associated with sporadic ASD, and supported the use of WES and bioinformatics analysis to identify disease-associated mutations">
    <entity charOffset="123-150" id="s5561.e0" ontology_id="GO_0002064" text="epithelial cell development" type="GO"/>
    <entity charOffset="167-175" id="s5561.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <pair e1="s5561.e0" e2="s5561.e1" id="s5561.p0" relation="false"/>
  </sentence>
  <sentence id="s5562" text="We suspected PVOD from CT characteristics and pulmonary edema after L-phenylalanine catabolic process-targeted vasodilator therapy, and then started oral imatinib treatment.">
    <entity charOffset="46-61" id="s5562.e0" ontology_id="HP_0100598" text="pulmonary edema" type="HP"/>
    <entity charOffset="68-101" id="s5562.e1" ontology_id="GO_0006559" text="L-phenylalanine catabolic process" type="GO"/>
    <pair e1="s5562.e0" e2="s5562.e1" id="s5562.p0" relation="false"/>
  </sentence>
  <sentence id="s5563" text="Animal models of viral-associated blood-brain barrier (BBB) disruption and experimental cerebral malaria (platelet degranulation) have identified perforin as critical for inducing pathologic central nervous system CNS vascular permeability.">
    <entity charOffset="106-128" id="s5563.e0" ontology_id="GO_0002576" text="platelet degranulation" type="GO"/>
    <entity charOffset="191-198" id="s5563.e1" ontology_id="HP_0030645" text="central" type="HP"/>
    <pair e1="s5563.e0" e2="s5563.e1" id="s5563.p0" relation="false"/>
  </sentence>
  <sentence id="s5564" text="The current study aims to investigate the biological roles and clinical significance of ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway in human gastric cancer.">
    <entity charOffset="88-177" id="s5564.e0" ontology_id="GO_0043162" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="195-201" id="s5564.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5564.e0" e2="s5564.e1" id="s5564.p0" relation="false"/>
  </sentence>
  <sentence id="s5565" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway downregulation was found in 57 of 137 human gastric cancer samples and correlated with advanced regulation of transcription by RNA polymerase III stage, positive positive regulation of cysteine-type endopeptidase activity involved in apoptotic process status, and relapse.">
    <entity charOffset="0-89" id="s5565.e0" ontology_id="GO_0043162" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="142-148" id="s5565.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5565.e0" e2="s5565.e1" id="s5565.p0" relation="false"/>
  </sentence>
  <sentence id="s5566" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway downregulation was found in 57 of 137 human gastric cancer samples and correlated with advanced regulation of transcription by RNA polymerase III stage, positive positive regulation of cysteine-type endopeptidase activity involved in apoptotic process status, and relapse.">
    <entity charOffset="142-148" id="s5566.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="186-235" id="s5566.e1" ontology_id="GO_0006359" text="regulation of transcription by RNA polymerase III" type="GO"/>
    <pair e1="s5566.e0" e2="s5566.e1" id="s5566.p0" relation="false"/>
  </sentence>
  <sentence id="s5567" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway downregulation was found in 57 of 137 human gastric cancer samples and correlated with advanced regulation of transcription by RNA polymerase III stage, positive positive regulation of cysteine-type endopeptidase activity involved in apoptotic process status, and relapse.">
    <entity charOffset="142-148" id="s5567.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="252-341" id="s5567.e1" ontology_id="GO_0043280" text="positive regulation of cysteine-type endopeptidase activity involved in apoptotic process" type="GO"/>
    <pair e1="s5567.e0" e2="s5567.e1" id="s5567.p0" relation="true"/>
  </sentence>
  <sentence id="s5568" text="In conclusion, our results suggest that ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway downregulation might serve as an indicator for poor prognosis in gastric cancer patients.">
    <entity charOffset="40-129" id="s5568.e0" ontology_id="GO_0043162" text="ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway" type="GO"/>
    <entity charOffset="203-209" id="s5568.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="s5568.e0" e2="s5568.e1" id="s5568.p0" relation="false"/>
  </sentence>
  <sentence id="s5569" text="To better understand the molecular changes in the AH content under such conditions, we analyzed the protein polyubiquitinationNA profiles of AH samples from patients with POAG and XFG compared to non-glaucoma controls.">
    <entity charOffset="100-126" id="s5569.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="200-208" id="s5569.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s5569.e0" e2="s5569.e1" id="s5569.p0" relation="false"/>
  </sentence>
  <sentence id="s5570" text="While none of these protein polyubiquitinationNAs have been previously linked to glaucoma, miR-122-5p may target three glaucoma-associated genes: OPTN, TMCO1 and TGF-1.">
    <entity charOffset="20-46" id="s5570.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="81-89" id="s5570.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s5570.e0" e2="s5570.e1" id="s5570.p0" relation="false"/>
  </sentence>
  <sentence id="s5571" text="Pathway analysis revealed that these protein polyubiquitinationNAs are involved in potential glaucoma pathways, including focal adhesion, tight junctions, and TGF- signaling.">
    <entity charOffset="37-63" id="s5571.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="93-101" id="s5571.e1" ontology_id="HP_0000501" text="glaucoma" type="HP"/>
    <pair e1="s5571.e0" e2="s5571.e1" id="s5571.p0" relation="false"/>
  </sentence>
  <sentence id="s5572" text="Trichothiodystrophy (nucleotide-excision repair), also known as sulfur-deficient brittle hair syndrome, is a rare autosomal recessive multisystem disorder, which manifests with brittle hair, mental retardation, ichthyosis and decreased fertility.">
    <entity charOffset="21-47" id="s5572.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="114-133" id="s5572.e1" ontology_id="HP_0000007" text="autosomal recessive" type="HP"/>
    <pair e1="s5572.e0" e2="s5572.e1" id="s5572.p0" relation="true"/>
  </sentence>
  <sentence id="s5573" text="Trichothiodystrophy (nucleotide-excision repair), also known as sulfur-deficient brittle hair syndrome, is a rare autosomal recessive multisystem disorder, which manifests with brittle hair, mental retardation, ichthyosis and decreased fertility.">
    <entity charOffset="21-47" id="s5573.e0" ontology_id="GO_0006289" text="nucleotide-excision repair" type="GO"/>
    <entity charOffset="81-93" id="s5573.e1" ontology_id="HP_0002299" text="brittle hair" type="HP"/>
    <pair e1="s5573.e0" e2="s5573.e1" id="s5573.p0" relation="true"/>
  </sentence>
</document>
